PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Li, WD; Zhou, Y; Tian, XL; Kim, TY; Ito, N; Watanabe, K; Tsuji, A; Niimi, K; Aoyama, Y; Arai, T; Takahashi, E				Li, Weidong; Zhou, Ying; Tian, Xiaoli; Kim, Tae Yeon; Ito, Namiko; Watanabe, Kaori; Tsuji, Akiko; Niimi, Kimie; Aoyama, Yo; Arai, Takashi; Takahashi, Eiki			New Ataxic Tottering-6j Mouse Allele Containing a Cacna1a Gene Mutation	PLOS ONE			English	Article							DEPENDENT CALCIUM-CHANNEL; CORTICAL SPREADING DEPRESSION; GATED CA2+ CHANNELS; NEUROTRANSMITTER RELEASE; MISSENSE MUTATION; ROLLING-NAGOYA; PURKINJE-CELLS; MUTANT MOUSE; MICE; DYSFUNCTION	Voltage-gated Ca2+ (Ca-v) channels control neuronal functions including neurotransmitter release and gene expression. The Cacna1a gene encodes the alpha 1 subunit of the pore-forming Ca(v)2.1 channel. Mice with mutations in this gene form useful tools for defining channel functions. The recessive ataxic tottering-6j strain that was generated in the Neuroscience Mutagenesis Facility at The Jackson Laboratory has a mutation in the Cacna1a gene. However, the effect of this mutation has not been investigated in detail. In this study, mutation analysis shows a base substitution (C-to-A) in the consensus splice acceptor sequence linked to exon 5, which results in the skipping of exon 5 and the splicing of exon 4 directly to exon 6. The effect of this mutation is expected to be severe as the expressed alpha 1 subunit protein lacks a significant part of the S4-S5 linker, S5, and part of S5-S6 linker in domain I. Tottering-6j mice display motor dysfunctions in the footprint, rotating rod, and hind-limb extension tests. Although cytoarchitecture of the mutant brains appears normal, tyrosine hydroxylase was persistently expressed in cerebellar Purkinje cells in the adult mutant mice. These results indicate that tottering-6j is a useful model for functional studies of the Ca(v)2.1 channel.	[Li, Weidong; Zhou, Ying; Takahashi, Eiki] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Tian, Xiaoli] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Kim, Tae Yeon; Ito, Namiko; Watanabe, Kaori; Tsuji, Akiko; Niimi, Kimie; Aoyama, Yo; Arai, Takashi; Takahashi, Eiki] RIKEN Brain Sci Inst, Res Resources Ctr, Saitama, Japan	Shanghai Jiao Tong University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN	Li, WD (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	liwd@sjtu.edu.cn; etakahashi@brain.riken.jp	Niimi, Kimie/S-8264-2019; Takahashi, Eiki/N-6998-2015	Niimi, Kimie/0000-0001-5240-5745; Dubnau, Josh/0000-0002-9285-7444; Hammell, Molly/0000-0003-0405-8392; Li, Weidong/0000-0001-5384-4838	KAKENHI [22500396]; China 973 Program [2010CB529604]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); China 973 Program(National Basic Research Program of China)	This work was supported by Grants-in-Aid for Scientific Research KAKENHI (22500396) to ET and China 973 Program (2010CB529604) to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN MC, 1992, MOL BRAIN RES, V15, P227, DOI 10.1016/0169-328X(92)90113-P; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Day NC, 1997, J NEUROSCI, V17, P6226; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FU XD, 1995, RNA, V1, P663; Jaworski DM, 2006, J NEUROBIOL, V66, P82, DOI 10.1002/neu.20205; Kaja S, 2007, EUR J NEUROSCI, V25, P2009, DOI 10.1111/j.1460-9568.2007.05438.x; Liu L, 2003, J BIOENERG BIOMEMBR, V35, P671, DOI 10.1023/B:JOBB.0000008031.12485.ee; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; Miki T, 2008, NEUROSCIENCE, V155, P31, DOI 10.1016/j.neuroscience.2008.05.028; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Mori Y, 2000, J NEUROSCI, V20, P5654, DOI 10.1523/JNEUROSCI.20-15-05654.2000; MURAMOTO O, 1981, BRAIN RES, V215, P295, DOI 10.1016/0006-8993(81)90508-4; Niimi K, 2009, PHYSIOL BEHAV, V96, P464, DOI 10.1016/j.physbeh.2008.11.012; Oda S, 1973, Jikken Dobutsu, V22, P281; Ogura H, 2001, BEHAV BRAIN RES, V122, P215, DOI 10.1016/S0166-4328(01)00187-5; Pietrobon D, 2005, CURR OPIN NEUROBIOL, V15, P257, DOI 10.1016/j.conb.2005.05.010; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Rhyu IJ, 1999, NEUROSCIENCE, V90, P717, DOI 10.1016/S0306-4522(98)00518-1; Rhyu IJ, 1999, NEUROSCI LETT, V266, P49, DOI 10.1016/S0304-3940(99)00254-2; Takahashi E., 2012, CALCIUM SIGNALING, P149; Takahashi E, 2009, BRAIN RES, V1279, P50, DOI 10.1016/j.brainres.2009.05.016; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Tokuda S, 2007, BRAIN RES, V1133, P168, DOI 10.1016/j.brainres.2006.10.086; Van Damme P, 2003, NEUROSCI LETT, V343, P81, DOI 10.1016/S0304-3940(03)00314-8; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; van den Maagdenberg AMJM, 2010, ANN NEUROL, V67, P85, DOI 10.1002/ana.21815; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Xie G, 2007, GENES BRAIN BEHAV, V6, P717, DOI 10.1111/j.1601-183X.2007.00302.x; Zwingman TA, 2001, J NEUROSCI, V21, P1169	38	85	87	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44230	10.1371/journal.pone.0044230	http://dx.doi.org/10.1371/journal.pone.0044230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952933	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300065
J	Gavins, FNE; Hughes, EL; Buss, NAPS; Holloway, PM; Getting, SJ; Buckingham, JC				Gavins, Felicity N. E.; Hughes, Ellen L.; Buss, Nicholas A. P. S.; Holloway, Paul M.; Getting, Stephen J.; Buckingham, Julia C.			Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system	FASEB JOURNAL			English	Article						endotoxemia; FPR	FORMYL-PEPTIDE RECEPTOR; TUMOR-NECROSIS-FACTOR; BACTERIAL LIPOPOLYSACCHARIDE; SEPTIC SHOCK; LIPOCORTIN 1; EXPRESSION; NEUROINFLAMMATION; INFLAMMATION; ACTIVATION; MD-2	Unregulated inflammation underlies many diseases, including sepsis. Much interest lies in targeting anti-inflammatory mechanisms to develop new treatments. One such target is the anti-inflammatory protein annexin A1 (AnxA1) and its receptor, FPR2/ALX. Using intravital videomicroscopy, we investigated the role of AnxA1 and FPR2/ALX in a murine model of endotoxin-induced cerebral inflammation [intraperitoneal injection of lipopolysaccharide (LPS)]. An inflammatory response was confirmed by elevations in proinflammatory serum cytokines, increased cerebrovascular permeability, elevation in brain myeloperoxidase, and increased leukocyte rolling and adhesion in cerebral venules of wild-type (WT) mice, which were further exacerbated in AnxA1-null mice. mRNA expression of TLR2, TLR4, MyD-88, and Ly96 was also assessed. The AnxA1-mimetic peptide, AnxA1(Ac2-26) (100 mu g/mouse, similar to 33 mu mol) mitigated LPS-induced leukocyte adhesion in WT and AnxA1-null animals without affecting leukocyte rolling, in comparison to saline control. AnxA1(Ac2-26) effects were attenuated by Boc2 (pan-FPR antagonist, 10 mu g/mouse, similar to 12 nmol), and by minocycline (2.25 mg/mouse, similar to 6.3 nmol). The nonselective Fpr agonists, fMLP (6 mu g/mouse, similar to 17 nmol) and AnxA1(Ac2-26), and the Fpr2-selective agonist ATLa (5 mu g/mouse, similar to 11 nmol) were without effect in Fpr2/3(-/-) mice. In summary, our novel results demonstrate that the AnxA1/FPR2 system has an important role in effecting the resolution of cerebral inflammation in sepsis and may, therefore, provide a novel therapeutic target.-Gavins, F. N. E., Hughes, E. L., Buss, N. A. P. S., Holloway, P. M., Getting, S. J., Buckingham, J. C. Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system. FASEB J. 26, 4977-4989 (2012). www.fasebj.org	[Gavins, Felicity N. E.; Hughes, Ellen L.; Holloway, Paul M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, London W12 0NN, England; [Buss, Nicholas A. P. S.; Buckingham, Julia C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Diabet, London W12 0NN, England; [Getting, Stephen J.] Univ Westminster, London W1R 8AL, England	Imperial College London; Imperial College London; University of Westminster	Gavins, FNE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, Hammersmith Hosp Campus,Burlington Danes Bldg,Du, London W12 0NN, England.	f.gavins@imperial.ac.uk	Gavins, Felicity N. E./AAU-6010-2020	Gavins, Felicity N. E./0000-0001-7008-5423; Holloway, Paul/0000-0002-1947-4885; Buss, Nicholas/0000-0002-8226-4311	UK Biotechnology and Biological Sciences Research Council (BBSRC) Integrative Mammalian Biology (IMB) fund; IMB grant; BBSRC; GlaxoSmithKline (Stevenage, UK); BBSRC [BB/E52708X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish; British Heart Foundation [FS/09/020/27184] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC) Integrative Mammalian Biology (IMB) fund(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); IMB grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline (Stevenage, UK)(GlaxoSmithKline); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by a grant to J.C.B. from the UK Biotechnology and Biological Sciences Research Council (BBSRC) Integrative Mammalian Biology (IMB) fund. F.N.E.G. is funded by the IMB grant. E. L. H. is funded by a BBSRC doctoral training award, and N.A.P.S.B. is funded by GlaxoSmithKline (Stevenage, UK). The authors also thank Dr. Pascal F. Durrenberger for his invaluable help and expertise, and Prof. Richard Reynolds for the use of his imaging facility. The authors declare no conflicts of interest.	Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Akrout N, 2009, CURR NEUROPHARMACOL, V7, P296, DOI 10.2174/157015909790031175; Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bamberger ME, 2001, MICROSC RES TECHNIQ, V54, P59, DOI 10.1002/jemt.1121; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; Bylund J, 2002, INFECT IMMUN, V70, P2908, DOI 10.1128/IAI.70.6.2908-2914.2002; Cai B., 2010, MEDIAT INFLAMM, V10, P642; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; CIRINO G, 1993, BRIT J PHARMACOL, V108, P573, DOI 10.1111/j.1476-5381.1993.tb12843.x; COMERA C, 1995, BRIT J PHARMACOL, V115, P1043, DOI 10.1111/j.1476-5381.1995.tb15916.x; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; Cuzzocrea S, 1997, J IMMUNOL, V159, P5089; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Dunn AJ, 2006, CLIN NEUROSCI RES, V6, P52, DOI 10.1016/j.cnr.2006.04.002; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gavins FNE, 2010, TRENDS PHARMACOL SCI, V31, P266, DOI 10.1016/j.tips.2010.04.001; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jacob A, 2007, LAB INVEST, V87, P1186, DOI 10.1038/labinvest.3700686; Le YY, 2000, J NEUROIMMUNOL, V111, P102, DOI 10.1016/S0165-5728(00)00373-8; Le YY, 2004, J IMMUNOL, V173, P962, DOI 10.4049/jimmunol.173.2.962; Lefkowitz DL, 2008, FREE RADICAL BIO MED, V45, P726, DOI 10.1016/j.freeradbiomed.2008.05.021; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lim LHK, 1998, P NATL ACAD SCI USA, V95, P14535, DOI 10.1073/pnas.95.24.14535; Liu N, 2004, J NEUROSCI RES, V77, P391, DOI 10.1002/jnr.20167; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Merson TD, 2010, NEUROMOL MED, V12, P99, DOI 10.1007/s12017-010-8112-z; MINGHETTI L, 1995, J NEUROCHEM, V65, P2690; Minghetti L, 1997, GLIA, V19, P152, DOI 10.1002/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; PERRETTI M, 1993, J IMMUNOL, V151, P4306; PERRETTI M, 1993, J IMMUNOL, V150, P992; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Peter C, 2010, SHOCK, V33, P405, DOI 10.1097/SHK.0b013e3181b77e82; Pytel P, 2009, CURR OPIN NEUROL, V22, P283, DOI 10.1097/WCO.0b013e32832b3101; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Sam Albert D. Ii, 1997, Frontiers in Bioscience, V2, pE72; Sandanger O, 2009, J IMMUNOL, V182, P588, DOI 10.4049/jimmunol.182.1.588; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tsuge M, 2010, MICROBIOL IMMUNOL, V54, P417, DOI 10.1111/j.1348-0421.2010.00226.x; Turrin NP, 2006, MOL NEUROBIOL, V34, P221, DOI 10.1385/MN:34:3:221; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823; Yona S, 2004, BRIT J PHARMACOL, V142, P890, DOI 10.1038/sj.bjp.0705858	59	57	66	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4977	4989		10.1096/fj.12-205971	http://dx.doi.org/10.1096/fj.12-205971			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22964301				2022-12-25	WOS:000311838300020
J	Nadeau, OW; Lane, LA; Xu, D; Sage, J; Priddy, TS; Artigues, A; Villar, MT; Yang, Q; Robinson, CV; Zhang, Y; Carlson, GM				Nadeau, Owen W.; Lane, Laura A.; Xu, Dong; Sage, Jessica; Priddy, Timothy S.; Artigues, Antonio; Villar, Maria T.; Yang, Qing; Robinson, Carol V.; Zhang, Yang; Carlson, Gerald M.			Structure and Location of the Regulatory beta Subunits in the (alpha beta gamma delta)(4) Phosphorylase Kinase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; ALPHA-SUBUNIT; CATALYTIC SUBUNIT; GAMMA-SUBUNIT; MACROMOLECULAR ASSEMBLIES; 3-DIMENSIONAL STRUCTURE; STRUCTURE PREDICTION; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; CROSS-LINKING	Phosphorylase kinase (PhK) is a hexadecameric (alpha beta gamma delta)(4) complex that regulates glycogenolysis in skeletal muscle. Activity of the catalytic gamma subunit is regulated by allosteric activators targeting the regulatory alpha, beta, and delta subunits. Three-dimensional EM reconstructions of PhK show it to be two large (alpha beta gamma delta)(2) lobes joined with D-2 symmetry through interconnecting bridges. The subunit composition of these bridges was unknown, although indirect evidence suggested the beta subunits may be involved in their formation. We have used biochemical, biophysical, and computational approaches to not only address the quaternary structure of the beta subunits within the PhK complex, i.e. whether they compose the bridges, but also their secondary and tertiary structures. The secondary structure of beta was determined to be predominantly helical by comparing the CD spectrum of an alpha gamma delta subcomplex with that of the native (alpha beta gamma delta)(4) complex. An atomic model displaying tertiary structure for the entire beta subunit was constructed using chemical cross-linking, MS, threading, and ab initio approaches. Nearly all this model is covered by two templates corresponding to glycosyl hydrolase 15 family members and theAsubunit of protein phosphatase 2A. Regarding the quaternary structure of the beta subunits, they were directly determined to compose the four interconnecting bridges in the (alpha beta gamma delta)(4) kinase core, because a beta(4) subcomplex was observed through both chemical cross-linking and top-down MS of PhK. The predicted model of the beta subunit was docked within the bridges of a cryoelectron microscopic density envelope of PhK utilizing known surface features of the subunit.	[Nadeau, Owen W.; Sage, Jessica; Priddy, Timothy S.; Artigues, Antonio; Villar, Maria T.; Yang, Qing; Carlson, Gerald M.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Lane, Laura A.; Robinson, Carol V.] Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, Oxford OX1 3QZ, England; [Xu, Dong; Zhang, Yang] Univ Michigan, Sch Med, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Kansas; University of Kansas Medical Center; University of Oxford; University of Michigan System; University of Michigan	Carlson, GM (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	gcarlson@kumc.edu	xu, dong/I-7737-2013	xu, dong/0000-0002-6616-1427; robinson, carol/0000-0001-7829-5505	National Institutes of Health [R01 DK32953]; NIGMS [GM083107, GM084222]; National Science Foundation Grant [DBI 1027394]; University of Michigan-Shanghai Jiao Tong University Joint Institute Foundation; Royal Society and the Engineering and Physical Sciences Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084222, R01GM083107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Grant(National Science Foundation (NSF)); University of Michigan-Shanghai Jiao Tong University Joint Institute Foundation; Royal Society and the Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK32953 (to G. M. C.) and Grants GM083107 and GM084222 from NIGMS (to Y. Z.). This work was also supported by National Science Foundation Grant DBI 1027394 and the University of Michigan-Shanghai Jiao Tong University Joint Institute Foundation (to Y. Z.) and the Royal Society and the Engineering and Physical Sciences Research Council (to C. V. M.). Downloaded from www.jbc.org at ISI, Thomson Scientific, on November 3, 2012	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Boulatnikov IG, 2009, BIOCHEMISTRY-US, V48, P10183, DOI 10.1021/bi901429y; Brill TB, 1999, J PHYS ORG CHEM, V12, P819, DOI 10.1002/(SICI)1099-1395(199911)12:11<819::AID-POC192>3.0.CO;2-R; Brushia Robert J., 1999, Frontiers in Bioscience, V4, pd618, DOI 10.2741/Brushia; Carriere C, 2008, PROTEINS, V71, P1597, DOI 10.1002/prot.22006; Carriere C, 2008, BBA-MOL BASIS DIS, V1782, P664, DOI 10.1016/j.bbadis.2008.09.011; Chalkley RJ, 2005, METHOD ENZYMOL, V402, P289, DOI 10.1016/S0076-6879(05)02009-4; CHAN KFJ, 1982, J BIOL CHEM, V257, P5939; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; CHENG A, 1985, J BIOL CHEM, V260, P2535; COHEN P, 1975, EUR J BIOCHEM, V51, P79, DOI 10.1111/j.1432-1033.1975.tb03909.x; COHEN P, 1973, EUR J BIOCHEM, V34, P1, DOI 10.1111/j.1432-1033.1973.tb02721.x; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; FITZGERALD TJ, 1984, J BIOL CHEM, V259, P3266; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Jeyasingham MD, 2008, J MOL BIOL, V377, P623, DOI 10.1016/j.jmb.2007.12.072; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KEE SM, 1986, J BIOL CHEM, V261, P4732; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; KING MM, 1983, J BIOL CHEM, V258, P9925; KING MM, 1981, J BIOL CHEM, V256, P1058; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; KREBS EG, 1964, BIOCHEMISTRY-US, V3, P1022, DOI 10.1021/bi00896a003; Lane L. A., 2012, MOL CELL PR IN PRESS; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Mizuno M, 2004, J BIOL CHEM, V279, P10575, DOI 10.1074/jbc.M310771200; Nadeau O. W., 2005, PROTEIN PROTEIN INTE, P105; Nadeau OW, 2005, PROTEIN SCI, V14, P914, DOI 10.1110/ps.041123905; Nadeau OW, 2002, STRUCTURE, V10, P23, DOI 10.1016/S0969-2126(01)00678-5; Nadeau OW, 1999, BIOCHEMISTRY-US, V38, P2551, DOI 10.1021/bi982060b; NADEAU OW, 1994, J BIOL CHEM, V269, P29670; Nadeau OW, 2008, MOL CELL PROTEOMICS, V7, P739, DOI 10.1074/mcp.M800020-MCP200; Nadeau OW, 2007, J MOL BIOL, V365, P1429, DOI 10.1016/j.jmb.2006.10.061; Nadeau OW, 2010, BIOCHEMISTRY-US, V49, P6505, DOI 10.1021/bi101006j; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; NEWSHOLME P, 1992, J BIOL CHEM, V267, P810; NORCUM MT, 1994, J MOL BIOL, V241, P94, DOI 10.1006/jmbi.1994.1476; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Pallen MJ, 2003, PROTEIN SCI, V12, P1804, DOI 10.1110/ps.0371103; PAUDEL HK, 1987, J BIOL CHEM, V262, P11912; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Priddy TS, 2007, PROTEIN SCI, V16, P517, DOI 10.1110/ps.062577507; Priddy TS, 2005, PROTEIN SCI, V14, P1039, DOI 10.1110/ps.041124705; Rice NA, 2002, J BIOL CHEM, V277, P14681, DOI 10.1074/jbc.M201229200; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sigman ME, 2005, RAPID COMMUN MASS SP, V19, P3731, DOI 10.1002/rcm.2247; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; SVENSSON B, 1992, CARBOHYD RES, V227, P29, DOI 10.1016/0008-6215(92)85059-9; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; TEO TS, 1973, J BIOL CHEM, V248, P588; Traxler KW, 2001, J STRUCT BIOL, V135, P231, DOI 10.1006/jsbi.2001.4411; TREMPE MR, 1987, J BIOL CHEM, V262, P4333; TREMPE MR, 1986, J BIOL CHEM, V261, P2882; Venien-Bryan C, 2002, STRUCTURE, V10, P33, DOI 10.1016/S0969-2126(01)00691-8; Venien-Bryan C, 2009, STRUCTURE, V17, P117, DOI 10.1016/j.str.2008.10.013; Wilkinson DA, 1997, J MOL BIOL, V265, P319, DOI 10.1006/jmbi.1996.0739; WILKINSON DA, 1994, J MOL BIOL, V235, P974, DOI 10.1006/jmbi.1994.1051; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	72	14	14	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36651	36661		10.1074/jbc.M112.412874	http://dx.doi.org/10.1074/jbc.M112.412874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22969083	hybrid, Green Published			2022-12-25	WOS:000310588500003
J	Song, MJ; Brady-Kalnay, SM; McBride, SH; Phillips-Mason, P; Dean, D; Tate, MLK				Song, Min Jae; Brady-Kalnay, Susann M.; McBride, Sara H.; Phillips-Mason, Polly; Dean, David; Tate, Melissa L. Knothe			Mapping the Mechanome of Live Stem Cells Using a Novel Method to Measure Local Strain Fields In Situ at the Fluid-Cell Interface	PLOS ONE			English	Article							MARROW STROMAL CELLS; LAMINAR SHEAR-STRESS; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; HYDROSTATIC-PRESSURE; OSTEOBLASTIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CHONDROGENIC PHENOTYPE; MECHANICAL MODULATION; LINEAGE COMMITMENT	During mesenchymal condensation, the initial step of skeletogenesis, transduction of minute mechanical forces to the nucleus is associated with up or down-regulation of genes, ultimately resulting in formation of the skeletal template and appropriate cell lineage commitment. The summation of these biophysical cues affects the cell's shape and fate. Here, we predict and measure surface strain, in live stem cells, in response to controlled delivery of stresses, providing a platform to direct short-term structure - function relationships and long-term fate decisions. We measure local strains on stem cell surfaces using fluorescent microbeads coated with Concanavalin A. During delivery of controlled mechanical stresses, 4-Dimensional (x,y,z,t) displacements of the bound beads are measured as surface strains using confocal microscopy and image reconstruction. Similarly, micro-particle image velocimetry (mu-piv) is used to track flow fields with fluorescent microspheres. The measured flow velocity gradient is used to calculate stress imparted by fluid drag at the surface of the cell. We compare strain measured on cell surfaces with those predicted computationally using parametric estimates of the cell's elastic and shear modulus. Finally, cross-correlating stress - strain data to measures of gene transcription marking lineage commitment enables us to create stress - strain - fate maps, for live stem cells in situ. The studies show significant correlations between live stem cell stress - strain relationships and lineage commitment. The method presented here provides a novel means to probe the live stem cell's mechanome, enabling mechanistic studies of the role of mechanics in lineage commitment as it unfolds.	[Song, Min Jae; McBride, Sara H.; Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Brady-Kalnay, Susann M.; Phillips-Mason, Polly] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Dean, David] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Song, MJ (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	knothetate@case.edu	Knothe Tate, Melissa L./O-2086-2015; Dean, David/F-9605-2017	Knothe Tate, Melissa L./0000-0002-3552-2525; Dean, David/0000-0002-1217-3764	National Institutes of Health grant (NIDCR) [R01-DE013740]; National Science Foundation grant [CMMI-0826435]; Alexander von Humboldt Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013740] Funding Source: NIH RePORTER	National Institutes of Health grant (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Science Foundation grant(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by a National Institutes of Health grant (NIDCR, R01-DE013740), a National Science Foundation grant (CMMI-0826435, Nano Bio Mechanics Program), and the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan T, 2010, TISSUE ENG PT A, V16, P3547, DOI [10.1089/ten.tea.2010.0014, 10.1089/ten.TEA.2010.0014]; Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Anderson EJ, 2005, ANN BIOMED ENG, V33, P52, DOI 10.1007/s10439-005-8962-y; Anderson EJ, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-46; Anderson EJ, 2007, TISSUE ENG, V13, P2525, DOI 10.1089/ten.2006.0443; Anderson EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-27; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Arnsdorf EJ, 2010, J BIOMECH, V43, P2881, DOI 10.1016/j.jbiomech.2010.07.033; Bai K, 2010, J BIOMECH, V43, P1176, DOI 10.1016/j.jbiomech.2009.11.030; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Billotte W G, 2001, Biomed Sci Instrum, V37, P1; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Campbell JJ, 2006, BIORHEOLOGY, V43, P455; Chowdhury F, 2008, BIOPHYS J, V95, P5719, DOI 10.1529/biophysj.108.139832; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elder SH, 2005, BIOMECH MODEL MECHAN, V3, P141, DOI 10.1007/s10237-004-0058-3; Ensley AE, 2012, TISSUE ENG PT A, V18, P127, DOI [10.1089/ten.tea.2010.0290, 10.1089/ten.TEA.2010.0290]; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gardiner M. B., 2005, HHMI B, V18, P32; Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002; Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63; Kasirer-Friede A, 2010, BLOOD, V115, P2274, DOI 10.1182/blood-2009-08-238238; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Kraemer BF, 2011, PLATELETS, V22, P415, DOI 10.3109/09537104.2011.556277; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Kuhn LT, 2010, TISSUE ENG PART C-ME, V16, P1357, DOI [10.1089/ten.tec.2009.0701, 10.1089/ten.TEC.2009.0701]; Malek AM, 1996, J CELL SCI, V109, P713; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112; McBride SH, 2008, TISSUE ENG PT A, V14, P1573, DOI 10.1089/ten.tea.2008.0113; McBride SH, 2011, ANN BIOMED ENG, V39, P1570, DOI 10.1007/s10439-010-0242-9; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419; Nikmanesh M, 2012, BIOTECHNOL BIOENG, V109, P583, DOI 10.1002/bit.23302; Potter CMF, 2011, ARTERIOSCL THROM VAS, V31, P384, DOI 10.1161/ATVBAHA.110.214031; Roelofsen J, 1995, J BIOMECH, V28, P1493, DOI 10.1016/0021-9290(95)00097-6; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001891; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Smith RL, 2000, BIORHEOLOGY, V37, P95; Song MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012796; Stolberg S, 2009, BIOTECHNOL PROGR, V25, P10, DOI 10.1002/btpr.124; Takahashi I, 1998, J CELL SCI, V111, P2067; Takai E, 2005, ANN BIOMED ENG, V33, P963, DOI 10.1007/s10439-005-3555-3; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Tate MLK, 2010, J ORTHOP RES, V28, P1657, DOI 10.1002/jor.21190; Trickey WR, 2006, J BIOMECH, V39, P78, DOI 10.1016/j.jbiomech.2004.11.006; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09; Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5; Wang H, 2006, BIOCHEM BIOPH RES CO, V346, P860, DOI 10.1016/j.bbrc.2006.05.196; Wu CC, 2008, J BIOMECH, V41, P813, DOI 10.1016/j.jbiomech.2007.11.008; Ye C, 2008, CLIN BIOMECH, V23, pS118, DOI 10.1016/j.clinbiomech.2007.08.018; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60; Zeng Y, 2011, CELL MOL BIOL, V57, P1550, DOI 10.1170/179; Zhang P, 2011, STEM CELLS DEV, V20, P977, DOI 10.1089/scd.2010.0152; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276; Zimmermann Joshua A., 2011, Molecular & Cellular Biomechanics, V8, P297; Zimmermann Joshua A., 2011, Molecular & Cellular Biomechanics, V8, P275	62	31	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43601	10.1371/journal.pone.0043601	http://dx.doi.org/10.1371/journal.pone.0043601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970134	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400006
J	Tare, P; China, A; Nagaraja, V				Tare, Priyanka; China, Arnab; Nagaraja, Valakunja			Distinct and Contrasting Transcription Initiation Patterns at Mycobacterium tuberculosis Promoters	PLOS ONE			English	Article							RIBOSOMAL-RNA SYNTHESIS; ESCHERICHIA-COLI K-12; GENE-REGULATION; POLYMERASE; DNA; PATHWAY; COMPLEX; OPERON; RESISTANCE; MECHANISM	Although sequencing of Mycobacterium tuberculosis genome lead to better understanding of transcription units and gene functions, interactions occurring during transcription initiation between RNA polymerase and promoters is yet to be elucidated. Different stages of transcription initiation include promoter specific binding of RNAP, isomerization, abortive initiation and promoter clearance. We have now analyzed these events with four promoters of M. tuberculosis viz. P-gyrB1, P-gyrR, P-rrnPCL1 and P-metU. The promoters differed from each other in their rates of open complex formation, decay, promoter clearance and abortive transcription. The equilibrium binding and kinetic studies of various steps revealed distinct rate limiting events for each of the promoter, which also differed markedly in their characteristics from the respective promoters of Mycobacterium smegmatis. Surprisingly, the transcription at gyr promoter was enhanced in the presence of initiating nucleotides and decreased in the presence of alarmone, pppGpp, a pattern typically seen with rRNA promoters studied so far. The gyr promoter of M. smegmatis, on the other hand, was not subjected to pppGpp mediated regulation. The marked differences in the transcription initiation pathway seen with rrn and gyr promoters of M. smegmatis and M. tuberculosis suggest that such species specific differences in the regulation of expression of the crucial housekeeping genes could be one of the key determinants contributing to the differences in growth rate and lifestyle of the two organisms. Moreover, the distinct rate limiting steps during transcription initiation of each one of the promoters studied point at variations in their intracellular regulation.	[Tare, Priyanka; China, Arnab; Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Tare, P (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in		China, Arnab/0000-0003-2832-2338	University Grant Commission; Council of Scientific and Industrial Research, Government of India; Centre of Excellence in tuberculosis research from Department of Biotechnology, Government of India	University Grant Commission(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Centre of Excellence in tuberculosis research from Department of Biotechnology, Government of India	PT and AC are recipients of Senior Research Fellowships from University Grant Commission and Council of Scientific and Industrial Research, Government of India, respectively. VN is a J.C. Bose Fellow of Department of Science and Technology, Government of India and is recipient of Centre of Excellence in tuberculosis research grant from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Chakraborty A, 2006, J BIOL CHEM, V281, P8511, DOI 10.1074/jbc.M512906200; China A, 2010, MICROBIOL-SGM, V156, P1942, DOI 10.1099/mic.0.038620-0; China A, 2010, PROTEIN EXPRES PURIF, V69, P235, DOI 10.1016/j.pep.2009.09.022; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; ELLINGER T, 1994, J MOL BIOL, V239, P455, DOI 10.1006/jmbi.1994.1388; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gomez M, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P111; GonzalezyMerchand JA, 1997, J BACTERIOL, V179, P6949, DOI 10.1128/jb.179.22.6949-6958.1997; Helmann JD, 2009, METHODS, V47, P1, DOI 10.1016/j.ymeth.2008.12.001; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Jain S, 1997, GENE, V190, P37, DOI 10.1016/S0378-1119(96)00746-9; Jain V, 2006, PROTEIN SCI, V15, P1449, DOI 10.1110/ps.062117006; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Johnson R, 2006, CURR ISSUES MOL BIOL, V8, P97; KENRI T, 1994, GENE, V138, P261, DOI 10.1016/0378-1119(94)90821-4; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; MENZEL R, 1987, J BACTERIOL, V169, P1272, DOI 10.1128/jb.169.3.1272-1278.1987; MILLER JH, 1992, SHORT COURSE BACTERI, P71; Mukherjee R, 2008, BIOCHEM BIOPH RES CO, V369, P899, DOI 10.1016/j.bbrc.2008.02.118; NAGASE T, 1988, GENE, V67, P49; OHLSEN KL, 1992, J BIOL CHEM, V267, P19813; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Schroeder LA, 2005, J BIOL CHEM, V280, P17422, DOI 10.1074/jbc.M501281200; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Smith I, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P219; Stadthagen-Gomez G, 2008, FEMS MICROBIOL LETT, V280, P102, DOI 10.1111/j.1574-6968.2007.01050.x; Tsujikawa L, 2002, P NATL ACAD SCI USA, V99, P3493, DOI 10.1073/pnas.062487299; Unniraman S, 1999, GENES CELLS, V4, P697, DOI 10.1046/j.1365-2443.1999.00296.x; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; Unniraman S, 2001, J BIOL CHEM, V276, P41850, DOI 10.1074/jbc.M106252200; Vasanthakrishna M, 1997, MICROBIOL-SGM, V143, P3591, DOI 10.1099/00221287-143-11-3591; Verma A, 1999, J BACTERIOL, V181, P4326, DOI 10.1128/JB.181.14.4326-4333.1999	41	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43900	10.1371/journal.pone.0043900	http://dx.doi.org/10.1371/journal.pone.0043900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970148	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000308462000008
J	Zhang, T; Zhu, QL; Zhang, XL; Ding, YF; Steinhoff, M; Black, S; Zhao, GM				Zhang, Tao; Zhu, Qiuli; Zhang, Xuelan; Ding, Yunfang; Steinhoff, Mark; Black, Steven; Zhao, Genming			The Clinical Characteristics and Direct Medical Cost of Influenza in Hospitalized Children: A Five-Year Retrospective Study in Suzhou, China	PLOS ONE			English	Article							IMMUNIZATION PRACTICES ACIP; PANDEMIC INFLUENZA; HONG-KONG; VACCINES RECOMMENDATIONS; ADVISORY-COMMITTEE; SEASONAL INFLUENZA; INFECTION-RATES; VIRUS-INFECTION; YOUNG-CHILDREN; A H1N1	Background: There have been few studies on children hospitalized with influenza published from mainland China. We performed a retrospective review of medical charts to describe the epidemiology, clinical features and direct medical cost of laboratory-proven influenza hospitalized children in Suzhou, China. Methods: Retrospective study on children with documented influenza infection hospitalized at Suzhou Children Hospital during 2005-2009 was conducted using a structured chart review instrument. Results: A total of 480 children were positive by immuno-fluorescent assay for influenza during 2005-2009. The hospitalizations for influenza occurred in 8-12 months of the year, most commonly in the winter with a second late summer peak (August-September). Influenza A accounted for 86.3%, and of these 286 (59.6%) were male, and 87.2% were <5 years of age. The median length of hospital stay was 7 days. Fever was the most common symptom, occurring in 398 (82.9%) children. There were 394 (82.1%) children with pneumonia and 70.2% of these hospitalized children had radiographic evidence of a pulmonary infiltrate. One hundred and twelve children (23.3%) required oxygen treatments and 13 (2.7%) were transferred to the ICU. Multivariable logistic regression showed that compared with the <= 6 months children, those aged >60 months old had shorter hospital stay (OR = 0.45); children with oxygen treatment tended to have longer hospital stays than those without oxygen treatment (OR = 2.14). The mean cost of each influenza-related hospitalization was US$ 624 (US$ 1323 for children referred to ICU and US$ 617 for those cared for on the wards). High risk children had higher total cost than low-risk patients. Conclusion: Compared to other countries, in Suzhou, children hospitalized with influenza have longer hospital stay and higher percentage of pneumonia. The direct medical cost is high relative to family income. Effective strategies of influenza immunization of young children in China may be beneficial in addressing this disease burden.	[Zhang, Tao; Zhu, Qiuli; Zhao, Genming] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Dept Epidemiol,Minist Educ, Shanghai 200433, Peoples R China; [Zhang, Xuelan; Ding, Yunfang] Suzhou Univ, Suzhou Childrens Hosp, Suzhou 215006, Peoples R China; [Steinhoff, Mark; Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA	Fudan University; Soochow University - China; Cincinnati Children's Hospital Medical Center	Zhang, T (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Dept Epidemiol,Minist Educ, Shanghai 200433, Peoples R China.	gmzhao@shmu.edu.cn			SINO-US; US CDC Influenza Branch; Shanghai Leading Academic Discipline Project [B118, 08-GWZX0201]	SINO-US; US CDC Influenza Branch; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research was partly funded by SINO-US collaborative Program on Emerging and Re-emerging Infectious Diseases, a grant from the US CDC Influenza Branch and Shanghai Leading Academic Discipline Project Number: B118 and Project Number: 08-GWZX0201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Bender JM, 2010, PEDIATR INFECT DIS J, V29, P6, DOI 10.1097/INF.0b013e3181b4b950; Burton C, 2008, Can Commun Dis Rep, V34, P17; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chiu SS, 2012, VACCINE, V30, P1895, DOI 10.1016/j.vaccine.2011.12.027; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Fang LQ, 2012, AM J EPIDEMIOL, V175, P890, DOI 10.1093/aje/kwr411; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Fitzner KA, 2001, HEALTH POLICY, V56, P215, DOI 10.1016/S0168-8510(00)00140-8; Fraaij PLA, 2011, VACCINE, V29, P7524, DOI 10.1016/j.vaccine.2011.08.010; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Hall JL, 2005, J PEDIATR-US, V147, P807, DOI 10.1016/j.jpeds.2005.06.031; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Hsieh YH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-106; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Ji W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-82; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Kwong KL, 2009, J PAEDIATR CHILD H, V45, P660, DOI 10.1111/j.1440-1754.2009.01591.x; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Moore DL, 2006, PEDIATRICS, V118, pE610, DOI 10.1542/peds.2005-2744; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Rothberg MB, 2010, CRIT CARE MED, V38, pE91, DOI 10.1097/CCM.0b013e3181c92eeb; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Small PA, 2010, JAMA-J AM MED ASSOC, V303, P2355, DOI 10.1001/jama.2010.779; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Streng A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-233; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tang LF, 2008, INDIAN PEDIATR, V45, P971; Ya XR, 2011, J HLTH LAB TECH, V121, p[178, 182]	36	13	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44391	10.1371/journal.pone.0044391	http://dx.doi.org/10.1371/journal.pone.0044391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957069	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800062
J	Joseph, TL; Lane, DP; Verma, CS				Joseph, Thomas L.; Lane, David P.; Verma, Chandra S.			Stapled BH3 Peptides against MCL-1: Mechanism and Design Using Atomistic Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-PROTEIN INTERACTIONS; FREE-ENERGY CALCULATIONS; AMBER FORCE-FIELD; NUCLEIC-ACIDS; P53 PEPTIDE; CELL-DEATH; BCL-XL; APOPTOSIS; BINDING	Atomistic simulations of a set of stapled alpha helical peptides derived from the BH3 helix of MCL-1 (Stewart et al. (2010) Nat Chem Biol 6: 595-601) complexed to a fragment (residues 172-320) of MCL-1 revealed that the highest affinity is achieved when the staples engage the surface of MCL-1 as has also been demonstrated for p53-MDM2 (Joseph et al. (2010) Cell Cycle 9: 4560-4568; Baek et al. (2012) J Am Chem Soc 134: 103-106). Affinity is also modulated by the ability of the staples to pre-organize the peptides as helices. Molecular dynamics simulations of these stapled BH3 peptides were carried out followed by determination of the energies of interactions using MM/GBSA methods. These show that the location of the staple is a key determinant of a good binding stapled peptide from a bad binder. The good binder derives binding affinity from interactions between the hydrophobic staple and a hydrophobic patch on MCL-1. The position of the staple was varied, guiding the design of new stapled peptides with higher affinities.	[Joseph, Thomas L.; Verma, Chandra S.] ASTAR, Bioinformat Inst, Singapore, Singapore; [Lane, David P.] ASTAR, Lab P53, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Joseph, TL (corresponding author), ASTAR, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu.sg		Lane, David/0000-0003-0551-3545	Agency for Science, Technology & Research (A*Star) of Singapore	Agency for Science, Technology & Research (A*Star) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology & Research (A*Star) of Singapore (http://www.a-star.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman N, 2011, BIOCHEM SOC T, V39, P1327, DOI 10.1042/BST0391327; Arumugam M, 2009, CELL CYCLE, V8, P2828; Azmi AS, 2011, EXPERT OPIN EMERG DR, V16, P59, DOI 10.1517/14728214.2010.515210; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bernardo PH, 2010, J MED CHEM, V53, P2314, DOI 10.1021/jm901469p; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Case D, 2006, AMBER 9; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czerski L, 2004, J MOL CELL CARDIOL, V37, P643, DOI 10.1016/j.yjmcc.2004.04.016; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Dastidar SG, 2012, CELL CYCLE, V11, P2239, DOI 10.4161/cc.20333; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Faver JC, 2011, J CHEM THEORY COMPUT, V7, P790, DOI 10.1021/ct100563b; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Hayes JM, 2011, J R SOC INTERFACE IN, P171, DOI [10.5772/37107, DOI 10.5772/37107]; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x; Jiang W, 2010, J CHEM THEORY COMPUT, V6, P2559, DOI 10.1021/ct1001768; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph TL, 2010, CELL CYCLE, V9, P4560, DOI 10.4161/cc.9.22.13816; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kim YW, 2009, BIOORG MED CHEM LETT, V19, P2533, DOI 10.1016/j.bmcl.2009.03.022; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lee EF, 2011, CHEMBIOCHEM, V12, P2025, DOI 10.1002/cbic.201100314; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mendes J, 1999, PROTEINS, V37, P530; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Ng YW, 2010, STRUCTURE, V18, P879, DOI 10.1016/j.str.2010.04.011; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; Singh N, 2010, PROTEINS, V78, P1705, DOI 10.1002/prot.22687; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Sviridov DO, 2011, BIOCHEM BIOPH RES CO, V410, P446, DOI 10.1016/j.bbrc.2011.05.154; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Valkov E, 2012, TOP CURR CHEM, V317, P145, DOI 10.1007/128_2011_265; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2012, J CLIN ONCOL, V30, P554, DOI 10.1200/JCO.2011.37.9339; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wilk S, 2005, SCI STKE, V285, ptr16; Wolfson W, 2009, CHEM BIOL, V16, P910, DOI 10.1016/j.chembiol.2009.09.008; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	76	37	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43985	10.1371/journal.pone.0043985	http://dx.doi.org/10.1371/journal.pone.0043985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952838	Green Submitted, gold, Green Published			2022-12-25	WOS:000308221300039
J	Distefano, G; Caruso, M; La Malfa, S; Gentile, A; Wu, SB				Distefano, Gaetano; Caruso, Marco; La Malfa, Stefano; Gentile, Alessandra; Wu, Shu-Biao			High Resolution Melting Analysis Is a More Sensitive and Effective Alternative to Gel-Based Platforms in Analysis of SSR - An Example in Citrus	PLOS ONE			English	Article							GENETIC DIVERSITY; CURVE-ANALYSIS; MARKERS; IDENTIFICATION; ORIGIN; TRANSFERABILITY; POLYMORPHISM; PHYLOGENY; SEQUENCES; HOMOPLASY	High resolution melting curve analysis (HRM) has been used as an efficient, accurate and cost-effective tool to detect single nucleotide polymorphisms (SNPs) or insertions or deletions (INDELs). However, its efficiency, accuracy and applicability to discriminate microsatellite polymorphism have not been extensively assessed. The traditional protocols used for SSR genotyping include PCR amplification of the DNA fragment and the separation of the fragments on electrophoresis-based platform. However, post-PCR handling processes are laborious and costly. Furthermore, SNPs present in the sequences flanking repeat motif cannot be detected by polyacrylamide-gel-electrophoresis based methods. In the present study, we compared the discriminating power of HRM with the traditional electrophoresis-based methods and provided a panel of primers for HRM genotyping in Citrus. The results showed that sixteen SSR markers produced distinct polymorphic melting curves among the Citrus spp investigated through HRM analysis. Among those, 10 showed more genotypes by HRM analysis than capillary electrophoresis owing to the presence of SNPs in the amplicons. For the SSR markers without SNPs present in the flanking region, HRM also gave distinct melting curves which detected same genotypes as were shown in capillary electrophoresis (CE) analysis. Moreover, HRM analysis allowed the discrimination of most of the 15 citrus genotypes and the resulting genetic distance analysis clustered them into three main branches. In conclusion, it has been approved that HRM is not only an efficient and cost-effective alternative of electrophoresis-based method for SSR markers, but also a method to uncover more polymorphisms contributed by SNPs present in SSRs. It was therefore suggested that the panel of SSR markers could be used in a variety of applications in the citrus biodiversity and breeding programs using HRM analysis. Furthermore, we speculate that the HRM analysis can be employed to analyse SSR markers in a wide range of applications in all other species.	[Distefano, Gaetano; Caruso, Marco; La Malfa, Stefano; Gentile, Alessandra] Univ Catania, Dipartimento Sci Prod Agr & Alimentari, Catania, Italy; [Distefano, Gaetano; Wu, Shu-Biao] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of Catania; University of New England	Distefano, G (corresponding author), Univ Catania, Dipartimento Sci Prod Agr & Alimentari, Catania, Italy.	gentilea@unict.it; shubiao.wu@une.edu.au	Caruso, Marco/F-8207-2011; Wu, Shu-Biao/R-5951-2019; Caruso, Marco/AAA-7279-2021	Caruso, Marco/0000-0001-9068-4490; Wu, Shu-Biao/0000-0002-1790-6015; Caruso, Marco/0000-0001-9068-4490; Gentile, Alessandra/0000-0002-4135-5620; Distefano, Gaetano/0000-0002-6080-6466; La Malfa, Stefano/0000-0001-5869-0348	Assessorato Risorse Agricole e Alimentari, Regione Siciliana	Assessorato Risorse Agricole e Alimentari, Regione Siciliana	This work was supported by Assessorato Risorse Agricole e Alimentari, Regione Siciliana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Arthofer W, 2011, MOL GENET GENOMICS, V286, P225, DOI 10.1007/s00438-011-0641-0; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barkley NA, 2009, PLANT SYST EVOL, V282, P71, DOI 10.1007/s00606-009-0208-2; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bhargava A, 2010, MOL BIOTECHNOL, V44, P250, DOI 10.1007/s12033-009-9230-4; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; Chen YH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-96; DENG ZN, 1995, J HORTIC SCI, V70, P117, DOI 10.1080/14620316.1995.11515281; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Fang DQ, 1997, THEOR APPL GENET, V95, P408, DOI 10.1007/s001220050577; FAOSTAT, 2012, FAOST STAT DAT; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Ganopoulos I, 2011, FOOD CONTROL, V22, P532, DOI 10.1016/j.foodcont.2010.09.040; Herrero R, 1996, THEOR APPL GENET, V92, P599, DOI 10.1007/BF00224564; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; Khan IA, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P1, DOI 10.1079/9780851990194.0000; Lehmensiek A, 2008, THEOR APPL GENET, V117, P721, DOI 10.1007/s00122-008-0813-4; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LURO F, 1995, HORTSCIENCE, V30, P1063, DOI 10.21273/HORTSCI.30.5.1063; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Mackay JF, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-8; Mader E, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-69; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Muleo R, 2009, GENOME, V52, P252, DOI 10.1139/G09-002; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Novelli VM, 2006, GENET MOL BIOL, V29, P90, DOI 10.1590/S1415-47572006000100018; Oliver RE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-77; Ollitrault F, 2010, AM J BOT, V97, pE124, DOI 10.3732/ajb.1000280; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Sambrook J, 2001, MOL CLONING LAB MANU; Scora R. W., 1988, Citriculture. Sixth international citrus congress, Middle-East, Tel Aviv, Israel, 6-11 March 1988. Volume 1., P277; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; van Oppen MJH, 2000, MOL BIOL EVOL, V17, P489, DOI 10.1093/oxfordjournals.molbev.a026329; White HE, 2007, CLIN CHEM, V53, P1960, DOI 10.1373/clinchem.2007.093351; Wu SB, 2010, MOL BREEDING, V25, P351, DOI 10.1007/s11032-009-9324-5; Wu SB, 2009, MOL GENET GENOMICS, V282, P273, DOI 10.1007/s00438-009-0464-4; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8	44	54	55	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44202	10.1371/journal.pone.0044202	http://dx.doi.org/10.1371/journal.pone.0044202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957003	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500055
J	Yang, J; Naumann, MC; Tsai, YT; Tosi, J; Erol, D; Lin, CS; Davis, RJ; Tsang, SH				Yang, Jin; Naumann, Matthew C.; Tsai, Yi-Ting; Tosi, Joaquin; Erol, Deniz; Lin, Chyuan-Sheng; Davis, Richard J.; Tsang, Stephen H.			Vigabatrin-Induced Retinal Toxicity Is Partially Mediated by Signaling in Rod and Cone Photoreceptors	PLOS ONE			English	Article							GABA-TRANSAMINASE INHIBITOR; CGMP PHOSPHODIESTERASE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; LIGHT; DEFICIENCY; TRANSDUCIN; EPILEPSY; CHILDREN; MUTATION	Vigabatrin (VGB) is a commonly prescribed antiepileptic drug designed to inhibit GABA-transaminase, effectively halting seizures. Unfortunately, VGB treatment is also associated with the highest frequencies of peripheral visual field constriction of any of the antiepileptic drugs and the mechanisms that lead to these visual field defects are uncertain. Recent studies have demonstrated light exposure exacerbates vigabatrin-induced retinal toxicity. We further assessed this relationship by examining the effects of vigabatrin treatment on the retinal structures of mice with genetically altered photoreception. In keeping with previous studies, we detected increased toxicity in mice exposed to continuous light. To study whether cone or rod photoreceptor function was involved in the pathway to toxicity, we tested mice with mutations in the cone-specific Gnat2 or rod-specific Pde6g genes, and found the mutations significantly reduced VGB toxicity. Our results confirm light is a significant enhancer of vigabatrin toxicity and that a portion of this is mediated, directly or indirectly, by phototransduction signaling in rod and cone photoreceptors.	[Yang, Jin; Naumann, Matthew C.; Tsai, Yi-Ting; Tosi, Joaquin; Erol, Deniz; Lin, Chyuan-Sheng; Davis, Richard J.; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Yang, Jin] Tianjin Med Univ Eye Ctr, Tianjin, Peoples R China; [Lin, Chyuan-Sheng] Columbia Univ, Herbert Irving Canc Res Ctr, New York, NY 10027 USA	Columbia University; Tianjin Medical University; Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA.	sht2@columbia.edu			National Institutes of Health [5P30CA013696, R01EY018213, P30EY019007]; Department of Defense [DOD-TS080017-W81XWH-09-1-0575]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY018213, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Institutes of Health grants 5P30CA013696, R01EY018213, P30EY019007, the Department of Defense grant DOD-TS080017-W81XWH-09-1-0575, and the Foundation Fighting Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Buncic JR, 2004, OPHTHALMOLOGY, V111, P1935, DOI 10.1016/j.ophtha.2004.03.036; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; DJAMGOZ MBA, 1995, TRENDS NEUROSCI, V18, P118, DOI 10.1016/0166-2236(95)93886-3; Duboc A, 2004, ANN NEUROL, V55, P695, DOI 10.1002/ana.20081; Durbin S, 2009, INVEST OPHTH VIS SCI, V50, P4011, DOI 10.1167/iovs.08-3237; GIBSON JP, 1990, TOXICOL PATHOL, V18, P225, DOI 10.1177/019262339001800201; Izumi Y, 2004, EPILEPSIA, V45, P1043, DOI 10.1111/j.0013-9580.2004.01004.x; Jammoul F, 2009, ANN NEUROL, V65, P98, DOI 10.1002/ana.21526; Kinirons P, 2006, EPILEPSY RES, V70, P229, DOI 10.1016/j.eplepsyres.2006.05.009; Kjellstrom U, 2009, GRAEF ARCH CLIN EXP, V247, P1057, DOI 10.1007/s00417-009-1093-7; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; LIVINGSTON JH, 1989, BRIT J CLIN PHARMACO, V27, pS109, DOI 10.1111/j.1365-2125.1989.tb03470.x; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Moskowitz A, 2012, DOC OPHTHALMOL, V124, P197, DOI 10.1007/s10633-012-9320-7; Sills GJ, 2003, EPILEPSIA, V44, P886, DOI 10.1046/j.1528-1157.2003.04203.x; Sills GJ, 2001, NEUROLOGY, V57, P196, DOI 10.1212/WNL.57.2.196; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Tsang SH, 2008, AM J OPHTHALMOL, V146, P780, DOI 10.1016/j.ajo.2008.06.017; van der Torren Kors, 2002, Documenta Ophthalmologica, V104, P181, DOI 10.1023/A:1014615517996; Wang QP, 2008, EUR J NEUROSCI, V27, P2177, DOI 10.1111/j.1460-9568.2008.06175.x; Waterhouse EJ, 2009, NEUROPSYCH DIS TREAT, V5, P505; Yee JM, 1998, EPILEPSY RES, V29, P195; Zhang Y, 2009, CHINA J CLIN NEUROSC, V5, P457	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43889	10.1371/journal.pone.0043889	http://dx.doi.org/10.1371/journal.pone.0043889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22970106	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500027
J	von Chamier, M; Allam, A; Brown, MB; Reinhard, MK; Reyes, L				von Chamier, Maria; Allam, Ayman; Brown, Mary B.; Reinhard, Mary K.; Reyes, Leticia			Host Genetic Background Impacts Disease Outcome During Intrauterine Infection with Ureaplasma parvum	PLOS ONE			English	Article							RAT STRAINS DIFFER; AMNIOTIC-FLUID; INFLAMMATORY RESPONSE; MYCOPLASMA-HOMINIS; INTRAAMNIOTIC INFECTION; TRACT-INFECTION; PRETERM LABOR; UREALYTICUM; CHORIOAMNIONITIS; MACROPHAGES	Ureaplasma parvum, an opportunistic pathogen of the human urogenital tract, has been implicated in contributing to chorioamnionitis, fetal morbidity, and fetal mortality. It has been proposed that the host genetic background is a critical factor in adverse pregnancy outcome as sequela to U. parvum intra-amniotic infection. To test this hypothesis we assessed the impact of intrauterine U. parvum infection in the prototypical TH1/M1 C57BL/6 and TH2/M2 BALB/c mouse strain. Sterile medium or U. parvum was inoculated into each uterine horn and animals were evaluated for intra-amniotic infection, fetal infection, chorioamnionitis and fetal pathology at 72 hours post-inoculation. Disease outcome was assessed by microbial culture, in situ detection of U. parvum in fetal and utero-placental tissues, grading of chorioamnionitis, and placental gene expression of IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, S100A8, and S100A9. Placental infection and colonization rates were equivalent in both strains. The in situ distribution of U. parvum in placental tissues was also similar. However, a significantly greater proportion of BALB/c fetuses were infected (P<0.02). C57BL/6 infected animals predominantly exhibited mild to moderate chorioamnionitis (P<0.0001), and a significant reduction in placental expression of IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, S100A8, and S100A9 compared to sham controls (P<0.02). Conversely, severe protracted chorioamnionitis with cellular necrosis was the predominant lesion phenotype in BALB/c mice, which also exhibited a significant increase in placental expression of IL-1a, IL-1 beta, IL-6, TNF-alpha, S100A8, and S100A9 (P<0.01). Fetal pathology in BALB/c was multi-organ and included brain, lung, heart, liver, and intestine, whereas fetal pathology in C57BL/6 was only detected in the liver and intestines. These results confirm that the host genetic background is a major determinant in ureaplasmal induced chorioamnionitis with fetal infection and fetal inflammatory response.	[von Chamier, Maria; Reinhard, Mary K.] Univ Florida, Anim Care Serv, Gainesville, FL USA; [Allam, Ayman; Brown, Mary B.; Reyes, Leticia] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA; [Allam, Ayman; Brown, Mary B.; Reyes, Leticia] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	von Chamier, M (corresponding author), Univ Florida, Anim Care Serv, Gainesville, FL USA.	lreyes@ufl.edu	Reyes, Leticia/H-7338-2019; Allam, Ayman/AAJ-7852-2020	Allam, Ayman/0000-0002-6726-089X	Animal Care Services Research and Graduate Program; National Institute of Diabetes And Digestive and Kidney Diseases (NIDDK) [K08DK075651]; University of Florida Open-Access Publishing Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK075651] Funding Source: NIH RePORTER	Animal Care Services Research and Graduate Program; National Institute of Diabetes And Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Florida Open-Access Publishing Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by the Animal Care Services Research and Graduate Program. A. Allam was supported by an American Recovery & Reinvestment Act supplement to K08DK075651 from the National Institute of Diabetes And Digestive and Kidney Diseases (NIDDK). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2007, BJOG-INT J OBSTET GY, V114, P1432, DOI 10.1111/j.1471-0528.2007.01410.x; Allam AB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-101; Allenbach C, 2006, J IMMUNOL, V176, P6656, DOI 10.4049/jimmunol.176.11.6656; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi CS, 2009, CURR OPIN INFECT DIS, V22, P235, DOI 10.1097/QCO.0b013e32832a5963; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Collins JJP, 2010, AM J PHYSIOL-LUNG C, V299, pL852, DOI 10.1152/ajplung.00183.2010; CROUSE DT, 1993, CLIN INFECT DIS, V17, pS122, DOI 10.1093/clinids/17.Supplement_1.S122; Dando SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029856; De Dooy JJ, 2001, EUR J PEDIATR, V160, P457, DOI 10.1007/s004310100785; DISCHE MR, 1979, AM J CLIN PATHOL, V72, P167; Espinoza J, 2002, J Matern Fetal Neonatal Med, V12, P304, DOI 10.1080/713605697; Estrada-Gutierrez G, 2010, INFECT IMMUN, V78, P4792, DOI 10.1128/IAI.00522-10; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; Goldenberg RL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.033; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Gravett MG, 2007, J PROTEOME RES, V6, P89, DOI 10.1021/pr060149v; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; HOROWITZ S, 1995, J REPROD MED, V40, P375; HOROWITZ S, 1995, ACTA OBSTET GYN SCAN, V74, P132, DOI 10.3109/00016349509008922; Kasper DC, 2010, DIAGN MICR INFEC DIS, V67, P117, DOI 10.1016/j.diagmicrobio.2009.12.023; Kemp MW, 2011, REPROD SCI, V18, P1128, DOI 10.1177/1933719111408114; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Kuroda E, 2002, J IMMUNOL, V168, P5477, DOI 10.4049/jimmunol.168.11.5477; Kuroda E, 2003, J IMMUNOL, V170, P757, DOI 10.4049/jimmunol.170.2.757; Li YH, 2001, BIOL NEONATE, V80, P124, DOI 10.1159/000047131; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Menon R, 2008, AM J OBSTET GYNECOL, V198; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Moss TJM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.065; Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962; Normann E, 2009, PEDIATR RES, V65, P430, DOI 10.1203/PDR.0b013e31819984ce; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Okogbule-Wonodi AC, 2011, PEDIATR RES, V69, P442, DOI 10.1203/PDR.0b013e3182111827; Olomu IN, 2009, PEDIATRICS, V123, P1329, DOI 10.1542/peds.2008-1113; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Oue S, 2009, ARCH DIS CHILD-FETAL, V94, pF17, DOI 10.1136/adc.2008.138321; Perni SC, 2004, AM J OBSTET GYNECOL, V191, P1382, DOI 10.1016/j.ajog.2004.05.070; Polglase GR, 2010, AM J PHYSIOL-LUNG C, V299, pL232, DOI 10.1152/ajplung.00369.2009; Redline RW, 2006, SEMIN FETAL NEONAT M, V11, P296, DOI 10.1016/j.siny.2006.02.011; Redline RW, 2012, SEMIN FETAL NEONAT M, V17, P20, DOI 10.1016/j.siny.2011.08.003; Reyes L, 2004, AM J REPROD IMMUNOL, V51, P211, DOI 10.1111/j.1600-0897.2004.00144.x; Reyes L, 2006, INFECT IMMUN, V74, P6656, DOI 10.1128/IAI.00984-06; Reyes L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-9; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2010, J MATERN-FETAL NEO M, V23, P261, DOI 10.3109/14767050903067386; Romero Roberto, 2002, Semin Neonatol, V7, P259, DOI 10.1053/siny.2002.0121; Salminen A, 2008, PEDIATR RES, V63, P280, DOI 10.1203/PDR.0b013e318163a8b2; SANCHEZ PJ, 1990, PEDIATR INFECT DIS J, V9, P398, DOI 10.1097/00006454-199006000-00006; Schelonka RL, 2007, SEMIN PERINATOL, V31, P2, DOI 10.1053/j.semperi.2007.01.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sung Tae-Jung, 2010, Korean J Pediatr, V53, P989, DOI 10.3345/kjp.2010.53.12.989; Sung TJ, 2011, PEDIATR INFECT DIS J, V30, P379, DOI 10.1097/INF.0b013e318202ac3a; Velez DR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003283; Velez DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.051; Viscardi RM, 2008, J PERINATOL, V28, P759, DOI 10.1038/jp.2008.98; Viscardi R, 2006, PEDIATR DEVEL PATHOL, V9, P143, DOI 10.2350/10-05-0112.1; Viscardi RM, 2006, PEDIATR RES, V60, P141, DOI 10.1203/01.pdr.0000228322.73777.05; Voloshchuk I. N., 1994, Arkhiv Patologii, V56, P76; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; WAITES KB, 1988, LANCET, V1, P17; Waites KB, 2009, SEMIN FETAL NEONAT M, V14, P190, DOI 10.1016/j.siny.2008.11.009; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Yoder BA, 2003, PEDIATR RES, V54, P797, DOI 10.1203/01.PDR.0000091284.84322.16	72	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44047	10.1371/journal.pone.0044047	http://dx.doi.org/10.1371/journal.pone.0044047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952869	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000074
J	Lake, MC; Nguyen, QD; Ali, S; Aboagye, EO				Lake, Madryn C.; Quang-De Nguyen; Ali, Simak; Aboagye, Eric O.			Development of a Novel Molecular Sensor for Imaging Estrogen Receptor-Coactivator Protein-Protein Interactions	PLOS ONE			English	Article							FRAGMENT-ASSISTED COMPLEMENTATION; SERUM TAMOXIFEN CONCENTRATIONS; SURGICAL ADJUVANT BREAST; ATHYMIC NUDE-MOUSE; CONFORMATIONAL-CHANGES; POSTMENOPAUSAL WOMEN; HORMONE-RECEPTORS; NUCLEAR RECEPTORS; CANCER PATIENTS; LUCIFERASE	Anti-estrogens, in particular tissue selective anti-estrogens, have been the bedrock of adjuvant therapy for patients with estrogen receptor alpha (ER alpha) positive breast cancer. Though current therapies have greatly enhanced patient prognosis, there continues to be an impetus for the development of improved anti-estrogens. ER alpha is a nuclear receptor transcription factor which activates gene expression through the recruitment of transcriptional coactivator proteins. The SRC family of coactivators, which includes AIB1, has been shown to be of particular importance for ER alpha mediated transcription. ER alpha-AIB1 interactions are indicative of gene expression and are inhibited by anti-estrogen treatment. We have exploited the interaction between ER alpha and AIB1 as a novel method for imaging ER alpha activity using a split luciferase molecular sensor. By producing a range of ER alpha ligand binding domain (ER-LBD) and AIB1 nuclear receptor interacting domain (AIB-RID) N- and C-terminal firefly luciferase fragment fusion proteins, constructs which exhibited more than a 10-fold increase in luciferase activity with E2 stimulation were identified. The specificity of the E2-stimulated luciferase activity to ER alpha-AIB1 interaction was validated through Y537S and L539/540A ER-LBD fusion protein mutants. The primed nature of the split luciferase assay allowed changes in ER alpha activity, with respect to the protein-protein interactions preceding transcription, to be assessed soon after drug treatment. The novel assay split luciferase detailed in this report enabled modulation of ER alpha activity to be sensitively imaged in vitro and in living subjects and potentially holds much promise for imaging the efficacy of novel ER alpha specific therapies.	[Lake, Madryn C.; Quang-De Nguyen; Aboagye, Eric O.] Univ London Imperial Coll Sci Technol & Med, Comprehens Canc Imaging Ctr, London, England; [Ali, Simak] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Imperial College London; Imperial College London	Lake, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Comprehens Canc Imaging Ctr, London, England.	eric.aboagye@imperial.ac.uk	Ali, Simak/N-4740-2019; Ali, Simak/M-6912-2018	Ali, Simak/0000-0002-1320-0816; Ali, Simak/0000-0002-1320-0816; ABOAGYE, Eric/0000-0003-2276-6771; Coombes, Raoul Charles/0000-0002-4811-1100	Cancer Research United Kingdom [C2536/A10337, C2536/A7991]; Department of Health; National Institute for Health Research Biomedical Research Centre; Cancer Research UK [12011, 10337] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); Department of Health; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	This study was supported by grants from Cancer Research United Kingdom (C2536/A10337 and C2536/A7991) and the Department of Health-funded Imperial College Cancer Medicine Centre (ECMC) grant. The authors are also grateful for support received from the National Institute for Health Research Biomedical Research Centre funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Anderson E, 2002, BREAST CANCER RES, V4, P197, DOI 10.1186/bcr452; Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Costantino JP, 1997, J NATL CANCER I, V89, P776, DOI 10.1093/jnci/89.11.776; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DEGREGORIO MW, 1989, CANCER CHEMOTH PHARM, V23, P68; DEGREGORIO MW, 1987, CANCER CHEMOTH PHARM, V20, P316; Della Torre S, 2011, ENDOCRINOLOGY, V152, P2256, DOI 10.1210/en.2011-0173; Ferlay J, 2010, IARC CANCERBASE, V10; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; Galande AK, 2005, CHEMBIOCHEM, V6, P1991, DOI 10.1002/cbic.200500083; Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619; Gunther JR, 2008, ACS CHEM BIOL, V3, P282, DOI 10.1021/cb800056r; Gustaftson JA, 2003, TRENDS PHARMACOL SCI, V24, P479, DOI 10.1016/S0165-6147(03)00229-3; Hartman J, 2009, STEROIDS, V74, P635, DOI 10.1016/j.steroids.2009.02.005; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Kim SB, 2007, ACS CHEM BIOL, V2, P484, DOI 10.1021/cb7000439; Kim SB, 2007, ANAL CHEM, V79, P4820, DOI 10.1021/ac0621571; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; Kraichely DM, 2000, ENDOCRINOLOGY, V141, P3534, DOI 10.1210/en.141.10.3534; KRISTENSEN B, 1994, J CLIN ONCOL, V12, P992, DOI 10.1200/JCO.1994.12.5.992; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Liu JW, 2003, MOL ENDOCRINOL, V17, P346, DOI 10.1210/me.2002-0331; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Rando G, 2010, MOL ENDOCRINOL, V24, P735, DOI 10.1210/me.2009-0514; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rodriguez AL, 2004, J MED CHEM, V47, P600, DOI 10.1021/jm030404c; RUTQVIST LE, 1993, J NATL CANCER I, V85, P1398, DOI 10.1093/jnci/85.17.1398; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Soto AM, 2006, BEST PRACT RES CL EN, V20, P15, DOI 10.1016/j.beem.2005.09.001; Taneoka A, 2009, BIOSENS BIOELECTRON, V25, P76, DOI 10.1016/j.bios.2009.06.004; Tikkanen MK, 2000, P NATL ACAD SCI USA, V97, P12536, DOI 10.1073/pnas.220427297; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; WAKELING AE, 1991, CANCER RES, V51, P3867; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Zhou GC, 1998, MOL ENDOCRINOL, V12, P1594, DOI 10.1210/me.12.10.1594	58	4	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44160	10.1371/journal.pone.0044160	http://dx.doi.org/10.1371/journal.pone.0044160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952913	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600086
J	Grispo, MT; Natarajan, C; Projecto-Garcia, J; Moriyama, H; Weber, RE; Storz, JF				Grispo, Michael T.; Natarajan, Chandrasekhar; Projecto-Garcia, Joana; Moriyama, Hideaki; Weber, Roy E.; Storz, Jay F.			Gene Duplication and the Evolution of Hemoglobin Isoform Differentiation in Birds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-ALTITUDE RESPIRATION; DUCK AYTHYA-FULIGULA; ALPHA-A-CHAINS; GLOBIN GENE; OXYGEN-BINDING; FUNCTIONAL DIVERSIFICATION; VERTEBRATE HEMOGLOBINS; ORGANIC-PHOSPHATES; CHICKEN HEMOGLOBIN; GYPS-RUEPPELLII	The majority of bird species co-express two functionally distinct hemoglobin (Hb) isoforms in definitive erythrocytes as follows: HbA (the major adult Hb isoform, with alpha-chain subunits encoded by the alpha(A)-globin gene) and HbD (the minor adult Hb isoform, with alpha-chain subunits encoded by the alpha(D)-globin gene). The alpha(D)-globin gene originated via tandem duplication of an embryonic alpha-like globin gene in the stem lineage of tetrapod vertebrates, which suggests the possibility that functional differentiation between the HbA and HbD isoforms may be attributable to a retained ancestral character state in HbD that harkens back to a primordial, embryonic function. To investigate this possibility, we conducted a combined analysis of protein biochemistry and sequence evolution to characterize the structural and functional basis of Hb isoform differentiation in birds. Functional experiments involving purified HbA and HbD isoforms from 11 different bird species revealed that HbD is characterized by a consistently higher O-2 affinity in the presence of allosteric effectors such as organic phosphates and Cl- ions. In the case of both HbA and HbD, analyses of oxygenation properties under the two-state Monod-Wyman-Changeux allosteric model revealed that the pH dependence of Hb-O-2 affinity stems primarily from changes in the O-2 association constant of deoxy (T-state)-Hb. Ancestral sequence reconstructions revealed that the amino acid substitutions that distinguish the adult-expressed Hb isoforms are not attributable to the retention of an ancestral (pre-duplication) character state in the alpha(D)-globin gene that is shared with the embryonic alpha-like globin gene.	[Grispo, Michael T.; Natarajan, Chandrasekhar; Projecto-Garcia, Joana; Moriyama, Hideaki; Storz, Jay F.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Weber, Roy E.] Aarhus Univ, Inst Biosci, DK-8000 Aarhus C, Denmark	University of Nebraska System; University of Nebraska Lincoln; Aarhus University	Storz, JF (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	jstorz2@unl.edu	Natarajan, Chandrasekar/ABG-5195-2020; Natarajan, Chandrasekhar/D-3144-2012	Natarajan, Chandrasekhar/0000-0002-4841-0426	National Institutes of Health from NHLBI [R01 HL087216, HL087216-S1]; National Science Foundation [IOS-0949931]; Science Faculty, Aarhus University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087216] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); Science Faculty, Aarhus University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL087216 and HL087216-S1 from NHLBI. This work was also supported by National Science Foundation Grant IOS-0949931 and the Science Faculty, Aarhus University.	Abbasi A, 2002, BIOCHEM BIOPH RES CO, V291, P176, DOI 10.1006/bbrc.2002.6399; Adair GS, 1925, J BIOL CHEM, V63, P529; Alev C, 2009, DEV GENES EVOL, V219, P353, DOI 10.1007/s00427-009-0294-8; AMICONI G, 1985, EUR J BIOCHEM, V150, P387, DOI 10.1111/j.1432-1033.1985.tb09032.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARNONE A, 1974, NATURE, V249, P34, DOI 10.1038/249034a0; BAUMANN R, 1987, J EXP ZOOL, P227; BINOTTI I, 1971, ARCH BIOCHEM BIOPHYS, V142, P274, DOI 10.1016/0003-9861(71)90284-0; Brittain T, 2002, MOL ASPECTS MED, V23, P293, DOI 10.1016/S0098-2997(02)00004-3; BRYGIER J, 1976, BIOCHIMIE, V58, P755, DOI 10.1016/S0300-9084(76)80403-8; Bunn HF, 1986, HEMOGLOBIN MOL GENET; CAO Y, 1994, J MOL EVOL, V39, P519; CIROTTO C, 1987, DEVELOPMENT, V101, P805; COBB JA, 1992, J BIOL CHEM, V267, P1183; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferry RM, 1929, J BIOL CHEM, V81, P175; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILL SJ, 1980, J BIOL CHEM, V255, P7855; GODOVAC-ZIMMERMANN J, 1985, BIOL CHEM H-S, V366, P503, DOI 10.1515/bchm3.1985.366.1.503; GODOVAC-ZIMMERMANN J, 1984, H-S Z PHYSIOL CHEM, V365, P1107, DOI 10.1515/bchm2.1984.365.2.1107; Gribaldo S, 2003, MOL BIOL EVOL, V20, P1754, DOI 10.1093/molbev/msg171; GRIGG GC, 1993, J EXP BIOL, V175, P15; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HIEBL I, 1987, BIOL CHEM H-S, V368, P333, DOI 10.1515/bchm3.1987.368.1.333; HIEBL I, 1988, BIOL CHEM H-S, V369, P217, DOI 10.1515/bchm3.1988.369.1.217; HIEBL I, 1989, BIOL CHEM H-S, V370, P699, DOI 10.1515/bchm3.1989.370.2.699; Hoffmann FG, 2008, MOL BIOL EVOL, V25, P591, DOI 10.1093/molbev/msn004; Hoffmann FG, 2007, MOL BIOL EVOL, V24, P1982, DOI 10.1093/molbev/msm127; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; Hoffmann FG, 2011, GENOME BIOL EVOL, V3, P588, DOI 10.1093/gbe/evr055; Hoffmann FG, 2010, MOL BIOL EVOL, V27, P1126, DOI 10.1093/molbev/msp325; Imai K., 1982, ALLOSTERIC EFFECTS H; Ingermann RL, 1997, HDB PHYSL, VI, P357; ISAACKS RE, 1976, ARCH BIOCHEM BIOPHYS, V173, P114, DOI 10.1016/0003-9861(76)90240-X; Jensen FB, 2004, ACTA PHYSIOL SCAND, V182, P215, DOI 10.1111/j.1365-201X.2004.01361.x; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Knapp JE, 1999, J BIOL CHEM, V274, P6411, DOI 10.1074/jbc.274.10.6411; LEE KS, 1976, BIOCHIM BIOPHYS ACTA, V427, P178, DOI 10.1016/0005-2795(76)90295-6; Lutfullah G, 2005, BIOCHEM BIOPH RES CO, V326, P123, DOI 10.1016/j.bbrc.2004.10.209; LUTZ PL, 1980, AM ZOOL, V20, P187; MILLS FC, 1976, BIOCHEMISTRY-US, V15, P5350, DOI 10.1021/bi00669a023; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nikinmaa M, 2001, RESP PHYSIOL, V128, P317, DOI 10.1016/S0034-5687(01)00309-7; NOTHUM R, 1989, BIOL CHEM H-S, V370, P1197, DOI 10.1515/bchm3.1989.370.2.1197; OBERTHUR W, 1986, BIOL CHEM H-S, V367, P507, DOI 10.1515/bchm3.1986.367.1.507; OBERTHUR W, 1983, H-S Z PHYSIOL CHEM, V364, P119, DOI 10.1515/bchm2.1983.364.1.119; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; PERUTZ MF, 1959, J MOL BIOL, V1, P402, DOI 10.1016/S0022-2836(59)80024-3; Rana MS, 2008, PROTEINS, V70, P553, DOI 10.1002/prot.21793; Rana MS, 2011, PROTEINS, V79, P1499, DOI 10.1002/prot.22978; Riccio A, 2001, BIOPHYS J, V81, P1938, DOI 10.1016/S0006-3495(01)75845-6; RIGGS A, 1976, FED PROC, V35, P2115; Riggs A., 1979, COMP BIOCH PHYSL, V62, P257; Riggs AF, 1998, J EXP BIOL, V201, P1073; SAHA A, 1965, COMP BIOCHEM PHYSIOL, V15, P217, DOI 10.1016/0010-406X(65)90348-8; Sanna MT, 2007, BIOL CHEM, V388, P787, DOI 10.1515/BC.2007.102; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Storz JF, 2011, IUBMB LIFE, V63, P313, DOI 10.1002/iub.482; Storz JF, 2011, J EXP BIOL, V214, P575, DOI 10.1242/jeb.050443; SULTANA C, 1989, J PROTEIN CHEM, V8, P629, DOI 10.1007/BF01025603; Tamburrini M, 2000, EUR J BIOCHEM, V267, P6089, DOI 10.1046/j.1432-1327.2000.01699.x; TAMBURRINI M, 1994, J MOL BIOL, V237, P615, DOI 10.1006/jmbi.1994.1259; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TYUMA I, 1973, BIOCHEMISTRY-US, V12, P1491, DOI 10.1021/bi00732a004; VANDECASSERIE C, 1973, COMP BIOCHEM PHYSIOL, V44, P711, DOI 10.1016/0300-9629(73)90136-9; Weber R. E, 1995, HYPOXIA BRAIN, P31; WEBER RE, 1994, J EXP BIOL, V192, P1; WEBER RE, 1987, J COMP PHYSIOL B, V157, P145, DOI 10.1007/BF00692358; WEBER RE, 1995, J MOL BIOL, V251, P703, DOI 10.1006/jmbi.1995.0466; WEBER RE, 1990, COMP PHYSIOL, V6, P58; WEBER RE, 1988, ANNU REV PHYSIOL, V50, P161, DOI 10.1146/annurev.ph.50.030188.001113; Weber RE, 2000, J BIOL CHEM, V275, P17297, DOI 10.1074/jbc.M001209200; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; Weber RE, 2004, AM J PHYSIOL-REG I, V287, pR454, DOI 10.1152/ajpregu.00060.2004; WEBER RE, 1988, BIOL CHEM H-S, V369, P233, DOI 10.1515/bchm3.1988.369.1.233; Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018; Weber RE, 2002, AM J PHYSIOL-REG I, V283, pR1052, DOI 10.1152/ajpregu.00292.2002; Weber RE, 2000, HEMOGLOBIN FUNCTION IN VERTEBRATES, P23; WEBER RE, 1986, AM J PHYSIOL, V251, pR901, DOI 10.1152/ajpregu.1986.251.5.R901; Weber Roy E., 1996, P75; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZUIDERWEG ERP, 1981, EUR J BIOCHEM, V118, P95, DOI 10.1111/j.1432-1033.1981.tb05490.x	87	49	52	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.375600	http://dx.doi.org/10.1074/jbc.M112.375600			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22962007	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000310642200006
J	Liu, SP; Mistry, A; Reynolds, JM; Lloyd, DB; Griffor, MC; Perry, DA; Ruggeri, RB; Clark, RW; Qiu, XY				Liu, Shenping; Mistry, Anil; Reynolds, Jennifer M.; Lloyd, David B.; Griffor, Matthew C.; Perry, David A.; Ruggeri, Roger B.; Clark, Ronald W.; Qiu, Xiayang			Crystal Structures of Cholesteryl Ester Transfer Protein in Complex with Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; RAISING HDL; ANTIINFLAMMATORY PROPERTIES; CETP INHIBITORS; BLOOD-PRESSURE; DOUBLE-BLIND; TORCETRAPIB; ATHEROSCLEROSIS; TARGET; RISK	Human plasma cholesteryl ester transfer protein (CETP) transports cholesteryl ester from the antiatherogenic high-density lipoproteins (HDL) to the proatherogenic low-density and very low-density lipoproteins (LDL and VLDL). Inhibition of CETP has been shown to raise human plasma HDL cholesterol (HDL-C) levels and is potentially a novel approach for the prevention of cardiovascular diseases. Here, we report the crystal structures of CETP in complex with torcetrapib, a CETP inhibitor that has been tested in phase 3 clinical trials, and compound 2, an analog from a structurally distinct inhibitor series. In both crystal structures, the inhibitors are buried deeply within the protein, shifting the bound cholesteryl ester in the N-terminal pocket of the long hydrophobic tunnel and displacing the phospholipid from that pocket. The lipids in the C-terminal pocket of the hydrophobic tunnel remain unchanged. The inhibitors are positioned near the narrowing neck of the hydrophobic tunnel of CETP and thus block the connection between the N- and C-terminal pockets. These structures illuminate the unusual inhibition mechanism of these compounds and support the tunnel mechanism for neutral lipid transfer by CETP. These highly lipophilic inhibitors bind mainly through extensive hydrophobic interactions with the protein and the shifted cholesteryl ester molecule. However, polar residues, such as Ser-230 and His-232, are also found in the inhibitor binding site. An enhanced understanding of the inhibitor binding site may provide opportunities to design novel CETP inhibitors possessing more drug-like physical properties, distinct modes of action, or alternative pharmacological profiles.	[Liu, Shenping; Mistry, Anil; Griffor, Matthew C.; Qiu, Xiayang] Pfizer Groton Labs, Dept Struct Biol & Biophys, Groton, CT 06340 USA; [Reynolds, Jennifer M.; Lloyd, David B.] Pfizer Groton Labs, Dept Pharmacokinet Dynam & Metab, Groton, CT 06340 USA; [Perry, David A.; Ruggeri, Roger B.; Clark, Ronald W.] Pfizer Groton Labs, Dept Cardiovasc Metab & Endocrine Dis Med Chem, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Liu, SP (corresponding author), Pfizer Groton Labs, Dept Struct Biol & Biophys, Eastern Point Rd, Groton, CT 06340 USA.	shenping.liu@pfizer.com; xiayang.qiu@pfizer.com						AGELLON LB, 1991, J BIOL CHEM, V266, P10796; Ali A., 2005, U.S. Patent, Patent No. [2006/0040999 A1, 20060040999]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bots ML, 2007, LANCET, V370, P153, DOI 10.1016/S0140-6736(07)61088-5; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Bruckert E, 2007, INT J CLIN PRACT, V61, P1905, DOI 10.1111/j.1742-1241.2007.01509.x; Cannon CP, 2011, JAMA-J AM MED ASSOC, V306, P2153, DOI 10.1001/jama.2011.1687; Cao GQ, 2011, J LIPID RES, V52, P2169, DOI 10.1194/jlr.M018069; Chang G., 2007, U.S. Patent, Patent No. 7919506; Clark RW, 2006, J LIPID RES, V47, P537, DOI 10.1194/jlr.M500349-JLR200; Damon D. B., 2003, U.S. Patent, Patent No. 6706881; Dullaart RPF, 2007, EUR J CLIN INVEST, V37, P90, DOI 10.1111/j.1365-2362.2007.01756.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forrest MJ, 2008, BRIT J PHARMACOL, V154, P1465, DOI 10.1038/bjp.2008.229; Gumkowski M. J., 2002, U.S. Patent, Patent No. 6962931; Hamilton JA, 2007, NAT STRUCT MOL BIOL, V14, P95, DOI 10.1038/nsmb0207-95; Hooper AJ, 2012, EXPERT OPIN INV DRUG, V21, P1427, DOI 10.1517/13543784.2012.699040; Howes LG, 2007, EXPERT OPIN INV DRUG, V16, P1509, DOI 10.1517/13543784.16.10.1509; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Joy T, 2009, CURR OPIN CARDIOL, V24, P364, DOI 10.1097/HCO.0b013e32832ac166; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Krishna R, 2007, LANCET, V370, P1907, DOI 10.1016/S0140-6736(07)61813-3; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lloyd DB, 2005, BBA-MOL CELL BIOL L, V1737, P69, DOI 10.1016/j.bbalip.2005.09.007; Lloyd DB, 2005, J BIOL CHEM, V280, P14918, DOI 10.1074/jbc.M500523200; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pecheniuk NM, 2006, J THROMB HAEMOST, V4, P2080, DOI 10.1111/j.1538-7836.2006.02099.x; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Ranalletta M, 2010, J LIPID RES, V51, P2739, DOI 10.1194/jlr.M007468; Ruggeri RB, 2005, CURR TOP MED CHEM, V5, P257, DOI 10.2174/1568026053544506; Stein EA, 2010, EUR HEART J, V31, P480, DOI 10.1093/eurheartj/ehp601; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; Tall AR, 2007, NEW ENGL J MED, V356, P1364, DOI 10.1056/NEJMe078029; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vergeer M, 2008, NAT CLIN PRACT CARD, V5, P302, DOI 10.1038/ncpcardio1190; WHO, 2008, ATLAS HEART DIS STRO; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1132, DOI 10.1161/ATVBAHA.106.138347; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	47	54	56	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37321	37329		10.1074/jbc.M112.380063	http://dx.doi.org/10.1074/jbc.M112.380063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961980	Green Published, hybrid			2022-12-25	WOS:000310588500063
J	Shan, JX; Fu, LC; Balasubramanian, MN; Anthony, T; Kilberg, MS				Shan, Jixiu; Fu, Lingchen; Balasubramanian, Mukundh N.; Anthony, Tracy; Kilberg, Michael S.			ATF4-dependent Regulation of the JMJD3 Gene during Amino Acid Deprivation Can Be Rescued in Atf4-deficient Cells by Inhibition of Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIETARY-PROTEIN RESTRICTION; ASPARAGINE SYNTHETASE GENE; DEMETHYLASE JMJD3; TRANSCRIPTION FACTORS; HISTONE ACETYLATION; PROMOTER REGION; COMPOSITE SITE; PREGNANT RATS; C-JUN; EXPRESSION	Following amino acid deprivation, the amino acid response (AAR) induces transcription from specific genes through a collection of signaling mechanisms, including the GCN2-eIF2-ATF4 pathway. The present report documents that the histone demethylase JMJD3 is an activating transcription factor 4 (ATF4)-dependent target gene. The JMJD3 gene contains two AAR-induced promoter activities and chromatin immunoprecipitation (ChIP) analysis showed that the AAR leads to enhanced ATF4 recruitment to the C/EBP-ATF response element (CARE) upstream of Promoter-1. AAR-induced histone modifications across the JMJD3 gene locus occur upon ATF4 binding. Jmjd3 transcription is not induced in Atf4-knock-out cells, but the AAR-dependent activation was rescued by inhibition of histone deacetylation with trichostatin A (TSA). The TSA rescue of AAR activation in the absence of Atf4 also occurred for the Atf3 and C/EBP homology protein (Chop) genes, but not for the asparagine synthetase gene. ChIP analysis of the Jmjd3, Atf3, and Chop genes in Atf4 knock-out cells documented that activation of the AAR in the presence of TSA led to specific changes in acetylation of histone H4. The results suggest that a primary function of ATF4 is to recruit histone acetyltransferase activity to a sub-set of AAR target genes. Thus, absolute binding of ATF4 to these particular genes is not required and no ATF4 interaction with the general transcription machinery is necessary. The data are consistent with the hypothesis that ATF4 functions as a pioneer factor to alter chromatin structure and thus, enhance transcription in a gene-specific manner.	[Shan, Jixiu; Fu, Lingchen; Balasubramanian, Mukundh N.; Kilberg, Michael S.] Univ Florida, Dept Biochem & Mol Biol, Genet Inst, Shands Canc Ctr,Coll Med, Gainesville, FL 32610 USA; [Shan, Jixiu; Fu, Lingchen; Balasubramanian, Mukundh N.; Kilberg, Michael S.] Univ Florida, Ctr Nutr Sci, Coll Med, Gainesville, FL 32610 USA; [Anthony, Tracy] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Rutgers State University New Brunswick	Kilberg, MS (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Genet Inst, Shands Canc Ctr,Coll Med, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	Anthony, Tracy/K-7951-2017	Anthony, Tracy/0000-0002-8586-5884	National Institutes of Health [DK092062, DK094729, HD070487]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094729, R01DK092062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by Grants DK092062 and DK094729 (to M. S. K.) and HD070487 (to T. G. A.) from the National Institutes of Health.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barkess G, 2012, BIOCHEM J, V442, P495, DOI 10.1042/BJ20111502; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Endo Y, 2002, J NUTR, V132, P3632, DOI 10.1093/jn/132.12.3632; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fu LC, 2011, J BIOL CHEM, V286, P36724, DOI 10.1074/jbc.M111.277673; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jones RS, 2007, NATURE, V450, P357, DOI 10.1038/450357a; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Su N, 2009, HEPATOLOGY, V50, P282, DOI 10.1002/hep.22971; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Zheng SS, 2012, J NUTR BIOCHEM, V23, P1064, DOI 10.1016/j.jnutbio.2011.05.013; Zheng SS, 2011, EPIGENETICS-US, V6, P161, DOI 10.4161/epi.6.2.13472	64	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36393	36403		10.1074/jbc.M112.399600	http://dx.doi.org/10.1074/jbc.M112.399600			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955275	Green Published, hybrid			2022-12-25	WOS:000310364000059
J	Nielsen, MV; Sarpong, N; Krumkamp, R; Dekker, D; Loag, W; Amemasor, S; Agyekum, A; Marks, F; Huenger, F; Krefis, AC; Hagen, RM; Adu-Sarkodie, Y; May, J; Schwarz, NG				Nielsen, Maja Verena; Sarpong, Nimako; Krumkamp, Ralf; Dekker, Denise; Loag, Wibke; Amemasor, Solomon; Agyekum, Alex; Marks, Florian; Huenger, Frank; Krefis, Anne Caroline; Hagen, Ralf Matthias; Adu-Sarkodie, Yaw; May, Juergen; Schwarz, Norbert Georg			Incidence and Characteristics of Bacteremia among Children in Rural Ghana	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ANTIMICROBIAL RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; BACTERIAL-MENINGITIS; INVASIVE BACTERIAL; SEVERE MALARIA; HEALTH-CARE; DISEASE; AFRICA	The objective of the study was to describe systemic bacterial infections occurring in acutely ill and hospitalized children in a rural region in Ghana, regarding frequency, incidence, antimicrobial susceptibility patterns and associations with anthropometrical data. Blood cultures were performed in all children below the age of five years, who were admitted to Agogo Presbyterian Hospital (APH), Asante Region, Ghana, between September 2007 and July 2009. Medical history and anthropometrical data were assessed using a standardized questionnaire at admission. Incidences were calculated after considering the coverage population adjusted for village-dependent health-seeking behavior. Among 1,196 hospitalized children, 19.9% (n = 238) were blood culture positive. The four most frequent isolated pathogens were nontyphoidal salmonellae (NTS) (53.3%; n = 129), Staphylococcus aureus (13.2%; n = 32), Streptococcus pneumoniae (9.1%; n = 22) and Salmonella ser. Typhi (7.0%; n = 17). Yearly cumulative incidence of bacteremia was 46.6 cases/1,000 (CI 40.9-52.2). Yearly cumulative incidences per 1,000 of the four most frequent isolates were 25.2 (CI 21.1-29.4) for NTS, 6.3 (CI 4.1-8.4) for S. aureus, 4.3 (CI 2.5-6.1) for S. pneumoniae and 3.3 (CI 1.8-4.9) for Salmonella ser. Typhi. Wasting was positively associated with bacteremia and systemic NTS bloodstream infection. Children older than three months had more often NTS bacteremia than younger children. Ninety-eight percent of NTS and 100% of Salmonella ser. Typhi isolates were susceptible to ciprofloxacin, whereas both tested 100% susceptible to ceftriaxone. Seventy-seven percent of NTS and 65% of Salmonella ser. Typhi isolates were multi-drug resistant (MDR). Systemic bacterial infections in nearly 20% of hospitalized children underline the need for microbiological diagnostics, to guide targeted antimicrobial treatment and prevention of bacteremia. If microbiological diagnostics are lacking, calculated antimicrobial treatment of severely ill children in malaria-endemic areas should be considered.	[Nielsen, Maja Verena; Krumkamp, Ralf; Dekker, Denise; Loag, Wibke; Krefis, Anne Caroline; Hagen, Ralf Matthias; May, Juergen; Schwarz, Norbert Georg] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Sarpong, Nimako; Dekker, Denise; Amemasor, Solomon; Agyekum, Alex; Huenger, Frank] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Marks, Florian] Int Vaccine Inst, Seoul, South Korea; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Huenger, Frank] Inst Transfus Med, Lab Med & Med Microbiol, Dortmund, Germany	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; International Vaccine Institute; Kwame Nkrumah University Science & Technology	Nielsen, MV (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	maja.v.nielsen@googlemail.com	Schwarz, Norbert G/C-8797-2012	Schwarz, Norbert G/0000-0002-8387-2837; Marks, Florian/0000-0002-6043-7170; May, Jurgen/0000-0001-7831-8420	UBS Optimus Foundation	UBS Optimus Foundation	This work was supported by the UBS Optimus Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; CIA, 2012, CIA FACTB 2012; COMMEY JOO, 1994, E AFR MED J, V71, P113; Cook J, 2008, VACCINE, V26, P6305, DOI 10.1016/j.vaccine.2008.09.040; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; Enwere G, 1998, ANN TROP PAEDIATR, V18, P275, DOI 10.1080/02724936.1998.11747959; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Ghana. Cities & Urban Localities, 2011, GHANA CITIES URBAN L; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Holliman RE, 2007, T ROY SOC TROP MED H, V101, P405, DOI 10.1016/j.trstmh.2006.08.014; Ilic K, 2012, EUR J PEDIATR, V171, P767, DOI 10.1007/s00431-011-1592-5; Ladhani S, 2004, ARCH DIS CHILD, V89, P568, DOI 10.1136/adc.2003.026781; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Mandomando I, 2010, AM J TROP MED HYG, V83, P152, DOI 10.4269/ajtmh.2010.09-0578; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Meremikwu MM, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-110; Mills-Robertson F, 2003, J APPL MICROBIOL, V94, P289, DOI 10.1046/j.1365-2672.2003.01833.x; MOTARJEMI Y, 1993, B WORLD HEALTH ORGAN, V71, P79; Motarjemi Y, 1994, World Health Forum, V15, P69; Nadjm B, 2010, BMJ-BRIT MED J, V340, pc1350; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Parry CM, 2008, CURR OPIN INFECT DIS, V21, P531, DOI 10.1097/QCO.0b013e32830f453a; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Renner LA, 2007, PEDIATR INFECT DIS J, V26, P356, DOI 10.1097/01.inf.0000258693.19247.8e; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Schwarz NG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-319; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; *UNICEF, 2004, STAT WORLDS CHILDR; Vinnemeier CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036678; WHO, 2011, AG PRESB HOSP GHAN; Wilkens Julia, 1997, Clin Microbiol Infect, V3, P616, DOI 10.1111/j.1469-0691.1997.tb00467.x	38	68	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44063	10.1371/journal.pone.0044063	http://dx.doi.org/10.1371/journal.pone.0044063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970162	Green Published, gold, Green Submitted			2022-12-25	WOS:000308748400009
J	Bettenbuhl, M; Rusconi, M; Engbert, R; Holschneider, M				Bettenbuehl, Mario; Rusconi, Marco; Engbert, Ralf; Holschneider, Matthias			Bayesian Selection of Markov Models for Symbol Sequences: Application to Microsaccadic Eye Movements	PLOS ONE			English	Article							SACCADIC INTRUSIONS; GENERATION	Complex biological dynamics often generate sequences of discrete events which can be described as a Markov process. The order of the underlying Markovian stochastic process is fundamental for characterizing statistical dependencies within sequences. As an example for this class of biological systems, we investigate the Markov order of sequences of microsaccadic eye movements from human observers. We calculate the integrated likelihood of a given sequence for various orders of the Markov process and use this in a Bayesian framework for statistical inference on the Markov order. Our analysis shows that data from most participants are best explained by a first-order Markov process. This is compatible with recent findings of a statistical coupling of subsequent microsaccade orientations. Our method might prove to be useful for a broad class of biological systems.	[Bettenbuehl, Mario; Rusconi, Marco; Holschneider, Matthias] Univ Potsdam, Inst Math, Focus Area Dynam Complex Syst, Potsdam, Germany; [Bettenbuehl, Mario; Engbert, Ralf] Univ Potsdam, Dept Psychol, DFG Res Unit Computat Modeling Behav Cognit & Neu, Potsdam, Germany	University of Potsdam; University of Potsdam	Bettenbuhl, M (corresponding author), Univ Potsdam, Inst Math, Focus Area Dynam Complex Syst, Potsdam, Germany.	mario.bettenbuehl@uni-potsdam.de	Engbert, Ralf/AAC-4860-2020	Engbert, Ralf/0000-0002-2909-5811; Holschneider, Matthias/0000-0003-3987-105X	Deutsche Forschungsgemeinschaft (Research Unit 868 Computational Modeling of Behavioral, Cognitive, and Neural Dynamics) [EN 471/3-2]	Deutsche Forschungsgemeinschaft (Research Unit 868 Computational Modeling of Behavioral, Cognitive, and Neural Dynamics)(German Research Foundation (DFG))	This research was supported by Deutsche Forschungsgemeinschaft (Research Unit 868 Computational Modeling of Behavioral, Cognitive, and Neural Dynamics, grant EN 471/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi R, 2004, VISION RES, V44, P2675, DOI 10.1016/j.visres.2004.05.009; Abadi RV, 2000, VISION RES, V40, P2813, DOI 10.1016/S0042-6989(00)00146-2; Badii R., 1999, COMPLEXITY HIERARCHI; Bettenbuhl M, 2010, J EYE MOVEMENT RES, V3; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; Engbert R, 2011, P NATL ACAD SCI USA, V108, pE765, DOI 10.1073/pnas.1102730108; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Jeffreys H., 1998, THEORY PROBABILITY; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Leigh R, 1999, NEUROLOGY EYE MOVEME, V55; Liversedge S, 2011, OXFORD HDB EYE MOVEM; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Mergenthaler K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.138104; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Perron O, 1907, MATH ANN, V64, P248, DOI 10.1007/BF01449896; Poletti M, 2010, J NEUROSCI, V30, P11143, DOI 10.1523/JNEUROSCI.1925-10.2010; Rieke F., 1997, SPIKES EXPLORING NEU; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; ROSENBLATT M, 1962, J SOC IND APPL MATH, V10, P537, DOI 10.1137/0110041; Salman MS, 2009, J CHILD NEUROL, V24, P161, DOI 10.1177/0883073808322326; Taylor H. M., 1984, INTRO STOCHASTIC MOD; TROOST BT, 1977, ANN NEUROL, V2, P397, DOI 10.1002/ana.410020509; van Kampen N. G., 1981, STOCHASTIC PROCESSES; VASUDEVAN R, 1972, KYBERNETIK, V11, P24, DOI 10.1007/BF00267762; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43388	10.1371/journal.pone.0043388	http://dx.doi.org/10.1371/journal.pone.0043388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970124	Green Submitted, gold, Green Published			2022-12-25	WOS:000308458400009
J	Saggurti, N; Mahapatra, B; Sabarwal, S; Ghosh, S; Johri, A				Saggurti, Niranjan; Mahapatra, Bidhubhusan; Sabarwal, Shrutika; Ghosh, Subash; Johri, Aradhana			Male Out-Migration: A Factor for the Spread of HIV Infection among Married Men and Women in Rural India	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; SOUTH-AFRICA; MIGRANT WORKERS; RISK-FACTORS; POPULATION; MOBILITY	Introduction: Thus far, the reasons for increasing HIV prevalence in northern and eastern Indian states are unknown. We investigated the role of male out-migration in the spread of human immunodeficiency virus (HIV) infection through a case-control study in rural India. Methods: Currently married men and women were recruited from HIV testing and treatment centers across seven selected districts with high rates of male out-migration in eastern and northern India in 2010 using a case-control study design. Case subjects (men: 595, women: 609) were people who tested HIV seropositive and control subjects (men: 611, women: 600) were those tested HIV seronegative. For each gender, we obtained adjusted odds ratios (AORs) and population attributable risks (PARs) for migration, and behavioral factors. Results: For men, the prevalence of HIV was significantly higher among those with a migration history (AOR, 4.4); for women, the prevalence of HIV was higher among those with migrant husbands (AOR, 2.3). For both genders, the returned male migration (men: AOR, 3.7; women: AOR, 2.8) was significantly associated with higher prevalence of HIV infection. The PAR associated with male migration was higher for men (54.5%-68.6%) than for women (32.7%-56.9%) across the study areas. Discussion: Male out-migration is the most important risk factor influencing the spread of HIV infection in rural areas with high out-migration rates, thereby emphasizing the need for interventions, particularly, for returned migrants and spouses of those migrants.	[Saggurti, Niranjan; Mahapatra, Bidhubhusan; Sabarwal, Shrutika] Populat Council, HIV & AIDS Program, New Delhi, India; [Ghosh, Subash; Johri, Aradhana] Govt India, Minist Hlth & Family Welf, Dept AIDS Control, Natl AIDS Control Org, New Delhi, India		Saggurti, N (corresponding author), Populat Council, HIV & AIDS Program, New Delhi, India.	bbmahapatra@popcouncil.org	Mahapatra, Bidhubhusan/M-1411-2019; Mahapatra, Bidhubhusan/A-8830-2013	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Saggurti, Niranjan/0000-0002-5267-8425	United Nations Development Programme (UNDP)	United Nations Development Programme (UNDP)	United Nations Development Programme (UNDP) provided a grant to Population Council to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockerhoff M, 1999, INT MIGR REV, V33, P833, DOI 10.2307/2547354; Chirwa WC, 1997, INT MIGR REV, V31, P628, DOI 10.2307/2547289; Decosas J, 1997, AIDS, V11, pS77; Duckett M, 2000, Dev Bull, P18; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; [International Institute for Population Sciences (IIPS) ORC Macro], 2007, NAT FAM HLTH SURV 3; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Lurie M, 1997, S AFR MED J, V87, P908; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Lydie N, 2004, JAIDS-J ACQ IMM DEF, V35, P67, DOI 10.1097/00126334-200401010-00010; Mrinalika Dhapola, 2007, Economic and Political Weekly, V42, P40; Mundandi C, 2006, TROP MED INT HEALTH, V11, P705, DOI 10.1111/j.1365-3156.2006.01614.x; [National AIDS Control Organisation (NACO) Department of AIDS Control MoHFW], 2007, HIV FACT SHEETS BAS; [National Institute for Medical Statistics (NIMS) National AIDS Control Organisation (NACO)], 2010, TECHN REP IND HIV ES; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; Parrado EA, 2004, PERSPECT SEX REPRO H, V36, P150, DOI 10.1111/j.1931-2393.2004.tb00016.x; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Population Council, 2008, PATT MIGR MOB HIV RI; Poudel KC, 2004, TROP DOCT, V34, P30, DOI 10.1177/004947550403400115; QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407; Registrar General of India (RGI), 2001, CENS IND MIGR PART; Registrar General of India (RGI), 2011, CENS IND PROV POP TO; Saggurti N, 2011, AIDS BEHAV; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S6; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; Sogarwal Ruchi, 2009, J Indian Med Assoc, V107, P276; Soskolne V, 2002, SOC SCI MED, V55, P1297, DOI 10.1016/S0277-9536(01)00282-9; Todd J, 2006, J INFECT DIS, V193, P458, DOI 10.1086/499313; Yang XS, 2004, INT MIGR REV, V38, P212, DOI 10.1111/j.1747-7379.2004.tb00194.x; Zuma K, 2003, INT J STD AIDS, V14, P814, DOI 10.1258/095646203322556147	33	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43222	10.1371/journal.pone.0043222	http://dx.doi.org/10.1371/journal.pone.0043222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970120	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400007
J	Philip, N; Vaikkinen, HJ; Tetley, L; Waters, AP				Philip, Nisha; Vaikkinen, Heli J.; Tetley, Laurence; Waters, Andrew P.			A Unique Kelch Domain Phosphatase in Plasmodium Regulates Ookinete Morphology, Motility and Invasion	PLOS ONE			English	Article							PROTEIN SERINE/THREONINE PHOSPHATASE; MALARIA PARASITE; LIFE-CYCLE; MOSQUITO TRANSMISSION; SER/THR PHOSPHATASES; SEXUAL DEVELOPMENT; PROTEOMIC ANALYSES; GAMETE FORMATION; REPEAT DOMAINS; KINASE	Signalling through post-translational modification (PTM) of proteins is a process central to cell homeostasis, development and responses to external stimuli. The best characterised PTM is protein phosphorylation which is reversibly catalysed at specific residues through the action of protein kinases (addition) and phosphatases (removal). Here, we report characterisation of an orphan protein phosphatase that possesses a domain architecture previously only described in Plantae. Through gene disruption and the production of active site mutants, the enzymatically active Protein Phosphatase containing Kelch-Like domains (PPKL, PBANKA_132950) is shown to play an essential role in the development of an infectious ookinete. PPKL is produced in schizonts and female gametocytes, is maternally inherited where its absence leads to the development of a malformed, immotile, non-infectious ookinete with an extended apical protrusion. The distribution of PPKL includes focussed localization at the ookinete apical tip implying a link between its activity and the correct deployment of the apical complex and microtubule cytoskeleton. Unlike wild type parasites, ppkl(-) ookinetes do not have a pronounced apical distribution of their micronemes yet secretion of microneme cargo is unaffected in the mutant implying that release of microneme cargo is either highly efficient at the malformed apical prominence or secretion may also occur from other points of the parasite, possibly the pellicular pores.	[Philip, Nisha; Vaikkinen, Heli J.; Tetley, Laurence; Waters, Andrew P.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Glasgow	Philip, N (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Sir Graeme Davies Bldg, Glasgow, Lanark, Scotland.	Nisha.philip@glasgow.ac.uk; Andy.Waters@glasgow.ac.uk		Philip, Nisha/0000-0001-9901-1997	European Molecular Biology Organization Long-Term Fellowship (EMBO LTF); Wellcome Trust [083811/Z/07/Z]; EU FP7 Network of Excellence EviMalar [242095]	European Molecular Biology Organization Long-Term Fellowship (EMBO LTF)(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); EU FP7 Network of Excellence EviMalar	The work was funded by a European Molecular Biology Organization Long-Term Fellowship (EMBO LTF) to NP, Wellcome Trust to APW (083811/Z/07/Z) and EU FP7 Network of Excellence EviMalar to APW (242095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Agarwal S, 2011, J CELL BIOCHEM, V112, P1295, DOI 10.1002/jcb.23034; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Ben Rached F, 2012, BIOL CELL, V104, P34, DOI 10.1111/boc.201100081; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Budhwar R, 2011, CELL CYCLE, V10, P767, DOI 10.4161/cc.10.5.14828; Bushell ESC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000539; CANNING EU, 1973, PARASITOLOGY, V67, P29, DOI 10.1017/S0031182000046266; Dixit A, 2010, J BIOL CHEM, V285, P38315, DOI 10.1074/jbc.M110.119255; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Hegge Stephan, 2009, Biotechnology Journal, V4, P903, DOI 10.1002/biot.200900007; Hirai M, 2006, J BIOCHEM, V140, P747, DOI 10.1093/jb/mvj205; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kim TW, 2011, MOL CELL, V43, P561, DOI 10.1016/j.molcel.2011.05.037; Kostich M, 2002, GENOME BIOL, V3; Kutuzov MA, 2002, CELL SIGNAL, V14, P745, DOI 10.1016/S0898-6568(02)00018-9; Kutuzov MA, 2008, MOL BIOCHEM PARASIT, V161, P81, DOI 10.1016/j.molbiopara.2008.06.008; Li JL, 1998, MOL BIOCHEM PARASIT, V95, P287, DOI 10.1016/S0166-6851(98)00106-6; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Melnikova I, 2004, NAT REV DRUG DISCOV, V3, P993, DOI 10.1038/nrd1600; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Philip N, 2007, P NATL ACAD SCI USA, V104, P7845, DOI 10.1073/pnas.0611601104; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; Reininger L, 2005, J BIOL CHEM, V280, P31957, DOI 10.1074/jbc.M504523200; Reininger L, 2009, J BIOL CHEM, V284, P20858, DOI 10.1074/jbc.M109.017988; SCHMID MF, 1994, J CELL BIOL, V124, P341, DOI 10.1083/jcb.124.3.341; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Szoor B, 2010, GENE DEV, V24, P1306, DOI 10.1101/gad.570310; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Tewari R, 2005, MOL MICROBIOL, V58, P1253, DOI 10.1111/j.1365-2958.2005.04793.x; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; Tremp AZ, 2011, J BIOL CHEM, V286, P5383, DOI 10.1074/jbc.M110.187195; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Yokoyama D, 1998, BIOCHEM BIOPH RES CO, V247, P18, DOI 10.1006/bbrc.1998.8730; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	51	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44617	10.1371/journal.pone.0044617	http://dx.doi.org/10.1371/journal.pone.0044617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957089	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000308463800082
J	Shetty, PK; Thamake, SI; Biswas, S; Johansson, SL; Vishwanatha, JK				Shetty, Praveenkumar K.; Thamake, Sanjay I.; Biswas, Swati; Johansson, Sonny L.; Vishwanatha, Jamboor K.			Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DEPENDENT PLASMINOGEN ACTIVATION; PROSTATE-CANCER; CELL-LINES; T-PA; PROTEIN EXPRESSION; II OVEREXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; TARGETING SRC	Alternative survival pathways are commonly seen to be upregulated upon inhibition of receptor tyrosine kinases (RTK), including Her-2. It is established that treatment with Herceptin leads to selective overexpression and activation of epidermal growth factor receptor (EGFR) and Src which further contributes to oncogenesis in Herceptin resistant and triple negative breast cancer (TNBC) patients. Here, we show a co-regulated upregulation in the expression of Annexin A2 (AnxA2), a known substrate of Src and one of the regulators of EGFR receptor endocytosis, in Herceptin resistant and Her-2 negative breast cancer. Immunohistochemical expression analysis revealed a reciprocal regulation between Her-2 and AnxA2 in breast cancer clinical samples as well as in cell lines as confirmed by protein and RNA analysis. The siRNA and Herceptin mediated downregulation/inhibition of Her-2 in Her-2 amplified cells induced AnxA2 expression and membrane translocation. In this study we report a possible involvement of AnxA2 in maintaining constitutively activated EGFR downstream signaling intermediates and hence in cell proliferation, migration and viability. This effect was consistent in Herceptin resistant JIMT-1 cells as well as in Her-2 negative breast cancer. The siRNA mediated AnxA2 downregulation leads to increased apoptosis, decreased cell viability and migration. Our studies further indicate the role of AnxA2 in EGFR-Src membrane bound signaling complex and ligand induced activation of downstream signaling pathways. Targeting this AnxA2 dependent positive regulation of EGFR signaling cascade may be of therapeutic value in Her-2 negative breast cancer.	[Shetty, Praveenkumar K.; Vishwanatha, Jamboor K.] SDM Coll Med Sci & Hosp, Dept Biochem, Dharwad, Karnataka, India; [Thamake, Sanjay I.; Vishwanatha, Jamboor K.] Univ N Texas, Hlth Sci Ctr, Dept Biomed Sci, Ft Worth, TX USA; [Johansson, Sonny L.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE USA; [Biswas, Swati] Univ Texas Dallas, Dept Math Sci, Dallas, TX 75230 USA	University of North Texas System; University of North Texas Health Science Center; University of Nebraska System; University of Nebraska Medical Center; University of Texas System; University of Texas Dallas	Shetty, PK (corresponding author), SDM Coll Med Sci & Hosp, Dept Biochem, Dharwad, Karnataka, India.	jamboor.vishwanatha@unthsc.edu		Vishwanatha, Jamboor/0000-0002-0266-6020	National Institutes of Health [MD001633, MD006882]; Cancer Research Foundation of North Texas; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001633] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Foundation of North Texas; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by grants from the National Institutes of Health (MD001633 and MD006882) and Cancer Research Foundation of North Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Banerjee Abhijit G, 2003, Mol Cancer, V2, P34, DOI 10.1186/1476-4598-2-34; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boyer J, 2004, ANTICANCER RES, V24, P417; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Choudhury A, 2004, INT J CANCER, V108, P71, DOI 10.1002/ijc.11497; Chuthapisith S, 2007, INT J ONCOL, V30, P1545; Chuthapisith S, 2009, EUR J CANCER, V45, P1274, DOI 10.1016/j.ejca.2008.12.026; CIOCCA DR, 1993, J NATL CANCER I, V85, P570, DOI 10.1093/jnci/85.7.570; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Diaz VM, 2004, GUT, V53, P993, DOI 10.1136/gut.2003.026831; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Emoto K, 2001, ANTICANCER RES, V21, P1339; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Hajjar KA, 1999, TRENDS CARDIOVAS MED, V9, P128, DOI 10.1016/S1050-1738(99)00020-1; Hayes MJ, 2009, J BIOL CHEM, V284, P10202, DOI 10.1074/jbc.M807043200; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kassam G, 1998, BIOCHEMISTRY-US, V37, P16958, DOI 10.1021/bi981713l; Kauraniemi P, 2004, ONCOGENE, V23, P1010, DOI 10.1038/sj.onc.1207200; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Koninki K, 2010, CANCER LETT, V294, P211, DOI 10.1016/j.canlet.2010.02.002; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Ohno Y, 2009, BRIT J CANCER, V101, P287, DOI 10.1038/sj.bjc.6605128; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Ribeiro-Silva A, 2006, AM J CLIN PATHOL, V125, P512, DOI 10.1309/D744C4NM15J3B00D; Pinilla SMR, 2006, BREAST CANCER RES TR, V99, P85, DOI 10.1007/s10549-006-9184-1; Sharma M, 2010, EXP MOL PATHOL, V88, P278, DOI 10.1016/j.yexmp.2010.01.001; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Shimizu M, 2011, CANCER RES, V71, P277, DOI 10.1158/0008-5472.CAN-10-2523; Snoj N, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2209; Takano S, 2008, ANN SURG ONCOL, V15, P3157, DOI 10.1245/s10434-008-0061-5; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Toyama T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-309; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Valapala M, 2011, J CELL SCI, V124, P1453, DOI 10.1242/jcs.079236; Viale G, 2008, BREAST CANC RES TREA; VISHWANATHA JK, 1992, J CELL SCI, V101, P25; Yao HX, 2009, LUNG CANCER, V65, P41, DOI 10.1016/j.lungcan.2008.10.024; Yoo JC, 2007, BIOCHEM BIOPH RES CO, V356, P906, DOI 10.1016/j.bbrc.2007.03.061; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhang Y, 2010, J CLIN ONCOL, V9, pP660; Zhao WQ, 2003, J BIOL CHEM, V278, P4205, DOI 10.1074/jbc.M210545200	58	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44299	10.1371/journal.pone.0044299	http://dx.doi.org/10.1371/journal.pone.0044299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957061	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800054
J	Sharma, S; Sun, XT; Rafikov, R; Kumar, S; Hou, YL; Oishi, PE; Datar, SA; Raff, G; Fineman, JR; Black, SM				Sharma, Shruti; Sun, Xutong; Rafikov, Ruslan; Kumar, Sanjiv; Hou, Yali; Oishi, Peter E.; Datar, Sanjeev A.; Raff, Gary; Fineman, Jeffrey R.; Black, Stephen M.			PPAR-gamma Regulates Carnitine Homeostasis and Mitochondrial Function in a Lamb Model of Increased Pulmonary Blood Flow	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; NITRIC-OXIDE SYNTHASE; ARTERIAL ENDOTHELIAL-CELLS; GTP CYCLOHYDROLASE I; GENE-EXPRESSION; SHEAR-STRESS; VASCULAR-DISEASE; LIPID-METABOLISM; LAMINAR-FLOW; FETAL LAMBS	Objective: Carnitine homeostasis is disrupted in lambs with endothelial dysfunction secondary to increased pulmonary blood flow (Shunt). Our recent studies have also indicated that the disruption in carnitine homeostasis correlates with a decrease in PPAR-gamma expression in Shunt lambs. Thus, this study was carried out to determine if there is a causal link between loss of PPAR-gamma signaling and carnitine dysfunction, and whether the PPAR-gamma agonist, rosiglitazone preserves carnitine homeostasis in Shunt lambs. Methods and Results: siRNA-mediated PPAR-gamma knockdown significantly reduced carnitine palmitoyltransferases 1 and 2 (CPT1 and 2) and carnitine acetyltransferase (CrAT) protein levels. This decrease in carnitine regulatory proteins resulted in a disruption in carnitine homeostasis and induced mitochondrial dysfunction, as determined by a reduction in cellular ATP levels. In turn, the decrease in cellular ATP attenuated NO signaling through a reduction in eNOS/Hsp90 interactions and enhanced eNOS uncoupling. In vivo, rosiglitazone treatment preserved carnitine homeostasis and attenuated the development of mitochondrial dysfunction in Shunt lambs maintaining ATP levels. This in turn preserved eNOS/Hsp90 interactions and NO signaling. Conclusion: Our study indicates that PPAR-gamma signaling plays an important role in maintaining mitochondrial function through the regulation of carnitine homeostasis both in vitro and in vivo. Further, it identifies a new mechanism by which PPAR-gamma regulates NO signaling through Hsp90. Thus, PPAR-gamma agonists may have therapeutic potential in preventing the endothelial dysfunction in children with increased pulmonary blood flow.	[Sharma, Shruti; Sun, Xutong; Rafikov, Ruslan; Kumar, Sanjiv; Hou, Yali; Black, Stephen M.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA; [Oishi, Peter E.; Datar, Sanjeev A.; Fineman, Jeffrey R.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Fineman, Jeffrey R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Raff, Gary] Univ Calif Davis, Dept Surg, Davis, CA 95616 USA	University System of Georgia; Augusta University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Sharma, S (corresponding author), Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA.	sblack@georgiahealth.edu	Rafikov, Ruslan/AAG-9352-2019	Sharma, Shruti/0000-0001-8200-108X; Rafikov, Ruslan/0000-0001-5950-4076	National Institutes of Health [HL60190, HL67841, HL72123, HL70061, R21HD057406]; Fondation Leducq; AHA Scientist Development Grant [11SDG7460024]; National Institutes of Health Training Grant [5T32-HL-06699]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060190, R01HL067841, R01HL072123, R01HL061284, R01HL070061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); AHA Scientist Development Grant(American Heart Association); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by grants HL60190 (SMB), HL67841 (SMB), HL72123 (SMB), HL70061 (SMB), R21HD057406 (SMB), and HL61284 (JRF) all from the National Institutes of Health, and by a grant from the Fondation Leducq (SMB and JRF), an AHA Scientist Development Grant 11SDG7460024 (SS) and by National Institutes of Health Training Grant, 5T32-HL-06699 (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameshima S, 2003, CIRC RES, V92, P1162, DOI 10.1161/01.RES.0000073585.50092.14; Bao YX, 2008, MOL CELL BIOCHEM, V317, P189, DOI 10.1007/s11010-008-9848-8; Bogacka I, 2007, DIABETES CARE, V30, P1179, DOI 10.2337/dc06-1962; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; D'Argenio G, 2010, J BIOL CHEM, V285, P27078, DOI 10.1074/jbc.M110.109678; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Dhaunsi GS, 2010, EUR J PHARMACOL, V638, P108, DOI 10.1016/j.ejphar.2010.04.030; Ewing JF, 1998, FREE RADICAL BIO MED, V25, P621, DOI 10.1016/S0891-5849(98)00083-5; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Gupta D, 2010, DIABETES OBES METAB, V12, P1036, DOI 10.1111/j.1463-1326.2010.01299.x; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hart CM, 2008, J INVEST MED, V56, P515, DOI 10.2310/JIM.0b013e318165e89d; Hart CM, 2008, J INVEST MED, V56, P518, DOI 10.2310/JIM.0b013e318165e921; Hashimoto R, 2010, J ATHEROSCLER THROMB, V17, P785, DOI 10.5551/jat.4556; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; Ikejima H, 2008, J HYPERTENS, V26, P964, DOI 10.1097/HJH.0b013e3282f52c36; Kelly LK, 2004, AM J PHYSIOL-LUNG C, V286, pL984, DOI 10.1152/ajplung.00224.2003; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim EK, 2010, RESPIROLOGY, V15, P659, DOI 10.1111/j.1440-1843.2010.01756.x; Kim S, 2005, J NUTR, V135, P33, DOI 10.1093/jn/135.1.33; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Konduri GG, 2000, BIOL NEONATE, V78, P220, DOI 10.1159/000014274; Konduri GG, 2002, AM J PHYSIOL-HEART C, V283, pH1600, DOI 10.1152/ajpheart.00245.2002; Lakshminrusimha S, 2007, AM J PHYSIOL-HEART C, V293, pH1491, DOI 10.1152/ajpheart.00185.2007; Lapsys NM, 2000, J CLIN ENDOCR METAB, V85, P4293, DOI 10.1210/jc.85.11.4293; Liu JK, 2002, P NATL ACAD SCI USA, V99, P1876, DOI 10.1073/pnas.261709098; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Liu Y, 2004, CIRCULATION, V110, P1128, DOI 10.1161/01.CIR.0000139850.08365.EC; MARBACH EP, 1967, CLIN CHEM, V13, P314; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Mata-Greenwood E, 2003, AM J PHYSIOL-LUNG C, V285, pL209, DOI 10.1152/ajplung.00171.2002; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Nisbet RE, 2007, PPAR RES, V2007, DOI 10.1155/2007/18797; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Poleni PE, 2007, OSTEOARTHR CARTILAGE, V15, P493, DOI 10.1016/j.joca.2006.10.009; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; REDDY VM, 1995, CIRCULATION, V92, P606, DOI 10.1161/01.CIR.92.3.606; Richir MC, 2009, PHARMACOL RES, V60, P519, DOI 10.1016/j.phrs.2009.06.007; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Sharma S, 2007, AM J PHYSIOL-LUNG C, V293, pL960, DOI 10.1152/ajplung.00449.2006; Sharma S, 2012, FREE RADICAL BIO MED, V53, P216, DOI 10.1016/j.freeradbiomed.2012.03.016; Shen W, 2011, BR J PHARM; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Sun XT, 2011, AM J RESP CELL MOL, V45, P163, DOI 10.1165/rcmb.2009-0467OC; Sutliff Roy L, 2010, Ther Adv Respir Dis, V4, P143, DOI 10.1177/1753465809369619; Tian J, 2009, PHYSIOL GENOMICS, V40, P48, DOI 10.1152/physiolgenomics.00094.2009; Tschudi MR, 1996, HYPERTENSION, V27, P32, DOI 10.1161/01.HYP.27.1.32; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; Viccica G, 2010, J Endocrinol Invest, V33, P9; Wedgwood S, 2003, AM J PHYSIOL-LUNG C, V284, pL650, DOI 10.1152/ajplung.00252.2002; Wedgwood S, 2001, AM J PHYSIOL-LUNG C, V281, pL490, DOI 10.1152/ajplung.2001.281.2.L490; Wiseman DA, 2007, AM J PHYSIOL-LUNG C, V292, pL165, DOI 10.1152/ajplung.00459.2005; Yuen CY, 2011, CARDIOVASC RES	61	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e41555	10.1371/journal.pone.0041555	http://dx.doi.org/10.1371/journal.pone.0041555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962578	gold, Green Submitted, Green Published			2022-12-25	WOS:000308577600005
J	Almog, N; Ma, LL; Schwager, C; Brinkmann, BG; Beheshti, A; Vajkoczy, P; Folkman, J; Hlatky, L; Abdollahi, A				Almog, Nava; Ma, Lili; Schwager, Christian; Brinkmann, Bastian G.; Beheshti, Afshin; Vajkoczy, Peter; Folkman, Judah; Hlatky, Lynn; Abdollahi, Amir			Consensus Micro RNAs Governing the Switch of Dormant Tumors to the Fast-Growing Angiogenic Phenotype	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER DORMANCY; ANGIOSTATIN; MECHANISMS; CELLS; BV8; SUPPRESSION; CARCINOMA; NETWORK; MODEL	Tumor dormancy refers to a critical stage in cancer development in which tumor cells remain occult for a prolonged period of time until they eventually progress and become clinically apparent. We previously showed that the switch of dormant tumors to fast-growth is angiogenesis dependent and requires a stable transcriptional reprogramming in tumor cells. Considering microRNAs (miRs) as master regulators of transcriptome, we sought to investigate their role in the control of tumor dormancy. We report here the identification of a consensus set of 19 miRs that govern the phenotypic switch of human dormant breast carcinoma, glioblastoma, osteosarcoma, and liposarcoma tumors to fast-growth. Loss of expression of dormancy-associated miRs (DmiRs, 16/19) was the prevailing regulation pattern correlating with the switch of dormant tumors to fast-growth. The expression pattern of two DmiRs (miR-580 and 190) was confirmed to correlate with disease stage in human glioma specimens. Reconstitution of a single DmiR (miR-580, 588 or 190) led to phenotypic reversal of fast-growing angiogenic tumors towards prolonged tumor dormancy. Of note, 60% of angiogenic glioblastoma and 100% of angiogenic osteosarcoma over-expressing miR190 remained dormant during the entire observation period of similar to 120 days. Next, the ability of DmiRs to regulate angiogenesis and dormancy-associated genes was evaluated. Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha. In addition, a G-CSF independent downregulation of Bv8 was found as a common target of all three DmiRs and correlated with decreased tumor recruitment of bone marrow-derived CD11b+ Gr-1+ myeloid cells. In contrast, antiangiogenic and dormancy promoting pathways such as EphA5 and Angiomotin were upregulated in DmiR over-expressing tumors. This work suggests novel means to reverse the malignant tumor phenotype into an asymptomatic dormant state and may provide promising targets for early detection or prevention of cancer.	[Almog, Nava; Ma, Lili; Beheshti, Afshin; Hlatky, Lynn; Abdollahi, Amir] Tufts Univ, Sch Med, Steward Res & Specialty Projects Corp, Ctr Canc Syst Biol,St Elizabeths Med Ctr, Boston, MA 02111 USA; [Schwager, Christian; Abdollahi, Amir] Heidelberg Univ, Sch Med, Heidelberg Ion Therapy Ctr, Heidelberg, Germany; [Ma, Lili; Abdollahi, Amir] German Canc Res Ctr, Natl Ctr Tumor Dis, D-6900 Heidelberg, Germany; [Brinkmann, Bastian G.; Vajkoczy, Peter] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Folkman, Judah] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Folkman, Judah] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA	St. Elizabeth's Medical Center; Tufts University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Almog, N (corresponding author), Tufts Univ, Sch Med, Steward Res & Specialty Projects Corp, Ctr Canc Syst Biol,St Elizabeths Med Ctr, Boston, MA 02111 USA.	Nava.Almog@Tufts.edu; Amir.Abdollahi@Tufts.edu	Beheshti, Afshin/AAH-7267-2019; Beheshti, Afshin/N-2241-2014	Beheshti, Afshin/0000-0003-4643-531X	National Aeronautics and Space Administration Specialized Center of Research (NSCOR) [NNJ06HA28G]; German Krebshilfe (Deutsche Krebshilfe) [108876]; German Research Foundation [SPP1190]; National Center for Tumor diseases (Heidelberg, Germany); German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung) [BMBF 03NUK004C]	National Aeronautics and Space Administration Specialized Center of Research (NSCOR); German Krebshilfe (Deutsche Krebshilfe)(Deutsche Krebshilfe); German Research Foundation(German Research Foundation (DFG)); National Center for Tumor diseases (Heidelberg, Germany); German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This material is based upon work supported by the National Aeronautics and Space Administration Specialized Center of Research (NSCOR, grant no. NNJ06HA28G) issued through the Human Research Program. It was also supported in part by the German Krebshilfe (Deutsche Krebshilfe, Max-Eder 108876), German Research Foundation National Priority Research Program: the Tumor-Vessel Interface "SPP1190", Intramural Grants of the National Center for Tumor diseases (Heidelberg, Germany) and the German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung - BMBF 03NUK004C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANC LETT; Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Domhan S, 2008, MOL CANCER THER, V7, P1656, DOI 10.1158/1535-7163.MCT-08-0193; Fainaru O, 2009, FASEB J; Favaro E, 2008, APMIS, V116, P648, DOI 10.1111/j.1600-0463.2008.01025.x; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Gilead A, 2004, INT J CANCER, V108, P524, DOI 10.1002/ijc.11583; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Indraccolo S, 2009, CANCER RES, V69, P1314, DOI 10.1158/0008-5472.CAN-08-2791; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; Lee TY, 2009, BLOOD, V114, P1987, DOI 10.1182/blood-2008-12-197236; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Naumov GN, 2008, CLIN EXP METASTASIS; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Tang Y, 2009, INT J CANCER, V124, P1545, DOI 10.1002/ijc.24118; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	35	55	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44001	10.1371/journal.pone.0044001	http://dx.doi.org/10.1371/journal.pone.0044001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952847	Green Submitted, gold, Green Published			2022-12-25	WOS:000308221300040
J	Milliman, EJ; Yadav, N; Chen, YC; Muddukrishna, B; Karunanithi, S; Yu, MC				Milliman, Eric J.; Yadav, Neelu; Chen, Yin-Chu; Muddukrishna, Bhavana; Karunanithi, Sheelarani; Yu, Michael C.			Recruitment of Rpd3 to the Telomere Depends on the Protein Arginine Methyltransferase Hmt1	PLOS ONE			English	Article							HISTONE DEACETYLASE COMPLEX; GENETIC INTERACTION MAP; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; SILENT CHROMATIN; IN-VIVO; INTERACTION NETWORKS; METHYLATION; YEAST; ACETYLATION	In the yeast Saccharomyces cerevisiae, the establishment and maintenance of silent chromatin at the telomere requires a delicate balance between opposing activities of histone modifying enzymes. Previously, we demonstrated that the protein arginine methyltransferase Hmt1 plays a role in the formation of yeast silent chromatin. To better understand the nature of the Hmt1 interactions that contribute to this phenomenon, we carried out a systematic reverse genetic screen using a null allele of HMT1 and the synthetic genetic array (SGA) methodology. This screen revealed interactions between HMT1 and genes encoding components of the histone deacetylase complex Rpd3L (large). A double mutant carrying both RPD3 and HMT1 deletions display increased telomeric silencing and Sir2 occupancy at the telomeric boundary regions, when comparing to a single mutant carrying Hmt1-deletion only. However, the dual rpd3/hmt1-null mutant behaves like the rpd3-null single mutant with respect to silencing behavior, indicating that RPD3 is epistatic to HMT1. Mutants lacking either Hmt1 or its catalytic activity display an increase in the recruitment of histone deacetylase Rpd3 to the telomeric boundary regions. Moreover, in such loss-of-function mutants the levels of acetylated H4K5, which is a substrate of Rpd3, are altered at the telomeric boundary regions. In contrast, the level of acetylated H4K16, a target of the histone deacetylase Sir2, was increased in these regions. Interestingly, mutants lacking either Rpd3 or Sir2 display various levels of reduction in dimethylated H4R3 at these telomeric boundary regions. Together, these data provide insight into the mechanism whereby Hmt1 promotes the proper establishment and maintenance of silent chromatin at the telomeres.	[Milliman, Eric J.; Yadav, Neelu; Chen, Yin-Chu; Muddukrishna, Bhavana; Karunanithi, Sheelarani; Yu, Michael C.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Milliman, EJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	mcyu@buffalo.edu	Yu, Michael C/GON-5550-2022	Yu, Michael/0000-0002-3611-9295	Scientist Development grant [0830279N]; American Heart Association; Julian Park Fund; College of Arts and Sciences, University at Buffalo; Direct For Biological Sciences [1051350] Funding Source: National Science Foundation	Scientist Development grant; American Heart Association(American Heart Association); Julian Park Fund; College of Arts and Sciences, University at Buffalo; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Scientist Development grant (0830279N) from the American Heart Association, to MCY. The publication costs of this article were supported by the Julian Park Fund, College of Arts and Sciences, University at Buffalo. The funders had no role in study design, data collection, data interpretation, or the decision to prepare and publish of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chang CS, 2009, GENETICS, V183, P149, DOI 10.1534/genetics.109.103846; Chavel CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000883; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; DeRubertis F, 1996, NATURE, V384, P589; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Ehrentraut S, 2010, P NATL ACAD SCI USA, V107, P5522, DOI 10.1073/pnas.0909169107; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hung ML, 2010, NUCLEIC ACIDS RES, V38, P3351, DOI 10.1093/nar/gkq033; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Hyun S, 2008, CHEMBIOCHEM, V9, P2790, DOI 10.1002/cbic.200800544; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Inai T, 2007, MOL CELL BIOL, V27, P1254, DOI 10.1128/MCB.01661-06; Jacobson S, 2009, MOL CELL BIOL, V29, P6033, DOI 10.1128/MCB.00542-09; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 2009, BBA-GENE REGUL MECH, V1789, P395, DOI 10.1016/j.bbagrm.2009.03.004; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lei EP, 2002, GENE DEV, V16, P2761, DOI 10.1101/gad.1032902; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh I, 2009, GENETICS, V181, P289, DOI 10.1534/genetics.108.092981; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Sun ZW, 1999, GENETICS, V152, P921; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vannier D, 1996, GENETICS, V144, P1343; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yu MC, 2006, GENE DEV, V20, P3249, DOI 10.1101/gad.1495206; Zhou J, 2009, NUCLEIC ACIDS RES, V37, P3699, DOI 10.1093/nar/gkp233	62	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44656	10.1371/journal.pone.0044656	http://dx.doi.org/10.1371/journal.pone.0044656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22953000	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300104
J	Almada, VC; Almada, F; Francisco, SM; Castilho, R; Robalo, JI				Almada, Vitor C.; Almada, Frederico; Francisco, Sara M.; Castilho, Rita; Robalo, Joana I.			Unexpected High Genetic Diversity at the Extreme Northern Geographic Limit of Taurulus bubalis (Euphrasen, 1786)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MEDITERRANEAN SEA; ATLANTIC; PHYLOGEOGRAPHY; PLEISTOCENE; EXPANSION; REFUGIA; FISH; POPULATIONS; LOBSTER	The longspined bullhead (Taurulus bubalis, Euphrasen 1786) belongs to the family Cottidae and is a rocky shore species that inhabits the intertidal zones of the Eastern Atlantic since Iceland, southward to Portugal and also the North Sea and Baltic, northward to the Gulf of Finland, with some occurrences in the northern Mediterranean coasts eastward to the Gulf of Genoa. We analysed the phylogeographic patterns of this species using mitochondrial and nuclear markers in populations throughout most of its distributional range in west Europe. We found that T. bubalis has a relatively shallow genealogy with some differentiation between Atlantic and North Sea. Genetic diversity was homogeneous across all populations studied. The possibility of a glacial refugium near the North Sea is discussed. In many, but not all, marine temperate organisms, patterns of diversity are similar across the species range. If this phenomenon proves to be most common in cold adapted species, it may reflect the availability of glacial refugia not far from their present-day northern limits.	[Almada, Vitor C.; Almada, Frederico; Francisco, Sara M.; Robalo, Joana I.] ISPA Univ Inst, Ecoethol Res Unit, Lisbon, Portugal; [Castilho, Rita] Univ Algarve, Ctr Ciencias Mar CCMAR, CIMAR Associate Lab, Faro, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade do Algarve	Almada, VC (corresponding author), ISPA Univ Inst, Ecoethol Res Unit, Lisbon, Portugal.	sara_francisco@ispa.pt	Robalo, Joana I./HIK-2365-2022; Francisco, Sara/K-8239-2013; Robalo, Joana Isabel/N-9960-2014; Castilho, Rita/B-6185-2008; Almada, Frederico/AAC-4340-2020	Robalo, Joana I./0000-0002-7470-0574; Francisco, Sara/0000-0003-0907-7453; Robalo, Joana Isabel/0000-0002-7470-0574; Castilho, Rita/0000-0003-0727-3688; Almada, Frederico/0000-0002-1389-8951	ASSEMBLE project [SBRmm -4]; European Science Foundation; Eco-Ethology Research Unit [331/94]; FEDER; FCT grant (Fundacao para a Ciencia e a Tecnologia) [SFRH/BPD/63170/2009]	ASSEMBLE project; European Science Foundation(European Science Foundation (ESF)European Commission); Eco-Ethology Research Unit; FEDER(European Commission); FCT grant (Fundacao para a Ciencia e a Tecnologia)	We are in debt to Wilfried Thomas and Laurent Leveque (Service d'expedition de modeles biologiques) from Station Biologique de Roscoff, France, for taking care of specimens' collection at Roscoff, financed by ASSEMBLE project #SBRmm -4: "Marine phylogeographic patterns of the North Eastern Atlantic Coast". We also would like to thank Halvor Knutsen (IMR - Norway) and Nicole Aberle-Malzahn and Arne Malzahn (Alfred Wegener Institute - Helgoland) for North Sea samples. We are grateful to Rafael Banon (Direccion Xeral de Ordenacion e Xestion dos Recursos Marinos Conselleria do Mar - Xunta de Galicia, Spain) for sample collection in Galicia. We appreciate the skilful technical assistance provided by S. Chenu, Hanne Sannaes, Pedro Coelho and Nicole Hielscher. We are grateful to Marta Pascual and Ferran Palero, from the University of Barcelona, for their assistance in implementing the Salicrutest of haplotype diversity.; This study was funded by the European Science Foundation's MarinERA project "Marine phylogeographic structuring during climate change: the signature of leading and rear edge of range shifting populations" and by the Eco-Ethology Research Unit (331/94) pluriannual financing programme (Fundacao para a Ciencia e Tecnologia (partially FEDER funded). FA (SFRH/BPD/63170/2009) research was supported by an FCT grant (Fundacao para a Ciencia e a Tecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almada VC, 2008, MOL PHYLOGENET EVOL, V46, P391, DOI 10.1016/j.ympev.2007.05.024; Alveirinho-Dias J, 1997, ESTUDOS Q, V1, P53; [Anonymous], 1984, QUATERNARY RES, V21, P123, DOI 10.1016/0033-5894(84)90098-X; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco J. C., 1992, LIBRO ROJO VERTEBRAD; Bowen BW, 1997, EVOLUTION, V51, P1601, DOI 10.1111/j.1558-5646.1997.tb01483.x; Bowen BW, 2006, J HERED, V97, P1, DOI 10.1093/jhered/esj006; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; CABRAL M. J., 2006, LIVRO VERMELHO VERTE; Chevolot M, 2006, MOL ECOL, V15, P3693, DOI 10.1111/j.1365-294X.2006.03043.x; Chow S, 1998, MOL ECOL, V7, P1255; *CLIMAP PROJ MEMB, 1981, GSA MAP CHART SER; Consuegra S, 2002, MOL ECOL, V11, P2037, DOI 10.1046/j.1365-294X.2002.01592.x; Dabney A, 2006, Q VALUE ESTIMATION F; de Abreu L, 2003, MAR GEOL, V196, P1, DOI 10.1016/S0025-3227(03)00046-X; Debes PV, 2008, MOL ECOL, V17, P3873, DOI 10.1111/j.1365-294X.2008.03872.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eschmeyer WN, 1983, FIELD GUIDE PACIFIC; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier Laurent, 2003, Human Genomics, V1, P7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Francisco SM, 2011, J EXP MAR BIOL ECOL, V403, P14, DOI 10.1016/j.jembe.2011.03.020; Francisco SM, 2009, MAR BIOL, V156, P1421, DOI 10.1007/s00227-009-1182-5; Fu YX, 1997, GENETICS, V147, P915; Gibson R.N., 1999, P97, DOI 10.1016/B978-012356040-7/50007-X; Gysels ES, 2004, MOL ECOL, V13, P403, DOI 10.1046/j.1365-294X.2003.02087.x; Hayes A, 2005, QUATERNARY SCI REV, V24, P999, DOI 10.1016/j.quascirev.2004.02.018; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Kettle AJ, 2011, CLIM PAST, V7, P181, DOI 10.5194/cp-7-181-2011; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Makinen HS, 2008, MOL PHYLOGENET EVOL, V46, P167, DOI 10.1016/j.ympev.2007.06.011; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nelson JS, 1984, FISHES WORLD; *NOAA, 2006, COMM LAND DAT; Ostellari L, 1996, ANIM GENET, V27, P423; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Rambaut A, 2014, TRACER V1 6; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SALICRU M, 1993, COMMUN STAT-THEOR M, V22, P2015, DOI 10.1080/03610929308831131; Stamatis C, 2004, MOL ECOL, V13, P1377, DOI 10.1111/j.1365-294X.2004.02165.x; TAJIMA F, 1983, GENETICS, V105, P437; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Triantafyllidis A, 2005, MAR BIOL, V146, P223, DOI 10.1007/s00227-004-1435-2; Uriarte A, 2011, EARTHS CLIMATE HIST; Wares JP, 2001, EVOLUTION, V55, P2455; Watanabe M, 1969, FAUNA JAPONICA COTTI; Whitehead P.J.P., 1986, FISHES NE ATLANTIC M; Wilson AB, 2010, MOL ECOL, V19, P4535, DOI 10.1111/j.1365-294X.2010.04811.x; Yabe M., 1985, COMP OSTEOLOGY MYOLO	57	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44404	10.1371/journal.pone.0044404	http://dx.doi.org/10.1371/journal.pone.0044404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952971	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500068
J	Ren, F; Guo, QQ; Chang, LL; Chen, L; Zhao, CZ; Zhong, H; Li, XB				Ren, Feng; Guo, Qian-Qian; Chang, Li-Li; Chen, Liang; Zhao, Cai-Zhi; Zhong, Hui; Li, Xue-Bao			Brassica napus PHR1 Gene Encoding a MYB-Like Protein Functions in Response to Phosphate Starvation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; MOLECULAR CHARACTERIZATION; ROOT-SYSTEM; PLANTS; PHOSPHORUS; ACQUISITION; EXPRESSION; AVAILABILITY; MICRORNA	Phosphorus (P) is one of the essential nutrient elements for plant development. In this work, BnPHR1 encoding a MYB transcription activator was isolated from Brassica napus. The characterization of nuclear localization and transcription activation ability suggest BnPHR1 is a transcriptional activator. The tissue expression and histochemical assay showed that BnPHR1 was predominantly expressed in roots and modulated by exogenous Pi in transcriptional level in roots under Pi deficiency conditions. Furthermore, overexpression of BnPHR1 in both Arabidopsis and B. napus remarkably enhanced the expression of the Pi-starvation-induced genes including ATPT2 and BnPT2 encoding the high-affinity Pi transporter. Additionally, BnPHR1 can in vivo bind the promoter sequence of ATPT2 and BnPT2 in both Arabidopsis and B. napus. Possibly, due to the activation of ATPT2 and BnPT2, or even more high-affinity Pi transporters, the excessive Pi was accumulated in transgenic plants, resulting in the crucially Pi toxicity to cells and subsequently retarding plant growth. Given the data together, BnPHR1, as crucial regulator, is regulated by exogenous Pi and directly activates those genes, which promote the uptake and homeostasis of Pi for plant growth.	[Ren, Feng; Guo, Qian-Qian; Chang, Li-Li; Chen, Liang; Zhao, Cai-Zhi; Zhong, Hui; Li, Xue-Bao] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University	Ren, F (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	xbli@mail.ccnu.edu.cn			Chenguang Project of Wuhan Municipality [200950431185]	Chenguang Project of Wuhan Municipality	This work was supported by the Chenguang Project of Wuhan Municipality (Grant No. 200950431185). The funders had no role in study design, data colection and analysis, decision to publish, or preparation of manuscript.	Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; BARIOLA PA, 1994, PLANT J, V6, P673, DOI 10.1046/j.1365-313X.1994.6050673.x; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chen YF, 2009, PLANT CELL, V21, P3554, DOI 10.1105/tpc.108.064980; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colby T, 2006, PLANT PHYSIOL, V142, P318, DOI 10.1104/pp.106.085415; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Dodds PN, 1996, PLANT MOL BIOL, V31, P227, DOI 10.1007/BF00021786; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Fischer K, 1997, PLANT CELL, V9, P453, DOI 10.1105/tpc.9.3.453; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Hammond JP, 2003, PLANT PHYSIOL, V132, P578, DOI 10.1104/pp.103.020941; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ren F, 2011, PLANT GROWTH REGUL, V65, P65, DOI 10.1007/s10725-011-9575-0; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Valdes-Lopez O, 2008, PLANT CELL ENVIRON, V31, P1834, DOI 10.1111/j.1365-3040.2008.01883.x; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; Weigel D., 2001, ARABIDOPSIS LAB MANU; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Yang XJ, 2010, ANN BOT-LONDON, V105, P513, DOI 10.1093/aob/mcq015; Yi KK, 2005, PLANT PHYSIOL, V138, P2087, DOI 10.1104/pp.105.063115; Zhang ZT, 2010, J EXP BOT, V61, P3331, DOI 10.1093/jxb/erq155; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443	40	61	73	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44005	10.1371/journal.pone.0044005	http://dx.doi.org/10.1371/journal.pone.0044005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952851	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000068
J	Cao, L; Zhang, YP; Cao, YX; Edvinsson, L; Xu, CB				Cao, Lei; Zhang, Yaping; Cao, Yong-Xiao; Edvinsson, Lars; Xu, Cang-Bao			Secondhand Smoke Exposure Causes Bronchial Hyperreactivity via Transcriptionally Upregulated Endothelin and 5-hydroxytryptamine 2A Receptors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PROTEIN-KINASE PATHWAYS; AIRWAY HYPERRESPONSIVENESS; CIGARETTE-SMOKE; PASSIVE SMOKING; IN-VITRO; CELL-PROLIFERATION; INHIBITOR GW5074; TOBACCO-SMOKE; MESSENGER-RNA	Background: Cigarette smoke exposure is strongly associated with airway hyperreactivity (AHR) which is the main characteristic seen in asthma. The intracellular MAPK signaling pathways are suggested to be associated with the airway damage to the AHR. In the present study, we hypothesize that secondhand cigarette smoke (SHS) exposure upregulates the bronchial contractile receptors via activation of the Raf/ERK/MAPK pathway. Methodology/Principal Findings: Rats were exposed to SHS for 3 h daily for up to 8 weeks. The receptor agonists-induced bronchial contractile reactivity was analyzed with a sensitive myograph system. The mRNA transcription and protein translation of the target receptors and the kinases in Raf/ERK/MAPK pathway were investigated by real-time PCR, Western blotting and immunofluorescence, respectively. Compared with exposure to fresh air, SHS induced enhanced bronchial contractile responses mediated by the 5-hydroxytryptamine 2A (5-HT2A) receptors as well as the endothelin type B (ETB) and type A (ETA) receptors. The response curves were shifted toward the left with an increased maximal contraction (E-max) demonstrating that SHS induced AHR. Additionally, the mRNA and protein levels of the 5-HT2A, ETB and ETA receptors were increased. Furthermore, SHS exposure increased the phosphorylation of Raf-1 and ERK1/2, but it did not alter p38 or JNK. A Raf-1 inhibitor (GW5074) suppressed the SHS-induced increase in the expression of 5-HT2A and ETA receptors and the receptor-mediated AHR. Conclusions/Significance: Our findings show that SHS exposure induces transcriptional upregulation of the 5-HT2A, ETB and ETA receptors in rat bronchial smooth muscle cells, which mediates AHR. The Raf/ERK/MAPK pathway is involved in SHS-associated receptor upregulation and AHR.	[Cao, Lei; Zhang, Yaping; Edvinsson, Lars; Xu, Cang-Bao] Lund Univ, Inst Clin Sci Lund, Div Expt Vasc Res, Lund, Sweden; [Cao, Yong-Xiao] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Shaanxi, Peoples R China	Lund University; Xi'an Jiaotong University	Cao, L (corresponding author), Lund Univ, Inst Clin Sci Lund, Div Expt Vasc Res, Lund, Sweden.	Cang-Bao.Xu@med.lu.se		Zhang, Yaping/0000-0002-9264-3120; Edvinsson, Lars/0000-0002-1805-1346; Xu, Cang-Bao/0000-0003-3421-3306	Swedish Research Council [5958]; Swedish Heart-Lung Foundation [20070273]; Flight Attendant Medical Research Institute (FAMRI, USA); National Natural Science Foundation of China [30772566]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Flight Attendant Medical Research Institute (FAMRI, USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Swedish Research Council (Grant 5958, http://www.vr.se); the Swedish Heart-Lung Foundation (Grant 20070273, www.hjart-lungfonden.se); the Flight Attendant Medical Research Institute (FAMRI, USA, www.famri.org); and the National Natural Science Foundation of China (Grant 30772566, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adner M, 1996, BRIT J PHARMACOL, V119, P1159, DOI 10.1111/j.1476-5381.1996.tb16018.x; Bergren Dale R., 2009, Inflammation & Allergy Drug Targets, V8, P340; Bryborn M, 2004, CLIN EXP ALLERGY, V34, P1291, DOI 10.1111/j.1365-2222.2004.02031.x; Cai Y, 2011, INT IMMUNOL, V23, P443, DOI 10.1093/intimm/dxr032; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033008; Cao L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-109; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Chiba Y, 2005, AM J RESP CELL MOL, V33, P574, DOI 10.1165/rcmb.2005-0177OC; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Daher N, 2010, ATMOS ENVIRON, V44, P8, DOI 10.1016/j.atmosenv.2009.10.004; De Bie JJ, 1998, BRIT J PHARMACOL, V124, P857, DOI 10.1038/sj.bjp.0701901; ERIKSEN MP, 1988, ANNU REV PUBL HEALTH, V9, P47, DOI 10.1146/annurev.pu.09.050188.000403; Esamai FO, 1998, E AFR MED J, V75, P47; GERRARD JW, 1980, AM REV RESPIR DIS, V122, P577; Granstrom Bengt W, 2006, BMC Pulm Med, V6, P6, DOI 10.1186/1471-2466-6-6; Granstrom BW, 2004, BASIC CLIN PHARMACOL, V95, P43, DOI 10.1111/j.1742-7843.2004.pto950109.x; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hirota S, 2005, CAN J PHYSIOL PHARM, V83, P725, DOI 10.1139/Y05-070; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Jang AS, 2004, J KOREAN MED SCI, V19, P214, DOI 10.3346/jkms.2004.19.2.214; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lei Y, 2011, EUR J PHARMACOL, V650, P629, DOI 10.1016/j.ejphar.2010.10.038; Lei Y, 2010, EUR J PHARMACOL, V634, P149, DOI 10.1016/j.ejphar.2010.02.020; Lei Y, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-71; MARTINEZ FD, 1988, AM REV RESPIR DIS, V138, P518, DOI 10.1164/ajrccm/138.3.518; Moller S, 1999, EUR J PHARMACOL, V365, pR1, DOI 10.1016/S0014-2999(98)00864-4; MURRAY AB, 1986, J ALLERGY CLIN IMMUN, V77, P575, DOI 10.1016/0091-6749(86)90348-9; OCONNOR GT, 1987, AM REV RESPIR DIS, V135, P800, DOI 10.1164/arrd.1987.135.4.800; Patel BD, 2004, THORAX, V59, P682, DOI 10.1136/thx.2003.010215; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Postma DS, 1998, AM J RESP CRIT CARE, V158, pS187, DOI 10.1164/ajrccm.158.supplement_2.13tac170; Rennard SI, 1996, J ALLERGY CLIN IMMUN, V98, pS278, DOI 10.1016/S0091-6749(96)70076-3; Schuh K, 2009, BIOCHEM PHARMACOL, V77, P1827, DOI 10.1016/j.bcp.2009.03.012; SEKHON HS, 1994, AM J PHYSIOL-LUNG C, V267, pL557, DOI 10.1152/ajplung.1994.267.5.L557; Tani Eiichi, 2004, Current Vascular Pharmacology, V2, P13, DOI 10.2174/1570161043476492; Xu CB, 2010, BASIC CLIN PHARMACOL, V107, P940, DOI 10.1111/j.1742-7843.2010.00610.x; Zhang Y, 2004, CLIN EXP ALLERGY, V34, P1480, DOI 10.1111/j.1365-2222.2004.02040.x; Zhang YP, 2010, THESCIENTIFICWORLDJO, V10, P2157, DOI 10.1100/tsw.2010.204; Zhang YP, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-29	43	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44170	10.1371/journal.pone.0044170	http://dx.doi.org/10.1371/journal.pone.0044170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952915	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800100
J	Inami, K; Yoshioka-Akiyama, C; Morita, Y; Yamasaki, M; Teraoka, T; Arie, T				Inami, Keigo; Yoshioka-Akiyama, Chizu; Morita, Yasuaki; Yamasaki, Mutsuko; Teraoka, Tohru; Arie, Tsutomu			A Genetic Mechanism for Emergence of Races in Fusarium oxysporum f. sp lycopersici: Inactivation of Avirulence Gene AVR1 by Transposon Insertion	PLOS ONE			English	Article							I-3-MEDIATED RESISTANCE; GENOME SEQUENCE; PROTEIN; PATHOGENICITY; PLANTS; LOCUS	Compatible/incompatible interactions between the tomato wilt fungus Fusarium oxysporum f. sp. lycopersici (FOL) and tomato Solanum lycopersicum are controlled by three avirulence genes (AVR1-3) in FOL and the corresponding resistance genes (I-I3) in tomato. The three known races (1, 2 and 3) of FOL carry AVR genes in different combinations. The current model to explain the proposed order of mutations in AVR genes is: i) FOL race 2 emerged from race 1 by losing the AVR1 and thus avoiding host resistance mediated by I (the resistance gene corresponding to AVR1), and ii) race 3 emerged when race 2 sustained a point mutation in AVR2, allowing it to evade I2-mediated resistance of the host. Here, an alternative mechanism of mutation of AVR genes was determined by analyses of a race 3 isolate, KoChi-1, that we recovered from a Japanese tomato field in 2008. Although KoChi-1 is race 3, it has an AVR1 gene that is truncated by the transposon Hormin, which belongs to the hAT family. This provides evidence that mobile genetic elements may be one of the driving forces underlying race evolution. KoChi-1 transformants carrying a wild type AVR1 gene from race 1 lost pathogenicity to cultivars carrying I, showing that the truncated KoChi-1 avr1 is not functional. These results imply that KoChi-1 is a new race 3 biotype and propose an additional path for emergence of FOL races: Race 2 emerged from race 1 by transposon-insertion into AVR1, not by deletion of the AVR1 locus; then a point mutation in race 2 AVR2 resulted in emergence of race 3.	[Inami, Keigo; Yoshioka-Akiyama, Chizu; Yamasaki, Mutsuko; Teraoka, Tohru; Arie, Tsutomu] TUAT, Grad Sch Agr, Fuchu, Tokyo, Japan; [Morita, Yasuaki; Yamasaki, Mutsuko] Kochi Agr Res Ctr, Nankoku, Japan	Tokyo University of Agriculture & Technology	Inami, K (corresponding author), TUAT, Grad Sch Agr, Fuchu, Tokyo, Japan.	arie@cc.tuat.ac.jp	Teraoka, Tohru/D-1566-2013; ARIE, Tsutomu/C-2831-2013	Teraoka, Tohru/0000-0002-2037-2456; ARIE, Tsutomu/0000-0002-4604-6608	Japan Society for the Promotion of Science [18380030, 22405018, 22-8126]; Ministry of Agricuture, Forestry and Fisheries Research Council of Japan [H23-25 B5 102]; Grants-in-Aid for Scientific Research [22405018] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agricuture, Forestry and Fisheries Research Council of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to TA (18380030 and 22405018) and to KI (22-8126)(http://www.jsps.go.jp/j-grantsinaid/index.html). This work was supported in part by a grant from the Ministry of Agricuture, Forestry and Fisheries Research Council of Japan (H23-25 B5 102) (http://www.s.affrc.go.jp/docs/project/2011/pdf/2011_kekka_07.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios GN, 2005, PLANT PATHOLOGY; Aime S, 2008, PHYSIOL MOL PLANT P, V73, P9, DOI 10.1016/j.pmpp.2008.10.001; Arie T, 2000, MOL PLANT MICROBE IN, V13, P1330, DOI 10.1094/MPMI.2000.13.12.1330; Arie T, 2010, J GEN PLANT PATHOL, V76, P403, DOI 10.1007/s10327-010-0264-z; ARMSTRONG GM, 1981, FUSARIUM DIS BIOL TA, P391; Barve MP, 2003, FUNGAL GENET BIOL, V39, P151, DOI 10.1016/S1087-1845(03)00015-X; Cai G, 2003, PHYTOPATHOLOGY, V93, P1014, DOI 10.1094/PHYTO.2003.93.8.1014; Chuma I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002147; Escobosa ARC, 2011, FUNGAL GENET BIOL, V48, P886, DOI 10.1016/j.fgb.2011.06.004; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fudal I, 2005, FUNGAL GENET BIOL, V42, P761, DOI 10.1016/j.fgb.2005.05.001; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Hua-Van A, 2000, CURR GENET, V37, P339, DOI 10.1007/s002940050537; Huang CC, 1997, EUPHYTICA, V93, P145, DOI 10.1023/A:1002943805229; Inami K, 2010, J GEN PLANT PATHOL, V76, P116, DOI 10.1007/s10327-010-0224-7; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; Kawabe Masato, 2005, Journal of General Plant Pathology, V71, P263, DOI 10.1007/s10327-005-0203-6; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kistler HC, 1997, PHYTOPATHOLOGY, V87, P474, DOI 10.1094/PHYTO.1997.87.4.474; Komada H., 2011, FUSARIUM; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie J. F., 2006, FUSARIUM LAB MANUAL, P212; Li W, 2009, MOL PLANT MICROBE IN, V22, P411, DOI 10.1094/MPMI-22-4-0411; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Maor R, 2005, CURR OPIN MICROBIOL, V8, P399, DOI 10.1016/j.mib.2005.06.008; Masunaga T., 1998, ANN PHYTOPATHOL SOC, V64, P435; Mes JJ, 1999, PHYTOPATHOLOGY, V89, P1131, DOI 10.1094/PHYTO.1999.89.12.1131; Michielse CB, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000637; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; Parlange F, 2009, MOL MICROBIOL, V71, P851, DOI 10.1111/j.1365-2958.2008.06547.x; Rep M, 2005, MOL PLANT MICROBE IN, V18, P15, DOI 10.1094/MPMI-18-0015; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Sacristan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007463; Saitoh Ken-ichiro, 2006, Journal of General Plant Pathology, V72, P348, DOI 10.1007/s10327-006-0300-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoffelmeer EAM, 2001, MOL GENET GENOMICS, V265, P143, DOI 10.1007/s004380000402; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003	49	36	40	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44101	10.1371/journal.pone.0044101	http://dx.doi.org/10.1371/journal.pone.0044101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952887	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800095
J	Yu, GJ; Wang, M; Huang, J; Yin, YL; Chen, YJ; Jiang, S; Jin, YX; Lan, XQ; Wong, BHC; Liang, Y; Sun, H				Yu, Guo-Jun; Wang, Man; Huang, Jie; Yin, Ya-Lin; Chen, Yi-Jie; Jiang, Shuai; Jin, Yan-Xia; Lan, Xian-Qing; Wong, Barry Hon Cheung; Liang, Yi; Sun, Hui			Deep Insight into the Ganoderma lucidum by Comprehensive Analysis of Its Transcriptome	PLOS ONE			English	Article							LING ZHI-8 LZ-8; MONOCYTIC LEUKEMIA-CELLS; WHITE-ROT FUNGI; MOLECULAR-CLONING; GENOME SEQUENCE; GENE-EXPRESSION; IMMUNOMODULATORY PROTEIN; SUBMERGED FERMENTATION; LENTINULA-EDODES; FR. KARST	Background: Ganoderma lucidum is a basidiomycete white rot fungus and is of medicinal importance in China, Japan and other countries in the Asiatic region. To date, much research has been performed in identifying the medicinal ingredients in Ganoderma lucidum. Despite its important therapeutic effects in disease, little is known about Ganoderma lucidum at the genomic level. In order to gain a molecular understanding of this fungus, we utilized Illumina high-throughput technology to sequence and analyze the transcriptome of Ganoderma lucidum. Methodology/Principal Findings: We obtained 6,439,690 and 6,416,670 high-quality reads from the mycelium and fruiting body of Ganoderma lucidum, and these were assembled to form 18,892 and 27,408 unigenes, respectively. A similarity search was performed against the NCBI non-redundant nucleotide database and a customized database composed of five fungal genomes. 11,098 and 8, 775 unigenes were matched to the NCBI non-redundant nucleotide database and our customized database, respectively. All unigenes were subjected to annotation by Gene Ontology, Eukaryotic Orthologous Group terms and Kyoto Encyclopedia of Genes and Genomes. Differentially expressed genes from the Ganoderma lucidum mycelium and fruiting body stage were analyzed, resulting in the identification of 13 unigenes which are involved in the terpenoid backbone biosynthesis pathway. Quantitative real-time PCR was used to confirm the expression levels of these unigenes. Ganoderma lucidum was also studied for wood degrading activity and a total of 22 putative FOLymes (fungal oxidative lignin enzymes) and 120 CAZymes (carbohydrate-active enzymes) were predicted from our Ganoderma lucidum transcriptome. Conclusions: Our study provides comprehensive gene expression information on Ganoderma lucidum at the transcriptional level, which will form the foundation for functional genomics studies in this fungus. The use of Illumina sequencing technology has made de novo transcriptome assembly and gene expression analysis possible in species that lack full genome information.	[Yu, Guo-Jun; Wang, Man; Huang, Jie; Yin, Ya-Lin; Chen, Yi-Jie; Jiang, Shuai; Jin, Yan-Xia; Lan, Xian-Qing; Wong, Barry Hon Cheung; Liang, Yi; Sun, Hui] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liang, Yi] Guangdong Med Coll, Dept Clin Immunol, Dongguan, Peoples R China; [Sun, Hui] Hubei Univ Technol, Minist Educ, Key Lab Fermentat Engn, Wuhan, Peoples R China; [Sun, Hui] Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discove, Wuhan 430072, Peoples R China	Wuhan University; Guangdong Medical University; Hubei University of Technology; Wuhan University	Yu, GJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	sunhui@whu.edu.cn	Jin, Yanxia/W-8478-2019	Huang, Jie/0000-0003-3842-6181	National Key Technologies RD Program [2009ZX09103-676]; Natural Science Foundation of China (NSFC) [30771501, 81102850]; Major State Basic Research Development Program of China, 973 Program [2011CB811302]; National Mega Project on Major Drug Development [2009ZX09301-014-1]; Chinese 111 project [B06018]; Wuhan municipal project [201160923296]	National Key Technologies RD Program(National Key Technology R&D Program); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China, 973 Program(National Basic Research Program of China); National Mega Project on Major Drug Development; Chinese 111 project(Ministry of Education, China - 111 Project); Wuhan municipal project	The present research project was funded by the National Key Technologies R&D Program [2009ZX09103-676] (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm), the Natural Science Foundation of China (NSFC) program [30771501, 81102850] (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), the Major State Basic Research Development Program of China, 973 Program [2011CB811302], National Mega Project on Major Drug Development [2009ZX09301-014-1], the Chinese 111 project [B06018] and Wuhan municipal project [No. 201160923296]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Nature, V467, P1026, DOI 10.1038/4671026a; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bao XF, 2000, ACTA BIOCH BIOPH SIN, V32, P557; Bao XF, 2001, CARBOHYD RES, V332, P67, DOI 10.1016/S0008-6215(01)00075-1; Bao XF, 2002, PHYTOCHEMISTRY, V59, P175, DOI 10.1016/S0031-9422(01)00450-2; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chan WK, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-9; Cheng KC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-411; Ding N, 2010, J PHARMACEUT BIOMED, V53, P1224, DOI 10.1016/j.jpba.2010.07.025; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Dudhgaonkar S, 2009, INT IMMUNOPHARMACOL, V9, P1272, DOI 10.1016/j.intimp.2009.07.011; Ekker SC, 2007, ZEBRAFISH, V4, P239, DOI 10.1089/zeb.2007.9979; Fei X, 2006, J MICROBIOL, V44, P515; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; Gao YH, 2002, LIFE SCI, V72, P731, DOI 10.1016/S0024-3205(02)02301-9; GARCIA S, 1987, APPL ENVIRON MICROB, V53, P2384, DOI 10.1128/AEM.53.10.2384-2387.1987; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guo L, 2009, INT IMMUNOPHARMACOL, V9, P1175, DOI 10.1016/j.intimp.2009.06.005; Hayashizaki Y, 2003, COLD SPRING HARB SYM, V68, P195, DOI 10.1101/sqb.2003.68.195; Huang L, 2009, PROTEINS, V75, P524, DOI 10.1002/prot.22346; Huie CW, 2002, ANAL BIOANAL CHEM, V373, P23, DOI 10.1007/s00216-002-1265-3; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jiang JH, 2008, INT J MOL MED, V21, P577; Joo SS, 2008, MOL CELLS, V25, P112; Kimura Y, 2002, ANTICANCER RES, V22, P3309; KINO K, 1991, INT J IMMUNOPHARMACO, V13, P1109; KINO K, 1990, DIABETOLOGIA, V33, P713, DOI 10.1007/BF00400340; KINO K, 1989, J BIOL CHEM, V264, P472; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; Ko HH, 2008, PHYTOCHEMISTRY, V69, P234, DOI 10.1016/j.phytochem.2007.06.008; Larsen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009780; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li SX, 2010, J MICROBIOL BIOTECHN, V20, P474, DOI 10.4014/jmb.0909.09014; Liang C, 2011, ONCOL REP; Liu J, 2010, PLANTA MED, V76, P137, DOI 10.1055/s-0029-1186035; Luo Hongmei, 2010, Chin Med, V5, P9, DOI 10.1186/1749-8546-5-9; Luo Jun, 2002, Yaoxue Xuebao, V37, P574; Lyashenko AV, 2011, ACTA CRYSTALLOGR F, V67, P926, DOI 10.1107/S1744309111021129; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Miyazaki Y, 2005, FUNGAL GENET BIOL, V42, P493, DOI 10.1016/j.fgb.2005.03.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sakamoto Y, 2005, CURR GENET, V47, P244, DOI 10.1007/s00294-005-0563-7; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Sato S, 2009, CURR GENET, V55, P273, DOI 10.1007/s00294-009-0243-0; Shang CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1333, DOI 10.1271/bbb.80011; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; TANAKA S, 1989, J BIOL CHEM, V264, P16372; Tang YJ, 2010, BIOTECHNOL PROGR, V26, P417, DOI 10.1002/btpr.352; Tang YJ, 2009, BIORESOURCE TECHNOL, V100, P1852, DOI 10.1016/j.biortech.2008.10.005; Tang YJ, 2003, ENZYME MICROB TECH, V32, P478, DOI 10.1016/S0141-0229(02)00338-1; Trombetti GA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S22; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Walbot V, 2000, NATURE, V408, P794, DOI 10.1038/35048685; Wang X, 2006, APPL MICROBIOL BIOT, V72, P508, DOI 10.1007/s00253-006-0314-9; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Xu JW, 2010, APPL MICROBIOL BIOT, V87, P457, DOI 10.1007/s00253-010-2576-5; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhang CR, 2008, NAT PROD RES, V22, P1137, DOI 10.1080/14786410601129721; Zhang W, 2008, BIOTECHNOL PROGR, V24, P1249, DOI 10.1002/btpr.36; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106; Zhou XW, 2007, AM J CHINESE MED, V35, P559, DOI 10.1142/S0192415X07005065	83	48	55	6	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44031	10.1371/journal.pone.0044031	http://dx.doi.org/10.1371/journal.pone.0044031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952861	gold, Green Submitted, Green Published			2022-12-25	WOS:000308044800089
J	Tripurani, SK; Cook, RW; Eldin, KW; Pangas, SA				Tripurani, S. K.; Cook, R. W.; Eldin, K. W.; Pangas, S. A.			BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors	ONCOGENE			English	Article						bone morphogenetic protein; platelet-derived growth factor; SMAD1; SMAD5; granulosa cell tumor	FACTOR-A-CHAIN; GROWTH-FACTORS; GENE-TRANSCRIPTION; RECEPTORS; BINDING; CANCER; PATHWAY; SP1	Platelet-derived growth factor alpha (PDGFA) is frequently upregulated in various cancers and thought to function as a key player in the development and progression of tumor growth by regulating aspects of cell proliferation, angiogenesis and metastasis. However, the mechanism by which it is upregulated is not fully understood. Previously, we demonstrated that conditional deletion of two transcription factors that signal for the bone morphogenetic proteins (Smad1 and Smad5) in ovarian granulosa cells causes metastatic granulosa cell tumors (GCTs) in female mice and phenocopies human juvenile GCTs (JGCTs). Smad1/5 double conditional knockout tumors, as well as human JGCTs, are highly vascularized, hemorrhagic and mitotically active. Expression analysis of these tumors and their metastases revealed a significant upregulation of key proliferation and pro-angiogenic factors such as Pdgfa, Pdgfb and Vegf. We examined whether these genes were direct targets of SMAD1 and SMAD5. Knockdown of SMAD1 and SMAD5 in mouse primary granulosa cells and a human GCT-derived cell line (COV434) resulted in upregulation of PDGFA, but not PDGFB nor VEGF. We identified several putative SMAD1/5-binding sites in the PDGFA promoter, and chromatin immunoprecipitation and reporter assays demonstrated that SMAD1/5 interact with the PDGFA promoter to regulate its activity. Further, SMAD1/5 antagonize the activity of the transcription factor Sp1, a well-known positive regulator of PDGFA, by inhibiting its occupancy at a key regulatory site on the proximal PDGFA promoter. Collectively, our studies establish that loss of SMAD1/5 leads to upregulation of PDGFA in ovarian granulosa cells, and that a novel regulatory interaction exists between the BR-SMADs and Sp1 in controlling PDGFA expression during granulosa cell tumorigenesis.	[Tripurani, S. K.; Cook, R. W.; Eldin, K. W.; Pangas, S. A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Pangas, S. A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Pangas, SA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	spangas@bcm.edu		Pangas, Stephanie/0000-0001-5748-5844	Burroughs Wellcome Career award in Biomedical Sciences; NIH [CA138628]; NATIONAL CANCER INSTITUTE [R01CA138628] Funding Source: NIH RePORTER	Burroughs Wellcome Career award in Biomedical Sciences(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Burroughs Wellcome Career award in Biomedical Sciences and a NIH CA138628 to SAP. We thank Dr David Kaetzel (University of Kentucky) for the PDGFA luciferase plasmids, Drs An Zwijsen (Leuven University), Elizabeth Robertson (University of Oxford), and Richard R Behringer (MD Anderson Cancer Center) for mouse lines, and Dr Xin-Hua Feng (Baylor College of Medicine) for the flag-tagged SMAD1 and SMAD5 expression plasmids. We thank Rebecca James, Hermann Piard and Yuxuan Lin for technical assistance and Nadera Mansouri-Attia, Krishna Jagarlamudi for critical reading of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chu S, 2008, GYNECOL ONCOL, V108, P182, DOI 10.1016/j.ygyno.2007.09.017; Edson MA, 2010, MOL ENDOCRINOL, V24, P1251, DOI 10.1210/me.2009-0461; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Fortin J, 2010, CELL SIGNAL, V22, P936, DOI 10.1016/j.cellsig.2010.01.019; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; George D, 2003, ADV EXP MED BIOL, V532, P141; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Iwamori T, 2010, MOL CELL BIOL, V30, P2280, DOI 10.1128/MCB.01392-09; Kaetzel DM, 2003, CYTOKINE GROWTH F R, V14, P427, DOI 10.1016/S1359-6101(03)00051-0; KAETZEL DM, 1994, BIOCHEM J, V301, P321, DOI 10.1042/bj3010321; Khachigian LM, 1999, CIRC RES, V84, P1258, DOI 10.1161/01.RES.84.11.1258; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Middlebrook BS, 2009, ENDOCRINOLOGY, V150, P5208, DOI 10.1210/en.2009-0644; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Pangas SA, 2004, J BIOL CHEM, V279, P32281, DOI 10.1074/jbc.M403212200; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Pinkas H, 2008, MOL HUM REPROD, V14, P199, DOI 10.1093/molehr/gan011; Rafty LA, 2002, EMBO J, V21, P334, DOI 10.1093/emboj/21.3.334; Rocconi RP, 2008, REPROD SCI, V15, P673, DOI 10.1177/1933719108317584; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Shih AH, 2006, CANCER LETT, V232, P139, DOI 10.1016/j.canlet.2005.02.002; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Uhrbom L, 1998, CANCER RES, V58, P5275; Yamamoto S, 2008, MODERN PATHOL, V21, P115, DOI 10.1038/modpathol.3800984; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	35	22	24	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3877	3885		10.1038/onc.2012.392	http://dx.doi.org/10.1038/onc.2012.392			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22964636	Green Accepted			2022-12-25	WOS:000323210200010
J	Meziane-Cherif, D; Saul, FA; Haouz, A; Courvalin, P				Meziane-Cherif, Djalal; Saul, Frederick A.; Haouz, Ahmed; Courvalin, Patrice			Structural and Functional Characterization of VanG D-Ala:D-Ser Ligase Associated with Vancomycin Resistance in Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ALANINE LIGASE; D-LACTATE LIGASE; ALANYL-D-ALANINE; MULTIPLE SEQUENCE ALIGNMENT; LEUCONOSTOC-MESENTEROIDES; PEPTIDOGLYCAN PRECURSORS; GLYCOPEPTIDE RESISTANCE; CRYSTAL-STRUCTURE; GENE-CLUSTER; SUBSITE 2	D-Alanyl: D-lactate (D-Ala: D-Lac) and D-alanyl: D-serine ligases are key enzymes in vancomycin resistance of Gram-positive cocci. They catalyze a critical step in the synthesis of modified peptidoglycan precursors that are low binding affinity targets for vancomycin. The structure of the D-Ala: D-Lac ligase VanA led to the understanding of the molecular basis for its specificity, but that of D-Ala: D-Ser ligases had not been determined. We have investigated the enzymatic kinetics of the D-Ala: D-Ser ligase VanG from Enterococcus faecalis and solved its crystal structure in complex with ADP. The overall structure of VanG is similar to that of VanA but has significant differences mainly in the N-terminal and central domains. Based on reported mutagenesis data and comparison of the VanG and VanA structures, we show that residues Asp-243, Phe-252, and Arg-324 are molecular determinants for D-Ser selectivity. These residues are conserved in both enzymes and explain why VanA also displays D-Ala: D-Ser ligase activity, albeit with low catalytic efficiency in comparison with VanG. These observations suggest that D-Ala: D-Lac and D-Ala: D-Ser enzymes have evolved from a common ancestral D-Ala: D-X ligase. The crystal structure of VanG showed an unusual interaction between two dimers involving residues of the omega loop that are deeply anchored in the active site. We constructed an octapeptide mimicking the omega loop and found that it selectively inhibits VanG and VanA but not Staphylococcus aureus D-Ala: D-Ala ligase. This study provides additional insight into the molecular evolution of D-Ala: D-X ligases and could contribute to the development of new structure-based inhibitors of vancomycin resistance enzymes.	[Meziane-Cherif, Djalal; Courvalin, Patrice] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris 15, France; [Saul, Frederick A.; Haouz, Ahmed] Inst Pasteur, CNRS, UMR3528, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meziane-Cherif, D (corresponding author), Inst Pasteur, Unite Agents Antibacteriens, 25 Rue Dr Roux, F-75724 Paris 15, France.	djalal.meziane-cherif@pasteur.fr		HAOUZ, Ahmed/0000-0003-1196-1635				Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; ARTHUR M, 1992, ANTIMICROB AGENTS CH, V36, P867, DOI 10.1128/AAC.36.4.867; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P2667, DOI 10.1128/AAC.01516-07; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; DAUB E, 1988, BIOCHEMISTRY-US, V27, P3701, DOI 10.1021/bi00410a027; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN C, 1994, SCIENCE, V266, P439, DOI 10.1126/science.7939684; GROVES P, 1994, STRUCTURE, V2, P747, DOI 10.1016/S0969-2126(94)00075-1; Healy VL, 1998, CHEM BIOL, V5, P197, DOI 10.1016/S1074-5521(98)90633-0; Healy VL, 2000, CHEM BIOL, V7, pR109, DOI 10.1016/S1074-5521(00)00116-2; Kitamura Y, 2009, ACTA CRYSTALLOGR D, V65, P1098, DOI 10.1107/S0907444909029710; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuzin AP, 2000, STRUCT FOLD DES, V8, P463, DOI 10.1016/S0969-2126(00)00129-5; Lebreton F, 2011, ANTIMICROB AGENTS CH, V55, P4606, DOI 10.1128/AAC.00714-11; Lessard IAD, 1999, BIOCHEMISTRY-US, V38, P14006, DOI 10.1021/bi991384c; Liu SP, 2006, P NATL ACAD SCI USA, V103, P15178, DOI 10.1073/pnas.0604905103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moubareck C, 2009, ANTIMICROB AGENTS CH, V53, P3657, DOI 10.1128/AAC.00338-09; MULLINS LS, 1990, J BIOL CHEM, V265, P8993; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEUHAUS FC, 1962, J BIOL CHEM, V237, P3128; Neuhaus FC, 2011, J MOL GRAPH MODEL, V30, P31, DOI 10.1016/j.jmgm.2011.06.002; Neuhaus FC, 2010, J MOL GRAPH MODEL, V28, P728, DOI 10.1016/j.jmgm.2010.01.010; Park IS, 1997, P NATL ACAD SCI USA, V94, P10040, DOI 10.1073/pnas.94.19.10040; Park IS, 1997, J BIOL CHEM, V272, P9210; REYNOLDS PE, 1994, BIOCHEM J, V301, P5, DOI 10.1042/bj3010005; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Roper DI, 2000, P NATL ACAD SCI USA, V97, P8921, DOI 10.1073/pnas.150116497; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHI Y, 1995, BIOCHEMISTRY-US, V34, P2768, DOI 10.1021/bi00009a005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tytgat I, 2009, CURR MED CHEM, V16, P2566, DOI 10.2174/092986709788682029; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber P, 2009, ACTA CRYSTALLOGR F, V65, P1024, DOI 10.1107/S1744309109033831; Wu DL, 2008, PROTEINS, V72, P1148, DOI 10.1002/prot.22009; Xu XG, 2010, ANTIMICROB AGENTS CH, V54, P4643, DOI 10.1128/AAC.01710-09	41	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.405522	http://dx.doi.org/10.1074/jbc.M112.405522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22969085	Green Published, hybrid			2022-12-25	WOS:000310642200001
J	Eschenbacher, WH; Song, MS; Chen, Y; Bhandari, P; Zhao, P; Jowdy, CC; Engelhard, JT; Dorn, GW				Eschenbacher, William H.; Song, Moshi; Chen, Yun; Bhandari, Poonam; Zhao, Peter; Jowdy, Casey C.; Engelhard, John T.; Dorn, Gerald W., II			Two Rare Human Mitofusin 2 Mutations Alter Mitochondrial Dynamics and Induce Retinal and Cardiac Pathology in Drosophila	PLOS ONE			English	Article							NEUROPATHY TYPE 2A; MUSCLE DYSFUNCTION; MEMBRANE FUSION; IN-VIVO; MFN2; DISEASE; HEART; NEURODEGENERATION; MORPHOLOGY; COMPLEXES	Mitochondrial fusion is essential to organelle homeostasis and organ health. Inexplicably, loss of function mutations of mitofusin 2 (Mfn2) specifically affect neurological tissue, causing Charcot Marie Tooth syndrome (CMT) and atypical optic atrophy. As CMT-linked Mfn2 mutations are predominantly within the GTPase domain, we postulated that Mfn2 mutations in other functional domains might affect non-neurological tissues. Here, we defined in vitro and in vivo consequences of rare human mutations in the poorly characterized Mfn2 HR1 domain. Human exome sequencing data identified 4 rare non-synonymous Mfn2 HR1 domain mutations, two bioinformatically predicted as damaging. Recombinant expression of these (Mfn2 M393I and R400Q) in Mfn2-null murine embryonic fibroblasts (MEFs) revealed incomplete rescue of characteristic mitochondrial fragmentation, compared to wild-type human Mfn2 (hMfn2); Mfn2 400Q uniquely induced mitochondrial fragmentation in normal MEFs. To compare Mfn2 mutation effects in neurological and non-neurological tissues in vivo, hMfn2 and the two mutants were expressed in Drosophila eyes or heart tubes made deficient in endogenous fly mitofusin (dMfn) through organ-specific RNAi expression. The two mutants induced similar Drosophila eye phenotypes: small eyes and an inability to rescue the eye pathology induced by suppression of dMfn. In contrast, Mfn2 400Q induced more severe cardiomyocyte mitochondrial fragmentation and cardiac phenotypes than Mfn2 393I, including heart tube dilation, depressed fractional shortening, and progressively impaired negative geotaxis. These data reveal a central functional role for Mfn2 HR1 domains, describe organ-specific effects of two Mfn2 HR1 mutations, and strongly support prospective studies of Mfn2 400Q in heritable human heart disease of unknown genetic etiology.	[Eschenbacher, William H.; Song, Moshi; Chen, Yun; Bhandari, Poonam; Zhao, Peter; Jowdy, Casey C.; Engelhard, John T.; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA	Washington University (WUSTL)	Eschenbacher, WH (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	gdorn@dom.wustl.edu			National Institutes of Health (NIH) [R21 HL1072726, R01HL598888]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) R21 HL1072726 and R01HL598888. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Caldeira J., 2011, GUT; Casasnovas C, 2010, J MED GENET, V47, P249, DOI 10.1136/jmg.2009.072488; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Choma MA, 2006, CIRCULATION, V114, pE35, DOI 10.1161/CIRCULATIONAHA.105.593541; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Engelfried K, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-53; FERNANDEZ JAS, 1994, ANN MED INTERNE, V11, P455; Goldstein JA, 2011, HUM MOL GENET, V20, P894, DOI 10.1093/hmg/ddq528; Griffin EE, 2006, BBA-MOL CELL RES, V1763, P482, DOI 10.1016/j.bbamcr.2006.02.003; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; Guillet V, 2010, NEUROGENETICS, V11, P127, DOI 10.1007/s10048-009-0207-z; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; McCorquodale DS, 2011, J NEUROL, V258, P1234, DOI 10.1007/s00415-011-5910-7; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Richardson ECN, 2010, DEVELOPMENT, V137, P641, DOI 10.1242/dev.041913; Sandu C, 2010, J CELL BIOL, V190, P1039, DOI 10.1083/jcb.201004086; Santel A, 2001, J CELL SCI, V114, P867; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; Yoshida H, 1991, Kokyu To Junkan, V39, P295; Yun J, 2008, J NEUROSCI, V28, P14500, DOI 10.1523/JNEUROSCI.5141-08.2008; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	42	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44296	10.1371/journal.pone.0044296	http://dx.doi.org/10.1371/journal.pone.0044296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957060	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800053
J	Ge, LS; Cornforth, AN; Hoa, NT; Delgado, C; Chiou, SK; Zhou, YH; Jadus, MR				Ge, Lisheng; Cornforth, Andrew N.; Hoa, Neil T.; Delgado, Christina; Chiou, Shiun Kwei; Zhou, Yi Hong; Jadus, Martin R.			Differential Glioma-Associated Tumor Antigen Expression Profiles of Human Glioma Cells Grown in Hypoxia	PLOS ONE			English	Article							POTENTIAL TARGETS; GLIOBLASTOMA; VACCINATION; IDENTIFICATION; IMMUNOTHERAPY; ANGIOGENESIS; SURVIVAL; VACCINES; COMPLEX; PROTEIN	Human U251 and D54 glioma cells were tested for expression of 25 glioma-associated tumor antigen precursor proteins (TAPP) under hypoxic (1% O-2) or normoxic (21% O-2) conditions. Hypoxic glioma cell lines increased their mRNA expression for nine TAPP (Aim2, Art-4, EphA2, EZH2, Fosl1, PTH-rP, Sox 11, Whsc2 and YKL-40), as assessed by quantitative reverse transcriptase real-time/polymerase chain reaction (qRT-PCR). Increased differences with three hypoxic-induced TAPP: EZH2, Whsc2 and YKL-40 were shown at the protein levels by fluorescent antibody staining and quantitative electrophoretic analysis. Two TAPP (MRP3 and Trp1) were down-regulated by hypoxia in glioma cell lines. Growing the glioma cells under hypoxia for 13 days, followed by returning them back to normoxic conditions for 7 days, and restored the original normoxic TAPP profile. Thus, hypoxia was an environmental factor that stimulated the transient expression of these antigens. Intracranial xenografts grown in nude mice derived from U251 cells that had been cultured under neurosphere stem cell conditions showed increased expression of Whsc2 or YKL-40, demonstrating that these in vitro properties of glioma also occur in vivo. Whsc2-specific cytotoxic T lymphocytes killed the hypoxic U251 glioma cells better than normoxic glioma cells. The antigens expressed by hypoxic tumor cells may be a better source of starting tumor material for loading dendritic cells for novel immunotherapy of glioma using tumor-associated antigens.	[Ge, Lisheng; Hoa, Neil T.; Delgado, Christina; Jadus, Martin R.] Vet Affairs Med Ctr, Diagnost & Mol Hlth Care Grp, Long Beach, CA USA; [Cornforth, Andrew N.] Calif Stem Cell Inc, Irvine, CA USA; [Hoa, Neil T.; Delgado, Christina; Chiou, Shiun Kwei; Jadus, Martin R.] Vet Affairs Med Ctr, Res Serv Healthcare Grp, Long Beach, CA USA; [Zhou, Yi Hong; Jadus, Martin R.] Univ Calif Irvine, Chao Comprehens Canc Ctr, Neurooncol Program, Orange, CA 92668 USA; [Zhou, Yi Hong] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA USA; [Zhou, Yi Hong] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Ge, LS (corresponding author), Vet Affairs Med Ctr, Diagnost & Mol Hlth Care Grp, Long Beach, CA USA.	martin.jadus@va.gov	Ge, Li/T-3955-2018	Ge, Li/0000-0002-1824-8034	Veterans Affairs Medical Cente; University of California, Irvine, School of Medicine and Committee on Research Award	Veterans Affairs Medical Cente; University of California, Irvine, School of Medicine and Committee on Research Award(University of California System)	This work was supported by grants supplied by the Veterans Affairs Medical Center (MRJ) and University of California, Irvine, School of Medicine and Committee on Research Award (YHZ). The funders had no role in study design, data collection and anlaysis, decision to publish or preparation of the manuscript.	Bar EE, 2011, BRAIN PATHOL, V21, P119, DOI 10.1111/j.1750-3639.2010.00460.x; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chouaib S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00021; Collingridge DR, 1999, RADIOTHER ONCOL, V53, P127, DOI 10.1016/S0167-8140(99)00121-8; Dutoit V, 2012, BRAIN, V135, P1042, DOI 10.1093/brain/aws042; Evans SM, 2004, CANCER RES, V64, P1886, DOI 10.1158/0008-5472.CAN-03-2424; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; FINCH CA, 1972, NEW ENGL J MED, V286, P407, DOI 10.1056/NEJM197202242860806; Ge LS, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/296453; Grauer OM, 2009, BRAIN PATHOL, V19, P674, DOI 10.1111/j.1750-3639.2009.00315.x; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Haque A, 2011, PROG MOL BIOL TRANSL, V98, P187, DOI 10.1016/B978-0-12-385506-0.00005-3; Harrison LB, 2002, ONCOLOGIST, V7, P492, DOI 10.1634/theoncologist.7-6-492; Heimberger AB, 2011, NEURO-ONCOLOGY, V13, P3, DOI 10.1093/neuonc/noq169; Hickey MJ, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-100; Hoa N, 2010, J IMMUNOL, V185, P4793, DOI 10.4049/jimmunol.1001526; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ito M, 2001, CANCER RES, V61, P2038; Izumoto S, 2012, ADV EXP MED BIOL, V746, P166, DOI 10.1007/978-1-4614-3146-6_13; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kim W, 2010, NEUROSURG CLIN N AM, V21, P139, DOI 10.1016/j.nec.2009.09.005; Kruse CA, 2001, BRAIN TUMOR IMMUNOTHERAPY, P149; Kruse CA, 1997, CANCER IMMUNOL IMMUN, V45, P77, DOI 10.1007/s002620050405; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li J, 2008, NEURO-ONCOLOGY, V10, P45, DOI 10.1215/15228517-2007-036; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Niu YM, 2009, CANCER SCI, V100, P2167, DOI 10.1111/j.1349-7006.2009.01298.x; Nutt CL, 2005, CLIN CANCER RES, V11, P2258, DOI 10.1158/1078-0432.CCR-04-1601; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Orzan F, 2011, NEUROPATH APPL NEURO, V37, P381, DOI 10.1111/j.1365-2990.2010.01132.x; Parney IF, 2012, ADV EXP MED BIOL, V746, P42, DOI 10.1007/978-1-4614-3146-6_4; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Sathornsumetee S, 2008, J CLIN ONCOL, V26, P271, DOI 10.1200/JCO.2007.13.3652; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Toda M, 2012, ADV EXP MED BIOL, V746, P77, DOI 10.1007/978-1-4614-3146-6_6; Yajima N, 2005, CLIN CANCER RES, V11, P5900, DOI 10.1158/1078-0432.CCR-05-0559; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamanaka R, 2012, ADV EXP MED BIOL, V746, P187, DOI 10.1007/978-1-4614-3146-6_15; Yu JS, 2001, CANCER RES, V61, P842; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zhang JG, 2008, J NEURO-ONCOL, V88, P65, DOI 10.1007/s11060-008-9534-4; Zhang JG, 2007, CLIN CANCER RES, V13, P566, DOI 10.1158/1078-0432.CCR-06-1576	55	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42661	10.1371/journal.pone.0042661	http://dx.doi.org/10.1371/journal.pone.0042661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957023	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800015
J	Ridnour, LA; Barasch, KM; Windhausen, AN; Dorsey, TH; Lizardo, MM; Yfantis, HG; Lee, DH; Switzer, CH; Cheng, RYS; Heinecke, JL; Brueggemann, E; Hines, HB; Khanna, C; Glynn, SA; Ambs, S; Wink, DA				Ridnour, Lisa A.; Barasch, Kimberly M.; Windhausen, Alisha N.; Dorsey, Tiffany H.; Lizardo, Michael M.; Yfantis, Harris G.; Lee, Dong H.; Switzer, Christopher H.; Cheng, Robert Y. S.; Heinecke, Julie L.; Brueggemann, Ernst; Hines, Harry B.; Khanna, Chand; Glynn, Sharon A.; Ambs, Stefan; Wink, David A.			Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt Activation	PLOS ONE			English	Article							TISSUE INHIBITOR; TUMOR PROGRESSION; S-NITROSATION; EXPRESSION; CELLS; METALLOPROTEINASE-1; PREDICTS; INDUCTION; APOPTOSIS; SURVIVAL	Prediction of therapeutic response and cancer patient survival can be improved by the identification of molecular markers including tumor Akt status. A direct correlation between NOS2 expression and elevated Akt phosphorylation status has been observed in breast tumors. Tissue inhibitor matrix metalloproteinase-1 (TIMP-1) has been proposed to exert oncogenic properties through CD63 cell surface receptor pathway initiation of pro-survival PI3k/Akt signaling. We employed immunohistochemistry to examine the influence of TIMP-1 on the functional relationship between NOS2 and phosphorylated Akt in breast tumors and found that NOS2-associated Akt phosphorylation was significantly increased in tumors expressing high TIMP-1, indicating that TIMP-1 may further enhance NO-induced Akt pathway activation. Moreover, TIMP-1 silencing by antisense technology blocked NO-induced PI3k/Akt/BAD phosphorylation in cultured MDA-MB-231 human breast cancer cells. TIMP-1 protein nitration and TIMP-1/CD63 co-immunoprecipitation was observed at NO concentrations that induced PI3k/Akt/BAD pro-survival signaling. In the survival analysis, elevated tumor TIMP-1 predicted poor patient survival. This association appears to be mainly restricted to tumors with high NOS2 protein. In contrast, TIMP-1 did not predict poor survival in patient tumors with low NOS2 expression. In summary, our findings suggest that tumors with high TIMP-1 and NOS2 behave more aggressively by mechanisms that favor Akt pathway activation.	[Ridnour, Lisa A.; Barasch, Kimberly M.; Windhausen, Alisha N.; Switzer, Christopher H.; Cheng, Robert Y. S.; Heinecke, Julie L.; Glynn, Sharon A.; Wink, David A.] NCI, Radiat Biol Branch, Bethesda, MD 20892 USA; [Dorsey, Tiffany H.; Glynn, Sharon A.; Ambs, Stefan] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA; [Lizardo, Michael M.; Khanna, Chand] NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Yfantis, Harris G.; Lee, Dong H.] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA; [Brueggemann, Ernst; Hines, Harry B.] USAMRIID, Ft Detrick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; United States Army Medical Research Institute of Infectious Diseases	Ridnour, LA (corresponding author), NCI, Radiat Biol Branch, Bethesda, MD 20892 USA.	ridnourl@mail.nih.gov; wink@mail.nih.gov	Switzer, Christopher/D-9203-2013; Glynn, Sharon A/D-7136-2013; Cheng, Robert/E-9799-2013	Glynn, Sharon A/0000-0003-1459-2580; Cheng, Robert/0000-0003-0287-6439; Azad, Mahan/0000-0002-8633-3513; Heinecke, Julie/0000-0001-5447-1914; Ambs, Stefan/0000-0001-7651-9309; Wink, David/0000-0002-5652-7480; Ridnour, Lisa A./0000-0001-9446-8349	United States National Institutes of Health, National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010887, ZIABC010898] Funding Source: NIH RePORTER	United States National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Intramural Research Program of the United States National Institutes of Health, National Cancer Institute, and Center for Cancer Research supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ambs S, 2011, CELL CYCLE, V10, P619, DOI 10.4161/cc.10.4.14864; American Cancer Society, 2010, AM CANC SOC FACTS FI; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; Brennan PA, 2008, HEAD NECK-J SCI SPEC, V30, P208, DOI 10.1002/hed.20675; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Clemons NJ, 2010, CARCINOGENESIS, V31, P1669, DOI 10.1093/carcin/bgq130; Connelly ST, 2005, ORAL ONCOL, V41, P261, DOI 10.1016/j.oraloncology.2004.09.007; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Davidsen ML, 2006, BRIT J CANCER, V95, P1114, DOI 10.1038/sj.bjc.6603378; Death AK, 2002, J AM COLL CARDIOL, V39, P1943, DOI 10.1016/S0735-1097(02)01907-1; Dilley TK, 2003, EXP CELL RES, V290, P38, DOI 10.1016/S0014-4827(03)00308-2; Duarte S, 2012, HEPATOLOGY IN PRESS; Ekmekcioglu S, 2000, CLIN CANCER RES, V6, P4768; Espey MG, 2000, J BIOL CHEM, V275, P11341, DOI 10.1074/jbc.275.15.11341; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Hsu YC, 2007, J DERMATOL SCI, V45, P37, DOI 10.1016/j.jdermsci.2006.10.002; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kim JE, 2004, J BIOL CHEM, V279, P9758, DOI 10.1074/jbc.M312722200; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Lackner MR, 2010, EXPERT REV MOL DIAGN, V10, P75, DOI [10.1586/erm.09.78, 10.1586/ERM.09.78]; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Lambert E, 2009, INT J BIOCHEM CELL B, V41, P1102, DOI 10.1016/j.biocel.2008.10.017; Li GY, 1999, CANCER RES, V59, P6267; Li SF, 2008, ADV CANCER RES, V101, P45, DOI 10.1016/S0065-230X(08)00403-X; Lipton A, 2008, J CLIN ONCOL, V26, P2653, DOI 10.1200/JCO.2007.15.4336; Lipton A, 2007, CANCER, V109, P1933, DOI 10.1002/cncr.22637; Liu XW, 2005, CANCER RES, V65, P898; Loibl S, 2005, EUR J CANCER, V41, P265, DOI 10.1016/j.ejca.2004.07.010; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Nakagawa SA, 2010, J BONE JOINT SURG AM, V92A, P1738, DOI 10.2106/JBJS.H.00717; Patruno A, 2012, J CELL PHYSIOL, V227, P2767, DOI 10.1002/jcp.23024; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Pervin S, 2007, CANCER RES, V67, P289, DOI 10.1158/0008-5472.CAN-05-4623; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Raspollini MR, 2004, GYNECOL ONCOL, V92, P806, DOI 10.1016/j.ygyno.2003.12.023; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Ridnour LA, 2008, NITRIC OXIDE-BIOL CH, V19, P73, DOI 10.1016/j.niox.2008.04.006; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Schrohl AS, 2006, CLIN CANCER RES, V12, P7054, DOI 10.1158/1078-0432.CCR-06-0950; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Sohn JJ, 2012, PLOS ONE IN PRESS; Sorensen NM, 2007, CLIN CANCER RES, V13, P4117, DOI 10.1158/1078-0432.CCR-07-0186; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Sumbayev VV, 2008, IMMUNOL LETT, V115, P126, DOI 10.1016/j.imlet.2007.10.013; Switzer CH, 2009, ONCOGENE, V28, P3837, DOI 10.1038/onc.2009.244; Switzer CH, 2012, CANCER RES, V72, P2394, DOI 10.1158/0008-5472.CAN-11-3115; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Wink DA, 2008, NITRIC OXIDE-BIOL CH, V19, P65, DOI 10.1016/j.niox.2008.05.003; Wurtz SO, 2008, ACTA ONCOL, V47, P580, DOI 10.1080/02841860802022976; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	57	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44081	10.1371/journal.pone.0044081	http://dx.doi.org/10.1371/journal.pone.0044081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957045	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800037
J	Castine, SA; Erler, DV; Trott, LA; Paul, NA; de Nys, R; Eyre, BD				Castine, Sarah A.; Erler, Dirk V.; Trott, Lindsay A.; Paul, Nicholas A.; de Nys, Rocky; Eyre, Bradley D.			Denitrification and Anammox in Tropical Aquaculture Settlement Ponds: An Isotope Tracer Approach for Evaluating N-2 Production	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; DISSIMILATORY NITRATE REDUCTION; MANGANESE REDUCTION; NITROGEN DYNAMICS; SEDIMENTS; NITRITE; NITRIFICATION; INHIBITION; ESTUARY	Settlement ponds are used to treat aquaculture discharge water by removing nutrients through physical (settling) and biological (microbial transformation) processes. Nutrient removal through settling has been quantified, however, the occurrence of, and potential for microbial nitrogen (N) removal is largely unknown in these systems. Therefore, isotope tracer techniques were used to measure potential rates of denitrification and anaerobic ammonium oxidation (anammox) in the sediment of settlement ponds in tropical aquaculture systems. Dinitrogen gas (N-2) was produced in all ponds, although potential rates were low (0-7.07 nmol N cm(-3) h(-1)) relative to other aquatic systems. Denitrification was the main driver of N-2 production, with anammox only detected in two of the four ponds. No correlations were detected between the measured sediment variables (total organic carbon, total nitrogen, iron, manganese, sulphur and phosphorous) and denitrification or anammox. Furthermore, denitrification was not carbon limited as the addition of particulate organic matter (paired t-Test; P = 0.350, n = 3) or methanol (paired t-Test; P = 0.744, n = 3) did not stimulate production of N-2. A simple mass balance model showed that only 2.5% of added fixed N was removed in the studied settlement ponds through the denitrification and anammox processes. It is recommended that settlement ponds be used in conjunction with additional technologies (i.e. constructed wetlands or biological reactors) to enhance N-2 production and N removal from aquaculture wastewater.	[Castine, Sarah A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Marine & Trop Biol, Australian Inst Marine Sci,AIMS JCU, Townsville, Qld 4811, Australia; [Erler, Dirk V.; Eyre, Bradley D.] So Cross Univ, Sch Environm Sci & Management, Ctr Coastal Biogeochem, Lismore, NSW 2480, Australia; [Trott, Lindsay A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine Trop Biol, Townsville, Qld 4811, Australia	Australian Institute of Marine Science; James Cook University; Southern Cross University; Australian Institute of Marine Science; James Cook University	Castine, SA (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Marine & Trop Biol, Australian Inst Marine Sci,AIMS JCU, Townsville, Qld 4811, Australia.	sarah.castine@my.jcu.edu.au	Erler, Dirk/I-7209-2012; Paul, Nicholas/B-6496-2009; Eyre, Bradley/C-2527-2013; de Nys, Rocky/D-6741-2012	Eyre, Bradley/0000-0001-5502-0680; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535; Erler, Dirk/0000-0003-1242-7311	AIMS@JCU	AIMS@JCU	This research was funded by an AIMS@JCU research scholarship awarded to Sarah Castine at the beginning of her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2010, APPL MICROBIOL BIOT, V85, P773, DOI 10.1007/s00253-009-2265-4; Alongi DM, 2000, MAR ECOL PROG SER, V194, P87, DOI 10.3354/meps194087; Amano T, 2011, MICROBES ENVIRON, V26, P1, DOI 10.1264/jsme2.ME10150; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Archer HE, 2003, WATER SCI TECHNOL, V48, P9, DOI 10.2166/wst.2003.0076; Avnimelech Y, 1999, AQUACULTURE, V176, P227, DOI 10.1016/S0044-8486(99)00085-X; Bartoli M, 2005, MAR POLLUT BULL, V50, P1386, DOI 10.1016/j.marpolbul.2005.06.011; Bolan NS, 2009, BIORESOURCE TECHNOL, V100, P5490, DOI 10.1016/j.biortech.2009.03.004; Brunet RC, 1996, FEMS MICROBIOL ECOL, V21, P131, DOI 10.1111/j.1574-6941.1996.tb00340.x; Bulow SE, 2010, DEEP-SEA RES PT I, V57, P384, DOI 10.1016/j.dsr.2009.10.014; Burford MA, 2004, AQUACULTURE, V229, P129, DOI 10.1016/S0044-8486(03)00358-2; Burford MA, 2001, MAR ECOL PROG SER, V224, P187, DOI 10.3354/meps224187; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; Christensen PB, 2000, AQUAT MICROB ECOL, V21, P73, DOI 10.3354/ame021073; Clarke K., 2005, PRIMER 6 COMPUTER PR; Craggs RJ, 2004, NEW ZEAL J AGR RES, V47, P449, DOI 10.1080/00288233.2004.9513613; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Dalsgaard T, 2002, APPL ENVIRON MICROB, V68, P3802, DOI 10.1128/AEM.68.8.3802-3808.2002; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; Dong LF, 2000, MAR ECOL PROG SER, V203, P109, DOI 10.3354/meps203109; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Engstrom P, 2005, GEOCHIM COSMOCHIM AC, V69, P2057, DOI 10.1016/j.gca.2004.09.032; Erler D, 2007, AQUACULT INT, V15, P55, DOI 10.1007/s10499-006-9068-8; Erler DV, 2008, ENVIRON SCI TECHNOL, V42, P9144, DOI 10.1021/es801175t; Galloway JN, 2008, SCIENCE, V320; Giblin AE, 2010, ESTUAR COAST, V33, P1054, DOI 10.1007/s12237-010-9280-7; Guven D, 2005, APPL ENVIRON MICROB, V71, P1066, DOI 10.1128/AEM.71.2.1066-1071.2005; Hietanen S, 2008, HYDROBIOLOGIA, V596, P67, DOI 10.1007/s10750-007-9058-5; Hulth S, 1999, GEOCHIM COSMOCHIM AC, V63, P49, DOI 10.1016/S0016-7037(98)00285-3; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Jackson CJ, 2003, AQUACULTURE, V226, P23, DOI 10.1016/S0044-8486(03)00464-2; Jensen MM, 2007, APPL ENVIRON MICROB, V73, P3151, DOI 10.1128/AEM.01898-06; Jetten MSM, 2001, CURR OPIN BIOTECH, V12, P283, DOI 10.1016/S0958-1669(00)00211-1; Jorgensen BB, 2010, ISME J, V4, P1083, DOI 10.1038/ismej.2010.106; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; KING D, 1984, J GEN MICROBIOL, V130, P2935; Koop-Jakobsen K, 2009, ESTUAR COAST, V32, P238, DOI 10.1007/s12237-008-9131-y; Li M, 2011, MICROBES ENVIRON, V26, P15, DOI 10.1264/jsme2.ME10131; LORING DH, 1992, EARTH-SCI REV, V32, P235, DOI 10.1016/0012-8252(92)90001-A; Madrid VM, 2006, FEMS MICROBIOL ECOL, V57, P169, DOI 10.1111/j.1574-6941.2006.00123.x; Meyer-Reil LA, 2000, MAR POLLUT BULL, V41, P255, DOI 10.1016/S0025-326X(00)00114-4; Minjeaud L, 2009, AQUAT SCI, V71, P425, DOI 10.1007/s00027-009-0100-8; Nicholls JC, 2009, AQUAT MICROB ECOL, V55, P105, DOI 10.3354/ame01285; Porrello S, 2003, AQUACULTURE, V219, P485, DOI 10.1016/S0044-8486(02)00637-3; Risgaard-Petersen N, 2005, AQUAT MICROB ECOL, V40, P67, DOI 10.3354/ame040067; Roy D, 2010, J IND MICROBIOL BIOT, V37, P1105, DOI 10.1007/s10295-010-0869-4; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Tanner CC, 2003, WATER SCI TECHNOL, V48, P331, DOI 10.2166/wst.2003.0138; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thomas Y, 2010, MAR POLLUT BULL, V61, P387, DOI 10.1016/j.marpolbul.2010.07.005; Trimmer M, 2005, APPL ENVIRON MICROB, V71, P1923, DOI 10.1128/AEM.71.4.1923-1930.2005; Trimmer M, 2003, APPL ENVIRON MICROB, V69, P6447, DOI 10.1128/AEM.69.11.6447-6454.2003; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P577, DOI 10.4319/lo.2009.54.2.0577; Yin SX, 2002, SOIL BIOL BIOCHEM, V34, P1131, DOI 10.1016/S0038-0717(02)00049-4	56	22	24	1	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e42810	10.1371/journal.pone.0042810	http://dx.doi.org/10.1371/journal.pone.0042810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962581	Green Published, gold, Green Accepted			2022-12-25	WOS:000308577600008
J	Jones, GN; Moschidou, D; Puga-Iglesias, TI; Kuleszewicz, K; Vanleene, M; Shefelbine, SJ; Bou-Gharios, G; Fisk, NM; David, AL; De Coppi, P; Guillot, PV				Jones, Gemma N.; Moschidou, Dafni; Puga-Iglesias, Tamara-Isabel; Kuleszewicz, Katarzyna; Vanleene, Maximilien; Shefelbine, Sandra J.; Bou-Gharios, George; Fisk, Nicholas M.; David, Anna L.; De Coppi, Paolo; Guillot, Pascale V.			Ontological Differences in First Compared to Third Trimester Human Fetal Placental Chorionic Stem Cells	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; MESENCHYMAL STROMAL CELLS; PROGENITOR CELLS; AMNIOTIC-FLUID; CORD BLOOD; PLX-PAD; C-KIT; BONE; MOUSE; EXPRESSION	Human mesenchymal stromal/stem cells (MSC) isolated from fetal tissues hold promise for use in tissue engineering applications and cell-based therapies, but their collection is restricted ethically and technically. In contrast, the placenta is a potential source of readily-obtainable stem cells throughout pregnancy. In fetal tissues, early gestational stem cells are known to have advantageous characteristics over neonatal and adult stem cells. Accordingly, we investigated whether early fetal placental chorionic stem cells (e-CSC) were physiologically superior to their late gestation fetal chorionic counterparts (l-CSC). We showed that e-CSC shared a common phenotype with l-CSC, differentiating down the osteogenic, adipogenic and neurogenic pathways, and containing a subset of cells endogenously expressing NANOG, SOX2, c-MYC, and KLF4, as well as an array of genes expressed in pluripotent stem cells and primordial germ cells, including CD24, NANOG, SSEA4, SSEA3, TRA-1-60, TRA-1-81, STELLA, FRAGILIS, NANOS3, DAZL and SSEA1. However, we showed that e-CSC have characteristics of an earlier state of stemness compared to l-CSC, such as smaller size, faster kinetics, uniquely expressing OCT4A variant 1 and showing higher levels of expression of NANOG, SOX2, c-MYC and KLF4 than l-CSC. Furthermore e-CSC, but not l-CSC, formed embryoid bodies containing cells from the three germ layer lineages. Finally, we showed that e-CSC demonstrate higher tissue repair in vivo; when transplanted in the osteogenesis imperfecta mice, e-CSC, but not l-CSC increased bone quality and plasticity; and when applied to a skin wound, e-CSC, but not l-CSC, accelerated healing compared to controls. Our results provide insight into the ontogeny of the stemness phenotype during fetal development and suggest that the more primitive characteristics of early compared to late gestation fetal chorionic stem cells may be translationally advantageous.	[Jones, Gemma N.; Moschidou, Dafni; Puga-Iglesias, Tamara-Isabel; Kuleszewicz, Katarzyna; Guillot, Pascale V.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Vanleene, Maximilien; Shefelbine, Sandra J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Bou-Gharios, George] Univ Oxford, Kennedy Inst Rheumatol, London, England; [Fisk, Nicholas M.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [David, Anna L.] UCL, Prenatal Cell & Gene Therapy Grp, Inst Womens Hlth, London, England; [De Coppi, Paolo] UCL Inst Child Hlth, Surg Unit, London, England	Imperial College London; Imperial College London; University of Oxford; University of Queensland; University of London; University College London; University of London; University College London	Jones, GN (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England.	Pascale.Guillot@imperial.ac.uk	Fisk, Nicholas M/B-2126-2009	Fisk, Nicholas M/0000-0003-0031-7975; De Coppi, Paolo/0000-0002-1659-0207; Kuleszewicz, Kasia/0000-0003-1381-6589; David, Anna/0000-0002-0199-6140; Guillot, Pascale V/0000-0002-3796-1572	Genesis Research Trust; Henry Smith Charity; Action Medical Research; Medical Research Council; Kidney Research United Kingdom; Biotechnology and Biological Science Research Council; Great Ormond Street Hospital Children's Charity; National Institute for Health Research (NIHR); Department of Health's NIHR Biomedical Research Centers funding scheme; Action Medical Research [1749] Funding Source: researchfish	Genesis Research Trust; Henry Smith Charity; Action Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research United Kingdom(Kidney Research UK (KRUK)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Great Ormond Street Hospital Children's Charity; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Department of Health's NIHR Biomedical Research Centers funding scheme; Action Medical Research	This research was funded by Genesis Research Trust, Henry Smith Charity and Action Medical Research. GNJ was supported by the Medical Research Council. DM was supported by Kidney Research United Kingdom. KK was supported by Biotechnology and Biological Science Research Council. PDC was supported by Great Ormond Street Hospital Children's Charity. ALD is supported by the National Institute for Health Research (NIHR) through a Senior Lectureship and the Department of Health's NIHR Biomedical Research Centers funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak H, 2010, J R SOC INTERFACE, V7, pS689, DOI 10.1098/rsif.2010.0347.focus; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Arnaud P, 2010, REPRODUCTION, V140, P411, DOI 10.1530/REP-10-0173; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Bacenkova D, 2011, CYTOTHERAPY, V13, P1047, DOI 10.3109/14653249.2011.592522; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Bowles J, 2003, CYTOGENET GENOME RES, V101, P261, DOI 10.1159/000074346; Brooke G, 2009, BRIT J HAEMATOL, V144, P571, DOI 10.1111/j.1365-2141.2008.07492.x; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Castrechini NM, 2010, PLACENTA, V31, P203, DOI 10.1016/j.placenta.2009.12.006; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chan J, 2008, HUM REPROD, V23, P2427, DOI 10.1093/humrep/den302; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Ciuca DR, 2011, ROM J MORPHOL EMBRYO, V52, P803; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Miguel MP, 2002, P NATL ACAD SCI USA, V99, P10458, DOI 10.1073/pnas.122249399; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donovan PJ, 1998, INT J DEV BIOL, V42, P1043; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Fariha MMN, 2011, CYTOTHERAPY, V13, P582, DOI 10.3109/14653249.2010.549121; Guillot P, 2008, J PATHOL, V214, P627, DOI 10.1002/path.2325; Guillot PV, 2008, BLOOD, V111, P1717, DOI 10.1182/blood-2007-08-105809; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hoyer PE, 2005, MOL CELL ENDOCRINOL, V234, P1, DOI 10.1016/j.mce.2004.09.012; Hua JL, 2009, TISSUE CELL, V41, P448, DOI 10.1016/j.tice.2009.05.004; Hua JL, 2009, REPROD BIOMED ONLINE, V19, P99, DOI 10.1016/S1472-6483(10)60052-1; Huygen S, 2002, BLOOD, V100, P2744, DOI 10.1182/blood.V100.8.2744; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Izumi M, 2009, J REPROD IMMUNOL, V81, P39, DOI 10.1016/j.jri.2009.02.007; Jones GN, 2012, STEM CELL TRANSL MED, V1, P70, DOI 10.5966/sctm.2011-0007; Kim MJ, 2011, CELL TISSUE RES, V346, P53, DOI 10.1007/s00441-011-1249-8; Kucia M, 2007, DEV DYNAM, V236, P3309, DOI 10.1002/dvdy.21180; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Kucia M, 2006, ACTA NEUROBIOL EXP, V66, P331; Kyo S, 1997, BIOCHEM BIOPH RES CO, V241, P498, DOI 10.1006/bbrc.1997.7767; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Li X, 2011, STEM CELLS, V29, P263, DOI 10.1002/stem.572; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Mohr S, 2010, REPROD SCI, V17, P1006, DOI 10.1177/1933719110377471; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Motohashi T, 2007, STEM CELLS, V25, P402, DOI 10.1634/stemcells.2006-0323; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okamoto K, 2007, EXP CELL RES, V313, P2550, DOI 10.1016/j.yexcr.2007.04.028; Park JH, 2004, MOL CELLS, V17, P309; Park S, 2011, PLACENTA, V32, P269, DOI 10.1016/j.placenta.2010.12.027; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Poloni A, 2012, CELL PROLIFERAT, V45, P66, DOI 10.1111/j.1365-2184.2011.00799.x; Poloni A, 2008, CYTOTHERAPY, V10, P690, DOI 10.1080/14653240802419310; Portmann-Lanz CB, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.893; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Prather WR, 2009, CYTOTHERAPY, V11, P427, DOI 10.1080/14653240902849762; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Ramot Y, 2009, TOXICOL PATHOL, V37, P606, DOI 10.1177/0192623309338383; Ratajczak MZ, 2011, METHOD CELL BIOL, V103, P31, DOI 10.1016/B978-0-12-385493-3.00003-6; Ryan JM, 2011, STEM CELL REV; Saiti D, 2007, BIOMARK INSIGHTS, V2, P241; Schmidt D, 2006, CIRCULATION, V114, pI125, DOI 10.1161/CIRCULATIONAHA.105.001040; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Shin DM, 2010, LEUKEMIA, V24, P1450, DOI 10.1038/leu.2010.121; Shin KS, 2010, CELL PROLIFERAT, V43, P435, DOI 10.1111/j.1365-2184.2010.00693.x; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Spitalieri P, 2009, CLONING STEM CELLS, V11, P535, DOI 10.1089/clo.2009.0046; Sung HJ, 2010, J KOREAN MED SCI, V25, P1418, DOI 10.3346/jkms.2010.25.10.1418; Susman S, 2010, ROM J MORPHOL EMBRYO, V51, P733; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Vanleene M, 2011, BLOOD, V117, P1053, DOI 10.1182/blood-2010-05-287565; Weber B, 2011, PLACENTA, V32, pS316, DOI 10.1016/j.placenta.2011.04.001; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; Zhang ZY, 2012, BIOMATERIALS	86	48	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43395	10.1371/journal.pone.0043395	http://dx.doi.org/10.1371/journal.pone.0043395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962584	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600011
J	Li, L; Stefan, MI; Le Novere, N				Li, Lu; Stefan, Melanie I.; Le Novere, Nicolas			Calcium Input Frequency, Duration and Amplitude Differentially Modulate the Relative Activation of Calcineurin and CaMKII	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; BIDIRECTIONAL SYNAPTIC PLASTICITY; NMDA RECEPTORS; CALMODULIN-BINDING; NEURONAL PHOSPHOPROTEIN; CA-2+ CALMODULIN; RAT-BRAIN; AREA CA1; DARPP-32	NMDA receptor dependent long-term potentiation (LTP) and long-term depression (LTD) are two prominent forms of synaptic plasticity, both of which are triggered by post-synaptic calcium elevation. To understand how calcium selectively stimulates two opposing processes, we developed a detailed computational model and performed simulations with different calcium input frequencies, amplitudes, and durations. We show that with a total amount of calcium ions kept constant, high frequencies of calcium pulses stimulate calmodulin more efficiently. Calcium input activates both calcineurin and Ca2+/calmodulin-dependent protein kinase II (CaMKII) at all frequencies, but increased frequencies shift the relative activation from calcineurin to CaMKII. Irrespective of amplitude and duration of the inputs, the total amount of calcium ions injected adjusts the sensitivity of the system to calcium input frequencies. At a given frequency, the quantity of CaMKII activated is proportional to the total amount of calcium. Thus, an input of a small amount of calcium at high frequencies can induce the same activation of CaMKII as a larger amount, at lower frequencies. Finally, the extent of activation of CaMKII signals with high calcium frequency is further controlled by other factors, including the availability of calmodulin, and by the potency of phosphatase inhibitors.	[Li, Lu; Stefan, Melanie I.; Le Novere, Nicolas] EMBL European Bioinformat Inst, Hinxton, England	European Molecular Biology Laboratory (EMBL)	Li, L (corresponding author), EMBL European Bioinformat Inst, Hinxton, England.	lenov@ebi.ac.uk		Li, Lu/0000-0002-6199-522X; Stefan, Melanie/0000-0002-6086-7357				AITKEN A, 1984, EUR J BIOCHEM, V139, P663, DOI 10.1111/j.1432-1033.1984.tb08055.x; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bhalla US, 2002, J COMPUT NEUROSCI, V13, P49, DOI 10.1023/A:1019644427655; Black DJ, 2007, BIOCHEMISTRY-US, V46, P13415, DOI 10.1021/bi700774s; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Byrne MJ, 2009, J COMPUT NEUROSCI, V27, P621, DOI 10.1007/s10827-009-0173-3; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Coomber C, 1998, COMPUT CHEM, V22, P251, DOI 10.1016/S0097-8485(97)00002-8; CROUCH TH, 1980, BIOCHEMISTRY-US, V19, P3692, DOI 10.1021/bi00557a009; d'Alcantara P, 2003, EUR J NEUROSCI, V17, P2521, DOI 10.1046/j.1460-9568.2003.02693.x; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; DESDOUITS F, 1995, BIOCHEM BIOPH RES CO, V206, P652, DOI 10.1006/bbrc.1995.1092; Dormand J.R., 1980, J COMPUT APPL MATH, V6, P19, DOI [10.1016/0771-050X(80)90013-3, DOI 10.1016/0771-050X(80)90013-3]; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dupont G, 2003, CELL CALCIUM, V34, P485, DOI 10.1016/S0143-4160(03)00152-0; Franks KM, 2001, NEUROCOMPUTING, V38, P9, DOI 10.1016/S0925-2312(01)00415-5; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; Graupner M, 2007, PLOS COMPUT BIOL, V3, P2299, DOI 10.1371/journal.pcbi.0030221; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayer A, 2005, PLOS COMPUT BIOL, V1, P137, DOI 10.1371/journal.pcbi.0010020; HEMMINGS HC, 1990, J BIOL CHEM, V265, P20369; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4491; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; Huang KP, 2000, BIOCHEMISTRY-US, V39, P7291, DOI 10.1021/bi000336l; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P297, DOI 10.1111/j.1432-1033.1983.tb07362.x; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; KING MM, 1984, J BIOL CHEM, V259, P8080; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kubota Y, 2001, J COMPUT NEUROSCI, V11, P263, DOI 10.1023/A:1013727331979; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LUBYPHELPS K, 1995, J BIOL CHEM, V270, P21532, DOI 10.1074/jbc.270.37.21532; Lucic V, 2008, EUR BIOPHYS J BIOPHY, V38, P83, DOI 10.1007/s00249-008-0362-4; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MICHELSON S, 1994, J THEOR BIOL, V171, P281, DOI 10.1006/jtbi.1994.1231; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; Petersen JD, 2003, J NEUROSCI, V23, P11270; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Quintana AR, 2005, BIOCHEM BIOPH RES CO, V334, P674, DOI 10.1016/j.bbrc.2005.06.152; REGEHR WG, 1992, J NEUROSCI, V12, P4202; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Stefan MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029406; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Takahashi K, 2004, BIOINFORMATICS, V20, P538, DOI 10.1093/bioinformatics/btg442; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Urakubo H, 2008, J NEUROSCI, V28, P3310, DOI 10.1523/JNEUROSCI.0303-08.2008; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1; Zhabotinsky AM, 2006, J NEUROSCI, V26, P7337, DOI 10.1523/JNEUROSCI.0729-06.2006	104	65	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43810	10.1371/journal.pone.0043810	http://dx.doi.org/10.1371/journal.pone.0043810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962589	gold, Green Published, Green Accepted			2022-12-25	WOS:000308577600017
J	Lichtenegger, FS; Mueller, K; Otte, B; Beck, B; Hiddemann, W; Schendel, DJ; Subklewe, M				Lichtenegger, Felix S.; Mueller, Katharina; Otte, Bettina; Beck, Barbara; Hiddemann, Wolfgang; Schendel, Dolores J.; Subklewe, Marion			CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; CANCER-IMMUNOTHERAPY; COSTIMULATORY MOLECULE; IN-VIVO; MATURATION; VACCINATION; EXPRESSION; IMMUNITY; GENERATION; INDUCTION	Background: Dendritic cells (DCs) determine the activation and polarization of T cells via expression of costimulatory molecules and secretion of cytokines. The function of DCs derived from monocytes ex vivo strongly depends on the composition of the maturation cocktail used. Methodology/Principal Findings: We analyzed the effect of costimulatory molecule expression and cytokine secretion by DCs on T and natural killer (NK) cell activation by conducting a head-to-head comparison of a Toll-like receptor (TLR) agonist-based cocktail with the standard combination of proinflammatory cytokines or IL-10 alone. We could show that TLR-induced DCs are characterized by a predominance of costimulatory over coinhibitory molecules and by high secretion of IL-12p70, but not IL-10. Functionally, these signals translated into an increase in IFN-gamma secreting Th1 cells and a decrease in regulatory T cells. T cell activation and polarization were dependent on IL-12p70 and CD86, but remarkably not on CD80 signaling. By means of IL-12p70 secretion, only TLR-induced DCs activated NK cells. Conclusions/Significance: TLR-matured DCs are highly suitable for application in immunotherapeutic strategies that rely on strong type 1 polarization and NK cell activation. Their effects particularly depend on high CD86 expression and IL-12p70 secretion.	[Lichtenegger, Felix S.; Mueller, Katharina; Otte, Bettina; Beck, Barbara; Hiddemann, Wolfgang; Subklewe, Marion] Klinikum Univ Munchen, Dept Internal Med 3, Munich, Germany; [Schendel, Dolores J.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lichtenegger, FS (corresponding author), Klinikum Univ Munchen, Dept Internal Med 3, Munich, Germany.	Felix.Lichtenegger@med.uni-muenchen.de	Subklewe, Marion/N-5873-2014; Lichtenegger, Felix S/H-3222-2019	Subklewe, Marion/0000-0001-9154-9469; 	BayImmuNet, the Bavarian Immunotherapy Network	BayImmuNet, the Bavarian Immunotherapy Network	This work was supported by funds from BayImmuNet, the Bavarian Immunotherapy Network (http://www.bayimmunet.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2011, SEMIN IMMUNOL, V23, P42, DOI 10.1016/j.smim.2011.01.003; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Beck B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-151; Boudreau JE, 2011, MOL THER, V19, P841, DOI 10.1038/mt.2011.57; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; Correll A, 2010, EXP DERMATOL, V19, pE213, DOI 10.1111/j.1600-0625.2009.01055.x; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; De Becker G, 1998, EUR J IMMUNOL, V28, P3161, DOI 10.1002/(SICI)1521-4141(199810)28:10<3161::AID-IMMU3161>3.3.CO;2-H; Dohnal AM, 2007, CYTOTHERAPY, V9, P755, DOI 10.1080/14653240701589221; Eksioglu EA, 2010, FRONT BIOSCI-LANDMRK, V15, P321, DOI 10.2741/3623; Flies DB, 2007, J IMMUNOTHER, V30, P251, DOI 10.1097/CJI.0b013e31802e085a; Fujii S, 2009, ARCH IMMUNOL THER EX, V57, P189, DOI 10.1007/s00005-009-0025-x; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Jacobs JFM, 2010, CLIN CANCER RES, V16, P5067, DOI 10.1158/1078-0432.CCR-10-1757; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalinski P, 2005, MOL IMMUNOL, V42, P535, DOI 10.1016/j.molimm.2004.07.038; Kalinski P, 1999, J IMMUNOL, V162, P3231; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LARSEN CP, 1992, J EXP MED, V176, P1215, DOI 10.1084/jem.176.4.1215; LARSEN CP, 1994, J IMMUNOL, V152, P5208; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Osada T, 2006, CANCER IMMUNOL IMMUN, V55, P1122, DOI 10.1007/s00262-005-0089-3; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Schuler G, 2011, CANCER J, V17, P337, DOI 10.1097/PPO.0b013e3182350077; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seliger B, 2008, TRENDS MOL MED, V14, P550, DOI 10.1016/j.molmed.2008.09.010; Skalova K, 2010, VACCINE, V28, P5153, DOI 10.1016/j.vaccine.2010.05.042; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Spranger S, 2010, J IMMUNOL, V185, P738, DOI 10.4049/jimmunol.1000060; Steinbrink K, 1997, J IMMUNOL, V159, P4772; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tuyaerts S, 2007, CANCER IMMUNOL IMMUN, V56, P1513, DOI 10.1007/s00262-007-0334-z; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Um SJ, 2010, LUNG CANCER, V70, P188, DOI 10.1016/j.lungcan.2010.02.006; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Xu SW, 2003, J IMMUNOL, V171, P2251, DOI 10.4049/jimmunol.171.5.2251; Zobywalski A, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-18	51	48	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44266	10.1371/journal.pone.0044266	http://dx.doi.org/10.1371/journal.pone.0044266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962607	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600035
J	Bruno, E; Nimaga, K; Foba, I; Vignoles, P; Genton, P; Doumbo, O; Gerard, D; Preux, PM; Farnarier, G				Bruno, Elisa; Nimaga, Karamoko; Foba, Ibrahima; Vignoles, Philippe; Genton, Pierre; Doumbo, Ogobara; Gerard, Daniel; Preux, Pierre-Marie; Farnarier, Guy			Results of an Action-Research on Epilepsy in Rural Mali	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; TREATMENT GAP; COMMUNITY; MANAGEMENT; PROGRAM; CARE; EXAMPLE; ACCESS; TRIAL	Purpose: To evaluate the RARE (Reseau Action-Recherche sur l'Epilepsie) program, a model of managing and treating people with epilepsy (PWE) at a primary health-care level in rural areas of Mali, we assessed treatment efficacy and compliance of patients who underwent the first year follow-up. Methods: A network of rural general practitioners (GPs) settled in six rural districts of the regions of Koulikoro, Segou and Sikasso, was involved in the diagnosis, evaluation and monitoring of all the identified PWE and in the distribution of phenobarbital (PB). All the participants were included in a prospective database and followed-up by GPs at 4 months intervals during the first year. Seizure frequency, treatment doses and appearance of adverse events (AEs) were systematically recorded. Efficacy was evaluated in terms of reduction of seizures frequency while noncompliance in terms of time to study withdrawal for any cause. Key findings: 596 patients treated with PB were included in the analysis. Of these, 74.0% completed the first year follow-up. At the final visit, 59.6% were seizure-free: 31.0% for 12 months, 10.2% for 8 months and 18.4% for 4 months. Adults and patients with convulsive seizures were the most drug-resistant (p<0.002). Few AEs were recorded. The multivariate analysis showed that being a woman, presenting convulsive seizures, having more than 5 seizures/month and had never be treated were predictors of withdrawal (p <= 0.05) at 12 months. Significance: This study showed a good response and compliance to the treatment and allowed the identification of some factors associated with failure of management in a setting very near to clinical practice. Awareness campaigns are needed to assure a broader accessibility to treatment and to improve the compliance and continuity with treatment programs.	[Bruno, Elisa; Vignoles, Philippe; Preux, Pierre-Marie] Univ Limoges, Sch Med, Inst Trop Neurol, CHU,INSERM,Trop Neuroepidemiol U1094, Limoges, France; [Bruno, Elisa] Univ Catania, Sect Neurosci, Dept Gian Filippo Ingrassia, Catania, Italy; [Nimaga, Karamoko; Foba, Ibrahima] Assoc Med Campagne, Reseau Act Rech Epilepsie RARE Network, Bamako, Mali; [Foba, Ibrahima; Doumbo, Ogobara] Fac Med, Dept Epidemiol Parasit Dis, Bamako, Mali; [Genton, Pierre; Doumbo, Ogobara; Farnarier, Guy] Sante S Nongovt Org, Bamako, Mali; [Genton, Pierre; Gerard, Daniel; Farnarier, Guy] Sanofi Aventis, Access Drugs Dept, Paris, France; [Genton, Pierre; Farnarier, Guy] Aix Marseille Univ, Dept Clin Neurophysiol, CHRU, Hop Nord, Marseille, France; [Genton, Pierre; Farnarier, Guy] Aix Marseille Univ, Fac Med, Marseille, France; [Genton, Pierre; Doumbo, Ogobara; Farnarier, Guy] Sante S Nongovt Org, Marseille, France	CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Limoges; University of Catania; Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Bruno, E (corresponding author), Univ Limoges, Sch Med, Inst Trop Neurol, CHU,INSERM,Trop Neuroepidemiol U1094, Limoges, France.	pierre-marie.preux@unilim.fr	Preux, Pierre-Marie/N-3538-2019; Bruno, Elisa/P-4317-2018; PREUX, Pierre-Marie/B-8393-2014	Preux, Pierre-Marie/0000-0002-2171-2977; Bruno, Elisa/0000-0001-8166-1190; PREUX, Pierre-Marie/0000-0002-2171-2977	Sanofi-Aventis within the project "RARE: Reseau Action-Recherche sur l'Epilepsie"	Sanofi-Aventis within the project "RARE: Reseau Action-Recherche sur l'Epilepsie"	This work was supported by Sanofi-Aventis within the project "RARE: Reseau Action-Recherche sur l'Epilepsie" coordinated by the NGO Sante-Sud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMOLEKUN B, 1995, TROP GEOGR MED, V47, P115; [Anonymous], 1993, EPILEPSIA, V34, P592; Arborio S, 1999, MED TROPICALE, V59, P170; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Barennes H, 2011, ARCH DIS CHILD, V96, P309, DOI 10.1136/adc.2009.181255; Birbeck GL, 2010, EPILEPSY CURR, V10, P105, DOI 10.1111/j.1535-7511.2010.01372.x; Calisir N, 2006, EPILEPSIA, V47, P1691, DOI 10.1111/j.1528-1167.2006.00635.x; Coulibaly S., 2007, EDUC HEALTH, V20, P1; Das K, 2007, SEIZURE-EUR J EPILEP, V16, P601, DOI 10.1016/j.seizure.2007.04.008; Desplats D, 2004, Med Trop (Mars), V64, P539; Diop AG, 2001, EPILEPSIA, V42, P439, DOI 10.1046/j.1528-1157.2001.38800.x; ELECHI CA, 1991, TROP GEOGR MED, V43, P242; Farnarier G, 2005, EPILEPSIA, V46, P73; Farnarier G, 2000, Med Trop (Mars), V60, P151; Farnarier G., 1999, EPILEPSIES, V11, P222; Farnarier G, 1998, EPILEPSIES, V10, P105; Farnarier G, 2010, EPILEPSIES, V22, P151; FEKSI AT, 1991, EPILEPSY RES, V8, P252, DOI 10.1016/0920-1211(91)90072-N; Genton P, 2005, EPILEPSIA, V46, P88; Genton P., 2003, EPILEPSIES, V15, P201; Grunitzky, 2001, EPILEPSIES, V13, P185; Humbert AJ, 2001, EPILEPSIES, V13, P3338; Jaffre Y, 2001, EPILEPSIES, V13, P29; JILEK W G, 1970, African Journal of Medical Sciences, V1, P305; JILEKAALL L, 1992, EPILEPSIA, V33, P645, DOI 10.1111/j.1528-1157.1992.tb02341.x; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Mani KS, 2001, LANCET, V357, P1316, DOI 10.1016/S0140-6736(00)04516-5; Mani KS, 1998, NEUROL INDIA, V46, P1; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Murthy JMK, 2003, EPILEPSIA, V44, P38, DOI 10.1046/j.1528-1157.44.s.1.3.x; Nimaga K, 2000, B WORLD HEALTH ORGAN, V80, P1; Organization WH, 1990, IN SUPP PEOPL EP; Pal DK, 1998, LANCET, V351, P19, DOI 10.1016/S0140-6736(97)06250-8; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Preux PM, 2000, EPILEPSIA, V41, P432, DOI 10.1111/j.1528-1157.2000.tb00185.x; Radhakrishnan K, 2010, ANN INDIAN ACAD NEUR, V13, P236, DOI 10.4103/0972-2327.74184; SHORVON SD, 1988, EPILEPSIA, V29, pS36, DOI 10.1111/j.1528-1157.1988.tb05790.x; Unwin N, 1999, PUBLIC HEALTH, V113, P141, DOI 10.1016/S0033-3506(99)00139-0; Van Dormael M, HUMAN RESOURCES HLTH, P6, DOI [10.1186/1478-4491-1186-1125, DOI 10.1186/1478-4491-1186-1125]; Wang WZ, 2006, LANCET NEUROL, V5, P46, DOI 10.1016/S1474-4422(05)70254-4; WATTS AE, 1989, BRIT MED J, V298, P805, DOI 10.1136/bmj.298.6676.805; WFN, 2004, ATL COUNTR RES NEUR; WHO, 2000, EP MAN PRIM HLTH LEV; WHO, 1994, EP WHO AFR REG BRIDG; WHO, 2006, TRAV ENS SANT	45	13	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44469	10.1371/journal.pone.0044469	http://dx.doi.org/10.1371/journal.pone.0044469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22970109	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300093
J	Moussa, MN; Steen, MR; Laurienti, PJ; Hayasaka, S				Moussa, Malaak N.; Steen, Matthew R.; Laurienti, Paul J.; Hayasaka, Satoru			Consistency of Network Modules in Resting-State fMRI Connectome Data	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; COMMUNITY STRUCTURE; HUMAN BRAIN; DEFAULT MODE; HEAD MOTION; SMALL-WORLD; ORGANIZATION; MULTISCALE; CORTEX	At rest, spontaneous brain activity measured by fMRI is summarized by a number of distinct resting state networks (RSNs) following similar temporal time courses. Such networks have been consistently identified across subjects using spatial ICA (independent component analysis). Moreover, graph theory-based network analyses have also been applied to resting-state fMRI data, identifying similar RSNs, although typically at a coarser spatial resolution. In this work, we examined resting-state fMRI networks from 194 subjects at a voxel-level resolution, and examined the consistency of RSNs across subjects using a metric called scaled inclusivity (SI), which summarizes consistency of modular partitions across networks. Our SI analyses indicated that some RSNs are robust across subjects, comparable to the corresponding RSNs identified by ICA. We also found that some commonly reported RSNs are less consistent across subjects. This is the first direct comparison of RSNs between ICAs and graph-based network analyses at a comparable resolution.	[Moussa, Malaak N.] Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27103 USA; [Steen, Matthew R.; Laurienti, Paul J.; Hayasaka, Satoru] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA; [Hayasaka, Satoru] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Moussa, MN (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27103 USA.	shayasak@wakehealth.edu			National Institute of Neurological Disorders and Stroke [NS070917]; National Institute on Alcohol Abuse and Alcoholism [T32-AA007565]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007565] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Institute of Neurological Disorders and Stroke (NS070917). MNM is supported by the National Institute on Alcohol Abuse and Alcoholism (T32-AA007565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Laurienti PJ, 2011, PHYSICA A, V390, P3608, DOI 10.1016/j.physa.2011.05.011; Luo C, 2012, HUM BRAIN MAPP, V33, P1279, DOI 10.1002/hbm.21286; Meunier David, 2009, Front Neuroinform, V3, P37, DOI 10.3389/neuro.11.037.2009; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Simpson SL, 2012, NEUROIMAGE, V60, P1117, DOI 10.1016/j.neuroimage.2012.01.071; Steen M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016111; Telesford QK, 2011, BRAIN CONNECT, V1, P295, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	44	111	112	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44428	10.1371/journal.pone.0044428	http://dx.doi.org/10.1371/journal.pone.0044428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952978	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300091
J	Nfonsam, LE; Cano, C; Mudge, J; Schilkey, FD; Curtiss, J				Nfonsam, Landry E.; Cano, Carlos; Mudge, Joann; Schilkey, Faye D.; Curtiss, Jennifer			Analysis of the Transcriptomes Downstream of Eyeless and the Hedgehog, Decapentaplegic and Notch Signaling Pathways in Drosophila melanogaster	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TWIN-OF-EYELESS; RETINAL DETERMINATION GENES; HOMEOBOX-CONTAINING GENE; ECTOPIC EYE DEVELOPMENT; WING IMAGINAL DISC; HUMAN PAX6 GENE; SINE-OCULIS; MORPHOGENETIC FURROW; PRONEURAL GENE	Tissue-specific transcription factors are thought to cooperate with signaling pathways to promote patterned tissue specification, in part by co-regulating transcription. The Drosophila melanogaster Pax6 homolog Eyeless forms a complex, incompletely understood regulatory network with the Hedgehog, Decapentaplegic and Notch signaling pathways to control eye-specific gene expression. We report a combinatorial approach, including mRNAseq and microarray analyses, to identify targets co-regulated by Eyeless and Hedgehog, Decapentaplegic or Notch. Multiple analyses suggest that the transcriptomes resulting from co-misexpression of Eyeless+signaling factors provide a more complete picture of eye development compared to previous efforts involving Eyeless alone: (1) Principal components analysis and two-way hierarchical clustering revealed that the Eyeless+signaling factor transcriptomes are closer to the eye control transcriptome than when Eyeless is misexpressed alone; (2) more genes are upregulated at least three-fold in response to Eyeless+signaling factors compared to Eyeless alone; (3) based on gene ontology analysis, the genes upregulated in response to Eyeless+signaling factors had a greater diversity of functions compared to Eyeless alone. Through a secondary screen that utilized RNA interference, we show that the predicted gene CG4721 has a role in eye development. CG4721 encodes a neprilysin family metalloprotease that is highly up-regulated in response to Eyeless+Notch, confirming the validity of our approach. Given the similarity between D. melanogaster and vertebrate eye development, the large number of novel genes identified as potential targets of Ey+signaling factors will provide novel insights to our understanding of eye development in D. melanogaster and humans.	[Nfonsam, Landry E.; Cano, Carlos; Curtiss, Jennifer] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Mudge, Joann; Schilkey, Faye D.] Natl Ctr Genome Resources, Santa Fe, NM USA	New Mexico State University; National Center for Genome Resources (NCGR)	Nfonsam, LE (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	curtij01@nmsu.edu		Mudge, Joann/0000-0002-2972-1640; Mudge, Joseph/0000-0001-6091-2966; Nfonsam, Landry/0000-0002-5715-2545	NIH NCRR [P20RR016480]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER	NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH NCRR P20RR016480 (http://www.ncrr.nih.gov/research_infrastructure/institutional_development_award/idea_networks_of_biomedical_research_excellence/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aerts S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000435; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; Baker NE, 1997, CURR BIOL, V7, P122, DOI 10.1016/S0960-9822(06)00056-X; Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; Baker NE, 2011, BIOESSAYS, V33, P538, DOI 10.1002/bies.201000131; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096; Baonza A, 2001, CURR BIOL, V11, P396, DOI 10.1016/S0960-9822(01)00125-7; Baonza A, 2001, DEVELOPMENT, V128, P3889; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Belacortu Y, 2011, DEV DYNAM, V240, P2379, DOI 10.1002/dvdy.22753; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Bessa J, 2005, DEVELOPMENT, V132, P5011, DOI 10.1242/dev.02082; BLACKMAN RK, 1987, CELL, V49, P497, DOI 10.1016/0092-8674(87)90452-1; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Bland ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-16; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Boyle M, 1997, DEVELOPMENT, V124, P971; Bramblett DE, 2004, NEURON, V43, P779, DOI 10.1016/j.neuron.2004.08.032; Bramblett DE, 2002, GENOMICS, V79, P402, DOI 10.1006/geno.2002.6708; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown KE, 2006, DEV BIOL, V300, P710, DOI 10.1016/j.ydbio.2006.08.003; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chauhan BK, 2002, J BIOL CHEM, V277, P11539, DOI 10.1074/jbc.M110531200; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chen KC, 1999, P NATL ACAD SCI USA, V96, P5055, DOI 10.1073/pnas.96.9.5055; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chen R, 1999, DEVELOPMENT, V126, P935; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Chow RL, 1999, DEVELOPMENT, V126, P4213; Clouthier DE, 2010, AM J MED GENET A, V152A, P2962, DOI 10.1002/ajmg.a.33568; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Curtiss J, 2002, NAT CELL BIOL, V4, pE48, DOI 10.1038/ncb0302-e48; Curtiss J, 2007, DEV BIOL, V306, P685, DOI 10.1016/j.ydbio.2007.04.006; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Daull P, 2007, J CARDIOVASC PHARM, V50, P247, DOI 10.1097/FJC.0b013e31813c6ca5; deCelis JF, 1996, DEVELOPMENT, V122, P359; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Ditch LM, 2005, DEVELOPMENT, V132, P155, DOI 10.1242/dev.01568; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Dominguez M, 1999, DEVELOPMENT, V126, P2345; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Duparc RH, 2007, DEV BIOL, V301, P374, DOI 10.1016/j.ydbio.2006.11.006; Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Firth LC, 2005, DEV CELL, V8, P541, DOI 10.1016/j.devcel.2005.01.017; Firth LC, 2009, DEV BIOL, V327, P366, DOI 10.1016/j.ydbio.2008.12.021; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Frankfort BJ, 2002, DEVELOPMENT, V129, P1295; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Freeman M, 1997, DEVELOPMENT, V124, P261; Fu WM, 2003, DEVELOPMENT, V130, P5229, DOI 10.1242/dev.00764; Fullaondo A, 2011, MOL CELL BIOL, V31, P2960, DOI 10.1128/MCB.01397-10; Furman DP, 2011, INT J DEV BIOL, V55, P133, DOI 10.1387/ijdb.103129df; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Glasscock E, 2005, GENETICS, V169, P2137, DOI 10.1534/genetics.104.028357; Go MJ, 1998, DEVELOPMENT, V125, P2031; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Greenwood S, 1999, DEVELOPMENT, V126, P5795; Guo R, 2002, BIOCHEM BIOPH RES CO, V297, P38, DOI 10.1016/S0006-291X(02)02125-3; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Hallermann S, 2010, HFSP J, V4, P72, DOI 10.2976/1.3338710; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Higuchi M, 2005, BBA-PROTEINS PROTEOM, V1751, P60, DOI 10.1016/j.bbapap.2005.02.013; HILL RE, 1992, NATURE, V355, P750, DOI 10.1038/355750a0; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hoang CQ, 2010, DEV DYNAM, V239, P2367, DOI 10.1002/dvdy.22380; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Li YX, 2001, CURR BIOL, V11, P330, DOI 10.1016/S0960-9822(01)00093-8; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Mann K, 2012, DEVELOPMENT, V139, P760, DOI 10.1242/dev.074104; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MARDON G, 1994, DEVELOPMENT, V120, P3473; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; McDonald EC, 2010, DEV BIOL, V347, P122, DOI 10.1016/j.ydbio.2010.08.016; Megason SG, 2002, DEVELOPMENT, V129, P2087; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; Melicharek D, 2008, GENETICS, V180, P2095, DOI 10.1534/genetics.108.093302; Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; MOHLER J, 1988, GENETICS, V120, P1061; Morrison CM, 2010, GENESIS, V48, P3, DOI 10.1002/dvg.20571; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Niimi T, 1999, DEVELOPMENT, V126, P2253; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; O'Keefe DD, 2009, DEV BIOL, V333, P143, DOI 10.1016/j.ydbio.2009.06.032; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pueyo JI, 2000, DEVELOPMENT, V127, P5391; Punzo C, 2004, DEVELOPMENT, V131, P3943, DOI 10.1242/dev.01278; Punzo C, 2002, DEVELOPMENT, V129, P625; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Rawlings N.D., 2004, HDB PROTEOLYTIC ENZY, P231; Repiso A, 2011, DEV GROWTH DIFFER, V53, P177, DOI 10.1111/j.1440-169X.2010.01247.x; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Rodriguez DD, 2002, DEVELOPMENT, V129, P3995; Rogers EM, 2005, DEVELOPMENT, V132, P4833, DOI 10.1242/dev.02061; Roignant JY, 2010, DEVELOPMENT, V137, P273, DOI 10.1242/dev.041244; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; SHELLENBARGER DL, 1975, GENETICS, V81, P143; Shen WP, 1997, DEVELOPMENT, V124, P45; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Storey John D, 2003, Methods Mol Biol, V224, P149; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sumitomo M, 2005, BBA-PROTEINS PROTEOM, V1751, P52, DOI 10.1016/j.bbapap.2004.11.001; Sun Y, 1998, DEVELOPMENT, V125, P3731; Suzanne M, 2003, DEV BIOL, V260, P465, DOI 10.1016/S0012-1606(03)00249-5; Testori J, 2011, BLOOD, V117, P2735, DOI 10.1182/blood-2010-07-293209; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Tsuji T, 2000, DEVELOPMENT, V127, P4315; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; VANDERMEERDEJONG R, 1990, GENOMICS, V7, P270, DOI 10.1016/0888-7543(90)90550-E; Vining MS, 2005, DEV BIOL, V287, P19, DOI 10.1016/j.ydbio.2005.08.017; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang Yang, 2010, Zhonghua Er Ke Za Zhi, V48, P397; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Wasserman JD, 2000, GENE DEV, V14, P1651; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; WELSHONS WJ, 1965, SCIENCE, V150, P1122, DOI 10.1126/science.150.3700.1122; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Whiteford N, 2009, BIOINFORMATICS, V25, P2194, DOI 10.1093/bioinformatics/btp383; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xie P, 2011, J BIOL CHEM, V286, P34131, DOI 10.1074/jbc.M111.241778; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	223	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44583	10.1371/journal.pone.0044583	http://dx.doi.org/10.1371/journal.pone.0044583			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952997	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300101
J	Zong, Y; Sun, L; Liu, B; Deng, YS; Zhan, D; Chen, YL; He, Y; Liu, J; Zhang, ZJ; Sun, J; Lu, D				Zong, Yi; Sun, Lin; Liu, Bin; Deng, Yi-Shu; Zhan, Dong; Chen, Yuan-Li; He, Ying; Liu, Jing; Zhang, Zong-Ji; Sun, Jun; Lu, Di			Resveratrol Inhibits LPS-Induced MAPKs Activation via Activation of the Phosphatidylinositol 3-Kinase Pathway in Murine RAW 264.7 Macrophage Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; PROTEIN-KINASE PATHWAYS; TNF-ALPHA PRODUCTION; INDUCED THP-1 CELLS; PHOSPHOINOSITIDE 3-KINASE; SIGNALING PATHWAYS; INFLAMMATORY RESPONSES; GENE-EXPRESSION; LIPOPOLYSACCHARIDE	Background: Resveratrol is a natural polyphenolic compound that has cardioprotective, anticancer and anti-inflammatory properties. We investigated the capacity of resveratrol to protect RAW 264.7 cells from inflammatory insults and explored mechanisms underlying inhibitory effects of resveratrol on RAW 264.7 cells. Methodology/Principal Findings: Murine RAW 264.7 cells were treated with resveratrol (1, 5, and 10 mu M) and/or LPS (5 mu g/ml). Nitric oxide (NO) and prostaglandin E2 (PGE2) were measured by Griess reagent and ELISA. The mRNA and protein levels of proinflammatory proteins and cytokines were analysed by ELISA, RT-PCR and double immunofluorescence labeling, respectively. Phosphorylation levels of Akt, cyclic AMP-responsive element-binding protein (CREB), mitogen-activated protein kinases (MAPKs) cascades, AMP-activated protein kinase (AMPK) and expression of SIRT1(Silent information regulator T1) were measured by western blot. Wortmannin (1 mM), a specific phosphatidylinositol 3-kinase (PI3-K) inhibitor, was used to determine if PI3-K/Akt signaling pathway might be involved in resveratrol's action on RAW 264.7 cells. Resveratrol significantly attenuated the LPS-induced expression of nitric oxide (NO), prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in RAW 264.7 cells. Resveratrol increased Akt phosphorylation in a time-dependent manner. Wortmannin, a specific phosphatidylinositol 3-kinase (PI3-K) inhibitor, blocked the effects of resveratrol on LPS-induced RAW 264.7 cells activation. In addition, PI3-K inhibition partially abolished the inhibitory effect of resveratrol on the phosphorylation of cyclic AMP-responsive element-binding protein (CREB) and mitogen-activated protein kinases (MAPKs) cascades. Meanwhile, PI3-K is essential for resveratrol-mediated phosphorylation of AMPK and expression of SIRT1. Conclusion and Implications: This investigation demonstrates that PI3-K/Akt activation is an important signaling in resveratrol-mediated activation of AMPK phosphorylation and SIRT1 expression, and inhibition of phosphorylation of CREB and MAPKs activation, proinflammatory mediators and cytokines production in response to LPS in RAW 264.7 cells.	[Zong, Yi; Zhan, Dong; Chen, Yuan-Li; He, Ying; Sun, Jun; Lu, Di] Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China; [Sun, Lin] Kunming Med Univ, Affiliated Hosp 2, Dept Cardiol, Kunming, Yunnan, Peoples R China; [Liu, Bin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Yi-Shu] Dept Resp Med, Kunming, Yunnan, Peoples R China; [Liu, Jing; Zhang, Zong-Ji] Kunming Med Univ, Dept Pathol, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Sun Yat Sen University; Kunming Medical University	Zong, Y (corresponding author), Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China.	zhzji@sina.com; sunjun6661@126.com; ludi20040609@126.com			National Natural Sciences Foundation of China [30860336, 30560170]; Department of Science and Technology of Yunnan Province [2008CC007, 2008CD207, 2008CD122, 2009CI033]; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University [2011FB193, 2011FB177, 2010CD156]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University	This work was supported in part by grants (30860336 and 30560170) from the National Natural Sciences Foundation of China, grants (2008CC007, 2008CD207, 2008CD122 and 2009CI033) from the Department of Science and Technology of Yunnan Province, and grants (2011FB193, 2011FB177 and 2010CD156) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bi XL, 2005, INT IMMUNOPHARMACOL, V5, P185, DOI 10.1016/j.intimp.2004.08.008; Campbell A, 2004, ANN NY ACAD SCI, V1035, P117, DOI 10.1196/annals.1332.008; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cantrell DA, 2001, J CELL SCI, V114, P1439; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Centeno-Baez C, 2011, AM J PHYSIOL-ENDOC M, V301, pE922, DOI 10.1152/ajpendo.00530.2010; Chiou WF, 2011, EUR J PHARMACOL, V650, P102, DOI 10.1016/j.ejphar.2010.10.004; Chung EY, 2003, PLANTA MED, V69, P710, DOI 10.1055/s-2003-42787; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; De Simone R, 2010, CHEM BIOL DRUG DES, V76, P17, DOI 10.1111/j.1747-0285.2010.00984.x; Ehlting C, 2011, J BIOL CHEM, V286, P24113, DOI 10.1074/jbc.M111.235275; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Hsieh TP, 2011, PHYTOMEDICINE, V18, P176, DOI 10.1016/j.phymed.2010.04.003; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kharitonov Sergei A., 2007, V14, P83, DOI 10.1159/000107056; Kim JH, 2006, BIOCHEM PHARMACOL, V71, P1198, DOI 10.1016/j.bcp.2005.12.031; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Lee YG, 2011, FRONT BIOSCI-LANDMRK, V16, P517, DOI 10.2741/3702; Li XQ, 2009, INT IMMUNOPHARMACOL, V9, P1032, DOI 10.1016/j.intimp.2009.04.010; Liu HE, 2011, SHOCK, V35, P191, DOI 10.1097/SHK.0b013e3181f0e9a8; Liu K, 2010, BIOCHIMIE, V92, P789, DOI 10.1016/j.biochi.2010.02.024; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Malemud CJ, 2007, CURR OPIN PHARMACOL, V7, P339, DOI 10.1016/j.coph.2006.11.012; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Murakami A, 2003, CANCER LETT, V195, P17, DOI 10.1016/S0304-3835(03)00058-2; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Oh YC, 2009, AM J CHINESE MED, V37, P1203, DOI 10.1142/S0192415X09007600; Olas B, 2008, PLATELETS, V19, P70, DOI 10.1080/09537100701708506; Park JH, 2004, ARCH PHARM, V337, P20, DOI 10.1002/ardp.200300791; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sebai H, 2010, ARCH BIOCHEM BIOPHYS, V495, P56, DOI 10.1016/j.abb.2009.12.019; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Shin JS, 2011, BRIT J PHARMACOL, V164, P145, DOI 10.1111/j.1476-5381.2011.01351.x; Sung MJ, 2009, INT IMMUNOPHARMACOL, V9, P319, DOI 10.1016/j.intimp.2008.12.005; Vaillancourt F, 2007, J CELL BIOCHEM, V100, P1217, DOI 10.1002/jcb.21110; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wang MJ, 2007, J IMMUNOL, V179, P6204, DOI 10.4049/jimmunol.179.9.6204; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Yi CO, 2011, ANAT CELL BIOL, V44, P194, DOI 10.5115/acb.2011.44.3.194; Youn HS, 2005, J IMMUNOL, V175, P3339, DOI 10.4049/jimmunol.175.5.3339; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104	62	113	121	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44107	10.1371/journal.pone.0044107	http://dx.doi.org/10.1371/journal.pone.0044107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952890	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300051
J	Bethell, EJ; Holmes, A; MacLarnon, A; Semple, S				Bethell, Emily J.; Holmes, Amanda; MacLarnon, Ann; Semple, Stuart			Evidence That Emotion Mediates Social Attention in Rhesus Macaques	PLOS ONE			English	Article							SELECTIVE ATTENTION; FACIAL EXPRESSIONS; NONHUMAN-PRIMATES; BEHAVIOR; ANXIETY; TESTOSTERONE; THREAT; FACES; STRESS; GAZE	Background: Recent work on non-human primates indicates that the allocation of social attention is mediated by characteristics of the attending animal, such as social status and genotype, as well as by the value of the target to which attention is directed. Studies of humans indicate that an individual's emotion state also plays a crucial role in mediating their social attention; for example, individuals look for longer towards aggressive faces when they are feeling more anxious, and this bias leads to increased negative arousal and distraction from other ongoing tasks. To our knowledge, no studies have tested for an effect of emotion state on allocation of social attention in any non-human species. Methodology: We presented captive adult male rhesus macaques with pairs of adult male conspecific face images - one with an aggressive expression, one with a neutral expression - and recorded gaze towards these images. Each animal was tested twice, once during a putatively stressful condition (i.e. following a veterinary health check), and once during a neutral (or potentially positive) condition (i.e. a period of environmental enrichment). Initial analyses revealed that behavioural indicators of anxiety and stress were significantly higher after the health check than during enrichment, indicating that the former caused a negative shift in emotional state. Principle Findings: The macaques showed initial vigilance for aggressive faces across both conditions, but subsequent responses differed between conditions. Following the health check, initial vigilance was followed by rapid and sustained avoidance of aggressive faces. By contrast, during the period of enrichment, the macaques showed sustained attention towards the same aggressive faces. Conclusions/Significance: These data provide, to our knowledge, the first evidence that shifts in emotion state mediate social attention towards and away from facial cues of emotion in a non-human animal. This work provides novel insights into the evolution of emotion-attention interactions in humans, and mechanisms of social behaviour in non-human primates, and may have important implications for understanding animal psychological wellbeing.	[Bethell, Emily J.; MacLarnon, Ann; Semple, Stuart] Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England; [Holmes, Amanda] Univ Roehampton, Dept Psychol, London, England	Roehampton University; Roehampton University	Bethell, EJ (corresponding author), Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England.	E.J.Bethell@ljmu.ac.uk	Bethell, Emily J/F-8506-2011	Bethell, Emily J/0000-0002-0371-8873; MacLarnon, Ann/0000-0003-2722-4998; Semple, Stuart/0000-0003-0452-8104	Roehampton University; Universities Federation for Animal Welfare; Primate Society of Great Britain	Roehampton University; Universities Federation for Animal Welfare; Primate Society of Great Britain	This work was supported by a postgraduate bursary from Roehampton University and grants from Universities Federation for Animal Welfare and the Primate Society of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amaral DG, 2003, GENES BRAIN BEHAV, V2, P295, DOI 10.1034/j.1601-183X.2003.00043.x; Anestis SF, 2010, EVOL ANTHROPOL, V19, P66, DOI 10.1002/evan.20253; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; Aureli F., 2003, PRIMATE PSYCHOL; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bar-Haim Y, 2011, J CHILD PSYCHOL PSYC, V52, P861, DOI 10.1111/j.1469-7610.2011.02368.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Chichinadze K, 2011, PHYSIOL BEHAV, V94, P595; Clark DM, 1999, BEHAV RES THER, V37, pS5, DOI 10.1016/S0005-7967(99)00048-0; Coss RG, 2002, PRIMATES, V43, P217, DOI 10.1007/BF02629649; Dalmaso M, BIOL LETT IN PRESS; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Derakshan N, 2007, COGNITION EMOTION, V21, P1585, DOI 10.1080/02699930701499857; Dobson S, 2012, PHILOS T R SOC B, V367, P1901, DOI 10.1098/rstb.2011.0224; Doyle LA, 2008, AM J PRIMATOL, V70, P542, DOI 10.1002/ajp.20526; Einhauser W, 2006, VISION RES, V46, P1194, DOI 10.1016/j.visres.2005.08.032; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; Fernandes AC, 2010, 40 ANN M NEUR; Fontenot MB, 2006, J AM ASSOC LAB ANIM, V45, P35; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Fridmun EP, 2002, MED PRIMATOLOGY HIST; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Green MJ, 2004, NEUROSCI BIOBEHAV R, V28, P333, DOI 10.1016/j.neubiorev.2004.03.006; Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222; Higham JP, 2011, P ROY SOC B-BIOL SCI, V278, P3452, DOI 10.1098/rspb.2011.0052; Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003; Holmes A, 2009, PSYCHOPHYSIOLOGY, V46, P62, DOI 10.1111/j.1469-8986.2008.00750.x; Honess PE, 2006, NEUROSCI BIOBEHAV R, V30, P390, DOI 10.1016/j.neubiorev.2005.04.003; Honess PE, 2006, NEUROSCI BIOBEHAV R, V30, P413, DOI 10.1016/j.neubiorev.2005.05.002; Josephs RA, 2012, PSYCHONEUROENDOCRINO, V37, P752, DOI 10.1016/j.psyneuen.2011.09.006; Kalin NH, 1998, BEHAV NEUROSCI, V112, P286, DOI 10.1037/0735-7044.112.2.286; King HM, 2012, PSYCHONEUROENDOCRINO, V37, P396, DOI 10.1016/j.psyneuen.2011.07.010; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; Lacreuse A, 2010, HORM BEHAV, V58, P854, DOI 10.1016/j.yhbeh.2010.08.010; LEDOUX JE, 1996, EMOTION BRAIN MYSTER; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Machado CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026598; MAESTRIPIERI D, 1993, ETHOLOGY, V95, P19; Mahajan N, 2011, J PERS SOC PSYCHOL, V100, P387, DOI 10.1037/a0022459; Major CA, 2009, LIFE SCI, V85, P753, DOI 10.1016/j.lfs.2009.10.003; Marechal L, 2011, BIOL CONSERV, V144, P2188, DOI 10.1016/j.biocon.2011.05.010; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mosher CP, 2011, BEHAV NEUROSCI, V125, P639, DOI 10.1037/a0024264; Mundry R, 1999, ANIM BEHAV, V58, P1143, DOI 10.1006/anbe.1999.1246; NC3Rs, 2011, NAT CTR REPL REF RED; Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Reamer L, 2010, APPL ANIM BEHAV SCI, V124, P68, DOI 10.1016/j.applanim.2010.01.012; Richards AB, 2009, HORM BEHAV, V56, P140, DOI 10.1016/j.yhbeh.2009.03.021; Richards A, 2002, EMOTION, V2, P273, DOI 10.1037/1528-3542.2.3.273; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Shively CA, 2009, NEUROSCI BIOBEHAV R, V33, P133, DOI 10.1016/j.neubiorev.2008.06.006; van Honk J, 1999, HORM BEHAV, V36, P17, DOI 10.1006/hbeh.1999.1521; Waller BM, 2008, PHYSIOL BEHAV, V95, P93, DOI 10.1016/j.physbeh.2008.05.002; Watson KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004156; West B. T., 2007, LINEAR MIXED MODELS; WHITESIDE JA, 1976, CHILD DEV, V47, P290; Wirth MM, 2007, PHYSIOL BEHAV, V90, P496, DOI 10.1016/j.physbeh.2006.10.016; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	69	71	71	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44387	10.1371/journal.pone.0044387	http://dx.doi.org/10.1371/journal.pone.0044387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952968	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500067
J	Lillo, P; Mioshi, E; Burrell, JR; Kiernan, MC; Hodges, JR; Hornberger, M				Lillo, Patricia; Mioshi, Eneida; Burrell, James R.; Kiernan, Matthew C.; Hodges, John R.; Hornberger, Michael			Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT EXPANSION; LOBAR DEGENERATION; WHOLE-BRAIN; CLINICAL CHARACTERISTICS; COGNITIVE IMPAIRMENT; BEHAVIORAL VARIANT; C9ORF72; TDP-43; ATROPHY; PATTERNS	There is increasing evidence that amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) lie on a clinical, pathological and genetic continuum with patients of one disease exhibiting features of the other. Nevertheless, to date, the underlying grey matter and white matter changes across the ALS-FTD disease continuum have not been explored. In this study fifty-three participants with ALS (n = 10), ALS-FTD (n = 10) and behavioural variant FTD (bvFTD; n = 15) as well as controls (n = 18), underwent detailed clinical assessment plus structural imaging using voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) analysis of magnetic resonance brain imaging to examine grey and white matter differences and commonalities across the continuum. Importantly, patient groups were matched for age, education, gender and disease duration. VBM and DTI results showed that changes in the ALS group were confined mainly to the motor cortex and anterior cingulate as well as their underlying white matter tracts. ALS-FTD and bvFTD showed widespread grey matter and white matter changes involving frontal and temporal lobes. Extensive prefrontal cortex changes emerged as a marker for bvFTD compared to other subtypes, while ALS-FTD could be distinguished from ALS by additional temporal lobe grey and white matter changes. Finally, ALS could be mainly distinguished from the other two groups by corticospinal tract degeneration. The present study shows for the first time that FTD and ALS overlap in anterior cingulate, motor cortex and related white matter tract changes across the whole continuum. Nevertheless, frontal and temporal atrophy as well as corticospinal tract degeneration emerged as marker for subtype classification, which will inform future diagnosis and target disease management across the continuum.	[Lillo, Patricia; Mioshi, Eneida; Burrell, James R.; Kiernan, Matthew C.; Hodges, John R.; Hornberger, Michael] Neurosci Res Australia, Sydney, NSW, Australia; [Lillo, Patricia; Mioshi, Eneida; Burrell, James R.; Kiernan, Matthew C.; Hodges, John R.; Hornberger, Michael] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Hodges, John R.; Hornberger, Michael] ARC Ctr Excellence Cognit & Disorders, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Lillo, P (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	m.hornberger@neura.edu.au	Hodges, John R/B-9907-2012; Kiernan, Matthew C/E-4460-2011; Mioshi, Eneida/AAZ-1043-2020; Hornberger, Michael/C-9610-2011; Lillo, Patricia/B-9730-2013	Hornberger, Michael/0000-0002-2214-3788; Kiernan, Matthew/0000-0001-9054-026X; Burrell, James/0000-0001-9638-2768; Lillo, Patricia/0000-0001-7398-7203	Comision Nacional de Investigacion Cientifica y Tecnologica, Government of Chile (CONICYT scholarship); Faculty of Medicine, University of Chile; NHMRC post-doctoral fellowship [1016399]; NHMRC; Australian Research Council Federation Fellowship [FF077622]; Australian Research Council Research Fellowship [DP110104202]	Comision Nacional de Investigacion Cientifica y Tecnologica, Government of Chile (CONICYT scholarship); Faculty of Medicine, University of Chile; NHMRC post-doctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Federation Fellowship(Australian Research Council); Australian Research Council Research Fellowship(Australian Research Council)	PL is supported by Comision Nacional de Investigacion Cientifica y Tecnologica, Government of Chile (CONICYT scholarship) and Faculty of Medicine, University of Chile; EM is supported by an NHMRC post-doctoral fellowship (1016399); JRB is supported by the NHMRC; MCK is supported by the NHMRC; JRH is supported by an Australian Research Council Federation Fellowship (FF077622); and MH is supported by an Australian Research Council Research Fellowship (DP110104202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; Bak TH, 2001, J NEUROL, V248, P260, DOI 10.1007/s004150170199; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Boxer AL, 2011, J NEUROL NEUROSUR PS, V82, P196, DOI 10.1136/jnnp.2009.204081; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Chen ZY, 2010, AMYOTROPH LATERAL SC, V11, P549, DOI 10.3109/17482968.2010.516265; Chio A, 2012, BRAIN, V135, P784, DOI 10.1093/brain/awr366; Cooper-Knock J, 2012, BRAIN, V135, P751, DOI 10.1093/brain/awr365; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Hodges J, 2012, BRAIN, V135, P652, DOI 10.1093/brain/aws033; Hsiung GYR, 2012, BRAIN, V135, P709, DOI 10.1093/brain/awr354; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Li J, 2011, NEUROBIOL AGING, DOI org/10.10161j.neurobiolaging.2011.04.007; Lillo P, 2012, AMYOTROPH LATERAL SC, V13, P102, DOI 10.3109/17482968.2011.639376; Lillo P, 2011, AMYOTROPH LATERAL SC, V12, P45, DOI 10.3109/17482968.2010.520718; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mori H, 2007, AM J NEURORADIOL, V28, P1511, DOI 10.3174/ajnr.A0624; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Phukan J, 2011, J NEUROL NEUROSURG P; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Simon-Sanchez J, 2012, BRAIN, V135, P723, DOI 10.1093/brain/awr353; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Strong MJ, 2003, ANN NEUROL, V54, pS20, DOI 10.1002/ana.10574; Tsujimoto M, 2011, J NEUROL SCI; Turner MR, 2011, LANCET NEUROL, V10, P400, DOI 10.1016/S1474-4422(11)70049-7; Wedderburn C, 2008, J NEUROL NEUROSUR PS, V79, P500, DOI 10.1136/jnnp.2007.122028; Whitwell JL, 2006, NEUROLOGY, V66, P102, DOI 10.1212/01.wnl.0000191395.69438.12; Witgert M, 2010, EUR J NEUROL, V17, P103, DOI 10.1111/j.1468-1331.2009.02801.x; Woolley SC, 2011, AMYOTROPH LATERAL SC, V12, P52, DOI 10.3109/17482968.2010.521842; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	52	132	133	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43993	10.1371/journal.pone.0043993	http://dx.doi.org/10.1371/journal.pone.0043993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952843	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000066
J	Drelon, C; Berthon, A; Ragazzon, B; Tissier, F; Bandiera, R; Sahut-Barnola, I; de Joussineau, C; Batisse-Lignier, M; Lefrancois-Martinez, AM; Bertherat, J; Martinez, A; Val, P				Drelon, Coralie; Berthon, Annabel; Ragazzon, Bruno; Tissier, Frederique; Bandiera, Roberto; Sahut-Barnola, Isabelle; de Joussineau, Cyrille; Batisse-Lignier, Marie; Lefrancois-Martinez, Anne-Marie; Bertherat, Jerome; Martinez, Antoine; Val, Pierre			Analysis of the Role of Igf2 in Adrenal Tumour Development in Transgenic Mouse Models	PLOS ONE			English	Article							GROWTH-FACTOR-II; BETA-CATENIN; ADRENOCORTICAL TUMORS; BECKWITH-WIEDEMANN; SONIC-HEDGEHOG; INTESTINAL ADENOMA; BINDING PROTEIN-2; EXPRESSION; PROLIFERATION; CANCER	Adrenal cortical carcinomas (ACC) are rare but aggressive tumours associated with poor prognosis. The two most frequent alterations in ACC in patients are overexpression of the growth factor IGF2 and constitutive activation of Wnt/beta-catenin signalling. Using a transgenic mouse model, we have previously shown that constitutive active beta-catenin is a bona fide adrenal oncogene. However, although all these mice developed benign adrenal hyperplasia, malignant progression was infrequent, suggesting that secondary genetic events were required for aggressive tumour development. In the present paper, we have tested IGF2 oncogenic properties by developing two distinct transgenic mouse models of Igf2 overexpression in the adrenal cortex. Our analysis shows that despite overexpression levels ranging from 7 (basal) to 87 (ACTH-induced) fold, Igf2 has no tumour initiating potential in the adrenal cortex. However, it induces aberrant accumulation of Gli1 and Pod1-positive progenitor cells, in a hedgehog-independent manner. We have also tested the hypothesis that Igf2 may cooperate with Wnt signalling by mating Igf2 overexpressing lines with mice that express constitutive active beta-catenin in the adrenal cortex. We show that the combination of both alterations has no effect on tumour phenotype at stages when beta-catenin-induced tumours are benign. However, there is a mild promoting effect at later stages, characterised by increased Weiss score and proliferation. Formation of malignant tumours is nonetheless a rare event, even when Igf2 expression is further increased by ACTH treatment. Altogether these experiments suggest that the growth factor IGF2 is a mild contributor to malignant adrenocortical tumourigenesis.	[Drelon, Coralie; Berthon, Annabel; Sahut-Barnola, Isabelle; de Joussineau, Cyrille; Batisse-Lignier, Marie; Lefrancois-Martinez, Anne-Marie; Martinez, Antoine; Val, Pierre] Univ Blaise Pascal, Clermont Univ, GReD, Clermont Ferrand, France; [Drelon, Coralie; Berthon, Annabel; Sahut-Barnola, Isabelle; de Joussineau, Cyrille; Batisse-Lignier, Marie; Lefrancois-Martinez, Anne-Marie; Martinez, Antoine; Val, Pierre] GReD, CNRS UMR 6293, Aubiere, France; [Drelon, Coralie; Berthon, Annabel; Sahut-Barnola, Isabelle; de Joussineau, Cyrille; Batisse-Lignier, Marie; Lefrancois-Martinez, Anne-Marie; Martinez, Antoine; Val, Pierre] GReD, Inserm U1103, Aubiere, France; [Ragazzon, Bruno; Tissier, Frederique; Bertherat, Jerome] Univ Paris 05, Inst Cochin, CNRS UMR 8104, Paris, France; [Ragazzon, Bruno; Tissier, Frederique; Bertherat, Jerome] Inserm U1016, Paris, France; [Ragazzon, Bruno; Tissier, Frederique; Bertherat, Jerome] Hop Cochin, AP HP, Dept Endocrinol, Reference Ctr Rare Adrenal Dis, F-75674 Paris, France; [Bandiera, Roberto] Inserm UMR636, Nice, France; [Batisse-Lignier, Marie] Ctr Hosp Univ, Fac Med, Serv Endocrinol, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand	Drelon, C (corresponding author), Univ Blaise Pascal, Clermont Univ, GReD, Clermont Ferrand, France.	pierre.val@univ-bpclermont.fr	Ragazzon, Bruno/E-6541-2017; Berthon, Annabel/T-1729-2019; Berthon, Annabel/AAG-6890-2019	Ragazzon, Bruno/0000-0001-9476-4973; BERTHERAT, Jerome/0000-0003-2551-3008; Val, Pierre/0000-0001-7648-5567; Berthon, Annabel/0000-0002-5576-9525	Universite Blaise Pascal; Universite d'Auvergne; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Association pour la Recherche contre le Cancer (ARC) [SFI 20101201397]; La Ligue Regionale Contre le Cancer, Allier committee	Universite Blaise Pascal; Universite d'Auvergne; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); La Ligue Regionale Contre le Cancer, Allier committee	This project was supported by Universite Blaise Pascal; Universite d'Auvergne; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Association pour la Recherche contre le Cancer (ARC, grant #SFI 20101201397) and La Ligue Regionale Contre le Cancer, Allier committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Almeida MQ, 2008, J CLIN ENDOCR METAB, V93, P3524, DOI 10.1210/jc.2008-0065; Assie G, 2007, J CLIN ENDOCR METAB, V92, P148, DOI 10.1210/jc.2006-0706; Barlaskar FM, 2009, J CLIN ENDOCR METAB, V94, P204, DOI 10.1210/jc.2008-1456; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P657, DOI 10.1677/erc.1.01025; Berthon A, 2012, MOL CELL ENDOCRINOL, V351, P87, DOI 10.1016/j.mce.2011.09.009; Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029; Bielinska M, 2006, VET PATHOL, V43, P97, DOI 10.1354/vp.43-2-97; Boulle N, 1998, J CLIN ENDOCR METAB, V83, P1713, DOI 10.1210/jc.83.5.1713; Corcoran RB, 2008, CANCER RES, V68, P8788, DOI 10.1158/0008-5472.CAN-08-2135; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Fraipont F, 2005, J CLIN ENDOCR METAB, V90, P1819, DOI 10.1210/jc.2004-1075; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fernandez C, 2010, DEV NEUROSCI-BASEL, V32, P59, DOI 10.1159/000274458; Gaujoux S, 2011, CLIN CANCER RES, V17, P328, DOI 10.1158/1078-0432.CCR-10-2006; Gicquel C, 1997, J CLIN ENDOCR METAB, V82, P2559, DOI 10.1210/jc.82.8.2559; Gicquel C, 2001, CANCER RES, V61, P6762; Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hardouin SN, 2011, DEVELOPMENT, V138, P203, DOI 10.1242/dev.054916; Harper J, 2006, CANCER RES, V66, P1940, DOI 10.1158/0008-5472.CAN-05-2036; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Hassan AB, 2000, CANCER RES, V60, P1070; Hoeflich A, 2000, CANCER RES, V60, P834; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Hu MC, 1999, ENDOCRINOLOGY, V140, P5609, DOI 10.1210/en.140.12.5609; Icard P, 2001, WORLD J SURG, V25, P891, DOI 10.1007/s00268-001-0047-y; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; King P, 2009, P NATL ACAD SCI USA, V106, P21185, DOI 10.1073/pnas.0909471106; Lambert-Langlais S, 2009, MOL CELL ENDOCRINOL, V300, P197, DOI 10.1016/j.mce.2008.10.045; Laufer E, 2012, MOL CELL ENDOCRINOL, V351, P19, DOI 10.1016/j.mce.2011.10.002; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Mattos GE, 2011, CELL TISSUE RES, V345, P343, DOI 10.1007/s00441-011-1220-8; MCCAULEY RGK, 1991, AM J ROENTGENOL, V157, P549, DOI 10.2214/ajr.157.3.1872243; Moorehead RA, 2003, ONCOGENE, V22, P853, DOI 10.1038/sj.onc.1206188; Moorehead RA, 2001, CELL DEATH DIFFER, V8, P16, DOI 10.1038/sj.cdd.4400762; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; Papotti Mauro, 2011, Hormones & Cancer, V2, P333, DOI 10.1007/s12672-011-0088-0; Romero DG, 2007, ENDOCRINOLOGY, V148, P2644, DOI 10.1210/en.2006-1509; Rump P, 2005, AM J MED GENET A, V136A, P95, DOI 10.1002/ajmg.a.30729; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; Terzolo M, 2007, NEW ENGL J MED, V356, P2372, DOI 10.1056/NEJMoa063360; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Val P, 2006, DEV BIOL, V299, P250, DOI 10.1016/j.ydbio.2006.07.030; Verras M, 2005, MOL ENDOCRINOL, V19, P391, DOI 10.1210/me.2004-0208; Wajchenberg BL, 2000, CANCER-AM CANCER SOC, V88, P711, DOI 10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W; Weber MM, 1997, EUR J ENDOCRINOL, V136, P296, DOI 10.1530/eje.0.1360296; Weber MM, 1999, ENDOCRINOLOGY, V140, P1537, DOI 10.1210/en.140.4.1537; Zini L, 2011, EUR UROL, V60, P1055, DOI 10.1016/j.eururo.2011.07.062	58	60	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44171	10.1371/journal.pone.0044171	http://dx.doi.org/10.1371/journal.pone.0044171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952916	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600087
J	Li, YL; Zhao, L; Sun, HG; Yu, JK; Li, N; Liang, JW; Wang, Y; He, M; Bai, XF; Yu, ZJ; Zheng, ZH; Mi, XY; Wang, EH; Wei, MJ				Li, Yanlin; Zhao, Lin; Sun, Haigang; Yu, Jiankun; Li, Na; Liang, Jingwei; Wang, Yan; He, Miao; Bai, Xuefeng; Yu, Zhaojin; Zheng, Zhihong; Mi, Xiaoyi; Wang, Enhua; Wei, Minjie			Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; ANEMIA/BRCA PATHWAY; FA/BRCA PATHWAY; PROMOTER HYPERMETHYLATION; INDUCED APOPTOSIS; TOPOISOMERASE-II; DNA-DAMAGE; RESISTANCE; INHIBITORS; EXPRESSION	Fanconi anemia complementation group-F (FANCF) is a key factor to maintain the function of FA/BRCA, a DNA-damage response pathway. However, the functional role of FANCF in breast cancer has not been elucidated. In this study, we examined the effects and mechanisms of FANCF-RNAi on the sensitivity of breast cancer cells to mitoxantrone (MX). FANCF silencing by FANCF-shRNA blocked functions of FA/BRCA pathway through inhibition of FANCD2 mono-ubiquitination in breast cancer cell lines MCF-7 and T-47D. In addition, FANCF shRNA inhibited cell proliferation, induced apoptosis, and chromosome fragmentation in both breast cancer cells. We also found that FANCF silencing potentiated the sensitivity to MX in breast cancer cells, accompanying with an increase in intracellular MX accumulation and a decrease in BCRP expression. Furthermore, we found that the blockade of FA/BRCA pathway by FANCF-RNAi activated p38 and JNK MAPK signal pathways in response to MX treatment. BCRP expression was restored by p38 inhibitor SB203580, but not by JNK inhibitor SP600125. FANCF silencing increased JNK and p38 mediated activation of p53 in MX-treated breast cancer cells, activated the mitochondrial apoptosis pathway. Our findings indicate that FANCF shRNA potentiates the sensitivity of breast cancer cells to MX, suggesting that FANCF may be a potential target for therapeutic strategies for the treatment of breast tumors.	[Li, Yanlin; Zhao, Lin; Sun, Haigang; Yu, Jiankun; Li, Na; Liang, Jingwei; Wang, Yan; He, Miao; Bai, Xuefeng; Yu, Zhaojin; Wei, Minjie] China Med Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China; [Zheng, Zhihong; Mi, Xiaoyi; Wang, Enhua; Wei, Minjie] China Med Univ, Inst Pathophysiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Wei, MJ (corresponding author), China Med Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China.	weiminjiecmu@163.com			National Natural Science Foundation of China [30873097, 30973559]; Specialized Research Fund for the Doctoral Program of Higher Education [20092104110020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Natural Science Foundation of China (No 30873097 and No 30973559) and this study was also supported by the Specialized Research Fund for the Doctoral Program of Higher Education (No 20092104110020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alan D, 2010, NEW ENGL J MED, V362, P1909, DOI DOI 10.1056/NEJMRA0809889; Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bakker ST, 2011, J PATHOLOGY; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Briot D, 2008, BLOOD, V111, P1913, DOI 10.1182/blood-2007-07-099218; Casado JA, 2008, MOL CANCER THER, V7, P1309, DOI 10.1158/1535-7163.MCT-07-2432; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; Cleator SJ, 2005, ANN ONCOL, V16, P267, DOI 10.1093/annonc/mdi049; D'Andrea AD, 2003, CELL CYCLE, V2, P290, DOI 10.4161/cc.2.4.413; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Follin-Arbelet V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-301; Hazlehurst LA, 2006, CANCER RES, V66, P2338, DOI 10.1158/0008-5472.CAN-05-3256; HOULBROOK S, 1995, BRIT J CANCER, V72, P1454, DOI 10.1038/bjc.1995.529; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Jang JY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-262; Kachnic LA, 2011, CANCER LETT, V305, P86, DOI 10.1016/j.canlet.2011.02.030; Kanagasabai R, 2011, J BIOL CHEM, V286, P33289, DOI 10.1074/jbc.M111.249102; Kim J, 2011, J BREAST CANCER, V14, P39, DOI 10.4048/jbc.2011.14.1.39; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Klaude M, 1996, MUTAT RES-DNA REPAIR, V363, P89, DOI 10.1016/0921-8777(95)00063-1; Kumpulainen EJ, 2008, ACTA ONCOL, V47, P120, DOI 10.1080/02841860701518074; Lim SL, 2008, BRIT J CANCER, V98, P1452, DOI 10.1038/sj.bjc.6604325; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lyakhovich A, 2007, CELL CYCLE, V6, P1019, DOI 10.4161/cc.6.9.4223; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Mooney LM, 2002, BRIT J CANCER, V87, P909, DOI 10.1038/sj.bjc.6600541; Nam C, 2006, NEUROTOXICOL TERATOL, V28, P664, DOI 10.1016/j.ntt.2006.09.021; Narayan G, 2004, CANCER RES, V64, P2994, DOI 10.1158/0008-5472.CAN-04-0245; Neveling K, 2007, CYTOGENET GENOME RES, V118, P166, DOI 10.1159/000108297; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Peng H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005676; Qi XD, 2011, ANTI-CANCER DRUG, V22, P556, DOI 10.1097/CAD.0b013e328345b4e7; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Sabisz M, 2010, BIOCHEM PHARMACOL, V79, P1387, DOI 10.1016/j.bcp.2009.12.023; Salerno S, 2010, CURR MED CHEM, V17, P4270, DOI 10.2174/092986710793361252; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stadheim TA, 2002, LEUKEMIA RES, V26, P55, DOI 10.1016/S0145-2126(01)00099-6; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tang D, 2011, ONCOGENE, V30, P1851, DOI 10.1038/onc.2010.573; Tischkowitz M, 2003, BRIT J HAEMATOL, V123, P469, DOI 10.1046/j.1365-2141.2003.04640.x; Tumini E, 2011, DNA REPAIR, V10, P149, DOI 10.1016/j.dnarep.2010.10.006; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang Zuomin, 2006, CHINESE J STOMATOLOG, V5, P5, DOI DOI 10.1021/0L060112G	53	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44254	10.1371/journal.pone.0044254	http://dx.doi.org/10.1371/journal.pone.0044254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952942	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600099
J	Dibaj, P; Zschuntzsch, J; Steffens, H; Scheffel, J; Goricke, B; Weishaupt, JH; Le Meur, K; Kirchhoff, F; Hanisch, UK; Schomburg, ED; Neusch, C				Dibaj, Payam; Zschuentzsch, Jana; Steffens, Heinz; Scheffel, Joerg; Goericke, Bettina; Weishaupt, Jochen H.; Le Meur, Karim; Kirchhoff, Frank; Hanisch, Uwe-Karsten; Schomburg, Eike D.; Neusch, Clemens			Influence of Methylene Blue on Microglia-Induced Inflammation and Motor Neuron Degeneration in the SOD1(G93A) Model for ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; MOUSE MODEL; GLIAL-CELLS; SPINAL-CORD; UNIT LOSS; MDX MICE; DISEASE; PROGRESSION; AGGREGATION	Mutations in SOD1 cause hereditary variants of the fatal motor neuron disease amyotrophic lateral sclerosis (ALS). Pathophysiology of the disease is non-cell-autonomous, with toxicity deriving also from glia. In particular, microglia contribute to disease progression. Methylene blue (MB) inhibits the effect of nitric oxide, which mediates microglial responses to injury. In vivo 2P-LSM imaging was performed in ALS-linked transgenic SOD1(G93A) mice to investigate the effect of MB on microglia-mediated inflammation in the spinal cord. Local superfusion of the lateral spinal cord with MB inhibited the microglial reaction directed at a laser-induced axon transection in control and SOD1(G93A) mice. In vitro, MB at high concentrations inhibited cytokine and chemokine release from microglia of control and advanced clinical SOD1(G93A) mice. Systemic MB-treatment of SOD1(G93A) mice at early preclinical stages significantly delayed disease onset and motor dysfunction. However, an increase of MB dose had no additional effect on disease progression; this was unexpected in view of the local anti-inflammatory effects. Furthermore, in vivo imaging of systemically MB-treated mice also showed no alterations of microglia activity in response to local lesions. Thus although systemic MB treatment had no effect on microgliosis, instead, its use revealed an important influence on motor neuron survival as indicated by an increased number of lumbar anterior horn neurons present at the time of disease onset. Thus, potentially beneficial effects of locally applied MB on inflammatory events contributing to disease progression could not be reproduced in SOD1(G93A) mice via systemic administration, whereas systemic MB application delayed disease onset via neuroprotection.	[Dibaj, Payam; Steffens, Heinz; Le Meur, Karim; Kirchhoff, Frank] Max Planck Inst Expt Med, D-3400 Gottingen, Germany; [Zschuentzsch, Jana; Goericke, Bettina; Weishaupt, Jochen H.; Neusch, Clemens] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Steffens, Heinz; Schomburg, Eike D.] Univ Gottingen, Inst Physiol, Gottingen, Germany; [Scheffel, Joerg; Hanisch, Uwe-Karsten] Univ Gottingen, Inst Neuropathol, Gottingen, Germany; [Steffens, Heinz] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Weishaupt, Jochen H.; Neusch, Clemens] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Le Meur, Karim; Kirchhoff, Frank] Univ Saarland, Dept Mol Physiol, D-6650 Homburg, Germany; [Le Meur, Karim] Univ Gottingen, Syst Neurosci Grp, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen; University of Gottingen; Max Planck Society; Ulm University; Saarland University; University of Gottingen	Dibaj, P (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-3400 Gottingen, Germany.	Dibaj@em.mpg.de	Dibaj, Payam/AAS-5479-2021; Dibaj, Payam/GQH-9423-2022; Kirchhoff, Frank/B-9335-2008	Dibaj, Payam/0000-0003-1585-6330; Kirchhoff, Frank/0000-0002-2324-2761	Deutsche Forschungsgemeinschaft [NE-767/3-3, SCHO 37/16-1, SFB/TRR43]; Tom-Wahlig-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tom-Wahlig-Foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (NE-767/3-3 to CN and SCHO 37/16-1 to EDS and SFB/TRR43 to UKH) and the Tom-Wahlig-Foundation (to CN and FK). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Audet JN, 2012, NEUROSCIENCE, V209, P136, DOI 10.1016/j.neuroscience.2011.12.047; Barbe C, 2002, INHAL TOXICOL, V14, P273, DOI 10.1080/08958370252809059; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2008, M S-MED SCI, V24, P124, DOI 10.1051/medsci/2008242124; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Braak H, 2010, ACTA NEUROPATHOL, V120, P67, DOI 10.1007/s00401-010-0683-0; Carre-Pierrat M, 2011, NEUROMUSCULAR DISORD, V21, P313, DOI 10.1016/j.nmd.2011.01.005; Carreras I, 2010, BRAIN RES, V1313, P192, DOI 10.1016/j.brainres.2009.11.051; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; Dibaj P, 2011, NEUROSCI LETT, V497, P148, DOI 10.1016/j.neulet.2011.04.049; Dibaj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017910; Dibaj P, 2011, NEUROSCI LETT, V487, P107, DOI 10.1016/j.neulet.2010.10.005; Dibaj P, 2010, J NEUROSCI RES, V88, P2431, DOI 10.1002/jnr.22402; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; Duan YL, 2003, J NEUROBIOL, V57, P183, DOI 10.1002/neu.10262; Duan YL, 2009, DEV NEUROBIOL, V69, P60, DOI 10.1002/dneu.20689; Golumbek PT, 2007, NEUROMUSCULAR DISORD, V17, P376, DOI 10.1016/j.nmd.2007.02.005; Guegan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610; Gura T, 2008, NAT MED, V14, P894, DOI 10.1038/nm0908-894; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Hegedus J, 2009, MUSCLE NERVE, V39, P318, DOI 10.1002/mus.21160; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaiser M, 2006, J NEUROCHEM, V99, P900, DOI 10.1111/j.1471-4159.2006.04131.x; Kulkarni SK, 2007, EUR J PHARMACOL, V569, P77, DOI 10.1016/j.ejphar.2007.05.002; Liebetanz D, 2004, EUR J NEUROSCI, V20, P3115, DOI 10.1111/j.1460-9568.2004.03769.x; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lougheed R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023141; Martinez JA, 2008, NEUROSCIENCE, V157, P908, DOI 10.1016/j.neuroscience.2008.08.073; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neusch C, 2007, MUSCLE NERVE, V35, P712, DOI 10.1002/mus.20768; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ozdinler PH, 2011, J NEUROSCI, V31, P4166, DOI 10.1523/JNEUROSCI.4184-10.2011; OLEARY JL, 1968, STAIN TECHNOL, V43, P197, DOI 10.3109/10520296809115068; Oz M, 2009, MED RES REV; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Regen T, 2011, BRAIN BEHAV IMMUN, V25, P957, DOI 10.1016/j.bbi.2010.10.009; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saywell SA, 2011, J NEUROPHYSIOL, V105, P806, DOI 10.1152/jn.00738.2010; Synofzik M, 2010, J NEUROL NEUROSUR PS, V81, P764, DOI 10.1136/jnnp.2009.181719; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; van Rossum D, 2008, GLIA, V56, P271, DOI 10.1002/glia.20611; Walter-Sack I, 2009, EUR J CLIN PHARMACOL, V65, P179, DOI 10.1007/s00228-008-0563-x; WONG PC, 1995, CURR OPIN NEUROL, V8, P294, DOI 10.1097/00019052-199508000-00008; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yamanaka K, 2006, ANN NEUROL, V60, P95, DOI 10.1002/ana.20888; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042	57	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43963	10.1371/journal.pone.0043963	http://dx.doi.org/10.1371/journal.pone.0043963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952827	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800079
J	Williams, JA; Thomas, AM; Li, GD; Kong, B; Zhan, L; Inaba, Y; Xie, W; Ding, WX; Guo, GL				Williams, Jessica A.; Thomas, Ann M.; Li, Guodong; Kong, Bo; Zhan, Le; Inaba, Yuka; Xie, Wen; Ding, Wen-Xing; Guo, Grace L.			Tissue Specific Induction of p62/Sqstm1 by Farnesoid X Receptor	PLOS ONE			English	Article							BILE-ACID RECEPTOR; TRANSCRIPTION FACTOR NRF2; ORPHAN NUCLEAR RECEPTOR; KAPPA-B ACTIVATION; FXR; P62; AUTOPHAGY; LIVER; IDENTIFICATION; CHOLESTEROL	Background: Farnesoid X Receptor (FXR) is a member of the nuclear receptor superfamily and is a ligand-activated transcription factor essential for maintaining liver and intestinal homeostasis. FXR is protective against carcinogenesis and inflammation in liver and intestine as demonstrated by the development of inflammation and tumors in the liver and intestine of FXR knock-out mice. However, mechanisms for the protective effects of FXR are not completely understood. This study reports a novel role of FXR in regulating expression of Sqstm1, which encodes for p62 protein. p62 plays an important role in maintaining cellular homeostasis through selective autophagy and activating signal transduction pathways, such as NF-kappa B to support cell survival and caspase-8 to initiate apoptosis. FXR regulation of Sqstm1 may serve as a protective mechanism. Methods and Results: This study showed that FXR bound to the Sqstm1 gene in both mouse livers and ileums as determined by chromatin immunoprecipitation. In addition, FXR activation enhanced transcriptional activation of Sqstm1 in vitro. However, wild-type mice treated with GW4064, a synthetic FXR ligand, showed that FXR activation induced mRNA and protein expression of Sqstm1/p62 in ileum, but not in liver. Interestingly, FXR-transgenic mice showed induced mRNA expression of Sqstm1 in both liver and ileum compared to wild-type mice. Conclusions: Our current study has identified a novel role of FXR in regulating the expression of p62, a key factor in protein degradation and cell signaling. Regulation of p62 by FXR indicates tissue-specific and gene-dosage effects. Furthermore, FXR-mediated induction of p62 may implicate a protective mechanism of FXR.	[Williams, Jessica A.; Thomas, Ann M.; Li, Guodong; Kong, Bo; Zhan, Le; Ding, Wen-Xing; Guo, Grace L.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Li, Guodong] Harbin Med Univ, Affiliated Hosp 4, Canc Treatment Ctr, Dept Abdominal Surg, Harbin, Peoples R China; [Inaba, Yuka; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA	University of Kansas; University of Kansas Medical Center; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Williams, JA (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	gracelguo@yahoo.com	Xie, Wen/M-1768-2016; Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817; Inaba, Yuka/0000-0001-9757-9669	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [DK081343]; National Center for Research Resources (NCRR) [P20-RR021940]; National Institute of Environmental Health Sciences [5 T32 ES007079]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grant DK081343], the National Center for Research Resources (NCRR) [Grant P20-RR021940] and J.A. Williams was supported by the "Training Program in Environmental Toxicology" [grant 5 T32 ES007079] from the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; De Gottardi A, 2004, DIGEST DIS SCI, V49, P982; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kim MS, 2003, J BIOL CHEM, V278, P8988, DOI 10.1074/jbc.M212633200; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Li GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035895; Li GD, 2010, MOL ENDOCRINOL, V24, P1404, DOI 10.1210/me.2010-0014; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Maynard AA, 2010, AM J PHYSIOL-GASTR L, V299, pG614, DOI 10.1152/ajpgi.00076.2010; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhu Y, 2011, PHARMACOL RES, V63, P259, DOI 10.1016/j.phrs.2010.12.018	42	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43961	10.1371/journal.pone.0043961	http://dx.doi.org/10.1371/journal.pone.0043961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952826	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000308044800078
J	Chowdhry, S; Zhang, Y; McMahon, M; Sutherland, C; Cuadrado, A; Hayes, JD				Chowdhry, S.; Zhang, Y.; McMahon, M.; Sutherland, C.; Cuadrado, A.; Hayes, J. D.			Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity	ONCOGENE			English	Article						Nrf2; beta-TrCP; GSK-3; oxidative stress; drug resistance; ubiquitylation	TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT RESPONSE ELEMENT; GLYCOGEN-SYNTHASE KINASE-3; OXIDATIVE STRESS; HEME OXYGENASE-1; KEAP1 GENE; PROTEASOMAL DEGRADATION; NEGATIVE REGULATION; MAP KINASES; E3 LIGASE	Identification of regulatable mechanisms by which transcription factor NF-E2 p45-related factor 2 (Nrf2) is repressed will allow strategies to be designed that counter drug resistance associated with its upregulation in tumours that harbour somatic mutations in Kelch-like ECH-associated protein-1 (Keap1), a gene that encodes a joint adaptor and substrate receptor for the Cul3-Rbx1/Roc1 ubiquitin ligase. We now show that mouse Nrf2 contains two binding sites for beta-transducin repeat-containing protein (beta-TrCP), which acts as a substrate receptor for the Skp1-Cul1-Rbx1/Roc1 ubiquitin ligase complex. Deletion of either binding site in Nrf2 decreased beta-TrCP-mediated ubiquitylation of the transcription factor. The ability of one of the two beta-TrCP-binding sites to serve as a degron could be both increased and decreased by manipulation of glycogen synthase kinase-3 (GSK-3) activity. Biotinylated-peptide pull-down assays identified DSGIS(338) and DSAPGS(378) as the two beta-TrCP-binding motifs in Nrf2. Significantly, our pull-down assays indicated that beta-TrCP binds a phosphorylated version of DSGIS more tightly than its non-phosphorylated counterpart, whereas this was not the case for DSAPGS. These data suggest that DSGIS, but not DSAPGS, contains a functional GSK-3 phosphorylation site. Activation of GSK-3 in Keap1-null mouse embryonic fibroblasts (MEFs), or in human lung A549 cells that contain mutant Keap1, by inhibition of the phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB)/Akt pathway markedly reduced endogenous Nrf2 protein and decreased to 10-50% of normal the levels of mRNA for prototypic Nrf2-regulated enzymes, including the glutamate-cysteine ligase catalytic and modifier subunits, glutathione S-transferases Alpha-1 and Mu-1, haem oxygenase-1 and NAD(P)H:quinone oxidoreductase-1. Pre-treatment of Keap1(-/-) MEFs or A549 cells with the LY294002 PI3K inhibitor or the MK-2206 PKB/Akt inhibitor increased their sensitivity to acrolein, chlorambucil and cisplatin between 1.9-fold and 3.1-fold, and this was substantially attenuated by simultaneous pre-treatment with the GSK-3 inhibitor CT99021.	[Chowdhry, S.; Zhang, Y.; McMahon, M.; Hayes, J. D.] Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res, Dundee DD1 9SY, Scotland; [Sutherland, C.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland; [Cuadrado, A.] Inst Invest Sanitaria Paz IdiPAZ, Dept Bioquim, Madrid, Spain; [Cuadrado, A.] Inst Invest Sanitaria Paz IdiPAZ, Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Inst Invest Biomed Alberto Sols UAM CSIC, Madrid, Spain	University of Dundee; University of Dundee; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Hayes, JD (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res, James Arrott Dr, Dundee DD1 9SY, Scotland.	j.d.hayes@dundee.ac.uk	McMahon, Michael J/F-7070-2010; chowdhry, sudhir/R-8310-2016	McMahon, Michael J/0000-0001-8615-9351; chowdhry, sudhir/0000-0002-8511-5717; Cuadrado, Antonio/0000-0002-4039-7140; Hayes, John/0000-0002-2927-5548; Sutherland, Calum/0000-0003-4398-7434; Cuadrado, Antonio/0000-0002-3444-9012; Zhang, Yiguo/0000-0003-3910-2779	Tenovus Scotland [T07/39]; Association for International Cancer Research [09-0254]; Cancer Research UK [C4909/A9990, C4909/A13786]; Biotechnology and Biological Sciences Research Council [C18727] Funding Source: researchfish; Cancer Research UK [13786] Funding Source: researchfish	Tenovus Scotland; Association for International Cancer Research; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We are very grateful to Professor Masayuki Yamamoto for supplying Keap1-null MEFs, and thank Dr Akira Kikuchi for the gift of the pCGN/GSK-3 beta<SUP>Delta 9</SUP> and pCGN/GSK-3 beta<SUP>Y216F</SUP> expression plasmids. We thank Professor Ronald T Hay and Dr David W Meek for valuable advice in establishing the peptide pull-down assay, and Dr Albena T Dinkova-Kostova and Professor C Roland Wolf for helpful suggestions. We gratefully acknowledge Tenovus Scotland (T07/39), the Association for International Cancer Research (09-0254) and Cancer Research UK (C4909/A9990; C4909/A13786) for funding this work.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Alam J, 2000, J BIOL CHEM, V275, P27694; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Finlay D, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-15; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Hwang YP, 2008, TOXICOL APPL PHARM, V231, P318, DOI 10.1016/j.taap.2008.04.019; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Murai H, 1996, FEBS LETT, V392, P153, DOI 10.1016/0014-5793(96)00806-X; Muscarella LA, 2011, EPIGENETICS-US, V6, P710, DOI 10.4161/epi.6.6.15773; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Putters J, 2011, CELL SIGNAL, V23, P641, DOI 10.1016/j.cellsig.2010.11.015; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rojo AI, 2008, MOL CELL NEUROSCI, V39, P125, DOI 10.1016/j.mcn.2008.06.007; Rojo AI, 2008, J NEUROCHEM, V105, P192, DOI 10.1111/j.1471-4159.2007.05124.x; Rojo AI, 2012, FREE RADICAL BIO MED, V52, P473, DOI 10.1016/j.freeradbiomed.2011.11.003; Rushworth SA, 2005, J IMMUNOL, V175, P4408, DOI 10.4049/jimmunol.175.7.4408; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Seo E, 2009, CELL SIGNAL, V21, P43, DOI 10.1016/j.cellsig.2008.09.009; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830	62	391	411	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 8	2013	32	32					3765	3781		10.1038/onc.2012.388	http://dx.doi.org/10.1038/onc.2012.388			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22964642	Green Accepted, hybrid, Green Submitted			2022-12-25	WOS:000322904400011
J	Araujo, THA; Souza-Brito, LI; Libin, P; Deforche, K; Edwards, D; de Albuquerque, AE; Vandamme, AM; Galvao-Castro, B; Alcantara, LC				Almeida Araujo, Thessika Hialla; Souza-Brito, Leandro Inacio; Libin, Pieter; Deforche, Koen; Edwards, Dustin; de Albuquerque-Junior, Antonio Eduardo; Vandamme, Anne-Mieke; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos			A Public HTLV-1 Molecular Epidemiology Database for Sequence Management and Data Mining	PLOS ONE			English	Article							VIRUS TYPE-I; T-CELL LEUKEMIA; BLOOD-DONORS; INFECTION	Background: It is estimated that 15 to 20 million people are infected with the human T-cell lymphotropic virus type 1 (HTLV-1). At present, there are more than 2,000 unique HTLV-1 isolate sequences published. A central database to aggregate sequence information from a range of epidemiological aspects including HTLV-1 infections, pathogenesis, origins, and evolutionary dynamics would be useful to scientists and physicians worldwide. Described here, we have developed a database that collects and annotates sequence data and can be accessed through a user- friendly search interface. The HTLV-1 Molecular Epidemiology Database website is available at http://htlv1db.bahia.fiocruz.br/. Methodology/Principal Findings: All data was obtained from publications available at GenBank or through contact with the authors. The database was developed using Apache Webserver 2.1.6 and SGBD MySQL. The webpage interfaces were developed in HTML and sever-side scripting written in PHP. The HTLV-1 Molecular Epidemiology Database is hosted on the Goncalo Moniz/FIOCRUZ Research Center server. There are currently 2,457 registered sequences with 2,024 (82.37%) of those sequences representing unique isolates. Of these sequences, 803 (39.67%) contain information about clinical status (TSP/HAM, 17.19%; ATL, 7.41%; asymptomatic, 12.89%; other diseases, 2.17%; and no information, 60.32%). Further, 7.26% of sequences contain information on patient gender while 5.23% of sequences provide the age of the patient. Conclusions/Significance: The HTLV-1 Molecular Epidemiology Database retrieves and stores annotated HTLV-1 proviral sequences from clinical, epidemiological, and geographical studies. The collected sequences and related information are now accessible on a publically available and user- friendly website. This open-access database will support clinical research and vaccine development related to viral genotype.	[Almeida Araujo, Thessika Hialla; de Albuquerque-Junior, Antonio Eduardo; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Goncalo Moniz Res Center, Salvador, BA, Brazil; [Souza-Brito, Leandro Inacio; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Bahia Fdn Sci Dev, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil; [Libin, Pieter; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Edwards, Dustin] NCI, Anim Models & Retroviral Vaccines Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Libin, Pieter; Deforche, Koen] MyBioData, Rotselaar, Belgium; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Trop, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal	Fundacao Oswaldo Cruz; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Araujo, THA (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Res Center, Salvador, BA, Brazil.	lalcan@bahia.fiocruz.br	Alcantara, Luiz Carlos Júnior/AAK-9468-2021; Vandamme, Anne-Mieke/I-4127-2012	Vandamme, Anne-Mieke/0000-0002-6594-2766; Alcantara, Luiz/0000-0002-6769-9931; Edwards, Dustin/0000-0001-6409-8041	Brazilian Ministry of Health [TC120/2010]	Brazilian Ministry of Health	This work was supported by funds from Brazilian Ministry of Health (TC120/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; deThe G, 1996, J ACQ IMMUN DEF SYND, V13, pS191, DOI 10.1097/00042560-199600001-00029; GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x; Gessain A, 1996, J ACQ IMMUN DEF SYND, V13, pS228, DOI 10.1097/00042560-199600001-00034; GESSAIN A, 1985, LANCET, V2, P407; Goncalves DU, 2003, AM J TROP MED HYG, V68, P562, DOI 10.4269/ajtmh.2003.68.562; HANCHARD B, 1990, HUMAN RETROVIROLOGY : HTLV, P173; La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439; McCallum RM, 1997, MED CLIN N AM, V81, P261, DOI 10.1016/S0025-7125(05)70514-9; MOCHIZUKI M, 1992, J INFECT DIS, V166, P943, DOI 10.1093/infdis/166.4.943; MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359; Mueller N, 1996, J ACQ IMMUN DEF SYND, V13, pS2, DOI 10.1097/00042560-199600001-00002; Nishioka K, 1996, J ACQUIRED DEFICIENC, V13, P57; OSAME M, 1986, LANCET, V1, P1031; Poiesz J, 1980, P NATL ACAD SCI USA, V77, P7415; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; YAMAGUCHI K, 1994, LANCET, V343, P213, DOI 10.1016/S0140-6736(94)90994-6; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	18	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e42123	10.1371/journal.pone.0042123	http://dx.doi.org/10.1371/journal.pone.0042123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970114	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400002
J	Kwong, A; Ng, EKO; Wong, CLP; Law, FBF; Au, T; Wong, HN; Kurian, AW; West, DW; Ford, JM; Ma, ESK				Kwong, Ava; Ng, Enders Kai On; Wong, Chris Lei Po; Law, Fian Bic Fai; Au, Tommy; Wong, Hong Nei; Kurian, Allison W.; West, Dee W.; Ford, James M.; Ma, Edmond Siu Kwan			Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis	PLOS ONE			English	Article							GERMLINE MUTATIONS; HEREDITARY BREAST; HIGH PROPORTION; OVARIAN-CANCER; PREVALENCE; FAMILIES; WOMEN; GUIDELINES; AGE	Background: Ethnic variations in breast cancer epidemiology and genetics have necessitated investigation of the spectra of BRCA1 and BRCA2 mutations in different populations. Knowledge of BRCA mutations in Chinese populations is still largely unknown. We conducted a multi-center study to characterize the spectra of BRCA mutations in Chinese breast and ovarian cancer patients from Southern China. Methodology/Principal Findings: A total of 651 clinically high-risk breast and/or ovarian cancer patients were recruited from the Hong Kong Hereditary Breast Cancer Family Registry from 2007 to 2011. Comprehensive BRCA1 and BRCA2 mutation screening was performed using bi-directional sequencing of all coding exons of BRCA1 and BRCA2. Sequencing results were confirmed by in-house developed full high resolution DNA melting (HRM) analysis. Among the 451 probands analyzed, 69 (15.3%) deleterious BRCA mutations were identified, comprising 29 in BRCA1 and 40 in BRCA2. The four recurrent BRCA1 mutations (c.470_471delCT, c.3342_3345delAGAA, c.5406+1_5406+3delGTA and c.981_982delAT) accounted for 34.5% (10/29) of all BRCA1 mutations in this cohort. The four recurrent BRCA2 mutations (c.2808_2811delACAA, c.3109C>T, c.7436_7805del370 and c.9097_9098insA) accounted for 40% (16/40) of all BRCA2 mutations. Haplotype analysis was performed to confirm 1 BRCA1 and 3 BRCA2 mutations are putative founder mutations. Rapid HRM mutation screening for a panel of the founder mutations were developed and validated. Conclusion: In this study, our findings suggest that BRCA mutations account for a substantial proportion of hereditary breast/ovarian cancer in Southern Chinese population. Knowing the spectrum and frequency of the founder mutations in this population will assist in the development of a cost-effective rapid screening assay, which in turn facilitates genetic counseling and testing for the purpose of cancer risk assessment.	[Kwong, Ava; Ng, Enders Kai On; Wong, Hong Nei] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava; Ng, Enders Kai On; Wong, Chris Lei Po; Law, Fian Bic Fai; Au, Tommy; Ma, Edmond Siu Kwan] Hong Kong Sanat & Hosp, Dept Mol Pathol, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava; Ng, Enders Kai On; Wong, Chris Lei Po; Law, Fian Bic Fai; Au, Tommy; Ma, Edmond Siu Kwan] Hong Kong Sanat & Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava; Wong, Chris Lei Po; Law, Fian Bic Fai; Ma, Edmond Siu Kwan] Hong Kong Hereditary Breast Canc Family Registry, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava; Kurian, Allison W.; West, Dee W.; Ford, James M.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Kwong, Ava; Kurian, Allison W.; West, Dee W.; Ford, James M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	University of Hong Kong; Stanford University; Stanford University	Kwong, A (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	akwong@asiabreastregistry.com	Ma, Shiu Kwan Edmond/AAZ-7637-2021; Kwong, Ava/D-8005-2013; Ng, Enders/T-3881-2019; wong, chris/GSN-0962-2022; Ng, Enders K.O./F-2787-2010; Kurian, Allison/A-4560-2019	Ma, Shiu Kwan Edmond/0000-0002-1259-2205; Kwong, Ava/0000-0002-6968-9489; Ng, Enders/0000-0002-6955-0030; Ng, Enders K.O./0000-0002-6955-0030; Ford, James/0000-0002-2513-7025; Ng, Enders Kai-on/0000-0002-5293-3529; Kurian, Allison/0000-0002-6175-9470	National Institutes of Health [1R03CA130065]; NATIONAL CANCER INSTITUTE [R03CA130065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health (1R03CA130065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen W, 2008, BREAST CANC RES TREA; Choi DH, 2004, J CLIN ONCOL, V22, P1638, DOI 10.1200/JCO.2004.04.179; Chou LS, 2005, AM J CLIN PATHOL, V124, P330, DOI 10.1309/BF3MLJN8J527MWQY; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Fukutomi, 1997, Breast Cancer, V4, P256, DOI 10.1007/BF02966517; Han SA, 2011, CLIN ONCOL-UK, V23, P434, DOI 10.1016/j.clon.2010.11.007; Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; HK Census, 2006, HK CENSUS STAT TABLE; Ho GH, 2000, CANCER-AM CANCER SOC, V89, P811, DOI 10.1002/1097-0142(20000815)89:4<811::AID-CNCR13>3.0.CO;2-R; Hu Zhen, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9156; Ikeda N, 2001, INT J CANCER, V91, P83, DOI 10.1002/1097-0215(20010101)91:1<83::AID-IJC1013>3.0.CO;2-5; Inoue R, 1997, INT J CANCER, V74, P199, DOI 10.1002/(SICI)1097-0215(19970422)74:2<199::AID-IJC11>3.0.CO;2-9; Katagiri T, 1998, J HUM GENET, V43, P42, DOI 10.1007/s100380050035; Khoo Ui-Soon, 2002, Hum Mutat, V19, P307, DOI 10.1002/humu.9015; Kurian AW, 2008, J CLIN ONCOL; Kwong A, 2010, BREAST CANC RES TREA; Kwong Ava, 2009, Hugo J, V3, P63, DOI 10.1007/s11568-010-9136-z; Kwong A, 2009, BREAST CANCER RES TR, V117, P683, DOI 10.1007/s10549-009-0385-2; Lee Ann S G, 2003, Hum Mutat, V22, P178, DOI 10.1002/humu.9162; Li CI, 2002, CANCER EPIDEM BIOMAR, V11, P601; Li WF, 2008, BREAST CANCER RES TR, V110, P99, DOI 10.1007/s10549-007-9708-3; Li WF, 2007, BREAST CANC RES TREA; Liede A, 2002, HUM MUTAT, V20, P413, DOI 10.1002/humu.10154; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Matsuda MLD, 2002, INT J CANCER, V98, P596, DOI 10.1002/ijc.10194; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Sekine M, 2001, CLIN CANCER RES, V7, P3144; Sng JH, 2000, BRIT J CANCER, V82, P538; Song CG, 2006, J CANCER RES CLIN, V132, P617, DOI 10.1007/s00432-006-0105-9; Tang NLS, 2001, CLIN CHIM ACTA, V313, P179, DOI 10.1016/S0009-8981(01)00671-4; Tang NLS, 1999, J NATL CANCER I, V91, P882, DOI 10.1093/jnci/91.10.882; The Hong Kong Cancer Registry, 2005, FAST STATS FEM BREAS; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Zhi XC, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9083; Zhou Yuan-zheng, 2004, Zhonghua Yi Xue Za Zhi, V84, P294	38	79	86	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43994	10.1371/journal.pone.0043994	http://dx.doi.org/10.1371/journal.pone.0043994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970155	Green Published, gold			2022-12-25	WOS:000308462000010
J	Masuda, N; Nakamura, M				Masuda, Naoki; Nakamura, Mitsuhiro			Coevolution of Trustful Buyers and Cooperative Sellers in the Trust Game	PLOS ONE			English	Article							INDIRECT RECIPROCITY; SOCIAL NORMS; MAINTAIN COOPERATION; REPUTATION; EVOLUTION; DYNAMICS; MARKET	Many online marketplaces enjoy great success. Buyers and sellers in successful markets carry out cooperative transactions even if they do not know each other in advance and a moral hazard exists. An indispensable component that enables cooperation in such social dilemma situations is the reputation system. Under the reputation system, a buyer can avoid transacting with a seller with a bad reputation. A transaction in online marketplaces is better modeled by the trust game than other social dilemma games, including the donation game and the prisoner's dilemma. In addition, most individuals participate mostly as buyers or sellers; each individual does not play the two roles with equal probability. Although the reputation mechanism is known to be able to remove the moral hazard in games with asymmetric roles, competition between different strategies and population dynamics of such a game are not sufficiently understood. On the other hand, existing models of reputation-based cooperation, also known as indirect reciprocity, are based on the symmetric donation game. We analyze the trust game with two fixed roles, where trustees (i.e., sellers) but not investors (i.e., buyers) possess reputation scores. We study the equilibria and the replicator dynamics of the game. We show that the reputation mechanism enables cooperation between unacquainted buyers and sellers under fairly generous conditions, even when such a cooperative equilibrium coexists with an asocial equilibrium in which buyers do not buy and sellers cheat. In addition, we show that not many buyers may care about the seller's reputation under cooperative equilibrium. Buyers' trusting behavior and sellers' reputation-driven cooperative behavior coevolve to alleviate the social dilemma.	[Masuda, Naoki; Nakamura, Mitsuhiro] Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo, Japan; [Masuda, Naoki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Masuda, N (corresponding author), Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo, Japan.	masuda@mist.i.u-tokyo.ac.jp		Nakamura, Mitsuhiro/0000-0003-4191-6915; Masuda, Naoki/0000-0003-1567-801X	MEXT, Japan [20760258]; Japan Society for the Promotion of Science (JSPS), Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by Grants-in-Aid for Scientific Research (No. 20760258) from MEXT, Japan, and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; [Anonymous], 1995, EVOLUTIONARY GAME TH; Basu S, 2009, P NATL ACAD SCI USA, V106, P1009, DOI 10.1073/pnas.0811967106; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bolton GE, 2004, MANAGE SCI, V50, P1587, DOI 10.1287/mnsc.1030.0199; Bracht J, 2009, J PUBLIC ECON, V93, P1036, DOI 10.1016/j.jpubeco.2009.06.004; Brandt H, 2006, J THEOR BIOL, V239, P183, DOI 10.1016/j.jtbi.2005.08.045; Brandt H, 2004, J THEOR BIOL, V231, P475, DOI 10.1016/j.jtbi.2004.06.032; Bravo G, 2008, RATION SOC, V20, P85, DOI 10.1177/1043463107085441; Brown J, 2006, CALIF MANAGE REV, V49, P61, DOI 10.2307/41166371; Chalub FACC, 2006, J THEOR BIOL, V241, P233, DOI 10.1016/j.jtbi.2005.11.028; Dasgupta P., 1988, TRUST MAKING BREAKIN, P49; Dellarocas C, 2003, MANAGE SCI, V49, P1407, DOI 10.1287/mnsc.49.10.1407.17308; Diekmann A, 2005, 3 ESSA C, P1; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; GREIF A, 1993, AM ECON REV, V83, P525; Greif A, 2006, POLIT ECON I DECIS, P1, DOI 10.1017/CBO9780511791307; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Johnstone RA, 2007, P ROY SOC B-BIOL SCI, V274, P3175, DOI 10.1098/rspb.2007.1322; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Keser C, 2003, IBM SYST J, V42, P498, DOI 10.1147/sj.423.0498; KLEIN B, 1981, J POLIT ECON, V89, P615, DOI 10.1086/260996; Kreps DM, 1990, PERSPECTIVES POSITIV, P90, DOI [DOI 10.1017/CBO9780511571657.006, 10.1017/CBO9780511571657.006]; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Malaga R. A., 2001, Electronic Commerce Research, V1, P403, DOI 10.1023/A:1011557319152; McCabe KA, 2000, P NATL ACAD SCI USA, V97, P4404, DOI 10.1073/pnas.97.8.4404; McCabe KA, 2003, J ECON BEHAV ORGAN, V52, P267, DOI 10.1016/S0167-2681(03)00003-9; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P605, DOI 10.1098/rspb.2008.1182; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2007, J THEOR BIOL, V244, P518, DOI 10.1016/j.jtbi.2006.08.018; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Panchanathan K, 2003, J THEOR BIOL, V224, P115, DOI 10.1016/S0022-5193(03)00154-1; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122; Resnick P, 2002, ADV APP M-E, V11, P127; Resnick P, 2006, EXP ECON, V9, P79, DOI 10.1007/s10683-006-4309-2; SAMUELSON L, 1992, J ECON THEORY, V57, P363, DOI 10.1016/0022-0531(92)90041-F; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K., 2010, CALCULUS SELFISHNESS; Uchida S, 2010, J THEOR BIOL, V263, P13, DOI 10.1016/j.jtbi.2009.11.013	47	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44169	10.1371/journal.pone.0044169	http://dx.doi.org/10.1371/journal.pone.0044169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970176	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000013
J	Kronforst, KD; Mancuso, CJ; Pettengill, M; Ninkovic, J; Coombs, MRP; Stevens, C; Otto, M; Mallard, C; Wang, XY; Goldmann, D; Levy, O				Kronforst, Kenny D.; Mancuso, Christy J.; Pettengill, Matthew; Ninkovic, Jana; Coombs, Melanie R. Power; Stevens, Chad; Otto, Michael; Mallard, Carina; Wang, Xiaoyang; Goldmann, Donald; Levy, Ofer			A Neonatal Model of Intravenous Staphylococcus epidermidis Infection in Mice < 24 h Old Enables Characterization of Early Innate Immune Responses	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; HUMAN NEWBORN; MOUSE MODEL; IN-VITRO; SUSCEPTIBILITY; SEPSIS; AUREUS; PENTOXIFYLLINE; EXPRESSION; VIRULENCE	Staphylococcus epidermidis (SE) causes late onset sepsis and significant morbidity in catheterized preterm newborns. Animal models of SE infection are useful in characterizing disease mechanisms and are an important approach to developing improved diagnostics and therapeutics. Current murine models of neonatal bacterial infection employ intraperitoneal or subcutaneous routes at several days of age, and may, therefore, not accurately reflect distinct features of innate immune responses to bacteremia. In this study we developed, validated, and characterized a murine model of intravenous (IV) infection in neonatal mice <24 hours (h) old to describe the early innate immune response to SE. C57BL/6 mice <24 h old were injected IV with 10(6), 10(7), 10(8) colony-forming units (CFU) of SE 1457, a clinical isolate from a central catheter infection. A prospective injection scoring system was developed and validated, with only high quality injections analyzed. Newborn mice were euthanized between 2 and 48 h post-injection and spleen, liver, and blood collected to assess bacterial viability, gene expression, and cytokine production. High quality IV injections demonstrated inoculum-dependent infection of spleen, liver and blood. Within 2 h of injection, SE induced selective transcription of TLR2 and MyD88 in the liver, and increased systemic production of plasma IL-6 and TNF-alpha. Despite clearance of bacteremia and solid organ infection within 48 h, inoculum-dependent impairment in weight gain was noted. We conclude that a model of IV SE infection in neonatal mice <24 h old is feasible, demonstrating inoculum-dependent infection of solid organs and a pattern of bacteremia, rapid and selective innate immune activation, and impairment of weight gain typical of infected human neonates. This novel model can now be used to characterize immune ontogeny, evaluate infection biomarkers, and assess preventative and therapeutic modalities.	[Kronforst, Kenny D.; Mancuso, Christy J.; Pettengill, Matthew; Ninkovic, Jana; Stevens, Chad; Goldmann, Donald; Levy, Ofer] Boston Childrens Hosp, Boston, MA USA; [Pettengill, Matthew; Ninkovic, Jana; Goldmann, Donald; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Coombs, Melanie R. Power] Dalhousie Univ, Halifax, NS, Canada; [Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Mallard, Carina; Wang, Xiaoyang] Univ Gothenburg, Gothenburg, Sweden	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Dalhousie University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Gothenburg	Kronforst, KD (corresponding author), Boston Childrens Hosp, Boston, MA USA.	ofer.levy@childrens.harvard.edu	Coombs, Melanie/GQH-9000-2022	Otto, Michael/0000-0002-2222-4115; Coombs, Melanie/0000-0002-2036-8414; Wang, Xiaoyang/0000-0001-9717-8160; Levy, Ofer/0000-0002-5859-1945; Mallard, Carina/0000-0001-8953-919X; Pettengill, Matthew/0000-0002-4579-0187	National Institute of Allergy and Infectious Diseases, National Institutes of Health [RO1 AI067353-01A1, 3R01AI067353-05S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067353] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support provided by National Institute of Allergy and Infectious Diseases, National Institutes of Health RO1 AI067353-01A1 and Administrative Supplement 3R01AI067353-05S1 (to OL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Belderbos ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033419; Burl S, 2011, PLOS ONE, V13; Chau V, 2012, PEDIATR RES, V71, P274, DOI 10.1038/pr.2011.40; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Fleiss B, 2010, PLOS ONE, V6; GALLIMORE B, 1991, J INFECT DIS, V164, P1220, DOI 10.1093/infdis/164.6.1220; GUNN BA, 1989, J CLIN MICROBIOL, V27, P507, DOI 10.1128/JCM.27.3.507-511.1989; Hartel C, 2008, ARCH DIS CHILD-FETAL, V93, pF140, DOI 10.1136/adc.2007.124685; Healy CM, 2004, PEDIATRICS, V114, P953, DOI 10.1542/peds.2004-0043; Hoff J, 2000, LAB ANIMAL, V29, P47; Isaacs D, 2003, ARCH DIS CHILD-FETAL, V88, pF89, DOI 10.1136/fn.88.2.F89; JAX Mice and services, 2009, MIC PUP APP AG; Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.17.3.638-680.2004; Kienstra KA, 2007, J AM ASSOC LAB ANIM, V46, P50; KINSMAN OS, 1980, J MED MICROBIOL, V13, P281, DOI 10.1099/00222615-13-2-281; Klingenberg C, 2007, CLIN MICROBIOL INFEC, V13, P1100, DOI 10.1111/j.1469-0691.2007.01818.x; Knuefermann P, 2004, CIRCULATION, V110, P3693, DOI 10.1161/01.CIR.0000143081.13042.04; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; KRAUSE PJ, 1987, AM J PATHOL, V129, P217; Le Rouzic V, 2011, INFLAMMATION, V34, P576, DOI 10.1007/s10753-010-9265-5; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Mack D, 2002, ANTIMICROB AGENTS CH, V46, P178, DOI 10.1128/AAC.46.1.178-183.2002; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; MADERAZO EG, 1990, ANTIMICROB AGENTS CH, V34, P1100, DOI 10.1128/AAC.34.6.1100; Major AS, 1996, J VIROL, V70, P5968, DOI 10.1128/JVI.70.9.5968-5974.1996; Mallard C, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/102153; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; MCKAY SE, 1979, J MED MICROBIOL, V12, P99, DOI 10.1099/00222615-12-1-99; Mohamed MA, 2007, CYTOKINE, V39, P171, DOI 10.1016/j.cyto.2007.07.004; Mrozek J D, 2000, J Perinatol, V20, P96, DOI 10.1038/sj.jp.7200319; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Placencia FX, 2009, PEDIATR RES, V65, P420, DOI 10.1203/PDR.0b013e3181994a53; Radbruch A, 2009, EUR J IMMUNOL, V39, P1991, DOI 10.1002/eji.200939772; RODEWALD AK, 1992, J INFECT DIS, V166, P635, DOI 10.1093/infdis/166.3.635; Santos-Sierra S, 2006, J ENDOTOXIN RES, V12, P307, DOI 10.1179/096805106X118762; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Schultz C, 2004, CLIN EXP IMMUNOL, V135, P130, DOI 10.1111/j.1365-2249.2004.02313.x; Schultz C, 2002, PEDIATR RES, V51, P317, DOI 10.1203/00006450-200203000-00009; Srinivasan L, 2012, CURR OPIN PEDIATR, V24, P165, DOI 10.1097/MOP.0b013e3283504df3; Strunk T, 2012, PEDIATR RES, V72, P10, DOI 10.1038/pr.2012.48; Strunk T, 2011, J MATERN-FETAL NEO M, V24, P25, DOI 10.3109/14767058.2010.482605; Strunk T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010111; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Sweeney TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025249; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Wang XY, 2012, ADV NEUROIMMUNE BIOL, V3, P41, DOI 10.3233/NIB-2012-012034; Widerstrom M, 2012, EUR J CLIN MICROBIOL, V31, P7, DOI 10.1007/s10096-011-1270-6; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301; Wynn JL, 2008, BLOOD, V112, P1750, DOI 10.1182/blood-2008-01-130500; Wynn JL, 2010, CLIN PERINATOL, V37, P307, DOI 10.1016/j.clp.2010.04.001; Zhang JP, 2010, PEDIATR RES, V68, P479, DOI 10.1203/PDR.0b013e3181f90810; Zhou SH, 2007, J IMMUNOL, V178, P5173, DOI 10.4049/jimmunol.178.8.5173	56	32	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43897	10.1371/journal.pone.0043897	http://dx.doi.org/10.1371/journal.pone.0043897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970147	Green Submitted, gold, Green Published			2022-12-25	WOS:000308458400022
J	Morissette, L; Christensen, V; Pauly, D				Morissette, Lyne; Christensen, Villy; Pauly, Daniel			Marine Mammal Impacts in Exploited Ecosystems: Would Large Scale Culling Benefit Fisheries?	PLOS ONE			English	Article							NORTH-ATLANTIC; CLIMATE-CHANGE; ST-LAWRENCE; BENGUELA ECOSYSTEM; SOUTHERN BENGUELA; GLOBAL FISHERIES; DIET COMPOSITION; MINKE WHALES; TROPHIC ROLE; FUR-SEAL	Competition between marine mammals and fisheries for marine resources-whether real or perceived-has become a major issue for several countries and in international fora. We examined trophic interactions between marine mammals and fisheries based on a resource overlap index, using seven Ecopath models including marine mammal groups. On a global scale, most food consumed by marine mammals consisted of prey types that were not the main target of fisheries. For each ecosystem, the primary production required (PPR) to sustain marine mammals was less than half the PPR to sustain fisheries catches. We also developed an index representing the mean trophic level of marine mammal's consumption (TLQ) and compared it with the mean trophic level of fisheries' catches (TLC). Our results showed that overall TLQ was lower than TLC (2.88 versus 3.42). As fisheries increasingly exploit lower-trophic level species, the competition with marine mammals may become more important. We used mixed trophic impact analysis to evaluate indirect trophic effects of marine mammals, and in some cases found beneficial effects on some prey. Finally, we assessed the change in the trophic structure of an ecosystem after a simulated extirpation of marine mammal populations. We found that this lead to alterations in the structure of the ecosystems, and that there was no clear and direct relationship between marine mammals' predation and the potential catch by fisheries. Indeed, total biomass, with no marine mammals in the ecosystem, generally remained surprisingly similar, or even decreased for some species.	[Morissette, Lyne] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Morissette, Lyne; Christensen, Villy; Pauly, Daniel] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of Quebec; University of British Columbia	Morissette, L (corresponding author), Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada.	lyne.morissette@globetrotter.net	Pauly, Daniel Marc/AAY-2316-2021; Christensen, Villy/C-3945-2009	Christensen, Villy/0000-0003-0688-2633; Pauly, Daniel/0000-0003-3756-4793	Lenfest Ocean Program	Lenfest Ocean Program	This research was carried out as a contribution to a doctoral thesis at the Fisheries Centre of the University of British Columbia, with financial support from the Lenfest Ocean Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN KR, 1971, J FISH RES BOARD CAN, V28, P1573, DOI 10.1139/f71-236; Angel MV, 1995, IEE C POLL LAND SEA, V165, p9/1; [Anonymous], 1995, MAR FISH REV; [Anonymous], 2000, MAR FISH REV; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bowen W. Donald, 1999, P423; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Christensen LB., 2006, MARINE MAMMAL POPULA, Vvol. 14; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Christensen V., 2008, ECOPATH ECOSIM VERSI; Christensen V, 2002, P INCO DC C PLAC FIS, P39; Christensen V, 2011, ECOSYSTEM APPROACHES TO FISHERIES: A GLOBAL PERSPECTIVE, P189; Clark R.B., 2001, MARINE POLLUTION, V5th; Dans SL, 2003, ECOL APPL, V13, P754, DOI 10.1890/1051-0761(2003)013[0754:ICODIT]2.0.CO;2; DeMaster DP, 2001, J MAMMAL, V82, P641, DOI 10.1644/1545-1542(2001)082<0641:PACTIO>2.0.CO;2; Dillingham PW, 2006, CAN J FISH AQUAT SCI, V63, P107, DOI 10.1139/F05-208; Dwyer E, 1999, SAINT JOHN TIME 0614; Essington TE, 2007, CAN J FISH AQUAT SCI, V64, P628, DOI 10.1139/F07-042; Estes JA, 2005, MAR MAMMAL SCI, V21, P169, DOI 10.1111/j.1748-7692.2005.tb01218.x; FAO/FISHCODE, 2001, REP BIOEC MOD WORKSH; Fisheries Resource Conservation Council, 2002, FRCC2002R2 MIN FISH; Froese R., 2012, FISHBASE VERSION 08; Gales N., 2003, MARINE MAMMALS FISHE; Gerber LR, 2009, SCIENCE, V323, P880, DOI 10.1126/science.1169981; Grellier K, 2006, CAN J FISH AQUAT SCI, V63, P1982, DOI 10.1139/F06-092; Gulland J.A., 1983, Marine Ecology (London), V5, P839; HAMMOND PS, 1994, J APPL ECOL, V31, P340, DOI 10.2307/2404548; HARDWOOD J, 2001, J MAMMAL, V82, P630; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HARWOOD J, 1988, MAR MAMMAL SCI, V4, P13, DOI 10.1111/j.1748-7692.1988.tb00179.x; Hume F, 2004, MAR BIOL, V144, P407, DOI 10.1007/s00227-003-1219-0; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kaneko H, 2006, MAR MAMMAL SCI, V22, P261, DOI 10.1111/j.1748-7692.2006.00030.x; Kaschner K., 2005, STATE ANIMALS 3, P95; KASCHNER K, 2001, FISHERIES CTR RES RE, V9, P35; Kenney Robert D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P155; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Laake JL, 2002, FISH B-NOAA, V100, P434; Lawson JW, 1995, SEALS WHALES FISH MA, P261; Lawson JW, 2008, NAFO S ROL MAR MAMM; Lesage V, 2001, MAR ECOL PROG SER, V210, P203, DOI 10.3354/meps210203; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lindstrom U, 2002, ICES J MAR SCI, V59, P58, DOI 10.1006/jmsc.2001.1135; Lockyer C., 1981, FAO FISHERIES SERIES, V5, P379; Loreng H, 2004, ACIA INT SCI S CLIM; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lydersen C, 2006, ECOGRAPHY, V14, P219; MacKenzie BR, 2002, CAN J FISH AQUAT SCI, V59, P173, DOI 10.1139/F01-201; Mackinson S, 2003, MAR MAMMAL SCI, V19, P661, DOI 10.1111/j.1748-7692.2003.tb01123.x; MARTELL S, 2002, FISHERIES CTR RES RE, V10, P16; Matthiopoulos J, 2008, MAMMAL REV, V38, P167, DOI 10.1111/j.1365-2907.2008.00123.x; Morissete L, 2006, MAR MAMMAL SCI, V22, P74, DOI 10.1111/j.1748-7692.2006.00007.x; Morissette L, 2005, NATO SCI S SS IV EAR, V50, P127; Morissette L., 2003, CAN TECH REP FISH AQ, V2497, P94; Morissette L, 2009, FISHERIES CTR RES RE, V17, P3; MORISSETTE L, 2001, THESIS U QUEBEC RIMO; Morissette L, 2010, FISH FISH, V11, P388, DOI 10.1111/j.1467-2979.2010.00366.x; Morissette L, 2010, MAR ECOL PROG SER, V404, P289, DOI 10.3354/meps08443; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; National Research Council, 2003, DECL STELL SEA LION; NORTHRIDGE S, 1991, 251 FAO S1; Olson R.J., 2003, B I ATCC, V22, P133; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; PARSONS TR, 1992, MAR POLLUT BULL, V25, P51, DOI 10.1016/0025-326X(92)90185-9; PATTERSON K, 1992, REV FISH BIOL FISHER, V2, P321, DOI 10.1007/BF00043521; Pauly D, 2005, PHILOS T ROY SOC B, V360, P415, DOI 10.1098/rstb.2004.1597; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 1995, ICES COUNC M; PERRIN WF, 2005, CMS TECHNICAL SERIES, V9; Pitcher TJ, 2005, FISHERIES CTR RES RE, V13, P3; Plaganyi EE, 2004, AFR J MAR SCI, V26, P261, DOI 10.2989/18142320409504061; Plaganyi EE., 2007, FAO FISHERIES TECHNI; Plaganzi E., 2002, ENCY MARINE MAMMALS, P268; Preikshot D., 1998, FISHERIES CTR RES RE, V6, P72; Punt AE, 1995, S AFR J MARINE SCI, V16, P255; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Sanae C, 2006, GLOBAL CHANGE BIOL, V12, P907; Savenkoff C, 2007, ECOL MODEL, V204, P115, DOI 10.1016/j.ecolmodel.2006.12.029; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shannon LJ, 2004, AFR J MAR SCI, V26, P179, DOI 10.2989/18142320409504056; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Simmonds MP, 2007, ORYX, V41, P19, DOI 10.1017/S0030605307001524; Sindermann C. J., 1996, OCEAN POLLUTION EFFE; Smith TD, 1995, DEV MAR BIO, V4, P527; SPARRE P, 1991, ICES MAR SC, V193, P12; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Tjelmeland S, 2005, ICES J MAR SCI, V62, P285, DOI 10.1016/j.icesjms.2004.12.011; Trites Andrew W., 1997, Journal of Northwest Atlantic Fishery Science, V22, P173; Trzcinski MK, 2006, ECOL APPL, V16, P2276, DOI 10.1890/1051-0761(2006)016[2276:CDOAAC]2.0.CO;2; ULANOWICZ R E, 1990, Coenoses, V5, P7; Vasconcellos V, 1997, ECOL MODEL, V100, P125; Wallace SS, 1998, FISHERIES CTR RES RE, V6, P58; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Whipple SJ, 2000, FISH FISH, V1, P22, DOI 10.1046/j.1467-2979.2000.00007.x; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x; 2001, INCREASING COMPETITI; [No title captured]	111	53	56	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43966	10.1371/journal.pone.0043966	http://dx.doi.org/10.1371/journal.pone.0043966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970153	Green Published, gold			2022-12-25	WOS:000308458400027
J	Nazarian, A; Sichtig, H; Riva, A				Nazarian, Alireza; Sichtig, Heike; Riva, Alberto			A Knowledge-Based Method for Association Studies on Complex Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-GENE INTERACTIONS; COMMON HUMAN-DISEASES; RHEUMATOID-ARTHRITIS; MISSING HERITABILITY; NEURAL-NETWORKS; CROHNS-DISEASE; RISK LOCUS; SUSCEPTIBILITY; POPULATION	Complex disorders are a class of diseases whose phenotypic variance is caused by the interplay of multiple genetic and environmental factors. Analyzing the complexity underlying the genetic architecture of such traits may help develop more efficient diagnostic tests and therapeutic protocols. Despite the continuous advances in revealing the genetic basis of many of complex diseases using genome-wide association studies (GWAS), a major proportion of their genetic variance has remained unexplained, in part because GWAS are unable to reliably detect small individual risk contributions and to capture the underlying genetic heterogeneity. In this paper we describe a hypothesis-based method to analyze the association between multiple genetic factors and a complex phenotype. Starting from sets of markers selected based on preexisting biomedical knowledge, our method generates multi-marker models relevant to the biological process underlying a complex trait for which genotype data is available. We tested the applicability of our method using the WTCCC case-control dataset. Analyzing a number of biological pathways, the method was able to identify several immune system related multi-SNP models significantly associated with Rheumatoid Arthritis (RA) and Crohn's disease (CD). RA-associated multi-SNP models were also replicated in an independent case-control dataset. The method we present provides a framework for capturing joint contributions of genetic factors to complex traits. In contrast to hypothesis-free approaches, its results can be given a direct biological interpretation. The replicated multi-SNP models generated by our analysis may serve as a predictor to estimate the risk of RA development in individuals of Caucasian ancestry.	[Nazarian, Alireza] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Florida, UF Genet Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Nazarian, A (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	ariva@ufl.edu		Riva, Alberto/0000-0001-9150-8333	National Institutes of Health (NIH) [R01 HL87681-01]; Genome-Wide Association Studies in Sickle Cell Anemia and in Centenarians; University of Florida Genetics Institute; University of Florida; Wellcome Trust [076113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome-Wide Association Studies in Sickle Cell Anemia and in Centenarians; University of Florida Genetics Institute(University of Florida); University of Florida(University of Florida); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01 HL87681-01, "Genome-Wide Association Studies in Sickle Cell Anemia and in Centenarians", and by funds from the University of Florida Genetics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the University of Florida Open-Access Publishing fund.; The authors would like to thank Dr. Paola Sebastiani for useful discussions, and Dr. Peter Gregersen for providing us with the NARAC dataset. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113.	Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bolstad WM., 2007, INTRO BAYESIAN STAT; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Cooles FAH, 2011, CURR OPIN RHEUMATOL, V23, P233, DOI 10.1097/BOR.0b013e32834518a3; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; de Vries R, 2011, CURR OPIN RHEUMATOL, V23, P227, DOI 10.1097/BOR.0b013e3283457524; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Eshelman L., 1991, FDN GENETIC ALGORITH, P265, DOI DOI 10.1016/B978-0-08-050684-5.50020-3; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Friedman S, 2011, HARRISONS PRINCIPLES, V1; Friedman S, 2011, HARRISONS PRINCIPLES, V2; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; HAAS JP, 1995, TISSUE ANTIGENS, V45, P317, DOI 10.1111/j.1399-0039.1995.tb02460.x; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; Martienssen R, 1999, TRENDS GENET, V15, P435, DOI 10.1016/S0168-9525(99)01833-8; Mitchell KJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-237; Moore Jason H, 2002, Pac Symp Biocomput, P53; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Motsinger AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-39; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Nuzzo A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-278; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Ritchie MD, 2007, APPL SOFT COMPUT, V7, P471, DOI 10.1016/j.asoc.2006.01.013; Riva A, 2010, J BIOMED INFORM, V43, P419, DOI 10.1016/j.jbi.2009.11.005; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sherriff A, 2001, ADV GENET, V42, P287, DOI 10.1016/S0065-2660(01)42029-3; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Van Belle G., 2004, BIOSTATISTICS METHOD; Wang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011384; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Ziegler A, 2008, BIOMETRICAL J, V50, P8, DOI 10.1002/bimj.200710398; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	51	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44162	10.1371/journal.pone.0044162	http://dx.doi.org/10.1371/journal.pone.0044162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970175	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400042
J	Castillo, P; Ibanez, F; Guajardo, A; Llanos, MN; Ronco, AM				Castillo, Paula; Ibanez, Freddy; Guajardo, Angelica; Llanos, Miguel N.; Ronco, Ana M.			Impact of Cadmium Exposure during Pregnancy on Hepatic Glucocorticoid Receptor Methylation and Expression in Rat Fetus	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; DNA METHYLATION; EPIGENETIC MECHANISMS; DEVELOPMENTAL PLASTICITY; PLACENTAL CADMIUM; GENE-EXPRESSION; BIRTH-WEIGHT; FETAL-GROWTH; RESTRICTION; DISRUPTION	Adverse fetal environment due to maternal undernutrition or exposure to environmental chemicals alters glucocorticoid (GC) metabolism increasing the risk of metabolic disorders in adulthood. In this study, we investigated the effects of maternal exposure to cadmium (Cd, 50 ppm) during pregnancy in the methylation of fetal hepatic glucocorticoid receptor promoter (GR) and the correlation with its expression and that of the DNA methyltransferases (DNMT1a and 3a). We also studied the expression of liver phosphoenolpyruvate carboxykinase (PEPCK) and acyl-CoA oxidase (AOX), two enzymes involved in the metabolism of carbohydrates and lipids respectively. The methylation of the rat GR gene exon 1(10) (GR1(10)) in nucleotides -2536 to -2361 was analyzed by pyrosequencing. Quantitative real time PCR was used to assess hepatic GR, PEPCK and AOX mRNA, and their protein levels using Western blotting analysis. Differential methylation was noted across groups at all CpG sites in the GR exon 110 in a sex-dependent manner. In males, CpG were more methylated than the controls (185 +/- 21%, p<0.001) but only CpG sites 1,6,7 and 9 showed a significantly different extent of methylation. In addition, a lower expression of GR (mRNA and protein) was found. On the contrary, in females, CpG were less methylated than the controls (62 +/- 11%, p<0.05) and overexpressed, affecting PEPCK and AOX expression, which did not change in males. The GR methylation profile correlates with DNMT3a expression which may explain epigenetic sex-dependent changes on GR1(10) promoter induced by Cd treatment. In conclusion, Cd exposure during pregnancy affects fetal liver DNMT3a resulting in sex-dependent changes in methylation and expression of GR1(10). Although these effects do not seem to be directly involved in the low birth weight and height, they may have relevant implications for long-term health.	[Castillo, Paula; Ibanez, Freddy; Guajardo, Angelica; Llanos, Miguel N.; Ronco, Ana M.] Univ Chile, Inst Nutr & Food Technol INTA, Lab Nutr & Metab Regulat, Santiago, Chile	Universidad de Chile	Castillo, P (corresponding author), Univ Chile, Inst Nutr & Food Technol INTA, Lab Nutr & Metab Regulat, Santiago, Chile.	amronco@inta.uchile.cl	Ronco, Ana M/F-9393-2015; Llanos, Miguel/M-9595-2017		Fondo Nacional de Ciencia y Tecnologia de Chile (Fondecyt) [1100168]	Fondo Nacional de Ciencia y Tecnologia de Chile (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Ciencia y Tecnologia de Chile (Fondecyt) grant #1100168 to AMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; ALLIS C.D., 2007, EPIGENETICS; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Baserga M, 2010, AM J PHYSIOL-REG I, V299, pR334, DOI 10.1152/ajpregu.00122.2010; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Berglund M, 2011, ENVIRON RES, V111, P1271, DOI 10.1016/j.envres.2011.09.002; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Clifton VL, 2004, PLACENTA, V25, pS45, DOI 10.1016/j.placenta.2004.01.004; Doi T, 2011, TOXICOL SCI, V120, P475, DOI 10.1093/toxsci/kfr022; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Feil R, 2006, MUTAT RES-FUND MOL M, V600, P46, DOI 10.1016/j.mrfmmm.2006.05.029; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Henson MC, 2004, EXP BIOL MED, V229, P383, DOI 10.1177/153537020422900506; HIDALGO J, 1987, TOXICOLOGY, V45, P113, DOI 10.1016/0300-483X(87)90119-3; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Jiang X, 2012, FASEB J, V26; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kasten-Jolly J, 2010, TOXICOL APPL PHARM, V247, P105, DOI 10.1016/j.taap.2010.06.003; Kippler M, 2012, ENVIRON HEALTH PERSP, V120, P284, DOI 10.1289/ehp.1103711; KUHNERT BR, 1988, OBSTET GYNECOL, V71, P67; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lathers CM, 2002, J CLIN PHARMACOL, V42, P7, DOI 10.1177/0091270002042001001; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Odermatt A, 2006, J STEROID BIOCHEM, V102, P222, DOI 10.1016/j.jsbmb.2006.09.010; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Piasek M, 2001, REPROD TOXICOL, V15, P673, DOI 10.1016/S0890-6238(01)00174-5; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Ronco AM, 2009, TOXICOL LETT, V188, P186, DOI 10.1016/j.toxlet.2009.04.008; Ronco AM, 2005, BIOMETALS, V18, P233, DOI 10.1007/s10534-005-0583-2; Ronco AM, 2010, TOXICOL IN VITRO, V24, P1532, DOI 10.1016/j.tiv.2010.07.003; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Seckl JR, 2000, KIDNEY INT, V57, P1412, DOI 10.1046/j.1523-1755.2000.00984.x; SHE QB, 1994, BIOCHEM BIOPH RES CO, V205, P1748, DOI 10.1006/bbrc.1994.2871; Sibley CP, 2010, PLACENTA, V31, pS70, DOI 10.1016/j.placenta.2009.12.020; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Whorwood CB, 2001, ENDOCRINOLOGY, V142, P2854, DOI 10.1210/en.142.7.2854; Yang KP, 2006, AM J PHYSIOL-ENDOC M, V290, pE135, DOI 10.1152/ajpendo.00356.2005; Zepeda R, 2011, TOXICOL APPL PHARM, V251, P137; Zepeda R, 2012, CARDIOVASC TOXICOL, V12, P64, DOI 10.1007/s12012-011-9139-6	63	33	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44139	10.1371/journal.pone.0044139	http://dx.doi.org/10.1371/journal.pone.0044139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957049	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800041
J	de Giuseppe, PO; Martins, NH; Meza, AN; dos Santos, CR; Pereira, HD; Murakami, MT				de Giuseppe, Priscila O.; Martins, Nadia H.; Meza, Andreia N.; dos Santos, Camila R.; Pereira, Humberto D'Muniz; Murakami, Mario T.			Insights into Phosphate Cooperativity and Influence of Substrate Modifications on Binding and Catalysis of Hexameric Purine Nucleoside Phosphorylases	PLOS ONE			English	Article							TRANSITION-STATE ANALOGS; RAY-DIFFRACTION DATA; ESCHERICHIA-COLI; TRICHOMONAS-VAGINALIS; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; STRUCTURAL BASIS; GENE-THERAPY; IN-VITRO	The hexameric purine nucleoside phosphorylase from Bacillus subtilis (BsPNP233) displays great potential to produce nucleoside analogues in industry and can be exploited in the development of new anti-tumor gene therapies. In order to provide structural basis for enzyme and substrates rational optimization, aiming at those applications, the present work shows a thorough and detailed structural description of the binding mode of substrates and nucleoside analogues to the active site of the hexameric BsPNP233. Here we report the crystal structure of BsPNP233 in the apo form and in complex with 11 ligands, including clinically relevant compounds. The crystal structure of six ligands (adenine, 2'deoxyguanosine, aciclovir, ganciclovir, 8-bromoguanosine, 6-chloroguanosine) in complex with a hexameric PNP are presented for the first time. Our data showed that free bases adopt alternative conformations in the BsPNP233 active site and indicated that binding of the co-substrate (2'deoxy) ribose 1-phosphate might contribute for stabilizing the bases in a favorable orientation for catalysis. The BsPNP233-adenosine complex revealed that a hydrogen bond between the 5' hydroxyl group of adenosine and Arg(43*) side chain contributes for the ribosyl radical to adopt an unusual C3'-endo conformation. The structures with 6-chloroguanosine and 8-bromoguanosine pointed out that the Cl-6 and Br-8 substrate modifications seem to be detrimental for catalysis and can be explored in the design of inhibitors for hexameric PNPs from pathogens. Our data also corroborated the competitive inhibition mechanism of hexameric PNPs by tubercidin and suggested that the acyclic nucleoside ganciclovir is a better inhibitor for hexameric PNPs than aciclovir. Furthermore, comparative structural analyses indicated that the replacement of Ser(90) by a threonine in the B. cereus hexameric adenosine phosphorylase (Thr(91)) is responsible for the lack of negative cooperativity of phosphate binding in this enzyme.	[de Giuseppe, Priscila O.; Martins, Nadia H.; Meza, Andreia N.; dos Santos, Camila R.; Murakami, Mario T.] Ctr Nacl Pesquisa Energia & Mat, LNBio, Sao Paulo, Brazil; [Pereira, Humberto D'Muniz] Univ Sao Paulo, Inst Fis Sao Carlos, Grp Cristalog, Sao Paulo, Brazil	Universidade de Sao Paulo	de Giuseppe, PO (corresponding author), Ctr Nacl Pesquisa Energia & Mat, LNBio, Sao Paulo, Brazil.	mario.murakami@lnbio.org.br	Oliveira de Giuseppe, Priscila/GLR-1319-2022; Pereira, Humberto M/J-7824-2016; Murakami, Mario T/F-5640-2016; Santos, Camila/F-7095-2013; Murakami, Mario T/C-2087-2012	Oliveira de Giuseppe, Priscila/0000-0003-2094-7325; Pereira, Humberto M/0000-0002-8652-6729; Murakami, Mario T/0000-0002-0405-8010; Santos, Camila/0000-0003-0652-4211; 	FAPESP [2007/00194-9, 2010/51890-8]; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the following research funding agencies: FAPESP [www.fapesp.br/] (grants numbers 2007/00194-9, 2010/51890-8) and CNPq [www.cnpq.br/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS G, 1964, P NATL ACAD SCI USA, V52, P493, DOI 10.1073/pnas.52.2.493; Afshar S, 2009, PROTEIN SCI, V18, P1107, DOI 10.1002/pro.91; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basso LA, 2001, BIOCHEMISTRY-US, V40, P8196, DOI 10.1021/bi010584x; Bennett EM, 2003, CHEM BIOL, V10, P1173, DOI 10.1016/j.chembiol.2003.11.008; Bennett EM, 2003, J BIOL CHEM, V278, P47110, DOI 10.1074/jbc.M304622200; Bzowska A, 1998, ACTA BIOCHIM POL, V45, P755, DOI 10.18388/abp.1998_4269; BZOWSKA A, 1988, J BIOL CHEM, V263, P9212; Caceres RA, 2012, BIOCHIMIE, V94, P155, DOI 10.1016/j.biochi.2011.10.003; Canduri F, 2005, ACTA CRYSTALLOGR D, V61, P856, DOI 10.1107/S0907444905005421; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Castilho MS, 2010, BIOORGAN MED CHEM, V18, P1421, DOI 10.1016/j.bmc.2010.01.022; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Clercq E, 2007, BIOCHEM PHARMACOL, V73, P911, DOI 10.1016/j.bcp.2006.09.014; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dessanti P, 2012, ACTA CRYSTALLOGR D, V68, P239, DOI 10.1107/S090744491200073X; dos Santos DM, 2003, BIOCHEM BIOPH RES CO, V308, P553, DOI 10.1016/S0006-291X(03)01433-5; ELKOUNI MH, 1987, BIOCHEM PHARMACOL, V36, P3815, DOI 10.1016/0006-2952(87)90443-6; ELKOUNI MH, 1983, P NATL ACAD SCI-BIOL, V80, P6667; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erion MD, 1997, BIOCHEMISTRY-US, V36, P11725, DOI 10.1021/bi961969w; Evans Gary B, 2007, Nucleic Acids Symp Ser (Oxf), P63; FAULDS D, 1990, DRUGS, V39, P597, DOI 10.2165/00003495-199039040-00008; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grenha R, 2005, ACTA CRYSTALLOGR F, V61, P459, DOI 10.1107/S174430910501095X; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Ho MC, 2010, P NATL ACAD SCI USA, V107, P4805, DOI 10.1073/pnas.0913439107; HWANG BK, 1994, CAN J BOT, V72, P480, DOI 10.1139/b94-064; JENSEN KF, 1978, BIOCHIM BIOPHYS ACTA, V525, P346, DOI 10.1016/0005-2744(78)90229-2; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Koellner G, 2002, J MOL BIOL, V315, P351, DOI 10.1006/jmbi.2001.5211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krohne TU, 2001, HEPATOLOGY, V34, P511, DOI 10.1053/jhep.2001.26749; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Long MC, 2007, J ANTIMICROB CHEMOTH, V59, P118, DOI 10.1093/jac/dkl448; Madrid DC, 2008, J BIOL CHEM, V283, P35899, DOI 10.1074/jbc.M807218200; Mao C, 1997, STRUCTURE, V5, P1373, DOI 10.1016/S0969-2126(97)00287-6; Martiniello-Wilks R, 2004, J GENE MED, V6, P43, DOI 10.1002/jgm.474; Martins NH, 2011, ACTA CRYSTALLOGR F, V67, P618, DOI 10.1107/S1744309111010414; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikleusevic G, 2011, BIOCHIMIE, V93, P1610, DOI 10.1016/j.biochi.2011.05.030; Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9; Munagala N, 2002, BIOCHEMISTRY-US, V41, P10382, DOI 10.1021/bi026025n; Munagala NR, 2003, MOL BIOCHEM PARASIT, V127, P143, DOI 10.1016/S0166-6851(02)00330-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OWEN SP, 1964, CANCER CHEMOTH REP, P19; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Parker WB, 2005, NUCLEOS NUCLEOT NUCL, V24, P387, DOI 10.1081/NCN-200059807; Parker WB, 2003, CANCER GENE THER, V10, P23, DOI 10.1038/sj.cgt.7700520; Patel RN., 2006, BIOCATALYSIS PHARM B; Pereira HD, 2005, J MOL BIOL, V353, P584, DOI 10.1016/j.jmb.2005.08.045; PERLMAN ME, 1994, BIOCHEMISTRY-US, V33, P7547, DOI 10.1021/bi00190a007; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; Postigo MP, 2010, J CHEM INF MODEL, V50, P1693, DOI 10.1021/ci100128k; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Ray AS, 2004, ANTIMICROB AGENTS CH, V48, P1089, DOI 10.1128/AAC.48.4.1089-1095.2004; Rinaldo-Matthis A, 2007, BIOCHEMISTRY-US, V46, P659, DOI 10.1021/bi061515r; Rocchietti S, 2004, BIOMACROMOLECULES, V5, P2195, DOI 10.1021/bm049765f; Sgarrella F, 2007, BBA-GEN SUBJECTS, V1770, P1498, DOI 10.1016/j.bbagen.2007.07.004; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; SORSCHER EJ, 1994, GENE THER, V1, P233; Tahirov TH, 2004, J MOL BIOL, V337, P1149, DOI 10.1016/j.jmb.2004.02.016; Tai CK, 2010, CANCER GENE THER, V17, P614, DOI 10.1038/cgt.2010.17; THIERS BH, 1990, DERMATOL CLIN, V8, P583, DOI 10.1016/S0733-8635(18)30490-X; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Torii T, 2006, NUCLEOS NUCLEOT NUCL, V25, P655, DOI 10.1080/15257770600686394; Ubiali D, 2004, ADV SYNTH CATAL, V346, P1361, DOI 10.1002/adsc.200404019; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Calenbergh S, 2012, CURR TOP MED CHEM, V12, P694, DOI 10.2174/156802612799984580; Wright JM, 2010, PARASITOL RES, V107, P847, DOI 10.1007/s00436-010-1938-3; Xie XX, 2011, BIOTECHNOL LETT, V33, P1107, DOI 10.1007/s10529-011-0535-6; Zang Y, 2005, J BIOL CHEM, V280, P22318, DOI 10.1074/jbc.M501843200; Zhang Y, 2005, CURR TOP MED CHEM, V5, P1259, DOI 10.2174/156802605774463105	79	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44282	10.1371/journal.pone.0044282	http://dx.doi.org/10.1371/journal.pone.0044282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957058	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800051
J	Fuchs, M; Scholz, M; Sendelbeck, A; Atorf, J; Schlegel, C; Enz, R; Brandstatter, JH				Fuchs, Michaela; Scholz, Michael; Sendelbeck, Anna; Atorf, Jenny; Schlegel, Christine; Enz, Ralf; Brandstaetter, Johann Helmut			Rod Photoreceptor Ribbon Synapses in DBA/2J Mice Show Progressive Age-Related Structural Changes	PLOS ONE			English	Article							RETINAL GENE-EXPRESSION; IRIS ATROPHY; OPTIC-NERVE; GLAUCOMA; COMPLEMENT; MODEL; COMPONENT; BASSOON; RIBEYE; C1Q	The DBA/2J mouse is a commonly used animal model in glaucoma research. The eyes of DBA/2J mice show severe age-related changes that finally lead to the degeneration of retinal ganglion cells and the optic nerve. Recent electroretinogram studies identified functional deficits, which suggest that also photoreceptor cells are involved in the pathological processes occurring in the DBA/2J mouse retina. In a comparative study, we examined anatomical and molecular changes in the retinae of DBA/2J and C57BL/6 control mice with light and electron microscopy and with PCR analyses. In the retina of the DBA/2J mouse, we found a thinning of the outer plexiform layer, the first synaptic layer in the transfer of visual signals, and age-dependent and progressive degenerative structural changes at rod photoreceptor ribbon synapses. The structural ribbon changes represent a photoreceptor synaptic phenotype that has not yet been described in this animal model of secondary angle-closure glaucoma. Furthermore, genes of the classical complement cascade were upregulated in the photoreceptor cells of aging DBA/2J mice, suggesting a putative link between ribbon synapse degradation and the innate immune system.	[Fuchs, Michaela; Sendelbeck, Anna; Schlegel, Christine; Brandstaetter, Johann Helmut] FAU Erlangen Nuremberg, Dept Biol, Erlangen, Germany; [Scholz, Michael] FAU Erlangen Nuremberg, Inst Anat Lehrstuhl 2, Erlangen, Germany; [Atorf, Jenny] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Enz, Ralf] Univ Hosp Erlangen, Inst Biochem, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Fuchs, M (corresponding author), FAU Erlangen Nuremberg, Dept Biol, Erlangen, Germany.	Ralf.Enz@biochem.uni-erlangen.de; jbrandst@biologie.uni-erlangen.de		Scholz, Michael/0000-0001-8440-6785; Fuchs, Michaela/0000-0001-7778-6708; Atorf, Jenny/0000-0003-0935-1897	Deutsche Forschungsgemeinschaft [SFB 539]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (SFB 539, A7) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birke MT, 2010, INVEST OPHTH VIS SCI, V51, P5759, DOI 10.1167/iovs.10-5558; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Dyka FM, 2005, J NEUROCHEM, V94, P120, DOI 10.1111/j.1471-4159.2005.03177.x; Dyka FM, 2004, J NEUROCHEM, V90, P190, DOI 10.1111/j.1471-4159.2004.02474.x; Frishman L. J., 2006, PRINCIPLES PRACTICE, P139; Grossman GH, 2009, INVEST OPHTH VIS SCI, V50, P3074; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heiduschka P, 2010, EXP EYE RES, V91, P779, DOI 10.1016/j.exer.2010.09.001; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang W, 2011, EXP EYE RES, V93, P700, DOI 10.1016/j.exer.2011.09.001; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; John Simon W M, 2005, Invest Ophthalmol Vis Sci, V46, P2649; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Moon JI, 2005, CELL TISSUE RES, V320, P51, DOI 10.1007/s00441-004-1062-8; Panagis L, 2011, INVEST OPHTH VIS SCI, V52, P7807, DOI 10.1167/iovs.10-7063; Perry VH, 2008, NAT REV NEUROSCI, V9, P807, DOI 10.1038/nrn2394; Regus-Leidig H, 2010, MOL VIS, V16, P2690; Regus-Leidig H, 2009, J COMP NEUROL, V512, P814, DOI 10.1002/cne.21915; Reim K, 2009, J CELL SCI, V122, P1352, DOI 10.1242/jcs.045401; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Scholz M, 2008, INVEST OPHTH VIS SCI, V49, P613, DOI 10.1167/iovs.07-0745; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036	36	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44645	10.1371/journal.pone.0044645	http://dx.doi.org/10.1371/journal.pone.0044645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957094	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800087
J	Dehbi, M; Uzzaman, T; Baturcam, E; Eldali, A; Ventura, W; Bouchama, A				Dehbi, Mohammed; Uzzaman, Taher; Baturcam, Engin; Eldali, Abdelmoneim; Ventura, Wilhelmina; Bouchama, Abderrezak			Toll-Like Receptor 4 and High-Mobility Group Box 1 Are Critical Mediators of Tissue Injury and Survival in a Mouse Model for Heatstroke	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; ISCHEMIA-REPERFUSION INJURY; LUNG INJURY; LIVER ISCHEMIA; HEAT-STROKE; PROTEIN; MICE; RELEASE; BABOON; DAMAGE	The molecular mechanisms that initiate the inflammatory response in heatstroke and their relation with tissue injury and lethality are not fully elucidated. We examined whether endogenous ligands released by damaged/stressed cells such as high-mobility group box 1 (HMGB1) signaling through Toll-like receptor 4 (TLR4) may play a pathogenic role in heatstroke. Mutant TLR4-defective (C3H/HeJ) and wild type (C3H/HeOuJ) mice were subjected to heat stress in an environmental chamber pre-warmed at 43.5 degrees C until their core temperature reached 42.7 degrees C, which was taken as the onset of heatstroke. The animals were then allowed to recover passively at ambient temperature. A sham-heated group served as a control. Mutant mice displayed more histological liver damage and higher mortality compared with wild type mice (73% vs. 27%, respectively, P < 0.001). Compared to wild type mice, mutant mice exhibited earlier plasma release of markers of systemic inflammation such as HMGB1 (206 +/- 105 vs. 63 +/- 21 ng/ml; P = 0.0018 and 209 +/- 100 vs. 46 +/- 32 ng/ml; P < 0.0001), IL-6 (144 +/- 40 vs. 46 +/- 20 pg/ml; P<0.001 and 184 +/- 21 vs. 84 +/- 54 pg/ml; P = 0.04), and IL-1 beta (27 +/- 4 vs. 1.7 +/- 2.3 pg/ml; P < 0.0001 at 1 hour). Both strains of mice displayed early release of HMGB1 into the circulation upstream of IL-1 beta and IL-6 responses which remained elevated up to 24 h. Specific inhibition of HMGB1 activity with DNA-binding A Box (600 mu g/mouse) protected the mutant mice against the lethal effect of heat stress (60% A Box vs. 18% GST protein, P = 0.04). These findings suggest a protective role for the TLR4 in the host response to severe heat stress. They also suggest that HMGB1 is an early mediator of inflammation, tissue injury and lethality in heatstroke in the presence of defective TLR4 signaling.	[Bouchama, Abderrezak] King Abdullah Int Med Res Ctr, Dept Expt Med, Riyadh, Saudi Arabia; [Dehbi, Mohammed; Uzzaman, Taher; Baturcam, Engin] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Faisal Specialist Hospital & Research Center	Dehbi, M (corresponding author), Dasman Diabet Inst, Dept Biomed Res, Biochem & Mol Biol Unit, Dasman, Kuwait.	mohammed.dehbi@dasmaninstitute.org		BOUCHAMA, abderrezak/0000-0003-3089-5936	King Faisal Specialist Hospital & Research Centre (KFSHRC) [RAC 2060 013]	King Faisal Specialist Hospital & Research Centre (KFSHRC)	This study was supported by a research grant (RAC 2060 013) from King Faisal Specialist Hospital & Research Centre (KFSHRC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Andersson U, 2010, ANN REV IMMUNOL; BIANCHI L, 1972, HUM PATHOL, V3, P237, DOI 10.1016/S0046-8177(72)80077-7; BOUCHAMA A, 1991, J APPL PHYSIOL, V70, P2640, DOI 10.1152/jappl.1991.70.6.2640; Bouchama A, 2005, SHOCK, V24, P332, DOI 10.1097/01.shk.0000180620.44435.9c; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bouchama A, 2008, ARTERIOSCL THROM VAS, V28, P1318, DOI 10.1161/ATVBAHA.107.161737; Bouchama A, 2007, SHOCK, V27, P578, DOI 10.1097/01.shk.0000246903.40142.aa; Chen CM, 2006, CRIT CARE MED, V34, P1960, DOI 10.1097/01.CCM.0000224231.01533.B1; Hagiwara S, 2010, SHOCK, V34, P402, DOI 10.1097/SHK.0b013e3181d492e4; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Leon LR, 2010, AM J PHYSIOL-REG I, V299, pR241, DOI 10.1152/ajpregu.00309.2009; Leon Lisa R, 2010, Front Biosci (Schol Ed), V2, P916; Leon LR, 2005, AM J PHYSIOL-REG I, V288, pR197, DOI 10.1152/ajpregu.00046.2004; Levy RM, 2006, AM J PHYSIOL-REG I, V291, pR970, DOI 10.1152/ajpregu.00793.2005; Lin MT, 1997, AM J PHYSIOL-HEART C, V273, pH2072, DOI 10.1152/ajpheart.1997.273.4.H2072; Liu CC, 2000, J PHYSIOL-LONDON, V527, P333, DOI 10.1111/j.1469-7793.2000.t01-1-00333.x; Makranz C, 2011, EUR J APPL PHYSIOL, V111, P2359, DOI 10.1007/s00421-011-1863-x; MALAMUD N, 1946, Mil Surg, V99, P397; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Roberts GT, 2008, ARTERIOSCL THROM VAS, V28, P1130, DOI 10.1161/ATVBAHA.107.158709; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zanotti G, 2009, AM J PHYSIOL-LUNG C, V297, pL52, DOI 10.1152/ajplung.90406.2008; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834	37	23	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44100	10.1371/journal.pone.0044100	http://dx.doi.org/10.1371/journal.pone.0044100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962600	Green Submitted, Green Published, gold			2022-12-25	WOS:000308577600028
J	Gianesin, K; Freguja, R; Carmona, F; Zanchetta, M; Del Bianco, P; Malacrida, S; Montagna, M; Rampon, O; Giaquinto, C; De Rossi, A				Gianesin, Ketty; Freguja, Riccardo; Carmona, Francesco; Zanchetta, Marisa; Del Bianco, Paola; Malacrida, Sandro; Montagna, Marco; Rampon, Osvalda; Giaquinto, Carlo; De Rossi, Anita			The Role of Genetic Variants of stromal Cell-Derived Factor 1 in Pediatric HIV-1 Infection and Disease Progression	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE-DEFICIENCY; CORECEPTOR USAGE; CCR5; CHILDREN; RECEPTOR; POLYMORPHISM; RESISTANCE; GENOTYPE; ENTRY	Stromal cell-Derived Factor 1 (SDF1) is the natural ligand of CXCR4, the coreceptor of HIV-1 X4 viruses. This study investigated the role of the single nucleotide polymorphism (SNP) rs1801157 (NM_000609.5:c.*519G>A) of the SDF1 gene in the natural history of mother-to-child transmission of HIV-1 and disease progression of HIV-1-infected children. The study was conducted in 428 children born to HIV-1-seropositive mothers, who had not undergone antiretroviral therapy (ART) during pregnancy, and in 120 HIV-1-infected children for whom the end-point was the onset of AIDS or the initiation of ART; 16 children developed early AIDS (<24 months of life), 13 from 24 to 84 months of age, and 14 had late AIDS (>84 months). The rs1801157 SNP was not associated with risk of perinatal infection in any genetic models tested. By contrast, this SNP influenced disease progression in a time-dependent manner. rs1801157 GA heterozygous children had a higher risk of late AIDS (HR = 6.3, 95% CI 1.9-20.7, p = 0.002) than children with the rs1801157 GG genotype. Children were studied for viral coreceptor usage at birth, after 84 months of age and/or at AIDS onset. While R5 viruses using CCR5 coreceptor were predominant at birth (94%) and at early AIDS (85%), viruses using CXCR4 coreceptor emerged during the course of infection and were detected in 49% of children older than 84 months and in 62% of late AIDS. The rs1801157 SNP did not influence the emergence of R5X4 viruses, but children with the rs1801157 GA genotype and R5XA viruses were at significantly higher risk of late AIDS than children with rs1801157 GG genotype (OR = 8.0, 95% CI 1.2-52.2, p=0.029). Our results indicate that the rs1801157 SNP does not influence perinatal infection, but impacts disease progression. This effect is time-dependent and linked to the coreceptor-usage of viral variants that undergo evolution during the course of HIV-1 infection.	[Gianesin, Ketty; Freguja, Riccardo; De Rossi, Anita] Univ Padua, Sect Oncol & Immunol, AIDS Reference Ctr, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Carmona, Francesco; Zanchetta, Marisa; Del Bianco, Paola; Montagna, Marco; De Rossi, Anita] IRCCS, Ist Oncol Veneto, Padua, Italy; [Malacrida, Sandro] Univ Padua, Dept Neurosci, Padua, Italy; [Rampon, Osvalda; Giaquinto, Carlo] Univ Padua, Dept Pediat, Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua	Gianesin, K (corresponding author), Univ Padua, Sect Oncol & Immunol, AIDS Reference Ctr, Dept Surg Oncol & Gastroenterol, Padua, Italy.	anita.derossi@unipd.it	De Rossi, A./L-3128-2015; De Rossi, Anita/Q-4845-2019; Giaquinto, Carlo/AAB-5016-2020; montagna, marco/E-2225-2012; Del Bianco, Paola/F-4655-2014	De Rossi, A./0000-0001-6435-7509; De Rossi, Anita/0000-0001-6435-7509; montagna, marco/0000-0002-4929-2150; Del Bianco, Paola/0000-0002-6597-0265; Malacrida, Sandro/0000-0002-4775-3857; GIAQUINTO, CARLO/0000-0001-9365-0413	PENTA Foundation	PENTA Foundation	The financial support for this research was received from the PENTA foundation. RF was supported by the PENTA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; Cavarelli M, 2010, AIDS, V24, P2521, DOI 10.1097/QAD.0b013e32833d7d8c; Cavarelli M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003292; Clevestig P, 2005, AIDS RES HUM RETROV, V21, P371, DOI 10.1089/aid.2005.21.371; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2005, J INFECT DIS, V192, P1597, DOI 10.1086/496893; De Rossi A, 2007, CURR OPIN HIV AIDS, V2, P399, DOI 10.1097/COH.0b013e3282ced163; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DEMARTINO M, 1994, LANCET, V343, P191; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; DEROSSI A, 1991, AIDS, V5, P15, DOI 10.1097/00002030-199101000-00002; DeRossi A, 1996, J CLIN INVEST, V97, P323, DOI 10.1172/JCI118419; DEROSSI A, 1992, AIDS, V6, P1117, DOI 10.1097/00002030-199210000-00008; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Garcia-Moruja C, 2009, CURR HIV RES, V7, P384, DOI 10.2174/157016209788680543; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; John GC, 2000, J VIROL, V74, P5736, DOI 10.1128/JVI.74.12.5736-5739.2000; Katz DA, 2010, INT J IMMUNOGENET, V37, P301, DOI 10.1111/j.1744-313X.2010.00924.x; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Koning FA, 2005, ANTIVIR THER, V10, P231; LIDINJANSSON G, 1994, PEDIATRICS, V94, P815; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu SJ, 2011, CURR HIV RES, V9, P112, DOI 10.2174/157016211795569113; Low AJ, 2007, AIDS, V21, pF19, DOI 10.1097/QAD.0b013e3282ef81ea; Mahajan SD, 2010, BIOCHEM BIOPH RES CO, V396, P348, DOI 10.1016/j.bbrc.2010.04.095; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; NEWELL ML, 1994, J GERONTOL B-PSYCHOL, V343, P1464; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ometto L, 2001, J INFECT DIS, V183, P814, DOI 10.1086/318828; Ometto L, 1999, AIDS RES HUM RETROV, V15, P1441, DOI 10.1089/088922299309955; Ometto L, 2000, AIDS, V14, P1721, DOI 10.1097/00002030-200008180-00006; Petersen DC, 2005, JAIDS-J ACQ IMM DEF, V40, P521, DOI 10.1097/01.qai.0000186360.42834.28; PIZZO PA, 1995, J ACQ IMMUN DEF SYND, V8, P30; Poveda E, 2010, HIV AIDS-RES PALLIAT, V2, P51; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Repits J, 2005, J GEN VIROL, V86, P2859, DOI 10.1099/vir.0.81111-0; Ricci E, 2009, JAIDS-J ACQ IMM DEF, V51, P13, DOI 10.1097/QAI.0b013e31819df249; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; Ruiz-Mateos E, 2011, ANTIMICROB AGENTS CH, V55, P4664, DOI 10.1128/AAC.00753-11; Salvatori F, 2001, AIDS RES HUM RETROV, V17, P925, DOI 10.1089/088922201750290041; Salvatori F, 1997, J VIROL, V71, P4694, DOI 10.1128/JVI.71.6.4694-4706.1997; Sei S, 2001, AIDS, V15, P1343, DOI 10.1097/00002030-200107270-00003; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Singh KK, 2003, J INFECT DIS, V188, P1461, DOI 10.1086/379038; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Tiensiwakul P, 2004, INTERVIROLOGY, V47, P87, DOI 10.1159/000077831; Tresoldi E, 2002, J INFECT DIS, V185, P696, DOI 10.1086/339004; van Rij RP, 1998, AIDS, V12, pF85, DOI 10.1097/00002030-199809000-00001; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681	65	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44460	10.1371/journal.pone.0044460	http://dx.doi.org/10.1371/journal.pone.0044460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962615	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600058
J	Veresoglou, SD; Thornton, B; Menexes, G; Mamolos, AP; Veresoglou, DS				Veresoglou, Stavros D.; Thornton, Barry; Menexes, George; Mamolos, Andreas P.; Veresoglou, Demetrios S.			Soil Fertilization Leads to a Decline in Between-Samples Variability of Microbial Community delta C-13 Profiles in a Grassland Fertilization Experiment	PLOS ONE			English	Article							ORGANIC-MATTER; STABLE-ISOTOPES; CARBON ISOTOPES; C-13 CONTENT; FATTY-ACIDS; NITROGEN; TEMPERATE; BIOMASS; BACTERIAL; MINERALIZATION	Gas chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) was used to measure the C-13/C-12 ratios of PLFAs at natural abundance levels from a temperate grassland nitrogen (N) and phosphorus (P) factorial fertilization experiment in northern Greece. In each plot two rhizosphere samples were derived centred around individual Agrostis capillaris and Prunella vulgaris plants. It was hypothesized that the isotopic signal of microbes that preferentially feed on recalcitrant litter such as fungi would be modified by fertilization more strongly than that of opportunistic microbes using labile C. Microbial community delta C-13 was affected by both P and N fertilization regime and plant species identity. However, we have been unable to detect significant nutrient effects on individual groups of microbes when analyzed separately in contrast to our original hypothesis. Intra-treatment variability, as evaluated from Hartley's F-max tests in the five first PCA components axes as well as the size of the convex hulls in PCA scoreplots and Mahalanobis distances, was considerably higher in the non-fertilized controls. Moreover, a significant relationship was established between the change in PLFA abundances and their respective changes in delta C-13 for the aggregate of samples and those simultaneously fertilized with N and P. We conclude that use of compound specific isotope analysis in the absence of labelling represents a valuable and overlooked tool in obtaining an insight of microbial community functioning.	[Veresoglou, Stavros D.; Mamolos, Andreas P.; Veresoglou, Demetrios S.] Aristotle Univ Thessaloniki, Fac Agr, Lab Ecol & Environm Protect, GR-54006 Thessaloniki, Greece; [Thornton, Barry] James Hutton Inst, Environm & Biochem Sci Grp, Craigiebuckler, Aberdeen, Scotland; [Menexes, George] Aristotle Univ Thessaloniki, Sch Agr, Agron Lab, GR-54006 Thessaloniki, Greece; [Veresoglou, Stavros D.] Free Univ Berlin, Berlin, Germany	Aristotle University of Thessaloniki; James Hutton Institute; Aristotle University of Thessaloniki; Free University of Berlin	Veresoglou, SD (corresponding author), Aristotle Univ Thessaloniki, Fac Agr, Lab Ecol & Environm Protect, GR-54006 Thessaloniki, Greece.	seby31@zeroone.net	Mamolos, Andreas/D-5301-2011; Veresoglou, Stavros D/D-5087-2011; Menexes, George/N-8603-2015	Mamolos, Andreas/0000-0002-1052-337X; Veresoglou, Stavros D/0000-0001-6387-4109; Menexes, George/0000-0002-1034-7345	Chloros Trust	Chloros Trust	The project was partially funded through a PhD studentship to SDV by the Chloros Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Berg B, 2002, PLANT SOIL, V242, P83, DOI 10.1023/A:1019637807021; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1; BLAIR N, 1985, APPL ENVIRON MICROB, V50, P996, DOI 10.1128/AEM.50.4.996-1001.1985; Boschker HTS, 2002, FEMS MICROBIOL ECOL, V40, P85, DOI 10.1111/j.1574-6941.2002.tb00940.x; Bowling DR, 2002, OECOLOGIA, V131, P113, DOI 10.1007/s00442-001-0851-y; Bradley K, 2006, SOIL BIOL BIOCHEM, V38, P1583, DOI 10.1016/j.soilbio.2005.11.011; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Denef K, 2009, SOIL BIOL BIOCHEM, V41, P144, DOI 10.1016/j.soilbio.2008.10.008; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; Emmett BA, 1999, WATER AIR SOIL POLL, V116, P65, DOI 10.1023/A:1005209622313; Entry JA, 2000, BIOL FERT SOILS, V31, P436, DOI 10.1007/s003749900191; EVANS JR, 1986, AUST J PLANT PHYSIOL, V13, P281, DOI 10.1071/PP9860281; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; Garten CT, 2000, ECOLOGY, V81, P1108, DOI 10.1890/0012-9658(2000)081[1108:CCOFSC]2.0.CO;2; GLEIXNER G, 1993, PLANT PHYSIOL, V102, P1287, DOI 10.1104/pp.102.4.1287; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; HARTLEY HO, 1950, BIOMETRIKA, V37, P271, DOI 10.1093/biomet/37.3-4.271; Hobbie EA, 2004, NEW PHYTOL, V164, P515, DOI 10.1111/j.1469-8137.2004.01187.x; Islam K, 2005, GEODERMA, V128, P249, DOI 10.1016/j.geoderma.2005.04.007; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kemmitt SJ, 2008, SOIL BIOL BIOCHEM, V40, P61, DOI 10.1016/j.soilbio.2007.06.021; Kroppenstedt R. M., 1992, PROKARYOTES, V2, P1139; Lajtha K, 1994, STABLE ISOTOPES ECOL, P1; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Lloyd J, 1999, FUNCT ECOL, V13, P439, DOI 10.1046/j.1365-2435.1999.00350.x; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Mamolos AP, 2011, ECOL RES, V26, P583, DOI 10.1007/s11284-011-0817-4; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Ngao J., 2011, BIOGEOSCIENCES DISCU, V8, P51, DOI DOI 10.5194/BGD-8-51-2011; OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; Palojarvi A., 2006, MICROBIOLOGICAL METH, P204; Paterson E, 2008, SOIL BIOL BIOCHEM, V40, P1103, DOI 10.1016/j.soilbio.2007.12.003; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Penny KI, 1996, APPL STAT-J ROY ST C, V45, P73, DOI 10.2307/2986224; R Core Team, 2022, R LANG ENV STAT COMP; Rodwell JS, 2000, BRIT PLANT COMMUNITI; Ruess L, 2005, ECOLOGY, V86, P2075, DOI 10.1890/04-1399; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; SCHNYDER H, 1992, PLANTA, V187, P128, DOI 10.1007/BF00201634; Staddon PL, 2004, TRENDS ECOL EVOL, V19, P148, DOI 10.1016/j.tree.2003.12.003; Tiunov AV, 2007, BIOL BULL+, V34, P395, DOI 10.1134/S1062359007040127; Veresoglou SD, 2011, PLANT SOIL, V344, P187, DOI 10.1007/s11104-011-0739-5; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9; Wallenstein MD, 2006, FOREST ECOL MANAG, V222, P459, DOI 10.1016/j.foreco.2005.11.002; Weast R.C., 1975, HDB CHEM PHYS; WEDIN DA, 1995, ECOLOGY, V76, P1383, DOI 10.2307/1938142; Werth M, 2010, SOIL BIOL BIOCHEM, V42, P1372, DOI 10.1016/j.soilbio.2010.04.009; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Zhang CLL, 2002, CURR OPIN BIOTECH, V13, P25, DOI 10.1016/S0958-1669(02)00280-X	58	5	5	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44203	10.1371/journal.pone.0044203	http://dx.doi.org/10.1371/journal.pone.0044203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962602	Green Submitted, gold, Green Published			2022-12-25	WOS:000308577600030
J	Sangha, JS; Sun, XL; Wally, OSD; Zhang, KB; Ji, XH; Wang, ZM; Wang, YW; Zidichouski, J; Prithiviraj, B; Zhang, JZ				Sangha, Jatinder S.; Sun, Xiaoli; Wally, Owen S. D.; Zhang, Kaibin; Ji, Xiuhong; Wang, Zhimin; Wang, Yanwen; Zidichouski, Jeffrey; Prithiviraj, Balakrishnan; Zhang, Junzeng			Liuwei Dihuang (LWDH), a Traditional Chinese Medicinal Formula, Protects against beta-Amyloid Toxicity in Transgenic Caenorhabditis elegans	PLOS ONE			English	Article							BILOBA EXTRACT EGB-761; INCREASES LIFE-SPAN; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; INDUCED IMPAIRMENT; GENE-EXPRESSION; MOUSE MODEL; C-ELEGANS; DECOCTION; AGGREGATION	Liuwei Dihuang (LWDH), a classic Chinese medicinal formula, has been used to improve or restore declined functions related to aging and geriatric diseases, such as impaired mobility, vision, hearing, cognition and memory. Here, we report on the effect and possible mechanisms of LWDH mediated protection of beta-amyloid (A beta) induced paralysis in Caenorhabditis elegans using ethanol extract (LWDH-EE) and water extract (LWDH-WE). Chemical profiling and quantitative analysis revealed the presence of different levels of bioactive components in these extracts. LWDH-WE was rich in polar components such as monosaccharide dimers and trimers, whereas LWDH-EE was enriched in terms of phenolic compounds such as gallic acid and paeonol. In vitro studies revealed higher DPPH radical scavenging activity for LWDH-EE as compared to that found for LWDH-WE. Neither LWDH-EE nor LWDH-WE were effective in inhibiting aggregation of Ab in vitro. By contrast, LWDH-EE effectively delayed A beta induced paralysis in the transgenic C. elegans (CL4176) model which expresses human A beta 1-42. Western blot revealed no treatment induced reduction in Ab accumulation in CL4176 although a significant reduction was observed at an early stage with respect to beta-amyloid deposition in C. elegans strain CL2006 which constitutively expresses human A beta 1-42. In addition, LWDH-EE reduced in vivo reactive oxygen species (ROS) in C. elegans (CL4176) that correlated with increased survival of LWDH-EE treated N2 worms under juglone-induced oxidative stress. Analysis with GFP reporter strain TJ375 revealed increased expression of hsp16.2::GFP after thermal stress whereas a minute induction was observed for sod3::GFP. Quantitative gene expression analysis revealed that LWDH-EE repressed the expression of amy1 in CL4176 while up-regulating hsp16.2 induced by elevating temperature. Taken together, these results suggest that LWDH extracts, particularly LWDH-EE, alleviated beta-amyloid induced toxicity, in part, through up-regulation of heat shock protein, antioxidant activity and reduced ROS in C. elegans.	[Sangha, Jatinder S.; Wally, Owen S. D.; Prithiviraj, Balakrishnan] Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada; [Sun, Xiaoli; Zhang, Kaibin; Ji, Xiuhong; Wang, Yanwen; Zidichouski, Jeffrey; Zhang, Junzeng] Natl Res Council Canada, Inst Nutrisci & Hlth, Charlottetown, PE, Canada; [Sun, Xiaoli; Zhang, Kaibin; Wang, Zhimin] China Acad Chinese Med Sci, Inst Chinese Materia Med, Beijing, Peoples R China; [Sun, Xiaoli] Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China; [Wang, Yanwen] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada; [Zhang, Junzeng] Univ Prince Edward Isl, Dept Chem, Charlottetown, PE C1A 4P3, Canada	Dalhousie University; National Research Council Canada; China Academy of Chinese Medical Sciences; Capital Medical University; University of Prince Edward Island; University of Prince Edward Island	Sangha, JS (corresponding author), Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada.	bprithiviraj@nsac.ca; Junzeng.zhang@nrc.gc.ca		Prithiviraj, Balakrishnan/0000-0002-9822-5261	National Research Council Canada - Institute for Nutrisciences and Health; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences; Natural Sciences and Engineering Council of Canada (NSERC), Nova Scotia Department of Agriculture and Acadian Seaplants Limited; Canadian Institutes of Health Research (CIHR)	National Research Council Canada - Institute for Nutrisciences and Health; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences; Natural Sciences and Engineering Council of Canada (NSERC), Nova Scotia Department of Agriculture and Acadian Seaplants Limited; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Financial support for X. Sun and K. Zhang from National Research Council Canada - Institute for Nutrisciences and Health (Drs. Y. Wang, J. Zidichouski, and J. Zhang) and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences (Dr. Z. Wang) is appreciated. B. Prithiviraj's Lab is supported by grants from the Natural Sciences and Engineering Council of Canada (NSERC), Nova Scotia Department of Agriculture and Acadian Seaplants Limited. Y. Wang and J. Zhang are also supported through Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, PHYTOMEDICINE, V17, P902, DOI 10.1016/j.phymed.2010.03.008; Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Arya U, 2009, EXP GERONTOL, V44, P462, DOI 10.1016/j.exger.2009.02.010; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Cao ZM, 2007, J GERONTOL A-BIOL, V62, P1337, DOI 10.1093/gerona/62.12.1337; Cheng XR, 2007, FITOTERAPIA, V78, P175, DOI 10.1016/j.fitote.2006.11.006; Cheng Xiao-rui, 2006, Chinese Pharmacological Bulletin, V22, P921; DaSilva KA, 2010, EXP NEUROL, V223, P311, DOI 10.1016/j.expneurol.2009.08.032; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Dostal V, 2010, JOVE-J VIS EXP, V44, pe2252; Dostal V, 2010, GENETICS, V186, P857, DOI 10.1534/genetics.110.120436; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Ewald CY, 2010, BRAIN STRUCT FUNCT, V214, P263, DOI 10.1007/s00429-009-0235-3; Feng J, 2010, SHANDONG J TRADITION, V29, P264; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Howes MJR, 2003, PHARMACOL BIOCHEM BE, V75, P513, DOI 10.1016/S0091-3057(03)00128-X; Hsieh MT, 2003, BIOL PHARM BULL, V26, P156, DOI 10.1248/bpb.26.156; Janusz M, 2009, FEBS LETT, V583, P190, DOI 10.1016/j.febslet.2008.11.053; Jiang HL, 2003, CURR MED CHEM, V10, P2231, DOI 10.2174/0929867033456747; Johnson JR, 2010, BIOCHEM SOC T, V38, P559, DOI 10.1042/BST0380559; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kampkotter A, 2007, PHARMACOL RES, V55, P139, DOI 10.1016/j.phrs.2006.11.006; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Liu J, 2011, PHARM CLIN RES CHINE, V19, P227; Liu YanHui, 2009, Chinese Journal of Gerontology, V29, P2455; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Ma Yuan, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P325; Miksys SL, 2010, CLIN PHARMACOL THER, V88, P427, DOI 10.1038/clpt.2010.198; Moreira Paula I, 2006, Expert Rev Neurother, V6, P897, DOI 10.1586/14737175.6.6.897; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; National Pharmacopoeia Committee, 2005, PHARM PEOPL REP CHIN, V1; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Re F, 2010, CURR MED CHEM, V17, P2990, DOI 10.2174/092986710791959729; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Smith JV, 2003, J ALZHEIMERS DIS, V5, P287, DOI 10.3233/JAD-2003-5404; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Szeto YT, 2009, INT J FOOD SCI NUTR, V60, P662, DOI 10.3109/09637480802012209; Wei X L, 2000, Sheng Li Ke Xue Jin Zhan, V31, P227; Wolozin B, 2011, PROG MOL BIOL TRANSL, V100, P499, DOI 10.1016/B978-0-12-384878-9.00015-7; Wu CR, 2007, J ETHNOPHARMACOL, V113, P79, DOI 10.1016/j.jep.2007.05.003; Wu YJ, 2010, NEUROBIOL AGING, V31, P1055, DOI 10.1016/j.neurobiolaging.2008.07.013; Wu Yanjue, 2005, Current Alzheimer Research, V2, P37, DOI 10.2174/1567205052772768; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Xia S, 2010, SHANXI J TRADITIONAL, V31, P614; Xie BG, 2008, J PHARMACEUT BIOMED, V48, P1261, DOI 10.1016/j.jpba.2008.09.011; Yan H, 2007, CLIN INTERV AGING, V2, P201; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang S, 2006, J ETHNOPHARMACOL, V106, P166, DOI 10.1016/j.jep.2005.12.017; Ye J, 2009, J PHARMACEUT BIOMED, V49, P638, DOI 10.1016/j.jpba.2008.12.009; Yin F, 2011, NEUROSCI LETT, V492, P76, DOI 10.1016/j.neulet.2011.01.055; Yin F, 2011, NEUROCHEM INT, V58, P399, DOI 10.1016/j.neuint.2010.12.017; Yu YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009339; Zarse K, 2011, HORM METAB RES, V43, P241, DOI 10.1055/s-0030-1270524; Zhang Q, 2006, J APPL PHYCOL, V18, P445, DOI 10.1007/s10811-006-9048-4; Zhang Wei-Wei, 2011, Sheng Li Xue Bao, V63, P245; Zhao XF, 2007, J CHROMATOGR SCI, V45, P549, DOI 10.1093/chromsci/45.8.549; Zhu K, 2006, CHIN J EXP TRADIT ME, V12, P44; 王迪, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P524; 蒋宁, 2007, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V23, P45	68	69	75	3	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43990	10.1371/journal.pone.0043990	http://dx.doi.org/10.1371/journal.pone.0043990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952840	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500036
J	Wu, ZY; Chen, YJ; Yang, T; Gao, QQ; Yuan, M; Ma, L				Wu, Ziyan; Chen, Yuejun; Yang, Tong; Gao, Qinqin; Yuan, Man; Ma, Lan			Targeted Ubiquitination and Degradation of G-Protein-Coupled Receptor Kinase 5 by the DDB1-CUL4 Ubiquitin Ligase Complex	PLOS ONE			English	Article							DNA-DAMAGE; DEPENDENT DEGRADATION; SELECTIVE REGULATION; COP9 SIGNALOSOME; NDR KINASE; S-PHASE; PROTEOLYSIS; CELLS; DDB1; PHOSPHORYLATION	The G protein-coupled receptor kinases (GRKs) phosphorylate agonist occupied G protein-coupled receptors (GPCRs) and desensitize GPCR-mediated signaling. Recent studies indicate they also function non-catalytically via interaction with other proteins. In this study, a proteomic approach was used to screen interacting proteins of GRK5 in MDA-MB-231 cells and HUVEC cells. Mass spectrometry analysis reveals several proteins in the GRK5 immunocomplex including damaged DNA-binding protein 1 (DDB1), an adaptor subunit of the CUL4-ROC1 E3 ubiquitin ligase complex. Co-immunoprecipitation experiments confirmed the association of GRK5 with DDB1-CUL4 complex, and reveal that DDB1 acts as an adapter to link GRK5 to CUL4 to form the complex. Overexpression of DDB1 promoted, whereas knockdown of DDB1 inhibited the ubiquitination of GRK5, and the degradation of GRK5 was reduced in cells deficient of DDB1. Furthermore, the depletion of DDB1 decreased Hsp90 inhibitor-induced GRK5 destabilization and UV irradiation-induced GRK5 degradation. Thus, our study identified potential GRK5 interacting proteins, and reveals the association of GRK5 with DDB1 in cell and the regulation of GRK5 level by DDB1-CUL4 ubiquitin ligase complex-dependent proteolysis pathway.	[Wu, Ziyan] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; Fudan Univ, Pharmacol Res Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, ZY (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	yuejunchen@fudan.edu.cn	Ma, Lan/B-9295-2009; chen, yuejun/AAL-4070-2020	Chen, Yuejun/0000-0002-4625-2604; Ma, Lan/0000-0001-9034-5472	Ministry of Science and Technology [2009CB522006]; National Natural Science Foundation of China [30830042, 31121061, 30900852]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Ministry of Science and Technology grant 2009CB522006 (to LM) and National Natural Science Foundation of China grants 30830042 and 31121061 (to Lan Ma), and 30900852 (to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Barthet G, 2009, EMBO J, V28, P2706, DOI 10.1038/emboj.2009.215; Blencowe BJ, 2000, RNA, V6, P111, DOI 10.1017/S1355838200991982; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chen XQ, 2010, J BIOL CHEM, V285, P12823, DOI 10.1074/jbc.M109.094243; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Chen YJ, 2011, J CELL BIOL, V194, P905, DOI 10.1083/jcb.201104114; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kim JI, 2012, J UROLOGY, V187, P322, DOI 10.1016/j.juro.2011.09.049; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Loudon RP, 1996, BLOOD, V88, P4547, DOI 10.1182/blood.V88.12.4547.bloodjournal88124547; Luo JS, 2003, J BIOL CHEM, V278, P50908, DOI 10.1074/jbc.M307637200; Michal AM, 2012, J BIOL CHEM, V287, P6928, DOI 10.1074/jbc.M111.298034; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Nogues L, 2011, J BIOL CHEM, V286, P1165, DOI 10.1074/jbc.M110.203406; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Salim S, 2007, J PHARMACOL EXP THER, V320, P1106, DOI 10.1124/jpet.106.114835; Sawada Y, 2000, BBA-GENE STRUCT EXPR, V1492, P191, DOI 10.1016/S0167-4781(00)00065-8; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549	54	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43997	10.1371/journal.pone.0043997	http://dx.doi.org/10.1371/journal.pone.0043997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952844	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800086
J	Guzman, A; Zelman-Femiak, M; Boergermann, JH; Paschkowsky, S; Kreuzaler, PA; Fratzl, P; Harms, GS; Knaus, P				Guzman, Asja; Zelman-Femiak, Monika; Boergermann, Jan H.; Paschkowsky, Sandra; Kreuzaler, Peter A.; Fratzl, Peter; Harms, Gregory S.; Knaus, Petra			SMAD versus Non-SMAD Signaling Is Determined by Lateral Mobility of Bone Morphogenetic Protein (BMP) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON REORGANIZATION; SINGLE-MOLECULE TRACKING; OSTEOBLAST DIFFERENTIATION; FUNCTIONAL-CHARACTERIZATION; SERINE/THREONINE KINASE; LIPID RAFTS; ACTIVATION; CELLS; COMPLEXES; REGULATOR	Bone (or body) morphogenetic proteins (BMPs) belong to the TGF beta superfamily and are crucial for embryonic patterning and organogenesis as well as for adult tissue homeostasis and repair. Activation of BMP receptors by their ligands leads to induction of several signaling cascades. Using fluorescence recovery after photobleaching, FRET, and single particle tracking microscopy, we demonstrate that BMP receptor type I and II (BMPRI and BMPRII) have distinct lateral mobility properties within the plasma membrane, which is mandatory for their involvement in different signaling pathways. Before ligand binding, BMPRI and a subpopulation of BMPRII exhibit confined motion, reflecting preassembled heteromeric receptor complexes. A second free diffusing BMPRII population only becomes restricted after ligand addition. This paper visualizes time-resolved BMP receptor complex formation and demonstrates that the lateral mobility of BMPRI has a major impact in stabilizing heteromeric BMPRI-BMPRII receptor complexes to differentially stimulate SMAD versus non-SMAD signaling.	[Harms, Gregory S.] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA; [Harms, Gregory S.] Wilkes Univ, Dept Phys, Wilkes Barre, PA 18766 USA; [Guzman, Asja; Boergermann, Jan H.; Paschkowsky, Sandra; Kreuzaler, Peter A.; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Zelman-Femiak, Monika; Harms, Gregory S.] Univ Wurzburg, Rudolf Virchow Ctr, Microscopy Grp, D-97080 Wurzburg, Germany; [Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany	Wilkes University; Wilkes University; Free University of Berlin; University of Wurzburg; Max Planck Society	Harms, GS (corresponding author), Wilkes Univ, Dept Biol, 84 S West St, Wilkes Barre, PA 18766 USA.	gregory.harms@imaging-microscopy.com; knaus@chemie.fu-berlin.de	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830; Kreuzaler, Peter/0000-0001-8684-9424	Deutsche Forschungsgemeinschaft (DFG) [SFB 449, SFB 958]; Rudolf Virchow Center [FZ-82, GK-1342, GK-1048]; Bavarian Ministry of Science and Education for the Bio-Imaging Center; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rudolf Virchow Center; Bavarian Ministry of Science and Education for the Bio-Imaging Center; DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB 449 and SFB 958 (to P. K.), FZ-82 (for the Rudolf Virchow Center) (to G. S. H.), GK-1342 (to G. S. H.), and GK-1048 (to G. S. H.) and also by the Bavarian Ministry of Science and Education for the Bio-Imaging Center (to G. S. H.).; Member of the Berlin-Brandenburg School for Regenerative Therapies, a DFG-funded graduate school.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Brdickova N, 2001, FEBS LETT, V507, P133, DOI 10.1016/S0014-5793(01)02955-6; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; de Keijzer S, 2011, BBA-BIOMEMBRANES, V1808, P1701, DOI 10.1016/j.bbamem.2011.02.009; Ebisawa T, 1999, J CELL SCI, V112, P3519; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hassel S, 2003, J BONE JOINT SURG AM, V85A, P44, DOI 10.2106/00004623-200300003-00009; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim J, 2008, CIRC RES, V102, P896, DOI 10.1161/CIRCRESAHA.107.163667; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Luga V, 2009, BIOCHEM J, V421, P119, DOI 10.1042/BJ20081131; Ma XY, 2007, BIOCHEM BIOPH RES CO, V356, P67, DOI 10.1016/j.bbrc.2007.02.080; Marom B, 2011, J BIOL CHEM, V286, P19287, DOI 10.1074/jbc.M110.210377; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nohe A, 2005, J CELL SCI, V118, P643, DOI 10.1242/jcs.01402; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Sammar M, 2009, BIOCHEM BIOPH RES CO, V381, P1, DOI 10.1016/j.bbrc.2008.12.162; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Xiao ZY, 2008, J PHYS CHEM B, V112, P4140, DOI 10.1021/jp710302j; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200; Zelman-Femiak M, 2010, BIOTECHNIQUES, V49, P574, DOI 10.2144/000113466; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	47	45	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.387639	http://dx.doi.org/10.1074/jbc.M112.387639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22961979	Green Published, hybrid			2022-12-25	WOS:000311233800021
J	Singh, K; Marchand, B; Rai, DK; Sharma, B; Michailidis, E; Ryan, EM; Matzek, KB; Leslie, MD; Hagedorn, AN; Li, Z; Norden, PR; Hachiya, A; Parniak, MA; Xu, HT; Wainberg, MA; Sarafianos, SG				Singh, Kamalendra; Marchand, Bruno; Rai, Devendra K.; Sharma, Bechan; Michailidis, Eleftherios; Ryan, Emily M.; Matzek, Kayla B.; Leslie, Maxwell D.; Hagedorn, Ariel N.; Li, Zhe; Norden, Pieter R.; Hachiya, Atsuko; Parniak, Michael A.; Xu, Hong-Tao; Wainberg, Mark A.; Sarafianos, Stefan G.			Biochemical Mechanism of HIV-1 Resistance to Rilpivirine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; SITE-DIRECTED MUTAGENESIS; DNA-POLYMERASE; NONNUCLEOSIDE INHIBITORS; 2-AMINOPURINE FLUORESCENCE; DRUG-RESISTANCE; CONNECTION SUBDOMAIN; CRYSTAL-STRUCTURES; RNA-POLYMERASE	Rilpivirine (RPV) is a second generation nonnucleoside reverse transcriptase (RT) inhibitor (NNRTI) that efficiently inhibits HIV-1 resistant to first generation NNRTIs. Virological failure during therapy with RPV and emtricitabine is associated with the appearance of E138K and M184I mutations in RT. Here we investigate the biochemical mechanism of RT inhibition and resistance to RPV. We used two transient kinetics approaches (quench-flow and stopped-flow) to determine how subunit-specific mutations in RT p66 or p51 affect association and dissociation of RPV to RT as well as their impact on binding of dNTP and DNA and the catalytic incorporation of nucleotide. We compared WT with four subunit-specific RT mutants, p66(M184I)/p51(WT), p66(E138K)/p51(E138K), p66(E138K/M184I)/p51(E138K), and p66(M184I)/p51(E138K). Ile-184 in p66 (p66(184I)) decreased the catalytic efficiency of RT (k(pol)/K-d.dNTP), primarily through a decrease in dNTP binding (K-d.dNTP). Lys-138 either in both sub-units or in p51 alone abrogated the negative effect of p66(184I) by restoring dNTP binding. Furthermore, p51(138K) reduced RPV susceptibility by altering the ratio of RPV dissociation to RPV association, resulting in a net reduction in RPV equilibrium binding affinity (K-d.RPV = k(off.RPV)/k(on.RPV)). Quantum mechanics/molecular mechanics hybrid molecular modeling revealed that p51(E138K) affects access to the RPV binding site by disrupting the salt bridge between p51(E138) and p66(K101). p66(184I) caused repositioning of the Tyr-183 active site residue and decreased the efficiency of RT, whereas the addition of p51(138K) restored Tyr-183 to a WT-like conformation, thus abrogating the Ile-184-induced functional defects.	[Ryan, Emily M.; Matzek, Kayla B.; Hagedorn, Ariel N.; Li, Zhe; Norden, Pieter R.] Univ Missouri, Sch Med, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA; [Singh, Kamalendra; Marchand, Bruno; Michailidis, Eleftherios; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Sharma, Bechan] Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India; [Parniak, Michael A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Xu, Hong-Tao; Wainberg, Mark A.] McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Wainberg, Mark A.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; [Sarafianos, Stefan G.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Allahabad; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lady Davis Institute; McGill University; McGill University; McGill University; University of Missouri System; University of Missouri Columbia	Sarafianos, SG (corresponding author), 471D Christopher Bond Life Sci Ctr, 1201 Rollins St, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Sharma, Bechan/G-6836-2015; Xu, Hongtao/AAA-2650-2021; Rai, Devendra/AAX-3100-2020; Rai, Devendra/J-3857-2013	Sharma, Bechan/0000-0002-7835-9406; Xu, Hongtao/0000-0002-8911-0649; Rai, Devendra/0000-0001-9035-685X; Michailidis, Eleftherios/0000-0002-9907-4346; Sarafianos, Stefan G/0000-0002-5840-154X; Norden, Pieter/0000-0002-5960-5245	National Institutes of Health [AI076119, AI074389, AI100890, AI079801]; Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079801, R01AI074389, R01AI100890, R33AI079801, R01AI076119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076119, AI074389, and AI100890 (to S. G. S.) and AI079801 (to M. A. P.). This work was also supported by grants from the Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; BALZARINI J, 1993, J VIROL, V67, P5353, DOI 10.1128/JVI.67.9.5353-5359.1993; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Cancio R, 2005, ANTIMICROB AGENTS CH, V49, P4546, DOI 10.1128/AAC.49.11.4546-4554.2005; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Das K, 2005, PROG BIOPHYS MOL BIO, V88, P209, DOI 10.1016/j.pbiomolbio.2004.07.001; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; Das K, 2004, J MED CHEM, V47, P2550, DOI 10.1021/jm030558s; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; Das K, 2007, J MOL BIOL, V365, P77, DOI 10.1016/j.jmb.2006.08.097; Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223; Das K, 2011, J MED CHEM, V54, P2727, DOI 10.1021/jm101536x; Daszykowski M, 2005, TALANTA, V68, P54, DOI 10.1016/j.talanta.2005.04.071; de Bethune MP, 2010, ANTIVIR RES, V85, P75, DOI 10.1016/j.antiviral.2009.09.008; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; De Clercq Erik, 2005, Expert Opin Emerg Drugs, V10, P241, DOI 10.1517/14728214.10.2.241; de Jonge MR, 2005, J MED CHEM, V48, P2176, DOI 10.1021/jm049534r; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Ditzler MA, 2011, NUCLEIC ACIDS RES, V39, P8237, DOI 10.1093/nar/gkr381; Domaoal RA, 2008, J BIOL CHEM, V283, P5452, DOI 10.1074/jbc.M707834200; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; Frenkel YV, 2005, J MED CHEM, V48, P1974, DOI 10.1021/jm049439i; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; GU ZX, 1992, J VIROL, V66, P7128, DOI 10.1128/JVI.66.12.7128-7135.1992; Guillemont J, 2005, J MED CHEM, V48, P2072, DOI 10.1021/jm040838n; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hachiya A, 2009, ANTIVIR RES, V82, P115, DOI 10.1016/j.antiviral.2009.02.189; Harris D, 1998, BIOCHEMISTRY-US, V37, P9630, DOI 10.1021/bi980549z; Heeres J, 2005, J MED CHEM, V48, P1910, DOI 10.1021/jm040829e; Herschhorn A, 2008, BIOCHEMISTRY-US, V47, P490, DOI 10.1021/bi7018139; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Hu ZX, 2011, J VIROL, V85, P11309, DOI 10.1128/JVI.05578-11; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Janssen PAJ, 2005, J MED CHEM, V48, P1901, DOI 10.1021/jm040840e; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kulkarni R, 2012, JAIDS-J ACQ IMM DEF, V59, P47, DOI 10.1097/QAI.0b013e31823aca74; Lai YT, 2012, NUCLEIC ACID THER, V22, P162, DOI 10.1089/nat.2011.0327; Lansdon EB, 2010, J MED CHEM, V53, P4295, DOI 10.1021/jm1002233; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Mandal SS, 2002, BIOCHEMISTRY-US, V41, P4399, DOI 10.1021/bi015723p; Margot NA, 2002, AIDS, V16, P1227, DOI 10.1097/00002030-200206140-00004; Menendez-Arias L, 2002, TRENDS PHARMACOL SCI, V23, P381, DOI 10.1016/S0165-6147(02)02054-0; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; National Institutes of Health, 2011, HIV ITS TREATM FDA A; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Njai HF, 2005, ANTIVIR THER, V10, P255; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; Pelemans H, 2001, VIROLOGY, V280, P97, DOI 10.1006/viro.2000.0742; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200; Reha-Krantz Linda J., 2009, V521, P381, DOI [10.1007/978-1-60327-815-7_21, 10.1007/978-1-60327-817-5_21]; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2004, CURR OPIN STRUC BIOL, V14, P716, DOI 10.1016/j.sbi.2004.10.013; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schrijvers R, 2011, LANCET, V378, P201, DOI 10.1016/S0140-6736(11)60992-6; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; Smidansky ED, 2011, BIOCHEMISTRY-US, V50, P5016, DOI 10.1021/bi200350d; Spence RA, 1996, BIOCHEMISTRY-US, V35, P1054, DOI 10.1021/bi952058+; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Vu BC, 2011, ANTIMICROB AGENTS CH, V55, P2379, DOI 10.1128/AAC.01290-10; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; Wainberg Mark A, 2004, Expert Rev Anti Infect Ther, V2, P147, DOI 10.1586/14787210.2.1.147; Wang LZ, 2004, J BIOL CHEM, V279, P38424, DOI 10.1074/jbc.M406241200; Wei X, 2003, VIROLOGY, V311, P202, DOI 10.1016/S0042-6822(03)00173-9; Wilson JE, 1996, J BIOL CHEM, V271, P13656, DOI 10.1074/jbc.271.23.13656; Xu HT, 2012, J VIROL, V86, P8422, DOI 10.1128/JVI.00271-12; Xu HT, 2011, J VIROL, V85, P11300, DOI 10.1128/JVI.05584-11; Xu HT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-80; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	97	45	46	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.398180	http://dx.doi.org/10.1074/jbc.M112.398180			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22955279	Green Published, hybrid			2022-12-25	WOS:000310642200045
J	Bruni, I; De Mattia, F; Martellos, S; Galimberti, A; Savadori, P; Casiraghi, M; Nimis, PL; Labra, M				Bruni, Ilaria; De Mattia, Fabrizio; Martellos, Stefano; Galimberti, Andrea; Savadori, Paolo; Casiraghi, Maurizio; Nimis, Pier Luigi; Labra, Massimo			DNA Barcoding as an Effective Tool in Improving a Digital Plant Identification System: A Case Study for the Area of Mt. Valerio, Trieste (NE Italy)	PLOS ONE			English	Article							PLASTID RBCL; MATK; TAXONOMY; WILL	Background: Identification keys are decision trees which require the observation of one or more morphological characters of an organism at each step of the process. While modern digital keys can overcome several constraints of classical paper-printed keys, their performance is not error-free. Moreover, identification cannot be always achieved when a specimen lacks some morphological features (i.e. because of season, incomplete development or miss-collecting). DNA barcoding was proven to have great potential in plant identification, while it can be ineffective with some closely related taxa, in which the relatively brief evolutionary distance did not produce differences in the core-barcode sequences. Methodology/Principal Findings: In this paper, we investigated how the DNA barcoding can support the modern digital approaches to the identification of organisms, using as a case study a local flora, that of Mt. Valerio, a small hill near the centre of Trieste (NE Italy). The core barcode markers (plastidial rbcL and matK), plus the additional trnH-psbA region, were used to identify vascular plants specimens. The usefulness of DNA barcoding data in enhancing the performance of a digital identification key was tested on three independent simulated scenarios. Conclusions/Significance: Our results show that the core barcode markers univocally identify most species of our local flora (96%). The trnH-psbA data improve the discriminating power of DNA barcoding among closely related plant taxa. In the multiparametric digital key, DNA barcoding data improves the identification success rate; in our simulation, DNA data overcame the absence of some morphological features, reaching a correct identification for 100% of the species. FRIDA, the software used to generate the digital key, has the potential to combine different data sources: we propose to use this feature to include molecular data as well, creating an integrated identification system for plant biodiversity surveys.	[Bruni, Ilaria; De Mattia, Fabrizio; Galimberti, Andrea; Savadori, Paolo; Casiraghi, Maurizio; Labra, Massimo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlant Lab, Milan, Italy; [Martellos, Stefano; Nimis, Pier Luigi] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy	University of Milano-Bicocca; University of Trieste	Bruni, I (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlant Lab, Piazza Sci 2, Milan, Italy.	massimo.labra@unimib.it	Labra, Massimo/J-2372-2012; Savadori, paolo/A-8769-2019; Casiraghi, Maurizio/E-7273-2011; Galimberti, Andrea/ABF-7019-2020	Labra, Massimo/0000-0003-1065-5804; Savadori, paolo/0000-0001-8606-4694; Casiraghi, Maurizio/0000-0002-2733-2094; Galimberti, Andrea/0000-0003-3140-3024; Bruni, Ilaria/0000-0002-9947-0963; Martellos, Stefano/0000-0001-5201-8948	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR) [20089BZYAH]	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR) grant 20089BZYAH with the project entitled "Tassonomia integrata per lo studio della biodiversita vegetale: DNA barcoding e analisi morfologiche". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Arif IA, 2010, INT J MOL SCI, V11, P2079, DOI 10.3390/ijms11052079; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Biemont C, 2010, HEREDITY, V105, P1, DOI 10.1038/hdy.2010.66; Brach AR, 2011, ANN MO BOT GARD, V98, P297, DOI 10.3417/2010035; Brach AR, 2005, TAXON, V54, P1041, DOI 10.2307/25065490; Bridgeman P., 1927, LOGIC MODERN PHYS; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Conti F, 2005, ANNOTATED CHECKLIST; Conti F, 2007, NATURA VICENTINA, V10, p[2006, 5]; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Dallwitz M.J., 2002, GLOBAL BIOL INFORM I, P23; Dallwitz MJ, 1995, USERS GUIDE INTKEY P; De Mattia F, 2011, FOOD RES INT, V44, P693, DOI 10.1016/j.foodres.2010.12.032; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fay MF, 1998, TAXON, V47, P43, DOI 10.2307/1224017; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Hagedorn G, 2010, TOOLS IDENTIFYING BI, P59; Hagedorn G, 2010, TOOLS IDENTIFYING BI, P13; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilu KW, 1997, AM J BOT, V84, P830, DOI 10.2307/2445819; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2008, HEREDITY, V101, P1, DOI 10.1038/hdy.2008.16; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Martellos S, 2010, TAXON, V59, P922, DOI 10.1002/tax.593020; Naciri Y, 2010, MOL ECOL RESOUR, V10, P728, DOI 10.1111/j.1755-0998.2009.02816.x; Newmaster SG, 2009, INT J COMPUT APPL T, V35, P50, DOI 10.1504/IJCAT.2009.024595; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nimis PL, 2009, ECO MONT, V1, P61, DOI 10.1553/ecomont2s61; Ren H, 2011, J SYST EVOL, V49, P411, DOI 10.1111/j.1759-6831.2011.00152.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Stace CA, 2005, TAXON, V54, P999, DOI 10.2307/25065484; Stevenson RD, 2003, CONSERV ECOL, V7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x	46	45	46	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43256	10.1371/journal.pone.0043256	http://dx.doi.org/10.1371/journal.pone.0043256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970123	Green Submitted, Green Published, gold			2022-12-25	WOS:000308748400004
J	Basu, S; Stuckler, D; Vellakkal, S; Ebrahim, S				Basu, Sanjay; Stuckler, David; Vellakkal, Sukumar; Ebrahim, Shah			Dietary Salt Reduction and Cardiovascular Disease Rates in India: A Mathematical Model	PLOS ONE			English	Article							BLOOD-PRESSURE; HEALTH; HYPERTENSION; METAANALYSIS; POPULATION; SODIUM; PREVENTION; STRATEGIES; COSTS	Background: Reducing salt intake has been proposed to prevent cardiovascular disease in India. We sought to determine whether salt reductions would be beneficial or feasible, given the worry that unrealistically large reductions would be required, worsening iodine deficiency and benefiting only urban subpopulations. Methods and Results: Future myocardial infarctions (MI) and strokes in India were predicted with a Markov model simulating men and women aged 40 to 69 in both urban and rural locations, incorporating the risk reduction from lower salt intake. If salt intake does not change, we expect similar to 8.3 million MIs (95% CI: 6.9-9.6 million), 830,000 strokes (690,000-960,000) and 2.0 million associated deaths (1.5-2.4 million) per year among Indian adults aged 40 to 69 over the next three decades. Reducing intake by 3 g/day over 30 years (-0.1 g/year, 25% reduction) would reduce annual MIs by 350,000 (a 4.6% reduction; 95% CI: 320,000-380,000), strokes by 48,000 (-6.5%; 13,000-83,000) and deaths by 81,000 (-4.9%; 59,000-100,000) among this group. The largest decline in MIs would be among younger urban men, but the greatest number of averted strokes would be among rural men, and nearly one-third of averted strokes and one-fifth of averted MIs would be among rural women. Only under a highly pessimistic scenario would iodine deficiency increase (by < 0.0001%, similar to 1600 persons), since inadequate iodized salt access-not low intake of iodized salt-is the major cause of deficiency and would be unaffected by dietary salt reduction. Conclusions: Modest reductions in salt intake could substantially reduce cardiovascular disease throughout India.	[Basu, Sanjay] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Stuckler, David] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge, England; [Vellakkal, Sukumar; Ebrahim, Shah] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India; [Ebrahim, Shah] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England	Stanford University; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine	Basu, S (corresponding author), Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	basus@stanford.edu	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0002-0594-1454; Stuckler, David/0000-0002-1288-8401; Vellakkal, Sukumar/0000-0003-2635-1944	University of California San Francisco Clinical and Translational Science Institute; Wellcome Trust strategic award [084674/Z/08/Z]	University of California San Francisco Clinical and Translational Science Institute(University of California System); Wellcome Trust strategic award(Wellcome Trust)	SB is supported by an award from the University of California San Francisco Clinical and Translational Science Institute. The South Asia Network for Chronic Disease (SE, SV) is supported by a Wellcome Trust strategic award 084674/Z/08/Z. No specific funding was received by DS for this research. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AGR RES SERV, 2008, NUTR INT FOOD MEAN A; [Anonymous], 1989, J Hum Hypertens, V3, P279; [Anonymous], 2011, TIMES INDIA; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Campbell N, 2012, B WORLD HEALTH ORGAN, V90, P73, DOI 10.2471/BLT.11.092080; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Elliott P, 2007, DIET PHYS ACTIVITY; Food Standards Agency, 2008, DIET SOD LEV SURV; Franceschini N, 2011, AM J HYPERTENS, V24, P392, DOI 10.1038/ajh.2010.218; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Indrayan A., 2005, FORECASTING VASCULAR; International Institute for Population Sciences, 2007, NAT FAM HLTH SURV; International Institute for Population Sciences, 2000, NAT FAM HLTH SURV; Kato N, 2012, HYPERTENS RES, V35, P574, DOI 10.1038/hr.2012.44; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; Ministry of Women and Child Development, 2007, IOD DEF DIS; Moyer M, 2011, ITS TIME END WAR SAL; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Pandav C S, 1982, Indian J Pediatr, V49, P259, DOI 10.1007/BF02830764; Panel on Dietary Reference Intakes for Electrolytes and Water, 2005, DIET REF INT WAT POT; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Radhika G, 2007, J Assoc Physicians India, V55, P405; Registrar-General of India, 2011, CENS DAT; Reinagel M, 2010, SELF MAGAZINE; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shah B, 2010, ASSESSMENT BURDEN NO; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; The R Foundation for Statistical Computing, 2011, MSTAT PACK; The Salt Institute, 2011, ISS FOC; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; WHO, 2007, SALT VEH FORT; WHO Forum on Reducing Salt Intake in Populations, 2007, WHO FOR TECHN M 5 7; World Health Organisation, 2011, STRAT MON EV POP SOD; World Health Organization, 2011, WHO STUD GLOB AGEING; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2011, STUD GLOB AGEING AD; World Health Organization, 2010, GLOB MORT DAT; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	48	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44037	10.1371/journal.pone.0044037	http://dx.doi.org/10.1371/journal.pone.0044037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970159	Green Published, gold			2022-12-25	WOS:000308458400030
J	Green, DM; Penman, DJ; Migaud, H; Bron, JE; Taggart, JB; McAndrew, BJ				Green, Darren M.; Penman, David J.; Migaud, Herve; Bron, James E.; Taggart, John B.; McAndrew, Brendan J.			The Impact of Escaped Farmed Atlantic Salmon (Salmo salar L.) on Catch Statistics in Scotland	PLOS ONE			English	Article							WILD SALMON; SIMULATED ESCAPE; FISH; SEA; POPULATION; PREVALENCE; NORWAY; ORIGIN; AUTUMN; RIVERS	In Scotland and elsewhere, there are concerns that escaped farmed Atlantic salmon (Salmo salar L.) may impact on wild salmon stocks. Potential detrimental effects could arise through disease spread, competition, or inter-breeding. We investigated whether there is evidence of a direct effect of recorded salmon escape events on wild stocks in Scotland using anglers' counts of caught salmon (classified as wild or farmed) and sea trout (Salmo trutta L.). This tests specifically whether documented escape events can be associated with reduced or elevated escapes detected in the catch over a five-year time window, after accounting for overall variation between areas and years. Alternate model frameworks were somewhat inconsistent, however no robust association was found between documented escape events and higher proportion of farm-origin salmon in anglers' catch, nor with overall catch size. A weak positive correlation was found between local escapes and subsequent sea trout catch. This is in the opposite direction to what would be expected if salmon escapes negatively affected wild fish numbers. Our approach specifically investigated documented escape events, contrasting with earlier studies examining potentially wider effects of salmon farming on wild catch size. This approach is more conservative, but alleviates some potential sources of confounding, which are always of concern in observational studies. Successful analysis of anglers' reports of escaped farmed salmon requires high data quality, particularly since reports of farmed salmon are a relatively rare event in the Scottish data. Therefore, as part of our analysis, we reviewed studies of potential sensitivity and specificity of determination of farmed origin. Specificity estimates are generally high in the literature, making an analysis of the form we have performed feasible.	[Green, Darren M.; Penman, David J.; Migaud, Herve; Bron, James E.; Taggart, John B.; McAndrew, Brendan J.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	University of Stirling	Green, DM (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	darren.green@stir.ac.uk	Bron, James E/B-6231-2018; Migaud, Herve/C-5647-2009; Green, Darren/I-6436-2012	Bron, James E/0000-0003-3544-0519; Migaud, Herve/0000-0002-5404-7512; Green, Darren/0000-0001-9026-5675; Taggart, John/0000-0002-3843-9663	Scottish Salmon Producers' Organisation (SSPO)	Scottish Salmon Producers' Organisation (SSPO)	This work was supported by funding from the Scottish Salmon Producers' Organisation (SSPO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; Butler JRA, 2005, FISHERIES MANAG ECOL, V12, P149, DOI 10.1111/j.1365-2400.2005.00437.x; Butler JRA, 2003, SALMON AT THE EDGE, P93, DOI 10.1002/9780470995495.ch9; Carr JW, 2006, ICES J MAR SCI, V63, P1263, DOI 10.1016/j.icesjms.2006.03.020; Crozier William Walter, 1998, Fisheries Management and Ecology, V5, P23, DOI 10.1046/j.1365-2400.1998.00054.x; Fiske P, 2006, ICES J MAR SCI, V63, P1182, DOI 10.1016/j.icesjms.2006.04.006; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Friedland KD, 2009, ICES J MAR SCI, V66, P289, DOI 10.1093/icesjms/fsn210; GART JJ, 1966, J ROY STAT SOC B, V28, P164; Hansen LP, 2010, FISHERIES MANAG ECOL, V17, P28, DOI 10.1111/j.1365-2400.2009.00709.x; Hansen LP, 1997, ICES J MAR SCI, V54, P152, DOI 10.1006/jmsc.1996.0178; Hansen LP, 1999, ICES J MAR SCI, V56, P200, DOI 10.1006/jmsc.1998.0437; ICES, 2010, ORAL HLTH STATUS ORA; Jacobsen JA, 2001, FISH RES, V52, P169, DOI 10.1016/S0165-7836(00)00255-1; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Jonsson B, 2006, ICES J MAR SCI, V63, P1162, DOI 10.1016/j.icesjms.2006.03.004; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Marine Scotland, 2012, SCOTT SALM SEA TROUT; Marine Scotland, 2012, IMPR CONT FISH FARM; Marine Scotland, 2011, SCOTLANDS MARINE ATL; Morris MRJ, 2008, CAN J FISH AQUAT SCI, V65, P2807, DOI 10.1139/F08-181; Olsen RE, 2010, AQUACULT ENV INTERAC, V1, P167, DOI 10.3354/aei00015; Skilbrei OT, 2006, ICES J MAR SCI, V63, P1190, DOI 10.1016/j.icesjms.2006.05.005; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P107, DOI 10.3354/aei00011; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P147, DOI 10.3354/aei00017; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P117, DOI 10.3354/aei00013; Strathspey Angling Improvement Association, 2012, MEMB PERM RUL COND C; Thorstad E.B., 2008, 36 NINA; Todd C, 2007, J PLANKTON RES, V29, pi67; Van Zwol JA, 2012, ECOL FRESHW FISH, V21, P533, DOI 10.1111/j.1600-0633.2012.00573.x; Walker AM, 2006, ICES J MAR SCI, V63, P1201, DOI 10.1016/j.icesjms.2006.04.018; WEBB JH, 1991, AQUACULTURE, V98, P97, DOI 10.1016/0044-8486(91)90375-H	32	14	14	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43560	10.1371/journal.pone.0043560	http://dx.doi.org/10.1371/journal.pone.0043560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970132	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400014
J	Hughes, CML; Seegelke, C; Spiegel, MA; Oehmichen, C; Hammes, J; Schack, T				Hughes, Charmayne M. L.; Seegelke, Christian; Spiegel, Marnie Ann; Oehmichen, Corinna; Hammes, Julia; Schack, Thomas			Corrections in Grasp Posture in Response to Modifications of Action Goals	PLOS ONE			English	Article							SELECTIVE PERTURBATION; PREHENSION MOVEMENTS; VISUAL INPUT; OBJECT; REACH; COMPONENTS; KINEMATICS	There is ample evidence that people plan their movements to ensure comfortable final grasp postures at the end of a movement. The end-state comfort effect has been found to be a robust constraint during unimanual movements, and leads to the inference that goal-postures are represented and planned prior to movement initiation. The purpose of this study was to examine whether individuals make appropriate corrections to ensure comfortable final goal postures when faced with an unexpected change in action goal. Participants reached for a horizontal cylinder and placed the left or right end of the object into the target disk. As soon as the participant began to move, a secondary stimuli was triggered, which indicated whether the intended action goal had changed or not. Confirming previous research, participants selected initial grasp postures that ensured end-state comfort during non-perturbed trials. In addition, participants made appropriate online corrections to their reach-to-grasp movements to ensure end-state comfort during perturbed trials. Corrections in grasp posture occurred early or late in the reach-to-grasp phase. The results indicate that individuals plan their movements to afford comfort at the end of the movement, and that grasp posture planning is controlled via both feedforward and feedback mechanisms.	[Hughes, Charmayne M. L.; Seegelke, Christian; Spiegel, Marnie Ann; Oehmichen, Corinna; Hammes, Julia; Schack, Thomas] Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany; [Hughes, Charmayne M. L.; Seegelke, Christian; Schack, Thomas] Res Inst Cognit & Robot, CoR Lab, Bielefeld, Germany; [Hughes, Charmayne M. L.; Spiegel, Marnie Ann; Schack, Thomas] Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany; [Hughes, Charmayne M. L.] Tech Univ Munich, Dept Sport & Hlth Sci, Inst Movement Sci, Munich, Germany	University of Bielefeld; Technical University of Munich	Hughes, CML (corresponding author), Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany.	charmayne.hughes@tum.de	Seegelke, Christian/AAH-9410-2019	Seegelke, Christian/0000-0001-9624-6395	German Research Foundation (DFG) [EC 277]; Honda Research Institute Europe	German Research Foundation (DFG)(German Research Foundation (DFG)); Honda Research Institute Europe	This research was funded by the German Research Foundation (DFG; EC 277). CS gratefully acknowledges the financial support from Honda Research Institute Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2008, EXP BRAIN RES, V185, P111, DOI 10.1007/s00221-007-1136-4; Armbruster C, 2006, MOTOR CONTROL, V10, P311, DOI 10.1123/mcj.10.4.311; BENNETT KMB, 1995, PSYCHOL AGING, V10, P204, DOI 10.1037/0882-7974.10.2.204; CASTIELLO U, 1992, BEHAV BRAIN RES, V50, P7, DOI 10.1016/S0166-4328(05)80283-9; Castiello U, 1998, EXP BRAIN RES, V120, P31, DOI 10.1007/s002210050375; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; Dragovic M, 2004, ACTA NEUROPSYCHIATR, V16, P212, DOI 10.1111/j.0924-2708.2004.00087.x; Elsinger CL, 2003, EXP BRAIN RES, V152, P499, DOI 10.1007/s00221-003-1573-7; Fecteau JH, 2001, CAN J EXP PSYCHOL, V55, P104, DOI 10.1037/h0087357; FLASH T, 1991, J COGNITIVE NEUROSCI, V3, P220, DOI 10.1162/jocn.1991.3.3.220; Gibson J.J., 1977, PERCEIVING ACTING KN, P67, DOI DOI 10.2307/1421838; Gibson JJ., 1966, SENSES CONSIDERED PE; Heath M, 1998, CAN J EXP PSYCHOL, V52, P163, DOI 10.1037/h0087289; Hwang EJ, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S09; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; ROSENBAUM DA, 1990, ATTENTION PERFORM, V8, P321; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; STELMACH GE, 1994, J MOTOR BEHAV, V26, P178, DOI 10.1080/00222895.1994.9941672; VANSONDEREN JF, 1988, EXP BRAIN RES, V71, P320, DOI 10.1007/BF00247492; WEIR PL, 1991, J MOTOR BEHAV, V23, P192, DOI 10.1080/00222895.1991.10118362; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; ZELAZNIK HN, 1983, J MOTOR BEHAV, V15, P217	31	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43015	10.1371/journal.pone.0043015	http://dx.doi.org/10.1371/journal.pone.0043015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970119	Green Submitted, gold, Green Published			2022-12-25	WOS:000308458400006
J	Jiang, N; Zhang, XS; Zheng, XF; Chen, D; Siu, KS; Wang, HM; Ichim, TE; Quan, D; McAlister, V; Chen, GH; Min, WP				Jiang, Nan; Zhang, Xusheng; Zheng, Xiufen; Chen, Di; Siu, Kingsun; Wang, Hongmei; Ichim, Thomas E.; Quan, Douglas; McAlister, Vivian; Chen, Guihua; Min, Wei-Ping			A Novel In Vivo siRNA Delivery System Specifically Targeting Liver Cells for Protection of ConA-Induced Fulminant Hepatitis	PLOS ONE			English	Article							SMALL INTERFERING RNA; GENE-EXPRESSION; B-VIRUS; RECEPTOR; INHIBITION; REDUCTION; LIPOSOMES; MECHANISM; APOPTOSIS; CASPASE-8	Background: Fulminant hepatitis progresses to acute liver failure (ALF) when the extent of hepatocyte death exceeds the liver's regenerative capacity. Although small interfering RNA (siRNA) appears promising in animal models of hepatitis, the approach is limited by drawbacks associated with systemic administration of siRNA. The aim of this study is to develop a hepatocyte-specific delivery system of siRNA for treatment of fulminant hepatitis. Methodology/Principal Findings: Galactose-conjugated liposome nano-particles (Gal-LipoNP) bearing siRNA was prepared, and the particle size and zeta potential of Gal-LipoNP/siRNA complexes were measured. The distribution, cytotoxicity and gene silence efficiency were studied in vivo in a concanavalin A (ConA)-induced hepatitis model. C57BL/6 mice were treated with Gal-LipoNP Fas siRNA by i.v. injection 72 h before ConA challenge, and hepatocyte injury was evaluated using serum alanine transferase (ALT) and aspartate transaminase (AST) levels, as well as liver histopathology and TUNEL-positive hepatocytes. The galactose-ligated liposomes were capable of encapsulating >96% siRNA and exhibited a higher stability than naked siRNA in plasma. Hepatocyte-specific targeting was confirmed by in vivo delivery experiment, in which the majority of Gal-LipoNP-siRNA evaded nuclease digestion and accumulated in the liver as soon as 6 h after administration. In vivo gene silencing was significant in the liver after treatment of Gal-Lipo-siRNA. In the ConA-induced hepatitis model, serum levels of ALT and AST were significantly reduced in mice treated with Gal-lipoNP-siRNA as compared with control mice. Additionally, tissue histopathology and apoptosis showed an overall reduction of injury in the Gal-LipoNP siRNA-treated mice. Conclusions/Significance: This study is the first to our knowledge to demonstrate reduction of hepatic injury by liver-specific induction of RNA interference using Gal-LipoNP Fas siRNA, highlighting a novel RNAi-based therapeutic potential in many liver diseases.	[Jiang, Nan; Zhang, Xusheng; Zheng, Xiufen; Chen, Di; Siu, Kingsun; Quan, Douglas; McAlister, Vivian; Min, Wei-Ping] London Hlth Sci Ctr, Multiorgan Transplant Program, London, ON, Canada; [Jiang, Nan; Zhang, Xusheng; Zheng, Xiufen; Chen, Di; Siu, Kingsun; Quan, Douglas; McAlister, Vivian; Min, Wei-Ping] Univ Western Ontario, Dept Surg Pathol & Oncol, London, ON, Canada; [Jiang, Nan; Chen, Guihua] Sun Yat Sen Univ, Transplantat Res Inst, Affiliated Hosp 3, Liver Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Hongmei; Min, Wei-Ping] Nanchang Univ, Jiangxi Prov Inst Med Sci, Nanchang, Peoples R China; [Wang, Hongmei; Min, Wei-Ping] Nanchang Univ, Sch Med, Nanchang, Peoples R China; [Ichim, Thomas E.] Medistem Labs, San Diego, CA USA	London Health Sciences Centre; Western University (University of Western Ontario); Sun Yat Sen University; Nanchang University; Nanchang University	Min, WP (corresponding author), Univ Hosp C9 136, 339 Windermere Rd, London, ON N6A 5A5, Canada.	weiping.min@uwo.ca	JIANG, NAN/AHB-1945-2022; McAlister, Vivian/B-9881-2008	McAlister, Vivian/0000-0002-2479-6862	Canadian Institute of Health Research; Heart and Stroke Foundation of Canada; National Nature Science Foundation of China [81160286]; CIHR Strategic Training Program in Cancer Research; Department of Surgery Institute Scientist, University of Western Ontario; Major State Basic Research Development Program (973 Program) of China [2009CB522404]; National 12th Five-Year Science and Technology Plan major projects of China [2012ZX10002017-005]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); CIHR Strategic Training Program in Cancer Research(Canadian Institutes of Health Research (CIHR)); Department of Surgery Institute Scientist, University of Western Ontario; Major State Basic Research Development Program (973 Program) of China(National Basic Research Program of China); National 12th Five-Year Science and Technology Plan major projects of China	This study was supported by the Canadian Institute of Health Research, the Heart and Stroke Foundation of Canada, and a grant from National Nature Science Foundation of China (No. 81160286). DC was supported by the CIHR Strategic Training Program in Cancer Research. WM is a recipient of Department of Surgery Institute Scientist, University of Western Ontario. NJ was supported by the grants from the Major State Basic Research Development Program (973 Program) of China (No. 2009CB522404), National 12th Five-Year Science and Technology Plan major projects of China (No. 2012ZX10002017-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Akhtar S, 2007, ADV DRUG DELIVER REV, V59, P164, DOI 10.1016/j.addr.2007.03.010; Gabizon A, 1999, BIOCONJUGATE CHEM, V10, P289, DOI 10.1021/bc9801124; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Grzelinski M, 2006, HUM GENE THER, V17, P751, DOI 10.1089/hum.2006.17.751; Hughes J, 2010, METHODS MOL BIOL, V605, P445, DOI 10.1007/978-1-60327-360-2_31; Kawakami S, 2007, DRUG METAB PHARMACOK, V22, P142, DOI 10.2133/dmpk.22.142; Kim M, 2006, VIRUS RES, V122, P1, DOI 10.1016/j.virusres.2006.05.003; Lacronique V, 1996, NAT MED, V2, P80, DOI 10.1038/nm0196-80; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024740; Moschos SA, 2007, BIOCONJUGATE CHEM, V18, P1450, DOI 10.1021/bc070077d; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Plank C, 1999, HUM GENE THER, V10, P319, DOI 10.1089/10430349950019101; Rauschhuber C, 2008, J GENE MED, V10, P878, DOI 10.1002/jgm.1207; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Rothdiener M, 2010, J CONTROL RELEASE, V144, P251, DOI 10.1016/j.jconrel.2010.02.020; Ryther RCC, 2005, GENE THER, V12, P5, DOI 10.1038/sj.gt.3302356; Santel A, 2006, GENE THER, V13, P1222, DOI 10.1038/sj.gt.3302777; Sass DA, 2005, LIVER TRANSPLANT, V11, P594, DOI 10.1002/lt.20435; Scherr M, 2003, OLIGONUCLEOTIDES, V13, P353, DOI 10.1089/154545703322617032; Schroeder A, 2010, J INTERN MED, V267, P9, DOI 10.1111/j.1365-2796.2009.02189.x; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Sorgi FL, 1997, GENE THER, V4, P961, DOI 10.1038/sj.gt.3300484; Tagami A, 2003, HEPATO-GASTROENTEROL, V50, P443; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; van de Water FM, 2006, DRUG METAB DISPOS, V34, P1393, DOI 10.1124/dmd.106.009555; Vaquero Javier, 2003, Curr Gastroenterol Rep, V5, P39, DOI 10.1007/s11894-003-0008-8; Wagner E, 1999, ADV DRUG DELIVER REV, V38, P279, DOI 10.1016/S0169-409X(99)00033-2; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Wu SY, 2009, AAPS J, V11, P639, DOI 10.1208/s12248-009-9140-1; Yano J, 2004, CLIN CANCER RES, V10, P7721, DOI 10.1158/1078-0432.CCR-04-1049; Ying RS, 2007, ANTIVIR RES, V73, P24, DOI 10.1016/j.antiviral.2006.05.022; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zheng XF, 2009, CIRCULATION, V120, P1099, DOI 10.1161/CIRCULATIONAHA.108.787390; Zheng XF, 2009, BLOOD, V113, P2646, DOI 10.1182/blood-2008-04-151191	38	30	30	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44138	10.1371/journal.pone.0044138	http://dx.doi.org/10.1371/journal.pone.0044138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970170	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400038
J	Chen, XJ; Min, DH; Yasir, TA; Hu, YG				Chen, Xiaojie; Min, Donghong; Yasir, Tauqeer Ahmad; Hu, Yin-Gang			Genetic Diversity, Population Structure and Linkage Disequilibrium in Elite Chinese Winter Wheat Investigated with SSR Markers	PLOS ONE			English	Article							LENGTH POLYMORPHISMS; MOLECULAR DIVERSITY; BREAD WHEAT; DNA	To ascertain genetic diversity, population structure and linkage disequilibrium (LD) among a representative collection of Chinese winter wheat cultivars and lines, 90 winter wheat accessions were analyzed with 269 SSR markers distributed throughout the wheat genome. A total of 1,358 alleles were detected, with 2 to 10 alleles per locus and a mean genetic richness of 5.05. The average genetic diversity index was 0.60, with values ranging from 0.05 to 0.86. Of the three genomes of wheat, ANOVA revealed that the B genome had the highest genetic diversity (0.63) and the D genome the lowest (0.56); significant differences were observed between these two genomes (P<0.01). The 90 Chinese winter wheat accessions could be divided into three subgroups based on STRUCTURE, UPGMA cluster and principal coordinate analyses. The population structure derived from STRUCTURE clustering was positively correlated to some extent with geographic eco-type. LD analysis revealed that there was a shorter LD decay distance in Chinese winter wheat compared with other wheat germplasm collections. The maximum LD decay distance, estimated by curvilinear regression, was 17.4 cM (r(2)>0.1), with a whole genome LD decay distance of approximately 2.2 cM (r(2)>0.1, P<0.001). Evidence from genetic diversity analyses suggest that wheat germplasm from other countries should be introduced into Chinese winter wheat and distant hybridization should be adopted to create new wheat germplasm with increased genetic diversity. The results of this study should provide valuable information for future association mapping using this Chinese winter wheat collection.	[Chen, Xiaojie; Min, Donghong; Yasir, Tauqeer Ahmad; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Hu, Yin-Gang] NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	cxj2638@163.com; huyingang@nwsuaf.edu.cn			Ministry of Science and Technology [2006AA100201, 2006AA100223]; Ministry of Education, P.R. China [B12007]; ACIAR Project of Australia [CIM/2005/111]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education, P.R. China(Ministry of Education, China); ACIAR Project of Australia(Australian Ctr Intl Agr Res)	This work was financially supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223) of the Ministry of Science and Technology, and the 111 Project (B12007) of Ministry of Education, P.R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKAYA MS, 1992, GENETICS, V132, P1131; Alheit KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-235; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Barrett BA, 1998, CROP SCI, V38, P1261, DOI 10.2135/cropsci1998.0011183X003800050025x; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Dreisigacker S, 2004, CROP SCI, V44, P381, DOI 10.2135/cropsci2004.0381; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Garris AJ, 2003, GENETICS, V165, P759; Hao CY, 2006, SCI CHINA SER C, V49, P218, DOI 10.1007/s11427-006-0218-z; Hao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024598; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Horvath A, 2009, THEOR APPL GENET, V119, P1523, DOI 10.1007/s00122-009-1153-8; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; MULLIS KB, 1990, SCI AM, V262, P56, DOI 10.1038/scientificamerican0490-56; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Rambaut A., 2009, FIGTREE VERSION 1 3; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1	33	86	91	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44510	10.1371/journal.pone.0044510	http://dx.doi.org/10.1371/journal.pone.0044510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957076	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800069
J	Hermann, A; Kupper, Y; Schmitz, A; Walter, B; Vaitl, D; Hennig, J; Stark, R; Tabbert, K				Hermann, Andrea; Kuepper, Yvonne; Schmitz, Anja; Walter, Bertram; Vaitl, Dieter; Hennig, Juergen; Stark, Rudolf; Tabbert, Katharina			Functional Gene Polymorphisms in the Serotonin System and Traumatic Life Events Modulate the Neural Basis of Fear Acquisition and Extinction	PLOS ONE			English	Article							TRANSPORTER GENE; AMYGDALA; ANXIETY; DISORDERS; ETIOLOGY; 5-HTTLPR; METAANALYSIS; ASSOCIATION; ACTIVATION; DEPRESSION	Fear acquisition and extinction are crucial mechanisms in the etiology and maintenance of anxiety disorders. Moreover, they might play a pivotal role in conveying the influence of genetic and environmental factors on the development of a (more or less) stronger proneness for, or resilience against psychopathology. There are only few insights in the neurobiology of genetically and environmentally based individual differences in fear learning and extinction. In this functional magnetic resonance imaging study, 74 healthy subjects were investigated. These were invited according to 5-HTTLPR/rs25531 (S+ vs. LALA; triallelic classification) and TPH2 (G(-703) T) (T+ vs. T-) genotype. The aim was to investigate the influence of genetic factors and traumatic life events on skin conductance responses (SCRs) and neural responses (amygdala, insula, dorsal anterior cingulate cortex (dACC) and ventromedial prefrontal cortex (vmPFC)) during acquisition and extinction learning in a differential fear conditioning paradigm. Fear acquisition was characterized by stronger late conditioned and unconditioned responses in the right insula in 5-HTTLPR S-allele carriers. During extinction traumatic life events were associated with reduced amygdala activation in S-allele carriers vs. non-carriers. Beyond that, T-allele carriers of the TPH2 (G(2703) T) polymorphism with a higher number of traumatic life events showed enhanced responsiveness in the amygdala during acquisition and in the vmPFC during extinction learning compared with non-carriers. Finally, a combined effect of the two polymorphisms with higher responses in S-and T-allele carriers was found in the dACC during extinction. The results indicate an increased expression of conditioned, but also unconditioned fear responses in the insula in 5-HTTLPR S-allele carriers. A combined effect of the two polymorphisms on dACC activation during extinction might be associated with prolonged fear expression. Gene-by-environment interactions in amygdala and vmPFC activation may reflect a neural endophenotype translating genetic and adverse environmental influences into vulnerability for or resilience against developing affective psychopathology.	[Hermann, Andrea; Walter, Bertram; Stark, Rudolf] Univ Giessen, Dept Psychotherapy & Syst Neurosci, Giessen, Germany; [Hermann, Andrea; Walter, Bertram; Vaitl, Dieter; Stark, Rudolf; Tabbert, Katharina] Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany; [Kuepper, Yvonne; Schmitz, Anja; Hennig, Juergen] Univ Giessen, Dept Psychol, Sect Differential Psychol & Personal Res, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Hermann, A (corresponding author), Univ Giessen, Dept Psychotherapy & Syst Neurosci, Giessen, Germany.	andrea.hermann@psychol.uni-giessen.de	Walter, Bertram/AAD-4695-2021					Alexander N, 2012, BIOL PSYCHIAT, V72, P49, DOI 10.1016/j.biopsych.2012.01.030; Alexander N, 2009, PSYCHONEUROENDOCRINO, V34, P1294, DOI 10.1016/j.psyneuen.2009.03.017; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Bockting CLH, 2013, MOL PSYCHIATR, V18, P744, DOI 10.1038/mp.2012.92; Brown SM, 2005, MOL PSYCHIATR, V10, P884, DOI 10.1038/sj.mp.4001716; Bryant RA, 2010, BIOL PSYCHIAT, V67, P1217, DOI 10.1016/j.biopsych.2010.03.016; Canli T, 2005, J NEURAL TRANSM, V112, P1479, DOI 10.1007/s00702-005-0391-4; Canli T, 2008, BIOL PSYCHOL, V79, P118, DOI 10.1016/j.biopsycho.2008.01.004; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Carlson JM, 2011, SOC COGN AFFECT NEUR, V6, P74, DOI 10.1093/scan/nsq017; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Eley TC, 2012, MOL PSYCHIATR, V17, P236, DOI 10.1038/mp.2011.132; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Hautzinger M, 2006, BECK DEPRESSION INVE, VII; Herrmann MJ, 2007, CEREB CORTEX, V17, P1160, DOI 10.1093/cercor/bhl026; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Jacob CP, 2010, EUR ARCH PSY CLIN N, V260, P317, DOI 10.1007/s00406-009-0079-0; Klucken T, 2013, HUM BRAIN MAPP, V34, P2549, DOI 10.1002/hbm.22085; Klucken T, 2013, SOC COGN AFFECT NEUR, V8, P318, DOI 10.1093/scan/nss005; Klumpers F, 2012, BIOL PSYCHOL, V89, P277, DOI 10.1016/j.biopsycho.2011.10.018; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; Laux L., 1981, STATE TRAIT ANXIETY; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Linnman C, 2012, AM J PSYCHIAT, V169, P415, DOI 10.1176/appi.ajp.2011.10121780; Lonsdorf TB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.36; Lonsdorf TB, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-99; Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Nobile M, 2009, J CHILD PSYCHOL PSYC, V50, P317, DOI 10.1111/j.1469-7610.2008.01958.x; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; PROKASY WF, 1967, J EXP PSYCHOL, V73, P247, DOI 10.1037/h0024108; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Reuter M, 2007, INT J NEUROPSYCHOPH, V10, P401, DOI 10.1017/S1461145706007073; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Walter B, 2003, NEUROIMAGE, V19; Worsley K. J., 2001, FUNCTIONAL MRI INTRO, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	61	41	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44352	10.1371/journal.pone.0044352	http://dx.doi.org/10.1371/journal.pone.0044352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957066	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800059
J	Hsu, SM; Wu, CH; Lee, JH; Hsieh, YJ; Yu, CY; Liao, YJ; Kuo, LC; Liang, JA; Huang, DYC				Hsu, Shih-Ming; Wu, Chin-Hui; Lee, Jeng-Hung; Hsieh, Ya-Ju; Yu, Chun-Yen; Liao, Yi-Jen; Kuo, Li-Cheng; Liang, Ji-An; Huang, David Y. C.			A Study on the Dose Distributions in Various Materials from an Ir-192 HDR Brachytherapy Source	PLOS ONE			English	Article							MONTE-CARLO; GLASS DOSIMETER; GAMMA-RAYS; ANISOTROPY; RECOMMENDATIONS; VERIFICATION; ATTENUATION; DIODE; I-125; TLD	Dose distributions of Ir-192 HDR brachytherapy in phantoms simulating water, bone, lung tissue, water-lung and bone-lung interfaces using the Monte Carlo codes EGS4, FLUKA and MCNP4C are reported. Experiments were designed to gather point dose measurements to verify the Monte Carlo results using Gafchromic film, radiophotoluminescent glass dosimeter, solid water, bone, and lung phantom. The results for radial dose functions and anisotropy functions in solid water phantom were consistent with previously reported data (Williamson and Li). The radial dose functions in bone were affected more by depth than those in water. Dose differences between homogeneous solid water phantoms and solid water-lung interfaces ranged from 0.6% to 14.4%. The range between homogeneous bone phantoms and bone-lung interfaces was 4.1% to 15.7%. These results support the understanding in dose distribution differences in water, bone, lung, and their interfaces. Our conclusion is that clinical parameters did not provide dose calculation accuracy for different materials, thus suggesting that dose calculation of HDR treatment planning systems should take into account material density to improve overall treatment quality.	[Hsu, Shih-Ming] China Med Univ Hosp, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Wu, Chin-Hui] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu, Taiwan; [Lee, Jeng-Hung] Inst Nucl Energy Res, Div Hlth Phys, Longtan, Taiwan; [Hsieh, Ya-Ju] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Yu, Chun-Yen; Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Liao, Yi-Jen] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Kuo, Li-Cheng] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Huang, David Y. C.] Rockville Ctr, Fac Mem Sloan Kettering Canc Ctr Rockville Ctr, New York, NY USA	China Medical University Taiwan; China Medical University Hospital - Taiwan; National Tsing Hua University; Institute of Nuclear Energy Research - Taiwan; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Memorial Sloan Kettering Cancer Center	Hsu, SM (corresponding author), China Med Univ Hosp, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	huangd@mskcc.org		Hsieh, Ya Ju/0000-0003-2082-9345; Kuo, Li Cheng/0000-0003-3740-7085	China Medical University and Hospital [CMU99-N1-08-1, CMU99-N1-08-2, DMR-98-102]	China Medical University and Hospital(China Medical University)	This work was supported by Grant Nos. CMU99-N1-08-1&2 and DMR-98-102 from the China Medical University and Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki F, 2003, MED PHYS, V30, P1976, DOI 10.1118/1.1587451; Chiu-Tsao ST, 2004, MED PHYS, V31, P201, DOI 10.1118/1.1637733; Hoshi Y, 2000, J RADIAT RES, V41, P129, DOI 10.1269/jrr.41.129; Hsu SM, 2008, MED PHYS, V35, P5558, DOI 10.1118/1.3005478; Karaiskos P, 1998, MED PHYS, V25, P1975, DOI 10.1118/1.598371; Kassas B, 2006, J APPL CLIN MED PHYS, V7, P28, DOI 10.1120/jacmp.v7i3.2293; Kirov AS, 1995, PHYS MED BIOL, V40, P2015, DOI 10.1088/0031-9155/40/12/002; MEISBERGER LL, 1968, RADIOLOGY, V90, P953, DOI 10.1148/90.5.953; MEREDITH WJ, 1966, BRIT J RADIOL, V39, P280, DOI 10.1259/0007-1285-39-460-280; Mishra V, 1997, MED PHYS, V24, P751, DOI 10.1118/1.597983; MULLERRUNKEL R, 1994, MED PHYS, V21, P1131, DOI 10.1118/1.597339; NATH R, 1990, MED PHYS, V17, P1032, DOI 10.1118/1.596584; NATH R, 1993, MED PHYS, V20, P1465, DOI 10.1118/1.597110; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Niroomand-Rad A, 1998, MED PHYS, V25, P2093, DOI 10.1118/1.598407; Pantelis E, 2005, INT J RADIAT ONCOL, V61, P1596, DOI 10.1016/j.ijrobp.2004.12.065; Sharma SD, 2004, PHYS MED BIOL, V49, P4065, DOI 10.1088/0031-9155/49/17/016; Taylor REP, 2008, MED PHYS, V35, P4933, DOI 10.1118/1.2987676; Tsuda Masayuki, 2000, Igaku Butsuri, V20, P131; Wang RQ, 1996, MED PHYS, V23, P1459, DOI 10.1118/1.597728; WILLIAMSON JF, 1995, MED PHYS, V22, P809, DOI 10.1118/1.597483	21	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44528	10.1371/journal.pone.0044528	http://dx.doi.org/10.1371/journal.pone.0044528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957078	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800071
J	Ng, SYL; Chow, BKC; Kasamatsu, J; Kasahara, M; Lee, LTO				Ng, Stephanie Y. L.; Chow, Billy K. C.; Kasamatsu, Jun; Kasahara, Masanori; Lee, Leo T. O.			Agnathan VIP, PACAP and Their Receptors: Ancestral Origins of Today's Highly Diversified Forms	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; ADENYLATE-CYCLASE; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; VPAC(1) RECEPTOR; BINDING-SITES; AMINO-ACIDS; HYPOTHALAMIC POLYPEPTIDE; HISTIDINE-ISOLEUCINE	VIP and PACAP are pleiotropic peptides belonging to the secretin superfamily of brain-gut peptides and interact specifically with three receptors (VPAC(1), PAC(1) and VPAC(2)) from the class II B G protein-coupled receptor family. There is immense interest regarding their molecular evolution which is often described closely alongside gene and/or genome duplications. Despite the wide array of information available in various vertebrates and one invertebrate the tunicate, their evolutionary origins remain unresolved. Through searches of genome databases and molecular cloning techniques, the first lamprey VIP/PACAP ligands and VPAC receptors are identified from the Japanese lamprey. In addition, two VPAC receptors (VPACa/b) are identified from inshore hagfish and ligands predicted for sea lamprey. Phylogenetic analyses group these molecules into their respective PHI/VIP, PRP/PACAP and VPAC receptor families and show they resemble ancestral forms. Japanese lamprey VIP/PACAP peptides synthesized were tested with the hagfish VPAC receptors. hfVPACa transduces signal via both adenylyl cylase and phospholipase C pathways, whilst hfVPACb was only able to transduce through the calcium pathway. In contrast to the widespread distribution of VIP/PACAP ligands and receptors in many species, the agnathan PACAP and VPAC receptors were found almost exclusively in the brain. In situ hybridisation further showed their abundance throughout the brain. The range of VIP/PACAP ligands and receptors found are highly useful, providing a glimpse into the evolutionary events both at the structural and functional levels. Though representative of ancestral forms, the VIP/PACAP ligands in particular have retained high sequence conservation indicating the importance of their functions even early in vertebrate evolution. During these nascent stages, only two VPAC receptors are likely responsible for eliciting functions before evolving later into specific subtypes post-Agnatha. We also propose VIP and PACAP's first functions to predominate in the brain, evolving alongside the central nervous system, subsequently establishing peripheral functions.	[Ng, Stephanie Y. L.; Chow, Billy K. C.; Lee, Leo T. O.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Kasamatsu, Jun; Kasahara, Masanori] Hokkaido Univ, Dept Pathol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 060, Japan	University of Hong Kong; Hokkaido University	Ng, SYL (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	ltolee2@hku.hk	Kasahara, Masanori/G-7651-2011; Lee, Leo T.O./AAB-1581-2021; Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	Hong Kong Government Research Grants Council [7686/08M, HKU6/CRF/11G]; Committee on Research and Conference [11159073]	Hong Kong Government Research Grants Council(Hong Kong Research Grants Council); Committee on Research and Conference	The present study was supported by the Hong Kong Government Research Grants Council Grants, 7686/08M to LTOL, HKU6/CRF/11G to BKCC and the Committee on Research and Conference Grants 11159073 to LTOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ben-Shlomo I, 2005, MOL ENDOCRINOL, V19, P1097, DOI 10.1210/me.2004-0451; Bentley P., 1998, COMP VERTEBRATE ENDO; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Bourgault S, 2008, P 30 EUR PEPT S, P352; CAMPBELL RM, 1992, GROWTH REGULAT, V2, P175; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; Cardoso JCR, 2007, PEPTIDES, V28, P1902, DOI 10.1016/j.peptides.2007.05.016; Cardoso JCR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-135; CAUVIN A, 1990, PEPTIDES, V11, P773, DOI 10.1016/0196-9781(90)90194-A; CHAKDER S, 1993, J PHARMACOL EXP THER, V266, P392; Chow BKC, 1997, GEN COMP ENDOCR, V105, P176, DOI 10.1006/gcen.1996.6818; Colbert E.H., 2001, COLBERTS EVOLUTION V, V5; Couvineau A, 2003, J BIOL CHEM, V278, P24759, DOI 10.1074/jbc.M301916200; COUVINEAU A, 1995, BIOCHEM BIOPH RES CO, V206, P246, DOI 10.1006/bbrc.1995.1034; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; GOTTSCHALL PE, 1990, ENDOCRINOLOGY, V127, P272, DOI 10.1210/endo-127-1-272; GOTTSCHALL PE, 1991, FASEB J, V5, P194, DOI 10.1096/fasebj.5.2.1848519; Gourlet P, 1996, REGUL PEPTIDES, V62, P125, DOI 10.1016/0167-0115(96)00010-9; Gourlet P, 1998, EUR J PHARMACOL, V348, P95, DOI 10.1016/S0014-2999(98)00133-2; Gozes I, 1999, CURR MED CHEM, V6, P1019; Gozes I, 1999, P NATL ACAD SCI USA, V96, P4143, DOI 10.1073/pnas.96.7.4143; HASHIMOTO H, 1993, NEURON, V11, P333, DOI 10.1016/0896-6273(93)90188-W; HOLLAND PWH, 1994, DEVELOPMENT, P125; Holmgren S, 2001, BRAIN RES BULL, V55, P723, DOI 10.1016/S0361-9230(01)00556-1; HOSOYA M, 1993, BIOCHEM BIOPH RES CO, V194, P133, DOI 10.1006/bbrc.1993.1795; Hoyle CHV, 1998, REGUL PEPTIDES, V73, P1, DOI 10.1016/S0167-0115(97)01073-2; Igarashi H, 2002, J PHARMACOL EXP THER, V301, P37, DOI 10.1124/jpet.301.1.37; Igarashi H, 2002, J PHARMACOL EXP THER, V303, P445, DOI 10.1124/jpet.102.038075; INAGAKI N, 1994, P NATL ACAD SCI USA, V91, P2679, DOI 10.1073/pnas.91.7.2679; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; Kamesh N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-129; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Langer I, 2005, CELL SIGNAL, V17, P17, DOI 10.1016/j.cellsig.2004.05.009; Lee LTO, 2007, P NATL ACAD SCI USA, V104, P2133, DOI 10.1073/pnas.0611008104; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; Matsuda K, 1998, PEPTIDES, V19, P1489, DOI 10.1016/S0196-9781(98)00091-6; McRory J, 1997, ENDOCRINOLOGY, V138, P2380, DOI 10.1210/en.138.6.2380; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; Montero M, 2000, J MOL ENDOCRINOL, V25, P157, DOI 10.1677/jme.0.0250157; MORROW JA, 1993, FEBS LETT, V329, P99, DOI 10.1016/0014-5793(93)80202-6; Nachtergael I, 2003, BIOCHEM J, V370, P1003, DOI 10.1042/BJ20020811; Nelson JS, 1994, FISHES WORLD, DOI 10.1002/9781119174844; Nicole P, 1998, J PHARMACOL EXP THER, V284, P744; Nicole P, 2000, J BIOL CHEM, V275, P24003, DOI 10.1074/jbc.M002325200; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; ODONNELL M, 1991, J BIOL CHEM, V266, P6389; Ohno S., 1970, P1; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; Onoue S, 1999, BIOMED RES-TOKYO, V20, P219, DOI 10.2220/biomedres.20.219; PISEGNA JR, 1993, P NATL ACAD SCI USA, V90, P6345, DOI 10.1073/pnas.90.13.6345; Pisegna JR, 1996, J BIOL CHEM, V271, P17267, DOI 10.1074/jbc.271.29.17267; ROBBERECHT P, 1992, MOL PHARMACOL, V42, P347; ROBBERECHT P, 1992, EUR J BIOCHEM, V207, P239, DOI 10.1111/j.1432-1033.1992.tb17043.x; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; Schafer H, 1999, REGUL PEPTIDES, V79, P83, DOI 10.1016/S0167-0115(98)00147-5; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; SUDA K, 1992, NEUROSCI LETT, V137, P19, DOI 10.1016/0304-3940(92)90288-I; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; SVOBODA M, 1993, BIOCHEM BIOPH RES CO, V195, P881, DOI 10.1006/bbrc.1993.2127; Tams JW, 2001, J MOL NEUROSCI, V17, P325, DOI 10.1385/JMN:17:3:325; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tse DLY, 2002, ENDOCRINOLOGY, V143, P1327, DOI 10.1210/en.143.4.1327; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; VANDERMEERS A, 1992, EUR J BIOCHEM, V208, P815, DOI 10.1111/j.1432-1033.1992.tb17252.x; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Wu S, 2008, J MOL ENDOCRINOL, V41, P343, DOI 10.1677/JME-08-0083	72	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44691	10.1371/journal.pone.0044691	http://dx.doi.org/10.1371/journal.pone.0044691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957100	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800093
J	Rivera-Serrano, EE; Rodriguez-Welsh, MF; Hicks, GR; Rojas-Pierce, M				Rivera-Serrano, Efrain E.; Rodriguez-Welsh, Maria F.; Hicks, Glenn R.; Rojas-Pierce, Marcela			A Small Molecule Inhibitor Partitions Two Distinct Pathways for Trafficking of Tonoplast Intrinsic Proteins in Arabidopsis	PLOS ONE			English	Article							AUXIN EFFLUX CARRIER; STORAGE VACUOLE; PLANT-CELLS; GOLGI-APPARATUS; IN-VIVO; ENDOSOMAL TRAFFICKING; SECRETORY PATHWAY; PLASMA-MEMBRANE; MECHANISMS; TRANSPORT	Tonoplast intrinsic proteins (TIPs) facilitate the membrane transport of water and other small molecules across the plant vacuolar membrane, and members of this family are expressed in specific developmental stages and tissue types. Delivery of TIP proteins to the tonoplast is thought to occur by vesicle-mediated traffic from the endoplasmic reticulum to the vacuole, and at least two pathways have been proposed, one that is Golgi-dependent and another that is Golgi-independent. However, the mechanisms for trafficking of vacuolar membrane proteins to the tonoplast remain poorly understood. Here we describe a chemical genetic approach to unravel the mechanisms of TIP protein targeting to the vacuole in Arabidopsis seedlings. We show that members of the TIP family are targeted to the vacuole via at least two distinct pathways, and we characterize the bioactivity of a novel inhibitor that can differentiate between them. We demonstrate that, unlike for TIP1;1, trafficking of markers for TIP3;1 and TIP2;1 is insensitive to Brefeldin A in Arabidopsis hypocotyls. Using a chemical inhibitor that may target this BFA-insensitive pathway for membrane proteins, we show that inhibition of this pathway results in impaired root hair growth and enhanced vacuolar targeting of the auxin efflux carrier PIN2 in the dark. Our results indicate that the vacuolar targeting of PIN2 and the BFA-insensitive pathway for tonoplast proteins may be mediated in part by common mechanisms.	[Rivera-Serrano, Efrain E.; Rodriguez-Welsh, Maria F.; Rojas-Pierce, Marcela] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Hicks, Glenn R.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Hicks, Glenn R.] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of North Carolina; North Carolina State University; University of California System; University of California Riverside; University of California System; University of California Riverside	Rivera-Serrano, EE (corresponding author), N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA.	mrojasp@ncsu.edu		Rivera-Serrano, Efrain E./0000-0002-1039-7182; Rojas-Pierce, Marcela/0000-0003-1051-1827	NC State Initiative for Maximizing Student Diversity (IMSD) program; U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; North Carolina State University; National Science Foundation [IOS-0951616]; North Carolina Space Grant New Investigators Program award	NC State Initiative for Maximizing Student Diversity (IMSD) program; U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; North Carolina State University; National Science Foundation(National Science Foundation (NSF)); North Carolina Space Grant New Investigators Program award	ERS was supported by the NC State Initiative for Maximizing Student Diversity (IMSD) program and a U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship. This work was supported by start-up funds from North Carolina State University, a grant for the National Science Foundation (IOS-0951616) and North Carolina Space Grant New Investigators Program award to MRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bolte S, 2011, PLANT CELL PHYSIOL, V52, P1142, DOI 10.1093/pcp/pcr065; Bottanelli F, 2011, PLANT CELL; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Di Sansebastiano GP, 2001, PLANT PHYSIOL, V126, P78, DOI 10.1104/pp.126.1.78; Ding ZJ, 2011, NAT CELL BIOL, V13, P447, DOI 10.1038/ncb2208; Drakakaki G, 2011, P NATL ACAD SCI USA, V108, P17850, DOI 10.1073/pnas.1108581108; Drakakaki G, 2009, PLANT SIGNAL BEHAV, V4, P57, DOI 10.4161/psb.4.1.7314; Dunkel M, 2008, MOL PLANT, V1, P938, DOI 10.1093/mp/ssn064; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Frigerio L, 2008, TRAFFIC, V9, P1564, DOI 10.1111/j.1600-0854.2008.00776.x; Fuji K, 2007, PLANT CELL, V19, P597, DOI 10.1105/tpc.106.045997; Gattolin S, 2011, MOL PLANT, V4, P180, DOI 10.1093/mp/ssq051; Gattolin S, 2010, BIOCHEM SOC T, V38, P769, DOI 10.1042/BST0380769; Gattolin S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-133; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; GOMEZ L, 1993, PLANT CELL, V5, P1113, DOI 10.1105/tpc.5.9.1113; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Grunewald W, 2010, EMBO J, V29, P2700, DOI 10.1038/emboj.2010.181; Hunter PR, 2007, PLANT PHYSIOL, V145, P1371, DOI 10.1104/pp.107.103945; Hwang I, 2008, PLANT PHYSIOL, V148, P673, DOI 10.1104/pp.108.124925; Isayenkov S, 2011, PLANT CELL, V23, P756, DOI 10.1105/tpc.110.081463; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jauh GY, 1999, PLANT CELL, V11, P1867, DOI 10.1105/tpc.11.10.1867; Jiang LW, 2000, J CELL BIOL, V150, P755, DOI 10.1083/jcb.150.4.755; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Lam SK, 2009, PLANT J, V60, P865, DOI 10.1111/j.1365-313X.2009.04007.x; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; Maurel C, 2009, CURR OPIN PLANT BIOL, V12, P690, DOI 10.1016/j.pbi.2009.09.002; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Olbrich A, 2007, PLANT PHYSIOL, V145, P1383, DOI 10.1104/pp.107.108985; Paris N, 1996, CELL, V85, P563, DOI 10.1016/S0092-8674(00)81256-8; Park M, 2004, PLANT PHYSIOL, V134, P625, DOI 10.1104/pp.103.030635; Reyes FC, 2011, CURR OPIN PLANT BIOL, V14, P666, DOI 10.1016/j.pbi.2011.07.009; Reyes FC, 2011, PLANT CELL, V23, P769, DOI 10.1105/tpc.110.082156; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Richter S, 2009, TRAFFIC, V10, P819, DOI 10.1111/j.1600-0854.2009.00916.x; Robert S, 2008, P NATL ACAD SCI USA, V105, P8464, DOI 10.1073/pnas.0711650105; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Rojo E, 2001, DEV CELL, V1, P303, DOI 10.1016/S1534-5807(01)00024-7; Rojo E, 2008, PLANT PHYSIOL, V147, P1493, DOI 10.1104/pp.108.124552; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; Sohn EJ, 2007, P NATL ACAD SCI USA, V104, P18801, DOI 10.1073/pnas.0708236104; Surpin M, 2004, NAT REV MOL CELL BIO, V5, P100, DOI 10.1038/nrm1311; Tanaka H, 2009, CURR BIOL, V19, P391, DOI 10.1016/j.cub.2009.01.057; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Tyrrell M, 2007, PLANT J, V51, P1099, DOI 10.1111/j.1365-313X.2007.03206.x; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; Wolfenstetter S, 2012, PLANT CELL; Wolfenstetter S, 2012, PLANT CELL, V24, P215, DOI 10.1105/tpc.111.090415; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Yao HY, 2011, CURR OPIN PLANT BIOL, V14, P571, DOI 10.1016/j.pbi.2011.06.009; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang Y, 2010, SEX PLANT REPROD, V23, P87, DOI 10.1007/s00497-009-0118-z; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x; Zheng HQ, 2011, PLANT PHYSIOL, V155, P2023, DOI 10.1104/pp.110.170159	72	31	31	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44735	10.1371/journal.pone.0044735	http://dx.doi.org/10.1371/journal.pone.0044735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957103	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800096
J	Sato, N; Suzuki, N; Sasaki, A; Aizawa, E; Obayashi, T; Kanazawa, M; Mizuno, T; Kano, M; Aoki, M; Fukudo, S				Sato, Naoko; Suzuki, Naoki; Sasaki, Ayaka; Aizawa, Emiko; Obayashi, Takeshi; Kanazawa, Motoyori; Mizuno, Tomoko; Kano, Michiko; Aoki, Masashi; Fukudo, Shin			Corticotropin-Releasing Hormone Receptor 1 Gene Variants in Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; ENTERIC NERVOUS-SYSTEM; ADULT DEPRESSION; CHILDHOOD MALTREATMENT; ANXIETY BEHAVIOR; SEX-DIFFERENCES; CRF1 RECEPTOR; EXPRESSION; BRAIN; STRESS	Background: Corticotropin-releasing hormone (CRH) acts mainly via the CRH receptor 1 (CRH-R1) and plays a crucial role in the stress-induced pathophysiology of irritable bowel syndrome (IBS). Several studies have demonstrated that variants of the CRH-R1 gene carry a potential risk for depression, but evidence for an association between CRH-R1 genotypes and IBS is lacking. We tested the hypothesis that genetic polymorphisms and haplotypes of CRH-R1 moderate the IBS phenotype and negative emotion in IBS patients. Methods: A total of 103 patients with IBS and 142 healthy controls participated in the study. Three single-nucleotide polymorphisms of the CRH-R1 gene (rs7209436, rs242924, and rs110402) were genotyped. Subjects' emotional states were evaluated using the Perceived-Stress Scale, the State-Trait Anxiety Inventory, and the Self-rating Depression Scale. Results: The TT genotype of rs7209436 (P = 0.01) and rs242924 (P = 0.02) was significantly more common in patients with IBS than in controls. Total sample analysis showed significant association between bowel pattern (normal, diarrhea, constipation, or mixed symptoms) and the T allele of rs7209436 (P = 0.008), T allele of rs242924 (P = 0.019), A allele of rs110402 (P = 0.047), and TAT haplocopies (P = 0.048). Negative emotion was not associated with the examined CRH-R1 SNPs. Conclusion: These findings suggest that genetic polymorphisms and the CRH-R1 haplotypes moderate IBS and related bowel patterns. There was no clear association between CRH-R1 genotypes and negative emotion accompanying IBS. Further studies on the CRH system are therefore warranted.	[Sato, Naoko; Sasaki, Ayaka; Aizawa, Emiko; Kanazawa, Motoyori; Mizuno, Tomoko; Kano, Michiko; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Suzuki, Naoki; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Obayashi, Takeshi] Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Human & Life Sci, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Sato, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan.	sfukudo@med.tohoku.ac.jp	Suzuki, Naoki/J-6331-2019; Kano, Michiko/K-6527-2013; Fukudo, Shin/J-4813-2014; Obayashi, Takeshi/E-9663-2011	Suzuki, Naoki/0000-0001-8880-8554; Obayashi, Takeshi/0000-0002-3106-722X	Ministry of Education, Science, and Culture of Japan; Ministry of Health, Welfare, and Labor of Japan; Grants-in-Aid for Scientific Research [24114005, 22590646] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan and Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouin M, 2002, GASTROENTEROLOGY, V122, P1771, DOI 10.1053/gast.2002.33601; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Brunton PJ, 2011, STRESS, V14, P634, DOI 10.3109/10253890.2011.604750; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DeYoung CG, 2011, J CHILD PSYCHOL PSYC, V52, P898, DOI 10.1111/j.1469-7610.2011.02404.x; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Fukudo S, 1998, GUT, V42, P845, DOI 10.1136/gut.42.6.845; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; FUKUDO S, 1993, J CLIN GASTROENTEROL, V17, P133, DOI 10.1097/00004836-199309000-00009; Fukudo S, 2012, PHYSL GASTROINTESTIN, P795; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Grammatopoulos DK, 2012, BRIT J PHARMACOL, V166, P85, DOI 10.1111/j.1476-5381.2011.01631.x; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hsu DT, 2012, J NEUROSCI, V32, P3253, DOI 10.1523/JNEUROSCI.5533-11.2012; Hubbard CS, 2011, J NEUROSCI, V31, P12491, DOI 10.1523/JNEUROSCI.1860-11.2011; Iwahasi S, 2002, JPN J PSYCHOSOM MED, V42, P459; Kageyama K, 2009, ENDOCR J, V56, P335, DOI 10.1507/endocrj.K09E-075; Kanazawa M, 2004, DIGEST DIS SCI, V49, P1046, DOI 10.1023/B:DDAS.0000034570.52305.10; Kanazawa M, 2008, AM J GASTROENTEROL, V103, P2550, DOI 10.1111/j.1572-0241.2008.02066.x; Liu SM, 2006, J COMP NEUROL, V494, P63, DOI 10.1002/cne.20781; Liu SM, 2005, J COMP NEUROL, V481, P284, DOI 10.1002/cne.20370; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Markovic D, 2009, TRENDS BIOCHEM SCI, V34, P443, DOI 10.1016/j.tibs.2009.06.002; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Miyata K, 1998, AM J PHYSIOL-GASTR L, V274, pG827, DOI 10.1152/ajpgi.1998.274.5.G827; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; MONNIKES H, 1993, GASTROENTEROLOGY, V104, P716; Muramatsu Y, 2000, PEPTIDES, V21, P1799, DOI 10.1016/S0196-9781(00)00335-1; NAKAZATO K, 1989, PERCEPT MOTOR SKILL, V69, P611, DOI 10.2466/pms.1989.69.2.611; Papiol S, 2007, J AFFECT DISORDERS, V104, P83, DOI 10.1016/j.jad.2007.02.017; Pisarchik A, 2001, FASEB J, V15, P2754, DOI 10.1096/fj.01-0487fje; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Saito K, 2005, GASTROENTEROLOGY, V129, P1533, DOI 10.1053/j.gastro.2005.07.053; Seino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032913; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steckler T, 1999, BIOL PSYCHIAT, V46, P1480, DOI 10.1016/S0006-3223(99)00170-5; Sterrenburg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028128; Tayama J, 2007, NEUROGASTROENT MOTIL, V19, P471, DOI 10.1111/j.1365-2982.2007.00903.x; Tyrka AR, 2009, BIOL PSYCHIAT, V66, P681, DOI 10.1016/j.biopsych.2009.05.012; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; Zmijewski MA, 2010, ACTA BIOCHIM POL, V57, P1; Zmijewski MA, 2009, J CELL PHYSIOL, V218, P593, DOI 10.1002/jcp.21632; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	53	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42450	10.1371/journal.pone.0042450	http://dx.doi.org/10.1371/journal.pone.0042450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957021	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800013
J	He, L; Ding, H; Wang, JH; Zhou, Y; Li, L; Yu, YH; Huang, L; Jia, WH; Zeng, MS; Yun, JP; Luo, RZ; Zheng, M				He, Li; Ding, Hui; Wang, Jian-Hua; Zhou, Yun; Li, Li; Yu, Yan-Hong; Huang, Long; Jia, Wei-Hua; Zeng, Musheng; Yun, Jing-Ping; Luo, Rong-Zhen; Zheng, Min			Overexpression of Karyopherin 2 in Human Ovarian Malignant Germ Cell Tumor Correlates with Poor Prognosis	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; BREAST-CANCER; DIAGNOSTIC UTILITY; GENETIC-ANALYSIS; EXPRESSION; ALPHA-2; KPNA2; CYTOGENETICS; TERATOMAS; SURVIVAL	Background: The aim of this study was to identify a biomarker useful in the diagnosis and therapy of ovarian malignant germ cell tumor (OMGCT). Methods: The karyopherin 2 (KPNA2) expression in OMGCT and normal ovarian tissue was determined by standard gene microarray assays, and further validated by a quantitative RT-PCR and immunohistochemistry. The correlation between KPNA2 expression in OMGCT and certain clinicopathological features were analyzed. Expression of SALL4, a stem cell marker, was also examined in comparison with KPNA2. Results: KPNA2 was found to be over-expressed by approximately eight-fold in yolk sac tumors and immature teratomas compared to normal ovarian tissue by microarray assays. Overexpression was detected in yolk sac tumors, immature teratomas, dysgerminomas, embryonal carcinomas, mature teratomas with malignant transformation and mixed ovarian germ cell tumors at both the transcription and translation levels. A positive correlation between KPNA2 and SALL4 expression at both the transcription level (R = 0.5120, P = 0.0125), and the translation level (R = 0.6636, P<0.0001), was presented. Extensive expression of KPNA2 was positively associated with pathologic type, recurrence and uncontrolled, ascitic fluid presence, suboptimal cytoreductive surgery necessity, resistance/refraction to initial chemotherapy, HCG level and SALL4 level in OMGCT patients. KPNA2 was found to be an independent factor for 5-year disease-free survival (DFS) of OMGCT (P = 0.02). The 5-year overall survival (OS) and DFS rate for KPNA2-low expression patients (88% and 79%, n = 48) were significantly higher than the OS and DFS rate for KPNA2-high expression patients (69% and 57.1%, n = 42)(P = 0.0151, P = 0.0109, respectively). The 5-year OS and DFS rate for SALL4-low expression patients (84% and 74%, n = 62) was marginally significantly higher than the high expression patients (78.6% and 71.4%, n = 28)(P = 0.0519, P = 0.0647, respectively). Conclusions: KPNA2 is a potential candidate molecular marker and important prognostic marker in OMGCT patients.	[He, Li; Ding, Hui; Zhou, Yun; Huang, Long; Jia, Wei-Hua; Zeng, Musheng; Zheng, Min] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [He, Li; Ding, Hui; Zhou, Yun; Huang, Long; Zheng, Min] Sun Yat Sen Univ, Dept Gynecol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Yun, Jing-Ping; Luo, Rong-Zhen] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jian-Hua] Second Peoples Hosp Guangdong Prov, Dept Chest, Guangzhou, Guangdong, Peoples R China; [Li, Li] Sun Yat Sen Univ, Dept Gynecol, Huang Pu Dist Hosp, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Yan-Hong] So Med Univ, Dept Obstet & Gynecol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	He, L (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	zheng_min_2006@yahoo.com.cn	Yu, Yan/GYV-4514-2022		National Natural Science Foundation of China [81171948]; Science and Technology Planning Project of Guangdong Province [2009B030801018]; Research Fund of State Key Laboratory of Oncology in Southern China [030041060004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Research Fund of State Key Laboratory of Oncology in Southern China	This study was supported by grants from the National Natural Science Foundation of China (grant 81171948), the Science and Technology Planning Project of Guangdong Province (grant 2009B030801018) and the Research Fund of State Key Laboratory of Oncology in Southern China (No. 030041060004) to Dr. Min Zheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade R, 2003, CHROMOSOMA, V112, P87, DOI 10.1007/s00412-003-0247-3; Bjerggaard JJ, 2011, EURO UROL, V59, P841; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Dankof A, 2007, VIRCHOWS ARCH, V451, P877, DOI 10.1007/s00428-007-0513-5; Dorr S, 2001, HUM GENET, V109, P479, DOI 10.1007/s004390100605; Faulkner SW, 2000, GYNECOL ONCOL, V77, P283, DOI 10.1006/gyno.2000.5762; Fischer N, 1997, J BIOL CHEM, V272, P3999, DOI 10.1074/jbc.272.7.3999; GERSHENSON DM, 1993, CANCER-AM CANCER SOC, V71, P1581, DOI 10.1002/cncr.2820710425; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; HOFFNER L, 1992, CANCER GENET CYTOGEN, V62, P58, DOI 10.1016/0165-4608(92)90040-F; KING ME, 1990, INT J GYNECOL PATHOL, V9, P178, DOI 10.1097/00004347-199004000-00009; Kraggerud SM, 2000, CANCER RES, V60, P3025; Kwon JS, 2010, J CLIN ONCOL, V28, P675, DOI 10.1200/JCO.2008.21.4684; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Liu AJ, 2010, AM J SURG PATHOL, V34, P697, DOI 10.1097/PAS.0b013e3181db84aa; Mei KY, 2009, MODERN PATHOL, V22, P1628, DOI 10.1038/modpathol.2009.148; Menon U, 2007, HUM REPROD, V22, P1573, DOI 10.1093/humrep/dem055; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; odriguez E, 1995, CAN GENET CYTO, V82, P62; Quinn JE, 2009, GYNECOL ONCOL, V113, P134, DOI 10.1016/j.ygyno.2008.12.015; Richards WE, 1999, GYNECOL ONCOL, V75, P468, DOI 10.1006/gyno.1999.5645; Riopel MA, 1998, CANCER RES, V58, P3105; Smith HO, 2006, OBSTET GYNECOL, V107, P1075, DOI 10.1097/01.AOG.0000216004.22588.ce; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; SPELEMAN F, 1990, CANCER GENET CYTOGEN, V45, P49, DOI 10.1016/0165-4608(90)90065-I; SURTI U, 1990, AM J HUM GENET, V47, P635; Teng SC, 2006, J MOL HISTOL, V37, P293, DOI 10.1007/s10735-006-9032-y; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Trinh DT, 2012, J OBSTET GYNAECOL RE, V38, P841, DOI 10.1111/j.1447-0756.2011.01798.x; Umegaki N, 2007, J INVEST DERMATOL, V127, P1456, DOI 10.1038/sj.jid.5700716; Umezu Tomokazu, 2008, Nagoya J Med Sci, V70, P29; Valarmathi Mani T, 2004, Hum Mutat, V23, P205, DOI 10.1002/humu.9213; van Echten J, 1998, INT J CANCER, V77, P217, DOI 10.1002/(SICI)1097-0215(19980717)77:2<217::AID-IJC8>3.0.CO;2-T; Wang CI, 2011, INT J CANCER, V128, P2364, DOI 10.1002/ijc.25568; Zheng M, 2010, OBSTET GYNECOL, V116, P884, DOI 10.1097/AOG.0b013e3181f104ce	38	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e42992	10.1371/journal.pone.0042992	http://dx.doi.org/10.1371/journal.pone.0042992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962582	Green Submitted, gold, Green Published			2022-12-25	WOS:000308577600009
J	Jung, JJ; Tiwari, A; Inamdar, SM; Thomas, CP; Goel, A; Choudhury, A				Jung, Jae-Joon; Tiwari, Ajit; Inamdar, Shivangi M.; Thomas, Christie P.; Goel, Apollina; Choudhury, Amit			Secretion of Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFlt1) Requires Arf1, Arf6, and Rab11 GTPases	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; REGULATED EXOCYTOSIS; ENDOCYTIC PATHWAYS; ANGIOGENIC FACTORS; GOLGI TRANSPORT; COAT PROTEINS; PREECLAMPSIA; TRAFFICKING; CELLS	The soluble form of vascular endothelial growth factor receptor 1 (sVEGFR-1/sFlt1) is generated by alternative splicing of the FLT1 gene. Secretion of sFlt1 from endothelial cells plays an important role in blood vessel sprouting and morphogenesis. However, excess sFlt1 secretion is associated with diseases such as preeclampsia and chronic kidney disease. To date, the secretory transport process involved in the secretion of sFlt1 is poorly understood. In the present study, we investigated the itinerary of sFlt1 trafficking along the secretory pathway. To understand the timecourse of sFlt1 secretion, endothelial cells stably expressing sFlt1 were metabolically radiolabeled with [S-35]-methionine and cysteine. Our results indicate that after initial synthesis the levels of secreted [S-35]-sFlt1 in the extracellular medium peaks at 8 hours. Treatment with brefeldin A (BFA), a drug which blocks trafficking between the endoplasmic reticulum (ER) and the Golgi complex, inhibited extracellular release of sFlt1 suggesting that ER to Golgi and intra-Golgi trafficking of sFlt1 are essential for its secretion. Furthermore, we show that ectopic expression of dominant-negative mutant forms of Arf1, Arf6, and Rab11 as well as siRNA-mediated knockdown of these GTPases block secretion of sFlt1 during normoxic and hypoxic conditions suggesting role for these small GTPases. This work is the first to report role of regulatory proteins involved in sFlt1 trafficking along the secretory pathway and may provide insights and new molecular targets for the modulation of sFlt-1 release during physiological and pathological conditions.	[Jung, Jae-Joon; Tiwari, Ajit; Inamdar, Shivangi M.; Choudhury, Amit] Univ Iowa, Dept Anat, Iowa City, IA 52242 USA; [Jung, Jae-Joon; Tiwari, Ajit; Inamdar, Shivangi M.; Choudhury, Amit] Univ Iowa, Dept Cell Biol, Iowa City, IA USA; [Choudhury, Amit] Univ Iowa, Dept Orthopaed, Iowa City, IA USA; [Choudhury, Amit] Univ Iowa, Dept Rehabil, Iowa City, IA USA; [Thomas, Christie P.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Goel, Apollina] Univ Iowa, Dept Radiat Oncol, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Jung, JJ (corresponding author), Univ Iowa, Dept Anat, Iowa City, IA 52242 USA.	amit-choudhury@uiowa.edu	Jung, Jae-Joon/I-2186-2014	Thomas, Christie/0000-0002-5989-9685	National Institutes of Health, National Heart, Lung, and Blood Institute [HL089599]; NATIONAL CANCER INSTITUTE [R01CA127958] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090053] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from National Institutes of Health, National Heart, Lung, and Blood Institute (HL089599 to AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Al-Awar O, 2000, MOL CELL BIOL, V20, P5998, DOI 10.1128/MCB.20.16.5998-6007.2000; Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Charnock-Jones DS, 2002, J ANAT, V200, P607, DOI 10.1046/j.1469-7580.2002.00063.x; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kuliawat R, 2004, MOL BIOL CELL, V15, P1690, DOI 10.1091/mbc.E03-08-0554; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lippincott-Schwartz J, 1998, HISTOCHEM CELL BIOL, V109, P449, DOI 10.1007/s004180050247; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; PARK JE, 1994, J BIOL CHEM, V269, P25646; Pau E, 2006, HUM REPROD, V21, P1453, DOI 10.1093/humrep/del005; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roeckl W, 1998, EXP CELL RES, V241, P161, DOI 10.1006/excr.1998.4039; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Yang CZ, 1999, J BIOL CHEM, V274, P25297, DOI 10.1074/jbc.274.36.25297	66	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44572	10.1371/journal.pone.0044572	http://dx.doi.org/10.1371/journal.pone.0044572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962618	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600070
J	Matarraz, S; Teodosio, C; Fernandez, C; Albors, M; Jara-Acevedo, M; Lopez, A; Gonzalez-Gonzalez, M; Gutierrez, ML; Flores-Montero, J; Cervero, C; Pizarro-Perea, M; Garrastazul, MP; Caballero, G; Gutierrez, O; Mendez, GD; Gonzalez-Silva, M; Laranjeira, P; Orfao, A				Matarraz, Sergio; Teodosio, Cristina; Fernandez, Carlos; Albors, Manuel; Jara-Acevedo, Maria; Lopez, Antonio; Gonzalez-Gonzalez, Maria; Laura Gutierrez, Maria; Flores-Montero, Juan; Cervero, Carlos; Pizarro-Perea, Marlies; Paz Garrastazul, Maria; Caballero, Gonzalo; Gutierrez, Oliver; Daniel Mendez, Guy; Gonzalez-Silva, Manuel; Laranjeira, Paula; Orfao, Alberto			The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome	PLOS ONE			English	Article							PROGNOSTIC SCORING SYSTEM; DNA-CONTENT; HEMATOPOIETIC-CELLS; GENE-EXPRESSION; RISK-ASSESSMENT; CLASSIFICATION; CYTOGENETICS; APOPTOSIS; SURVIVAL; DENSITY	Myelodysplastic syndromes (MDS) are clonal stem cell disorders which frequently show a hypercellular dysplastic bone marrow (BM) associated with inefficient hematopoiesis and peripheral cytopenias due to increased apoptosis and maturation blockades. Currently, little is known about the role of cell proliferation in compensating for the BM failure syndrome and in determining patient outcome. Here, we analyzed the proliferation index (PI) of different compartments of BM hematopoietic cells in 106 MDS patients compared to both normal/reactive BM (n = 94) and acute myeloid leukemia (AML; n = 30 cases) using multiparameter flow cytometry. Our results show abnormally increased overall BM proliferation profiles in MDS which significantly differ between early/low-risk and advanced/high-risk cases. Early/low-risk patients showed increased proliferation of non-lymphoid CD34(+) precursors, maturing neutrophils and nucleated red blood cells (NRBC), while the PI of these compartments of BM precursors progressively fell below normal values towards AML levels in advanced/high-risk MDS. Decreased proliferation of non-lymphoid CD34(+) and NRBC precursors was significantly associated with adverse disease features, shorter overall survival (OS) and transformation to AML, both in the whole series and when low-and high-risk MDS patients were separately considered, the PI of NRBC emerging as the most powerful independent predictor for OS and progression to AML. In conclusion, assessment of the PI of NRBC, and potentially also of other compartments of BM precursors (e. g.: myeloid CD34(+) HPC), could significantly contribute to a better management of MDS.	[Matarraz, Sergio; Teodosio, Cristina; Fernandez, Carlos; Jara-Acevedo, Maria; Lopez, Antonio; Gonzalez-Gonzalez, Maria; Laura Gutierrez, Maria; Flores-Montero, Juan; Laranjeira, Paula; Orfao, Alberto] Univ Salamanca, Inst Biol Celular & Mol Canc, CSIC USAL, Ctr Invest Canc,IBSAL,Serv Citometria, E-37008 Salamanca, Spain; [Matarraz, Sergio; Teodosio, Cristina; Fernandez, Carlos; Jara-Acevedo, Maria; Lopez, Antonio; Gonzalez-Gonzalez, Maria; Laura Gutierrez, Maria; Flores-Montero, Juan; Laranjeira, Paula; Orfao, Alberto] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Albors, Manuel] Hosp Juan Canalejo, Serv Hematol, La Coruna, Spain; [Cervero, Carlos] Hosp Virgen de la Luz, Serv Hematol, Cuenca, Spain; [Pizarro-Perea, Marlies] Hosp Lucus Augusti, Serv Hematol, Lugo, Spain; [Paz Garrastazul, Maria] Hosp Punta de Europa, Serv Hematol, Algeciras, Spain; [Caballero, Gonzalo] Hosp San Jorge, Serv Hematol, Huesca, Spain; [Gutierrez, Oliver] Hosp Rio Hortega, Serv Hematol, Valladolid, Spain; [Daniel Mendez, Guy] Hosp Jerez de la Frontera, Serv Hematol, Cadiz, Spain; [Gonzalez-Silva, Manuel] Hosp La Linea, Serv Hematol, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Salamanca; Complejo Hospitalario Universitario A Coruna; Hospital Universitario Lucus Augusti-Lugo; Hospital Universidad San Jorge; Hospital del Rio Hortega	Matarraz, S (corresponding author), Univ Salamanca, Inst Biol Celular & Mol Canc, CSIC USAL, Ctr Invest Canc,IBSAL,Serv Citometria, E-37008 Salamanca, Spain.	orfao@usal.es	Laranjeira, Paula/B-3806-2014; Mendez, Guy D/AAE-9169-2020; Gutiérrez, María Laura/AAY-9195-2020; Orfao, Alberto/B-5801-2017; Gutiérrez, María Laura ML/J-4313-2016; Matarraz, Sergio/AAE-8249-2019; Flores-Montero, Juan/AAA-2312-2020; Caballero, Gonzalo/GZG-3828-2022	Laranjeira, Paula/0000-0002-1136-6118; Gutiérrez, María Laura/0000-0003-2997-6317; Gutiérrez, María Laura ML/0000-0003-2997-6317; Flores-Montero, Juan/0000-0002-1119-4387; MATARRAZ, SERGIO/0000-0003-4634-8005; Jara-Acevedo, Maria/0000-0001-7965-7512; Teodosio, Cristina/0000-0002-2097-7199; Fernandez-Gimenez, Carlos/0000-0002-6871-454X; , Maria Gonzalez-Gonzalez/0000-0001-8115-1086	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain [RTICC RD06/0020/0035]; Programa Personal Tecnico de Apoyo a la Investigacion, Ministerio de Ciencia e Innovacion - Universidad de Salamanca, Spain	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; Programa Personal Tecnico de Apoyo a la Investigacion, Ministerio de Ciencia e Innovacion - Universidad de Salamanca, Spain	This work has been partially supported by the following grants: RTICC RD06/0020/0035 - Fondo Europeo de Desarrollo Regional FEDER) - from the Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; M.J.-A. was supported by a grant from the Programa Personal Tecnico de Apoyo a la Investigacion, Ministerio de Ciencia e Innovacion - Universidad de Salamanca, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agool A, 2006, J NUCL MED, V47, P1592; Alexandrakis MG, 2004, J MOL HISTOL, V35, P857, DOI 10.1007/s10735-004-2341-0; ALIMENA G, 1985, CANCER GENET CYTOGEN, V16, P207, DOI 10.1016/0165-4608(85)90047-0; Cazzola M, 2011, HAEMATOL-HEMATOL J, V96, P349, DOI 10.3324/haematol.2010.030023; Cazzola M, 2010, HEMATOL ONCOL CLIN N, V24, P459, DOI 10.1016/j.hoc.2010.02.005; Darzynkiewicz Z, 1998, Hum Cell, V11, P3; Economopoulou C, 2010, ANN HEMATOL, V89, P349, DOI 10.1007/s00277-009-0835-2; FONATSCH C, 1994, LEUKEMIA, V8, P1318; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Gueller S, 2010, EXP HEMATOL, V38, P718, DOI 10.1016/j.exphem.2010.04.018; Head DR, 2011, BONE MARROW RES, DOI 10.1155/2011/950934; Hofmann WK, 2006, LEUKEMIA RES, V30, P1347, DOI 10.1016/j.leukres.2006.03.015; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1351, DOI 10.1002/cncr.23697; Ketterling RP, 2002, LEUKEMIA RES, V26, P235, DOI 10.1016/S0145-2126(01)00117-5; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Malcovati L, 2011, HAEMATOL-HEMATOL J, V96, P1433, DOI 10.3324/haematol.2011.044602; Matarraz S, 2008, LEUKEMIA, V22, P1175, DOI 10.1038/leu.2008.49; Matarraz S, 2011, CYTOM PART B-CLIN CY, V80B, P354, DOI 10.1002/cyto.b.20605; Matarraz S, 2010, CYTOM PART B-CLIN CY, V78B, P154, DOI 10.1002/cyto.b.20513; Mitelman F, 1995, ISCN INT SYSTEM HUMA, P78; MONTECUCCO C, 1983, CYTOMETRY, V4, P238, DOI 10.1002/cyto.990040308; MONTECUCCO C, 1983, CANCER, V52, P1190, DOI 10.1002/1097-0142(19831001)52:7<1190::AID-CNCR2820520711>3.0.CO;2-R; Mossner M, 2010, EXP HEMATOL, V38, P661, DOI 10.1016/j.exphem.2010.03.022; Naqvi K, 2011, J CLIN ONCOL, V29, P2240, DOI 10.1200/JCO.2010.31.3353; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; PETERS SW, 1986, BRIT J HAEMATOL, V62, P239, DOI 10.1111/j.1365-2141.1986.tb02927.x; Primo D, 2006, BRIT J HAEMATOL, V135, P43, DOI 10.1111/j.1365-2141.2006.06265.x; Rajapaksa R, 1996, BLOOD, V88, P4275; Saunthararajah Y, 2012, SEMIN ONCOL, V39, P97, DOI 10.1053/j.seminoncol.2011.11.011; Swerts K, 2007, CLIN CHIM ACTA, V379, P154, DOI 10.1016/j.cca.2006.12.008; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Teofili L, 1998, EXP HEMATOL, V26, P1133; Valencia A, 2010, LEUKEMIA RES, V35, P479; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Varma N, 2008, INDIAN J PATHOL MICR, V51, P97, DOI 10.4103/0377-4929.40416; Vasikova A, 2010, LEUKEMIA RES, V34, P1566, DOI 10.1016/j.leukres.2010.02.021	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44321	10.1371/journal.pone.0044321	http://dx.doi.org/10.1371/journal.pone.0044321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952954	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300080
J	Rodger, S; Stephens, E; Clark, M; Ash, S; Hurst, C; Graves, N				Rodger, Sylvia; Stephens, Elizabeth; Clark, Michele; Ash, Susan; Hurst, Cameron; Graves, Nicholas			Productivity and Time Use during Occupational Therapy and Nutrition/Dietetics Clinical Education: A Cohort Study	PLOS ONE			English	Article							LEVEL-II FIELDWORK; DIETETIC INTERNSHIPS; BENEFITS; STUDENTS; COST	Background: Currently in the Australian higher education sector higher productivity from allied health clinical education placements is a contested issue. This paper will report results of a study that investigated output changes associated with occupational therapy and nutrition/dietetics clinical education placements in Queensland, Australia. Supervisors' and students' time use during placements and how this changes for supervisors compared to when students are not present in the workplace is also presented. Methodology/Principal Findings: A cohort design was used with students from four Queensland universities, and their supervisors employed by Queensland Health. There was an increasing trend in the number of occasions of service delivered when the students were present, and a statistically significant increase in the daily mean length of occasions of service delivered during the placement compared to pre-placement levels. Conclusions/Significance: A novel method for estimating productivity and time use changes during clinical education programs for allied health disciplines has been applied. During clinical education placements there was a net increase in outputs, suggesting supervisors engage in longer consultations with patients for the purpose of training students, while maintaining patient numbers. Other activities were reduced. This paper is the first time these data have been shown in Australia and form a sound basis for future assessments of the economic impact of student placements for allied health disciplines.	[Rodger, Sylvia] Univ Queensland, Div Occupat Therapy, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Stephens, Elizabeth; Clark, Michele; Ash, Susan; Hurst, Cameron; Graves, Nicholas] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia	University of Queensland; Queensland University of Technology (QUT)	Rodger, S (corresponding author), Univ Queensland, Div Occupat Therapy, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	elizabeth.stephens@qut.edu.au	Hurst, Cameron P/P-5175-2017; Ash, Susan/I-9664-2012; Hurst, Cameron/AAD-5753-2019; Martin, Elizabeth/O-3573-2019	Hurst, Cameron P/0000-0002-4577-8962; Ash, Susan/0000-0003-2078-7560; Hurst, Cameron/0000-0002-4577-8962; Martin, Elizabeth/0000-0003-0252-8303; Graves, Nicholas/0000-0002-5559-3267	Queensland Health ClinED Queensland research grant	Queensland Health ClinED Queensland research grant	This manuscript was made possible with funding from Queensland Health ClinED Queensland research grant 2009-2010 (http://www.health.qld.gov.au/clinedq/default.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown S, 1990, J AM DENT ASSOC S, V90, pA; BURKHARDT BF, 1985, AM J OCCUP THER, V39, P35, DOI 10.5014/ajot.39.1.35; Campbell AR, 2011, AM J PHARM EDUC, V75, DOI 10.5688/ajpe7518; Chisholm MA, 1997, HOSP PHARM, V32, P370; Chung Y I, 1980, Inquiry, V17, P216; CHUNG YI, 1983, AM J OCCUP THER, V37, P681, DOI 10.5014/ajot.37.10.681; CONKLIN MT, 1994, J AM DIET ASSOC, V94, P174, DOI 10.1016/0002-8223(94)90243-7; Conklin MT, 1995, TOP CLIN NUTR, V10, P71; Demory-Luce D, 1990, J AM DENT ASSOC S, V90, pA; Dietitians Association of Australia, 2009, NAT COMP STAND ENTR; Dillon Loretta Schoen, 2003, J Allied Health, V32, P261; Gilbride JA, 1996, J AM DIET ASSOC, V96, P758, DOI 10.1016/S0002-8223(96)00211-8; Haines TP., 2011, FOCUS HEALTH PROF ED, V12, P53; Kincaid C, 2005, 30 ANN SAS US GROUP; Ladyshewsky RK, 1998, PHYS THER, V78, P1288, DOI 10.1093/ptj/78.12.1288; Ladyshewsky RW, 1994, PHYSIOTHER CAN, V46, P89; Leiken A M, 1983, Inquiry, V20, P88; LEIKEN AM, 1983, PHYS THER, V63, P56, DOI 10.1093/ptj/63.1.56; MacKinnon J R, 1986, J Allied Health, V15, P225; McAllister L, 2005, ADV SPEECH LANGUAGE, V7, P138, DOI DOI 10.1080/14417040500181239; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Mersfelder TL, 2012, ANN PHARMACOTHER, V46, P541, DOI 10.1345/aph.1Q544; MUELLER BA, 1990, DICP ANN PHARMAC, V24, P422, DOI 10.1177/106002809002400416; Murray E, 2000, MED EDUC, V34, P871, DOI 10.1046/j.1365-2923.2000.00757.x; National Allied Health Casemix Committee, 1997, AUSTR ALL HLTH CLASS; PAGE GG, 1987, PHYS THER, V67, P238, DOI 10.1093/ptj/67.2.238; Rodger Sylvia, 2008, J Allied Health, V37, P53; Rose M, 2005, ADV SPEECH LANGUAGE, V7, P158, DOI [10.1080/14417040500181353, DOI 10.1080/14417040500181353]; SHALIK H, 1988, AM J OCCUP THER, V42, P164, DOI 10.5014/ajot.42.3.164; SHALIK LD, 1987, AM J OCCUP THER, V41, P638, DOI 10.5014/ajot.41.10.638; Verbeke G, 2009, SPRINGER SER STAT, P1; World Federation of Occupational Therapists, 2002, MIN STAND ED OCC THE	32	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44356	10.1371/journal.pone.0044356	http://dx.doi.org/10.1371/journal.pone.0044356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952964	gold, Green Submitted, Green Published			2022-12-25	WOS:000308221300086
J	Walcott, BP; Sheth, SA; Nahed, BV; Coumans, JV				Walcott, Brian P.; Sheth, Sameer A.; Nahed, Brian V.; Coumans, Jean-Valery			Conflict of Interest in Spine Research Reporting	PLOS ONE			English	Article							CLINICAL-TRIALS; FUSION; COMPLICATIONS; PHYSICIANS	Background: Medical studies are more likely to report favorable findings when a conflict of interest is declared. We aim to quantify and determine the effect of author disclosure of conflict of interest on scientific reporting. Methods: Abstracts from an international spine research meeting (North American Spine Society 2010) were selected that specifically evaluated a device, biologic, or proprietary procedure. They were then made anonymous to reviewers. An item of interest was established in each of the abstracts in order to standardize evaluation. Next, three blinded reviewers independently rated the abstracts as favorable, neutral, or unfavorable with regard to the item of interest. Additionally, the blinded reviewers attempted to predict whether a related disclosure was made. The meeting disclosure index was used to tabulate the minimum US dollar value attributable to disclosures. Results: Of the 344 total abstracts, 76 met inclusion criteria. In 79%, a related conflict of interest was reported. The amount of the disclosure was incompletely reported in 30% of cases. Where available, it averaged a cumulative minimum of $219,634 USD per abstract. The results of the abstracts were judged to be favorable, neutral, and unfavorable in 63%, 32% and 5% of abstracts, respectively. There was no correlation between the presence of a related disclosure and the findings of the studies (p = 0.81), although interpretation of this is limited by a small sample size and an overall apparent bias to report favorable studies. Additionally, the blinded reviewers were unable to predict whether a related disclosure was made (p = 0.40). Conclusion: No association existed between the presence of a related disclosure and the results of the studies. While the actual compliance with reporting a potential conflict of interest is unable to be determined, the value amount related to the disclosures made was inadequately reported according to meeting guidelines.	[Walcott, Brian P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Walcott, BP (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA.	walcott.brian@mgh.harvard.edu	Nahed, Brian/E-4239-2014	Nahed, Brian/0000-0001-8537-106X	Council of State Neurological Societies Socioeconomic fellowship	Council of State Neurological Societies Socioeconomic fellowship	Dr. Walcott is supported by the Council of State Neurological Societies Socioeconomic fellowship (2012-2013). http://www.csnsonline.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu MA, 2011, J NEUROL NEUROSUR PS, V82, P948, DOI 10.1136/jnnp.2010.231860; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Cowan JA, 2006, NEUROSURGERY, V59, P15, DOI 10.1227/01.NEU.0000219836.54861.CD; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Hopewell S, 2009, COCHRANE DATABASE SY, V1; Ju BL, 2011, SPINE J, V11, P1, DOI 10.1016/j.spinee.2010.08.022; Medicare and Medicaid Services C, 2012, PHYS FEE SCHED; NASS, 2010, 2010 NASS ANN M PROG; Okike K, 2007, J BONE JOINT SURG AM, V89A, P608, DOI 10.2106/JBJS.F.00994; Okike K, 2009, NEW ENGL J MED, V361, P1466, DOI 10.1056/NEJMsa0807160; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shah RV, 2005, SPINE, V30, P1099, DOI 10.1097/01.brs.0000161004.15308.b4; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Society NAS, 2012, DISCL ETH PROF; Steinbrook R, 2008, NEW ENGL J MED, V359, P559, DOI 10.1056/NEJMp0805309; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Walcott BP, 2011, SURGICAL NEUROLOGY I, V2; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44327	10.1371/journal.pone.0044327	http://dx.doi.org/10.1371/journal.pone.0044327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952956	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300082
J	Kelley, LC; Weed, SA				Kelley, Laura C.; Weed, Scott A.			Cortactin Is a Substrate of Activated Cdc42-Associated Kinase 1 (ACK1) during Ligand-induced Epidermal Growth Factor Receptor Downregulation	PLOS ONE			English	Article							CLATHRIN-COATED PITS; SQUAMOUS-CELL CARCINOMA; TYROSINE KINASE; MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; ARP2/3 COMPLEX; EGF RECEPTOR; N-WASP; MEMBRANE DYNAMICS; BINDING PROTEIN	Background: Epidermal growth factor receptor (EGFR) internalization following ligand binding controls EGFR downstream pathway signaling activity. Internalized EGFR is poly-ubiquitinated by Cbl to promote lysosome-mediated degradation and signal downregulation. ACK1 is a non-receptor tyrosine kinase that interacts with ubiquitinated EGFR to facilitate EGFR degradation. Dynamic reorganization of the cortical actin cytoskeleton controlled by the actin related protein (Arp)2/3 complex is important in regulating EGFR endocytosis and vesicle trafficking. How ACK1-mediated EGFR internalization cooperates with Arp2/3-based actin dynamics during EGFR downregulation is unclear. Methodology/Principal Findings: Here we show that ACK1 directly binds and phosphorylates the Arp2/3 regulatory protein cortactin, potentially providing a direct link to Arp2/3-based actin dynamics during EGFR degradation. Co-immunoprecipitation analysis indicates that the cortactin SH3 domain is responsible for binding to ACK1. In vitro kinase assays demonstrate that ACK1 phosphorylates cortactin on key tyrosine residues that create docking sites for adaptor proteins responsible for enhancing Arp2/3 nucleation. Analysis with phosphorylation-specific antibodies determined that EGFR-induced cortactin tyrosine phosphorylation is diminished coincident with EGFR degradation, whereas ERK1/2 cortactin phosphorylation utilized in promoting activation of the Arp2/3 regulator N-WASp is sustained during EGFR downregulation. Cortactin and ACK1 localize to internalized vesicles containing EGF bound to EGFR visualized by confocal microscopy. RNA interference and rescue studies indicate that ACK1 and the cortactin SH3 domain are essential for ligand-mediated EGFR internalization. Conclusions/Significance: Cortactin is a direct binding partner and novel substrate of ACK1. Tyrosine phosphorylation of cortactin by ACK1 creates an additional means to amplify Arp2/3 dynamics through N-WASp activation, potentially contributing to the overall necessary tensile and/or propulsive forces utilized during EGFR endocytic internalization and trafficking involved in receptor degradation.	[Kelley, Laura C.; Weed, Scott A.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Dept Neurobiol & Anat, Morgantown, WV USA; [Kelley, Laura C.; Weed, Scott A.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Program Canc Cell Biol, Morgantown, WV USA	West Virginia University; West Virginia University	Kelley, LC (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	sweed@hsc.wvu.edu		Weed, Scott/0000-0001-7033-9999	United States National Institutes of Health (NIH) [DE014364, DE014578]; West Virginia University Office of Research and Graduate Education; NIH [P20 RR16440, P30 RR032138/GM103488];  [RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032138, P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014578, K22DE014364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia University Office of Research and Graduate Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health (NIH) Grants DE014364, DE014578 and a subproject of RR16440 to SAW. LCK was supported in part by the West Virginia University Office of Research and Graduate Education. The West Virginia University Microscope Imaging Facility, Mary Babb Randolph Cancer Center is supported by NIH grants P20 RR16440 and P30 RR032138/GM103488. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Campbell DH, 1999, CANCER RES, V59, P5376; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chan W, 2011, BIOCH J; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Chua BT, 2010, MOL ONCOL, V4, P323, DOI 10.1016/j.molonc.2010.03.001; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Garcia-Castillo J, 2009, J BIOL CHEM, V284, P25302, DOI 10.1074/jbc.M109.001982; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Grassart A, 2010, TRAFFIC; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Howlin J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2087; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang JH, 2003, J BIOL CHEM, V278, P48367, DOI 10.1074/jbc.M308213200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kapus A, 2000, J BIOL CHEM, V275, P32289, DOI 10.1074/jbc.M003172200; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Kato-Stankiewicz J, 2001, BIOCHEM BIOPH RES CO, V284, P470, DOI 10.1006/bbrc.2001.5004; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kelley LC, 2010, J CELL SCI, V123, P3923, DOI 10.1242/jcs.075200; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Lin Q, 2010, MOL CELL BIOL, V30, P1541, DOI 10.1128/MCB.00013-10; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Ohashi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019942; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Prieto-Echague V., 2011, J SIGNAL TRANSDUCT, V2011; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; SACKS PG, 1988, CANCER RES, V48, P2858; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schroeder B, 2010, EMBO J, V29, P3039, DOI 10.1038/emboj.2010.190; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Singh B, 2001, CANCER RES, V61, P4506; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stoorvogel W, 2004, J BIOL CHEM, V279, P11562, DOI 10.1074/jbc.M308449200; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; Timpson P, 2005, CANCER RES, V65, P3273, DOI 10.1158/0008-5472.CAN-04-2118; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yamazaki T, 2002, J CELL SCI, V115, P1791; Yokoyama N, 2005, J BIOL CHEM, V280, P42219, DOI 10.1074/jbc.M506996200; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhu JW, 2007, J BIOL CHEM, V282, P16086, DOI 10.1074/jbc.M701997200; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	80	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44363	10.1371/journal.pone.0044363	http://dx.doi.org/10.1371/journal.pone.0044363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952966	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500065
J	Kornej, J; Reinhardt, C; Kosiuk, J; Arya, A; Hindricks, G; Adams, V; Husser, D; Bollmann, A				Kornej, Jelena; Reinhardt, Claudia; Kosiuk, Jedrzej; Arya, Arash; Hindricks, Gerhard; Adams, Volker; Husser, Daniela; Bollmann, Andreas			Response of High-Sensitive C-Reactive Protein to Catheter Ablation of Atrial Fibrillation and Its Relation with Rhythm Outcome	PLOS ONE			English	Article							ELECTRICAL CARDIOVERSION; HS-CRP; INFLAMMATION; RECURRENCE; ELEVATION; PERPETUATION; ASSOCIATION; PERSISTENCE; EXPRESSION	Aims: This study investigated the possible association between hs-CRP as well as hs-CRP changes and rhythm outcome after AF catheter ablation. Methods: We studied 68 consecutive patients with AF undergoing catheter ablation. hs-CRP levels were measured using commercially available assays before and 6 months after catheter ablation. Serial 7-day Holter ECGs were used to detect AF recurrences. Results: Early AF recurrence (ERAF, within one week) was observed in 38%, while late AF recurrence (LRAF, between 3 and 6 months) occurred in 18% of the patients. None of the baseline clinical or echocardiographic variables was predictive of ERAF or LRAF. Baseline hs-CRP measured 2.07 +/- 1.1 mu g/ml and was not associated with ERAF and LRAF. At 6 months, hs-CRP levels were comparable with baseline values (2.14 +/- 1.19 mu g/ml, p = 0.409) and were also not related with LRAF. However, patients with LRAF showed an hs-CRP increase from 2.03 +/- 0.61 to 2.62 +/- 1.52 mu g/ml (p = 0.028). Patients with an hs-CRP change in the upper tertile (>0.2 mu g/ml) had LRAF in 32% as opposed to 11% (p = 0.042) in patients in the lower (<-0.3 mu g/ml) or intermediate (20.3-0.2 mu g/ml) tertile. Conclusions: Changes in hs-CRP but not baseline hs-CRP are associated with rhythm outcome after AF catheter ablation. This finding points to a link between an inflammatory response and AF recurrence in this setting.	[Kornej, Jelena; Kosiuk, Jedrzej; Arya, Arash; Hindricks, Gerhard; Husser, Daniela; Bollmann, Andreas] Ctr Heart, Dept Electrophysiol, Leipzig, Germany; [Reinhardt, Claudia; Adams, Volker] Ctr Heart, Dept Cardiol, Leipzig, Germany	Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kornej, J (corresponding author), Ctr Heart, Dept Electrophysiol, Leipzig, Germany.	jelena.kornej@gmx.de		Kosiuk, Jedrzej/0000-0002-7856-1372	Volkswagen Foundation, Germany [I/81545]	Volkswagen Foundation, Germany(Volkswagen)	This study was supported in part by a grant from the Volkswagen Foundation, Germany to Dr. Husser [grant number I/81545]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo M, 2006, INT J CARDIOL, V108, P326, DOI 10.1016/j.ijcard.2005.05.017; Anderson JL, 2004, AM J CARDIOL, V94, P1255, DOI 10.1016/j.amjcard.2004.07.108; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Eitel C, 2010, HEART RHYTHM, V7, P157, DOI 10.1016/j.hrthm.2009.10.003; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Henningsen KMA, 2009, SCAND J CLIN LAB INV, V69, P425, DOI 10.1080/00365510802676848; Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Joshi MS, 2012, CARDIOVASC PATHOL; Kallergis EM, 2008, HEART, V94, P200, DOI 10.1136/hrt.2006.108688; Korantzopoulos P, 2005, INT J CLIN PRACT, V59, P881, DOI 10.1111/j.1368-5031.2005.00569.x; Kourliouros A, 2009, AM HEART J, V157, P243, DOI 10.1016/j.ahj.2008.10.009; Lellouche N, 2009, EUROPACE, V11, P662, DOI 10.1093/europace/eup077; Letsas KP, 2009, EUROPACE, V11, P158, DOI 10.1093/europace/eun309; Lin YJ, 2010, AM J CARDIOL, V105, P495, DOI 10.1016/j.amjcard.2009.10.019; Liu J, 2010, PACING CLIN ELECTROP, P1540; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Malouf JF, 2005, J AM COLL CARDIOL, V46, P1284, DOI 10.1016/j.jacc.2005.06.053; McCabe JM, 2008, PACE, V31, P1146, DOI 10.1111/j.1540-8159.2008.01155.x; Nakamura Y, 2003, THROMB RES, V111, P137, DOI 10.1016/S0049-3848(03)00405-5; Narducci ML, 2011, EUROPACE, P29; Psychari SN, 2005, AM J CARDIOL, V95, P764, DOI 10.1016/j.amjcard.2004.11.032; Rotter M, 2006, J AM COLL CARDIOL, V47, P1231, DOI 10.1016/j.jacc.2005.12.038; Stein A, 2008, EUROPACE, V10, P444, DOI 10.1093/europace/eun041; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Watanabe T, 2005, HEART VESSELS, V20, P45, DOI 10.1007/s00380-004-0800-x	30	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44165	10.1371/journal.pone.0044165	http://dx.doi.org/10.1371/journal.pone.0044165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957001	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500051
J	Matthews, SB; Santra, M; Mensack, MM; Wolfe, P; Byrne, PF; Thompson, HJ				Matthews, Shawna B.; Santra, Meenakshi; Mensack, Meghan M.; Wolfe, Pamela; Byrne, Patrick F.; Thompson, Henry J.			Metabolite Profiling of a Diverse Collection of Wheat Lines Using Ultraperformance Liquid Chromatography Coupled with Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; CLASSIFICATION; REDUCTION; ORIGINS; LIPIDS; WILD	Genetic differences among major types of wheat are well characterized; however, little is known about how these distinctions affect the small molecule profile of the wheat seed. Ethanol/water (65% v/v) extracts of seed from 45 wheat lines representing 3 genetically distinct classes, tetraploid durum (Triticum turgidum subspecies durum) (DW) and hexaploid hard and soft bread wheat (T. aestivum subspecies aestivum) (BW) were subjected to ultraperformance liquid chromatography coupled with time-of-flight mass spectrometry (UPLC-TOF-MS). Discriminant analyses distinguished DW from BW with 100% accuracy due to differences in expression of nonpolar and polar ions, with differences attributed to sterol lipids/fatty acids and phospholipids/glycerolipids, respectively. Hard versus soft BW was distinguished with 100% accuracy by polar ions, with differences attributed to heterocyclic amines and polyketides versus phospholipid ions, respectively. This work provides a foundation for identification of metabolite profiles associated with desirable agronomic and human health traits and for assessing how environmental factors impact these characteristics.	[Matthews, Shawna B.; Santra, Meenakshi; Thompson, Henry J.] Colorado State Univ, Canc Prevent Lab, Ft Collins, CO 80523 USA; [Matthews, Shawna B.; Santra, Meenakshi; Thompson, Henry J.] Colorado State Univ, Dept Hort, Ft Collins, CO 80523 USA; [Matthews, Shawna B.] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Mensack, Meghan M.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Wolfe, Pamela] Univ Colorado, Colorado Biostat Consortium, Denver, CO 80202 USA; [Byrne, Patrick F.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University; University of Colorado System; University of Colorado Denver; Colorado State University	Matthews, SB (corresponding author), Colorado State Univ, Canc Prevent Lab, Ft Collins, CO 80523 USA.	henry.thompson@colostate.edu	Byrne, Patrick/AFP-4228-2022		Colorado Wheat Administrative Committee; Colorado Wheat Research Foundation	Colorado Wheat Administrative Committee; Colorado Wheat Research Foundation	This work was supported in part by a grant from the Colorado Wheat Administrative Committee and Colorado Wheat Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanino C, 2002, ANAL CHIM ACTA, V454, P315, DOI 10.1016/S0003-2670(01)01548-3; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Charmet G, 2011, CR BIOL, V334, P212, DOI 10.1016/j.crvi.2010.12.013; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2011, BBA-MOL CELL BIOL L, V1811, P637, DOI 10.1016/j.bbalip.2011.06.009; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Gabrielsson J, 2006, CHEMOMETR INTELL LAB, V84, P153, DOI 10.1016/j.chemolab.2006.03.013; Gooding M. J., 2009, WHEAT CHEM TECHNOLOG, V4th, P19; Heldt H.-W., 2005, PLANT BIOCH; Heuberger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012915; Kilian B, 2007, MOL BIOL EVOL, V24, P2657, DOI 10.1093/molbev/msm192; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Kopka J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-109; Luque-Garcia JL, 2003, TRAC-TREND ANAL CHEM, V22, P41, DOI 10.1016/S0165-9936(03)00102-X; MAPLESTONE RA, 1992, GENE, V115, P151, DOI 10.1016/0378-1119(92)90553-2; Mensack MM, 2010, J AGR FOOD CHEM, V58, P6697, DOI 10.1021/jf1007538; Morrison D. F., 1990, MULTIVARIATE STAT ME; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ohm J.-B., 2009, WHEAT CHEM TECHNOLOG, P363; Rawsthorne S, 2002, PROG LIPID RES, V41, P182, DOI 10.1016/S0163-7827(01)00023-6; Reynolds MP, 2002, FAO PLANT PRODUCTION, P567; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sumner Lloyd W, 2007, EXS, V97, P195; Thompson MD, 2012, CARCINOGENESIS, V33, P226, DOI 10.1093/carcin/bgr247; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tuominen LK, 2009, METHODS MOL BIOL, V547, P373, DOI 10.1007/978-1-60327-287-2_30; Tushar, 2008, DATA MIN KNOWL DISC, P98; US Census Bureau, 2011, INT DAT BAS; Villagrasa M, 2006, J AGR FOOD CHEM, V54, P1009, DOI 10.1021/jf050898h; Wiklund S., 2008, UMETRICS; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Williams PC, 1993, WORLD WHEAT GRAIN OI; Williams PC, 1993, WORLD WHEAT GRAIN OI, V2; Wrigley, 2009, WHEAT CHEM TECHNOLOG, P1, DOI [10.1016/B978-1-891127-55-7.50008-2, DOI 10.1016/B978-1-891127-55-7.50008-2]	37	33	33	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44179	10.1371/journal.pone.0044179	http://dx.doi.org/10.1371/journal.pone.0044179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957002	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500053
J	Scotland, PB; Heath, JL; Conway, AE; Porter, NB; Armstrong, MB; Walker, JA; Klebig, ML; Lavau, CP; Wechsler, DS				Scotland, Paula B.; Heath, Jessica L.; Conway, Amanda E.; Porter, Natasha B.; Armstrong, Michael B.; Walker, Jennifer A.; Klebig, Mitchell L.; Lavau, Catherine P.; Wechsler, Daniel S.			The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation	PLOS ONE			English	Article							CLATHRIN ASSEMBLY PROTEIN; ENDOCYTIC ACCESSORY PROTEINS; SYNAPTIC VESICLE ENDOCYTOSIS; ACUTE MYELOID-LEUKEMIA; ALZHEIMERS-DISEASE; FITNESS1(4226SB) LOCUS; RNA INTERFERENCE; COATED PITS; CALM; FUSION	The ubiquitously expressed phosphatidylinositol binding clathrin assembly (PICALM) protein associates with the plasma membrane, binds clathrin, and plays a role in clathrin-mediated endocytosis. Alterations of the human PICALM gene are present in aggressive hematopoietic malignancies, and genome-wide association studies have recently linked the PICALM locus to late-onset Alzheimer's disease. Inactivating and hypomorphic Picalm mutations in mice cause different degrees of severity of anemia, abnormal iron metabolism, growth retardation and shortened lifespan. To understand PICALM's function, we studied the consequences of PICALM overexpression and characterized PICALM-deficient cells derived from mutant fit1 mice. Our results identify a role for PICALM in transferrin receptor (TfR) internalization and demonstrate that the C-terminal PICALM residues are critical for its association with clathrin and for the inhibitory effect of PICALM overexpression on TfR internalization. Murine embryonic fibroblasts (MEFs) that are deficient in PICALM display several characteristics of iron deficiency (increased surface TfR expression, decreased intracellular iron levels, and reduced cellular proliferation), all of which are rescued by retroviral PICALM expression. The proliferation defect of cells that lack PICALM results, at least in part, from insufficient iron uptake, since it can be corrected by iron supplementation. Moreover, PICALM-deficient cells are particularly sensitive to iron chelation. Taken together, these data reveal that PICALM plays a critical role in iron homeostasis, and offer new perspectives into the pathogenesis of PICALM-associated diseases.	[Scotland, Paula B.; Heath, Jessica L.; Porter, Natasha B.; Armstrong, Michael B.; Walker, Jennifer A.; Lavau, Catherine P.; Wechsler, Daniel S.] Duke Univ, Med Ctr, Div Pediat Hematol Oncol, Durham, NC 27706 USA; [Conway, Amanda E.; Wechsler, Daniel S.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Klebig, Mitchell L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Duke University; Duke University; Mayo Clinic	Scotland, PB (corresponding author), Duke Univ, Med Ctr, Div Pediat Hematol Oncol, Durham, NC 27706 USA.	dan.wechsler@duke.edu	Lavau, Catherine/Q-2928-2019; Heath, Jessica/O-9948-2019	Lavau, Catherine/0000-0003-4800-1320	NCI [R01 CA 109281]; St. Baldrick's Foundation; V Foundation; NATIONAL CANCER INSTITUTE [R01CA109281] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; V Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI R01 CA 109281 (DSW), a Research Grant to DSW from the St. Baldrick's Foundation (www.stbaldricks.org), a Fellow Grant to JAW from the St. Baldrick's Foundation and a Research Grant to DSW from the V Foundation (www.jimmyv.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archangelo LF, 2006, ONCOGENE, V25, P4099, DOI 10.1038/sj.onc.1209438; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Asnafi V, 2003, BLOOD, V102, P1000, DOI 10.1182/blood-2002-09-2913; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; Caudell D, 2008, LEUKEMIA, V22, P678, DOI 10.1038/sj.leu.2405074; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Di Fiore PP, 2009, MOL ONCOL, V3, P273, DOI 10.1016/j.molonc.2009.06.002; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Du CC, 1999, BLOOD, V94, P793, DOI 10.1182/blood.V94.2.793.414k43_793_802; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huh JY, 2010, KOREAN J LAB MED, V30, P117, DOI 10.3343/kjlm.2010.30.2.117; Hupalowska A, 2012, TRAFFIC, V13, P9, DOI 10.1111/j.1600-0854.2011.01249.x; Jones L, 2010, BBA-MOL CELL BIOL L, V1801, P754, DOI 10.1016/j.bbalip.2010.04.005; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; Kim HL, 2000, EXP MOL MED, V32, P222, DOI 10.1038/emm.2000.36; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Kumon K, 1999, GENE CHROMOSOME CANC, V25, P33, DOI 10.1002/(SICI)1098-2264(199905)25:1<33::AID-GCC5>3.0.CO;2-3; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Morgan JR, 2000, J NEUROSCI, V20, P8667; Morgan JR, 1999, J NEUROSCI, V19, P10201; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Oshiro S., 2011, ADV PHARM SCI, V2011, DOI DOI 10.1155/2011/378278; Petralia RS, 2007, J COMP NEUROL, V504, P314, DOI 10.1002/cne.21454; POTTER MD, 1995, MAMM GENOME, V6, P70, DOI 10.1007/BF00303247; Potter MD, 1997, BLOOD, V90, P1850, DOI 10.1182/blood.V90.5.1850; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Savage NM, 2010, CANCER GENET CYTOGEN, V202, P129, DOI 10.1016/j.cancergencyto.2010.07.126; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultze AE, 1998, COMP HAEMATOL INT, V8, P72, DOI 10.1007/BF02642494; Schultze AE, 1997, COMP HAEMATOL INT, V7, P143, DOI 10.1007/BF02652592; Schultze AE, 1999, LAB ANIM SCI, V49, P260; Schwartz CM, 2010, J COMP NEUROL, V518, P3803, DOI 10.1002/cne.22425; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Silliman CC, 1998, LEUKEMIA, V12, P1404, DOI 10.1038/sj.leu.2401109; Smith MA, 2010, J ALZHEIMERS DIS, V19, P363, DOI 10.3233/JAD-2010-1239; Suzuki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031854; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Wechsler DS, 2003, GENE CHROMOSOME CANC, V36, P26, DOI 10.1002/gcc.10136; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Yao PJ, 2005, J COMP NEUROL, V481, P58, DOI 10.1002/cne.20362; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	61	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44252	10.1371/journal.pone.0044252	http://dx.doi.org/10.1371/journal.pone.0044252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952941	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500058
J	Song, JY; Shi, LC; Li, DZ; Sun, YZ; Niu, YY; Chen, ZD; Luo, HM; Pang, XH; Sun, ZY; Liu, C; Lv, AP; Deng, YP; Larson-Rabin, Z; Wilkinson, M; Chen, SL				Song, Jingyuan; Shi, Linchun; Li, Dezhu; Sun, Yongzhen; Niu, Yunyun; Chen, Zhiduan; Luo, Hongmei; Pang, Xiaohui; Sun, Zhiying; Liu, Chang; Lv, Aiping; Deng, Youping; Larson-Rabin, Zachary; Wilkinson, Mike; Chen, Shilin			Extensive Pyrosequencing Reveals Frequent Intra-Genomic Variations of Internal Transcribed Spacer Regions of Nuclear Ribosomal DNA	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SPECIES IDENTIFICATION; DRAFT SEQUENCE; LIFE-HISTORY; RNA GENES; ITS2; EVOLUTIONARY; PHYLOGENY; BARCODE; DIVERSITY	Background: Internal transcribed spacer of nuclear ribosomal DNA (nrDNA) is already one of the most popular phylogenetic and DNA barcoding markers. However, the existence of its multiple copies has complicated such usage and a detailed characterization of intra-genomic variations is critical to address such concerns. Methodology/Principal Findings: In this study, we used sequence-tagged pyrosequencing and genome-wide analyses to characterize intra-genomic variations of internal transcribed spacer 2 (ITS2) regions from 178 plant species. We discovered that mutation of ITS2 is frequent, with a mean of 35 variants per species. And on average, three of the most abundant variants make up 91% of all ITS2 copies. Moreover, we found different congeneric species share identical variants in 13 genera. Interestingly, different species across different genera also share identical variants. In particular, one minor variant of ITS2 in Eleutherococcus giraldii was found identical to the ITS2 major variant of Panax ginseng, both from Araliaceae family. In addition, DNA barcoding gap analysis showed that the intra-genomic distances were markedly smaller than those of the intra-specific or inter-specific variants. When each of 5543 variants were examined for its species discrimination efficiency, a 97% success rate was obtained at the species level. Conclusions: Identification of identical ITS2 variants across intra-generic or inter-generic species revealed complex species evolutionary history, possibly, horizontal gene transfer and ancestral hybridization. Although intra-genomic multiple variants are frequently found within each genome, the usage of the major variants alone is sufficient for phylogeny construction and species determination in most cases. Furthermore, the inclusion of minor variants further improves the resolution of species identification.	[Song, Jingyuan; Shi, Linchun; Sun, Yongzhen; Niu, Yunyun; Luo, Hongmei; Pang, Xiaohui; Sun, Zhiying; Liu, Chang; Chen, Shilin] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Li, Dezhu; Larson-Rabin, Zachary] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Chen, Zhiduan] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Lv, Aiping] China Acad Chinese Med Sci, Beijing, Peoples R China; [Deng, Youping] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Wilkinson, Mike] Univ Adelaide, Adelaide, SA, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; China Academy of Chinese Medical Sciences; Rush University; University of Adelaide	Song, JY (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China.	cliu6688@yahoo.com; slchen@implad.ac.cn	Liu, Chang/A-1148-2014; Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Wilkinson, Michael/0000-0002-9881-6993	National Natural Science Foundation of China [30970307, 81130069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Natural Science Foundation of China (No. 30970307, No. 81130069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, SCI SIGNAL; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; De Schrijver JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-269; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gough NR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3128eg5; Hasselmann M, 2010, P NATL ACAD SCI USA, V107, P13378, DOI 10.1073/pnas.1005617107; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Hribova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017863; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; Wen J, 2008, J SYST EVOL, V46, P322, DOI 10.3724/SP.J.1002.2008.08050; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; KELLOGG EA, 1995, GENETICS, V140, P325; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; Lee S, 2001, AM J BOT, V88, P150, DOI 10.2307/2657135; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li DZ, 2011, J SYST EVOL, V49, P165, DOI 10.1111/j.1759-6831.2011.00137.x; Li Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-268; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Michaud M, 2011, PLANT J, V66, P80, DOI 10.1111/j.1365-313X.2011.04490.x; Mitchell A, 2005, SYST BOT, V30, P872, DOI 10.1600/036364405775097761; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Nei M, 1998, SCIENCE, V282, P1428, DOI 10.1126/science.282.5393.1428; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Pang X, 2012, PLANT BIOLOGY, V14, P839, DOI 10.1111/j.1438-8677.2011.00554.x; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Razafimandimbison SG, 2004, SYST BIOL, V53, P177, DOI 10.1080/10635150490423278; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Ruhl MW, 2010, MOL PHYLOGENET EVOL, V54, P664, DOI 10.1016/j.ympev.2009.07.036; Sanderson MJ, 2008, SCIENCE, V321, P121, DOI 10.1126/science.1154449; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz J, 2009, SCI SIGNAL; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thomas C, 2009, SCIENCE, V325, P526, DOI 10.1126/science.325_526; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiemers M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-300; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Yang SH, 2010, P NATL ACAD SCI USA, V107, P10395, DOI 10.1073/pnas.0914506107; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhu S, 2003, PLANTA MED, V69, P647, DOI 10.1055/s-2003-41117	79	80	119	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43971	10.1371/journal.pone.0043971	http://dx.doi.org/10.1371/journal.pone.0043971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952830	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500032
J	Wu, QP; Xie, YZ; Deng, ZQ; Li, XM; Yang, WN; Jiao, CW; Fang, L; Li, SZ; Pan, HH; Yee, AJ; Lee, DY; Li, C; Zhang, Z; Guo, J; Yang, BB				Wu, Qing-Ping; Xie, Yi-Zhen; Deng, Zhaoqun; Li, Xiang-Min; Yang, Weining; Jiao, Chun-Wei; Fang, Ling; Li, Sen-Zhu; Pan, Hong-Hui; Yee, Albert J.; Lee, Daniel Y.; Li, Chong; Zhang, Zhi; Guo, Jun; Yang, Burton B.			Ergosterol Peroxide Isolated from Ganoderma lucidum Abolishes MicroRNA miR-378-Mediated Tumor Cells on Chemoresistance	PLOS ONE			English	Article							CANCER CELLS; T-LYMPHOCYTES; FR KARST; EXPRESSION; BREAST; GROWTH; MACROPHAGES; SENSITIVITY; ACTIVATION; MECHANISM	Due to an altered expression of oncogenic factors and tumor suppressors, aggressive cancer cells have an intrinsic or acquired resistance to chemotherapeutic agents. This typically contributes to cancer recurrence after chemotherapy. microRNAs are short non-coding RNAs that are involved in both cell self-renewal and cancer development. Here we report that tumor cells transfected with miR-378 acquired properties of aggressive cancer cells. Overexpression of miR-378 enhanced both cell survival and colony formation, and contributed to multiple drug resistance. Higher concentrations of chemotherapeutic drugs were needed to induce death of miR-378-transfected cells than to induce death of control cells. We found that the biologically active component isolated from Ganoderma lucidum could overcome the drug-resistance conferred by miR-378. We purified and identified the biologically active component of Ganoderma lucidum as ergosterol peroxide. We demonstrated that ergosterol peroxide produced greater activity in inducing death of miR-378 cells than the GFP cells. Lower concentrations of ergosterol peroxide were needed to induce death of the miR-378-transfected cells than in the control cells. With further clinical development, ergosterol peroxide represents a promising new reagent that can overcome the drug-resistance of tumor cells.	[Wu, Qing-Ping; Xie, Yi-Zhen; Li, Xiang-Min; Jiao, Chun-Wei; Li, Sen-Zhu; Pan, Hong-Hui; Li, Chong; Zhang, Zhi; Guo, Jun] Minist Guangdong Prov Jointly Breeding Base, State Key Lab Appl Microbiol S China, Guangzhou, Guangdong, Peoples R China; [Wu, Qing-Ping; Xie, Yi-Zhen; Li, Xiang-Min; Jiao, Chun-Wei; Li, Sen-Zhu; Pan, Hong-Hui; Li, Chong; Zhang, Zhi; Guo, Jun] Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China; [Xie, Yi-Zhen; Li, Sen-Zhu; Pan, Hong-Hui] Guangdong Yuewei Edible Fungi Technol Co Ltd, Guangzhou, Guangdong, Peoples R China; [Deng, Zhaoqun; Yang, Weining; Jiao, Chun-Wei; Fang, Ling; Yee, Albert J.; Lee, Daniel Y.; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Deng, Zhaoqun; Jiao, Chun-Wei; Fang, Ling; Lee, Daniel Y.; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Wu, QP (corresponding author), Minist Guangdong Prov Jointly Breeding Base, State Key Lab Appl Microbiol S China, Guangzhou, Guangdong, Peoples R China.	byang@sri.utoronto.ca			Canadian Institutes of Health Research [MOP-102635, MOP-111171]; Heart and Stroke Foundation of Ontario [CI 7418]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from Canadian Institutes of Health Research (MOP-102635, MOP-111171) to BBY, who is the recipient of a Career Investigator Award (CI 7418) from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Duarte N, 2007, PHYTOTHER RES, V21, P601, DOI 10.1002/ptr.2119; El-Mekkawy S, 1998, PHYTOCHEMISTRY, V49, P1651, DOI 10.1016/S0031-9422(98)00254-4; Fang L, ONCOGENE, V30, P806; Gao YH, 2002, LIFE SCI, V72, P731, DOI 10.1016/S0024-3205(02)02301-9; Hsu MJ, 2002, J LEUKOCYTE BIOL, V72, P207; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jeyapalan Z, NUCL ACIDS RES, V39, P3026; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kawasaki H, 2003, NATURE, V426, P100, DOI 10.1038/nature02141; Kim DH, 2005, ARCH PHARM RES, V28, P541, DOI 10.1007/BF02977755; Kobori M, 2007, BRIT J PHARMACOL, V150, P209, DOI 10.1038/sj.bjp.0706972; KOHDA H, 1985, CHEM PHARM BULL, V33, P1367; Kuo YC, 2003, BRIT J PHARMACOL, V140, P895, DOI 10.1038/sj.bjp.0705500; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee D. Y., PLOS ONE, V5; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; LIEU CW, 1992, ANTICANCER RES, V12, P1211; MARUYAMA H, 1989, J PHARMACOBIO-DYNAM, V12, P118, DOI 10.1248/bpb1978.12.118; MURASUGI A, 1991, J BIOL CHEM, V266, P2486; Park EJ, 1997, BIOL PHARM BULL, V20, P417, DOI 10.1248/bpb.20.417; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shatseva T, J CELL SCI, V124, P2826; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; Sliva D, 2003, J ALTERN COMPLEM MED, V9, P491, DOI 10.1089/107555303322284776; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wu TS, 2001, J NAT PROD, V64, P1121, DOI 10.1021/np010115w; Xu S, ENDOCRINOLOGY, V152, P3941; Yang X, 2012, CELL CYCLE, V11; Ye G, J CELL SCI, V124, P359; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao SF, 2011, INT J ONCOL, V38, P1319, DOI 10.3892/ijo.2011.965; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	42	68	71	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44579	10.1371/journal.pone.0044579	http://dx.doi.org/10.1371/journal.pone.0044579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952996	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500078
J	Barker, CS; Samatey, FA				Barker, Clive S.; Samatey, Fadel A.			Cross-Complementation Study of the Flagellar Type III Export Apparatus Membrane Protein FlhB	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; SUBSTRATE-SPECIFICITY; ELECTRON-TRANSPORT; CRYSTAL-STRUCTURE; SALMONELLA; BIOSYNTHESIS; COMPONENTS; GENE; DELIVERY; PATHWAY	The bacterial type III export apparatus is found in the flagellum and in the needle complex of some pathogenic Gram-negative bacteria. In the needle complex its function is to secrete effector proteins for infection into Eukaryotic cells. In the bacterial flagellum it exports specific proteins for the building of the flagellum during its assembly. The export apparatus is composed of about five membrane proteins and three soluble proteins. The mechanism of the export apparatus is not fully understood. The five membrane proteins are well conserved and essential. Here a cross-complementation assay was performed: substituting in the flagellar system of Salmonella one of these membrane proteins, FlhB, by the FlhB ortholog from Aquifex aeolicus (an evolutionary distant hyperthermophilic bacteria) or a chimeric protein (AquSalFlhB) made by the combination of the trans-membrane domain of A. aeolicus FlhB with the cytoplasmic domain of Salmonella FlhB dramatically reduced numbers of flagella and motility. From cells expressing the chimeric AquSalFlhB protein, suppressor mutants with enhanced motility were isolated and the mutations were identified using whole genome sequencing. Gain-offunction mutations were found in the gene encoding FlhA, another membrane protein of the type III export apparatus. Also, mutations were identified in genes encoding 4-hydroxybenzoate octaprenyltransferase, ubiquinone/menaquinone biosynthesis methyltransferase, and 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase, which are required for ubiquinone biosynthesis. The mutations were shown by reversed-phase high performance liquid chromatography to reduce the quinone pool of the cytoplasmic membrane. Ubiquinone biosynthesis could be restored for the strain bearing a mutated gene for 4-hydroxybenzoate octaprenyltransferase by the addition of excess exogenous 4-hydroxybenzoate. Restoring the level of ubiquinone reduced flagella biogenesis with the AquSalFlhB chimera demonstrating that the respiratory chain quinone pool is responsible for this phenomenon.	[Barker, Clive S.; Samatey, Fadel A.] Okinawa Inst Sci & Technol, Trans Membrane Trafficking Unit, Kunigami, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Barker, CS (corresponding author), Okinawa Inst Sci & Technol, Trans Membrane Trafficking Unit, Kunigami, Okinawa, Japan.	f.a.samatey@oist.jp	Samatey, Fadel/A-3204-2012	Samatey, Fadel/0000-0002-0733-2863				Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Barker CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001143; BARTANA J, 1977, J BACTERIOL, V130, P787, DOI 10.1128/JB.130.2.787-792.1977; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Erhardt M, 2010, MOL MICROBIOL, V75, P1272, DOI 10.1111/j.1365-2958.2010.07050.x; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GARZA AG, 1995, P NATL ACAD SCI USA, V92, P1970, DOI 10.1073/pnas.92.6.1970; GINOCCHIO CC, 1995, INFECT IMMUN, V63, P729, DOI 10.1128/IAI.63.2.729-732.1995; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022417; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HERTZ R, 1977, J BACTERIOL, V132, P1034, DOI 10.1128/JB.132.3.1034-1035.1977; JIANG WH, 1995, J BACTERIOL, V177, P6411, DOI 10.1128/jb.177.22.6411-6421.1995; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kihara M, 2001, J BACTERIOL, V183, P1655, DOI 10.1128/JB.183.5.1655-1662.2001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee M, 2010, J MOL BIOL, V404, P600, DOI 10.1016/j.jmb.2010.09.050; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Meganathan R, 2009, ECOSAL ESCHERICHIA C; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2010, J BACTERIOL, V192, P1929, DOI 10.1128/JB.01328-09; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morris DP, 2010, BIOCHEMISTRY-US, V49, P6386, DOI 10.1021/bi100487p; Ohnishi K, 1997, J BACTERIOL, V179, P6092, DOI 10.1128/jb.179.19.6092-6099.1997; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Qi J, 2010, BIOINFORMATICS, V26, P127, DOI 10.1093/bioinformatics/btp615; Rekittke I, 2011, FEBS LETT, V585, P447, DOI 10.1016/j.febslet.2010.12.012; RYU J, 1990, BIOTECHNIQUES, V8, P43; Singh S, 2008, J BIOL CHEM, V283, P22628, DOI 10.1074/jbc.M800503200; Skinner MM, 2000, STRUCTURE, V8, P1189, DOI 10.1016/S0969-2126(00)00522-0; Toker AS, 1996, J BACTERIOL, V178, P7069, DOI 10.1128/jb.178.24.7069-7079.1996; Yakushi T, 2006, J BACTERIOL, V188, P1466, DOI 10.1128/JB.188.4.1466-1472.2006; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255; YOUNG IG, 1972, J BACTERIOL, V110, P18, DOI 10.1128/JB.110.1.18-25.1972; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Zhu K, 2002, BIOCHEMISTRY-US, V41, P9516, DOI 10.1021/bi0203280	50	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44030	10.1371/journal.pone.0044030	http://dx.doi.org/10.1371/journal.pone.0044030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952860	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000070
J	Kano, F; Nakatsu, D; Noguchi, Y; Yamamoto, A; Murata, M				Kano, Fumi; Nakatsu, Daiki; Noguchi, Yoshiyuki; Yamamoto, Akitsugu; Murata, Masayuki			A Resealed-Cell System for Analyzing Pathogenic Intracellular Events: Perturbation of Endocytic Pathways under Diabetic Conditions	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; STREPTOLYSIN-O; GOLGI-COMPLEX; CDC2 KINASE; MDCK CELLS; RECONSTITUTION; TRANSPORT; ALPHA; PHOSPHORYLATION	Cell-based assay systems that can serve as cellular models of aberrant function in pathogenic organs would be novel and useful tools for screening drugs and clarifying the molecular mechanisms of various diseases. We constructed model cells that replicated the conditions in diabetic hepatocytes by using the cell resealing technique, which enables the exchange of cytosol. The plasma membrane of HeLa cells was permeabilized with the streptococcal toxin streptolysin O, and cytosol that had been prepared from wild-type or db/db diabetic mice was introduced into the resulting semi-intact cells. By resealing the plasma membrane by exposure to Ca2+, we created WT or Db model cells, in which the cytosolic conditions replicated those of healthy or diabetic liver. Interestingly, phosphorylation of p38 MAPK was promoted, whereas the level of endosomal phosphatidylinositol-3-phosphate was decreased, in Db cells. We investigated several endocytic pathways in WT and Db cells, and found that retrograde endosome-to-Golgi transport was delayed in a p38 MAPK-dependent manner in Db cells. Furthermore, the degradation pathway of the EGF receptor from endosomes to lysosomes was enhanced in Db cells, and this did not depend on the activation of p38 MAPK. The disease model cell system should become a powerful tool for the detection of aberrant processes in cells under pathogenic conditions and for therapeutic applications.	[Kano, Fumi; Nakatsu, Daiki; Noguchi, Yoshiyuki; Murata, Masayuki] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Kano, Fumi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Cell Biol, Nagahama, Shiga, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Kano, F (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	mmurata@bio.c.u-tokyo.ac.jp			Kanagawa Academy of Science and Technology; PRESTO, Japan Science Technology Agency; Grants-in-Aid for Scientific Research [23657124] Funding Source: KAKEN	Kanagawa Academy of Science and Technology; PRESTO, Japan Science Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from Kanagawa Academy of Science and Technology (to M. M.) and PRESTO, Japan Science Technology Agency (to F. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; Apodaca G, 1996, EMBO J, V15, P1471, DOI 10.1002/j.1460-2075.1996.tb00491.x; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; BALCH WE, 1987, J CELL BIOL, V104, P749, DOI 10.1083/jcb.104.3.749; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Dahmane A, 1996, EUR J CELL BIOL, V69, P335; DEDIEGO JG, 1992, EXP CELL RES, V200, P77, DOI 10.1016/S0014-4827(05)80073-4; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gum RJ, 2003, MOL ENDOCRINOL, V17, P1131, DOI 10.1210/me.2002-0288; Hakelien AM, 2002, NAT BIOTECHNOL, V20, P460, DOI 10.1038/nbt0502-460; HELMS JB, 1990, J BIOL CHEM, V265, P20027; Hemi R, 2011, DIABETES, V60, P1134, DOI 10.2337/db09-1323; Husmann M, 2006, BIOCHEM BIOPH RES CO, V344, P1128, DOI 10.1016/j.bbrc.2006.03.241; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x; Kano F, 2005, GENES CELLS, V10, P333, DOI 10.1111/j.1365-2443.2005.00837.x; Kano F, 2004, MOL BIOL CELL, V15, P4289, DOI 10.1091/mbc.E03-11-0822; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Kano F, 2000, MOL BIOL CELL, V11, P3073, DOI 10.1091/mbc.11.9.3073; Kano F, 2011, BBA-MOL CELL RES, V1813, P784, DOI 10.1016/j.bbamcr.2011.01.023; Kano F, 2009, J CELL SCI, V122, P2218, DOI 10.1242/jcs.043414; Kano Fumi, 2006, V322, P357; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Kloft N, 2009, BIOCHEM BIOPH RES CO, V385, P503, DOI 10.1016/j.bbrc.2009.05.121; KRISCHER J, 1993, DIABETES, V42, P1303, DOI 10.2337/diabetes.42.9.1303; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAFONT F, 1994, NATURE, V372, P801; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; LEVRAN A, 1986, BIOCHEM BIOPH RES CO, V137, P258, DOI 10.1016/0006-291X(86)91204-0; Li C, 2001, J MUSCLE RES CELL M, V22, P521, DOI 10.1023/A:1015026530258; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Monte MJ, 2008, AM J PHYSIOL-GASTR L, V295, pG54, DOI 10.1152/ajpgi.00592.2007; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; PETERS R, 1986, BIOCHIM BIOPHYS ACTA, V864, P305, DOI 10.1016/0304-4157(86)90003-1; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; RUOHOLA H, 1988, J CELL BIOL, V107, P1465, DOI 10.1083/jcb.107.4.1465; Schram K, 2010, CELL MOL BIOL LETT, V15, P551, DOI 10.2478/s11658-010-0027-z; SEKIYA K, 1993, J BACTERIOL, V175, P5953, DOI 10.1128/JB.175.18.5953-5961.1993; Shaik GM, 2009, CELL SIGNAL, V21, P1337, DOI 10.1016/j.cellsig.2009.04.001; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stassen M, 2003, INFECT IMMUN, V71, P6171, DOI 10.1128/IAI.71.11.6171-6177.2003; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Walev I, 2001, FASEB J, V15, P237, DOI 10.1096/fj.01-0572fje; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Yan KF, 2012, MOL MED, V18, P10, DOI 10.2119/molmed.2011.00243; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	56	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44127	10.1371/journal.pone.0044127	http://dx.doi.org/10.1371/journal.pone.0044127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952896	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000085
J	Chiang, CY; Yu, MC; Shih, HC; Yen, MY; Hsu, YL; Yang, SL; Lin, TP; Bai, KJ				Chiang, Chen-Yuan; Yu, Ming-Chih; Shih, Hsiu-Chen; Yen, Muh-Yong; Hsu, Yu-Ling; Yang, Shiang-Lin; Lin, Tao-Ping; Bai, Kuan-Jen			Improved Consistency in Dosing Anti-Tuberculosis Drugs in Taipei, Taiwan	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SERVICES; RIFAMPIN; DOSAGES	Background: It was reported that 35.5% of tuberculosis (TB) cases reported in 2003 in Taipei City had no recorded pretreatment body weight and that among those who had, inconsistent dosing of anti-TB drugs was frequent. Taiwan Centers for Disease Control (CDC) have taken actions to strengthen dosing of anti-TB drugs among general practitioners. Prescribing practices of anti-TB drugs in Taipei City in 2007-2010 were investigated to assess whether interventions on dosing were effective. Methodology/Principal Findings: Lists of all notified culture positive TB cases in 2007-2010 were obtained from National TB Registry at Taiwan CDC. A medical audit of TB case management files was performed to collect pretreatment body weight and regimens prescribed at commencement of treatment. Dosages prescribed were compared with dosages recommended. The proportion of patients with recorded pre-treatment body weight was 64.5% in 2003, which increased to 96.5% in 2007-2010 (p<0.001). The proportion of patients treated with consistent dosing of a 3-drug fixed-dose combination (FDC) increased from 73.9% in 2003 to 87.7% in 2007-2010 (p<0.001), and that for 2-drug FDC from 76.0% to 86.1% (p = 0.024), for rifampicin (RMP) from 62.8% to 85.5% (p<0.001), and for isoniazid from 87.8% to 95.3% (p<0.001). In 2007-2010, among 2917 patients treated with either FDCs or RMP in single-drug preparation, the dosage of RMP was adequate (8-12 mg/kg) in 2571(88.1%) patients, too high in 282(9.7%), too low in 64(2.2%). In multinomial logistic regression models, factors significantly associated with adequate dosage of RMP were body weight and preparations of RMP. Patients weighting <40kg (relative risk ratio (rrr) 6010.5, 95% CI 781.1-46249.7) and patients weighting 40-49 kg (rrr 1495.3, 95% CI 200.6-11144.6) were more likely to receive higher-than-recommended dose of RMP. Conclusions/Significance: Prescribing practice in the treatment of TB in Taipei City has remarkably improved after health authorities implemented a series of interventions.	[Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France; [Chiang, Chen-Yuan; Yu, Ming-Chih; Bai, Kuan-Jen] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen-Yuan; Yu, Ming-Chih; Bai, Kuan-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Shih, Hsiu-Chen; Yen, Muh-Yong] Taipei City Govt, Taipei City Hosp, Dept Dis Control & Prevent, Taipei, Taiwan; [Hsu, Yu-Ling; Yang, Shiang-Lin] Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Lin, Tao-Ping] Taiwan AntiTB Assoc, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei City Hospital; Centers For Disease Control - Taiwan	Chiang, CY (corresponding author), Int Union TB & Lung Dis, Paris, France.	kjbai@wanfang.gov.tw			Centers for Disease Control, Department of Health, Taiwan, People's Republic of China	Centers for Disease Control, Department of Health, Taiwan, People's Republic of China	This work was funded by Centers for Disease Control, Department of Health, Taiwan, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Centers for Disease Control. Department of Health. Republic of China, 2011, MOB ALL CIT RED TUB; Chan P-C, 2009, INT J TUBERC LUNG S, V13, ps207; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P739; Chiang CY, 2010, INT J TUBERC LUNG D, V14, P878; Diop AH, 2002, INT J TUBERC LUNG D, V6, P215; Harries AD, 2004, INT J TUBERC LUNG D, V8, P724; Hoa NB, 2012, PUBLIC HEALTH ACTION, V2, P15, DOI [10.5588/pha.11.0024, 10.5588/pha.11.0015]; International Union against Tuberculosis and Lung Disease, 2010, MAN TUB GUID ESS GOO; Kimerling ME, 1998, CHEST, V113, P1178, DOI 10.1378/chest.113.5.1178; Li Y-P, 2009, INT J TUBERC LUNG S, V13, ps107; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Norval PY, 2010, INT J TUBERC LUNG D, V14, P795; Ruslami R, 2007, ANTIMICROB AGENTS CH, V51, P2546, DOI 10.1128/AAC.01550-06; Steingart KR, 2011, INT J TUBERC LUNG D, V15, P305; Taiwan Centers for Disease Control Department of Health, 2008, TAIW GUID TUB DIAGN; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2010, RAP ADV TREATM TUB C	20	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44133	10.1371/journal.pone.0044133	http://dx.doi.org/10.1371/journal.pone.0044133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952900	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800097
J	Dorval, V; Smith, PY; Delay, C; Calvo, E; Planel, E; Zommer, N; Buee, L; Hebert, SS				Dorval, Veronique; Smith, Pascal Y.; Delay, Charlotte; Calvo, Ezequiel; Planel, Emmanuel; Zommer, Nadege; Buee, Luc; Hebert, Sebastien S.			Gene Network and Pathway Analysis of Mice with Conditional Ablation of Dicer in Post-Mitotic Neurons	PLOS ONE			English	Article							ADULT FOREBRAIN NEURONS; MICRORNA EXPRESSION; MAMMALIAN MICRORNAS; MICROARRAY ANALYSIS; DNA METHYLATION; MESSENGER-RNAS; HUMAN TISSUES; RIP-CHIP; BRAIN; DIFFERENTIATION	Background: The small non-protein-coding microRNAs (miRNAs) have emerged as critical regulators of neuronal differentiation, identity and survival. To date, however, little is known about the genes and molecular networks regulated by neuronal miRNAs in vivo, particularly in the adult mammalian brain. Methodology/Principal Findings: We analyzed whole genome microarrays from mice lacking Dicer, the enzyme responsible for miRNA production, specifically in postnatal forebrain neurons. A total of 755 mRNA transcripts were significantly (P<0.05, FDR<0.25) misregulated in the conditional Dicer knockout mice. Ten genes, including Tnrc6c, Dnmt3a, and Limk1, were validated by real time quantitative RT-PCR. Upregulated transcripts were enriched in nonneuronal genes, which is consistent with previous studies in vitro. Microarray data mining showed that upregulated genes were enriched in biological processes related to gene expression regulation, while downregulated genes were associated with neuronal functions. Molecular pathways associated with neurological disorders, cellular organization and cellular maintenance were altered in the Dicer mutant mice. Numerous miRNA target sites were enriched in the 3' untranslated region (3'UTR) of upregulated genes, the most significant corresponding to the miR-124 seed sequence. Interestingly, our results suggest that, in addition to miR-124, a large fraction of the neuronal miRNome participates, by order of abundance, in coordinated gene expression regulation and neuronal maintenance. Conclusions/Significance: Taken together, these results provide new clues into the role of specific miRNA pathways in the regulation of brain identity and maintenance in adult mice.	[Dorval, Veronique; Smith, Pascal Y.; Delay, Charlotte; Calvo, Ezequiel; Planel, Emmanuel; Hebert, Sebastien S.] Ctr Rech CHUQ CHUL, Quebec City, PQ, Canada; [Dorval, Veronique; Smith, Pascal Y.; Delay, Charlotte; Calvo, Ezequiel; Planel, Emmanuel; Hebert, Sebastien S.] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Zommer, Nadege; Buee, Luc] INSERM, UMR837, F-59045 Lille, France; [Zommer, Nadege; Buee, Luc] Univ Lille Nord France, Fac Med, UDSL, Lille, France	Laval University; Laval University; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Dorval, V (corresponding author), Ctr Rech CHUQ CHUL, Quebec City, PQ, Canada.	sebastien.hebert@crchul.ulaval.ca	Delay, Charlotte/F-3139-2011; Hébert, Sébastien S./Q-2729-2017; BUEE, Luc/B-3126-2010	BUEE, Luc/0000-0002-6261-4230; Planel, Emmanuel/0000-0001-5128-0565; Hebert, Sebastien/0000-0002-0391-9325	Natural Sciences and Engineering Research Council of Canada; Scottish Rite Charitable Foundation of Canada; Alzheimer Society of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Scottish Rite Charitable Foundation of Canada; Alzheimer Society of Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Scottish Rite Charitable Foundation of Canada, and the Alzheimer Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hebert SS, 2012, EXP NEUROL, V235, P397, DOI 10.1016/j.expneurol.2011.12.004; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lau P, 2010, BRAIN RES, V1338, P14, DOI 10.1016/j.brainres.2010.04.002; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Manakov SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-419; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Qureshi IA, 2009, NEUROSCI LETT, V466, P73, DOI 10.1016/j.neulet.2009.07.093; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith P, 2011, J NEUROCHEM; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910	49	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44060	10.1371/journal.pone.0044060	http://dx.doi.org/10.1371/journal.pone.0044060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952873	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800093
J	Martin, N; Ruddick, A; Arthur, GK; Wan, HD; Woodman, L; Brightling, CE; Jones, DJL; Pavord, ID; Bradding, P				Martin, Neil; Ruddick, Andrew; Arthur, Greer K.; Wan, Heidi; Woodman, Lucy; Brightling, Christopher E.; Jones, Don J. L.; Pavord, Ian D.; Bradding, Peter			Primary Human Airway Epithelial Cell-Dependent Inhibition of Human Lung Mast Cell Degranulation	PLOS ONE			English	Article							PRO-RESOLVING MEDIATORS; LIPOXIN A(4) RECEPTOR; SMOOTH-MUSCLE; LIPID MEDIATORS; BRONCHIAL EPITHELIUM; ASTHMA PATHOGENESIS; SYSTEMS-APPROACH; INFLAMMATION; RESOLUTION; EXPRESSION	Introduction: Chronic mast cell activation is a characteristic feature of asthma. BEAS-2B human airway epithelial cells (AEC) profoundly inhibit both constitutive and IgE-dependent human lung mast cell (HLMC) histamine release. The aim of this study was to examine the regulation of HLMC degranulation by primary AEC from healthy and asthmatic subjects, and investigate further the inhibitory mechanism. Methods: HLMC were co-cultured with both BEAS-2B and primary AEC grown as monolayers or air-liquid interface (ALI) cultures. Results: Both constitutive and IgE-dependent HLMC histamine release were attenuated by BEAS-2B, primary AEC monolayers and ALI cultures. This occurred in the absence of HLMC-AEC contact indicating the presence of a soluble factor. Unlike healthy ALI AEC, asthmatic ALI-AEC did not significantly reduce constitutive histamine release. AEC inhibitory activity was transferable in primary AEC monolayer supernatant, but less active than with Transwell co-culture, suggesting that the inhibitory factor was labile. The AEC inhibitory effects were attenuated by both AEC wounding and pertussis toxin, indicating the involvement of a G(0)/G(i) receptor coupled mechanism. Solid phase extraction of lipids (<10 kDa) removed the AEC inhibitory activity. The lipid derivatives resolvin D1 and D2 and lipoxin A(4) attenuated HLMC histamine release in a dose-dependent fashion but were not detectable in co-culture supernatants. Conclusions: Primary AEC suppress HLMC constitutive and IgE-dependent histamine secretion through the release of a soluble, labile lipid mediator(s) that signals through the G(0)/G(i) receptor coupled mechanism. Manipulation of this interaction may have a significant therapeutic role in asthma.	[Martin, Neil; Ruddick, Andrew; Arthur, Greer K.; Wan, Heidi; Woodman, Lucy; Brightling, Christopher E.; Pavord, Ian D.; Bradding, Peter] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Jones, Don J. L.] Univ Leicester, RKCSB, Leicester, Leics, England	University of Leicester; University of Leicester	Martin, N (corresponding author), Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England.	nmartin@doctors.org.uk		brightling, chris/0000-0002-9345-4903; Arthur, Greer/0000-0002-4849-4076; Bradding, Peter/0000-0001-8403-0319; Pavord, Ian/0000-0002-4288-5973	European Regional Development Fund, ERDF [05567]; Defence Postgraduate Medical Deanery; National Institute for Health Research [NF-SI-0510-10157] Funding Source: researchfish	European Regional Development Fund, ERDF; Defence Postgraduate Medical Deanery; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was conducted in laboratories partially funded by European Regional Development Fund, ERDF #05567. NM was partially funded by the Defence Postgraduate Medical Deanery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; AUSTEN KF, 1987, DRUGS, V33, P10, DOI 10.2165/00003495-198700331-00004; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Bonnans C, 2006, AM J PATHOL, V168, P1064, DOI 10.2353/ajpath.2006.051056; Bonnans C, 2007, BIOMED PHARMACOTHER, V61, P261, DOI 10.1016/j.biopha.2007.02.016; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; BRADDING P, 1994, AM J RESP CELL MOL, V10, P471, DOI 10.1165/ajrcmb.10.5.8179909; Bradding P, 2003, CURR OPIN ALLERGY CL, V3, P45, DOI 10.1097/01.all.0000053267.39029.fd; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Carroll NG, 2002, THORAX, V57, P677, DOI 10.1136/thorax.57.8.677; CHRISTIE PE, 1992, AM REV RESPIR DIS, V145, P1281, DOI 10.1164/ajrccm/145.6.1281; Crivellato E, 2003, ANAT REC PART A, V274A, P778, DOI 10.1002/ar.a.10095; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Duffy SM, 2008, EUR J IMMUNOL, V38, P2548, DOI 10.1002/eji.200738106; FINOTTO S, 1994, CLIN EXP IMMUNOL, V95, P343; Gulliksson M, 2007, BBA-MOL CELL BIOL L, V1771, P1156, DOI 10.1016/j.bbalip.2007.06.001; Henry PJ, 2005, J PHARMACOL EXP THER, V314, P995, DOI 10.1124/jpet.105.086124; Hirasawa N, 1997, CELL SIGNAL, V9, P305, DOI 10.1016/S0898-6568(96)00189-1; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Holgate ST, 2010, DISCOV MED, V9, P439; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Hsieh FH, 2005, P NATL ACAD SCI USA, V102, P14380, DOI 10.1073/pnas.0503948102; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Mitchell D, 2007, J BIOL CHEM, V282, P15606, DOI 10.1074/jbc.M611004200; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; NG CF, 1989, ADV PROSTAG THROMB L, V19, P128; NG CF, 1989, BIOCHIM BIOPHYS ACTA, V1004, P332, DOI 10.1016/0005-2760(89)90081-7; Peden DB, 1997, AM J PHYSIOL-LUNG C, V272, pL1181, DOI 10.1152/ajplung.1997.272.6.L1181; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Ruiz-Gutierrez V, 2000, J CHROMATOGR A, V885, P321, DOI 10.1016/S0021-9673(00)00181-3; Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38; Schafer D, 1996, THORAX, V51, P919, DOI 10.1136/thx.51.9.919; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, PROSTAG LEUKOTR ESS, V79, P157, DOI 10.1016/j.plefa.2008.09.012; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Tahan F, 2008, J ASTHMA, V45, P161, DOI 10.1080/02770900701847068; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Yang W, 2006, ALLERGY, V61, P569, DOI 10.1111/j.1398-9995.2006.01041.x	43	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43545	10.1371/journal.pone.0043545	http://dx.doi.org/10.1371/journal.pone.0043545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22970103	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800036
J	Paglia, MG; Bevilacqua, N; Haji, HS; Vairo, F; Girardi, E; Nicastri, E; Muhsin, J; Racalbuto, V; Jiddawi, MS; Ippolito, G				Paglia, Maria G.; Bevilacqua, Nazario; Haji, Haji Said; Vairo, Francesco; Girardi, Enrico; Nicastri, Emanuele; Muhsin, Juma; Racalbuto, Vincenzo; Jiddawi, Mohammed S.; Ippolito, Giuseppe			Improvement of Tuberculosis Laboratory Capacity on Pemba Island, Zanzibar: A Health Cooperation Project	PLOS ONE			English	Article							DELAYS	Low-income countries with high Tuberculosis burden have few reference laboratories able to perform TB culture. In 2006, the Zanzibar National TB Control Programme planned to decentralize TB diagnostics. The Italian Cooperation Agency with the scientific support of the "L. Spallanzani" National Institute for Infectious Diseases sustained the project through the implementation of a TB reference laboratory in a low-income country with a high prevalence of TB. The implementation steps were: 1) TB laboratory design according to the WHO standards; 2) laboratory equipment and reagent supplies for microscopy, cultures, and identification; 3) on-the-job training of the local staff; 4) web-and telemedicine-based supervision. From April 2007 to December 2010, 921 sputum samples were received from 40 peripheral laboratories: 120 TB cases were diagnosed. Of all the smear-positive cases, 74.2% were culture-positive. During the year 2010, the smear positive to culture positive rate increased up to 100%. In March 20, 2010 the Ministry of Health and Social Welfare of Zanzibar officially recognized the Public Health Laboratory-Ivo de Carneri as the National TB Reference Laboratory for the Zanzibar Archipelago. An advanced TB laboratory can represent a low cost solution to strengthen the TB diagnosis, to provide capacity building and mid-term sustainability.	[Paglia, Maria G.; Bevilacqua, Nazario; Vairo, Francesco; Girardi, Enrico; Nicastri, Emanuele; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Microbiol Lab, Dept Epidemiol, Rome, Italy; [Paglia, Maria G.; Bevilacqua, Nazario; Vairo, Francesco; Girardi, Enrico; Nicastri, Emanuele; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Microbiol Lab, Clin Dept, Rome, Italy; [Haji, Haji Said] Publ Hlth Lab Ivo De Carneri, Pemba Isl, Zanzibar, Tanzania; [Muhsin, Juma] Minist Hlth & Social Welf, Natl TB & Leprosy Programme, Unguja Isl, Zanzibar, Tanzania; [Vairo, Francesco; Racalbuto, Vincenzo] Italian Minist Foreign Affairs, Italian Cooperat Agcy, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Paglia, MG (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Microbiol Lab, Dept Epidemiol, Rome, Italy.	nazario.bevilacqua@inmi.it	Ippolito, Giuseppe/J-7207-2017; nicastri, emanuele/K-7780-2016; Paglia, Maria Grazia/B-8849-2017; Vairo, Francesco/M-5676-2013	nicastri, emanuele/0000-0002-5606-8712; Girardi, Enrico/0000-0001-8182-5896; Ippolito, Giuseppe/0000-0002-1076-2979; Paglia, Maria Grazia/0000-0002-3469-6216; Vairo, Francesco/0000-0002-8375-7468	Italian Cooperation and Ministry of Foreign Affairs of Italy [8282]	Italian Cooperation and Ministry of Foreign Affairs of Italy	This work was part of the activities carried out by the Programme Aid 8282 in Tanzania, entirely funded by the Italian Cooperation and Ministry of Foreign Affairs of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimiku AG, 2009, AM J CLIN PATHOL, V131, P875, DOI 10.1309/AJCPELMG6GX6RQSM; Hepple P, 2011, INT J TUBERC LUNG D, V15, P405; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Massambu C, 2009, AM J CLIN PATHOL, V131, P861, DOI 10.1309/AJCP3ZAAFUPCIXIG; Mfinanga SG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-158; Ministry of Health and Social Welfare Zanzibar, HLTH MAN INF SYST UN; Odusanya OO, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-18; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P59; Shin SS, 2008, EMERG INFECT DIS, V14, P701, DOI 10.3201/eid1405.070721; TACAIDS - Tanzania Commission for HIV and AIDS, TANZ COMM HIV AIDS U; UNAIDS, 2010, REP GLOB AIDS EP; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133; World Health Organization, GLOB TUB CONTR EP ST; World Health Organization, 2011, GLOB TUB CONTR WHO R; World Health Organization, 2010, ROADM ENS QUAL TUB D	15	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44109	10.1371/journal.pone.0044109	http://dx.doi.org/10.1371/journal.pone.0044109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952891	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800096
J	Valdes, V; Valenzuela, JI; Salas, DA; Jaureguiberry-Bravo, M; Otero, C; Thiede, C; Schmidt, CF; Couve, A				Valdes, Viviana; Ignacio Valenzuela, Jose; Salas, Daniela A.; Jaureguiberry-Bravo, Matias; Otero, Carolina; Thiede, Christina; Schmidt, Christoph F.; Couve, Andres			Endoplasmic Reticulum Sorting and Kinesin-1 Command the Targeting of Axonal GABA(B) Receptors	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; TRANSPORT; DENDRITES; PROTEINS; TRAFFICKING; DISTINCT; CELLS; SUBUNITS; LOCALIZATION; MICROTUBULES	In neuronal cells the intracellular trafficking machinery controls the availability of neurotransmitter receptors at the plasma membrane, which is a critical determinant of synaptic strength. Metabotropic c amino-butyric acid (GABA) type B receptors (GABA(B)Rs) are neurotransmitter receptors that modulate synaptic transmission by mediating the slow and prolonged responses to GABA. GABA(B)Rs are obligatory heteromers constituted by two subunits, GABA(B)R1 and GABA(B)R2. GABA(B)R1a and GABA(B)R1b are the most abundant subunit variants. GABA(B)R1b is located in the somatodendritic domain whereas GABA(B)R1a is additionally targeted to the axon. Sushi domains located at the N-terminus of GABA(B)R1a constitute the only difference between both variants and are necessary and sufficient for axonal targeting. The precise targeting machinery and the organelles involved in sorting and transport have not been described. Here we demonstrate that GABA(B)Rs require the Golgi apparatus for plasma membrane delivery but that axonal sorting and targeting of GABA(B)R1a operate in a pre-Golgi compartment. In the axon GABA(B)R1a subunits are enriched in the endoplasmic reticulum (ER), and their dynamic behavior and colocalization with other secretory organelles like the ER-to-Golgi intermediate compartment (ERGIC) suggest that they employ a local secretory route. The transport of axonal GABA(B)R1a is microtubule-dependent and kinesin-1, a molecular motor of the kinesin family, determines axonal localization. Considering that progression of GABA(B)Rs through the secretory pathway is regulated by an ER retention motif our data contribute to understand the role of the axonal ER in non-canonical sorting and targeting of neurotransmitter receptors.	[Valdes, Viviana; Ignacio Valenzuela, Jose; Salas, Daniela A.; Jaureguiberry-Bravo, Matias; Couve, Andres] Univ Chile, Fac Med, BNI, Santiago 7, Chile; [Valdes, Viviana; Ignacio Valenzuela, Jose; Salas, Daniela A.; Jaureguiberry-Bravo, Matias; Couve, Andres] Univ Chile, Fac Med, Program Physiol & Biophys, Inst Biomed Sci ICBM, Santiago 7, Chile; [Jaureguiberry-Bravo, Matias] Univ Andres Bello, Fac Biol Sci, Sch Biochem, Santiago, Chile; [Otero, Carolina] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; [Thiede, Christina; Schmidt, Christoph F.] Univ Gottingen, Fak Phys, Drittes Phys Inst Biophys, Gottingen, Germany	Universidad de Chile; Universidad de Chile; Universidad Andres Bello; Pontificia Universidad Catolica de Chile; University of Gottingen	Valdes, V (corresponding author), Univ Chile, Fac Med, BNI, Santiago 7, Chile.	andres@neuro.med.uchile.cl	couve, andres/I-2249-2013; Schmidt, Christoph F/G-3787-2011; Salas, Daniela A./GRF-6423-2022	couve, andres/0000-0003-4216-8672; Schmidt, Christoph F/0000-0003-2864-6973; Salas, Daniela A./0000-0003-4951-0688; Jaureguiberry, Matias/0000-0001-9937-7008; Otero, Carolina/0000-0002-8608-9813	Iniciativa Cientifica Milenio (ICM) [P09-015-F]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100137]; ICM [P09-015-F]; Lower Saxony Grant [11-76251-99-26/08 (ZN2440)]; Deutsche Forschungsgemeinschaft (DFG)-CONICYT [AZ: 444 CHL-113/26/0-1]; Center for Molecular Physiology of the Brain (CMPB); DFG; FONDECYT [1100137]	Iniciativa Cientifica Milenio (ICM); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM; Lower Saxony Grant; Deutsche Forschungsgemeinschaft (DFG)-CONICYT; Center for Molecular Physiology of the Brain (CMPB); DFG(German Research Foundation (DFG)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	VV was supported by Iniciativa Cientifica Milenio (ICM) P09-015-F. JIV was supported by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT). MJB was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1100137 and ICM P09-015-F. CT was supported in part by the Lower Saxony Grant No 11-76251-99-26/08 (ZN2440). CO was supported by Deutsche Forschungsgemeinschaft (DFG)-CONICYT international grant AZ: 444 CHL-113/26/0-1. CFS was supported by the Center for Molecular Physiology of the Brain (CMPB), funded by the DFG. AC was supported by FONDECYT 1100137 and ICM P09-015-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; Aridor M, 2009, TRAFFIC, V10, P1669, DOI 10.1111/j.1600-0854.2009.00974.x; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; BROADWELL RD, 1984, J COMP NEUROL, V230, P231, DOI 10.1002/cne.902300208; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Calver AR, 2001, J NEUROSCI, V21, P1203; Casanova E, 2009, GENESIS, V47, P595, DOI 10.1002/dvg.20535; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Goslin K., 1991, CULTURING NERVE CELL, P251; Herpers B, 2004, MOL BIOL CELL, V15, P5306, DOI 10.1091/mbc.E04-05-0398; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kulik A, 2003, J NEUROSCI, V23, P11026; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Shah JV, 2002, CURR OPIN CELL BIOL, V14, P58, DOI 10.1016/S0955-0674(01)00294-0; Soza A, 2004, J BIOL CHEM, V279, P17376, DOI 10.1074/jbc.M313197200; Terada S, 2010, EMBO J, V29, P843, DOI 10.1038/emboj.2009.389; TSUKITA S, 1976, J ELECTRON MICROSC, V25, P141; Vidal RL, 2007, MOL CELL NEUROSCI, V35, P501, DOI 10.1016/j.mcn.2007.04.008; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; WECLEWICZ K, 1993, J NEUROCYTOL, V22, P616, DOI 10.1007/BF01181488; Weclewicz K, 1998, BRAIN RES BULL, V46, P353, DOI 10.1016/S0361-9230(98)00013-6; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Yogev S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000505; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289	50	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44168	10.1371/journal.pone.0044168	http://dx.doi.org/10.1371/journal.pone.0044168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952914	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800099
J	Smith, LR; Chambers, HG; Subramaniam, S; Lieber, RL				Smith, Lucas R.; Chambers, Henry G.; Subramaniam, Shankar; Lieber, Richard L.			Transcriptional Abnormalities of Hamstring Muscle Contractures in Children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; MEDIAL GASTROCNEMIUS; SPASTIC DIPLEGIA; GENE ONTOLOGY; STIFFNESS; HYPOEXTENSIBILITY; DIFFERENTIATION; ARCHITECTURE	Cerebral palsy (CP) is an upper motor neuron disease that results in a spectrum of movement disorders. Secondary to the neurological lesion, muscles from patients with CP are often spastic and form debilitating contractures that limit range of motion and joint function. With no genetic component, the pathology of skeletal muscle in CP is a response to aberrant complex neurological input in ways that are not fully understood. This study was designed to gain further understanding of the skeletal muscle response in CP using transcriptional profiling correlated with functional measures to broadly investigate muscle adaptations leading to mechanical deficits. Biospsies were obtained from both the gracilis and semitendinosus muscles from a cohort of patients with CP (n = 10) and typically developing patients (n = 10) undergoing surgery. Biopsies were obtained to define the unique expression profile of the contractures and passive mechanical testing was conducted to determine stiffness values in previously published work. Affymetrix HG-U133A 2.0 chips (n = 40) generated expression data, which was validated for selected transcripts using quantitative real-time PCR. Chips were clustered based on their expression and those from patients with CP clustered separately. Significant genes were determined conservatively based on the overlap of three summarization algorithms (n = 1,398). Significantly altered genes were analyzed for over-representation among gene ontologies and muscle specific networks. The majority of altered transcripts were related to increased extracellular matrix expression in CP and a decrease in metabolism and ubiquitin ligase activity. The increase in extracellular matrix products was correlated with mechanical measures demonstrating the importance in disability. These data lay a framework for further studies and development of novel therapies.	[Smith, Lucas R.; Subramaniam, Shankar; Lieber, Richard L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Chambers, Henry G.] Rady Childrens Hosp, Dept Orthoped Surg, San Diego, CA USA; [Chambers, Henry G.; Lieber, Richard L.] Univ Calif San Diego, Dept Orthoped Surg, La Jolla, CA 92093 USA; [Lieber, Richard L.] US Dept Vet Affairs, Med Ctr, San Diego, CA USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs	Smith, LR (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	rlieber@ucsd.edu	Smith, Lucas R/S-2157-2018	Smith, Lucas R/0000-0002-7610-4231; Lieber, Richard/0000-0002-7203-4520	National Institutes of Health [AR057393]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health [grant number AR057393]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache CE, 2003, CURR ORTHOPAED, V17, P88, DOI 10.1054/cuor.2003.0328; Barrett RS, 2010, DEV MED CHILD NEUROL, V52, P794, DOI 10.1111/j.1469-8749.2010.03686.x; Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; Booth CM, 2001, DEV MED CHILD NEUROL, V43, P314, DOI 10.1017/S0012162201000597; Brown CA, 2011, J HUMAN GENETICS; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Clavet H, 2008, CAN MED ASSOC J, V178, P691, DOI 10.1503/cmaj.071056; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crenna P, 1998, NEUROSCI BIOBEHAV R, V22, P571, DOI 10.1016/S0149-7634(97)00046-8; Ducomps C, 2003, ACTA PHYSIOL SCAND, V178, P215, DOI 10.1046/j.1365-201X.2003.01109.x; Dzienkowski R C, 1996, Nurse Pract, V21, P45, DOI 10.1097/00006205-199602000-00004; Dzienkowski RC, 1996, NURSE PRACT, V21, P51; Dzienkowski RC, 1996, NURSE PRACT, V21, P60; Dzienkowski RC, 1996, NURSE PRACT, V21, P57; Elder GCB, 2003, DEV MED CHILD NEUROL, V45, P542, DOI 10.1111/j.1469-8749.2003.tb00954.x; Feltrin E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-6; Foran JRH, 2005, DEV MED CHILD NEUROL, V47, P713, DOI 10.1017/S0012162205001465; Friden J, 2003, MUSCLE NERVE, V27, P157, DOI 10.1002/mus.10247; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Graham HK, 2003, J BONE JOINT SURG BR, V85B, P157, DOI 10.1302/0301620X.85B2.14066; Hankins GDV, 2003, OBSTET GYNECOL, V102, P628, DOI 10.1016/S0029-7844(03)00574-X; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Ivanhoe CB, 2004, AM J PHYS MED REHAB, V83, pS3, DOI 10.1097/01.PHM.0000141125.28611.3E; Kim WH, 2011, DEV MED CHILD NEUROL, V53, P68, DOI [10.1111/j.1469-8749.2010.03777.x, 10.1111/j.1469-8749.2011.04006.x]; Klebanov L, 2007, NAT BIOTECHNOL, V25, P24, DOI 10.1038/nbt0107-25; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; Kovanen V, 2002, EXERC SPORT SCI REV, V30, P20, DOI 10.1097/00003677-200201000-00005; Lieber RL, 2003, MUSCLE NERVE, V28, P464, DOI 10.1002/mus.10446; Lieber RL, 2002, MUSCLE NERVE, V25, P265, DOI 10.1002/mus.10036; Lin JP, 2011, DEV MED CHILD NEUROL, V53, P7, DOI 10.1111/j.1469-8749.2010.03843.x; Lorentzen J, 2010, CLIN NEUROPHYSIOL; Malaiya R, 2007, J ELECTROMYOGR KINES, V17, P657, DOI 10.1016/j.jelekin.2007.02.009; Maraldi NM, 2011, ADV ENZYME REGUL, V51, P246, DOI 10.1016/j.advenzreg.2010.09.006; Mohagheghi AA, 2008, DEV MED CHILD NEUROL, V50, P44, DOI 10.1111/j.1469-8749.2007.02008.x; Mohagheghi AA, 2007, CLIN BIOMECH, V22, P718, DOI 10.1016/j.clinbiomech.2007.03.004; Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com; Neagoe C, 2003, J MUSCLE RES CELL M, V24, P175, DOI 10.1023/A:1026053530766; Olive M, 2008, NEUROMUSCULAR DISORD, V18, P929, DOI 10.1016/j.nmd.2008.07.009; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pohl M, 2007, BRAIN INJURY, V21, P421, DOI 10.1080/02699050701311109; Ponten EM, 2007, J NEUROL SCI, V253, P25, DOI 10.1016/j.jns.2006.11.006; Reddihough DS, 2003, AUST J PHYSIOTHER, V49, P7, DOI 10.1016/S0004-9514(14)60183-5; Rose J, 2005, DEV MED CHILD NEUROL, V47, P329, DOI 10.1017/S0012162205000629; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCELSI R, 1984, ACTA NEUROPATHOL, V62, P324, DOI 10.1007/BF00687615; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Shortland AP, 2002, DEV MED CHILD NEUROL, V44, P158, DOI 10.1017/S0012162201001864; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Smith LR, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-44; Stackhouse SK, 2005, MUSCLE NERVE, V31, P594, DOI 10.1002/mus.20302; TARDIEU C, 1982, ARCH PHYS MED REHAB, V63, P97; TARDIEU G, 1982, ARCH PHYS MED REHAB, V63, P103; Theroux MC, 2002, ANESTHESIOLOGY, V96, P330, DOI 10.1097/00000542-200202000-00017; Tilton Ann H, 2006, NeuroRx, V3, P217, DOI 10.1016/j.nurx.2006.01.008; TSAY HJ, 1989, J CELL BIOL, V108, P1523, DOI 10.1083/jcb.108.4.1523; Verrotti A, 2006, PEDIATR NEUROL, V34, P1, DOI 10.1016/j.pediatrneurol.2005.05.001; Yeargin-Allsopp M, 2008, PEDIATRICS, V121, P547, DOI 10.1542/peds.2007-1270; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	63	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e40686	10.1371/journal.pone.0040686	http://dx.doi.org/10.1371/journal.pone.0040686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22956992	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300004
J	Sunaga, N; Kaira, K; Imai, H; Shimizu, K; Nakano, T; Shames, DS; Girard, L; Soh, J; Sato, M; Iwasaki, Y; Ishizuka, T; Gazdar, AF; Minna, JD; Mori, M				Sunaga, N.; Kaira, K.; Imai, H.; Shimizu, K.; Nakano, T.; Shames, D. S.; Girard, L.; Soh, J.; Sato, M.; Iwasaki, Y.; Ishizuka, T.; Gazdar, A. F.; Minna, J. D.; Mori, M.			Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer	ONCOGENE			English	Article						NSCLC; KRAS; EREG; therapeutic target	EPIDERMAL-GROWTH-FACTOR; COPY NUMBER GAINS; SIGNALING PATHWAY; RAS ONCOGENE; EXPRESSION; MUTATIONS; EGFR; ACTIVATION; RESISTANCE; GEFITINIB	KRAS mutations are one of the most common driver mutations in non-small-cell lung cancer (NSCLC) and finding druggable target molecules to inhibit oncogenic KRAS signaling is a significant challenge in NSCLC therapy. We recently identified epiregulin (EREG) as one of several putative transcriptional targets of oncogenic KRAS signaling in both KRAS-mutant NSCLC cells and immortalized bronchial epithelial cells expressing ectopic mutant KRAS. In the current study, we found that EREG is overexpressed in NSCLCs harboring KRAS, BRAF or EGFR mutations compared with NSCLCs with wild-type KRAS/BRAF/EGFR. Small interfering RNAs (siRNAs) targeting mutant KRAS, but not an siRNA targeting wild-type KRAS, significantly reduced EREG expression in KRAS-mutant and EREG-overexpressing NSCLC cell lines. In these cell lines, EREG expression was downregulated by MEK and ERK inhibitors. Importantly, EREG expression significantly correlated with KRAS expression or KRAS copy number in KRAS-mutant NSCLC cell lines. Further expression analysis using 89 NSCLC specimens showed that EREG was predominantly expressed in NSCLCs with pleural involvement, lymphatic permeation or vascular invasion and in KRAS-mutant adenocarcinomas. In addition, multivariate analysis revealed that EREG expression is an independent prognostic marker and EREG overexpression in combination with KRAS mutations was associated with an unfavorable prognosis for lung adenocarcinoma patients. In KRAS-mutant and EREG overexpressing NSCLC cells, siRNA-mediated EREG silencing inhibited anchorage-dependent and -independent growth and induced apoptosis. Our findings suggest that oncogenic KRAS-induced EREG overexpression contributes to an aggressive phenotype and could be a promising therapeutic target in oncogenic KRAS-driven NSCLC.	[Sunaga, N.; Kaira, K.; Imai, H.; Iwasaki, Y.; Ishizuka, T.; Mori, M.] Gunma Univ, Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan; [Shimizu, K.; Nakano, T.] Gunma Univ, Sch Med, Maebashi, Gunma 3718511, Japan; [Shames, D. S.] Genentech Inc, Oncol Diagnost, San Francisco, CA 94080 USA; [Shames, D. S.; Girard, L.; Minna, J. D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Girard, L.; Minna, J. D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Soh, J.; Gazdar, A. F.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Minna, J. D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sato, M.] Nagoya Univ, Grad Sch Med, Dept Resp Med, Showa Ku, Nagoya, Aichi 4648601, Japan; [Soh, J.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Canc & Thorac Surg, Kita Ku, Okayama, Japan	Gunma University; Gunma University; Roche Holding; Genentech; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Nagoya University; Okayama University	Sunaga, N (corresponding author), Gunma Univ, Sch Med, Dept Canc & Thorac Med & Mol Sci, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan.	nsunaga@showa.gunma-u.ac.jp	Soh, Junichi/AAV-1053-2020; Sato, MITSUO/I-7280-2014; Soh, Junichi/AAT-7095-2021; Imai, Hisao/AAB-7248-2021	Soh, Junichi/0000-0001-8532-7915; Sato, MITSUO/0000-0001-5458-9576; Soh, Junichi/0000-0001-8532-7915; Imai, Hisao/0000-0003-3097-4255	Japan Society for the Promotion of Science [23591134]; SPORE [P50CA70907]; DOD PROSPECT, Texas Higher Education Coordinating Board Advanced Technology Program [01001901392003]; Gillson Longenbaugh Foundation; NASA Specialized Center of Research [NNJ05HD36G]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23591134] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SPORE; DOD PROSPECT, Texas Higher Education Coordinating Board Advanced Technology Program; Gillson Longenbaugh Foundation; NASA Specialized Center of Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) (grant #23591134) from the Japan Society for the Promotion of Science. Funding for this work also came from SPORE (P50CA70907); DOD PROSPECT, Texas Higher Education Coordinating Board Advanced Technology Program (grant #01001901392003); Gillson Longenbaugh Foundation; NASA Specialized Center of Research (grant #NNJ05HD36G). We thank Drs Yoshio Tomizawa, Noriko Yanagitani, Hironobu Iijima, Takeshi Hisada, Mitsuyoshi Utsugi of the Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan for technical support and critical advices. We also thank Drs Kenneth Huffman and Victor Stastny of the Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas for kind assistance.	Baba I, 2000, CANCER RES, V60, P6886; Cho MC, 2008, BIOCHEM BIOPH RES CO, V377, P832, DOI 10.1016/j.bbrc.2008.10.053; Chu EK, 2005, AM J RESP CELL MOL, V32, P373, DOI 10.1165/rcmb.2004-0266OC; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Draper BK, 2003, J CELL BIOCHEM, V89, P1126, DOI 10.1002/jcb.10584; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gazdar AF, 2008, CANCER PREV RES, V1, P156, DOI 10.1158/1940-6207.CAPR-08-0080; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hu K, 2009, ORAL ONCOL, V45, P156, DOI 10.1016/j.oraloncology.2008.04.009; Imai H, 2010, INT J IMMUNOPATH PH, V23, P153, DOI 10.1177/039463201002300114; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaira K, 2010, J CLIN ONCOL, V28, P3746, DOI 10.1200/JCO.2009.27.4662; Kris MG, 2011, J CLIN ONCOL, V29; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Lee S, 2009, INT J ONCOL, V34, P161, DOI 10.3892/ijo_00000138; Lindvall C, 2003, CANCER RES, V63, P1743; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Nicholson BE, 2004, CANCER RES, V64, P7813, DOI 10.1158/0008-5472.CAN-04-0826; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Phelps RM, 1996, J CELL BIOCHEM, P32; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Riese DJ, 1998, J BIOL CHEM, V273, P11288, DOI 10.1074/jbc.273.18.11288; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Sun MH, 2009, CLIN CANCER RES, V15, P4829, DOI 10.1158/1078-0432.CCR-08-2921; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Sunaga N, 2012, INT J CANCER, V130, P1733, DOI 10.1002/ijc.26164; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Takahashi M, 2003, CIRCULATION, V108, P2524, DOI 10.1161/01.CIR.0000096482.02567.8C; Thogersen VB, 2001, CANCER RES, V61, P6227; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Toyoda H, 1997, BIOCHEM J, V326, P69, DOI 10.1042/bj3260069; Wang XY, 2009, MOL CARCINOGEN, V48, P1, DOI 10.1002/mc.20449; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zhang J, 2008, CANCER PREV RES, V1, P201, DOI 10.1158/1940-6207.CAPR-08-0014; Zhao M, 2009, BIOCHEM BIOPH RES CO, V387, P239, DOI 10.1016/j.bbrc.2009.06.128; Zhu ZW, 2000, BIOCHEM BIOPH RES CO, V273, P1019, DOI 10.1006/bbrc.2000.3033	47	42	44	2	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					4034	4042		10.1038/onc.2012.402	http://dx.doi.org/10.1038/onc.2012.402			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22964644	Green Accepted			2022-12-25	WOS:000323748100012
J	Budiu, RA; Elishaev, E; Brozick, J; Lee, M; Edwards, RP; Kalinski, P; Vlad, AM				Budiu, R. A.; Elishaev, E.; Brozick, J.; Lee, M.; Edwards, R. P.; Kalinski, P.; Vlad, A. M.			Immunobiology of human mucin 1 in a preclinical ovarian tumor model	ONCOGENE			English	Article						ovarian cancer; MUC1; Kras; Pten; dendritic cells	CARCINOMA-ASSOCIATED ANTIGEN; MAJOR HISTOCOMPATIBILITY COMPLEX; REGULATORY T-CELLS; MOUSE MODEL; MOLECULAR-CLONING; GENE-EXPRESSION; CANCER; MICE; TOLERANCE; PTEN	Epithelial ovarian cancer is an aggressive malignancy, with a low 5-year median survival. Continued improvement on the development of more effective therapies depends in part on the availability of adequate preclinical models for in vivo testing of treatment efficacy. Mucin 1 (MUC1) glycoprotein is a tumor-associated antigen overexpressed in ovarian cancer cells, making it a potential target for immune therapy. To create a preclinical mouse model for MUC1-positive ovarian tumors, we generated triple transgenic (Tg) mice that heterozygously express human MUC1(+/+) as a transgene, and carry the conditional K-rasG12D oncoallele (loxP-Stop-loxP-K-ras(G12D/+)) and the floxed Pten gene (Pten/(loxP/loxP)). Injection of Cre recombinase-encoding adenovirus (AdCre) in the ovarian bursa of triple (MUC1KrasPten) Tg mice triggers ovarian tumors that, in analogy to human ovarian cancer, express strongly elevated MUC1 levels. The tumors metastasize loco-regionally and are accompanied by high serum MUC1, closely mimicking the human disease. Compared with the KrasPten mice with tumors, the MUC1KrasPten mice show increased loco-regional metastasis and augmented accumulation of CD4+Foxp3+ immune-suppressive regulatory T cells. Vaccination of MUC1KrasPten mice with type 1 polarized dendritic cells (DC1) loaded with a MUC1 peptide (DC1-MUC1) can circumvent tumor-mediated immune suppression in the host, activate multiple immune effector genes and effectively prolong survival. Our studies report the first human MUC1-expressing, orthotopic ovarian tumor model, reveal novel MUC1 functions in ovarian cancer biology and demonstrate its suitability as a target for immune-based therapies.	[Budiu, R. A.; Elishaev, E.; Edwards, R. P.; Vlad, A. M.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Budiu, R. A.; Brozick, J.; Lee, M.; Edwards, R. P.; Vlad, A. M.] Magee Womens Res Inst, Pittsburgh, PA USA; [Elishaev, E.] Univ Pittsburgh, Med Ctr, Dept Pathol, Magee Womens Hosp, Pittsburgh, PA 15213 USA; [Kalinski, P.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Kalinski, P.] Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Dept Surg, Pittsburgh, PA 15213 USA; [Kalinski, P.; Vlad, A. M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vlad, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Room B403,204 Craft Ave, Pittsburgh, PA 15213 USA.	vladam@upmc.edu	Brozick, Joan/AAA-5785-2019		Department of Defense Ovarian Cancer Academy Award; Pennsylvania Department of Health; Scaife Foundation; NIH/NCI [1 R01 CA163462-01]; NATIONAL CANCER INSTITUTE [R01CA163462] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Department of Defense Ovarian Cancer Academy Award; Pennsylvania Department of Health; Scaife Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to thank Dr Daniela Dinulescu for discussion on various aspects of the mouse model, Dr Olivera Finn for critical review of the paper and Julia Thaller for technical assistance with histology work. This study was supported by the Department of Defense Ovarian Cancer Academy Award, Pennsylvania Department of Health, Scaife Foundation and NIH/NCI 1 R01 CA163462-01 (to AMV).	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; Beatty PL, 2007, J IMMUNOL, V179, P735, DOI 10.4049/jimmunol.179.2.735; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Boyd J, 2005, NEW ENGL J MED, V352, P2240, DOI 10.1056/NEJMcibr051024; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; Budiu RA, 2011, CANCER IMMUNOL IMMUN, V60, P975, DOI 10.1007/s00262-011-1010-x; Budiu RA, 2009, DIS MODEL MECH, V2, P593, DOI 10.1242/dmm.002535; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen DS, 2000, BREAST CANCER RES TR, V60, P107, DOI 10.1023/A:1006332009414; Connolly DC, 2003, CANCER RES, V63, P1389; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Fan HY, 2009, CANCER RES, V69, P6463, DOI 10.1158/0008-5472.CAN-08-3363; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Giermasz AS, 2009, CANCER IMMUNOL IMMUN, V58, P1329, DOI 10.1007/s00262-008-0648-5; Hiltbold EM, 2000, J IMMUNOL, V165, P3730, DOI 10.4049/jimmunol.165.7.3730; HO SB, 1993, CANCER RES, V53, P641; IOANNIDES CG, 1993, J IMMUNOL, V151, P3693; JEROME KR, 1993, J IMMUNOL, V151, P1654; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; Karam AK, 2010, NAT REV CLIN ONCOL, V7, P335, DOI 10.1038/nrclinonc.2010.44; KOTERA Y, 1994, CANCER RES, V54, P2856; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Matzuk MM, 2005, NAT MED, V11, P24, DOI 10.1038/nm0105-24; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Odunsi K, 2008, AM J REPROD IMMUNOL, V59, P62, DOI 10.1111/j.1600-0897.2007.00560.x; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reinartz S, 2012, EUR J CANCER, V48, P1558, DOI 10.1016/j.ejca.2011.07.004; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rowse GJ, 1998, CANCER RES, V58, P315; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Rustin GJS, 2004, CLIN CANCER RES, V10, P3919, DOI 10.1158/1078-0432.CCR-03-0787; Ryan SO, 2009, BIOL CHEM, V390, P611, DOI 10.1515/BC.2009.070; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shan WW, 2009, CELL CYCLE, V8, P731, DOI 10.4161/cc.8.5.7848; SPICER AP, 1991, J BIOL CHEM, V266, P15099; Tanwar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020715; Theriault C, 2011, GYNECOL ONCOL, V121, P434, DOI 10.1016/j.ygyno.2011.02.020; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; Vlad AM, 2006, IMMUNOL RES, V36, P229, DOI 10.1385/IR:36:1:229; Wei CW, 1997, P NATL ACAD SCI USA, V94, P6369, DOI 10.1073/pnas.94.12.6369; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yang DH, 2006, AM J PATHOL, V169, P258, DOI 10.2353/ajpath.2006.060036	58	24	24	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 8	2013	32	32					3664	3675		10.1038/onc.2012.397	http://dx.doi.org/10.1038/onc.2012.397			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22964632	Green Accepted			2022-12-25	WOS:000322904400002
J	Wang, SP; Li, XL; Song, XL; Geng, ZR; Hu, X; Wang, ZL				Wang, Shuping; Li, Xiangli; Song, Xiaoli; Geng, Zhirong; Hu, Xin; Wang, Zhilin			Rapid Equilibrium Kinetic Analysis of Arsenite Methylation Catalyzed by Recombinant Human Arsenic (+3 Oxidation State) Methyltransferase (hAS3MT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SERUM-ALBUMIN; TRIVALENT ARSENICALS; CYSTEINE RESIDUES; DRINKING-WATER; PLUS B; ENZYME; METABOLISM; PROTEIN; IDENTIFICATION; FLUORESCENCE	In the human body, arsenic is metabolized by methylation. Understanding this process is important and provides insight into the relationship between arsenic and its related diseases. We used the rapid equilibrium kinetic model to study the reaction sequence of arsenite methylation. The results suggest that the mechanism for arsenite methylation is a completely ordered mechanism that is also of general interest in reaction systems with different reductants, such as tris(2-carboxyethyl)phosphine, cysteine, and glutathione. In the reaction, cysteine residues of recombinant human arsenic (+3 oxidation state) methyltransferase (hAS3MT) coordinate with arsenicals and involve the methyl transfer step. S-Adenosyl-L-methionine (AdoMet) is the first-order reactant, which modulates the conformation of hAS3MT to a best matched state by hydrophobic interaction. As the second-order reactant, reductant reduces the disulfide bond, most likely between Cys-250 and another cysteine residue of hAS3MT, and exposes the active site cysteine residues for binding trivalent inorganic arsenic(iAs(3+)) to give monomethylarsonic dicysteine (MADC(3+)). In addition, the reaction can be extended to further methylate MADC(3+) to dimethylarsinic cysteine (DAMC(3+)). In the methylation reaction, the beta-pleated sheet content of hAS3MT is increased, and the hydrophobicity of the microenvironment around the active sites is decreased. Similarly, we confirm that both the high beta-pleated sheet content of hAS3MT and the high dissociation ability of the enzyme-AdoMet-reductant improve the yield of dimethylated arsenicals.	[Wang, Shuping; Li, Xiangli; Song, Xiaoli; Geng, Zhirong; Wang, Zhilin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Hu, Xin] Nanjing Univ, Modern Anal Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Song, Xiaoli] Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou 225002, Peoples R China	Nanjing University; Nanjing University; Yangzhou University	Wang, ZL (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China.	wangzl@nju.edu.cn	Hu, Xin/B-1792-2009; Geng, Zhirong/HGC-1447-2022	Hu, Xin/0000-0003-3400-554X; Geng, Zhirong/0000-0003-3766-9034	National Natural Science Foundation of China [21075064, 21027013, 21021062, 21275072, 21201101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 21075064, 21027013, 21021062, 21275072, and 21201101.	Alberty RA, 2009, J PHYS CHEM B, V113, P10043, DOI 10.1021/jp9021097; Alberty RA, 2009, J PHYS CHEM B, V113, P1225, DOI 10.1021/jp8080436; Aposhian HV, 2006, CHEM RES TOXICOL, V19, P1, DOI 10.1021/tx050106d; Bi SY, 2005, SPECTROCHIM ACTA A, V61, P629, DOI 10.1016/j.saa.2004.05.028; CHALLENGER F, 1951, ADV ENZYMOL REL S BI, V12, P429; CHALLENGER F, 1945, CHEM REV, V36, P315, DOI 10.1021/cr60115a003; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Concha G, 2002, INT ARCH OCC ENV HEA, V75, P576, DOI 10.1007/s00420-002-0361-1; Cui FL, 2008, PESTIC BIOCHEM PHYS, V90, P126, DOI 10.1016/j.pestbp.2007.11.002; CULLEN WR, 1984, J INORG BIOCHEM, V21, P179, DOI 10.1016/0162-0134(84)83002-0; Dopp E, 2004, TOXICOL APPL PHARM, V201, P156, DOI 10.1016/j.taap.2004.05.017; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Kitchin KT, 2005, TOXICOL APPL PHARM, V206, P66, DOI 10.1016/j.taap.2004.12.010; Kligerman AD, 2003, ENVIRON MOL MUTAGEN, V42, P192, DOI 10.1002/em.10192; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Mass MJ, 2001, CHEM RES TOXICOL, V14, P355, DOI 10.1021/tx000251l; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; Naranmandura H, 2006, CHEM RES TOXICOL, V19, P1010, DOI 10.1021/tx060053f; Ortiz JGM, 2011, TOXICOL SCI, V121, P303, DOI 10.1093/toxsci/kfr074; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Song XL, 2010, BIOCHIMIE, V92, P1397, DOI 10.1016/j.biochi.2010.07.002; Song XL, 2009, CHEM-BIOL INTERACT, V179, P321, DOI 10.1016/j.cbi.2008.12.018; Sulkowska A, 2006, J MOL STRUCT, V792, P249, DOI 10.1016/j.molstruc.2006.01.002; Suzuki KT, 2007, TOXICOL APPL PHARM, V218, P166, DOI 10.1016/j.taap.2006.10.027; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Thomas DJ, 2007, TOXICOL APPL PHARM, V222, P365, DOI 10.1016/j.taap.2007.02.007; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Thomas DJ, 2010, TOXICOL SCI, V113, P70, DOI 10.1093/toxsci/kfp250; Thomas DJ, 2009, TOXICOL SCI, V107, P309, DOI 10.1093/toxsci/kfn257; Thomas DJ, 2004, TOXICOL APPL PHARM, V198, P319, DOI 10.1016/j.taap.2003.10.020; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Tian JN, 2005, BIOORGAN MED CHEM, V13, P4124, DOI 10.1016/j.bmc.2005.02.065; Tsai SM, 1999, ARCH ENVIRON HEALTH, V54, P186, DOI 10.1080/00039899909602258; Tseng CH, 2003, TOXICOL LETT, V137, P15, DOI 10.1016/S0378-4274(02)00377-6; Walton FS, 2003, CHEM RES TOXICOL, V16, P261, DOI 10.1021/tx025649r; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zakharyan RA, 1999, TOXICOL APPL PHARM, V154, P287, DOI 10.1006/taap.1998.8587; Zhang LY, 2010, BIOPOLYMERS, V93, P141, DOI 10.1002/bip.21312; Zhang YZ, 2008, J FLUORESC, V18, P109, DOI 10.1007/s10895-007-0247-4	42	22	22	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38790	38799		10.1074/jbc.M112.368050	http://dx.doi.org/10.1074/jbc.M112.368050			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22955273	Green Published, hybrid			2022-12-25	WOS:000310982800036
J	Illert, AL; Zech, M; Moll, C; Albers, C; Kreutmair, S; Peschel, C; Bassermann, F; Duyster, J				Illert, Anna Lena; Zech, Michael; Moll, Cathrin; Albers, Corinna; Kreutmair, Stefanie; Peschel, Christian; Bassermann, Florian; Duyster, Justus			Extracellular Signal-regulated Kinase 2 (ERK2) Mediates Phosphorylation and Inactivation of Nuclear Interaction Partner of Anaplastic Lymphoma Kinase (NIPA) at G(2)/M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SCF UBIQUITIN-LIGASE; MAP KINASE; M-PHASE; CYCLIN D1; G1 PHASE; XENOPUS; IDENTIFICATION; PATHWAY; REQUIREMENT	NIPA is an F-box-like protein that contributes to the timing of mitotic entry. It targets nuclear cyclin B1 for ubiquitination in interphase, whereas in G(2)/M phase, NIPA is inactivated by phosphorylation to allow for cyclin B1 accumulation, a critical event for proper G(2)/M transition. We recently specified three serine residues of NIPA and demonstrated a sequential phosphorylation at G(2)/M, where initial Ser-354 and Ser-359 phosphorylation is most crucial for SCFNIPA inactivation. In this study, we identified ERK2 as the kinase responsible for this critical initial phosphorylation step. Using in vitro kinase assays, we found that both ERK1 and ERK2 phosphorylated NIPA with high efficiency. Mutation of either Ser-354 or Ser-359 abolished ERK-dependent NIPA phosphorylation. Pharmacologic inhibition of ERK1/2 in cell lines resulted in decreased NIPA phosphorylation at G(2)/M. By combining cell cycle synchronization with stable expression of shRNA targeting either ERK1 or ERK2, we showed that ERK2 but not ERK1 mediated NIPA inactivation at G(2)/M. ERK2 knockdown led to a delay at the G(2)/M transition, a phenotype also observed in cells expressing a phospho-deficient mutant of NIPA. Thus, our data add to the recently described divergent functions of ERK1 and ERK2 in cell cycle regulation, which may be due in part to the differential ability of these kinases to phosphorylate and inactivate NIPA at G(2)/M.	[Duyster, Justus] Univ Med Ctr Freiburg, Dept Hematol Oncol, D-79106 Freiburg, Germany; [Illert, Anna Lena; Zech, Michael; Moll, Cathrin; Albers, Corinna; Kreutmair, Stefanie; Peschel, Christian; Bassermann, Florian] Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany	University of Freiburg; Technical University of Munich; University of Munich	Duyster, J (corresponding author), Univ Med Ctr Freiburg, Dept Hematol Oncol, Hugstetter Str 55, D-79106 Freiburg, Germany.	direktion-med1@uniklinik-freiburg.de	Illert, Anna L/G-8127-2019; Kreutmair, Stefanie/GOK-2757-2022; Kreutmair, Stefanie/AAE-6952-2022	Kreutmair, Stefanie/0000-0001-8466-6675	Deutsche Jose Carreras Leukamie Stiftung (DJCLS) [R 08/02v]; Wilhelm Sander Stiftung; Technical University of Munich [KKF-B07-08]; German Research Foundation [DU 227/3-1, BA 2851/3-1]; German Cancer Aid Grant [109543]	Deutsche Jose Carreras Leukamie Stiftung (DJCLS); Wilhelm Sander Stiftung; Technical University of Munich; German Research Foundation(German Research Foundation (DFG)); German Cancer Aid Grant	This work was supported by Deutsche Jose Carreras Leukamie Stiftung (DJCLS) Grant R 08/02v and the Wilhelm Sander Stiftung (to J. D.), Technical University of Munich Research Grant KKF-B07-08 (to A. L. I.), German Research Foundation Grant DU 227/3-1 (to A. L. I. and J. D.), and German Research Foundation Grant BA 2851/3-1 and German Cancer Aid Grant 109543 (to F. B.).	Abrieu A, 1997, MOL BIOL CELL, V8, P249, DOI 10.1091/mbc.8.2.249; Abrieu A, 1997, EMBO J, V16, P6407, DOI 10.1093/emboj/16.21.6407; Abrieu A, 2001, J CELL SCI, V114, P257; Albers C, 2011, BLOOD, V118, P2200, DOI 10.1182/blood-2010-10-309583; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Bassermann F, 2005, CELL CYCLE, V4, P1515, DOI 10.4161/cc.4.11.2192; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Bassermann F, 2007, J BIOL CHEM, V282, P15965, DOI 10.1074/jbc.M610819200; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Bitangcol JC, 1998, MOL BIOL CELL, V9, P451, DOI 10.1091/mbc.9.2.451; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chau ASS, 1999, J BIOL CHEM, V274, P32085, DOI 10.1074/jbc.274.45.32085; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hindley A, 2002, J CELL SCI, V115, P1575; Illert AL, 2012, DEVELOPMENT, V139, P2523, DOI 10.1242/dev.073072; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; MACNICOL AM, 1995, MOL CELL BIOL, V15, P6686; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Murakami MS, 1998, DEVELOPMENT, V125, P237; Ouyang T, 2003, J BIOL CHEM, V278, P30028, DOI 10.1074/jbc.M300883200; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Tolwinski NS, 1999, J BIOL CHEM, V274, P6168, DOI 10.1074/jbc.274.10.6168; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; von Klitzing C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028998; Walsh S, 2003, MOL CANCER RES, V1, P280; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	65	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.373464	http://dx.doi.org/10.1074/jbc.M112.373464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22955283	hybrid, Green Published			2022-12-25	WOS:000310642200034
J	Kimberley, FC; van der Sloot, AM; Guadagnoli, M; Cameron, K; Schneider, P; Marquart, JA; Versloot, M; Serrano, L; Medema, JP				Kimberley, Fiona C.; van der Sloot, Almer M.; Guadagnoli, Marco; Cameron, Katherine; Schneider, Pascal; Marquart, J. Arnoud; Versloot, Miranda; Serrano, Luis; Medema, Jan Paul			The Design and Characterization of Receptor-selective APRIL Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR FAMILY; NF-KAPPA-B; TNF RECEPTOR; BAFF-R; AGONIST ANTIBODY; TACI; LIGAND; APOPTOSIS; BINDING; BCMA	A proliferation-inducing ligand (APRIL), a member of the TNF ligand superfamily with an important role in humoral immunity, is also implicated in several cancers as a prosurvival factor. APRIL binds two different TNF receptors, B cell maturation antigen (BCMA) and transmembrane activator and cylclophilin ligand interactor (TACI), and also interacts independently with heparan sulfate proteoglycans. Because APRIL shares binding of the TNF receptors with B cell activation factor, separating the precise signaling pathways activated by either ligand in a given context has proven quite difficult. In this study, we have used the protein design algorithm FoldX to successfully generate a BCMA-specific variant of APRIL, APRIL-R206E, and two TACI-selective variants, D132F and D132Y. These APRIL variants show selective activity toward their receptors in several in vitro assays. Moreover, we have used these ligands to show that BCMA and TACI have a distinct role in APRIL-induced B cell stimulation. We conclude that these ligands are useful tools for studying APRIL biology in the context of individual receptor activation.	[Kimberley, Fiona C.; Guadagnoli, Marco; Cameron, Katherine; Versloot, Miranda; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 Amsterdam, Netherlands; [van der Sloot, Almer M.; Serrano, Luis] Univ Pompeu Fabra, Ctr Genom Regulat, EMBL CRG Syst Biol Res Unit, Barcelona 08003, Spain; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Serrano, Luis] Inst Catalana Rec & Estudis Avancats, Barcelona 08010, Spain	University of Amsterdam; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Lausanne; ICREA	Serrano, L (corresponding author), C Dr Aiguader 88, Barcelona 08003, Spain.	luis.serrano@crg.es; j.p.medema@amc.uva.nl	van der Sloot, Almer/M-7083-2015; Serrano, Luis/B-3355-2013	van der Sloot, Almer/0000-0003-0049-2044; Serrano, Luis/0000-0002-5276-1392; Schneider, Pascal/0000-0003-0677-9409; Medema, Jan Paul/0000-0003-3045-2924	Dutch Cancer Society Grant [UvA 2007-3750]; Swiss National Science Foundation; European Union (PROSPECTS) [HEALTH-F4-2008-201648]; European Union (TRIDENT) [FP6-LIFESCIHEALTH-37686]; Juan de la Cierva fellowship; ICREA Funding Source: Custom	Dutch Cancer Society Grant(KWF Kankerbestrijding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union (PROSPECTS); European Union (TRIDENT); Juan de la Cierva fellowship; ICREA(ICREA)	This work was supported by Dutch Cancer Society Grant UvA 2007-3750, the Swiss National Science Foundation (to P. S.), and the European Union (PROSPECTS (Grant Agreement HEALTH-F4-2008-201648) and TRIDENT (Grant Agreement FP6-LIFESCIHEALTH-37686); both to L. S.).; Supported in part by a Juan de la Cierva fellowship. Present address: Institute for Research in Immunology and Cancer, Universite de Montreal, Montreal, Quebec H3C 3J7, Canada.	Allen J. E., 2012, MOL CANC TH IN PRESS; Ameloot P, 2001, J BIOL CHEM, V276, P37426, DOI 10.1074/jbc.M102020200; Bischof D, 2006, BLOOD, V107, P3235, DOI 10.1182/blood-2005-01-0256; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Cancro MP, 2008, IMMUNITY, V28, P300, DOI 10.1016/j.immuni.2008.02.010; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Deshayes F, 2004, ONCOGENE, V23, P3005, DOI 10.1038/sj.onc.1207350; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Guadagnoli M, 2011, BLOOD, V117, P6856, DOI 10.1182/blood-2011-01-330852; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Kanno Y, 2010, J RECEPT SIG TRANSD, V30, P121, DOI 10.3109/10799891003634509; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; Kimberley FC, 2009, RESULTS PROBL CELL D, V49, P161, DOI 10.1007/400_2008_19; Kimberley FC, 2009, FASEB J, V23, P1584, DOI 10.1096/fj.08-124669; Lascano V., 2012, CELL DEATH IN PRESS; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Mhawech-Fauceglia P, 2006, J LEUKOCYTE BIOL, V80, P697, DOI 10.1189/jlb.1105655; Morishige T, 2010, BIOMATERIALS, V31, P3357, DOI 10.1016/j.biomaterials.2010.01.022; Motoki K, 2005, CLIN CANCER RES, V11, P3126, DOI 10.1158/1078-0432.CCR-04-1867; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Reis CR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.61; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Szegezdi E, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013730; Thilenius ARB, 1997, EUR J IMMUNOL, V27, P1108, DOI 10.1002/eji.1830270510; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; van der Sloot AM, 2011, ADV EXP MED BIOL, V691, P521, DOI 10.1007/978-1-4419-6612-4_54; Van der Sloot AM, 2009, PROTEIN ENG DES SEL, V22, P537, DOI 10.1093/protein/gzp032; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	45	8	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37434	37446		10.1074/jbc.M112.406090	http://dx.doi.org/10.1074/jbc.M112.406090			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961987	Green Published, hybrid			2022-12-25	WOS:000310588500073
J	McLachlan, SM; Aliesky, HA; Chen, CR; Chong, G; Rapoport, B				McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Chong, Gao; Rapoport, Basil			Breaking Tolerance in Transgenic Mice Expressing the Human TSH Receptor A-Subunit: Thyroiditis, Epitope Spreading and Adjuvant as a 'Double Edged Sword'	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; MURINE GRAVES-DISEASE; T-CELLS; HYPERTHYROIDISM; ADENOVIRUS; ANTIBODY; MOUSE; IMMUNIZATION; AUTOANTIBODIES; INSIGHT	Transgenic mice with the human thyrotropin-receptor (TSHR) A-subunit targeted to the thyroid are tolerant of the transgene. In transgenics that express low A-subunit levels (Lo-expressors), regulatory T cell (Treg) depletion using anti-CD25 before immunization with adenovirus encoding the A-subunit (A-sub-Ad) breaks tolerance, inducing extensive thyroid lymphocytic infiltration, thyroid damage and antibody spreading to other thyroid proteins. In contrast, no thyroiditis develops in Hi-expressor transgenics or wild-type mice. Our present goal was to determine if thyroiditis could be induced in Hi-expressor transgenics using a more potent immunization protocol: Treg depletion, priming with Complete Freund's Adjuvant (CFA)+A-subunit protein and further Treg depletions before two boosts with A-sub-Ad. As controls, anti-CD25 treated Hi- and Lo-expressors and wild-type mice were primed with CFA+ mouse thyroglobulin (Tg) or CFA alone before Asub-Ad boosting. Thyroiditis developed after CFA+ A-subunit protein or Tg and A-sub-Ad boosting in Lo-expressor transgenics but Hi-expressors (and wild-type mice) were resistant to thyroiditis induction. Importantly, in Lo-expressors, thyroiditis was associated with the development of antibodies to the mouse TSHR downstream of the A-subunit. Unexpectedly, we observed that the effect of bacterial products on the immune system is a "double-edged sword''. On the one hand, priming with CFA (mycobacteria emulsified in oil) plus A-subunit protein broke tolerance to the A-subunit in Hi-expressor transgenics leading to high TSHR antibody levels. On the other hand, prior treatment with CFA in the absence of A-subunit protein inhibited responses to subsequent immunization with A-sub-Ad. Consequently, adjuvant activity arising in vivo after bacterial infections combined with a protein autoantigen can break self-tolerance but in the absence of the autoantigen, adjuvant activity can inhibit the induction of immunity to autoantigens (like the TSHR) displaying strong self-tolerance.	[McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Chong, Gao; Rapoport, Basil] Cedars Sinai Res Inst, Thyroid Autoimmune Dis Unit, Los Angeles, CA USA; [McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Chong, Gao; Rapoport, Basil] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	McLachlan, SM (corresponding author), Cedars Sinai Res Inst, Thyroid Autoimmune Dis Unit, Los Angeles, CA USA.	mclachlans@cshs.org			National Institutes of Health [DK54684, DK19289]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289, R01DK054684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK54684 (SMM) and DK19289 (BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chazenbalk GD, 1999, J CLIN ENDOCR METAB, V84, P702, DOI 10.1210/jc.84.2.702; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Chen CR, 2006, THYROID, V16, P427, DOI 10.1089/thy.2006.16.427; Chen CR, 2010, ENDOCRINOLOGY, V151, P4583, DOI 10.1210/en.2010-0321; Chen CR, 2004, ENDOCRINOLOGY, V145, P228, DOI 10.1210/en.2003-1134; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Mauri C, 1996, EUR J IMMUNOL, V26, P1511, DOI 10.1002/eji.1830260716; Misharin AV, 2009, ENDOCRINOLOGY, V150, P3944, DOI 10.1210/en.2009-0181; Misharin AV, 2009, ENDOCRINOLOGY, V150, P2948, DOI 10.1210/en.2008-1690; Mizutori Y, 2008, CLIN EXP IMMUNOL, V154, P305, DOI 10.1111/j.1365-2249.2008.03769.x; MORRIS JC, 1993, J BIOL CHEM, V268, P10900; Nagayama Y, 2007, THYROID, V17, P981, DOI 10.1089/thy.2007.0161; Pichurin P, 2001, ENDOCRINOLOGY, V142, P3530, DOI 10.1210/en.142.8.3530; Pichurin PN, 2006, J IMMUNOL, V176, P668, DOI 10.4049/jimmunol.176.1.668; Pichurin PN, 2004, CLIN EXP IMMUNOL, V135, P391, DOI 10.1111/j.1365-2249.2004.02399.x; Saitoh O, 2006, ENDOCRINOLOGY, V147, P2417, DOI 10.1210/en.2005-1024; Saitoh O, 2007, ENDOCRINOLOGY, V148, P6040, DOI 10.1210/en.2007-0300; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schwarz-Lauer L, 2003, ENDOCRINOLOGY, V144, P1718, DOI 10.1210/en.2002-0069; STEIN SA, 1994, MOL ENDOCRINOL, V8, P129, DOI 10.1210/me.8.2.129; Wei WZ, 2005, CANCER RES, V65, P8471, DOI 10.1158/0008-5472.CAN-05-0934; YAMAMOTO M, 1978, ENDOCRINOLOGY, V103, P2011, DOI 10.1210/endo-103-6-2011	22	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43517	10.1371/journal.pone.0043517	http://dx.doi.org/10.1371/journal.pone.0043517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970131	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000003
J	Patisaul, HB; Sullivan, AW; Radford, ME; Walker, DM; Adewale, HB; Winnik, B; Coughlin, JL; Buckley, B; Gore, AC				Patisaul, Heather B.; Sullivan, Alana W.; Radford, Meghan E.; Walker, Deena M.; Adewale, Heather B.; Winnik, Bozena; Coughlin, Janis L.; Buckley, Brian; Gore, Andrea C.			Anxiogenic Effects of Developmental Bisphenol A Exposure Are Associated with Gene Expression Changes in the Juvenile Rat Amygdala and Mitigated by Soy	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ELEVATED PLUS-MAZE; SEX-DIFFERENCES; INTACT MALE; GESTATIONAL EXPOSURE; LACTATIONAL TRANSFER; FEMALE RATS; ANXIETY; OXYTOCIN; BEHAVIOR	Early life exposure to Bisphenol A (BPA), a component of polycarbonate plastics and epoxy resins, alters sociosexual behavior in numerous species including humans. The present study focused on the ontogeny of these behavioral effects beginning in adolescence and assessed the underlying molecular changes in the amygdala. We also explored the mitigating potential of a soy-rich diet on these endpoints. Wistar rats were exposed to BPA via drinking water (1 mg/L) from gestation through puberty, and reared on a soy-based or soy-free diet. A group exposed to ethinyl estradiol (50 mg/L) and a soy-free diet was used as a positive estrogenic control. Animals were tested as juveniles or adults for anxiety-like and exploratory behavior. Assessment of serum BPA and genistein (GEN), a soy phytoestrogen, confirmed that internal dose was within a human-relevant range. BPA induced anxiogenic behavior in juveniles and loss of sexual dimorphisms in adult exploratory behavior, but only in the animals reared on the soy-free diet. Expression analysis revealed a suite of genes, including a subset known to mediate sociosexual behavior, associated with BPA-induced juvenile anxiety. Notably, expression of estrogen receptor beta (Esr2) and two melanocortin receptors (Mc3r, Mc4r) were downregulated. Collectively, these results show that behavioral impacts of BPA can manifest during adolescence, but wane in adulthood, and may be mitigated by diet. These data also reveal that, because ERb and melanocortin receptors are crucial to their function, oxytocin/vasopressin signaling pathways, which have previously been linked to human affective disorders, may underlie these behavioral outcomes.	[Patisaul, Heather B.; Sullivan, Alana W.; Radford, Meghan E.; Adewale, Heather B.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Patisaul, Heather B.; Sullivan, Alana W.; Radford, Meghan E.; Adewale, Heather B.] N Carolina State Univ, Keck Ctr Behav Sci, Raleigh, NC 27695 USA; [Walker, Deena M.; Gore, Andrea C.] Univ Texas Austin, Inst Neurosci, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Walker, Deena M.; Gore, Andrea C.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Winnik, Bozena; Coughlin, Janis L.] Joint Inst Rutgers Univ & Univ Med & Dent New Jer, Joint Grad Program Toxicol, Piscataway, NJ USA; [Buckley, Brian] Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Rutgers State University New Brunswick; Rutgers State University Medical Center	Patisaul, HB (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	hbpatisa@ncsu.edu	Walker, Deena/GOE-5789-2022	Rebuli, Meghan/0000-0003-1918-2257; Gore, Andrea/0000-0001-5549-6793	National Institute of Environmental Health Sciences (NIEHS) [ES16001, ES05022, ES018139, ES07784, ES020662]; National Institutes on Aging [AG034813]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022, T32ES007148, P30ES007784, RC1ES018139, R01ES016001, R01ES020662, R21ES021233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG034813] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by the National Institute of Environmental Health Sciences (NIEHS) grants ES16001 to HBP; ES05022 to BB; and ES018139, ES07784, and ES020662 to ACG; and National Institutes on Aging grant AG034813 to DMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P2, DOI 10.1111/j.1751-0813.1946.tb15473.x; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Bonthuis PJ, 2010, FRONT NEUROENDOCRIN, V31, P341, DOI 10.1016/j.yfrne.2010.05.001; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Brown NM, 2001, LAB INVEST, V81, P735, DOI 10.1038/labinvest.3780282; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Cederroth CR, 2010, MOL CELL ENDOCRINOL, V321, P152, DOI 10.1016/j.mce.2010.02.011; Choleris E, 2006, GENES BRAIN BEHAV, V5, P528, DOI 10.1111/j.1601-183X.2006.00203.x; Cooper JE, 2011, CHEMOSPHERE, V85, P943, DOI 10.1016/j.chemosphere.2011.06.060; Cooper S, 2006, TOXICOL SCI, V91, P631, DOI 10.1093/toxsci/kfj171; Coughlin JL, 2011, ANAL BIOANAL CHEM, V401, P995, DOI 10.1007/s00216-011-5151-8; Cox KH, 2010, HORM BEHAV, V58, P754, DOI 10.1016/j.yhbeh.2010.07.008; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Dixon RA, 2002, PHYTOCHEMISTRY, V60, P205, DOI 10.1016/S0031-9422(02)00116-4; Doerge DR, 2010, TOXICOL LETT, V199, P372, DOI 10.1016/j.toxlet.2010.09.022; Doerge DR, 2006, REPROD TOXICOL, V21, P307, DOI 10.1016/j.reprotox.2005.09.007; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Donner J, 2008, BIOL PSYCHIAT, V64, P672, DOI 10.1016/j.biopsych.2008.06.002; Rodriguez-Landa JF, 2009, PROG NEURO-PSYCHOPH, V33, P367, DOI 10.1016/j.pnpbp.2008.12.024; Frye CA, 2012, J NEUROENDOCRINOL, V24, P144, DOI 10.1111/j.1365-2826.2011.02229.x; Fujimoto T, 2006, BRAIN RES, V1068, P49, DOI 10.1016/j.brainres.2005.11.028; Gabor CS, 2012, BEHAV NEUROSCI, V126, P97, DOI 10.1037/a0026464; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Hohoff C, 2009, J NEURAL TRANSM, V116, P679, DOI 10.1007/s00702-009-0215-z; Hovatta I, 2008, ANN MED, V40, P92, DOI 10.1080/07853890701747096; IMHOF JT, 1993, BEHAV BRAIN RES, V56, P177, DOI 10.1016/0166-4328(93)90036-P; JAKUBOWSKI M, 1991, ENDOCRINOLOGY, V128, P2702, DOI 10.1210/endo-128-6-2702; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Jones DC, 2008, BIOCHEM PHARMACOL, V76, P569, DOI 10.1016/j.bcp.2008.05.010; Kabuto H, 2004, LIFE SCI, V74, P2931, DOI 10.1016/j.lfs.2003.07.060; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kauffman AS, 2010, J NEUROENDOCRINOL, V22, P682, DOI 10.1111/j.1365-2826.2010.02030.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim J, 2011, ENDOCRINOLOGY, V152, P2020, DOI 10.1210/en.2010-1498; Koolhaas JM, 2007, BRAIN BEHAV EVOLUT, V70, P218, DOI 10.1159/000105485; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Landgraf R, 2002, BEHAV GENET, V32, P301, DOI 10.1023/A:1020258104318; Lephart ED, 2004, ILAR J, V45, P443, DOI 10.1093/ilar.45.4.443; Liao CY, 2011, ENVIRON SCI TECHNOL, V45, P9372, DOI 10.1021/es202507f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund TD, 2005, ENDOCRINOLOGY, V146, P797, DOI 10.1210/en.2004-1158; Lund TD, 2001, BRAIN RES, V913, P180, DOI 10.1016/S0006-8993(01)02793-7; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Martel MM, 2009, HORM BEHAV, V55, P465, DOI 10.1016/j.yhbeh.2009.02.004; McCARRISON R., 1933, INDIAN JOUR MED RES, V21, P179; McCarthy MM, 1997, MOL MED TODAY, V3, P269, DOI 10.1016/S1357-4310(97)01058-7; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Muhlhauser A, 2009, BIOL REPROD, V80, P1066, DOI 10.1095/biolreprod.108.074815; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Nakagami A, 2009, PSYCHONEUROENDOCRINO, V34, P1189, DOI 10.1016/j.psyneuen.2009.03.005; Nomura M, 2002, MOL BRAIN RES, V109, P84, DOI 10.1016/S0169-328X(02)00525-9; Osterlund MK, 2005, ENDOCRINE, V28, P235, DOI 10.1385/ENDO:28:3:235; Palanza P, 2008, ENVIRON RES, V108, P150, DOI 10.1016/j.envres.2008.07.023; Patisaul HB, 2005, BEHAV NEUROSCI, V119, P587, DOI 10.1037/0735-7044.119.2.587; Patisaul HB, 2003, J NEUROENDOCRINOL, V15, P787, DOI 10.1046/j.1365-2826.2003.01061.x; Patisaul HB, 2008, HORM BEHAV, V53, P580, DOI 10.1016/j.yhbeh.2008.01.008; Patisaul HB, 2010, FRONT NEUROENDOCRIN, V31, P400, DOI 10.1016/j.yfrne.2010.03.003; Patisaul HB, 2009, HORM BEHAV, V55, P319, DOI 10.1016/j.yhbeh.2008.11.004; Pelayo S, 2012, AQUAT TOXICOL, V110, P114, DOI 10.1016/j.aquatox.2011.12.016; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Sabatier N, 2003, J NEUROSCI, V23, P10351; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott V, 2011, ENDOCRINOLOGY, V152, P3862, DOI 10.1210/en.2011-1181; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Sullivan AW, 2011, HORM BEHAV, V60, P185, DOI 10.1016/j.yhbeh.2011.04.006; Thigpen JE, 1999, LAB ANIM SCI, V49, P530; Todaka E, 2005, ENVIRON RES, V99, P195, DOI 10.1016/j.envres.2004.11.006; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Walker DM, 2009, ENDOCRINOLOGY, V150, P2308, DOI 10.1210/en.2008-1396; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Zhang YK, 2011, EPIGENETICS-US, V6, P888, DOI 10.4161/epi.6.7.16315	93	86	89	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43890	10.1371/journal.pone.0043890	http://dx.doi.org/10.1371/journal.pone.0043890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957036	gold, Green Submitted, Green Published			2022-12-25	WOS:000308463800028
J	Zhang, YC; Zhang, QY; Sammul, M				Zhang, Yunchun; Zhang, Qiaoying; Sammul, Marek			Physiological Integration Ameliorates Negative Effects of Drought Stress in the Clonal Herb Fragaria orientalis	PLOS ONE			English	Article							HYDROGEN-PEROXIDE METABOLISM; UV-B RADIATION; WATER TRANSLOCATION; PSAMMOCHLOA-VILLOSA; LIPID-PEROXIDATION; OXIDATIVE STRESS; INTERCONNECTED RAMETS; ANTIOXIDANT ENZYMES; SAND BURIAL; PLANT	Clonal growth allows plants to spread horizontally and to establish ramets in sites of contrasting resource status. If ramets remain physiologically integrated, clones in heterogeneous environments can act as cooperative systems - effects of stress on one ramet can be ameliorated by another connected ramet inhabiting benign conditions. But little is known about the effects of patch contrast on physiological integration of clonal plants and no study has addressed its effects on physiological traits like osmolytes, reactive oxygen intermediates and antioxidant enzymes. We examined the effect of physiological integration on survival, growth and stress indicators such as osmolytes, reactive oxygen intermediates (ROIs) and antioxidant enzymes in a clonal plant, Fragaria orientalis, growing in homogenous and heterogeneous environments differing in patch contrast of water availability (1 homogeneous (no contrast) group; 2 low contrast group; 3 high contrast group). Drought stress markedly reduced the survival and growth of the severed ramets of F. orientalis, especially in high contrast treatments. Support from a ramet growing in benign patch considerably reduced drought stress and enhanced growth of ramets in dry patches. The larger the contrast between water availability, the larger the amount of support the depending ramet received from the supporting one. This support strongly affected the growth of the supporting ramet, but not to an extent to cause increase in stress indicators. We also found indication of costs related to maintenance of physiological connection between ramets. Thus, the net benefit of physiological integration depends on the environment and integration between ramets of F. orientalis could be advantageous only in heterogeneous conditions with a high contrast.	[Zhang, Yunchun; Sammul, Marek] Estonian Univ Life Sci, Inst Agr & Environm Sci, Dept Bot, Tartu, Estonia; [Zhang, Yunchun; Zhang, Qiaoying] Shandong Polytech Univ, Jinan, Shandong, Peoples R China; [Zhang, Qiaoying] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia	Estonian University of Life Sciences; Qilu University of Technology; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Zhang, YC (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Dept Bot, Tartu, Estonia.	yunchunzhang@163.com		Zhang, Yunchun/0000-0001-8259-5850	ERMOS Postdoctoral Research Grants [ERMOS 11]; Estonian Science Foundation [8745]; National Natural Science Foundation of China [31170502]	ERMOS Postdoctoral Research Grants; Estonian Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by ERMOS Postdoctoral Research Grants (ERMOS 11), grant no 8745 from the Estonian Science Foundation and the National Natural Science Foundation of China (31170502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain-Lhout F, 2001, PLANT SOIL, V230, P175, DOI 10.1023/A:1010387610098; ALPERT P, 1991, ECOLOGY, V72, P69, DOI 10.2307/1938903; ALPERT P, 1990, AM J BOT, V77, P1648, DOI 10.2307/2444496; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Ashraf M, 2005, FLORA, V200, P535, DOI 10.1016/j.flora.2005.06.005; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BECANA M, 1986, PLANT PHYSIOL, V82, P1169, DOI 10.1104/pp.82.4.1169; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARACO T, 1991, ECOLOGY, V72, P81, DOI 10.2307/1938904; Cavalcanti FR, 2004, NEW PHYTOL, V163, P563, DOI 10.1111/j.1469-8137.2004.01139.x; Chen JS, 2011, ACTA OECOL, V37, P355, DOI 10.1016/j.actao.2011.04.002; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; CHOWDHURY SR, 1985, PHYSIOL PLANTARUM, V65, P476, DOI 10.1111/j.1399-3054.1985.tb08676.x; Chu Y, 2006, J INTEGR PLANT BIOL, V48, P400, DOI 10.1111/j.1744-7909.2006.00237.x; Costa H, 2002, PLANT SCI, V162, P939, DOI 10.1016/S0168-9452(02)00051-1; de Kroon H, 1998, OECOLOGIA, V116, P38, DOI 10.1007/s004420050561; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; DHERTEFELDT T, 1994, SPEC FEAT VEGET SCI, V4, P167; Dong M, 1999, PLANT ECOL, V141, P53, DOI 10.1023/A:1009875000149; Du JA, 2010, FLORA, V205, P399, DOI 10.1016/j.flora.2009.12.018; Ederli L, 2004, PHYSIOL PLANTARUM, V121, P66, DOI 10.1111/j.0031-9317.2004.00295.x; Ekmekci Y, 2005, PESTIC BIOCHEM PHYS, V83, P69, DOI 10.1016/j.pestbp.2005.03.012; EPSTEIN E, 1972, P412; Eriksson O., 1990, CLONAL GROWTH PLANTS, P79; EVANS JP, 1991, OECOLOGIA, V86, P268, DOI 10.1007/BF00317540; Fazeli F, 2007, BIOL PLANTARUM, V51, P98, DOI 10.1007/s10535-007-0020-1; Gomez S, 2006, OECOLOGIA, V147, P461, DOI 10.1007/s00442-005-0293-z; Gomez S, 2008, NEW PHYTOL, V179, P1142, DOI 10.1111/j.1469-8137.2008.02542.x; Grime J. P., 1979, Plant strategies and vegetation processes.; Guan WB, 2004, P 5 NAT S CONS SUST, P288; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; He WM, 2010, ECOL RES, V25, P967, DOI 10.1007/s11284-010-0724-0; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Jain M, 2001, PLANT CELL REP, V20, P463, DOI 10.1007/s002990100353; Jonsdottir IS, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P109; JONSDOTTIR IS, 1990, NEW PHYTOL, V114, P419, DOI 10.1111/j.1469-8137.1990.tb00409.x; JONSDOTTIR IS, 1989, OIKOS, V54, P211, DOI 10.2307/3565269; KATO M, 1987, CAN J BOT, V65, P729, DOI 10.1139/b87-097; KELLY CK, 1995, EVOL ECOL, V9, P575, DOI 10.1007/BF01237656; Kolasa J., 1991, ECOLOGICAL HETEROGEN, V86, P1, DOI DOI 10.1007/978-1-4612-3062-5_1; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Koubek T, 2008, EVOL ECOL, V22, P449, DOI 10.1007/s10682-007-9219-z; LAU RR, 1988, ECOLOGY, V69, P215, DOI 10.2307/1943177; Li CL, 2003, FLORA CHINA, P337; Li L., 1998, Plant Growth Regulation, V24, P55, DOI 10.1023/A:1005954532397; Liu CC, 2011, ACTA PHYSIOL PLANT, V33, P93, DOI 10.1007/s11738-010-0520-z; Liu FH, 2007, FLORA, V202, P106, DOI 10.1016/j.flora.2006.05.004; Liu RH, 2012, PLANT SPEC BIOL, V27, P210, DOI 10.1111/j.1442-1984.2011.00346.x; Mao SY, 2009, PHYSIOL PLANTARUM, V137, P225, DOI 10.1111/j.1399-3054.2009.01275.x; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; Matlaga DP, 2009, AM J BOT, V96, P431, DOI 10.3732/ajb.0800164; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mizuki I, 2009, J FOREST RES-JPN, V14, P95, DOI 10.1007/s10310-008-0106-4; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noda H, 2004, ECOL RES, V19, P331, DOI 10.1111/j.1440-1703.2004.00642.x; ONG CK, 1979, ANN BOT-LONDON, V43, P147, DOI 10.1093/oxfordjournals.aob.a085619; Opik H., 2005, PHYSL FLOWERING PLAN, DOI [10.1017/CBO9781139164450, DOI 10.1017/CBO9781139164450]; Pinto ME, 1999, J PHOTOCH PHOTOBIO B, V48, P200, DOI 10.1016/S1011-1344(99)00031-7; Pitelka L.F., 1985, POPULATION BIOL EVOL, P399; Prakash J, 2009, SCI HORTIC-AMSTERDAM, V120, P288, DOI 10.1016/j.scienta.2008.11.016; Prochazkova D, 2001, PLANT SCI, V161, P765, DOI 10.1016/S0168-9452(01)00462-9; Ren A., 1999, J DESERT RES, V19, P30; Roiloa SR, 2012, ECOL RES, V27, P95, DOI 10.1007/s11284-011-0876-6; SALZMAN AG, 1985, OECOLOGIA, V65, P273, DOI 10.1007/BF00379229; Sankar B, 2007, COLLOID SURFACE B, V60, P229, DOI 10.1016/j.colsurfb.2007.06.016; Savini G, 2008, PHYSIOL PLANTARUM, V134, P421, DOI 10.1111/j.1399-3054.2008.01145.x; SLADE AJ, 1987, OECOLOGIA, V73, P425, DOI 10.1007/BF00385260; Sohrabi Y, 2012, SYMBIOSIS, V56, P5, DOI 10.1007/s13199-012-0152-8; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; Stuefer JF, 2004, EVOL ECOL, V18, P647, DOI 10.1007/s10682-004-5148-2; Sun XL, 2010, AFR J BIOTECHNOL, V9, P5503; Uzilday B, 2012, PLANT SCI, V182, P59, DOI 10.1016/j.plantsci.2011.03.015; van Kleunen M, 1999, OIKOS, V85, P135, DOI 10.2307/3546799; Wang JC, 2011, POL J ECOL, V59, P455; Wang YH, 2011, J ARID ENVIRON, V75, P974, DOI 10.1016/j.jaridenv.2011.04.019; Xu L, 2012, ANN BOT-LONDON, V109, P1001, DOI 10.1093/aob/mcs006; Yang F, 2009, BIOL PLANTARUM, V53, P511, DOI 10.1007/s10535-009-0092-1; Yang Y, 2007, PHOTOSYNTHETICA, V45, P613, DOI 10.1007/s11099-007-0106-1; Yin GH, 2012, J FOOD AGRIC ENVIRON, V10, P853; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Zhang CY, 2003, ACTA BOT SIN, V45, P1210; Zhang YC, 2008, BOT STUD, V49, P373; Zhang YC, 2009, ECOL RES, V24, P617, DOI 10.1007/s11284-008-0533-x; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314; Zhuang L, 2006, J INTEGR PLANT BIOL, V48, P520, DOI 10.1111/j.1744-7909.2006.00238.x	91	11	16	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44221	10.1371/journal.pone.0044221	http://dx.doi.org/10.1371/journal.pone.0044221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957054	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800046
J	Lee, MJ; Lee, JK; Choi, JW; Lee, CS; Sim, JH; Cho, CH; Lee, KH; Cho, IH; Chung, MH; Kim, HR; Ye, SK				Lee, Min Jeoung; Lee, Jin-Ku; Choi, Ji Won; Lee, Chang-Seok; Sim, Ji Hyun; Cho, Chung-Hyun; Lee, Kwang-Ho; Cho, Ik-Hyun; Chung, Myung-Hee; Kim, Hang-Rae; Ye, Sang-Kyu			Interleukin-6 Induces S100A9 Expression in Colonic Epithelial Cells through STAT3 Activation in Experimental Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CALCIUM-BINDING PROTEINS; INTESTINAL INFLAMMATION; MULTIPLE-SCLEROSIS; COLORECTAL-CANCER; CROHNS-DISEASE; SERUM-LEVELS; IL-6; MRP14; NEUTROPHILS	Background: Intestinal epithelium is essential for maintaining normal intestinal homeostasis; its breakdown leads to chronic inflammatory pathologies, such as inflammatory bowel diseases (IBDs). Although high concentrations of S100A9 protein and interleukin-6 (IL-6) are found in patients with IBD, the expression mechanism of S100A9 in colonic epithelial cells (CECs) remains elusive. We investigated the role of IL-6 in S100A9 expression in CECs using a colitis model. Methods: IL-6 and S100A9 expression, signal transducer and activator of transcription 3 (STAT3) phosphorylation, and infiltration of immune cells were analyzed in mice with dextran sulfate sodium (DSS)-induced colitis. The effects of soluble gp130-Fc protein (sgp130Fc) and S100A9 small interfering (si) RNA (si-S100A9) on DSS-induced colitis were evaluated. The molecular mechanism of S100A9 expression was investigated in an IL-6-treated Caco-2 cell line using chromatin immunoprecipitation assays. Results: IL-6 concentrations increased significantly in the colon tissues of DSS-treated mice. sgp130Fc or si-S100A9 administration to DSS-treated mice reduced granulocyte infiltration in CECs and induced the down-regulation of S100A9 and colitis disease activity. Treatment with STAT3 inhibitors upon IL-6 stimulation in the Caco-2 cell line demonstrated that IL-6 mediated S100A9 expression through STAT3 activation. Moreover, we found that phospho-STAT3 binds directly to the S100A9 promoter. S100A9 may recruit immune cells into inflamed colon tissues. Conclusions: Elevated S100A9 expression in CECs mediated by an IL-6/STAT3 signaling cascade may play an important role in the development of colitis.	[Lee, Min Jeoung; Lee, Jin-Ku; Choi, Ji Won; Lee, Chang-Seok; Cho, Chung-Hyun; Chung, Myung-Hee; Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Lee, Min Jeoung; Lee, Jin-Ku; Choi, Ji Won; Lee, Chang-Seok; Cho, Chung-Hyun; Chung, Myung-Hee; Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea; [Sim, Ji Hyun; Kim, Hang-Rae] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Lee, Kwang-Ho] Konkuk Univ, Dept Biotechnol, Coll Biomed & Hlth Sci, Chungju, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Dept Anat, Coll Oriental Med, Seoul, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Inst Oriental Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Kyung Hee University; Korea Institute of Oriental Medicine (KIOM); Kyung Hee University	Lee, MJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea.	hangrae2@snu.ac.kr; sangkyu@snu.ac.kr	Ye, Sang Kyu/J-2768-2012; Kim, Hang-Rae/J-5448-2012; Cho, Ik-Hyun/A-9348-2014; Cho, Chung-Hyun/H-7286-2012	Kim, Hang-Rae/0000-0002-3983-6193; Lee, Jin-Ku/0000-0003-0263-3234	National Research & Development (R&D) Program for Cancer Control; Ministry of Health & Welfare, Republic of Korea [1020160, 0720540]; National Research Foundation (NRF); Ministry of Education, Science and Technology [2010-0027827, 2011-0010571]	National Research & Development (R&D) Program for Cancer Control; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation (NRF); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by grants from the National Research & Development (R&D) Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1020160 and 0720540 to SK Ye) and from National Research Foundation (NRF), Ministry of Education, Science and Technology (2010-0027827 and 2011-0010571 to SK Ye). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bogumil T, 1998, NEUROSCI LETT, V247, P195, DOI 10.1016/S0304-3940(98)00263-8; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Cenit MC, 2010, GENES IMMUN, V11, P264, DOI 10.1038/gene.2010.10; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; COOPER HS, 1993, LAB INVEST, V69, P238; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Fagerhol MK, 2000, LANCET, V356, P1783, DOI 10.1016/S0140-6736(00)03224-4; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Frosch M, 2005, EXP DERMATOL, V14, P259, DOI 10.1111/j.0906-6705.2005.00271.x; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Garud Sagar, 2009, Therap Adv Gastroenterol, V2, P99, DOI 10.1177/1756283X09102329; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Jin XL, 2010, GUT, V59, P186, DOI 10.1136/gut.2008.151175; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katz AB, 1999, J INVEST DERMATOL, V112, P818, DOI 10.1046/j.1523-1747.1999.00572.x; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KURUTO R, 1990, J BIOCHEM, V108, P650, DOI 10.1093/oxfordjournals.jbchem.a123257; Li C, 2004, BREAST CANCER RES TR, V87, P123, DOI 10.1023/B:BREA.0000041594.36418.f6; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; LUGERING N, 1995, DIGESTION, V56, P406, DOI 10.1159/000201267; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; Montufar-Solis D, 2006, J IMMUNOL METHODS, V308, P251, DOI 10.1016/j.jim.2005.10.008; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Neurath MF, 2001, TRENDS IMMUNOL, V22, P21, DOI 10.1016/S1471-4906(00)01798-1; Newton RA, 1998, J IMMUNOL, V160, P1427; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; PANJA A, 1993, J EXP MED, V178, P1115, DOI 10.1084/jem.178.3.1115; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rammes A, 1997, J BIOL CHEM, V272, P9496; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rose-John S, 2009, CURR PHARM DESIGN, V15, P2095, DOI 10.2174/138161209788489140; ROTH J, 1993, BLOOD, V82, P1875; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Soliman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015044; Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x; SUZUKI Y, 1990, LIFE SCI, V47, P2193, DOI 10.1016/0024-3205(90)90149-L; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Umehara Y, 2006, HEPATO-GASTROENTEROL, V53, P879; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; WILKINSON MM, 1988, J CELL SCI, V91, P221	63	25	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e38801	10.1371/journal.pone.0038801	http://dx.doi.org/10.1371/journal.pone.0038801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962574	Green Submitted, gold, Green Published			2022-12-25	WOS:000308577600001
J	Kang, S; Kim, CU; Gu, XL; Owens, RM; van Rijn, SJ; Boonyaleepun, V; Mao, YX; Springer, TA; Jin, MM				Kang, Sungkwon; Kim, Chae Un; Gu, Xiaoling; Owens, Roisin M.; van Rijn, Sarah J.; Boonyaleepun, Vanissra; Mao, Yuxin; Springer, Timothy A.; Jin, Moonsoo M.			Complex Structure of Engineered Modular Domains Defining Molecular Interaction between ICAM-1 and Integrin LFA-1	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; CRYSTAL-STRUCTURE; I-DOMAIN; CONFORMATIONAL REGULATION; RHINOVIRUS SEROTYPES; A-DOMAIN; RECEPTOR; EXPRESSION; RECOGNITION; EVOLUTION	Intermolecular contacts between integrin LFA-1 (alpha(L)beta(2)) and ICAM-1 derive solely from the integrin alpha(L) I domain and the first domain (D1) of ICAM-1. This study presents a crystal structure of the engineered complex of the aL I domain and ICAM-1 D1. Previously, we engineered the I domain for high affinity by point mutations that were identified by a directed evolution approach. In order to examine alpha(L) I domain allostery between the C-terminal alpha 7-helix (allosteric site) and the metal-ion dependent adhesion site (active site), we have chosen a high affinity variant without mutations directly influencing either the position of the alpha 7-helix or the active sites. In our crystal, the alpha(L) I domain was found to have a high affinity conformation to D1 with its alpha 7-helix displaced downward away from the binding interface, recapitulating a current understanding of the allostery in the I domain and its linkage to neighboring domains of integrins in signaling. To enable soluble D1 of ICAM-1 to fold on its own, we also engineered D1 to be functional by mutations, which were found to be those that would convert hydrogen bond networks in the solvent-excluded core into vdW contacts. The backbone structure of the beta-sandwich fold and the epitope for I domain binding of the engineered D1 were essentially identical to those of wild-type D1. Most deviations in engineered D1 were found in the loops at the N-terminal region that interacts with human rhinovirus (HRV). Structural deviation found in engineered D1 was overall in agreement with the function of engineered D1 observed previously, i.e., full capacity binding to alpha(L) I domain but reduced interaction with HRV.	[Kang, Sungkwon; Gu, Xiaoling; Owens, Roisin M.; van Rijn, Sarah J.; Boonyaleepun, Vanissra; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Kim, Chae Un] Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; [Mao, Yuxin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Springer, Timothy A.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Cornell University; Cornell University; Cornell University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Jin, MM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	mj227@cornell.edu	Owens, Roisin/O-4371-2019; Kim, Chae Un/D-2956-2014	Owens, Roisin/0000-0001-7856-2108; Mao, Yuxin/0000-0002-5064-1397	National Institutes of Health (NIH) [R21 AI079532]; National Science Foundation (NSF); NIH [GM103485]; NSF award [DMR-0936384]; Macromolecular Diffraction at CHESS (MacCHESS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF award(National Science Foundation (NSF)); Macromolecular Diffraction at CHESS (MacCHESS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a grant (R21 AI079532) from the National Institutes of Health (NIH). This work is also based upon research conducted at CHESS, which is supported by the National Science Foundation (NSF) and the NIH. The authors acknowledge NSF award DMR-0936384 and the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by the award GM103485 from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; Bella J, 2000, Pharm Acta Helv, V74, P291, DOI 10.1016/S0031-6865(99)00056-4; Buitrago D, 2011, ANN SURG ONCOL; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chen XY, 2011, BIOMATERIALS, V32, P7651, DOI 10.1016/j.biomaterials.2011.06.030; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Hadfield AT, 1997, STRUCTURE, V5, P427, DOI 10.1016/S0969-2126(97)00199-8; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; KELLY CP, 1992, AM J PHYSIOL, V263, pG864, DOI 10.1152/ajpgi.1992.263.6.G864; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Maurer CA, 1998, INT J CANCER, V79, P76, DOI 10.1002/(SICI)1097-0215(19980220)79:1<76::AID-IJC15>3.0.CO;2-F; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON H, 1994, CLIN IMMUNOL IMMUNOP, V72, P129, DOI 10.1006/clin.1994.1116; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens RM, 2010, J BIOL CHEM, V285, P15906, DOI 10.1074/jbc.M110.104349; Roland CL, 2010, EXP BIOL MED, V235, P263, DOI 10.1258/ebm.2009.009215; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; TOMITA Y, 1990, INT J CANCER, V46, P1001, DOI 10.1002/ijc.2910460609; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022; Zhang HM, 2009, FASEB J, V23, P2735, DOI 10.1096/fj.09-129908	45	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44124	10.1371/journal.pone.0044124	http://dx.doi.org/10.1371/journal.pone.0044124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956999	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500048
J	Mazumdar, B; Meyer, K; Ray, R				Mazumdar, Budhaditya; Meyer, Keith; Ray, Ranjit			N-Terminal Region of Gelsolin Induces Apoptosis of Activated Hepatic Stellate Cells by a Caspase-Dependent Mechanism	PLOS ONE			English	Article							VIRUS CORE PROTEIN; FAMILIAL AMYLOIDOSIS; LIVER FIBROSIS; ACTIN; EXPRESSION; PLASMA; RESOLUTION; COMPLEXES; VARIANTS	Activated hepatic stellate cells (HSCs) are the major source for alteration of extracellular matrix in fibrosis and cirrhosis. Conditioned medium (CM) collected from immortalized human hepatocytes (IHH) have earlier been shown to be responsible for apoptosis of HSCs. In this study, we have shown that antibodies raised against a peptide derived from a linear B-cell epitope in the N-terminal region of gelsolin identified a gelsolin fragment in IHH CM. Analysis of activated stellate cell death by CM collected from Huh7 cells transfected with plasmids encoding gelsolin deletion mutants suggested that the N-terminal half of gelsolin contained sequences which were responsible for stellate cell death. Further analysis determined that this activity was restricted to a region encompassing amino acids 1-70 in the gelsolin sequence; antibody directed to an epitope within this region was able to neutralize stellate cell death. Gelsolin modulation of cell death using this fragment involved upregulation of TRAIL-R1 and TRAIL-R2, and involved caspase 3 activation by extrinsic pathway. The apoptotic activity of N-terminal gelsolin fragments was restricted to activated but not quiescent stellate cells indicating its potential application in therapeutic use as an anti-fibrotic agent. Gelsolin fragments encompassing N-terminal regions in polypeptides of different molecular sizes were detected by N-terminal peptide specific antiserum in IHH CM immunoprecipitated with chronically HCV infected patient sera, suggesting the presence of autoantibodies generated against N-terminal gelsolin fragments in patients with chronic liver disease.	[Mazumdar, Budhaditya; Meyer, Keith; Ray, Ranjit] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA; [Ray, Ranjit] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University	Mazumdar, B (corresponding author), St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA.	rayr@slu.edu			Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080812] Funding Source: NIH RePORTER	Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an internal research grant from Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado R, 1997, CLIN SCI, V92, P103, DOI 10.1042/cs0920103; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Arai M, 1999, DEV DYNAM, V215, P297, DOI 10.1002/(SICI)1097-0177(199908)215:4<297::AID-AJA2>3.3.CO;2-9; Arthur MJP, 2002, GASTROENTEROLOGY, V122, P1525, DOI 10.1053/gast.2002.33367; Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Basu A, 2002, VIROLOGY, V298, P53, DOI 10.1006/viro.2002.1460; Basu A, 2006, APOPTOSIS, V11, P1391, DOI 10.1007/s10495-006-8312-z; Chen CD, 2001, EMBO J, V20, P6277, DOI 10.1093/emboj/20.22.6277; Fischer R, 2001, GASTROENTEROLOGY, V120, P1212, DOI 10.1053/gast.2001.23260; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; GRIFFITHS MR, 1991, J CLIN PATHOL, V44, P646, DOI 10.1136/jcp.44.8.646; Huff ME, 2003, J MOL BIOL, V334, P119, DOI 10.1016/j.jmb.2003.09.029; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; JANMEY PA, 1987, BLOOD, V70, P524; Kamada S, 1998, P NATL ACAD SCI USA, V95, P8532, DOI 10.1073/pnas.95.15.8532; Kangas H, 2002, AMYLOID, V9, P83, DOI 10.3109/13506120208995240; Khaitlina S, 2002, FEBS LETT, V521, P14, DOI 10.1016/S0014-5793(02)02657-1; Kiuru S, 1998, AMYLOID, V5, P55, DOI 10.3109/13506129809007291; Kiuru-Enari S, 2002, J NEUROPATH EXP NEUR, V61, P565, DOI 10.1093/jnen/61.6.565; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P8239; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57; MISHRA VS, 1994, GENOMICS, V23, P560, DOI 10.1006/geno.1994.1543; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; SMITH DB, 1988, AM J PATHOL, V130, P261; SMITH DB, 1987, J LAB CLIN MED, V110, P189; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Taimr P, 2003, HEPATOLOGY, V37, P87, DOI 10.1053/jhep.2003.50002; YIN HL, 1984, J BIOL CHEM, V259, P5271; Zapun A, 2000, BIOCHEM J, V350, P873, DOI 10.1042/0264-6021:3500873	34	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44461	10.1371/journal.pone.0044461	http://dx.doi.org/10.1371/journal.pone.0044461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952982	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000101
J	Islam, Z; Gilbert, M; Mohammad, QD; Klaij, K; Li, JJ; van Rijs, W; Tio-Gillen, AP; Talukder, KA; Willison, HJ; van Belkum, A; Endtz, HP; Jacobs, BC				Islam, Zhahirul; Gilbert, Michel; Mohammad, Quazi D.; Klaij, Kevin; Li, Jianjun; van Rijs, Wouter; Tio-Gillen, Anne P.; Talukder, Kaisar A.; Willison, Hugh J.; van Belkum, Alex; Endtz, Hubert P.; Jacobs, Bart C.			Guillain-Barre Syndrome-Related Campylobacter jejuni in Bangladesh: Ganglioside Mimicry and Cross-Reactive Antibodies	PLOS ONE			English	Article							CLINICAL-FEATURES; LIPOPOLYSACCHARIDES; INDUCTION; INFECTION; CHILDREN	Background: Campylobacter jejuni is the predominant antecedent infection in Guillain-Barre syndrome (GBS). Molecular mimicry and cross-reactive immune responses to C. jejuni lipo-oligosaccharides (LOS) precipitate the development of GBS, although this mechanism has not been established in patients from developing countries. We determined the carbohydrate mimicry between C. jejuni LOS and gangliosides, and the cross-reactive antibody response in patients with GBS in Bangladesh. Methodology: Sera from 97 GBS patients, and 120 neurological and family controls were tested for antibody reactivity against LOS from C. jejuni isolates from GBS patients in Bangladesh (BD-07, BD-39, BD-10, BD-67 and BD-94) by enzyme-linked immunosorbent assay (ELISA). Cross-reactivity to LOS was determined by ELISA. The LOS outer core structures of C. jejuni strains associated with GBS/MFS were determined by mass spectrometry. Principle Findings: IgG antibodies to LOS from C. jejuni BD-07, BD-39, BD-10, and BD-67 IgG antibodies were found in serum from 56%, 58%, 14% and 15% of GBS patients respectively, as compared to very low frequency (<3%) in controls (p<0.001). Monoclonal antibodies specific for GM1 and GD1a reacted strongly with LOS from the C. jejuni strains (BD-07 and BD-39). Mass spectrometry analysis confirmed the presence of GM1 and GD1a carbohydrate mimics in the LOS from C. jejuni BD-07 and BD-39. Both BD-10 and BD-67 express the same LOS outer core, which appears to be a novel structure displaying GA2 and GD3 mimicry. Up to 90-100% of serum reactivity to gangliosides in two patients (DK-07 and DK-39) was inhibited by 50 mu g/ml of LOS from the autologous C. jejuni isolates. However, patient DK-07 developed an anti-GD1a immune response while patient DK-39 developed an anti-GM1 immune response. Conclusion: Carbohydrate mimicry between C. jejuni LOS and gangliosides, and cross-reactive serum antibody precipitate the majority of GBS cases in Bangladesh.	[Islam, Zhahirul; Talukder, Kaisar A.; Endtz, Hubert P.] ICDDR B, Ctr Food & Waterborne Dis, Dhaka, Bangladesh; [Islam, Zhahirul; van Belkum, Alex; Endtz, Hubert P.] Univ Med Ctr, Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Gilbert, Michel; Li, Jianjun] Natl Res Council Canada, Ottawa, ON, Canada; [Mohammad, Quazi D.] Dhaka Med Coll Hosp, Dept Neurol, Dhaka, Bangladesh; [Willison, Hugh J.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	International Centre for Diarrhoeal Disease Research (ICDDR); Erasmus University Rotterdam; Erasmus MC; National Research Council Canada; Dhaka Medical College; University of Glasgow	Islam, Z (corresponding author), ICDDR B, Ctr Food & Waterborne Dis, Dhaka, Bangladesh.	zislam@icddrb.org	willison, hugh/HCI-7819-2022; Jacobs, Bart/ABE-2210-2021	Gilbert, Michel/0000-0002-0204-4408; Li, Jianjun/0000-0002-6531-3687; Islam, Dr. Zhahirul/0000-0003-0935-8079	Erasmus University Medical Centre, Rotterdam, The Netherlands; International Centre for Diarrhoeal Disease Research, Bangladesh's (icddr,b)	Erasmus University Medical Centre, Rotterdam, The Netherlands(Netherlands Government); International Centre for Diarrhoeal Disease Research, Bangladesh's (icddr,b)	This research study was funded by the Erasmus University Medical Centre, Rotterdam, The Netherlands and the International Centre for Diarrhoeal Disease Research, Bangladesh's (icddr,b) core donors which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Ang CW, 1999, NEUROLOGY, V53, P2122, DOI 10.1212/WNL.53.9.2122; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; ASPINALL GO, 1995, EUR J BIOCHEM, V231, P570, DOI 10.1111/j.1432-1033.1995.0570d.x; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735; Islam Z, 2011, EMERG INFECT DIS, V17, P1317, DOI [10.3201/eid1707.101999, 10.3201/eid1707.102031]; Islam Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007257; Islam Z, 2009, EMERG INFECT DIS, V15, P1316, DOI 10.3201/eid1508.090120; Jacobs BC, 1997, J NEUROIMMUNOL, V79, P62, DOI 10.1016/S0165-5728(97)00110-0; Jacobs BC, 1997, J INFECT DIS, V175, P729, DOI 10.1093/infdis/175.3.729; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209; Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222; Kaida K, 2009, GLYCOBIOLOGY, V19, P676, DOI 10.1093/glycob/cwp027; Kaida KI, 2006, J NEUROL NEUROSUR PS, DOI [10.1136/jnnp, DOI 10.1136/JNNP;087940]; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Kuijf ML, 2007, J NEUROIMMUNOL, V188, P69, DOI 10.1016/j.jneuroim.2007.05.014; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Kuijf ML, 2005, J NEUROL SCI, V239, P37, DOI 10.1016/j.jns.2005.07.009; Kusunoki S, 1999, MUSCLE NERVE, V22, P1071, DOI 10.1002/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0; Li JJ, 2005, ELECTROPHORESIS, V26, P3360, DOI 10.1002/elps.200500145; Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; PENNER JL, 1983, EUR J CLIN MICROBIOL, V2, P378, DOI 10.1007/BF02019474; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; Salloway S, 1996, INFECT IMMUN, V64, P2945, DOI 10.1128/IAI.64.8.2945-2949.1996; van Belkum A, 2001, NAT MED, V7, P752, DOI 10.1038/89831; Xiang SL, 2006, J NEUROIMMUNOL, V174, P126, DOI 10.1016/j.jneuroim.2006.02.009; Yuki N, 1997, J INFECT DIS, V176, pS150, DOI 10.1086/513800; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2007, J PERIPHER NERV SYST, V12, P238, DOI 10.1111/j.1529-8027.2007.00153.x	37	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43976	10.1371/journal.pone.0043976	http://dx.doi.org/10.1371/journal.pone.0043976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952833	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000308044800083
J	Singh, VK; Das, K; Seshadri, K				Singh, Vivek K.; Das, Kaveri; Seshadri, Kothandaraman			Kinetic Modelling of GlmU Reactions - Prioritization of Reaction for Therapeutic Application	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRYPANOSOMA-BRUCEI; SYSTEMS BIOLOGY; ACETYLTRANSFERASE; REPRESENTATION; INHIBITORS; DRUGBANK; TOOLBOX; MATLAB; GENES	Mycobacterium tuberculosis(Mtu), a successful pathogen, has developed resistance against the existing anti-tubercular drugs necessitating discovery of drugs with novel action. Enzymes involved in peptidoglycan biosynthesis are attractive targets for antibacterial drug discovery. The bifunctional enzyme mycobacterial GlmU (Glucosamine 1-phosphate N-acetyltransferase/N-acetylglucosamine-1-phosphate uridyltransferase) has been a target enzyme for drug discovery. Its C-and N-terminal domains catalyze acetyltransferase (rxn-1) and uridyltransferase (rxn-2) activities respectively and the final product is involved in peptidoglycan synthesis. However, the bifunctional nature of GlmU poses difficulty in deciding which function to be intervened for therapeutic advantage. Genetic analysis showed this as an essential gene but it is still unclear whether any one or both of the activities are critical for cell survival. Often enzymatic activity with suitable high-throughput assay is chosen for random screening, which may not be the appropriate biological function inhibited for maximal effect. Prediction of rate-limiting function by dynamic network analysis of reactions could be an option to identify the appropriate function. With a view to provide insights into biochemical assays with appropriate activity for inhibitor screening, kinetic modelling studies on GlmU were undertaken. Kinetic model of Mtu GlmU-catalyzed reactions was built based on the available kinetic data on Mtu and deduction from Escherichia coli data. Several model variants were constructed including coupled/decoupled, varying metabolite concentrations and presence/absence of product inhibitions. This study demonstrates that in coupled model at low metabolite concentrations, inhibition of either of the GlmU reactions cause significant decrement in the overall GlmU rate. However at higher metabolite concentrations, rxn-2 showed higher decrement. Moreover, with available intracellular concentration of the metabolites and in vivo variant of model, uncompetitive inhibition of rxn-2 caused highest decrement. Thus, at physiologically relevant metabolite concentrations, targeting uridyltranferase activity of Mtu GlmU would be a better choice for therapeutic intervention.	[Singh, Vivek K.; Das, Kaveri; Seshadri, Kothandaraman] AstraZeneca India Pvt Ltd, Innovat Med Infect iMed Infect, Bangalore, Karnataka, India	AstraZeneca	Singh, VK (corresponding author), AstraZeneca India Pvt Ltd, Innovat Med Infect iMed Infect, Bangalore, Karnataka, India.	kothandaraman.seshadri@gmail.com			Astra Zeneca	Astra Zeneca(AstraZeneca)	The authors have read the journal's policy and have the following conflicts: This work was funded by Astra Zeneca, the employer of all authors. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Eisenthal R, 1998, J BIOL CHEM, V273, P5500, DOI 10.1074/jbc.273.10.5500; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Gehring AM, 1996, BIOCHEMISTRY-US, V35, P579, DOI 10.1021/bi952275a; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Irwin HS, 1993, ENZYME KINETICS BEHA; Jamshidi N, 2001, BIOINFORMATICS, V17, P286, DOI 10.1093/bioinformatics/17.3.286; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keating SM, 2006, BIOINFORMATICS, V22, P1275, DOI 10.1093/bioinformatics/btl111; KUKKOKALSKE E, 1989, J BACTERIOL, V171, P4498, DOI 10.1128/JB.171.8.4498-4500.1989; Li YM, 2011, CARBOHYD RES, V346, P1714, DOI 10.1016/j.carres.2011.05.024; Marcellin Esteban, 2009, Biotechnology Journal, V4, P58, DOI 10.1002/biot.200800197; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; Mochalkin I, 2008, PROTEIN SCI, V17, P577, DOI 10.1110/ps.073271408; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Pereira MP, 2009, ANTIMICROB AGENTS CH, V53, P2306, DOI 10.1128/AAC.01572-08; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Singh VK, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-27; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Vadali RV, 2004, METAB ENG, V6, P133, DOI 10.1016/j.ymben.2004.02.001; Who, 2010, TUB DAT; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Young JD, 2008, BIOTECHNOL BIOENG, V100, P542, DOI 10.1002/bit.21780; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; Zhang Z, 2009, ACTA CRYSTALLOGR D, V65, P275, DOI 10.1107/S0907444909001036; Zhou Y, 2011, ARCH MICROBIOL, V193, P751, DOI 10.1007/s00203-011-0715-8	33	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43969	10.1371/journal.pone.0043969	http://dx.doi.org/10.1371/journal.pone.0043969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952829	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800080
J	Quintavalle, C; Donnarumma, E; Iaboni, M; Roscigno, G; Garofalo, M; Romano, G; Fiore, D; De Marinis, P; Croce, CM; Condorelli, G				Quintavalle, C.; Donnarumma, E.; Iaboni, M.; Roscigno, G.; Garofalo, M.; Romano, G.; Fiore, D.; De Marinis, P.; Croce, C. M.; Condorelli, G.			Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells	ONCOGENE			English	Article						glioblastoma; TRAIL; therapy; microRNA; treatment; apoptosis	GROWTH IN-VIVO; MICRORNA SIGNATURES; MONOCLONAL-ANTIBODY; DEATH RECEPTORS; DOWN-REGULATION; STEM-CELLS; GLIOBLASTOMA; EXPRESSION; RESISTANCE; TARGETS	Glioblastoma is the most frequent brain tumor in adults and is the most lethal form of human cancer. Despite the improvements in treatments, survival of patients remains poor. To define novel pathways that regulate susceptibility to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in glioma, we have performed genome-wide expression profiling of microRNAs (miRs). We show that in TRAIL-resistant glioma cells, levels of different miRs are increased, and in particular, miR-30b/c and -21. We demonstrate that these miRs impair TRAIL-dependent apoptosis by inhibiting the expression of key functional proteins. T98G-sensitive cells treated with miR-21 or -30b/c become resistant to TRAIL. Furthermore, we demonstrate that miR-30b/c and miR-21 target respectively the 30 untranslated region of caspase-3 and TAp63 mRNAs, and that those proteins mediate some of the effects of miR-30 and -21 on TRAIL resistance, even in human glioblastoma primary cells and in lung cancer cells. In conclusion, we show that high expression levels of miR-21 and -30b/c are needed to maintain the TRAIL-resistant phenotype, thus making these miRs as promising therapeutic targets for TRAIL resistance in glioma.	[Quintavalle, C.; Iaboni, M.; Roscigno, G.; Fiore, D.; Condorelli, G.] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, I-80131 Naples, Italy; [Quintavalle, C.; Iaboni, M.; Roscigno, G.; Condorelli, G.] CNR, IEOS, I-80125 Naples, Italy; [Donnarumma, E.; Romano, G.] Fdn IRCCS SDN, Naples, Italy; [Garofalo, M.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [De Marinis, P.] Osped Antonio Cardarelli, Neurosurg Unit, Naples, Italy; [Condorelli, G.] Univ Naples Federico II, Fac Sci Biotechnol, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Antonio Cardarelli Hospital; University of Naples Federico II	Condorelli, G (corresponding author), Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Via Pansini,5,Ed 19 A,2 Floor, I-80131 Naples, Italy.	gecondor@unina.it	Young, Richard A/F-6495-2012; Quintavalle, Cristina/AHH-9379-2022; Condorelli, Gerolama/AAC-3472-2022; Fiore, Danilo/A-6002-2019	Young, Richard A/0000-0001-8855-8647; Condorelli, Gerolama/0000-0003-0177-8829; Fiore, Danilo/0000-0003-3004-6862; Roscigno, Giuseppina/0000-0002-5359-6376	Associazione Italiana Ricerca sul Cancro, AIRC [10620]; MERIT [RBNE08E8CZ_002]; 'Federazione Italiana Ricerca sul Cancro' (FIRC); MERIT project Fellowship	Associazione Italiana Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro); MERIT; 'Federazione Italiana Ricerca sul Cancro' (FIRC)(Fondazione AIRC per la ricerca sul cancro); MERIT project Fellowship	This work was partially supported by funds from Associazione Italiana Ricerca sul Cancro, AIRC to GC (grant n.ro 10620), and MERIT (RBNE08E8CZ_002) to GC. CQ and MI are supported by the 'Federazione Italiana Ricerca sul Cancro' (FIRC) Post-Doctoral Research Fellowship. GR is supported by a MERIT project Fellowship.	Balyasnikova IV, 2011, CANCER LETT, V310, P148, DOI 10.1016/j.canlet.2011.06.029; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2007, INT J CANCER, V120, P1215, DOI 10.1002/ijc.22495; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Garofalo M, 2008, CURR OPIN PHARMACOL, V8, P661, DOI 10.1016/j.coph.2008.06.005; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li N, 2012, CANCER RES, V72, P154, DOI 10.1158/0008-5472.CAN-11-2484; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Moore LM, 2010, EXPERT OPIN THER TAR, V14, P1247, DOI 10.1517/14728222.2010.527334; Nagane M, 2001, APOPTOSIS, V6, P191, DOI 10.1023/A:1011336726649; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Plummer R, 2007, CLIN CANCER RES, V13, P6187, DOI 10.1158/1078-0432.CCR-07-0950; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Quintavalle C, 2010, CELL DEATH DIFFER, V17, P1908, DOI 10.1038/cdd.2010.65; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Tran B, 2010, J CLIN NEUROSCI, V17, P417, DOI 10.1016/j.jocn.2009.09.004; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; Unterkircher T, 2011, CLIN CANCER RES, V17, P4019, DOI 10.1158/1078-0432.CCR-11-0075; Walczak H, 2000, CANCER RES, V60, P3051; Younes A, 2010, BRIT J CANCER, V103, P1783, DOI 10.1038/sj.bjc.6605987; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zanca C, 2008, J CELL MOL MED, V12, P2416, DOI 10.1111/j.1582-4934.2008.00283.x; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	42	80	84	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					4001	4008		10.1038/onc.2012.410	http://dx.doi.org/10.1038/onc.2012.410			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22964638				2022-12-25	WOS:000323748100008
J	Garg, R; Blando, J; Perez, CJ; Wang, HB; Benavides, FJ; Kazanietz, MG				Garg, Rachana; Blando, Jorge; Perez, Carlos J.; Wang, HongBin; Benavides, Fernando J.; Kazanietz, Marcelo G.			Activation of Nuclear Factor kappa B (NF-kappa B) in Prostate Cancer Is Mediated by Protein Kinase C epsilon (PKC epsilon)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER-INDUCED APOPTOSIS; CONSTITUTIVE ACTIVATION; TNF-ALPHA; DELTA-PKC; CELLS; GROWTH; INFLAMMATION; EXPRESSION; CARCINOMA; TARGET	Protein kinase C epsilon (PKC epsilon) has emerged as an oncogenic kinase and plays important roles in cell survival, mitogenesis and invasion. PKC epsilon is up-regulated in most epithelial cancers, including prostate, breast, and lung cancer. Here we report that PKC epsilon is an essential mediator of NF-kappa B activation in prostate cancer cells. A strong correlation exists between PKC epsilon overexpression and NF-kappa B activation status in prostate cancer cells. Moreover, transgenic overexpression of PKC epsilon in the mouse prostate causes preneoplastic lesions that display significant NF-kappa B hyperactivation. PKC epsilon RNAi depletion or inhibition in prostate cancer cells diminishes NF-kappa B translocation to the nucleus with subsequent impairment of both activation of NF-kappa B transcription and induction of NF-kappa B responsive genes in response to the proinflammatory cytokine tumor necrosis factor alpha (TNF alpha). On the other hand, PKC epsilon overexpression in normal prostate cells enhances activation of the NF-kappa B pathway. A mechanistic analysis revealed that TNF alpha activates PKC epsilon via a C1 domain/diacylglycerol-dependent mechanism that involves phosphatidylcholine-phospholipase C. Moreover, PKC epsilon facilitates the assembly of the TNF receptor-I signaling complex to trigger NF-kappa B activation. Our studies identified a molecular link between PKC epsilon and NF-kappa B that controls key responses implicated in prostate cancer progression.	[Garg, Rachana; Wang, HongBin; Kazanietz, Marcelo G.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Blando, Jorge] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Perez, Carlos J.; Benavides, Fernando J.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Kazanietz, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, 1256 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Garg, Rachana/AAQ-9518-2020	Garg, Rachana/0000-0002-7808-1053; Benavides, Fernando/0000-0003-1275-4320	National Institutes of Health Grant [R01-CA89202]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA089202] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA89202 (to M. G. K.).	Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Bao LW, 2009, CANCER RES, V69, P5829, DOI 10.1158/0008-5472.CAN-08-3465; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Bin Hafeez B, 2011, CANCER RES, V71, P2318, DOI 10.1158/0008-5472.CAN-10-4170; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Chang Q, 2003, BRIT J PHARMACOL, V140, P41, DOI 10.1038/sj.bjp.0705398; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Fernandez-Marcos PJ, 2009, P NATL ACAD SCI USA, V106, P12962, DOI 10.1073/pnas.0813055106; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Garg R, 2008, TOXICOL APPL PHARM, V232, P428, DOI 10.1016/j.taap.2008.07.007; Garg R, 2008, CARCINOGENESIS, V29, P1249, DOI 10.1093/carcin/bgn114; Gavrielides MV, 2004, CURR DRUG TARGETS, V5, P431, DOI 10.2174/1389450043345380; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Griner EM, 2010, J BIOL CHEM, V285, P16931, DOI 10.1074/jbc.M109.099036; Hammond G, 2004, CURR TOP MICROBIOL, V282, P177; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kilpatrick LE, 2004, AM J PHYSIOL-CELL PH, V287, pC633, DOI 10.1152/ajpcell.00486.2003; Koren R, 2004, ONCOL REP, V11, P321; Koyanagi T, 2007, J MOL CELL CARDIOL, V43, P517, DOI 10.1016/j.yjmcc.2007.06.003; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Lu ZG, 2009, CANCER RES, V69, P5927, DOI 10.1158/0008-5472.CAN-08-4786; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; Madrid Lee V, 2003, Methods Mol Biol, V223, P523; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Meshki J, 2010, J BIOL CHEM, V285, P26033, DOI 10.1074/jbc.M110.128371; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; Shinohara H, 2001, BIOCHEM BIOPH RES CO, V284, P1162, DOI 10.1006/bbrc.2001.5104; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Stock D, 2008, UROL CLIN N AM, V35, P117, DOI 10.1016/j.ucl.2007.09.006; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wang HB, 2010, MOL BIOL CELL, V21, P1398, DOI 10.1091/mbc.E09-08-0735; Wang SM, 1996, J MED CHEM, V39, P2541, DOI 10.1021/jm950403n; Win HY, 2008, CANCER LETT, V270, P302, DOI 10.1016/j.canlet.2008.05.023; Wu DQ, 2002, CANCER RES, V62, P2423; Yang DZ, 2010, CANCER RES, V70, P7905, DOI 10.1158/0008-5472.CAN-09-4729; Yemelyanov A, 2006, ONCOGENE, V25, P387, DOI 10.1038/sj.onc.1209066; Zerbini LF, 2003, CANCER RES, V63, P2206	61	48	51	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37570	37582		10.1074/jbc.M112.398925	http://dx.doi.org/10.1074/jbc.M112.398925			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955280	Green Published, hybrid			2022-12-25	WOS:000310588500085
J	Shniffer, A; Visschedyk, DD; Ravulapalli, R; Suarez, G; Turgeon, ZJ; Petrie, AA; Chopra, AK; Merrill, AR				Shniffer, Adin; Visschedyk, Danielle D.; Ravulapalli, Ravikiran; Suarez, Giovanni; Turgeon, Zachari J.; Petrie, Anthony A.; Chopra, Ashok K.; Merrill, A. Rod			Characterization of an Actin-targeting ADP-ribosyltransferase from Aeromonas hydrophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA EXOTOXIN; MULTIPLE SEQUENCE ALIGNMENTS; PERFRINGENS IOTA-TOXIN; RIBOSYLATES ACTIN; MEMBRANE-PROTEINS; VIRULENCE FACTORS; CRYSTAL-STRUCTURE; DOMAIN-III; CELL-DEATH; IDENTIFICATION	The mono-ADP-ribosyltransferase (mART) toxins are contributing factors to a number of human diseases, including cholera, diphtheria, traveler's diarrhea, and whooping cough. VahC is a cytotoxic, actin-targeting mART from Aeromonas hydrophila PPD134/91. This bacterium is implicated primarily in diseases among freshwater fish species but also contributes to gastrointestinal and extraintestinal infections in humans. VahC was shown to ADP-ribosylate Arg-177 of actin, and the kinetic parameters were K-m(NAD(+)) = 6 mu M, K-m(actin) = 24 mu M, and k(cat) = 22 s(-1). VahC activity caused depolymerization of actin filaments, which induced caspase-mediated apoptosis in HeLa Tet-Off cells. Alanine-scanning mutagenesis of predicted catalytic residues showed the predicted loss of in vitro mART activity and cytotoxicity. Bioinformatic and kinetic analysis also identified three residues in the active site loop that were critical for the catalytic mechanism. A 1.9 angstrom crystal structure supported the proposed roles of these residues and their conserved nature among toxin homologues. Several small molecules were characterized as inhibitors of in vitro VahC mART activity and suramin was the best inhibitor (IC50 = 20 mu M). Inhibitor activity was also characterized against two other actin-targeting mART toxins. Notably, these inhibitors represent the first report of broad spectrum inhibition of actin-targeting mART toxins.	[Shniffer, Adin; Visschedyk, Danielle D.; Ravulapalli, Ravikiran; Turgeon, Zachari J.; Petrie, Anthony A.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Suarez, Giovanni; Chopra, Ashok K.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Guelph; University of Texas System; University of Texas Medical Branch Galveston	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014	Turgeon, Zachari/0000-0002-0883-8292	Natural Sciences and Engineering Research Council (NSERC); NSERC; Canadian Institutes of Health Research; Human Frontier Science Program	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program)	Supported by a Natural Sciences and Engineering Research Council (NSERC) studentship.; Supported by an NSERC Undergraduate Student Research Awards Program summer award.; Supported by the Canadian Institutes of Health Research and the Human Frontier Science Program. To whom correspondence should be addressed. Fax: 519-837-1802; E-mail: rmerrill@uoguelph.ca.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beattie BK, 1999, J BIOL CHEM, V274, P15646, DOI 10.1074/jbc.274.22.15646; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P15134, DOI 10.1021/bi961985t; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; DeLano WL, 2002, PYMOL USERS MANUAL; Edberg SC, 2007, CRIT REV MICROBIOL, V33, P89, DOI 10.1080/10408410601172180; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Escaich S, 2010, EXPERT OPIN THER PAT, V20, P1401, DOI 10.1517/13543776.2010.511176; FANG FC, 1991, J BACTERIOL, V173, P6783, DOI 10.1128/jb.173.21.6783-6789.1991; Fehr D, 2007, J BIOL CHEM, V282, P28843, DOI 10.1074/jbc.M704797200; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Kozinska A, 2012, SCI WORLD J, P1, DOI 10.1100/2012/949358; Laohachai KN, 2003, TOXICON, V42, P687, DOI 10.1016/j.toxicon.2003.08.010; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Monette S, 2006, VET PATHOL, V43, P302, DOI 10.1354/vp.43-3-302; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Pemberton JM, 1997, FEMS MICROBIOL LETT, V152, P1, DOI 10.1016/S0378-1097(97)00186-9; Pepe CM, 1996, MOL MICROBIOL, V19, P857, DOI 10.1046/j.1365-2958.1996.431958.x; Presley SM, 2006, ENVIRON SCI TECHNOL, V40, P468, DOI 10.1021/es052219p; Pust S, 2007, J BIOL CHEM, V282, P10272, DOI 10.1074/jbc.M610254200; QUINN DM, 1993, INFECT IMMUN, V61, P371, DOI 10.1128/IAI.61.2.371-377.1993; Sakurai J, 2003, ADV ENZYME REGUL, V43, P361, DOI 10.1016/S0065-2571(02)00044-4; Schmitt CK, 1999, EMERG INFECT DIS, V5, P224, DOI 10.3201/eid0502.990206; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; Uckay I, 2008, J HOSP INFECT, V68, P1, DOI 10.1016/j.jhin.2007.10.018; Visschedyk DD, 2010, J BIOL CHEM, V285, P13525, DOI 10.1074/jbc.M109.077339; WEIGT C, 1989, FEBS LETT, V246, P181, DOI 10.1016/0014-5793(89)80279-0; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018; Yu HB, 2005, APPL ENVIRON MICROB, V71, P4469, DOI 10.1128/AEM.71.8.4469-4477.2005; Zhang YL, 2002, INFECT IMMUN, V70, P2326, DOI 10.1128/IAI.70.5.2326-2335.2002	60	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37030	37041		10.1074/jbc.M112.397612	http://dx.doi.org/10.1074/jbc.M112.397612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22969084	Green Published, hybrid			2022-12-25	WOS:000310588500038
J	Sun, RH; Fan, HT; Gao, F; Lin, YJ; Zhang, LX; Gong, WM; Liu, L				Sun, Renhua; Fan, Haitian; Gao, Feng; Lin, Yajing; Zhang, Lixin; Gong, Weimin; Liu, Lin			Crystal Structure of Arabidopsis Deg2 Protein Reveals an Internal PDZ Ligand Locking the Hexameric Resting State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTODAMAGED D1 PROTEIN; PHOTOSYSTEM-II; QUALITY-CONTROL; HTRA FAMILY; PROTEASES; LIGHT; PHOTOINHIBITION; DEGRADATION; ADAPTATION; SYSTEM	Eukaryotic organelles have developed elaborate protein quality control systems to ensure their normal activity, among which Deg/HtrA proteases play an essential role. Plant Deg2 protease is a homologue of prokaryotic DegQ/DegP proteases and is located in the chloroplast stroma, where its proteolytic activity is required to maintain the efficiency of photosynthetic machinery during stress. Here, we demonstrate that Deg2 exhibits dual protease-chaperone activities, and we present the hexameric structure of Deg2 complexed with co-purified peptides. The structure shows that Deg2 contains a unique second PDZ domain (PDZ2) following a conventional PDZ domain (PDZ1), with PDZ2 orchestrating the cage assembly of Deg2. We discovered a conserved internal ligand for PDZ2 that mediates hexamer formation and thus locks the protease in the resting state. These findings provide insight into the diverse modes of PDZ domain-mediated regulation of Deg proteases.	[Fan, Haitian; Gao, Feng; Lin, Yajing; Gong, Weimin] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China; [Sun, Renhua; Zhang, Lixin; Liu, Lin] Chinese Acad Sci, Inst Bot, Photosynthesis Res Ctr, Lab Photobiol, Beijing 100093, Peoples R China; [Sun, Renhua] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gong, WM (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China.	wgong@ibp.ac.cn; liulin@ibcas.ac.cn		Fan, Haitian/0000-0003-4337-665X; Sun (Genuine), Renhua/0000-0002-8203-4946	Ministry of Science and Technology of China [2011CBA00901]; National Natural Science Foundation of China [31170688]; Hundred Talents Program of Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grant 2011CBA00901, National Natural Science Foundation of China Grant 31170688, and the Hundred Talents Program of Chinese Academy of Sciences.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allahverdiyeva Y., 2011, PHOTOSYNTHESIS PLAST, P275; Bai XC, 2011, STRUCTURE, V19, P1328, DOI 10.1016/j.str.2011.06.013; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huesgen PF, 2005, PHYSIOL PLANTARUM, V123, P413, DOI 10.1111/j.1399-3054.2005.00458.x; Huesgen PF, 2006, FEBS LETT, V580, P6929, DOI 10.1016/j.febslet.2006.11.058; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Kley J, 2011, NAT STRUCT MOL BIOL, V18, P728, DOI 10.1038/nsmb.2055; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Lucinski R, 2011, NEW PHYTOL, V192, P74, DOI 10.1111/j.1469-8137.2011.03782.x; Malet H, 2012, NAT STRUCT MOL BIOL, V19, P152, DOI 10.1038/nsmb.2210; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Skorko-Glonek J, 2007, ARCH BIOCHEM BIOPHYS, V464, P80, DOI 10.1016/j.abb.2007.04.006; Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510; Sun XW, 2010, PLANT J, V62, P240, DOI 10.1111/j.1365-313X.2010.04140.x; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4	33	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37564	37569		10.1074/jbc.M112.394585	http://dx.doi.org/10.1074/jbc.M112.394585			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961982	Green Published, hybrid			2022-12-25	WOS:000310588500084
J	Green, AR; Hayes, RP; Xun, LY; Kang, C				Green, Abigail R.; Hayes, Robert P.; Xun, Luying; Kang, ChulHee			Structural Understanding of the Glutathione-dependent Reduction Mechanism of Glutathionyl-Hydroquinone Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-GLUTATHIONYL-(CHLORO)HYDROQUINONE REDUCTASES; OMEGA CLASS; IDENTIFICATION; TRANSFERASES	Glutathionyl-hydroquinone reductases (GS- HQRs) are a newly identified group of glutathione transferases, and they are widely distributed in bacteria, halobacteria, fungi, and plants. GS-HQRs catalyze glutathione (GSH)-dependent reduction of glutathionyl-hydroquinones (GS-hydroquinones) to hydroquinones. GS-hydroquinones can be spontaneously formed from benzoquinones reacting with reduced GSH via Michael addition, and GS-HQRs convert the conjugates to hydroquinones. In this report we have determined the structures of two bacterial GS-HQRs, PcpF of Sphingobium chlorophenolicum and YqjG of Escherichia coli. The two structures and the previously reported structure of a fungal GS-HQR shared many features and displayed complete conservation for all the critical residues. Furthermore, we obtained the binary complex structures with GS-menadione, which in its reduced form, GS-menadiol, is a substrate. The structure revealed a large H-site that could accommodate various substituted hydroquinones and a hydrogen network of three Tyr residues that could provide the proton for reductive deglutathionylation. Mutation of the Tyr residues and the position of two GSH molecules confirmed the proposed mechanism of GS-HQRs. The conservation of GS-HQRs across bacteria, halobacteria, fungi, and plants potentiates the physiological role of these enzymes in quinone metabolism.	[Green, Abigail R.; Xun, Luying; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Hayes, Robert P.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Xun, LY (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	luying_xun@wsu.edu; chkang@wsu.edu		Kang, ChulHee/0000-0002-0693-7860; Hayes, Robert/0000-0003-4947-4410	National Science Foundation [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grants MCB 1021148 and DBI 0959778 and by the M. J. Murdock Charitable Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Belchik SM, 2011, DRUG METAB REV, V43, P307, DOI 10.3109/03602532.2011.552909; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; BRUNMARK A, 1988, CHEM-BIOL INTERACT, V68, P273, DOI 10.1016/0009-2797(88)90021-X; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; HILL BA, 1993, CHEM RES TOXICOL, V6, P459, DOI 10.1021/tx00034a012; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang Y, 2008, J BACTERIOL, V190, P7595, DOI 10.1128/JB.00489-08; Lam LKM, 2012, BIOCHEMISTRY-US, V51, P5014, DOI 10.1021/bi300477z; Li J, 2005, PROTEIN SCI, V14, P2361, DOI 10.1110/ps.051463905; Meux E, 2011, J BIOL CHEM, V286, P9162, DOI 10.1074/jbc.M110.194548; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NERLAND DE, 1990, DRUG METAB DISPOS, V18, P958; NICKERSON WJ, 1963, BIOCHEMISTRY-US, V2, P537, DOI 10.1021/bi00903a025; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; WEFERS H, 1983, ARCH BIOCHEM BIOPHYS, V224, P568, DOI 10.1016/0003-9861(83)90244-8; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Xun LY, 2010, BIOCHEM J, V428, P419, DOI 10.1042/BJ20091863	23	11	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35838	35848		10.1074/jbc.M112.395541	http://dx.doi.org/10.1074/jbc.M112.395541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955277	Green Published, hybrid			2022-12-25	WOS:000310364000007
J	Das, A; Dey, N; Ghosh, A; Das, S; Chattopadhyay, DJ; Chatterjee, IB				Das, Archita; Dey, Neekkan; Ghosh, Arunava; Das, Shovanendu; Chattopadhyay, Dhruba J.; Chatterjee, Indu B.			Molecular and Cellular Mechanisms of Cigarette Smoke-Induced Myocardial Injury: Prevention by Vitamin C	PLOS ONE			English	Article							OXIDATIVE STRESS; SIGNALING PATHWAYS; HEART-FAILURE; TOBACCO-SMOKE; ASCORBIC-ACID; APOPTOSIS; ISCHEMIA; DISEASE; DAMAGE; BENZOSEMIQUINONE	Background: Cardiovascular disease (CVD) remains one of the major killers in modern society. One strong risk factor of CVD is cigarette smoking that causes myocardial injury and leads to the genesis of pathological cardiovascular events. However, the exact toxic component(s) of cigarette smoke (CS) and its molecular and cellular mechanisms for causing myocardial injury leading to heart damage and its prevention are largely unknown. Methodology/Principal Findings: Using a guinea pig model, here we show that chronic exposure to CS produces myocardial injury that is prevented by vitamin C. Male guinea pigs were fed either vitamin C-deficient (0.5 mg/day) or vitamin C-sufficient (15 mg/day) diet and subjected to CS exposure from 5 Kentucky Research cigarettes (3R4F)/day (6 days/week) in a smoke chamber up to 8 weeks. Pair-fed sham controls were subjected to air exposure instead of CS exposure under similar conditions. Myocardial injury was produced in CS-exposed marginal vitamin C-deficient guinea pigs as evidenced by release of cardiac Troponin-T and I in the serum, oxidative stress, inflammation, apoptosis, thrombosis and collagen deposition in the myocardium. Treatment of rat cardiomyocyte cells (H9c2) in vitro and guinea pigs in vivo with p-benzoquinone (p-BQ) in amounts derived from CS revealed that p-BQ was a major factor responsible for CS-induced myocardial damage. A moderately large dose of vitamin C (15 mg/day) prevented CS/p-BQ-induced myocardial injury. Population based studies indicated that plasma vitamin C levels of smokers without disease were significantly lower (p = 0,0000) than that of non-smokers. Vitamin C levels of CS-related cardiovascular patients were further lower (p = 0.0000) than that of smokers without disease. Conclusions/Significance: The results indicate that dietary supplementation of vitamin C may be a novel and simple therapy for the prevention of pathological cardiovascular events in habitual smokers.	[Das, Archita; Dey, Neekkan; Ghosh, Arunava; Chattopadhyay, Dhruba J.; Chatterjee, Indu B.] Univ Coll Sci Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Dept Biotechnol, Kolkata, India; [Das, Shovanendu] VLCC Hlth Care, Kolkata, India	University of Calcutta	Das, A (corresponding author), Univ Coll Sci Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Dept Biotechnol, Kolkata, India.	ibc123@rediffmail.com	DAS, ARCHITA/ABD-5437-2020; Ghosh, Arunava/I-5939-2019	Ghosh, Arunava/0000-0001-9550-1366; Dey, Neekkan/0000-0002-4042-7215	Juthika Research Foundation of Calcutta University, Department of Biotechnology, Government of West Bengal; Council of Scientific and Industrial Research, Government of India	Juthika Research Foundation of Calcutta University, Department of Biotechnology, Government of West Bengal; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by Juthika Research Foundation of Calcutta University, Department of Biotechnology, Government of West Bengal and Council of Scientific and Industrial Research, Government of India. Indu B. Chatterjee is INSA (Indian National Science Academy) Honorary Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Banerjee S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-21; Barbieri SS, 2011, CARDIOVASC RES, V90, P475, DOI 10.1093/cvr/cvr032; Bernhard D, 2007, CURR MED CHEM, V14, P1703; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; CHAKRABARTY S, 1992, MOL CELL BIOCHEM, V111, P41; CHATTERJEE I, 1961, NATURE, V192, P163, DOI 10.1038/192163a0; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Chatterjee IB, 2005, US Patent, Patent No. [6,929,012, 6929012, 6,929, 012]; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Csordas A, 2008, BIOMARK INSIGHTS, V3, P127; Das A., 2011, PLOS ONE, V6; Das A, 2010, CHEM RES TOXICOL, V23, P1054, DOI 10.1021/tx1000442; Dept of Health and Human Services, 2005, DHHS PUBL, P89; Dey N, 2011, J ONCOL, V2011, DOI 10.1155/2011/561862; Dey N, 2010, J BIOSCIENCES, V35, P217, DOI 10.1007/s12038-010-0026-2; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Ghosh A, 2012, TOXICOLOGY, V292, P78, DOI 10.1016/j.tox.2011.11.014; Gill C, 2002, FASEB J, V16, P135, DOI 10.1096/fj.01-0629com; Gilles S, 2003, CARDIOVASC RES, V60, P608, DOI 10.1016/j.cardiores.2003.08.016; Giovino GA, 2007, AM J PREV MED, V33, pS318, DOI 10.1016/j.amepre.2007.09.008; Guaiquil VH, 2004, FREE RADICAL BIO MED, V37, P1419, DOI 10.1016/j.freeradbiomed.2004.06.041; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Khanna AK, 2011, LEGALITY TARGETED KI, P1; Kim H, 2009, J IMMUNOL, V182; LEHR HA, 1994, P NATL ACAD SCI USA, V91, P7688, DOI 10.1073/pnas.91.16.7688; Lu L, 2000, AM J PHYSIOL-HEART C, V279, pH601, DOI 10.1152/ajpheart.2000.279.2.H601; McCully JD, 2004, AM J PHYSIOL-HEART C, V286, pH1923, DOI 10.1152/ajpheart.00935.2003; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; NIKI E, 1991, AM J CLIN NUTR, V54, pS1119, DOI 10.1093/ajcn/54.6.1119s; O'Brien PJ, 2008, TOXICOLOGY, V245, P206, DOI 10.1016/j.tox.2007.12.006; Panda K, 2000, FREE RADICAL BIO MED, V29, P115, DOI 10.1016/S0891-5849(00)00297-5; Panda KChatterjeeIB, 2007, ENCY VITAMIN E, P883; Preston AM, 2003, AM J CLIN NUTR, V77, P167, DOI 10.1093/ajcn/77.1.167; Pryor WA, 1998, CHEM RES TOXICOL, V11, P441, DOI 10.1021/tx970159y; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Saraste A, 1997, CIRCULATION, V95, P320; SCHECTMAN G, 1989, AM J PUBLIC HEALTH, V79, P158, DOI 10.2105/AJPH.79.2.158; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Stewart B. W., 2003, WORLD CANC REPORT, P21; SULLIVAN AB, 1976, J PHYS CHEM-US, V80, P2671, DOI 10.1021/j100565a010; Takano H, 2003, ANTIOXID REDOX SIGN, V5, P789, DOI 10.1089/152308603770380098; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Valkonen MM, 2000, FREE RADICAL BIO MED, V28, P428, DOI 10.1016/S0891-5849(99)00260-9; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; White William B, 2007, Prev Cardiol, V10, P1, DOI 10.1111/j.1520-037X.2007.06050.x; WINNIFORD MD, 1986, CIRCULATION, V73, P662, DOI 10.1161/01.CIR.73.4.662; Wright JL, 2002, CHEST, V121, p188S, DOI 10.1378/chest.121.5_suppl.188S; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	53	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44151	10.1371/journal.pone.0044151	http://dx.doi.org/10.1371/journal.pone.0044151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970172	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400039
J	Laco, MN; Cortes, L; Travis, SM; Paulson, HL; Rego, AC				Laco, Mario N.; Cortes, Luisa; Travis, Sue M.; Paulson, Henry L.; Cristina Rego, A.			Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; DEUBIQUITINATING ENZYME ATAXIN-3; NON-EXPANDED ATAXIN-3; NUCLEAR-LOCALIZATION; STRUCTURAL DETERMINANTS; POLYGLUTAMINE DISEASES; UBIQUITIN CHAINS; GENE-PRODUCT; CELL-NUCLEUS; HHR23A	Alterations in the ubiquitin-proteasome system (UPS) have been reported in several neurodegenerative disorders characterized by protein misfolding and aggregation, including the polylgutamine diseases. Machado-Joseph disease (MJD) or Spinocerebellar Ataxia type 3 is caused by a polyglutamine-encoding CAG expansion in the ATXN3 gene, which encodes a 42 kDa deubiquitinating enzyme (DUB), ataxin-3. We investigated ataxin-3 deubiquitinating activity and the functional relevance of ataxin-3 interactions with two proteins previously described to interact with ataxin-3, hHR23A and valosin-containing protein (VCP/p97). We confirmed ataxin-3 affinity for both hHR23A and VCP/p97. hHR23A and ataxin-3 were shown to co-localize in discrete nuclear foci, while VCP/p97 was primarily cytoplasmic. hHR23A and VCP/p97 recombinant proteins were added, separately or together, to normal and expanded ataxin-3 in in vitro deubiquitination assays to evaluate their influence on ataxin-3 activity. VCP/p97 was shown to be an activator specifically of wild-type ataxin-3, exhibiting no effect on expanded ataxin-3, In contrast, we observed no significant alterations in ataxin-3 enzyme kinetics or substrate preference in the presence of hHR23A alone or in combination with VCP. Based on our results we propose a model where ataxin-3 normally functions with its interactors to specify the cellular fate of ubiquitinated proteins.	[Laco, Mario N.; Cortes, Luisa; Cristina Rego, A.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Laco, Mario N.; Cristina Rego, A.] Univ Coimbra, Fac Med, Coimbra, Portugal; [Travis, Sue M.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Paulson, Henry L.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA	Universidade de Coimbra; Universidade de Coimbra; University of Iowa; University of Michigan System; University of Michigan	Laco, MN (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	henryp@umich.edu; acrego@cnc.cj.uc.pt	Cortes, Luisa/F-7349-2014; Rego, Ana Cristina/AAH-2606-2020; Rego, Ana Cristina C/L-4272-2014	Cortes, Luisa/0000-0001-5292-4369; Rego, Ana Cristina C/0000-0003-0700-3776; Noro Laco, Mario/0000-0003-4823-3340	NINDS NIH HHS [R01 NS038712] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antony PMA, 2009, NEUROBIOL DIS, V36, P280, DOI 10.1016/j.nbd.2009.07.020; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bevivino AE, 2001, P NATL ACAD SCI USA, V98, P11955, DOI 10.1073/pnas.211305198; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chen L, 2006, FEBS LETT, V580, P3401, DOI 10.1016/j.febslet.2006.05.012; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Dalal S, 2001, CELL, V104, P5, DOI 10.1016/S0092-8674(01)00186-6; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Diaz-Hernandez M, 2006, J NEUROCHEM, V98, P1585, DOI 10.1111/j.1471-4159.2006.03968.x; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Evert BO, 2003, J NEUROPATH EXP NEUR, V62, P1006, DOI 10.1093/jnen/62.10.1006; Evert BO, 2001, J NEUROSCI, V21, P5389, DOI 10.1523/JNEUROSCI.21-15-05389.2001; Fei EK, 2007, BIOCHEM BIOPH RES CO, V357, P487, DOI 10.1016/j.bbrc.2007.03.160; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Hsieh HC, 2005, BIOCHEM BIOPH RES CO, V335, P181, DOI 10.1016/j.bbrc.2005.07.067; Kang Y, 2007, J MOL BIOL, V369, P168, DOI 10.1016/j.jmb.2007.03.008; Kuhlbrodt K, 2011, NAT CELL BIOL, V13, P273, DOI 10.1038/ncb2200; Macedo-Ribeiro S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005834; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Mazzucchelli S, 2009, INT J BIOCHEM CELL B, V41, P2485, DOI 10.1016/j.biocel.2009.08.003; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012430; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Paulson HL, 2007, SEMIN NEUROL, V27, P133, DOI 10.1055/s-2007-971172; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Pozzi C, 2008, NEUROBIOL DIS, V30, P190, DOI 10.1016/j.nbd.2008.01.011; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Rodrigues AJ, 2009, BIOCHEM BIOPH RES CO, V386, P575, DOI 10.1016/j.bbrc.2009.06.092; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Scharf A, 2007, HISTOCHEM CELL BIOL, V127, P591, DOI 10.1007/s00418-006-0266-2; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; Takeshita Y, 2011, NEUROREPORT, V22, P232, DOI 10.1097/WNR.0b013e32834505f4; Tao Rui-Song, 2008, Neurosci Bull, V24, P271, DOI 10.1007/s12264-008-0605-5; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Trottier Y, 1998, NEUROBIOL DIS, V5, P335, DOI 10.1006/nbdi.1998.0208; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	64	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43563	10.1371/journal.pone.0043563	http://dx.doi.org/10.1371/journal.pone.0043563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970133	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400015
J	Reis, LA; Borges, FT; Simoes, MJ; Borges, AA; Sinigaglia-Coimbra, R; Schor, N				Reis, Luciana A.; Borges, Fernanda T.; Simoes, Manuel J.; Borges, Andrea A.; Sinigaglia-Coimbra, Rita; Schor, Nestor			Bone Marrow-Derived Mesenchymal Stem Cells Repaired but Did Not Prevent Gentamicin-Induced Acute Kidney Injury through Paracrine Effects in Rats	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; POSTISCHEMIC KIDNEY; STROMAL CELLS; NEPHROTOXICITY; DIFFERENTIATION; CONTRIBUTE; PROTECT; MICE	This study evaluated the effects of bone marrow-derived mesenchymal stem cells (BMSCs) or their conditioned medium (CM) on the repair and prevention of Acute Kidney Injury (AKI) induced by gentamicin (G). Animals received daily injections of G up to 20 days. On the 10th day, injections of BMSCs, CM, CM+trypsin, CM+RNase or exosome-like microvesicles extracted from the CM were administered. In the prevention groups, the animals received the BMSCs 24 h before or on the 5th day of G treatment. Creatinine (Cr), urea (U), FENa and cytokines were quantified. The kidneys were evaluated using hematoxylin/eosin staining and immunohystochemistry. The levels of Cr, U and FENa increased during all the periods of G treatment. The BMSC transplantation, its CM or exosome injections inhibited the increase in Cr, U, FENa, necrosis, apoptosis and also increased cell proliferation. The pro-inflammatory cytokines decreased while the anti-inflammatory cytokines increased compared to G. When the CM or its exosomes were incubated with RNase (but not trypsin), these effects were blunted. The Y chromosome was not observed in the 24-h prevention group, but it persisted in the kidney for all of the periods analyzed, suggesting that the injury is necessary for the docking and maintenance of BMSCs in the kidney. In conclusion, the BMSCs and CM minimized the G-induced renal damage through paracrine effects, most likely through the RNA carried by the exosome-like microvesicles. The use of the CM from BMSCs can be a potential therapeutic tool for this type of nephrotoxicity, allowing for the avoidance of cell transplantations.	[Reis, Luciana A.; Borges, Fernanda T.; Schor, Nestor] UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Simoes, Manuel J.] UNIFESP EPM, Dept Morphol, Histol & Biol Struct Div, Sao Paulo, Brazil; [Borges, Andrea A.; Sinigaglia-Coimbra, Rita] UNIFESP EPM, Elect Microscopy Ctr, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Reis, LA (corresponding author), UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil.	nestor@nefro.epm.br	Sinigaglia, Rita de Cássia/C-9155-2012; Simoes, Manuel J/H-2642-2014; Schor, Nestor/K-4364-2013; Borges, Fernanda Teixeira/Y-3439-2018; Borges, Andrea A/F-2416-2012; Batista, Marcelo/K-4305-2013	Sinigaglia, Rita de Cássia/0000-0001-8747-6316; Simoes, Manuel J/0000-0003-2770-8618; Borges, Fernanda Teixeira/0000-0002-9790-0915; Borges, Andrea/0000-0002-0606-8511	Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Fundacao Oswaldo Ramos (FOR); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao Oswaldo Ramos (FOR); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), Fundacao Oswaldo Ramos (FOR), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BH, 1995, GEN PHARMACOL, V26, P1477, DOI 10.1016/0306-3623(95)00049-6; BAYLIS C, 1977, KIDNEY INT, V12, P344, DOI 10.1038/ki.1977.121; BENNETT WM, 1986, CLIN NEPHROL, V25, pS126; Bergmeyer H. U., 1985, METHOD ENZYMAT AN, V9, P449; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cao HL, 2010, BIOTECHNOL LETT, V32, P725, DOI 10.1007/s10529-010-0207-y; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Deregibus MC, 2010, HISTOL HISTOPATHOL, V25, P397, DOI 10.14670/HH-25.397; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Herrera MB, 2004, INT J MOL MED, V14, P1035; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; O'Driscoll Lorraine, 2005, Cancer Genomics & Proteomics, V2, P43; Ohshima K, 1997, PLOS ONE, V5; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rentsch J, 1996, FEBS LETT, V379, P55, DOI 10.1016/0014-5793(95)01485-3; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; SCHOR N, 1981, KIDNEY INT, V19, P288, DOI 10.1038/ki.1981.19; SOLEZ K, 1974, KIDNEY INT, V6, P24, DOI 10.1038/ki.1974.74; 최용, 2010, Childhood Kidney diseases, V14, P32; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Villanueva S, 2011, CLIN SCI, V121, P489, DOI 10.1042/CS20110108; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242	33	199	212	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44092	10.1371/journal.pone.0044092	http://dx.doi.org/10.1371/journal.pone.0044092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970165	gold, Green Submitted, Green Published			2022-12-25	WOS:000308458400034
J	Neirynck, N; Eloot, S; Glorieux, G; Barreto, DV; Barreto, FC; Liabeuf, S; Lenglet, A; Lemke, HD; Massy, ZA; Vanholder, R				Neirynck, Nathalie; Eloot, Sunny; Glorieux, Griet; Barreto, Daniela V.; Barreto, Fellype C.; Liabeuf, Sophie; Lenglet, Aurelie; Lemke, Horst D.; Massy, Ziad A.; Vanholder, Raymond			Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease	PLOS ONE			English	Article							GROWTH-FACTOR 23; CYSTATIN-C; CARDIOVASCULAR MORTALITY; CREATININE CLEARANCE; SERUM CREATININE; POOLED ANALYSIS; RENAL-DISEASE; ALL-CAUSE; HEMODIALYSIS; INTERLEUKIN-6	Background: Uremic solute concentration increases as Glomerular Filtration Rate (GFR) declines. Weak associations were demonstrated between estimated GFR (eGFR) and the concentrations of several small water-soluble and protein-bound uremic solutes (MW<500Da). Since also middle molecular weight proteins have been associated with mortality and cardiovascular damage in Chronic Kidney Disease (CKD), we investigated the association between several eGFR formulae and the concentration of Low Molecular Weight Proteins (LMWP) (MW>500Da). Materials and Methods: In 95 CKD-patients (CKD-stage 2-5 not on dialysis), associations between different eGFR-formulae (creatinine, CystatinC-based or both) and the natural logarithm of the concentration of several LMWP's were analyzed: i.e. parathyroid hormone (PTH), Cystatin C (CystC), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), leptin, retinol binding protein (RbP), immunoglobin light chains kappa and lambda (Ig-kappa and Ig-lambda), beta-2-microglobulin (beta M-2), myoglobin and fibroblast growth factor-23 (FGF-23)). Results: The regression coefficients (R-2) between eGFR, based on the CKD-EPI-Crea-CystC-formula as reference, and the examined LMWP's could be divided into three groups. Most of the LMWP's associated weakly (R-2 <0.2) (FGF-23, leptin, IL-6, TNF-alpha, Ig-kappa, Ig-lambda) or intermediately (R-2 0.2-0.7) (RbP, myoglobin, PTH). Only beta M-2 and CystC showed a strong association (R-2 >0.7). Almost identical R-2-values were found per LMWP for all eGFR-formulae, with exception of CystC and beta M-2 which showed weaker associations with creatinine-based than with CystC-based eGFR. Conclusion: The association between eGFR and the concentration of several LMWP's is inconsistent, with in general low R-2-values. Thus, the use of eGFR to evaluate kidney function does not reflect the concentration of several LMWP's with proven toxic impact in CKD.	[Neirynck, Nathalie; Eloot, Sunny; Glorieux, Griet; Vanholder, Raymond] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Barreto, Daniela V.; Barreto, Fellype C.; Liabeuf, Sophie; Lenglet, Aurelie; Massy, Ziad A.] INSERM, U1088, Amiens, France; [Barreto, Daniela V.; Barreto, Fellype C.; Liabeuf, Sophie; Massy, Ziad A.] Amiens Univ Hosp, Div Clin Pharmacol, Clin Res Ctr, Amiens, France; [Barreto, Daniela V.; Barreto, Fellype C.; Liabeuf, Sophie; Massy, Ziad A.] Jules Verne Univ Picardy, Amiens, France; [Lenglet, Aurelie; Massy, Ziad A.] Amiens Univ Hosp, Div Nephrol, Amiens, France; [Lemke, Horst D.] EXcorLab GmbH, Obernburg, Germany	Ghent University; Ghent University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Neirynck, N (corresponding author), Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium.	n.neirynck@ugent.be	, liabeuf/AFB-7848-2022; Barreto, Fellype C/C-6517-2012	Barreto, Fellype C/0000-0002-6394-9227	Amiens University hospital [PHRC: 2006/0100]; European Uremic Toxin Workgroup (EUTox); Belgian Fund for research Flanders (FWO Vlaanderen); Picardy Regional Council/Jules Verne University of Picardy; National Council of Technological and Scientific Development (CNPq), Brazil	Amiens University hospital; European Uremic Toxin Workgroup (EUTox); Belgian Fund for research Flanders (FWO Vlaanderen); Picardy Regional Council/Jules Verne University of Picardy(Region Hauts-de-France); National Council of Technological and Scientific Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by a Grant of the Amiens University hospital [PHRC: 2006/0100 (27/03/2006)] and a Grant from European Uremic Toxin Workgroup (EUTox). SE received post-doctoral grant of the Belgian Fund for research Flanders (FWO Vlaanderen). DVB and FCB received postdoctoral grants from the Picardy Regional Council/Jules Verne University of Picardy and postdoctoral scolarships from the National Council of Technological and Scientific Development (CNPq), Brazil. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astor BC, 2012, AM J KIDNEY DIS, V59, P653, DOI 10.1053/j.ajkd.2011.11.042; Bacchetta J, 2010, J CLIN ENDOCR METAB, V95, P1741, DOI 10.1210/jc.2009-1576; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Christensen EI, 2001, AM J PHYSIOL-RENAL, V280, pF562, DOI 10.1152/ajprenal.2001.280.4.F562; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Donadio C, 2001, J PHARMACEUT BIOMED, V24, P835, DOI 10.1016/S0731-7085(00)00550-1; Drueke TB, 2009, SEMIN DIALYSIS, V22, P378, DOI 10.1111/j.1525-139X.2009.00584.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eloot S, 2011, CLIN J AM SOC NEPHRO, V6, P1266, DOI 10.2215/CJN.09981110; Futh R, 2004, CYTOKINE, V27, P166, DOI 10.1016/j.cyto.2004.05.006; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; HALLGREN R, 1978, J LAB CLIN MED, V91, P246; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Ix JH, 2010, NEPHROL DIAL TRANSPL, V25, P993, DOI 10.1093/ndt/gfp699; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Keller C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-9; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; Kuan Y, 2005, NEPHROL DIAL TRANSPL, V20, P2394, DOI 10.1093/ndt/gfi076; Le Bricon T, 2000, CLIN CHEM, V46, P1206; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lilitkarntakul P, 2011, ATHEROSCLEROSIS, V216, P217, DOI 10.1016/j.atherosclerosis.2011.01.045; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Menon V, 2004, CLIN NEPHROL, V61, P163; Okuno S, 2009, NEPHROL DIAL TRANSPL, V24, P571, DOI 10.1093/ndt/gfn521; Panichi V, 2004, NEPHROL DIAL TRANSPL, V19, P1154, DOI 10.1093/ndt/gfh052; Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Schepers E, 2011, CLIN J AM SOC NEPHRO, V6, P2374, DOI 10.2215/CJN.01720211; Sciarretta S, 2010, J HYPERTENS, V28, P251, DOI 10.1097/HJH.0b013e3283326718; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Vanholder R, 2012, SEMIN DIALYSIS, V25, P9, DOI 10.1111/j.1525-139X.2011.01003.x; Weiner DE, 2007, J AM COLL CARDIOL, V50, P217, DOI 10.1016/j.jacc.2007.03.037; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	54	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44201	10.1371/journal.pone.0044201	http://dx.doi.org/10.1371/journal.pone.0044201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952928	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300063
J	Talishinsky, A; Rosen, GD				Talishinsky, Alexander; Rosen, Glenn D.			Systems Genetics of the Lateral Septal Nucleus in Mouse: Heritability, Genetic Control, and Covariation with Behavioral and Morphological Traits	PLOS ONE			English	Article							RECOMBINANT INBRED STRAINS; CORTICOTROPIN-RELEASING-FACTOR; SEIZURE SUSCEPTIBILITY; NATURAL VARIATION; INTELLECTUAL DISABILITY; MEMORY IMPAIRMENTS; NERVOUS-SYSTEM; LEIGH-SYNDROME; CHANNEL GENE; BRAIN VOLUME	The lateral septum has strong efferent projections to hypothalamic and midbrain regions, and has been associated with modulation of social behavior, anxiety, fear conditioning, memory-related behaviors, and the mesolimbic reward pathways. Understanding natural variation of lateral septal anatomy and function, as well as its genetic modulation, may provide important insights into individual differences in these evolutionarily important functions. Here we address these issues by using efficient and unbiased stereological probes to estimate the volume of the lateral septum in the BXD line of recombinant inbred mice. Lateral septum volume is a highly variable trait, with a 2.5-fold difference among animals. We find that this trait covaries with a number of behavioral and physiological phenotypes, many of which have already been associated with behaviors modulated by the lateral septum, such as spatial learning, anxiety, and reward-seeking. Heritability of lateral septal volume is moderate (h(2) = 0.52), and much of the heritable variation is caused by a locus on the distal portion of chromosome (Chr) 1. Composite interval analysis identified a secondary interval on Chr 2 that works additively with the Chr 1 locus to increase lateral septum volume. Using bioinformatic resources, we identified plausible candidate genes in both intervals that may influence the volume of this key nucleus, as well as associated behaviors.	[Talishinsky, Alexander; Rosen, Glenn D.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Talishinsky, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	grosen@bidmc.harvard.edu		Talishinsky, Aleksandr/0000-0002-7225-2130; Rosen, Glenn/0000-0001-8281-5446	National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01 NS052397]; National Institutes of Health, National Institute on Drug Abuse; National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health, National Institute of Mental Health [P20 DA021131]; National Institute on Alcohol Abuse and Alcoholism [U01AA014425, U01AA13499, R01 AA018776]; Mouse Models of Human Cancers Consortium from the National Cancer Institue [U01CA105417]; National Center for Research Resources [U24 RR021760]; NATIONAL CANCER INSTITUTE [U01CA105417] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018776, U01AA013499, U01AA014425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Mouse Models of Human Cancers Consortium from the National Cancer Institue; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, by institutes of the National Institutes of Health, including the National Institute of Neurological Disorders and Stroke (grant number R01 NS052397) and by National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, and the National Institute of Mental Health (grant number P20 DA021131). GeneNetwork is supported by the National Institute on Alcohol Abuse and Alcoholism (grants U01AA014425 and U01AA13499), the Mouse Models of Human Cancers Consortium from the National Cancer Institue (grant number U01CA105417), and by the the National Center for Research Resources (grant number U24 RR021760). Gene Weaver is supported by the National Institute on Alcohol Abuse and Alcoholism (R01 AA018776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airey DC, 2001, J NEUROSCI, V21, P5099, DOI 10.1523/JNEUROSCI.21-14-05099.2001; ALBERT DJ, 1984, PHYSIOL BEHAV, V33, P517, DOI 10.1016/0031-9384(84)90364-0; Alberts R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-516; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Baker EJ, 2012, NUCLEIC ACIDS RES, V40, pD1067, DOI 10.1093/nar/gkr968; Bao JX, 1996, ONCOGENE, V12, P2171; Beatty J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-16; Boughter JD, 2007, GENES BRAIN BEHAV, V6, P619, DOI 10.1111/j.1601-183X.2006.00293.x; Boughter JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038169; BRADY JV, 1955, J COMP PHYSIOL PSYCH, V48, P412, DOI 10.1037/h0046406; Bulfone A, 2004, GENE EXPR PATTERNS, V4, P297, DOI 10.1016/j.modgep.2003.11.001; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Chen G, 2009, ALCOHOL, V43, P411, DOI 10.1016/j.alcohol.2009.05.003; Cheng YC, 2011, G3-GENES GENOM GENET, V1, P505, DOI 10.1534/g3.111.001164; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; CHROBAK JJ, 1991, BEHAV NEURAL BIOL, V55, P247, DOI 10.1016/0163-1047(91)80142-2; CHROBAK JJ, 1989, BEHAV NEURAL BIOL, V52, P357, DOI 10.1016/S0163-1047(89)90472-X; Chung BHY, 2012, EUR J HUM GENET, V20, P398, DOI 10.1038/ejhg.2011.199; Chung BHY, 2011, AM J MED GENET A, V155A, P424, DOI 10.1002/ajmg.a.33821; Dains K, 1996, J PHARMACOL EXP THER, V279, P1430; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; Degroot A, 2001, PHARMACOL BIOCHEM BE, V69, P391, DOI 10.1016/S0091-3057(01)00541-X; Di Curzio DL, 2011, MAMM GENOME, V22, P209, DOI 10.1007/s00335-011-9315-9; Dong H, 2007, HEREDITY, V99, P62, DOI 10.1038/sj.hdy.6800965; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; Englot DJ, 2009, PROG BRAIN RES, V177, P147, DOI 10.1016/S0079-6123(09)17711-7; Escayg A, 1998, GENOMICS, V50, P14, DOI 10.1006/geno.1998.5311; Ferraro TN, 2007, EPILEPSIA, V48, P1667, DOI 10.1111/j.1528-1167.2007.01126.x; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Garcia-Hernandez A, 2010, EXP NEUROL, V222, P86, DOI 10.1016/j.expneurol.2009.12.010; Gardberg M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-55; Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hamel MG, 2008, EXP NEUROL, V210, P428, DOI 10.1016/j.expneurol.2007.11.014; ISHIZAWA H, 1990, BRAIN RES, V507, P189, DOI 10.1016/0006-8993(90)90271-C; Jan TA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-3; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Kozell LB, 2009, J NEUROSCI, V29, P11662, DOI 10.1523/JNEUROSCI.1413-09.2009; Le Merrer J, 2006, PHARMACOL BIOCHEM BE, V83, P465, DOI 10.1016/j.pbb.2006.03.008; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Leranth C, 1999, NEUROSCIENCE, V88, P701, DOI 10.1016/S0306-4522(98)00245-0; Li YH, 2002, NEUROSCI LETT, V323, P60, DOI 10.1016/S0304-3940(01)02531-9; Lionikas A, 2003, PHYSIOL GENOMICS, V16, P141, DOI 10.1152/physiolgenomics.00103.2003; Lu L, 2001, J NEUROSCI, V21, P3503, DOI 10.1523/JNEUROSCI.21-10-03503.2001; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Martin MV, 2006, GENES BRAIN BEHAV, V5, P614, DOI 10.1111/j.1601-183X.2006.00215.x; Matsuyama N, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00026; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; Mohamed S, 2010, AM J MED GENET A, V152A, P2318, DOI 10.1002/ajmg.a.33560; MOORE RY, 1964, J COMP PHYSIOL PSYCH, V57, P65, DOI 10.1037/h0042989; MORTENSEN RF, 1985, IMMUNOGENETICS, V22, P367, DOI 10.1007/BF00430920; Mozhui K, 2007, BEHAV GENET, V37, P223, DOI 10.1007/s10519-006-9122-3; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Murdoch JN, 2003, MOL CELL NEUROSCI, V22, P62, DOI 10.1016/S1044-7431(02)00021-0; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; Ngu LH, 2012, BBA-MOL BASIS DIS, V1822, P168, DOI 10.1016/j.bbadis.2011.10.012; Ophir AG, 2009, BEHAV NEUROSCI, V123, P979, DOI 10.1037/a0016663; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Peirce JL, 2003, GENES BRAIN BEHAV, V2, P238, DOI 10.1034/j.1601-183X.2003.00030.x; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; PHILLIPS TJ, 1994, BEHAV NEUROSCI, V108, P789, DOI 10.1037/0735-7044.108.4.789; Price ML, 2001, J NEUROSCI, V21, P2833, DOI 10.1523/JNEUROSCI.21-08-02833.2001; Reis DG, 2010, LEARN MEMORY, V17, P134, DOI 10.1101/lm.1534710; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; Rosen GD, 2009, GENES BRAIN BEHAV, V8, P296, DOI 10.1111/j.1601-183X.2009.00473.x; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Rosen GD, 2003, CURRENT PROTOCOLS NE; Rosen Glenn D, 2007, Methods Mol Biol, V401, P287, DOI 10.1007/978-1-59745-520-6_16; Rosen GD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-5; Ryabinin AE, 2008, NEUROSCIENCE, V151, P780, DOI 10.1016/j.neuroscience.2007.11.014; Sanabria ERG, 2006, NEUROSCIENCE, V142, P871, DOI 10.1016/j.neuroscience.2006.06.057; Seecharan DJ, 2003, J NEUROSCI, V23, P11178; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; Smith SB, 2008, PHARMACOGENET GENOM, V18, P231, DOI 10.1097/FPC.0b013e3282f55ab2; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; Thifault S, 2008, HUM MOL GENET, V17, P331, DOI 10.1093/hmg/ddm277; Thomas E, 2003, BRAIN RES, V960, P201, DOI 10.1016/S0006-8993(02)03882-9; Torrecilla M, 2008, EUR J NEUROSCI, V28, P618, DOI 10.1111/j.1460-9568.2008.06348.x; Trent NL, 2011, PHARMACOL BIOCHEM BE, V99, P580, DOI 10.1016/j.pbb.2011.06.009; Trent NL, 2010, PHYSIOL BEHAV, V101, P141, DOI 10.1016/j.physbeh.2010.04.035; Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232; Waselus M, 2006, J CHEM NEUROANAT, V31, P233, DOI 10.1016/j.jchemneu.2006.01.007; Williams RW, 2001, BEHAV GENET, V31, P61, DOI 10.1023/A:1010209925783; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Zou SB, 2009, ALCOHOL CLIN EXP RES, V33, P394, DOI 10.1111/j.1530-0277.2008.00848.x	98	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44236	10.1371/journal.pone.0044236	http://dx.doi.org/10.1371/journal.pone.0044236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952935	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300067
J	Wright, MJ; Angrish, D; Aarde, SM; Barlow, DJ; Buczynski, MW; Creehan, KM; Vandewater, SA; Parsons, LH; Houseknecht, KL; Dickerson, TJ; Taffe, MA				Wright, M. Jerry, Jr.; Angrish, Deepshikha; Aarde, Shawn M.; Barlow, Deborah J.; Buczynski, Matthew W.; Creehan, Kevin M.; Vandewater, Sophia A.; Parsons, Loren H.; Houseknecht, Karen L.; Dickerson, Tobin J.; Taffe, Michael A.			Effect of Ambient Temperature on the Thermoregulatory and Locomotor Stimulant Effects of 4-Methylmethcathinone in Wistar and Sprague-Dawley Rats	PLOS ONE			English	Article							CORE BODY-TEMPERATURE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; NUCLEUS-ACCUMBENS; AMPHETAMINE; MEPHEDRONE; CATHINONE; ECSTASY; METHAMPHETAMINE; SEROTONIN; DOPAMINE	The drug 4-methylmethcathinone (4-MMC; aka, mephedrone, MMCAT, "plant food'', "bath salts'') is a recent addition to the list of popular recreational psychomotor-stimulant compounds. Relatively little information about this drug is available in the scientific literature, but popular media reports have driven recent drug control actions in the UK and several US States. Online user reports of subjective similarity to 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy'') prompted the current investigation of the thermoregulatory and locomotor effects of 4-MMC. Male Wistar and Sprague-Dawley rats were monitored after subcutaneous administration of 4-MMC (1-10 mg/kg) using an implantable radiotelemetry system under conditions of low (23 degrees C) and high (27 degrees C) ambient temperature. A reliable reduction of body temperature was produced by 4-MMC in Wistar rats at 23 degrees C or 27 degrees C with only minimal effect in Sprague-Dawley rats. Increased locomotor activity was observed after 4-MMC administration in both strains with significantly more activity produced in the Sprague-Dawley strain. The 10 mg/kg s.c. dose evoked greater increase in extracellular serotonin, compared with dopamine, in the nucleus accumbens. Follow-up studies confirmed that the degree of locomotor stimulation produced by 10 mg/kg 4-MMC was nearly identical to that produced by 1 mg/kg d-methamphetamine in each strain. Furthermore, hypothermia produced by the serotonin 1(A/7) receptor agonist 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-OH-DPAT) was similar in each strain. These results show that the cathinone analog 4-MMC exhibits thermoregulatory and locomotor properties that are distinct from those established for methamphetamine or MDMA in prior work, despite recent evidence of neuropharmacological similarity with MDMA.	[Wright, M. Jerry, Jr.; Aarde, Shawn M.; Buczynski, Matthew W.; Creehan, Kevin M.; Vandewater, Sophia A.; Parsons, Loren H.; Taffe, Michael A.] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA; [Angrish, Deepshikha; Dickerson, Tobin J.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Barlow, Deborah J.; Houseknecht, Karen L.] Univ New England, Dept Pharmaceut Sci, Portland, ME USA	Scripps Research Institute; Scripps Research Institute; University of New England - Maine	Wright, MJ (corresponding author), Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA.	mtaffe@scripps.edu	Taffe, Michael A/A-3153-2008; Taffe, Michael/AAJ-8159-2021	Taffe, Michael A/0000-0001-9827-1738; Wright Jr, Mayo Jerry/0000-0003-4073-0991	United States Public Health Service [DA018418, DA024705, DA024105]; National Institutes of Health; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018418, R01DA024105, F32DA029994, R01DA024705] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by United States Public Health Service grants DA018418, DA024705 and DA024105. The funding agencies (National Institutes of Health/National Institute on Drug Abuse) had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banjaw MY, 2005, BEHAV BRAIN RES, V160, P365, DOI 10.1016/j.bbr.2005.01.002; Bankson MG, 2002, NEUROPSYCHOPHARMACOL, V26, P40, DOI 10.1016/S0893-133X(01)00345-1; BATTAGLIA G, 1988, EUR J PHARMACOL, V149, P159, DOI 10.1016/0014-2999(88)90056-8; Baumann MH, 2008, PHARMACOL BIOCHEM BE, V90, P208, DOI 10.1016/j.pbb.2008.02.018; Baumann MH, 2012, NEUROPSYCHOPHARMACOL, V37, P1192, DOI 10.1038/npp.2011.304; Bexis S, 2006, BR J PHARM; Blessing WW, 2003, J NEUROSCI, V23, P6385; Caille S, 2007, J NEUROSCI, V27, P3695, DOI 10.1523/JNEUROSCI.4403-06.2007; Camilleri A, 2010, FORENSIC SCI INT, V197, P59, DOI 10.1016/j.forsciint.2009.12.048; Clark J.D., 1996, GUIDE CARE USE LAB A; Cuoco J, 2010, KXXV NEWS CHANNEL; DAFTERS RI, 1994, PSYCHOPHARMACOLOGY, V114, P505, DOI 10.1007/BF02249342; DalCason TA, 1997, PHARMACOL BIOCHEM BE, V58, P1109, DOI 10.1016/S0091-3057(97)00323-7; DEA, 2009, MICROGRAM B, V4, P61; DEA, 2011, MICROGRAM B, V44, P31; Docherty JR, 2010, BRIT J PHARMACOL, V160, P1029, DOI 10.1111/j.1476-5381.2010.00722.x; Freedman RR, 2005, PSYCHOPHARMACOLOGY, V183, P248, DOI 10.1007/s00213-005-0149-6; Geezaman DF, 2009, SURPRISINGLY E EXPER; Gilpin NW, 2011, PHARMACOL BIOCHEM BE, V99, P295, DOI 10.1016/j.pbb.2011.05.006; GLENNON RA, 1987, PHARMACOL BIOCHEM BE, V26, P547, DOI 10.1016/0091-3057(87)90164-X; GOLD LH, 1988, J PHARMACOL EXP THER, V247, P547; GORDON TL, 1993, PHARMACOL BIOCHEM BE, V44, P657, DOI 10.1016/0091-3057(93)90182-S; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Hadlock GC, 2011, J PHARMACOL EXP THER, V339, P530, DOI 10.1124/jpet.111.184119; Hall DA, 2008, PSYCHOPHARMACOLOGY, V195, P469, DOI 10.1007/s00213-007-0923-8; Huang PK, 2012, DRUG ALCOHOL DEPEND; HUGHES RN, 1976, NEUROPHARMACOLOGY, V15, P673, DOI 10.1016/0028-3908(76)90035-6; ITOH K, 1984, LIFE SCI, V34, P827, DOI 10.1016/0024-3205(84)90199-1; Iversen L, 2010, CONSIDERATION CATHIN; JOHANSON CE, 1981, J PHARMACOL EXP THER, V219, P355; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; Lopez-Arnau R, 2012, BR J PHARM; Malberg JE, 1998, J NEUROSCI, V18, P5086; Martinez-Clemente J, 2012, EUR NEUROPSYCHOPHARM, V22, P231, DOI 10.1016/j.euroneuro.2011.07.009; McDermott C, 2008, PROG NEURO-PSYCHOPH, V32, P1816, DOI 10.1016/j.pnpbp.2008.08.004; Meph_Test, 2009, GOOD ALTERNATIVE NDM; Michael J, 2010, BISMARCK TRIBUNE; Miller ML, 2012, DRUG ALCOHOL DEPEND; Motbey CP, 2012, ADDICT BIOL, V17, P409, DOI 10.1111/j.1369-1600.2011.00384.x; MUELLER K, 1989, PSYCHOPHARMACOLOGY, V99, P501, DOI 10.1007/BF00589899; Myles BJ, 2008, PSYCHOPHARMACOLOGY, V198, P301, DOI 10.1007/s00213-007-1061-z; NENCINI P, 1984, J ETHNOPHARMACOL, V11, P79, DOI 10.1016/0378-8741(84)90097-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedersen NP, 2001, J NEUROSCI, V21, P8648, DOI 10.1523/JNEUROSCI.21-21-08648.2001; Psychonaut Webmapping Research Group, 2010, MEPH REP; Rockhold RW, 1997, ANN EMERG MED, V29, P383, DOI 10.1016/S0196-0644(97)70351-2; Rusyniak DE, 2007, J PHARMACOL EXP THER, V323, P477, DOI 10.1124/jpet.107.126169; Sedefov R, 2010, EUROPOL EMCDDA JOINT; TARIQ M, 1989, LIFE SCI, V44, P951, DOI 10.1016/0024-3205(89)90494-3; Von Huben SN, 2007, NEUROPSYCHOPHARMACOL, V32, P673, DOI 10.1038/sj.npp.1301078; Walker QD, 2007, PSYCHOPHARMACOLOGY, V189, P435, DOI 10.1007/s00213-006-0531-z; Winstock AR, 2011, ADDICTION, V106, P154, DOI 10.1111/j.1360-0443.2010.03130.x; Winstock AR, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1605; Wright Jr MJ, 2012, BR J PHARM, DOI 10.1111/j.1476-5381.2012.02091.x; ZELGER JL, 1980, B NARCOTICS, V32, P67	56	70	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44652	10.1371/journal.pone.0044652	http://dx.doi.org/10.1371/journal.pone.0044652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952999	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300103
J	Xu, L; Xu, CF; Yu, CH; Miao, M; Zhang, XQ; Zhu, ZW; Ding, XY; Li, YM				Xu, Lei; Xu, Chengfu; Yu, Chaohui; Miao, Min; Zhang, Xuequn; Zhu, Zhongwei; Ding, Xiaoyun; Li, Youming			Association between Serum Growth Hormone Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study	PLOS ONE			English	Article							HEPATIC STEATOSIS; VISCERAL ADIPOSITY; METABOLIC SYNDROME; RISK-FACTORS; PREVALENCE; DEFICIENCY; STEATOHEPATITIS; OVERWEIGHT; MARKERS	Growth hormone (GH) is an important regulator of metabolism and body composition. GH deficiency is associated with increased visceral body fat and other features of the metabolic syndrome. Here we performed a cross-sectional study to explore the association of GH levels with nonalcoholic fatty liver disease (NAFLD), which is considered to be the hepatic manifestation of the metabolic syndrome. A total of 1,667 subjects were diagnosed as NAFLD according the diagnostic criteria, and 5,479 subjects were defined as the controls. The subjects with NAFLD had significantly lower levels of serum GH than the controls. Those with low GH levels had a higher prevalence of NAFLD and the metabolic syndrome. A stepwise logistic regression analysis showed that GH levels were significantly associated with the risk factor for NAFLD (OR = 0.651, 95% CI = 0.574-0.738, P < 0.001). Our results showed a significant association between lower serum GH levels and NAFLD.	[Xu, Lei; Ding, Xiaoyun] Ningbo No 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China; [Xu, Lei; Xu, Chengfu; Yu, Chaohui; Zhang, Xuequn; Li, Youming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Miao, Min; Zhu, Zhongwei] Zhenhai Lianhua Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China	Zhejiang University	Xu, L (corresponding author), Ningbo No 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China.	xulei22@163.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, Han/0000-0001-9985-3035; Ding, Xiaoyun/0000-0002-3731-3508	National Key Basic Research Development Program [2012CB524905]; National Science and Technology Support Plan Project [2012BAI06B04]; National Natural Science Foundation of China [31070315, 81100278, 81170378]; Zhejiang Provincial Natural Science Foundation of China [Y2090463]; Science Foundation of Health Bureau of Zhejiang Province [2012RCA026]; Medical Science & Technology Foundation in Ningbo City [2010B03]	National Key Basic Research Development Program(National Basic Research Program of China); National Science and Technology Support Plan Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science Foundation of Health Bureau of Zhejiang Province; Medical Science & Technology Foundation in Ningbo City	This study was supported by National Key Basic Research Development Program (No. 2012CB524905), National Science and Technology Support Plan Project (No. 2012BAI06B04), National Natural Science Foundation of China (No. 31070315, No. 81100278, and No. 81170378), Zhejiang Provincial Natural Science Foundation of China (No. Y2090463), Science Foundation of Health Bureau of Zhejiang Province (No. 2012RCA026), and Medical Science & Technology Foundation in Ningbo City (No. 2010B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2004, HEPATOLOGY, V39, P909, DOI 10.1002/hep.20140; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Attanasio AF, 2010, J CLIN ENDOCR METAB, V95, P74, DOI 10.1210/jc.2009-1326; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Cerda C, 2007, J HEPATOL, V47, P412, DOI 10.1016/j.jhep.2007.04.012; Di Somma C, 2010, J ENDOCRINOL INVEST, V33, P171, DOI [10.1007/BF03346577, 10.3275/6519]; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Follin C, 2006, J CLIN ENDOCR METAB, V91, P1872, DOI 10.1210/jc.2005-2298; Fusco A, 2012, CLIN ENDOCRINOL, V77, P531, DOI 10.1111/j.1365-2265.2011.04291.x; Gambino R, 2011, ANTIOXID REDOX SIGN, V15, P1325, DOI 10.1089/ars.2009.3058; Gardner CJ, 2012, EUR J ENDOCRINOL, V166, P993, DOI 10.1530/EJE-12-0002; Hong JW, 2011, HORM METAB RES, V43, P48, DOI 10.1055/s-0030-1265217; Ichikawa T, 2003, GUT, V52, P914, DOI 10.1136/gut.52.6.914; Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4; Johannsson G., 1999, Journal of Endocrinological Investigation, V22, P41; Lanes R, 2004, J PEDIATR-US, V145, P657, DOI 10.1016/j.jpeds.2004.07.037; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; MELMED S, 1984, J CLIN INVEST, V73, P1425, DOI 10.1172/JCI111347; Misra M, 2008, AM J PHYSIOL-ENDOC M, V295, pE385, DOI 10.1152/ajpendo.00052.2008; Pasarica M, 2007, J CLIN ENDOCR METAB, V92, P4265, DOI 10.1210/jc.2007-0786; Qin Y, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-78; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Tarantino G, 2010, WORLD J GASTROENTERO, V16, P4773, DOI 10.3748/wjg.v16.i38.4773; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P501, DOI 10.1093/gerona/glr004; Utz AL, 2008, J CLIN ENDOCR METAB, V93, P2507, DOI 10.1210/jc.2008-0169	28	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44136	10.1371/journal.pone.0044136	http://dx.doi.org/10.1371/journal.pone.0044136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952901	gold, Green Submitted, Green Published			2022-12-25	WOS:000308221300054
J	Kuo, CY; Yuen, YS; Meng, PJ; Ho, PH; Wang, JT; Liu, PJ; Chang, YC; Dai, CF; Fan, TY; Lin, HJ; Baird, AH; Chen, CA				Kuo, Chao-Yang; Yuen, Yeong Shyan; Meng, Pei-Jie; Ho, Ping-Ho; Wang, Jih-Terng; Liu, Pi-Jen; Chang, Yang-Chi; Dai, Chang-Feng; Fan, Tung-Yung; Lin, Hsing-Juh; Baird, Andrew Hamilton; Chen, Chaolun Allen			Recurrent Disturbances and the Degradation of Hard Coral Communities in Taiwan	PLOS ONE			English	Article							KENTING NATIONAL-PARK; SOUTHERN TAIWAN; PHASE-SHIFTS; MASS MORTALITY; REEF; RESILIENCE; RECOVERY; IMPACTS; SEA; ASSEMBLAGES	Recurrent disturbances can have a critical effect on the structure and function of coral reef communities. In this study, long-term changes were examined in the hard coral community at Wanlitung, in southern Taiwan, between 1985 and 2010. In this 26 year interval, the reef has experienced repeated disturbances that include six typhoons and two coral-bleaching events. The frequency of disturbance has meant that species susceptible to disturbance, such as those in the genus Acropora and Montipora have almost disappeared from the reef. Indeed, almost all hard coral species have declined in abundance, with the result that total hard coral cover in 2010 (17.7%) was less than half what it was in 1985 (47.5%). In addition, macro-algal cover has increased from 11.3% in 2003 to 28.5% in 2010. The frequency of disturbance combined with possible chronic influence of a growing human population mean that a diverse reef assemblage is unlikely to persist on this reef into the future.	[Kuo, Chao-Yang; Yuen, Yeong Shyan; Chen, Chaolun Allen] Acad Sinica, TIGP, Biodivers Res Ctr, Taipei 115, Taiwan; [Kuo, Chao-Yang; Baird, Andrew Hamilton] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Yuen, Yeong Shyan] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Meng, Pei-Jie; Liu, Pi-Jen; Fan, Tung-Yung] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Meng, Pei-Jie; Liu, Pi-Jen; Fan, Tung-Yung] Natl Dong Hwa Univ, Grad Inst Marine Biodivers & Evolutionary Biol, Checheng, Pingtung, Taiwan; [Ho, Ping-Ho] Natl Taiwan Ocean Univ, Inst Fishery & Environm Biol, Keelung, Taiwan; [Wang, Jih-Terng] Tajen Univ, Inst Biotechnol, Yanpu, Pingtung, Taiwan; [Chang, Yang-Chi] Natl Sun Yat Sen Univ, Dept Marine Environm & Engn, Kaohsiung 80424, Taiwan; [Dai, Chang-Feng; Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Lin, Hsing-Juh] Natl Chung Hsing Univ, Inst Life Sci, Taichung 40227, Taiwan	Academia Sinica - Taiwan; James Cook University; Universiti Malaya; National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Taiwan Ocean University; National Sun Yat Sen University; National Taiwan University; National Chung Hsing University	Kuo, CY (corresponding author), Acad Sinica, TIGP, Biodivers Res Ctr, Taipei 115, Taiwan.	cac@gate.sinica.edu.tw	Liu, Pi-Jen/ABC-6596-2021; Yuen, Yeong Shyan/K-1262-2012; Meng, PJ/AAC-3677-2021; Baird, Andrew Hamilton/C-8449-2009; Chang, Yang-Chi/M-8849-2016	Yuen, Yeong Shyan/0000-0002-2413-4156; Baird, Andrew Hamilton/0000-0001-8504-4077; DAI, CHANG-FENG/0000-0003-2242-5643; Lin, Hsing-Juh/0000-0001-8322-7195; Chang, Yang-Chi/0000-0002-1088-9427	National Science Council (NSC); Australian Endeavour Award; NSC-Australian Academy of Science (AAS); Kenting National Park; Academia Sinica [AS-97-TP-B01, AS-100-TP2-A02-SUB3]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Australian Endeavour Award(Australian GovernmentDepartment of Industry, Innovation and Science); NSC-Australian Academy of Science (AAS); Kenting National Park; Academia Sinica(Academia Sinica - Taiwan)	Many thanks go to Chieh Wei for field assistance, and to members of the Coral Reef Evolutionary Ecology and Genetics (CREEG) laboratory, Biodiversity Research Center, Academia Sinica (BRCAS), for constructive comments before submission and ARC Centre of Excellence for Coral Reef Studies at James Cook University for hosting the sabbatical of CAC. YSY is a recipient of a National Science Council (NSC) postdoctoral fellowship (2010-2011). CAC was a recipient of an Australian Endeavour Award (2010-2011) and an NSC-Australian Academy of Science (AAS) fellowship (2010). Permits for monitoring were granted by the Kenting National Park. This is CREEG contribution no. 71.; This study was supported by a long-term ecological research grant from the NSC (http://web1.nsc.gov.tw/mp.aspx?mp=7) and Kenting National Park (http://www.ktnp.gov.tw/eng/) from 2003 to 2010, and Academia Sinica (http://www.sinica.edu.tw/main_e.shtml) Thematic Grant (AS-97-TP-B01; AS-100-TP2-A02-SUB3) to CAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; Chang KH, 1985, ELLIPTIC FUNCTIONS, P1; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Dai C.-F., 1991, ATOLL RES B, V354, P1, DOI [10.5479/si.00775630.354.1, DOI 10.5479/SI.00775630.354.1]; Dai C-F, 1999, J NATL PARK, V9, P112; Dai C-F, 1998, J NATL PARK, V8, P79; Dai CF, 2007, DISTRIBUTION SPECIE, P49; Dai CF, 1988, THESIS YALE U, P315; Dai CF, 2002, P IUCN WCPA EA4 TAIP, P265; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; KNOWLTON N, 1992, AM ZOOL, V32, P674; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuo CY, 2011, ZOOL STUD, V50, P85; Kuo CY, 2007, THESIS NATL SUN YS U, P71; Kuo YM, 2010, ESTUAR COAST SHELF S, V86, P225, DOI 10.1016/j.ecss.2009.11.017; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; Meng PJ, 2008, ENVIRON POLLUT, V156, P67, DOI 10.1016/j.envpol.2007.12.039; Meng PJ, 2004, J NATL PARK, V14, P43; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Nystrom M, 2001, TRENDS ECOL EVOL, V16, P127, DOI 10.1016/S0169-5347(00)02089-9; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Shao KT, 2002, P IUCN WCPA EA 4 TAI, P351; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Tsai CC, 2004, BOT MAR, V47, P439, DOI 10.1515/BOT.2004.061; Wielgus J, 2003, J EXP MAR BIOL ECOL, V297, P31, DOI 10.1016/S0022-0981(03)00354-X; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	43	38	38	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44364	10.1371/journal.pone.0044364	http://dx.doi.org/10.1371/journal.pone.0044364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952967	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000308206500066
J	Zhao, YL; Verma, V; Belcheva, A; Singh, A; Fridman, M; Golemi-Kotra, D				Zhao, Yinglu; Verma, Vidhu; Belcheva, Antoaneta; Singh, Atul; Fridman, Michael; Golemi-Kotra, Dasantila			Staphylococcus aureus Methicillin-Resistance Factor fmtA Is Regulated by the Global Regulator SarA	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; VIRULENCE DETERMINANT PRODUCTION; PENICILLIN-BINDING PROTEINS; WALL-ACTIVE ANTIBIOTICS; CELL-WALL; RNA-POLYMERASE; PROMOTER RECOGNITION; SIGMA-FACTOR; MOLECULAR-CLONING; BIOFILM FORMATION	fmtA encodes a low-affinity penicillin binding protein in Staphylococcus aureus. It is part of the core cell wall stimulon and is involved in methicillin resistance in S. aureus. Here, we report that the transcription factor, SarA, a pleiotropic regulator of virulence genes in S. aureus, regulates the expression of fmtA. In vitro binding studies with purified SarA revealed that it binds to specific sites within the 541-bp promoter region of fmtA. Mutation of a key residue of the regulatory activity of SarA (Arg90) abolished binding of SarA to the fmtA promoter, suggesting that SarA binds specifically to the fmtA promoter region. In vivo analysis of the fmtA promoter using a lux operon reporter fusion show high level expression following oxacillin induction, which was abrogated in a sarA mutant strain. These data suggest that SarA is essential for the induction of fmtA expression by cell wall-specific antibiotics. Further, in vitro transcription studies show that SarA enhances fmtA transcription and suggest that regulation of fmtA could be via a SigA-dependent mechanism. Overall, our results show that SarA plays a direct role in the regulation of fmtA expression via binding to the fmtA promoter.	[Belcheva, Antoaneta; Fridman, Michael; Golemi-Kotra, Dasantila] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Zhao, Yinglu; Verma, Vidhu; Singh, Atul; Golemi-Kotra, Dasantila] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Zhao, YL (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	dgkotra@yorku.ca	/N-6611-2013	/0000-0003-1299-6987; Belcheva, Antoaneta/0000-0001-5061-7533	Canadian Institutes of Health Research [93530]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors declare that there are no financial, personal, or professional interests that could be construed to have influenced the manuscript. This study was supported by a grant from Canadian Institutes of Health Research (http://www.cihr.ca/e/193.html) to DGK (Operating Grant nr. 93530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley Judene, 2002, Infect Control Hosp Epidemiol, V23, P480; Belcheva A, 2012, J BACTERIOL, V194, P61, DOI 10.1128/JB.06143-11; Belcheva A, 2009, BIOCHEMISTRY-US, V48, P5592, DOI 10.1021/bi900478b; BERGERBACHI B, 1992, ANTIMICROB AGENTS CH, V36, P1367, DOI 10.1128/AAC.36.7.1367; Bernal P, 2010, J BIOL CHEM, V285, P24055, DOI 10.1074/jbc.M110.114793; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Chan PF, 1998, J BACTERIOL, V180, P6232; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Cheung AL, 2008, J BACTERIOL, V190, P2239, DOI 10.1128/JB.01826-07; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Chien YT, 1998, J BIOL CHEM, V273, P2645, DOI 10.1074/jbc.273.5.2645; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; Deora R, 1996, J BIOL CHEM, V271, P21828, DOI 10.1074/jbc.271.36.21828; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; Duran SP, 1996, FEMS MICROBIOL LETT, V141, P255, DOI 10.1016/0378-1097(96)00231-5; Fan X, 2007, J BIOL CHEM, V282, P35143, DOI 10.1074/jbc.M706296200; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; GEORGOPAPADAKOU NH, 1993, ANTIMICROB AGENTS CH, V37, P2045, DOI 10.1128/AAC.37.10.2045; HENZE U, 1993, J BACTERIOL, V175, P1612, DOI 10.1128/JB.175.6.1612-1620.1993; Henze UU, 1996, MICROB DRUG RESIST, V2, P193, DOI 10.1089/mdr.1996.2.193; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Ingavale SS, 2003, MOL MICROBIOL, V48, P1451, DOI 10.1046/j.1365-2958.2003.03503.x; Jo DS, 2011, ANTIMICROB AGENTS CH, V55, P2818, DOI 10.1128/AAC.01704-10; Komatsuzawa H, 1999, ANTIMICROB AGENTS CH, V43, P2121, DOI 10.1128/AAC.43.9.2121; Komatsuzawa H, 1997, ANTIMICROB AGENTS CH, V41, P2355, DOI 10.1128/AAC.41.11.2355; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Lamichhane-Khadka R, 2009, INT J ANTIMICROB AG, V34, P136, DOI 10.1016/j.ijantimicag.2009.01.018; Lindsay JA, 1999, MOL GEN GENET, V262, P323, DOI 10.1007/s004380051090; Liu YF, 2006, P NATL ACAD SCI USA, V103, P2392, DOI 10.1073/pnas.0510439103; Livermore DM, 2000, INT J ANTIMICROB AG, V16, pS3; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MAKI H, 1994, J BACTERIOL, V176, P4993, DOI 10.1128/jb.176.16.4993-5000.1994; Manna AC, 2004, J BACTERIOL, V186, P5267, DOI 10.1128/JB.186.16.5267-5280.2004; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McCallum N, 2006, BBA-GEN SUBJECTS, V1760, P1475, DOI 10.1016/j.bbagen.2006.06.008; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Schumacher MA, 2001, NATURE, V409, P215, DOI 10.1038/35051623; Sengupta M, 2012, CAN J MICROBIOL, V58, P703, DOI [10.1139/W2012-043, 10.1139/w2012-043]; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; SMITH IM, 1960, LANCET, V1, P1318; Sobral RG, 2007, J BACTERIOL, V189, P2376, DOI 10.1128/JB.01439-06; Sterba KM, 2003, J BACTERIOL, V185, P4410, DOI 10.1128/JB.185.15.4410-4417.2003; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; Suzuki J, 1997, FEMS MICROBIOL LETT, V153, P327, DOI 10.1016/S0378-1097(97)00269-3; Suzuki T, 2011, INVEST OPHTH VIS SCI, V52, P3187, DOI 10.1167/iovs.10-6558; TATTI KM, 1995, J MOL BIOL, V253, P8, DOI 10.1006/jmbi.1995.0531; Trotonda MP, 2008, INFECT IMMUN, V76, P5645, DOI 10.1128/IAI.00735-08; Trotonda MP, 2009, J INFECT DIS, V199, P209, DOI 10.1086/595740; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6; Wolz C, 2000, MOL MICROBIOL, V36, P230, DOI 10.1046/j.1365-2958.2000.01853.x; Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996; Wu SW, 1996, MICROB DRUG RESIST, V2, P277, DOI 10.1089/mdr.1996.2.277	69	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43998	10.1371/journal.pone.0043998	http://dx.doi.org/10.1371/journal.pone.0043998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952845	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500038
J	Matsui, A; Yokoo, H; Negishi, Y; Endo-Takahashi, Y; Chun, NAL; Kadouchi, I; Suzuki, R; Maruyama, K; Aramaki, Y; Semba, K; Kobayashi, E; Takahashi, M; Murakami, T				Matsui, Aya; Yokoo, Hideaki; Negishi, Yoichi; Endo-Takahashi, Yoko; Chun, Nicole A. L.; Kadouchi, Ichiro; Suzuki, Ryo; Maruyama, Kazuo; Aramaki, Yukihiko; Semba, Kentaro; Kobayashi, Eiji; Takahashi, Masafumi; Murakami, Takashi			CXCL17 Expression by Tumor Cells Recruits CD11b(+)Gr1(high)F4/80(-) Cells and Promotes Tumor Progression	PLOS ONE			English	Article							MURINE B16 MELANOMA; ANGIOGENIC SWITCH; SUPPRESSOR-CELLS; MYELOID CELLS; CANCER; CHEMOKINE; MIGRATION; GROWTH; TRANSFORMATION; TUMORIGENESIS	Background: Chemokines are involved in multiple aspects of pathogenesis and cellular trafficking in tumorigenesis. In this study, we report that the latest member of the C-X-C-type chemokines, CXCL17 (DMC/VCC-1), recruits immature myeloid-derived cells and enhances early tumor progression. Methodology/Principal Findings: CXCL17 was preferentially expressed in some aggressive types of gastrointestinal, breast, and lung cancer cells. CXCL17 expression did not impart NIH3T3 cells with oncogenic potential in vitro, but CXCL17-expressing NIH3T3 cells could form vasculature-rich tumors in immunodeficient mice. Our data showed that CXCL17-expressing tumor cells increased immature CD11b(+)Gr1(+) myeloid-derived cells at tumor sites in mice and promoted CD31(+) tumor angiogenesis. Extensive chemotactic assays proved that CXCL17-responding cells were CD11b(+)Gr1(high)F4/80(-) cells (similar to 90%) with a neutrophil-like morphology in vitro. Although CXCL17 expression could not increase the number of CD11b(+)Gr1(+) cells in tumor-burdened SCID mice or promote metastases of low metastatic colon cancer cells, the existence of CXCL17-responding myeloid-derived cells caused a striking enhancement of xenograft tumor formation. Conclusions/Significance: These results suggest that aberrant expression of CXCL17 in tumor cells recruits immature myeloid-derived cells and promotes tumor progression through angiogenesis.	[Matsui, Aya; Murakami, Takashi] Takasaki Univ Hlth & Welf, Lab Tumor Biol, Takasaki, Gunma, Japan; [Matsui, Aya; Chun, Nicole A. L.; Kadouchi, Ichiro; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Bioimaging Sci, Shimotsuke, Tochigi, Japan; [Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 371, Japan; [Negishi, Yoichi; Endo-Takahashi, Yoko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Drug & Gene Delivery Syst, Tokyo, Japan; [Suzuki, Ryo; Maruyama, Kazuo; Aramaki, Yukihiko] Teikyo Univ, Sch Pharmaceut Sci, Dept Biopharmaceut, Sagamihara, Kanagawa, Japan; [Semba, Kentaro] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Kobayashi, Eiji] Jichi Med Univ, Div Dev Adv Med Technol, Shimotsuke, Tochigi, Japan	Jichi Medical University; Gunma University; Tokyo University of Pharmacy & Life Sciences; Teikyo University; Waseda University; Jichi Medical University	Matsui, A (corresponding author), Takasaki Univ Hlth & Welf, Lab Tumor Biol, Takasaki, Gunma, Japan.	murakami@takasaki-u.ac.jp		Suzuki, Ryo/0000-0001-6614-4486; Takahashi, Yoko/0000-0002-6881-6044	Health and Labour Science Research Grants of the Ministry of Health, Labor, and Welfare (Research on Biological Resources); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [20591326, 2008-2010, 23591627, 2011]; Takeda Science Foundation; "Strategic Research Platform" for Private Universities: matching fund subsidy from MEXT	Health and Labour Science Research Grants of the Ministry of Health, Labor, and Welfare (Research on Biological Resources); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); "Strategic Research Platform" for Private Universities: matching fund subsidy from MEXT	This study was supported by a grant to T.M. from the Health and Labour Science Research Grants of the Ministry of Health, Labor, and Welfare (Research on Biological Resources), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Project No. 20591326, 2008-2010 and Project No. 23591627, 2011), Takeda Science Foundation (2010), and a grant from the "Strategic Research Platform" for Private Universities: matching fund subsidy from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; COPELAND NG, 1979, CELL, V16, P347, DOI 10.1016/0092-8674(79)90011-4; Fridlender ZG, 2010, CANCER RES, V70, P109, DOI 10.1158/0008-5472.CAN-09-2326; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; FUJITA J, 1984, NATURE, V309, P464, DOI 10.1038/309464a0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2009, CANCER CELL, V16, P173, DOI 10.1016/j.ccr.2009.08.014; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murakami T, 2002, CANCER RES, V62, P7328; Murakami T, 2008, J INVEST DERMATOL, V128, P1506, DOI 10.1038/sj.jid.5701216; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Negishi Y, 2008, J CONTROL RELEASE, V132, P124, DOI 10.1016/j.jconrel.2008.08.019; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Poole TJ, 2001, DEV DYNAM, V220, P1, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1087>3.0.CO;2-2; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Tadmor T, 2011, BRIT J HAEMATOL, V153, P557, DOI 10.1111/j.1365-2141.2011.08678.x; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Weinstein EJ, 2006, BIOCHEM BIOPH RES CO, V350, P74, DOI 10.1016/j.bbrc.2006.08.194; Whitehead IP, 2001, ONCOGENE, V20, P1547, DOI 10.1038/sj.onc.1204188; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Yanagisawa S, 2009, CLIN CANCER RES, V15, P3014, DOI 10.1158/1078-0432.CCR-08-2237	37	55	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44080	10.1371/journal.pone.0044080	http://dx.doi.org/10.1371/journal.pone.0044080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952881	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000080
J	Tomar, A; Lawson, C; Ghassemian, M; Schlaepfer, DD				Tomar, Alok; Lawson, Christine; Ghassemian, Majid; Schlaepfer, David D.			Cortactin as a Target for FAK in the Regulation of Focal Adhesion Dynamics	PLOS ONE			English	Article							CELL MOTILITY; KINASE-ACTIVITY; N-WASP; TYROSINE PHOSPHORYLATION; SUBSTRATE P130(CAS); RHOA ACTIVITY; V-SRC; ACTIN; MIGRATION; DOMAIN	Background: Efficient cell movement requires the dynamic regulation of focal adhesion (FA) formation and turnover. FAs are integrin-associated sites of cell attachment and establish linkages to the cellular actin cytoskeleton. Cells without focal adhesion kinase (FAK), an integrin-activated tyrosine kinase, exhibit defects in FA turnover and cell motility. Cortactin is an actin binding adaptor protein that can influence FA dynamics. FAK and cortactin interact, but the cellular role of this complex remains unclear. Principal Findings: Using FAK-null fibroblasts stably reconstituted with green fluorescent protein (GFP) tagged FAK constructs, we find that FAK activity and FAK C-terminal proline-rich region 2 (PRR2) and PRR3 are required for FA turnover and cell motility. Cortactin binds directly to FAK PRR2 and PRR3 sites via its SH3 domain and cortactin expression is important in promoting FA turnover and GFP-FAK release from FAs. FAK-cortactin binding is negatively-regulated by FAK activity and associated with cortactin tyrosine phosphorylation. FAK directly phosphorylates cortactin at Y421 and Y466 and over-expression of cortactin Y421, Y466, and Y482 mutated to phenylalanine (3YF) prevented FAK-enhanced FA turnover and cell motility. However, phospho-mimetic cortactin mutated to glutamic acid (3YE) did not affect FA dynamics and did not rescue FA turnover defects in cells with inhibited FAK activity or with PRR2-mutated FAK that does not bind cortactin. Conclusions: Our results support a model whereby FAK-mediated FA remodeling may occur through the formation of a FAK-cortactin signaling complex. This involves a cycle of cortactin binding to FAK, cortactin tyrosine phosphorylation, and subsequent cortactin-FAK dissociation accompanied by FA turnover and cell movement.	[Tomar, Alok; Lawson, Christine; Schlaepfer, David D.] Univ Calif San Diego, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Tomar, A (corresponding author), Aerotek, San Diego, CA USA.	dschlaepfer@ucsd.edu			National Institutes of Health [GM087400, CA102310]; AHA fellowship [0825166F]; CIHR fellowship [200810MFE-193594-139144]; NATIONAL CANCER INSTITUTE [R01CA102310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA fellowship(American Heart Association); CIHR fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM087400 and CA102310 to David Schlaepfer. Alok Tomar was supported by an AHA fellowship (0825166F) and Christine Lawson by CIHR fellowship (200810MFE-193594-139144) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Corsi JM, 2009, J BIOL CHEM, V284, P34769, DOI 10.1074/jbc.M109.067280; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Eke I, 2012, J CLIN INVEST, V122, P1529, DOI 10.1172/JCI61350; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Hauck CR, 2001, J BIOL CHEM, V276, P17653, DOI 10.1074/jbc.M009329200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Meiler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033662; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Ren G, 2009, CELL MOTIL CYTOSKEL, V66, P865, DOI 10.1002/cm.20380; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 2007, J BIOL CHEM, V282, P17450, DOI 10.1074/jbc.M610672200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sieg DJ, 1999, J CELL SCI, V112, P2677; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200	59	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44041	10.1371/journal.pone.0044041	http://dx.doi.org/10.1371/journal.pone.0044041			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952866	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000072
J	Wang, PH; Bai, FW; Zenewicz, LA; Dai, JF; Gate, D; Cheng, G; Yang, L; Qian, F; Yuan, XL; Montgomery, RR; Flavell, RA; Town, T; Fikrig, E				Wang, Penghua; Bai, Fengwei; Zenewicz, Lauren A.; Dai, Jianfeng; Gate, David; Cheng, Gong; Yang, Long; Qian, Feng; Yuan, Xiaoling; Montgomery, Ruth R.; Flavell, Richard A.; Town, Terrence; Fikrig, Erol			IL-22 Signaling Contributes to West Nile Encephalitis Pathogenesis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROINFLAMMATORY GENE-EXPRESSION; CD8(+) T-CELLS; VIRUS-INFECTION; HOST-DEFENSE; INTERLEUKIN-22; BRAIN; TRAFFICKING; ENTRY; SURVIVAL	The Th17 cytokine, IL-22, regulates host immune responses to extracellular pathogens. Whether IL-22 plays a role in viral infection, however, is poorly understood. We report here that Il22(-/-) mice were more resistant to lethal West Nile virus (WNV) encephalitis, but had similar viral loads in the periphery compared to wild type (WT) mice. Viral loads, leukocyte infiltrates, proinflammatory cytokines and apoptotic cells in the central nervous system (CNS) of Il22(-/-) mice were also strikingly reduced. Further examination showed that Cxcr2, a chemokine receptor that plays a non-redundant role in mediating neutrophil migration, was significantly reduced in Il22(-/-) compared to WT leukocytes. Expression of Cxcr2 ligands, cxcl1 and cxcl5, was lower in Il22(-/-) brains than wild type mice. Correspondingly, neutrophil migration from the blood into the brain was attenuated following lethal WNV infection of Il22(-/-) mice. Our results suggest that IL-22 signaling exacerbates lethal WNV encephalitis likely by promoting WNV neuroinvasion.	[Wang, Penghua; Bai, Fengwei; Dai, Jianfeng; Cheng, Gong; Yang, Long; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Qian, Feng; Yuan, Xiaoling; Montgomery, Ruth R.] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA; [Zenewicz, Lauren A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Gate, David; Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Gate, David; Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst, Dept Neurosurg, Los Angeles, CA 90048 USA; [Town, Terrence] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Flavell, Richard A.; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bai, Fengwei] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	Yale University; Yale University; Yale University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Southern Mississippi	Wang, PH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	penghua.wang@yale.edu	Qian, Feng/F-8186-2010; Dai, Jianfeng/ACP-1114-2022; wang, Penghua/AAL-4011-2020; Gate, David/AAM-5007-2021	Gate, David/0000-0003-0481-9657; Montgomery, Ruth/0000-0002-8661-4454; Zenewicz, Lauren/0000-0002-8787-5955	National Institutes of Health [AI-055749, AI-50031, HHSN272201100019C, AI-079348]; National Institutes of Health/National Institute on Aging [5R00AG029726-04, 3R00AG029726-04S1]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, N01AI050031, R01AI055749, R03AI079348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health grants AI-055749, AI-50031, HHSN272201100019C and AI-079348. EF and RAF are investigators of the Howard Hughes Medical Institute. TT is supported by National Institutes of Health/National Institute on Aging 'Pathway to Independence' awards (5R00AG029726-04 and 3R00AG029726-04S1) and is the inaugural holder of the Ben Winters Endowed Chair in Regenerative Medicine. PW is supported by a Career Development Award from Northeast Biodefense Center U54-AI057158-Lipkin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DM, 1999, J VIROL, V73, P8781, DOI 10.1128/JVI.73.10.8781-8790.1999; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; BenNathan D, 1996, ARCH VIROL, V141, P459, DOI 10.1007/BF01718310; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brehin AC, 2008, J IMMUNOL, V180, P6760, DOI 10.4049/jimmunol.180.10.6760; Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07; Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016; Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hosking MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011340; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rawal A, 2006, DIAGN CYTOPATHOL, V34, P127, DOI 10.1002/dc.20410; Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Sitati E, 2007, J VIROL, V81, P9801, DOI 10.1128/JVI.00941-07; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Tyler KL, 2006, NEUROLOGY, V66, P361, DOI 10.1212/01.wnl.0000195890.70898.1f; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036; Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wu ZH, 2003, J NEUROSCI METH, V130, P53, DOI 10.1016/S0165-0270(03)00206-1; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	36	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44153	10.1371/journal.pone.0044153	http://dx.doi.org/10.1371/journal.pone.0044153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952908	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600085
J	Koyama-Nasu, R; Nasu-Nishimura, Y; Todo, T; Ino, Y; Saito, N; Aburatani, H; Funato, K; Echizen, K; Sugano, H; Haruta, R; Matsui, M; Takahashi, R; Manabe, E; Oda, T; Akiyama, T				Koyama-Nasu, R.; Nasu-Nishimura, Y.; Todo, T.; Ino, Y.; Saito, N.; Aburatani, H.; Funato, K.; Echizen, K.; Sugano, H.; Haruta, R.; Matsui, M.; Takahashi, R.; Manabe, E.; Oda, T.; Akiyama, T.			The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells	ONCOGENE			English	Article						cancer stem cells; cell cycle; cyclin D2; glioblastoma	CANCER; PROLIFERATION; PATHWAYS; GLIOMAS; ORIGIN; TUMORS; BRAIN; LINES	Cancer stem cells are believed to be responsible for tumor initiation and development. Much current research on human brain tumors is focused on the stem-like properties of glioblastoma stem cells (GSCs). However, little is known about the molecular mechanisms of cell cycle regulation that discriminate between GSCs and differentiated glioblastoma cells. Here we show that cyclin D2 is the cyclin that is predominantly expressed in GSCs and suppression of its expression by RNA interference causes G1 arrest in vitro and growth retardation of GSCs xenografted into immunocompromised mice in vivo. We also demonstrate that the expression of cyclin D2 is suppressed upon serum-induced differentiation similar to what was observed for the cancer stem cell marker CD133. Taken together, our results demonstrate that cyclin D2 has a critical role in cell cycle progression and the tumorigenicity of GSCs.	[Koyama-Nasu, R.; Nasu-Nishimura, Y.; Funato, K.; Echizen, K.; Sugano, H.; Haruta, R.; Matsui, M.; Takahashi, R.; Manabe, E.; Oda, T.; Akiyama, T.] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 1100032, Japan; [Todo, T.; Ino, Y.; Saito, N.] Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 113, Japan; [Aburatani, H.] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1100032, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1100032, Japan.	akiyama@iam.u-tokyo.ac.jp		Funato, Kosuke/0000-0003-2437-1116; Todo, Tomoki/0000-0003-0523-8010	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Integrative Research on Cancer Microenvironment Network; Takeda Science Foundation; MEXT, Japan; Grants-in-Aid for Scientific Research [25670138] Funding Source: KAKEN	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Integrative Research on Cancer Microenvironment Network; Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks), Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Research on Cancer Microenvironment Network), Takeda Science Foundation and in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan.	Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; [Anonymous], 2008, NATURE, V455, P1061; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Singh SK, 2003, CANCER RES, V63, P5821; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Walzlein JH, 2008, STEM CELLS, V26, P2945, DOI 10.1634/stemcells.2008-0307; Zhang X, 2005, J CLIN NEUROSCI, V12, P166, DOI 10.1016/j.jocn.2004.03.036	17	40	41	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 15	2013	32	33					3840	3845		10.1038/onc.2012.399	http://dx.doi.org/10.1038/onc.2012.399			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22964630				2022-12-25	WOS:000323210200006
J	Sakurikar, N; Eichhorn, JM; Chambers, TC				Sakurikar, Nandini; Eichhorn, Joshua M.; Chambers, Timothy C.			Cyclin-dependent Kinase-1 (Cdk1)/Cyclin B1 Dictates Cell Fate after Mitotic Arrest via Phosphoregulation of Antiapoptotic Bcl-2 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CANCER-CELLS; PHOSPHORYLATION; APOPTOSIS; MITOSIS; MCL-1; CDK1; IDENTIFICATION; DRUGS; TIME	The prevailing model suggests that cell fate after mitotic arrest depends on two independent and competing networks that control cyclin B1 degradation and the generation of death signals. However, recent evidence for Cdk1/cyclin B1-mediated phosphorylation and inactivation of antiapoptotic Bcl-2 proteins suggests the existence of significant cross-talk and inter-dependence between these pathways. Further, the nature of the mitotic death signals has remained elusive. In this study, we sought to test the hypothesis that fate after mitotic arrest is dictated by the robustness of Cdk1/cyclin B1 signaling to Bcl-2 proteins and to identify signals that may represent a mitotic death signature. We show that when treated with Taxol, slippage-resistant HT29 colon carcinoma cells display robust Cdk1 activity and extensive Mcl-1/Bcl-x(L) phosphorylation and die in mitosis, whereas slippage-prone DLD-1 colon carcinoma cells display weak Cdk1 activity and partial and transient Mcl-1/Bcl-x(L) phosphorylation and die in subsequent interphase or survive. Furthermore, modulation of this signaling axis, either by inhibition of Cdk1 in slippage-resistant HT29 or by enforcing mitotic arrest in slippage-prone DLD-1 cells, evokes a switch in fate, indicating that the strength of Cdk1 signaling to Bcl-2 proteins is a key determinant of outcome. These findings provide novel insight into the pathways that regulate mitotic death, suggest that the robustness of these signaling events may be useful as a marker to define susceptibility to antimitotic drugs, and encourage a revision in the current model describing fate after mitotic arrest.	[Sakurikar, Nandini; Eichhorn, Joshua M.; Chambers, Timothy C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chambers, TC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Mail Slot 516,4301 W Markham St, Little Rock, AR 72205 USA.	chamberstimothyc@uams.edu			National Institutes of Health from NCI [CA-109821]; Translational Research Institute Grant [UL1TR000039]; NATIONAL CANCER INSTITUTE [R01CA109821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Translational Research Institute Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-109821 from the NCI (to T.C.C.). This work was also supported in part by pilot funds from Translational Research Institute Grant UL1TR000039.	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Andersen JL, 2009, EMBO J, V28, P3216, DOI 10.1038/emboj.2009.253; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; Clarke PR, 2010, CELL CYCLE, V9, P4035, DOI 10.4161/cc.9.20.13522; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Huang HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015724; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rosania GR, 1999, P NATL ACAD SCI USA, V96, P4797, DOI 10.1073/pnas.96.9.4797; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Tunquist BJ, 2010, MOL CANCER THER, V9, P2046, DOI 10.1158/1535-7163.MCT-10-0033; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wolf F, 2007, CELL CYCLE, V6, P1408	26	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39193	39204		10.1074/jbc.M112.391854	http://dx.doi.org/10.1074/jbc.M112.391854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22965228	Green Published, hybrid			2022-12-25	WOS:000310982800074
J	Nagamatsu, G; Saito, S; Kosaka, T; Takubo, K; Kinoshita, T; Oya, M; Horimoto, K; Suda, T				Nagamatsu, Go; Saito, Shigeru; Kosaka, Takeo; Takubo, Keiyo; Kinoshita, Taisuke; Oya, Mototsugu; Horimoto, Katsuhisa; Suda, Toshio			Optimal Ratio of Transcription Factors for Somatic Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; MOUSE FIBROBLASTS; DIRECT CONVERSION; DEFINED FACTORS; SELF-RENEWAL; E-CADHERIN; EXPRESSION; INDUCTION; DIFFERENTIATION; GENERATION	Somatic cell reprogramming is achieved by four reprogramming transcription factors (RTFs), Oct3/4, Sox2, Klf4, and c-Myc. However, in addition to the induction of pluripotent cells, these RTFs also generate pseudo-pluripotent cells, which do not show Nanog promoter activity. Therefore, it should be possible to fine-tune the RTFs to produce only fully pluripotent cells. For this study, a tagging system was developed to sort induced pluripotent stem (iPS) cells according to the expression levels of each of the four RTFs. Using this system, the most effective ratio (Oct3/4-high, Sox2-low, Klf4-high, c-Myc-high) of the RTFs was 88 times more efficient at producing iPS cells than the worst effective ratio (Oct3/4-low, Sox2-high, Klf4-low, c-Myc-low). Among the various RTF combinations, Oct3/4-high and Sox2-low produced the most efficient results. To investigate the molecular basis, microarray analysis was performed on iPS cells generated under high (Oct3/4-high and Sox2-low) and low (Oct3/4-low and Sox2-high) efficiency reprogramming conditions. Pathway analysis revealed that the G protein-coupled receptor (GPCR) pathway was up-regulated significantly under the high efficiency condition and treatment with the chemokine, C-C motif ligand 2, a member of the GPCR family, enhanced somatic cell reprogramming 12.3 times. Furthermore, data from the analysis of the signature gene expression profiles of mouse embryonic fibroblasts at 2 days after RTF infection revealed that the genetic modifier, Whsc1l1 (variant 1), also improved the efficiency of somatic cell reprogramming. Finally, comparison of the overall gene expression profiles between the high and low efficiency conditions will provide novel insights into mechanisms underlying somatic cell reprogramming.	[Nagamatsu, Go] Keio Univ, Dept Cell Differentiat, Sakaguchi Lab, Sch Med,Shinju Ku, Tokyo 1608582, Japan; [Kosaka, Takeo; Oya, Mototsugu] Keio Univ, Dept Urol, Sch Med, Tokyo 1608582, Japan; [Saito, Shigeru; Horimoto, Katsuhisa] Natl Inst Ind Sci & Technol AIST, CBRC, Tokyo 1350064, Japan; [Nagamatsu, Go] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Saito, Shigeru] INFOCOM Corp, Chem & Bio Informat Dept, Tokyo 1500001, Japan; [Horimoto, Katsuhisa] Shanghai Univ, Inst Syst Biol, Shanghai 200444, Peoples R China	Keio University; Keio University; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Shanghai University	Nagamatsu, G (corresponding author), Keio Univ, Dept Cell Differentiat, Sakaguchi Lab, Sch Med,Shinju Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	gonag@z2.keio.jp	Suda, Toshio/H-6761-2013; Oya, Mototsugu/K-8592-2013; Takubo, Keiyo/AAX-5546-2020; Saito, Shigeru/B-2785-2012	Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592; Saito, Shigeru/0000-0002-8708-9102	PRESTO of the Japan Science and Technology Agency; MEXT; Global century COE program from MEXT; Keio University Medical Science Fund; Project for Realization of Regenerative Medicine	PRESTO of the Japan Science and Technology Agency; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global century COE program from MEXT; Keio University Medical Science Fund; Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by PRESTO of the Japan Science and Technology Agency and Scientific Research (C), a grant from the Project for Realization of Regenerative Medicine, support for the core institutes for iPS cell research was provided by MEXT, a grant-in-aid for the Global century COE program from MEXT to Keio University, and the Keio University Medical Science Fund.	Araki R, 2010, STEM CELLS, V28, P213, DOI 10.1002/stem.282; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hasegawa Y, 2011, STEM CELLS, V29, P1196, DOI 10.1002/stem.673; Hirai H, 2011, STEM CELLS, V29, P1349, DOI 10.1002/stem.684; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Lin ZY, 2011, STEM CELLS, V29, P1963, DOI 10.1002/stem.752; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stec I, 2001, GENOMICS, V76, P5, DOI 10.1006/geno.2001.6581; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Xu PF, 2010, P NATL ACAD SCI USA, V107, P2521, DOI 10.1073/pnas.0914396107; Yamaguchi S, 2011, STEM CELL RES, V6, P177, DOI 10.1016/j.scr.2010.09.004; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	32	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36273	36282		10.1074/jbc.M112.380683	http://dx.doi.org/10.1074/jbc.M112.380683			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955270	Green Published, hybrid			2022-12-25	WOS:000310364000048
J	Zhou, LX; Pelengaris, S; Abouna, S; Young, J; Epstein, D; Herold, J; Nattkemper, TW; Nakhai, H; Khan, M				Zhou, Luxian; Pelengaris, Stella; Abouna, Sylvie; Young, James; Epstein, David; Herold, Julia; Nattkemper, Tim Wilhelm; Nakhai, Hassan; Khan, Michael			Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice	PLOS ONE			English	Article							GROWTH-FACTOR-II; GLUCAGON-LIKE PEPTIDE-1; PARTIAL PANCREATECTOMY; ISLET REGENERATION; DIABETES-MELLITUS; INSULIN-RECEPTOR; PROGENITOR CELLS; MASS; PANCREAS; RAT	Background: The key factors which support re-expansion of beta cell numbers after injury are largely unknown. Insulin-like growth factor II (IGF-II) plays a critical role in supporting cell division and differentiation during ontogeny but its role in the adult is not known. In this study we investigated the effect of IGF-II on beta cell regeneration. Methodology/Principal Findings: We employed an in vivo model of 'switchable' c-Myc-induced beta cell ablation, pIns-cMycER(TAM), in which 90% of beta cells are lost following 11 days of c-Myc (Myc) activation in vivo. Importantly, such ablation is normally followed by beta cell regeneration once Myc is deactivated, enabling functional studies of beta cell regeneration in vivo. IGF-II was shown to be re-expressed in the adult pancreas of pIns-c-MycER(TAM)/IGF-II+/+ (MIG) mice, following beta cell injury. As expected in the presence of IGF-II beta cell mass and numbers recover rapidly after ablation. In contrast, in pIns-c-MycER(TAM)/IGF-II+/- (MIGKO) mice, which express no IGF-II, recovery of beta cell mass and numbers were delayed and impaired. Despite failure of beta cell number increase, MIGKO mice recovered from hyperglycaemia, although this was delayed. Conclusions/Significance: Our results demonstrate that beta cell regeneration in adult mice depends on re-expression of IGF-II, and supports the utility of using such ablation-recovery models for identifying other potential factors critical for underpinning successful beta cell regeneration in vivo. The potential therapeutic benefits of manipulating the IGF-II signaling systems merit further exploration.	[Zhou, Luxian; Abouna, Sylvie; Nakhai, Hassan] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Pelengaris, Stella; Young, James; Khan, Michael] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Epstein, David] Univ Warwick, Dept Math, Coventry CV4 7AL, W Midlands, England; [Herold, Julia; Nattkemper, Tim Wilhelm] Univ Bielefeld, Biodata Min Grp, D-33615 Bielefeld, Germany	University of Warwick; University of Warwick; University of Warwick; University of Bielefeld	Zhou, LX (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	Michael.Khan@warwick.ac.uk	Zhou, Luxian/CAA-2078-2022; Nattkemper, Tim W/F-3332-2017	Nattkemper, Tim W/0000-0002-7986-1158; Khan, Michael/0000-0002-8591-384X	Warwick Postgraduate Research Fellowship (WPRF); Engineering and Physical Sciences Research Council (EPSRC); Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Fund [1139383]	Warwick Postgraduate Research Fellowship (WPRF); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Fund	This project was supported by: Warwick Postgraduate Research Fellowship (WPRF), Engineering and Physical Sciences Research Council (EPSRC), Biotechnology and Biological Sciences Research Council (BBSRC), and Medical Research Fund (Registered charity number 1139383; Provided support for LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Bock T, 2004, BIOESSAYS, V26, P1156, DOI 10.1002/bies.20143; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; BROWN AL, 1986, J BIOL CHEM, V261, P3144; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Calderari S, 2007, DIABETOLOGIA, V50, P1463, DOI 10.1007/s00125-007-0676-2; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Cheung L, 2010, ISLETS, V2, P37, DOI 10.4161/isl.2.1.10196; CHRISTOFORI G, 1995, NAT GENET, V10, P196, DOI 10.1038/ng0695-196; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cui HM, 2007, DIS MARKERS, V23, P105, DOI 10.1155/2007/363464; De Leon DD, 2006, INT J BIOCHEM CELL B, V38, P845, DOI 10.1016/j.biocel.2005.07.011; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DERCOLE AJ, 1980, DEV BIOL, V75, P315, DOI 10.1016/0012-1606(80)90166-9; Desgraz R, 2011, TRENDS ENDOCRIN MET, V22, P34, DOI 10.1016/j.tem.2010.09.004; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Drab SR, 2009, PHARMACOTHERAPY, V29, p43S, DOI 10.1592/phco.29.pt2.43S; George M, 2002, J CLIN INVEST, V109, P1153, DOI 10.1172/JCI200212969; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Herold J, 2010, COMPUT MED IMAG GRAP, V34, P446, DOI 10.1016/j.compmedimag.2009.10.004; Hill DJ, 2000, ENDOCRINOLOGY, V141, P1151, DOI 10.1210/en.141.3.1151; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; MOSES AC, 1980, P NATL ACAD SCI-BIOL, V77, P3649, DOI 10.1073/pnas.77.6.3649; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Rolin B, 2002, AM J PHYSIOL-ENDOC M, V283, pE745, DOI 10.1152/ajpendo.00030.2002; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Salpeter SJ, 2010, DEVELOPMENT, V137, P3205, DOI 10.1242/dev.054304; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wang ZV, 2008, DIABETES, V57, P2137, DOI 10.2337/db07-1631; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790	43	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43623	10.1371/journal.pone.0043623	http://dx.doi.org/10.1371/journal.pone.0043623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970135	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000004
J	Chassaing, B; Srinivasan, G; Delgado, MA; Young, AN; Gewirtz, AT; Vijay-Kumar, M				Chassaing, Benoit; Srinivasan, Gayathri; Delgado, Maria A.; Young, Andrew N.; Gewirtz, Andrew T.; Vijay-Kumar, Matam			Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; BOWEL-DISEASE; INSULIN-RESISTANCE; EXPERIMENTAL COLITIS; MICE; MARKER; MOUSE; IDENTIFICATION; PATHOGENESIS; MACROPHAGES	Inflammation has classically been defined histopathologically, especially by the presence of immune cell infiltrates. However, more recent studies suggest a role for "low-grade" inflammation in a variety of disorders ranging from metabolic syndrome to cancer, which is defined by modest elevations in pro-inflammatory gene expression. Consequently, there is a need for cost-effective, non-invasive biomarkers that, ideally, would have the sensitivity to detect low-grade inflammation and have a dynamic range broad enough to reflect classic robust intestinal inflammation. Herein, we report that, for assessment of intestinal inflammation, fecal lipocalin 2 (Lcn-2), measured by ELISA, serves this purpose. Specifically, using a well-characterized mouse model of DSS colitis, we observed that fecal Lcn-2 and intestinal expression of pro-inflammatory cytokines (IL-1 beta, CXCL1, TNF alpha) are modestly but significantly induced by very low concentrations of DSS (0.25 and 0.5%), and become markedly elevated at higher concentrations of DSS (1.0 and 4.0%). As expected, careful histopathologic analysis noted only modest immune infiltrates at low DSS concentration and robust colitis at higher DSS concentrations. In accordance, increased levels of the neutrophil product myeloperoxidase (MPO) was only detected in mice given 1.0 and 4.0% DSS. In addition, fecal Lcn-2 marks the severity of spontaneous colitis development in IL-10 deficient mice. Unlike histopathology, MPO, and q-RT-PCR, the assay of fecal Lcn-2 requires only a stool sample, permits measurement over time, and can detect inflammation as early as 1 day following DSS administration. Thus, assay of fecal Lcn-2 by ELISA can function as a non-invasive, sensitive, dynamic, stable and cost-effective means to monitor intestinal inflammation in mice.	[Chassaing, Benoit; Srinivasan, Gayathri; Gewirtz, Andrew T.; Vijay-Kumar, Matam] Georgia State Univ, Dept Biol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Delgado, Maria A.; Young, Andrew N.; Gewirtz, Andrew T.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Delgado, Maria A.; Young, Andrew N.] Grady Med Ctr, Atlanta, GA USA	University System of Georgia; Georgia State University; Emory University	Chassaing, B (corresponding author), Georgia State Univ, Dept Biol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	mkumar@gsu.edu	Vijay-Kumar, Matam/Q-8988-2019; Chassaing, Benoit/R-3819-2017	Chassaing, Benoit/0000-0002-4285-769X	NIH [DK061417, DK083890]; K01 R03 [DK083275]; CCFA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061417, K01DK083275, R01DK083890] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); K01 R03; CCFA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK061417 and DK083890 to A. T. G. and K01 & R03 (DK083275) and CCFA Career Development award to M.V-K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadland E, 2002, EUR J GASTROEN HEPAT, V14, P823, DOI 10.1097/00042737-200208000-00002; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Logsdon LK, 2006, J IMMUNOL METHODS, V313, P183, DOI 10.1016/j.jim.2006.05.001; MEHEUS LA, 1993, J IMMUNOL, V151, P1535; Nielsen OH, 1999, AM J GASTROENTEROL, V94, P2923, DOI 10.1016/S0002-9270(99)00495-5; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Parikh CR, 2012, KIDNEY INT, V81, P784, DOI 10.1038/ki.2011.465; Playford RJ, 2006, GASTROENTEROLOGY, V131, P809, DOI 10.1053/j.gastro.2006.05.051; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Srinivasan G, 2012, J IMMUNOL, V189, P1911, DOI 10.4049/jimmunol.1200892; van Dam RM, 2007, CLIN CHEM, V53, P5, DOI 10.1373/clinchem.2006.080432; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zisman TL, 2008, WORLD J GASTROENTERO, V14, P2662, DOI 10.3748/wjg.14.2662	32	296	303	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44328	10.1371/journal.pone.0044328	http://dx.doi.org/10.1371/journal.pone.0044328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957064	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800057
J	Limousin, D; Streiff, R; Courtois, B; Dupuy, V; Alem, S; Greenfield, MD				Limousin, Denis; Streiff, Rejane; Courtois, Brigitte; Dupuy, Virginie; Alem, Sylvain; Greenfield, Michael D.			Genetic Architecture of Sexual Selection: QTL Mapping of Male Song and Female Receiver Traits in an Acoustic Moth	PLOS ONE			English	Article							ACHROIA-GRISELLA LEPIDOPTERA; MATE CHOICE; ULTRASONIC ADVERTISEMENT; QUANTITATIVE GENETICS; LESSER WAXMOTH; WAX MOTHS; PREFERENCE; EVOLUTION; SIGNAL; LOCI	Models of indirect (genetic) benefits sexual selection predict linkage disequilibria between genes that influence male traits and female preferences, owing to non-random mate choice or physical linkage. Such linkage disequilibria can accelerate the evolution of traits and preferences to exaggerated levels. Both theory and recent empirical findings on species recognition suggest that such linkage disequilibria may result from physical linkage or pleiotropy, but very little work has addressed this possibility within the context of sexual selection. We studied the genetic architecture of sexually selected traits by analyzing signals and preferences in an acoustic moth, Achroia grisella, in which males attract females with a train of ultrasound pulses and females prefer loud songs and a fast pulse rhythm. Both male signal characters and female preferences are repeatable and heritable traits. Moreover, female choice is based largely on male song, while males do not appear to provide direct benefits at mating. Thus, some genetic correlation between song and preference traits is expected. We employed a standard crossing design between inbred lines and used AFLP markers to build a linkage map for this species and locate quantitative trait loci (QTL) that influence male song and female preference. Our analyses mostly revealed QTLs of moderate strength that influence various male signal and female receiver traits, but one QTL was found that exerts a major influence on the pulse-pair rate of male song, a critical trait in female attraction. However, we found no evidence of specific co-localization of QTLs influencing male signal and female receiver traits on the same linkage groups. This finding suggests that the sexual selection process would proceed at a modest rate in A. grisella and that evolution toward exaggerated character states may be tempered. We suggest that this equilibrium state may be more the norm than the exception among animal species.	[Limousin, Denis; Alem, Sylvain; Greenfield, Michael D.] Univ Tours, CNRS, UMR IRBI 7261, Tours, France; [Streiff, Rejane; Dupuy, Virginie] Montpellier SupAgro, INRA, UMR CBGP, IRD,CIRAD, Montferrier Sur Lez, France; [Courtois, Brigitte] UMR AGAP, CIRAD, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; Universite de Montpellier	Limousin, D (corresponding author), INRA, UMR 1272, F-78026 Versailles, France.	michael.greenfield@univ-tours.fr	COURTOIS, Brigitte/A-4004-2009	COURTOIS, Brigitte/0000-0003-2118-7102; Greenfield, Michael D./0000-0003-1935-3423; Streiff, Rejane/0000-0002-2731-8129	Agence Nationale de la Recherche of France [ANR-07-BLAN-0113-01]; Centre National de la Recherche Scientifique (CNRS); Universite Francois Rabelais de Tours; Ministere de l'Education of France; U.S. National Science Foundation [IOB-0516634]	Agence Nationale de la Recherche of France(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Francois Rabelais de Tours; Ministere de l'Education of France; U.S. National Science Foundation(National Science Foundation (NSF))	The project was supported financially by the Agence Nationale de la Recherche of France (contrat ANR-07-BLAN-0113-01), the Centre National de la Recherche Scientifique (CNRS), the Universite Francois Rabelais de Tours, the Ministere de l'Education of France and the U.S. National Science Foundation (grant IOB-0516634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1962, EVOLUTION, V16, P443, DOI 10.1111/j.1558-5646.1962.tb03236.x; Allison JD, 2008, J EVOLUTION BIOL, V21, P1666, DOI 10.1111/j.1420-9101.2008.01595.x; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; Boake CRB, 2005, BEHAV GENET, V35, P297, DOI 10.1007/s10519-005-3221-4; Bousquet F, 2012, P NATL ACAD SCI USA, V109, P249, DOI 10.1073/pnas.1109166108; Brandt LSE, 2004, J EVOLUTION BIOL, V17, P821, DOI 10.1111/j.1420-9101.2004.00716.x; Charmantier A, 2006, TRENDS ECOL EVOL, V21, P417, DOI 10.1016/j.tree.2006.06.001; Chenoweth SF, 2006, NAT REV GENET, V7, P681, DOI 10.1038/nrg1924; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins RD, 1999, HEREDITY, V83, P644, DOI 10.1038/sj.hdy.6885540; DUTKY S. R., 1962, PROC ENTOMOL SOC WASHINGTON, V64, P56; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1958, GENETICAL THEORY NAT; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; GREENFIELD MD, 1983, BEHAVIOUR, V84, P287, DOI 10.1163/156853983X00534; Greig EI, 2004, BEHAVIOUR, V141, P799, DOI 10.1163/1568539042265626; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Jang Y, 1997, J INSECT BEHAV, V10, P87, DOI 10.1007/BF02765476; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; Jang YW, 1996, ANIM BEHAV, V51, P1095, DOI 10.1006/anbe.1996.0111; Jang YW, 1998, EVOLUTION, V52, P1383, DOI [10.2307/2411308, 10.1111/j.1558-5646.1998.tb02020.x]; Jia FY, 2001, J INSECT BEHAV, V14, P19, DOI 10.1023/A:1007893411662; Jia FY, 1997, P ROY SOC B-BIOL SCI, V264, P1057, DOI 10.1098/rspb.1997.0146; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kunike G., 1930, Zeitschrift fuer Angewandte Entomologie, V16, P304; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Limousin D, 2009, J EXP BIOL, V212, P4091, DOI 10.1242/jeb.035345; LOFSTEDT C, 1989, GENETICS, V123, P553; Midamegbe A, 2011, MOL ECOL, V20, P1414, DOI 10.1111/j.1365-294X.2011.05035.x; Morris MR, 1996, ANIM BEHAV, V52, P1193, DOI 10.1006/anbe.1996.0267; Muranty H, 1996, HEREDITY, V76, P156, DOI 10.1038/hdy.1996.23; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; Pomiankowski A.N., 1988, Oxford Surveys in Evolutionary Biology, V5, P136; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Reinhold K, 1998, ANIM BEHAV, V55, P905, DOI 10.1006/anbe.1997.0594; Ritchie MG, 2005, ANIM BEHAV, V70, P849, DOI 10.1016/j.anbehav.2005.01.018; Ritchie MG, 1998, ANIM BEHAV, V56, P713, DOI 10.1006/anbe.1998.0799; Ritchie MG, 1996, P NATL ACAD SCI USA, V93, P14628, DOI 10.1073/pnas.93.25.14628; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Rundus AS, 2011, EVOLUTION, V65, P268, DOI 10.1111/j.1558-5646.2010.01125.x; Sasabe M, 2010, MOL ECOL, V19, P5231, DOI 10.1111/j.1365-294X.2010.04883.x; Shaw KL, 2007, MOL ECOL, V16, P2879, DOI 10.1111/j.1365-294X.2007.03321.x; Shaw KL, 2011, BEHAV ECOL, V22, P1154, DOI 10.1093/beheco/arr136; Simmons LW, 2007, P NATL ACAD SCI USA, V104, P16604, DOI 10.1073/pnas.0704871104; Simmons LW, 2004, ANIM BEHAV, V68, P313, DOI 10.1016/j.anbehav.2003.12.004; Singh ND, 2012, P NATL ACAD SCI USA, V109, P5, DOI 10.1073/pnas.1118531109; SPANGLER HG, 1984, PHYSIOL ENTOMOL, V9, P87, DOI 10.1111/j.1365-3032.1984.tb00684.x; Uetz GW, 2009, ANIM BEHAV, V78, P299, DOI 10.1016/j.anbehav.2009.04.023; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; Velthuis BJ, 2005, ANIM BEHAV, V69, P1107, DOI 10.1016/j.anbehav.2004.06.032; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; WAGNER WE, 1995, ANIM BEHAV, V49, P1269, DOI 10.1006/anbe.1995.0159; Welch AM, 2003, EVOLUTION, V57, P883; Wiley C, 2012, P ROY SOC B-BIOL SCI, V279, P1203, DOI 10.1098/rspb.2011.1740; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Xu SZ, 2003, GENETICS, V165, P2259; Zhou YH, 2011, EVOL ECOL, V25, P307, DOI 10.1007/s10682-010-9421-2	71	17	18	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44554	10.1371/journal.pone.0044554	http://dx.doi.org/10.1371/journal.pone.0044554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957082	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800075
J	Moorthy, M; Samuel, P; Peter, JV; Vijayakumar, S; Sekhar, D; Verghese, VP; Agarwal, I; Moses, PD; Ebenezer, K; Abraham, OC; Thomas, K; Mathews, P; Mishra, AC; Lal, R; Muliyil, J; Abraham, AM				Moorthy, Mahesh; Samuel, Prasanna; Peter, John Victor; Vijayakumar, Saranya; Sekhar, Dipika; Verghese, Valsan P.; Agarwal, Indira; Moses, Prabhakar D.; Ebenezer, Kala; Abraham, Ooriapadickal Cherian; Thomas, Kurien; Mathews, Prasad; Mishra, Akhilesh C.; Lal, Renu; Muliyil, Jayaprakash; Abraham, Asha Mary			Estimation of the Burden of Pandemic(H1N1)2009 in Developing Countries: Experience from a Tertiary Care Center in South India	PLOS ONE			English	Article							INFLUENZA; VIRUS; INFECTION; MORTALITY; FEATURES	Background: The burden of the pandemic (H1N1) 2009 influenza might be underestimated if detection of the virus is mandated to diagnose infection. Using an alternate approach, we propose that a much higher pandemic burden was experienced in our institution. Methodology/Principal Findings: Consecutive patients (n = 2588) presenting to our hospital with influenza like illness (ILI) or severe acute respiratory infection (SARI) during a 1-year period (May 2009-April 2010) were prospectively recruited and tested for influenza A by real-time RT-PCR. Analysis of weekly trends showed an 11-fold increase in patients presenting with ILI/SARI during the peak pandemic period when compared with the pre-pandemic period and a significant (P < 0.001) increase in SARI admissions during the pandemic period (30+/-15.9 admissions/week) when compared with pre-pandemic (7+/-2.5) and post-pandemic periods (5+/-3.8). However, Influenza A was detected in less than one-third of patients with ILI/SARI [699 (27.0%)]; a majority of these (557/699, 79.7%) were Pandemic (H1N1) 2009 virus [A/H1N1/09]. An A/H1N1/09 positive test was correlated with shorter symptom duration prior to presentation (p = 0.03). More ILI cases tested positive for A/H1N1/09 when compared with SARI (27.4% vs. 14.6%, P = 0.037). When the entire study population was considered, A/H1N1/09 positivity was associated with lower risk of hospitalization (p < 0.0001) and ICU admission (p = 0.013) suggesting mild self-limiting illness in a majority. Conclusion/Significance: Analysis of weekly trends of ILI/SARI suggest a higher burden of the pandemic attributable to A/H1N1/09 than estimates assessed by a positive PCR test alone. The study highlights methodological consideration in the estimation of burden of pandemic influenza in developing countries using hospital-based data that may help assess the impact of future outbreaks of respiratory illnesses.	[Moorthy, Mahesh; Vijayakumar, Saranya; Sekhar, Dipika; Abraham, Asha Mary] Christian Med Coll & Hosp, Dept Clin Virol, Vellore 632004, Tamil Nadu, India; [Samuel, Prasanna] Christian Med Coll & Hosp, Dept Biostat, Vellore 632004, Tamil Nadu, India; [Verghese, Valsan P.; Agarwal, Indira; Moses, Prabhakar D.; Ebenezer, Kala] Christian Med Coll & Hosp, Dept Child Hlth, Vellore 632004, Tamil Nadu, India; [Peter, John Victor; Abraham, Ooriapadickal Cherian; Thomas, Kurien; Mathews, Prasad] Christian Med Coll & Hosp, Dept Med, Vellore 632004, Tamil Nadu, India; [Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India; [Lal, Renu] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resppiratory Dis, Atlanta, GA USA	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Centers for Disease Control & Prevention - USA	Moorthy, M (corresponding author), Christian Med Coll & Hosp, Dept Clin Virol, Vellore 632004, Tamil Nadu, India.	asha_ma@cmcvellore.ac.in	Peter, John Victor/R-7700-2019; Moorthy, Mahesh/J-4486-2019	Moorthy, Mahesh/0000-0001-6040-040X; Abraham, Asha/0000-0002-0736-1445; Vijayakumar, Saranya/0000-0002-5063-6897	Department of Health and Human Services, USA; Indian Council of Medical Research, India [5U50/CI024407-05]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U50CI024407] Funding Source: NIH RePORTER	Department of Health and Human Services, USA; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Department of Health and Human Services, USA and the Indian Council of Medical Research, India (Co-operative Agreement No. 5U50/CI024407-05). Reagents for testing were in addition supplied by the National Institute of Virology, Pune, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P481; [Anonymous], MMWR MORB MORTAL WKL, V59, P682; Broor S, 2011, INFLUENZA OTHER RESP; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644; Cutter JL, 2010, ANN ACAD MED SINGAP, V39, P273; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; John TJ, 2009, INDIAN J MED RES, V130, P101; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Maltezou HC, 2011, VACCINE, V29, P6664, DOI 10.1016/j.vaccine.2011.06.098; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mishra AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010540; Moorthy M, 2011, J HOSP INFECT, V77, P365, DOI 10.1016/j.jhin.2010.12.001; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Muscatello DJ, 2010, EMERG INFECT DIS, V16, P1396, DOI 10.3201/eid1609.091723; *NEW S WAL PUBL HL, 2009, EURO SURVEILL, V14; Shu B, 2011, J CLIN MICROBIOL, V49, P2614, DOI 10.1128/JCM.02636-10; Siau C, 2009, SINGAP MED J, V52, P475; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Van Gageldonk-Lafeber AB, 2011, INFLUENZA OTHER RESP; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Van Kerkhove MD, 2011, INFLUENZA OTHER RESP, DOI [10.1111/j.1750-2659.2011.00249.x, DOI 10.1111/J.1750-2659.2011.00249.X.]; WHO, 2005, INT MAN CHILDH ILLN; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, 2009, PAT CAR CHECK LIST; World Health Organization, 2009, WORLD NOW START 2009; World Health Organization, 2009, CLIN MAN HUM INF PAN	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41507	10.1371/journal.pone.0041507	http://dx.doi.org/10.1371/journal.pone.0041507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957015	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800007
J	Wootton, JT				Wootton, J. Timothy			Effects of Timber Harvest on River Food Webs: Physical, Chemical and Biological Responses	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-KISUTCH; LARGE WOODY DEBRIS; STREAM ECOSYSTEM; COHO SALMON; RIPARIAN BUFFERS; NITRATE REMOVAL; ORGANIC-MATTER; FOREST; USA; PRODUCTIVITY	I compared physical, chemical and biological characteristics of nine rivers running through three timber harvest regimes to investigate the effects of land use on river ecosystems, to determine whether these corresponded to changes linked with downstream location, and to compare the response of different types of indicator variables. Physical variables changed with downstream location, but varied little with timber harvest. Most chemical variables increased strongly with timber harvest, but not with downstream location. Most biological variables did not vary systematically with either timber harvst or downstream location. Dissolved organic carbon did not vary with timber harvest or downstream location, but correlated positively with salmonid abundance. Nutrient manipulations revealed no general pattern of nutrient limitation with timber harvest or downstream location. The results suggest that chemical variables most reliably indicate timber harvest impact in these systems. The biological variables most relevant to human stakeholders were surprisingly insensitive to timber harvest, however, apparently because of decoupling from nutrient responses and unexpectedly weak responses by physical variables.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344	Andrew W. Mellon Foundation; Olympic Natural Resources Center (University of Washington); Division Of Environmental Biology [0919420] Funding Source: National Science Foundation	Andrew W. Mellon Foundation; Olympic Natural Resources Center (University of Washington); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided in part by the Andrew W. Mellon Foundation (http://www.mellon.org/) and the Olympic Natural Resources Center (University of Washington; http://www.onrc.washington.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe TB, 1996, REGUL RIVER, V12, P201, DOI 10.1002/(SICI)1099-1646(199603)12:2/3<201::AID-RRR390>3.0.CO;2-A; Bernot MJ, 2010, FRESHWATER BIOL, V55, P1874, DOI 10.1111/j.1365-2427.2010.02422.x; Bilby RE, 1996, CAN J FISH AQUAT SCI, V53, P164, DOI 10.1139/cjfas-53-1-164; BILBY RE, 1992, CAN J FISH AQUAT SCI, V49, P540, DOI 10.1139/f92-064; Bilby RE, 1998, CAN J FISH AQUAT SCI, V55, P1909, DOI 10.1139/cjfas-55-8-1909; BLAUSTEIN AR, 1994, P NATL ACAD SCI USA, V91, P1791, DOI 10.1073/pnas.91.5.1791; Cirmo CP, 1997, J HYDROL, V199, P88, DOI 10.1016/S0022-1694(96)03286-6; Collins SF, 2011, J N AM BENTHOL SOC, V30, P831, DOI 10.1899/10-164.1; Cottingham KL, 1998, ECOL APPL, V8, P508, DOI 10.2307/2641090; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; FAIRCHILD GW, 1985, ECOLOGY, V66, P465, DOI 10.2307/1940395; Fellman JB, 2009, ECOSYSTEMS, V12, P747, DOI 10.1007/s10021-009-9254-4; Finlay JC, 2011, ECOLOGY, V92, P140, DOI 10.1890/09-2243.1; Flecker AS, 2002, ECOLOGY, V83, P1831, DOI 10.2307/3071768; Franklin J.F., 1988, US DEP AGR FOR SERV, P8; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Ganatsios HP, 2010, FOREST ECOL MANAG, V260, P1367, DOI 10.1016/j.foreco.2010.07.033; GIBEAU GG, 1989, J FRESHWATER ECOL, V5, P171, DOI 10.1080/02705060.1989.9665226; GLEESON SK, 1992, AM NAT, V139, P1322, DOI 10.1086/285389; Hall RO, 2009, LIMNOL OCEANOGR, V54, P653, DOI 10.4319/lo.2009.54.3.0653; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Helton AM, 2011, FRONT ECOL ENVIRON, V9, P229, DOI 10.1890/080211; HOLTBY LB, 1988, CAN J FISH AQUAT SCI, V45, P502, DOI 10.1139/f88-060; Hubbart JA, 2007, FOREST SCI, V53, P169; Janisch JE, 2012, FOREST ECOL MANAG, V270, P302, DOI 10.1016/j.foreco.2011.12.035; JONES JB, 1995, J N AM BENTHOL SOC, V14, P249, DOI 10.2307/1467777; Kiffney PM, 1997, J N AM BENTHOL SOC, V16, P520, DOI 10.2307/1468141; LAMBERTI GA, 1985, FRESHWATER BIOL, V15, P21, DOI 10.1111/j.1365-2427.1985.tb00693.x; LAMBERTI GA, 1991, CAN J FISH AQUAT SCI, V48, P196, DOI 10.1139/f91-027; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Little Edward E., 1994, Advances in Limnology, V43, P217; Marks JC, 2000, OIKOS, V90, P20, DOI 10.1034/j.1600-0706.2000.900103.x; MAYER LM, 1980, LIMNOL OCEANOGR, V25, P12, DOI 10.4319/lo.1980.25.1.0012; McHenry ML, 1998, CAN J FISH AQUAT SCI, V55, P1395, DOI 10.1139/cjfas-55-6-1395; MONTGOMERY DR, 1995, WATER RESOUR RES, V31, P1097, DOI 10.1029/94WR03285; Montgomery DR, 1996, NATURE, V381, P587, DOI 10.1038/381587a0; Mulholland PJ, 2009, LIMNOL OCEANOGR, V54, P666, DOI 10.4319/lo.2009.54.3.0666; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Ralf SC, 1994, CAN J FISH AQUAT SCI, V51, P37; SCHINDLER DW, 1985, SCIENCE, V228, P1395, DOI 10.1126/science.228.4706.1395; Snyder EB, 2002, CAN J FISH AQUAT SCI, V59, P564, DOI 10.1139/F02-021; Swank WT, 2001, FOREST ECOL MANAG, V143, P163, DOI 10.1016/S0378-1127(00)00515-6; TANG SM, 1995, ENVIRON MANAGE, V19, P741, DOI 10.1007/BF02471956; Tank JL, 2003, FRESHWATER BIOL, V48, P1031, DOI 10.1046/j.1365-2427.2003.01067.x; TAYLOR RL, 1986, WATER RESOUR BULL, V22, P629; TUCHMAN ML, 1980, HYDROBIOLOGIA, V75, P73, DOI 10.1007/BF00006564; Turner MG, 1996, ECOL APPL, V6, P1150, DOI 10.2307/2269599; *UNESCO, 1994, IOC MAN GUID, V29; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WARNING R H, 1979, Science (Washington D C), V204, P1380; Webster J. R., 1992, RIVER CONSERVATION M, P231; Webster JR, 2007, J N AM BENTHOL SOC, V26, P375, DOI 10.1899/06-095.1; Wigington PJ, 1998, J AM WATER RESOUR AS, V34, P1035, DOI 10.1111/j.1752-1688.1998.tb04152.x; Wootton JT, 1996, P NATL ACAD SCI USA, V93, P13855, DOI 10.1073/pnas.93.24.13855; WOOTTON JT, 1993, P NATL ACAD SCI USA, V90, P1384, DOI 10.1073/pnas.90.4.1384; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; YEAKLEY JA, 1994, WATER AIR SOIL POLL, V77, P229, DOI 10.1007/BF00478421	59	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43561	10.1371/journal.pone.0043561	http://dx.doi.org/10.1371/journal.pone.0043561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957030	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800022
J	Thiel, WH; Bair, T; Peek, AS; Liu, XY; Dassie, J; Stockdale, KR; Behlke, MA; Miller, FJ; Giangrande, PH				Thiel, William H.; Bair, Thomas; Peek, Andrew S.; Liu, Xiuying; Dassie, Justin; Stockdale, Katie R.; Behlke, Mark A.; Miller, Francis J., Jr.; Giangrande, Paloma H.			Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection	PLOS ONE			English	Article							IN-VITRO SELECTION; SYSTEMATIC EVOLUTION; DNA LIGANDS; GROWTH; SELEX; INHIBITION; BINDING; MOLECULES; SEQUENCES; PROTEINS	Background: The broad applicability of RNA aptamers as cell-specific delivery tools for therapeutic reagents depends on the ability to identify aptamer sequences that selectively access the cytoplasm of distinct cell types. Towards this end, we have developed a novel approach that combines a cell-based selection method (cell-internalization SELEX) with high-throughput sequencing (HTS) and bioinformatics analyses to rapidly identify cell-specific, internalization-competent RNA aptamers. Methodology/Principal Findings: We demonstrate the utility of this approach by enriching for RNA aptamers capable of selective internalization into vascular smooth muscle cells (VSMCs). Several rounds of positive (VSMCs) and negative (endothelial cells; ECs) selection were performed to enrich for aptamer sequences that preferentially internalize into VSMCs. To identify candidate RNA aptamer sequences, HTS data from each round of selection were analyzed using bioinformatics methods: (1) metrics of selection enrichment; and (2) pairwise comparisons of sequence and structural similarity, termed edit and tree distance, respectively. Correlation analyses of experimentally validated aptamers or rounds revealed that the best cell-specific, internalizing aptamers are enriched as a result of the negative selection step performed against ECs. Conclusions and Significance: We describe a novel approach that combines cell-internalization SELEX with HTS and bioinformatics analysis to identify cell-specific, cell-internalizing RNA aptamers. Our data highlight the importance of performing a pre-clear step against a non-target cell in order to select for cell-specific aptamers. We expect the extended use of this approach to enable the identification of aptamers to a multitude of different cell types, thereby facilitating the broad development of targeted cell therapies.	[Thiel, William H.; Bair, Thomas; Liu, Xiuying; Dassie, Justin; Stockdale, Katie R.; Miller, Francis J., Jr.; Giangrande, Paloma H.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Peek, Andrew S.] Roche Mol Syst, San Francisco, CA USA; [Behlke, Mark A.] Integrated DNA Technol, Coralville, IA USA; [Giangrande, Paloma H.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA	University of Iowa; Roche Holding; University of Iowa	Thiel, WH (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	paloma-giangrande@uiowa.edu	Miller Jr, Francis/N-7312-2015; Miller, Francis J/F-3801-2017	Miller Jr, Francis/0000-0001-5822-0549; Miller, Francis J/0000-0001-5822-0549; Behlke, Mark/0000-0002-4218-857X; Thiel, William/0000-0002-2372-2925	National Institutes of Health [NIH 1RO1 CA138503-01, 1R21DE019953-01, NIH 2 T32 HL007121-36]; Mary Kay Ash Foundation [MKACF 001-09]; American Heart Association [AHA 11POST7620018]; NATIONAL CANCER INSTITUTE [R01CA138503] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, T32HL007344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Kay Ash Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by funding to PHG (National Institutes of Health, NIH 1RO1 CA138503-01 and 1R21DE019953-01; Mary Kay Ash Foundation, MKACF 001-09) and WHT (National Institutes of Health, NIH 2 T32 HL007121-36 and American Heart Association, AHA 11POST7620018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051; ALLEN P, 1995, VIROLOGY, V209, P327, DOI 10.1006/viro.1995.1264; Berezhnoy A., 2012, MOL THER; BINKLEY J, 1995, NUCLEIC ACIDS RES, V23, P3198, DOI 10.1093/nar/23.16.3198; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia L, 2010, TRENDS BIOTECHNOL, V28, P517, DOI 10.1016/j.tibtech.2010.07.005; Cerchia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007971; Charlton J, 1997, BIOCHEMISTRY-US, V36, P3018, DOI 10.1021/bi962669h; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fukuda K, 2000, EUR J BIOCHEM, V267, P3685, DOI 10.1046/j.1432-1327.2000.01400.x; Giangrande PH, 2007, P NATL ACAD SCI USA, V104, P12988, DOI 10.1073/pnas.0704754104; GIVER L, 1993, GENE, V137, P19, DOI 10.1016/0378-1119(93)90246-Y; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Guo KT, 2008, INT J MOL SCI, V9, P668, DOI 10.3390/ijms9040668; Hernandez FJ, 2012, NUCLEIC ACID THER, V22, P58, DOI 10.1089/nat.2011.0316; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; JELLINEK D, 1993, P NATL ACAD SCI USA, V90, P11227, DOI 10.1073/pnas.90.23.11227; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Khati M, 2003, J VIROL, V77, P12692, DOI 10.1128/JVI.77.23.12692-12698.2003; Kraus E, 1998, J IMMUNOL, V160, P5209; Kubik MF, 1997, J IMMUNOL, V159, P259; Layzer JM, 2007, OLIGONUCLEOTIDES, V17, P1, DOI 10.1089/oli.2006.0059; Lebruska LL, 1999, BIOCHEMISTRY-US, V38, P3168, DOI 10.1021/bi982515x; Li L, 2009, ANAL BIOANAL CHEM, V393, P2051, DOI 10.1007/s00216-009-2640-0; Liu YM, 2009, J NEUROCHEM, V108, P147, DOI 10.1111/j.1471-4159.2008.05748.x; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lupold SE, 2002, CANCER RES, V62, P4029; Mallikaratchy P, 2006, CHEM COMMUN, P3229, DOI 10.1039/b604778e; Martell RE, 2002, MOL THER, V6, P30, DOI 10.1006/mthe.2002.0624; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Meyer C, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/904750; Mi J, 2005, BIOCHEM BIOPH RES CO, V338, P956, DOI 10.1016/j.bbrc.2005.10.043; Mi J, 2010, NAT CHEM BIOL, V6, P22, DOI [10.1038/NCHEMBIO.277, 10.1038/nchembio.277]; Mi ZY, 2009, MOL THER, V17, P153, DOI 10.1038/mt.2008.235; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Rockey WM, 2011, NUCLEIC ACID THER, V21, P299, DOI 10.1089/nat.2011.0313; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Schutze T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029604; Schutze T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1108; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Theis MG, 2004, P NATL ACAD SCI USA, V101, P11221, DOI 10.1073/pnas.0402901101; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; Thiel KW, 2012, NUCL ACIDS RES; Thiel WH, 2011, NUCLEIC ACID THER, V21, P253, DOI 10.1089/nat.2011.0288; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wullner U, 2008, CURR CANCER DRUG TAR, V8, P554, DOI 10.2174/156800908786241078; Zimmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009169; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	64	84	90	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43836	10.1371/journal.pone.0043836	http://dx.doi.org/10.1371/journal.pone.0043836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962591	Green Submitted, gold, Green Published			2022-12-25	WOS:000308577600019
J	Zakir, HM; Mostafeezur, RM; Suzuki, A; Hitomi, S; Suzuki, I; Maeda, T; Seo, K; Yamada, Y; Yamamura, K; Lev, S; Binshtok, AM; Iwata, K; Kitagawa, J				Zakir, Hossain Md; Mostafeezur, Rahman Md; Suzuki, Akiko; Hitomi, Suzuro; Suzuki, Ikuko; Maeda, Takeyasu; Seo, Kenji; Yamada, Yoshiaki; Yamamura, Kensuke; Lev, Shaya; Binshtok, Alexander M.; Iwata, Koichi; Kitagawa, Junichi			Expression of TRPV1 Channels after Nerve Injury Provides an Essential Delivery Tool for Neuropathic Pain Attenuation	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; INFERIOR ALVEOLAR NERVE; GENE-EXPRESSION; SCHWANN-CELLS; SCIATIC-NERVE; DIFFERENTIAL CHANGES; NOCICEPTIVE NEURONS; POTASSIUM CHANNELS; NUCLEUS CAUDALIS; SENSORY NEURONS	Increased expression of the transient receptor potential vanilloid 1 (TRPV1) channels, following nerve injury, may facilitate the entry of QX-314 into nociceptive neurons in order to achieve effective and selective pain relief. In this study we hypothesized that the level of QX-314/capsaicin (QX-CAP) - induced blockade of nocifensive behavior could be used as an indirect in-vivo measurement of functional expression of TRPV1 channels. We used the QX-CAP combination to monitor the functional expression of TRPV1 in regenerated neurons after inferior alveolar nerve (IAN) transection in rats. We evaluated the effect of this combination on pain threshold at different time points after IAN transection by analyzing the escape thresholds to mechanical stimulation of lateral mental skin. At 2 weeks after IAN transection, there was no QX-CAP mediated block of mechanical hyperalgesia, implying that there was no functional expression of TRPV1 channels. These results were confirmed immunohistochemically by staining of regenerated trigeminal ganglion (TG) neurons. This suggests that TRPV1 channel expression is an essential necessity for the QX-CAP mediated blockade. Furthermore, we show that 3 and 4 weeks after IAN transection, application of QX-CAP produced a gradual increase in escape threshold, which paralleled the increased levels of TRPV1 channels that were detected in regenerated TG neurons. Immunohistochemical analysis also revealed that non-myelinated neurons regenerated slowly compared to myelinated neurons following IAN transection. We also show that TRPV1 expression shifted towards myelinated neurons. Our findings suggest that nerve injury modulates the TRPV1 expression pattern in regenerated neurons and that the effectiveness of QX-CAP induced blockade depends on the availability of functional TRPV1 receptors in regenerated neurons. The results of this study also suggest that the QX-CAP based approach can be used as a new behavioral tool to detect dynamic changes in TRPV1 expression, in various pathological conditions.	[Zakir, Hossain Md; Mostafeezur, Rahman Md; Yamada, Yoshiaki; Yamamura, Kensuke; Kitagawa, Junichi] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Physiol, Dept Oral Biol Sci, Niigata, Japan; [Suzuki, Akiko; Maeda, Takeyasu] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Anat, Dept Oral Biol Sci, Niigata, Japan; [Hitomi, Suzuro; Suzuki, Ikuko; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan; [Seo, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Div Dent Anesthesiol, Dept Oral Biol Sci, Niigata, Japan; [Lev, Shaya; Binshtok, Alexander M.] Hebrew Univ Jerusalem, Sch Med, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Lev, Shaya; Binshtok, Alexander M.] Hebrew Univ Jerusalem, Sch Med, Ctr Res Pain, IL-91010 Jerusalem, Israel	Niigata University; Niigata University; Nihon University; Niigata University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Zakir, HM (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Physiol, Dept Oral Biol Sci, Niigata, Japan.	kitagawa@dent.niigata-u.ac.jp	Rahman, Mostafeezur/N-2738-2013; Hossain, Mohammad Zakir/H-1668-2013	Hossain, Mohammad Zakir/0000-0002-6621-8737; Kitagawa, Junichi/0000-0001-6471-9960; Binshtok, Alexander/0000-0002-3620-8116	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23592730, 22659367]; Grants-in-Aid for Scientific Research [23592730, 23390418] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-Aid for Scientific Research Kakenhi 23592730 and 22659367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; BIANCHI CP, 1967, J PHARMACOL EXP THER, V157, P388; Biggs JE, 2007, EUR J PAIN, V11, P192, DOI 10.1016/j.ejpain.2006.02.004; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2011, INT REV NEUROBIOL, V97, P143, DOI 10.1016/B978-0-12-385198-7.00006-0; BISBY MA, 1986, BRAIN RES, V365, P85, DOI 10.1016/0006-8993(86)90725-0; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campbell JN, 2001, MUSCLE NERVE, V24, P1261, DOI 10.1002/mus.1143; CARTER DA, 1987, J NEUROL SCI, V80, P163, DOI 10.1016/0022-510X(87)90152-3; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Fukuoka T, 2002, PAIN, V99, P111, DOI 10.1016/S0304-3959(02)00067-2; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Ishikawa K, 1999, MUSCLE NERVE, V22, P502, DOI 10.1002/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K; Iwata K, 2001, J NEUROPHYSIOL, V86, P2868, DOI 10.1152/jn.2001.86.6.2868; Jabbar S, 2007, J COMP NEUROL, V501, P400, DOI 10.1002/cne.21256; Kanai Y, 2005, NEUROPHARMACOLOGY, V49, P977, DOI 10.1016/j.neuropharm.2005.05.003; Kim DS, 2001, MOL BRAIN RES, V96, P151, DOI 10.1016/S0169-328X(01)00285-6; Kim HY, 2008, J PAIN, V9, P280, DOI 10.1016/j.jpain.2007.11.013; Kim HY, 2010, PAIN, V150, P29, DOI 10.1016/j.pain.2010.02.016; Kitagawa J, 2005, J NEUROPHYSIOL, V93, P3594, DOI 10.1152/jn.01075.2004; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; KOERBER HR, 1994, J NEUROSCI, V14, P3655; Koerber HR, 1999, J NEUROPHYSIOL, V81, P1636, DOI 10.1152/jn.1999.81.4.1636; Kury P, 2001, CURR OPIN NEUROL, V14, P635, DOI 10.1097/00019052-200110000-00013; LISNEY SJW, 1987, J NEUROL SCI, V80, P289, DOI 10.1016/0022-510X(87)90163-8; Liu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029395; Lozeron P, 2004, J NEUROSCI METH, V138, P225, DOI 10.1016/j.jneumeth.2004.04.012; Luo H, 2004, NEUROREPORT, V15, P655, DOI 10.1097/00001756-200403220-00016; Matsumoto M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-25; Michael GJ, 1999, J NEUROSCI, V19, P1844; Miki K, 1998, NEUROSCIENCE, V82, P1243; Nakagawa K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-9; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; NOGUCHI K, 1994, J NEUROSCI RES, V37, P596, DOI 10.1002/jnr.490370506; NOGUCHI K, 1995, J NEUROSCI, V15, P7633; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; Oaklander AL, 2004, ANN NEUROL, V55, P639, DOI 10.1002/ana.20048; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Obata K, 2003, PAIN, V101, P65, DOI 10.1016/S0304-3959(02)00296-8; OBRIEN RD, 1967, FED PROC, V26, P1056; Okamoto M, 2001, J PHYSIOL-LONDON, V532, P241, DOI 10.1111/j.1469-7793.2001.0241g.x; PRICE DD, 1976, J NEUROPHYSIOL, V39, P936, DOI 10.1152/jn.1976.39.5.936; RITCHIE JM, 1965, J PHARMACOL EXP THER, V150, P152; RITCHIE JM, 1965, J PHARMACOL EXP THER, V150, P160; Robinson PP, 2004, J OROFAC PAIN, V18, P287; Ruocco I, 2000, J COMP NEUROL, V422, P287, DOI 10.1002/(SICI)1096-9861(20000626)422:2<287::AID-CNE9>3.0.CO;2-E; Saito K, 2008, J NEUROPHYSIOL, V99, P2251, DOI 10.1152/jn.00794.2007; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smith DS, 1997, J NEUROSCI, V17, P646; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TERENGHI G, 1995, HISTOL HISTOPATHOL, V10, P709; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Tsuboi Y, 2004, PAIN, V111, P323, DOI 10.1016/j.pain.2004.07.014; Vilceanu D, 2010, J PAIN, V11, P588, DOI 10.1016/j.jpain.2009.09.018; WOOLF CJ, 1992, J NEUROSCI, V12, P3999; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xie WJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-46; Youn SH, 1997, BRAIN RES, V752, P161, DOI 10.1016/S0006-8993(96)01451-5; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	65	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44023	10.1371/journal.pone.0044023	http://dx.doi.org/10.1371/journal.pone.0044023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962595	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600023
J	Caron, NS; Munsie, LN; Keillor, JW; Truant, R				Caron, Nicholas S.; Munsie, Lise N.; Keillor, Jeffrey W.; Truant, Ray			Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells	PLOS ONE			English	Article							LIFETIME IMAGING MICROSCOPY; TISSUE TRANSGLUTAMINASE; HEAT-SHOCK; PROTEIN; LOCALIZATION; MUTATION; DISEASE; SINGLE; CYAN	Transglutaminase type 2 (TG2) is a ubiquitously expressed member of the transglutaminase family, capable of mediating a transamidation reaction between a variety of protein substrates. TG2 also has a unique role as a G-protein with GTPase activity. In response to GDP/GTP binding and increases in intracellular calcium levels, TG2 can undergo a large conformational change that reciprocally modulates the enzymatic activities of TG2. We have generated a TG2 biosensor that allows for quantitative assessment of TG2 conformational changes in live cells using Forster resonance energy transfer (FRET), as measured by fluorescence lifetime imaging microscopy (FLIM). Quantifying FRET efficiency with this biosensor provides a robust assay to quickly measure the effects of cell stress, changes in calcium levels, point mutations and chemical inhibitors on the conformation and localization of TG2 in living cells. The TG2 FRET biosensor was validated using established TG2 conformational point mutants, as well as cell stress events known to elevate intracellular calcium levels. We demonstrate in live cells that inhibitors of TG2 transamidation activity can differentially influence the conformation of the enzyme. The irreversible inhibitor of TG2, NC9, forces the enzyme into an open conformation, whereas the reversible inhibitor CP4d traps TG2 in the closed conformation. Thus, this biosensor provides new mechanistic insights into the action of two TG2 inhibitors and defines two new classes based on ability to alter TG2 conformation in addition to inhibiting transamidation activity. Future applications of this biosensor could be to discover small molecules that specifically alter TG2 conformation to affect GDP/GTP or calcium binding.	[Caron, Nicholas S.; Munsie, Lise N.; Truant, Ray] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Keillor, Jeffrey W.] Univ Ottawa, Dept Chem, Ottawa, ON, Canada	McMaster University; University of Ottawa	Caron, NS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	truantr@mcmaster.ca		Caron, Nicholas/0000-0002-3877-455X	Canadian Institutes of Health Research [MOP-16574]; CHDI Inc. (Los Angeles); Krembil Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CHDI Inc. (Los Angeles); Krembil Foundation	This work was funded by the Canadian Institutes of Health Research, grant MOP-16574, support from CHDI Inc. (Los Angeles) and the Krembil Foundation to RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcor Damien, 2009, V462, P307, DOI 10.1007/978-1-60327-115-8_21; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chen Y, 2003, DIFFERENTIATION, V71, P528, DOI 10.1111/j.1432-0436.2003.07109007.x; Colak G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016665; Cooper AJL, 2002, NEUROCHEM INT, V40, P1, DOI 10.1016/S0197-0186(01)00055-9; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRUMMOND IAS, 1986, MOL CELL BIOL, V6, P1767, DOI 10.1128/MCB.6.5.1767; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kim SY, 2002, NEUROCHEM INT, V40, P85, DOI 10.1016/S0197-0186(01)00064-X; LUNEC J, 1983, RADIAT RES, V93, P588, DOI 10.2307/3576038; Majoul Irina, 2002, J Biotechnol, V82, P267; Munsie L, 2011, HUM MOL GENET, V20, P1937, DOI 10.1093/hmg/ddr075; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Pardin C, 2008, CHEM BIOL DRUG DES, V72, P189, DOI 10.1111/j.1747-0285.2008.00696.x; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Ruan QM, 2008, INT J CLIN EXP MED, V1, P248; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wiemann M, 1998, CALCIFIED TISSUE INT, V63, P154, DOI 10.1007/s002239900507	31	49	49	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44159	10.1371/journal.pone.0044159	http://dx.doi.org/10.1371/journal.pone.0044159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952912	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300057
J	de Bruin, M; Viechtbauer, W				de Bruin, Marijn; Viechtbauer, Wolfgang			The Meaning of Adherence When Behavioral Risk Patterns Vary: Obscured Use- and Method-Effectiveness in HIV-Prevention Trials	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; MALE CIRCUMCISION; SOUTH-AFRICA; INFECTION; WOMEN; MEN; METAANALYSIS; PREVALENCE; EFFICACY; KISUMU	Background: Recently promising trials of innovative biomedical approaches to prevent HIV transmission have been reported. Participants' non-adherence to the prevention methods complicates the analyses and interpretation of trial results. The influence of variable sexual behaviors within and between participants of trials further obscures matters. Current methodological and statistical approaches in HIV-prevention studies, as well as ongoing debates on contradictory trial results, may fail to accurately address these topics. Methodology/Principal Findings: Through developing a cumulative probability model of infection within HIV prevention trials, we demonstrate how adherence and sexual behavior patterns impact the overall estimate of effectiveness, the effectiveness of prevention methods as a function of adherence, and conclusions about methods' true effectiveness. Applying the model to summary-level data from the CAPRISA trial, we observe markedly different values for the true method effectiveness of the microbicide, and show that if the gel would have been tested among women with slightly different sexual behavior patterns, conclusions might well have been that the gel is not effective. Conclusions/Significance: Relative risk and adherence analyses in HIV prevention trials overlook the complex interplay between adherence and sexual behavior patterns. Consequently, they may not provide accurate estimates of use-and method-effectiveness. Moreover, trial conclusions are contingent upon the predominant sexual behavior pattern of participants and cannot be directly generalized to other contexts. We recommend researchers to (re) examine their data and use the cumulative probability model to estimate the true method effectiveness, which might contribute to resolving current questions about contradictory trial results. Moreover, we suggest taking into account the issues raised in the design of future trials and in population models estimating the impact of large-scale dissemination of prevention methods. Comprehension of the topics described will help readers to better interpret (apparently contradictory) trial outcomes.	[de Bruin, Marijn] Wageningen Univ, Dept Commun Sci, Wageningen, Netherlands; [Viechtbauer, Wolfgang] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands	Wageningen University & Research; Maastricht University	de Bruin, M (corresponding author), Wageningen Univ, Dept Commun Sci, Wageningen, Netherlands.	marijn.debruin@wur.nl	Viechtbauer, Wolfgang/M-1549-2013; de Bruin, Marijn/X-8418-2018	Viechtbauer, Wolfgang/0000-0003-3463-4063; de Bruin, Marijn/0000-0003-3100-6803				[Anonymous], COCHRANE DATABASE SY; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; HARTER JG, 1991, ANN NY ACAD SCI, V618, P563, DOI 10.1111/j.1749-6632.1991.tb27276.x; Holtgrave D, 1997, AIDS BEHAV, V1, P169, DOI DOI 10.1023/B:AIBE.0000002977.08417.5E; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lagakos SW, 2008, METHODOLOGICAL CHALL; Mattson CL, 2010, AIDS BEHAV, V14, P162, DOI 10.1007/s10461-008-9423-z; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; PINKERTON SD, 1998, HDB EC EVALUATION HI, P13; Pinkerton SD, 2010, EVALUATION REV, V34, P19, DOI 10.1177/0193841X09353534; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011600; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011632; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Rottingen JA, 2002, SEX TRANSM DIS, V29, P818, DOI 10.1097/00007435-200212000-00014; Shisana O, 2009, S AFRICAN NATL HIV P; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Turner AN, 2009, J CLIN EPIDEMIOL, V62, P759, DOI 10.1016/j.jclinepi.2008.07.011; UNAIDS, 2010, REP GLOB AIDS EP; Urquhart J, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_A.8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vickerman P, 2008, JAIDS-J ACQ IMM DEF, V48, P460, DOI 10.1097/QAI.0b013e31817aebd6; Vrijens B, 1997, CONTROL CLIN TRIALS, V18, P187, DOI 10.1016/S0197-2456(96)00235-8; Weiss HA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-8; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44029	10.1371/journal.pone.0044029	http://dx.doi.org/10.1371/journal.pone.0044029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22970107	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300043
J	de Magny, GC; Thiaw, W; Kumar, V; Manga, NM; Diop, BM; Gueye, L; Kamara, M; Roche, B; Murtugudde, R; Colwell, RR				de Magny, Guillaume Constantin; Thiaw, Wassila; Kumar, Vadlamani; Manga, Noel M.; Diop, Bernard M.; Gueye, Lamine; Kamara, Mamina; Roche, Benjamin; Murtugudde, Raghu; Colwell, Rita R.			Cholera Outbreak in Senegal in 2005: Was Climate a Factor?	PLOS ONE			English	Article							GLOBAL CLIMATE; INFECTIOUS-DISEASE; TEMPERATURE; EPIDEMICS; VARIABILITY; RAINFALL	Cholera is an acute diarrheal illness caused by Vibrio cholerae and occurs as widespread epidemics in Africa. In 2005, there were 31,719 cholera cases, with 458 deaths in the Republic of Senegal. We retrospectively investigated the climate origin of the devastating floods in mid-August 2005, in the Dakar Region of Senegal and the subsequent outbreak of cholera along with the pattern of cholera outbreaks in three other regions of that country. We compared rainfall patterns between 2002 and 2005 and the relationship between the sea surface temperature (SST) gradient in the tropical Atlantic Ocean and precipitation over Senegal for 2005. Results showed a specific pattern of rainfall throughout the Dakar region during August, 2005, and the associated rainfall anomaly coincided with an exacerbation of the cholera epidemic. Comparison of rainfall and epidemiological patterns revealed that the temporal dynamics of precipitation, which was abrupt and heavy, was presumably the determining factor. Analysis of the SST gradient showed that the Atlantic Ocean SST variability in 2005 differed from that of 2002 to 2004, a result of a prominent Atlantic meridional mode. The influence of this intense precipitation on cholera transmission over a densely populated and crowded region was detectable for both Dakar and Thies, Senegal. Thus, high resolution rainfall forecasts at subseasonal time scales should provide a way forward for an early warning system in Africa for cholera and, thereby, trigger epidemic preparedness. Clearly, attention must be paid to both natural and human induced environmental factors to devise appropriate action to prevent cholera and other waterborne disease epidemics in the region.	[de Magny, Guillaume Constantin] Ctr Rech IRD, MIVEGEC, UMR CNRS IRD UM1&2 5290, Montpellier, France; [Thiaw, Wassila; Kumar, Vadlamani] Climate Predict Ctr, Natl Ctr Environm Predict, Camp Springs, MD USA; [Manga, Noel M.; Diop, Bernard M.] Ctr Natl & Univ Fann, Clin Malad Infect, Dakar, Senegal; [Gueye, Lamine] Univ Cheikh Anta Diop Dakar UCAD, Unite Mixte Int Rech Environm Sante Soc UMI 3189, Dakar, Senegal; [Kamara, Mamina] Agence Natl Meteorol Senegal, Aeroport Leopold Sedar SENGHOR, Direct Meteorol Natl, Dakar Yoff, Senegal; [Roche, Benjamin] Ctr IRD Bondy, UMI IRD UPMC UMMISCO 209, Bondy, France; [Murtugudde, Raghu] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Colwell, Rita R.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Colwell, Rita R.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Colwell, Rita R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth, Baltimore, MD USA	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; National Oceanic Atmospheric Admin (NOAA) - USA; University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	de Magny, GC (corresponding author), Ctr Rech IRD, MIVEGEC, UMR CNRS IRD UM1&2 5290, Montpellier, France.	guillaume.demagny@ird.fr	, Nobody/M-9571-2019; Constantin de Magny, Guillaume/L-6706-2017	Roche, Benjamin/0000-0001-7975-4232	National Oceanic and Atmospheric Administration (NOAA) [S0660009]; National Institutes of Health [R01A139129-01]; NASA PO; ONR DYNAMO	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA PO; ONR DYNAMO	GCdeM and RRC were funded by National Oceanic and Atmospheric Administration (NOAA) grant no. S0660009 and National Institutes of Health grant no. R01A139129-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RM gratefully acknowledges his NASA PO and ONR DYNAMO grants for partial support.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P297; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P309; Chang P, 1997, NATURE, V385, P516, DOI 10.1038/385516a0; Chiang JCH, 2002, J CLIMATE, V15, P2616, DOI 10.1175/1520-0442(2002)015<2616:TTTVCB>2.0.CO;2; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; de Magny G.C., 2005, CEMRACS 2004 MATH AP, V14, P156, DOI [10.1051/proc:2005013, DOI 10.1051/PROC:200501, DOI 10.1051/PROC:2005013]; de Magny GC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-20; de Magny GC, 2006, ECOHEALTH, V3, P223, DOI 10.1007/s10393-006-0061-5; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Fall S, 2006, INT J CLIMATOL, V26, P2057, DOI 10.1002/joc.1355; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; Hashizume M, 2008, J WATER HEALTH, V6, P323, DOI 10.2166/wh.2008.062; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; IPCC, 2007, CLIM CHANG 2007; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Love TB, 2004, P 84 AMS ANN M SEATT, P54; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; Mendelsohn J, 2008, INT J HYG ENVIR HEAL, V211, P156, DOI 10.1016/j.ijheh.2006.12.002; Murtugudde RG, 2001, GEOPHYS RES LETT, V28, P4463, DOI 10.1029/2001GL013407; Ndiaye M, 2005, INONDATIONS DAKAR EC, P4; Ndour C T, 2006, Med Trop (Mars), V66, P33; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Patz JA, 2002, P NATL ACAD SCI USA, V99, P12506, DOI 10.1073/pnas.212467899; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Service Regional de la Statistique et de la Demographie de Diourbel, 2006, SIT EC SOC REG DAK; Shumway RH, 2006, TIME SERIES ANAL ITS, pxiii; Sun Y, 2007, J CLIMATE, V20, P4801, DOI 10.1175/JCLI4263.1; Thiaw W, 2006, RECENT CLIMATE ANOMA; United Nations, 2009, FLOODS AFF 600000 PE; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; World Health Organization, 2008, CHOL COUNTR PROF SEN, P2; World Health Organization, 2009, CHOL SURV NUMB CAS; World Health Organization, 1993, GUID LUTT CHOL	42	39	39	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44577	10.1371/journal.pone.0044577	http://dx.doi.org/10.1371/journal.pone.0044577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952995	Green Submitted, gold, Green Published			2022-12-25	WOS:000308221300100
J	Gao, N; Luo, JL; Uray, K; Qian, AH; Yin, SJ; Wang, GD; Wang, XY; Xia, Y; Wood, JD; Hu, HZ				Gao, Na; Luo, Jialie; Uray, Karen; Qian, Aihua; Yin, Shijin; Wang, Guodu; Wang, Xiyu; Xia, Yun; Wood, Jackie D.; Hu, Hongzhen			CaMKII Is Essential for the Function of the Enteric Nervous System	PLOS ONE			English	Article							PIG SMALL-INTESTINE; DEPENDENT PROTEIN-KINASE; NK1 TACHYKININ RECEPTORS; GASTROINTESTINAL-TRACT; SYNAPTIC-TRANSMISSION; INTERSTITIAL-CELLS; MYENTERIC NEURONS; SUBMUCOUS PLEXUS; MUSCLE; AUTOPHOSPHORYLATION	Background: Ca2+/calmodulin-dependent protein kinases (CaMKs) are major downstream mediators of neuronal calcium signaling that regulate multiple neuronal functions. CaMKII, one of the key CaMKs, plays a significant role in mediating cellular responses to external signaling molecules. Although calcium signaling plays an essential role in the enteric nervous system (ENS), the role of CaMKII in neurogenic intestinal function has not been determined. In this study, we investigated the function and expression pattern of CaMKII in the ENS across several mammalian species. Methodology/Principal Findings: CaMKII expression was characterized by immunofluorescence analyses and Western Blot. CaMKII function was examined by intracellular recordings and by assays of colonic contractile activity. Immunoreactivity for CaMKII was detected in the ENS of guinea pig, mouse, rat and human preparations. In guinea pig ENS, CaMKII immunoreactivity was enriched in both nitric oxide synthase (NOS)- and calretinin-containing myenteric plexus neurons and non-cholinergic secretomotor/vasodilator neurons in the submucosal plexus. CaMKII immunoreactivity was also expressed in both cholinergic and non-cholinergic neurons in the ENS of mouse, rat and human. The selective CaMKII inhibitor, KN-62, suppressed stimulus-evoked purinergic slow EPSPs and ATP-induced slow EPSP-like response in guinea pig submucosal plexus, suggesting that CaMKII activity is required for some metabotropic synaptic transmissions in the ENS. More importantly, KN-62 significantly suppressed tetrodotoxin-induced contractile response in mouse colon, which suggests that CaMKII activity is a major determinant of the tonic neurogenic inhibition of this tissue. Conclusion: ENS neurons across multiple mammalian species express CaMKII. CaMKII signaling constitutes an important molecular mechanism for controlling intestinal motility and secretion by regulating the excitability of musculomotor and secretomotor neurons. These findings revealed a fundamental role of CaMKII in the ENS and provide clues for the treatment of intestinal dysfunctions.	[Gao, Na; Luo, Jialie; Qian, Aihua; Yin, Shijin; Hu, Hongzhen] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA; [Uray, Karen] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX USA; [Wang, Guodu; Wang, Xiyu; Wood, Jackie D.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Xia, Yun] Ohio State Univ, Coll Med, Dept Anesthesiol, Columbus, OH 43210 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gao, N (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA.	wood.13@osu.edu; Hongzhen.Hu@uth.tmc.edu	wang, xiyu/GYA-4086-2022	Uray, Karen/0000-0001-6997-459X; Hu, Hongzhen/0000-0002-8967-7522	United States National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [DK56338]; Texas Medical Center Digestive Diseases Center [0008355]; Mission Connect/The Institute for Rehabilitation and Research (TIRR) Foundation [011-101]; University of Texas Health Science Center; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK37238]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037238, P30DK056338] Funding Source: NIH RePORTER	United States National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Texas Medical Center Digestive Diseases Center; Mission Connect/The Institute for Rehabilitation and Research (TIRR) Foundation; University of Texas Health Science Center; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported partly by grants from the United States National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases grant DK56338, which supports the Texas Medical Center Digestive Diseases Center to HH (0008355) and Mission Connect/The Institute for Rehabilitation and Research (TIRR) Foundation to HH (011-101), the University of Texas Health Science Center to HH, and the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to JDW (R01 DK37238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaeser F, 2006, MOL CELL BIOL, V26, P9105, DOI 10.1128/MCB.01452-06; Bolton TB, 1999, ANNU REV PHYSIOL, V61, P85, DOI 10.1146/annurev.physiol.61.1.85; Costa M, 2008, EUR REV MED PHARMACO, V12, P3; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fang XC, 2006, EUR J PHARMACOL, V536, P113, DOI 10.1016/j.ejphar.2006.02.040; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Gwynne RM, 2007, CURR NEUROPHARMACOL, V5, P1, DOI 10.2174/157015907780077141; Gwynne RM, 2009, AM J PHYSIOL-GASTR L, V297, pG179, DOI 10.1152/ajpgi.90700.2008; Hu HZ, 2004, J PHARMACOL EXP THER, V309, P310, DOI 10.1124/jpet.103.059204; Hu HZ, 2003, J PHYSIOL-LONDON, V550, P493, DOI 10.1113/jphysiol.2003.041731; Hu HZ, 2002, J COMP NEUROL, V442, P189, DOI 10.1002/cne.1424; JEITNER TM, 1991, NEUROSCIENCE, V40, P555, DOI 10.1016/0306-4522(91)90141-A; Koh SD, 1999, J PHYSIOL-LONDON, V517, P75, DOI 10.1111/j.1469-7793.1999.0075z.x; Lin Z, 2002, NEUROGASTROENT MOTIL, V14, P197, DOI 10.1046/j.1365-2982.2002.00317.x; Lomax AEG, 1998, CELL TISSUE RES, V294, P27, DOI 10.1007/s004410051153; Lorenz JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1399, DOI 10.1152/ajpcell.00020.2002; MATOVCIK LM, 1993, AM J PHYSIOL, V264, pC1029, DOI 10.1152/ajpcell.1993.264.4.C1029; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Monro RL, 2004, J PHYSIOL-LONDON, V556, P571, DOI 10.1113/jphysiol.2004.060848; Okuno Y., 2011, Autonomic & Autacoid Pharmacology, V31, P21, DOI 10.1111/j.1474-8673.2011.00462.x; Perrino BA, 2011, ARCH BIOCHEM BIOPHYS, V510, P174, DOI 10.1016/j.abb.2011.03.009; Poole DP, 2004, HISTOCHEM CELL BIOL, V121, P21, DOI 10.1007/s00418-003-0602-8; Poole DP, 2003, HISTOCHEM CELL BIOL, V120, P51, DOI 10.1007/s00418-003-0541-4; Portbury AL, 1996, J COMP NEUROL, V367, P342, DOI 10.1002/(SICI)1096-9861(19960408)367:3<342::AID-CNE2>3.0.CO;2-5; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01406.x; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, pe164; Sanders KM, 2010, J PHYSIOL-LONDON, V588, P4621, DOI 10.1113/jphysiol.2010.196030; Schneider J, 2001, NEUROGASTROENT MOTIL, V13, P255, DOI 10.1046/j.1365-2982.2001.00265.x; Schulman H, 2004, J NEUROSCI, V24, P8399, DOI 10.1523/JNEUROSCI.3606-04.2004; Tack J, 2004, NEUROGASTROENT MOTIL, V16, P86, DOI 10.1111/j.1743-3150.2004.00481.x; Thornton PDJ, 2002, J PHYSIOL-LONDON, V539, P589, DOI 10.1113/jphysiol.2001.013399; Turner D J, 1999, Int J Surg Investig, V1, P87; Uemura S, 1995, ARCH HISTOL CYTOL, V58, P523, DOI 10.1679/aohc.58.523; Uray KS, 2011, SURGERY, V149, P114, DOI 10.1016/j.surg.2010.04.001; Vincent KM, 2011, NEUROGASTROENT MOTIL, V23, pE282, DOI 10.1111/j.1365-2982.2011.01673.x; Vittone L, 2008, FRONT BIOSCI-LANDMRK, V13, P5988, DOI 10.2741/3131; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wood JD, 2008, CURR OPIN GASTROEN, V24, P149, DOI 10.1097/MOG.0b013e3282f56125; Wood JD, 2010, CURR OPIN GASTROEN, V26, P102, DOI 10.1097/MOG.0b013e328334df4f; Wood JD, 2004, NEUROGASTROENT MOTIL, V16, P71, DOI 10.1111/j.1743-3150.2004.00479.x; WOOD JD, 1972, AM J PHYSIOL, V222, P118, DOI 10.1152/ajplegacy.1972.222.1.118	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44426	10.1371/journal.pone.0044426	http://dx.doi.org/10.1371/journal.pone.0044426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952977	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300090
J	Hanberry, BB; He, HS; Palik, BJ				Hanberry, Brice B.; He, Hong S.; Palik, Brian J.			Pseudoabsence Generation Strategies for Species Distribution Models	PLOS ONE			English	Article							PRESENCE-ONLY DATA; CLASSIFIER PERFORMANCE; THRESHOLD CRITERIA; PSEUDO-ABSENCES; SAMPLE-SIZE; PREVALENCE; SELECTION; ACCURACY	Background: Species distribution models require selection of species, study extent and spatial unit, statistical methods, variables, and assessment metrics. If absence data are not available, another important consideration is pseudoabsence generation. Different strategies for pseudoabsence generation can produce varying spatial representation of species. Methodology: We considered model outcomes from four different strategies for generating pseudoabsences. We generating pseudoabsences randomly by 1) selection from the entire study extent, 2) a two-step process of selection first from the entire study extent, followed by selection for pseudoabsences from areas with predicted probability <25%, 3) selection from plots surveyed without detection of species presence, 4) a two-step process of selection first for pseudoabsences from plots surveyed without detection of species presence, followed by selection for pseudoabsences from the areas with predicted probability <25%. We used Random Forests as our statistical method and sixteen predictor variables to model tree species with at least 150 records from Forest Inventory and Analysis surveys in the Laurentian Mixed Forest province of Minnesota. Conclusions: Pseudoabsence generation strategy completely affected the area predicted as present for species distribution models and may be one of the most influential determinants of models. All the pseudoabsence strategies produced mean AUC values of at least 0.87. More importantly than accuracy metrics, the two-step strategies over-predicted species presence, due to too much environmental distance between the pseudoabsences and recorded presences, whereas models based on random pseudoabsences under-predicted species presence, due to too little environmental distance between the pseudoabsences and recorded presences. Models using pseudoabsences from surveyed plots produced a balance between areas with high and low predicted probabilities and the strongest relationship between density and area with predicted probabilities >= 75%. Because of imperfect accuracy assessment, the best assessment currently may be evaluation of whether the species has been sufficiently but not excessively predicted to occur.	[Hanberry, Brice B.; He, Hong S.] Univ Missouri, Dept Forestry, Columbia, MO 65211 USA; [Palik, Brian J.] US Forest Serv, USDA, No Res Stn, Grand Rapids, MN USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service	Hanberry, BB (corresponding author), Univ Missouri, Dept Forestry, Columbia, MO 65211 USA.	hanberryb@missouri.edu		Palik, Brian/0000-0003-0300-9644; Hanberry, Brice/0000-0001-8657-9540; He, Hong S./0000-0002-3983-2512	National Fire Plan of the USDA Forest Service, Northern Research Station	National Fire Plan of the USDA Forest Service, Northern Research Station	Funding was provided by the National Fire Plan of the USDA Forest Service, Northern Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; BEERS TW, 1966, J FOREST, V64, P691; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; ECOMAP, 1993, NAT HIER FRAM EC UN; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Gomez-Rodriguez C, 2012, DIVERS DISTRIB, V18, P260, DOI 10.1111/j.1472-4642.2011.00837.x; Hanczar B, 2010, BIOINFORMATICS, V26, P822, DOI 10.1093/bioinformatics/btq037; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lutolf M, 2006, J APPL ECOL, V43, P802, DOI 10.1111/j.1365-2664.2006.01191.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Santika T, 2011, GLOBAL ECOL BIOGEOGR, V20, P181, DOI 10.1111/j.1466-8238.2010.00581.x; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; VanDerWal J, 2009, ECOLOGICAL MODELLING, V220, P598; Ward G, 2009, BIOMETRICS, V65, P554, DOI 10.1111/j.1541-0420.2008.01116.x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	28	23	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44486	10.1371/journal.pone.0044486	http://dx.doi.org/10.1371/journal.pone.0044486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952985	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300094
J	Zhu, YC; Hua, WQ; Xu, M; He, W; Wang, XT; Dai, Y; Zhao, S; Tang, JX; Wang, SX; Lu, S				Zhu, Yinchang; Hua, Wanquan; Xu, Ming; He, Wei; Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia; Wang, Shixia; Lu, Shan			A Novel Immunodiagnostic Assay to Detect Serum Antibody Response against Selected Soluble Egg Antigen Fractions from Schistosoma japonicum	PLOS ONE			English	Article							DIPSTICK DYE IMMUNOASSAY	Background: Schistosomiasis japonica remains a real threat to public health in China. The currently used immunodiagnostic assays are sensitive and have a certain degree of specificity, however, they all use complex crude antigens, are based on detection of schistosome-specific antibodies, and have been shown to cross-react with other parasitic diseases. Therefore, these assays cannot be used to evaluate chemotherapy efficacy. The development of highly sensitive and highly specific immunodiagnostic techniques that can monitor the decline of antibodies specific for S. japonica will be extremely valuable as part of the ongoing strategy to control schistosomiasis in endemic areas. Here we report on the identification of unique fraction antigens of soluble egg antigen (SEA) to which the antibodies disappear 7 weeks after effective treatment. Furthermore, we use these SEA fractions to develop a modified assay with both high sensitivity and specificity. Methodology/Principal Findings: SEA of S. japonicum was fractionated by electrophoresis using 7.5% SDS-PAGE under non-reducing conditions. The SEA fraction antigens to which antibodies were decreased soon after treatment were collected and used as the detection antigens to establish the FA-ELISA. Sera from patients with acute and chronic schistosomiasis infection, healthy people, and those with other parasitic diseases, were used to evaluate their sensitivity and specificity. Furthermore, sera from patients with chronic schistosomiasis infection were evaluated before and after treatment at different time points to evaluate their chemotherapeutic efficacy. Conclusion/Significance: We demonstrated that this novel FA-ELISA provided high sensitivity and specificity, with very low cross-reactivity, and can serve as an effective tool to determine the efficacy of chemotherapy against S. japonicum.	[Zhu, Yinchang; Hua, Wanquan; Xu, Ming; He, Wei; Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia] Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China; [Zhu, Yinchang; Hua, Wanquan; Xu, Ming; He, Wei; Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia] Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Mol Biol Parasites, Wuxi, Jiangsu, Peoples R China; [Zhu, Yinchang] Wuxi Hosp Maternal & Child Hlth Care, Wuxi, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Jiangsu Prov Hosp, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA USA	Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester	Zhu, YC (corresponding author), Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China.	yczhu2006@yahoo.com.cn	Wang, Xiaoting/AAI-3159-2020		Ministry of Health/ the Special Programme for Research and Training in Tropical Diseases (MOH/TDR) Joint Research Management Committee part of the World Bank Loan Project in China [JRMC:5-26]; National Natural Science Foundation of China [81000749, 81000748]; Natural Science Foundation of Jiangsu Province [BK2010152]	Ministry of Health/ the Special Programme for Research and Training in Tropical Diseases (MOH/TDR) Joint Research Management Committee part of the World Bank Loan Project in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The project was funded by Ministry of Health/ the Special Programme for Research and Training in Tropical Diseases (MOH/TDR) Joint Research Management Committee (JRMC:5-26) as part of the World Bank Loan Project in China, National Natural Science Foundation of China (81000749, 81000748), Natural Science Foundation of Jiangsu Province (BK2010152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGQUIST NR, 1992, MEM I OSWALDO CRUZ, V87, P29, DOI 10.1590/S0074-02761992000800004; Department of Parasitology Hunan Medical University Hunan Institute of parasitic Diseases Hunan Expert Committee on schistosomiasis, 1995, CHIN J PARASITOL PAR, V13, P277; Guan XiaoHong, 1996, Chinese Journal of Schistosomiasis Control, V8, P72; Hao Yang, 2009, Chinese Journal of Schistosomiasis Control, V21, P451; Lei Zheng-long, 2011, Zhongguo Xuexichongbing Fangzhi Zazhi, V23, P599; LI Y, 1991, IMMUNOLOGY IMMUNODIA, P210; Lin Dan-Dan, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P642; Lin DanDan, 2009, Chinese Journal of Schistosomiasis Control, V21, P1; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Wang TianPing, 2009, Chinese Journal of Schistosomiasis Control, V21, P241; Wu GL, 2002, ACTA TROP, V82, P193, DOI 10.1016/S0001-706X(02)00010-4; ZHAO WX, 1993, CHINESE MED J-PEKING, V106, P623; Zhou Xiao-Nong, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P1; Zhu HongQing, 2005, Chinese Journal of Schistosomiasis Control, V17, P273; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007; Zhu YC, 2005, ACTA TROP, V96, P137, DOI 10.1016/j.actatropica.2005.07.008; Zhu YC, 2002, J IMMUNOL METHODS, V266, P1, DOI 10.1016/S0022-1759(02)00086-8; Zhu YC, 2008, IMMUNOLOGY SCHISTOSO, P158	19	15	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44032	10.1371/journal.pone.0044032	http://dx.doi.org/10.1371/journal.pone.0044032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952862	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300044
J	Limberger, R; Wickham, SA				Limberger, Romana; Wickham, Stephen A.			Transitory versus Persistent Effects of Connectivity in Environmentally Homogeneous Metacommunities	PLOS ONE			English	Article							SPECIES-DIVERSITY; DISPERSAL; BIODIVERSITY; COMPETITION; DISTURBANCE; STABILITY; RICHNESS	While the effect of habitat connectivity on local and regional diversity has been analysed in a number of studies, time-dependent dynamics in metacommunities have received comparatively little consideration. When local patches of a metacommunity are identical in environmental conditions but differ in initial community composition, dispersal among patches may result in homogenization of local communities. In a microcosm experiment with benthic ciliates, we tested the hypothesis that the effect of connectivity on diversity is time-dependent and only transitory, with the degree of connectivity affecting the time to homogenization but not the final outcome. Six microcosms were connected to a metacommunity with one of three levels of connectivity. The six patches differed in initial community composition but were identical in environmental conditions. We found a time-dependent and transitory effect of connectivity on local and regional richness and on local Shannon diversity, while Bray-Curtis dissimilarity and regional Shannon diversity were persistently affected by connectivity. Local richness increased and regional richness decreased with connectivity during the initial phase of the experiment but soon converged to similar values in all three connectivity treatments. Local Shannon diversity was unimodally related to time, with maximum diversity reached sooner with high than with medium or low connectivity. Eventually, however, local diversity converged to similar values irrespective of connectivity. At the regional scale, Shannon diversity was persistently lower with high than with low connectivity. While initial differences in community composition vanished with medium and high connectivity, they were maintained with low connectivity resulting in persistently high beta and regional diversity. The effect of connectivity on ciliate community composition translated down to the algal resource, as stronger dominance of the superior competitor with high and medium connectivity resulted in stronger depletion of the resource.	[Limberger, Romana] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Limberger, Romana; Wickham, Stephen A.] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria	McGill University; Salzburg University	Limberger, R (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	romana.limberger@mail.mcgill.ca		Limberger, Romana/0000-0002-9421-7520	Austrian Science Fund, FWF [P19117-B17]; University of Salzburg	Austrian Science Fund, FWF(Austrian Science Fund (FWF)); University of Salzburg	This study was funded by the Austrian Science Fund, FWF, grant P19117-B17 to S. Wickham and a Marie-Andessner scholarship of the University of Salzburg to R. Limberger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019525; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Cadotte MW, 2005, ECOL LETT, V8, P548, DOI 10.1111/j.1461-0248.2005.00750.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chisholm C, 2011, ECOGRAPHY, V34, P415, DOI 10.1111/j.1600-0587.2010.06588.x; Fukami Tadashi, 2010, P45; Gilbert F, 1998, P ROY SOC B-BIOL SCI, V265, P577, DOI 10.1098/rspb.1998.0333; Howeth JG, 2008, ECOL LETT, V11, P245, DOI 10.1111/j.1461-0248.2007.01143.x; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Kunte K, 2008, OIKOS, V117, P69, DOI 10.1111/j.2007.0030-1299.16125.x; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Limberger R, 2012, OECOLOGIA, V168, P785, DOI 10.1007/s00442-011-2140-8; Limberger R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029071; Limberger R, 2011, OECOLOGIA, V167, P723, DOI 10.1007/s00442-011-2013-1; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Marie D., 2005, ALGAL CULTURING TECH, P253, DOI DOI 10.1016/B978-012088426-1/50018-4; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; Matthiessen B, 2010, HYDROBIOLOGIA, V653, P65, DOI 10.1007/s10750-010-0349-x; Matthiessen B, 2010, ECOLOGY, V91, P2022, DOI 10.1890/09-1395.1; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2003, OIKOS, V103, P618, DOI 10.1034/j.1600-0706.2003.12772.x; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Verreydt D, 2012, ECOL LETT, V15, P218, DOI 10.1111/j.1461-0248.2011.01728.x; Warren PH, 1996, OIKOS, V77, P317, DOI 10.2307/3546071; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449	34	10	10	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44555	10.1371/journal.pone.0044555	http://dx.doi.org/10.1371/journal.pone.0044555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952993	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500077
J	Ouchida, M; Kanzaki, H; Ito, S; Hanafusa, H; Jitsumori, Y; Tamaru, S; Shimizu, K				Ouchida, Mamoru; Kanzaki, Hirotaka; Ito, Sachio; Hanafusa, Hiroko; Jitsumori, Yoshimi; Tamaru, Seiji; Shimizu, Kenji			Novel Direct Targets of miR-19a Identified in Breast Cancer Cells by a Quantitative Proteomic Approach	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; MIR-17-92 CLUSTER; MICROARRAY ANALYSIS; MICRORNAS; PROLIFERATION; EXPRESSION; PREDICTION; GENES; ESTABLISHMENT; MIR-20A	The miR-17-92 cluster encodes 7 miRNAs inside a single polycistronic transcript, and is known as a group of oncogenic miRNAs that contribute to tumorigenesis in several cancers. However, their direct targets remain unclear, and it has been suggested that a single miRNA is capable of reducing the production of hundreds of proteins. The majority of reports on the identification of miRNA targets are based on computational approaches or the detection of altered mRNA levels, despite the fact that most miRNAs are thought to regulate their targets primarily by translational inhibition in higher organisms. In this study, we examined the target profiles of miR-19a, miR-20a and miR-92-1 in MCF-7 breast cancer cells by a quantitative proteomic strategy to identify their direct targets. A total of 123 proteins were significantly increased after the endogenous miR-19a, miR-20a and miR-92-1 were knocked down, and were identified as potential targets by two-dimensional electrophoresis and a mass spectrometric analysis. Among the upregulated proteins, four (PPP2R2A, ARHGAP1, IMPDH1 and NPEPL1) were shown to have miR-19a or miR-20a binding sites on their mRNAs. The luciferase activity of the plasmids with each binding site was observed to decrease, and an increased luciferase activity was observed in the presence of the specific anti-miRNA-LNA. A Western blot analysis showed the expression levels of IMPDH1 and NPEPL1 to increase after treatment with anti-miR-19a, while the expression levels of PPP2R2A and ARHGAP1 did not change. The expression levels of IMPDH1 and NPEPL1 did not significantly change by anti-miR-19a-LNA at the mRNA level. These results suggest that the IMPDH1 and NPEPL1 genes are direct targets of miR-19a in breast cancer, while the exogenous expression of these genes is not associated with the growth suppression of MCF-7 cells. Furthermore, our proteomic approaches were shown to be valuable for identifying direct miRNA targets.	[Ouchida, Mamoru; Kanzaki, Hirotaka; Ito, Sachio; Hanafusa, Hiroko; Jitsumori, Yoshimi; Shimizu, Kenji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama 7008530, Japan; [Tamaru, Seiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Cent Res Lab, Okayama 7008530, Japan; [Kanzaki, Hirotaka] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Okayama University; Okayama University; Cedars Sinai Medical Center	Ouchida, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama 7008530, Japan.	ouchidam@md.okayama-u.ac.jp			New Energy and Industrial Technology Development Organization; Okayama University Budget for Centers of Excellence	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Okayama University Budget for Centers of Excellence	This work was supported by grants from the New Energy and Industrial Technology Development Organization (to KS), and from the Okayama University Budget for Centers of Excellence (to KS and MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; COLLART FR, 1988, J BIOL CHEM, V263, P15769; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kanzaki H, 2011, PROTEOMICS, V11, P3531, DOI 10.1002/pmic.201000501; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Martin G, 2007, J BIOSCIENCES, V32, P1049, DOI 10.1007/s12038-007-0106-0; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; SONOBE H, 1992, LAB INVEST, V67, P498; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	44	37	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44095	10.1371/journal.pone.0044095	http://dx.doi.org/10.1371/journal.pone.0044095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952885	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500045
J	Hoef-Emden, K				Hoef-Emden, Kerstin			Pitfalls of Establishing DNA Barcoding Systems in Protists: The Cryptophyceae as a Test Case	PLOS ONE			English	Article							GENUS CRYPTOMONAS CRYPTOPHYCEAE; INTERNAL TRANSCRIBED SPACERS; MOLECULAR PHYLOGENY; PLASTID GENOME; SPECIES DELIMITATION; MITOCHONDRIAL GENOME; INTRAGENOMIC VARIATION; EVOLUTIONARY RATES; SEQUENCE ALIGNMENT; RDNA PHYLOGENY	A DNA barcode is a preferrably short and highly variable region of DNA supposed to facilitate a rapid identification of species. In many protistan lineages, a lack of species-specific morphological characters hampers an identification of species by light or electron microscopy, and difficulties to perform mating experiments in laboratory cultures also do not allow for an identification of biological species. Thus, testing candidate barcode markers as well as establishment of accurately working species identification systems are more challenging than in multicellular organisms. In cryptic species complexes the performance of a potential barcode marker can not be monitored using morphological characters as a feedback, but an inappropriate choice of DNA region may result in artifactual species trees for several reasons. Therefore a priori knowledge of the systematics of a group is required. In addition to identification of known species, methods for an automatic delimitation of species with DNA barcodes have been proposed. The Cryptophyceae provide a mixture of systematically well characterized as well as badly characterized groups and are used in this study to test the suitability of some of the methods for protists. As species identification method the performance of blast in searches against badly to well-sampled reference databases has been tested with COI-5P and 59-partial LSU rDNA (domains A to D of the nuclear LSU rRNA gene). In addition the performance of two different methods for automatic species delimitation, fixed thresholds of genetic divergence and the general mixed Yule-coalescent model (GMYC), have been examined. The study demonstrates some pitfalls of barcoding methods that have to be taken care of. Also a best-practice approach towards establishing a DNA barcode system in protists is proposed.	Univ Cologne, Inst Bot, Cologne Bioctr, Cologne, Germany	University of Cologne	Hoef-Emden, K (corresponding author), Univ Cologne, Inst Bot, Cologne Bioctr, Gyrhofstr 15, Cologne, Germany.	kerstin.hoef-emden@uni-koeln.de			German Research Foundation [HO 2015/5]	German Research Foundation(German Research Foundation (DFG))	Funding provided by German Research Foundation grant no. HO 2015/5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Anderson I, 1998, BIOINFORMATICS, V14, P349, DOI 10.1093/bioinformatics/14.4.349; Auinger BM, 2008, APPL ENVIRON MICROB, V74, P2505, DOI 10.1128/AEM.01803-07; Barraclough TG, 2012, BARRALAB WEBSITE DES; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bass D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-162; Ben Ali A, 1999, NUCLEIC ACIDS RES, V27, P2825; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Bock C, 2011, J PHYCOL, V47, P638, DOI 10.1111/j.1529-8817.2011.00989.x; Boenigk J, 2006, APPL ENVIRON MICROB, V72, P5159, DOI 10.1128/AEM.00601-06; Boenigk J, 2012, EUR J PROTISTOL, V48, P96, DOI 10.1016/j.ejop.2011.11.004; Boyer SL, 2011, J N AM BENTHOL SOC, V30, P182, DOI 10.1899/10-004.1; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Butcher RW, 1967, INTRO ACCOUNT SMAL 4; Caisova L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-262; Chantangsi C, 2007, INT J SYST EVOL MICR, V57, P2412, DOI 10.1099/ijs.0.64865-0; CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Clay BL, 1999, PROTIST, V150, P297, DOI 10.1016/S1434-4610(99)70031-3; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Cochrane G, 2011, NUCLEIC ACIDS RES, V39, pD15, DOI 10.1093/nar/gkq1150; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; D'Alelio D, 2009, PROTIST, V160, P9, DOI 10.1016/j.protis.2008.07.001; Deane JA, 2002, J PHYCOL, V38, P1236, DOI 10.1046/j.1529-8817.2002.01250.x; DEPAMPHILIS CW, 1990, NATURE, V348, P337, DOI 10.1038/348337a0; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Drummond AJ, MOL BIOL EVOL; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Esselstyn JA, 2012, P R SOC B; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fabry S, 1999, J MOL EVOL, V48, P94, DOI 10.1007/PL00006449; Feliner GN, 2004, ANN BOT-LONDON, V93, P189, DOI 10.1093/aob/mch027; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Feuchtmayr H, 2012, FRESHWATER BIOL, V57, P331, DOI 10.1111/j.1365-2427.2011.02671.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Gontcharov AA, 2011, PROTIST, V162, P253, DOI 10.1016/j.protis.2010.08.003; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gu ZL, 2005, P NATL ACAD SCI USA, V102, P1092, DOI 10.1073/pnas.0409159102; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; Harper JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006577; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILL DRA, 1986, PHYCOLOGIA, V25, P521, DOI 10.2216/i0031-8884-25-4-521.1; Hirst MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028158; Hoef-Emden K, 2002, J MOL EVOL, V55, P161, DOI 10.1007/s00239-002-2313-5; Hoef-Emden K, 2003, PROTIST, V154, P371, DOI 10.1078/143446103322454130; Hoef-Emden K, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-56; Hoef-Emden K, 2008, J PHYCOL, V44, P985, DOI 10.1111/j.1529-8817.2008.00530.x; Hoef-Emden K, 2007, PHYCOLOGIA, V46, P402, DOI 10.2216/06-83.1; Hoef-Emden Kerstin, 2007, Protist, V158, P135, DOI 10.1016/j.protis.2007.02.001; Howe AT, 2011, PROTIST, V162, P332, DOI 10.1016/j.protis.2010.10.002; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Inagaki Y, 2004, SYST BIOL, V53, P582, DOI 10.1080/10635150490468756; Kies L, 1967, MITT STAATSINST ALLG, V12, P35; Kim E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-215; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klaveness D., 1988, P105; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lane CE, 2008, J PHYCOL, V44, P439, DOI 10.1111/j.1529-8817.2008.00486.x; Lara E, 2009, ENVIRON MICROBIOL, V11, P47, DOI 10.1111/j.1462-2920.2008.01737.x; Lawley B, 2004, APPL ENVIRON MICROB, V70, P5963, DOI 10.1128/AEM.70.10.5963-5972.2004; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Ledergerber C, 2011, BRIEF BIOINFORM, V12, P489, DOI 10.1093/bib/bbq077; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Marin B, 2003, PROTIST, V154, P99, DOI 10.1078/143446103764928521; Masuda I, 2011, HARMFUL ALGAE, V10, P130, DOI 10.1016/j.hal.2010.08.004; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; MCFADDEN GI, 1986, PHYCOLOGIA, V25, P551, DOI 10.2216/i0031-8884-25-4-551.1; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mcmanus GB, 2009, J PLANKTON RES, V31, P1119, DOI 10.1093/plankt/fbp061; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Nitsche F, 2011, J EUKARYOT MICROBIOL, V58, P452, DOI 10.1111/j.1550-7408.2011.00572.x; Oudot-le Secq MP, 2002, EUR J PHYCOL, V37, P163, DOI 10.1017/S0967026202003542; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell JR, 2011, MOL ECOL, V20, P655, DOI 10.1111/j.1365-294X.2010.04964.x; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; PROVASOLI L, 1957, ARCH MIKROBIOL, V25, P392, DOI 10.1007/BF00446694; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Rambaut A., 2007, FIGTREE V1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shalchian-Tabrizi K, 2008, ENVIRON MICROBIOL, V10, P2635, DOI 10.1111/j.1462-2920.2008.01685.x; Shalchian-Tabrizi K, 2011, J EUKARYOT MICROBIOL, V58, P315, DOI 10.1111/j.1550-7408.2011.00547.x; SLATKIN M, 1991, GENETICS, V129, P555; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Stock A, 2012, EXTREMOPHILES, V16, P21, DOI 10.1007/s00792-011-0401-4; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Vralstad T, 2011, MOL ECOL, V20, P2873, DOI 10.1111/j.1365-294X.2011.05149.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; WARIS H, 1953, PHYSIOL PLANTARUM, V6, P538, DOI 10.1111/j.1399-3054.1953.tb08411.x; Watson SB, 1997, LIMNOL OCEANOGR, V42, P487, DOI 10.4319/lo.1997.42.3.0487; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P83, DOI 10.1093/oxfordjournals.molbev.a026040; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang Z, 1996, MOL BIOL EVOL, V10, P1396; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhao P, 2011, FUNGAL DIVERS, V46, P183, DOI 10.1007/s13225-010-0064-y	152	23	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43652	10.1371/journal.pone.0043652	http://dx.doi.org/10.1371/journal.pone.0043652			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22970104	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500072
J	Itel, F; Al-Samir, S; Oberg, F; Chami, M; Kumar, M; Supuran, CT; Deen, PMT; Meier, W; Hedfalk, K; Gros, G; Endeward, V				Itel, Fabian; Al-Samir, Samer; Oberg, Fredrik; Chami, Mohamed; Kumar, Manish; Supuran, Claudiu T.; Deen, Peter M. T.; Meier, Wolfgang; Hedfalk, Kristina; Gros, Gerolf; Endeward, Volker			CO2 permeability of cell membranes is regulated by membrane cholesterol and protein gas channels	FASEB JOURNAL			English	Article						aquaporin 1; aquaporin Z; phospholipid vesicles; MDCK cells	CARBON-DIOXIDE PERMEABILITY; LIPID BILAYER-MEMBRANES; WATER CHANNEL; EPITHELIAL MEMBRANE; TRANSPORT; AQUAPORIN-1; LIPOSOMES; ANHYDRASE; AMMONIA; BLOOD	Recent observations that some membrane proteins act as gas channels seem surprising in view of the classical concept that membranes generally are highly permeable to gases. Here, we study the gas permeability of membranes for the case of CO2, using a previously established mass spectrometric technique. We first show that biological membranes lacking protein gas channels but containing normal amounts of cholesterol (30-50 mol% of total lipid), e.g., MDCK and tsA201 cells, in fact possess an unexpectedly low CO2 permeability (PCO2) of similar to 0.01 cm/s, which is 2 orders of magnitude lower than the PCO2 of pure planar phospholipid bilayers (similar to 1 cm/s). Phospholipid vesicles enriched with similar amounts of cholesterol also exhibit PCO2 approximate to 0.01 cm/s, identifying cholesterol as the major determinant of membrane PCO2. This is confirmed by the demonstration that MDCK cells depleted of or enriched with membrane cholesterol show dramatic increases or decreases in PCO2, respectively. We demonstrate, furthermore, that reconstitution of human AQP-1 into cholesterol-containing vesicles, as well as expression of human AQP-1 in MDCK cells, leads to drastic increases in PCO2, indicating that gas channels are of high functional significance for gas transfer across membranes of low intrinsic gas permeability.-Itel, F., Al-Samir, S., Oberg, F., Chami, M., Kumar, M., Supuran, C. T., Deen, P. M. T., Meier, W., Hedfalk, K., Gros, G., Endeward, V. CO2 permeability of cell membranes is regulated by membrane cholesterol and protein gas channels. FASEB J. 26, 5182-5191 (2012). www.fasebj.org	[Al-Samir, Samer; Gros, Gerolf; Endeward, Volker] Hannover Med Sch, Zentrum Physiol, Dept Vegetat Physiol, D-30625 Hannover, Germany; [Itel, Fabian; Meier, Wolfgang] Univ Basel, Dept Chem, Basel, Switzerland; [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt C CINA, Basel, Switzerland; [Oberg, Fredrik; Hedfalk, Kristina] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Kumar, Manish] Penn State Univ, Dept Chem Engn, State Coll, PA USA; [Supuran, Claudiu T.] Univ Florence, Dipartimento Chim, Lab Chim Bioinorgan, I-50144 Florence, Italy; [Deen, Peter M. T.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 ED Nijmegen, Netherlands	Hannover Medical School; University of Basel; University of Basel; University of Gothenburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Florence; Radboud University Nijmegen	Gros, G (corresponding author), Hannover Med Sch, Zentrum Physiol, Dept Vegetat Physiol, D-30625 Hannover, Germany.	gros.gerolf@mh-hannover.de	Itel, Fabian/AAU-2465-2021; Deen, Peter MT/B-9854-2013; Öberg, Fredrik Kryh/B-1241-2011; Kumar, Manish/C-2346-2008; Hedfalk, Kristina/A-8244-2010; Deen, P.M.T./H-8023-2014; Supuran, Claudiu T/A-5151-2008; Gros, Gerolf/K-8421-2012; Kumar, Manish/ABD-7273-2021	Itel, Fabian/0000-0002-4161-2383; Deen, Peter MT/0000-0002-7868-4655; Öberg, Fredrik Kryh/0000-0002-7089-2118; Deen, P.M.T./0000-0002-7868-4655; Kumar, Manish/0000-0001-5545-3793; Supuran, Claudiu/0000-0003-4262-0323	Deutsche Forschungsgemeinschaft [EN 908/1-1]; National Center of Competence in Nanoscale Science; Netherlands Organization for Scientific research (NWO); VICI [865.07.002]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Center of Competence in Nanoscale Science; Netherlands Organization for Scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); VICI(Netherlands Organization for Scientific Research (NWO))	The authors thank Prof. Ernst Ungewickell (Medizinische Hochschule Hannover) and Dawid Krenc (Universitat Kiel, Kiel, Germany) for helpful discussions, and Mr. Mark Inglin (University of Basel) for language-editing the manuscript. The authors are indebted to Dr. Aleksandra Rojek (University of Aarhus, Aarhus, Denmark) for the kind gift of the AQP-1 antibody RA3391/2353AP. This work was supported by the Deutsche Forschungsgemeinschaft through grant EN 908/1-1 to V. E., S. A.-S., and G. G.. F. I., W. M., and M. C. gratefully acknowledge the National Center of Competence in Nanoscale Science for financial support and Prof. Henning Stahlberg (University of Basel) for access to the electron microscopy facility. P. M. T. D. is a recipient of a VICI grant of the Netherlands Organization for Scientific research (NWO) and acknowledges VICI grant 865.07.002. Author contributions: V. E. and G. G. conceived the study; V. E. designed the research and performed all mass spectrometric <SUP>18</SUP>O exchange experiments; F. I. and W. M. prepared liposomes and proteoliposomes, as well as AqpZ; S.A.-S. performed all experiments with MDCK and tsA201 cells; F. O. and K. H. contributed hAQP-1 protein; M. C. performed the freeze-fracture studies; P. T. M. D. contributed the pCB6-hAQP-1 expression construct; C. T. S. contributed the extracellular carbonic anhydrase inhibitor; M. K. contributed to lipo- and proteoliposome preparation; G. G. and V. E. wrote the paper; all authors critically commented on the manuscript. The authors declare no conflicts of interest.	AGGERBECK LP, 1986, METHOD ENZYMOL, V128, P457; Antonenko YN, 1997, BIOPHYS J, V72, P2187, DOI 10.1016/S0006-3495(97)78862-3; BATTINO R, 1984, J PHYS CHEM REF DATA, V13, P563, DOI 10.1063/1.555713; Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Boron WF, 2011, CHEMPHYSCHEM, V12, P1017, DOI 10.1002/cphc.201100034; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BUNCE AS, 1974, BIOCHIM BIOPHYS ACTA, V363, P423, DOI 10.1016/0005-2736(74)90081-9; Christian AE, 1997, J LIPID RES, V38, P2264; CORVERA E, 1992, BIOCHIM BIOPHYS ACTA, V1107, P261, DOI 10.1016/0005-2736(92)90413-G; de Groot Bert L, 2011, Chemphyschem, V12, P1021, DOI 10.1002/cphc.201000974; Duttingdorf HDMZ, 1999, ANAL BIOCHEM, V269, P45, DOI 10.1006/abio.1998.3075; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Endeward V, 2005, J PHYSIOL-LONDON, V567, P253, DOI 10.1113/jphysiol.2005.085761; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; Endeward V, 2009, J PHYSIOL-LONDON, V587, P1153, DOI 10.1113/jphysiol.2008.165027; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Forster R. E., 1969, NASA, P275; Francis SA, 1999, EUR J CELL BIOL, V78, P473, DOI 10.1016/S0171-9335(99)80074-0; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; HANSSON GC, 1986, EMBO J, V5, P483, DOI 10.1002/j.1460-2075.1986.tb04237.x; Hasselblatt P, 2000, PFLUG ARCH EUR J PHY, V441, P118, DOI 10.1007/s004240000377; Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; Hub JS, 2006, BIOPHYS J, V91, P842, DOI 10.1529/biophysj.106.081406; Hub JS, 2010, J AM CHEM SOC, V132, P13251, DOI 10.1021/ja102133x; ITADA N, 1977, J BIOL CHEM, V252, P3881; JUNG JS, 1994, J BIOL CHEM, V269, P14648; KIKERI D, 1989, NATURE, V339, P478, DOI 10.1038/339478a0; KORN ED, 1969, ANNU REV BIOCHEM, V38, P263, DOI 10.1146/annurev.bi.38.070169.001403; Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Missner A, 2009, CHEMPHYSCHEM, V10, P1405, DOI 10.1002/cphc.200900270; Moller M, 2005, J BIOL CHEM, V280, P8850, DOI 10.1074/jbc.M413699200; Musa-Aziz R., 2011, FASEB J S, V25, P10405; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007; OBRIEN JS, 1967, J THEOR BIOL, V15, P307, DOI 10.1016/0022-5193(67)90140-3; Overton E., 1901, STUDIEN NARKOSE; Plancon L, 1997, J BIOL CHEM, V272, P16868, DOI 10.1074/jbc.272.27.16868; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8; SIMON SA, 1980, BIOCHIM BIOPHYS ACTA, V596, P352, DOI 10.1016/0005-2736(80)90122-4; Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Trandum C, 2000, BIOPHYS J, V78, P2486, DOI 10.1016/S0006-3495(00)76793-2; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; van Beest M, 2006, BBA-BIOMEMBRANES, V1758, P1126, DOI 10.1016/j.bbamem.2006.03.007; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Verkman AS, 2002, J PHYSIOL-LONDON, V542, P31, DOI 10.1113/jphysiol.2002.024398; WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; WILCOCK RJ, 1978, J CHEM THERMODYN, V10, P817, DOI 10.1016/0021-9614(78)90154-4; Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686	61	67	67	1	68	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5182	5191		10.1096/fj.12-209916	http://dx.doi.org/10.1096/fj.12-209916			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22964306				2022-12-25	WOS:000311838300038
J	Charlson, ES; Bittinger, K; Chen, J; Diamond, JM; Li, HZ; Collman, RG; Bushman, FD				Charlson, Emily S.; Bittinger, Kyle; Chen, Jun; Diamond, Joshua M.; Li, Hongzhe; Collman, Ronald G.; Bushman, Frederic D.			Assessing Bacterial Populations in the Lung by Replicate Analysis of Samples from the Upper and Lower Respiratory Tracts	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; FIBEROPTIC BRONCHOSCOPY; QUANTITATIVE ASPIRATION; NOSOCOMIAL PNEUMONIA; DIVERSITY; OROPHARYNGEAL; CULTURE; BRUSH; COLONIZATION; PSEUDOMONAS	Microbes of the human respiratory tract are important in health and disease, but accurate sampling of the lung presents challenges. Lung microbes are commonly sampled by bronchoscopy, but to acquire samples the bronchoscope must pass through the upper respiratory tract, which is rich in microbes. Here we present methods to identify authentic lung microbiota in bronchoalveolar lavage (BAL) fluid that contains substantial oropharyngeal admixture. We studied clinical BAL samples from six selected subjects with potential heavy lung colonization. A single sample of BAL fluid was obtained from each subject along with contemporaneous oral wash (OW) to sample the oropharynx, and then DNA was extracted from three separate aliquots of each. Bacterial 16S rDNA sequences were amplified and products analyzed by 454 pyrosequencing. By comparing replicates, we were able to specify the depth of sequencing needed to reach a 95% chance of identifying a bacterial lineage of a given proportion-for example, at a depth of 5,000 tags, OTUs of proportion 0.3% or greater would be called with 95% confidence. We next constructed a single-sided outlier test that allowed lung-enriched organisms to be quantified against a background of oropharyngeal admixture, and assessed improvements available with replicate sequence analysis. This allowed identification of lineages enriched in lung in some BAL specimens. Finally, using samples from healthy volunteers collected at multiple sites in the upper respiratory tract, we show that OW provides a reasonable but not perfect surrogate for bacteria carried into to the lung by a bronchoscope. These methods allow identification of microbes that can replicate in the lung despite the background due to oropharyngeal microbes derived from aspiration and bronchoscopic carry-over.	[Charlson, Emily S.; Bittinger, Kyle; Collman, Ronald G.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Charlson, Emily S.; Diamond, Joshua M.; Collman, Ronald G.] Univ Penn, Sch Med, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Chen, Jun; Li, Hongzhe] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Chen, Jun; Li, Hongzhe] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Charlson, ES (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	collmanr@mail.med.upenn.edu; bushman@mail.med.upenn.edu	Bittinger, Kyle/ABG-2342-2020	Bushman, Frederic/0000-0003-4740-4056; Collman, Ronald/0000-0002-0508-3701	National Institutes of Health [U01 HL98957]; National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) T32: Ruth L. Kirschstein National Research Service Award Institutional Research Training Grants [(T32) (NIAID) 5T32AI060516 - 06]; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, T32AI060516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) T32: Ruth L. Kirschstein National Research Service Award Institutional Research Training Grants; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Lung Human Microbiome Project Grant U01 HL98957 from the National Institutes of Health to R. G. C. and F. D. B., and E. S. C. was supported by National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) T32: Ruth L. Kirschstein National Research Service Award Institutional Research Training Grants (T32) (NIAID) 5T32AI060516 - 06 "Microbial Pathogenesis and Genomics." The authors also acknowledge the Penn Genome Frontiers Institute and the Penn Center for AIDS Research (AI045008) and a grant with the Pennsylvania Department of Health; the Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; BARTLETT JG, 1976, AM REV RESPIR DIS, V114, P73; Beal M, 2004, LARYNGOSCOPE, V114, P965, DOI 10.1097/00005537-200406000-00002; Bousbia S, 2010, EMERG INFECT DIS, V16, P258, DOI 10.3201/eid1602.090610; CANTRAL DE, 1993, AM J MED, V95, P601, DOI 10.1016/0002-9343(93)90356-T; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; GarrousteOrgeas M, 1997, AM J RESP CRIT CARE, V156, P1647, DOI 10.1164/ajrccm.156.5.96-04076; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; JORDAN GW, 1976, J INFECT DIS, V134, P428, DOI 10.1093/infdis/134.5.428; KIRKPATRICK MB, 1989, AM REV RESPIR DIS, V139, P546, DOI 10.1164/ajrccm/139.2.546; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Nadkarni MA, 2012, EUR J CLIN MICROBIOL; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; ORTQVIST A, 1990, CHEST, V97, P576, DOI 10.1378/chest.97.3.576; PANG JA, 1989, LUNG, V167, P261, DOI 10.1007/BF02714955; PECORA DV, 1963, NEW ENGL J MED, V269, P664, DOI 10.1056/NEJM196309262691304; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; PUGIN J, 1991, JAMA-J AM MED ASSOC, V265, P2704, DOI 10.1001/jama.265.20.2704; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Robinson Joan, 2004, Paediatr Child Health, V9, P21; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Souweine B, 1998, CRIT CARE MED, V26, P236, DOI 10.1097/00003246-199802000-00017; Spasenovski T, 2009, DIAGN MICR INFEC DIS, V63, P261, DOI 10.1016/j.diagmicrobio.2008.11.011; THORPE JE, 1987, J INFECT DIS, V155, P855, DOI 10.1093/infdis/155.5.855; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940	44	101	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e42786	10.1371/journal.pone.0042786	http://dx.doi.org/10.1371/journal.pone.0042786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970118	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400005
J	Chen, H; Xia, CA; Deng, Y; Wen, B; Wang, W; Xiong, SQ; Ruan, L; Tan, WJ				Chen, Hong; Xia Chuai; Deng, Yao; Wen, Bo; Wang, Wen; Xiong, Shaoqing; Ruan, Li; Tan, Wenjie			Optimisation of Prime-Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; T-CELL RESPONSES; NEUTRALIZING EPITOPES; INFECTION; COMBINATION; LAMIVUDINE; SUPPRESSION; MECHANISMS; INDUCTION; POXVIRUS	Background: A therapeutic vaccine for chronic hepatitis B virus (HBV) infection that enhances virus-specific cellular immune responses is urgently needed. The "prime-boost" regimen is a widely used vaccine strategy against many persistence infections. However, few reports have addressed this strategy applying for HBV therapeutic vaccine development. Methodology/Principal Findings: To develop an effective HBV therapeutic vaccine, we constructed a recombinant vaccinia virus (Tiantan) containing the S+PreS1 fusion antigen (RVJSS1) combined with the HBV particle-like subunit vaccine HBVSS1 to explore the most effective prime-boost regimen against HBV. The immune responses to different prime-boost regimens were assessed in C57BL/C mice by ELISA, ELISpot assay and Intracellular cytokine staining analysis. Among the combinations tested, an HBV protein particle vaccine priming and recombinant vaccinia virus boosting strategy accelerated specific seroconversion and produced high antibody (anti-PreS1, anti-S antibody) titres as well as the strongest multi-antigen (PreS1, and S)-specific cellular immune response. HBSS1 protein prime/RVJSS1 boost immunization was also generated more significant level of both CD4+ and CD8+ T cell responses for Th1 cytokines (TNF-alpha and IFN-gamma). Conclusions: The HBSS1 protein-vaccine prime plus RVJSS1 vector boost elicits specific antibody as well as CD4 and CD8 cells secreting Th1-like cytokines, and these immune responses may be important parameters for the future HBV therapeutic vaccines.	[Chen, Hong; Xia Chuai; Deng, Yao; Wen, Bo; Wang, Wen; Ruan, Li; Tan, Wenjie] Chinese Ctr Dis Control & Prevent, Biotech Ctr Viral Dis Emergency, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xia Chuai] Hebei Med Univ, Dept Microbiol, Shijiazhuang, Peoples R China; [Wen, Bo] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Xiong, Shaoqing] Beijing Univ Technol, Sch Life Sci & Bioengn, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Hebei Medical University; Jilin University; Beijing University of Technology	Chen, H (corresponding author), Chinese Ctr Dis Control & Prevent, Biotech Ctr Viral Dis Emergency, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	tanwj28@yahoo.cn			China Mega-projects of Science Research for the RD of New Drugs [2009ZX09102-237]	China Mega-projects of Science Research for the RD of New Drugs	The present study was supported by the China Mega-projects of Science Research for the R&D of New Drugs (No. 2009ZX09102-237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, VACCINE, V27, P88, DOI 10.1016/j.vaccine.2008.10.031; Bertoletti Antonio, 2009, Expert Rev Gastroenterol Hepatol, V3, P561, DOI 10.1586/egh.09.48; Bremer CM, 2011, J HEPATOL, V55, P29, DOI 10.1016/j.jhep.2010.10.019; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Chen H, 2011, CLIN VACCINE IMMUNOL, V18, P1789, DOI 10.1128/CVI.05113-11; Chen Hong, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P95; Chen Hong, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P74; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Chisari FV, 1997, J CLIN INVEST, V99, P1472, DOI 10.1172/JCI119308; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Franco A, 1997, J IMMUNOL, V159, P2001; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GU S, 1991, Chinese Medical Sciences Journal, V6, P241; Hemachandra A, 2010, HUM VACCINES, V6, P835, DOI 10.4161/hv.6.10.12635; Horiike N, 2005, J CLIN VIROL, V32, P156, DOI 10.1016/j.jcv.2004.07.004; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liu MA, 2010, CURR OPIN MOL THER, V12, P86; Maeng CY, 2000, VIROLOGY, V270, P9, DOI 10.1006/viro.2000.0250; Mancini-Bourgine M, 2004, HEPATOLOGY, V40, P874, DOI 10.1002/hep.20408; Mehrizi AA, 2011, PARASITE IMMUNOL, V33, P594, DOI 10.1111/j.1365-3024.2011.01331.x; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; NEURATH AR, 1989, VACCINE, V7, P234; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Pol S, 1994, J GERONTOL B-PSYCHOL, V343, P1460; QIAO M, 1994, VIROLOGY, V201, P356, DOI 10.1006/viro.1994.1301; Radcliffe JN, 2006, J IMMUNOL, V177, P6626, DOI 10.4049/jimmunol.177.10.6626; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ribas A, 2011, CLIN CANCER RES, V17, P2987, DOI 10.1158/1078-0432.CCR-10-3272; RUAN L, 1992, CHINESE J VIROL, V8, P101; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Sjogren MH, 2005, AM J MED, V118, P34, DOI 10.1016/j.amjmed.2005.07.012; [田淑芳 Tian Shufang], 2002, [病毒学报, Chinese Journal of Virology], V18, P312; TSAO H, 1988, J VIROL, V62, P4832, DOI 10.1128/JVI.62.12.4832-4834.1988; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; WEN YM, 1995, LANCET, V345, P1575, DOI 10.1016/S0140-6736(95)91126-X; Yang SH, 2006, GENE THER, V13, P1110, DOI 10.1038/sj.gt.3302751; Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018	40	18	24	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43730	10.1371/journal.pone.0043730	http://dx.doi.org/10.1371/journal.pone.0043730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970140	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400018
J	Raju, M; Santhoshkumar, P; Sharma, KK				Raju, Murugesan; Santhoshkumar, Puttur; Sharma, K. Krishna			alpha A-Crystallin-Derived Mini-Chaperone Modulates Stability and Function of Cataract Causing alpha AG98R-Crystallin	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; B-CRYSTALLIN; MOLECULAR CHAPERONE; ARGININE HYDROCHLORIDE; CONGENITAL CATARACT; SYNTHETIC PEPTIDE; EYE LENS; MUTATION; MUTANT; CRYAA	Background: A substitution mutation in human alpha A-crystallin (alpha AG98R) is associated with autosomal dominant cataract. The recombinant mutant alpha AG98R protein exhibits altered structure, substrate-dependent chaperone activity, impaired oligomer stability and aggregation on prolonged incubation at 37 degrees C. Our previous studies have shown that alpha A-crystallin-derived mini-chaperone (DFVIFLDVKHFSPEDLTVK) functions like a molecular chaperone by suppressing the aggregation of denaturing proteins. The present study was undertaken to determine the effect of alpha A-crystallin-derived mini-chaperone on the stability and chaperone activity of alpha AG98R-crystallin. Methodology/Principal Findings: Recombinant alpha AG98R was incubated in presence and absence of mini-chaperone and analyzed by chromatographic and spectrometric methods. Transmission electron microscope was used to examine the effect of mini-chaperone on the aggregation propensity of mutant protein. Mini-chaperone containing photoactive benzoylphenylalanine was used to confirm the interaction of mini-chaperone with alpha AG98R. The rescuing of chaperone activity in mutanta-crystallin (alpha AG98R) by mini-chaperone was confirmed by chaperone assays. We found that the addition of the mini-chaperone during incubation of alpha AG98R protected the mutant crystallin from forming larger aggregates that precipitate with time. The mini-chaperone-stabilized alpha AG98R displayed chaperone activity comparable to that of wild-type alpha A-crystallin. The complexes formed between mini-alpha A-alpha AG98R complex and ADH were more stable than the complexes formed between alpha AG98R and ADH. Western-blotting and mass spectrometry confirmed the binding of mini-chaperone to mutant crystallin. Conclusion/Significance: These results demonstrate that mini-chaperone stabilizes the mutant alpha A-crystallin and modulates the chaperone activity of alpha AG98R. These findings aid in our understanding of how to design peptide chaperones that can be used to stabilize mutant alpha A-crystallins and preserve the chaperone function.	[Raju, Murugesan; Santhoshkumar, Puttur; Sharma, K. Krishna] Univ Missouri, Columbia Sch Med, Dept Ophthalmol, Columbia, MO 65211 USA; [Sharma, K. Krishna] Univ Missouri, Columbia Sch Med, Dept Biochem, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Raju, M (corresponding author), Univ Missouri, Columbia Sch Med, Dept Ophthalmol, Columbia, MO 65211 USA.	sharmak@health.missouri.edu	Santhoshkumar, Puttur/G-1798-2010	Santhoshkumar, Puttur/0000-0002-6897-7278	United States National Institutes of Health [EY 011981, EY 021011]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011981, R21EY021011] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants EY 011981 and EY 021011 from the United States National Institutes of Health (http://www.nih.gov/) and an unrestricted grant-in-aid from Research to Prevent Blindness to the Department of Ophthalmology (http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bhattacharyya J, 2001, J PEPT RES, V57, P428, DOI 10.1034/j.1399-3011.2001.00871.x; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; BLOEMENDAL H, 1977, SCIENCE, V197, P127, DOI 10.1126/science.877544; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; DEJONG WW, 1984, EUR J BIOCHEM, V141, P131; Dorman G, 1998, Acta Pharm Hung, V68, P95; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Girault S, 1996, EUR J BIOCHEM, V240, P215, DOI 10.1111/j.1432-1033.1996.0215h.x; GRAW J, 1984, EXP EYE RES, V39, P37, DOI 10.1016/0014-4835(84)90112-X; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; HAWKINS JW, 1987, HUM GENET, V76, P375, DOI 10.1007/BF00272448; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, INT J BIOL MACROMOL, V22, P263, DOI 10.1016/S0141-8130(98)00024-5; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Kumar RS, 2000, J PEPT RES, V56, P157, DOI 10.1034/j.1399-3011.2000.00785.x; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Murugesan R, 2007, MOL VIS, V13, P2301; Pal J, 1998, OPHTHALMIC RES, V30, P271, DOI 10.1159/000055484; Rajaraman K, 2001, FEBS LETT, V497, P118, DOI 10.1016/S0014-5793(01)02451-6; Raju M, 2011, MOL VIS, V17, P7; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Reddy GB, 2001, BIOCHEM BIOPH RES CO, V282, P712, DOI 10.1006/bbrc.2001.4642; Santhiya S, 2006, MOL VIS, V12, P768; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; SHARMA KK, 1995, EXP EYE RES, V61, P413; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Singh D, 2006, MOL VIS, V12, P1372; Sreelakshmi Y, 2001, J PROTEIN CHEM, V20, P123, DOI 10.1023/A:1011077307262; Srinivas V, 2005, MOL VIS, V11, P249; Srinivas V, 2003, PROTEIN SCI, V12, P1262, DOI 10.1110/ps.0302003; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178	46	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44077	10.1371/journal.pone.0044077	http://dx.doi.org/10.1371/journal.pone.0044077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970163	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400033
J	Sommer, IE; Clos, M; Meijering, AL; Diederen, KMJ; Eickhoff, SB				Sommer, Iris E.; Clos, Mareike; Meijering, Anne Lotte; Diederen, Kelly M. J.; Eickhoff, Simon B.			Resting State Functional Connectivity in Patients with Chronic Hallucinations	PLOS ONE			English	Article							AUDITORY VERBAL HALLUCINATIONS; GLOBAL SIGNAL; BRAIN; SCHIZOPHRENIA; NETWORKS; CORTEX; OSCILLATIONS; ACTIVATIONS; PERCEPTION; SYMPTOMS	Auditory verbal hallucinations (AVH) are not only among the most common but also one of the most distressing symptoms of schizophrenia. Despite elaborate research, the underlying brain mechanisms are as yet elusive. Functional MRI studies have associated the experience of AVH with activation of bilateral language-related areas, in particular the right inferior frontal gyrus (rIFG) and the left superior temporal gyrus (lSTG). While these findings helped to understand the neural underpinnings of hearing voices, they provide little information about possible brain mechanisms that predispose a person to experience AVH, i.e. the traits to hallucinate. In this study, we compared resting state connectivity between 49 psychotic patients with chronic AVH and 49 matched controls using the rIFG and the lSTG as seed regions, to identify functional brain systems underlying the predisposition to hallucinate. The right parahippocampal gyrus showed increased connectivity with the rIFG in patients as compared to controls. Reduced connectivity with the rIFG in patients was found for the right dorsolateral prefrontal cortex. Reduced connectivity with the lSTG in patients was identified in the left frontal operculum as well as the parietal opercular area. Connectivity between the lSTG and the left hippocampus was also reduced in patients and showed a negative correlation with the severity of hallucinations. Concluding, we found aberrant connectivity between the seed regions and medial temporal lobe structures which have a prominent role in memory retrieval. Moreover, we found decreased connectivity between language-related areas, indicating aberrant integration in this system potentially including corollary discharge mechanisms.	[Sommer, Iris E.; Meijering, Anne Lotte; Diederen, Kelly M. J.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Sommer, Iris E.; Meijering, Anne Lotte; Diederen, Kelly M. J.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [Clos, Mareike; Eickhoff, Simon B.] Res Ctr Julich, Inst Neurosci & Med, INM 1, INM 22, Julich, Germany; [Eickhoff, Simon B.] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Eickhoff, Simon B.] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Helmholtz Association; Research Center Julich; RWTH Aachen University; Heinrich Heine University Dusseldorf	Sommer, IE (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands.	I.Sommer@umcutrecht.nl	sommer, iris E/D-1190-2014; Eickhoff, Simon B./K-2061-2013	sommer, iris E/0000-0002-2682-5313; Eickhoff, Simon B./0000-0001-6363-2759; Sommer, Iris/0000-0001-5597-3262; Clos, Mareike/0000-0002-1611-9474; Diederen, Kelly/0000-0002-9619-6583	NWO/ZonMW (Dutch Scientific Research Organization) [40-00703-97-270]; NWO/ZonMW Innovation Impulse (VIDI) [017.106.301]	NWO/ZonMW (Dutch Scientific Research Organization)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); NWO/ZonMW Innovation Impulse (VIDI)	This work was supported by NWO/ZonMW (Dutch Scientific Research Organization) Clinical Fellowship [40-00703-97-270] and by NWO/ZonMW Innovation Impulse (VIDI) [017.106.301]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2007, INT REV PSYCHIATR, V19, P409, DOI 10.1080/09540260701486498; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Badcock Johanna C, 2005, Cogn Neuropsychiatry, V10, P125, DOI 10.1080/13546800344000363; Bandettini PA, 2008, HUM BRAIN MAPP, V29, P737, DOI 10.1002/hbm.20607; Bartsch T, 2011, P NATL ACAD SCI USA, V108, P17562, DOI 10.1073/pnas.1110266108; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bellec P, 2006, NEUROIMAGE, V29, P1231, DOI 10.1016/j.neuroimage.2005.08.044; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Copolov DL, 2003, PSYCHIAT RES-NEUROIM, V122, P139, DOI 10.1016/S0925-4927(02)00121-X; de Weijer AD, 2011, SCHIZOPHR RES, V130, P68, DOI 10.1016/j.schres.2011.05.010; de Weijer AD, 2013, HUM BRAIN MAPP, V34, P626, DOI 10.1002/hbm.21463; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2011, NEUROIMAGE, V57, P938, DOI 10.1016/j.neuroimage.2011.05.021; Ford JM, 2005, INT J PSYCHOPHYSIOL, V58, P179, DOI 10.1016/j.ijpsycho.2005.01.014; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gavrilescu M, 2010, PSYCHOL MED, V40, P1149, DOI 10.1017/S0033291709991632; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hoffman RE, 2008, BRIT J PSYCHIAT, V193, P424, DOI 10.1192/bjp.bp.107.040501; Hoffman RE, 2011, BIOL PSYCHIAT, V69, P407, DOI 10.1016/j.biopsych.2010.09.050; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hunter MD, 2010, NEUROIMAGE, V53, P611, DOI 10.1016/j.neuroimage.2010.06.053; Hunter MD, 2006, P NATL ACAD SCI USA, V103, P189, DOI 10.1073/pnas.0506268103; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Lichtheim Ludwig, 1885, BRAIN, V7, P433, DOI DOI 10.1093/BRAIN/7.4.433; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sommer IEC, 2007, SCHIZOPHR RES, V93, P406, DOI 10.1016/j.schres.2007.03.020; Sommer IE, 2010, PSYCHOPATHOLOGY, V43, P137, DOI 10.1159/000277003; Sommer IEC, 2008, BRAIN, V131, P3169, DOI 10.1093/brain/awn251; Vercammen A, 2010, BIOL PSYCHIAT, V67, P912, DOI 10.1016/j.biopsych.2009.11.017; Vercammen A, 2010, SCHIZOPHRENIA BULL, V36, P151, DOI 10.1093/schbul/sbn063; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P741, DOI 10.1093/schbul/sbq144; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005	43	72	73	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43516	10.1371/journal.pone.0043516	http://dx.doi.org/10.1371/journal.pone.0043516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970130	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400013
J	Beiki, AH; Saboor, S; Ebrahimi, M				Beiki, Amir H.; Saboor, Saba; Ebrahimi, Mansour			A New Avenue for Classification and Prediction of Olive Cultivars Using Supervised and Unsupervised Algorithms	PLOS ONE			English	Article							OLEA-EUROPAEA L.; GENETIC DIVERSITY; ENZYME THERMOSTABILITY; FEATURE-SELECTION; SP-NOV.; SEQUENCE; FEATURES; IDENTIFICATION; MARKER; OIL	Various methods have been used to identify cultivares of olive trees; herein we used different bioinformatics algorithms to propose new tools to classify 10 cultivares of olive based on RAPD and ISSR genetic markers datasets generated from PCR reactions. Five RAPD markers (OPA0a21, OPD16a, OP01a1, OPD16a1 and OPA0a8) and five ISSR markers (UBC841a4, UBC868a7, UBC841a14, U12BC807a and UBC810a13) selected as the most important markers by all attribute weighting models. K-Medoids unsupervised clustering run on SVM dataset was fully able to cluster each olive cultivar to the right classes. All trees (176) induced by decision tree models generated meaningful trees and UBC841a4 attribute clearly distinguished between foreign and domestic olive cultivars with 100% accuracy. Predictive machine learning algorithms (SVM and Naive Bayes) were also able to predict the right class of olive cultivares with 100% accuracy. For the first time, our results showed data mining techniques can be effectively used to distinguish between plant cultivares and proposed machine learning based systems in this study can predict new olive cultivars with the best possible accuracy.	[Beiki, Amir H.; Ebrahimi, Mansour] Univ Qom, Dept Biol, Sch Basic Sci, Qom, Iran; [Beiki, Amir H.; Ebrahimi, Mansour] Univ Qom, Bioinformat Res Grp, Qom, Iran; [Saboor, Saba] IKIU, Fac Engn & Technol, Dept Agr Biotechnol, Qazvin, Iran	Imam Khomeini International University	Beiki, AH (corresponding author), Univ Qom, Dept Biol, Sch Basic Sci, Qom, Iran.	mansour@future.org	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021; ebrahimi, mansour/D-9950-2011	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; 	IKIU; Bioinformatics Research Group, GRC, University of Qom	IKIU; Bioinformatics Research Group, GRC, University of Qom	The authors greatly appreciate support from IKIU and Bioinformatics Research Group, GRC, University of Qom.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Alonso-Salces RM, 2010, J AGR FOOD CHEM, V58, P5586, DOI 10.1021/jf903989b; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; Bakhtiarizadeh MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027118; Banilas G, 2003, GENOME, V46, P370, DOI [10.1139/g03-011, 10.1139/G03-011]; Baseri S, 2011, ADV STUDIES BIOL, V3, P181; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Biedermann A, 2012, FORENSIC SCI INT-GEN, V6, P147, DOI 10.1016/j.fsigen.2011.06.009; Bijanzadeh E, 2010, AUST J CROP SCI, V4, P402; Corrado G, 2009, GENOME, V52, P692, DOI [10.1139/G09-044, 10.1139/g09-044]; Dabbou S, 2010, CHEM BIODIVERS, V7, P1801, DOI 10.1002/cbdv.200900385; Ebrahimi M, 2009, EXCLI J, V8, P218; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; Ebrahimie E, 2010, NEW BIOTECHNOL, V27, pS43, DOI 10.1016/j.nbt.2010.01.063; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Elbeaino T, 2011, VIRUS RES, V161, P198, DOI 10.1016/j.virusres.2011.07.022; Ercisli S, 2011, BIOCHEM GENET, V49, P555, DOI 10.1007/s10528-011-9430-z; Fernandez MF, 2012, INT J ANDROL, V35, P1, DOI 10.1111/j.1365-2605.2010.01131.x; Freire-Aradas A, 2012, FORENSIC SCI INT-GEN, V6, P341, DOI 10.1016/j.fsigen.2011.07.010; Garcia-Gonzalez DL, 2010, J AGR FOOD CHEM, V58, P12899, DOI 10.1021/jf1031313; Georis J, 2000, PROTEIN SCI, V9, P466; Guzman E, 2012, TALANTA, V93, P94, DOI 10.1016/j.talanta.2012.01.053; Habashy HO, 2011, BREAST CANCER RES TR, V128, P315, DOI 10.1007/s10549-010-1073-y; Hameed U, 2012, GENET MOL RES, V11, P1195, DOI 10.4238/2012.May.8.1; HELFERT RH, 1987, AM J ANAT, V179, P55, DOI 10.1002/aja.1001790108; Hosseinzadeh F, 2012, PLOS ONE IN PRESS; Jimenez-Diaz RM, 2011, PHYTOPATHOLOGY, V101, P304, DOI 10.1094/PHYTO-07-10-0176; Kumla S, 2012, MOL BIOL REP, V39, P5201, DOI 10.1007/s11033-011-1317-x; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Mishra D, 2011, ADV EXP MED BIOL, V696, P91, DOI 10.1007/978-1-4419-7046-6_10; Montemurro F, 2009, BIORESOURCE TECHNOL, V100, P2969, DOI 10.1016/j.biortech.2009.01.038; Nisiotou AA, 2010, INT J SYST EVOL MICR, V60, P1219, DOI 10.1099/ijs.0.012955-0; Owen CA, 2005, THEOR APPL GENET, V110, P1169, DOI 10.1007/s00122-004-1861-z; Pafundo S, 2005, J AGR FOOD CHEM, V53, P6995, DOI 10.1021/jf050775x; Perez-Jimenez F, 2000, MED CLIN-BARCELONA, V114, P219, DOI 10.1016/S0025-7753(00)71250-4; Randhawa GJ, 2012, J AOAC INT, V95, P186, DOI 10.5740/jaoacint.10-429; Reale S, 2006, GENOME, V49, P1193, DOI 10.1139/G06-068; Riaz S, 2012, GENET MOL RES, V11, P440, DOI 10.4238/2012.February.24.3; Rjiba I, 2010, CHEM BIODIVERS, V7, P649, DOI 10.1002/cbdv.200900092; Rojas AM, 2004, INT J SYST EVOL MICR, V54, P2217, DOI 10.1099/ijs.0.02924-0; Sesli M, 2010, GENET MOL RES, V9, P966, DOI 10.4238/vol9-2gmr783; Sheridan H, 2012, J ETHNOPHARMACOL, V140, P482, DOI 10.1016/j.jep.2012.01.050; Simon M, 2012, PLANT J, V69, P1094, DOI 10.1111/j.1365-313X.2011.04852.x; Simopoulos AP, 2001, J NUTR, V131, p3065S, DOI 10.1093/jn/131.11.3065S; Talhinhas P, 2005, APPL ENVIRON MICROB, V71, P2987, DOI 10.1128/AEM.71.6.2987-2998.2005; Vietina M, 2011, J SCI FOOD AGR, V91, P1381, DOI 10.1002/jsfa.4317; Vitale S, 2011, PHYTOPATHOLOGY, V101, P679, DOI 10.1094/PHYTO-04-10-0120; West M, 2003, BAYESIAN STATISTICS 7, P733; Xu R, 2010, ARTIF INTELL MED, V48, P91, DOI 10.1016/j.artmed.2009.06.001; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Zhang JJ, 2012, PLANT CELL REP, V31, P299, DOI 10.1007/s00299-011-1164-1; Zhu L, 2010, J COMPUT CHEM, V31, P1478, DOI 10.1002/jcc.21433; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	56	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44164	10.1371/journal.pone.0044164	http://dx.doi.org/10.1371/journal.pone.0044164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957050	gold, Green Submitted, Green Published			2022-12-25	WOS:000308463800042
J	Dykstra, AR; Koh, CK; Braida, LD; Tramo, MJ				Dykstra, Andrew R.; Koh, Christine K.; Braida, Louis D.; Tramo, Mark Jude			Dissociation of Detection and Discrimination of Pure Tones following Bilateral Lesions of Auditory Cortex	PLOS ONE			English	Article							SOUND LEVEL DEPENDENCE; RESPONSE PROPERTIES; FUNCTIONAL-ANATOMY; FMRI ACTIVATION; HESCHLS GYRUS; INTENSITY; FREQUENCY; BRAIN; DEACTIVATION; LOCALIZATION	It is well known that damage to the peripheral auditory system causes deficits in tone detection as well as pitch and loudness perception across a wide range of frequencies. However, the extent to which to which the auditory cortex plays a critical role in these basic aspects of spectral processing, especially with regard to speech, music, and environmental sound perception, remains unclear. Recent experiments indicate that primary auditory cortex is necessary for the normally-high perceptual acuity exhibited by humans in pure-tone frequency discrimination. The present study assessed whether the auditory cortex plays a similar role in the intensity domain and contrasted its contribution to sensory versus discriminative aspects of intensity processing. We measured intensity thresholds for pure-tone detection and pure-tone loudness discrimination in a population of healthy adults and a middle-aged man with complete or near-complete lesions of the auditory cortex bilaterally. Detection thresholds in his left and right ears were 16 and 7 dB HL, respectively, within clinically-defined normal limits. In contrast, the intensity threshold for monaural loudness discrimination at 1 kHz was 6.5 +/- 2.1 dB in the left ear and 6.5 +/- 1.9 dB in the right ear at 40 dB sensation level, well above the means of the control population (left ear: 1.6 +/- 0.22 dB; right ear: 1.7 +/- 0.19 dB). The results indicate that auditory cortex lowers just-noticeable differences for loudness discrimination by approximately 5 dB but is not necessary for tone detection in quiet. Previous human and Old-world monkey experiments employing lesion-effect, neurophysiology, and neuroimaging methods to investigate the role of auditory cortex in intensity processing are reviewed.	[Dykstra, Andrew R.; Braida, Louis D.; Tramo, Mark Jude] MIT, Harvard Mit Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02139 USA; [Dykstra, Andrew R.; Koh, Christine K.; Braida, Louis D.; Tramo, Mark Jude] Massachusetts Gen Hosp, Dept Neurol, Inst Mus & Brain Sci, Auditory Neurosci Program, Boston, MA 02114 USA; [Dykstra, Andrew R.; Koh, Christine K.; Braida, Louis D.; Tramo, Mark Jude] Harvard Univ, Sch Med, Boston, MA USA; [Koh, Christine K.; Braida, Louis D.; Tramo, Mark Jude] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Dykstra, AR (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02139 USA.	Andrew.Dykstra@med.uni-heidelberg.de			NIH [DC03328, DC006353, DC00117, T32-DC00038]; Harvard-MIT Division of Health Sciences and Technology; Institute for Music and Brain Science	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-MIT Division of Health Sciences and Technology; Institute for Music and Brain Science	This work was supported by NIH (http://www.nih.gov/) DC03328, DC006353, DC00117, T32-DC00038, The Harvard-MIT Division of Health Sciences and Technology (http://hst.mit.edu/index.jsp), and The Institute for Music and Brain Science (http://www.brainmusic.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baran Jane A, 2004, J Am Acad Audiol, V15, P106, DOI 10.3766/jaaa.15.2.2; Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Baru A, 1972, NEUROPSYCHOLOGY EVER, P1; Belin P, 1998, J NEUROSCI, V18, P6388; Bendor D, 2008, J NEUROPHYSIOL, V100, P888, DOI 10.1152/jn.00884.2007; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; DIVENYI PL, 1989, BRAIN LANG, V37, P290, DOI 10.1016/0093-934X(89)90020-5; Hall DA, 2001, J ACOUST SOC AM, V109, P1559, DOI 10.1121/1.1345697; Harrington I, 2003, INTENSITY DISCRIMINA; Hart HC, 2003, HEARING RES, V179, P104, DOI 10.1016/S0378-5955(03)00100-X; Hart HC, 2002, HEARING RES, V171, P177, DOI 10.1016/S0378-5955(02)00498-7; HODGSON WR, 1967, J SPEECH HEAR DISORD, V32, P39, DOI 10.1044/jshd.3201.39; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Jerger J, 1969, Acta Otolaryngol Suppl, V258, P1; JERGER J, 1972, J SPEECH HEAR DISORD, V37, P523, DOI 10.1044/jshd.3704.523; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; King AJ, 2007, HEARING RES, V229, P106, DOI 10.1016/j.heares.2007.01.001; Lasota KJ, 2003, J COMPUT ASSIST TOMO, V27, P213, DOI 10.1097/00004728-200303000-00018; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; Malhotra S, 2007, J NEUROPHYSIOL, V97, P26, DOI 10.1152/jn.00720.2006; MARSHALL L, 1986, J SPEECH HEAR RES, V29, P82, DOI 10.1044/jshr.2901.82; MASTERTON RB, 1974, ANNU REV PSYCHOL, V25, P277, DOI 10.1146/annurev.ps.25.020174.001425; MENDEZ MF, 1988, J NEUROL NEUROSUR PS, V51, P1, DOI 10.1136/jnnp.51.1.1; MILLEN SJ, 1995, LARYNGOSCOPE, V105, P1305, DOI 10.1288/00005537-199512000-00008; Milner B, 1962, LATERALITY EFFECTS A, P177; Mohr CM, 1999, J ACOUST SOC AM, V105, P2738, DOI 10.1121/1.426942; Moore BCJ, 2000, BRIT J AUDIOL, V34, P205, DOI 10.3109/03005364000000131; Moore DR, 2001, CURR BIOL, V11, pR782, DOI 10.1016/S0960-9822(01)00477-8; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Musiek FE, 1993, NEUROAUDIOLOGY CASE; Nakamoto KT, 2008, J NEUROPHYSIOL, V99, P2347, DOI 10.1152/jn.01326.2007; Neff WD, 1975, HDB SENSORY PHYSIOLO, P307; PARKER S, 1980, PERCEPT PSYCHOPHYS, V28, P398, DOI 10.3758/BF03204883; RABINOWITZ WM, 1976, J ACOUST SOC AM, V59, P1506, DOI 10.1121/1.381000; RAPIN I, 1966, ELECTROEN CLIN NEURO, V21, P335, DOI 10.1016/0013-4694(66)90039-3; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Rinne T, 2008, J NEUROPHYSIOL, V100, P3323, DOI 10.1152/jn.90607.2008; Rybalko N, 2010, BEHAV BRAIN RES, V209, P123, DOI 10.1016/j.bbr.2010.01.028; Sigalovsky IS, 2006, NEUROIMAGE, V32, P1524, DOI 10.1016/j.neuroimage.2006.05.023; Sigalovsky IS, 2006, HEARING RES, V215, P67, DOI 10.1016/j.heares.2006.03.002; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; STROMINGER NL, 1980, PHYSIOL BEHAV, V24, P1149, DOI 10.1016/0031-9384(80)90062-1; Swisher LP, 1967, CORTEX, V3, P179; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Thaerig S, 2008, INT J PSYCHOPHYSIOL, V67, P235, DOI 10.1016/j.ijpsycho.2007.06.007; Tramo M J, 1990, J Cogn Neurosci, V2, P195, DOI 10.1162/jocn.1990.2.3.195; Tramo MJ, 2002, J NEUROPHYSIOL, V87, P122, DOI 10.1152/jn.00104.1999; Tramo MJ, 1994, PSYCHOPHYSICAL MEASU; Watkins PV, 2008, NAT NEUROSCI, V11, P1259, DOI 10.1038/nn.2201; Watkins PV, 2011, HEARING RES, V275, P30, DOI 10.1016/j.heares.2010.11.011; Watkins PV, 2011, CEREB CORTEX, V21, P178, DOI 10.1093/cercor/bhq079; Woods DL, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00155; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Yost W A., 2006, FUNDAMENTALS HEARING	60	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44602	10.1371/journal.pone.0044602	http://dx.doi.org/10.1371/journal.pone.0044602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957087	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800080
J	Ferreira, PA; Ruela-de-Sousa, RR; Queiroz, KCS; Souza, ACS; Milani, R; Pilli, RA; Peppelenbosch, MP; den Hertog, J; Ferreira, CV				Ferreira, Paula A.; Ruela-de-Sousa, Roberta R.; Queiroz, Karla C. S.; Souza, Ana Carolina S.; Milani, Renato; Pilli, Ronaldo Aloise; Peppelenbosch, Maikel P.; den Hertog, Jeroen; Ferreira, Carmen V.			Knocking Down Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP) Reverts Chemoresistance through Inactivation of Src and Bcr-Abl Proteins	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; CANCER; ACTIVATION; KINASES; CELLS	The development of multidrug resistance (MDR) limits the efficacy of continuous chemotherapeutic treatment in chronic myelogenous leukemia (CML). Low molecular weight protein tyrosine phosphatase (LMW-PTP) is up-regulated in several cancers and has been associated to poor prognosis. This prompted us to investigate the involvement of LMW-PTP in MDR. In this study, we investigated the role of LMW-PTP in a chemoresistant CML cell line, Lucena-1. Our results showed that LMW-PTP is highly expressed and 7-fold more active in Lucena-1 cells compared to K562 cells, the non-resistant cell line. Knocking down LMW-PTP in Lucena-1 cells reverted chemoresistance to vincristine and imatinib mesylate, followed by a decrease of Src and Bcr-Abl phosphorylation at the activating sites, inactivating both kinases. On the other hand, overexpression of LMW-PTP in K562 cells led to chemoresistance to vincristine. Our findings describe, for the first time, that LMW-PTP cooperates with MDR phenotype, at least in part, through maintaining Src and Bcr-Abl kinases in more active statuses. These findings suggest that inhibition of LMW-PTP may be a useful strategy for the development of therapies for multidrug resistant CML.	[Ferreira, Paula A.; Ruela-de-Sousa, Roberta R.; Milani, Renato; Ferreira, Carmen V.] Univ Campinas UNICAMP, Inst Biol, Dept Biochem, Lab Bioassays & Signal Transduct, Sao Paulo, Brazil; [Ruela-de-Sousa, Roberta R.; Queiroz, Karla C. S.] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol & Med, NL-1105 AZ Amsterdam, Netherlands; [Queiroz, Karla C. S.; Peppelenbosch, Maikel P.] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Souza, Ana Carolina S.] Univ Fed ABC, Sao Paulo, Brazil; [Pilli, Ronaldo Aloise] Univ Campinas UNICAMP, Inst Chem, Dept Organ Chem, Sao Paulo, Brazil; [den Hertog, Jeroen] Hubrecht Inst, Utrecht, Netherlands	Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Universidade Federal do ABC (UFABC); Universidade Estadual de Campinas; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Ferreira, PA (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Biochem, Lab Bioassays & Signal Transduct, Sao Paulo, Brazil.	carmenv@unicamp.br	de Souza Galvão, Ana Carolina Santos/B-8114-2014; Milani, Renato/G-1037-2010; Pilli, Ronaldo/V-3380-2019; Souza, Ana Carolina Santos/B-8122-2014; Santos, Ana Carolina/GWR-2410-2022; Ruela de Sousa, Roberta/C-6825-2012; Peppelenbosch, Maikel P./U-5304-2019; Queiroz, Karla/L-6438-2014	de Souza Galvão, Ana Carolina Santos/0000-0003-1748-3494; Milani, Renato/0000-0002-6902-6589; Ruela de Sousa, Roberta/0000-0002-3762-2247; Pilli, Ronaldo/0000-0002-5919-7763; Peppelenbosch, Maikel/0000-0001-9112-6028	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - http://fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Boehrer S, 2011, CELL CYCLE, V10, P3168, DOI 10.4161/cc.10.18.16599; Chen SY, 2008, ARCH DERMATOL RES, V300, P195, DOI 10.1007/s00403-008-0829-2; Chiarugi P, 2004, ONCOGENE, V23, P3905, DOI 10.1038/sj.onc.1207508; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; Daley G, 1990, SCIENCE; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Kikawa KD, 2002, J BIOL CHEM, V277, P39274, DOI 10.1074/jbc.M207127200; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Mahon F, 2008, CANC RES; Malentacchi F, 2005, BIOCHEM BIOPH RES CO, V334, P875, DOI 10.1016/j.bbrc.2005.06.176; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Ren MQ, 2011, CANCER RES, V71, P7312, DOI 10.1158/0008-5472.CAN-11-1109; RENZI NL, 1983, J CHROMATOGR, V278, P179, DOI 10.1016/S0378-4347(00)84771-4; Rigacci S, 2003, BIOCHEM BIOPH RES CO, V312, P360, DOI 10.1016/j.bbrc.2003.10.126; Ruela-de-Sousa RR, 2010, BBA-REV CANCER, V1806, P287, DOI 10.1016/j.bbcan.2010.07.007; Rumjanek VM, 2001, AN ACAD BRAS CIENC, V73, P57, DOI 10.1590/S0001-37652001000100007; Souza ACS, 2009, CELL MOL LIFE SCI, V66, P1140, DOI 10.1007/s00018-008-8501-8; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125	23	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44312	10.1371/journal.pone.0044312	http://dx.doi.org/10.1371/journal.pone.0044312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957062	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800055
J	Wagner, BG; Blower, S				Wagner, Bradley G.; Blower, Sally			Universal Access to HIV Treatment versus Universal 'Test and Treat': Transmission, Drug Resistance & Treatment Costs	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; MALE CIRCUMCISION; SAN-FRANCISCO; PREVENTION; STRATEGY; EPIDEMICS; GROWTH; UGANDA; CURB	In South Africa (SA) universal access to treatment for HIV-infected individuals in need has yet to be achieved. Currently similar to 1 million receive treatment, but an additional 1.6 million are in need. It is being debated whether to use a universal 'test and treat' (T&T) strategy to try to eliminate HIV in SA; treatment reduces infectivity and hence transmission. Under a T&T strategy all HIV-infected individuals would receive treatment whether in need or not. This would require treating 5 million individuals almost immediately and providing treatment for several decades. We use a validated mathematical model to predict impact and costs of: (i) a universal T&T strategy and (ii) achieving universal access to treatment. Using modeling the WHO has predicted a universal T&T strategy in SA would eliminate HIV within a decade, and (after 40 years) cost similar to$10 billion less than achieving universal access. In contrast, we predict a universal T&T strategy in SA could eliminate HIV, but take 40 years and cost similar to$12 billion more than achieving universal access. We determine the difference in predictions is because the WHO has under-estimated survival time on treatment and ignored the risk of resistance. We predict, after 20 years, similar to 2 million individuals would need second-line regimens if a universal T&T strategy is implemented versus similar to 1.5 million if universal access is achieved. Costs need to be realistically estimated and multiple evaluation criteria used to compare 'treatment as prevention' with other prevention strategies. Before implementing a universal T&T strategy, which may not be sustainable, we recommend striving to achieve universal access to treatment as quickly as possible. We predict achieving universal access to treatment would be a very effective 'treatment as prevention' approach and bring the HIV epidemic in SA close to elimination, preventing similar to 4 million infections after 20 years and similar to 11 million after 40 years.	[Wagner, Bradley G.; Blower, Sally] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wagner, BG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	sblower@mednet.ucla.edu			National Institutes of Health [RO1 AI041935, R21 AI086701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041935, R21AI086701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants RO1 AI041935 and R21 AI086701 website: www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2012, NEW ENGL J MED; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Dodd PJ, 2009, EXAMINING PROMISE HI, P1; El-Sadr WM, 2010, JAIDS-J ACQ IMM DEF, V55, pS116, DOI 10.1097/QAI.0b013e3181fbca6e; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Statistics South Africa, 2010, MID POP EST 2010; Thigpen MC, 2012, N ENGL J MED; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Wagner B, 2010, LANCET, V376, P953, DOI 10.1016/S0140-6736(10)61442-0; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782	23	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41212	10.1371/journal.pone.0041212	http://dx.doi.org/10.1371/journal.pone.0041212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957012	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800004
J	Yeh, SP; Liao, YM; Lo, WJ; Lin, CL; Bai, LY; Lin, CY; Hsieh, CY; Chang, YC; Huang, YT; Chiu, CF				Yeh, Su-Peng; Liao, Yu-Min; Lo, Wen-Jyi; Lin, Chiao-Lin; Bai, Li-Yuan; Lin, Chen-Yuan; Hsieh, Ching-Yun; Chang, Yu-Chien; Huang, Yu-Ting; Chiu, Chang-Fang			Kinetics of T Helper Subsets and Associated Cytokines Correlate Well with the Clinical Activity of Graft-Versus-Host Disease	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; INTERFERON-GAMMA; B-CELLS; PLASMA CYTOKINES; SERUM-LEVELS; IFN-GAMMA; TH2 CELLS; IL-10; INTERLEUKIN-10	Background: CD4(+) interferon (IFN)-gamma(+) T cell (Th1) and CD4(+) interleukin (IL)-4(+) T cell (Th2) polarizations are crucial in the pathogenesis of graft-versus-host disease (GVHD). However, this hypothesis is largely based on animal experiments of Parent-into-F1 GVHD model. The causal relationship between kinetics of Th1, Th2 and associated cytokines and the clinical activity of GVHD in a real world situation remains unknown. Methodology: Peripheral blood was collected every week prospectively from Day 0 to Day 210 (patients without GVHD) or Day 300 (patients with chronic GVHD) after allogeneic peripheral blood stem cell transplantation in consecutive 27 patients. The frequencies of Th1 and Th2 within CD4(+) T cells were determined by flow cytometry and pplasma IFN-gamma, IL-12, IL-4, and IL-10 were determined by ELISA. Principal Findings: Kinetics of Th1, Th2 frequency, and the plasma IL-10 and IFN-gamma more commonly coincided with, rather than predicted, the activity of GVHD. These markers are significantly higher when acute or chronic GVHD developed. The kinetics of IL-10 is especially correlated well with the activity of GVHD during clinical course of immunosuppressive treatment. For patients with hepatic GVHD, there is a positive correlation between plasma IL-10 levels and the severity of hepatic injury. The frequency of Th2 is also significant higher in acute GVHD and tends to be higher in chronic GVHD. Interestingly, there is a very good positive correlation between the frequency of Th1 and Th2 (r = 0.951, p< 0.001). The plasma level of IL-4 and IL-12 are not associated with the activity of GVHD. Conclusions: The frequency of Th1, Th2 within CD4(+) T cells and plasma IL-10 and IFN-gamma are good biomarkers of GVHD. Plasma IL-10 can also be used to monitor the therapeutic responsiveness. Furthermore, both Th1 and Th2 likely contribute to the pathogenesis of GVHD.	[Yeh, Su-Peng; Lo, Wen-Jyi; Lin, Chiao-Lin; Chang, Yu-Chien; Huang, Yu-Ting] China Med Univ Hosp, Dept Med Res, Stem Cell Res Lab, Taichung, Taiwan; [Yeh, Su-Peng; Liao, Yu-Min; Bai, Li-Yuan; Lin, Chen-Yuan; Hsieh, Ching-Yun; Chiu, Chang-Fang] China Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Taichung, Taiwan; [Yeh, Su-Peng; Bai, Li-Yuan; Chiu, Chang-Fang] China Med Univ, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Yeh, SP (corresponding author), China Med Univ Hosp, Dept Med Res, Stem Cell Res Lab, Taichung, Taiwan.	supengyeh@gmail.com			Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence [DOH-100-TD-C-111-005]; China Medical University Hospital [DMR 93-016]	Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence; China Medical University Hospital	This work was supported in part by the research grant from Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence (DOH-100-TD-C-111-005) and research grant from China Medical University Hospital (DMR 93-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Abdallah AN, 1997, HEMATOL CELL THER, V39, P27, DOI 10.1007/s00282-997-0027-2; ALLEN RD, 1993, EUR J IMMUNOL, V23, P333, DOI 10.1002/eji.1830230205; ANTIN JH, 1992, BLOOD, V80, P2964; Bucher C, 2009, BLOOD, V114, P5375, DOI 10.1182/blood-2009-05-221135; Chik KW, 2003, J PEDIAT HEMATOL ONC, V25, P960, DOI 10.1097/00043426-200312000-00011; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; DEWIT D, 1993, J IMMUNOL, V150, P361; FOWLER DH, 1994, J IMMUNOL, V152, P1004; FOWLER DH, 1994, BLOOD, V84, P3540; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Fujii N, 2006, INT J MOL MED, V17, P881; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hanash AM, 2011, BLOOD, V118, P446, DOI 10.1182/blood-2010-07-294785; Holler E, 2000, BONE MARROW TRANSPL, V25, P237, DOI 10.1038/sj.bmt.1702126; IMAMURA M, 1994, BONE MARROW TRANSPL, V13, P745; Kayaba H, 2000, J ALLERGY CLIN IMMUN, V106, pS40, DOI 10.1067/mai.2000.106060; KERNAN NA, 1986, BLOOD, V68, P770; Korngold B, 1978, J EXP MED, V148, P1687; Krenger W, 1996, TRANSPLANTATION, V62, P1278, DOI 10.1097/00007890-199611150-00018; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; Min CK, 2001, BONE MARROW TRANSPL, V28, P935, DOI 10.1038/sj.bmt.1703258; Miura Y, 2002, BLOOD, V100, P2650, DOI 10.1182/blood-2002-01-0176; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morel PA, 1998, CRIT REV IMMUNOL, V18, P275, DOI 10.1615/CritRevImmunol.v18.i4.10; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakamura H, 2000, J ALLERGY CLIN IMMUN, V106, pS45, DOI 10.1067/mai.2000.106774; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; Remberger M, 2003, EUR J HAEMATOL, V70, P384, DOI 10.1034/j.1600-0609.2003.00078.x; Rowe V, 2006, BLOOD, V108, P2485, DOI 10.1182/blood-2006-04-016063; Sakata N, 2001, BONE MARROW TRANSPL, V27, P1153, DOI 10.1038/sj.bmt.1703060; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Tanaka J, 1997, BONE MARROW TRANSPL, V19, P571, DOI 10.1038/sj.bmt.1700708; Terrier B, 2012, ARTHRITIS RHEUM-US, V64, P2001, DOI 10.1002/art.34327; Visentainer JEL, 2003, EXP HEMATOL, V31, P1044, DOI 10.1016/j.exphem.2003.08.005; Wang TH, 2011, J IMMUNOL, V186, P708, DOI 10.4049/jimmunol.1001203; Yeh S-P, 2006, HAEMATOLOGICA S1, V91, pa0309	43	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44416	10.1371/journal.pone.0044416	http://dx.doi.org/10.1371/journal.pone.0044416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957070	Green Submitted, gold, Green Published			2022-12-25	WOS:000308463800063
J	Peer, N; Steyn, K; Lombard, C; Lambert, EV; Vythilingum, B; Levitt, NS				Peer, Nasheeta; Steyn, Krisela; Lombard, Carl; Lambert, Estelle V.; Vythilingum, Bavanisha; Levitt, Naomi S.			Rising Diabetes Prevalence among Urban-Dwelling Black South Africans	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK-FACTORS; COHERENCE; SENSE; MANAGEMENT; OBESITY; BURDEN	Objective: To examine the prevalence of and the association of psychosocial risk factors with diabetes in 25-74-year-old black Africans in Cape Town in 2008/09 and to compare the prevalence with a 1990 study. Research Design and Methods: A randomly selected cross-sectional sample had oral glucose tolerance tests. The prevalence of diabetes (1998 WHO criteria), other cardiovascular risk factors and psychosocial measures, including sense of coherence (SOC), locus of control and adverse life events, were determined. The comparison of diabetes prevalence between this and a 1990 study used the 1985 WHO diabetes criteria. Results: There were 1099 participants, 392 men and 707 women (response rate 86%). The age-standardised (SEGI) prevalence of diabetes was 13.1% (95% confidence interval (CI) 11.0-15.1), impaired glucose tolerance (IGT) 11.2% (9.2-13.1) and impaired fasting glycaemia 1.2% (0.6-1.9). Diabetes prevalence peaked in 65-74-year-olds (38.6%). Among diabetic participants, 57.9% were known and 38.6% treated. Using 1985 WHO criteria, age-standardised diabetes prevalence was higher by 53% in 2008/09 (12.2% (10.2-14.2)) compared to 1990 (8.0% (5.8-10.3)) and IGT by 67% (2008/09: 11.7% (9.8-13.7); 1990: 7.0% (4.9-9.1)). In women, older age (OR: 1.05, 95% CI: 1.03-1.08, p<0.001), diabetes family history (OR: 3.13, 95% CI: 1.92-5.12, p<0.001), higher BMI (OR: 1.44, 95% CI: 1.20-1.82, p = 0.001), better quality housing (OR: 2.08, 95% CI: 1.01-3.04, p = 0.047) and a lower SOC score (<= 40) was positively associated with diabetes (OR: 2.57, 95% CI: 1.37-4.80, p = 0.003). Diabetes was not associated with the other psychosocial measures in women or with any psychosocial measure in men. Only older age (OR: 1.05, 95% CI: 1.02-1.08, p = 0.002) and higher BMI (OR: 1.10, 95% CI: 1.04-1.18, p = 0.003) were significantly associated with diabetes in men. Conclusions: The current high prevalence of diabetes in urban-dwelling South Africans, and the likelihood of further rises given the high rates of IGT and obesity, is concerning. Multi-facetted diabetes prevention strategies are essential to address this burden.	[Peer, Nasheeta] MRC, Chron Dis Lifestyle Unit, Durban, South Africa; [Steyn, Krisela; Levitt, Naomi S.] Univ Cape Town, Dept Med, Chron Dis Initiat Africa, ZA-7925 Cape Town, South Africa; [Lombard, Carl] MRC, Biostat Unit, Durban, South Africa; [Lambert, Estelle V.] Univ Cape Town, MRC, Unit Exercise Sci & Sports Med, ZA-7925 Cape Town, South Africa; [Vythilingum, Bavanisha] Univ Cape Town, Dept Psychiat, ZA-7925 Cape Town, South Africa; [Levitt, Naomi S.] Univ Cape Town, Dept Med, Div Endocrinol & Diabet, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Peer, N (corresponding author), MRC, Chron Dis Lifestyle Unit, Durban, South Africa.	naomi.levitt@uct.ac.za	Lambert, Estelle/ABF-1268-2020	Lambert, Estelle/0000-0003-4315-9153; Levitt, Naomi/0000-0001-6480-8066; Peer, Nasheeta/0000-0003-2131-8344; Lombard, Carl/0000-0002-2136-6533	Servier Laboratories (South Africa); Medical Research Council of South Africa; Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; Brigham Hospital/Harvard University	Servier Laboratories (South Africa); Medical Research Council of South Africa(South African Medical Research Council); Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; Brigham Hospital/Harvard University	This study was funded by an unrestricted grant from Servier Laboratories (South Africa), the Medical Research Council of South Africa, the Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council and Brigham Hospital/Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2003, DIABETES CARE, V26, P719, DOI 10.2337/diacare.26.3.719; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 1982, IARC PUBL, P671; Berger GMB, 2000, S AFR MED J, V90, P164; Bonita R, 2002, SURVEILLANCE RISK FA; Botha KF, 2002, J HEALTH PSYCHOL, V7, P519, DOI 10.1177/1359105302007005672; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P700; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Christensen DL, 2009, DIABETES RES CLIN PR, V84, P303, DOI 10.1016/j.diabres.2009.03.007; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavin JR, 1997, DIABETES CARE, V20, P1183; Joint WHO-FAO Expert Consultation on Diet Nutrition and the Prevention of Chronic Diseases, 2003, DIET NUTR PREV CHRON; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kouvonen AM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-46; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; LEVITT NS, 1993, DIABETES CARE, V16, P601, DOI 10.2337/diacare.16.4.601; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Mooy JM, 2000, DIABETES CARE, V23, P197, DOI 10.2337/diacare.23.2.197; Motala AA, 2008, DIABETES CARE, V31, P1783, DOI 10.2337/dc08-0212; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; South African Medical Association and Lipid and Atherosclerosis Society of Southern Africa Working Group, 2000, S AFR MED J, V90, P176; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 1985, DIAB MELL REP WHO ST; World Health Organization (WHO) Department of Non-communicable Diseases, 2002, GLOB PHYS ACT QUEST	29	134	135	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43336	10.1371/journal.pone.0043336	http://dx.doi.org/10.1371/journal.pone.0043336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22962583	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600010
J	Rah, B; Amin, H; Yousuf, K; Khan, S; Jamwal, G; Mukherjee, D; Goswami, A				Rah, Bilal; Amin, Hina; Yousuf, Khalid; Khan, Sheema; Jamwal, Gayatri; Mukherjee, Debaraj; Goswami, Anindya			A Novel MMP-2 Inhibitor 3-azidowithaferin A (3-azidoWA) Abrogates Cancer Cell Invasion and Angiogenesis by Modulating Extracellular Par-4	PLOS ONE			English	Article							COMPOUND WITHAFERIN-A; TUMOR-CELL; MATRIX METALLOPROTEINASES; GELATINASE-A; APOPTOSIS; EXPRESSION; ACTIVATION; WITHANOLIDES; TRAFFICKING; METASTASIS	Background: Withaferin A, which is a naturally derived steroidal lactone, has been found to prevent angiogenesis and metastasis in diverse tumor models. It has also been recognized by different groups for prominent anti-carcinogenic roles. However, in spite of these studies on withanolides, their detailed anti-metastatic mechanism of action remained unknown. The current study has poised to address the machinery involved in invasion regulation by stable derivative of Withaferin A, 3-azido Withaferin A (3-azidoWA) in human cervical HeLa and prostate PC-3 cells. Methods and Principal Findings: Sub-toxic concentration of 3-azidowithaferin A (3-azido WA) inhibited cancer cell motility and invasion in wound healing and Boyden chamber invasion by suppressing MMP-2 activity in gelatin zymography and its expression has proved to be a major obstacle in chemo-sensitivity. We have uncovered a novel mechanism of 3-azidoWA induced extracellular pro-apoptotic candidate tumor suppressor Par-4 protein stimulation in conditioned media and also noticed a concomitant marked reduction in pAkt and pERK signaling by immunoblot analysis. Furthermore, our zymography results suggest 3-azidoWA induced MMP-2 inhibition was mediated through secretory Par-4. The inhibition of apoptosis by 3-azidoWA could not restore MMP-2 gelatinase activity. In addition to this, our in vivo animal experiments data showed 3-azidoWA abrogated neovascularisation in dose dependent manner in mouse Matrigel plug assay. Conclusion/Significance: For this report, we found that 3-azidoWA suppressed motility and invasion of HeLa and PC-3 cells in MMP-2 dependent manner. Our in vitro result strongly suggests that sub-toxic doses of 3-azidoWA enhanced the secretion of extracellular Par-4 that abolished secretory MMP-2 expression and activity. Depletion of secretory Par-4 restored MMP-2 expression and invasion capability of HeLa and PC-3 cells. Further, our findings implied that 3-azidoWA attenuated internal phospho-ERK and phospho-Akt expression in a dose dependent manner might play a key role in inhibition of mouse angiogenesis by 3-azidoWA.	[Rah, Bilal; Amin, Hina; Khan, Sheema; Jamwal, Gayatri; Goswami, Anindya] Indian Inst Integrat Med CSIR, Canc Pharmacol Div, Mol Signal Transduct Lab, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Rah, B (corresponding author), Indian Inst Integrat Med CSIR, Canc Pharmacol Div, Mol Signal Transduct Lab, Jammu, India.	agoswami@iiim.ac.in						ANBALAGAN K, 1984, BIOCHEM MED METAB B, V31, P236, DOI 10.1016/0006-2944(84)90028-0; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Banerji A, 2004, CANCER LETT, V211, P235, DOI 10.1016/j.canlet.2004.02.007; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Boehrer S, 2006, LEUKEMIA RES, V30, P597, DOI 10.1016/j.leukres.2005.09.003; Brand K, 2000, CANCER RES, V60, P5723; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chakraborty M, 2001, CANCER RES, V61, P7255; Chen Pin-Shern, 2011, PLoS One, V6, pe20164, DOI 10.1371/journal.pone.0020164; Chetty C, 2007, ONCOGENE, V26, P7675, DOI 10.1038/sj.onc.1210584; Chetty C, 2006, MOL CANCER THER, V5, P2289, DOI 10.1158/1535-7163.MCT-06-0169; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; Hanemaaijer R, 2000, INT J CANCER, V86, P204, DOI 10.1002/(SICI)1097-0215(20000415)86:2<204::AID-IJC9>3.0.CO;2-6; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim MM, 2006, FEBS LETT, V580, P2661, DOI 10.1016/j.febslet.2006.04.015; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kour K, 2009, INT IMMUNOPHARMACOL, V9, P1137, DOI 10.1016/j.intimp.2009.05.011; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mitsiades N, 2001, EXPERT OPIN INV DRUG, V10, P1075, DOI 10.1517/13543784.10.6.1075; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Nemeth JA, 2002, J NATL CANCER I, V94, P17; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Prakash J, 2002, NUTR CANCER, V42, P91, DOI 10.1207/S15327914NC421_12; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; Sen N, 2007, CELL DEATH DIFFER, V14, P358, DOI 10.1038/sj.cdd.4402002; SHOHAT B., 1967, CANCER CHEMOTHER REP, V51, P271; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stearns M, 1996, ONCOL RES, V8, P69; Strand S, 2004, ONCOGENE, V23, P3732, DOI 10.1038/sj.onc.1207387; SUDHIR S, 1986, PLANTA MED, P61, DOI 10.1055/s-2007-969072; WEISSENBERG M, 1977, J CHEM SOC PERK T 1, P795, DOI 10.1039/p19770000795; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yousuf SK, 2011, STEROIDS, V76, P1213, DOI 10.1016/j.steroids.2011.05.012; Zhen MC, 2006, ACTA PHARMACOL SIN, V27, P1600, DOI 10.1111/j.1745-7254.2006.00439.x; Zucker S, 2009, CANCER BIOL THER, V8, P2371, DOI 10.4161/cbt.8.24.10353	51	76	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44039	10.1371/journal.pone.0044039	http://dx.doi.org/10.1371/journal.pone.0044039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962598	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600026
J	Stavropoulos, I; Khaldi, N; Davey, NE; O'Brien, K; Martin, F; Shields, DC				Stavropoulos, Ilias; Khaldi, Nora; Davey, Norman E.; O'Brien, Kevin; Martin, Finian; Shields, Denis C.			Protein Disorder and Short Conserved Motifs in Disordered Regions Are Enriched near the Cytoplasmic Side of Single-Pass Transmembrane Proteins	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; CASEIN KINASE-II; EUKARYOTIC LINEAR MOTIFS; SYNAPTOTAGMIN GENES; ENERGY CONTENT; DOMAIN; PHOSPHORYLATION; DISCOVERY; RECEPTOR; INTERNALIZATION	Intracellular juxtamembrane regions of transmembrane proteins play pivotal roles in cell signalling, mediated by protein-protein interactions. Disordered protein regions, and short conserved motifs within them, are emerging as key determinants of many such interactions. Here, we investigated whether disorder and conserved motifs are enriched in the juxtamembrane area of human single-pass transmembrane proteins. Conserved motifs were defined as short disordered regions that were much more conserved than the adjacent disordered residues. Human single-pass proteins had higher mean disorder in their cytoplasmic segments than their extracellular parts. Some, but not all, of this effect reflected the shorter length of the cytoplasmic tail. A peak of cytoplasmic disorder was seen at around 30 residues from the membrane. We noted a significant increase in the incidence of conserved motifs within the disordered regions at the same location, even after correcting for the extent of disorder. We conclude that elevated disorder within the cytoplasmic tail of many transmembrane proteins is likely to be associated with enrichment for signalling interactions mediated by conserved short motifs.	[Stavropoulos, Ilias; Khaldi, Nora; O'Brien, Kevin; Shields, Denis C.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Stavropoulos, Ilias; Khaldi, Nora; O'Brien, Kevin; Shields, Denis C.] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland; [Stavropoulos, Ilias; Khaldi, Nora; O'Brien, Kevin; Martin, Finian; Shields, Denis C.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Martin, Finian] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Davey, Norman E.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Khaldi, Nora] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University College Dublin; University College Dublin; University College Dublin; University College Dublin; European Molecular Biology Laboratory (EMBL); University of California System; University of California Davis	Stavropoulos, I (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	denis.shields@ucd.ie	Davey, Norman E/D-5362-2013	Davey, Norman/0000-0001-6988-4850; Shields, Denis/0000-0003-4015-2474	Irish Research Council for Science, Engineering and Technology (IRCSET) Graduate Education Research Programme; Science Foundation Ireland [PI 08/IN.1/B1864]	Irish Research Council for Science, Engineering and Technology (IRCSET) Graduate Education Research Programme(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by the Irish Research Council for Science, Engineering and Technology (IRCSET) Graduate Education Research Programme (http://bioinformatics.ucd.ie/PhD), and by Science Foundation Ireland (PI 08/IN.1/B1864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002341; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Craxton M, 2001, GENOMICS, V77, P43, DOI 10.1006/geno.2001.6619; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; Davey N. E., 2011, MOL BIOSYST; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; De Biasio A, 2008, J PROTEOME RES, V7, P2496, DOI 10.1021/pr800063u; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RJ, 2008, BIOINFORMATICS, V24, P1307, DOI 10.1093/bioinformatics/btn105; Fukuda M, 2003, J BIOCHEM, V133, P641, DOI 10.1093/jb/mvg082; Fukuda M, 2000, J BIOCHEM, V128, P637, DOI 10.1093/oxfordjournals.jbchem.a022796; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Mauxion F, 1996, J BIOL CHEM, V271, P2171, DOI 10.1074/jbc.271.4.2171; Michael S, 2008, BIOINFORMATICS, V24, P453, DOI 10.1093/bioinformatics/btm624; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Richards JP, 1996, J BIOL CHEM, V271, P13716, DOI 10.1074/jbc.271.23.13716; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Van Roey K, 2012, CURR OPIN STRUC BIOL, V22, P378, DOI 10.1016/j.sbi.2012.03.004	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44389	10.1371/journal.pone.0044389	http://dx.doi.org/10.1371/journal.pone.0044389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962613	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600045
J	Astorga, G; Hartel, S; Sanhueza, M; Bacigalupo, J				Astorga, Guadalupe; Haertel, Steffen; Sanhueza, Magdalena; Bacigalupo, Juan			TRP, TRPL and Cacophony Channels Mediate Ca2+ Influx and Exocytosis in Photoreceptors Axons in Drosophila	PLOS ONE			English	Article							LIGHT-SENSITIVE CHANNELS; PHOSPHOLIPASE-C; CALCIUM-CHANNELS; INSP(3) RECEPTOR; SPIDER TOXINS; PROTEIN; ACTIVATION; SYNAPSES; MELANOGASTER; RELEASE	In Drosophila photoreceptors Ca2+-permeable channels TRP and TRPL are the targets of phototransduction, occurring in photosensitive microvilli and mediated by a phospholipase C (PLC) pathway. Using a novel Drosophila brain slice preparation, we studied the distribution and physiological properties of TRP and TRPL in the lamina of the visual system. Immunohistochemical images revealed considerable expression in photoreceptors axons at the lamina. Other phototransduction proteins are also present, mainly PLC and protein kinase C, while rhodopsin is absent. The voltage-dependent Ca2+ channel cacophony is also present there. Measurements in the lamina with the Ca2+ fluorescent protein G-CaMP ectopically expressed in photoreceptors, revealed depolarization-induced Ca2+ increments mediated by cacophony. Additional Ca2+ influx depends on TRP and TRPL, apparently functioning as store-operated channels. Single synaptic boutons resolved in the lamina by FM4-64 fluorescence revealed that vesicle exocytosis depends on cacophony, TRP and TRPL. In the PLC mutant norpA bouton labeling was also impaired, implicating an additional modulation by this enzyme. Internal Ca2+ also contributes to exocytosis, since this process was reduced after Ca2+-store depletion. Therefore, several Ca2+ pathways participate in photoreceptor neurotransmitter release: one is activated by depolarization and involves cacophony; this is complemented by internal Ca2+ release and the activation of TRP and TRPL coupled to Ca2+ depletion of internal reservoirs. PLC may regulate the last two processes. TRP and TRPL would participate in two different functions in distant cellular regions, where they are opened by different mechanisms. This work sheds new light on the mechanism of neurotransmitter release in tonic synapses of non-spiking neurons.	[Astorga, Guadalupe; Sanhueza, Magdalena; Bacigalupo, Juan] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Astorga, Guadalupe; Sanhueza, Magdalena; Bacigalupo, Juan] Univ Chile, Millennium Inst Cell Dynam & Biotechnol, Fac Sci, Santiago, Chile; [Haertel, Steffen] Univ Chile, Fac Med, Program Anat & Dev Biol, Lab Sci Image Anal,SCIAN Lab,BNI,ICBM, Santiago 7, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Astorga, G (corresponding author), Univ Paris 05, Lab Physiol Cerebrale, Paris, France.	masanhue@uchile.cl; bacigalu@uchile.cl	Härtel, Steffen/AAA-2336-2020	Härtel, Steffen/0000-0002-8913-1757	Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN [ICM-P05-001-F]; Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1100730]; Consejo Nacional de Ciencia y Tecnologia (CONICYT); FONDECYT [1120579]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) [D07I1019]; German-Chilean Center of Excellence Initiative for Medical Informatics (DAAD); BNI [ICM P09-015-F]; Advanced Imaging & Bioinformatics Initiative AI.BI	Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN; Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Consejo Nacional de Ciencia y Tecnologia (CONICYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); German-Chilean Center of Excellence Initiative for Medical Informatics (DAAD); BNI; Advanced Imaging & Bioinformatics Initiative AI.BI	Supported by Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN ICM-P05-001-F (JB, MS), Fondo Nacional de Ciencia y Tecnologia (FONDECYT) 1100730 (RD, JB), Doctoral Fellowship and Thesis grant by the Consejo Nacional de Ciencia y Tecnologia (CONICYT) (GA). Research in SCIAN-Lab (SH) is funded by FONDECYT (1120579), Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) (D07I1019), the German-Chilean Center of Excellence Initiative for Medical Informatics (DAAD), BNI (ICM P09-015-F) and the Advanced Imaging & Bioinformatics Initiative AI.BI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Agrawal N, 2010, J NEUROSCI, V30, P1301, DOI 10.1523/JNEUROSCI.3668-09.2010; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; DEER JLR, 1995, J BIOL CHEM, V270, P12623, DOI 10.1074/jbc.270.21.12623; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Delgado R, 2009, J NEUROPHYSIOL, V101, P2372, DOI 10.1152/jn.90578.2008; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Gu H, 2009, J NEUROPHYSIOL, V101, P42, DOI 10.1152/jn.91103.2008; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Hamanaka Y, 2010, J COMP NEUROL, V518, P1133, DOI 10.1002/cne.22268; Hardie R.C., 2008, SENSES COMPREHENSIVE, P77; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; King GF, 2007, TOXICON, V49, P513, DOI 10.1016/j.toxicon.2006.11.012; LEUNG HT, 1989, NEURON, V3, P767, DOI 10.1016/0896-6273(89)90245-6; Lev S, 2012, J BIOL CHEM, V287, P1436, DOI 10.1074/jbc.M111.266585; LoGiudice L, 2009, NEUROSCIENTIST, V15, P380, DOI 10.1177/1073858408331373; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Ortiz-Miranda SI, 2010, J CELL PHYSIOL, V225, P276, DOI 10.1002/jcp.22263; Peixoto AA, 1998, GENETICS, V148, P827; Peng IF, 2007, J NEUROSCI, V27, P1072, DOI 10.1523/JNEUROSCI.4746-06.2007; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; Pyza E, 2002, MICROSC RES TECHNIQ, V58, P335, DOI 10.1002/jemt.10141; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x; Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Smith L A, 1998, J Neurogenet, V12, P227; Smith LA, 1996, J NEUROSCI, V16, P7868; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; Szikra T, 2008, J PHYSIOL-LONDON, V586, P4859, DOI 10.1113/jphysiol.2008.160051; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Vazquez-Martinez O, 2003, J CELL SCI, V116, P2483, DOI 10.1242/jcs.00455; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WECKSTROM M, 1995, ANN BIOMED ENG, V23, P70, DOI 10.1007/BF02368302; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590	50	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44182	10.1371/journal.pone.0044182	http://dx.doi.org/10.1371/journal.pone.0044182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952921	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300060
J	Chang, CH; Wang, Y; Trisal, P; Li, RX; Rossi, DL; Nair, A; Gupta, P; Losman, M; Cardillo, TM; Rossi, EA; Goldenberg, DM				Chang, Chien-Hsing; Wang, Yang; Trisal, Preeti; Li, Rongxiu; Rossi, Diane L.; Nair, Anju; Gupta, Pankaj; Losman, Michele; Cardillo, Thomas M.; Rossi, Edmund A.; Goldenberg, David M.			Evaluation of a Novel Hexavalent Humanized Anti-IGF-1R Antibody and Its Bivalent Parental IgG in Diverse Cancer Cell Lines	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; ALANINE SCANNING MUTAGENESIS; INSULIN-RECEPTOR; BREAST-CANCER; MONOCLONAL-ANTIBODIES; BINDING-SITE; MULTIFUNCTIONAL STRUCTURES; SOMATOMEDIN RECEPTOR; LIGAND-BINDING	A major mechanism of monoclonal antibodies that selectively target the insulin-like growth factor type 1 receptor (IGF-1R) to inhibit tumor growth is by downregulating the receptor, regardless whether they are capable (antagonistic) or incapable (agonistic) of blocking the binding of cognate ligands. We have developed and characterized a novel agonistic anti-IGF-1R humanized antibody, hR1, and used the Dock-and-Lock (DNL) method to construct Hex-hR1, the first multivalent antibody comprising 6 functional Fabs of hR1, with the aim of enhancing potency of hR1. Based on cross-blocking experiments, hR1 recognizes a region of cysteine-rich domain on the alpha-subunit, different from the epitopes mapped for existing anti-IGF-1R antibodies, yet hR1 is similar to other anti-IGF-1R antibodies in downregulating IGF-1R and inhibiting proliferation, colony formation, or invasion of selected cancer cell lines in vitro, as well as suppressing growth of the RH-30 rhabdomyosarcoma xenograft in nude mice when combined with the mTOR inhibitor, rapamycin. Hex-hR1 and hR1 are generally comparable in their bioactivities under the in-intro and in-vivo conditions investigated. Nevertheless, in selective experiments involving a direct comparison of potency, Hex-hR1 demonstrated a stronger effect on inhibiting cell proliferation stimulated by IGF-1 and could effectively downregulate IGF-1R at a concentration as low as 20 pM.	[Chang, Chien-Hsing; Wang, Yang; Trisal, Preeti; Li, Rongxiu; Rossi, Diane L.; Nair, Anju; Gupta, Pankaj; Losman, Michele; Cardillo, Thomas M.; Goldenberg, David M.] Immunomedics Inc, Morris Plains, NJ USA; [Chang, Chien-Hsing; Rossi, Edmund A.; Goldenberg, David M.] IBC Pharmaceut Inc, Morris Plains, NJ USA; [Goldenberg, David M.] Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA	Immunomedics Inc	Chang, CH (corresponding author), Immunomedics Inc, Morris Plains, NJ USA.	kchang@Immunomedics.com; dmg.gscancer@att.net			National Cancer Institute, United States National Institutes of Health [1R 43CA150742-01]	National Cancer Institute, United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Cancer Institute grant 1R 43CA150742-01 from the United States National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; ARTEAGA CL, 1989, CANCER RES, V49, P6237; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bohula EA, 2003, ANTI-CANCER DRUG, V14, P669, DOI 10.1097/01.cad.0000092782.37568.04; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Burtrum D, 2003, CANCER RES, V63, P8912; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Chakravarti A, 2002, CANCER RES, V62, P200; Chang CH, 2007, CLIN CANCER RES, V13, p5586S, DOI 10.1158/1078-0432.CCR-07-1217; Chang CH, 2011, BISPECIFIC ANTIBODIES, P199, DOI 10.1007/978-3-642-20910-9_12; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Croasdale R, 2012, ARCH BIOCH BIOPHYS; Desbois-Mouthon C, 2009, CLIN CANCER RES, V15, P5445, DOI 10.1158/1078-0432.CCR-08-2980; Dong JY, 2011, J BIOL CHEM, V286, P4703, DOI 10.1074/jbc.M110.184317; Dong JY, 2010, MOL CANCER THER, V9, P2593, DOI 10.1158/1535-7163.MCT-09-1018; Gao J, 2012, CANCER RES, V72, P3, DOI 10.1158/0008-5472.CAN-11-0550; Gao J, 2011, CANCER RES, V71, P1029, DOI 10.1158/0008-5472.CAN-10-2274; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Gualberto A, 2011, BRIT J CANCER, V104, P68, DOI 10.1038/sj.bjc.6605972; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hailey J, 2002, MOL CANCER THER, V1, P1349; Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Jassem J, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.7500; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; Kim SY, 2009, ONCOLOGIST, V14, P83, DOI 10.1634/theoncologist.2008-0189; KULL FC, 1983, J BIOL CHEM, V258, P6561; Li S-I, 1992, BICH BIOPHYS RES COM, V196, P92; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Olmos D, 2010, CANCER J, V16, P183, DOI 10.1097/PPO.0b013e3181dbebf9; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qu ZX, 2005, METHODS, V36, P84, DOI 10.1016/j.ymeth.2005.01.008; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Riedemann J, 2007, BIOCHEM BIOPH RES CO, V355, P700, DOI 10.1016/j.bbrc.2007.02.041; Robert G, 2010, J CLIN ONCOL, V28, P4985; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Rossi DL, 2011, BIOTECHNOL PROGR, V27, P766, DOI 10.1002/btpr.584; Rossi EA, 2008, CANCER RES, V68, P8384, DOI 10.1158/0008-5472.CAN-08-2033; Rossi EA, 2012, BIOCONJUGATE CHEM, V23, P309, DOI 10.1021/bc2004999; Rossi EA, 2009, BLOOD, V113, P6161, DOI 10.1182/blood-2008-10-187138; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Sachdev D, 2003, CANCER RES, V63, P627; Sachdev D, 2010, ONCOGENE, V29, P251, DOI 10.1038/onc.2009.316; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Shang YL, 2008, MOL CANCER THER, V7, P2599, DOI 10.1158/1535-7163.MCT-07-2401; SOOS MA, 1992, J BIOL CHEM, V267, P12955; Sorensen H, 2004, FEBS LETT, V565, P19, DOI 10.1016/j.febslet.2004.03.077; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Wang Y, 2012, AACR M; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Wilsbacher JL, 2008, J BIOL CHEM, V283, P23721, DOI 10.1074/jbc.M708360200; XIONG LM, 1992, P NATL ACAD SCI USA, V89, P5356, DOI 10.1073/pnas.89.12.5356; Zha JP, 2010, CLIN CANCER RES, V16, P2512, DOI 10.1158/1078-0432.CCR-09-2232; Zha JP, 2009, MOL CANCER THER, V8, P2110, DOI 10.1158/1535-7163.MCT-09-0381	66	5	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44235	10.1371/journal.pone.0044235	http://dx.doi.org/10.1371/journal.pone.0044235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952934	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300066
J	Lin, WH; Huang, XL; Zhang, LN; Chen, DM; Wang, DY; Peng, QL; Xu, L; Li, JY; Liu, XJ; Li, KA; Ding, K; Jin, SG; Li, J; Wu, DH				Lin, Wanhua; Huang, Xiaoli; Zhang, Lina; Chen, Dongmei; Wang, Dongye; Peng, Qilong; Xu, Lei; Li, Jingya; Liu, Xiujie; Li, Kuai; Ding, Ke; Jin, Shouguang; Li, Jia; Wu, Donghai			BMS309403 Stimulates Glucose Uptake in Myotubes through Activation of AMP-Activated Protein Kinase	PLOS ONE			English	Article							ACID-BINDING PROTEIN; SKELETAL-MUSCLE; CASCADE; GLUT4; ALPHA; CELLS	BMS309403 is a biphenyl azole inhibitor against fatty acid binding protein 4 (FABP4) and regarded as a lead compound for effective treatment of obesity related cardio-metabolic diseases. Here we discovered an off-target activity of BMS309403 in that it stimulates glucose uptake in C2C12 myotubes in a temporal and dose dependent manner via activation of AMP-activated protein kinase (AMPK) signaling pathway but independent of FABPs. Further analysis indicated that BMS309403 activates AMPK through increasing the ratio of intracellular AMP:ATP while decreasing mitochondrial membrane potential. These findings provide mechanistic insights on the action of BMS309403.	[Lin, Wanhua; Huang, Xiaoli; Wang, Dongye; Li, Kuai; Wu, Donghai] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Zhang, Lina; Chen, Dongmei; Xu, Lei; Li, Jingya; Li, Jia] Chinese Acad Sci, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai Inst Mat Med, Guangzhou, Guangdong, Peoples R China; [Peng, Qilong; Liu, Xiujie; Ding, Ke] Chinese Acad Sci, Inst Biol Chem, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State University System of Florida; University of Florida	Lin, WH (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	jli@mail.shcnc.ac.cn; wu_donghai@gibh.ac.cn	Jin, Shouguang/N-5548-2016; Li, Jia/F-9116-2011; li, jia/GVT-7587-2022; Ding, Ke/B-3257-2010	Ding, Ke/0000-0001-9016-812X; ding, ke/0000-0001-8167-0476	National Basic Research Program of China (973 Program) [2011CB504004, 2010CB945500]; strategic program of stem cell (Chinese Academy of Sciences) [XDA01020303]; National Science Foundation of China [30970637, 30810099, 90813033, 30811120429]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); strategic program of stem cell (Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported by the National Basic Research Program of China (973 Program) (2011CB504004 and 2010CB945500), the strategic program of stem cell (Chinese Academy of Sciences XDA01020303) and the National Science Foundation of China (30970637, 30810099, 90813033 and 30811120429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Hallsten K, 2003, OBES RES, V11, P257, DOI 10.1038/oby.2003.39; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Lee MYK, 2011, BRIT J PHARMACOL, V162, P1564, DOI 10.1111/j.1476-5381.2010.01158.x; Lemieux K, 2003, FASEB J, V17, P1658, DOI 10.1096/fj.02-1125com; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Prinsen CFM, 1998, BIOCHEM J, V329, P265; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Rump R, 1996, EUR J CELL BIOL, V69, P135; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; van den Berg SAA, 2011, CURR OPIN CLIN NUTR, V14, P243, DOI 10.1097/MCO.0b013e3283455d7a; Xie ZL, 2009, DIABETES, V58, pA492	18	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44570	10.1371/journal.pone.0044570	http://dx.doi.org/10.1371/journal.pone.0044570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952994	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300099
J	Olivas, AD; Shogan, BD; Valuckaite, V; Zaborin, A; Belogortseva, N; Musch, M; Meyer, F; Trimble, WL; An, G; Gilbert, J; Zaborina, O; Alverdy, JC				Olivas, Andrea D.; Shogan, Benjamin D.; Valuckaite, Vesta; Zaborin, Alexander; Belogortseva, Natalya; Musch, Mark; Meyer, Folker; Trimble, William L.; An, Gary; Gilbert, Jack; Zaborina, Olga; Alverdy, John C.			Intestinal Tissues Induce an SNP Mutation in Pseudomonas aeruginosa That Enhances Its Virulence: Possible Role in Anastomotic Leak	PLOS ONE			English	Article							MULTIDRUG EFFLUX SYSTEM; MEXT; REGULATOR; RESECTION; DECONTAMINATION; PREVENTION; PLACEBO; PAO1	The most feared complication following intestinal resection is anastomotic leakage. In high risk areas (esophagus/rectum) where neoadjuvant chemoradiation is used, the incidence of anastomotic leaks remains unacceptably high (similar to 10%) even when performed by specialist surgeons in high volume centers. The aims of this study were to test the hypothesis that anastomotic leakage develops when pathogens colonizing anastomotic sites become in vivo transformed to express a tissue destroying phenotype. We developed a novel model of anastomotic leak in which rats were exposed to pre-operative radiation as in cancer surgery, underwent distal colon resection and then were intestinally inoculated with Pseudomonas aeruginosa, a common colonizer of the radiated intestine. Results demonstrated that intestinal tissues exposed to preoperative radiation developed a significant incidence of anastomotic leak (>60%; p<0.01) when colonized by P. aeruginosa compared to radiated tissues alone (0%). Phenotype analysis comparing the original inoculating strain (MPAO1-termed P1) and the strain retrieved from leaking anastomotic tissues (termed P2) demonstrated that P2 was altered in pyocyanin production and displayed enhanced collagenase activity, high swarming motility, and a destructive phenotype against cultured intestinal epithelial cells (i.e. apoptosis, barrier function, cytolysis). Comparative genotype analysis between P1 and P2 revealed a single nucleotide polymorphism (SNP) mutation in the mexT gene that led to a stop codon resulting in a non-functional truncated protein. Replacement of the mutated mexT gene in P2 with mexT from the original parental strain P1 led to reversion of P2 to the P1 phenotype. No spontaneous transformation was detected during 20 passages in TSB media. Use of a novel virulence suppressing compound PEG/Pi prevented P. aeruginosa transformation to the tissue destructive phenotype and prevented anastomotic leak in rats. This work demonstrates that in vivo transformation of microbial pathogens to a tissue destroying phenotype may have important implications in the pathogenesis of anastomotic leak.	[Olivas, Andrea D.; Shogan, Benjamin D.; Valuckaite, Vesta; Zaborin, Alexander; Belogortseva, Natalya; An, Gary; Zaborina, Olga; Alverdy, John C.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Musch, Mark] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Meyer, Folker; Trimble, William L.; Gilbert, Jack] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Valuckaite, Vesta; Alverdy, John C.] Bioengn Inst Adv Surg & Endoscopy, Chicago, IL USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Olivas, AD (corresponding author), Univ Chicago, Dept Surg, Chicago, IL 60637 USA.	jalverdy@surgery.bsd.uchicago.edu	Zaborina, Olga/AAQ-6977-2021; Gilbert, Jack/AAF-3270-2019	Meyer, Folker/0000-0003-1112-2284; An, Gary/0000-0003-4549-9004; Trimble, William L./0000-0001-7029-2676	National Institute of Health [RO1-GM062344-12]; Digestive Disease Research Core Center of the University of Chicago [DK42086]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062344] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Center of the University of Chicago(University of Chicago); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institute of Health (RO1-GM062344-12), Digestive Disease Research Core Center of the University of Chicago (DK42086) and the United States Department of Energy under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2011, AM J SURG, V202, P259, DOI 10.1016/j.amjsurg.2010.11.014; Alanezi Khaled, 2004, Ann Thorac Cardiovasc Surg, V10, P71; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blewett C J, 2001, Ann Thorac Cardiovasc Surg, V7, P75; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Choi Dong Hyun, 2010, J Korean Soc Coloproctol, V26, P265, DOI 10.3393/jksc.2010.26.4.265; COHEN SR, 1985, SURGERY, V97, P443; COHN I, 1955, ANN SURG, V141, P707, DOI 10.1097/00000658-195514150-00016; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Jin YX, 2011, J BACTERIOL, V193, P399, DOI 10.1128/JB.01079-10; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Kohler T, 1999, J BACTERIOL, V181, P6300; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Lin JK, 2011, J GASTROINTEST SURG, V15, P2251, DOI 10.1007/s11605-011-1721-5; Maseda H, 2000, FEMS MICROBIOL LETT, V192, P107, DOI 10.1016/S0378-1097(00)00419-5; Maseda H, 2010, FEMS MICROBIOL LETT, V311, P36, DOI 10.1111/j.1574-6968.2010.02063.x; Merkel S, 2001, Colorectal Dis, V3, P154, DOI 10.1046/j.1463-1318.2001.00232.x; Ricciardi R, 2009, ARCH SURG-CHICAGO, V144, P407, DOI 10.1001/archsurg.2009.43; Romanowski K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-212; Roos D, 2011, BRIT J SURG, V98, P1365, DOI 10.1002/bjs.7631; Schardey HM, 1997, ANN SURG, V225, P172, DOI 10.1097/00000658-199702000-00005; SCHARDEY HM, 1994, ANTIMICROB AGENTS CH, V38, P2564, DOI 10.1128/AAC.38.11.2564; Seal JB, 2010, SURGERY, V147, P757, DOI 10.1016/j.surg.2010.03.008; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tian ZX, 2009, MICROB PATHOGENESIS, V47, P237, DOI 10.1016/j.micpath.2009.08.003; Tian ZX, 2009, NUCLEIC ACIDS RES, V37, P7546, DOI 10.1093/nar/gkp828; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; Valuckaite V, 2009, AM J PHYSIOL-GASTR L, V297, pG1041, DOI 10.1152/ajpgi.00328.2009; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Zaborin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034883; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106; Zaborina Olga, 2006, Ann Clin Microbiol Antimicrob, V5, P14, DOI 10.1186/1476-0711-5-14; Zaborina O, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030035; Zaoui C, 2012, MOL MICROBIOL, V83, P536, DOI 10.1111/j.1365-2958.2011.07947.x	35	116	119	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44326	10.1371/journal.pone.0044326	http://dx.doi.org/10.1371/journal.pone.0044326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952955	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300081
J	Flores-Martin, J; Rena, V; Marquez, S; Panzetta-Dutari, GM; Genti-Raimondi, S				Flores-Martin, Jesica; Rena, Viviana; Marquez, Sebastian; Panzetta-Dutari, Graciela M.; Genti-Raimondi, Susana			StarD7 Knockdown Modulates ABCG2 Expression, Cell Migration, Proliferation, and Differentiation of Human Choriocarcinoma JEG-3 Cells	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; STEM-LIKE CELLS; GENE-EXPRESSION; TROPHOBLAST DIFFERENTIATION; LIPID TRANSPORT; PHOSPHATIDYLCHOLINE; IDENTIFICATION; BCRP/ABCG2; PLAYS; BEWO	Background: StAR-related lipid transfer domain containing 7 (StarD7) is a member of the START-domain protein family whose function still remains unclear. Our data from an explorative microarray assay performed with mRNAs from StarD7 siRNA-transfected JEG-3 cells indicated that ABCG2 (ATP-binding cassette sub-family G member 2) was one of the most abundantly downregulated mRNAs. Methodology/Principal Findings: Here, we have confirmed that knocking down StarD7 mRNA lead to a decrease in the xenobiotic/lipid transporter ABCG2 at both the mRNA and protein levels (-26.4% and -41%, p<0.05, at 48 h of culture, respectively). Also a concomitant reduction in phospholipid synthesis, bromodeoxyuridine (BrdU) uptake and 3 H-thymidine incorporation was detected. Wound healing and transwell assays revealed that JEG-3 cell migration was significantly diminished (p<0.05). Conversely, biochemical differentiation markers such as human chorionic gonadotrophin beta-subunit (beta hCG) protein synthesis and secretion as well as bhCG and syncytin-1 mRNAs were increased approximately 2-fold. In addition, desmoplakin immunostaining suggested that there was a reduction of intercellular desmosomes between adjacent JEG-3 cells after knocking down StarD7. Conclusions/Significance: Altogether these findings provide evidence for a role of StarD7 in cell physiology indicating that StarD7 modulates ABCG2 multidrug transporter level, cell migration, proliferation, and biochemical and morphological differentiation marker expression in a human trophoblast cell model.	[Flores-Martin, Jesica; Rena, Viviana; Marquez, Sebastian; Panzetta-Dutari, Graciela M.; Genti-Raimondi, Susana] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, Consejo Nacl Invest Cient & Tecn,Dept Bioquim Cli, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Flores-Martin, J (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, Consejo Nacl Invest Cient & Tecn,Dept Bioquim Cli, RA-5000 Cordoba, Argentina.	sgenti@fcq.unc.edu.ar		Flores Martin, Jesica Belen/0000-0002-1619-399X	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) [6352, 919]; Agencia Nacional de Promocion Ciencia y Tecnica [FONCYT: PICT 2006/00147]; Ministerio de Ciencia y de la Provincia de Cordoba; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba [SECyT-UNC: 05/C244]	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Ciencia y Tecnica(ANPCyT); Ministerio de Ciencia y de la Provincia de Cordoba; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT))	This work was granted by the Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET: PIP No 6352, PIP No 919), the Agencia Nacional de Promocion Ciencia y Tecnica (FONCYT: PICT 2006/00147), the Ministerio de Ciencia y de la Provincia de Cordoba and the Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyT-UNC: 05/C244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khan A, 2011, PLACENTA, V32, pS90, DOI 10.1016/j.placenta.2010.12.025; Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Angeletti S, 2008, PLACENTA, V29, P396, DOI 10.1016/j.placenta.2008.02.011; Angeletti S, 2004, BIOCHEM BIOPH RES CO, V314, P181, DOI 10.1016/j.bbrc.2003.12.076; Angeletti S, 2012, BBA-BIOMEMBRANES, V1818, P425, DOI 10.1016/j.bbamem.2011.10.024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burleigh DW, 2007, PLACENTA, V28, P383, DOI 10.1016/j.placenta.2006.05.001; Chen Z, 2010, INT J CANCER, V126, P841, DOI 10.1002/ijc.24796; Clark AG, 2003, COLD SPRING HARB SYM, V68, P471; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; COLEMAN RA, 1987, J LIPID RES, V28, P1335; Durand S, 2004, PLACENTA, V25, P37, DOI 10.1016/S0143-4004(03)00214-5; Ee PLR, 2004, MOL CANCER THER, V3, P1577; Evseenko DA, 2007, PLACENTA, V28, pS116, DOI 10.1016/j.placenta.2006.12.003; Evseenko DA, 2006, AM J PHYSIOL-REG I, V290, pR1357, DOI 10.1152/ajpregu.00630.2005; Evseenko DA, 2007, FASEB J, V21, P3592, DOI 10.1096/fj.07-8688com; GUIDO ME, 1990, J NEUROCHEM, V55, P1855, DOI 10.1111/j.1471-4159.1990.tb05768.x; Herzog M, 2010, N-S ARCH PHARMACOL, V383, P1; Higashikuni Y, 2010, ARTERIOSCL THROM VAS, V30, P2128, DOI 10.1161/ATVBAHA.110.211755; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; HSU CD, 1994, AM J OBSTET GYNECOL, V170, P1135, DOI 10.1016/S0002-9378(94)70108-3; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Kharfi A, 2005, CLIN BIOCHEM, V38, P717, DOI 10.1016/j.clinbiochem.2005.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao QC, 2008, PHARM RES-DORDR, V25, P1244, DOI 10.1007/s11095-008-9537-z; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; Ni ZL, 2011, CURR PHARM BIOTECHNO, V12, P674, DOI 10.2174/138920111795164057; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Prouillac C, 2010, DRUG METAB DISPOS, V38, P1623, DOI 10.1124/dmd.110.033571; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Rena V, 2009, PLACENTA, V30, P876, DOI 10.1016/j.placenta.2009.07.010; Rena V, 2011, MOL ENDOCRINOL, V25, P1364, DOI 10.1210/me.2010-0503; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Singh AT, 2012, REPROD BIOMED ONLINE, V24, P224, DOI 10.1016/j.rbmo.2011.10.012; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; VAITUKAITIS J L, 1976, Journal of Clinical Endocrinology and Metabolism, V42, P1048; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; WEISS SJ, 1982, BIOCHEM J, V204, P587, DOI 10.1042/bj2040587; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Woehlecke H, 2003, BIOCHEM J, V376, P489, DOI 10.1042/BJ20030886; Wu MK, 2005, AM J PHYSIOL-GASTR L, V289, pG1067, DOI 10.1152/ajpgi.00194.2005; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595	55	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44152	10.1371/journal.pone.0044152	http://dx.doi.org/10.1371/journal.pone.0044152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952907	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000089
J	Graff, JW; Powers, LS; Dickson, AM; Kim, J; Reisetter, AC; Hassan, IH; Kremens, K; Gross, TJ; Wilson, ME; Monick, MM				Graff, Joel W.; Powers, Linda S.; Dickson, Anne M.; Kim, Jongkwang; Reisetter, Anna C.; Hassan, Ihab H.; Kremens, Karol; Gross, Thomas J.; Wilson, Mary E.; Monick, Martha M.			Cigarette Smoking Decreases Global MicroRNA Expression in Human Alveolar Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; ACTIVATION; INDUCTION; SMOKERS; INFLAMMATION; POLARIZATION; EMPHYSEMA; PROFILES; MODEL	Human alveolar macrophages are critical components of the innate immune system. Cigarette smoking-induced changes in alveolar macrophage gene expression are linked to reduced resistance to pulmonary infections and to the development of emphysema/COPD. We hypothesized that microRNAs (miRNAs) could control, in part, the unique messenger RNA (mRNA) expression profiles found in alveolar macrophages of cigarette smokers. Activation of macrophages with different stimuli in vitro leads to a diverse range of M1 (inflammatory) and M2 (anti-inflammatory) polarized phenotypes that are thought to mimic activated macrophages in distinct tissue environments. Microarray mRNA data indicated that smoking promoted an "inverse" M1 mRNA expression program, defined by decreased expression of M1-induced transcripts and increased expression of M1-repressed transcripts with few changes in M2-regulated transcripts. RT-PCR arrays identified altered expression of many miRNAs in alveolar macrophages of smokers and a decrease in global miRNA abundance. Stratification of human subjects suggested that the magnitude of the global decrease in miRNA abundance was associated with smoking history. We found that many of the miRNAs with reduced expression in alveolar macrophages of smokers were predicted to target mRNAs upregulated in alveolar macrophages of smokers. For example, miR-452 is predicted to target the transcript encoding MMP12, an important effector of smoking-related diseases. Experimental antagonism of miR-452 in differentiated monocytic cells resulted in increased expression of MMP12. The comprehensive mRNA and miRNA expression profiles described here provide insight into gene expression regulation that may underlie the adverse effects cigarette smoking has on alveolar macrophages.	[Graff, Joel W.; Powers, Linda S.; Dickson, Anne M.; Kim, Jongkwang; Reisetter, Anna C.; Hassan, Ihab H.; Kremens, Karol; Gross, Thomas J.; Wilson, Mary E.; Monick, Martha M.] Univ Iowa, Dept Med, Iowa City, IA 52242 USA; [Graff, Joel W.; Wilson, Mary E.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Graff, JW (corresponding author), Univ Iowa, Dept Med, Iowa City, IA 52242 USA.	martha-monick@uiowa.edu	Gross, Thomas/AAO-9404-2021	Gross, Thomas/0000-0001-9617-6606; Kim, Jong K./0000-0001-9290-0820; Wilson, Mary/0000-0001-8680-7275	NIH [R01 HL079901, R21HL109589, R21 AI080801, R01 AI045540]; Department of Veteran's Affairs; National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH [P30 ES005605]; National Center for Research Resources (NCRR), Clinical and Translational Science Awards (CTSA) [UL1RR024979]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079901, R01HL096625, R21HL109589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080801, R01AI045540, R01AI032135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran's Affairs(US Department of Veterans Affairs); National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH; National Center for Research Resources (NCRR), Clinical and Translational Science Awards (CTSA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by NIH R01 HL079901 and NIH R21HL109589 to M.M., NIH R21 AI080801, NIH R01 AI045540 and a Merit Review Award from the Department of Veteran's Affairs to M.W., and CDA-1 award from the Department of Veterans' Affairs to J.G. This publication was also made possible by funding from the National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH P30 ES005605 and Grant Number UL1RR024979 from the National Center for Research Resources (NCRR), Clinical and Translational Science Awards (CTSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamini Y., 2001, 2 STAGED LINEAR STEP; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; BITTERMAN PB, 1986, J CLIN INVEST, V77, P700, DOI 10.1172/JCI112364; BITTERMAN PB, 1982, J CLIN INVEST, V70, P806, DOI 10.1172/JCI110677; Chen H, 2007, J IMMUNOL, V179, P6097, DOI 10.4049/jimmunol.179.9.6097; D'hulst AI, 2006, EUR RESPIR J, V28, P102, DOI 10.1183/09031936.06.00059305; Dhillon NK, 2009, TOXICOL APPL PHARM, V237, P22, DOI 10.1016/j.taap.2009.02.021; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Gao CJ, 2007, J IMMUNOL, V178, P1870, DOI 10.4049/jimmunol.178.3.1870; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HT, 2008, SURGERY, V144, P182, DOI 10.1016/j.surg.2008.03.007; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; KING TE, 1988, J INFECT DIS, V158, P1309, DOI 10.1093/infdis/158.6.1309; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Modestou MA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-64; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Monick MM, 1998, AM J PHYSIOL-LUNG C, V275, pL389, DOI 10.1152/ajplung.1998.275.2.L389; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Russell REK, 2002, AM J PHYSIOL-LUNG C, V283, pL867, DOI 10.1152/ajplung.00020.2002; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Shapiro SD, 2005, NEW ENGL J MED, V352, P2016, DOI 10.1056/NEJMe058044; Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; VENET A, 1985, J CLIN INVEST, V75, P293, DOI 10.1172/JCI111688; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC	65	88	91	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44066	10.1371/journal.pone.0044066	http://dx.doi.org/10.1371/journal.pone.0044066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952876	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000077
J	Mane, M; Muller, M				Mane, Maria; Mueller, Michael			Temporo-Spectral Imaging of Intrinsic Optical Signals during Hypoxia-Induced Spreading Depression-Like Depolarization	PLOS ONE			English	Article							LIGHT-SCATTERING; SYNAPTIC-TRANSMISSION; EPILEPTIFORM ACTIVITY; SULFHYDRYL OXIDATION; HIPPOCAMPAL SLICES; BRAIN-STEM; INHIBITION; MITOCHONDRIAL; REDUCTION; MEMBRANE	Spreading depression (SD) is characterized by a sustained near-complete depolarization of neurons, a massive depolarization of glia, and a negative deflection of the extracellular DC potential. These electrophysiological signs are accompanied by an intrinsic optical signal (IOS) which arises from changes in light scattering and absorption. Even though the underlying mechanisms are unclear, the IOS serves as non-invasive tool to define the spatiotemporal dynamics of SD in brain slices. Usually the tissue is illuminated by white light, and light reflectance or transmittance is monitored. Using a polychromatic, fast-switchable light source we now performed temporo-spectral recordings of the IOS associated with hypoxia-induced SD-like depolarization (HSD) in rat hippocampal slices kept in an interface recording chamber. Recording full illumination spectra (320-680 nm) yielded distinct reflectance profiles for the different phases of HSD. Early during hypoxia tissue reflectance decreased within almost the entire spectrum due to cell swelling. HSD was accompanied by a reversible reflectance increase being most pronounced at 400 nm and 460 nm. At 440 nm massive porphyrin absorption (Soret band) was detected. Hypotonic solutions, Ca2+-withdrawal and glial poisoning intensified the reflectance increase during HSD, whereas hypertonic solutions dampened it. Replacement of Cl- inverted the reflectance increase. Inducing HSD by cyanide distorted the IOS and reflectance at 340-400 nm increased irreversibly. The pronounced changes at short wavelengths (380 nm, 460 nm) and their cyanide sensitivity suggest that block of mitochondrial metabolism contributes to the IOS during HSD. For stable and reliable IOS recordings during HSD wavelengths of 460-560 nm are recommended.	[Mane, Maria; Mueller, Michael] Univ Gottingen, Abt Neuro & Sinnesphysiol, Zentrum Physiol & Pathophysiol, DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany	German Research Foundation (DFG); University of Gottingen	Mane, M (corresponding author), Univ Gottingen, Abt Neuro & Sinnesphysiol, Zentrum Physiol & Pathophysiol, DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany.	mmuelle7@gwdg.de	Müller, Michael/F-7222-2010	Müller, Michael/0000-0002-5863-1994	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants of the Deutsche Forschungsgemeinschaft to M. Muller (Research Center "Molecular Physiology of the Brain" CMPB, and Cluster of Excellence EXC171, "Microscopy at the Nanometer Range"). The funders (Deutsche Forschungsgemeinschaft) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; Andrew RD, 1999, METHODS, V18, P185, DOI 10.1006/meth.1999.0771; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Bahar S, 2000, J NEUROPHYSIOL, V84, P311; Bailey N.T., 1992, STAT METHODS BIOL; Basarsky TA, 1998, J NEUROSCI, V18, P7189; BURES J, 1956, J NEUROCHEM, V1, P153, DOI 10.1111/j.1471-4159.1956.tb12067.x; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; CHEBABO SR, 1995, BRAIN RES, V695, P203, DOI 10.1016/0006-8993(95)00778-O; CLARKE DD, 1970, BIOCHEM J, V120, P345, DOI 10.1042/bj1200345; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; ECCLES J, 1977, PROC R SOC SER B-BIO, V198, P345, DOI 10.1098/rspb.1977.0102; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Fayuk D, 2002, J NEUROPHYSIOL, V87, P1924, DOI 10.1152/jn.00231.2001; Fischer M, 2009, J NEUROPHYSIOL, V101, P1016, DOI 10.1152/jn.91124.2008; Foster KA, 2005, NEUROSCIENCE, V132, P645, DOI 10.1016/j.neuroscience.2005.01.040; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; Fujii F, 2004, BRAIN RES, V999, P29, DOI 10.1016/j.brainres.2003.11.017; Funke F, 2009, J NEUROPHYSIOL, V101, P2395, DOI 10.1152/jn.91260.2008; Gerich FJ, 2006, J NEUROPHYSIOL, V96, P492, DOI 10.1152/jn.01015.2005; Gorji A, 2004, EUR J NEUROSCI, V19, P3371, DOI 10.1111/j.0953-816X.2004.03436.x; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Haglund MM, 2004, EPILEPSIA, V45, P43, DOI 10.1111/j.0013-9580.2004.04010.x; Haglund MM, 1997, NEUROSURG CLIN N AM, V8, P413; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Hepp S, 2008, NEUROSCIENCE, V152, P903, DOI 10.1016/j.neuroscience.2008.01.029; Hepp S, 2005, J NEUROPHYSIOL, V94, P1091, DOI 10.1152/jn.00291.2005; Holthoff K, 1996, J NEUROSCI, V16, P2740, DOI 10.1523/jneurosci.16-08-02740.1996; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Huang R, 1996, J CEREBR BLOOD F MET, V16, P462, DOI 10.1097/00004647-199605000-00012; JOBSIS FF, 1977, J APPL PHYSIOL, V43, P858; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kawauchi S, 2008, APPL OPTICS, V47, P4164, DOI 10.1364/AO.47.004164; Kohl M, 1998, OPT LETT, V23, P555, DOI 10.1364/OL.23.000555; Kron M, 2011, J NEUROPHYSIOL, V105, P3067, DOI 10.1152/jn.00822.2010; Largo C, 1997, J NEUROPHYSIOL, V78, P295, DOI 10.1152/jn.1997.78.1.295; Largo C, 1996, J NEUROSCI, V16, P1219; LAURITZEN M, 1984, BRAIN, V107, P447, DOI 10.1093/brain/107.2.447; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LIPTON P, 1973, J PHYSIOL-LONDON, V231, P365, DOI 10.1113/jphysiol.1973.sp010238; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MARTINSF.H, 1966, J NEUROPHYSIOL, V29, P715, DOI 10.1152/jn.1966.29.4.715; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1982, SCIENCE, V217, P537, DOI 10.1126/science.7201167; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Muller M, 2000, NEUROSCIENCE, V97, P33, DOI 10.1016/S0306-4522(00)00025-7; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; Muller M, 2000, J NEUROPHYSIOL, V83, P735, DOI 10.1152/jn.2000.83.2.735; Risher WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022351; Shkirman S. F., 1999, Journal of Applied Spectroscopy, V66, P68, DOI 10.1007/BF02679221; Sick TJ, 1999, METHODS, V18, P104, DOI 10.1006/meth.1999.0763; SNOW RW, 1983, J NEUROPHYSIOL, V50, P561, DOI 10.1152/jn.1983.50.3.561; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Somjen GG, 2004, IONS BRAIN; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; VANDERKOOI JM, 1976, EUR J BIOCHEM, V64, P381, DOI 10.1111/j.1432-1033.1976.tb10312.x; VANHARREVELD A, 1953, J NEUROPHYSIOL, V16, P352, DOI 10.1152/jn.1953.16.4.352; VANHARREVELD A, 1958, AM J PHYSIOL, V192, P457, DOI 10.1152/ajplegacy.1958.192.3.457; Vasil'ev AS, 2000, J EVOL BIOCHEM PHYS+, V36, P5, DOI 10.1007/BF02890658	65	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43981	10.1371/journal.pone.0043981	http://dx.doi.org/10.1371/journal.pone.0043981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952835	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000065
J	Sellam, A; Tebbji, F; Whiteway, M; Nantel, A				Sellam, Adnane; Tebbji, Faiza; Whiteway, Malcolm; Nantel, Andre			A Novel Role for the Transcription Factor Cwt1p as a Negative Regulator of Nitrosative Stress in Candida albicans	PLOS ONE			English	Article							WALL DAMAGE RESPONSE; NITRIC-OXIDE; SACCHAROMYCES-CEREVISIAE; CICLOPIROX OLAMINE; GENE; EXPRESSION; RESISTANCE; VIRULENCE; LIBRARY	The ability of Candida albicans to survive in the presence of nitrosative stress during the initial contact with the host immune system is crucial for its ability to colonize mammalian hosts. Thus, this fungus must activate robust mechanisms to neutralize and repair nitrosative-induced damage. Until now, very little was known regarding the regulatory circuits associated with reactive nitrogen species detoxification in fungi. To gain insight into the transcriptional regulatory networks controlling nitrosative stress response (NRS) in C. albicans a compilation of transcriptional regulator-defective mutants were screened. This led to the identification of Cwt1p as a negative regulator of NSR. By combining genome-wide location and expression analyses, we have characterized the Cwt1p regulon and demonstrated that Cwt1p is directly required for proper repression of the flavohemoglobin Yhb1p, a key NO-detoxification enzyme. Furthermore, Cwt1p operates both by activating and repressing genes of specific functions solicited upon NSR. Additionally, we used Gene Set Enrichment Analysis to reinvestigate the C. albicans NSR-transcriptome and demonstrate a significant similarity with the transcriptional profiles of C. albicans interacting with phagocytic host-cells. In summary, we have characterized a novel negative regulator of NSR and bring new insights into the transcriptional regulatory network governing fungal NSR.	[Sellam, Adnane] Univ Montreal, IRIC, Montreal, PQ, Canada; [Tebbji, Faiza; Whiteway, Malcolm; Nantel, Andre] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Tebbji, Faiza; Whiteway, Malcolm] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Nantel, Andre] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	Universite de Montreal; National Research Council Canada; McGill University; McGill University	Sellam, A (corresponding author), Univ Montreal, IRIC, Montreal, PQ, Canada.	adnane.sellam@gmail.com; andre.nantel@nrc-cnrc.gc.ca	Sellam, Adnane/H-9765-2013	Sellam, Adnane/0000-0002-0506-7752; Tebbji, Faiza/0000-0002-7359-727X	Canadian Institutes of Health Research (CIHR) [MOP-84341]; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT)	This work was supported by grant MOP-84341 from the Canadian Institutes of Health Research (CIHR) to AN and MW. FT is supported by a postdoctoral fellowship from the Fonds quebecois de la recherche sur la nature et les technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS BB, 1991, CLIN DERMATOL, V9, P471, DOI 10.1016/0738-081X(91)90075-V; Bachewich C, 2005, MOL MICROBIOL, V57, P942, DOI 10.1111/j.1365-2958.2005.04727.x; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Bruno VM, 2006, PLOS PATHOG, V2, P204, DOI 10.1371/journal.ppat.0020021; Chiranand W, 2008, EUKARYOT CELL, V7, P268, DOI 10.1128/EC.00240-07; Cote P, 2009, MOL BIOL CELL, V20, P3363, DOI 10.1091/mbc.E09-03-0210; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Elahi S, 2001, IMMUNOLOGY, V104, P447, DOI 10.1046/j.1365-2567.2001.01331.x; Epp E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000753; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fung Man-Lung, 2007, Open Biochem J, V1, P1, DOI 10.2174/1874091X00701010001; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Guillemette T, 2004, CURR GENET, V45, P214, DOI 10.1007/s00294-003-0479-z; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; Lavoie H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-578; Lee REB, 2005, J ANTIMICROB CHEMOTH, V55, P655, DOI 10.1093/jac/dki105; Moreno I, 2003, FEMS MICROBIOL LETT, V226, P159, DOI 10.1016/S0378-1097(03)00588-3; Moreno I, 2010, YEAST, V27, P77, DOI 10.1002/yea.1733; Nantel A, 2006, MED MYCOLOGY; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Navarathna DH, 2012, 11 ASM C CAND CAND, P61; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Rauceo JM, 2008, MOL BIOL CELL, V19, P2741, DOI 10.1091/mbc.E08-02-0191; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Soontorngun N, 2007, MOL CELL BIOL, V27, P7895, DOI 10.1128/MCB.01055-07; Spiering MJ, 2010, EUKARYOT CELL, V9, P251, DOI 10.1128/EC.00291-09; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ullmann BD, 2004, EUKARYOT CELL, V3, P715, DOI 10.1128/EC.3.3.715-723.2004	35	20	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43956	10.1371/journal.pone.0043956	http://dx.doi.org/10.1371/journal.pone.0043956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952822	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000063
J	Ujvari, B; Pearse, AM; Taylor, R; Pyecroft, S; Flanagan, C; Gombert, S; Papenfuss, AT; Madsen, T; Belov, K				Ujvari, Beata; Pearse, Anne-Maree; Taylor, Robyn; Pyecroft, Stephen; Flanagan, Cassandra; Gombert, Sara; Papenfuss, Anthony T.; Madsen, Thomas; Belov, Katherine			Telomere Dynamics and Homeostasis in a Transmissible Cancer	PLOS ONE			English	Article							FACIAL-TUMOR DISEASE; TASMANIAN DEVIL; CONSERVATION; INSTABILITY; LENGTH; TRF2; TIN2; EXPRESSION; SHELTERIN; ROLES	Background: Devil Facial Tumour Disease (DFTD) is a unique clonal cancer that threatens the world's largest carnivorous marsupial, the Tasmanian devil (Sarcophilus harrisii) with extinction. This transmissible cancer is passed between individual devils by cell implantation during social interactions. The tumour arose in a Schwann cell of a single devil over 15 years ago and since then has expanded clonally, without showing signs of replicative senescence; in stark contrast to a somatic cell that displays a finite capacity for replication, known as the "Hayflick limit". Methodology/Principal Findings: In the present study we investigate the role of telomere length, measured as Telomere Copy Number (TCN), and telomerase and shelterin gene expression, as well as telomerase activity in maintaining hyperproliferation of Devil Facial Tumour (DFT) cells. Our results show that DFT cells have short telomeres. DFTD TCN does not differ between geographic regions or between strains. However, TCN has increased over time. Unlimited cell proliferation is likely to have been achieved through the observed up-regulation of the catalytic subunit of telomerase (TERT) and concomitant activation of telomerase. Up-regulation of the central component of shelterin, the TRF1-intercating nuclear factor 2 (TINF2) provides DFT a mechanism for telomere length homeostasis. The higher expression of both TERT and TINF2 may also protect DFT cells from genomic instability and enhance tumour proliferation. Conclusions/Significance: DFT cells appear to monitor and regulate the length of individual telomeres: i.e. shorter telomeres are elongated by up-regulation of telomerase-related genes; longer telomeres are protected from further elongation by members of the shelterin complex, which may explain the lack of spatial and strain variation in DFT telomere copy number. The observed longitudinal increase in gene expression in DFT tissue samples and telomerase activity in DFT cell lines might indicate a selection for more stable tumours with higher proliferative potential.	[Ujvari, Beata; Flanagan, Cassandra; Gombert, Sara; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Pearse, Anne-Maree; Taylor, Robyn; Pyecroft, Stephen] Devil Facial Tumour Project, Diagnost Serv, Hlth Anim Lab, Dept Primary Ind Water & Environm, Launceston, Tas, Australia; [Madsen, Thomas] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Papenfuss, Anthony T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Papenfuss, Anthony T.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia	University of Sydney; University of Wollongong; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Ujvari, B (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	kathy.belov@sydney.edu.au	Ujvari, Beata/L-7541-2019; Papenfuss, Anthony T/C-6297-2008; Ujvari, Beata/K-8722-2012	Ujvari, Beata/0000-0003-2391-2988; Papenfuss, Anthony T/0000-0002-1102-8506; Ujvari, Beata/0000-0003-2391-2988; Madsen, Thomas/0000-0002-0998-8372; Belov, Katherine/0000-0002-9762-5554	Eric Guiler Fund [F3F98304778C800ECA2576CB007D1E6B]; Australian Research Council; ARC Future Fellowship; NHMRC Career Development Fellowship	Eric Guiler Fund; Australian Research Council(Australian Research Council); ARC Future Fellowship(Australian Research Council); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the Eric Guiler Fund (Save the Tasmanian Devil Appeal): http://www.tassiedevil.com.au/tasdevil.nsf/Grants-&-scholarships/F3F98304778C800ECA2576CB007D1E6B, and the Australian Research Council: http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Kate Swift, Pamela Hodson and Bobby Hua for providing the lysed tumour cell line samples. We thank the Save the Tasmanian Devil Program and researchers from the School of Zoology at the University of Tasmania for collecting samples. We are grateful to Dr. Gabriele Saretzki and two anonymous reviewers for their comments, which have led to substantial improvements to this manuscript. KB is supported by an ARC Future Fellowship. ATP is supported by an NHMRC Career Development Fellowship. ATP's contribution was made possible through Victorian State Government Operational Infrastructure Support and NHMRC IRIISS.	[Anonymous], 1989, JMP VERS 7; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bellon M, 2006, INT J CANCER, V119, P2090, DOI 10.1002/ijc.22026; Belov K, 2011, MAMM GENOME, V22, P83, DOI 10.1007/s00335-010-9294-2; Blackburn, 2006, TELOMERES; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; De Lange T, 2005, COLD SH Q B, V70, P197, DOI 10.1101/sqb.2005.70.032; Deakin JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002483; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; IUCN IUfCoN, 2011, RED LIST THREAT SPEC; Jones ME, 2008, P NATL ACAD SCI USA, V105, P10023, DOI 10.1073/pnas.0711236105; Jones ME, 2007, ECOHEALTH, V4, P326, DOI 10.1007/s10393-007-0120-6; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pearse AM, 2012, CANCER GENET-NY, V205, P101, DOI 10.1016/j.cancergen.2011.12.001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Savre-Train I, 2000, P SOC EXP BIOL MED, V223, P379, DOI 10.1046/j.1525-1373.2000.22354.x; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; *STATSDIRECT LTD, 2008, STATSDIRECT STAT SOF; Xu Yucheng, 2011, Clin Adv Hematol Oncol, V9, P442; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200	47	20	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44085	10.1371/journal.pone.0044085	http://dx.doi.org/10.1371/journal.pone.0044085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952882	Green Published, gold			2022-12-25	WOS:000308206000081
J	Meinen, S; Lin, S; Ruegg, MA; Punga, AR				Meinen, Sarina; Lin, Shuo; Rueegg, Markus A.; Punga, Anna Rostedt			Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; ACETYLCHOLINE-RECEPTOR; NO PRODUCTION; NEURONAL NOS; MDX MICE; MUSK; ANTIBODIES; VASOMODULATION	Myasthenia Gravis (MG) patients suffer from chronic fatigue of skeletal muscles, even after initiation of proper immunosuppressive medication. Since the localization of neuronal nitric oxide synthase (nNOS) at the muscle membrane is important for sustained muscle contraction, we here study the localization of nNOS in muscles from mice with acetylcholine receptor antibody seropositive (AChR+) experimental autoimmune MG (EAMG). EAMG was induced in 8 week-old male mice by immunization with AChRs purified from torpedo californica. Sham-injected wild type mice and mdx mice, a model for Duchenne muscular dystrophy, were used for comparison. At EAMG disease grade 3 (severe myasthenic weakness), the triceps, sternomastoid and masseter muscles were collected for analysis. Unlike in mdx muscles, total nNOS expression as well as the presence of its binding partner syntrophin alpha-1, were not altered in EAMG. Immunohistological and biochemical analysis showed that nNOS was lost from the muscle membrane and accumulated in the cytosol, which is likely the consequence of blocked neuromuscular transmission. Atrophy of all examined EAMG muscles were supported by upregulated transcript levels of the atrogenes atrogin-1 and MuRF1, as well as MuRF1 protein, in combination with reduced muscle fiber diameters. We propose that loss of sarcolemmal nNOS provides an additional mechanism for the chronic muscle fatigue and secondary muscle atrophy in EAMG and MG.	[Meinen, Sarina; Lin, Shuo; Rueegg, Markus A.; Punga, Anna Rostedt] Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland	University of Basel	Meinen, S (corresponding author), Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland.	annarostedtpunga@gmail.com	Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Punga, Anna/0000-0002-2178-9413; Lin, Shuo/0000-0003-2317-0339	Canton of Basel-Stadt; Canton of Baselland; Swiss Foundation for Research on Muscle Disease; European Union [242210]	Canton of Basel-Stadt; Canton of Baselland; Swiss Foundation for Research on Muscle Disease; European Union(European Commission)	The work was supported by the Cantons of Basel-Stadt and Baselland, The Swiss Foundation for Research on Muscle Disease and the European Union through FP7 project number 242210 "FIGHT-MG". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aricha R, 2006, FASEB J, V20, P374, DOI 10.1096/fj.05-4909fje; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Christadoss P, 2002, J NEUROIMMUNOL, V122, P186, DOI 10.1016/S0165-5728(01)00473-8; Fadel PJ, 2003, J PHYSIOL-LONDON, V549, P243, DOI 10.1113/jphysiol.2003.038828; Farrugia ME, 2007, CLIN NEUROPHYSIOL, V118, P269, DOI 10.1016/j.clinph.2006.10.004; Figueroa XF, 2009, AM J PHYSIOL-HEART C, V297, pH134, DOI 10.1152/ajpheart.00023.2009; Ghedini PC, 2008, MUSCLE NERVE, V38, P1585, DOI 10.1002/mus.21183; GRAVES J, 1993, BRIT J PHARMACOL, V108, P631, DOI 10.1111/j.1476-5381.1993.tb12853.x; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; KOLTGEN D, 1994, NEUROSCI LETT, V173, P79, DOI 10.1016/0304-3940(94)90154-6; Lau T, 2000, J CLIN INVEST, V105, P1217, DOI 10.1172/JCI7199; Liewluck T, 2011, MUSCLE NERVE, V44, P789, DOI 10.1002/mus.22176; Martignago S, 2009, NEUROPATH APPL NEURO, V35, P103, DOI 10.1111/j.1365-2990.2008.00965.x; Matell G, 1998, ANN NY ACAD SCI, V841, P785, DOI 10.1111/j.1749-6632.1998.tb11019.x; Mizrachi K, 2010, J NEUROIMMUNOL, V220, P43, DOI 10.1016/j.jneuroim.2009.12.012; Nakayashiki N, 2000, J NEUROIMMUNOL, V105, P131, DOI 10.1016/S0165-5728(00)00199-5; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387; Punga AR, 2006, CLIN NEUROPHYSIOL, V117, P1434, DOI 10.1016/j.clinph.2006.03.028; Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018; SCHMID A, 1985, J BIOL CHEM, V260, P3041; Soliven B, 2009, J NEUROL SCI, V277, P150, DOI 10.1016/j.jns.2008.09.033; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Suzuki N, 2010, J NEUROL SCI, V294, P95, DOI 10.1016/j.jns.2010.03.022; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246	34	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44148	10.1371/journal.pone.0044148	http://dx.doi.org/10.1371/journal.pone.0044148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952904	Green Accepted, gold, Green Published			2022-12-25	WOS:000308213600083
J	Zheng, XF; Yang, SY; Han, YC; Zhao, XY; Zhao, L; Tian, T; Tong, JY; Xu, PF; Xiong, C; Meng, AM				Zheng, Xiaofeng; Yang, Shuyan; Han, Yanchao; Zhao, Xinyi; Zhao, Long; Tian, Tian; Tong, Jingyuan; Xu, Pengfei; Xiong, Cong; Meng, Anming			Loss of Zygotic NUP107 Protein Causes Missing of Pharyngeal Skeleton and Other Tissue Defects with Impaired Nuclear Pore Function in Zebrafish Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; EXPRESSION; NUCLEOPORIN; GENE; REVEALS; DEATH; DIFFERENTIATION; DISRUPTION; COMPONENT; APOPTOSIS	The Nup107-160 multiprotein subcomplex is essential for the assembly of nuclear pore complexes. The developmental functions of individual constituents of this subcomplex in vertebrates remain elusive. In particular, it is unknown whether Nup107 plays an important role in development of vertebrate embryos. Zebrafish nup107 is maternally expressed and its zygotic expression becomes prominent in the head region and the intestine from 24 h postfertilization (hpf) onward. In this study, we generate a zebrafish mutant line, nup107(tsu068Gt), in which the nup107 locus is disrupted by an insertion of Tol2 transposon element in the first intron and as a result it fails to produce normal transcripts. Homozygous nup107(tsu068Gt) mutant embryos exhibit tissue-specific defects after 3 days postfertilization (dpf), including loss of the pharyngeal skeletons, degeneration of the intestine, absence of the swim bladder, and smaller eyes. These mutants die at 5-6 days. Extensive apoptosis occurs in the affected tissues, which is partially dependent on p53 apoptotic pathways. In cells of the defective tissues, FG-repeat nucleoporins are disturbed and nuclear pore number is reduced, leading to impaired translocation of mRNAs from the nucleus to the cytoplasm. Our findings shed new light on developmental function of Nup107 in vertebrates.	[Zheng, Xiaofeng; Yang, Shuyan; Han, Yanchao; Zhao, Xinyi; Zhao, Long; Tian, Tian; Tong, Jingyuan; Xu, Pengfei; Xiong, Cong; Meng, Anming] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Yang, Shuyan; Meng, Anming] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Zoology, CAS	Meng, AM (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Zhao, Long/A-6439-2014; Meng, Anming/A-4785-2012	Zhao, Long/0000-0003-2691-7055; Meng, Anming/0000-0001-7228-3431	Major Science Programs of China [2011CB943800]	Major Science Programs of China	This work was supported by grants from the Major Science Programs of China (2011CB943800).	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Andre M, 2000, INT J DEV BIOL, V44, P249; Basel-Vanagaite L, 2006, ANN NEUROL, V60, P214, DOI 10.1002/ana.20902; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Cronshaw JM, 2003, P NATL ACAD SCI USA, V100, P5823, DOI 10.1073/pnas.1031047100; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; de Jong-Curtain TA, 2009, GASTROENTEROLOGY, V136, P902, DOI 10.1053/j.gastro.2008.11.012; Faria AMC, 2006, IMMUNITY, V24, P295, DOI 10.1016/j.immuni.2006.01.014; Fernandez-Martinez J, 2009, CURR OPIN CELL BIOL, V21, P603, DOI 10.1016/j.ceb.2009.05.001; Gao N, 2011, GASTROENTEROLOGY, V140, P1547, DOI 10.1053/j.gastro.2011.01.048; Gonzalez-Aguilera C., 2012, NUCLEUS, V3; Han YC, 2011, HUM MOL GENET, V20, P3213, DOI 10.1093/hmg/ddr234; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009; Okita K, 2004, GENES CELLS, V9, P1083, DOI 10.1111/j.1365-2443.2004.00791.x; Plaster N, 2006, CELL DEATH DIFFER, V13, P223, DOI 10.1038/sj.cdd.4401747; Rodenas E, 2012, MOL BIOL CELL, V23, P930, DOI 10.1091/mbc.E11-11-0927; Schilling TF, 1997, DEVELOPMENT, V124, P2945; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Schwend T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-59; Senger S, 2011, DEVELOPMENT, V138, P2133, DOI 10.1242/dev.057372; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Zhang XQ, 2008, CELL, V135, P1017, DOI 10.1016/j.cell.2008.10.022; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zhao L, 2008, CARDIOVASC RES, V80, P200, DOI 10.1093/cvr/cvn177; Zhao XY, 2010, J BIOL CHEM, V285, P27924, DOI 10.1074/jbc.M110.136077	39	18	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.408997	http://dx.doi.org/10.1074/jbc.M112.408997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22965233	hybrid, Green Published			2022-12-25	WOS:000310642200058
J	Pignatelli, J; LaLonde, SE; LaLonde, DP; Clarke, D; Turner, CE				Pignatelli, Jeanine; LaLonde, Sara E.; LaLonde, David P.; Clarke, Dominic; Turner, Christopher E.			Actopaxin (alpha-Parvin) Phosphorylation Is Required for Matrix Degradation and Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; FOCAL ADHESION PROTEIN; BREAST EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; P21-ACTIVATED KINASES; INVADOPODIA FORMATION; EXCHANGE FACTOR; UP-REGULATION; P38 MAPK	Dysregulation of cell adhesion and motility is known to be an important factor in the development of tumor malignancy. Actopaxin (alpha-parvin) is a paxillin, integrin-linked kinase, and F-actin binding focal adhesion protein with several serine phosphorylation sites in the amino terminus that contribute to the regulation of cell spreading and migration. Here, phosphorylation of actopaxin is shown to contribute to the regulation of matrix degradation and cell invasion. Osteosarcoma cells stably expressing wild type (WT), nonphosphorylatable (Quint), and phosphomimetic (S4D/S8D) actopaxin demonstrate that actopaxin phosphorylation is necessary for efficient Src and matrix metalloproteinase-driven degradation of extracellular matrix. Rac1 was found to be required for actopaxin-induced matrix degradation whereas inhibition of myosin contractility promoted degradation in the phosphomutant-expressing Quint cells, indicating that a balance of Rho GTPase signaling and regulation of cellular tension are important for the process. Furthermore, actopaxin forms a complex with the Rac1/Cdc42 GEF beta-PIX and Rac1/Cdc42 effector PAK1, to regulate actopaxin-dependent matrix degradation. Actopaxin phosphorylation is elevated in the invasive breast cancer cell line MDA-MB-231 compared with normal breast epithelial MCF10A cells. Expression of the nonphosphorylatable Quint actopaxin in MDA-MB-231 cells inhibits cell invasion whereas overexpression of WT actopaxin promotes invasion in MCF10A cells. Taken together, this study demonstrates a new role for actopaxin phosphorylation in matrix degradation and cell invasion via regulation of Rho GTPase signaling.	[Pignatelli, Jeanine; Turner, Christopher E.] SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [LaLonde, Sara E.] Cornell Univ, Coll Vet Med, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA; [LaLonde, David P.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Clarke, Dominic] Charter Med Inc, Dept Cellular Therapy, Winston Salem, NC 27103 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University; Cornell University	Turner, CE (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, 750 E Adams St, Syracuse, NY 13210 USA.	turnerce@upstate.edu			National Institutes of Health [R01HL070244, R01GM47607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL070244 and R01GM47607 (to C. E. T.).	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bakin AV, 2002, J CELL SCI, V115, P3193; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Curtis M, 2002, BIOCHEM J, V363, P233, DOI 10.1042/0264-6021:3630233; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Furmaniak-Kazmierczak E, 2007, CIRC RES, V100, P1328, DOI 10.1161/CIRCRESAHA.106.147744; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Johnstone CN, 2008, MOL CELL BIOL, V28, P687, DOI 10.1128/MCB.01617-06; Kim ES, 2004, INT J ONCOL, V25, P1375; Kim MS, 2003, CANCER RES, V63, P5454; Kogata N, 2009, GENE DEV, V23, P2278, DOI 10.1101/gad.535409; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Matsuda C, 2008, FEBS LETT, V582, P1189, DOI 10.1016/j.febslet.2008.01.064; Mongroo PS, 2004, ONCOGENE, V23, P8959, DOI 10.1038/sj.onc.1208112; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Olski TM, 2001, J CELL SCI, V114, P525; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Wormer D, 2012, CYTOSKELETON, V69, P644, DOI 10.1002/cm.21057; Yong HY, 2010, INT J ONCOL, V36, P501, DOI 10.3892/ijo_00000524; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200	52	23	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37309	37320		10.1074/jbc.M112.385229	http://dx.doi.org/10.1074/jbc.M112.385229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955285	hybrid, Green Published			2022-12-25	WOS:000310588500062
J	Pierre, MD; Bravi, CM; Motti, JMB; Fuku, N; Tanaka, M; Llop, E; Bonatto, SL; Moraga, M				de Saint Pierre, Michelle; Bravi, Claudio M.; Motti, Josefina M. B.; Fuku, Noriyuki; Tanaka, Masashi; Llop, Elena; Bonatto, Sandro L.; Moraga, Mauricio			An Alternative Model for the Early Peopling of Southern South America Revealed by Analyses of Three Mitochondrial DNA Haplogroups	PLOS ONE			English	Article							MTDNA VARIATION; CONTROL REGION; AMERINDIAN POPULATIONS; GENETIC CONTINUITY; EXTINCT ABORIGINES; SEQUENCE VARIATION; MONTE-VERDE; DIVERSITY; GENOME; EVOLUTIONARY	After several years of research, there is now a consensus that America was populated from Asia through Beringia, probably at the end of the Pleistocene. But many details such as the timing, route(s), and origin of the first settlers remain uncertain. In the last decade genetic evidence has taken on a major role in elucidating the peopling of the Americas. To study the early peopling of South America, we sequenced the control region of mitochondrial DNA from 300 individuals belonging to indigenous populations of Chile and Argentina, and also obtained seven complete mitochondrial DNA sequences. We identified two novel mtDNA monophyletic clades, preliminarily designated B2l and C1b13, which together with the recently described D1g sub-haplogroup have locally high frequencies and are basically restricted to populations from the extreme south of South America. The estimated ages of D1g and B2l, about,15,000 years BP, together with their similar population dynamics and the high haplotype diversity shown by the networks, suggests that they probably appeared soon after the arrival of the first settlers and agrees with the dating of the earliest archaeological sites in South America (Monte Verde, Chile, 14,500 BP). One further sub-haplogroup, D4h3a5, appears to be restricted to Fuegian-Patagonian populations and reinforces our hypothesis of the continuity of the current Patagonian populations with the initial founders. Our results indicate that the extant native populations inhabiting South Chile and Argentina are a group which had a common origin, and suggest a population break between the extreme south of South America and the more northern part of the continent. Thus the early colonization process was not just an expansion from north to south, but also included movements across the Andes.	[de Saint Pierre, Michelle] Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile; [de Saint Pierre, Michelle; Llop, Elena; Moraga, Mauricio] Univ Chile, Fac Med, ICBM, Programa Genet Humana, Santiago 7, Chile; [Bravi, Claudio M.; Motti, Josefina M. B.] CCT CONICET La Plata, Inst Multidisciplinario Biol Celular IMBICE, Lab Genet Mol Poblac, La Plata, Argentina; [Fuku, Noriyuki; Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo, Japan; [Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Genom & Mol Biol Lab, Porto Alegre, RS, Brazil; [Moraga, Mauricio] Univ Chile, Fac Ciencias Sociales, Dept Antropol, Santiago, Chile	Universidad de Chile; Universidad de Chile; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Tokyo Metropolitan Institute of Gerontology; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidad de Chile	Pierre, MD (corresponding author), Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile.	mmoraga@med.uchile.cl	de Saint Pierre, Michelle/K-3894-2015; Bonatto, Sandro L/A-1240-2010	de Saint Pierre, Michelle/0000-0001-6516-5314; Bonatto, Sandro L/0000-0002-0064-467X; Fuku, Noriyuki/0000-0001-7792-5835	FONDECYT, Chile [11060442, 1100643]; FONCyT PICT, Argentina [32450, 715]; CONICYT, Chile [24090072]; Doctoral fellowship CONICET, Argentina; Grants-in-Aid for Scientific Research [22240072] Funding Source: KAKEN	FONDECYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONCyT PICT, Argentina(ANPCyTFONCyT); CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Doctoral fellowship CONICET, Argentina; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Research grants: FONDECYT #11060442 and 1100643, Chile; FONCyT PICT 2005 #32450 and PICT 2008 #715, Argentina. Ph.D, students: MSP: Doctoral fellowship and Thesis Support Research Scholarship #24090072 from CONICYT, Chile; JMBM: Doctoral fellowship CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; BAILLIET G, 1994, AM J HUM GENET, V55, P27; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Barbieri C, 2011, AM J HUM BIOL, V23, P89, DOI 10.1002/ajhb.21107; Barbosa ABG, 2008, J FORENSIC SCI, V53, P142, DOI 10.1111/j.1556-4029.2007.00619.x; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Bechis MA, 2010, PIEZAS ETNOHISTORIA; Bengoa J, 2008, HIST ANTIGUOS MAPUCH; Bert F, 2004, ANN HUM BIOL, V31, P9, DOI 10.1080/03014460310001616464; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Brandstatter A, 2004, INT J LEGAL MED, V118, P294, DOI 10.1007/s00414-004-0466-z; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Bobillo MC, 2010, INT J LEGAL MED, V124, P263, DOI 10.1007/s00414-009-0366-3; Cooper JM, 1917, BUREAU AM ETHNOLOGY, V93; Corella A, 2007, ANN HUM BIOL, V34, P34, DOI 10.1080/03014460601075819; Costa HA, 2010, J FORENSIC LEG MED, V17, P247, DOI 10.1016/j.jflm.2010.02.011; Dillehay TD, 2005, P NATL ACAD SCI USA, V102, P17241, DOI 10.1073/pnas.0508583102; DILLEHAY TD, 1988, NATURE, V332, P150, DOI 10.1038/332150a0; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2007, SCIENCE, V316, P1890, DOI 10.1126/science.1141395; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Dornelles CL, 2004, AM J HUM BIOL, V16, P479, DOI 10.1002/ajhb.20038; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Easton RD, 1996, AM J HUM GENET, V59, P213; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fehren-Schmitz L, 2010, AM J PHYS ANTHROPOL, V141, P208, DOI 10.1002/ajpa.21135; Forster P, 1996, AM J HUM GENET, V59, P935; Fuselli S, 2003, MOL BIOL EVOL, V20, P1682, DOI 10.1093/molbev/msg188; Garcia F, 2006, AM J PHYS ANTHROPOL, V129, P473, DOI 10.1002/ajpa.20297; Garcia-Bour J, 2004, AM J PHYS ANTHROPOL, V123, P361, DOI 10.1002/ajpa.10337; Gaya-Vidal M, 2011, AM J PHYS ANTHROPOL, V145, P215, DOI 10.1002/ajpa.21487; GINTHER C, 1993, EXS, V67, P211; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gomez-Carballa A, 2012, AM J PHYS ANTHROPOL, V147, P78, DOI 10.1002/ajpa.21629; Hartmann A, 2008, VALIDATION MICROARRA; Hernandez I, 1995, INDIOS ARGENTINA; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Hunley KL, 2002, THESIS U MICHIGAN AN; Irwin J, 2007, INT J LEGAL MED, V121, P377, DOI 10.1007/s00414-006-0128-4; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2009, AM J PHYS ANTHROPOL, V140, P80, DOI 10.1002/ajpa.21037; Kolman CJ, 1997, GENETICS, V147, P1289; Lalueza C, 1997, HUM MOL GENET, V6, P41, DOI 10.1093/hmg/6.1.41; Lander N, 2008, Forensic Sci Int Genet, V2, pe61, DOI 10.1016/j.fsigen.2007.12.009; Lewis CM, 2007, HUM BIOL, V79, P159, DOI 10.1353/hub.2007.0031; Lewis CM, 2005, AM J PHYS ANTHROPOL, V127, P351, DOI 10.1002/ajpa.20102; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Manriquez V, 2004, POBLACIONES CHILENAS, P19; Marrero AR, 2007, AM J PHYS ANTHROPOL, V132, P301, DOI 10.1002/ajpa.20515; Massone M., 1987, SERIE CIENCIAS SOCIA, V17, P47; Melton PE, 2007, AM J PHYS ANTHROPOL, V133, P753, DOI 10.1002/ajpa.20581; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Meyer S, 1999, GENETICS, V152, P1103; Miotti L, 1995, CURRENT RES PLEISTOC, V12, P37; Moraga M, 2010, MAGALLANIA, V38, P103, DOI 10.4067/S0718-22442010000200006; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Museo Chileno de Arte Precolombino, 1997, CHIL ANT CHIL PREH; ORQUERA LA, 1987, J WORLD PREHIST, V1, P333, DOI 10.1007/BF00974880; Palencia L, 2010, INT J LEGAL MED, V124, P331, DOI 10.1007/s00414-010-0464-2; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pinotti L, 2001, SIN EMBARGO EXISTIMO; Prieto L, 2011, FORENSIC SCI INT-GEN, V5, P146, DOI 10.1016/j.fsigen.2010.10.013; Ribeiro-dos-Santos AKC, 2000, HUM HERED, V51, P79, DOI 10.1159/000022962; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sala A, 2010, HUM BIOL, V82, P433, DOI 10.3378/027.082.0406; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006882; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Schmitt R, 2004, ANN HUM BIOL, V31, P87, DOI 10.1080/03014460310001602063; Shinoda K, 2006, AM J PHYS ANTHROPOL, V131, P98, DOI 10.1002/ajpa.20408; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Spicer Edward H., 1962, CYCLES CONQUEST IMPA; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torres MM, 2006, AM J HUM BIOL, V18, P59, DOI 10.1002/ajhb.20461; TORRONI A, 1993, AM J HUM GENET, V53, P563; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019; Vona G, 2005, AM J PHYS ANTHROPOL, V127, P361, DOI 10.1002/ajpa.20070; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007	92	68	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43486	10.1371/journal.pone.0043486	http://dx.doi.org/10.1371/journal.pone.0043486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005KD	22970129	Green Published, gold			2022-12-25	WOS:000308748400005
J	McDole, T; Nulton, J; Barott, KL; Felts, B; Hand, C; Hatay, M; Lee, H; Nadon, MO; Nosrat, B; Salamon, P; Bailey, B; Sandin, SA; Vargas-Angel, B; Youle, M; Zgliczynski, BJ; Brainard, RE; Rohwer, F				McDole, Tracey; Nulton, James; Barott, Katie L.; Felts, Ben; Hand, Carol; Hatay, Mark; Lee, Hochul; Nadon, Marc O.; Nosrat, Bahador; Salamon, Peter; Bailey, Barbara; Sandin, Stuart A.; Vargas-Angel, Bernardo; Youle, Merry; Zgliczynski, Brian J.; Brainard, Russell E.; Rohwer, Forest			Assessing Coral Reefs on a Pacific-Wide Scale Using the Microbialization Score	PLOS ONE			English	Article							NORTHERN LINE ISLANDS; FISH-ASSEMBLAGE; BASE-LINES; BACTERIA; PHYTOPLANKTON; ECOSYSTEMS; ENRICHMENT; STRESSORS; IMPACTS; ECOLOGY	The majority of the world's coral reefs are in various stages of decline. While a suite of disturbances (overfishing, eutrophication, and global climate change) have been identified, the mechanism(s) of reef system decline remain elusive. Increased microbial and viral loading with higher percentages of opportunistic and specific microbial pathogens have been identified as potentially unifying features of coral reefs in decline. Due to their relative size and high per cell activity, a small change in microbial biomass may signal a large reallocation of available energy in an ecosystem; that is the microbialization of the coral reef. Our hypothesis was that human activities alter the energy budget of the reef system, specifically by altering the allocation of metabolic energy between microbes and macrobes. To determine if this is occurring on a regional scale, we calculated the basal metabolic rates for the fish and microbial communities at 99 sites on twenty-nine coral islands throughout the Pacific Ocean using previously established scaling relationships. From these metabolic rate predictions, we derived a new metric for assessing and comparing reef health called the microbialization score. The microbialization score represents the percentage of the combined fish and microbial predicted metabolic rate that is microbial. Our results demonstrate a strong positive correlation between reef microbialization scores and human impact. In contrast, microbialization scores did not significantly correlate with ocean net primary production, local chla concentrations, or the combined metabolic rate of the fish and microbial communities. These findings support the hypothesis that human activities are shifting energy to the microbes, at the expense of the macrobes. Regardless of oceanographic context, the microbialization score is a powerful metric for assessing the level of human impact a reef system is experiencing.	[McDole, Tracey; Barott, Katie L.; Hatay, Mark; Nosrat, Bahador; Youle, Merry; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Nulton, James; Felts, Ben; Hand, Carol; Lee, Hochul; Salamon, Peter; Bailey, Barbara] San Diego State Univ, Dept Math & Comp Sci, San Diego, CA 92182 USA; [Vargas-Angel, Bernardo; Brainard, Russell E.] NOAA Fisheries, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Sandin, Stuart A.; Zgliczynski, Brian J.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Nadon, Marc O.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Nadon, Marc O.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	California State University System; San Diego State University; California State University System; San Diego State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Miami; University of Hawaii System; University of Hawaii Manoa	McDole, T (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	tsmcdole@yahoo.com	Rohwer, Forest/AAC-5315-2019	Rohwer, Forest/0000-0003-1548-5429; Barott, Katie/0000-0001-7371-4870	National Science Foundation (NSF) [OCE-0927415]; CIFAR [LTRDTD62207]	National Science Foundation (NSF)(National Science Foundation (NSF)); CIFAR(Canadian Institute for Advanced Research (CIFAR))	This work was supported by National Science Foundation (NSF) (OCE-0927415) and a grant from CIFAR (LTRDTD62207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], P 5 BERK S MATH STAT; Arias-Gonzalez JE, 1997, CORAL REEFS, V16, P231; Atkins P., 2007, 4 LAWS DRIVE UNIVERS; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; BJORNSEN PK, 1986, APPL ENVIRON MICROB, V51, P1199; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; BROCK RE, 1982, B MAR SCI, V32, P269; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; FROESE R, 1994, NETH J SEA RES, V32, P235, DOI 10.1016/0077-7579(94)90001-9; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOHNSON C, 1995, MAR ECOL PROG SER, V126, P123, DOI 10.3354/meps126123; Jolliffe, 2002, PRINCIPAL COMPONENT; Kelly LW, 2011, ISME J; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kulbicki M, 2005, CYBIUM, V29, P235; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Maliao RJ, 2008, MAR BIOL, V154, P841, DOI 10.1007/s00227-008-0977-0; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith VH, 2006, LIMNOL OCEANOGR, V51, P377, DOI 10.4319/lo.2006.51.1_part_2.0377; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; Strickland JDH, 1965, FISH RES BOARD CAN, V125; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Turgeon DD, 2008, STATE CORAL REEF ECO; Vargas-Angel B, 2011, B MAR SCI, V87, P623, DOI 10.5343/bms.2010.1095; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876	46	48	49	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43233	10.1371/journal.pone.0043233	http://dx.doi.org/10.1371/journal.pone.0043233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970122	Green Submitted, gold, Green Published			2022-12-25	WOS:000308462000001
J	Chen, J; Kwong, DLW; Zhu, CL; Chen, LL; Dong, SS; Zhang, LY; Tian, J; Qi, CB; Cao, TT; Wong, AMG; Kong, KL; Li, Y; Liu, M; Fu, L; Guan, XY				Chen, Juan; Kwong, Dora Lai-Wan; Zhu, Cai-Lei; Chen, Lei-Lei; Dong, Sui-Sui; Zhang, Li-Yi; Tian, Jun; Qi, Chu-Bo; Cao, Ting-Ting; Wong, Alissa Michelle Go; Kong, Kar-Lok; Li, Yan; Liu, Ming; Fu, Li; Guan, Xin-Yuan			RBMS3 at 3p24 Inhibits Nasopharyngeal Carcinoma Development via Inhibiting Cell Proliferation, Angiogenesis, and Inducing Apoptosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EPSTEIN-BARR-VIRUS; BETA-CATENIN; C-MYC; IN-VIVO; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CDK INHIBITORS; POOR-PROGNOSIS; RAS ONCOGENES	Deletion of the short arm of chromosome 3 is one of the most frequent genetic alterations in many solid tumors including nasopharyngeal carcinoma (NPC), suggesting the existence of one or more tumor suppressor genes (TSGs) within the frequently deleted region. A putative TSG RBMS3 (RNA binding motif, single stranded interacting protein 3), located at 3p24-p23, has been identified in our previous study. Here, we reported that downregulation of RBMS3 was detected in 3/3 NPC cell lines and 13/15 (86.7%) primary NPC tissues. Functional studies using both overexpression and suppression systems demonstrated that RBMS3 has a strong tumor suppressive role in NPC. The tumor suppressive mechanism of RBMS3 was associated with its role in cell cycle arrest at the G1/S checkpoint by upregulating p53 and p21, downregulating cyclin E and CDK2, and the subsequent inhibition of Rb-ser780. Further analysis demonstrated that RBMS3 had a pro-apoptotic role in a mitochondrial-dependent manner via activation of caspase-9 and PARP. Finally, RBMS3 inhibited microvessel formation, which may be mediated by down-regulation of MMP2 and beta-catenin and inactivation of its downstream targets, including cyclin-D1, c-Myc, MMP7, and MMP9. Taken together, our findings define a function for RBMS3 as an important tumor suppressor gene in NPC.	[Chen, Juan; Kwong, Dora Lai-Wan; Zhu, Cai-Lei; Chen, Lei-Lei; Dong, Sui-Sui; Zhang, Li-Yi; Cao, Ting-Ting; Wong, Alissa Michelle Go; Kong, Kar-Lok; Liu, Ming; Fu, Li; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Chen, Juan] Huazhong Univ Sci & Technol, Ctr Canc, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Li, Yan; Fu, Li; Guan, Xin-Yuan] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Jun] Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Qi, Chu-Bo] Hubei Canc Hosp, Dept Pathol, Wuhan, Peoples R China	University of Hong Kong; Huazhong University of Science & Technology; Sun Yat Sen University; Huazhong University of Science & Technology	Chen, J (corresponding author), Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China.	xyguan@hkucc.hku.hk; gracelfu@hkucc.hku.hk	Fu, Li/F-7182-2010; /A-3639-2009	Fu, Li/0000-0003-2643-6278; Wong, Alissa/0000-0001-7858-1368; LIU, MING/0000-0003-3222-8715; /0000-0003-1874-9805; Chen, Polly Leilei/0000-0002-1987-3878	National Natural Science Foundation of China [30700820, 30772475, 30971606]; National Key Sci-Tech Special Project of China [2008ZX10002-022]; Hong Kong UGC Area of Excellent Scheme [AoE/M-06/08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Hong Kong UGC Area of Excellent Scheme	This work was supported by grants from the National Natural Science Foundation of China (30700820, 30772475 and 30971606), the National Key Sci-Tech Special Project of China (2008ZX10002-022), and the Hong Kong UGC Area of Excellent Scheme (AoE/M-06/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Carnero A, 1998, CURR TOP MICROBIOL, V227, P43; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Claudio PP, 2001, CANCER RES, V61, P462; Fan CS, 2000, HUM PATHOL, V31, P169, DOI 10.1016/S0046-8177(00)80216-6; Fang YJ, 2009, INT J COLORECTAL DIS, V24, P875, DOI 10.1007/s00384-009-0725-z; Fox SB, 2001, METH MOLEC MED, V46, P29, DOI 10.1385/1-59259-143-4:029; Fritz D, 2007, J MOL BIOL, V371, P585, DOI 10.1016/j.jmb.2007.06.006; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hoshino I, 2007, ONCOL REP, V18, P867; Hu XT, 2009, ONCOGENE, V28, P2466, DOI 10.1038/onc.2009.92; Hui ABY, 1998, CANCER GENET CYTOGEN, V101, P83, DOI 10.1016/S0165-4608(97)00231-8; Hui ABY, 2002, INT J ONCOL, V20, P467; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Jeannel D, 1999, CANCER SURV, V33, P125; Kraemer M, 1999, CELL GROWTH DIFFER, V10, P193; Kwong D, 2004, HUM PATHOL, V35, P309, DOI 10.1016/j.humpath.2003.10.020; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Li Y, 2011, CANCER RES, V71, P6106, DOI 10.1158/0008-5472.CAN-10-4291; LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Luo JL, 1997, CHINESE MED J-PEKING, V110, P229; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pellegrini M, 2005, APOPTOSIS, V10, P13, DOI 10.1007/s10495-005-6057-8; Penkov D, 2000, GENE, V243, P27, DOI 10.1016/S0378-1119(99)00515-6; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; PORTER MJ, 1994, ACTA OTO-LARYNGOL, V114, P105, DOI 10.3109/00016489409126025; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Qiu GH, 2008, J HEPATOL, V48, P433, DOI 10.1016/j.jhep.2007.11.015; RAK J, 1995, CANCER RES, V55, P4575; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vokes EE, 1997, LANCET, V350, P1087, DOI 10.1016/S0140-6736(97)07269-3; Wang XH, 2010, ONCOL REP, V24, P1093, DOI 10.3892/or_00000960; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509	52	18	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44636	10.1371/journal.pone.0044636	http://dx.doi.org/10.1371/journal.pone.0044636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957092	Green Published, gold			2022-12-25	WOS:000308463800085
J	Greenblatt, MB; Vbranac, V; Tivey, T; Tsang, K; Tager, AM; Aliprantis, AO				Greenblatt, Matthew B.; Vbranac, Vladimir; Tivey, Trevor; Tsang, Kelly; Tager, Andrew M.; Aliprantis, Antonios O.			Graft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse Model	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; INTERFERON-GAMMA; IMMUNE-RESPONSES; MICE; TRANSPLANTATION; BLOOD; CELLS; CHAIN; ACTIVATION; EXPRESSION	Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/gamma c(-/-)) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.	[Greenblatt, Matthew B.; Tsang, Kelly; Aliprantis, Antonios O.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Vbranac, Vladimir; Tivey, Trevor; Tager, Andrew M.] Harvard Univ, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp,Med Sch, Charlestown, MA USA; [Vbranac, Vladimir; Tivey, Trevor; Tager, Andrew M.] MIT, Ragon Inst Massachusetts Gen Hosp, Charlestown, MA USA; [Vbranac, Vladimir; Tivey, Trevor; Tager, Andrew M.] Harvard, Charlestown, MA USA; [Vbranac, Vladimir; Tivey, Trevor; Tager, Andrew M.] Harvard Univ, Div Aids, Sch Med, Charlestown, MA USA; [Aliprantis, Antonios O.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Aliprantis, Antonios O.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Greenblatt, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	aaliprantis@partners.org		Tivey, Trevor/0000-0003-2124-5528	Scleroderma Research Foundation; National Institute of Allergy and Infectious Diseases [P30AI060354, P01AI078897]; Ragon Institute of MGH; Massachusetts Institute of Technology; Harvard; Burroughs Wellcome Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K08AR054859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078897, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Scleroderma Research Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ragon Institute of MGH; Massachusetts Institute of Technology; Harvard; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Scleroderma Research Foundation (ww.srfcure.org) to AOA. The Massachusetts General Hospital (MGH) Humanized Mouse Program was supported by P30AI060354 and P01AI078897 from National Institute of Allergy and Infectious Diseases, and a platform award from the Ragon Institute of MGH, Massachusetts Institute of Technology and Harvard. AOA holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is supported by K08AR054859 from National Institute of Arthritis and Musculoskeletal and Skin Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Cao TH, 2009, CELL IMMUNOL, V258, P65, DOI 10.1016/j.cellimm.2009.03.013; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Denton PW, 2011, AIDS REV, V13, P135; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Greenblatt MB, 2012, AM J PATHOL; Gregoire-Gauthier J, 2011, STEM CELLS DEV; Gupta V, 2009, BIOL BLOOD MARROW TR, V15, P864, DOI 10.1016/j.bbmt.2009.03.023; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Juchem KW, 2011, BLOOD, V118, P6209, DOI 10.1182/blood-2011-01-330035; Kalscheuer H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003481; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Khanna D, 2009, ARTHRITIS RHEUM-US, V60, P1102, DOI 10.1002/art.24380; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Littera R, 2012, BRIT J HAEMATOL, V156, P118, DOI 10.1111/j.1365-2141.2011.08923.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Murphy WJ, 1998, J CLIN INVEST, V102, P1742, DOI 10.1172/JCI3906; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Olesen R, 2011, J REPROD IMMUNOL, V88, P195, DOI 10.1016/j.jri.2010.11.005; Papp G, 2012, CLIN IMMUNOL, V142, P150, DOI 10.1016/j.clim.2011.09.014; Petersdorf EW, 2006, SEMIN HEMATOL, V43, P11, DOI 10.1053/j.seminhematol.2005.09.002; Ruzek MC, 2004, ARTHRITIS RHEUM, V50, P1319, DOI 10.1002/art.20160; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sora F, 2002, EXP HEMATOL, V30, P279, DOI 10.1016/S0301-472X(01)00793-7; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Tsiakalou V, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-20; Verlinden S F, 1998, Stem Cells, V16 Suppl 1, P205; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang YG, 1998, J CLIN INVEST, V102, P2126, DOI 10.1172/JCI4992; Zhang BJ, 2009, J CELL MOL MED, V13, P1043, DOI 10.1111/j.1582-4934.2008.00347.x; Zimmermann N, 2005, AM J RESP CELL MOL, V32, P428, DOI 10.1165/rcmb.2004-0269OC	45	103	110	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44664	10.1371/journal.pone.0044664	http://dx.doi.org/10.1371/journal.pone.0044664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957096	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800089
J	Spampanato, J; Sullivan, RK; Turpin, FR; Bartlett, PF; Sah, P				Spampanato, Jay; Sullivan, Robert K.; Turpin, Fabrice R.; Bartlett, Perry F.; Sah, Pankaj			Properties of Doublecortin Expressing Neurons in the Adult Mouse Dentate Gyrus	PLOS ONE			English	Article							GENERATED GRANULE CELLS; ENHANCED SYNAPTIC PLASTICITY; HIPPOCAMPAL PYRAMIDAL CELLS; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL MATURATION; DENDRITIC SPINES; NR2A SUBUNIT; NEUROGENESIS; RECEPTOR; RAT	The dentate gyrus is a neurogenic zone where neurons continue to be born throughout life, mature and integrate into the local circuitry. In adults, this generation of new neurons is thought to contribute to learning and memory formation. As newborn neurons mature, they undergo a developmental sequence in which different stages of development are marked by expression of different proteins. Doublecortin (DCX) is an early marker that is expressed in immature granule cells that are beginning migration and dendritic growth but is turned off before neurons reach maturity. In the present study, we use a mouse strain in which enhanced green fluorescent protein (EGFP) is expressed under the control of the DCX promoter. We show that these neurons have high input resistances and some cells can discharge trains of action potentials. In mature granule cells, action potentials are followed by a slow afterhyperpolarization that is absent in EGFP-positive neurons. EGFP-positive neurons had a lower spine density than mature neurons and stimulation of either the medial or lateral perforant pathway activated dual component glutamatergic synapses that had both AMPA and NMDA receptors. NMDA receptors present at these synapses had slow kinetics and were blocked by ifenprodil, indicative of high GluN2B subunit content. These results show that EGFP-positive neurons in the DCX-EGFP mice are functionally immature both in their firing properties and excitatory synapses.	[Spampanato, Jay; Sullivan, Robert K.; Turpin, Fabrice R.; Bartlett, Perry F.; Sah, Pankaj] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Spampanato, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	Pankaj.Sah@uq.edu.au	Bartlett, Perry/F-3813-2012; Sah, Pankaj/C-8175-2009; Sullivan, Robert KP/A-8639-2012; Turpin, Fabrice/G-1717-2011	Sullivan, Robert KP/0000-0003-3414-2448; Sah, Pankaj/0000-0001-5063-1589; Spampanato, Jay/0000-0003-3968-0608	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (NH&MRC) and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Delaney AJ, 2012, J NEUROPHYSIOL, V107, P1571, DOI 10.1152/jn.01066.2011; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Flint AC, 1997, J NEUROSCI, V17, P2469; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Liu XS, 2000, BRAIN RES, V856, P202, DOI 10.1016/S0006-8993(99)02421-X; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Stocca G, 2008, J PHYSIOL-LONDON, V586, P3795, DOI 10.1113/jphysiol.2008.155739; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Ye GL, 2005, DEV BRAIN RES, V155, P26, DOI 10.1016/j.devbrainres.2004.12.002; Ye GL, 2000, DEV BRAIN RES, V124, P33, DOI 10.1016/S0165-3806(00)00103-6; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; ZAFIROV S, 1994, J COMP NEUROL, V345, P472, DOI 10.1002/cne.903450312; Zhang JZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-158; Zhao SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012506; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	50	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41029	10.1371/journal.pone.0041029	http://dx.doi.org/10.1371/journal.pone.0041029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957010	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800002
J	Dillon, LM; Hida, A; Garcia, S; Prolla, TA; Moraes, CT				Dillon, Lloye M.; Hida, Aline; Garcia, Sofia; Prolla, Tomas A.; Moraes, Carlos T.			Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; MICE; MYOPATHY	Pharmacological agents, such as bezafibrate, that activate peroxisome proliferator-activated receptors (PPARs) and PPAR gamma coactivator-1 alpha (PGC-1 alpha) pathways have been shown to improve mitochondrial function and energy metabolism. The mitochondrial DNA (mtDNA) mutator mouse is a mouse model of aging that harbors a proofreading-deficient mtDNA polymerase gamma. These mice develop many features of premature aging including hair loss, anemia, osteoporosis, sarcopenia and decreased lifespan. They also have increased mtDNA mutations and marked mitochondrial dysfunction. We found that mutator mice treated with bezafibrate for 8-months had delayed hair loss and improved skin and spleen aging-like phenotypes. Although we observed an increase in markers of fatty acid oxidation in these tissues, we did not detect a generalized increase in mitochondrial markers. On the other hand, there were no improvements in muscle function or lifespan of the mutator mouse, which we attributed to the rodent-specific hepatomegaly associated with fibrate treatment. These results showed that despite its secondary effects in rodent's liver, bezafibrate was able to improve some of the aging phenotypes in the mutator mouse. Because the associated hepatomegaly is not observed in primates, long-term bezafibrate treatment in humans could have beneficial effects on tissues undergoing chronic bioenergetic-related degeneration.	[Dillon, Lloye M.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Hida, Aline; Garcia, Sofia; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Miami; University of Miami; University of Wisconsin System; University of Wisconsin Madison	Dillon, LM (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.	cmoraes@med.miami.edu	Moraes, Carlos/AAT-3818-2021	Dillon, Lloye/0000-0002-5118-1126	U.S. Public Health Service (PHS) [AG036871, EY010804, NS079965]; Muscular Dystrophy Association; Florida Biomedical Research Foundation; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036871] Funding Source: NIH RePORTER	U.S. Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); Muscular Dystrophy Association(Muscular Dystrophy Association); Florida Biomedical Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The U.S. Public Health Service (PHS) grants AG036871, EY010804, NS079965; the Muscular Dystrophy Association and the Florida Biomedical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Cheung MC, 2009, J SURG RES, V153, P326, DOI 10.1016/j.jss.2008.05.002; De Souza AT, 2006, TOXICOL SCI, V92, P578, DOI 10.1093/toxsci/kfl019; Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049; Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608; Djouadi F, 2011, CELL METAB, V14, P715, DOI 10.1016/j.cmet.2011.11.003; Ham SA, 2010, J CELL MOL MED, V14, P1747, DOI 10.1111/j.1582-4934.2009.00816.x; Harries MJ, 2009, J INVEST DERMATOL, V129, P1066, DOI 10.1038/jid.2008.425; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Johri A, 2012, HUM MOL GENET, V21, P1124, DOI 10.1093/hmg/ddr541; Kuenzli S, 2003, BRIT J DERMATOL, V149, P229, DOI 10.1046/j.1365-2133.2003.05532.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; OIKARINEN A, 1994, PHOTODERMATOL PHOTO, V10, P47; Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011; Smaldone S, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-8; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482	23	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44335	10.1371/journal.pone.0044335	http://dx.doi.org/10.1371/journal.pone.0044335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962610	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600038
J	Pendleton, L; Donato, DC; Murray, BC; Crooks, S; Jenkins, WA; Sifleet, S; Craft, C; Fourqurean, JW; Kauffman, JB; Marba, N; Megonigal, P; Pidgeon, E; Herr, D; Gordon, D; Baldera, A				Pendleton, Linwood; Donato, Daniel C.; Murray, Brian C.; Crooks, Stephen; Jenkins, W. Aaron; Sifleet, Samantha; Craft, Christopher; Fourqurean, James W.; Kauffman, J. Boone; Marba, Nuria; Megonigal, Patrick; Pidgeon, Emily; Herr, Dorothee; Gordon, David; Baldera, Alexis			Estimating Global "Blue Carbon" Emissions from Conversion and Degradation of Vegetated Coastal Ecosystems	PLOS ONE			English	Article							MANGROVE FOREST DISTRIBUTIONS; DYNAMICS; METHANE; SEQUESTRATION; CONSERVATION; ESTUARY; BIOMASS; SOILS	Recent attention has focused on the high rates of annual carbon sequestration in vegetated coastal ecosystems-marshes, mangroves, and seagrasses-that may be lost with habitat destruction ('conversion'). Relatively unappreciated, however, is that conversion of these coastal ecosystems also impacts very large pools of previously-sequestered carbon. Residing mostly in sediments, this 'blue carbon' can be released to the atmosphere when these ecosystems are converted or degraded. Here we provide the first global estimates of this impact and evaluate its economic implications. Combining the best available data on global area, land-use conversion rates, and near-surface carbon stocks in each of the three ecosystems, using an uncertainty-propagation approach, we estimate that 0.15-1.02 Pg (billion tons) of carbon dioxide are being released annually, several times higher than previous estimates that account only for lost sequestration. These emissions are equivalent to 3-19% of those from deforestation globally, and result in economic damages of $US 6-42 billion annually. The largest sources of uncertainty in these estimates stems from limited certitude in global area and rates of land-use conversion, but research is also needed on the fates of ecosystem carbon upon conversion. Currently, carbon emissions from the conversion of vegetated coastal ecosystems are not included in emissions accounting or carbon market protocols, but this analysis suggests they may be disproportionally important to both. Although the relevant science supporting these initial estimates will need to be refined in coming years, it is clear that policies encouraging the sustainable management of coastal ecosystems could significantly reduce carbon emissions from the land-use sector, in addition to sustaining the well-recognized ecosystem services of coastal habitats.	[Pendleton, Linwood; Murray, Brian C.; Jenkins, W. Aaron; Gordon, David] Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA; [Donato, Daniel C.] Univ Wisconsin, Ecosyst & Landscape Ecol Lab, Madison, WI USA; [Crooks, Stephen] ESA Phillip Williams & Associates, San Francisco, CA USA; [Sifleet, Samantha] US EPA, Res Triangle Pk, NC 27711 USA; [Craft, Christopher] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA; [Fourqurean, James W.] Florida Int Univ, Dept Biol Sci, N Miami, FL USA; [Fourqurean, James W.] Florida Int Univ, SE Environm Res Ctr, N Miami, FL USA; [Kauffman, J. Boone] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Kauffman, J. Boone] Ctr Int Forest Res, Bogor, Indonesia; [Marba, Nuria] Mediterranean Inst Adv Studies, Dept Global Change Res, Esporles, Illes Balears, Spain; [Megonigal, Patrick] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Pidgeon, Emily] Conservat Int, Arlington, VA USA; [Herr, Dorothee] Int Union Conservat Nat, Washington, DC USA; [Baldera, Alexis] Ocean Conservancy, Baton Rouge, LA USA	Duke University; University of Wisconsin System; University of Wisconsin Madison; United States Environmental Protection Agency; Indiana University System; Indiana University Bloomington; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Oregon State University; CGIAR; Center for International Forestry Research (CIFOR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Smithsonian Institution; Smithsonian Environmental Research Center; Conservation International	Pendleton, L (corresponding author), Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA.	ddonato@wisc.edu	Marba, Nuria/H-8136-2015; Fourqurean, James/AAY-9611-2020; Marbà, Nuria/N-8143-2019; Fourqurean, James/B-4606-2008	Marba, Nuria/0000-0002-8048-6789; Fourqurean, James/0000-0002-0811-8500; Marbà, Nuria/0000-0002-8048-6789; Fourqurean, James/0000-0002-0811-8500; Megonigal, Patrick/0000-0002-2018-7883	Linden Trust for Conservation; Roger and Victoria Sant	Linden Trust for Conservation; Roger and Victoria Sant	Funding for this effort was provided by the Linden Trust for Conservation (lindentrust.org) and Roger and Victoria Sant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2011, ENVIRON SCI POLICY, V14, P462, DOI 10.1016/j.envsci.2011.02.004; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; CHARPY-ROUBAUD C, 1990, Marine Microbial Food Webs, V4, P31; Chen CTA, 2009, DEEP-SEA RES PT II, V56, P578, DOI 10.1016/j.dsr2.2009.01.001; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Climate Focus, 2011, BLUE CARB POL OPT AS; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crooks S, 2011, REGULATING CLIMATE C; Deverel S, 2010, SAN FRANCISCO ESTUAR, V8, P1, DOI [10.15447/sfews.2010v8iss2art1, DOI 10.15447/SFEWS.2010V8ISS2ART1]; Donato DC, 2012, J ENVIRON MANAGE, V97, P89, DOI 10.1016/j.jenvman.2011.12.004; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Doucet A, 2001, STAT ENG IN, P3; Drever J. I., 1988, GEOCHEMISTRY NATURAL; Duarte C.M., 2005, AQUATIC ECOSYSTEMS T; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Giri C, 2008, J BIOGEOGR, V35, P519, DOI 10.1111/j.1365-2699.2007.01806.x; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Giri C, 2008, SENSORS-BASEL, V8, P2104, DOI 10.3390/s8042104; GOLLEY F, 1962, ECOLOGY, V43, P9, DOI 10.2307/1932034; Gordon D, 2011, 1111 NI EP; Granek E, 2008, ESTUAR COAST SHELF S, V80, P555, DOI 10.1016/j.ecss.2008.09.012; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Herr D., 2011, BLUE CARBON POLICY F; Intergovernmental Panel on Climate Change, 2003, GOOD PRACTICE GUIDAN; IPCC, 2007, CLIM CHANG 2007 ASS; Irving AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018311; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Kristensen E, 2008, AQUAT BOT, V89, P201, DOI 10.1016/j.aquabot.2007.12.005; Krithika K, 2008, CURR SCI INDIA, V94, P218; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Morgan PA, 2002, RESTOR ECOL, V10, P461, DOI 10.1046/j.1526-100X.2002.01037.x; Murdiyarso D, 2010, P NATL ACAD SCI USA, V107, P19655, DOI 10.1073/pnas.0911966107; Murray B. C., 2011, Green payments for blue carbon: economic incentives for protecting threatened coastal habitats; Nellemann C., 2009, BLUE CARBON RAPID RE; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pearson TRH, 2007, GEN TECHNICAL REPORT; Pidgeon E, 2009, MANAGEMENT NATURAL C; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Sjoling S, 2005, ESTUAR COAST SHELF S, V63, P397, DOI 10.1016/j.ecss.2004.12.002; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; Strangmann A, 2008, BIOL FERT SOILS, V44, P511, DOI 10.1007/s00374-007-0233-7; Sweetman AK, 2010, BIOGEOSCIENCES, V7, P2129, DOI 10.5194/bg-7-2129-2010; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; *UN FAO, 2007, WORLDS MANGR 1980 20; UNFCCC, 2011, DEC CMP 7 LAND US LA; UNFCCC (United Nations Forum Convention on Climate Change, 2011, DRAFT DEC CP 17 GUID; United States Government (USG), 2010, 12866 USG USEPA; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Vichkovitten T, 2005, J EXP MAR BIOL ECOL, V316, P183, DOI 10.1016/j.jembe.2004.11.002; Walker, 2005, SOURCEBOOK LAND USE; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Yu OT, 2009, ENVIRON CONSERV, V36, P312, DOI 10.1017/S0376892910000184	65	788	818	57	675	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43542	10.1371/journal.pone.0043542	http://dx.doi.org/10.1371/journal.pone.0043542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962585	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600013
J	Elias, RM; Correa-Costa, M; Barreto, CR; Silva, RC; Hayashida, CY; Castoldi, A; Goncalves, GM; Braga, TT; Barboza, R; Rios, FJ; Keller, AC; Cenedeze, MA; Hyane, MI; D'Imperio-Lima, MR; Figueiredo-Neto, AM; Reis, MA; Marinho, CRF; Pacheco-Silva, A; Camara, NOS				Elias, Rosa Maria; Correa-Costa, Matheus; Barreto, Claudiene Rodrigues; Silva, Reinaldo Correia; Hayashida, Caroline Y.; Castoldi, Angela; Goncalves, Giselle Martins; Braga, Tarcio Teodoro; Barboza, Renato; Rios, Francisco Jose; Keller, Alexandre Castro; Cenedeze, Marcos Antonio; Hyane, Meire Ioshie; D'Imperio-Lima, Maria Regina; Figueiredo-Neto, Antonio Martins; Reis, Marlene Antonia; Farias Marinho, Claudio Romero; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen			Oxidative Stress and Modification of Renal Vascular Permeability Are Associated with Acute Kidney Injury during P. berghei ANKA Infection	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEME OXYGENASE-1; ADHESION MOLECULES; FALCIPARUM-MALARIA; REPERFUSION INJURY; KAPPA-B; FAILURE; SEQUESTRATION; CYTOADHERENCE; DYSFUNCTION	Malaria associated-acute kidney injury (AKI) is associated with 45% of mortality in adult patients hospitalized with severe form of the disease. However, the causes that lead to a framework of malaria-associated AKI are still poorly characterized. Some clinical studies speculate that oxidative stress products, a characteristic of Plasmodium infection, as well as proinflammatory response induced by the parasite are involved in its pathophysiology. Therefore, we aimed to investigate the development of malaria-associated AKI during infection by P. berghei ANKA, with special attention to the role played by the inflammatory response and the involvement of oxidative stress. For that, we took advantage of an experimental model of severe malaria that showed significant changes in the renal pathophysiology to investigate the role of malaria infection in the renal microvascular permeability and tissue injury. Therefore, BALB/c mice were infected with P. berghei ANKA. To assess renal function, creatinine, blood urea nitrogen, and ratio of proteinuria and creatininuria were evaluated. The products of oxidative stress, as well as cytokine profile were quantified in plasma and renal tissue. The change of renal microvascular permeability, tissue hypoxia and cellular apoptosis were also evaluated. Parasite infection resulted in renal dysfunction. Furthermore, we observed increased expression of adhesion molecule, proinflammatory cytokines and products of oxidative stress, associated with a decrease mRNA expression of HO-1 in kidney tissue of infected mice. The measurement of lipoprotein oxidizability also showed a significant increase in plasma of infected animals. Together, our findings support the idea that products of oxidative stress, as well as the immune response against the parasite are crucial to changes in kidney architecture and microvascular endothelial permeability of BALB/c mice infected with P. berghei ANKA.	[Elias, Rosa Maria; Barreto, Claudiene Rodrigues; Silva, Reinaldo Correia; Castoldi, Angela; Cenedeze, Marcos Antonio; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Dept Med, Disciplina Nefrol, Sao Paulo, Brazil; [Correa-Costa, Matheus; Hayashida, Caroline Y.; Goncalves, Giselle Martins; Braga, Tarcio Teodoro; Rios, Francisco Jose; Hyane, Meire Ioshie; D'Imperio-Lima, Maria Regina; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Dept Imunol, Lab Imunobiol Transplantes, Sao Paulo, Brazil; [Keller, Alexandre Castro] Univ Fed Sao Paulo, Dept Imunol, Sao Paulo, Brazil; [Figueiredo-Neto, Antonio Martins] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil; [Reis, Marlene Antonia] Univ Fed Triangulo Mineiro, Div Patol, Uberaba, Brazil; [Barboza, Renato; Farias Marinho, Claudio Romero] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Pacheco-Silva, Alvaro] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Elias, RM (corresponding author), Univ Fed Sao Paulo, Dept Med, Disciplina Nefrol, Sao Paulo, Brazil.	niels@icb.usp.br	Complexos, INCT Fluidos/H-9172-2013; D'Império Lima, Maria Regina/I-4747-2012; Barboza, Renato/G-5833-2012; Marinho, Claudio Romero Farias/F-7507-2012; Pacheco-Silva, Alvaro/K-3583-2013; Castoldi, Angela/K-1889-2015; Keller, Alexandre C/E-4621-2012; Rios, Francisco J./C-6059-2012; Braga, Tarcio/AAG-4475-2020; Camara, Niels OS/G-8336-2011; camara, niels olsen saraiva/AAX-3269-2020; Correa-Costa, Matheus/B-2006-2014; Silva, Reinaldo/C-6285-2013; Braga, Tarcio T/E-4827-2014; Neto, Antonio Martins Figueiredo/ABA-5229-2020; Neto, Antonio MF/A-5222-2009	D'Império Lima, Maria Regina/0000-0002-4683-7709; Barboza, Renato/0000-0002-6441-7513; Marinho, Claudio Romero Farias/0000-0002-1227-3845; Keller, Alexandre C/0000-0002-7827-0292; Camara, Niels OS/0000-0001-5436-1248; camara, niels olsen saraiva/0000-0001-5436-1248; Braga, Tarcio T/0000-0002-2989-1076; Neto, Antonio Martins Figueiredo/0000-0002-6339-8699; Neto, Antonio MF/0000-0002-6339-8699; Rios, Francisco/0000-0002-8194-0787; Castoldi, Angela/0000-0002-8434-7989	State of Sao Paulo Foundation for Research Support (FAPESP) [07/07139-3, 10/52180-4, 12/02270-2]; CAPES; Brazilian Council of Scientific and Technologic Development (International Associated Laboratory of Renal Immunopathology, CNPq/Inserm); Complex Fluids INCT (FAPESP/CNPq)	State of Sao Paulo Foundation for Research Support (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Council of Scientific and Technologic Development (International Associated Laboratory of Renal Immunopathology, CNPq/Inserm); Complex Fluids INCT (FAPESP/CNPq)	This study was supported by grants 07/07139-3, 10/52180-4 and 12/02270-2 from the State of Sao Paulo Foundation for Research Support (FAPESP), CAPES (PRODOC grant), Brazilian Council of Scientific and Technologic Development (International Associated Laboratory of Renal Immunopathology, CNPq/Inserm) and Complex Fluids INCT (FAPESP/CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rohani M, SAUDI J KIDNEY DIS T, V22, P829; Andrade BB, J IMMUNOL, V185, P1196; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barsoum RS, 2000, J AM SOC NEPHROL, V11, P2147, DOI 10.1681/ASN.V11112147; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Chen XP, 2007, CHINESE MED J-PEKING, V120, P421, DOI 10.1097/00029330-200703010-00015; Cojean S, 2008, PARASITE, V15, P163, DOI 10.1051/parasite/2008152163; Correa-Costa M, PLOS ONE, V5; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; Eiam-Ong S, 2003, SEMIN NEPHROL, V23, P21, DOI 10.1053/snep.2003.50002; Eiam-Ong S, 1998, AM J KIDNEY DIS, V32, P361, DOI 10.1053/ajkd.1998.v32.pm9740151; Epiphanio S, 2008, CELL HOST MICROBE, V3, P331, DOI 10.1016/j.chom.2008.04.003; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Furuichi K, NEPHRON EXTRA, V2, P27; Goncalves GM, 2006, KIDNEY INT, V70, P1742, DOI 10.1038/sj.ki.5001893; Goncalves GM, 2006, INT IMMUNOPHARMACOL, V6, P1966, DOI 10.1016/j.intimp.2006.07.009; Heyman SN, CONTRIB NEPHROL, V174, P138; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kanodia KV, SAUDI J KIDNEY DIS T, V21, P1088; Kaur D, 2007, J TROP PEDIATRICS, V53, P210, DOI 10.1093/tropej/fml092; Kontush A, 1997, BIOFACTORS, V6, P99, DOI 10.1002/biof.5520060203; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; LAWRENCE C, 1986, AM J CLIN PATHOL, V86, P360, DOI 10.1093/ajcp/86.3.360; Lee HS, 2009, AM J NEPHROL, V29, P62, DOI 10.1159/000151277; Liu MC, 2009, MICROVASC RES, V77, P340, DOI 10.1016/j.mvr.2009.01.011; Mishra SK, 2008, SEMIN NEPHROL, V28, P395, DOI 10.1016/j.semnephrol.2008.04.007; Mshana R N, 1991, J Clin Lab Immunol, V34, P131; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Rabb H, 1997, KIDNEY INT, V51, P1463, DOI 10.1038/ki.1997.200; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shibahara S, 2003, TOHOKU J EXP MED, V200, P167, DOI 10.1620/tjem.200.167; Sibmooh Nathawut, 2004, Lipids Health Dis, V3, P15, DOI 10.1186/1476-511X-3-15; Sinniah R, 1999, INT J EXP PATHOL, V80, P87, DOI 10.1046/j.1365-2613.1999.00101.x; Siqueira AM, AM J TROP MED HYG, V83, P271; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; Tristao VR, J FLUORESC, V20, P665; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; Weiser S, 2007, CYTOKINE, V37, P84, DOI 10.1016/j.cyto.2007.02.021; William T, EMERG INFECT DIS, V17, P1248; Xu Y, INT J MOL MED, V26, P679; Yasuda H, 2006, KIDNEY INT, V69, P1535, DOI 10.1038/sj.ki.5000300; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Yurdakan G, KAOHSIUNG J MED SCI, V28, P16	50	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44004	10.1371/journal.pone.0044004	http://dx.doi.org/10.1371/journal.pone.0044004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952850	gold, Green Submitted, Green Published			2022-12-25	WOS:000308221300041
J	Alba, A; Bicout, DJ; Vidal, F; Curco, A; Allepuz, A; Napp, S; Garcia-Bocanegra, I; Costa, T; Casal, J				Alba, Anna; Bicout, Dominique J.; Vidal, Francesc; Curco, Antoni; Allepuz, Alberto; Napp, Sebastian; Garcia-Bocanegra, Ignacio; Costa, Taiana; Casal, Jordi			Model to Track Wild Birds for Avian Influenza by Means of Population Dynamics and Surveillance Information	PLOS ONE			English	Article							A-VIRUS; SHEDDING PATTERNS; SENTINEL DUCKS; INFECTION; EPIZOOTIOLOGY; PERPETUATION; TRANSMISSION; MALLARDS; TURKEYS; GULLS	Design, sampling and data interpretation constitute an important challenge for wildlife surveillance of avian influenza viruses (AIV). The aim of this study was to construct a model to improve and enhance identification in both different periods and locations of avian species likely at high risk of contact with AIV in a specific wetland. This study presents an individual-based stochastic model for the Ebre Delta as an example of this appliance. Based on the Monte-Carlo method, the model simulates the dynamics of the spread of AIV among wild birds in a natural park following introduction of an infected bird. Data on wild bird species population, apparent AIV prevalence recorded in wild birds during the period of study, and ecological information on factors such as behaviour, contact rates or patterns of movements of waterfowl were incorporated as inputs of the model. From these inputs, the model predicted those species that would introduce most of AIV in different periods and those species and areas that would be at high risk as a consequence of the spread of these AIV incursions. This method can serve as a complementary tool to previous studies to optimize the allocation of the limited AI surveillance resources in a local complex ecosystem. However, this study indicates that in order to predict the evolution of the spread of AIV at the local scale, there is a need for further research on the identification of host factors involved in the interspecies transmission of AIV.	[Alba, Anna; Allepuz, Alberto; Napp, Sebastian; Garcia-Bocanegra, Ignacio; Casal, Jordi] Univ Autonoma Barcelona IRTA, Ctr Recerca Sanitat Anim, Barcelona, Spain; [Bicout, Dominique J.] Ctr Natl Rech Sci VetAgro Sup, Unite Biomath & Epidemiol, Environm & Predict Sante Populat TIMC, Marcy Letoile, France; [Vidal, Francesc; Curco, Antoni] Parc Nat Delta Ebre, Dept Medi Ambient & Habitatge, Tarragona, Spain; [Allepuz, Alberto; Costa, Taiana; Casal, Jordi] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Garcia-Bocanegra, Ignacio] Univ Cordoba, Fac Vet, Dept Sanidad Anim, Cordoba, Spain	IRTA; VetAgro Sup; Autonomous University of Barcelona; Universidad de Cordoba	Alba, A (corresponding author), Univ Autonoma Barcelona IRTA, Ctr Recerca Sanitat Anim, Campus Univ Autonoma Barcelona, Barcelona, Spain.	ana.alba@cresa.uab.es	Bocanegra, Ignacio Garcia/G-1443-2016; Costa, Taiana/HHS-5800-2022; Costa, Taiana/O-9469-2019; Casal, Jordi/F-3020-2016; Napp, Sebastian/F-3331-2016; Allepuz, Alberto/N-2398-2014	Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Costa, Taiana/0000-0002-5010-4188; Costa, Taiana/0000-0002-5010-4188; Casal, Jordi/0000-0002-6909-9366; Napp, Sebastian/0000-0001-5813-7286; Allepuz, Alberto/0000-0003-3518-1991	Department of Agriculture, Livestock, Fisheries, Food and Environment (DAAM) of the Catalan Government (Spain)	Department of Agriculture, Livestock, Fisheries, Food and Environment (DAAM) of the Catalan Government (Spain)	This work has been supported by the Department of Agriculture, Livestock, Fisheries, Food and Environment (DAAM) of the Catalan Government (Spain) as part of Surveillance Program for Avian Influenza in Catalonia, financing the expenses of technical personnel. URL: http://www20.gencat.cat/portal/site/DAR. The funders accepted the publication of this work and had no role in its design, data analysis, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Atkinson P.W., 2006, URGENT PRELIMINARY A; Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Busquets N, 2010, VIRUS RES, V149, P10, DOI 10.1016/j.virusres.2009.12.005; Caron A, 2011, ECOHEALTH, V8, P109, DOI 10.1007/s10393-010-0356-4; Cebolla M, 1999, GENERALITAT CATALUNY, P86; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; Costa TP, 2010, AVIAN DIS, V54, P1286, DOI 10.1637/9480-072210-Reg.1; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; EC, 2007, EUR COMM AN DIS NOT; EC, 2009, EUR COMM AN DIS NOT; EC, 2008, EUR COMM AN DIS NOT; EC, 2006, EUR COMM AN DIS NOT; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; HALVORSON D, 1983, AVIAN DIS, V27, P77, DOI 10.2307/1590374; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henaux V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010997; Hesterberg U, 2007, ANN REPORT SURVEILLA; Hesterberg U., 2008, ANN REPORT SURVEILLA; Hesterberg U, 2009, INFLUENZA OTHER RESP, V3, P1, DOI 10.1111/j.1750-2659.2008.00058.x; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Krauss S, 2010, AVIAN DIS, V54, P394, DOI 10.1637/8703-031609-Review.1; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; SINNECKER R, 1983, ACTA VIROL, V27, P75; Stallknecht D. E., 2008, ECOLOGY AVIAN INFLUE, P43; Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x	35	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44354	10.1371/journal.pone.0044354	http://dx.doi.org/10.1371/journal.pone.0044354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952962	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500063
J	Wang, LB; Su, LF; Shen, H; Hu, DW				Wang, Lubin; Su, Longfei; Shen, Hui; Hu, Dewen			Decoding Lifespan Changes of the Human Brain Using Resting-State Functional Connectivity MRI	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DEFAULT NETWORK; QUANTITATIVE METAANALYSIS; DIMENSIONALITY REDUCTION; MOTOR-PERFORMANCE; FACE RECOGNITION; WHITE-MATTER; GRAY-MATTER; FMRI; REGRESSION	The development of large-scale functional brain networks is a complex, lifelong process that can be investigated using resting-state functional connectivity MRI (rs-fcMRI). In this study, we aimed to decode the developmental dynamics of the whole-brain functional network in seven decades (8-79 years) of the human lifespan. We first used parametric curve fitting to examine linear and nonlinear age effect on the resting human brain, and then combined manifold learning and support vector machine methods to predict individuals' "brain ages" from rs-fcMRI data. We found that age-related changes in interregional functional connectivity exhibited spatially and temporally specific patterns. During brain development from childhood to senescence, functional connections tended to linearly increase in the emotion system and decrease in the sensorimotor system; while quadratic trajectories were observed in functional connections related to higher-order cognitive functions. The complex patterns of age effect on the whole-brain functional network could be effectively represented by a low-dimensional, nonlinear manifold embedded in the functional connectivity space, which uncovered the inherent structure of brain maturation and aging. Regression of manifold coordinates with age further showed that the manifold representation extracted sufficient information from rs-fcMRI data to make prediction about individual brains' functional development levels. Our study not only gives insights into the neural substrates that underlie behavioral and cognitive changes over age, but also provides a possible way to quantitatively describe the typical and atypical developmental progression of human brain function using rs-fcMRI.	[Wang, Lubin; Su, Longfei; Shen, Hui; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Wang, LB (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/AAN-8511-2020; Hu, Dewen/D-1978-2015	Su, Longfei/0000-0003-0573-2756	National Basic Research Program of China [2011CB707802]; National High-Tech Program of China [2012AA011601]; National Science Foundation of China [90820304, 61003202]	National Basic Research Program of China(National Basic Research Program of China); National High-Tech Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB707802), the National High-Tech Program of China (2012AA011601), and the National Science Foundation of China (90820304, 61003202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brodersen KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002079; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fu Y, 2008, IEEE T MULTIMEDIA, V10, P578, DOI 10.1109/TMM.2008.921847; Gerber S, 2010, MED IMAGE ANAL, V14, P643, DOI 10.1016/j.media.2010.05.008; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guo GD, 2008, IEEE T IMAGE PROCESS, V17, P1178, DOI 10.1109/TIP.2008.924280; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hasan KM, 2007, NEUROREPORT, V18, P1735, DOI 10.1097/WNR.0b013e3282f0d40c; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; He XF, 2005, IEEE T PATTERN ANAL, V27, P328, DOI 10.1109/TPAMI.2005.55; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kochunov P, 2011, NEUROIMAGE, V58, P41, DOI 10.1016/j.neuroimage.2011.05.050; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Shen XL, 2008, NEUROIMAGE, V41, P886, DOI 10.1016/j.neuroimage.2008.02.051; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Su LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036147; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Williams LM, 2006, J NEUROSCI, V26, P6422, DOI 10.1523/JNEUROSCI.0022-06.2006; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	72	35	37	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44530	10.1371/journal.pone.0044530	http://dx.doi.org/10.1371/journal.pone.0044530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952990	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500076
J	Feng, S; Tian, EB; Zhang, L; Wang, QT; Deng, HT				Feng, Shan; Tian, Enbing; Zhang, Lei; Wang, Qingtao; Deng, Haiteng			Development of the Fc-III Tagged Protein Expression System for Protein Purification and Detection	PLOS ONE			English	Article							RECOMBINANT PROTEINS; FUSION PROTEINS; BINDING	In the present work, we developed the Fc-III tagged protein expression system for protein purification and detection. The Fc-III sequence encodes for a 13 residue peptide and this peptide is cyclized by disulfide bond formation when the fusion protein is expressed. The Fc-III-fusion proteins selectively bind to immunoglobulin Fc domains (IgG-Fc) expressed from E. coli. We showed the efficient purification of Fc-III tagged proteins by immobilized non-native IgG-Fc and the detection of the cellular locations of fusion proteins by fluorescent-conjugated IgG-Fc. Our results prove that Fc-III tagged protein expression system is a simple and efficient tool for protein purification and detection and is a useful addition to the biochemistry and proteomics toolbox.	[Feng, Shan; Zhang, Lei; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Tian, Enbing; Wang, Qingtao] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China	Tsinghua University; Capital Medical University	Feng, S (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	dht@mail.tsinghua.edu.cn		Deng, Haiteng/0000-0001-9496-1280	Center for Life Sciences (Tsinghua University); National Natural Science Foundation of China [30872391]; U.S. National Institutes of Health [U19 DE018385]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE018385] Funding Source: NIH RePORTER	Center for Life Sciences (Tsinghua University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the Center for Life Sciences (Tsinghua University), the National Natural Science Foundation of China (No.30872391), and U.S. National Institutes of Health grants (U19 DE018385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonyarattanakalin S, 2006, J AM CHEM SOC, V128, P11463, DOI 10.1021/ja062377w; Byers HL, 2009, J PROTEOMICS, V73, P231, DOI 10.1016/j.jprot.2009.09.002; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dias RLA, 2006, J AM CHEM SOC, V128, P2726, DOI 10.1021/ja057513w; HENGEN PN, 1995, TRENDS BIOCHEM SCI, V20, P285, DOI 10.1016/S0968-0004(00)89045-3; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; KARLSSON R, 1995, J IMMUNOL METHODS, V183, P43, DOI 10.1016/0022-1759(95)00030-E; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; POCKER Y, 1967, BIOCHEMISTRY-US, V6, P668, DOI 10.1021/bi00855a005; Sakamoto K, 2009, J BIOL CHEM, V284, P9986, DOI 10.1074/jbc.M807618200; Strambio-de-Castillia C, 2005, J PROTEOME RES, V4, P2250, DOI 10.1021/pr0501517; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; UHLEN M, 1992, Current Opinion in Biotechnology, V3, P363, DOI 10.1016/0958-1669(92)90164-E	14	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44208	10.1371/journal.pone.0044208	http://dx.doi.org/10.1371/journal.pone.0044208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952929	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000093
J	Huang, CC; Orvis, GD; Wang, Y; Behringer, RR				Huang, Cheng-Chiu; Orvis, Grant D.; Wang, Ying; Behringer, Richard R.			Stromal-to-Epithelial Transition during Postpartum Endometrial Regeneration	PLOS ONE			English	Article							STEM-CELLS; REPRODUCTIVE-TRACT; CANCER; IDENTIFICATION; POPULATION; EXPRESSION; REGRESSION; ESTROGEN; PTEN	Endometrium is the inner lining of the uterus which is composed of epithelial and stromal tissue compartments enclosed by the two smooth muscle layers of the myometrium. In women, much of the endometrium is shed and regenerated each month during the menstrual cycle. Endometrial regeneration also occurs after parturition. The cellular mechanisms that regulate endometrial regeneration are still poorly understood. Using genetic fate-mapping in the mouse, we found that the epithelial compartment of the endometrium maintains its epithelial identity during the estrous cycle and postpartum regeneration. However, whereas the stromal compartment maintains its identity during homeostatic cycling, after parturition a subset of stromal cells differentiates into epithelium that is subsequently maintained. These findings identify potential progenitor cells within the endometrial stromal compartment that produce long-term epithelial tissue during postpartum endometrial regeneration.	[Huang, Cheng-Chiu; Behringer, Richard R.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Huang, Cheng-Chiu; Orvis, Grant D.; Wang, Ying; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Huang, Cheng-Chiu; Wang, Ying; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Orvis, Grant D.; Behringer, Richard R.] Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Huang, CC (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	rrb@mdanderson.org			National Institutes of Health (NIH) [HD030284]; Ben F. Love Endowment; Kleberg Foundation; National Cancer Institute [CA09299]; NIH [CA16672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030284, R37HD030284] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009299, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ben F. Love Endowment; Kleberg Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant HD030284, the Ben F. Love Endowment, and the Kleberg Foundation to RRB. GDO was supported by National Cancer Institute T32 grant CA09299. Veterinary resources were supported by NIH grant CA16672. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Daikoku T, 2011, GYNECOL ONCOL, V122, P424, DOI 10.1016/j.ygyno.2011.04.022; Dharma S. J., 2001, Indian Journal of Experimental Biology, V39, P218; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Garry R, 2010, BJOG-INT J OBSTET GY, V117, P1175, DOI 10.1111/j.1471-0528.2010.02630.x; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; HE WW, 1993, DEV DYNAM, V196, P133, DOI 10.1002/aja.1001960207; Hu FF, 2010, REPROD SCI, V17, P629, DOI 10.1177/1933719110369180; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Kaitu'u-Lino TJ, 2007, ENDOCRINOLOGY, V148, P5105, DOI 10.1210/en.2007-0716; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Legue E, 2010, METHOD ENZYMOL, V477, P153, DOI 10.1016/S0076-6879(10)77010-5; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Memarzadeh S, 2010, P NATL ACAD SCI USA, V107, P17298, DOI 10.1073/pnas.1012548107; Miller C, 1998, DEVELOPMENT, V125, P3201; Rasweiler John J., 2000, P157, DOI 10.1016/B978-012195670-7/50006-0; Roy A, 2011, NAT REV ENDOCRINOL, V7, P517, DOI 10.1038/nrendo.2011.79; Sipos F, 2012, WORLD J GASTROENTERO, V18, P601, DOI 10.3748/wjg.v18.i7.601; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tanwar PS, 2011, CANCER RES, V71, P1584, DOI 10.1158/0008-5472.CAN-10-3166; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200	38	72	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44285	10.1371/journal.pone.0044285	http://dx.doi.org/10.1371/journal.pone.0044285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22970108	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800102
J	Ketchart, W; Smith, KM; Krupka, T; Wittmann, BM; Hu, Y; Rayman, PA; Doughman, YQ; Albert, JM; Bai, X; Finke, JH; Xu, Y; Exner, AA; Montano, MM				Ketchart, W.; Smith, K. M.; Krupka, T.; Wittmann, B. M.; Hu, Y.; Rayman, P. A.; Doughman, Y. Q.; Albert, J. M.; Bai, X.; Finke, J. H.; Xu, Y.; Exner, A. A.; Montano, M. M.			Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis	ONCOGENE			English	Article						HEXIM1; breast cancer; metastasis; angiogenesis	67-KDA LAMININ RECEPTOR; ENDOTHELIAL PROGENITOR CELLS; BREAST-CANCER; GROWTH-FACTOR; HEXAMETHYLENE BISACETAMIDE; TUMOR VASCULATURE; TGF-BETA; EXPRESSION; IDENTIFICATION; CHEMOTHERAPY	We report on the role of hexamethylene-bis-acetamide-inducible protein 1 (HEXIM1) as an inhibitor of metastasis. HEXIM1 expression is decreased in human metastatic breast cancers when compared with matched primary breast tumors. Similarly we observed decreased expression of HEXIM1 in lung metastasis when compared with primary mammary tumors in a mouse model of metastatic breast cancer, the polyoma middle T antigen (PyMT) transgenic mouse. Re-expression of HEXIM1 (through transgene expression or localized delivery of a small molecule inducer of HEXIM1 expression, hexamethylene-bis-acetamide) in PyMT mice resulted in inhibition of metastasis to the lung. Our present studies indicate that HEXIM1 downregulation of HIF-1 alpha protein allows not only for inhibition of vascular endothelial growth factor-regulated angiogenesis, but also for inhibition of compensatory proangiogenic pathways and recruitment of bone marrow-derived cells (BMDCs). Another novel finding is that HEXIM1 inhibits cell migration and invasion that can be partly attributed to decreased membrane localization of the 67 kDa laminin receptor, 67LR, and inhibition of the functional interaction of 67LR with laminin. Thus, HEXIM1 re-expression in breast cancer has therapeutic advantages by simultaneously targeting more than one pathway involved in angiogenesis and metastasis. Our results also support the potential for HEXIM1 to indirectly act on multiple cell types to suppress metastatic cancer.	[Ketchart, W.; Wittmann, B. M.; Hu, Y.; Doughman, Y. Q.; Montano, M. M.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Smith, K. M.; Xu, Y.] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Krupka, T.; Exner, A. A.] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA; [Rayman, P. A.; Finke, J. H.] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Albert, J. M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Bai, X.] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH USA	Case Western Reserve University; University System of Ohio; Cleveland State University; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Montano, MM (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, HG Wood Bldg W305,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mxm126@case.edu	Xu, Yan/AAW-4085-2021; Smith, Kerri/P-4609-2019; Smith, Kerri M/D-9878-2011; Albert, Jeffrey/P-7273-2019	Albert, Jeffrey/0000-0003-2245-1745; Exner, Agata/0000-0003-3913-7066; Smith, Kerri/0000-0001-5161-3278	National Institute of Health [CA92440, R01CA118399]; Chulalongkorn University in Thailand; National Science Foundation MRI [CHE-0923308]; US Department of Education GAANN [P200A070595-08]; NATIONAL CANCER INSTITUTE [R01CA092440, R01CA118399] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chulalongkorn University in Thailand; National Science Foundation MRI(National Science Foundation (NSF)); US Department of Education GAANN(US Department of Education); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health grants CA92440 grant to MMM and R01CA118399 to AAE. WK was supported by a Scholarship for the Development of New Faculty Staff from the Chulalongkorn University in Thailand. The HPLC-MS-MS instrument used for HMBA analysis was funded by National Science Foundation MRI grant (CHE-0923308) to YX. KS is supported by a US Department of Education GAANN grant (P200A070595-08) to YX.	Ahn GO, 2009, ANGIOGENESIS, V12, P159, DOI 10.1007/s10456-009-9135-7; Ardini E, 2002, CANCER RES, V62, P1321; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; CASTRONOVO V, 1993, INVAS METAST, V13, P1; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Gad HA, 2008, AAPS PHARMSCITECH, V9, P878, DOI 10.1208/s12249-008-9126-9; Gao D, 2009, TRENDS MOL MED, V15, P333, DOI 10.1016/j.molmed.2009.06.006; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Grepin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/835680; Gu YC, 2003, BLOOD, V101, P877, DOI 10.1182/blood-2002-03-0796; GUILBAUD NF, 1990, J CELL PHYSIOL, V145, P162, DOI 10.1002/jcp.1041450122; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoenig MR, 2008, CURR DRUG TARGETS, V9, P422, DOI 10.2174/138945008784221215; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang M, 2008, INT J BIOCHEM CELL B, V40, P2284, DOI 10.1016/j.biocel.2008.03.012; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Ketchart W, 2011, ONCOGENE, V30, P3563, DOI 10.1038/onc.2011.76; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Magnifico A, 1996, J BIOL CHEM, V271, P31179, DOI 10.1074/jbc.271.49.31179; Marks P A, 1978, Antibiot Chemother (1971), V23, P33; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Montuori N, 1996, CURR TOP MICROBIOL, V213, P205; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Ogba N, 2010, ONCOGENE, V29, P3639, DOI 10.1038/onc.2010.110; Ogba N, 2008, CANCER RES, V68, P7015, DOI 10.1158/0008-5472.CAN-08-0814; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Ravivarapu H B, 2000, AAPS PharmSciTech, V1, pE1, DOI 10.1208/pt010101; Relf M, 1997, CANCER RES, V57, P963; REUBEN RC, 1976, P NATL ACAD SCI USA, V73, P862, DOI 10.1073/pnas.73.3.862; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Seagroves TN, 2009, PHARMACEUTICAL PERSPECTIVES OF CANCER THERAPEUTICS, P521, DOI 10.1007/978-1-4419-0131-6_16; Selleri C, 2006, BLOOD, V108, P2476, DOI 10.1182/blood-2005-11-012625; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Siler U, 2000, BLOOD, V96, P4194; Smith KM, 2011, J CHROMATOGR B, V879, P2206, DOI 10.1016/j.jchromb.2011.06.002; Southard G L, 1998, Expert Opin Investig Drugs, V7, P1483, DOI 10.1517/13543784.7.9.1483; Taylor MA, 2011, GENE EXPRESSION, V15, P117, DOI 10.3727/105221611X13176664479322; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Viacava P, 1997, J PATHOL, V182, P36, DOI 10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Westwell AD, 2004, DRUG DISCOV TODAY, V9, P625, DOI 10.1016/S1359-6446(04)03162-9; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wittmann BM, 2003, CANCER RES, V63, P5151; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; YOUNG CW, 1988, CANCER RES, V48, P7304	62	25	25	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3829	3839		10.1038/onc.2012.405	http://dx.doi.org/10.1038/onc.2012.405			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22964639	Green Accepted			2022-12-25	WOS:000323210200005
J	Fujimori, H; Shikanai, M; Teraoka, H; Masutani, M; Yoshioka, K				Fujimori, Hiroaki; Shikanai, Mima; Teraoka, Hirobumi; Masutani, Mitsuko; Yoshioka, Ken-ichi			Induction of Cancerous Stem Cells during Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; STEM/PROGENITOR CELLS; CHECKPOINT; SENESCENCE; TUMORIGENICITY; TRANSFORMATION; PROLIFERATION; INSTABILITY; FIBROBLASTS; SENSITIVITY	Stem cell maintenance depends on their surrounding microenvironment, and aberrancies in the environment have been associated with tumorigenesis. However, it remains to be elucidated whether an environmental aberrancy can act as a carcinogenic stress for cellular transformation of differentiating stem cells into cancer stem cells. Here, utilizing mouse embryonic stem cells as a model, it was illustrated that environmental aberrancy during differentiation leads to the emergence of pluripotent cells showing cancerous characteristics. Analogous to precancerous stages, DNA lesions were spontaneously accumulated during embryonic stem cell differentiation under aberrational environments, which activates barrier responses such as senescence and apoptosis. However, overwhelming such barrier responses, piled-up spheres were subsequently induced from the previously senescent cells. The sphere cells exhibit aneuploidy and dysfunction of the Arf-p53 module as well as enhanced tumorigenicity and a strong self-renewal capacity, suggesting development of cancerous stem cells. Our current study suggests that stem cells differentiating in an aberrational environment are at risk of cellular transformation into malignant counterparts.	[Fujimori, Hiroaki; Masutani, Mitsuko; Yoshioka, Ken-ichi] Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, Tokyo 1040045, Japan; [Fujimori, Hiroaki; Shikanai, Mima; Teraoka, Hirobumi; Yoshioka, Ken-ichi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Chiyoda Ku, Tokyo 1010062, Japan	National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Yoshioka, K (corresponding author), Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kyoshiok@ncc.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan KAKENHI [20770136, 20659047]; Third Term Comprehensive 10-Year Strategy for Cancer Control [10103833]; National Cancer Center Research and Development Fund [23-C-10]	Ministry of Education, Culture, Sports, Science, and Technology of Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Third Term Comprehensive 10-Year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported, in whole or in part, by Ministry of Education, Culture, Sports, Science, and Technology of Japan KAKENHI (20770136, 20659047), Grant-in-aid and the Third Term Comprehensive 10-Year Strategy for Cancer Control (10103833), and the National Cancer Center Research and Development Fund (23-C-10).	Atsumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023432; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guachalla LM, 2010, CELL CYCLE, V9, P4058, DOI 10.4161/cc.9.20.13577; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; KIM JH, 1978, SCIENCE, V200, P206, DOI 10.1126/science.635582; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Kondoh H, 2005, CANCER RES, V65, P177; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Morange M, 2006, J BIOSCIENCES, V31, P537, DOI 10.1007/BF02708404; Nitou M, 2002, EXP CELL RES, V279, P330, DOI 10.1006/excr.2002.5615; Oh SKW, 2006, CLIN EXP PHARMACOL P, V33, P489, DOI 10.1111/j.1440-1681.2006.04397.x; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Smith JA, 2012, AGING DIS, V3, P260; Spierings DCJ, 2003, J PATHOL, V200, P137, DOI 10.1002/path.1373; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Werbowetski-Ogilvie TE, 2008, TRENDS MOL MED, V14, P323, DOI 10.1016/j.molmed.2008.06.005; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; WILES MV, 1991, DEVELOPMENT, V111, P259; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yang YM, 2008, CANCER INVEST, V26, P741, DOI 10.1080/07357900801901856; Yoshioka K, 2012, INT J MOL SCI, V13, P6492, DOI 10.3390/ijms13056492; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	49	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36777	36791		10.1074/jbc.M112.372557	http://dx.doi.org/10.1074/jbc.M112.372557			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961983	hybrid, Green Published			2022-12-25	WOS:000310588500015
J	Rogers, H; Lambers, JHR; Miller, R; Tewksbury, JJ				Rogers, Haldre; Lambers, Janneke Hille Ris; Miller, Ross; Tewksbury, Joshua J.			'Natural experiment' Demonstrates Top-Down Control of Spiders by Birds on a Landscape Level	PLOS ONE			English	Article							NIGHTINGALE REED-WARBLER; INSECTIVOROUS BIRDS; MARIANA SWIFTLET; TROPHIC CASCADE; NATIONAL-PARK; NEST SITES; WHITE-EYE; ORB WEBS; BEHAVIOR; ISLAND	The combination of small-scale manipulative experiments and large-scale natural experiments provides a powerful approach for demonstrating the importance of top-down trophic control on the ecosystem scale. The most compelling natural experiments have come from studies examining the landscape-scale loss of apex predators like sea otters, wolves, fish and land crabs. Birds are dominant apex predators in terrestrial systems around the world, yet all studies on their role as predators have come from small-scale experiments; the top-down impact of bird loss on their arthropod prey has yet to be examined at a landscape scale. Here, we use a unique natural experiment, the extirpation of insectivorous birds from nearly all forests on the island of Guam by the invasive brown tree snake, to produce the first assessment of the impacts of bird loss on their prey. We focused on spiders because experimental studies showed a consistent top-down effect of birds on spiders. We conducted spider web surveys in native forest on Guam and three nearby islands with healthy bird populations. Spider web densities on the island of Guam were 40 times greater than densities on islands with birds during the wet season, and 2.3 times greater during the dry season. These results confirm the general trend from manipulative experiments conducted in other systems however, the effect size was much greater in this natural experiment than in most manipulative experiments. In addition, bird loss appears to have removed the seasonality of spider webs and led to larger webs in at least one spider species in the forests of Guam than on nearby islands with birds. We discuss several possible mechanisms for the observed changes. Overall, our results suggest that effect sizes from smaller-scale experimental studies may significantly underestimate the impact of bird loss on spider density as demonstrated by this large-scale natural experiment.	[Rogers, Haldre; Lambers, Janneke Hille Ris; Tewksbury, Joshua J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Miller, Ross] Univ Guam, Western Pacific Trop Res Ctr, Mangilao, GU USA	University of Washington; University of Washington Seattle; University of Guam	Rogers, H (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	haldre@rice.edu		Rogers, Haldre/0000-0003-4763-5006; Tewksbury, Joshua/0000-0002-9786-1477	Budweiser Conservation Scholarship through the National Fish and Wildlife Foundation; University of Washington Department of Biology Giles Award; Howard Hughes Medical Institute undergraduate research fellowship; National Science Foundation Graduate Research Fellowship; National Science Foundation [DEB-0816465]; United States Department of Agriculture National Research Initiative [2008-03106]	Budweiser Conservation Scholarship through the National Fish and Wildlife Foundation; University of Washington Department of Biology Giles Award; Howard Hughes Medical Institute undergraduate research fellowship(Howard Hughes Medical Institute); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA))	This study was funded by the Budweiser Conservation Scholarship through the National Fish and Wildlife Foundation (HR), the University of Washington Department of Biology Giles Award (HR), Howard Hughes Medical Institute undergraduate research fellowship (to field assistant TK), National Science Foundation Graduate Research Fellowship (HR), National Science Foundation DEB-0816465, and United States Department of Agriculture National Research Initiative 2008-03106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amidon FA, 2004, WILSON BULL, V116, P342, DOI 10.1676/04-037; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; Beschta RL, 2005, ECOLOGY, V86, P391, DOI 10.1890/04-0964; Blackledge TA, 1999, BEHAV ECOL, V10, P372, DOI 10.1093/beheco/10.4.372; Blackledge TA, 2007, BIOL LETTERS, V3, P456, DOI 10.1098/rsbl.2007.0218; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Camp RJ, 2009, BIRD CONSERV INT, V19, P323, DOI 10.1017/S0959270909008417; Craig RJ, 1996, WILSON BULL, V108, P246; DIAMOND JM, 1983, NATURE, V304, P586, DOI 10.1038/304586a0; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Gruner DS, 2005, BIOL INVASIONS, V7, P541, DOI 10.1007/s10530-004-2509-2; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Guard C.P., 2003, CREATION 50 YEAR RAI; Gunnarsson B, 2007, J ARACHNOL, V35, P509, DOI 10.1636/RT07-64.1; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JANZEN DH, 1973, ECOLOGY, V54, P687, DOI 10.2307/1935359; Jenkins JM., 1983, NATIVE FOREST BIRDS; Kerr Alexander M., 1993, Pacific Science, V47, P328; Lander M.A., 2004, RAINFALL CLIMATOLOGY; Li DQ, 2004, ANIM BEHAV, V67, P309, DOI 10.1016/j.anbehav.2003.06.011; Mantyla E, 2011, OECOLOGIA, V165, P143, DOI 10.1007/s00442-010-1774-2; MARSHALL JOE T., 1949, CONDOR, V51, P200, DOI 10.2307/1364563; MARSHALL SD, 1989, WILSON BULL, V101, P472; Mooney KA, 2006, J ANIM ECOL, V75, P350, DOI 10.1111/j.1365-2656.2006.01054.x; Mooney KA, 2007, ECOLOGY, V88, P2005, DOI 10.1890/06-1095.1; Mosher SM, 2002, WILSON BULL, V114, P1, DOI 10.1676/0043-5643(2002)114[0001:DONEAN]2.0.CO;2; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reichel JD, 2007, WILSON J ORNITHOL, V119, P686, DOI 10.1676/06-132.1; ROBINSON MH, 1974, PAC INSECTS, V16, P117; RODDA G H, 1992, Pacific Science, V46, P46; Sagarin R, 2010, FRONT ECOL ENVIRON, V8, P379, DOI 10.1890/090001; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; SCHOENER TW, 1987, SCIENCE, V236, P949, DOI 10.1126/science.236.4804.949; SCHOENER TW, 1995, SCIENCE, V267, P1811, DOI 10.1126/science.267.5205.1811; Schoener TW, 1996, NATURE, V381, P691, DOI 10.1038/381691a0; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sekercioglu CH, 2002, BIOL CONSERV, V107, P229, DOI 10.1016/S0006-3207(02)00097-6; SPILLER DA, 1990, OECOLOGIA, V83, P150, DOI 10.1007/BF00317746; STINSON CM, 1994, J FIELD ORNITHOL, V65, P65; Terborgh J., 2010, TROPHIC CASCADES PRE; Valdez EW, 2011, PAC SCI, V65, P301, DOI 10.2984/65.3.301; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Van Bael SA, 2005, OECOLOGIA, V145, P658, DOI 10.1007/s00442-005-0134-0; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Wiles GJ, 2003, CONSERV BIOL, V17, P1350, DOI 10.1046/j.1523-1739.2003.01526.x	52	51	54	2	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43446	10.1371/journal.pone.0043446	http://dx.doi.org/10.1371/journal.pone.0043446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970126	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000002
J	Whitworth, WC; Hamilton, LR; Goodwin, DJ; Barrera, C; West, KB; Racster, L; Daniels, LJ; Chuke, SO; Campbell, BH; Bohanon, J; Jaffar, AT; Drane, W; Maserang, D; Mazurek, GH				Whitworth, William C.; Hamilton, Lanette R.; Goodwin, Donald J.; Barrera, Carlos; West, Kevin B.; Racster, Laura; Daniels, Laura J.; Chuke, Stella O.; Campbell, Brandon H.; Bohanon, Jamaria; Jaffar, Atheer T.; Drane, Wanzer; Maserang, David; Mazurek, Gerald H.			Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; INTERFERON-GAMMA RESPONSES; HEALTH-CARE WORKERS; RELEASE ASSAYS; REPRODUCIBILITY; CONVERSIONS; GUIDELINES	Background: The QuantiFERON (R)-TB Gold In-Tube test (QFT-GIT) is a viable alternative to the tuberculin skin test (TST) for detecting Mycobacterium tuberculosis infection. However, within-subject variability may limit test utility. To assess variability, we compared results from the same subjects when QFT-GIT enzyme-linked immunosorbent assays (ELISAs) were performed in different laboratories. Methods: Subjects were recruited at two sites and blood was tested in three labs. Two labs used the same type of automated ELISA workstation, 8-point calibration curves, and electronic data transfer. The third lab used a different automated ELISA workstation, 4-point calibration curves, and manual data entry. Variability was assessed by interpretation agreement and comparison of interferon-gamma (IFN-gamma) measurements. Data for subjects with discordant interpretations or discrepancies in TB Response >0.05 IU/mL were verified or corrected, and variability was reassessed using a reconciled dataset. Results: Ninety-seven subjects had results from three labs. Eleven (11.3%) had discordant interpretations and 72 (74.2%) had discrepancies >0.05 IU/mL using unreconciled results. After correction of manual data entry errors for 9 subjects, and exclusion of 6 subjects due to methodological errors, 7 (7.7%) subjects were discordant. Of these, 6 (85.7%) had all TB Responses within 0.25 IU/mL of the manufacturer's recommended cutoff. Non-uniform error of measurement was observed, with greater variation in higher IFN-gamma measurements. Within-subject standard deviation for TB Response was as high as 0.16 IU/mL, and limits of agreement ranged from -0.46 to 0.43 IU/mL for subjects with mean TB Response within 0.25 IU/mL of the cutoff. Conclusion: Greater interlaboratory variability was associated with manual data entry and higher IFN-gamma measurements. Manual data entry should be avoided. Because variability in measuring TB Response may affect interpretation, especially near the cutoff, consideration should be given to developing a range of values near the cutoff to be interpreted as "borderline," rather than negative or positive.	[Whitworth, William C.; Daniels, Laura J.; Chuke, Stella O.; Campbell, Brandon H.; Mazurek, Gerald H.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA; [Hamilton, Lanette R.; Barrera, Carlos] Tripler Army Med Ctr, Dept Med, Honolulu, HI 96859 USA; [Goodwin, Donald J.; Racster, Laura; Bohanon, Jamaria; Jaffar, Atheer T.] USAF, Sch Aerosp Med, Epidemiol Serv Branch, Brooks City Base, TX USA; [West, Kevin B.] Wilford Hall USAF Med Ctr, Reid Clin, Dept Occupat Med TB Prevent Deployment Med, Lackland AFB, TX 78236 USA; [Daniels, Laura J.; Bohanon, Jamaria; Jaffar, Atheer T.] CDC Fdn, Atlanta, GA USA; [Chuke, Stella O.] Northrop Grumman Informat Syst Sect, Atlanta, GA USA; [Drane, Wanzer] Univ S Carolina, Columbia, SC 29208 USA; [Maserang, David] USAF, Sch Aerosp Med, Appl Technol Ctr, Brooks City Base, TX USA	Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army; United States Department of Defense; United States Air Force; United States Department of Defense; United States Air Force; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; United States Department of Defense; United States Air Force	Whitworth, WC (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA.	wcw2@cdc.gov			United States Air Force (USAF)	United States Air Force (USAF)	The United States Air Force (USAF) funded this study as part of a larger project assessing reproducibility of the QuantiFERON-TB Gold In-Tube tests. The USAF and the Centers for Disease Control and Prevention (CDC) reviewed the study design, data collection methods, and analysis plans prior to approval. The USAF, U. S. Army, and CDC cleared the manuscript for publication according to established guidelines. No outside funders had a role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Atkinson G, 2000, SPORTS MED, V30, P375, DOI 10.2165/00007256-200030050-00005; Baker CA, 2009, AM J TROP MED HYG, V80, P628, DOI 10.4269/ajtmh.2009.80.628; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Belknap R, 2009, AM J RESP CRIT CARE, V179; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bland JM., 2006, SHOULD I CALCULATE W; Cellestis, 2009, QUANTIFERON TB GOLD; Costa JT, 2010, REV PORT PNEUMOL, V16, P211, DOI 10.1016/S0873-2159(15)30022-2; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Doberne D, 2011, J CLIN MICROBIOL, V49, P3061, DOI 10.1128/JCM.01136-11; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P1146; Lu L, 2007, NE SAS USERS GROUP 2; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262; Pollock NR, 2009, INFECT CONT HOSP EP, V30, P392, DOI 10.1086/596606; Powell RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020061; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Zwerling AA, 2009, AM J RESP CRIT CARE, V179; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	34	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43790	10.1371/journal.pone.0043790	http://dx.doi.org/10.1371/journal.pone.0043790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970142	Green Published, gold			2022-12-25	WOS:000308458400019
J	Heath, JP; Montevecchi, WA; Esler, D				Heath, Joel P.; Montevecchi, William A.; Esler, Daniel			A Method for Quantifying Consistency in Animal Distributions Using Survey Data	PLOS ONE			English	Article							HABITAT SELECTION; ECOLOGY; DISPERSAL; PHILOPATRY; LANDSCAPES; DENSITY; QUALITY; SCALES; BIRDS; PREY	The degree of consistency with which groups of animals use the landscape is determined by a variety of ecological processes that influence their movements and patterns of habitat use. We developed a technique termed Distributional Consistency that uses survey data of unmarked individuals to quantify temporal consistency in their spatial distribution, while accounting for changes in population size. Distributional consistency is quantified by comparing the observed distribution patterns to all theoretically possible distribution patterns of observed individuals, leading to a proportional score between 0 and 1, reflecting increasingly consistent use of sites within a region. The technique can be applied to survey data for any taxa across a range of spatial and temporal scales. We suggest ways in which distributional consistency could provide inferences about the dispersal and habitat decisions of individuals, and the scales at which these decisions operate. Distributional consistency integrates spatial and temporal processes to quantify an important characteristic of different habitats and their use by populations, which in turn will be particularly useful in complimenting and interpreting other ecological measures such as population density and stability. The technique can be applied to many existing data sets to investigate and evaluate a range of important ecological questions using simple survey data.	[Heath, Joel P.] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Montevecchi, William A.] Mem Univ Newfoundland, Cognit & Behav Ecol Programme, St John, NF, Canada; [Esler, Daniel] Simon Fraser Univ, Ctr Wildlife Ecol, Delta, BC, Canada	University of British Columbia; Memorial University Newfoundland; Simon Fraser University	Heath, JP (corresponding author), Univ British Columbia, Dept Math, Vancouver, BC, Canada.	heath.joel@gmail.com			Memorial University of Newfoundland graduate fellowship; National Sciences and Engineering Research Council of Canada (NSERC) PGS-B Fellowship	Memorial University of Newfoundland graduate fellowship; National Sciences and Engineering Research Council of Canada (NSERC) PGS-B Fellowship	Funding to JPH was provided by a Memorial University of Newfoundland graduate fellowship and a National Sciences and Engineering Research Council of Canada (NSERC) PGS-B Fellowship (www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson Michael G., 1992, P365; Clark RG, 2004, CONDOR, V106, P717, DOI 10.1650/7644; Davoren GK, 2003, MAR ECOL PROG SER, V256, P229, DOI 10.3354/meps256229; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Heath JP, 2006, CAN J ZOOL, V84, P855, DOI 10.1139/Z06-059; Heath JP, 2006, OIKOS, V115, P573; Heath JP, 2001, THESIS MEMORIAL U NE; Hines, 2017, OCCUPANCY ESTIMATION; Jones WT, 1988, ECOLOGY, V69, P1475; Kendall WL, 2004, CONDOR, V106, P720, DOI 10.1650/7630; Kirk M, 2008, OECOLOGIA, V155, P859, DOI 10.1007/s00442-007-0947-0; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Newton I., 1998, POPULATION LIMITATIO; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Schneider D. C., 1994, QUANTITATIVE ECOLOGY; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; SKEEL MA, 1983, CAN J ZOOL, V61, P218, DOI 10.1139/z83-027; Sokal R. R., 2012, BIOMETRY; Sutherland W.J., 1996, OXFORD SERIES ECOLOG; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; White G.C., 1990, ANAL WILDLIFE RADIO; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; [No title captured]	28	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44353	10.1371/journal.pone.0044353	http://dx.doi.org/10.1371/journal.pone.0044353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957067	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000308463800060
J	Picardi, E; Gallo, A; Galeano, F; Tomaselli, S; Pesole, G				Picardi, Ernesto; Gallo, Angela; Galeano, Federica; Tomaselli, Sara; Pesole, Graziano			A Novel Computational Strategy to Identify A-to-I RNA Editing Sites by RNA-Seq Data: De Novo Detection in Human Spinal Cord Tissue	PLOS ONE			English	Article							MESSENGER-RNA; PARALLEL DNA; INOSINE RNA; TRANSCRIPT; DIVERSIFICATION; IDENTIFICATION; DIVERSITY; EVOLUTION; ADENOSINE; REVEALS	RNA editing is a post-transcriptional process occurring in a wide range of organisms. In human brain, the A-to-I RNA editing, in which individual adenosine (A) bases in pre-mRNA are modified to yield inosine (I), is the most frequent event. Modulating gene expression, RNA editing is essential for cellular homeostasis. Indeed, its deregulation has been linked to several neurological and neurodegenerative diseases. To date, many RNA editing sites have been identified by next generation sequencing technologies employing massive transcriptome sequencing together with whole genome or exome sequencing. While genome and transcriptome reads are not always available for single individuals, RNA-Seq data are widespread through public databases and represent a relevant source of yet unexplored RNA editing sites. In this context, we propose a simple computational strategy to identify genomic positions enriched in novel hypothetical RNA editing events by means of a new two-steps mapping procedure requiring only RNA-Seq data and no a priori knowledge of RNA editing characteristics and genomic reads. We assessed the suitability of our procedure by confirming A-to-I candidates using conventional Sanger sequencing and performing RNA-Seq as well as whole exome sequencing of human spinal cord tissue from a single individual.	[Picardi, Ernesto; Pesole, Graziano] Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, Bari, Italy; [Picardi, Ernesto; Pesole, Graziano] CNR, Ist Biomembrane & Bioenerget, I-70126 Bari, Italy; [Gallo, Angela; Galeano, Federica; Tomaselli, Sara] Osped Pediat Bambino Gesu, IRCCS, Oncohaematol Dept, RNA Editing Lab, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); IRCCS Bambino Gesu	Picardi, E (corresponding author), Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, Bari, Italy.	graziano.pesole@uniba.it	Pesole, Graziano/E-9051-2014; Gallo, Angela/AAA-5003-2020; Pesole, Graziano/C-1408-2009; Pesole, Graziano/K-5283-2019; Picardi, Ernesto/A-5863-2015; Gallo, Angela/E-7837-2011	Pesole, Graziano/0000-0003-3663-0859; Gallo, Angela/0000-0003-0297-1807; Pesole, Graziano/0000-0003-3663-0859; Picardi, Ernesto/0000-0002-6549-0114; Gallo, Angela/0000-0003-0297-1807	Ministero dell'Istruzione, Universita e Ricerca" (MIUR, Italy): "Laboratorio Internazionale di Bioinformatica", "Laboratorio di Bioinformatica per la Biodiversita Molecolare" [DM19410]; Consiglio Nazionale delle Ricerche: Flagship Project "Epigen"; PNR-CNR; Center of Excellence in Genomics (CEGBA, Italy); Italian Research Foundation for amyotrophic lateral sclerosis (AriSLA); Italian Ministry for Foreign Affairs (Italy-Israel actions)	Ministero dell'Istruzione, Universita e Ricerca" (MIUR, Italy): "Laboratorio Internazionale di Bioinformatica", "Laboratorio di Bioinformatica per la Biodiversita Molecolare"; Consiglio Nazionale delle Ricerche: Flagship Project "Epigen"; PNR-CNR; Center of Excellence in Genomics (CEGBA, Italy); Italian Research Foundation for amyotrophic lateral sclerosis (AriSLA); Italian Ministry for Foreign Affairs (Italy-Israel actions)	This work was supported by "Ministero dell'Istruzione, Universita e Ricerca" (MIUR, Italy): "Laboratorio Internazionale di Bioinformatica", "Laboratorio di Bioinformatica per la Biodiversita Molecolare" (Project DM19410), "PRIN 2009"; Consiglio Nazionale delle Ricerche: Flagship Project "Epigen", PNR-CNR Aging Program 2012-2014, the Center of Excellence in Genomics (CEGBA, Italy), Italian Research Foundation for amyotrophic lateral sclerosis (AriSLA), and by Italian Ministry for Foreign Affairs (Italy-Israel actions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2011, GENOME RES; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chepelev I, 2012, METHODS MOL BIOL, V815, P91, DOI 10.1007/978-1-61779-424-7_8; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Gray MW, 2003, IUBMB LIFE, V55, P227, DOI 10.1080/1521654031000119425; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Irimia M, 2012, RNA BIOL, V9, P12, DOI 10.4161/rna.9.1.18387; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas Stefan, 2006, RNA Biol, V3, P1; Martelli PL, 2011, NUCLEIC ACIDS RES, V39, pD80, DOI 10.1093/nar/gkq1073; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2007, REDIDB RNA EDITING D; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Picardi E, 2011, BIOINFORMATICS, V27, P1311, DOI 10.1093/bioinformatics/btr117; Picardi E, 2011, MITOCHONDRION, V11, P360, DOI 10.1016/j.mito.2010.10.005; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wulff BE, 2010, WIRES RNA, V1, P90, DOI 10.1002/wrna.10; Wulff BE, 2011, NAT REV GENET, V12, P81, DOI 10.1038/nrg2915	49	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44184	10.1371/journal.pone.0044184	http://dx.doi.org/10.1371/journal.pone.0044184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957051	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800043
J	Ramos-Sevillano, E; Rodriguez-Sosa, C; Cafini, F; Gimenez, MJ; Navarro, A; Sevillano, D; Alou, L; Garcia, E; Aguilar, L; Yuste, J				Ramos-Sevillano, Elisa; Rodriguez-Sosa, Cinthya; Cafini, Fabio; Gimenez, Maria-Jose; Navarro, Ana; Sevillano, David; Alou, Luis; Garcia, Ernesto; Aguilar, Lorenzo; Yuste, Jose			Cefditoren and Ceftriaxone Enhance Complement-Mediated Immunity in the Presence of Specific Antibodies against Antibiotic-Resistant Pneumococcal Strains	PLOS ONE			English	Article							C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE INFECTION; MOUSE SEPSIS MODEL; STAPHYLOCOCCUS-AUREUS; 2 PARTS; PHAGOCYTOSIS; CHILDREN; PATHWAY; DISEASE; POLYSACCHARIDES	Background: Specific antibodies mediate humoral and cellular protection against invading pathogens such as Streptococcus pneumoniae by activating complement mediated immunity, promoting phagocytosis and stimulating bacterial clearance. The emergence of pneumococcal strains with high levels of antibiotic resistance is of great concern worldwide and a serious threat for public health. Methodology/Principal Findings: Flow cytometry was used to determine whether complement-mediated immunity against three antibiotic-resistant S. pneumoniae clinical isolates is enhanced in the presence of sub-inhibitory concentrations of cefditoren and ceftriaxone. The binding of acute phase proteins such as C-reactive protein and serum amyloid P component, and of complement component C1q, to pneumococci was enhanced in the presence of serum plus either of these antibiotics. Both antibiotics therefore trigger the activation of the classical complement pathway against S. pneumoniae. C3b deposition was also increased in the presence of specific anti-pneumococcal antibodies and sub-inhibitory concentrations of cefditoren and ceftriaxone confirming that the presence of these antibiotics enhances complement-mediated immunity to S. pneumoniae. Conclusions/Significance: Using cefditoren and ceftriaxone to promote the binding of acute phase proteins and C1q to pneumococci, and to increase C3b deposition, when anti-pneumococcal antibodies are present, might help reduce the impact of antibiotic resistance in S. pneumoniae infections.	[Ramos-Sevillano, Elisa; Garcia, Ernesto; Yuste, Jose] CSIC, Ctr Invest Biol, Madrid, Spain; [Ramos-Sevillano, Elisa; Garcia, Ernesto; Yuste, Jose] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Rodriguez-Sosa, Cinthya; Navarro, Ana; Yuste, Jose] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Cafini, Fabio; Gimenez, Maria-Jose; Sevillano, David; Alou, Luis; Aguilar, Lorenzo] Univ Complutense, Fac Med, Dept Microbiol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Complutense University of Madrid	Ramos-Sevillano, E (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	jyuste@isciii.es	Alou, Luis/B-8170-2011; Cafini, Fabio/AAA-7938-2020; YUSTE, JOSE/ABG-9851-2020; Gimenez, Maria Jose/GXF-2237-2022; Sevillano, David/G-5661-2010; Sevillano, Elisa Ramos/J-4824-2016	Alou, Luis/0000-0002-0859-008X; Cafini, Fabio/0000-0002-5442-1674; Gimenez, Maria Jose/0000-0003-0830-4095; Sevillano, Elisa Ramos/0000-0003-0803-2755; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; YUSTE, JOSE/0000-0001-7996-0837; Sevillano Fernandez, David/0000-0003-0212-2194	Direccion General de Investigacion Cientifica y Tecnica [SAF2009-10824]; ISCIII [MPY 1350/10]; Tedec-Meiji Farma S.A. (Madrid, Spain); FPU fellowship from Ministerio de Ciencia e Innovacion; MAEC-AECID	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII(Instituto de Salud Carlos III); Tedec-Meiji Farma S.A. (Madrid, Spain); FPU fellowship from Ministerio de Ciencia e Innovacion; MAEC-AECID	This work was supported by grants SAF2009-10824 from Direccion General de Investigacion Cientifica y Tecnica, MPY 1350/10 from ISCIII and an unrestricted educational grant from Tedec-Meiji Farma S.A. (Madrid, Spain). Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) is an initiative of the ISCIII. E.R-S. was supported by an FPU fellowship from Ministerio de Ciencia e Innovacion and C. R-S was supported by a fellowship from MAEC-AECID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2004, CHEST, V125, P1335, DOI 10.1378/chest.125.4.1335; Baxendale HE, 2008, CLIN EXP IMMUNOL, V151, P51, DOI 10.1111/j.1365-2249.2007.03535.x; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Cafini F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012041; Casal J, 2002, ANTIMICROB AGENTS CH, V46, P1340, DOI 10.1128/AAC.46.5.1340-1344.2002; DARVEAU RP, 1990, J INFECT DIS, V162, P914, DOI 10.1093/infdis/162.4.914; Du Clos TW, 2001, CURR OPIN INFECT DIS, V14, P289, DOI 10.1097/00001432-200106000-00007; FENOLL A, 1991, REV INFECT DIS, V13, P56; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jansen WTM, 2004, INDIAN J MED RES, V119, P7; Johnson Heather L., 1999, Journal of Microbiology Immunology and Infection, V32, P73; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Jung E, 1998, AM J MED SCI, V315, P307, DOI 10.1097/00000441-199805000-00004; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Labro MT, 2000, CLIN MICROBIOL REV, V13, P615, DOI 10.1128/CMR.13.4.615-650.2000; McCullers JA, 2001, FRONT BIOSCI-LANDMRK, V6, pD877, DOI 10.2741/McCullers; MILATOVIC D, 1983, EUR J CLIN MICROBIOL, V2, P414, DOI 10.1007/BF02013898; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; Mold C, 2001, J IMMUNOL, V166, P1200, DOI 10.4049/jimmunol.166.2.1200; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ramos-Sevillano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023626; Soriano F, 2008, J ANTIMICROB CHEMOTH, V62, P1234, DOI 10.1093/jac/dkn392; Subrt N, 2011, J ANTIMICROB CHEMOTH, V66, P979, DOI 10.1093/jac/dkr043; Thomas-Rudolph D, 2007, J IMMUNOL, V178, P7283, DOI 10.4049/jimmunol.178.11.7283; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; VANDAM JEG, 1990, ANTON LEEUW INT J G, V58, P1; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WILLIAMS P, 1987, ANTIMICROB AGENTS CH, V31, P758, DOI 10.1128/AAC.31.5.758; Yuste J, 2002, CLIN EXP IMMUNOL, V128, P411, DOI 10.1046/j.1365-2249.2002.01860.x; Yuste J, 2001, J ANTIMICROB CHEMOTH, V48, P594, DOI 10.1093/jac/48.4.594; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08	38	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44135	10.1371/journal.pone.0044135	http://dx.doi.org/10.1371/journal.pone.0044135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957048	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800040
J	Chu, K; Cortier, H; Maldonado, F; Mashant, T; Ford, N; Trelles, M				Chu, Kathryn; Cortier, Hilde; Maldonado, Fernando; Mashant, Tshiteng; Ford, Nathan; Trelles, Miguel			Cesarean Section Rates and Indications in Sub-Saharan Africa: A Multi-Country Study from Medecins sans Frontieres	PLOS ONE			English	Article							DELIVERY; CARE	Objectives: The World Health Organization considers Cesarean section rates of 5-15% to be the optimal range for targeted provision of this life saving intervention. However, access to safe Cesarean section in resource-limited settings is much lower, estimated at 1-2% reported in sub-Saharan Africa. This study reports Cesarean sections rates and indications in Democratic Republic of Congo, Burundi, and Sierra Leone, and describe the main parameters associated with maternal and early neonatal mortality. Methods: Women undergoing Cesarean section from August 1 2010 to January 31 2011 were included in this prospective study. Logistic regression was used to model determinants of maternal and early neonatal mortality. Results: 1276 women underwent a Cesarean section, giving a frequency of 6.2% (range 4.1-16.8%). The most common indications were obstructed labor (399, 31%), poor presentation (233, 18%), previous Cesarean section (184, 14%), and fetal distress (128, 10%), uterine rupture (117, 9%) and antepartum hemorrhage (101, 8%). Parity >6 (adjusted odds ratio [aOR] = 8.6, P = 0.015), uterine rupture (aOR = 20.5; P = .010), antepartum hemorrhage (aOR = 13.1; P = .045), and pre-eclampsia/eclampsia (aOR = 42.9; P = .017) were associated with maternal death. Uterine rupture (aOR = 6.6, P < 0.001), anterpartum hemorrhage (aOR = 3.6, P < 0.001), and cord prolapse (aOR = 2.7, P = 0.017) were associated with early neonatal death. Conclusions: This study demonstrates that target Cesarean section rates can be achieved in sub-Saharan Africa. Identifying the common indications for Cesarean section and associations with mortality can target improvements in antenatal services and emergency obstetric care.	[Chu, Kathryn; Ford, Nathan] Med Sans Frontieres, Johannesburg, South Africa; [Chu, Kathryn] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Chu, Kathryn] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA; [Cortier, Hilde; Trelles, Miguel] Med Sans Frontieres, Dept Med, Brussels, Belgium; [Maldonado, Fernando] Med Sans Frontieres, Kinshasa, DEM REP CONGO; [Mashant, Tshiteng] Med Sans Frontieres, Bujumbura, Burundi; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	Johns Hopkins University; Johns Hopkins University; Doctors Without Borders; University of Cape Town	Chu, K (corresponding author), Med Sans Frontieres, Johannesburg, South Africa.	kathryn.chu@joburg.msf.org						[Anonymous], 1985, LANCET, V2, P436; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; Dolea C., 2003, GLOBAL BURDEN OBSTRU; Douangphachanh X, 2010, BIOSCI TRENDS, V4, P318; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Guise JM, 2004, OBSTET GYNECOL, V103, P420, DOI 10.1097/01.AOG.0000116259.41678.f1; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Koonin L M, 1997, MMWR CDC Surveill Summ, V46, P17; Okonta P I, 2002, J Obstet Gynaecol, V22, P626, DOI 10.1080/0144361021000020394; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Stanton C, 2008, BIRTH-ISS PERINAT C, V35, P204, DOI 10.1111/j.1523-536X.2008.00241.x; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Weil O, 1999, LANCET, V354, P940, DOI 10.1016/S0140-6736(99)02369-7; WHO, 2010, TRENDS MAT MORT 1990	15	74	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44484	10.1371/journal.pone.0044484	http://dx.doi.org/10.1371/journal.pone.0044484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22962616	gold, Green Published			2022-12-25	WOS:000308577600061
J	Xia, HP; Ooi, LLPJ; Hui, KM				Xia, Hongping; Ooi, London Lucien P. J.; Hui, Kam M.			MiR-214 Targets beta-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							E-CADHERIN; MICRORNA EXPRESSION; UP-REGULATION; PROTEIN EZH2; CANCER; GROWTH; CELLS; REPRESSION; IDENTIFICATION; ASSOCIATION	The down-regulation of miR-214 has previously been observed in human hepatocellular carcinoma (HCC). Here, we demonstrated the down-regulation of miR-214 is associated with cell invasion, stem-like traits and early recurrence of HCC. Firstly, we validated the suppression of miR-214 in human HCC by real-time quantitative RT-PCR (qRT-PCR) in 20 paired tumor and non-tumor liver tissues of HCC patients and 10 histologically normal liver tissues from colorectal cancer patients with liver metastases. Further qRT-PCR analysis of 50 HCC tissues from an independent cohort of HCC patients of whom 29 with early recurrent disease (<2 years) and 21 with late recurrent disease demonstrated that the suppression of miR-214 was significantly more suppressed in samples from HCC patients with early recurrent disease compared those from patients with no recurrence. Re-expression of miR-214 significantly suppressed the growth of HCC cells in vitro and reduced their tumorigenicity in vivo. The enhancer of zeste homologue 2 (EZH2) and beta-catenin (CTNNB1) was identified as two potential direct downstream targets of miR-214 through bioinformatics analysis and experimentally validated the miRNA-target interactions with a dual-firefly luciferase reporter assay. In corroborate with this, both EZH2 and CTNNB1 are found to be significantly overexpressed in human HCC biopsies. Since EZH2 can regulate CTNNB1, CTNNB1 can also be an indirect target of miR-214 through EZH2. Silencing EZH2 or CTNNB1 expression suppressed the growth and invasion of HCC cells and induced E-cadherin (CDH1), known to inhibit cell invasion and metastasis. Furthermore, the silencing of miR-214 or overexpression of EZH2 increased EpCAM(+) stem-like cells through the activation of CTNNB1. Interestingly, the up-regulation of EZH2, CTNNB1 and the down-regulation of CDH1 in HCC patients correlated with early recurrent disease and can be an independent predictor of poor survival. Therefore, miR-214 can directly or indirectly target CTNNB1 to modulate the beta-catenin signaling pathway in HCC.	[Xia, Hongping; Hui, Kam M.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Bek Chai Heah Lab Canc Genom, Singapore, Singapore; [Ooi, London Lucien P. J.] Singapore Gen Hosp, Dept Surg Oncol, Singapore 0316, Singapore; [Hui, Kam M.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Hui, Kam M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Hui, Kam M.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Xia, HP (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Bek Chai Heah Lab Canc Genom, Singapore, Singapore.	cmrhkm@nccs.com.sg	Ooi, London Lucien/AGK-1395-2022; XIA, HONGPING/AAK-7100-2020		National Medical Research Council; Biomedical Research Council of Singapore; Singapore Millennium Foundation	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation(Singapore Millennium Foundation)	This work was supported by by grants from the National Medical Research Council, Biomedical Research Council of Singapore and The Singapore Millennium Foundation, http://www.nmrc.gov.sg/content/nmrc_internet/home.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Babashah S, 2011, EUR J CANCER, V47, P1127, DOI 10.1016/j.ejca.2011.02.008; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar-Eli M, 2011, EMBO J, V30, P1880, DOI 10.1038/emboj.2011.132; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Law PTY, 2011, J GASTROEN HEPATOL, V26, P437, DOI 10.1111/j.1440-1746.2010.06512.x; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Oishi N, 2011, INT J BIOL SCI, V7, P517, DOI 10.7150/ijbs.7.517; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pei YF, 2009, ACTA BIOCH BIOPH SIN, V41, P1, DOI 10.1093/abbs/gmn001; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang SM, 2011, CLIN CANCER RES, V17, P6040, DOI 10.1158/1078-0432.CCR-11-0557; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469	48	129	134	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44206	10.1371/journal.pone.0044206	http://dx.doi.org/10.1371/journal.pone.0044206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962603	gold, Green Submitted, Green Published			2022-12-25	WOS:000308577600031
J	Liu, JN; Hettmer, S; Milsom, MD; Hofmann, I; Hua, F; Miller, C; Bronson, RT; Wagers, AJ				Liu, Jianing; Hettmer, Simone; Milsom, Michael D.; Hofmann, Inga; Hua, Frederic; Miller, Christine; Bronson, Roderick T.; Wagers, Amy J.			Induction of Histiocytic Sarcoma in Mouse Skeletal Muscle	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; GRANULOCYTIC SARCOMA; ONCOGENIC KRAS; EXTRAMEDULLARY LEUKEMIA; TUMOR SUPPRESSION; MICE; INK4A/ARF; CANCER; CD47	Myeloid sarcomas are extramedullary accumulations of immature myeloid cells that may present with or without evidence of pathologic involvement of the bone marrow or peripheral blood, and often coincide with or precede a diagnosis of acute myeloid leukemia (AML). A dearth of experimental models has hampered the study of myeloid sarcomas and led us to establish a new system in which tumor induction can be evaluated in an easily accessible non-hematopoietic tissue compartment. Using ex-vivo transduction of oncogenic Kras(G12V) into p16/p19(-/-) bone marrow cells, we generated transplantable leukemia-initiating cells that rapidly induced tumor formation in the skeletal muscle of immunocompromised NOD. SCID mice. In this model, murine histiocytic sarcomas, equivalent to human myeloid sarcomas, emerged at the injection site 30-50 days after cell implantation and consisted of tightly packed monotypic cells that were CD48+, CD47+ and Mac1+, with low or absent expression of other hematopoietic lineage markers. Tumor cells also infiltrated the bone marrow, spleen and other non-hematopoietic organs of tumor-bearing animals, leading to systemic illness (leukemia) within two weeks of tumor detection. P16/p19(-/-); Kras(G12V) myeloid sarcomas were multi-clonal, with dominant clones selected during secondary transplantation. The systemic leukemic phenotypes exhibited by histiocytic sarcoma-bearing mice were nearly identical to those of animals in which leukemia was introduced by intravenous transplantation of the same donor cells. Moreover, murine histiocytic sarcoma could be similarly induced by intramuscular injection of MLL-AF9 leukemia cells. This study establishes a novel, transplantable model of murine histiocytic/myeloid sarcoma that recapitulates the natural progression of these malignancies to systemic disease and indicates a cell autonomous leukemogenic mechanism.	[Liu, Jianing; Hettmer, Simone; Hua, Frederic; Miller, Christine; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Liu, Jianing; Hettmer, Simone; Hua, Frederic; Miller, Christine; Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA USA; [Hettmer, Simone; Hofmann, Inga] Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hettmer, Simone; Hofmann, Inga] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Milsom, Michael D.] HI STEM Heidelberg Inst Stem Cell Technol & Expt, Heidelberg, Germany; [Milsom, Michael D.] DKFZ German Canc Res Ctr, Heidelberg, Germany; [Bronson, Roderick T.] Tufts Univ, Sch Vet Med, Cumming Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Tufts University	Liu, JN (corresponding author), Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	amy_wagers@harvard.edu	Milsom, Michael/AAK-4600-2020	/0000-0002-3567-254X; Hettmer, Simone/0000-0003-1709-4448	Harvard Stem Cell Institute; National Institutes of Health (NIH) [1RO1 HL088582, HL088582-01S1]; Hope Street Kids; P.A.L.S. Bermuda/St. Baldrick's; ALSF; Bear Necessities; Spitzencluster "Molecular and Cell Based Medicine"; German Bundesministerium fur Bildung and Forschung (BMBF); Dietmar Hopp Stiftung; NIH [K08 5K08CA140723]; NATIONAL CANCER INSTITUTE [K08CA140723] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Street Kids; P.A.L.S. Bermuda/St. Baldrick's; ALSF; Bear Necessities; Spitzencluster "Molecular and Cell Based Medicine"; German Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Dietmar Hopp Stiftung; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by grants from the Harvard Stem Cell Institute, and National Institutes of Health (NIH) (1RO1 HL088582 and HL088582-01S1) to AJW, by Hope Street Kids, P.A.L.S. Bermuda/St. Baldrick's, ALSF and Bear Necessities to SH, grant of Spitzencluster "Molecular and Cell Based Medicine" funded by the German Bundesministerium fur Bildung and Forschung (BMBF) and the Dietmar Hopp Stiftung to MM, and NIH (K08 5K08CA140723) to IH. Content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Askmyr M, 2011, BONE, V48, P115, DOI 10.1016/j.bone.2010.06.003; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Braun BS, 2008, CLIN CANCER RES, V14, P2249, DOI 10.1158/1078-0432.CCR-07-1005; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Byrd JC, 1997, J CLIN ONCOL, V15, P466, DOI 10.1200/JCO.1997.15.2.466; Campidelli C, 2009, AM J CLIN PATHOL, V132, P426, DOI 10.1309/AJCP1ZA7HYZKAZHS; Carrasco DR, 2006, CANCER CELL, V9, P379, DOI 10.1016/j.ccr.2006.03.028; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Dai SM, 2000, NAT BIOTECHNOL, V18, P1108, DOI 10.1038/80323; de Vries NA, 2010, CLIN CANCER RES, V16, P3431, DOI 10.1158/1078-0432.CCR-09-3414; DOUAY L, 1991, BRIT J HAEMATOL, V79, P27, DOI 10.1111/j.1365-2141.1991.tb08002.x; Dusenbery KE, 2003, J PEDIAT HEMATOL ONC, V25, P760, DOI 10.1097/00043426-200310000-00004; Fatrai S, 2011, J BIOL CHEM, V286, P6061, DOI 10.1074/jbc.M110.201848; Frisch BJ, 2011, BLOOD; Fritz J, 2007, SKELETAL RADIOL, V36, P985, DOI 10.1007/s00256-007-0314-6; Ginsberg JP, 2002, MED PEDIATR ONCOL, V38, P387, DOI 10.1002/mpo.10069; Harris N. L., 2000, Histopathology (Oxford), V36, P69; HAUPT Y, 1992, ONCOGENE, V7, P981; Hettmer S, 2011, P NATL ACAD SCI USA, V108, P20002, DOI 10.1073/pnas.1111733108; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Johnston DL, 2012, PEDIATR BLOOD CANCER, V58, P519, DOI 10.1002/pbc.23201; Kikuchi Y, 2005, LEUKEMIA RES, V29, P445, DOI 10.1016/j.leukres.2004.09.005; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Koc Y, 1999, CANCER-AM CANCER SOC, V85, P608, DOI 10.1002/(SICI)1097-0142(19990201)85:3<608::AID-CNCR11>3.0.CO;2-5; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Koo S, 2010, HAEMATOL-HEMATOL J, V95, P1642, DOI 10.3324/haematol.2010.023168; Lane SW, 2011, BLOOD; LEMISCHKA IR, 1993, CURR OPIN GENET DEV, V3, P115, DOI 10.1016/S0959-437X(05)80351-X; LIU PI, 1973, CANCER, V31, P948, DOI 10.1002/1097-0142(197304)31:4<948::AID-CNCR2820310428>3.0.CO;2-N; Mashima R, 2010, LAB INVEST, V90, P1357, DOI 10.1038/labinvest.2010.121; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; NEIMAN RS, 1981, CANCER-AM CANCER SOC, V48, P1426, DOI 10.1002/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Puri P, 1999, EUR J CANCER CARE, V8, P113; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; SEARS HF, 1976, CANCER-AM CANCER SOC, V37, P1808, DOI 10.1002/1097-0142(197604)37:4<1808::AID-CNCR2820370427>3.0.CO;2-U; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shank-Calvo JA, 2006, ONCOGENE, V25, P3023, DOI 10.1038/sj.onc.1209326; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sisack MJ, 1997, J AM ACAD DERMATOL, V37, P308; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Uhrbom L, 2002, CANCER RES, V62, P5551; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262	60	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44044	10.1371/journal.pone.0044044	http://dx.doi.org/10.1371/journal.pone.0044044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952867	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300046
J	Martins, GM; Arenas, F; Neto, AI; Jenkins, SR				Martins, Gustavo M.; Arenas, Francisco; Neto, Ana I.; Jenkins, Stuart R.			Effects of Fishing and Regional Species Pool on the Functional Diversity of Fish Communities	PLOS ONE			English	Article							BIODIVERSITY LOSS; ECOSYSTEM; BIOGEOGRAPHY; RICHNESS; PRODUCTIVITY; EXTINCTION; RESILIENCE; INSURANCE; SELECTION; PATTERNS	The potential population and community level impacts of fishing have received considerable attention, but little is known about how fishing influences communities' functional diversity at regional scales. We examined how estimates of functional diversity differed among 25 regions of variable richness and investigated the functional consequences of removing species targeted by commercial fisheries. Our study shows that fishing leads to substantial losses in functional diversity. The magnitude of such loss was, however, reduced in the more speciose regions. Moreover, the removal of commercially targeted species caused a much larger reduction in functional diversity than expected by random species deletions, which was a consequence of the selective nature of fishing for particular species traits. Results suggest that functional redundancy is spatially variable, that richer biotas provide some degree of insurance against the impact of fishing on communities' functional diversity and that fishing predominantly selects for particular species traits. Understanding how fishing impacts community functional diversity is key to predict its effects for biodiversity as well as ecosystem functioning.	[Martins, Gustavo M.; Arenas, Francisco; Neto, Ana I.] Ctr Interdisciplinar Invest Marinha & Ambiental C, Oporto, Portugal; [Martins, Gustavo M.; Neto, Ana I.] Univ Acores, Grp Biol Marina, CIRN, Ponta Delgada, Portugal; [Martins, Gustavo M.; Neto, Ana I.] Univ Acores, Dept Biol, Ponta Delgada, Portugal; [Jenkins, Stuart R.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Jenkins, Stuart R.] Marine Biol Assoc UK, Plymouth, Devon, England	Universidade do Porto; Universidade dos Acores; Universidade dos Acores; Bangor University; Marine Biological Association United Kingdom	Martins, GM (corresponding author), Ctr Interdisciplinar Invest Marinha & Ambiental C, Oporto, Portugal.	gmartins@uac.pt	de Melo Azevedo Neto, Ana Isabel/C-1505-2010; Arenas, Francisco/M-7095-2015; Jenkins, Stuart R/D-2032-2010; Martins, Gustavo M./A-8857-2008; Arenas, Francisco/M-6367-2013	de Melo Azevedo Neto, Ana Isabel/0000-0003-0708-5636; Arenas, Francisco/0000-0001-6925-3805; Jenkins, Stuart R/0000-0002-2299-6318; Martins, Gustavo M./0000-0001-5051-2221; Arenas, Francisco/0000-0001-6925-3805	Foundation for Science and Technology, Portugal [SFRH/BDP/63040/2009]; Natural Environment Research Council [NE/B504649/1] Funding Source: researchfish	Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	GMM was supported by a post-doctoral grant awarded by the Foundation for Science and Technology, Portugal (SFRH/BDP/63040/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Cardinale BJ, 2004, OIKOS, V104, P437, DOI 10.1111/j.0030-1299.2004.13254.x; Carlton JT, 1999, ANNU REV ECOL SYST, V30, P515, DOI 10.1146/annurev.ecolsys.30.1.515; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Fisher JAD, 2010, MAR ECOL PROG SER, V405, P1, DOI 10.3354/meps08601; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; FROESE R, 2000, FISHBASE 2000 CONCEP; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Halpern BS, 2008, MAR ECOL PROG SER, V364, P147, DOI 10.3354/meps07553; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; LOMOLINO MV, 1984, OECOLOGIA, V61, P376, DOI 10.1007/BF00379638; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Miller TE, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P122; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naeslund B, 2006, OIKOS, V115, P504, DOI 10.1111/j.2006.0030-1299.14782.x; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; O'Connor NE, 2005, ECOLOGY, V86, P1783, DOI 10.1890/04-1172; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; Scott BE, 2006, ECOL MODEL, V191, P383, DOI 10.1016/j.ecolmodel.2005.05.015; Tegner MJ, 1996, TRENDS ECOL EVOL, V11, P278, DOI 10.1016/0169-5347(96)30029-3; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	55	22	23	8	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44297	10.1371/journal.pone.0044297	http://dx.doi.org/10.1371/journal.pone.0044297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952950	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300076
J	Giacopuzzi, E; Bresciani, R; Schauer, R; Monti, E; Borsani, G				Giacopuzzi, Edoardo; Bresciani, Roberto; Schauer, Roland; Monti, Eugenio; Borsani, Giuseppe			New Insights on the Sialidase Protein Family Revealed by a Phylogenetic Analysis in Metazoa	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; TRANS-SIALIDASE; SEQUENCE; ACID; EVOLUTION; BINDING; IDENTIFICATION; GANGLIOSIDES	Sialidases are glycohydrolytic enzymes present from virus to mammals that remove sialic acid from oligosaccharide chains. Four different sialidase forms are known in vertebrates: the lysosomal NEU1, the cytosolic NEU2 and the membrane-associated NEU3 and NEU4. These enzymes modulate the cell sialic acid content and are involved in several cellular processes and pathological conditions. Molecular defects in NEU1 are responsible for sialidosis, an inherited disease characterized by lysosomal storage disorder and neurodegeneration. The studies on the biology of sialic acids and sialyltransferases, the anabolic counterparts of sialidases, have revealed a complex picture with more than 50 sialic acid variants selectively present in the different branches of the tree of life. The gain/loss of specific sialoconjugates have been proposed as key events in the evolution of deuterostomes and Homo sapiens, as well as in the host-pathogen interactions. To date, less attention has been paid to the evolution of sialidases. Thus we have conducted a survey on the state of the sialidase family in metazoan. Using an in silico approach, we identified and characterized sialidase orthologs from 21 different organisms distributed among the evolutionary tree: Metazoa relative (Monosiga brevicollis), early Deuterostomia, precursor of Chordata and Vertebrata (teleost fishes, amphibians, reptiles, avians and early and recent mammals). We were able to reconstruct the evolution of the sialidase protein family from the ancestral sialidase NEU1 and identify a new form of the enzyme, NEU5, representing an intermediate step in the evolution leading to the modern NEU3, NEU4 and NEU2. Our study provides new insights on the mechanisms that shaped the substrate specificity and other peculiar properties of the modern mammalian sialidases. Moreover, we further confirm findings on the catalytic residues and identified enzyme loop portions that behave as rapidly diverging regions and may be involved in the evolution of specific properties of sialidases.	[Giacopuzzi, Edoardo; Borsani, Giuseppe] Univ Brescia, Unit Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Bresciani, Roberto; Monti, Eugenio] Univ Brescia, Unit Biochem & Clin Chem, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Schauer, Roland] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany	University of Brescia; University of Brescia; University of Kiel	Giacopuzzi, E (corresponding author), Univ Brescia, Unit Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy.	monti@med.unibs.it	Bresciani, Roberto/AAA-9728-2020; Borsani, Giuseppe/B-1709-2010	Bresciani, Roberto/0000-0002-7881-7550; Borsani, Giuseppe/0000-0003-0110-1148; MONTI, Eugenio/0000-0002-4742-7445; Giacopuzzi, Edoardo/0000-0002-5692-366X	Fondazione Cariplo; ZEBRAGENE grant; Regione Lombardia; Network Enable Drug Discovery (NEDD) grant	Fondazione Cariplo(Fondazione Cariplo); ZEBRAGENE grant; Regione Lombardia(Regione Lombardia); Network Enable Drug Discovery (NEDD) grant	This work was supported by Fondazione Cariplo (http://www.fondazionecariplo.it), ZEBRAGENE grant to G. B. and E. M. and by the Regione Lombardia (http://www.regione.lombardia.it), and Network Enable Drug Discovery (NEDD) grant to E. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Amino R, 1998, J BIOL CHEM, V273, P24575, DOI 10.1074/jbc.273.38.24575; AMINO R, 1995, GLYCOBIOLOGY, V5, P625, DOI 10.1093/glycob/5.6.625; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bao Y, 2010, MICROBES INFECT, V12, P716, DOI 10.1016/j.micinf.2010.04.014; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beitz E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-313; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blouin C, 2004, PROTEIN SCI, V13, P608, DOI 10.1110/ps.03299804; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; CHUANG NN, 1990, COMP BIOCHEM PHYS C, V97, P353, DOI 10.1016/0742-8413(90)90153-Z; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; Dell A, 1999, BBA-GEN SUBJECTS, V1473, P196, DOI 10.1016/S0304-4165(99)00179-8; Giacopuzzi E, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-45; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hollister J, 2003, GLYCOBIOLOGY, V13, P487, DOI 10.1093/glycob/cwg053; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; Koles K, 2009, GLYCOCONJUGATE J, V26, P313, DOI 10.1007/s10719-008-9154-4; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Lukong KE, 2001, J BIOL CHEM, V276, P17286, DOI 10.1074/jbc.M100460200; Maddison WP, 2017, MESQUITE MODULAR SYS; Manzoni M, 2007, BIOCHEM J, V408, P395, DOI 10.1042/BJ20070627; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyata S, 2011, GLYCOBIOLOGY, V21, P1596, DOI 10.1093/glycob/cwr081; Monti E, 2004, GENOMICS, V83, P445, DOI 10.1016/j.ygeno.2003.08.019; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Mozzi A, 2012, PROTEINS, V80, P1123, DOI 10.1002/prot.24013; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito M, 2001, BBA-BIOMEMBRANES, V1511, P271, DOI 10.1016/S0005-2736(01)00282-6; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Schauer R, 1997, N COMP BIOC B, V29, P243; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schwerdtfeger SM, 2010, PHARMAZIE, V65, P551, DOI 10.1691/ph.2010.0546; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tollis Marc, 2011, Mob Genet Elements, V1, P107; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	55	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44193	10.1371/journal.pone.0044193	http://dx.doi.org/10.1371/journal.pone.0044193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952925	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206500054
J	Keller, AA; Garner, K; Miller, RJ; Lenihan, HS				Keller, Arturo A.; Garner, Kendra; Miller, Robert J.; Lenihan, Hunter S.			Toxicity of Nano-Zero Valent Iron to Freshwater and Marine Organisms	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; ZEROVALENT IRON; REACTIVITY; MOBILITY	We tested whether three commercial forms (uncoated, organic coating, and iron oxide coating) of nano zero-valent iron (nZVI) are toxic to freshwater and marine organisms, specifically three species of marine phytoplankton, one species of freshwater phytoplankton, and a freshwater zooplankton species (Daphnia magna), because these organisms may be exposed downstream of where nZVI is applied to remediate polluted soil. The aggregation and reactivity of the three types of nZVI varied considerably, which was reflected in their toxicity. Since levels of Fe2+ and Fe3+ increase as the nZVI react, we also evaluated their toxicity independently. All four phytoplankton species displayed decreasing population growth rates, and Daphnia magna showed increasing mortality, in response to increasing levels of nZVI, and to a lesser degree with increasing Fe2+ and Fe3+. All forms of nZVI aggregated in soil and water, especially in the presence of a high concentration of calcium ions in groundwater, thus reducing their transports through the environment. However, uncoated nZVI aggregated extremely rapidly, thus vastly reducing the probability of environmental transport and potential for toxicity. This information can be used to design a risk management strategy to arrest the transport of injected nZVI beyond the intended remediation area, by injecting inert calcium salts as a barrier to transport.	[Keller, Arturo A.; Garner, Kendra; Miller, Robert J.; Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Keller, AA (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA.	keller@bren.ucsb.edu		Miller, Robert/0000-0002-8350-3759	National Science Foundation; U.S. Environmental Protection Agency [NSF-EF0830117]; National Science Foundation Grant [EF-0742521]; AECOM Environment; AECOM; Directorate For Geosciences [0962306] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation Grant(National Science Foundation (NSF)); AECOM Environment; AECOM; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation and the U.S. Environmental Protection Agency under Cooperative Agreement # NSF-EF0830117, and by National Science Foundation Grant EF-0742521. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or the U.S. Environmental Protection Agency. The work was also supported by a grant from AECOM Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The authors received a $86,000 grant from AECOM to study the toxicity, mobility and persistence of nZVI, to inform their risk assessment. Arturo Keller is member of the Advisory Board of AECOM and receives a small ($3,000/yr) honorarium from AECOM. None of the authors have been employed by AECOM, and there are no patents, or conflicts with products in development or marketed products. In particular, the authors have no commercial or other conflict of interest with the manufacturer of the nano-scale zero valent iron particles used in this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barbouti A, 2001, FREE RADICAL BIO MED, V31, P490, DOI 10.1016/S0891-5849(01)00608-6; Bennett P, 2010, J CONTAM HYDROL, V116, P35, DOI 10.1016/j.jconhyd.2010.05.006; Comba S, 2009, WATER RES, V43, P3717, DOI 10.1016/j.watres.2009.05.046; Diao MH, 2009, WATER RES, V43, P5243, DOI 10.1016/j.watres.2009.08.051; EPA United States Environmental Protection Agency, 2002, 821R02012 EPA; Gavaskar A., 2005, COST PERFORMANCE REP; He F, 2007, ENVIRON SCI TECHNOL, V41, P6216, DOI 10.1021/es0705543; He F, 2010, WATER RES, V44, P2360, DOI 10.1016/j.watres.2009.12.041; He F, 2009, J COLLOID INTERF SCI, V334, P96, DOI 10.1016/j.jcis.2009.02.058; Kadar E, 2010, ENVIRON POLLUT, V158, P3490, DOI 10.1016/j.envpol.2010.03.025; Karn B, 2009, ENVIRON HEALTH PERSP, V117, P1823, DOI 10.1289/ehp.0900793; Keenan CR, 2009, ENVIRON SCI TECHNOL, V43, P4555, DOI 10.1021/es9006383; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u; Li HC, 2009, ECOTOX ENVIRON SAFE, V72, P684, DOI 10.1016/j.ecoenv.2008.09.027; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Lin YH, 2010, SCI TOTAL ENVIRON, V408, P2260, DOI 10.1016/j.scitotenv.2010.01.039; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P195, DOI 10.1021/es801955n; Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P1507, DOI 10.1021/es802187d; Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI [10.1038/nnano.2011.10, 10.1038/NNANO.2011.10]; Saleh N, 2008, ENVIRON SCI TECHNOL, V42, P3349, DOI 10.1021/es071936b; Shin MC, 2008, DESALINATION, V223, P299, DOI 10.1016/j.desal.2007.01.223; Wang W, 2010, J HAZARD MATER, V173, P724, DOI 10.1016/j.jhazmat.2009.08.145; Xiu ZM, 2010, ENVIRON SCI TECHNOL, V44, P7647, DOI 10.1021/es101786y; Zhang WX, 2003, J NANOPART RES, V5, P323, DOI 10.1023/A:1025520116015	27	112	120	0	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43983	10.1371/journal.pone.0043983	http://dx.doi.org/10.1371/journal.pone.0043983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952836	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500034
J	Khan, N; Kazmi, RH; Willems, LAJ; van Heusden, AW; Ligterink, W; Hilhorst, HWM				Khan, Noorullah; Kazmi, Rashid H.; Willems, Leo A. J.; van Heusden, Adriaan W.; Ligterink, Wilco; Hilhorst, Henk W. M.			Exploring the Natural Variation for Seedling Traits and Their Link with Seed Dimensions in Tomato	PLOS ONE			English	Article							LYCOPERSICON-PIMPINELLIFOLIUM; INTERSPECIFIC CROSS; QUANTITATIVE TRAITS; SALT TOLERANCE; WATER-STRESS; QTL ANALYSIS; SIZE; GROWTH; GERMINATION; WEIGHT	The success of germination, growth and final yield of every crop depends to a large extent on the quality of the seeds used to grow the crop. Seed quality is defined as the viability and vigor attribute of a seed that enables the emergence and establishment of normal seedlings under a wide range of environments. We attempt to dissect the mechanisms involved in the acquisition of seed quality, through a combined approach of physiology and genetics. To achieve this goal we explored the genetic variation found in a RIL population of Solanum lycopersicum (cv. Moneymaker) x Solanum pimpinellifolium through extensive phenotyping of seed and seedling traits under both normal and nutrient stress conditions and root system architecture (RSA) traits under optimal conditions. We have identified 62 major QTLs on 21 different positions for seed, seedling and RSA traits in this population. We identified QTLs that were common across both conditions, as well as specific to stress conditions. Most of the QTLs identified for seedling traits co-located with seed size and seed weight QTLs and the positive alleles were mostly contributed by the S. lycopersicum parent. Co-location of QTLs for different traits might suggest that the same locus has pleiotropic effects on multiple traits due to a common mechanistic basis. We show that seed weight has a strong effect on seedling vigor and these results are of great importance for the isolation of the corresponding genes and elucidation of the underlying mechanisms.	[Khan, Noorullah; Kazmi, Rashid H.; Willems, Leo A. J.; Ligterink, Wilco; Hilhorst, Henk W. M.] Wageningen Univ, Lab Plant Physiol, Wageningen Seed Lab, Wageningen, Netherlands; [van Heusden, Adriaan W.] Wageningen Univ & Res Ctr Plant Breeding, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Khan, N (corresponding author), Wageningen Univ, Lab Plant Physiol, Wageningen Seed Lab, Wageningen, Netherlands.	wilco.ligterink@wur.nl	Ligterink, Wilco/C-8103-2009; Hilhorst, Henk/K-1658-2013	Ligterink, Wilco/0000-0002-0228-169X; hilhorst, henk/0000-0002-6743-583X	Higher Education Commission, Pakistan; Technology Foundation STW	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan); Technology Foundation STW(Technologiestichting STW)	This work was supported by the Higher Education Commission, Pakistan (NK) and by the Technology Foundation STW (RHK, LAJW, WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Armengaud P, 2009, PLANT J, V57, P945, DOI 10.1111/j.1365-313X.2008.03739.x; BAKER HG, 1972, ECOLOGY, V53, P997, DOI 10.2307/1935413; Bettey M, 2000, NEW PHYTOL, V148, P277, DOI 10.1046/j.1469-8137.2000.00760.x; BLEASDALE JK, 1967, J HORTIC SCI BIOTECH, V42, P51, DOI 10.1080/00221589.1967.11514192; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CANNON O S, 1973, Hortscience, V8, P404; Castro J., 2006, Handbook of seed science and technology, P397; CHAMBERS JC, 1995, ECOLOGY, V76, P2124, DOI 10.2307/1941687; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; Coolbear P, 1995, SEED QUALITY BASIC M, P223; Cornelissen JHC, 1999, OECOLOGIA, V118, P248, DOI 10.1007/s004420050725; DEVICENTE MC, 1993, GENETICS, V134, P585; DICKSON MH, 1980, HORTSCIENCE, V15, P771; Doerge RW, 1996, GENETICS, V142, P285; Doganlar S, 2000, THEOR APPL GENET, V100, P1267, DOI 10.1007/s001220051433; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; DOLAN RW, 1984, AM J BOT, V71, P1302, DOI 10.2307/2443655; ELLIS RH, 1992, PLANT GROWTH REGUL, V11, P249, DOI 10.1007/BF00024563; Epstein E, 2004, NATURE, V430, P829, DOI 10.1038/430829c; Fenner M., 1991, Seed Science Research, V1, P75, DOI 10.1017/S0960258500000696; Finch-Savage W, 2010, PLANT SCI; Finch -Savage W., 1995, SEED QUALITY BASIC M, P361; Fita A, 2008, J AM SOC HORTIC SCI, V133, P448, DOI 10.21273/JASHS.133.3.448; Foolad Majid R, 2007, Int J Plant Genomics, V2007, P97386, DOI [10.1155/2007/64358, 10.1155/2007/97386]; Foolad MR, 1998, MOL BREEDING, V4, P519, DOI 10.1023/A:1009648112491; Foolad MR, 1997, MOL BREEDING, V3, P269, DOI 10.1023/A:1009668325331; GOLDMAN IL, 1995, THEOR APPL GENET, V90, P925, DOI 10.1007/BF00222905; Grandillo S, 1996, THEOR APPL GENET, V92, P935, DOI 10.1007/BF00224033; Greene DF, 1998, CAN J FOREST RES, V28, P1307, DOI 10.1139/cjfr-28-9-1307; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; Hilhorst H, 2007, ENCY LIFE SCI, P1; Hilhorst HWM, 1997, ADV AGRON, V61, P111, DOI 10.1016/S0065-2113(08)60663-X; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JANZEN DH, 1969, EVOLUTION, V23, P1, DOI [10.2307/2406478, 10.1111/j.1558-5646.1969.tb03489.x]; JONES RA, 1986, EUPHYTICA, V35, P575, DOI 10.1007/BF00021866; Joosen RVL, 2009, CURR GENOMICS, V10, P540, DOI 10.2174/138920209789503914; Joosen RVL, 2010, PLANT J, V62, P148, DOI 10.1111/j.1365-313X.2009.04116.x; JURADO E, 1992, J ECOL, V80, P407, DOI 10.2307/2260686; Kazmi RH, 2012, PLANT CELL ENVIRON, V35, P929, DOI 10.1111/j.1365-3040.2011.02463.x; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Koller DL, 2009, MAMM GENOME, V20, P180, DOI 10.1007/s00335-008-9161-6; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; LEE WG, 1989, J ECOL, V77, P704, DOI 10.2307/2260980; Ligterink W, 2012, SEED SCI RES, V22, pS45, DOI 10.1017/S0960258511000328; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Malamy JE, 1997, TRENDS PLANT SCI, V2, P390, DOI 10.1016/S1360-1385(97)90054-6; MARSHALL DL, 1986, AM J BOT, V73, P457, DOI 10.2307/2444249; McDonald MB, 1998, SEED SCI RES, V8, P265, DOI 10.1017/S0960258500004165; Moegenburg SM, 1996, OECOLOGIA, V106, P539, DOI 10.1007/BF00329713; MORSE DH, 1985, OECOLOGIA, V67, P372, DOI 10.1007/BF00384943; NIEUWHOF M, 1989, PLANT BREEDING, V102, P248, DOI 10.1111/j.1439-0523.1989.tb00343.x; Orsi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000347; Pijl van der L., 1972, PRINCIPLES DISPERSAL; Rick C M, 1973, Basic Life Sci, V2, P255; Rick C. M., 1982, Plant improvement and somatic cell genetics, P1; RICK CHARLES M., 1958, ECON BOT, V12, P346, DOI 10.1007/BF02860023; RICK CM, 1977, PLANT SYST EVOL, V127, P139, DOI 10.1007/BF00984147; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; SCOTT SJ, 1982, EUPHYTICA, V31, P869, DOI 10.1007/BF00039227; SEIWA K, 1991, CAN J BOT, V69, P532, DOI 10.1139/b91-072; Seiwa K, 1996, VEGETATIO, V123, P51, DOI 10.1007/BF00044887; SORENSEN K, 1986, EXPERIENTIA, V42, P161, DOI 10.1007/BF01952446; STANTON ML, 1984, ECOLOGY, V65, P1105, DOI 10.2307/1938318; STEBBINS GL, 1976, OECOLOG PLANTAR, V11, P321; Stubbe H, 1960, GENET RESOUR CROP EV, V8, P110; Stubbe H, 1965, GENET RESOUR CROP EV, V13, P517; TANKSLEY SD, 1982, HEREDITY, V49, P11, DOI 10.1038/hdy.1982.61; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Teng W, 2009, HEREDITY, V102, P372, DOI 10.1038/hdy.2008.108; TRIPATHI RS, 1990, OIKOS, V57, P289, DOI 10.2307/3565956; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2000, ACTA PHYSIOL PLANT, V22, P259, DOI 10.1007/s11738-000-0026-1; WELLER JI, 1988, GENETICS, V118, P329; Whalley WR, 1999, PLANT CELL ENVIRON, V22, P229, DOI 10.1046/j.1365-3040.1999.00412.x; Whittington W., 1973, SEED ECOLOGY, P5; Willson M.F., 1983, PLANT REPROD ECOLOGY; WINN AA, 1988, ECOLOGY, V69, P1537, DOI 10.2307/1941651; WOLF S, 1986, J AM SOC HORTIC SCI, V111, P960; WOOD DM, 1990, AM J BOT, V77, P1411, DOI 10.2307/2444751; Wothke J.L, 1999, AMOS 4 0 USERS GUIDE; Wright IJ, 1999, J ECOL, V87, P85, DOI 10.1046/j.1365-2745.1999.00330.x; WUDIRI BB, 1985, SCI HORTIC-AMSTERDAM, V27, P189, DOI 10.1016/0304-4238(85)90022-6; WULFF RD, 1986, J ECOL, V74, P99, DOI 10.2307/2260351; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; ZHANG JH, 1991, B TORREY BOT CLUB, V118, P141, DOI 10.2307/2996855	86	40	41	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43991	10.1371/journal.pone.0043991	http://dx.doi.org/10.1371/journal.pone.0043991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952841	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206500037
J	Kudo, Y; Iizuka, S; Yoshida, M; Nguyen, PT; Siriwardena, SBSM; Tsunematsu, T; Ohbayashi, M; Ando, T; Hatakeyama, D; Shibata, T; Koizumi, K; Maeda, M; Ishimaru, N; Ogawa, I; Takata, T				Kudo, Yasusei; Iizuka, Shinji; Yoshida, Maki; Phuong Thao Nguyen; Siriwardena, Samadarani B. S. M.; Tsunematsu, Takaaki; Ohbayashi, Mariko; Ando, Toshinori; Hatakeyama, Daijiro; Shibata, Toshiyuki; Koizumi, Keiichi; Maeda, Masahiro; Ishimaru, Naozumi; Ogawa, Ikuko; Takata, Takashi			Periostin Directly and Indirectly Promotes Tumor Lymphangiogenesis of Head and Neck Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; VEGF-C; CELL-SURVIVAL; ORAL-CANCER; RECEPTOR-BINDING; GENE-EXPRESSION; LUNG-CANCER; IN-VIVO; ANGIOGENESIS	Background: Metastasis to regional lymph nodes via lymphatic vessels plays a key role in cancer progression. Tumor lymphangiogenesis is known to promote lymphatic metastasis, and vascular endothelial growth factor C (VEGF-C) is a critical activator of tumor lymphangiogenesis during the process of metastasis. We previously identified periostin as an invasion-and angiogenesis-promoting factor in head and neck squamous cell carcinoma (HNSCC). In this study, we discovered a novel role for periostin in tumor lymphangiogenesis. Methods and Findings: Periostin overexpression upregulated VEGF-C mRNA expression in HNSCC cells. By using conditioned media from periostin-overexpressing HNSCC cells, we examined tube formation of lymphatic endothelial cells. Conditioned media from periostin-overexpressing cells promoted tube formation. To know the correlation between periostin and VEGF-C, we compared Periostin expression with VEGF-C expression in 54 HNSCC cases by immunohistochemistry. Periostin expression was correlated well with VEGF-C expression in HNSCC cases. Moreover, correlation between periostin and VEGF-C secretion was observed in serum from HNSCC patients. Interestingly, periostin itself promoted tube formation of lymphatic endothelial cells independently of VEGF-C. Periostin-promoted lymphangiogenesis was mediated by Src and Akt activity. Indeed possible correlation between periostin and lymphatic status in periostin-overexpressing xenograft tumors and HNSCC cases was observed. Conclusions: Our findings suggest that periostin itself as well as periostin-induced upregulation of VEGF-C may promote lymphangiogenesis. We suggest that periostin may be a marker for prediction of malignant behaviors in HNSCC and a potential target for future therapeutic intervention to obstruct tumoral lymphatic invasion and lymphangiogenesis in HNSCC patients.	[Kudo, Yasusei; Iizuka, Shinji; Yoshida, Maki; Phuong Thao Nguyen; Siriwardena, Samadarani B. S. M.; Tsunematsu, Takaaki; Ohbayashi, Mariko; Ando, Toshinori; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Hatakeyama, Daijiro; Shibata, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Oral & Maxillofacial Sci, Gifu, Japan; [Koizumi, Keiichi] Toyama Univ, Inst Nat Med, Dept Kampo Diagnost, Toyama 930, Japan; [Maeda, Masahiro] Immuno Biol Labs Co Ltd, Dept Res & Dev, Fujioka, Gunma, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Kudo, Yasusei; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan	Hiroshima University; Gifu University; University of Toyama; Hiroshima University; Tokushima University	Kudo, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan.	yasusei@tokushima-u.ac.jp; ttakata@hiroshima-u.ac.jp	Ando, Toshinori/AAA-6401-2021; Koizumi, Keiichi/AAG-6915-2019; Ando, Toshinori/AAG-4033-2021; Nguyen, Thao/AAH-7394-2019	Ando, Toshinori/0000-0002-3141-8173; Ando, Toshinori/0000-0002-3141-8173; Nguyen, Thao/0000-0003-4651-5168; Kudo, Yasusei/0000-0002-0392-7720	Ministry of Education, Science, and Culture of Japan; Japan Society for the Promotion of Science; Kurozumi Memorial Foundation; Grants-in-Aid for Scientific Research [23659858] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kurozumi Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, and Culture of Japan (Y. Kudo and T. Takata), a Research Fellowship for Young Scientists and the Excellent Young Researchers Overseas Visit Program from the Japan Society for the Promotion of Science (S. Iizuka), and a Kurozumi Memorial Foundation grant (Y. Kudo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2009, CANCER LETT, V281, P188, DOI 10.1016/j.canlet.2009.02.043; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Beasley NJP, 2002, CANCER RES, V62, P1315; Ben QW, 2011, ONCOL REP, V25, P709, DOI 10.3892/or.2011.1140; Ben QW, 2009, INT J ONCOL, V34, P821, DOI 10.3892/ijo_00000208; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Eriksson U, 1999, CURR TOP MICROBIOL, V237, P41; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; FIDLER IJ, 1997, PRINCIPLES PRACTICE, P135; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Fujimoto K, 2011, ONCOL REP, V25, P1211, DOI 10.3892/or.2011.1194; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; Hamada K, 2000, BLOOD, V96, P3793, DOI 10.1182/blood.V96.12.3793.h8003793_3793_3800; Hong LZ, 2010, MOL BIOL REP, V37, P2285, DOI 10.1007/s11033-009-9721-1; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Ischenko I, 2010, CURR CANCER DRUG TAR, V10, P546, DOI 10.2174/156800910791517181; Joukov V, 1996, EMBO J, V15, P290; Li JS, 2007, WORLD J GASTROENTERO, V13, P5261, DOI 10.3748/wjg.v13.i39.5261; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Kudo Y, 2003, ORAL ONCOL, V39, P515, DOI 10.1016/S1368-8375(03)00015-0; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Kukk E, 1996, DEVELOPMENT, V122, P3829; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Lymboussaki A, 1999, CIRC RES, V85, P992; Lymboussaki A, 1997, SCIENCE, V276, P1423; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Matsuo M, 2006, CELL TISSUE RES, V326, P749, DOI 10.1007/s00441-006-0229-x; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Regezi J. A., 1989, ORAL PATHOLOGY CLIN, P70; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Scatena MT, 2002, TRENDS CARDIOVAS MED, V12, P83, DOI 10.1016/S1050-1738(01)00151-7; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Siriwardena BSMS, 2008, J CLIN PATHOL, V61, P103, DOI 10.1136/jcp.2007.047662; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; Stetler-Stevenson WG, 2001, PRINCIPLES PRACTICE, P123; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Takanami I, 2008, INT J BIOL MARKER, V23, P182, DOI 10.1177/172460080802300308; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; Utispan K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-13; Wen PY, 2001, PRINCIPLES PRACTICE, P2655; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301	54	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44488	10.1371/journal.pone.0044488	http://dx.doi.org/10.1371/journal.pone.0044488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952986	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500074
J	Hubo, M; Jonuleit, H				Hubo, Mario; Jonuleit, Helmut			Plasmacytoid Dendritic Cells Are Inefficient in Activation of Human Regulatory T Cells	PLOS ONE			English	Article							IN-VITRO; INTERFERON; EXPANSION; INDUCE; INTERLEUKIN-2; STIMULATION; INITIATION; EXPRESSION; IMMUNITY; DISEASE	Background: Dendritic cells (DC) play a key role in initiation and regulation of immune responses. Plasmacytoid DC (pDC), a small subset of DC, characterized as type-I interferon producing cells, are critically involved in anti-viral immune responses, but also mediate tolerance by induction of regulatory T cells (Treg). In this study, we compared the capacity of human pDC and conventional DC (cDC) to modulate T cell activity in presence of Foxp3(+) Treg. Principal Findings: In coculture of T effector cells (Teff) and Treg, activated cDC overcome Treg anergy, abrogate their suppressive function and induce Teff proliferation. In contrast, pDC do not break Treg anergy but induce Teff proliferation even in coculture with Treg. Lack of Treg-mediated suppression is independent of proinflammatory cytokines like IFN-alpha, IL-1, IL-6 and TNF-alpha. Phenotyping of pDC-stimulated Treg reveals a reduced expression of Treg activation markers GARP and CTLA-4. Additional stimulation by anti-CD3 antibodies enhances surface expression of GARP and CTLA-4 on Treg and consequently reconstitutes their suppressive function, while increased costimulation with anti-CD28 antibodies is ineffective. Conclusions/Significance: Our data show that activated pDC induce Teff proliferation, but are insufficient for functional Treg activation and, therefore, allow expansion of Teff also in presence of Treg.	[Hubo, Mario; Jonuleit, Helmut] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, Mainz, Germany	Johannes Gutenberg University of Mainz	Hubo, M (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, Mainz, Germany.	mario.hubo@unimedizin-mainz.de	Jonuleit, Helmut/D-8059-2011	Jonuleit, Helmut/0000-0002-5672-9365	German Research Foundation [Transregio52]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (Transregio52, http://gepris.dfg.de/gepris/OCTOPUS/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Boor PPC, 2011, EUR J IMMUNOL, V41, P1663, DOI 10.1002/eji.201041229; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Chen SC, 2010, ARCH DERMATOL RES, V302, P113, DOI 10.1007/s00403-009-0966-2; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; Houot R, 2006, J IMMUNOL, V176, P5293, DOI 10.4049/jimmunol.176.9.5293; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Martin-Gayo E, 2010, BLOOD, V115, P5366, DOI 10.1182/blood-2009-10-248260; Matta BM, 2010, EUR J IMMUNOL, V40, P2667, DOI 10.1002/eji.201040839; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Noel G, 2009, INT IMMUNOL, V21, P1025, DOI 10.1093/intimm/dxp068; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Swiecki M, 2010, EUR J IMMUNOL, V40, P2094, DOI 10.1002/eji.201040602; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	41	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44056	10.1371/journal.pone.0044056	http://dx.doi.org/10.1371/journal.pone.0044056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952871	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000075
J	Mazzotti, DR; Guindalini, C; de Souza, AAL; Sato, JR; Santos-Silva, R; Bittencourt, LRA; Tufik, S				Mazzotti, Diego Robles; Guindalini, Camila; Lino de Souza, Altay Alves; Sato, Joao Ricardo; Santos-Silva, Rogerio; Azeredo Bittencourt, Lia Rita; Tufik, Sergio			Adenosine Deaminase Polymorphism Affects Sleep EEG Spectral Power in a Large Epidemiological Sample	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; POPULATION; HUMANS	Slow wave oscillations in the electroencephalogram (EEG) during sleep may reflect both sleep need and intensity, which are implied in homeostatic regulation. Adenosine is strongly implicated in sleep homeostasis, and a single nucleotide polymorphism in the adenosine deaminase gene (ADA G22A) has been associated with deeper and more efficient sleep. The present study verified the association between the ADA G22A polymorphism and changes in sleep EEG spectral power (from C3-A2, C4-A1, O1-A2, and O2-A1 derivations) in the Epidemiologic Sleep Study (EPISONO) sample from Sao Paulo, Brazil. Eight-hundred individuals were subjected to full-night polysomnography and ADA G22A genotyping. Spectral analysis of the EEG was carried out in all individuals using fast Fourier transformation of the signals from each EEG electrode. The genotype groups were compared in the whole sample and in a subsample of 120 individuals matched according to ADA genotype for age, gender, body mass index, caffeine intake status, presence of sleep disturbance, and sleep-disturbing medication. When compared with homozygous GG genotype carriers, A allele carriers showed higher delta spectral power in Stage 1 and Stages 3+4 of sleep, and increased theta spectral power in Stages 1, 2 and REM sleep. These changes were seen both in the whole sample and in the matched subset. The higher EEG spectral power indicates that the sleep of individuals carrying the A allele may be more intense. Therefore, this polymorphism may be an important source of variation in sleep homeostasis in humans, through modulation of specific components of the sleep EEG.	[Mazzotti, Diego Robles; Guindalini, Camila; Lino de Souza, Altay Alves; Santos-Silva, Rogerio; Azeredo Bittencourt, Lia Rita; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil; [Guindalini, Camila] Univ Fed Sao Paulo, Dept Psiquiatria, Lab Neurociencias Clin LiNC, Sao Paulo, Brazil; [Sato, Joao Ricardo] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Santo Andre, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC)	Mazzotti, DR (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil.	camilascg@googlemail.com	Seguranca Publica, Inct/I-2423-2013; Sono, Cepid/I-5371-2013; Mazzotti, Diego/C-3968-2012; Mazzotti, Diego R./S-1886-2019; de Souza, Altay A Lino/K-7797-2012; Bittencourt, Lia/C-6551-2012; Santos-Silva, Rogerio/E-4630-2013	Mazzotti, Diego R./0000-0003-3924-9199; de Souza, Altay A Lino/0000-0002-3331-4087; Bittencourt, Lia/0000-0001-7738-0927; Sato, Joao Ricardo/0000-0002-7503-9781; Guindalini, Camila/0000-0002-6278-5881	Associacao Fundo de Incentivo a Psicofarmacologia (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID) [98/14303-3]	Associacao Fundo de Incentivo a Psicofarmacologia (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Associacao Fundo de Incentivo a Psicofarmacologia (AFIP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID #98/14303-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Ambrosius U, 2008, BIOL PSYCHIAT, V64, P344, DOI 10.1016/j.biopsych.2008.03.002; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; BATTISTUZZI G, 1981, ANN HUM GENET, V45, P15, DOI 10.1111/j.1469-1809.1981.tb00301.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Chikahisa Sachiko, 2011, Front Neurol, V2, P87, DOI 10.3389/fneur.2011.00087; De Gennaro L, 2008, ANN NEUROL, V64, P455, DOI 10.1002/ana.21434; Diamond A, 2006, GENETIC MATCHING EST; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; HIRSCHHORN R, 1994, ANN HUM GENET, V58, P1, DOI 10.1111/j.1469-1809.1994.tb00720.x; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Iber C., 2007, RULES TERMINOL TECH, V176, P2012; Kalinchuk AV, 2011, J NEUROCHEM, V116, P260, DOI 10.1111/j.1471-4159.2010.07100.x; Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024; Landolt HP, 2011, PROG BRAIN RES, V193, P51, DOI 10.1016/B978-0-444-53839-0.00004-1; Mazzotti DR, 2011, SLEEP, V34, P399, DOI 10.1093/sleep/34.3.399; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Retey JV, 2005, P NATL ACAD SCI USA, V102, P15676, DOI 10.1073/pnas.0505414102; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Tafti M, 2009, SLEEP MED, V10, pS17, DOI 10.1016/j.sleep.2009.07.002; Vyazovskiy VV, 2005, J SLEEP RES, V14, P299, DOI 10.1111/j.1365-2869.2005.00456.x; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7	24	26	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44154	10.1371/journal.pone.0044154	http://dx.doi.org/10.1371/journal.pone.0044154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952909	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000090
J	Meganathan, K; Jagtap, S; Wagh, V; Winkler, J; Gaspar, JA; Hildebrand, D; Trusch, M; Lehmann, K; Hescheler, J; Schluter, H; Sachinidis, A				Meganathan, Kesavan; Jagtap, Smita; Wagh, Vilas; Winkler, Johannes; Gaspar, John Antonydas; Hildebrand, Diana; Trusch, Maria; Lehmann, Karola; Hescheler, Juergen; Schlueter, Hartmut; Sachinidis, Agapios			Identification of Thalidomide-Specific Transcriptomics and Proteomics Signatures during Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							VERTEBRATE LIMB DEVELOPMENT; DEVELOPMENTAL TOXICITY TEST; IN-VITRO; MULTIPLE-MYELOMA; EXPRESSION; MICE; RABBITS; TERATOGENICITY; TRANSFORMATION; MALFORMATIONS	Embryonic development can be partially recapitulated in vitro by differentiating human embryonic stem cells (hESCs). Thalidomide is a developmental toxicant in vivo and acts in a species-dependent manner. Besides its therapeutic value, thalidomide also serves as a prototypical model to study teratogenecity. Although many in vivo and in vitro platforms have demonstrated its toxicity, only a few test systems accurately reflect human physiology. We used global gene expression and proteomics profiling (two dimensional electrophoresis (2DE) coupled with Tandem Mass spectrometry) to demonstrate hESC differentiation and thalidomide embryotoxicity/teratogenecity with clinically relevant dose(s). Proteome analysis showed loss of POU5F1 regulatory proteins PKM2 and RBM14 and an over expression of proteins involved in neuronal development (such as PAK2, PAFAH1B2 and PAFAH1B3) after 14 days of differentiation. The genomic and proteomic expression pattern demonstrated differential expression of limb, heart and embryonic development related transcription factors and biological processes. Moreover, this study uncovered novel possible mechanisms, such as the inhibition of RANBP1, that participate in the nucleocytoplasmic trafficking of proteins and inhibition of glutathione transferases (GSTA1, GSTA2), that protect the cell from secondary oxidative stress. As a proof of principle, we demonstrated that a combination of transcriptomics and proteomics, along with consistent differentiation of hESCs, enabled the detection of canonical and novel teratogenic intracellular mechanisms of thalidomide.	[Meganathan, Kesavan; Jagtap, Smita; Wagh, Vilas; Winkler, Johannes; Gaspar, John Antonydas; Hescheler, Juergen; Sachinidis, Agapios] Ctr Physiol & Pathophysiol, Inst Neurophysiol, Cologne, Germany; [Hildebrand, Diana; Schlueter, Hartmut] Univ Med Ctr, Inst Clin Chem, Hamburg, Germany; [Trusch, Maria] Univ Hamburg, Inst Organ Chem, Mass Spectrometry Grp, D-2000 Hamburg, Germany; [Lehmann, Karola] Proteome Factory AG, Berlin, Germany	University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg	Meganathan, K (corresponding author), Ctr Physiol & Pathophysiol, Inst Neurophysiol, Cologne, Germany.	a.sachinidis@uni-koeln.de	Wagh, Vilas/B-3267-2009; Schluter, Hartmut/D-1371-2015; Wagh, Vilas/A-9522-2010; Sachinidis, Agapios/AAD-4178-2020; Sachinidis, Agapios/AAM-7988-2020; Riedner, Maria/W-5546-2019	Schluter, Hartmut/0000-0002-9358-7036; Winkler, Johannes/0000-0001-7309-8342	EU	EU(European Commission)	This work was supported by the EU FP7 project Embryonic Stem cell-based Novel Alterntaive Testing Strategies (ESNATS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler S, 2008, TOXICOL IN VITRO, V22, P200, DOI 10.1016/j.tiv.2007.07.013; Assadi AH, 2008, NEUROSCI LETT, V439, P100, DOI 10.1016/j.neulet.2008.04.096; Augustine-Rauch K, 2010, BIRTH DEFECTS RES C, V90, P87, DOI 10.1002/bdrc.20175; Breckenridge RA, 2010, INT J DEV BIOL, V54, P215, DOI 10.1387/ijdb.072356rb; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; CHERNOFF N, 1982, J TOXICOL ENV HEALTH, V10, P541, DOI 10.1080/15287398209530275; Chung F, 2004, CLIN CANCER RES, V10, P5949, DOI 10.1158/1078-0432.CCR-04-0421; Church VL, 2002, INT J DEV BIOL, V46, P927; DELAHUNT CS, 1964, SCIENCE, V146, P1300, DOI 10.1126/science.146.3649.1300; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ema M, 2010, REPROD TOXICOL, V29, P49, DOI 10.1016/j.reprotox.2009.09.003; FRATTA ID, 1965, TOXICOL APPL PHARM, V7, P268, DOI 10.1016/0041-008X(65)90095-5; Gove C, 1997, EMBO J, V16, P1806; Hansen JM, 2004, ANTIOXID REDOX SIGN, V6, P1, DOI 10.1089/152308604771978291; Hansen JM, 1999, REPROD TOXICOL, V13, P547, DOI 10.1016/S0890-6238(99)00053-2; HARDIN BD, 1987, TERATOGEN CARCIN MUT, V7, P29, DOI 10.1002/tcm.1770070106; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HOAR RM, 1995, J AM COLL TOXICOL, V14, P11, DOI 10.3109/10915819509008677; Ito T, 2011, CELL MOL LIFE SCI, V68, P1569, DOI 10.1007/s00018-010-0619-9; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jagtap S, 2011, BRIT J PHARMACOL, V162, P1743, DOI 10.1111/j.1476-5381.2010.01197.x; KAJII T, 1963, LANCET, V2, P151; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Knobloch J, 2008, MOL CELL BIOL, V28, P529, DOI 10.1128/MCB.00533-07; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Knobloch J, 2008, MOL PHARMACEUT, V5, P1138, DOI 10.1021/mp8001232; Kodama T, 2009, CLIN LYMPHOMA MYELOM, V9, P154, DOI 10.3816/CLM.2009.n.037; Kodiha M., 2012, J SIGNAL TRANSDUCT, P18; Kraljevic S, 2004, EMBO REP, V5, P837, DOI 10.1038/sj.embor.7400236; Lu HC, 1997, DEVELOPMENT, V124, P1643; Mayshar Y, 2011, J CELL MOL MED, V15, P1393, DOI 10.1111/j.1582-4934.2010.01105.x; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SAWIN PB, 1965, EXPERIENTIA, V21, P672, DOI 10.1007/BF02144076; Scholz G, 1999, TOXICOL IN VITRO, V13, P675, DOI 10.1016/S0887-2333(99)00046-6; SCHUMACHER H, 1968, J PHARMACOL EXP THER, V160, P189; SEIDENBERG JM, 1986, TERATOGEN CARCIN MUT, V6, P361, DOI 10.1002/tcm.1770060503; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; SMITHELLS RW, 1973, BMJ-BRIT MED J, V1, P269, DOI 10.1136/bmj.1.5848.269; Stephens TD, 2009, BIRTH DEFECTS RES A, V85, P725, DOI 10.1002/bdra.20597; Teo SK, 2004, TOXICOL SCI, V81, P379, DOI 10.1093/toxsci/kfh207; Teo SK, 2001, TOXICOL SCI, V59, P160, DOI 10.1093/toxsci/59.1.160; Tumpel S, 2002, DEV BIOL, V250, P251, DOI 10.1006/dbio.2002.0762; Winkler J, 2009, CURR MED CHEM, V16, P4814, DOI 10.2174/092986709789909657; WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zimny-Arndt Ursula, 2009, V492, P65, DOI 10.1007/978-1-59745-493-3_4	54	72	74	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44228	10.1371/journal.pone.0044228	http://dx.doi.org/10.1371/journal.pone.0044228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952932	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600094
J	Gabrielli, E; Pericolini, E; Cenci, E; Monari, C; Magliani, W; Ciociola, T; Conti, S; Gatti, R; Bistoni, F; Polonelli, L; Vecchiarelli, A				Gabrielli, Elena; Pericolini, Eva; Cenci, Elio; Monari, Claudia; Magliani, Walter; Ciociola, Tecla; Conti, Stefania; Gatti, Rita; Bistoni, Francesco; Polonelli, Luciano; Vecchiarelli, Anna			Antibody Constant Region Peptides Can Display Immunomodulatory Activity through Activation of the Dectin-1 Signalling Pathway	PLOS ONE			English	Article							BETA-GLUCAN RECOGNITION; HUMAN DENDRITIC CELLS; CANDIDA-ALBICANS; THERAPEUTIC ACTIVITY; INNATE IMMUNITY; CRYPTOCOCCUS-NEOFORMANS; LIGHT-CHAINS; HOST-DEFENSE; KAPPA-B; MONOCYTES	We previously reported that a synthetic peptide with sequence identical to a CDR of a mouse monoclonal antibody specific for difucosyl human blood group A exerted an immunomodulatory activity on murine macrophages. It was therapeutic against systemic candidiasis without possessing direct candidacidal properties. Here we demonstrate that a selected peptide, N10K, putatively deriving from the enzymatic cleavage of the constant region (Fc) of human IgG(1), is able to induce IL-6 secretion and pIkB-alpha activation. More importantly, it causes an up-regulation of Dectin-1 expression. This leads to an increased activation of beta-glucan-induced pSyk, CARD9 and pIkB-alpha, and an increase in the production of pro-inflammatory cytokines such as IL-6, IL-12, IL-1 beta and TNF-alpha. The increased activation of this pathway coincides with an augmented phagocytosis of non opsonized Candida albicans cells by monocytes. The findings suggest that some Fc-peptides, potentially deriving from the proteolysis of immunoglobulins, may cause an unexpected immunoregulation in a way reminiscent of innate immunity molecules.	[Gabrielli, Elena; Pericolini, Eva; Cenci, Elio; Monari, Claudia; Bistoni, Francesco; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Magliani, Walter; Ciociola, Tecla; Conti, Stefania; Polonelli, Luciano] Univ Parma, Dept Pathol & Lab Med, Microbiol Sect, I-43100 Parma, Italy; [Gatti, Rita] Univ Parma, Dept Expt Med, Histol Sect, I-43100 Parma, Italy	University of Perugia; University of Parma; University Hospital of Parma; University of Parma	Gabrielli, E (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy.	vecchiar@unipg.it	Conti, Stefania/N-3558-2015; MONARI, Claudia/AAY-3848-2020; Ciociola, Tecla/AFN-5212-2022; Pericolini, Eva/AAZ-5848-2021; Ciociola, Tecla/HCH-2453-2022; monari, claudia/O-4563-2018	Conti, Stefania/0000-0001-9973-8352; MONARI, Claudia/0000-0002-5027-9367; Ciociola, Tecla/0000-0001-6499-2545; monari, claudia/0000-0002-5027-9367; CENCI, ELIO/0000-0003-0752-7262; Vecchiarelli, Anna/0000-0002-3185-6720; Pericolini, Eva/0000-0002-5299-8197	Italian Ministry of Health [40H39]	Italian Ministry of Health(Ministry of Health, Italy)	The work was supported by funding from Italian Ministry of Health for the National AIDS Research Program (Grant number 40H39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda DC, 2012, J BIOL CHEM, V287, P14912, DOI 10.1074/jbc.M111.322362; BISTONI F, 1986, INFECT IMMUN, V51, P668, DOI 10.1128/IAI.51.2.668-674.1986; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Busetto S, 2004, CYTOM PART A, V58A, P201, DOI 10.1002/cyto.a.20014; Casoli C, 2006, AIDS, V20, P975, DOI 10.1097/01.aids.0000222068.14878.0d; Cenci E, 2006, J LEUKOCYTE BIOL, V79, P40, DOI 10.1189/jlb.0205113; CHAKA W, 1995, CLIN DIAGN LAB IMMUN, V2, P753, DOI 10.1128/CDLI.2.6.753-759.1995; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; COHEN S, 1964, ADV IMMUNOL, V4, P287, DOI 10.1016/S0065-2776(08)60710-5; Conti G, 2008, ANTIMICROB AGENTS CH, V52, P4331, DOI 10.1128/AAC.00506-08; Dennehy KM, 2007, J LEUKOCYTE BIOL, V82, P253, DOI 10.1189/jlb.1206753; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Gabrielli E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008187; Gaffen SL, 2011, IMMUNOL RES, V50, P181, DOI 10.1007/s12026-011-8226-x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Haas A, 2008, CYTOM PART A, V73A, P799, DOI 10.1002/cyto.a.20598; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Lee YG, 2009, INT J BIOCHEM CELL B, V41, P811, DOI 10.1016/j.biocel.2008.08.011; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li M, 2009, CHINESE MED J-PEKING, V122, P496, DOI 10.3760/cma.j.issn.0366-6999.2009.05.003; Magliani W, 2009, CURR MED CHEM, V16, P2305, DOI 10.2174/092986709788453104; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Monari C, 2003, EUR J IMMUNOL, V33, P1041, DOI 10.1002/eji.200323388; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pietrella D, 2008, INFECT IMMUN, V76, P4359, DOI 10.1128/IAI.00669-08; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034105; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sengul S, 2002, KIDNEY INT, V62, P1977, DOI 10.1046/j.1523-1755.2002.00660.x; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Skrzypek F, 2009, MICROBES INFECT, V11, P661, DOI 10.1016/j.micinf.2009.03.010; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tsoni SV, 2008, ANN NY ACAD SCI, V1143, P45, DOI 10.1196/annals.1443.019; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Yang Z, 2009, IMMUNOBIOLOGY, V214, P321, DOI 10.1016/j.imbio.2008.09.002	44	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43972	10.1371/journal.pone.0043972	http://dx.doi.org/10.1371/journal.pone.0043972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952831	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800081
J	Mishra, NN; Bayer, AS; Tran, TT; Shamoo, Y; Mileykovskaya, E; Dowhan, W; Guan, ZQ; Arias, CA				Mishra, Nagendra N.; Bayer, Arnold S.; Tran, Truc T.; Shamoo, Yousif; Mileykovskaya, Eugenia; Dowhan, William; Guan, Ziqiang; Arias, Cesar A.			Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-FAECALIS; DIGLUCOSYL DIGLYCERIDE; ATCC 9790; VANCOMYCIN; ACID; SUSCEPTIBILITY; STRAINS; FAECIUM; PROTEIN	Background: The lipopeptide antibiotic, daptomycin (DAP) interacts with the bacterial cell membrane (CM). Development of DAP resistance during therapy in a clinical strain of Enterococcus faecalis was associated with mutations in genes encoding enzymes involved in cell envelope homeostasis and phospholipid metabolism. Here we characterized changes in CM phospholipid profiles associated with development of DAP resistance in clinical enterococcal strains. Methodology: Using two clinical strain-pairs of DAP-susceptible and DAP-resistant E. faecalis (S613 vs. R712) and E. faecium (S447 vs. R446) recovered before and after DAP therapy, we compared four distinct CM profiles: phospholipid content, fatty acid composition, membrane fluidity and capacity to be permeabilized and/or depolarized by DAP. Additionally, we characterized the cell envelope of the E. faecium strain-pair by transmission electron microscopy and determined the relative cell surface charge of both strain-pairs. Principal Findings: Both E. faecalis and E. faecium mainly contained four major CM PLs: phosphatidylglycerol (PG), cardiolipin, lysyl-phosphatidylglycerol (L-PG) and glycerolphospho-diglycodiacylglycerol (GP-DGDAG). In addition, E. faecalis CMs (but not E. faecium) also contained: i) phosphatidic acid; and ii) two other unknown species of amino-containing PLs. Development of DAP resistance in both enterococcal species was associated with a significant decrease in CM fluidity and PG content, with a concomitant increase in GP-DGDAG. The strain-pairs did not differ in their outer CM translocation (flipping) of amino-containing PLs. Fatty acid content did not change in the E. faecalis strain-pair, whereas a significant decrease in unsaturated fatty acids was observed in the DAP-resistant E. faecium isolate R446 (vs S447). Resistance to DAP in E. faecium was associated with distinct structural alterations of the cell envelope and cell wall thickening, as well as a decreased ability of DAP to depolarize and permeabilize the CM. Conclusion: Distinct alterations in PL content and fatty acid composition are associated with development of enterococcal DAP resistance.	[Mishra, Nagendra N.; Bayer, Arnold S.] Harbor Univ Calif Los Angeles Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA USA; [Bayer, Arnold S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Tran, Truc T.; Arias, Cesar A.] Univ Texas Med Sch Houston, Lab Antimicrobial Res, Div Infect Dis, Houston, TX USA; [Tran, Truc T.] Univ Houston Coll Pharm, Houston, TX USA; [Shamoo, Yousif] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Shamoo, Yousif] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Mileykovskaya, Eugenia; Dowhan, William] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Guan, Ziqiang] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Arias, Cesar A.] Univ Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; Rice University; Rice University; University of Texas System; University of Texas Health Science Center Houston; Duke University; Universidad El Bosque	Mishra, NN (corresponding author), Harbor Univ Calif Los Angeles Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA USA.	cesar.arias@uth.tmc.edu	Guan, Ziqiang/AAE-5110-2019	Shamoo, Yousif/0000-0001-9241-8962; Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health (NIH) from the National Institute of Allergy and Infectious Diseases (NIAID) [R00 AI72961, R01 AI093749]; NIH [R01 AI39108, R01 AI080714]; NIAID; John S. Dunn Foundation Collaborative Research Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039108, R01AI080714, R00AI072961, R01AI093749] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Institute of Allergy and Infectious Diseases (NIAID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); John S. Dunn Foundation Collaborative Research Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CAA is supported by National Institutes of Health (NIH) grants R00 AI72961 and R01 AI093749 to CAA from the National Institute of Allergy and Infectious Diseases (NIAID). ASB and YS are supported by NIH grants R01 AI39108 and R01 AI080714 also from NIAID. This work was also supported in part by a John S. Dunn Foundation Collaborative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBRON RT, 1971, J BIOL CHEM, V246, P4216; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Bao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038458; Bayer AS, 2000, INFECT IMMUN, V68, P3548, DOI 10.1128/IAI.68.6.3548-3553.2000; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; CARSON DD, 1981, J BACTERIOL, V146, P590, DOI 10.1128/JB.146.2.590-604.1981; Cui LZ, 2010, ANTIMICROB AGENTS CH, V54, P5222, DOI 10.1128/AAC.00437-10; Dixit BL, 1998, EUR J BIOCHEM, V254, P202, DOI 10.1046/j.1432-1327.1998.2540202.x; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P1434, DOI 10.1128/JCM.33.5.1434-1434.1995; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; FISCHER W, 1973, BIOCHIM BIOPHYS ACTA, V296, P527, DOI 10.1016/0005-2760(73)90113-6; FISCHER W, 1975, BIOCHIM BIOPHYS ACTA, V380, P227, DOI 10.1016/0005-2760(75)90009-0; FISCHER W, 1973, BIOCHIM BIOPHYS ACTA, V306, P353, DOI 10.1016/0005-2760(73)90174-4; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; GANFIELD MCW, 1980, J BIOL CHEM, V255, P5164; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; GOLDBERG DE, 1981, P NATL ACAD SCI-BIOL, V78, P5513, DOI 10.1073/pnas.78.9.5513; Green Myke R, 2006, J Oncol Pharm Pract, V12, P179, DOI 10.1177/1078155206069165; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128/AAC.49.3.1127-1134.2005; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Leuko S, 2004, APPL ENVIRON MICROB, V70, P6884, DOI 10.1128/AEM.70.11.6884-6886.2004; Mave V, 2009, J ANTIMICROB CHEMOTH, V64, P175, DOI 10.1093/jac/dkp154; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Munoz-Price LS, 2005, CLIN INFECT DIS, V41, P565, DOI 10.1086/432121; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Panesso D, 2010, J CLIN MICROBIOL, V48, P1562, DOI 10.1128/JCM.02526-09; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028316; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Pogliano J, 2012, J BACTERIOL IN PRESS; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rubio A, 2012, MOL MEMBR BIOL, V29, P1, DOI 10.3109/09687688.2011.640948; Sabol K, 2005, ANTIMICROB AGENTS CH, V49, P1664, DOI 10.1128/AAC.49.4.1664-1665.2005; Sader HS, 2009, DIAGN MICR INFEC DIS, V65, P158, DOI 10.1016/j.diagmicrobio.2009.06.016; Sakayori Y, 2003, MICROBIOL-SGM, V149, P2901, DOI 10.1099/mic.0.26435-0; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Tsai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-13; Twilla JD, 2012, J HOSP MED, V7, P243, DOI 10.1002/jhm.994; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	49	96	99	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43958	10.1371/journal.pone.0043958	http://dx.doi.org/10.1371/journal.pone.0043958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952824	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800077
J	Chen, M; Bresnick, AR; O'Connor, KL				Chen, M.; Bresnick, A. R.; O'Connor, K. L.			Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cells	ONCOGENE			English	Article						Rho; Rhotekin; S100A4/metastasin; lamellipodia; invasive growth	NONMUSCLE MYOSIN-II; ALPHA-6-BETA-4 INTEGRIN; LAMELLAE FORMATION; CARCINOMA CELLS; IN-VIVO; METASTASIS; PROTEIN; ACTIVATION; MIGRATION; EFFECTOR	Rho signaling is increasingly recognized to contribute to invasion and metastasis. In this study, we discovered that metastasis-associated protein S100A4 interacts with the Rho-binding domain (RBD) of Rhotekin, thus connecting S100A4 to the Rho pathway. Glutathione S-transferase pull-down and immunoprecipitation assays demonstrated that S100A4 specifically and directly binds to Rhotekin RBD, but not the other Rho effector RBDs. S100A4 binding to Rhotekin is calcium-dependent and uses residues distinct from those bound by active Rho. Interestingly, we found that S100A4 and Rhotekin can form a complex with active RhoA. Using RNA interference, we determined that suppression of both S100A4 and Rhotekin leads to loss of Rho-dependent membrane ruffling in response to epidermal growth factor, an increase in contractile F-actin 'stress' fibers and blocks invasive growth in three-dimensional culture. Accordingly, our data suggest that interaction of S100A4 and Rhotekin permits S100A4 to complex with RhoA and switch Rho function from stress fiber formation to membrane ruffling to confer an invasive phenotype.	[Chen, M.; O'Connor, K. L.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Bresnick, A. R.] Albert Einstein Coll Med, Bronx, NY 10467 USA	University of Kentucky; Yeshiva University; Albert Einstein College of Medicine	O'Connor, KL (corresponding author), Univ Kentucky, Markey Canc Ctr, 741 South Limestone St, Lexington, KY 40506 USA.	mch235@uky.edu; kloconnor@uky.edu	O'Connor, Kathleen L/H-2569-2013	O'Connor, Kathleen L/0000-0002-1088-9734	National Institutes of Health [CA109136, CA129598]; NATIONAL CANCER INSTITUTE [R01CA109136, R01CA129598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Ren Xu for his kind aid with 3D culture-related experiments; Dr Jianhang Jia for assistance with the confocal microscopy analysis; Drs Tianyan Gao and Jianyu Liu for reagents and technical support for generating shRNA stable cell line; Drs Kohich Nagata, Shuh Narumiya and G Steven Martin for reagents; Dr Juanjuan Yang for validating select data; and Diane Wright for assistance with graphics. This work was supported with National Institutes of Health Grants CA109136 (KLO) and CA129598 (ARB).	Andersen K, 2011, DEV BIOL, V352, P181, DOI 10.1016/j.ydbio.2010.12.033; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Condeelis JS, 2001, SEMIN CANCER BIOL, V11, P119, DOI 10.1006/scbi.2000.0363; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Ito H, 2006, NEUROSCI RES, V56, P165, DOI 10.1016/j.neures.2006.06.014; Kelloff GJ, 1997, CANCER EPIDEM BIOMAR, V6, P267; Kim EJ, 2003, J BIOL CHEM, V278, P30063, DOI 10.1074/jbc.M304909200; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Li ZH, 2010, MOL BIOL CELL, V21, P2598, DOI 10.1091/mbc.E09-07-0609; Liu CA, 2004, ONCOGENE, V23, P8731, DOI 10.1038/sj.onc.1208106; Liu CA, 2004, J BIOMED SCI, V11, P661, DOI 10.1159/000079679; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Nagata K, 2009, MED MOL MORPHOL, V42, P9, DOI 10.1007/s00795-008-0433-8; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nishiyama T, 1994, MOL CELL BIOL, V14, P2247; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Pusapati GV, 2012, J BIOL CHEM, V287, P9473, DOI 10.1074/jbc.M112.339564; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Rudland PS, 2000, CANCER RES, V60, P1595; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Sudo K, 2006, NEUROSCI RES, V56, P347, DOI 10.1016/j.neures.2006.08.003; Takenaga K, 1997, CLIN CANCER RES, V3, P2309; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wyckoff JB, 2000, CANCER RES, V60, P2504; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Ying-Tao Z, 2005, EUR J GASTROEN HEPAT, V17, P725, DOI 10.1097/00042737-200507000-00006; Zhao XS, 2009, CANCER RES, V69, P483, DOI 10.1158/0008-5472.CAN-08-2907	49	36	37	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 8	2013	32	32					3754	3764		10.1038/onc.2012.383	http://dx.doi.org/10.1038/onc.2012.383			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22964635	Green Published, Green Accepted			2022-12-25	WOS:000322904400010
J	Clark, AA; Liggett, SB; Munger, SD				Clark, Adam A.; Liggett, Stephen B.; Munger, Steven D.			Extraoral bitter taste receptors as mediators of off-target drug effects	FASEB JOURNAL			English	Article						T2R; gastrointestinal system; respiratory system; gustatory system; side effects	CHEMOSENSORY CELLS; FAMILY; SENSITIVITY; GENES; PHENYLTHIOCARBAMIDE; PERCEPTION; EXPRESSION; SECRETION; SACCHARIN; MOUSE	We present a novel hypothesis that could explain many off-target effects of diverse pharmaceuticals. Specifically, we propose that any drug with a bitter taste could have unintended actions in the body through stimulation of extraoral type 2 taste receptors (T2Rs). T2Rs were first identified in the oral cavity, where they function as bitter taste receptors. However, recent findings indicate that they are also expressed outside the gustatory system, including in the gastrointestinal and respiratory systems. T2R ligands include a diverse array of natural and synthetic compounds, many of which are toxins. Notably, many pharmaceuticals taste bitter, with compounds such as chloroquine, haloperidol, erythromycin, procainamide, and ofloxacin known to activate T2Rs. Bitter-tasting compounds can have specific physiological effects in T2R-expressing cells. For example, T2Rs are found in some gastrointestinal endocrine cells, including those that secrete the peptide hormones (e. g., ghrelin and glucagon-like peptide-1) in response to stimulation by bitter-tasting compounds. In the respiratory system, stimulation of T2Rs expressed in respiratory epithelia and smooth muscle has been implicated in protective airway reflexes, ciliary beating, and bronchodilation. If our hypothesis is confirmed, it would offer a new paradigm for understanding the off-target actions of diverse drugs and could reveal potential new therapeutic targets.-Clark, A. A., Liggett, S. B., Munger, S. D. Extraoral bitter taste receptors as mediators of off-target drug effects. FASEB J. 26, 4827-4831 (2012). www.fasebj.org	[Clark, Adam A.; Munger, Steven D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Clark, Adam A.; Munger, Steven D.] Univ Maryland, Sch Med, Toxicol Program, Baltimore, MD 21201 USA; [Munger, Steven D.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Dept Med, Baltimore, MD 21201 USA; [Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Med, Tampa, FL USA; [Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Ctr Personalized Med & Genom, Tampa, FL USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Munger, SD (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St,S251, Baltimore, MD 21201 USA.	smung001@umaryland.edu		Liggett, Stephen B./0000-0002-0128-3669	U.S. National Institute on Deafness and Other Communication Disorders [DC-010110]; U.S. National Heart, Lung, and Blood Institute [HL-071609]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010110] Funding Source: NIH RePORTER	U.S. National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support for this work was provided by the U.S. National Institute on Deafness and Other Communication Disorders, grant DC-010110 (to S. D. M.) and the U.S. National Heart, Lung, and Blood Institute, grant HL-071609 (to S. B. L.). The authors declare no conflicts of interest.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2012, AM J PHYSIOL-LUNG C, V303, pL304, DOI 10.1152/ajplung.00126.2012; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Behrens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040304; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Conte C, 2003, PHYSIOL GENOMICS, V14, P73, DOI 10.1152/physiolgenomics.00060.2003; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dotson CD, 2010, CURR OPIN INVEST DR, V11, P447; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Wooding S, 2010, CHEM SENSES, V35, P685, DOI 10.1093/chemse/bjq061; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yasuoka A, 2009, RESULTS PROBL CELL D, V47, P239, DOI 10.1007/400_2008_6	40	84	88	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4827	4831		10.1096/fj.12-215087	http://dx.doi.org/10.1096/fj.12-215087			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22964302	Green Published			2022-12-25	WOS:000311838300006
J	Grosse, J; Wehland, M; Pietsch, J; Schulz, H; Saar, K; Hubner, N; Eilles, C; Bauer, J; Abou-El-Ardat, K; Baatout, S; Ma, X; Infanger, M; Hemmersbach, R; Grimm, D				Grosse, Jirka; Wehland, Markus; Pietsch, Jessica; Schulz, Herbert; Saar, Katrin; Huebner, Norbert; Eilles, Christoph; Bauer, Johann; Abou-El-Ardat, Khalil; Baatout, Sarah; Ma, Xiao; Infanger, Manfred; Hemmersbach, Ruth; Grimm, Daniela			Gravity-sensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids	FASEB JOURNAL			English	Article						gene expression; simulated microgravity; cytokines; neoangiogenesis	NF-KAPPA-B; RANDOM POSITIONING MACHINE; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION PATTERNS; SIMULATED MICROGRAVITY; CARCINOMA CELLS; IN-VIVO; EXTRACELLULAR-MATRIX; PROTEIN	This study focused on the effects induced by a random positioning machine (RPM) on FTC-133 thyroid cancer cells and evaluated signaling elements involved in 3-dimensional multicellular tumor spheroid (MCTS) formation. The cells were cultured on the RPM, a device developed to simulate microgravity, and under static 1-g conditions. After 24 h on the RPM, MCTSs swimming in culture supernatants were found, in addition to growth of adherent (AD) cells. Cells grown on the RPM showed higher levels of NF-kappa B p65 protein and apoptosis than 1-g controls, a result also found earlier in endothelial cells. Employing microarray analysis, we found 487 significantly regulated transcripts belonging not only to the apoptosis pathway but also to other biological processes. Selected transcripts were analyzed with quantitative real-time PCR using the same samples. Compared with 1-g IL-6, IL-8, CD44, and OPN were significantly up-regulated in AD cells but not in MCTSs, while ERK1/2, CAV2, TLN1, and CTGF were significantly down-regulated in AD cells. Simultaneously, the expression of ERK2, IL-6, CAV2, TLN1, and CTGF was reduced in MCTSs. IL-6 protein expression and secretion mirrored its gene expression. Thus, we concluded that the signaling elements IL-6, IL-8, OPN, TLN1, and CTGF are involved with NF-kappa B p65 in RPM-dependent thyroid carcinoma cell spheroid formation.-Grosse, J., Wehland, M., Pietsch, J., Schulz, H., Saar, K., Hubner, N., Eilles, C., Bauer, J., Abou-El-Ardat, K., Baatout, S., Ma, X., Infanger, M., Hemmersbach, R., Grimm, D. Gravity-sensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids. FASEB J. 26, 5124-5140 (2012). www.fasebj.org	[Ma, Xiao; Grimm, Daniela] Aarhus Univ, Inst Biomed, DK-8000 Aarhus C, Denmark; [Grosse, Jirka; Eilles, Christoph] Univ Regensburg, Dept Nucl Med, Regensburg, Germany; [Wehland, Markus; Pietsch, Jessica; Infanger, Manfred; Grimm, Daniela] Univ Magdeburg, Clin Plast Aesthet & Hand Surg, D-39106 Magdeburg, Germany; [Schulz, Herbert; Saar, Katrin; Huebner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Bauer, Johann] Max Planck Inst Biochem, D-8033 Martinsried, Germany; [Abou-El-Ardat, Khalil; Baatout, Sarah] Belgian Nucl Res Ctr, Studiectr Kernenergie, Ctr Etud Energie Nucl SCK CEN, Mol, Belgium; [Abou-El-Ardat, Khalil; Baatout, Sarah] Univ Ghent, Dept Mol Biotechnol, Ghent, Belgium; [Hemmersbach, Ruth] German Aerosp Ctr, Inst Aerosp Med, Deutsch Zentrum Luft & Raumfahrt DLR, Cologne, Germany	Aarhus University; University of Regensburg; Otto von Guericke University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Belgian Nuclear Research Centre (SCK-CEN); Ghent University; Helmholtz Association; German Aerospace Centre (DLR)	Grimm, D (corresponding author), Aarhus Univ, Inst Biomed, Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	daniela.grimm@farm.au.dk		Saar, Kathrin/0000-0002-4483-1557; Grimm, Daniela/0000-0002-4991-3105; Wehland, Markus/0000-0002-8160-859X; Baatout, Sarah/0000-0001-8110-751X	European Space Agency (ESA) [CORA-GBF-2004-003-II, 20507, ESA-CORA-GBF-2010-202, 4000102463, ESA-CORA-GBF-2011-005, 4000104144]; Deutsches Zentrum fur Luft- und Raumfahrt (DLR; German Aerospace Agency) [50WB0824, 50WB1124]; Aarhus University, Denmark; University of Regensburg, Germany	European Space Agency (ESA)(European Space Agency); Deutsches Zentrum fur Luft- und Raumfahrt (DLR; German Aerospace Agency); Aarhus University, Denmark; University of Regensburg, Germany	The authors thank Henriette Dam and Heidi Skou Knudsen for their excellent technical assistance. This study was supported by the European Space Agency (ESA; CORA-GBF-2004-003-II, with contract 20507, ESA-CORA-GBF-2010-202 with contract 4000102463, ESA-CORA-GBF-2011-005 with contract 4000104144; D.G.), the Deutsches Zentrum fur Luft- und Raumfahrt (DLR; German Aerospace Agency; BMWi grants 50WB0824 and 50WB1124; D.G.), Aarhus University, Denmark (D.G.), and the University of Regensburg, Germany (C.E.).	Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Battista N, 2012, FASEB J, V26, P1791, DOI 10.1096/fj.11-199406; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Binder BR, 2002, NEWS PHYSIOL SCI, V17, P56, DOI 10.1152/nips.01369.2001; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Borst AG, 2009, MICROGRAVITY SCI TEC, V21, P287, DOI 10.1007/s12217-008-9043-2; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; De Winter P, 2008, GROWTH FACTORS, V26, P80, DOI 10.1080/08977190802025602; DUKE PJ, 1993, J CELL BIOCHEM, V51, P274, DOI 10.1002/jcb.240510306; Eberle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021496; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Fain JN, 2005, METABOLISM, V54, P220, DOI 10.1016/j.metabol.2004.08.016; Fay WP, 1997, BLOOD, V90, P204; Freeman MR, 2012, ADV EXP MED BIOL, V729, P95, DOI 10.1007/978-1-4614-1222-9_7; Goretzki P E, 1990, Recent Results Cancer Res, V118, P48; Grimm D, 1997, THYROID, V7, P859, DOI 10.1089/thy.1997.7.859; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Grimm D, 2009, CURR VASC PHARMACOL, V7, P347, DOI 10.2174/157016109788340640; Grimm D, 2009, TISSUE ENG PT A, V15, P2267, DOI 10.1089/ten.tea.2008.0576; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; Gupta M, 2005, J BIOL CHEM, V280, P8109, DOI 10.1074/jbc.M413697200; Haier J, 1999, CLIN EXP METASTAS, V17, P713, DOI 10.1023/A:1006754829564; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; Infanger M, 2004, J GRAVIT PHYSL, V11, P169; Infanger M, 2007, CARDIOVASC PATHOL, V16, P291, DOI 10.1016/j.carpath.2007.04.001; Ingram M, 1997, IN VITRO CELL DEV-AN, V33, P459; Irby R, 2004, CLIN EXP METASTAS, V21, P515, DOI 10.1007/s10585-004-2873-4; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; Jiang CG, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-122; Kim D, 2012, PATHOBIOLOGY, V79, P1, DOI 10.1159/000329472; Kim JY, 2009, CANCER RES TREAT, V41, P29, DOI 10.4143/crt.2009.41.1.29; Konstantinov SM, 2004, ANN NY ACAD SCI, V1030, P103, DOI 10.1196/annals.1329.013; Kossmehl P, 2006, APOPTOSIS, V11, P347, DOI 10.1007/s10495-006-4350-9; Leguy C. A. D., 2011, GRAVITATIONAL SPACE, V25, P36; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Magiera MM, 2004, BIOCHEM J, V382, P803, DOI 10.1042/BJ20040122; Margolis L, 1999, J UROLOGY, V161, P290, DOI 10.1016/S0022-5347(01)62134-7; Marrero B, 2009, IN VITRO CELL DEV-AN, V45, P523, DOI 10.1007/s11626-009-9217-2; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Pardo SJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1211, DOI 10.1152/ajpcell.00222.2004; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Pietsch J, 2012, PROTEOMICS, V12, P2539, DOI 10.1002/pmic.201200070; Pietsch J, 2011, PROTEOMICS, V11, P2095, DOI 10.1002/pmic.201000817; Pietsch J, 2010, PROTEOMICS, V10, P904, DOI 10.1002/pmic.200900226; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Savage K, 2008, BREAST CANCER RES TR, V110, P245, DOI 10.1007/s10549-007-9718-1; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schoenberger J, 2008, CURR MED CHEM, V15, P187, DOI 10.2174/092986708783330647; Schwarzenberg M, 1999, ADV SPACE RES, V24, P793, DOI 10.1016/S0273-1177(99)00075-7; Shimizu S, 2007, MOL HUM REPROD, V13, P181, DOI 10.1093/molehr/gal113; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Steffens S, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-25; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Ulbrich C, 2010, CELL PHYSIOL BIOCHEM, V25, P551, DOI 10.1159/000303059; Uva BM, 2002, EUR J HISTOCHEM, V46, P209; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; Vignoud L, 1997, J CELL SCI, V110, P1421; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Weber GF, 2011, CANCER GENOM PROTEOM, V8, P263; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328; Zhang X, 2008, CHEM ENG J, V135, pS82, DOI 10.1016/j.cej.2007.07.054; Zhu AX, 2009, J CLIN ONCOL, V27, P3027, DOI 10.1200/JCO.2008.20.9908	79	75	78	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2012	26	12					5124	5140		10.1096/fj.12-215749	http://dx.doi.org/10.1096/fj.12-215749			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22964303				2022-12-25	WOS:000311838300033
J	Jacobs, RA; Siebenmann, C; Hug, M; Toigo, M; Meinild, AK; Lundby, C				Jacobs, Robert A.; Siebenmann, Christoph; Hug, Mike; Toigo, Marco; Meinild, Anne-Kristine; Lundby, Carsten			Twenty-eight days at 3454-m altitude diminishes respiratory capacity but enhances efficiency in human skeletal muscle mitochondria	FASEB JOURNAL			English	Article						acclimatization; exercise; mitochondrial efficiency; respiratory control	OPERATION EVEREST-II; OXIDATIVE DNA-DAMAGE; HYPOXIA; ADAPTATIONS; PHOSPHORYLATION; ACCLIMATIZATION; EXERCISE	Modifications of skeletal muscle mitochondria following exposure to high altitude (HA) are generally studied by morphological examinations and biochemical analysis of expression. The aim of this study was to examine tangible measures of mitochondrial function following a prolonged exposure to HA. For this purpose, skeletal muscle biopsies were obtained from 8 lowland natives at sea level (SL) prior to exposure and again after 28 d of exposure to HA at 3454 m. High-resolution respirometry was performed on the muscle samples comparing respiratory capacity and efficiency. Exercise capacity was assessed at SL and HA. Respirometric analysis revealed that mitochondrial respiratory capacity diminished in complex I-and complex II-specific respiration in addition to a loss of maximal state-3 oxidative phosphorylation capacity from SL to HA, all independent from alterations in mitochondrial content. Leak control coupling, respiratory control ratio, and oligomycin-induced leak respiration, all measures of mitochondrial efficiency, improved in response to HA exposure. SL respiratory capacities correlated with measures of exercise capacity near SL, whereas mitochondrial efficiency correlated best with exercise capacity following HA. This data demonstrate that 1 mo of exposure to HA reduces respiratory capacity in human skeletal muscle; however, the efficiency of electron transport improves.-Jacobs, R. A., Siebenmann, C., Hug, M., Toigo, M., Meinild, A.-K., Lundby, C. Twenty-eight days at 3454-m altitude diminishes respiratory capacity but enhances efficiency in human skeletal muscle mitochondria. FASEB J. 26, 5192-5200 (2012). www.fasebj.org	[Lundby, Carsten] Univ Zurich, ZIHP, Inst Physiol, CH-8057 Zurich, Switzerland; [Jacobs, Robert A.; Siebenmann, Christoph; Toigo, Marco; Lundby, Carsten] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8057 Zurich, Switzerland; [Jacobs, Robert A.] Univ Zurich, Vetsuisse Fac, Inst Vet Physiol, CH-8057 Zurich, Switzerland; [Toigo, Marco] ETH, Inst Human Movement Sci, Dept Exercise Physiol, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lundby, C (corresponding author), Univ Zurich, ZIHP, Inst Physiol, Off 23 H 6,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	carsten.lundby@access.uzh.ch	Jacobs, Robert A/G-8439-2015	Jacobs, Robert A/0000-0003-0180-8266; Siebenmann, Christoph/0000-0002-0315-3761				ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; CHANCE B, 1955, J BIOL CHEM, V217, P409; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Green H, 2000, J APPL PHYSIOL, V88, P634, DOI 10.1152/jappl.2000.88.2.634; GREEN HJ, 1989, J APPL PHYSIOL, V66, P2454, DOI 10.1152/jappl.1989.66.5.2454; GREEN HJ, 1992, J APPL PHYSIOL, V73, P2701, DOI 10.1152/jappl.1992.73.6.2701; HOCHLI D, 1995, INT J SPORTS MED, V16, P343, DOI 10.1055/s-2007-973017; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; HOWALD H, 1990, INT J SPORTS MED, V11, pS10, DOI 10.1055/s-2007-1024847; Jacobs RA, 2011, J APPL PHYSIOL, V111, P1422, DOI 10.1152/japplphysiol.00625.2011; Jacobs R. A., 2012, EXP PHYSL IN PRESS; Jacobs RA, 2012, SPORTS MED, V42, P643, DOI 10.2165/11632440-000000000-00000; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lundby C, 2003, TOXICOLOGY, V192, P229, DOI 10.1016/S0300-483X(03)00328-7; MACDOUGALL JD, 1991, ACTA PHYSIOL SCAND, V142, P421, DOI 10.1111/j.1748-1716.1991.tb09176.x; MATHIEU O, 1981, RESP PHYSIOL, V44, P113, DOI 10.1016/0034-5687(81)90079-7; McCarthy J, 2011, J CELL PHYSIOL, V226, P2457, DOI 10.1002/jcp.22592; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Moller P, 2001, FASEB J, V15, P1181, DOI 10.1096/fj.00-0703com; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Ponsot E, 2010, AM J PHYSIOL-REG I, V298, pR558, DOI 10.1152/ajpregu.00216.2009; Rasmussen UF, 2000, ACTA PHYSIOL SCAND, V168, P473, DOI 10.1046/j.1365-201x.2000.00699.x; Robach P, 2012, BRIT J SPORT MED, V46, P822, DOI 10.1136/bjsports-2012-091078; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Vigano A, 2008, PROTEOMICS, V8, P4668, DOI 10.1002/pmic.200800232; WESTERTERP KR, 1992, J APPL PHYSIOL, V73, P1815, DOI 10.1152/jappl.1992.73.5.1815; Yin Y, 2010, J BIOL CHEM, V285, P17038, DOI 10.1074/jbc.M110.104364	37	63	63	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5192	5200		10.1096/fj.12-218206	http://dx.doi.org/10.1096/fj.12-218206			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22968913				2022-12-25	WOS:000311838300039
J	Won, HY; Lee, JY; Shin, DH; Park, JH; Nam, JS; Kim, HC; Kong, G				Won, Hee-Young; Lee, Jeong-Yeon; Shin, Dong-Hui; Park, Ji-Hye; Nam, Jeong-Seok; Kim, Hyoung-Chin; Kong, Gu			Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway	FASEB JOURNAL			English	Article						polycomb; stemness; self-renewal; Jagged-1	POLYCOMB GROUP PROTEINS; SELF-RENEWAL; TUMOR-SUPPRESSOR; PROSTATE-CANCER; SIDE POPULATION; POOR-PROGNOSIS; EXPRESSION; BMI1; TARGET; GENE	Mel-18 has been proposed as a negative regulator of Bmi-1, a cancer stem cell (CSC) marker, but it is still unclear whether Mel-18 is involved in CSC regulation. Here, we examined the effect of Mel-18 on the stemness of human breast CSCs. In Mel-18 small hairpin RNA (shRNA)-transduced MCF-7 cells, side population (SP) cells and breast CSC surface marker (CD44(+)/CD24(-)/ESA(+))-expressing cells, which imply a CSC population, were enriched. Moreover, the self-renewal of CSCs was enhanced by Mel-18 knockdown, as measured by the ability for tumorsphere formation in vitro and tumor-initiating capacity in vivo. Similarly, Mel-18 overexpression inhibited the number and self-renewal activity of breast CSCs in SK-BR-3 cells. Furthermore, our data showed that Mel-18 blockade up-regulated the expression of the Wnt/TCF target Jagged-1, a Notch ligand, and consequently activated the Notch pathway. Pharmacologic inhibition of the Notch and Wnt pathways abrogated Mel-18 knockdown-mediated tumorsphere formation ability. Taken together, our findings suggest that Mel-18 is a novel negative regulator of breast CSCs that inhibits the stem cell population and in vitro and in vivo self-renewal through the inactivation of Wnt-mediated Notch signaling.-Won, H.-Y., Lee, J.-Y., Shin, D.-H., Park, J.-H., Nam, J.-S., Kim, H.-C., Kong, G. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway. FASEB J. 26, 5002-5013 (2012). www.fasebj.org	[Won, Hee-Young; Shin, Dong-Hui; Park, Ji-Hye; Kong, Gu] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea; [Lee, Jeong-Yeon; Kong, Gu] Hanyang Univ, Inst Bioengn & Biopharmaceut Res, Seoul 133791, South Korea; [Nam, Jeong-Seok] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Lab Tumor Suppressor, Inchon, South Korea; [Kim, Hyoung-Chin] Korea Res Inst Biosci & Biotechnol, Biomed Mouse Resource Ctr, Cheongju, South Korea	Hanyang University; Hanyang University; Gachon University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kong, G (corresponding author), Hanyang Univ, Coll Med, Dept Pathol, 17 Haengdang Dong, Seoul 133791, South Korea.	gkong@hanyang.ac.kr			National Research Foundation of Korea; Korean Ministry of Education, Science, and Technology (MEST) [2011K000803]; Bio and Medical Technology Development Program of the National Research Foundation; MEST [2011-0027836]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Bio and Medical Technology Development Program of the National Research Foundation(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea, funded by the Korean Ministry of Education, Science, and Technology (MEST; grant 2011K000803) and the Bio and Medical Technology Development Program of the National Research Foundation, funded by MEST (grant 2011-0027836).	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guo BH, 2010, ANN ONCOL, V21, P2361, DOI 10.1093/annonc/mdq241; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Kajiume T, 2009, EXP HEMATOL, V37, P857, DOI 10.1016/j.exphem.2009.04.011; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Katoh M, 2006, INT J MOL MED, V17, P681; Kim RJ, 2010, CANCER LETT, V287, P172, DOI 10.1016/j.canlet.2009.06.010; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lee JY, 2008, CANCER RES, V68, P4201, DOI 10.1158/0008-5472.CAN-07-2570; Lin JT, 2010, ANN SURG ONCOL, V17, P2976, DOI 10.1245/s10434-010-1118-9; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; McDermott SP, 2010, MOL ONCOL, V4, P404, DOI 10.1016/j.molonc.2010.06.005; Nefedova Y, 2008, BLOOD, V111, P2220, DOI 10.1182/blood-2007-07-102632; Pannequin J, 2009, CANCER RES, V69, P6065, DOI 10.1158/0008-5472.CAN-08-2409; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Platet N, 2007, FEBS LETT, V581, P1435, DOI 10.1016/j.febslet.2007.02.071; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang W, 2009, INT J CANCER, V125, P2836, DOI 10.1002/ijc.24721; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	55	40	44	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5002	5013		10.1096/fj.12-209247	http://dx.doi.org/10.1096/fj.12-209247			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22954590				2022-12-25	WOS:000311838300022
J	Qadri, I; Choudhury, M; Rahman, SM; Knotts, TA; Janssen, RC; Schaack, J; Iwahashi, M; Puljak, L; Simon, FR; Kilic, G; Fitz, JG; Friedman, JE				Qadri, Ishtiaq; Choudhury, Mahua; Rahman, Shaikh Mizanoor; Knotts, Trina A.; Janssen, Rachel C.; Schaack, Jerome; Iwahashi, Mieko; Puljak, Livia; Simon, Francis R.; Kilic, Gordan; Fitz, J. Gregory; Friedman, Jacob E.			Increased Phosphoenolpyruvate Carboxykinase Gene Expression and Steatosis during Hepatitis C Virus Subgenome Replication ROLE OF NONSTRUCTURAL COMPONENT 5A AND CCAAT/ENHANCER-BINDING PROTEIN beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; CCAAT/ENHANCER-BINDING-PROTEIN; SERINE PHOSPHORYLATION; LIPID-ACCUMULATION; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; GLUCONEOGENESIS; TRANSCRIPTION; INFECTION; RESISTANCE	Chronic hepatitis C virus (HCV) infection greatly increases the risk for type 2 diabetes and nonalcoholic steatohepatitis; however, the pathogenic mechanisms remain incompletely understood. Here we report gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) transcription and associated transcription factors are dramatically up-regulated in Huh.8 cells, which stably express an HCV subgenome replicon. HCV increased activation of cAMP response element-binding protein (CREB), CCAAT/enhancer-binding protein (C/EBP beta), forkhead box protein O1 (FOXO1), and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and involved activation of the cAMP response element in the PEPCK promoter. Infection with dominant-negative CREB or C/EBP beta-shRNA significantly reduced or normalized PEPCK expression, with no change in PGC-1 alpha or FOXO1 levels. Notably, expression of HCV nonstructural component NS5A in Huh7 or primary hepatocytes stimulated PEPCK gene expression and glucose output in HepG2 cells, whereas a deletion in NS5A reduced PEPCK expression and lowered cellular lipids but was without effect on insulin resistance, as demonstrated by the inability of insulin to stimulate mobilization of a pool of insulin-responsive vesicles to the plasma membrane. HCV-replicating cells demonstrated increases in cellular lipids with insulin resistance at the level of the insulin receptor, increased insulin receptor substrate 1 (Ser-312), and decreased Akt (Ser-473) activation in response to insulin. C/EBP beta-RNAi normalized lipogenic genes sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor beta, and liver X receptor alpha but was unable to reduce accumulation of triglycerides in Huh.8 cells or reverse the increase in ApoB expression, suggesting a role for increased lipid retention in steatotic hepatocytes. Collectively, these data reveal an important role of NS5A, C/EBP beta, and pCREB in promoting HCV-induced gluconeogenic gene expression and suggest that increased C/EBP beta and NS5A may be essential components leading to increased gluconeogenesis associated with HCV infection.	[Qadri, Ishtiaq; Choudhury, Mahua; Rahman, Shaikh Mizanoor; Knotts, Trina A.; Janssen, Rachel C.; Friedman, Jacob E.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Schaack, Jerome] Univ Colorado Denver, Dept Microbiol, Aurora, CO 80045 USA; [Friedman, Jacob E.] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Iwahashi, Mieko; Simon, Francis R.] Univ Colorado Denver, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Puljak, Livia; Kilic, Gordan; Fitz, J. Gregory] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas	Friedman, JE (corresponding author), Univ Colorado Denver, Dept Pediat, Mail Stop 8106,12801 E 17th Ave, Aurora, CO 80045 USA.	Jed.Friedman@ucdenver.edu	Rahman, Shaikh Mizanoor/GLN-7518-2022; Puljak, Livia/D-5080-2017; Qadri, Ishtiaq/I-6889-2013	Rahman, Shaikh Mizanoor/0000-0002-4879-2663; Puljak, Livia/0000-0002-8467-6061; Qadri, Ishtiaq/0000-0003-4334-0585	National Institutes of Health [R01-DK46802, R01-DK43278, R01-DK46082, R01-DK59767]; Herman Lopeta Memorial Award; American Liver Foundation; American Diabetes Association Mentored Post-Doctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046082, R01DK043278, R01DK059767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman Lopeta Memorial Award; American Liver Foundation; American Diabetes Association Mentored Post-Doctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK46802 (to G. K.), R01-DK43278 (to J. G. F.), R01-DK46082 (to J. G. F.), and R01-DK59767 (to J. E. F.). This work was also supported by funding from the Herman Lopeta Memorial Award and the American Liver Foundation (to I. Q.) and by an American Diabetes Association Mentored Post-Doctoral Fellowship (to M. C.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bevan P, 2001, J CELL SCI, V114, P1429; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bugianesi E, 2012, J HEPATOL, V56, pS56, DOI 10.1016/S0168-8278(12)60007-5; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Choudhury M, 2008, ALCOHOL CLIN EXP RES, V32, P829, DOI 10.1111/j.1530-0277.2008.00630.x; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; Davis RC, 2010, DIABETES, V59, P1616, DOI 10.2337/db09-0878; De Gottardi A, 2006, ALIMENT PHARM THER, V23, P107, DOI 10.1111/j.1365-2036.2006.02729.x; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Jackel-Cram C, 2010, J GEN VIROL, V91, P1388, DOI 10.1099/vir.0.017418-0; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2010, WORLD J GASTROENTERO, V16, P1943, DOI 10.3748/wjg.v16.i16.1943; Kilic G, 2001, J BIOL CHEM, V276, P26762, DOI 10.1074/jbc.M100992200; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kim WR, 2002, MICROBES INFECT, V4, P1219, DOI 10.1016/S1286-4579(02)01649-0; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Monto A, 2002, HEPATOLOGY, V36, P729, DOI 10.1053/jhep.2002.35064; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Ortiz V, 2002, AM J GASTROENTEROL, V97, P2408, DOI 10.1111/j.1572-0241.2002.05995.x; OSHINO N, 1966, BIOCHIM BIOPHYS ACTA, V128, P13, DOI 10.1016/0926-6593(66)90137-8; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; PARK EA, 1993, J BIOL CHEM, V268, P613; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qadri I, 2004, BIOCHEM J, V378, P919, DOI 10.1042/BJ20031587; Rahman S. M., 2012, J BIOL CHEM IN PRESS; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Rahman SM, 2009, J LIPID RES, V50, P2193, DOI 10.1194/jlr.M800633-JLR200; Routes JM, 2000, BIOCHEM J, V352, P335, DOI 10.1042/0264-6021:3520335; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Shoji I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00278; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tanti JF, 2004, ANN ENDOCRINOL-PARIS, V65, P43, DOI 10.1016/S0003-4266(04)95629-6; Tellinghuisen TL, 2006, J VIROL, V80, P7450, DOI 10.1128/JVI.00358-06; Thuluvath PJ, 2003, AM J GASTROENTEROL, V98, P438, DOI 10.1016/S0002-9270(02)05924-5; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang CS, 2003, AM J EPIDEMIOL, V158, P1154, DOI 10.1093/aje/kwg259; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	57	18	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37340	37351		10.1074/jbc.M112.384743	http://dx.doi.org/10.1074/jbc.M112.384743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955269	Green Published, hybrid			2022-12-25	WOS:000310588500065
J	Goldman, AD; Baross, JA; Samudrala, R				Goldman, Aaron David; Baross, John A.; Samudrala, Ram			The Enzymatic and Metabolic Capabilities of Early Life	PLOS ONE			English	Article							PROTEIN FOLD ARCHITECTURE; UNIVERSAL COMMON ANCESTOR; PHYLOGENOMIC ANALYSIS; ZINC-SULFIDE; EVOLUTION; ORIGIN; PROTEOMES; WORLD; NETWORKS; ANNOTATION	We introduce the concept of metaconsensus and employ it to make high confidence predictions of early enzyme functions and the metabolic properties that they may have produced. Several independent studies have used comparative bioinformatics methods to identify taxonomically broad features of genomic sequence data, protein structure data, and metabolic pathway data in order to predict physiological features that were present in early, ancestral life forms. But all such methods carry with them some level of technical bias. Here, we cross-reference the results of these previous studies to determine enzyme functions predicted to be ancient by multiple methods. We survey modern metabolic pathways to identify those that maintain the highest frequency of metaconsensus enzymes. Using the full set of modern reactions catalyzed by these metaconsensus enzyme functions, we reconstruct a representative metabolic network that may reflect the core metabolism of early life forms. Our results show that ten enzyme functions, four hydrolases, three transferases, one oxidoreductase, one lyase, and one ligase, are determined by metaconsensus to be present at least as late as the last universal common ancestor. Subnetworks within central metabolic processes related to sugar and starch metabolism, amino acid biosynthesis, phospholipid metabolism, and CoA biosynthesis, have high frequencies of these enzyme functions. We demonstrate that a large metabolic network can be generated from this small number of enzyme functions.	[Goldman, Aaron David] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Baross, John A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Baross, John A.; Samudrala, Ram] Univ Washington, Ctr Astrobiol & Early Evolut, Seattle, WA 98195 USA; [Samudrala, Ram] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Goldman, AD (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	adg@princeton.edu			National Science Foundation Integrative Graduate Education and Research Traineeship through the Center for Astrobiology and Early Evolution at the University of Washington; Helen Whitely Graduate Fellowship Award through the Department of Microbiology at the University of Washington; National Science Foundation's Career Award [DBI-0217241]; NATIONAL LIBRARY OF MEDICINE [DP1LM011509] Funding Source: NIH RePORTER	National Science Foundation Integrative Graduate Education and Research Traineeship through the Center for Astrobiology and Early Evolution at the University of Washington; Helen Whitely Graduate Fellowship Award through the Department of Microbiology at the University of Washington; National Science Foundation's Career Award; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was primarily supported by the National Science Foundation Integrative Graduate Education and Research Traineeship through the Center for Astrobiology and Early Evolution at the University of Washington and the Helen Whitely Graduate Fellowship Award through the Department of Microbiology at the University of Washington. Additional funding came from the National Science Foundation's Career Award DBI-0217241. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becerra A, 2007, ANNU REV ECOL EVOL S, V38, P361, DOI 10.1146/annurev.ecolsys.38.091206.095825; Benson DA, 2010, NUCL ACIDS RES; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Caetano-Anolles G, 2005, J MOL EVOL, V60, P484, DOI 10.1007/s00239-004-0221-6; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Cody GD, 2004, ANNU REV EARTH PL SC, V32, P569, DOI 10.1146/annurev.earth.32.101802.120225; De Duve C., 1995, VITAL DUST ORIGIN EV; Delaye L, 2005, PHYS LIFE REV, V2, P47, DOI 10.1016/j.plrev.2004.12.002; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Doolittle FW, 1999, LOGIC CIRCUITS CARBO, V284, P2124; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Goldman AD, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-15; Goldman AD, 2012, EVOLUTION PROTEIN RE, P207; Goldman AD, 2012, OXYTRICHA MODERN ANA, DOI [10.1016/j.tig.2012.03.010, DOI 10.1016/J.TIG.2012.03.010]; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; Jadhav VR, 2002, BIOCHEMISTRY-US, V41, P723, DOI 10.1021/bi011803h; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kim HS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-351; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Lazcano A, 1999, J MOL EVOL, V49, P424, DOI 10.1007/PL00006565; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; McDermott J, 2003, NUCLEIC ACIDS RES, V31, P3736, DOI 10.1093/nar/gkg550; Mulkidjanian AY, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-26; Mulkidjanian AY, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-27; Petrey D, 2009, P NATL ACAD SCI USA, V106, P17377, DOI 10.1073/pnas.0907971106; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; Rao RP, 2008, PROSTAG OTH LIPID M, V85, P1, DOI 10.1016/j.prostaglandins.2007.10.002; Sadowski M, 2010, J STRUCT BI IN PRESS; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Shimizu M, 2008, J BIOCHEM, V144, P383, DOI 10.1093/jb/mvn073; Srinivasan V, 2009, BIOL BULL-US, V216, P126; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Theobald DL, 2010, NATURE, V465, P219, DOI 10.1038/nature09014; van der Gulik P, 2009, J THEOR BIOL, V261, P531, DOI 10.1016/j.jtbi.2009.09.004; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wang ML, 2006, MOL BIOL EVOL, V23, P2444, DOI 10.1093/molbev/msl117; Wang ML, 2006, COMPLEXITY, V12, P27, DOI 10.1002/cplx.20141; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	54	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e39912	10.1371/journal.pone.0039912	http://dx.doi.org/10.1371/journal.pone.0039912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970111	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400001
J	Bae, YK; Sung, JY; Kim, YN; Kim, S; Hong, KM; Kim, HT; Choi, MS; Kwon, JY; Shim, J				Bae, Young-Ki; Sung, Jee Young; Kim, Yong-Nyun; Kim, Sunshin; Hong, Kyeong Man; Kim, Heung Tae; Choi, Min Sung; Kwon, Jae Young; Shim, Jaegal			An In Vivo C. elegans Model System for Screening EGFR-Inhibiting Anti-Cancer Drugs	PLOS ONE			English	Article							CELL LUNG-CANCER; CAENORHABDITIS-ELEGANS; TYROSINE KINASE; GEFITINIB-RESISTANCE; ACQUIRED-RESISTANCE; VULVAL DEVELOPMENT; CLINICAL-RESPONSE; RECEPTOR; MUTATIONS; ENCODES	The epidermal growth factor receptor (EGFR) is a well-established target for cancer treatment. EGFR tyrosine kinase (TK) inhibitors, such as gefinitib and erlotinib, have been developed as anti-cancer drugs. Although non-small cell lung carcinoma with an activating EGFR mutation, L858R, responds well to gefinitib and erlotinib, tumors with a doubly mutated EGFR, T790M-L858R, acquire resistance to these drugs. The C. elegans EGFR homolog LET-23 and its downstream signaling pathway have been studied extensively to provide insight into regulatory mechanisms conserved from C. elegans to humans. To develop an in vivo screening system for potential cancer drugs targeting specific EGFR mutants, we expressed three LET-23 chimeras in which the TK domain was replaced with either the human wild-type TK domain (LET-23:: hEGFR-TK), a TK domain with the L858R mutation (LET-23:: hEGFR-TK[L858R]), or a TK domain with the T790M-L858R mutations (LET23:: hEGFR-TK[T790M-L858R]) in C. elegans vulval cells using the let-23 promoter. The wild-type hEGFR-TK chimeric protein rescued the let-23 mutant phenotype, and the activating mutant hEGFR-TK chimeras induced a multivulva (Muv) phenotype in a wild-type C. elegans background. The anti-cancer drugs gefitinib and erlotinib suppressed the Muv phenotype in LET23:: hEGFR-TK[L858R]-expressing transgenic animals, but not in LET-23:: hEGFR-TK[T790M-L858R] transgenic animals. As a pilot screen, 8,960 small chemicals were tested for Muv suppression, and AG1478 (an EGFR-TK inhibitor) and U0126 (a MEK inhibitor) were identified as potential inhibitors of EGFR-mediated biological function. In conclusion, transgenic C. elegans expressing chimeric LET-23:: hEGFR-TK proteins are a model system that can be used in mutation-specific screens for new anti-cancer drugs.	[Bae, Young-Ki; Kim, Yong-Nyun; Shim, Jaegal] Natl Canc Ctr, Comparat Biomed Res Branch, Goyang Si, Gyeonggi Do, South Korea; [Sung, Jee Young] Natl Canc Ctr, Pediat Oncol Res Branch, Goyang Si, Gyeonggi Do, South Korea; [Kim, Sunshin] Natl Canc Ctr, New Expt Therapeut Branch, Goyang Si, Gyeonggi Do, South Korea; [Hong, Kyeong Man] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Goyang Si, Gyeonggi Do, South Korea; [Kim, Heung Tae] Natl Canc Ctr, Ctr Lung Canc, Goyang Si, Gyeonggi Do, South Korea; [Choi, Min Sung; Kwon, Jae Young] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU)	Bae, YK (corresponding author), Natl Canc Ctr, Comparat Biomed Res Branch, Goyang Si, Gyeonggi Do, South Korea.	jaegal@ncc.re.kr			National Cancer Center of South Korea [NCC-1110060]; NIH National Center for Research Resources (NCRR)	National Cancer Center of South Korea; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was solely supported by a research grant from the National Cancer Center (NCC-1110060) of South Korea (www.ncc.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Korea Chemical Bank of KRICT for providing 7,680 chemicals. Some nematode strains including let-23, let-60, lin-15, JJ1136, PS4657 and PS3352 used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; BRENNER S, 1974, GENETICS, V77, P71; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Cappuzzo F, 2006, ANN ONCOL, V17, P1120, DOI 10.1093/annonc/mdl077; Chang C, 1999, CANCER METAST REV, V18, P203, DOI 10.1023/A:1006317206443; CLARK SG, 1994, GENETICS, V137, P987; Dengg Marlene, 2004, Journal of Pharmacological and Toxicological Methods, V50, P209, DOI 10.1016/j.vascn.2004.04.002; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gonzalez-Perez Vanessa, 2010, J Mol Signal, V5, P2, DOI 10.1186/1750-2187-5-2; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; HARA M, 1995, P NATL ACAD SCI USA, V92, P3333, DOI 10.1073/pnas.92.8.3333; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inoue T, 2005, P NATL ACAD SCI USA, V102, P4972, DOI 10.1073/pnas.0408122102; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kim TH, 2011, FEBS LETT, V585, P121, DOI 10.1016/j.febslet.2010.11.020; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Labouesse Michel, 2006, WormBook, P1; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Moghal N, 2003, EXP CELL RES, V284, P150, DOI 10.1016/S0014-4827(02)00097-6; Muhsin M, 2003, NAT REV DRUG DISCOV, V2, P515, DOI 10.1038/nrd1136; Myers TR, 2007, P NATL ACAD SCI USA, V104, P20368, DOI 10.1073/pnas.0709989104; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Uchida A, 2007, CANCER SCI, V98, P357, DOI 10.1111/j.1349-7006.2007.00387.x; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; Wong KK, 2009, RECENT PAT ANTI-CANC, V4, P28, DOI 10.2174/157489209787002461; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	43	14	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42441	10.1371/journal.pone.0042441	http://dx.doi.org/10.1371/journal.pone.0042441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957020	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800012
J	Fillon, SA; Harris, JK; Wagner, BD; Kelly, CJ; Stevens, MJ; Moore, W; Fang, R; Schroeder, S; Masterson, JC; Robertson, CE; Pace, NR; Ackerman, SJ; Furuta, GT				Fillon, Sophie A.; Harris, J. Kirk; Wagner, Brandie D.; Kelly, Caleb J.; Stevens, Mark J.; Moore, Wendy; Fang, Rui; Schroeder, Shauna; Masterson, Joanne C.; Robertson, Charles E.; Pace, Norman R.; Ackerman, Steven J.; Furuta, Glenn T.			Novel Device to Sample the Esophageal Microbiome-The Esophageal String Test	PLOS ONE			English	Article							ENTEROTEST DUODENAL CAPSULE; INFLAMMATORY BOWEL DISEASES; BARRETTS-ESOPHAGUS; BARCODED PRIMERS; DISTAL ESOPHAGUS; BACTERIAL BIOTA; DIVERSITY; INFECTIONS; DIAGNOSIS; TWINS	A growing number of studies implicate the microbiome in the pathogenesis of intestinal inflammation. Previous work has shown that adults with esophagitis related to gastroesophageal reflux disease have altered esophageal microbiota compared to those who do not have esophagitis. In these studies, sampling of the esophageal microbiome was accomplished by isolating DNA from esophageal biopsies obtained at the time of upper endoscopy. The aim of the current study was to identify the esophageal microbiome in pediatric individuals with normal esophageal mucosa using a minimally invasive, capsule-based string technology, the Enterotest (TM). We used the proximal segment of the Enterotest string to sample the esophagus, and term this the "Esophageal String Test" (EST). We hypothesized that the less invasive EST would capture mucosal adherent bacteria present in the esophagus in a similar fashion as mucosal biopsy. EST samples and mucosal biopsies were collected from children with no esophageal inflammation (n = 15) and their microbiome composition determined by 16S rRNA gene sequencing. Microbiota from esophageal biopsies and ESTs produced nearly identical profiles of bacterial genera and were different from the bacterial contents of samples collected from the nasal and oral cavity. We conclude that the minimally invasive EST can serve as a useful device for study of the esophageal microbiome.	[Fillon, Sophie A.; Kelly, Caleb J.; Moore, Wendy; Schroeder, Shauna; Masterson, Joanne C.; Furuta, Glenn T.] Univ Colorado Denver, Sect Gastroenterol Hepatol & Nutr,Dept Pediat, Gastrointestinal Eosinophil Dis Program,Sch Med, Childrens Hosp Colordo,Digest Hlth Inst,Mucosal I, Aurora, CO USA; [Harris, J. Kirk; Stevens, Mark J.] Univ Colorado Denver, Sch Med, Dept Pediat, Div Pulmonol, Aurora, CO USA; [Wagner, Brandie D.; Fang, Rui] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Robertson, Charles E.; Pace, Norman R.] Univ Colorado Boulder, Dept Mol Cellular & Dev Biol, Boulder, CO USA; [Ackerman, Steven J.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fillon, SA (corresponding author), Univ Colorado Denver, Sect Gastroenterol Hepatol & Nutr,Dept Pediat, Gastrointestinal Eosinophil Dis Program,Sch Med, Childrens Hosp Colordo,Digest Hlth Inst,Mucosal I, Aurora, CO USA.	sophie.fillon@ucdenver.edu		Wagner, brandie/0000-0002-2745-0103; ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202; Kelly, Caleb/0000-0003-4861-1479	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI [UL1 RR025780, KL2 RR025779]; American Partnership For Eosinophilic Disorders (APFED); Campaign Urging Research for Eosinophilic Diseases (CURED); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025779, UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI; American Partnership For Eosinophilic Disorders (APFED); Campaign Urging Research for Eosinophilic Diseases (CURED); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors recognize the support of REDCap for subjects' database supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI Grant Number UL1 RR025780. This work was supported by the American Partnership For Eosinophilic Disorders (APFED) Junior Faculty HOPE Research Grant (SF); National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI Grant Number KL2 RR025779 (SF) and UL1 RR025780 (GTF) and the Campaign Urging Research for Eosinophilic Diseases (CURED) (SJA/GTF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dahlen G, 2009, PERIODONTOL 2000, V49, P13, DOI 10.1111/j.1600-0757.2008.00295.x; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gagliardi D, 1998, Dis Esophagus, V11, P248; GOLDSMID JM, 1978, MED J AUSTRALIA, V1, P519, DOI 10.5694/j.1326-5377.1978.tb112594.x; GRACEY M, 1977, ARCH DIS CHILD, V52, P74, DOI 10.1136/adc.52.1.74; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2010, APPL ENV MICROBIOL; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kopanski Z, 1996, Eur J Med Res, V1, P520; Lawson R Daniel, 2010, Curr Gastroenterol Rep, V12, P259, DOI 10.1007/s11894-010-0111-6; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Leong RWL, 2003, WORLD J GASTROENTERO, V9, P309, DOI 10.3748/wjg.v9.i2.309; Macfarlane S, 2007, CLIN INFECT DIS, V45, P29, DOI 10.1086/518578; Michail S, 2011, INFLAMM BOWEL DIS; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Norder Grusell E, 2012, DIS ESOPHAGUS; Osias GL, 2004, DIGEST DIS SCI, V49, P228, DOI 10.1023/B:DDAS.0000017443.44802.4b; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pajecki D, 2002, J GASTROINTEST SURG, V6, P723, DOI 10.1016/S1091-255X(02)00028-8; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Pei ZH, 2005, WORLD J GASTROENTERO, V11, P7277, DOI 10.3748/wjg.v11.i46.7277; THOMAS GE, 1974, S AFR MED J, V48, P2219; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046	36	66	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42938	10.1371/journal.pone.0042938	http://dx.doi.org/10.1371/journal.pone.0042938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957025	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000308463800017
J	Gupta, S; Marcel, N; Talwar, S; Garg, M; Indulaxmi, R; Perumalsamy, LR; Sarin, A; Shivashankar, GV				Gupta, Soumya; Marcel, Nimi; Talwar, Shefali; Garg, Megha; Indulaxmi, R.; Perumalsamy, Lakshmi R.; Sarin, Apurva; Shivashankar, G. V.			Developmental Heterogeneity in DNA Packaging Patterns Influences T-Cell Activation and Transmigration	PLOS ONE			English	Article							KAPPA-B ACTIVATION; STEM-CELLS; GENOMIC ORGANIZATION; GENE-EXPRESSION; CHROMATIN; DIFFERENTIATION; PLASTICITY; PROTEINS; DYNAMICS; NUCLEOSOME	Cellular differentiation programs are accompanied by large-scale changes in nuclear organization and gene expression. In this context, accompanying transitions in chromatin assembly that facilitates changes in gene expression and cell behavior in a developmental system are poorly understood. Here, we address this gap and map structural changes in chromatin organization during murine T-cell development, to describe an unusual heterogeneity in chromatin organization and associated functional correlates in T-cell lineage. Confocal imaging of DNA assembly in cells isolated from bone marrow, thymus and spleen reveal the emergence of heterogeneous patterns in DNA organization in mature T-cells following their exit from the thymus. The central DNA pattern dominated in immature precursor cells in the thymus whereas both central and peripheral DNA patterns were observed in naive and memory cells in circulation. Naive T-cells with central DNA patterns exhibited higher mechanical pliability in response to compressive loads in vitro and transmigration assays in vivo, and demonstrated accelerated expression of activation-induced marker CD69. T-cell activation was characterized by marked redistribution of DNA assembly to a central DNA pattern and increased nuclear size. Notably, heterogeneity in DNA patterns recovered in cells induced into quiescence in culture, suggesting an internal regulatory mechanism for chromatin reorganization. Taken together, our results uncover an important component of plasticity in nuclear organization, reflected in chromatin assembly, during T-cell development, differentiation and transmigration.	[Gupta, Soumya; Marcel, Nimi; Talwar, Shefali; Garg, Megha; Indulaxmi, R.; Perumalsamy, Lakshmi R.; Sarin, Apurva; Shivashankar, G. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Gupta, Soumya; Talwar, Shefali; Shivashankar, G. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Gupta, Soumya; Talwar, Shefali; Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Marcel, Nimi] Manipal Univ, Dept Hlth Sci, Manipal, Karnataka, India; [Garg, Megha] Univ Mysore, Dept Biotechnol, Mysore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); National University of Singapore; National University of Singapore; Manipal Academy of Higher Education (MAHE); University of Mysore	Gupta, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	dbsgvs@nus.edu.sg			Nanoscience Initiative Grant from Department of Science and Technology, India; MechanoBiology Institute at National University of Singapore; Department of Biotechnology, India; Swarnajayanti Grant from Department of Science and Technology, India; Council of Scientific and Industrial Research	Nanoscience Initiative Grant from Department of Science and Technology, India; MechanoBiology Institute at National University of Singapore(National University of Singapore); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Swarnajayanti Grant from Department of Science and Technology, India; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	We thank the Nanoscience Initiative and Swarnajayanti Grants from the Department of Science and Technology, India, MechanoBiology Institute at National University of Singapore and Department of Biotechnology, India for funding. ST and LRP were funded by the Council of Scientific and Industrial Research, and MG was funded by Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075; Blazquez MV, 1999, AIDS RES HUM RETROV, V15, P1209, DOI 10.1089/088922299310304; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mehta IS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r5; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Purushothaman D, 2009, J EXP MED, V206, P1515, DOI 10.1084/jem.20082851; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Shivashankar GV, 2010, METHOD CELL BIOL, V98, pXIII, DOI 10.1016/S0091-679X(10)98019-9; Shu L, 2006, BLOOD CELL MOL DIS, V37, P64, DOI 10.1016/j.bcmd.2006.04.002; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sutcliffe EL, 2009, MOL CELL BIOL, V29, P1972, DOI 10.1128/MCB.01590-08; Wang ZF, 1996, GENOME RES, V6, P688, DOI 10.1101/gr.6.8.688; Westwood JA, 2005, P NATL ACAD SCI USA, V102, P19051, DOI 10.1073/pnas.0504312102; Wilson CB, 2006, CURR OPIN IMMUNOL, V18, P143, DOI 10.1016/j.coi.2006.01.013	40	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43718	10.1371/journal.pone.0043718	http://dx.doi.org/10.1371/journal.pone.0043718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957031	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000308463800023
J	Wurster, CM; Robertson, J; Westcott, DA; Dryden, B; Zazzo, A; Bird, MI				Wurster, Christopher M.; Robertson, Jack; Westcott, David A.; Dryden, Bart; Zazzo, Antoine; Bird, Michael I.			Utilization of Sugarcane Habitat by Feral Pig (Sus scrofa) in Northern Tropical Queensland: Evidence from the Stable Isotope Composition of Hair	PLOS ONE			English	Article							DIETARY CARBON TURNOVER; RAIN-FORESTS; PATTERNS; MANAGEMENT; MIGRATION; DIGGINGS; CO2	Feral pigs (Sus scrofa) are an invasive species that disrupt ecosystem functioning throughout their introduced range. In tropical environments, feral pigs are associated with predation and displacement of endangered species, modification of habitat, and act as a vector for the spread of exotic vegetation and disease. Across many parts of their introduced range, the diet of feral pigs is poorly known. Although the remote location and difficult terrain of far north Queensland makes observing feral pig behavior difficult, feral pigs are perceived to seek refuge in World Heritage tropical rainforests and seasonally 'crop raid' into lowland sugarcane crops. Thus, identifying how feral pigs are using different components of the landscape is important to the design of management strategies. We used the stable isotope composition of captured feral pigs to determine the extent of rainforest and sugarcane habitat usage. Recently grown hair (basal hair) from feral pigs captured in remote rainforest indicated pigs met their dietary needs solely within this habitat. Stable carbon and nitrogen isotope values of basal hair from feral pigs captured near sugarcane plantations were more variable, with some individuals estimated to consume over 85% of their diet within a sugarcane habitat, while a few consumed as much as 90% of their diet from adjacent forested environments. We estimated whether feral pigs switch habitats by sequentially sampling delta C-13 and delta N-15 values of long tail hair from a subset of seven captured animals, and demonstrate that four of these individuals moved between habitats. Our results indicate that feral pigs utilize both sugarcane and forest habitats, and can switch between these resources.	[Wurster, Christopher M.; Robertson, Jack; Bird, Michael I.] James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld, Australia; [Wurster, Christopher M.; Robertson, Jack; Bird, Michael I.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Westcott, David A.] Commonwealth Sci & Ind Res Org CSIRO Ecosyst Sci, Atherton, Qld, Australia; [Dryden, Bart] Terrain Nat Resource Management, Innisfail, Qld, Australia; [Zazzo, Antoine] CNRS, UMR 7209, Paris, France; [Zazzo, Antoine] Museum Natl Hist Nat, F-75231 Paris, France	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN)	Wurster, CM (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld, Australia.	christopher.wurster@jcu.edu.au	Westcott, David A/G-5559-2010; zazzo, Antoine/H-1697-2011; Wurster, Christopher M/A-1983-2011; Bird, Michael/G-5364-2010	zazzo, Antoine/0000-0001-7608-2207; Bird, Michael/0000-0003-1801-8703; Wurster, Christopher/0000-0002-2866-5798	Australian Government's Marine and Tropical Science Fund; Terrain Natural Resource Management (NRM) Ltd.; Austrailia Research Council [FF0883221]	Australian Government's Marine and Tropical Science Fund(Australian Government); Terrain Natural Resource Management (NRM) Ltd.; Austrailia Research Council	Funding for this work was provided by the Australian Government's Marine and Tropical Science Fund, Terrain Natural Resource Management (NRM) Ltd., and Austrailia Research Council Federation fellowship to MB (FF0883221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BD and Terrain NRM provided samples and information critical to this study, but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, on the analysis, interpretations.	Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bird MI, 1996, NATURE, V381, P143, DOI 10.1038/381143a0; Bird MI, 1997, GLOBAL BIOGEOCHEM CY, V11, P313, DOI 10.1029/97GB01197; Campbell TA, 2009, FOREST ECOL MANAG, V257, P2319, DOI 10.1016/j.foreco.2009.03.036; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cerling TE, 2004, AFR J ECOL, V42, P88, DOI 10.1111/j.1365-2028.2004.00500.x; Cerling TE, 2004, PALAEOGEOGR PALAEOCL, V206, P367, DOI 10.1016/j.palaeo.2004.01.013; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Cowled BD, 2008, CONSERV GENET, V9, P211, DOI 10.1007/s10592-007-9331-1; Ehleringer J.R., 2002, ENCY GLOBAL ENV CHAN, V2, P186; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Hilbert D. W., 2008, LIVING DYNAMIC TROPI, P107; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Huelsemann F, 2009, RAPID COMMUN MASS SP, V23, P2448, DOI 10.1002/rcm.4039; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Laurance WF, 1997, WILDLIFE RES, V24, P579, DOI 10.1071/WR96029; Mitchell J, 2007, WILDLIFE RES, V34, P597, DOI 10.1071/WR06064; Mitchell J, 2007, WILDLIFE RES, V34, P603, DOI 10.1071/WR06065; Mitchell J, 2009, WILDLIFE RES, V36, P110, DOI 10.1071/WR06066; Pavlov P, 1995, J MOUNTAIN ECOLOGY, V3, P148; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Spain A, 1997, BIOL FERT SOILS, V24, P118, DOI 10.1007/s003740050218; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Sponheimer M, 2007, KOEDOE AFRICAN PROTE, V46, P101; Stork NE, 2008, LIVING DYNAMIC TROPI, P4, DOI DOI 10.1002/9781444300321; The State of Queensland DoPIaF, 2008, PR083564 STAT QUEENS; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; WINTER J W, 1987, Proceedings of the Royal Society of Queensland, V98, P41; Zazzo A, 2007, CAN J ZOOL, V85, P1239, DOI 10.1139/Z07-110; Zazzo A, 2008, RAPID COMMUN MASS SP, V22, P2937, DOI 10.1002/rcm.3693	31	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43538	10.1371/journal.pone.0043538	http://dx.doi.org/10.1371/journal.pone.0043538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957029	gold, Green Published, Green Accepted			2022-12-25	WOS:000308463800021
J	Neal-McKinney, JM; Lu, X; Duong, T; Larson, CL; Call, DR; Shah, DH; Konkel, ME				Neal-McKinney, Jason M.; Lu, Xiaonan; Tri Duong; Larson, Charles L.; Call, Douglas R.; Shah, Devendra H.; Konkel, Michael E.			Production of Organic Acids by Probiotic Lactobacilli Can Be Used to Reduce Pathogen Load in Poultry	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI COLONIZATION; COMPETITIVE-EXCLUSION BACTERIA; GARLIC ALLIUM-SATIVUM; INFRARED-SPECTROSCOPY; BROILER-CHICKENS; IDENTIFICATION; MILK; SALMONELLA; TAXONOMY; PRIMALAC	Probiotic Lactobacillus can be used to reduce the colonization of pathogenic bacteria in food animals, and therefore reduce the risk of foodborne illness to consumers. As a model system, we examined the mechanism of protection conferred by Lactobacillus species to inhibit C. jejuni growth in vitro and reduce colonization in broiler chickens. Possible mechanisms for the reduction of pathogens by lactobacilli include: 1) stimulation of adaptive immunity; 2) alteration of the cecal microbiome; and, 3) production of inhibitory metabolites, such as organic acids. The Lactobacillus species produced lactic acid at concentrations sufficient to kill C. jejuni in vitro. We determined that lactic acid produced by Lactobacillus disrupted the membrane of C. jejuni, as judged by biophotonics. The spectral features obtained using Fourier-transform infrared (FTIR) and Raman spectroscopy techniques were used to accurately predict bacterial viability and differentiate C. jejuni samples according to lactic acid treatment. FT-IR spectral features of C. jejuni and Lactobacillus grown in co-culture revealed that the metabolism was dominated by Lactobacillus prior to the killing of C. jejuni. Based on our results, the development of future competitive exclusion strategies should include the evaluation of organic acid production.	[Neal-McKinney, Jason M.; Lu, Xiaonan; Tri Duong; Larson, Charles L.; Konkel, Michael E.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Call, Douglas R.; Shah, Devendra H.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University; Washington State University	Neal-McKinney, JM (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	konkel@vetmed.wsu.edu	Shah, Devendra H./S-4965-2016; Duong, Tri/B-5594-2012; Duong, Tri/F-9458-2019	Shah, Devendra H./0000-0001-6365-7868; Duong, Tri/0000-0002-4803-8564; Konkel, Michael/0000-0002-8950-0903	National Institutes of Health (NIH) [R56 AI088518-01A1]; United States Department of Agriculture, National Institute of Food and Agriculture [2011-67015-30772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI088518] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported from funds awarded to MEK from the National Institutes of Health (NIH, Award Number R56 AI088518-01A1) and from the United States Department of Agriculture, National Institute of Food and Agriculture (Award Number 2011-67015-30772). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qadiri HM, 2008, J DAIRY SCI, V91, P950, DOI 10.3168/jds.2007-0618; Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; BAREFOOT SF, 1993, J DAIRY SCI, V76, P2366, DOI 10.3168/jds.S0022-0302(93)77574-8; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Berndtson E, 1996, PREV VET MED, V26, P167, DOI 10.1016/0167-5877(95)01008-4; Byrd J. A., 2005, Food safety control in the poultry industry, P310; Chaveerach P, 2002, POULTRY SCI, V81, P621, DOI 10.1093/ps/81.5.621; Chen HC, 2001, APPL ENVIRON MICROB, V67, P848, DOI 10.1128/AEM.67.2.848-851.2001; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Corry JEL, 2001, J APPL MICROBIOL, V90, p96S, DOI 10.1046/j.1365-2672.2001.01358.x; Davis GS, 2002, POULTRY SCI, V81, P755, DOI 10.1093/ps/81.6.755; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Ding W, 2005, J FOOD PROTECT, V68, P2295, DOI 10.4315/0362-028X-68.11.2295; Dobson AE, 2007, J APPL MICROBIOL, V103, P1766, DOI 10.1111/j.1365-2672.2007.03417.x; Duong T, 2009, CURR OPIN BIOTECH, V20, P158, DOI 10.1016/j.copbio.2009.03.004; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Friedman C.R., 2000, CAMPYLOBACTER, P121; Haghighi HR, 2006, CLIN VACCINE IMMUNOL, V13, P975, DOI 10.1128/CVI.00161-06; Haghighi HR, 2005, CLIN DIAGN LAB IMMUN, V12, P1387, DOI 10.1128/CDLI.12.12.1387-1392.2005; Hakkinen M, 1999, BRIT POULTRY SCI, V40, P619, DOI 10.1080/00071669986990; Jacobs-Reitsma W, 2008, CAMPYLOBACTER, 3RD EDITION, P627; Koenen ME, 2004, BRIT POULTRY SCI, V45, P355, DOI 10.1080/00071660410001730851; Krebs C. J., 2014, ECOLOGICAL METHODOLO; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Lu XN, 2011, APPL ENVIRON MICROB, V77, P5257, DOI 10.1128/AEM.02845-10; Lu XN, 2011, J AGR FOOD CHEM, V59, P6376, DOI 10.1021/jf200953z; Lu XN, 2011, J AGR FOOD CHEM, V59, P5215, DOI 10.1021/jf201254f; Lu XN, 2011, FOOD BIOPROCESS TECH, V4, P919, DOI 10.1007/s11947-011-0516-8; Maniatis T., 1982, MOL CLONING; Mead GC, 1995, EPIDEMIOL INFECT, V115, P495, DOI 10.1017/S0950268800058659; Mercenier A, 2003, CURR PHARM DESIGN, V9, P175, DOI 10.2174/1381612033392224; Morishita TY, 1997, AVIAN DIS, V41, P850, DOI 10.2307/1592338; Nachamkin I., 2000, CAMPYLOBACTER, P155; Nava G. M., 2005, Animal Health Research Reviews, V6, P105, DOI 10.1079/AHR2005103; Nazef L, 2008, POULTRY SCI, V87, P329, DOI 10.3382/ps.2007-00282; Neal-McKinney JM, 2010, MOL MICROBIOL, V76, P918, DOI 10.1111/j.1365-2958.2010.07144.x; Nicolaou N, 2011, ANAL CHEM, V83, P5681, DOI 10.1021/ac2008256; Ogawa T, 2006, BRIT J NUTR, V95, P430, DOI 10.1079/BJN20051629; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; ROBINSON DA, 1981, BRIT MED J, V282, P1584, DOI 10.1136/bmj.282.6276.1584; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Sahin Orhan, 2002, Animal Health Research Reviews, V3, P95, DOI 10.1079/AHRR200244; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SCHOENI JL, 1992, APPL ENVIRON MICROB, V58, P664, DOI 10.1128/AEM.58.2.664-670.1992; SCHOENI JL, 1994, APPL ENVIRON MICROB, V60, P1191, DOI 10.1128/AEM.60.4.1191-1197.1994; Stern NJ, 2006, ANTIMICROB AGENTS CH, V50, P3111, DOI 10.1128/AAC.00259-06; Stern NJ, 2001, POULTRY SCI, V80, P156, DOI 10.1093/ps/80.2.156; Stiles ME, 1997, INT J FOOD MICROBIOL, V36, P1, DOI 10.1016/S0168-1605(96)01233-0; Talebi A, 2008, AVIAN PATHOL, V37, P509, DOI 10.1080/03079450802356995; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang GD, 2007, J FOOD PROTECT, V70, P867, DOI 10.4315/0362-028X-70.4.867; Zhao T, 2006, J FOOD PROTECT, V69, P762, DOI 10.4315/0362-028X-69.4.762; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	53	153	159	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43928	10.1371/journal.pone.0043928	http://dx.doi.org/10.1371/journal.pone.0043928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962594	Green Submitted, gold, Green Published			2022-12-25	WOS:000308577600022
J	Rai, A; Surolia, A; Panda, D				Rai, Ankit; Surolia, Avadhesha; Panda, Dulal			An Antitubulin Agent BCFMT Inhibits Proliferation of Cancer Cells and Induces Cell Death by Inhibiting Microtubule Dynamics	PLOS ONE			English	Article							INDIVIDUAL MICROTUBULES; KINETIC STABILIZATION; INTRACELLULAR-TRANSPORT; SUPPRESSES DYNAMICS; ASSEMBLY DYNAMICS; DRUG DISCOVERY; TUBULIN; RHODANINE; BINDING; APOPTOSIS	Using cell based screening assay, we identified a novel anti-tubulin agent (Z)-5-((5-(4-bromo-3-chlorophenyl)furan-2-yl)methylene)-2-thioxothiazolidin-4-one (BCFMT) that inhibited proliferation of human cervical carcinoma (HeLa) (IC50, 7.2 +/- 1.8 mu M), human breast adenocarcinoma (MCF-7) (IC50, 10.0 +/- 0.5 mu M), highly metastatic breast adenocarcinoma (MDA-MB-231) (IC50, 6.0 +/- 1 mu M), cisplatin-resistant human ovarian carcinoma (A2780-cis) (IC50, 5.8 +/- 0.3 mu M) and multi-drug resistant mouse mammary tumor (EMT6/AR1) (IC50, 6.5 +/- 1 mu M) cells. Using several complimentary strategies, BCFMT was found to inhibit cancer cell proliferation at G2/M phase of the cell cycle apparently by targeting microtubules. In addition, BCFMT strongly suppressed the dynamics of individual microtubules in live MCF-7 cells. At its half maximal proliferation inhibitory concentration (10 mu M), BCFMT reduced the rates of growing and shortening phases of microtubules in MCF-7 cells by 37 and 40%, respectively. Further, it increased the time microtubules spent in the pause (neither growing nor shortening detectably) state by 135% and reduced the dynamicity (dimer exchange per unit time) of microtubules by 70%. In vitro, BCFMT bound to tubulin with a dissociation constant of 8.3 +/- 1.8 mu M, inhibited tubulin assembly and suppressed GTPase activity of microtubules. BCFMT competitively inhibited the binding of BODIPY FL-vinblastine to tubulin with an inhibitory concentration (K-i) of 5.2 +/- 1.5 mu M suggesting that it binds to tubulin at the vinblastine site. In cultured cells, BCFMT-treatment depolymerized interphase microtubules, perturbed the spindle organization and accumulated checkpoint proteins (BubR1 and Mad2) at the kinetochores. BCFMT-treated MCF-7 cells showed enhanced nuclear accumulation of p53 and its downstream p21, which consequently activated apoptosis in these cells. The results suggested that BCFMT inhibits proliferation of several types of cancer cells including drug resistance cells by suppressing microtubule dynamics and indicated that the compound may have chemotherapeutic potential.	[Rai, Ankit; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Science (IISC) - Bangalore	Rai, A (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	surolia@mbu.iisc.ernet.in; panda@iitb.ac.in		Rai, Ankit/0000-0002-3732-3597	DAE-SRC fellowship, Department of Atomic energy; J.C. Bose fellowship, Government of India	DAE-SRC fellowship, Department of Atomic energy; J.C. Bose fellowship, Government of India	D.P. is supported by a DAE-SRC fellowship, Department of Atomic energy. A. S. is supported by a J.C. Bose fellowship, Government of India. A. R. is a CSIR (Council of Scientific & Industrial Research) fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Balis FM, 2002, J NATL CANCER I, V94, P78, DOI 10.1093/jnci/94.2.78; Beuria TK, 2009, BIOCHEM J, V423, P61, DOI 10.1042/BJ20090817; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; Bhattacharyya B, 2010, METHOD CELL BIOL, V95, P301, DOI 10.1016/S0091-679X(10)95017-6; Chatterji BP, 2011, EXPERT OPIN THER PAT, V21, P167, DOI 10.1517/13543776.2011.545349; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cruz-Monserrate Z, 2003, EUR J BIOCHEM, V270, P3822, DOI 10.1046/j.1432-1033.2003.03776.x; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; DHAMODHARAN R, 1995, MOL BIOL CELL, V6, P1215, DOI 10.1091/mbc.6.9.1215; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Drake DM, 2008, J PHARM SCI-US, V97, P1399, DOI 10.1002/jps.21106; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Dziadyk JM, 2004, ANTICANCER RES, V24, P27; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gerdes JM, 2005, HUM MOL GENET, V14, pR291, DOI 10.1093/hmg/ddi269; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303, DOI 10.2174/138945010790711996; Kamath K, 2003, CANCER RES, V63, P6026; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kumar G, 2007, J MED CHEM, V50, P2665, DOI 10.1021/jm061257w; Lam JKW, 2011, J DRUG TARGET, V19, P56, DOI 10.3109/10611861003733938; LEE JC, 1975, J BIOL CHEM, V250, P9276; Mohan R, 2006, BIOCHEMISTRY-US, V45, P5440, DOI 10.1021/bi0523409; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; O'Connor R, 2007, EXPERT OPIN DRUG MET, V3, P805, DOI 10.1517/17425255.3.6.805; PANDA D, 1992, BIOCHEMISTRY-US, V31, P9709, DOI 10.1021/bi00155a026; Panda D, 1997, P NATL ACAD SCI USA, V94, P10560, DOI 10.1073/pnas.94.20.10560; Panda D, 1998, P NATL ACAD SCI USA, V95, P9313, DOI 10.1073/pnas.95.16.9313; Pourroy B, 2004, MOL PHARMACOL, V66, P580; Ramkumar K, 2010, MOLECULES, V15, P3958, DOI 10.3390/molecules15063958; Rathinasamy K, 2006, FEBS J, V273, P4114, DOI 10.1111/j.1742-4658.2006.05413.x; Rathinasamy K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-213; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Sharma SV, 2008, NAT REV CANCER, V10, P241; Sing WT, 2001, BIOORG MED CHEM LETT, V11, P91, DOI 10.1016/S0960-894X(00)00610-7; Singh P, 2008, IUBMB LIFE, V60, P368, DOI 10.1002/iub.42; Singh P, 2012, BIOCHEMISTRY-US, V51, P5434, DOI 10.1021/bi201813u; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Srivastava P, 2007, FEBS J, V274, P4788, DOI 10.1111/j.1742-4658.2007.06004.x; Tomasic T, 2009, CURR MED CHEM, V16, P1596, DOI 10.2174/092986709788186200; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799	54	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44311	10.1371/journal.pone.0044311	http://dx.doi.org/10.1371/journal.pone.0044311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952952	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300078
J	Clarke, M; Pentz, R; Bobyn, J; Hayley, S				Clarke, Melanie; Pentz, Rowan; Bobyn, Jessica; Hayley, Shawn			Stressor-Like Effects of c-Jun N-Terminal Kinase (JNK) Inhibition	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOCORTICOID-RECEPTOR; PARKINSONS-DISEASE; HIPPOCAMPAL CA1; LOCUS-COERULEUS; BRAIN-INJURY; DEPRESSION; CORTICOSTERONE; RESPONSES; NEURONS	There is an urgent need for novel treatment strategies for stressor related disorders, particularly depression and anxiety disorders. Indeed, existing drug treatments are only clinically successful in a subset of patients and relapse is common. This likely stems from the fact that stressor disorders are heterogeneous with multiple biological pathways being affected. To this end, the present investigation sought to assess in mice the contribution of the c-Jun N terminal kinase (JNK) pathway to the behavioral, hormonal and neurochemical effects of an acute stressor. Indeed, although JNK has been shown to modulate glucocorticoid receptors in vitro, virtually nothing is known of the role for JNK in affecting stressor induced pathology. We presently found that the JNK antagonist, SP600125, (but not the p38 antagonist, SB203580) increased plasma corticosterone levels under resting conditions and in the context of an acute stressor (wet bedding + restraint). SP600125 also reduced exploration in an open field arena, but prevented the stressor induced increase in open arm exploration in an elevated plus maze. Finally, SP600125 affected noradrenergic activity in the central amygdala and locus coruleus under resting condition, but prevented the noradrenergic effects within the paraventricular nucleus of the hypothalamus that were induced by the acute stressor exposure. These data suggest inhibiting endogenous JNK can have stressor-like corticoid, behavioral and central monoamine effects under basal conditions, but can actually reverse some behavioral and neurochemical effects of an acute stressor. Thus, endogenous JNK appears to affect stress relevant processes in a context-dependent manner.	[Clarke, Melanie; Pentz, Rowan; Bobyn, Jessica; Hayley, Shawn] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Clarke, M (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	shawn_hayley@carleton.ca			CIHR (Canadian Institutes of Health Research); NSERC (Natural Sciences and Engineering Research Council of Canada); NSERC scholarship	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by grants to S.H. from the CIHR (Canadian Institutes of Health Research) and NSERC (Natural Sciences and Engineering Research Council of Canada). M.C. was supported, in part, by an NSERC scholarship. S.H. is a Canada Research Chair in Neuroscience (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1988, BRAIN RES, V441, P362, DOI 10.1016/0006-8993(88)91415-1; Adzic M, 2009, J ENDOCRINOL, V202, P87, DOI 10.1677/JOE-08-0509; Anisman H, 2009, J PSYCHIATR NEUROSCI, V34, P4; Bevilaqua LRM, 2003, EUR J NEUROSCI, V17, P897, DOI 10.1046/j.1460-9568.2003.02524.x; Bland ST, 2006, NEUROREPORT, V17, P593, DOI 10.1097/00001756-200604240-00008; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Bruna A, 2003, EMBO J, V22, P6035, DOI 10.1093/emboj/cdg590; Budziszewska B, 2010, J PHYSIOL PHARMACOL, V61, P207; CHANPALAY V, 1993, ADV NEUROL, V60, P438; Choi DC, 2008, PSYCHONEUROENDOCRINO, V33, P659, DOI 10.1016/j.psyneuen.2008.02.006; Colombo A, 2007, CELL DEATH DIFFER, V14, P1845, DOI 10.1038/sj.cdd.4402202; Curran BP, 2003, NEUROSCIENCE, V118, P347, DOI 10.1016/S0306-4522(02)00941-7; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; De Oliveira ACP, 2008, GLIA, V56, P844, DOI 10.1002/glia.20658; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; FELDMAN S, 1994, BRAIN RES, V658, P21, DOI 10.1016/S0006-8993(09)90005-1; Frodl T, 2012, NEUROBIOL D IN PRESS; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Haeusgen W, 2009, NEUROSCIENCE, V161, P951, DOI 10.1016/j.neuroscience.2009.04.014; Harvey BH, 2006, PHYSIOL BEHAV, V87, P881, DOI 10.1016/j.physbeh.2006.01.033; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; JOHNSON RW, 1993, PHYSIOL BEHAV, V53, P127, DOI 10.1016/0031-9384(93)90020-G; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Karten YJG, 1999, P NATL ACAD SCI USA, V96, P13456, DOI 10.1073/pnas.96.23.13456; Li HH, 2009, BEHAV BRAIN RES, V205, P32, DOI 10.1016/j.bbr.2009.06.036; Li XM, 2007, EUR J NEUROSCI, V25, P391, DOI 10.1111/j.1460-9568.2006.05300.x; Ma S, 2008, NEUROSCIENCE, V154, P1639, DOI 10.1016/j.neuroscience.2008.04.068; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Meller E, 2003, BRAIN RES, V979, P57, DOI 10.1016/S0006-8993(03)02866-X; Niimi K, 2011, BIOCHEM BIOPH RES CO, V406, P524, DOI 10.1016/j.bbrc.2011.02.071; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Roy V, 2007, BEHAV BRAIN RES, V185, P49, DOI 10.1016/j.bbr.2007.07.008; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Szumlinski KK, 2001, PHARMACOL BIOCHEM BE, V69, P485, DOI 10.1016/S0091-3057(01)00564-0; Tanaka M, 1983, PHARM BIOCH BEHAV, V19, P287; Unger EK, 2010, ENDOCRINOLOGY, V151, P671, DOI 10.1210/en.2009-0711; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Wang WY, 2004, NEUROSCI RES, V48, P195, DOI 10.1016/j.neures.2003.10.012; Wang XH, 2005, NEUROPSYCHOPHARMACOL, V30, P242, DOI 10.1038/sj.npp.1300606; Watanabe G, 1997, J BIOL CHEM, V272, P20063, DOI 10.1074/jbc.272.32.20063; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281; Yoshimura K, 2011, NEUROSCI RES, V71, P266, DOI 10.1016/j.neures.2011.07.1830; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	51	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44073	10.1371/journal.pone.0044073	http://dx.doi.org/10.1371/journal.pone.0044073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952879	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000079
J	Xing, LD; Bell, PR; Persons, WS; Ji, SA; Miyashita, T; Burns, ME; Ji, Q; Currie, PJ				Xing, Lida; Bell, Phil R.; Persons, W. Scott; Ji, Shuan; Miyashita, Tetsuto; Burns, Michael E.; Ji, Qiang; Currie, Philip J.			Abdominal Contents from Two Large Early Cretaceous Compsognathids (Dinosauria: Theropoda) Demonstrate Feeding on Confuciusornithids and Dromaeosaurids	PLOS ONE			English	Article							FEATHERED DINOSAURS; YIXIAN FORMATION; BIRD; DIET; TISSUE; PRESERVATION; VERTEBRATES; EVOLUTION; PATTERNS; ANATOMY	Two skeletons of the large compsognathid Sinocalliopteryx gigas include intact abdominal contents. Both specimens come from the Jianshangou Beds of the lower Yixian Formation (Neocomian), Liaoning, China. The holotype of S. gigas preserves a partial dromaeosaurid leg in the abdominal cavity, here attributed to Sinornithosaurus. A second, newly-discovered specimen preserves the remains of at least two individuals of the primitive avialan, Confuciusornis sanctus, in addition to acid-etched bones from a possible ornithischian. Although it cannot be stated whether such prey items were scavenged or actively hunted, the presence of two Confuciusornis in a grossly similar state of digestion suggests they were consumed in rapid succession. Given the lack of clear arboreal adaptations in Sinocalliopteryx, we suggest it may have been an adept stealth hunter.	[Xing, Lida; Persons, W. Scott; Miyashita, Tetsuto; Burns, Michael E.; Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Bell, Phil R.] Pipestone Creek Dinosaur Initiat, Clairmont, AB, Canada; [Ji, Shuan; Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China	University of Alberta; Chinese Academy of Geological Sciences	Xing, LD (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	philbyb@gmail.com	Burns, Michael E/GPC-8311-2022	Xing, Lida/0000-0003-3923-9206; Burns, Michael/0000-0002-9587-563X				[Anonymous], HOWE RANCH DINOSAURS; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Chen PJ, 2005, SCI CHINA SER D, V48, P298, DOI 10.1360/04yd0038; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe LM, 2010, NEUES JAHRB GEOL P-A, V258, P257, DOI 10.1127/0077-7749/2010/0125; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Chin K, 2003, PALAIOS, V18, P286, DOI 10.1669/0883-1351(2003)018<0286:RPOUMT>2.0.CO;2; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Dal Sasso C, 1998, NATURE, V392, P383; Dal Sasso Cristiano, 2011, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V37, P1; Dalsatt J, 2006, NATURWISSENSCHAFTEN, V93, P444, DOI 10.1007/s00114-006-0125-y; De Klerk WJ, 2000, J VERTEBR PALEONTOL, V20, P324, DOI 10.1671/0272-4634(2000)020[0324:ANCDFT]2.0.CO;2; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dong Z., 2000, VERTEBRATA PALASIA S, V38, P10; Farmer CG, 2008, PHYSIOL BIOCHEM ZOOL, V81, P125, DOI 10.1086/524150; Fursich FT, 2007, PALAEOGEOGR PALAEOCL, V253, P434, DOI 10.1016/j.palaeo.2007.06.012; Gishlick AD, 2007, ZOOL J LINN SOC-LOND, V149, P569, DOI 10.1111/j.1096-3642.2007.00269.x; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; HOU LH, 1995, NATURE, V377, P616, DOI 10.1038/377616a0; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Huchzermeyer F.W., 2003, CROCODILES BIOL HUSB; Hunter Luke, 2005, CATS AFRICA BEHAV EC; Hurum JH, 2006, ACTA PALAEONTOL POL, V51, P1; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji S, 2007, ACTA GEOL SIN-ENGL, V81, P8; Kingdon J., 1977, E AFRICAN MAMMALS A; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; LOSOS JB, 1988, BIOL J LINN SOC, V35, P379, DOI 10.1111/j.1095-8312.1988.tb00477.x; Martin LD, 1998, NATURWISSENSCHAFTEN, V85, P286, DOI 10.1007/s001140050501; Marugan-Lobon J, 2011, J SYST PALAEONTOL, V9, P91, DOI 10.1080/14772019.2010.517786; Mateus Isabel, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P101; Norell Mark A., 1999, American Museum Novitates, V3282, P1; O'Connor J, 2011, P NATL ACAD SCI USA, V108, P19662, DOI 10.1073/pnas.1117727108; OSTROM J H, 1978, Zitteliana, V4, P73; Peyer K, 2006, J VERTEBR PALEONTOL, V26, P879, DOI 10.1671/0272-4634(2006)26[879:AROCFT]2.0.CO;2; Qiang J, 1999, J VERTEBR PALEONTOL, V19, P1, DOI 10.1080/02724634.1999.10011117; RICHARDS DF, 1977, J ZOOL, V183, P495, DOI 10.1111/j.1469-7998.1977.tb04201.x; Rodriguez-Robles JA, 1999, J ZOOL, V248, P49; SARGEANT AB, 1984, WILDLIFE MONOGR, P1; SLIP DJ, 1988, J HERPETOL, V22, P323, DOI 10.2307/1564156; Smithers R. H. N., 1971, MUS MEM NAT MUS MONU, V4, P1; Stevens CE., 1995, COMP PHYSL VERTEBRAT, DOI 10.1086/416640; Sturkie P., 2000, AVIAN PHYSL; Sunquist ME, 2002, WILD CATS WORLD; Suzuki S, 2000, HAYASHIBARA MUS NAT, V1, P83; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Uriona TJ, 2005, J EXP BIOL, V208, P3047, DOI 10.1242/jeb.01746; Vestjens WJM, 1976, EMU, V77, P36; Whittle Christopher H., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P75; Whittow GC, 2000, STURKIES AVIAN PHYSL; Wings O, 2007, ACTA PALAEONTOL POL, V52, P1; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu X., 2000, SPECIAL PUBLICATION, V2000, P179; Xu Xing, 2004, Vertebrata Palasiatica, V42, P111; Xu Xing, 1998, Vertebrata Palasiatica, V36, P147; [袁崇喜 Yuan Chongxi], 2004, [地质学报, Acta Geologica Sinica], V78, P464; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zheng WJ, 2012, CRETACEOUS RES, V34, P208, DOI 10.1016/j.cretres.2011.11.001; Zheng X, 2010, P ROY SOC B, V22, P211; Zheng XT, 2011, P NATL ACAD SCI USA, V108, P15904, DOI 10.1073/pnas.1112694108; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P571, DOI 10.1007/s00114-004-0567-z; Zhou Zhong-He, 2009, Vertebrata Palasiatica, V47, P299; Zhou ZH, 2010, SCI CHINA EARTH SCI, V53, P1894, DOI 10.1007/s11430-010-4094-9	71	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44012	10.1371/journal.pone.0044012	http://dx.doi.org/10.1371/journal.pone.0044012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952855	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000069
J	Campos, F; Perez-Mato, M; Agulla, J; Blanco, M; Barral, D; Almeida, A; Brea, D; Waeber, C; Castillo, J; Ramos-Cabrer, P				Campos, Francisco; Perez-Mato, Maria; Agulla, Jesus; Blanco, Miguel; Barral, David; Almeida, Angeles; Brea, David; Waeber, Christian; Castillo, Jose; Ramos-Cabrer, Pedro			Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; MILD HYPOTHERMIA; BLOOD-FLOW; OXALOACETATE; LACTATE; SPECTROSCOPY; COMBINATION; METABOLISM; GLUCOSE; DEATH	Glutamate excitotoxicity, metabolic rate and inflammatory response have been associated to the deleterious effects of temperature during the acute phase of stroke. So far, the association of temperature with these mechanisms has been studied individually. However, the simultaneous study of the influence of temperature on these mechanisms is necessary to clarify their contributions to temperature-mediated ischemic damage. We used non-invasive Magnetic Resonance Spectroscopy to simultaneously measure temperature, glutamate excitotoxicity and metabolic rate in the brain in animal models of ischemia. The immune response to ischemia was measured through molecular serum markers in peripheral blood. We submitted groups of animals to different experimental conditions (hypothermia at 33 degrees C, normothermia at 37 degrees C and hyperthermia at 39 degrees C), and combined these conditions with pharmacological modulation of glutamate levels in the brain through systemic injections of glutamate and oxaloacetate. We show that pharmacological modulation of glutamate levels can neutralize the deleterious effects of hyperthermia and the beneficial effects of hypothermia, however the analysis of the inflammatory response and metabolic rate, demonstrated that their effects on ischemic damage are less critical than glutamate excitotoxity. We conclude that glutamate excitotoxicity is the key molecular mechanism which is influenced by body temperature during the acute phase of brain stroke.	[Campos, Francisco; Perez-Mato, Maria; Agulla, Jesus; Blanco, Miguel; Barral, David; Brea, David; Castillo, Jose; Ramos-Cabrer, Pedro] Univ Santiago de Compostela, IDIS, Hosp Univ Santiago, Clin Neurosci Res Lab,Dept Neurol, Santiago De Compostela, Spain; [Almeida, Angeles] Hosp Univ Salamanca, Res Unit, Salamanca, Spain; [Almeida, Angeles] Inst Hlth Sci Castilla & Leon, Salamanca, Spain; [Almeida, Angeles] Univ Salamanca, Dept Biochem & Mol Biol, E-37008 Salamanca, Spain; [Waeber, Christian] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA	Universidade de Santiago de Compostela; University of Salamanca; University of Salamanca; Harvard University; Massachusetts General Hospital	Campos, F (corresponding author), Univ Santiago de Compostela, IDIS, Hosp Univ Santiago, Clin Neurosci Res Lab,Dept Neurol, Santiago De Compostela, Spain.	francampos@linc-stg.eu; pedro.ramos@usc.es	Ramos-Cabrer, Pedro/J-5306-2014; Agulla, Jesus/E-2326-2018; Ramos-Cabrer, Pedro/AAF-1467-2020; ALMEIDA, ANGELES/B-4727-2017; Barral, David/AAA-3314-2020; Waeber, Christian/B-3171-2016; Brea López, David/M-1128-2015; Waeber, Christian/A-8333-2009	Ramos-Cabrer, Pedro/0000-0003-0368-7031; Agulla, Jesus/0000-0001-9574-2549; Ramos-Cabrer, Pedro/0000-0003-0368-7031; ALMEIDA, ANGELES/0000-0003-0485-8904; Barral, David/0000-0001-6658-4684; Waeber, Christian/0000-0001-6078-0027; Brea López, David/0000-0003-2365-7374; Waeber, Christian/0000-0001-6078-0027; Castillo, Jose/0000-0002-6685-3001	Spanish Ministry of Science and Innovation [SAF2011-30517]; Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III [RETICS-RD06/0026]; Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio) [09CSA057918PR]; Xunta de Galicia (Conselleria de Sanidade) [PS09/32]; Xunta de Galicia (Fundacion Mutua Madrilena); Red de Investigacion Cooperativa Neurovascular	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III(Instituto de Salud Carlos III); Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio)(Xunta de Galicia); Xunta de Galicia (Conselleria de Sanidade)(Xunta de Galicia); Xunta de Galicia (Fundacion Mutua Madrilena)(Xunta de Galicia); Red de Investigacion Cooperativa Neurovascular	This project has been partially supported by grants from the Spanish Ministry of Science and Innovation SAF2011-30517 and Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III, RETICS-RD06/0026; Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio: 09CSA057918PR; Conselleria de Sanidade: PS09/32 and; Fundacion Mutua Madrilena and by Red de Investigacion Cooperativa Neurovascular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668; Antonelli T, 2008, CEREB CORTEX, V18, P1748, DOI 10.1093/cercor/bhm217; Berger R, 1998, DEV BRAIN RES, V105, P67, DOI 10.1016/S0165-3806(97)00165-X; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; Brea D, 2011, REV NEUROLOGIA, V52, P12, DOI 10.33588/rn.5201.2010494; Brea D, 2011, CLIN IMMUNOL, V139, P193, DOI 10.1016/j.clim.2011.02.001; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Campos F, 2012, NEUROCHEM INT, V60, P495, DOI 10.1016/j.neuint.2012.02.003; Campos F, 2012, INT J BIOCHEM CELL B, V44, P262, DOI 10.1016/j.biocel.2011.11.003; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Castellanos M, 2008, NEUROLOGY, V71, P1862, DOI 10.1212/01.wnl.0000326064.42186.7e; Castellanos Mar, 2007, Cerebrovasc Dis, V24 Suppl 1, P7, DOI 10.1159/000107374; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1999, CEREBROVASC DIS, V9, P1, DOI 10.1159/000047548; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Clark DL, 2008, EXP NEUROL, V212, P386, DOI 10.1016/j.expneurol.2008.04.016; Davalos A, 1997, CEREBROVASC DIS, V7, P64, DOI 10.1159/000108169; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Germain D, 2001, MAGN RESON MATER PHY, V13, P47, DOI 10.1016/S1352-8661(01)00123-5; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Higuchi T, 1997, MAGNET RESON MED, V37, P851, DOI 10.1002/mrm.1910370608; Karaszewski B, 2006, ANN NEUROL, V60, P438, DOI 10.1002/ana.20957; Karaszewski B, 2009, BRAIN, V132, P955, DOI 10.1093/brain/awp010; LO EH, 1992, STROKE, V23, P889, DOI 10.1161/01.STR.23.6.889; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Paxinos G, 2008, RAT BRAIN STEREOTAXI; Rodriguez-Yanez M, 2008, CURR OPIN NEUROL, V21, P353, DOI 10.1097/WCO.0b013e3282ffafbf; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; STILLMAN AE, 1993, JMRI-J MAGN RESON IM, V3, P682, DOI 10.1002/jmri.1880030421; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tomsick TA, 2010, NEUROLOGY, V74, P1069, DOI 10.1212/WNL.0b013e3181d76b8f; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; WHITE JA, 1986, J AUTOM CHEM, V8, P170, DOI 10.1155/S1463924686000330; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zaremba J, 2004, MED SCI MONITOR, V10, pRA148; Zausinger S, 2003, STROKE, V34, P1526, DOI 10.1161/01.STR.0000070841.31224.29; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540; Zhu HD, 2005, EXP NEUROL, V193, P361, DOI 10.1016/j.expneurol.2005.01.022; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731; Zlotnik A, 2010, ANESTH ANALG, V111, P1497, DOI 10.1213/ANE.0b013e3181fc0112	45	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44191	10.1371/journal.pone.0044191	http://dx.doi.org/10.1371/journal.pone.0044191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952923	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600090
J	Bojesen, KB; Clausen, O; Rohde, K; Christensen, C; Zhang, LJ; Li, SZ; Kohler, L; Nielbo, S; Nielsen, J; Gjorlund, MD; Poulsen, FM; Bock, E; Berezin, V				Bojesen, Kirsten B.; Clausen, Ole; Rohde, Kristian; Christensen, Claus; Zhang, Lanjun; Li, Shizhong; Kohler, Lene; Nielbo, Steen; Nielsen, Janne; Gjorlund, Michelle D.; Poulsen, Flemming M.; Bock, Elisabeth; Berezin, Vladimir			Nectin-1 Binds and Signals through the Fibroblast Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; FGF-RECEPTOR; NEURITE OUTGROWTH; V-DOMAIN; AFADIN; IMMUNOGLOBULIN; EXPRESSION; INTERACTS; CADHERIN; FAMILY	Nectins belong to a family of immunoglobulin (Ig)-like celladhesion molecules comprising four members, nectin-1 through nectin-4. Nectins are involved in formation of the mechanical adhesive puncta adherentia junctions of synapses. Nectins share the same overall structural topology with an extracellular region containing three Ig modules, a transmembrane region, and a cytoplasmic region. In nectin-1, the first and second Ig module in the extracellular region are necessary for the trans-interaction with nectin-3 and formation of cis-dimers, respectively. The function of the third Ig module of nectin-1 remains unknown. We here report the structure in solution of the third, membrane-proximal Ig module of mouse nectin-1 (nectin-1 Ig3) solved by means of nuclear magnetic resonance (NMR) spectroscopy. It belongs to the C1 set of the Ig superfamily. Nectin-1 Ig3 was produced as a recombinant protein and induced neurite outgrowth in primary cultures of hippocampal and cerebellar granule neurons, an effect abolished by treatment with the fibroblast growth factor receptor (FGFR) inhibitor SU5402, or by transfection with a dominant-negative FGFR1 construct. We showed by surface plasmon resonance (SPR) analysis that nectin-1 Ig3 directly interacted with various isoforms of FGFR. Nectin-1 Ig3 induced phosphorylation of FGFR1c in the same manner as the whole nectin-1 ectodomain, and promoted survival of cerebellar granule neurons induced to undergo apoptosis. Finally, we constructed a peptide, nectide, by employing in silico modeling of various FGFR ligand-binding sites. Nectide mimicked all the effects of nectin-1 Ig3. We suggest that FGFR is a downstream signaling partner of nectin-1.	[Bojesen, Kirsten B.; Clausen, Ole; Rohde, Kristian; Christensen, Claus; Zhang, Lanjun; Li, Shizhong; Kohler, Lene; Nielsen, Janne; Gjorlund, Michelle D.; Bock, Elisabeth; Berezin, Vladimir] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Prot Lab, DK-2200 Copenhagen, Denmark; [Clausen, Ole; Nielbo, Steen; Poulsen, Flemming M.] Univ Copenhagen, Dept Biol, SBiN Lab, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Berezin, V (corresponding author), Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Prot Lab, Blegdamsvej 3C, DK-2200 Copenhagen, Denmark.	berezin@sund.ku.dk	Nielsen, Janne/J-5987-2014	Nielsen, Janne/0000-0001-8521-7353; Rohde, Kristian/0000-0002-5077-0607; Bojesen, Kirsten/0000-0002-7996-3154	Seventh Framework Programme (FP7) European Union Collaborative Project MemStick Grant [201600]; Lundbeck Foundation; Danish Research Councils; John and Birthe Meyer Foundation; Carlsberg Foundation	Seventh Framework Programme (FP7) European Union Collaborative Project MemStick Grant; Lundbeck Foundation(Lundbeckfonden); Danish Research Councils(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Seventh Framework Programme (FP7) European Union Collaborative Project MemStick Grant 201600, the Lundbeck Foundation, the Danish Research Councils, the John and Birthe Meyer Foundation, and the Carlsberg Foundation.	Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; Christensen C, 2011, NEUROREPORT, V22, P727, DOI 10.1097/WNR.0b013e3283491682; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fabre S, 2002, J BIOL CHEM, V277, P27006, DOI 10.1074/jbc.M203228200; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haarr L, 2001, VIROLOGY, V287, P301, DOI 10.1006/viro.2001.1041; Hossain MA, 1998, EUR J NEUROSCI, V10, P2490, DOI 10.1046/j.1460-9568.1998.00259.x; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Kim J, 2011, J NEUROCHEM, V119, P945, DOI 10.1111/j.1471-4159.2011.07479.x; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Kirschbaum K, 2009, J BIOL CHEM, V284, P28533, DOI 10.1074/jbc.M109.004440; Kiselyov VV, 2006, PROTEIN SCI, V15, P2318, DOI 10.1110/ps.062206106; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; KJAER M, 1994, METHODS ENZYMOL, V239, P288; Kruman I, 1997, J NEUROSCI, V17, P5089; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Li SZ, 2008, J NEUROCHEM, V104, P667, DOI 10.1111/j.1471-4159.2007.05070.x; Lim ST, 2012, J NEUROCHEM, V120, P741, DOI 10.1111/j.1471-4159.2011.07592.x; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; MORRISON ME, 1992, J VIROL, V66, P2807, DOI 10.1128/JVI.66.5.2807-2813.1992; Narita H, 2011, ACTA CRYSTALLOGR F, V67, P344, DOI 10.1107/S174430911100337X; Narita H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197368; Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Owczarek S, 2010, FASEB J, V24, P1139, DOI 10.1096/fj.09-140509; Reymond N, 2000, GENE, V255, P347, DOI 10.1016/S0378-1119(00)00316-4; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Ronn LCB, 1999, NAT BIOTECHNOL, V17, P1000, DOI 10.1038/13697; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; SCHOUSBOE A, 1989, NEUROCHEM RES, V14, P871, DOI 10.1007/BF00964817; Shukla D, 2006, APPL IMMUNOHISTO M M, V14, P341, DOI 10.1097/00129039-200609000-00014; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yasumi M, 2003, BIOCHEM BIOPH RES CO, V302, P61, DOI 10.1016/S0006-291X(03)00106-2; YAZAKI N, 1994, J NEUROSCI RES, V37, P445, DOI 10.1002/jnr.490370403	52	27	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37420	37433		10.1074/jbc.M112.345215	http://dx.doi.org/10.1074/jbc.M112.345215			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955284	hybrid, Green Published			2022-12-25	WOS:000310588500072
J	Gregory, KJ; Sexton, PM; Tobin, AB; Christopoulos, A				Gregory, Karen J.; Sexton, Patrick M.; Tobin, Andrew B.; Christopoulos, Arthur			Stimulus Bias Provides Evidence for Conformational Constraints in the Structure of a G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; PARATHYROID-HORMONE RECEPTOR; BETA-ARRESTIN; 7-TRANSMEMBRANE RECEPTORS; FUNCTIONAL SELECTIVITY; DRUG DISCOVERY; N-DESMETHYLCLOZAPINE; ALLOSTERIC SITE; LIGAND; ACTIVATION	A key characteristic of G protein-coupled receptors (GPCRs) is that they activate a plethora of signaling pathways. It is now clear that a GPCR coupling to these pathways can be regulated selectively by ligands that differentially drive signaling down one pathway in preference to another. This concept, termed stimulus bias, is revolutionizing receptor biology and drug discovery by providing a means of selectively targeting receptor signaling pathways that have therapeutic impact. Herein, we utilized a novel quantitative method that determines stimulus bias of synthetic GPCR ligands in a manner that nullifies the impact of both the cellular background and the "natural bias" of the endogenous ligand. By applying this method to the M-2 muscarinic acetylcholine receptor, a prototypical GPCR, we found that mutation of key residues (Tyr-802.61 and Trp-993.28) in an allosteric binding pocket introduces stimulus bias in response to the atypical ligands AC-42 (4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl) piperidine HCl) and 77-LH-28-1 (1-(3-(4-butyl-1-piperidinyl) propyl)-3,3-dihydro-2(1H)-quinolinone). By comparing stimulus bias factors among receptor internalization, G protein activation, extracellular-regulated protein kinase 1/2 (ERK1/2) signaling, and receptor phosphorylation, we provide evidence that Tyr-802.61 and Trp-993.28 act either as molecular switches or as gatekeeper residues that introduce constraints limiting the active conformation of the M2 muscarinic acetylcholine receptor and thereby regulate stimulus bias. Furthermore, we provide evidence that downstream signaling pathways previously considered to be related to each other (i.e. receptor phosphorylation, internalization, and activation of ERK1/2) can act independently.	[Tobin, Andrew B.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Gregory, Karen J.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia; [Gregory, Karen J.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia	University of Leicester; Monash University; Monash University	Tobin, AB (corresponding author), Univ Leicester, MRC, Toxicol Unit, Lancaster Rd, Leicester LE1 9HN, Leics, England.	tba@leicester.ac.uk; arthur.christopoulos@monash.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Gregory, Karen/0000-0002-3833-2137	National Health and Medical Research Council (NHMRC) of Australia [519461]; NHMRC; Dowd Foundation; Monash University; Medical Research Council (MRC), United Kingdom; Medical Research Council [MC_UP_A600_1110] Funding Source: researchfish; MRC [MC_UP_A600_1110] Funding Source: UKRI	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Dowd Foundation; Monash University(Monash University); Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Program Grant 519461 from the National Health and Medical Research Council (NHMRC) of Australia.; Recipient of an NHMRC biomedical postgraduate research scholarship, a Dowd Foundation postgraduate scholarship for neuroscience, and a Monash University postgraduate publication award.; Supported by the Medical Research Council (MRC), United Kingdom. To whom correspondence may be addressed: MRC Toxicology Unit, University of Leicester, Lancaster Rd., Leicester, LE1 9HN, United Kingdom. Tel.: 44-116-2522935; E-mail: tba@leicester.ac.uk.	[Anonymous], 2008, NAT REV DRUG DISCOV, V7, P339; Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; BARKER EL, 1994, J BIOL CHEM, V269, P11687; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gesty-Palmer D, 2011, BRIT J PHARMACOL, V164, P59, DOI 10.1111/j.1476-5381.2011.01450.x; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; LABRECQUE J, 1995, MOL PHARMACOL, V48, P150; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roettger BF, 1997, MOL PHARMACOL, V51, P357; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Spalding TA, 2002, MOL PHARMACOL, V61, P1297, DOI 10.1124/mol.61.6.1297; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104	37	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37066	37077		10.1074/jbc.M112.408534	http://dx.doi.org/10.1074/jbc.M112.408534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22965232	hybrid, Green Published			2022-12-25	WOS:000310588500041
J	Uyttendaele, I; Lavens, D; Catteeuw, D; Lemmens, I; Bovijn, C; Tavernier, J; Peelman, F				Uyttendaele, Isabel; Lavens, Delphine; Catteeuw, Dominiek; Lemmens, Irma; Bovijn, Celia; Tavernier, Jan; Peelman, Frank			Random Mutagenesis MAPPIT Analysis Identifies Binding Sites for Vif and Gag in Both Cytidine Deaminase Domains of Apobec3G	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; HIV-1 REVERSE TRANSCRIPTION; MULTIPLE SEQUENCE ALIGNMENT; VIRION INFECTIVITY FACTOR; INTERACTOME NETWORK; ANTIVIRAL ACTIVITY; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; FUNCTIONAL IMPLICATIONS; INTERACTION TRAP	The mammalian two-hybrid system MAPPIT allows the detection of protein-protein interactions in intact human cells. We developed a random mutagenesis screening strategy based on MAPPIT to detect mutations that disrupt the interaction of one protein with multiple protein interactors simultanously. The strategy was used to detect residues of the human cytidine deaminase Apobec3G that are important for its homodimerization and its interaction with the HIV-1 Gag and Vif proteins. The strategy is able to identify the previously described head-to-head homodimerization interface in the N-terminal domain of Apobec3G. Our analysis further detects two new potential interaction surfaces in the N- and C-terminal domain of Apobec3G for interaction with Vif and Gag or for Apobec3G dimerization.	[Uyttendaele, Isabel; Lavens, Delphine; Catteeuw, Dominiek; Lemmens, Irma; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] VIB, Dept Med Prot Res, Ghent, Belgium; [Uyttendaele, Isabel; Lavens, Delphine; Catteeuw, Dominiek; Lemmens, Irma; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Uyttendaele, I (corresponding author), VIB, Dept Med Prot Res, Ghent, Belgium.	jan.tavernier@vib-ugent.be; frank.peelman@vib-ugent.be	Tavernier, Jan/AAG-3636-2019		Fund of Scientific Research (FWO) Grant [G.0747.10N]; Interuniversitary Attraction Poles [P6:28]; Ghent University Methusalem grant	Fund of Scientific Research (FWO) Grant; Interuniversitary Attraction Poles; Ghent University Methusalem grant	This work is supported by the Fund of Scientific Research (FWO, www.fwo.be) Grant (G.0747.10N), Interuniversitary Attraction Poles (P6:28) (http://www.belspo.be/belspo iap/index_en.stm) and a Ghent University Methusalem grant (http://www.ugent.be/en/research/topresearch methusalem_laureates.htm/). DL and IL are postdoctoral fellows of the Fund of Scientific Research (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Daggett KA, 2009, ACS CHEM BIOL, V4, P109, DOI 10.1021/cb800271f; de Vries SJ, 2010, PROTEINS, V78, P3242, DOI 10.1002/prot.22814; Dhayalan A, 2008, J MOL BIOL, V376, P1091, DOI 10.1016/j.jmb.2007.12.032; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Gooch BD, 2008, VIROLOGY, V379, P118, DOI 10.1016/j.virol.2008.06.013; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2009, P NATL ACAD SCI USA, V106, P19539, DOI 10.1073/pnas.0906652106; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khan MA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-99; Kim JY, 2012, METHODS MOL BIOL, V812, P209, DOI 10.1007/978-1-61779-455-1_12; Kundrotas PJ, 2008, INT J BIOL MACROMOL, V43, P198, DOI 10.1016/j.ijbiomac.2008.05.004; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; Lemmens I, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng075; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Lickfeld M, 2011, YEAST, V28, P535, DOI 10.1002/yea.1856; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Liu J, 2012, PROTEIN ENG DES SEL, V25, P67, DOI 10.1093/protein/gzr060; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poussu E, 2004, PROTEINS, V54, P681, DOI 10.1002/prot.10467; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Stefan N, 2011, J MOL BIOL, V413, P826, DOI 10.1016/j.jmb.2011.09.016; Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tavernier J, 2002, CLIN EXP ALLERGY, V32, P1397, DOI 10.1046/j.1365-2745.2002.01520.x; Uyttendaele I, 2007, MOL ENDOCRINOL, V21, P2821, DOI 10.1210/me.2006-0541; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wong TS, 2006, J MOL BIOL, V355, P858, DOI 10.1016/j.jmb.2005.10.082; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yahav T, 2011, CURR OPIN STRUC BIOL, V21, P670, DOI 10.1016/j.sbi.2011.07.004; Yep A, 2008, P NATL ACAD SCI USA, V105, P5733, DOI 10.1073/pnas.0709657105; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027	91	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44143	10.1371/journal.pone.0044143	http://dx.doi.org/10.1371/journal.pone.0044143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970171	Green Published, gold, Green Submitted			2022-12-25	WOS:000308748400011
J	Sarkisian, MR; Siebzehnrubl, D				Sarkisian, Matthew R.; Siebzehnrubl, Dorit			Abnormal Levels of Gadd45alpha in Developing Neocortex Impair Neurite Outgrowth	PLOS ONE			English	Article							DAMAGE-INDUCIBLE GENE; GROWTH ARREST; VALPROIC ACID; ANIMAL-MODEL; IN-VIVO; DNA; EXPRESSION; GADD45-ALPHA; MIGRATION; ACTIVATION	To better understand the short and long-term effects of stress on the developing cerebral cortex, it is necessary to understand how early stress response genes protect or permanently alter cells. One family of highly conserved, stress response genes is the growth arrest and DNA damage-45 (Gadd45) genes. The expression of these genes is induced by a host of genotoxic, drug, and environmental stressors. Here we examined the impact of altering the expression of Gadd45alpha (Gadd45a), a member of the Gadd45 protein family that is expressed throughout the developing cortices of mice and humans. To manipulate levels of Gadd45a protein in developing mouse cortex, we electroporated cDNA plasmids encoding either Gadd45a or Gadd45a shRNA to either overexpress or knockdown Gadd45a levels in the developing cortices of mice, respectively. The effects of these manipulations were assessed by examining the fates and morphologies of the labeled neurons. Gadd45a overexpression both in vitro and in vivo significantly impaired the morphology of neurons, decreasing neurite complexity, inducing soma hypertrophy and increasing cell death. Knockdown of Gadd45a partially inhibited neuronal migration and reduced neurite complexity, an effect that was reversed in the presence of an shRNA-resistant Gadd45a. Finally, we found that shRNA against MEKK4, a direct target of Gadd45a, also stunted neurite outgrowth. Our findings suggest that the expression of Gadd45a in normal, developing brain is tightly regulated and that treatments or environmental stimuli that alter its expression could produce significant changes in neuronal circuitry development.	[Sarkisian, Matthew R.; Siebzehnrubl, Dorit] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Sarkisian, MR (corresponding author), Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA.	matt.sarkisian@mbi.ufl.edu			McKnight Brain Research Foundation; Evelyn F. and William L. McKnight Brain Institute at the University of Florida; University of Florida	McKnight Brain Research Foundation; Evelyn F. and William L. McKnight Brain Institute at the University of Florida; University of Florida(University of Florida)	This work was supported by funds from the McKnight Brain Research Foundation and the Evelyn F. and William L. McKnight Brain Institute at the University of Florida (to M. R. S.) and a University of Florida Opportunity Fund Award (to M. R. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Chang QS, 2007, CANCER RES, V67, P6146, DOI 10.1158/0008-5472.CAN-07-0867; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; Chiou SK, 2009, APOPTOSIS, V14, P1341, DOI 10.1007/s10495-009-0399-6; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Friedlander DR, 1998, J NEUROBIOL, V37, P291, DOI 10.1002/(SICI)1097-4695(19981105)37:2<291::AID-NEU8>3.0.CO;2-F; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Henshall DC, 1999, J NEUROCHEM, V73, P1573, DOI 10.1046/j.1471-4159.1999.0731573.x; Hocevar Z, 2012, J ULTRAS MED, V31, P923, DOI 10.7863/jum.2012.31.6.923; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Huang HS, 2010, MOL CELL NEUROSCI, V44, P282, DOI 10.1016/j.mcn.2010.03.014; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kaufmann LT, 2011, GENE EXPR PATTERNS, V11, P465, DOI 10.1016/j.gep.2011.07.005; Kuwagata M, 2009, INT J DEV NEUROSCI, V27, P399, DOI 10.1016/j.ijdevneu.2009.01.006; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Meador KJ, 2009, NEW ENGL J MED, V360, P1597, DOI 10.1056/NEJMoa0803531; Patterson AD, 2006, BIRTH DEFECTS RES A, V76, P129, DOI 10.1002/bdra.20217; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Saffary R, 2011, J NEUROSCI, V31, P1427, DOI 10.1523/JNEUROSCI.4854-10.2011; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Sytnikova YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014500; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Yamauchi J, 2007, EXP CELL RES, V313, P1886, DOI 10.1016/j.yexcr.2007.02.019; Yang C, 2011, CANCER CHEMOTH PHARM, V67, P439, DOI 10.1007/s00280-010-1344-7; Yochum CL, 2008, BRAIN RES, V1203, P126, DOI 10.1016/j.brainres.2008.01.055; Zhang YD, 2009, MOL CARCINOGEN, V48, P454, DOI 10.1002/mc.20483; Zhu RL, 1997, NEUROSCIENCE, V81, P707, DOI 10.1016/S0306-4522(97)00205-4	38	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44207	10.1371/journal.pone.0044207	http://dx.doi.org/10.1371/journal.pone.0044207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970179	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400045
J	Lee, SJ; Lee, EJ; Kim, SK; Jeong, P; Cho, YH; Yun, SJ; Kim, S; Kim, GY; Choi, YH; Cha, EJ; Kim, WJ; Moon, SK				Lee, Se-Jung; Lee, Eo-Jin; Kim, Seon-Kyu; Jeong, Pildu; Cho, Young-Hwa; Yun, Seok Joong; Kim, Sangtae; Kim, Gi-Young; Choi, Yung Hyun; Cha, Eun-Jong; Kim, Wun-Jae; Moon, Sung-Kwon			Identification of Pro-Inflammatory Cytokines Associated with Muscle Invasive Bladder Cancer; The Roles of IL-5, IL-20, and IL-28A	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; IV COLLAGENASE GENE; SIGNAL-TRANSDUCTION; MATRIX-METALLOPROTEINASE-9 EXPRESSION; MATRIX METALLOPROTEINASES; ANTITUMOR-ACTIVITY; HUMAN EOSINOPHILS; TUMOR-CELLS; MECHANISM; PATHWAY	We used gene expression profiling to identify inflammatory cytokines that correlate with bladder cancer development. Gene expression profiles of the tissue samples were investigated using cDNA microarrays that contained 103 non-muscle invasive bladder cancers (NMIBC), 62 muscle invasive bladder cancers (MIBC), 58 samples of histologically normal-looking surrounding tissues, and 10 normal, healthy subjects who served as the control cohort for comparison. We grouped the data-sets according to biological characterizations and focused on immune response genes with at least 2-fold differential expression in MIBC vs. controls. The experimental data-set identified 36 immune-related genes that were significantly altered in MIBC samples. In addition, 10 genes were up-regulated and 26 genes were down-regulated in MIBC samples compared with the normal tissues. Among the 10 up-regulated molecules examined, the capacity for both wound-healing migration and invasion was enhanced in response to IL-5, IL-20, and IL-28A in bladder cancer cell lines (253J and EJ cells), compared with untreated cells. The expression levels of IL-5, IL-20, and IL-28A were increased in patients with MIBC. All 3 cytokines and their receptors were produced in bladder cancer cell lines, as determined by real-time PCR, immunoblot analysis and confocal immunofluorescence. Up-regulation of MMP-2 and MMP-9 was found after IL-5, IL-20, and IL-28A stimulation in both cell types. Moreover, an EMSA assay showed that treatment with IL-5, IL-20, and IL-28A induced activation of the transcription factors NF-kappa B and AP-1 that regulate the MMP-9 promoter. Finally, activation of MAPK and Jak-Stat signaling was observed after the addition of IL-5, IL-20, and IL-28A to bladder cancer cells. This study suggests the presence of specific inflammatory cytokine (IL-5, IL-20, and IL-28A)-mediated association in bladder cancer development. All 3 cytokines may be important new molecular targets for the modulation of migration and invasion in bladder cancer.	[Lee, Se-Jung; Lee, Eo-Jin; Kim, Sangtae; Moon, Sung-Kwon] Chungju Natl Univ, Dept Biotechnol, Chungju, Chungbuk, South Korea; [Lee, Se-Jung] Chung Ang Univ, Dept Food Sci & Technol, Ansung, South Korea; [Cho, Young-Hwa] Juseong Univ, Juseong Gene Therapy R&D Ctr, Chungbuk, South Korea; [Kim, Gi-Young] Jeju Natl Univ, Dept Marine Life Sci, Immunobiol Lab, Cheju, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Pusan, South Korea; [Lee, Se-Jung; Lee, Eo-Jin; Jeong, Pildu; Yun, Seok Joong; Kim, Wun-Jae; Moon, Sung-Kwon] Chungbuk Natl Univ, Dept Urol, Coll Med, Chungbuk, Chungbuk, South Korea; [Kim, Seon-Kyu] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Cha, Eun-Jong] Chungbuk Natl Univ, Dept Biomed Engn, Cheongju, South Korea	Chung Ang University; Jeju National University; Dong-Eui University; Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University	Lee, SJ (corresponding author), Chungju Natl Univ, Dept Biotechnol, Chungju, Chungbuk, South Korea.	wjkim@chungbuk.ac.kr; sumoon66@dreamwiz.com		Kim, Seon-Kyu/0000-0002-4176-5187; Yun, Seok-Joong/0000-0001-7737-4746	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0001736]; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A100651-1011-0000200]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2010-0001736) and the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A100651-1011-0000200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 1998, AM J PHYSIOL-CELL PH, V275, pC623, DOI 10.1152/ajpcell.1998.275.3.C623; Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Bianco FJ, 1998, CLIN CANCER RES, V4, P3011; Black PC, 2007, CANCER METAST REV, V26, P623, DOI 10.1007/s10555-007-9084-9; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Bohle A, 2003, J UROLOGY, V170, P964, DOI 10.1097/01.ju.0000073852.24341.4a; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Brumatti G, 2010, CELL MOL LIFE SCI, V67, P1619, DOI 10.1007/s00018-010-0288-8; Chen WY, 2009, J IMMUNOL, V182, P5003, DOI 10.4049/jimmunol.0803653; Coffer PJ, 1998, BLOOD, V91, P2547, DOI 10.1182/blood.V91.7.2547.2547_2547_2557; DAVIES B, 1993, CANCER RES, V53, P5365; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Gerhards S, 2001, UROLOGY, V57, P675, DOI 10.1016/S0090-4295(00)01087-6; Goswami B, 2008, INT J GYNECOL CANCER, V18, P591, DOI 10.1111/j.1525-1438.2007.01089.x; Hsieh MY, 2006, GENES IMMUN, V7, P234, DOI 10.1038/sj.gene.6364291; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; Inoue K, 2000, CANCER RES, V60, P2290; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lee CF, 2004, J UROLOGY, V171, P1343, DOI 10.1097/01.ju.0000103924.93206.93; Li CG, 2010, CANCER CHEMOTH PHARM, V66, P981, DOI 10.1007/s00280-010-1336-7; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; LIOTTA LA, 1986, CANCER RES, V46, P1; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Matsumoto K, 2011, HUM GENE THER, V22, P1423, DOI 10.1089/hum.2011.013; Mitra AP, 2009, CANCER METAST REV, V28, P317, DOI 10.1007/s10555-009-9196-5; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Moses MA, 1998, CANCER RES, V58, P1395; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Okamoto M, 1997, INT J CANCER, V72, P149, DOI 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D; PAZDRAK K, 1995, J IMMUNOL, V155, P397; PAZDRAK K, 1995, J EXP MED, V181, P1827, DOI 10.1084/jem.181.5.1827; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Saban Marcia R, 2006, BMC Physiol, V6, P1, DOI 10.1186/1472-6793-6-1; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Sato S, 1994, J EXP MED; Satyam A, 2011, UROL ONCOL-SEMIN ORI, V29, P58, DOI 10.1016/j.urolonc.2009.06.002; Shen ZC, 2008, PHARM RES-DORDR, V25, P1500, DOI 10.1007/s11095-008-9566-7; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sier CFM, 2000, CLIN CANCER RES, V6, P2333; So MK, 2006, NAT PROTOC, V1, P1160, DOI 10.1038/nprot.2006.162; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Takatsu K, 2009, ADV IMMUNOL, V101, P191, DOI 10.1016/S0065-2776(08)01006-7; TYAGI P, 2009, INT UROL NEPHROL; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wegenka UM, 2010, CYTOKINE GROWTH F R, V21, P353, DOI 10.1016/j.cytogfr.2010.08.001; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xu WF, 2004, INT IMMUNOPHARMACOL, V4, P627, DOI 10.1016/j.intimp.2004.01.006; Yoon TJ, 2006, SMALL, V2, P209, DOI [10.1002/smll.200500360, 10.1002/511111.200500360]; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	62	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e40267	10.1371/journal.pone.0040267	http://dx.doi.org/10.1371/journal.pone.0040267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962576	Green Submitted, Green Published, gold			2022-12-25	WOS:000308577600003
J	Huang, GL; Li, BK; Zhang, MY; Wei, RR; Yuan, YF; Shi, M; Chen, XQ; Huang, L; Zhang, HZ; Liu, WQ; Huang, BJ; Li, HH; Zheng, XF; Luo, XR; Wang, HY				Huang, Guo-Liang; Li, Bin-Kui; Zhang, Mei-Yin; Wei, Rong-Rong; Yuan, Yun-Fei; Shi, Ming; Chen, Xiao-Qian; Huang, Long; Zhang, Hui-Zhong; Liu, Wanqing; Huang, Bi-Jun; Li, Honghua; Zheng, Xiao-Feng; Luo, Xian-Rong; Wang, Hui-Yun			Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; TUMOR PROGRESSION; CIRRHOTIC LIVER; INHIBITOR PI-88; PHASE-II; EXPRESSION; CANCER; GROWTH; PHOSPHORYLATION; RECEPTOR	Objectives: The role of heparanase (HPSE) gene in cancers including hepatocellular carcinoma (HCC) is currently controversial. This study was aimed at investigating the impact of genetic alteration and expression change of HPSE on the progression and prognosis of HCC. Methods: The HPSE gene was studied in three different aspects: (1) loss of heterozygosity (LOH) by a custom SNP microarray and DNA copy number by real-time PCR; (2) mRNA level by qRT-PCR; and (3) protein expression by immunohistochemistry. The clinical significances of allele loss and expression change of HPSE were analyzed. Results: Microarray analysis showed that the average LOH frequency for 10 SNPs located within HPSE gene was 31.6%, three of which were significantly correlated with tumor grade, serum HBV-DNA level, and AFP concentration. In agreement with SNP LOH data, DNA copy number loss of HPSE was observed in 38.74% (43/111) of HCC cases. HPSE mRNA level was notably reduced in 74.1% (83/112) of tumor tissues compared with non-tumor liver tissues, which was significantly associated with DNA copy number loss, increased tumor size, and post-operative metastasis. HPSE protein level was also remarkably reduced in 66.3% (53/80) of tumor tissues, which was correlated with tumor grade. Patients with lower expression level of HPSE mRNA or protein had a significantly lower survival rate than those with higher expression. Cox regression analysis suggested that HPSE protein was an independent predictor of overall survival in HCC patients. Conclusions: The results in this study demonstrate that genetic alteration and reduction of HPSE expression are associated with tumor progression and poor prognosis of HCCs, suggesting that HPSE behaves like a tumor suppressor gene and is a potential prognostic marker for HCC patients.	[Huang, Guo-Liang; Zhang, Mei-Yin; Wei, Rong-Rong; Chen, Xiao-Qian; Huang, Long; Huang, Bi-Jun; Wang, Hui-Yun] Sun Yat Sen Univ, Ctr Canc, Natl Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Guo-Liang] Guangdong Med Coll, Sino Amer Canc Res Inst, Dongguan, Guangdong, Peoples R China; [Li, Bin-Kui; Yuan, Yun-Fei; Shi, Ming] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Hui-Zhong] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Wanqing] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Li, Honghua; Zheng, Xiao-Feng; Wang, Hui-Yun] UMDNJ, Robert W Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA; [Luo, Xian-Rong] PLA, Hosp 458, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Sun Yat Sen University; Sun Yat Sen University; University of Chicago; Rutgers State University New Brunswick; Rutgers State University Medical Center	Huang, GL (corresponding author), Sun Yat Sen Univ, Ctr Canc, Natl Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn	Huang, Bi-Jun/GSD-2430-2022; Huang, Guoliang/H-1625-2011	Huang, Guoliang/0000-0002-8902-8100; Shi, Ming/0000-0002-4051-4474; Yuan, Yunfei/0000-0003-2467-3683; Li, Binkui/0000-0003-3201-2914; Liu, Wanqing/0000-0001-7727-6900	National Natural Science Foundation of China [30772491]; Research Fund of National Key Laboratory of Oncology in South China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of National Key Laboratory of Oncology in South China	This work was supported by a grant (No: 30772491) from the National Natural Science Foundation of China (to H-YW) and partially supported by the Research Fund of National Key Laboratory of Oncology in South China (to H-YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bando K, 1999, GENE CHROMOSOME CANC, V25, P284, DOI 10.1002/(SICI)1098-2264(199907)25:3<284::AID-GCC11>3.0.CO;2-I; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Dong SO, 2010, WORLD J GASTROENTERO, V16, P306, DOI 10.3748/wjg.v16.i3.306; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; El-Assal ON, 2001, CLIN CANCER RES, V7, P1299; Esti C, 2008, CANCER, V113, P1004; Hu GH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl601; Huang GL, 2010, WORLD J GASTROENTERO, V16, P2046, DOI 10.3748/wjg.v16.i16.2046; Huang SF, 1999, CANCER GENET CYTOGEN, V111, P21, DOI 10.1016/S0165-4608(98)00215-5; Ikeguchi M, 2003, ANN SURG ONCOL, V10, P297, DOI 10.1245/ASO.2003.05.022; Ikeguchi M, 2003, EUR J CANCER, V39, P86, DOI 10.1016/S0959-8049(02)00558-0; Ikeguchi M, 2002, J SURG ONCOL, V81, P148, DOI 10.1002/jso.10163; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Khasraw M, 2010, ANN ONCOL, V21, P1302, DOI 10.1093/annonc/mdp524; Koliopanos A, 2001, CANCER RES, V61, P4655; Lewis KD, 2008, INVEST NEW DRUG, V26, P89, DOI 10.1007/s10637-007-9080-5; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; Liu WQ, 2009, CLIN CANCER RES, V15, P7602, DOI 10.1158/1078-0432.CCR-09-0890; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106; Nasser NJ, 2005, P NATL ACAD SCI USA, V102, P15161, DOI 10.1073/pnas.0507279102; Nishimura T, 2006, CANCER GENET CYTOGEN, V167, P57, DOI 10.1016/j.cancergencyto.2005.09.002; Nobuhisa T, 2007, CANCER SCI, V98, P535, DOI 10.1111/j.1349-7006.2007.00420.x; Ohkawa T, 2004, LAB INVEST, V84, P1289, DOI 10.1038/labinvest.3700159; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205; Xiao Y, 2003, HEPATOL RES, V26, P192, DOI 10.1016/S1386-6346(03)00107-4; Yeh SH, 2004, HEPATOLOGY, V40, P847, DOI 10.1002/hep.20409; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44061	10.1371/journal.pone.0044061	http://dx.doi.org/10.1371/journal.pone.0044061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952874	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300047
J	Vittecoq, M; Grandhomme, V; Champagnon, J; Guillemain, M; Crescenzo-Chaigne, B; Renaud, F; Thomas, F; Gauthier-Clerc, M; van der Werf, S				Vittecoq, Marion; Grandhomme, Viviane; Champagnon, Jocelyn; Guillemain, Matthieu; Crescenzo-Chaigne, Bernadette; Renaud, Francois; Thomas, Frederic; Gauthier-Clerc, Michel; van der Werf, Sylvie			High Influenza A Virus Infection Rates in Mallards Bred for Hunting in the Camargue, South of France	PLOS ONE			English	Article							AVIAN INFLUENZA; AMINO-ACID; WILD BIRDS; DISEASE; RESTOCKING; PATHOGEN; ORIGINS; HOST; CONSERVATION; REPLICATION	During the last decade, the role of wildlife in emerging pathogen transmission to domestic animals has often been pointed out. Conversely, far less attention has been paid to pathogen transmission from domestic animals to wildlife. Here, we focus on the case of game restocking, which implies the release of millions of animals worldwide each year. We conducted a 2-year study in the Camargue (Southern France) to investigate the influence of hand-reared Mallard releases on avain influenza virus dynamics in surrounding wildlife. We sampled Mallards (cloacal swabs) from several game duck facilities in 2009 and 2010 before their release. A very high (99%) infection rate caused by an H10N7 strain was detected in the game bird facility we sampled in 2009. We did not detect this strain in shot ducks we sampled, neither during the 2008/2009 nor the 2009/2010 hunting seasons. In 2010 infection rates ranged from 0 to 24% in hand-reared ducks. The 2009 H10N7 strain was fully sequenced. It results from multiple reassortment events between Eurasian low pathogenic strains. Interestingly, H10N7 strains had previously caused human infection in Egypt and Australia. The H10 and N7 segments we sequenced were clearly distinct from the Australian ones but they belonged to the same large cluster as the Egyptian ones. We did not observe any mutation linked to increased virulence, transmission to mammals, or antiviral resistence in the H10N7 strain we identified. Our results indicate that the potential role of hand-reared Mallards in influenza virus epizootics must be taken into account given the likely risk of viral exchange between game bird facilities and wild habitats, owing to duck rearing conditions. Measures implemented to limit transmission from wildlife to domestic animals as well as measures to control transmission from domestic animals to wild ones need to be equally reinforced.	[Vittecoq, Marion; Champagnon, Jocelyn; Gauthier-Clerc, Michel] Ctr Rech Tour du Valat, Arles, France; [Vittecoq, Marion; Grandhomme, Viviane; Renaud, Francois; Thomas, Frederic] Univ Montpellier, CNRS, Inst Rech Dev, Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Montpellier, France; [Vittecoq, Marion; Grandhomme, Viviane; Crescenzo-Chaigne, Bernadette; van der Werf, Sylvie] Inst Pasteur, Unite Genet Mol Virus ARN, Dept Virol, Paris, France; [Grandhomme, Viviane; van der Werf, Sylvie] CNRS, Unite Rech Assoc 3015, Paris, France; [Champagnon, Jocelyn; Guillemain, Matthieu] Ctr Natl Etud & Rech Appl Avifaune Migratrice, Off Natl Chasse & Faune Sauvage, Arles, France; [Grandhomme, Viviane; van der Werf, Sylvie] Univ Paris Diderot Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Vittecoq, M (corresponding author), Ctr Rech Tour du Valat, Arles, France.	vittecoq@tourduvalat.org	Champagnon, Jocelyn/AAM-4028-2020	THOMAS, Frederic/0000-0003-2238-1978; van der WERF, Sylvie/0000-0002-1148-4456; Champagnon, Jocelyn/0000-0003-4850-8033	French "Agence Inter-etablissement pour la Recherche et le Developpement"; Centre National de la Recherche Scientifique; MAVA foundation	French "Agence Inter-etablissement pour la Recherche et le Developpement"; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); MAVA foundation	M. Vittecoq was supported by an axa. Ph.D research fellowship. The authors thank the French "Agence Inter-etablissement pour la Recherche et le Developpement", the Centre National de la Recherche Scientifique, and the MAVA foundation for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bell D, 2004, PHILOS T R SOC B, V359, P1107, DOI 10.1098/rstb.2004.1492; BYERS SM, 1991, J WILDLIFE MANAGE, V55, P580, DOI 10.2307/3809502; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Campitelli L, 2008, J GEN VIROL, V89, P48, DOI 10.1099/vir.0.83111-0; Champagnon J, 2011, CONSEQUENCES MASSIVE; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Champagnon J, 2012, EUR J WILDLIFE RES, V58, P255, DOI 10.1007/s10344-011-0573-3; Champagnon Jocelyn, 2009, Wildfowl, P184; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; de la Barrera CA, 2005, ARCH MED RES, V36, P628, DOI 10.1016/j.arcmed.2005.05.002; Deceuninck (B.), 2010, ORNITHOS, V17, P266; Diaz-Sanchez S, 2012, EUR J WILDLIFE RES, V58, P99, DOI 10.1007/s10344-011-0547-5; Dobson A, 1996, ECOLOGY, V77, P1026, DOI 10.2307/2265573; Duval X, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000362; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; French ministry of agriculture and fisheries, 2006, DGALSDSPAN20068163 F; Gall A, 2008, J CLIN MICROBIOL, V46, P2561, DOI 10.1128/JCM.00466-08; Gog J, 2002, P ROY SOC B-BIOL SCI, V269, P671, DOI 10.1098/rspb.2001.1667; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; Gunnarsson G, 2006, OECOLOGIA, V149, P203, DOI 10.1007/s00442-006-0446-8; Handberg KJ, 2010, AVIAN DIS, V54, P420, DOI 10.1637/8746-032709-Reg.1; HATTA M, 2001, AIDS RES HUM RETRO S, V293, P1840; Hedrick RP, 1998, IMMUNOL REV, V166, P365, DOI 10.1111/j.1600-065X.1998.tb01276.x; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Huang YY, 2009, VIRUS GENES, V38, P398, DOI 10.1007/s11262-009-0339-0; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kiesecker JM, 2001, CONSERV BIOL, V15, P1064, DOI 10.1046/j.1523-1739.2001.0150041064.x; Kobasa D, 1997, J VIROL, V71, P6706, DOI 10.1128/JVI.71.9.6706-6713.1997; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2007, INFECT GENET EVOL, V7, P604, DOI 10.1016/j.meegid.2007.05.009; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lebarbenchon C, 2010, AVIAN DIS, V54, P446, DOI 10.1637/8665-022509-ResNote.1; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lu HG, 2004, AVIAN DIS, V48, P263, DOI 10.1637/7064; Mathevet R, 2002, LAND USE POLICY, V19, P277, DOI 10.1016/S0264-8377(02)00025-X; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Mondain-Monval J-Y, 2000, FAUNE SAUVAGE, V251, P124; Mondain-Monval Jean-Yves, 2009, Wildfowl, P192; Navarro-Gonzalez N, 2010, ANIM CONSERV, V13, P586, DOI 10.1111/j.1469-1795.2010.00390.x; OBENAUER JC, 2006, AIDS RES HUM RETRO S, V311, P1576, DOI DOI 10.1126/SCIENCE.1121586; OIE, 2012, UPD HIGHL PATH AV IN; OIE, 2011, TERR COD OIE WORLD O; OLSEN B, 2006, AIDS RES HUM RETRO S, V312, P384, DOI DOI 10.1126/SCIENCE.1122438; Orozovic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016028; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Siembieda JL, 2010, VECTOR-BORNE ZOONOT, V10, P793, DOI 10.1089/vbz.2009.0095; Slota KE, 2011, VECTOR-BORNE ZOONOT, V11, P1115, DOI 10.1089/vbz.2010.0114; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Szeleczky Z, 2010, VET MICROBIOL, V145, P142, DOI 10.1016/j.vetmic.2010.03.008; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Varghese JN, 1997, P NATL ACAD SCI USA, V94, P11808, DOI 10.1073/pnas.94.22.11808; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1; VIGGERS KL, 1993, WILDLIFE RES, V20, P687, DOI 10.1071/WR9930687; Villanua D, 2008, EUR J WILDLIFE RES, V54, P199, DOI 10.1007/s10344-007-0130-2; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325; WHO, 2012, WHO CUM NUMB CONF HU; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560	74	11	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43974	10.1371/journal.pone.0043974	http://dx.doi.org/10.1371/journal.pone.0043974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952832	gold, Green Submitted, Green Published			2022-12-25	WOS:000308044800082
J	Andrieu, G; Quaranta, M; Leprince, C; Hatzoglou, A				Andrieu, Guillaume; Quaranta, Muriel; Leprince, Corinne; Hatzoglou, Anastassia			The GTPase Gem and its partner Kif9 are required for chromosome alignment, spindle length control, and mitotic progression	FASEB JOURNAL			English	Article						cell division; cytoskeleton; microtubules; prometaphase	KINESIN-LIKE PROTEIN; BINDING PROTEINS; MICROTUBULE DYNAMICS; RAS FAMILY; RGK FAMILY; INTERACTS; MEMBER; PATHWAY; REORGANIZATION; ACTIVATION	Within the Ras superfamily, Gem is a small GTP-binding protein that plays a role in regulating Ca2+ channels and cytoskeletal remodeling in interphase cells. Here, we report for the first time that Gem is a spindle-associated protein and is required for proper mitotic progression. Functionally, loss of Gem leads to misaligned chromosomes and prometaphase delay. On the basis of different experimental approaches, we demonstrate that loss of Gem by RNA interference induces spindle elongation, while its enforced expression results in spindle shortening. The spindle length phenotype is generated through deregulation of spindle dynamics on Gem depletion and requires the expression of its downstream effector, the kinesin Kif9. Loss of Kif9 induces spindle abnormalities similar to those observed when Gem expression is repressed by siRNA. We further identify Kif9 as a new regulator of spindle dynamics. Kif9 depletion increases the steady-state levels of spindle alpha-tubulin by increasing the rate of microtubule polymerization. Overall, this study demonstrates a novel mechanism by which Gem contributes to the mitotic progression by maintaining correct spindle length through the kinesin Kif9.-Andrieu, G., Quaranta, M., Leprince, C., Hatzoglou, A. The GTPase Gem and its partner Kif9 are required for chromosome alignment, spindle length control, and mitotic progression. FASEB J. 26, 5025-5034 (2012). www.fasebj.org	[Andrieu, Guillaume; Hatzoglou, Anastassia] CNRS UMR 5089, IPBS, Toulouse, France; [Andrieu, Guillaume; Quaranta, Muriel; Leprince, Corinne; Hatzoglou, Anastassia] CNRS UMR 5089, Lab Biol Cellulaire & Mol Controle Proliferat, Toulouse, France; [Andrieu, Guillaume; Quaranta, Muriel; Hatzoglou, Anastassia] Univ Toulouse 3, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Hatzoglou, A (corresponding author), CNRS UMR 5089, IPBS, 205 Route Narbonne,BP 64182, Toulouse, France.	anastassia.hatzoglou@ipbs.fr	Leprince, Corinne/M-7109-2018	Leprince, Corinne/0000-0002-4462-5737; Andrieu, Guillaume/0000-0003-0289-4952	Ligue Nationale Contre le Cancer; Universite de Toulouse, UPS; Ministere de l'Education Nationale	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Universite de Toulouse, UPS; Ministere de l'Education Nationale	The authors thank Dr. J. Goetz (Hopital de Strasbourg, Strasbourg, France) for CREST serum; N. Galjart (Erasmus Medical Center, Rotterdam, The Netherlands) for EB3-GFP plasmid; A. Ledoux, B. Caussares, and I. Dais for their contribution; and the Toulouse Reseau Imagerie-Laboratoire de Biologie Cellulaire et Moleculaire du Controle de la Proliferation (TRI-LBCMCP) microscopy facilities [Universite Paul Sabatier (UPS), Toulouse, France]. This work was supported by grants from Ligue Nationale Contre le Cancer and Universite de Toulouse, UPS, to A. H. G. A. was supported by a Ph.D. fellowship from Ministere de l'Education Nationale.	Aresta S, 2002, BIOCHEM J, V367, P57, DOI 10.1042/BJ20020829; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Birk M, 2012, INT J CANCER, V130, P798, DOI 10.1002/ijc.26036; COHEN L, 1994, P NATL ACAD SCI USA, V91, P12448, DOI 10.1073/pnas.91.26.12448; Cornfine S, 2011, MOL BIOL CELL, V22, P202, DOI 10.1091/mbc.E10-05-0394; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Demonchy R, 2009, J CELL BIOL, V187, P615, DOI 10.1083/jcb.200903139; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Finlin BS, 1997, J BIOL CHEM, V272, P21982, DOI 10.1074/jbc.272.35.21982; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jang CY, 2008, J CELL BIOL, V181, P255, DOI 10.1083/jcb.200711032; Kelly K, 2005, TRENDS CELL BIOL, V15, P640, DOI 10.1016/j.tcb.2005.10.002; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Leone A, 2001, ONCOGENE, V20, P3217, DOI 10.1038/sj.onc.1204420; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Mazumdar M, 2005, TRENDS CELL BIOL, V15, P349, DOI 10.1016/j.tcb.2005.05.006; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Pan JY, 2000, J CELL BIOL, V149, P1107, DOI 10.1083/jcb.149.5.1107; Piddini E, 2001, EMBO J, V20, P4076, DOI 10.1093/emboj/20.15.4076; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Tikhonenko I, 2009, EUKARYOT CELL, V8, P723, DOI 10.1128/EC.00018-09; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Vanhove B, 1997, ENDOTHELIUM-J ENDOTH, V5, P51, DOI 10.3109/10623329709044158; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Yokoyama R, 2004, P NATL ACAD SCI USA, V101, P17398, DOI 10.1073/pnas.0406817101; Zhu JH, 1996, J BIOL CHEM, V271, P768, DOI 10.1074/jbc.271.2.768; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	39	15	15	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5025	5034		10.1096/fj.12-209460	http://dx.doi.org/10.1096/fj.12-209460			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22964304				2022-12-25	WOS:000311838300024
J	Bogdanov, M; Dowhan, W				Bogdanov, Mikhail; Dowhan, William			Lipid-dependent Generation of Dual Topology for a Membrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; MONOCLONAL-ANTIBODY 4B1; ESCHERICHIA-COLI; LACTOSE PERMEASE; PHOSPHOLIPID-COMPOSITION; BACILLUS-SUBTILIS; PHOSPHATIDYLETHANOLAMINE; TOPOGENESIS; TRANSLOCATION; LOCALIZATION	The mechanism by which membrane proteins exhibit structural and functional duality in the same membrane or different membranes is unknown. We posit that such duality is determined by both the protein sequence and the membrane lipid composition wherein a spatial or temporal change in the latter can result in a post-assembly change in protein structure and function. To investigate whether co-existence of multiple topological conformers is dependent on the membrane lipid composition, we determined the topological organization of lactose permease in an Escherichia coli model cell system in which phosphatidylethanolamine membrane content can be systematically varied. At intermediate levels of phosphatidylethanolamine a mixture of native and topologically mis-oriented conformers co-existed. There was no threshold level of phosphatidylethanolamine determining a sharp transition from one conformer to the other. Co-existing conformers were not in rapid equilibrium at a static lipid composition indicating that duality of topology is established during an early folding step. Depletion of intermediate levels of phosphatidylethanolamine after final protein assembly resulted in complete mis-orientation of the native conformer. Combined with previous results, such topological dynamics are reversible in both directions. We propose a thermodynamically based model for how lipid-protein interactions can result in a mixed topological organization and how changes in lipid composition can result in changes in the ratio of topologically distinct conformers of proteins. These observations demonstrate a potential lipid-dependent biological switch for generating dynamic structural and functional heterogeneity for a protein within the same membrane or between different membranes in more complex eukaryotic cells.	[Bogdanov, Mikhail; Dowhan, William] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77303 USA	University of Texas System; University of Texas Health Science Center Houston	Bogdanov, M (corresponding author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77303 USA.	mikhail.v.bogdanov@uth.tmc.edu; William.Dowhan@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017		National Institutes of Health [GM R37 20478]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37 20478 and a grant from the John Dunn Research Foundation (to W. D.).	BELTZER JP, 1991, J BIOL CHEM, V266, P973; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Bogdanov M, 2010, METHODS MOL BIOL, V619, P79, DOI 10.1007/978-1-60327-412-8_5; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Bowie JU, 2006, NAT STRUCT MOL BIOL, V13, P94, DOI 10.1038/nsmb0206-94; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; Dorobantu C, 2011, J VIROL, V85, P13373, DOI 10.1128/JVI.05423-11; Dowhan W, 2011, BIOCHEM SOC T, V39, P767, DOI 10.1042/BST0390767; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; FINE JB, 1982, J LIPID RES, V23, P660; Fontaine F, 2011, J BIOL CHEM, V286, P32464, DOI 10.1074/jbc.M111.245696; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P6408, DOI 10.1021/bi970233b; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Hickey K. D., 2011, LIPIDS, V2011; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Levy D, 1996, Essays Biochem, V31, P49; Luirink J, 2012, BBA-BIOENERGETICS, V1817, P965, DOI 10.1016/j.bbabio.2011.12.006; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; McGinnes LW, 2003, J VIROL, V77, P1951, DOI 10.1128/JVI.77.3.1951-1963.2003; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Moss K, 1998, MOL BIOL CELL, V9, P2681, DOI 10.1091/mbc.9.9.2681; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nagamori S, 2003, J BIOL CHEM, V278, P14820, DOI 10.1074/jbc.M300332200; Nesic I, 2012, AGING CELL, V11, P63, DOI 10.1111/j.1474-9726.2011.00760.x; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; Pedersen LB, 1999, J BACTERIOL, V181, P3201, DOI 10.1128/JB.181.10.3201-3211.1999; Prange R, 2004, J GEN VIROL, V85, P1221, DOI 10.1099/vir.0.19737-0; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Schuldiner S, 2007, SCIENCE, V317, P748; Schuldiner S, 2012, TRENDS BIOCHEM SCI, V37, P215, DOI 10.1016/j.tibs.2012.02.006; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Sun JZ, 1996, BIOCHEMISTRY-US, V35, P990, DOI 10.1021/bi952166w; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Weinglass AB, 2000, P NATL ACAD SCI USA, V97, P8938, DOI 10.1073/pnas.140224497; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Yamamoto H, 2012, BIOCHEMISTRY-US, V51, P3596, DOI 10.1021/bi2018915; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zhu QS, 1999, J BIOL CHEM, V274, P27898, DOI 10.1074/jbc.274.39.27898	64	45	45	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.404103	http://dx.doi.org/10.1074/jbc.M112.404103			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22969082	Green Published, hybrid			2022-12-25	WOS:000310642200029
J	Varma, S; Cao, YX; Tagne, JB; Lakshminarayanan, M; Li, J; Friedman, TB; Morell, RJ; Warburton, D; Kotton, DN; Ramirez, MI				Varma, Saaket; Cao, Yuxia; Tagne, Jean-Bosco; Lakshminarayanan, Meenakshi; Li, Jun; Friedman, Thomas B.; Morell, Robert J.; Warburton, David; Kotton, Darrell N.; Ramirez, Maria I.			The Transcription Factors Grainyhead-like 2 and NK2-Homeobox 1 Form a Regulatory Loop That Coordinates Lung Epithelial Cell Morphogenesis and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; PROBE LEVEL DATA; FACTOR-I; GENE-EXPRESSION; EPIDERMAL DIFFERENTIATION; BRANCHING MORPHOGENESIS; STEM-CELLS; TELOMERASE; PROTEIN; MOUSE	The Grainyhead family of transcription factors controls morphogenesis and differentiation of epithelial cell layers in multicellular organisms by regulating cell junction- and proliferation-related genes. Grainyhead-like 2 (Grhl2) is expressed in developing mouse lung epithelium and is required for normal lung organogenesis. The specific epithelial cells expressing Grhl2 and the genes regulated by Grhl2 in normal lungs are mostly unknown. In these studies we identified the NK2-homeobox 1 transcription factor (Nkx2-1) as a direct transcriptional target of Grhl2. By binding and transcriptional assays and by confocal microscopy we showed that these two transcription factors form a positive feedback loop in vivo and in cell lines and are co-expressed in lung bronchiolar and alveolar type II cells. The morphological changes observed in flattening lung alveolar type II cells in culture are associated with down-regulation of Grhl2 and Nkx2-1. Reduction of Grhl2 in lung epithelial cell lines results in lower expression levels of Nkx2-1 and of known Grhl2 target genes. By microarray analysis we identified that in addition to Cadherin1 and Claudin4, Grhl2 regulates other cell interaction genes such as semaphorins and their receptors, which also play a functional role in developing lung epithelium. Impaired collective cell migration observed in Grhl2 knock-down cell monolayers is associated with reduced expression of these genes and may contribute to the altered epithelial phenotype reported in Grhl2 mutant mice. Thus, Grhl2 functions at the nexus of a novel regulatory network, connecting lung epithelial cell identity, migration, and cell-cell interactions.	[Varma, Saaket; Cao, Yuxia; Tagne, Jean-Bosco; Lakshminarayanan, Meenakshi; Li, Jun; Kotton, Darrell N.; Ramirez, Maria I.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Warburton, David] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Friedman, Thomas B.; Morell, Robert J.] NIDCD, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA	Boston University; Children's Hospital Los Angeles; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Ramirez, MI (corresponding author), 72 E Concord St,R304, Boston, MA 02118 USA.	mramirez@bu.edu	Warburton, David/AAD-5709-2020; Morell, Robert James/Q-2042-2019	Cao, Yu-Xia/0000-0001-7396-9988; Ramirez, Maria Isabel/0000-0001-6294-4419; Kotton, Darrell/0000-0002-9604-8476; Morell, Robert/0000-0003-1537-7356; Tagne, Jean-Bosco/0000-0003-1830-9156	National Institutes of Health Grant [R01 HL0833034, P01 HL47049]; California Institute of Regenerative Medicine [TG2-01168]; NIDCD, National Institutes of Health, Intramural Funds [DC000039-15]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083034, P01HL047049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIDCD, National Institutes of Health, Intramural Funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL0833034 (NHLBI; to M. I. R., D. N. K., and S. V.) and in part by P01 HL47049 (NHLBI; to M. I. R. and D. N. K.). This work was also supported by the California Institute of Regenerative Medicine TG2-01168 (to S. V. and D. W.).; Supported by NIDCD, National Institutes of Health, Intramural Funds DC000039-15.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; Cao YX, 2010, J BIOL CHEM, V285, P2152, DOI 10.1074/jbc.M109.039172; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Das A, 2011, AM J PHYSIOL-LUNG C, V301, pL427, DOI 10.1152/ajplung.00090.2011; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Galambos C, 2010, AM J RESP CRIT CARE, V182, P549, DOI 10.1164/rccm.201002-0167CR; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gustavsson P, 2008, BIRTH DEFECTS RES A, V82, P728, DOI 10.1002/bdra.20494; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito T, 2000, MECH DEVELOP, V97, P35, DOI 10.1016/S0925-4773(00)00401-9; Janicke M, 2010, INT J DEV BIOL, V54, P837, DOI 10.1387/ijdb.092877mj; Kagoshima M, 2001, GENES CELLS, V6, P559, DOI 10.1046/j.1365-2443.2001.00441.x; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Li CG, 2000, BBA-GENE STRUCT EXPR, V1490, P213, DOI 10.1016/S0167-4781(99)00183-9; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.0.CO;2-Z; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Olsen CE, 2005, EXP LUNG RES, V31, P461, DOI 10.1080/01902140590918830; Osborne NJ, 2005, DEV DYNAM, V232, P939, DOI 10.1002/dvdy.20258; Peters LM, 2002, HUM MOL GENET, V11, P2877, DOI 10.1093/hmg/11.23.2877; Porter SE, 2001, AM J PHYSIOL-LUNG C, V280, pL1282, DOI 10.1152/ajplung.2001.280.6.L1282; POTIRON V, 2005, SCI STKE, pPE24; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Ramirez MI, 1997, J BIOL CHEM, V272, P26285, DOI 10.1074/jbc.272.42.26285; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Roth C, 2000, GENOMICS, V63, P384, DOI 10.1006/geno.1999.6084; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Shaw-White JR, 1999, J BIOL CHEM, V274, P2658, DOI 10.1074/jbc.274.5.2658; Shimamura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020804; Tagne JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029907; Tanaka Y, 2008, J HEPATOL, V49, P746, DOI 10.1016/j.jhep.2008.06.019; Tao JN, 2005, DEVELOPMENT, V132, P1021, DOI 10.1242/dev.01641; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Warburton David, 2004, Paediatr Respir Rev, V5 Suppl A, pS283, DOI 10.1016/S1526-0542(04)90052-8; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; Wilson AA, 2008, AM J RESP CELL MOL, V39, P133, DOI 10.1165/rcmb.2007-0133OC; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yu ZQ, 2008, DEV BIOL, V319, P56, DOI 10.1016/j.ydbio.2008.04.001; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3	60	57	60	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37282	37295		10.1074/jbc.M112.408401	http://dx.doi.org/10.1074/jbc.M112.408401			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955271	Green Published, hybrid			2022-12-25	WOS:000310588500060
J	Liu, SP; Harn, HJ; Chien, YJ; Chang, CH; Hsu, CY; Fu, RH; Huang, YC; Chen, SY; Shyu, WC; Lin, SZ				Liu, Shih-Ping; Harn, Horng-Jyh; Chien, Ying-Jiun; Chang, Cheng-Hsuan; Hsu, Chien-Yu; Fu, Ru-Huei; Huang, Yu-Chuen; Chen, Shih-Yin; Shyu, Woei-Cherng; Lin, Shinn-Zong			n-Butylidenephthalide (BP) Maintains Stem Cell Pluripotency by Activating Jak2/Stat3 Pathway and Increases the Efficiency of iPS Cells Generation	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; SIGNAL TRANSDUCER GP130; ANGELICA-SINENSIS; HUMAN FIBROBLASTS; SELF-RENEWAL; BRAIN-TUMOR; IN-VITRO; STAT3; DIFFERENTIATION; INTERLEUKIN-6	In 2006, induced pluripotent stem (iPS) cells were generated from somatic cells by introducing Oct4, Sox2, c-Myc and Klf4. The original process was inefficient; maintaining the pluripotency of embryonic stem (ES) and iPS cell cultures required an expensive reagent-leukemia induced factor (LIF). Our goal is to find a pure compound that not only maintains ES and iPS cell pluripotency, but also increases iPS cell generation efficiency. From 15 candidate compounds we determined that 10 mu g/ml n-Butylidenephthalide (BP), an Angelica sinensis extract, triggers the up-regulation of Oct4 and Sox2 gene expression levels in MEF cells. We used ES and iPS cells treated with different concentrations of BP to test its usefulness for maintaining stem cell pluripotency. Results indicate higher expression levels of several stem cell markers in BP-treated ES and iPS cells compared to controls that did not contain LIF, including alkaline phosphatase, SSEA1, and Nanog. Embryoid body formation and differentiation results confirm that BP containing medium culture was capable of maintaining ES cell pluripotency after six time passage. Microarray analysis data identified PPAR, ECM, and Jak-Stat signaling as the top three deregulated pathways. We subsequently determined that phosphorylated Jak2 and phosphorylated Stat3 protein levels increased following BP treatment and suppressed with the Jak2 inhibitor, AG490. The gene expression levels of cytokines associated with the Jak2-Stat3 pathway were also up-regulated. Last, we used pou5f1-GFP MEF cells to test iPS generation efficiency following BP treatment. Our data demonstrate the ability of BP to maintain stem cell pluripotency via the Jak2-Stat3 pathway by inducing cytokine expression levels, at the same time improving iPS generation efficiency.	[Liu, Shih-Ping; Chien, Ying-Jiun; Chang, Cheng-Hsuan; Hsu, Chien-Yu] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Liu, Shih-Ping; Fu, Ru-Huei; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Harn, Horng-Jyh] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Fu, Ru-Huei] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Huang, Yu-Chuen; Chen, Shih-Yin] China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung, Taiwan; [Huang, Yu-Chuen; Chen, Shih-Yin] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Liu, SP (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	spliu@mail.cmu.edu.tw	Lin, Shinn-Zong/AAX-2379-2020	Liu, Shih-Ping/0000-0002-5803-4460; Fu, Ru-Huei/0000-0001-9367-1759	Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; National Science Council [NSC 101-2314-B-039-009-MY2]; China Medical University [CMU99-COL-45]	Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	The authors wish to thank the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004), National Science Council plan (NSC 101-2314-B-039-009-MY2) and China Medical University (CMU99-COL-45) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakaj A, 2008, J BIOL CHEM, V283, P9505, DOI 10.1074/jbc.R800002200; BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; CARMICHAEL J, 1987, CANCER RES, V47, P943; Chen YL, 2008, MOL PHARMACOL, V74, P1046, DOI 10.1124/mol.107.044800; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Lee CM, 2006, TOXICOL APPL PHARM, V214, P126, DOI 10.1016/j.taap.2005.12.020; Lin PC, 2008, J NEUROCHEM, V106, P1017, DOI 10.1111/j.1471-4159.2008.05432.x; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Liu SP, 2011, CELL TRANSPLANT, V20, P15, DOI 10.3727/096368910X532828; Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; METCALF D, 1991, INT J CELL CLONING, V9, P95, DOI 10.1002/stem.5530090201; Mo CQ, 2010, CELL SIGNAL, V22, P495, DOI 10.1016/j.cellsig.2009.11.003; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tejedo JR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.57; Tsai NM, 2005, CLIN CANCER RES, V11, P3475, DOI 10.1158/1078-0432.CCR-04-1827; Tsai NM, 2006, J NEUROCHEM, V99, P1251, DOI 10.1111/j.1471-4159.2006.04151.x; Wang Haiyan, 1998, Zhongguo Zhongyao Zazhi, V23, P167; Wijdenes J, 1995, EUR J IMMUNOL, V25, P3474, DOI 10.1002/eji.1830251240	34	19	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44024	10.1371/journal.pone.0044024	http://dx.doi.org/10.1371/journal.pone.0044024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970157	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000011
J	Nagano, K; Hasegawa, Y; Abiko, Y; Yoshida, Y; Murakami, Y; Yoshimura, F				Nagano, Keiji; Hasegawa, Yoshiaki; Abiko, Yuki; Yoshida, Yasuo; Murakami, Yukitaka; Yoshimura, Fuminobu			Porphyromonas gingivalis FimA Fimbriae: Fimbrial Assembly by fimA Alone in the fim Gene Cluster and Differential Antigenicity among fimA Genotypes	PLOS ONE			English	Article							ANAEROBE BACTEROIDES-GINGIVALIS; COMPLETE GENOME SEQUENCE; OUTER-MEMBRANE PROTEINS; ORAL ANAEROBE; STRAIN W83; VIRULENCE; EXPRESSION; COMPONENTS; PERIODONTITIS; IDENTIFICATION	The periodontal pathogen Porphyromonas gingivalis colonizes largely through FimA fimbriae, composed of polymerized FimA encoded by fimA. fimA exists as a single copy within the fim gene cluster (fim cluster), which consists of seven genes: fimX, pgmA and fimA-E. Using an expression vector, fimA alone was inserted into a mutant from which the whole fim cluster was deleted, and the resultant complement exhibited a fimbrial structure. Thus, the genes of the fim cluster other than fimA were not essential for the assembly of FimA fimbriae, although they were reported to influence FimA protein expression. It is known that there are various genotypes for fimA, and it was indicated that the genotype was related to the morphological features of FimA fimbriae, especially the length, and to the pathogenicity of the bacterium. We next complemented the fim cluster-deletion mutant with fimA genes cloned from P. gingivalis strains including genotypes I to V. All genotypes showed a long fimbrial structure, indicating that FimA itself had nothing to do with regulation of the fimbrial length. In FimA fimbriae purified from the complemented strains, types I, II, and III showed slightly higher thermostability than types IV and V. Antisera of mice immunized with each purified fimbria principally recognized the polymeric, structural conformation of the fimbriae, and showed low cross-reactivity among genotypes, indicating that FimA fimbriae of each genotype were antigenically different. Additionally, the activity of a macrophage cell line stimulated with the purified fimbriae was much lower than that induced by Escherichia coli lipopolysaccharide.	[Nagano, Keiji; Abiko, Yuki; Yoshida, Yasuo; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi 464, Japan; [Hasegawa, Yoshiaki; Murakami, Yukitaka] Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci, Gifu, Japan	Aichi Gakuin University; Asahi University	Nagano, K (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Microbiol, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	nagano@dpc.agu.ac.jp	Nagano, Keiji/AAS-4912-2020	Nagano, Keiji/0000-0003-3587-7606	Strategic Research AGU-Platform Formation; Aichi Health Promotion Foundation; Grants-in-Aid for Scientific Research [22791783] Funding Source: KAKEN	Strategic Research AGU-Platform Formation; Aichi Health Promotion Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Strategic Research AGU-Platform Formation, Aichi Health Promotion Foundation, and Furukawa Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2010, BIOCHEM BIOPH RES CO, V398, P86, DOI 10.1016/j.bbrc.2010.06.040; DICKINSON DP, 1988, J BACTERIOL, V170, P1658, DOI 10.1128/jb.170.4.1658-1665.1988; Enersen M., 2011, J ORAL MICROBIOL, V3, P8487, DOI [10.3402/jom.v3i0.8487, DOI 10.3402/J0M.V3I0.8487]; Enersen M, 2008, J CLIN MICROBIOL, V46, P31, DOI 10.1128/JCM.00986-07; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Hajishengallis G, 2004, IMMUNOL INVEST, V33, P157, DOI 10.1081/IMM-120030917; Hongo H, 1999, MICROBIOL IMMUNOL, V43, P937, DOI 10.1111/j.1348-0421.1999.tb03354.x; Inaba H, 2008, ORAL MICROBIOL IMMUN, V23, P29, DOI 10.1111/j.1399-302X.2007.00386.x; Ito HO, 2003, BIOCHEM BIOPH RES CO, V308, P770, DOI 10.1016/S0006-291X(03)01466-9; Kato T, 2007, CELL MICROBIOL, V9, P753, DOI 10.1111/j.1462-5822.2006.00825.x; Kuboniwa M, 2010, PERIODONTOL 2000, V54, P136, DOI 10.1111/j.1600-0757.2010.00352.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; LEE JY, 1991, INFECT IMMUN, V59, P383, DOI 10.1128/IAI.59.1.383-389.1991; Masuda T, 2006, APPL ENVIRON MICROB, V72, P3458, DOI 10.1128/AEM.72.5.3458-3467.2006; Moon JH, 2012, FEMS IMMUNOL MED MIC, V64, P425, DOI 10.1111/j.1574-695X.2011.00889.x; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; MURAKAMI Y, 1993, BIOCHEM BIOPH RES CO, V192, P826, DOI 10.1006/bbrc.1993.1489; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nakagawa I, 2000, J CLIN MICROBIOL, V38, P1909, DOI 10.1128/JCM.38.5.1909-1914.2000; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishikawa K, 2004, MOL MICROBIOL, V54, P546, DOI 10.1111/j.1365-2958.2004.04291.x; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Ogawa T, 2002, EUR J IMMUNOL, V32, P2543, DOI 10.1002/1521-4141(200209)32:9<2543::AID-IMMU2543>3.0.CO;2-2; Perez-Chaparro PJ, 2009, ORAL MICROBIOL IMMUN, V24, P423, DOI 10.1111/j.1399-302X.2009.00519.x; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; Shoji M, 2010, CAN J MICROBIOL, V56, P959, DOI [10.1139/W10-084, 10.1139/w10-084]; SUZUKI Y, 1988, J GEN MICROBIOL, V134, P2713; Umeda JE, 2006, ORAL MICROBIOL IMMUN, V21, P415, DOI 10.1111/j.1399-302X.2006.00312.x; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Watanabe K, 1996, MICROBIOL IMMUNOL, V40, P725, DOI 10.1111/j.1348-0421.1996.tb01133.x; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; YOSHIMURA F, 1993, INFECT IMMUN, V61, P5181, DOI 10.1128/IAI.61.12.5181-5189.1993; YOSHIMURA F, 1987, MICROBIOL IMMUNOL, V31, P935, DOI 10.1111/j.1348-0421.1987.tb03154.x; YOSHIMURA F, 1985, J BACTERIOL, V163, P730, DOI 10.1128/JB.163.2.730-734.1985; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; YOSHIMURA F, 1984, J BACTERIOL, V160, P949, DOI 10.1128/JB.160.3.949-957.1984; Zheng C, 2011, MOL ORAL MICROBIOL, V26, P388, DOI 10.1111/j.2041-1014.2011.00626.x	42	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43722	10.1371/journal.pone.0043722	http://dx.doi.org/10.1371/journal.pone.0043722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970139	Green Submitted, gold, Green Published			2022-12-25	WOS:000308462000005
J	Hu, G; Horswell, R; Wang, YJ; Li, W; Besse, J; Xiao, K; Chen, HL; Keller, JN; Heymsfield, SB; Ryan, DH; Katzmarzyk, PT				Hu, Gang; Horswell, Ronald; Wang, Yujie; Li, Wei; Besse, Jay; Xiao, Ke; Chen, Honglei; Keller, Jeffrey N.; Heymsfield, Steven B.; Ryan, Donna H.; Katzmarzyk, Peter T.			Body Mass Index and the Risk of Dementia among Louisiana Low Income Diabetic Patients	PLOS ONE			English	Article							AGED FINNISH MEN; TO-HIP RATIO; IGF-I LEVELS; PHYSICAL-ACTIVITY; LATE-LIFE; WAIST CIRCUMFERENCE; CARDIOMETABOLIC RISK; FOLLOW-UP; OBESITY; ASSOCIATION	Background: The association between obesity and dementia risk remains debatable and no studies have assessed this association among diabetic patients. The aim of our study was to investigate the association between body mass index (BMI) and dementia risk among middle and low income diabetic patients. Methodology/Principal Findings: The sample included 44,660 diabetic patients (19,618 white and 25,042 African American) 30 to 96 years of age without a history of dementia in the Louisiana State University Hospital-Based Longitudinal Study. During a mean follow-up period of 3.9 years, 388 subjects developed incident dementia. The age-and sex-adjusted hazards ratios (HRs) for incident dementia at different levels of BMI (<= 25, 25-26.9, 27-29.9, 30-34.9, and >= 35 kg/m(2)) were 1.00, 0.53 (95% CI 0.34-0.83), 0.29 (0.18-0.45), 0.37 (0.25-0.56), and 0.31 (0.21-0.48) (P-trend<0.001) in white diabetic patients, and 1.00, 1.00 (95% CI 0.62-1.63), 0.62 (0.39-0.98), 0.56 (0.36-0.86), and 0.65 (0.43-1.01) (P-trend = 0.029) in African American diabetic patients. Further adjustment for other confounding factors affected the results only slightly. There was a significant interaction between race and BMI on dementia risk (chi(2) = 5.52, 1df, p<0.025), such that the association was stronger in white patients. In stratified analyses, the multivariate-adjusted inverse association between BMI and risk of dementia was present in subjects aged 55-64 years, 65-74 years, and >= 75 years, in men and women, in non-smokers and smokers, and in subjects with different types of health insurance. Conclusions/Significance: Higher baseline BMI was associated with a lower risk of dementia among diabetic patients, and this association was stronger among white than among African American diabetic patients.	[Hu, Gang; Horswell, Ronald; Wang, Yujie; Li, Wei; Keller, Jeffrey N.; Heymsfield, Steven B.; Ryan, Donna H.; Katzmarzyk, Peter T.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Horswell, Ronald; Besse, Jay; Xiao, Ke] Louisiana State Univ, Div Hlth Care Serv, Baton Rouge, LA 70803 USA; [Wang, Yujie] Louisiana State Univ, Sch Human Ecol, Ctr Agr, Baton Rouge, LA 70803 USA; [Xiao, Ke] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hu, G (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	gang.hu@pbrc.edu	Katzmarzyk, Peter T/N-1974-2017; Heymsfield, Steven B/N-1968-2017; Hu, Gang/V-7947-2019; Hu, Gang/N-1971-2017; Keller, Jeffrey N/N-1975-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Heymsfield, Steven B/0000-0003-1127-9425; Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017; Chen, Honglei/0000-0003-3446-7779; Ryan, Donna/0000-0001-8374-2277; keller, jeffrey/0000-0002-9892-7423	Louisiana State University's Improving Clinical Outcomes Network (LSU ICON); Intramural Research Program of the NIH, the National Institute of Environmental Health Sciences [Z01-ES-101986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, Z01ES101986] Funding Source: NIH RePORTER	Louisiana State University's Improving Clinical Outcomes Network (LSU ICON); Intramural Research Program of the NIH, the National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Louisiana State University's Improving Clinical Outcomes Network (LSU ICON), and Dr. Chen was supported by the Intramural Research Program of the NIH, the National Institute of Environmental Health Sciences (Z01-ES-101986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; COX DR, 1972, J R STAT SOC B, V34, P187; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Gustafson DR, 2012, J ALZHEIMERS DIS, V28, P162, DOI 10.3233/JAD-2011-110917; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870; Hu G, 2006, NEUROLOGY, V67, P1955, DOI 10.1212/01.wnl.0000247052.18422.e5; Hu G, 2007, ARCH INTERN MED, V167, P1420, DOI 10.1001/archinte.167.13.1420; Hu G, 2011, DIABETES CARE, V34, P1415, DOI 10.2337/dc10-2019; Hu G, 2010, CIRCULATION, V121, P237, DOI 10.1161/CIRCULATIONAHA.109.887893; Hughes Elizabeth, 2010, Morbidity and Mortality Weekly Report, V59, P1; Hughes TF, 2009, NEUROLOGY, V72, P1741, DOI 10.1212/WNL.0b013e3181a60a58; Kamogawa K, 2010, DEMENT GERIATR COGN, V30, P432, DOI 10.1159/000321985; Kanaya AM, 2011, DIABETES CARE, V34, P930, DOI 10.2337/dc10-1964; Katzmarzyk PT, 2010, AM J CLIN NUTR, V91, P7, DOI 10.3945/ajcn.2009.28136; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Klein S, 2007, AM J CLIN NUTR, V85, P1197, DOI 10.1093/ajcn/85.5.1197; Li W, 2011, DIABETES RES CLIN PR, V94, P262, DOI 10.1016/j.diabres.2011.08.010; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Okereke O, 2007, NEUROBIOL AGING, V28, P135, DOI 10.1016/j.neurobiolaging.2005.10.012; Phung TKT, 2007, DEMENT GERIATR COGN, V24, P220, DOI 10.1159/000107084; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Power BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017902; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rosengren A, 2005, ARCH INTERN MED, V165, P321, DOI 10.1001/archinte.165.3.321; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Wang YJ, 2012, J WOMENS HEALTH, V21, P628, DOI 10.1089/jwh.2011.3318; Wang YJ, 2012, J WOMENS HEALTH, V21, P319, DOI 10.1089/jwh.2011.2838; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Xu WL, 2009, DIABETES, V58, P71, DOI 10.2337/db08-0586; YAMAMOTO H, 1993, ENDOCR J, V40, P41, DOI 10.1507/endocrj.40.41	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44537	10.1371/journal.pone.0044537	http://dx.doi.org/10.1371/journal.pone.0044537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001MC	22957079	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800072
J	Hinterleitner, R; Gruber, T; Pfeifhofer-Obermair, C; Lutz-Nicoladoni, C; Tzankov, A; Schuster, M; Penninger, JM; Loibner, H; Lametschwandtner, G; Wolf, D; Baier, G				Hinterleitner, Reinhard; Gruber, Thomas; Pfeifhofer-Obermair, Christa; Lutz-Nicoladoni, Christina; Tzankov, Alexander; Schuster, Manfred; Penninger, Josef M.; Loibner, Hans; Lametschwandtner, Guenther; Wolf, Dominik; Baier, Gottfried			Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model	PLOS ONE			English	Article							GENE-THERAPY; CUTTING EDGE; CELLS; CANCER; IMMUNOTHERAPY; CD28; COSTIMULATION; AUTOIMMUNITY; ACTIVATION; REGRESSION	The ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We recently showed that adoptive cell transfer (ACT) of cblb(-/-) CD8(+) T cells enhances dendritic cell (DC) immunization-mediated anti-tumor effects in immune-competent recipients. However, translation of cblb targeting to clinically applicable concepts requires that inhibition of cblb activity be transient and reversible. Here we provide experimental evidence that inhibition of cblb using chemically synthesized siRNA has such potential. Silencing cblb expression by ex vivo siRNA transfection of polyclonal CD8(+) T cells prior to ACT increased T cell tumor infiltration, significantly delayed tumor outgrowth, and increased survival rates of tumor-bearing mice. As shown by ex vivo recall assays, cblb silencing resulted in significant augmentation of intratumoral T cell cytokine response. ACT of cblb-silenced polyclonal CD8(+) T cells combined with DC-based tumor vaccines predominantly mediated anti-tumor immune responses, whereas no signs of autoimmunity could be detected. Importantly, CBLB silencing in human CD8(+) T cells mirrored the effects observed for cblb-silenced and cblb-deficient murine T cells. Our data validate the concept of enhanced anti-tumor immunity by repetitive ACT of ex vivo cblb siRNA-silenced hyper-reactive CD8(+) T cells as add-on adjuvant therapy to augment the efficacy of existing cancer immunotherapy regimens in clinical practice.	[Hinterleitner, Reinhard; Gruber, Thomas; Pfeifhofer-Obermair, Christa; Lutz-Nicoladoni, Christina; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria; [Lutz-Nicoladoni, Christina; Wolf, Dominik] Tyrolean Canc Res Inst, Lab Tumor Immunol, Innsbruck, Austria; [Tzankov, Alexander] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Schuster, Manfred; Loibner, Hans; Lametschwandtner, Guenther] Apeiron Biol AG, Vienna, Austria; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Wolf, Dominik] Med Univ Bonn, Dept Hematol & Oncol, Bonn, Germany	Medical University of Innsbruck; University of Basel; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Bonn	Hinterleitner, R (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria.	Gottfried.Baier@i-med.ac.at	Tzankov, Alexandar/H-5656-2019; Penninger, Josef M/I-6860-2013; Hinterleitner, Reinhard/N-7091-2019	Tzankov, Alexandar/0000-0002-1100-3819; Penninger, Josef M/0000-0002-8194-3777; Baier, Gottfried/0000-0002-2085-8325; Gruber, Thomas/0000-0002-5796-7090; Pfeifhofer-Obermair, Christa/0000-0002-9942-6540	FWF Austrian Science Fund [SFB021, T264-B13, P22207]; Austrian Federal Ministries BMVIT/BMWFJ via FFG; Tiroler Zukunftsstiftung/Standortagentur Tirol; Apeiron Biologics Forschungs-und Entwicklungsgesellschaft m.b.H.; Swiss Kamillo Eisner-Foundation [CH-6052 Hergiswil]; Tiroler Landeskrankenanstalten GmbH; Krebshilfe-KG Tirol; MFF-Tirol; Austrian Science Fund (FWF) [T 264, P 22207] Funding Source: researchfish	FWF Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministries BMVIT/BMWFJ via FFG; Tiroler Zukunftsstiftung/Standortagentur Tirol; Apeiron Biologics Forschungs-und Entwicklungsgesellschaft m.b.H.; Swiss Kamillo Eisner-Foundation; Tiroler Landeskrankenanstalten GmbH; Krebshilfe-KG Tirol; MFF-Tirol; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the FWF Austrian Science Fund (SFB021, T264-B13, and P22207), the COMET Center ONCOTYROL funded by the Austrian Federal Ministries BMVIT/BMWFJ (via FFG) and the Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT), Apeiron Biologics Forschungs-und Entwicklungsgesellschaft m.b.H., the Swiss Kamillo Eisner-Foundation (CH-6052 Hergiswil), the Tiroler Landeskrankenanstalten GmbH, the Krebshilfe-KG Tirol, and MFF-Tirol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bouwhuis MG, 2011, CURR OPIN ONCOL, V23, P170, DOI 10.1097/CCO.0b013e328341edff; Chiang JY, 2007, J CLIN INVEST, V117, P1029, DOI 10.1172/JCI29472; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Coccoris M, 2010, EXPERT OPIN BIOL TH, V10, P547, DOI 10.1517/14712591003614756; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Gruber T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000046; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kawakami Y, 1997, IMMUNOL RES, V16, P313, DOI 10.1007/BF02786397; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Li DD, 2004, J IMMUNOL, V173, P7135, DOI 10.4049/jimmunol.173.12.7135; Loeser S, 2007, CELL CYCLE, V6, P2478, DOI 10.4161/cc.6.20.4797; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Lutz-Nicoladoni C, 2011, IMMUNOL CELL BIOL; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Paolino M, 2011, J IMMUNOL, V186, P2138, DOI 10.4049/jimmunol.1003390; Powell DJ, 2006, J IMMUNOL, V177, P6527, DOI 10.4049/jimmunol.177.9.6527; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Sondak VK, 2011, NAT REV DRUG DISCOV, V10, P411, DOI 10.1038/nrd3463; Stoitzner P, 2010, IMMUNOL CELL BIOL, V88, P431, DOI 10.1038/icb.2010.31; Stromnes IM, 2010, J CLIN INVEST, V120, P3722, DOI 10.1172/JCI41991; Thara E, 2011, MATURITAS; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thoeni G, 2005, J IMMUNOL, V174, P7584, DOI 10.4049/jimmunol.174.12.7584; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Wolf D, 2006, MINI-REV MED CHEM, V6, P509, DOI 10.2174/138955706776876230; Yang TM, 2009, CANCER IMMUNOL IMMUN, V58, P1867, DOI 10.1007/s00262-009-0698-3	35	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44295	10.1371/journal.pone.0044295	http://dx.doi.org/10.1371/journal.pone.0044295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962608	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600036
J	Zheng, MH; Shi, KQ; Fan, YC; Liu, WY; Lin, XF; Li, LF; Chen, YP				Zheng, Ming-Hua; Shi, Ke-Qing; Fan, Yu-Chen; Liu, Wen-Yue; Lin, Xian-Feng; Li, Ling-Fei; Chen, Yong-Ping			Upper Limits of Normal for Serum Alanine Aminotransferase Levels in Chinese Han Population	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CHRONIC HEPATITIS-B; RISK; COHORT	Background and Objectives: Serum alanine aminotransferase (ALT) activity is the most common tool for the assessment of liver diseases. However, it is not clear whether the current normal ALT range really discriminate patients with or without liver diseases. The present study was to establish a new normal range of ALT and examine its ability to identify patients with hepatitis B or nonalcoholic fatty liver disease (NAFLD) in Chinese Han population. Methods: 53037 adults were included in this study from January 1st 2008 to August 31st 2010. The 95th percentile of ALT in population with relative low risk factors for liver diseases was set as the new upper limits of normal ALT in gender-specific manner. Results: The 95th percentile levels at low risk factors for liver diseases were achieved at 35 U/L for men and 23 U/L for women. The concordance statistics for detection were 0.873 (95% CI: 0.865-0.881) for HBV and 0.932 (95% CI: 0.927-0.937) for NAFLD in men while 0.857 (95% CI: 0.850-0.864) for HBV and 0.909 (95% CI: 0.903-0.915) for NAFLD in women. The median sensitivity of the current used ALT upper limit (40 U/L) was 6.6% for HBV and 29.7% for NAFLD and median specificity was 98.7% for men and 99.4% for women. Using our new-derived thresholds, the sensitivities ranged from 35.3% to 61.1% and the specificities were 94.8% for men and 94.6% for women. Conclusions: Our results suggest that upper limits of ALT 35 U/L for men and 23 U/L for women in Chinese Han population. Re-consideration of normal limits of ALT should be recommended.	[Zheng, Ming-Hua; Shi, Ke-Qing; Liu, Wen-Yue; Lin, Xian-Feng; Li, Ling-Fei; Chen, Yong-Ping] Wenzhou Med Coll, Dept Infect & Liver Dis, Liver Res Ctr, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zheng, Ming-Hua; Shi, Ke-Qing; Chen, Yong-Ping] Wenzhou Med Coll, Inst Hepatol, Wenzhou, Peoples R China; [Fan, Yu-Chen] Shandong Univ, Dept Hepatol, Qilu Hosp, Jinan, Peoples R China; [Liu, Wen-Yue; Lin, Xian-Feng; Li, Ling-Fei] Wenzhou Med Coll, Sch Clin Med Sci 1, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Shandong University; Wenzhou Medical University	Zheng, MH (corresponding author), Wenzhou Med Coll, Dept Infect & Liver Dis, Liver Res Ctr, Affiliated Hosp 1, Wenzhou, Peoples R China.	blueman1320@163.com	Lin, Xianfeng/ABA-2917-2020; Zheng, Ming-Hua/H-5584-2019; Fan, Yu-Chen/A-8035-2013; Shi, KeQing/A-3411-2009; Shi, Keqing/GZK-5146-2022	Zheng, Ming-Hua/0000-0003-4984-2631; Fan, Yu-Chen/0000-0003-1621-8007; Shi, KeQing/0000-0002-5070-3834; Shi, Keqing/0000-0002-5070-3834; Fan, Yu-Chen/0000-0002-9126-679X; Liu, Wen-yue/0000-0003-1454-7077	National Science and Technology Major Project of China [2012ZX10002004]; Scientific Research Foundation of Wenzhou, Zhejiang Province, China [H20090014, Y20090269]; Health Bureau of Zhejiang Province [2010KYB070]; Research Foundation of Education Bureau of Zhejiang Province [Y201009942]; Project of New Century 551 Talent Nurturing in Wenzhou	National Science and Technology Major Project of China; Scientific Research Foundation of Wenzhou, Zhejiang Province, China; Health Bureau of Zhejiang Province; Research Foundation of Education Bureau of Zhejiang Province; Project of New Century 551 Talent Nurturing in Wenzhou	This work was supported by grants from National Science and Technology Major Project of China (2012ZX10002004), Scientific Research Foundation of Wenzhou, Zhejiang Province, China (H20090014, Y20090269), Health Bureau of Zhejiang Province (2010KYB070), Research Foundation of Education Bureau of Zhejiang Province (Y201009942) and Project of New Century 551 Talent Nurturing in Wenzhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boppidi H, 2008, POSTGRAD MED, V120, pE01; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Jian-gao Fan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P163; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Schwimmer JB, 2010, GASTROENTEROLOGY, V138, P1357, DOI 10.1053/j.gastro.2009.12.052; Singal AK, 2010, HEPATOLOGY, V52, p506A; Van der Poorten D, 2007, HEPATOLOGY, V46, P1750, DOI 10.1002/hep.21918; Wong VWS, 2009, ALIMENT PHARM THER, V29, P387, DOI 10.1111/j.1365-2036.2008.03896.x; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; [World Health Organization Western Pacific Region Force IAftSoOIOT], 2000, AS PAC PERSP RED OB; Yang Yue, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P879; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136	23	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43736	10.1371/journal.pone.0043736	http://dx.doi.org/10.1371/journal.pone.0043736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962588	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600016
J	Alkawareek, MY; Algwari, QT; Laverty, G; Gorman, SP; Graham, WG; O'Connell, D; Gilmore, BF				Alkawareek, Mahmoud Y.; Algwari, Qais Th.; Laverty, Garry; Gorman, Sean P.; Graham, William G.; O'Connell, Deborah; Gilmore, Brendan F.			Eradication of Pseudomonas aeruginosa Biofilms by Atmospheric Pressure Non-Thermal Plasma	PLOS ONE			English	Article							BARRIER DISCHARGE PLASMA; BACTERIAL BIOFILMS; NOSOCOMIAL INFECTIONS; PERSISTER CELLS; IN-VITRO; INACTIVATION; MECHANISMS; DISEASE; JET; STERILIZATION	Bacteria exist, in most environments, as complex, organised communities of sessile cells embedded within a matrix of self-produced, hydrated extracellular polymeric substances known as biofilms. Bacterial biofilms represent a ubiquitous and predominant cause of both chronic infections and infections associated with the use of indwelling medical devices such as catheters and prostheses. Such infections typically exhibit significantly enhanced tolerance to antimicrobial, biocidal and immunological challenge. This renders them difficult, sometimes impossible, to treat using conventional chemotherapeutic agents. Effective alternative approaches for prevention and eradication of biofilm associated chronic and device-associated infections are therefore urgently required. Atmospheric pressure non-thermal plasmas are gaining increasing attention as a potential approach for the eradication and control of bacterial infection and contamination. To date, however, the majority of studies have been conducted with reference to planktonic bacteria and rather less attention has been directed towards bacteria in the biofilm mode of growth. In this study, the activity of a kilohertz-driven atmospheric pressure non-thermal plasma jet, operated in a helium oxygen mixture, against Pseudomonas aeruginosa in vitro biofilms was evaluated. Pseudomonas aeruginosa biofilms exhibit marked susceptibility to exposure of the plasma jet effluent, following even relatively short (similar to 10's s) exposure times. Manipulation of plasma operating conditions, for example, plasma operating frequency, had a significant effect on the bacterial inactivation rate. Survival curves exhibit a rapid decline in the number of surviving cells in the first 60 seconds followed by slower rate of cell number reduction. Excellent anti-biofilm activity of the plasma jet was also demonstrated by both confocal scanning laser microscopy and metabolism of the tetrazolium salt, XTT, a measure of bactericidal activity.	[Alkawareek, Mahmoud Y.; Laverty, Garry; Gorman, Sean P.; Gilmore, Brendan F.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Algwari, Qais Th.; Graham, William G.; O'Connell, Deborah] Queens Univ Belfast, Ctr Plasma Phys, Belfast, Antrim, North Ireland; [O'Connell, Deborah] Univ York, Dept Phys, York Plasma Inst, York YO10 5DD, N Yorkshire, England; [Algwari, Qais Th.] Univ Mosul, Coll Elect Engn, Dept Elect, Mosul, Iraq	Queens University Belfast; Queens University Belfast; University of York - UK; University of Mosul	Alkawareek, MY (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	b.gilmore@qub.ac.uk	O'Connell, Deborah/N-2782-2019; Alkawareek, Mahmoud Y/H-5871-2012; O'Connell, Deborah/D-7967-2018	O'Connell, Deborah/0000-0002-1457-9004; Alkawareek, Mahmoud Y/0000-0002-4852-0617; O'Connell, Deborah/0000-0002-1457-9004; Algwari, Qais/0000-0002-6524-946X; Laverty, Garry/0000-0002-1435-2942; Graham, William/0000-0003-2759-4657	The University of Jordan; EPSRC [EP/H003797/1]; EPSRC [EP/H003797/2, EP/I500987/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H003797/1, EP/I500987/1, EP/H003797/2] Funding Source: researchfish	The University of Jordan; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to thank The University of Jordan for supporting Mahmoud Alkawareek in his PhD study, as well as EPSRC for supporting Deborah O'Connell through a Career Acceleration Fellowship (Grant No. EP/H003797/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; Algwari QT, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3628455; Alkawareek MY, 2012, FEMS IMMUNOL MED MIC, V65, P381, DOI 10.1111/j.1574-695X.2012.00942.x; Aslam S, 2008, AM J INFECT CONTROL, V36; Berthelot P, 2001, INTENS CARE MED, V27, P503, DOI 10.1007/s001340100870; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chaieb K, 2011, MICROB PATHOGENESIS, V50, P1, DOI 10.1016/j.micpath.2010.11.004; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dongari-Bagtzoglou A, 2008, EXPERT REV ANTI-INFE, V6, P141, DOI 10.1586/14787210.6.2.141; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; ELIASSON B, 1987, J PHYS D APPL PHYS, V20, P1421, DOI 10.1088/0022-3727/20/11/010; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P3156, DOI 10.1109/TPS.2010.2070811; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Harris A, 1999, CLIN INFECT DIS, V28, P1128, DOI 10.1086/514760; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koban I, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073039; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220; Lee MH, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115022; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lu X, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349475; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Ma Y, 2008, IEEE T PLASMA SCI, V36, P1615, DOI 10.1109/TPS.2008.917165; MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339; Mericam-Bourdet N, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/055207; Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349; Nwankire CE, 2010, PLASMA CHEM PLASMA P, V30, P537, DOI 10.1007/s11090-010-9236-5; Obritsch MD, 2005, PHARMACOTHERAPY, V25, P1353, DOI 10.1592/phco.2005.25.10.1353; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pitts B, 2003, J MICROBIOL METH, V54, P269, DOI 10.1016/S0167-7012(03)00034-4; Reid G, 1999, INT J ANTIMICROB AG, V11, P223, DOI 10.1016/S0924-8579(99)00020-5; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rossi F, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115017; Rupf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025893; Salamitou S., 2009, BIOTECHNOLOGY, V8, P228, DOI DOI 10.1186/1475-2875-8-228; Shi JJ, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2828551; Sladek REJ, 2007, LETT APPL MICROBIOL, V45, P318, DOI 10.1111/j.1472-765X.2007.02194.x; Sousa JS, 2011, J APPL PHYS, V109, DOI 10.1063/1.3601347; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Walsh JL, 2008, IEEE T PLASMA SCI, V36, P954, DOI 10.1109/TPS.2008.924495; Wei GD, 2011, IEEE T PLASMA SCI, V39, P1842, DOI 10.1109/TPS.2011.2159810; Xu L, 2011, EUR J CLIN MICROBIOL, V30, P25, DOI 10.1007/s10096-010-1047-3; Yardimci O, 2010, IEEE T PLASMA SCI, V38, P973, DOI 10.1109/TPS.2010.2041674	60	133	138	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44289	10.1371/journal.pone.0044289	http://dx.doi.org/10.1371/journal.pone.0044289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952948	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300074
J	Hofmann, I; Weiss, A; Elain, G; Schwaederle, M; Sterker, D; Romanet, V; Schmelzle, T; Lai, A; Brachmann, SM; Bentires-Alj, M; Roberts, TM; Sellers, WR; Hofmann, F; Maira, SM				Hofmann, Irmgard; Weiss, Andreas; Elain, Gaelle; Schwaederle, Maria; Sterker, Dario; Romanet, Vincent; Schmelzle, Tobias; Lai, Albert; Brachmann, Saskia M.; Bentires-Alj, Mohamed; Roberts, Thomas M.; Sellers, William R.; Hofmann, Francesco; Maira, Sauveur-Michel			K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo	PLOS ONE			English	Article							CANCER CELLS; ANTITUMOR-ACTIVITY; DRUG DISCOVERY; BREAST-CANCER; DUCTAL ADENOCARCINOMA; SIGNALING PATHWAYS; ONCOGENIC RAS; KINASE; GROWTH; VASCULATURE	Activating K-RAS mutations occur at a frequency of 90% in pancreatic cancer, and to date no therapies exist targeting this oncogene. K-RAS signals via downstream effector pathways such as the MAPK and the PI3K signaling pathways, and much effort has been focused on developing drugs targeting components of these pathways. To better understand the requirements for K-RAS and its downstream signaling pathways MAPK and PI3K in pancreatic tumor maintenance, we established an inducible K-RAS knock down system that allowed us to ablate K-RAS in established tumors. Knock down of K-RAS resulted in impaired tumor growth in all pancreatic xenograft models tested, demonstrating that K-RAS expression is indeed required for tumor maintenance of K-RAS mutant pancreatic tumors. We further examined signaling downstream of K-RAS, and detected a robust reduction of pERK levels upon K-RAS knock down. In contrast, no effect on pAKT levels could be observed due to almost undetectable basal expression levels. To investigate the requirement of the MAPK and the PI3K pathways on tumor maintenance, three selected pancreatic xenograft models were tested for their response to MEK or PI3K inhibition. Tumors of all three models regressed upon MEK inhibition, but showed less pronounced response to PI3K inhibition. The effect of MEK inhibition on pancreatic xenografts could be enhanced further by combined application of a PI3K inhibitor. These data provide further rationale for testing combinations of MEK and PI3K inhibitors in clinical trials comprising a patient population with pancreatic cancer harboring mutations in K-RAS.	[Hofmann, Irmgard; Weiss, Andreas; Elain, Gaelle; Schwaederle, Maria; Sterker, Dario; Romanet, Vincent; Schmelzle, Tobias; Brachmann, Saskia M.; Hofmann, Francesco; Maira, Sauveur-Michel] Novartis Inst Biomed Res, Oncol Dis Area, Basel, Switzerland; [Lai, Albert] Novartis Inst Biomed Res, Oncol Dis Area, Emeryville, CA USA; [Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Roberts, Thomas M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sellers, William R.] Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA USA	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research; Harvard University; Dana-Farber Cancer Institute; Novartis	Hofmann, I (corresponding author), Novartis Inst Biomed Res, Oncol Dis Area, Basel, Switzerland.	irmgard.hofmann@novartis.com	Mohamed, Bentires-Alj/F-4484-2015	Mohamed, Bentires-Alj/0000-0001-6344-1127	Novartis AG	Novartis AG	All research costs were covered by Novartis AG. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bodoky G, 2012, INVEST NEW DRUG, V30, P1216, DOI 10.1007/s10637-011-9687-4; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chang Q, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-515; Chang Q, 2009, CANCER BIOL THER, V8, P1893, DOI 10.4161/cbt.8.20.9430; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Clarke R, 1997, BREAST CANCER RES TR, V46, P255, DOI 10.1023/A:1005938428456; Cleary JM, 2010, CURR ONCOL REP, V12, P87, DOI 10.1007/s11912-010-0091-6; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fleming JB, 2005, MOL CANCER RES, V3, P413, DOI 10.1158/1541-7786.MCR-04-0206; Fokas E, 2012, CANCER RES, V72, P239, DOI 10.1158/0008-5472.CAN-11-2263; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188; Matsuo Y, 2009, MOL CANCER RES, V7, P799, DOI 10.1158/1541-7786.MCR-08-0577; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Qayum N, 2012, CLIN CANCER RES, V18, P161, DOI 10.1158/1078-0432.CCR-11-1413; Qayum N, 2009, CANCER RES, V69, P6347, DOI 10.1158/0008-5472.CAN-09-0657; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Sheikh R, 2010, EXPERT REV ANTICANC, V10, P1647, DOI [10.1586/era.10.148, 10.1586/ERA.10.148]; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Yu K, 2008, CANCER BIOL THER, V7, P307; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao YP, 2006, J SURG RES, V136, P325, DOI 10.1016/j.jss.2006.06.031; Zhu H, 2006, CANCER BIOL THER, V5, P1693, DOI 10.4161/cbt.5.12.3466	53	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44146	10.1371/journal.pone.0044146	http://dx.doi.org/10.1371/journal.pone.0044146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952903	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300055
J	Mahmood, S; Kanwar, N; Tran, J; Zhang, ML; Kung, SKP				Mahmood, Sajid; Kanwar, Namita; Tran, Jimmy; Zhang, Man-li; Kung, Sam K. P.			SHP-1 Phosphatase Is a Critical Regulator in Preventing Natural Killer Cell Self-Killing	PLOS ONE			English	Article							INHIBITORY LY49 RECEPTORS; NK CELLS; MEDIATED CYTOTOXICITY; TYROSINE PHOSPHATASE; NKG2D RECEPTOR; NK1.1 ANTIGEN; MOTH-EATEN; IN-VITRO; T-CELL; ACTIVATION	Balance of signals generated from the engaged activating and inhibitory surface receptors regulates mature NK cell activities. The inhibitory receptors signal through immunoreceptor tyrosine based inhibitory motifs (ITIM), and recruit phosphatases such as SHP-1 to inhibit NK cell activation. To directly examine the importance of SHP-1 in regulating activities and cell fate of mature NK cells, we used our established lentiviral-based engineering protocol to knock down the SHP-1 protein expression in primary C57BL/6NCrl cells. Gene silencing of the SHP-1 in primary NK cells abrogated the ability of ITIM-containing NK inhibitory receptors to suppress the activation signals induced by NK1.1 activating receptors. We followed the fates of stably transduced SHP-1 silenced primary NK cells over a longer period of time in IL-2 containing cultures. We observed an impaired IL-2 induced proliferation in the SHP-1 knockdown NK cells. More interestingly, these "de-regulated'' SHP-1 knockdown NK cells mediated specific self-killing in a real-time live cell microscopic imaging system we developed to study NK cell cytotoxicity in vitro. Selective target recognition of the SHP-1 knockdown NK cells revealed also possible involvement of the SHP-1 phosphatase in regulating other NK functions in mature NK cells.	[Mahmood, Sajid; Tran, Jimmy; Zhang, Man-li; Kung, Sam K. P.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Kanwar, Namita] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, John Buhler Res Ctr, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Mahmood, S (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	kung@cc.umanitoba.ca			Manitoba Health Research Council; Natural Sciences and Engineering Research Council [RGPIN/355727-2008]; Manitoba Institute of Child Health; CIHR IID; Global Health Training Program; Manitoba Medical Service Foundation; Manitoba Blue Cross	Manitoba Health Research Council; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Institute of Child Health; CIHR IID(Canadian Institutes of Health Research (CIHR)); Global Health Training Program; Manitoba Medical Service Foundation; Manitoba Blue Cross	This work was supported by Establishment and Operating Grants from the Manitoba Health Research Council, and Natural Sciences and Engineering Research Council (RGPIN/355727-2008 to S. K. P. K.). J.T. was supported by a fellowship provided by Manitoba Health Research Council. S. M. has been supported by a graduate fellowship provided by Manitoba Institute of Child Health, Manitoba Health Research Council and CIHR IID and Global Health Training Program. S. K. P. K. was a Basic Science Career Development Research Awardee of the Manitoba Medical Service Foundation supported with funds provided by the Manitoba Blue Cross. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyweera TP, 2011, J CELL BIOL, V192, P675, DOI 10.1083/jcb.201009135; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Biassoni Roberto, 2010, Self Nonself, V1, P103; Binstadt BA, 1997, IMMUNOL REV, V155, P197, DOI 10.1111/j.1600-065X.1997.tb00952.x; Gunturi A, 2003, J IMMUNOL, V170, P1737, DOI 10.4049/jimmunol.170.4.1737; KARLHOFER FM, 1991, J IMMUNOL, V146, P3662; Koh CY, 2001, BLOOD, V97, P3132, DOI 10.1182/blood.V97.10.3132; KOO GC, 1991, J IMMUNOL, V147, P1194; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; Kung SKP, 2010, METHODS MOL BIOL, V612, P233, DOI 10.1007/978-1-60761-362-6_16; Kung SKP, 2000, J VIROL, V74, P3668, DOI 10.1128/JVI.74.8.3668-3681.2000; KUNG SKP, 1995, J IMMUNOL, V154, P1624; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Ljutic B, 2005, J IMMUNOL, V174, P4789, DOI 10.4049/jimmunol.174.8.4789; Long EO, 2001, IMMUNOL REV, V181, P223, DOI 10.1034/j.1600-065X.2001.1810119.x; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Lowin-Kropf B, 2000, J IMMUNOL, V165, P1314, DOI 10.4049/jimmunol.165.3.1314; Lunemann A, 2011, INT IMMUNOL, V23, P139, DOI 10.1093/intimm/dxq463; Moretta Lorenzo, 2001, Current Opinion in Pharmacology, V1, P387, DOI 10.1016/S1471-4892(01)00067-4; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Orr MT, 2011, CURR TOP MICROBIOL, V350, P67, DOI 10.1007/82_2010_85; Ortaldo JR, 2005, MOL IMMUNOL, V42, P445, DOI 10.1016/j.molimm.2004.07.024; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Purdy AK, 2009, J IMMUNOL, V183, P7234, DOI 10.4049/jimmunol.0900088; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Sentman CL, 2006, ADV CANCER RES, V95, P249, DOI 10.1016/S0065-230X(06)95007-6; Tran J, 2007, MOL THER, V15, P1331, DOI 10.1038/sj.mt.6300184; Tran J, 2010, VACCINE, V28, P3767, DOI 10.1016/j.vaccine.2010.03.013; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang LL, 1999, J IMMUNOL, V162, P1318; Whittaker GC, 2008, BLOOD, V112, P2869, DOI 10.1182/blood-2007-11-121590; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X; Yusa S, 2002, J IMMUNOL, V168, P5047, DOI 10.4049/jimmunol.168.10.5047; Zafirova B, 2011, CELL MOL LIFE SCI, V68, P3519, DOI 10.1007/s00018-011-0797-0; Zaritskaya L, 2010, EXPERT REV VACCINES, V9, P601, DOI [10.1586/erv.10.49, 10.1586/ERV.10.49]	46	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44244	10.1371/journal.pone.0044244	http://dx.doi.org/10.1371/journal.pone.0044244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952938	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300068
J	Nagel, CH; Dohner, K; Binz, A; Bauerfeind, R; Sodeik, B				Nagel, Claus-Henning; Doehner, Katinka; Binz, Anne; Bauerfeind, Rudolf; Sodeik, Beate			Improper Tagging of the Non-Essential Small Capsid Protein VP26 Impairs Nuclear Capsid Egress of Herpes Simplex Virus	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; LARGE TEGUMENT PROTEIN; 3-DIMENSIONAL LOCALIZATION; MUTANT VIRUS; CELL-CULTURE; VIRAL GROWTH; UL36 GENE; TYPE-1; TRANSPORT; DNA	To analyze the subcellular trafficking of herpesvirus capsids, the small capsid protein has been labeled with different fluorescent proteins. Here, we analyzed the infectivity of several HSV1(17(+)) strains in which the N-terminal region of the non-essential small capsid protein VP26 had been tagged at different positions. While some variants replicated with similar kinetics as their parental wild type strain, others were not infectious at all. Improper tagging resulted in the aggregation of VP26 in the nucleus, prevented efficient nuclear egress of viral capsids, and thus virion formation. Correlative fluorescence and electron microscopy showed that these aggregates had sequestered several other viral proteins, but often did not contain viral capsids. The propensity for aggregate formation was influenced by the type of the fluorescent protein domain, the position of the inserted tag, the cell type, and the progression of infection. Among the tags that we have tested, mRFPVP26 had the lowest tendency to induce nuclear aggregates, and showed the least reduction in replication when compared to wild type. Our data suggest that bona fide monomeric fluorescent protein tags have less impact on proper assembly of HSV1 capsids and nuclear capsid egress than tags that tend to dimerize. Small chemical compounds capable of inducing aggregate formation of VP26 may lead to new antiviral drugs against HSV infections.	[Nagel, Claus-Henning; Doehner, Katinka; Binz, Anne; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany; [Bauerfeind, Rudolf] Hannover Med Sch, Inst Cell Biol, Hannover, Germany	Hannover Medical School; Hannover Medical School	Nagel, CH (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	sodeik.beate@mh-hannover.de	Sodeik, Beate/C-9732-2010	Sodeik, Beate/0000-0003-4650-3036	German Research Council [DFG-SPP1175, DFG-SFP900]; European Union [12702]; Research Core Unit for Laser Microscopy at Hannover Medical School; Research Core Unit for Electron Microscopy at Hannover Medical School	German Research Council(German Research Foundation (DFG)); European Union(European Commission); Research Core Unit for Laser Microscopy at Hannover Medical School; Research Core Unit for Electron Microscopy at Hannover Medical School	This study was supported by the German Research Council (DFG-SPP1175 to BS and RB; DFG-SFP900 to BS), and the European Union 6th Framework Program (EU-NEST AXON SUPPORT, contract number 12702 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Anja Pohlmann, Anna Buch, Daniela Kieneke, Deepika Devadas, Eva Borst, Fenja Anderson, Randi Diestel and Malte Sandbaumhuter for their comments on the manuscript, and Christof Bohnen and Julia Schipke for support with BAC-mutagenesis (Institute of Virology, Hannover Medical School) as well as Joel Baines (Cornell University, USA) and Prashant Desai (Johns Hopkins University, Baltimore, MD) for helpful discussions. We are grateful to John Subak-Sharpe (MRC Virology Unit, Glasgow, UK) and Prashant Desai for providing HSV1 strains. We thank Susanne Bailer (Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany), Jay Brown and Bill Newcomb (University of Virginia, Charlottesville, VA), Edouard Cantin (City of Hope National Medical Center, Duarte,; California), Richard J. Courtney (Pennsylvania State University College of Medicine, Hershey, PA), Prashant Desai, Roselyn Eisenberg and Gary Cohen (University of Pennsylvania, Philadelphia, PA), Regine Heilbronn (Charite-Universit Delta tsmedizin, Berlin, Germany), Ari Helenius (Eidgenossische Technische Hochschule Zurich, Switzerland), Helena Browne and Anthony Minson (University of Cambridge, UK), Valerie Preston (MRC Virology Unit, Glasgow, UK), Bernard Roizman (University of Chicago, Chicago, Illinois), and Dan Tenney (Bristol-Myers Squibb, Wallingford, CT) for donating invaluable antibodies. We furthermore acknowledge the support of the Research Core Units for Laser Microscopy and Electron Microscopy at Hannover Medical School.	Ali MA, 1996, VIROLOGY, V216, P278, DOI 10.1006/viro.1996.0061; Antinone SE, 2006, J VIROL, V80, P5494, DOI 10.1128/JVI.00026-06; Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; Apcarian A, 2010, J GEN VIROL, V91, P2659, DOI 10.1099/vir.0.019984-0; Baines JD, 2011, TRENDS MICROBIOL, V19, P606, DOI 10.1016/j.tim.2011.09.001; Baker ML, 2006, PLOS COMPUT BIOL, V2, P1313, DOI 10.1371/journal.pcbi.0020146; Bohannon KP, 2012, J GEN VIROL, V93, P124, DOI 10.1099/vir.0.036145-0; BOOY FP, 1994, P NATL ACAD SCI USA, V91, P5652, DOI 10.1073/pnas.91.12.5652; Borst EM, 2001, J VIROL, V75, P1450, DOI 10.1128/JVI.75.3.1450-1458.2001; Bosse JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040585; Bowman BR, 2003, EMBO J, V22, P757, DOI 10.1093/emboj/cdg086; BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cardone G, 2012, J VIROL; Chaudhuri V, 2008, J VIROL, V82, P10231, DOI 10.1128/JVI.01890-07; Chen DH, 2001, J VIROL, V75, P11863, DOI 10.1128/JVI.75.23.11863-11867.2001; Cheng SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017966; Chi JHI, 2000, J VIROL, V74, P1468, DOI 10.1128/JVI.74.3.1468-1476.2000; Church GA, 1997, J VIROL, V71, P3603, DOI 10.1128/JVI.71.5.3603-3612.1997; COHEN GH, 1980, J VIROL, V34, P521, DOI 10.1128/JVI.34.2.521-531.1980; Dasgupta A, 1999, J VIROL, V73, P2006, DOI 10.1128/JVI.73.3.2006-2015.1999; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; Desai P, 2003, J VIROL, V77, P391, DOI 10.1128/JVI.77.1.391-404.2003; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Desai P, 1998, VIROLOGY, V247, P115, DOI 10.1006/viro.1998.9230; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Dohner K, 2006, J VIROL, V80, P8211, DOI 10.1128/JVI.02528-05; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Espagne A, 2011, BIOCHEMISTRY-US, V50, P437, DOI 10.1021/bi1015875; Everett RD, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P51; Forest T, 2005, NAT CELL BIOL, V7, P429, DOI 10.1038/ncb1243; Fuchs W, 2004, J VIROL, V78, P11879, DOI 10.1128/JVI.78.21.11879-11889.2004; GAO M, 1994, J VIROL, V68, P3702, DOI 10.1128/JVI.68.6.3702-3712.1994; Henson BW, 2009, J VIROL, V83, P3877, DOI 10.1128/JVI.01733-08; Homa FL, 1997, REV MED VIROL, V7, P107, DOI 10.1002/(SICI)1099-1654(199707)7:2<107::AID-RMV191>3.0.CO;2-M; HUANG AS, 1964, P SOC EXP BIOL MED, V116, P863, DOI 10.3181/00379727-116-29392; Jirmo AC, 2009, J IMMUNOL, V182, P283, DOI 10.4049/jimmunol.182.1.283; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kim DB, 2002, J VIROL, V76, P1548, DOI 10.1128/JVI.76.4.1548-1558.2002; Ko DH, 2010, J VIROL, V84, P1397, DOI 10.1128/JVI.01721-09; Kobiler O, 2011, MBIO, V2, DOI 10.1128/mBio.00278-11; Kops AD, 1998, VIROLOGY, V252, P162, DOI 10.1006/viro.1998.9450; Koslowski KM, 1997, J VIROL, V71, P9118, DOI 10.1128/JVI.71.12.9118-9123.1997; Krautwald M, 2008, J GEN VIROL, V89, P1346, DOI 10.1099/vir.0.83652-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamberti C, 1998, J VIROL, V72, P2463, DOI 10.1128/JVI.72.3.2463-2473.1998; Lee JH, 2008, VIROLOGY, V378, P347, DOI 10.1016/j.virol.2008.05.035; Leelawong M, 2012, J VIROL, V86, P6303, DOI 10.1128/JVI.07051-11; Livingston CM, 2008, J VIROL, V82, P6324, DOI 10.1128/JVI.00455-08; Lo P, 2003, J VIROL, V77, P4291, DOI 10.1128/JVI.77.7.4291-4297.2003; Luxton GWG, 2006, J VIROL, V80, P201, DOI 10.1128/JVI.80.1.201-209.2006; MATUSICKKUMAR L, 1994, J VIROL, V68, P5384, DOI 10.1128/JVI.68.9.5384-5394.1994; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; MCNABB DS, 1992, J VIROL, V66, P7581, DOI 10.1128/JVI.66.12.7581-7584.1992; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Munger J, 2001, J VIROL, V75, P5491, DOI 10.1128/JVI.75.12.5491-5497.2001; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Newcomb WW, 2000, J VIROL, V74, P1663, DOI 10.1128/JVI.74.4.1663-1673.2000; Nijman SMB, 2011, FEBS LETT, V585, P1, DOI 10.1016/j.febslet.2010.11.024; Ott M, 2011, J GEN VIROL, V92, P2734, DOI 10.1099/vir.0.032730-0; Perkins EM, 2008, J VIROL, V82, P7201, DOI 10.1128/JVI.00423-08; Phelan A, 1997, J VIROL, V71, P1124, DOI 10.1128/JVI.71.2.1124-1132.1997; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Reichelt M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002740; Reichelt M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001266; Rixon FJ, 1996, J GEN VIROL, V77, P2251, DOI 10.1099/0022-1317-77-9-2251; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; Rode K, 2011, J VIROL, V85, P4271, DOI 10.1128/JVI.02067-10; Schipke J, 2012, J VIROL, V86, P3682, DOI 10.1128/JVI.06432-11; Shanda SK, 2008, J VIROL, V82, P7388, DOI 10.1128/JVI.00225-08; Simpson-Holley M, 2005, J VIROL, V79, P12840, DOI 10.1128/JVI.79.20.12840-12851.2005; Smith GA, 2004, P NATL ACAD SCI USA, V101, P16034, DOI 10.1073/pnas.0404686101; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Snyder A, 2006, J VIROL, V80, P11165, DOI 10.1128/JVI.01107-06; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Sugimoto K, 2008, J VIROL, V82, P5198, DOI 10.1128/JVI.02681-07; Thurlow JK, 2005, J VIROL, V79, P150, DOI 10.1128/JVI.79.1.150-158.2005; TRUS BL, 1992, P NATL ACAD SCI USA, V89, P11508, DOI 10.1073/pnas.89.23.11508; TRUS BL, 1995, J VIROL, V69, P7362, DOI 10.1128/JVI.69.11.7362-7366.1995; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tucker CL, 2003, NAT GENET, V35, P204, DOI 10.1038/ng1103-204; Wang L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-156; Ward PL, 1996, J VIROL, V70, P4623, DOI 10.1128/JVI.70.7.4623-4631.1996; Ward SA, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P89; Wingfield PT, 1997, J VIROL, V71, P8955, DOI 10.1128/JVI.71.12.8955-8961.1997; Wisner TW, 2011, J VIROL, V85, P5919, DOI 10.1128/JVI.00116-11; Wolfstein A, 2006, TRAFFIC, V7, P227, DOI 10.1111/j.1600-0854.2005.00379.x; Yu XK, 2005, J VIROL, V79, P1327, DOI 10.1128/JVI.79.2.1327-1332.2005; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeng W, 2006, BIOCHEMISTRY-US, V45, P10482, DOI 10.1021/bi060943u; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026	94	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44177	10.1371/journal.pone.0044177	http://dx.doi.org/10.1371/journal.pone.0044177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952920	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300059
J	Chaillon, A; Braibant, M; Hue, S; Bencharif, S; Enard, D; Moreau, A; Samri, A; Agut, H; Barin, F				Chaillon, Antoine; Braibant, Martine; Hue, Stephane; Bencharif, Samia; Enard, David; Moreau, Alain; Samri, Assia; Agut, Henri; Barin, Francis			Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection	PLOS ONE			English	Article							LONG-TERM NONPROGRESSORS; DISEASE PROGRESSION; GLYCOSYLATION SITES; HUMORAL IMMUNITY; 2G12 RECOGNIZES; SHIV CHALLENGE; GLYCAN SHIELD; C INFECTION; SUBTYPE-B; ENVELOPE	Background: The evolution of HIV-1 and its immune escape to autologous neutralizing antibodies (Nabs) during the acute/early phases of infection have been analyzed in depth in many studies. In contrast, little is known about neither the longterm evolution of the virus in patients who developed broadly Nabs (bNabs) or the mechanism of escape in presence of these bNabs. Results: We have studied the viral population infecting a long term non progressor HIV-1 infected patient who had developed broadly neutralizing antibodies toward all tier 2/3 viruses (6 clades) tested, 9 years after infection, and was then followed up over 7 years. The autologous neutralization titers of the sequential sera toward env variants representative of the viral population significantly increased during the follow-up period. The most resistant pseudotyped virus was identified at the last visit suggesting that it represented a late emerging escape variant. We identified 5 amino acids substitutions that appeared associated with escape to broadly neutralizing antibodies. They were V319I/S, R/K355T, R/W429G, Q460E and G/T463E, in V3, C3 and V5 regions. Conclusion: This study showed that HIV-1 may continue to evolve in presence of both broadly neutralizing antibodies and increasing autologous neutralizing activity more than 10 years post-infection.	[Chaillon, Antoine; Braibant, Martine; Bencharif, Samia; Moreau, Alain; Barin, Francis] Univ Tours, Inserm UMR 966, Tours, France; [Chaillon, Antoine; Barin, Francis] CHU Bretonneau, Virol Lab, F-37044 Tours, France; [Hue, Stephane] UCL, Ctr Med Mol Virol, London, England; [Enard, David] Ecole Normale Super, Lab Ecol & Evolut CNRS UMR 7625, F-75231 Paris, France; [Samri, Assia] Univ Paris 06, Hop La Pitie Salpetriere, IFR 113, Inserm UMRS 945, Paris, France; [Agut, Henri] Univ Paris 06, DETIV ER1, Hop La Pitie Salpetriere, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; University of London; University College London; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Chaillon, A (corresponding author), Univ Tours, Inserm UMR 966, Tours, France.	francis.barin@univ-tours.fr	Chaillon, Antoine/GNH-6121-2022; chaillon, antoine/GNH-1623-2022	Enard, David/0000-0003-2634-8016; Hue, Stephane/0000-0002-8580-6905	Agence Nationale de Recherche sur le SIDA et les hepatites (ANRS, Paris, France)	Agence Nationale de Recherche sur le SIDA et les hepatites (ANRS, Paris, France)(ANRS)	This work was supported by the Agence Nationale de Recherche sur le SIDA et les hepatites (ANRS, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barin F, 2004, J INFECT DIS, V189, P322, DOI 10.1086/380099; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Braibant M, 2008, JAIDS-J ACQ IMM DEF, V47, P274, DOI 10.1097/QAI.0b013e318162cac2; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; Braibant M, 2010, VIROLOGY, V405, P81, DOI 10.1016/j.virol.2010.05.026; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Bunnik EM, 2009, VIROLOGY, V390, P348, DOI 10.1016/j.virol.2009.05.028; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Chaillon A, 2011, J VIROL, V85, P3642, DOI 10.1128/JVI.02424-10; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edo-Matas D, 2010, VIROLOGY, V405, P492, DOI 10.1016/j.virol.2010.06.029; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Joos B, 2007, J INFECT DIS, V196, P313, DOI 10.1086/518935; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Kirchherr JL, 2011, VIROLOGY, V409, P163, DOI 10.1016/j.virol.2010.09.031; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori DC, 2009, CURR OPIN HIV AIDS, V4, P347, DOI 10.1097/COH.0b013e32832f4a4d; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; van Gils MJ, 2011, J VIROL, V85, P8443, DOI 10.1128/JVI.05214-11; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; Varela M, J VIROL; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Williamson S, 2005, MOL BIOL EVOL, V22, P456, DOI 10.1093/molbev/msi029; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu X, 2010, SCIENCE; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	83	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44163	10.1371/journal.pone.0044163	http://dx.doi.org/10.1371/journal.pone.0044163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957000	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000308206500050
J	Han, EH; Rha, GB; Chi, YI				Han, Eun Hee; Rha, Geun Bae; Chi, Young-In			MED25 Is a Mediator Component of HNF4 alpha-Driven Transcription Leading to Insulin Secretion in Pancreatic Beta-Cells	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-4; PROTEIN-PROTEIN INTERACTIONS; VITAMIN-D-RECEPTOR; COACTIVATOR COMPLEX; GLUCOSE-METABOLISM; STRUCTURAL BASIS; GENE-EXPRESSION; YOUNG MODY1; ACTIVATION; INHIBITORS	Unique nuclear receptor Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) is an essential transcriptional regulator for early development and proper function of pancreatic beta-cells, and its mutations are monogenic causes of a dominant inherited form of diabetes referred to as Maturity Onset Diabetes of the Young 1 (MODY1). As a gene-specific transcription factor, HNF4 alpha exerts its function through various molecular interactions, but its protein recruiting network has not been fully characterized. Here we report the identification of MED25 as one of the HNF4 alpha binding partners in pancreatic beta-cells leading to insulin secretion which is impaired in MODY patients. MED25 is one of the subunits of the Mediator complex that is required for induction of RNA polymerase II transcription by various transcription factors including nuclear receptors. This HNF4 alpha-MED25 interaction was initially identified by a yeast-two-hybrid method, confirmed by in vivo and in vitro analyses, and proven to be mediated through the MED25-LXXLL motif in a ligand-independent manner. Reporter-gene based transcription assays and siRNA/shRNA-based gene silencing approaches revealed that this interaction is crucial for full activation of HNF4 alpha-mediated transcription, especially expression of target genes implicated in glucose-stimulated insulin secretion. Selected MODY mutations at the LXXLL motif binding pocket disrupt these interactions and cause impaired insulin secretion through a 'loss-of-function' mechanism.	[Han, Eun Hee; Rha, Geun Bae; Chi, Young-In] Univ Minnesota, Hormel Inst, Sect Struct Biol, Austin, MN 55912 USA	University of Minnesota System	Han, EH (corresponding author), Univ Minnesota, Hormel Inst, Sect Struct Biol, 801 16th Ave NE, Austin, MN 55912 USA.	ychi@hi.umn.edu	Han, Eun Hee/X-8570-2019		American Diabetes Association [7-08-CD-03]; Commonwealth of Kentucky Diabetes Research Trust Fund [KDR-PP09-09]	American Diabetes Association(American Diabetes Association); Commonwealth of Kentucky Diabetes Research Trust Fund	This work was funded by the American Diabetes Association (7-08-CD-03) and the Commonwealth of Kentucky Diabetes Research Trust Fund (KDR-PP09-09) to YIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Belakavadi M, 2006, REV PHYSIOL BIOCH P, V156, P23, DOI 10.1007/s10254-005-0002-7; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Ding N, 2009, J BIOL CHEM, V284, P2648, DOI 10.1074/jbc.M806514200; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Galande AK, 2005, CHEMBIOCHEM, V6, P1991, DOI 10.1002/cbic.200500083; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Haider S, 2005, J MOL CELL CARDIOL, V38, P927, DOI 10.1016/j.yjmcc.2005.01.007; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Kim TW, 2004, P NATL ACAD SCI USA, V101, P12153, DOI 10.1073/pnas.0401985101; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; Maeda Y, 2002, MOL ENDOCRINOL, V16, P1502, DOI 10.1210/me.16.7.1502; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; Mita Y, 2010, BIOORG MED CHEM LETT, V20, P1712, DOI 10.1016/j.bmcl.2010.01.079; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mukherjee S, 2010, PHARM RES-DORDR, V27, P1439, DOI 10.1007/s11095-010-0117-7; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Owen K, 2001, BEST PRACT RES CL EN, V15, P309, DOI 10.1053/beem.2001.0148; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Rana R, 2011, MOL CELL BIOL, V31, P466, DOI 10.1128/MCB.00847-10; Rha GB, 2009, J BIOL CHEM; Rha GB, 2011, BIOSCIENCE REP, V31, P411, DOI 10.1042/BSR20110013; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Rosano C, 2011, CURR MED CHEM, V18, P1188, DOI 10.2174/092986711795029645; Shanle EK, 2010, ADV DRUG DELIVER REV, V62, P1265, DOI 10.1016/j.addr.2010.08.001; Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Sladek FM, 2001, NUCL RECEPTORS GENET; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Sun AM, 2011, CHEMMEDCHEM, V6, P654, DOI 10.1002/cmdc.201000507; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	52	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44007	10.1371/journal.pone.0044007	http://dx.doi.org/10.1371/journal.pone.0044007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952853	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500040
J	Noguchi, C; Rapp, JB; Skorobogatko, YV; Bailey, LD; Noguchi, E				Noguchi, Chiaki; Rapp, Jordan B.; Skorobogatko, Yuliya V.; Bailey, Lauren D.; Noguchi, Eishi			Swi1 Associates with Chromatin through the DDT Domain and Recruits Swi3 to Preserve Genomic Integrity	PLOS ONE			English	Article							DNA-REPLICATION CHECKPOINT; FORK PROTECTION COMPLEX; XENOPUS EGG EXTRACTS; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; RESPONSE PATHWAY; STRAND BREAKS; DAMAGED DNA; TIPIN	Swi1 and Swi3 form the replication fork protection complex and play critical roles in proper activation of the replication checkpoint and stabilization of replication forks in the fission yeast Schizosaccharomyces pombe. However, the mechanisms by which the Swi1-Swi3 complex regulates these processes are not well understood. Here, we report functional analyses of the Swi1-Swi3 complex in fission yeast. Swi1 possesses the DDT domain, a putative DNA binding domain found in a variety of chromatin remodeling factors. Consistently, the DDT domain-containing region of Swi1 interacts with DNA in vitro, and mutations in the DDT domain eliminate the association of Swi1 with chromatin in S. pombe cells. DDT domain mutations also render cells highly sensitive to S-phase stressing agents and induce strong accumulation of Rad22-DNA repair foci, indicating that the DDT domain is involved in the activity of the Swi1-Swi3 complex. Interestingly, DDT domain mutations also abolish Swi1's ability to interact with Swi3 in cells. Furthermore, we show that Swi1 is required for efficient chromatin association of Swi3 and that the Swi1 C-terminal domain directly interacts with Swi3. These results indicate that Swi1 associates with chromatin through its DDT domain and recruits Swi3 to function together as the replication fork protection complex.	[Noguchi, Chiaki; Rapp, Jordan B.; Skorobogatko, Yuliya V.; Bailey, Lauren D.; Noguchi, Eishi] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Drexel University	Noguchi, C (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA.	enoguchi@drexelmed.edu	Noguchi, Eishi/AAF-3986-2021; Noguchi, Eishi/E-7283-2013	Noguchi, Eishi/0000-0001-5470-5127	Leukemia Research Foundation; National Institutes of Health [GM077604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077604] Funding Source: NIH RePORTER	Leukemia Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by funds from Leukemia Research Foundation (to EN) and National Institutes of Health (GM077604, to EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alfa C., 1993, EXPT FISSION YEAST; Ansbach AB, 2008, MOL BIOL CELL, V19, P595, DOI 10.1091/mbc.E07-06-0618; Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Doerks T, 2001, TRENDS BIOCHEM SCI, V26, P145, DOI 10.1016/S0968-0004(00)01769-2; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KEENEY JB, 1994, GENETICS, V136, P849; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee BS, 2004, MOL CELL BIOL, V24, P9813, DOI 10.1128/MCB.24.22.9813-9822.2004; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Matsumoto S, 2005, J BIOL CHEM, V280, P42536, DOI 10.1074/jbc.M510575200; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi C, 2007, GENETICS, V175, P553, DOI 10.1534/genetics.106.065334; Noguchi Chiaki, 2008, Biotechnology Journal, V3, P1280, DOI 10.1002/biot.200800140; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Noguchi E., 2010, NATURE ED, V3, P46; Noguchi Eishi, 2009, V521, P493, DOI [10.1007/978-1-60327-817-5_28, 10.1007/978-1-60327-815-7_28]; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Rapp JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013379; Rapp Jordan B., 2009, V521, P191, DOI [10.1007/978-1-60327-815-7_10, 10.1007/978-1-60327-817-5_10]; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sabatinos SA., 2010, NAT ED, V3, P40; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; Shiozaki K, 1997, FOREIGN GENE EXPRESS, P133; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tanaka T, 2010, J BIOL CHEM, V285, P39609, DOI 10.1074/jbc.M110.173344; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200	56	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43988	10.1371/journal.pone.0043988	http://dx.doi.org/10.1371/journal.pone.0043988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952839	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206500035
J	Zhu, YY; Su, Y; Li, ZG; Zhang, Y				Zhu, Yun-Yan; Su, Yin; Li, Zhan-Guo; Zhang, Yu			The Largely Normal Response to Toll-Like Receptor 7 and 9 Stimulation and the Enhanced Expression of SIGIRR by B Cells in Systemic Lupus Erythematosus	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; MURINE LUPUS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; FAMILY-MEMBER; UP-REGULATION; INFLAMMATION; TIR8/SIGIRR; TLR7	Background: Altered Toll-like receptor (TLR) signaling has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). The present study was undertaken to characterize responses of B cells from SLE patients to TLR7 and TLR9 stimulation and to explore the potential role of single immunoglobulin interleukin-1 receptor related molecule (SIGIRR) in the regulation of TLR-mediated responses of SLE B cells. Methodology/Principal Findings: Peripheral blood mononuclear cells (PBMC) were isolated from 64 patients with SLE and 37 healthy donors. CD19+ B cells purified using microbeads were cultured with TLR7 or TLR9 agonists. Cell proliferation was measured by thymine incorporation and the frequency of antibody-secreting cells was determined by ELISPOT assay. SIGIRR expression in PBMCs and B cells was analyzed using flow cytometry analysis. In contrast to the enhanced proliferation following B cell receptor (BCR) engagement, B cells from SLE patients exhibited a virtually normal proliferative response to TLR7 or TLR9 stimulation. Moreover, B cells from SLE patients and healthy donors were almost equally competent to differentiate into antibody-secreting cells upon TLR engagement except for a reduction in the generation of IgG-secreting cells by TLR9-stimulated lupus B cells. In line with these somehow unexpected observations, SLE B cells were found to express a significantly higher level of SIGIRR than normal B cells. Conclusions/Significance: Despite the reported upregulation of TLR7 and TLR9 expression in B cell from SLE patients, their responses to TLR stimulation were largely normal. The increased expression of the negative regulator SIGIRR may be partly responsible for the "balance of terror".	[Zhu, Yun-Yan; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Dept Immunol, Minist Hlth, Beijing 100871, Peoples R China; [Zhu, Yun-Yan; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Minist Hlth, Key Lab Med Immunol, Beijing 100871, Peoples R China; [Su, Yin; Li, Zhan-Guo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhu, YY (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Minist Hlth, Beijing 100871, Peoples R China.	zhangyu007@hsc.pku.edu.cn; zgli@yahoo.cn			National Science Foundation of China [30830091, 81172844]; Ministry of Science and Technology of China [2011CB946100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Science and Technology of China (2011CB946100) and the National Science Foundation of China (30830091) to Y.Z. 1, National Science Foundation of China (81172844) to Z.G.L.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; ANDERSON CC, 1994, IMMUNOL RES, V13, P10, DOI 10.1007/BF02918220; Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Drexler SK, 2010, ARTHRITIS RHEUM-US, V62, P2249, DOI 10.1002/art.27517; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; Huang X, 2006, J IMMUNOL, V177, P548, DOI 10.4049/jimmunol.177.1.548; KLINMAN DM, 1991, ARTHRITIS RHEUM, V34, P1404; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lech M, 2007, KIDNEY INT, V72, P182, DOI 10.1038/sj.ki.5002293; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lech M, 2010, J PATHOL, V220, P596, DOI 10.1002/path.2678; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Migita K, 2007, J RHEUMATOL, V34, P493; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Muzio M, 2009, BRIT J HAEMATOL, V144, P507, DOI 10.1111/j.1365-2141.2008.07475.x; Nakano S, 2008, RHEUMATOLOGY, V47, P145, DOI 10.1093/rheumatology/kem327; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Polentarutti N, 2003, EUR CYTOKINE NETW, V14, P211; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; SALATA M, 1988, CLIN EXP IMMUNOL, V71, P439; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wu O, 2009, IMMUNOBIOLOGY, V214, P392, DOI 10.1016/j.imbio.2008.10.004; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zeuner RA, 2003, RHEUMATOLOGY, V42, P563, DOI 10.1093/rheumatology/keg191; Zhang C, 2011, MOL BIOL REP, V38, P601, DOI 10.1007/s11033-010-0146-7	43	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44131	10.1371/journal.pone.0044131	http://dx.doi.org/10.1371/journal.pone.0044131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952899	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000088
J	Cai, X; Li, L; Krumholz, A; Guo, ZJ; Erpelding, TN; Zhang, C; Zhang, Y; Xi, YN; Wang, LHV				Cai, Xin; Li, Li; Krumholz, Arie; Guo, Zijian; Erpelding, Todd N.; Zhang, Chi; Zhang, Yu; Xi, Younan; Wang, Lihong V.			Multi-Scale Molecular Photoacoustic Tomography of Gene Expression	PLOS ONE			English	Article							IN-VIVO; MICROSCOPY; SYSTEM; PROBE	Photoacoustic tomography (PAT) is a molecular imaging technology. Unlike conventional reporter gene imaging, which is usually based on fluorescence, photoacoustic reporter gene imaging relies only on optical absorption. This work demonstrates several key merits of PAT using lacZ, one of the most widely used reporter genes in biology. We show that the expression of lacZ can be imaged by PAT as deep as 5.0 cm in biological tissue, with resolutions of similar to 1.0 mm and similar to 0.4 mm in the lateral and axial directions, respectively. We further demonstrate non-invasive, simultaneous imaging of a lacZ-expressing tumor and its surrounding microvasculature in vivo by dual-wavelength acoustic-resolution photoacoustic microscopy (AR-PAM), with a lateral resolution of 45 mu m and an axial resolution of 15 mu m. Finally, using optical-resolution photoacoustic microscopy (OR-PAM), we show intra-cellular localization of lacZ expression, with a lateral resolution of a fraction of a micron. These results suggest that PAT is a complementary tool to conventional optical fluorescence imaging of reporter genes for linking biological studies from the microscopic to the macroscopic scales.	[Cai, Xin; Li, Li; Krumholz, Arie; Guo, Zijian; Zhang, Chi; Zhang, Yu; Xi, Younan; Wang, Lihong V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Erpelding, Todd N.] Philips Res N Amer, Briarcliff Manor, NY USA	Washington University (WUSTL); Philips; Philips Research	Cai, X (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	lhwang@biomed.wustl.edu	Xia, Younan/E-8499-2011; Guo, Zijian/D-8652-2012; Wang, Lihong V./A-7147-2009; Zhang, Yu Shrike/H-4885-2013	Wang, Lihong V./0000-0001-9783-4383; Zhang, Yu Shrike/0000-0002-0045-0808	National Institutes of Health [R01 EB000712, R01 EB008085, R01 CA134539, U54 CA136398]; NATIONAL CANCER INSTITUTE [U54CA136398, R01CA134539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000712, R01EB008085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health Grant Nos. R01 EB000712, R01 EB008085, R01 CA134539, and U54 CA136398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Beard P, 2009, QUANTITATIVE PHOTOAC, P121; CEPKO C, 1998, CELLS LAB MANUAL, V3; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Filonov GS, 2012, ANGEW CHEM INT EDIT, V51, P1448, DOI 10.1002/anie.201107026; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Kim C, 2011, PHILOS T R SOC A, V369, P4644, DOI 10.1098/rsta.2010.0353; Kim C, 2010, BIOMED OPT EXPRESS, V1, P278, DOI 10.1364/BOE.1.000278; Kostli KP, 2001, PHYS MED BIOL, V46, P1863, DOI 10.1088/0031-9155/46/7/309; Laufer JG, 2010, PROC SPIE, V7564, DOI 10.1117/12.842204; Li L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717531; Li L, 2008, J INNOV OPT HEAL SCI, V1, P207, DOI 10.1142/S1793545808000212; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; Song KH, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818045; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	19	43	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43999	10.1371/journal.pone.0043999	http://dx.doi.org/10.1371/journal.pone.0043999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952846	Green Published, Green Accepted, gold			2022-12-25	WOS:000308044800087
J	Fruhwald, J; Londono, JC; Dembla, S; Mannebach, S; Lis, A; Drews, A; Wissenbach, U; Oberwinkler, J; Philipp, SE				Fruehwald, Julia; Londono, Julia Camacho; Dembla, Sandeep; Mannebach, Stefanie; Lis, Annette; Drews, Anna; Wissenbach, Ulrich; Oberwinkler, Johannes; Philipp, Stephan E.			Alternative Splicing of a Protein Domain Indispensable for Function of Transient Receptor Potential Melastatin 3 (TRPM3) Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PREDICTION; EXPRESSION; MECHANISM; PCR	TRPM3 channels form ionotropic steroid receptors in the plasma membrane of pancreatic beta and dorsal root ganglion cells and link steroid hormone signaling to insulin release and pain perception, respectively. We identified and compared the function of a number of TRPM3 splice variants present in mouse, rat and human tissues. Wefound that variants lacking a region of 18 amino acid residues display neither Ca2+ entry nor ionic currents when expressed alone. Hence, splicing removes a region that is indispensable for channel function, which is called the ICF region. TRPM3 variants devoid of this region (TRPM3 Delta ICF), are ubiquitously present in different tissues and cell types where their transcripts constitute up to 15% of the TRPM3 isoforms. The ICF region is conserved throughout the TRPM family, and its presence in TRPM8 proteins is also necessary for function. Within the ICF region, 10 amino acid residues form a domain essential for the formation of operative TRPM3 channels. TRPM3 Delta ICF variants showed reduced interaction with other TRPM3 isoforms, and their occurrence at the cell membrane was diminished. Correspondingly, coexpression of Delta ICF proteins with functional TRPM3 subunits not only reduced the number of channels but also impaired TRPM3-mediated Ca2+ entry. We conclude that TRPM3 Delta ICF variants are regulatory channel subunits fine-tuning TRPM3 channel activity.	[Lis, Annette] Univ Saarland, Inst Biophys, D-66421 Homburg, Germany; [Drews, Anna] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Oberwinkler, Johannes] Univ Marburg, Inst Physiol & Pathophysiol, D-35037 Marburg, Germany	Saarland University; University of Cambridge; Philipps University Marburg	Philipp, SE (corresponding author), Univ Saarland, Inst Biophys, Gebaude 46, D-66421 Homburg, Germany.	stephan.philipp@uks.eu	Philipp, Stephan/AAR-7519-2020	Philipp, Stephan/0000-0003-1959-9167; Oberwinkler, Johannes/0000-0002-8541-3626; Dembla, Sandeep/0000-0003-2708-4390	Deutsche Forschungsgemeinschaft [SFB 530]; Emmy-Noether Programm [GK 1326]; Universitat des Saarlandes (Homburger Forschungsforderungsprogramm)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy-Noether Programm(German Research Foundation (DFG)); Universitat des Saarlandes (Homburger Forschungsforderungsprogramm)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 530 (to J. F. and S. E. P.), Emmy-Noether Programm (to J. O.), GK 1326 (to J. C. L., S. D., and A. D.), and the Universitat des Saarlandes (Homburger Forschungsforderungsprogramm).	Ando S, 2001, MOL ENDOCRINOL, V15, P1529, DOI 10.1210/me.15.9.1529; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; COCAPRADOS M, 1986, P NATL ACAD SCI USA, V83, P8754, DOI 10.1073/pnas.83.22.8754; Hindle KL, 2009, PROTEINS, V77, P342, DOI 10.1002/prot.22440; Hoffmann A, 2010, J NEUROCHEM, V114, P654, DOI 10.1111/j.1471-4159.2010.06644.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Mery L, 2002, J CELL SCI, V115, P3497; Moiseenkova-Bell VY, 2009, J GEN PHYSIOL, V133, P239, DOI 10.1085/jgp.200810123; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Oberwinkler J., 2007, V179, P253; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Po SS, 2001, AM J PHYSIOL-HEART C, V281, pH2518, DOI 10.1152/ajpheart.2001.281.6.H2518; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tseng CN, 2003, J BIOL CHEM, V278, P17236, DOI 10.1074/jbc.M300282200; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Warnat J, 1999, J PHYSIOL-LONDON, V518, P631, DOI 10.1111/j.1469-7793.1999.0631p.x; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198	33	49	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36663	36672		10.1074/jbc.M112.396663	http://dx.doi.org/10.1074/jbc.M112.396663			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961981	Green Published, hybrid			2022-12-25	WOS:000310588500004
J	Maira-Litran, T; Bentancor, LV; Bozkurt-Guzel, C; O'Malley, JM; Cywes-Bentley, C; Pier, GB				Maira-Litran, Tomas; Bentancor, Leticia V.; Bozkurt-Guzel, Cagla; O'Malley, Jennifer M.; Cywes-Bentley, Colette; Pier, Gerald B.			Synthesis and Evaluation of a Conjugate Vaccine Composed of Staphylococcus aureus Poly-N-Acetyl-Glucosamine and Clumping Factor A	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; PROTECTIVE EFFICACY; FACTOR-A; ANTIBODIES; FIBRINOGEN; VIRULENCE; QUANTITATION	The increasing frequency, severity and antimicrobial resistance of Staphylococcus aureus infections has made the development of immunotherapies against this pathogen more urgent than ever. Previous immunization attempts using monovalent antigens resulted in at best partial levels of protection against S. aureus infection. We therefore reasoned that synthesizing a bivalent conjugate vaccine composed of two widely expressed antigens of S. aureus would result in additive/synergetic activities by antibodies to each vaccine component and/or in increased strain coverage. For this we used reductive amination, to covalently link the S. aureus antigens clumping factor A (ClfA) and deacetylated poly-N-beta-(1-6)-acetyl-glucosamine (dPNAG). Mice immunized with 1, 5 or 10 mu g of the dPNAG-ClfA conjugate responded in a dose-dependent manner with IgG to dPNAG and ClfA, whereas mice immunized with a mixture of ClfA and dPNAG developed significantly lower antibody titers to ClfA and no antibodies to PNAG. The dPNAG-ClfA vaccine was also highly immunogenic in rabbits, rhesus monkeys and a goat. Moreover, affinity-purified, antibodies to ClfA from dPNAG-ClfA immune serum blocked the binding of three S. aureus strains to immobilized fibrinogen. In an opsonophagocytic assay (OPKA) goat antibodies to dPNAG-ClfA vaccine, in the presence of complement and polymorphonuclear cells, killed S. aureus Newman and, to a lower extent, S. aureus Newman Delta clfA. A PNAG-negative isogenic mutant was not killed. Moreover, PNAG antigen fully inhibited the killing of S. aureus Newman by antisera to dPNAG-ClfA vaccine. Finally, mice passively vaccinated with goat antisera to dPNAG-ClfA or dPNAG-diphtheria toxoid conjugate had comparable levels of reductions of bacteria in the blood 2 h after infection with three different S. aureus strains as compared to mice given normal goat serum. In conclusion, ClfA is an immunogenic carrier protein that elicited anti-adhesive antibodies that fail to augment the OPK and protective activities of antibodies to the PNAG cell surface polysaccharide.	[Maira-Litran, Tomas; Bentancor, Leticia V.; Bozkurt-Guzel, Cagla; O'Malley, Jennifer M.; Cywes-Bentley, Colette; Pier, Gerald B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Maira-Litran, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA.	tmaira@rics.bwh.harvard.edu	Pier, Gerald/AAO-2692-2021; guzel, cagla bozkurt/AAD-6086-2020	Pier, Gerald/0000-0002-9112-2331; Cywes Bentley, Colette/0000-0002-6301-0930	National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI46706, AI057159, U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046706, U54AI057159, R21AI046706] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases numbers AI46706 (GBP) and AI057159, a component of Award Number U54 AI057159. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07; Domanski PJ, 2005, INFECT IMMUN, V73, P5229, DOI 10.1128/IAI.73.8.5229-5232.2005; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Lee JC, 1997, INFECT IMMUN, V65, P4146, DOI 10.1128/IAI.65.10.4146-4151.1997; Lowy F, 2005, HARRISONS PRINCIPLES; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Risley AL, 2007, J INFECT DIS, V196, P919, DOI 10.1086/520932; SMITH RL, 1979, ANAL BIOCHEM, V98, P478, DOI 10.1016/0003-2697(79)90170-2; Vernachio JH, 2006, ANTIMICROB AGENTS CH, V50, P511, DOI 10.1128/AAC.50.2.511-518.2006; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200	24	27	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43813	10.1371/journal.pone.0043813	http://dx.doi.org/10.1371/journal.pone.0043813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970144	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400021
J	Smith, KF; Schmidt, V; Rosen, GE; Amaral-Zettler, L				Smith, Katherine F.; Schmidt, Victor; Rosen, Gail E.; Amaral-Zettler, Linda			Microbial Diversity and Potential Pathogens in Ornamental Fish Aquarium Water	PLOS ONE			English	Article							VIBRIO-CHOLERAE; PLESIOMONAS-SHIGELLOIDES; FRESH-WATER; LEGIONELLA-PNEUMOPHILA; LEGIONNAIRES-DISEASE; HIGH-THROUGHPUT; RARE BIOSPHERE; UNITED-STATES; VULNIFICUS; INFECTION	Ornamental fishes are among the most popular and fastest growing categories of pets in the United States (U. S.). The global scope and scale of the ornamental fish trade and growing popularity of pet fish in the U. S. are strong indicators of the myriad economic and social benefits the pet industry provides. Relatively little is known about the microbial communities associated with these ornamental fishes or the aquarium water in which they are transported and housed. Using conventional molecular approaches and next generation high-throughput amplicon sequencing of 16S ribosomal RNA gene hypervariable regions, we characterized the bacterial community of aquarium water containing common goldfish (Carassius auratus) and Chinese algae eaters (Gyrinocheilus aymonieri) purchased from seven pet/aquarium shops in Rhode Island and identified the presence of potential pathogens. Our survey identified a total of 30 phyla, the most common being Proteobacteria (52%), Bacteroidetes (18%) and Planctomycetes (6%), with the top four phyla representing >80% of all sequences. Sequences from our water samples were most closely related to eleven bacterial species that have the potential to cause disease in fishes, humans and other species: Coxiella burnetii, Flavobacterium columnare, Legionella birminghamensis, L. pneumophila, Vibrio cholerae, V. mimicus. V. vulnificus, Aeromonas schubertii, A. veronii, A. hydrophila and Plesiomonas shigelloides. Our results, combined with evidence from the literature, suggest aquarium tank water harboring ornamental fish are an understudied source for novel microbial communities and pathogens that pose potential risks to the pet industry, fishes in trade, humans and other species.	[Smith, Katherine F.; Schmidt, Victor; Rosen, Gail E.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Schmidt, Victor; Amaral-Zettler, Linda] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Rosen, Gail E.] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA; [Amaral-Zettler, Linda] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University; Marine Biological Laboratory - Woods Hole; Columbia University; Brown University	Smith, KF (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	amaral@mbl.edu			Brown University Office of the Vice President of Research SEED grant	Brown University Office of the Vice President of Research SEED grant	A Brown University Office of the Vice President of Research SEED grant to KFS and LAZ entitled "Tracking disease spread through the wildlife trade: New techniques to identify infectious microbes in aquarium fishes" funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler Linda, 2010, P223; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Amaro C, 1996, APPL ENVIRON MICROB, V62, P1454, DOI 10.1128/AEM.62.4.1454-1457.1996; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Broza M, 2005, ENVIRON MICROBIOL, V7, P576, DOI 10.1111/j.1462-2920.2005.00745.x; Bunge J, 2011, BIOCOMPUT-PAC SYM, P121; Campos E, 1996, APPL ENVIRON MICROB, V62, P1141, DOI 10.1128/AEM.62.4.1141-1144.1996; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casati S, 2010, CLIN MICROBIOL INFEC, V16, P945, DOI 10.1111/j.1469-0691.2009.03009.x; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Crump BC, 2012, ISME J, V6, P1629, DOI 10.1038/ismej.2012.9; de Magny GC, 2011, APPL ENVIRON MICROB, V77, P6125, DOI 10.1128/AEM.01472-10; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Drummond A., 2011, GENEIOUS V5 5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Filler G, 2000, J CLIN MICROBIOL, V38, P469; Gobin I, 2009, REV MED MICROBIOL, V20, P1, DOI 10.1097/MRM.0b013e32832e82da; Gonzalez-Rey C, 2000, FEMS IMMUNOL MED MIC, V29, P107, DOI 10.1016/S0928-8244(00)00194-2; Greig JE, 2004, MED J AUSTRALIA, V180, P566, DOI 10.5694/j.1326-5377.2004.tb06093.x; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Howden BP, 2003, INTERN MED J, V33, P484, DOI 10.1046/j.1445-5994.2003.00422.x; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Iijima S, 2009, MICROB BIOTECHNOL, V2, P361, DOI 10.1111/j.1751-7915.2009.00097.x; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jermyn WS, 2005, MICROBIOL-SGM, V151, P311, DOI 10.1099/mic.0.27621-0; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; KAM KM, 1995, PUBLIC HEALTH, V109, P389, DOI 10.1016/S0033-3506(95)80012-3; KAYSNER CA, 1987, APPL ENVIRON MICROB, V53, P1344, DOI 10.1128/AEM.53.6.1344-1348.1987; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kunttu H, 2010, THESIS U JYVASKYLA; Levin RE, 2008, FOOD BIOTECHNOL, V22, P189, DOI 10.1080/08905430802043339; Lim LC, 2003, AQUAC RES, V34, P923, DOI 10.1046/j.1365-2109.2003.00946.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Macri D, 2008, VET RES COMMUN, V32, pS215, DOI 10.1007/s11259-008-9157-4; Marco-Noales E, 2001, APPL ENVIRON MICROB, V67, P4717, DOI 10.1128/AEM.67.10.4717-4725.2001; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Olivares-Fuster O, 2007, SYST APPL MICROBIOL, V30, P624, DOI 10.1016/j.syapm.2007.07.003; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Pfeffer CS, 2003, APPL ENVIRON MICROB, V69, P3526, DOI 10.1128/AEM.69.6.3526-3531.2003; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raja K., 2006, RES J MICROBIOL, V5, P448; REDDACLIFF GL, 1993, J FISH DIS, V16, P517, DOI 10.1111/j.1365-2761.1993.tb00887.x; Rodolakis A, 2006, SMALL RUMINANT RES, V62, P121, DOI 10.1016/j.smallrumres.2005.07.038; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Senderovich Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008607; Shotts Jr E, 1984, DISTRIBUTION BIOL MA; Sindermann C, 1991, B MAR SCI, V4, P745; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Smith KF, 2008, CONSERV LETT, V1, P103, DOI 10.1111/j.1755-263X.2008.00014.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sugita H, 2005, AQUACULTURE, V243, P403, DOI 10.1016/j.aquaculture.2004.09.028; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; TRUST TJ, 1974, APPL MICROBIOL, V28, P35, DOI 10.1128/AEM.28.1.35-40.1974; University of Florida IFAS Extension website, AER INF FISH 2009; University of Florida IFAS Extension website, VIBR INF FISH 2009; VANDAMME LR, 1980, APPL ENVIRON MICROB, V39, P475, DOI 10.1128/AEM.39.3.475-479.1980; Waag DM, 2007, VACCINE, V25, P7288, DOI 10.1016/j.vaccine.2007.08.002; WADSTROM T, 1991, INT J FOOD MICROBIOL, V12, P303, DOI 10.1016/0168-1605(91)90144-E; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weir M, 2012, EPIDEMIOL INFECT, V140, P192, DOI 10.1017/S0950268811001798; WILKINSON HW, 1987, J CLIN MICROBIOL, V25, P2120, DOI 10.1128/JCM.25.11.2120-2122.1987	72	33	33	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e39971	10.1371/journal.pone.0039971	http://dx.doi.org/10.1371/journal.pone.0039971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970112	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400001
J	Brazhe, NA; Treiman, M; Brazhe, AR; Find, NL; Maksimov, GV; Sosnovtseva, OV				Brazhe, Nadezda A.; Treiman, Marek; Brazhe, Alexey R.; Find, Ninett L.; Maksimov, Georgy V.; Sosnovtseva, Olga V.			Mapping of Redox State of Mitochondrial Cytochromes in Live Cardiomyocytes Using Raman Microspectroscopy	PLOS ONE			English	Article							SELF-ORGANIZING MAPS; ELECTRON-TRANSFER; CELLS; REPERFUSION; SPECTRA; DISEASE; COMPLEX	This paper presents a nonivasive approach to study redox state of reduced cytochromes c, c1 and b of complexes II and III in mitochondria of live cardiomyocytes by means of Raman microspectroscopy. For the first time with the proposed approach we perform studies of rod- and round-shaped cardiomyocytes, representing different morphological and functional states. Raman mapping and cluster analysis reveal that these cardiomyocytes differ in the amounts of reduced cytochromes c, c1 and b. The rod- shaped cardiomyocytes possess uneven distribution of reduced cytochromes c, c1 and b in cell center and periphery. Moreover, by means of Raman spectroscopy we demonstrated the decrease in the relative amounts of reduced cytochromes c, c1 and b in the rod-shaped cardiomyocytes caused by H2O2-induced oxidative stress before any visible changes. Results of Raman mapping and time-dependent study of reduced cytochromes of complexes II and III and cytochrome c in cardiomyocytes are in a good agreement with our fluorescence indicator studies and other published data.	[Brazhe, Nadezda A.; Brazhe, Alexey R.; Maksimov, Georgy V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Brazhe, Nadezda A.; Treiman, Marek; Find, Ninett L.; Sosnovtseva, Olga V.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Treiman, Marek; Find, Ninett L.] Danish Natl Fdn, Res Ctr Heart Arrhythmia, Copenhagen, Denmark	Lomonosov Moscow State University; University of Copenhagen	Brazhe, NA (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	olga@sund.ku.dk	Maksimov, Georgy V/B-4396-2016; Sosnovtseva, Olga/H-5115-2016; Brazhe, Nadezda/K-1369-2015; Brazhe, Alexey/G-9635-2016	Maksimov, Georgy V/0000-0002-7377-0773; Sosnovtseva, Olga/0000-0001-7334-9869; Brazhe, Alexey/0000-0002-1495-4652	Danish Council for Independent Research \ Natural Sciences; Danish National Research Foundation for Heart Arrhythmia; Novo Nordisk Foundation; A. and E. Danielsen's Foundation	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation for Heart Arrhythmia(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A. and E. Danielsen's Foundation	Support for this work came from The Danish Council for Independent Research vertical bar Natural Sciences (to N.A.B. and O.V.S.). M. T and N.L.F. were supported by The Danish National Research Foundation for Heart Arrhythmia, The Novo Nordisk Foundation and the A. and E. Danielsen's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAR F, 1977, FEBS LETT, V80, P195, DOI 10.1016/0014-5793(77)80438-9; ADAR F, 1974, ARCH BIOCHEM BIOPHYS, V165, P570, DOI 10.1016/0003-9861(74)90284-7; Akao M, 2003, CIRC RES, V92, P186, DOI 10.1161/01.RES.0000051861.21316.E9; ARGADE PV, 1986, BIOPHYS J, V50, P613, DOI 10.1016/S0006-3495(86)83500-7; Bacao F, 2005, LECT NOTES COMPUT SC, V3516, P476; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Berezhna S, 2003, BIOCHEMISTRY-US, V42, P6149, DOI 10.1021/bi027387y; Borchert GH, 2008, AM J PHYSIOL-HEART C, V294, pH1948, DOI 10.1152/ajpheart.01209.2007; Brazhe NA, 2009, BIOPHYS J, V97, P3206, DOI 10.1016/j.bpj.2009.09.029; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Christensen MLM, 2008, ANAL BIOCHEM, V378, P25, DOI 10.1016/j.ab.2008.03.042; Delfino I, 2005, BIOPHYS CHEM, V113, P41, DOI 10.1016/j.bpc.2004.07.006; Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201; Hendgen-Cotta UB, 2010, J EXP BIOL, V213, P2734, DOI 10.1242/jeb.041178; Huang YS, 2005, BIOCHEMISTRY-US, V44, P10009, DOI 10.1021/bi050179w; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Matthaus C, 2007, BIOPHYS J, V93, P668, DOI 10.1529/biophysj.106.102061; MIKI T, 1994, J BIOL CHEM, V269, P1827; Mitchell P, 1977, Annu Rev Biochem, V46, P996, DOI 10.1146/annurev.bi.46.070177.005024; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls D., 2002, BIOENERGETICS; Ogawa M, 2009, BIOCHEM BIOPH RES CO, V382, P370, DOI 10.1016/j.bbrc.2009.03.028; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; PAPA S, 1981, BIOCHEM J, V194, P395, DOI 10.1042/bj1940395; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; VANDERHEIDE RS, 1986, AM J PATHOL, V125, P55; Viola HM, 2010, J MOL CELL CARDIOL, V49, P875, DOI 10.1016/j.yjmcc.2010.07.015; Ward MW, 2000, J NEUROSCI, V20, P7208; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	34	64	64	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41990	10.1371/journal.pone.0041990	http://dx.doi.org/10.1371/journal.pone.0041990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957018	gold, Green Submitted, Green Published			2022-12-25	WOS:000308463800010
J	Cousijn, J; Goudriaan, AE; Ridderinkhof, KR; van den Brink, W; Veltman, DJ; Wiers, RW				Cousijn, Janna; Goudriaan, Anna E.; Ridderinkhof, K. Richard; van den Brink, Wim; Veltman, Dick J.; Wiers, Reinout W.			Approach-Bias Predicts Development of Cannabis Problem Severity in Heavy Cannabis Users: Results from a Prospective FMRI Study	PLOS ONE			English	Article							AUTOMATIC ACTION-TENDENCIES; NICOTINE DEPENDENCE; SMOKING CUES; ALCOHOL CUES; AVOIDANCE; CORTEX	A potentially powerful predictor for the course of drug (ab) use is the approach-bias, that is, the pre-reflective tendency to approach rather than avoid drug-related stimuli. Here we investigated the neural underpinnings of cannabis approach and avoidance tendencies. By elucidating the predictive power of neural approach-bias activations for future cannabis use and problem severity, we aimed at identifying new intervention targets. Using functional Magnetic Resonance Imaging (fMRI), neural approach-bias activations were measured with a Stimulus Response Compatibility task (SRC) and compared between 33 heavy cannabis users and 36 matched controls. In addition, associations were examined between approach-bias activations and cannabis use and problem severity at baseline and at six-month follow-up. Approach-bias activations did not differ between heavy cannabis users and controls. However, within the group of heavy cannabis users, a positive relation was observed between total lifetime cannabis use and approach-bias activations in various fronto-limbic areas. Moreover, approach-bias activations in the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC) independently predicted cannabis problem severity after six months over and beyond session-induced subjective measures of craving. Higher DLPFC/ACC activity during cannabis approach trials, but lower activity during cannabis avoidance trials were associated with decreases in cannabis problem severity. These findings suggest that cannabis users with deficient control over cannabis action tendencies are more likely to develop cannabis related problems. Moreover, the balance between cannabis approach and avoidance responses in the DLPFC and ACC may help identify individuals at-risk for cannabis use disorders and may be new targets for prevention and treatment.	[Cousijn, Janna; Ridderinkhof, K. Richard; Wiers, Reinout W.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cousijn, Janna; Goudriaan, Anna E.; van den Brink, Wim; Veltman, Dick J.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam Inst Addict Res, NL-1105 AZ Amsterdam, Netherlands; [Ridderinkhof, K. Richard] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Veltman, Dick J.] Vriie Univ, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Cousijn, J (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	j.cousijn@gmail.com	Wiers, Reinout/AAB-4008-2021	Wiers, Reinout/0000-0002-4312-9766; Cousijn, Janna/0000-0002-7699-2582	Netherlands Organization for Scientific Research - Health Research and Development, ZON-Mw [31180002]; Amsterdam Brain Imaging Platform; National Science Foundation (N.W.O.) [453.008.001]	Netherlands Organization for Scientific Research - Health Research and Development, ZON-Mw; Amsterdam Brain Imaging Platform; National Science Foundation (N.W.O.)(Netherlands Organization for Scientific Research (NWO)National Science Foundation (NSF))	This research was supported by a grant from the Netherlands Organization for Scientific Research - Health Research and Development, ZON-Mw grant # 31180002, awarded to A. E. Goudriaan, D.J. Veltman, and W. van den Brink. Scanning costs were partly funded by a grant of the Amsterdam Brain Imaging Platform to J. Cousijn. R. W. Wiers is supported by National Science Foundation (N.W.O.) Vici grant 453.008.001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SJ, 2003, DRUG ALCOHOL REV, V22, P309, DOI 10.1080/0959523031000154454; Bachman JG, 2002, DECLINE SUBSTANCE US; Bennett A, 2008, MONOGRAPH SERIES, P171; Berkman ET, 2010, J COGNITIVE NEUROSCI, V22, P1970, DOI 10.1162/jocn.2009.21317; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Bradley B, 2004, BEHAV PHARMACOL, V15, P29, DOI 10.1097/00008877-200402000-00004; Chiew KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017635; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Cousijn J, 2013, ADDICT BIOL, V18, P570, DOI 10.1111/j.1369-1600.2011.00417.x; Cousijn J, 2012, NEUROIMAGE, V59, P3845, DOI 10.1016/j.neuroimage.2011.09.046; Cousijn J, 2011, ADDICTION, V106, P1667, DOI 10.1111/j.1360-0443.2011.03475.x; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Field M, 2005, ALCOHOL ALCOHOLISM, V40, P504, DOI 10.1093/alcalc/agh213; Field M, 2008, J BEHAV THER EXP PSY, V39, P209, DOI 10.1016/j.jbtep.2007.06.001; Field M, 2006, DRUG ALCOHOL DEPEN, V85, P75, DOI 10.1016/j.drugalcdep.2006.03.018; Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heishman SJ, 2009, DRUG ALCOHOL DEPEN, V102, P35, DOI 10.1016/j.drugalcdep.2008.12.010; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mogg K, 2005, PSYCHOPHARMACOLOGY, V180, P333, DOI 10.1007/s00213-005-2158-x; Ostafin BD, 2006, PSYCHOL ADDICT BEHAV, V20, P322, DOI 10.1037/0893-164X.20.3.322; Palfai TP, 2003, BEHAV RES THER, V41, P1149, DOI 10.1016/S0005-7967(03)00018-4; Perkonigg A, 2008, ADDICTION, V103, P439, DOI 10.1111/j.1360-0443.2007.02064.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Roelofs K, 2009, SOC COGN AFFECT NEUR, V4, P50, DOI 10.1093/scan/nsn036; ROESE NJ, 1993, PSYCHOL BULL, V114, P363, DOI 10.1037/0033-2909.114.2.363; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schlund MW, 2011, BEHAV BRAIN RES, V225, P437, DOI 10.1016/j.bbr.2011.07.054; Schmand B, 1991, Tijdschr Gerontol Geriatr, V22, P15; Schulenberg JE, 2005, J DRUG ISSUES, V35, P255, DOI 10.1177/002204260503500203; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; United Nations Office on Drugs and Crime, 2009, UNODC WORLD DRUG REP; Volman I, 2011, CEREB CORTEX, V21, P2282, DOI 10.1093/cercor/bhr001; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	46	59	59	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42394	10.1371/journal.pone.0042394	http://dx.doi.org/10.1371/journal.pone.0042394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957019	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800011
J	Gevins, A; Chan, CS; Sam-Vargas, L				Gevins, Alan; Chan, Cynthia S.; Sam-Vargas, Lita			Towards Measuring Brain Function on Groups of People in the Real World	PLOS ONE			English	Article							PATTERN-RECOGNITION; EEG; PERFORMANCE; ARTIFACT	In three studies, EEGs from three groups of participants were recorded during progressively more real world situations after drinking alcoholic beverages that brought breath alcohol contents near the limit for driving in California 30 minutes after drinking. A simple equation that measured neurophysiological effects of alcohol in the first group of 15 participants performing repetitive cognitive tasks was applied to a second group of 15 operating an automobile driving simulator, and to a third group of 10 ambulatory people recorded simultaneously during a cocktail party. The equation derived from the first group quantified alcohol's effect by combining measures of higher frequency (beta) and lower frequency (theta) power into a single score. It produced an Area Under the Receiver Operator Characteristic Curve of .73 (p<.05; 67% sensitivity in recognizing alcohol and 87% specificity in recognizing placebo). Applying the same equation to the second group operating the driving simulator, AUC was .95, (p<.0001; 93% sensitivity and 73% specificity), while for the cocktail party group AUC was .87 (p<.01; 80% sensitivity and 80% specificity). EEG scores were significantly related to breath alcohol content in all studies. Some individuals differed markedly from the overall response evident in their respective groups. The feasibility of measuring the neurophysiological effect of a psychoactive substance from an entire group of ambulatory people at a cocktail party suggests that future studies may be able to fruitfully apply brain function measures derived under rigorously controlled laboratory conditions to assess drug effects on groups of people interacting in real world situations.	[Gevins, Alan; Chan, Cynthia S.; Sam-Vargas, Lita] San Francisco Brain Res Inst & SAM Technol, San Francisco, CA USA		Gevins, A (corresponding author), San Francisco Brain Res Inst & SAM Technol, San Francisco, CA USA.	alan@sfbri.org			National Institute of Mental Health [R43MH071865]; National Institute of Neurological Diseases and Strokes [R44NS048815]; National Institute of Alcoholism and Alcohol Abuse [R44AA014824]; United States Air Force Research Laboratory [FA8650-05-C-6553]; U.S. Federal Government; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS048815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R44AA014824] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Diseases and Strokes; National Institute of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); United States Air Force Research Laboratory(United States Department of DefenseUS Air Force Research Laboratory); U.S. Federal Government; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding came from the National Institute of Mental Health R43MH071865, National Institute of Neurological Diseases and Strokes R44NS048815, National Institute of Alcoholism and Alcohol Abuse R44AA014824, and the United States Air Force Research Laboratory FA8650-05-C-6553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The authors are employed by the San Francisco Brain Research Institute & SAM Technology which are 100% supported by competing research grants from the U.S. Federal Government. Alan Gevins is the founder and owner of this private research laboratory which has been operating independently of the University of California San Francisco School of Medicine since 1980. The organization only performs research and offers no services or products. None of the authors perform consulting work. It is very unlikely that any corporation, investor, etc. would find it commercially worthwhile to buy or license the technologies that the authors have made to do their research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Begleiter H, 1972, BIOL ALCOHOL, V2, P308; Cacioppo JT, 2011, ANN NY ACAD SCI, V1224, P162, DOI 10.1111/j.1749-6632.2010.05858.x; COHEN HL, 1993, NEUROPSYCHOPHARMACOL, V8, P365, DOI 10.1038/npp.1993.36; Du, 1994, IEEE 7 SP WORKSH STA, P433; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V73, P179, DOI 10.1016/0013-4694(89)90118-1; FINK M, 1984, NEUROPSYCHOBIOLOGY, V12, P173, DOI 10.1159/000118132; Friel PN, 1999, J STUD ALCOHOL, V60, P555, DOI 10.15288/jsa.1999.60.555; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Gevins A, 1999, AVIAT SPACE ENVIR MD, V70, P1018; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; Gevins A, 2002, NEUROPSYCHOPHARMACOL, V26, P27, DOI 10.1016/S0893-133X(01)00300-1; GEVINS A, 1995, TRENDS NEUROSCI, V18, P429, DOI 10.1016/0166-2236(95)94489-R; Gevins A., 2009, A Sandoval-US Patent, Patent No. [7551952, 7, 551, 952]; Gevins A, 2011, J PSYCHOPHARMACOL, V25, P1062, DOI 10.1177/0269881110388334; Gevins A, 2011, CLIN NEUROPHYSIOL, V122, P114, DOI 10.1016/j.clinph.2010.06.010; Gevins A, 2011, DEMENT GERIATR COGN, V31, P7, DOI 10.1159/000322108; GEVINS AS, 1983, SCIENCE, V220, P97, DOI 10.1126/science.6828886; GEVINS AS, 1990, ELECTROEN CLIN NEURO, V76, P339, DOI 10.1016/0013-4694(90)90035-I; GEVINS AS, 1984, IEEE T BIO-MED ENG, V31, P833, DOI 10.1109/TBME.1984.325246; GEVINS AS, 1987, SCIENCE, V235, P580, DOI 10.1126/science.3810158; GEVINS AS, 1980, IEEE T PATTERN ANAL, V2, P383, DOI 10.1109/TPAMI.1980.6592360; GEVINS AS, 1979, SCIENCE, V203, P665, DOI 10.1126/science.760212; GEVINS AS, 1977, ELECTROEN CLIN NEURO, V43, P31, DOI 10.1016/0013-4694(77)90192-4; GEVINS AS, 1977, ELECTROEN CLIN NEURO, V42, P267, DOI 10.1016/0013-4694(77)90035-9; GEVINS AS, 1981, SCIENCE, V213, P918, DOI 10.1126/science.7256287; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; HERMANN WM, 1982, ELECTROENCEPHALOGRAP; Ilan AB, 2001, ALCOHOL, V25, P137, DOI 10.1016/S0741-8329(01)00191-4; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Lehmann D, 1988, STATISTICS TOPOGRAPH, P27; LUKAS SE, 1986, PHARMACOL BIOCHEM BE, V25, P889, DOI 10.1016/0091-3057(86)90403-X; Mackie R.R., 1977, VIGILANCE PP, P537; Makeig S, 1996, ADV NEUR IN, V8, P145; Mitchell JP, 2008, CURR DIR PSYCHOL SCI, V17, P142, DOI 10.1111/j.1467-8721.2008.00564.x; RAMAEKERS JG, 1992, EUR J CLIN PHARMACOL, V42, P363; Smith ME, 2001, HUM FACTORS, V43, P366, DOI 10.1518/001872001775898287; STENBERG G, 1994, J STUD ALCOHOL, V55, P645, DOI 10.15288/jsa.1994.55.645; Tou J. T., 1974, PATTERN RECOGN	44	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44676	10.1371/journal.pone.0044676	http://dx.doi.org/10.1371/journal.pone.0044676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957099	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800092
J	Thayanithy, V; Park, C; Sarver, AL; Kartha, RV; Korpela, DM; Graef, AJ; Steer, CJ; Modiano, JF; Subramanian, S				Thayanithy, Venugopal; Park, ChangWon; Sarver, Aaron L.; Kartha, Reena V.; Korpela, Derek M.; Graef, Ashley J.; Steer, Clifford J.; Modiano, Jaime F.; Subramanian, Subbaya			Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines	PLOS ONE			English	Article							VALPROIC ACID; MICRORNA EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; AMPLIFICATION; INHIBITION; MODULATION; ACTIVATION; APOPTOSIS; CLUSTER	Downregulation of microRNAs (miRNAs) at the 14q32 locus stabilizes the expression of cMYC, thus significantly contributing to osteosarcoma (OS) pathobiology. Here, we show that downregulation of 14q32 miRNAs is epigenetically regulated. The predicted promoter regions of miRNA clusters at 14q32 locus showed no recurrent patterns of differential methylation, but Saos2 cells showed elevated histone deacetylase (HDAC) activity. Treatment with 4-phenylbutyrate increased acetylation of histones associated with 14q32 miRNAs, but interestingly, robust restoration of 14q32 miRNA expression, attenuation of cMYC expression, and induction of apoptosis required concomitant treatment with 5-Azacytidine, an inhibitor of DNA methylation. These events were associated with genome-wide gene expression changes including induction of proapoptotic genes and downregulation of cell cycle genes. Comparable effects were achieved in human and canine OS cells using the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA/Vorinostat) and the DNA methylation inhibitor Zebularine (Zeb), with significantly more pronounced cytotoxicity in cells whose molecular phenotypes were indicative of aggressive biological behavior. These results suggested that the combination of these chromatin-modifying drugs may be a useful adjuvant in the treatment of rapidly progressive OS.	[Thayanithy, Venugopal; Subramanian, Subbaya] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Park, ChangWon; Steer, Clifford J.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Sarver, Aaron L.; Modiano, Jaime F.; Subramanian, Subbaya] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Kartha, Reena V.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Korpela, Derek M.; Graef, Ashley J.; Modiano, Jaime F.] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Steer, Clifford J.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Thayanithy, V (corresponding author), Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.	subree@umn.edu	Kartha, Reena/AAG-3969-2021; Fiumefreddo, Andrea/T-2977-2019; Thayanithy, Venugopal/C-2777-2013; MODIANO, JAIME/K-3583-2019	Kartha, Reena/0000-0002-1692-1539; MODIANO, JAIME/0000-0001-6398-7648; Subramanian, Subbaya/0000-0002-2544-480X	University of Minnesota Academic Health Center; Masonic Cancer Center, University of Minnesota; Wyckoff Rein in Sarcoma Foundation; AKC Canine Health Foundation; Van Sloun Foundation; Kate Koogler Canine Cancer Fund	University of Minnesota Academic Health Center; Masonic Cancer Center, University of Minnesota(University of Minnesota System); Wyckoff Rein in Sarcoma Foundation; AKC Canine Health Foundation; Van Sloun Foundation; Kate Koogler Canine Cancer Fund	This study was supported by a grant from the University of Minnesota Academic Health Center, by a translational research grant from the Masonic Cancer Center, University of Minnesota, and by grants from the Wyckoff Rein in Sarcoma Foundation, the AKC Canine Health Foundation, the Van Sloun Foundation, and the Kate Koogler Canine Cancer Fund (JFM and SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Al-Romaih K, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-14; BOGENMANN E, 1987, CANCER RES, V47, P3808; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carraway HE, 2007, J CLIN ONCOL, V25, P1955, DOI 10.1200/JCO.2006.09.8293; Catalano MG, 2006, J ENDOCRINOL, V191, P465, DOI 10.1677/joe.1.06970; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; Imai T, 2003, ONCOGENE, V22, P9231, DOI 10.1038/sj.onc.1207184; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kim MS, 2003, CANCER RES, V63, P7291; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; LADANYI M, 1993, DIAGN MOL PATHOL, V2, P163, DOI 10.1097/00019606-199303000-00024; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Marulanda German A, 2008, Cancer Control, V15, P13; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Moriarty B, 2011, C GEN ENG SING; Munster P, 2007, J CLIN ONCOL, V25, P1979, DOI 10.1200/JCO.2006.08.6165; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sarver A, 2011, PREFECT POLICE F PEC; Sarver AL, 2010, LAB INVEST, V90, P753, DOI 10.1038/labinvest.2010.53; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Thomas R, 2005, GENOME RES, V15, P1831, DOI 10.1101/gr.3825705; Thomas R, 2009, CHROMOSOME RES, V17, P365, DOI 10.1007/s10577-009-9028-z; Watanabe K, 2005, CELL DEATH DIFFER, V12, P10, DOI 10.1038/sj.cdd.4401507; Wittenburg LA, 2011, CANCER CHEMOTH PHARM, V67, P83, DOI 10.1007/s00280-010-1287-z; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	42	45	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43720	10.1371/journal.pone.0043720	http://dx.doi.org/10.1371/journal.pone.0043720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957032	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800024
J	Yanai, S; Semba, Y; Endo, S				Yanai, Shuichi; Semba, Yuki; Endo, Shogo			Remarkable Changes in Behavior and Physiology of Laboratory Mice after the Massive 2011 Tohoku Earthquake in Japan	PLOS ONE			English	Article							CHRONIC UNPREDICTABLE STRESS; SYNAPTIC PLASTICITY; WATER MAZE; RATS; MEMORY; CORTICOSTERONE; BRAIN; HIPPOCAMPUS; ENVIRONMENT; AMYGDALA	A devastating earthquake and tsunami hit Japan on March 11, 2011, followed by several long and intense aftershocks. Laboratory mice housed in the Tokyo, located approximately 330 km south of this earthquake's epicenter, displayed remarkable changes in a variety of behaviors and physiological measures. Although unusual pre-earthquake behaviors have been previously reported in laboratory animals, little is known about behavioral and physiological changes that occur after a great earthquake. In the present study, the effects of Tohoku earthquake on mice behavior were investigated. "Earthquake-experienced" mice displayed a marked increase in food consumption without gaining body weight in response to the earthquake. They also displayed enhanced anxiety, and in a formal fear memory task, showed significantly greater tone-and context-dependent conditioned freezing. Water maze performance of earthquake-experienced mice showed the quicker acquisition of the task, faster swim speed and longer swim distance than the naive mice. Serum corticosterone levels were elevated compared to the naive mice, indicating that the earthquake and aftershocks were stressful for the mice. These results demonstrate that great earthquakes strongly affect mouse behaviors and physiology. Although the effects of a variety of experimental manipulations on mouse behaviors in disease models or in models of higher cognitive functions have been extensively examined, researchers need to be aware how natural phenomena, such as earthquakes and perhaps other natural environmental factors, influence laboratory animal behaviors and physiology.	[Yanai, Shuichi; Semba, Yuki; Endo, Shogo] Tokyo Metropolitan Inst Gerontol, Aging Regulat Res Grp, Itabashi Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology	Yanai, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Aging Regulat Res Grp, Itabashi Ku, Tokyo, Japan.	sendo@tmig.or.jp		Yanai, Shuichi/0000-0002-4604-5525	Naito Foundation; MEXT of Japan; Japan Foundation for Aging and Health	Naito Foundation(Naito Memorial Foundation); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Aging and Health	This work was supported in part by the Naito Foundation, MEXT of Japan (www.mext.go.jp), and Japan Foundation for Aging and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2004, LEARN MEMORY, V11, P188, DOI 10.1101/lm.61704; Artiga AI, 2007, PHYSIOL BEHAV, V91, P424, DOI 10.1016/j.physbeh.2007.04.001; Baldwin AL, 2007, J AM ASSOC LAB ANIM, V46, P45; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Chen LL, 2010, EXP BIOL MED, V235, P1216, DOI 10.1258/ebm.2010.010042; CONRAD CD, 1993, J NEUROSCI, V13, P2582, DOI 10.1523/JNEUROSCI.13-06-02582.1993; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Dell'Osso L, 2011, J AFFECT DISORDERS, V131, P79, DOI 10.1016/j.jad.2010.11.023; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Gouirand AM, 2005, PHYSIOL BEHAV, V86, P21, DOI 10.1016/j.physbeh.2005.06.027; Grant RA, 2011, INT J ENV RES PUB HE, V8, P1936, DOI 10.3390/ijerph8061936; Haile CN, 2001, PSYCHOPHARMACOLOGY, V154, P213, DOI 10.1007/s002130000650; Hendriksen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011943; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JHANWARUNIYAL M, 1986, BRAIN RES, V368, P404, DOI 10.1016/0006-8993(86)90591-3; Kirschvink JL, 2000, B SEISMOL SOC AM, V90, P312, DOI 10.1785/0119980114; Kojima N, 2008, J NEUROSCI, V28, P6459, DOI 10.1523/JNEUROSCI.0412-08.2008; Kotozaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034612; Kyutoku Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031014; LEIBOWITZ SF, 1986, FASEB J, V45, P1396; Li YH, 2009, BIOELECTROMAGNETICS, V30, P613, DOI 10.1002/bem.20520; Lilly MM, 2010, VIOLENCE VICTIMS, V25, P604, DOI 10.1891/0886-6708.25.5.604; Lubbers ME, 2007, BEHAV BRAIN RES, V180, P107, DOI 10.1016/j.bbr.2007.02.021; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Naeem F, 2011, J AFFECT DISORDERS, V130, P268, DOI 10.1016/j.jad.2010.10.035; Nguyen L, 2011, INT J GROUP PSYCHOTH, V61, P27, DOI 10.1521/ijgp.2011.61.1.26; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Pankevich DE, 2008, OBESITY, V16, P1539, DOI 10.1038/oby.2008.221; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rasmussen S, 2009, J AM ASSOC LAB ANIM, V48, P363; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Robinaugh DJ, 2011, J TRAUMA STRESS, V24, P483, DOI 10.1002/jts.20656; ROLAND CR, 1986, NEUROENDOCRINOLOGY, V42, P296, DOI 10.1159/000124455; Roozendaal B, 1997, EUR J NEUROSCI, V9, P76, DOI 10.1111/j.1460-9568.1997.tb01355.x; Sanford LD, 2010, SLEEP, V33, P621, DOI 10.1093/sleep/33.5.621; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Trull FL, 1999, SCIENCE, V284, P1463, DOI 10.1126/science.284.5419.1463; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Yokoi S, 2003, BIOELECTROMAGNETICS, V24, P289, DOI 10.1002/bem.10108	44	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44475	10.1371/journal.pone.0044475	http://dx.doi.org/10.1371/journal.pone.0044475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957073	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800066
J	Chen, CA; Carolan, PC; Annes, JP				Chen, Chen Amy; Carolan, Peter C.; Annes, Justin P.			In Vivo Screening for Secreted Proteins That Modulate Glucose Handling Identifies Interleukin-6 Family Members as Potent Hypoglycemic Agents	PLOS ONE			English	Article							SLEEPING-BEAUTY TRANSPOSASE; TYPE-2 DIABETES-MELLITUS; BETA-CELL FAILURE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GENE-TRANSFER; PLASMID DNA; TNF-ALPHA; DELIVERY; OBESITY	Diabetes is a disease of abnormal glucose homeostasis characterized by chronic hyperglycemia and a broad array of consequent organ damage. Because normal glucose homeostasis is maintained by a complex interaction between behavior (feeding and physical activity) and metabolic activity that is modulated by inter-organ signaling through secreted factors, disease modeling in vitro is necessarily limited. In contrast, in vivo studies allow complex metabolic phenotypes to be studied but present a barrier to high throughput studies. Here we present the development of a novel in vivo screening platform that addresses this primary limitation of in vivo experimentation. Our platform leverages the large secretory capacity of the liver and the hepatocyte transfection technique of hydrodynamic tail vein injection to achieve supraphysiologic blood levels of secreted proteins. To date, the utility of hydrodynamic transfection has been limited by the deleterious impact of the variable transfection efficiency inherent to this technique. We overcome this constraint by co-transfection of a secreted luciferase cDNA whose product can be easily monitored in the blood of a living animal and used as a surrogate marker for transfection efficiency and gene expression levels. To demonstrate the utility of our strategy, we screened 248 secreted proteins for the ability to enhance glucose tolerance. Surprisingly, interleukin-6 and several of its family members but not other well-recognized insulin sensitizing agents were identified as potent hypoglycemic factors. We propose this experimental system as a powerful and flexible in vivo screening platform for identifying genes that modulate complex behavioral and metabolic phenotypes.	[Chen, Chen Amy] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Carolan, Peter C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Annes, Justin P.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Harvard University; Harvard University; Massachusetts General Hospital; Stanford University	Chen, CA (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	jannes@stanford.edu		Annes, Justin/0000-0001-8431-3589	National Institutes of Health [DK084206, U01DK072505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084206, U01DK072505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants DK084206 and U01DK072505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2003, DIABETES CARE, V26, P2860, DOI 10.2337/diacare.26.10.2860; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DELAMATA J, 1995, J CLIN INVEST, V95, P2846, DOI 10.1172/JCI117990; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; Higuchi N, 2003, GENE THER, V10, P1297, DOI 10.1038/sj.gt.3301988; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; JHALA U, 1994, LIFE SCI, V54, P413, DOI 10.1016/0024-3205(94)00699-7; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu H, 2005, CIRCULATION, V111, P1593, DOI 10.1161/01.CIR.0000160348.75918.CA; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Miao CH, 2005, ADV GENET, V54, P143, DOI 10.1016/S0065-2660(05)54007-0; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Porter MH, 2002, J LAB CLIN MED, V139, P140, DOI 10.1067/mlc.2002.121552; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; SOWA R, 1990, DIABETOLOGIA, V33, P118, DOI 10.1007/BF00401051; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tong PCY, 2008, DIABETES RES CLIN PR, V82, P346, DOI 10.1016/j.diabres.2008.09.006; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xia Y, 1999, J CLIN INVEST, V103, P1309, DOI 10.1172/JCI5823; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210	50	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44600	10.1371/journal.pone.0044600	http://dx.doi.org/10.1371/journal.pone.0044600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962620	gold, Green Published, Green Submitted			2022-12-25	WOS:000308577600073
J	Flores, GE; Henley, JB; Fierer, N				Flores, Gilberto E.; Henley, Jessica B.; Fierer, Noah			A Direct PCR Approach to Accelerate Analyses of Human-Associated Microbial Communities	PLOS ONE			English	Article							GUT MICROBIOME; DIVERSITY; SEQUENCES; AGE	Since the composition of the human microbiome is highly variable both within and between individuals, researchers are increasingly reliant on high-throughput molecular approaches to identify linkages between the composition of these communities and human health. While new sequencing technologies have made it increasingly feasible to analyze large numbers of human-associated samples, the extraction of DNA from samples often remains a bottleneck in the process. Here we tested a direct PCR approach using the Extract-N-Amp Plant PCR Kit to accelerate the 16S rRNA gene-based analyses of human-associated bacterial communities, directly comparing this method to a more commonly-used approach whereby DNA is first extracted and purified from samples using a series of steps prior to PCR amplification. We used both approaches on replicate samples collected from each of five body habitats (tongue surface, feces, forehead skin, underarm skin, and forearm skin) from four individuals. With the exception of the tongue samples, there were few significant differences in the estimates of taxon richness or phylogenetic diversity obtained using the two approaches. Perhaps more importantly, there were no significant differences between the methods in their ability resolve body habitat differences or inter-individual differences in bacterial community composition and the estimates of the relative abundances of individual taxa were nearly identical with the two methods. Overall, the two methods gave very similar results and the direct PCR approach is clearly advantageous for many studies exploring the diversity and composition of human-associated bacterial communities given that large numbers of samples can be processed far more quickly and efficiently.	[Flores, Gilberto E.; Henley, Jessica B.; Fierer, Noah] Univ Colorado, NOAA, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Flores, GE (corresponding author), Univ Colorado, NOAA, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	noah.fierer@colorado.edu		FIERER, NOAH/0000-0002-6432-4261; Flores, Gilberto/0000-0002-3338-611X	National Science Foundation; Alfred P. Sloan Foundation	National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported by grants to N.F. from the National Science Foundation and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Caporaso J.G., 2012, ISME J; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035294; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	38	53	56	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44563	10.1371/journal.pone.0044563	http://dx.doi.org/10.1371/journal.pone.0044563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962617	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600068
J	Oommen, S; Francois, M; Kawasaki, M; Murrell, M; Kawasaki, K; Porntaveetus, T; Ghafoor, S; Young, NJ; Okamatsu, Y; McGrath, J; Koopman, P; Sharpe, PT; Ohazama, A				Oommen, Shelly; Francois, Mathias; Kawasaki, Maiko; Murrell, Melanie; Kawasaki, Katsushige; Porntaveetus, Thantrira; Ghafoor, Sarah; Young, Neville J.; Okamatsu, Yoshimasa; McGrath, John; Koopman, Peter; Sharpe, Paul T.; Ohazama, Atsushi			Cytoplasmic Plaque Formation in Hemidesmosome Development Is Dependent on SoxF Transcription Factor Function	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; EPIDERMAL BASEMENT-MEMBRANE; MOLECULAR-ORGANIZATION; PYLORIC ATRESIA; CELL-MIGRATION; GROWTH-FACTOR; INTEGRIN; MICE; MUTATIONS; ADHESION	Hemidesmosomes are composed of intricate networks of proteins, that are an essential attachment apparatus for the integrity of epithelial tissue. Disruption leads to blistering diseases such as epidermolysis bullosa. Members of the Sox gene family show dynamic and diverse expression patterns during development and mutation analyses in humans and mice provide evidence that they play a remarkable variety of roles in development and human disease. Previous studies have established that the mouse mutant ragged-opossum (Ra-op) expresses a dominant-negative form of the SOX18 transcription factor that interferes with the function of wild type SOX18 and of the related SOXF-subgroup proteins SOX7 and -17. Here we show that skin and oral mucosa in homozygous Ra-op mice display extensive detachment of epithelium from the underlying mesenchymal tissue, caused by tearing of epithelial cells just above the plasma membrane due to hemidesmosome disruption. In addition, several hemidesmosome proteins expression were found to be dysregulated in the Ra-op mice. Our data suggest that SOXF transcription factors play a role in regulating formation of cytoplasmic plaque protein assembly, and that disrupted SOXF function results in epidermolysis bullosa-like skin phenotypes.	[Oommen, Shelly; Kawasaki, Maiko; Kawasaki, Katsushige; Porntaveetus, Thantrira; Ghafoor, Sarah; Sharpe, Paul T.; Ohazama, Atsushi] Kings Coll London, Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England; [Oommen, Shelly; Kawasaki, Maiko; Kawasaki, Katsushige; Porntaveetus, Thantrira; Ghafoor, Sarah; Sharpe, Paul T.; Ohazama, Atsushi] Kings Coll London, Biomed Res Ctr, Inst Dent, London WC2R 2LS, England; [Francois, Mathias; Murrell, Melanie; Young, Neville J.; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Okamatsu, Yoshimasa; Ohazama, Atsushi] Showa Univ, Sch Dent, Dept Periodontol, Tokyo 142, Japan; [McGrath, John] Kings Coll London, Genet Skin Dis Grp, St Johns Inst Dermatol, Div Skin Sci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of Queensland; Showa University; University of London; King's College London	Oommen, S (corresponding author), Kings Coll London, Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England.	atsushi.2.ohazama@kcl.ac.uk	Koopman, Peter A/C-9416-2009; McGrath, John/N-3529-2019; francois, mathias/A-9604-2014; Porntaveetus, Thantrira/ABF-6854-2020	Koopman, Peter A/0000-0001-6939-0914; francois, mathias/0000-0002-9846-6882; Sharpe, Paul/0000-0003-2116-9561; porntaveetus, thantrira/0000-0003-0145-9801	Europen Orthodontic Society; Higher Education of Pakistan; JSPS; Medical Research Council [MR/J006742/1] Funding Source: researchfish	Europen Orthodontic Society; Higher Education of Pakistan(Higher Education Commission of Pakistan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AO is an Research Councils UK (RCUK) Fellow. TP is supported by W J B Houston Research Scholarship (Europen Orthodontic Society). SG is supported by Higher Education of Pakistan under the scheme Overseas Scholarship Phase II (Batch2). KK is supported by JSPS International Program for Young Researcher Overseas Visits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; CARTER TC, 1954, J HERED, V45, P151; CHAN FL, 1994, MICROSC RES TECHNIQ, V28, P48, DOI 10.1002/jemt.1070280106; Chiba H, 2003, EXP CELL RES, V286, P288, DOI 10.1016/S0014-4827(03)00116-2; DiPersio CM, 2000, J CELL SCI, V113, P3051; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Downes M, 2001, TRENDS CARDIOVAS MED, V11, P318, DOI 10.1016/S1050-1738(01)00131-1; Eger A, 1997, J CELL SCI, V110, P1307; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Ghohestani RF, 2001, CLIN DERMATOL, V19, P551, DOI 10.1016/S0738-081X(00)00175-9; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; HOSKING B, 2008, INBORN ERRORS DEV, P883; Hosking B, 2009, DEVELOPMENT, V136, P2385, DOI 10.1242/dev.034827; Huber M, 2002, J INVEST DERMATOL, V118, P185, DOI 10.1046/j.0022-202x.2001.01617.x; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jonkman MF, 2002, J INVEST DERMATOL, V119, P1275, DOI 10.1046/j.1523-1747.2002.19609.x; KURPAKUS MA, 1991, J CELL BIOL, V115, P1737, DOI 10.1083/jcb.115.6.1737; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Masunaga T, 2006, CONNECT TISSUE RES, V47, P55, DOI 10.1080/03008200600584157; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McMillan JR, 2003, J DERMATOL SCI, V31, P169, DOI 10.1016/S0923-1811(03)00045-8; McMillan JR, 1996, ARCH DERMATOL RES, V288, P91, DOI 10.1007/s004030050029; Morita K, 2003, EXP DERMATOL, V12, P289, DOI 10.1034/j.1600-0625.2003.120309.x; Nakamura H, 2005, J MOL DIAGN, V7, P28, DOI 10.1016/S1525-1578(10)60005-0; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; POTTS AJ, 1994, EXP CELL RES, V212, P2, DOI 10.1006/excr.1994.1111; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Tennenbaum T, 1996, CELL GROWTH DIFFER, V7, P615; Tucker AS, 1999, DEVELOPMENT, V126, P51; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Uitto J, 2004, AM J MED GENET C, V131C, P61, DOI 10.1002/ajmg.c.30035; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Walko G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002396; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Werner ME, 2007, J BIOL CHEM, V282, P5560, DOI 10.1074/jbc.M603669200	49	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43857	10.1371/journal.pone.0043857	http://dx.doi.org/10.1371/journal.pone.0043857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962592	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600020
J	Reijmer, YD; Leemans, A; Heringa, SM; Wielaard, I; Jeurissen, B; Koek, HL; Biessels, GJ				Reijmer, Yael D.; Leemans, Alexander; Heringa, Sophie M.; Wielaard, Ilse; Jeurissen, Ben; Koek, Huiberdina L.; Biessels, Geert Jan		Vasc Cognitive Impairment Study Gr	Improved Sensitivity to Cerebral White Matter Abnormalities in Alzheimer's Disease with Spherical Deconvolution Based Tractography	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TENSOR IMAGING TRACTOGRAPHY; IN-VIVO; HUMAN BRAIN; DIFFUSION TRACTOGRAPHY; CORPUS-CALLOSUM; MRI DATA; RESOLUTION; ANISOTROPY; INTEGRITY	Diffusion tensor imaging (DTI) based fiber tractography (FT) is the most popular approach for investigating white matter tracts in vivo, despite its inability to reconstruct fiber pathways in regions with "crossing fibers." Recently, constrained spherical deconvolution (CSD) has been developed to mitigate the adverse effects of "crossing fibers" on DTI based FT. Notwithstanding the methodological benefit, the clinical relevance of CSD based FT for the assessment of white matter abnormalities remains unclear. In this work, we evaluated the applicability of a hybrid framework, in which CSD based FT is combined with conventional DTI metrics to assess white matter abnormalities in 25 patients with early Alzheimer's disease. Both CSD and DTI based FT were used to reconstruct two white matter tracts: one with regions of "crossing fibers," i.e., the superior longitudinal fasciculus (SLF) and one which contains only one fiber orientation, i.e. the midsagittal section of the corpus callosum (CC). The DTI metrics, fractional anisotropy (FA) and mean diffusivity (MD), obtained from these tracts were related to memory function. Our results show that in the tract with "crossing fibers" the relation between FA/MD and memory was stronger with CSD than with DTI based FT. By contrast, in the fiber bundle where one fiber population predominates, the relation between FA/MD and memory was comparable between both tractography methods. Importantly, these associations were most pronounced after adjustment for the planar diffusion coefficient, a measure reflecting the degree of fiber organization complexity. These findings indicate that compared to conventionally applied DTI based FT, CSD based FT combined with DTI metrics can increase the sensitivity to detect functionally significant white matter abnormalities in tracts with complex white matter architecture.	[Reijmer, Yael D.; Heringa, Sophie M.; Wielaard, Ilse; Biessels, Geert Jan] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Jeurissen, Ben] Univ Antwerp, Dept Phys, Vis Lab, B-2020 Antwerp, Belgium; [Koek, Huiberdina L.] Univ Med Ctr Utrecht, Dept Geriatr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Antwerp; Utrecht University; Utrecht University Medical Center	Reijmer, YD (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands.	y.d.reijmer@umcutrecht.nl	Leemans, Alexander/A-1784-2011; Jeurissen, Ben/C-3246-2011	Leemans, Alexander/0000-0002-9306-6126; Jeurissen, Ben/0000-0002-3488-9819	Utrecht University; VIDI from ZonMw, The Netherlands Organisation for Health Research and Development [91711384]; project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research programme ITEA (Information Technology for European Advancement)	Utrecht University; VIDI from ZonMw, The Netherlands Organisation for Health Research and Development; project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research programme ITEA (Information Technology for European Advancement)	The research of GJB is supported by a high potential grant from Utrecht University and VIDI grant 91711384 from ZonMw, The Netherlands Organisation for Health Research and Development. The research of AL is supported by the project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research programme ITEA (Information Technology for European Advancement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Anderson AW, 2005, MAGN RESON MED, V54, P1194, DOI 10.1002/mrm.20667; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chang LC, 2012, MAGN RESON IN PRESS; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672; Jeurissen B, 2012, HUM BRAIN M IN PRESS; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Kavcic V, 2008, ALZHEIMERS DEMENT, V4, P381, DOI 10.1016/j.jalz.2008.07.001; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Leemans A, 2011, DIFFUSION MRI, P354; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Reisberg B, 1999, EUR ARCH PSY CLIN N, V249, P28; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Van Hecke W, 2008, NEUROIMAGE, V43, P69, DOI 10.1016/j.neuroimage.2008.07.006; Van Hecke W, 2011, NEUROIMAGE, V55, P566, DOI 10.1016/j.neuroimage.2010.12.005; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Virta A, 1999, MAGN RESON IMAGING, V17, P1121, DOI 10.1016/S0730-725X(99)00048-X; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897	62	67	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44074	10.1371/journal.pone.0044074	http://dx.doi.org/10.1371/journal.pone.0044074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952880	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300048
J	Scott, MM; Perello, M; Chuang, JC; Sakata, I; Gautron, L; Lee, CE; Lauzon, D; Elmquist, JK; Zigman, JM				Scott, Michael M.; Perello, Mario; Chuang, Jen-Chieh; Sakata, Ichiro; Gautron, Laurent; Lee, Charlotte E.; Lauzon, Danielle; Elmquist, Joel K.; Zigman, Jeffrey M.			Hindbrain Ghrelin Receptor Signaling Is Sufficient to Maintain Fasting Glucose	PLOS ONE			English	Article							ENERGY-BALANCE; INSULIN SENSITIVITY; PANCREATIC-ISLETS; ARCUATE NUCLEUS; MOUSE-BRAIN; FOOD-INTAKE; MICE; HORMONE; EXPRESSION; NEURONS	The neuronal coordination of metabolic homeostasis requires the integration of hormonal signals with multiple interrelated central neuronal circuits to produce appropriate levels of food intake, energy expenditure and fuel availability. Ghrelin, a peripherally produced peptide hormone, circulates at high concentrations during nutrient scarcity. Ghrelin promotes food intake, an action lost in ghrelin receptor null mice and also helps maintain fasting blood glucose levels, ensuring an adequate supply of nutrients to the central nervous system. To better understand mechanisms of ghrelin action, we have examined the roles of ghrelin receptor (GHSR) expression in the mouse hindbrain. Notably, selective hindbrain ghrelin receptor expression was not sufficient to restore ghrelin-stimulated food intake. In contrast, the lowered fasting blood glucose levels observed in ghrelin receptor-deficient mice were returned to wild-type levels by selective re-expression of the ghrelin receptor in the hindbrain. Our results demonstrate the distributed nature of the neurons mediating ghrelin action.	[Scott, Michael M.; Perello, Mario; Chuang, Jen-Chieh; Sakata, Ichiro; Gautron, Laurent; Lee, Charlotte E.; Lauzon, Danielle; Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Scott, Michael M.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA; [Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scott, MM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA.	joel.elmquist@utsouthwestern.edu; jeffrey.zigman@utsouthwestern.edu	gautron, laurent/AAQ-5983-2021; Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407; Zigman, Jeffrey/0000-0003-3477-1295; Perello, Mario/0000-0003-2114-6765	National Institutes of Health; NIDA; NIMH; NIDDK;  [5K99DA024719-02];  [1R01DA024680];  [1R01MH085298];  [1K08DK068069];  [R01DK071320];  [RL1DK081185]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071320, RL1DK081185, K08DK068069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024680, K99DA024719, R00DA024719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funds used to conduct this study were provided by the National Institutes of Health, specifically, NIDA, NIMH, and NIDDK. The relevant grants are listed below: 5K99DA024719-02 to M. S., 1R01DA024680, 1R01MH085298, and 1K08DK068069 to J.M.Z., and R01DK071320 and RL1DK081185 to J.K.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Arnold M, 2006, J NEUROSCI, V26, P11052, DOI 10.1523/JNEUROSCI.2606-06.2006; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bailey ART, 2000, J NEUROENDOCRINOL, V12, P191; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Chuang JC, 2011, MOL ENDOCRINOL, V25, P1600, DOI 10.1210/me.2011-1001; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2001, BIOCHEM BIOPH RES CO, V280, P904, DOI 10.1006/bbrc.2000.4212; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Dezaki K, 2008, PHARMACOL THERAPEUT, V118, P239, DOI 10.1016/j.pharmthera.2008.02.008; Faulconbridge LF, 2003, DIABETES, V52, P2260, DOI 10.2337/diabetes.52.9.2260; Faulconbridge LF, 2008, BRAIN RES, V1218, P151, DOI 10.1016/j.brainres.2008.04.068; Hashimoto H, 2007, ENDOCRINOLOGY, V148, P1638, DOI 10.1210/en.2006-0993; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P4521, DOI 10.1210/jc.2004-2537; Li RL, 2012, J BIOL CHEM; Longo KA, 2008, REGUL PEPTIDES, V150, P55, DOI 10.1016/j.regpep.2008.03.011; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; Olszewski PK, 2003, PEPTIDES, V24, P919, DOI 10.1016/S0196-9781(03)00159-1; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Qi Yong, 2011, BMC Physiology, V11, P1, DOI 10.1186/1472-6793-11-1; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Scott V, 2007, PHYSIOL BEHAV, V90, P180, DOI 10.1016/j.physbeh.2006.09.026; Takayama K, 2007, NEUROSCI LETT, V417, P292, DOI 10.1016/j.neulet.2007.02.089; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yi CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032100; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	37	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44089	10.1371/journal.pone.0044089	http://dx.doi.org/10.1371/journal.pone.0044089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952883	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300049
J	Rogalski, MA; Skelly, DK				Rogalski, Mary Alta; Skelly, David Kiernan			Positive Effects of Nonnative Invasive Phragmites australis on Larval Bullfrogs	PLOS ONE			English	Article							COMMON REED; TYPHA-ANGUSTIFOLIA; EXPERIMENTAL VENUE; TIDAL MARSHES; PLANT; FISH; CONSERVATION; RESTORATION; PERFORMANCE; RESPONSES	Background: Nonnative Phragmites australis (common reed) is one of the most intensively researched and managed invasive plant species in the United States, yet as with many invasive species, our ability to predict, control or understand the consequences of invasions is limited. Rapid spread of dense Phragmites monocultures has prompted efforts to limit its expansion and remove existing stands. Motivation for large-scale Phragmites eradication programs includes purported negative impacts on native wildlife, a view based primarily on observational results. We took an experimental approach to test this assumption, estimating the effects of nonnative Phragmites australis on a native amphibian. Methodology/Principal Findings: Concurrent common garden and reciprocal transplant field experiments revealed consistently strong positive influences of Phragmites on Rana catesbeiana (North American bullfrog) larval performance. Decomposing Phragmites litter appears to contribute to the effect. Conclusions/Significance: Positive effects of Phragmites merit further research, particularly in regions where both Phragmites and R. catesbeiana are invasive. More broadly, the findings of this study reinforce the importance of experimental evaluations of the effects of biological invasion to make informed conservation and restoration decisions.	[Rogalski, Mary Alta; Skelly, David Kiernan] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Yale University	Rogalski, MA (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	mary.rogalski@yale.edu	Skelly, David/D-3878-2013	Rogalski, Mary/0000-0003-1728-3409	Norcross Wildlife Foundation A.V. Stout Fund; Yale School of Forestry & Environmental Studies Carpenter/Sperry Fund	Norcross Wildlife Foundation A.V. Stout Fund; Yale School of Forestry & Environmental Studies Carpenter/Sperry Fund	Norcross Wildlife Foundation A.V. Stout Fund (http://www.norcrossws.org/Grants/Andystout.htm) and the Yale School of Forestry & Environmental Studies Carpenter/Sperry Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Michael J., 2007, V2, P679; Adams MJ, 2000, ECOL APPL, V10, P559, DOI 10.1890/1051-0761(2000)010[0559:PPATEO]2.0.CO;2; Ailstock MS, 2001, RESTOR ECOL, V9, P49, DOI 10.1046/j.1526-100x.2001.009001049.x; Alford RA, 1999, TADPOLES, P240; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Brown CJ, 2006, BIOL INVASIONS, V8, P327, DOI 10.1007/s10530-004-8244-x; Brown JH, 2004, AUSTRAL ECOL, V29, P530, DOI 10.1111/j.1442-9993.2004.01340.x; Bruno JF, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P13; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; CLARKSON RW, 1986, J HERPETOL, V20, P42, DOI 10.2307/1564123; Cohen JS, 2012, ECOL APPL, V22, P218, DOI 10.1890/11-0078.1; Fell PE, 2003, ESTUARIES, V26, P534, DOI 10.1007/BF02823729; Freidenburg LK, 2004, ECOL LETT, V7, P369, DOI 10.1111/j.1461-0248.2004.00587.x; Gosner K. L., 1960, Herpetologica, V16, P183; Gratton C, 2006, ECOL APPL, V16, P622, DOI 10.1890/1051-0761(2006)016[0622:AFWRFR]2.0.CO;2; HANSEN RM, 1978, PALEOBIOLOGY, V4, P302, DOI 10.1017/S0094837300006011; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hunter KL, 2006, ESTUAR COAST, V29, P487, DOI 10.1007/BF02784996; Jivoff PR, 2003, ESTUARIES, V26, P587, DOI 10.1007/BF02823733; KAY SH, 1995, J AQUAT PLANT MANAGE, V33, P25; Kennedy TA, 2004, FRESHWATER BIOL, V49, P65, DOI 10.1046/j.1365-2426.2003.01166.x; Kulesza AE, 2006, WETLANDS, V26, P1079, DOI 10.1672/0277-5212(2006)26[1079:APRTDL]2.0.CO;2; Larson BMH, 2007, BIOL INVASIONS, V9, P947, DOI 10.1007/s10530-007-9095-z; Lawler SP, 1999, CONSERV BIOL, V13, P613, DOI 10.1046/j.1523-1739.1999.98075.x; Maerz JC, 2005, FUNCT ECOL, V19, P970, DOI 10.1111/j.1365-2435.2005.01054.x; Maerz JC, 2010, FRESHWATER BIOL, V55, P1694, DOI 10.1111/j.1365-2427.2010.02404.x; Maret TJ, 2006, BIOL CONSERV, V127, P129, DOI 10.1016/j.biocon.2005.08.003; MARKS M, 1994, NAT AREA J, V14, P285; Marris E, 2005, NATURE, V438, P272, DOI 10.1038/438272a; Meyerson L.A., 2009, HUMAN IMPACTS SALT M, P57; Meyerson LA, 2000, WETLANDS ECOLOGY MAN, V8, P89, DOI DOI 10.1023/A:1008432200133; Miller JR, 2007, RESTOR ECOL, V15, P382, DOI 10.1111/j.1526-100X.2007.00234.x; Osgood DT, 2003, ESTUARIES, V26, P522, DOI 10.1007/BF02823728; Parsons KC, 2003, ESTUARIES, V26, P596, DOI 10.1007/BF02823734; Paxton BJ., 2006, CTR CONSERVATION BIO; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Robertson TL, 2005, WETLANDS, V25, P1, DOI 10.1672/0277-5212(2005)025[0001:ACOECA]2.0.CO;2; ROMAN CT, 1984, ENVIRON MANAGE, V8, P141, DOI 10.1007/BF01866935; Rudrappa T, 2007, J CHEM ECOL, V33, P1898, DOI 10.1007/s10886-007-9353-7; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Saltonstall Kristin, 2004, SIDA Contributions to Botany, V21, P683; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Skelly DK, 2000, ECOL LETT, V3, P483, DOI 10.1046/j.1461-0248.2000.00186.x; Skelly DK, 2003, HERPETOLOGICA, V59, P37, DOI 10.1655/0018-0831(2003)059[0037:AONBSB]2.0.CO;2; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Townsend CR, 2003, CONSERV BIOL, V17, P38, DOI 10.1046/j.1523-1739.2003.02017.x; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; Weinstein MP, 1999, ESTUARIES, V22, P793, DOI 10.2307/1353112; Weis JS, 2003, MAR POLLUT BULL, V46, P816, DOI 10.1016/S0025-326X(03)00036-5; Weis Judith S., 2002, Wetlands Ecology and Management, V10, P71, DOI 10.1023/A:1014311521708; Windham L, 2003, ESTUARIES, V26, P452, DOI 10.1007/BF02823722	54	24	24	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44420	10.1371/journal.pone.0044420	http://dx.doi.org/10.1371/journal.pone.0044420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952976	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500070
J	Yoon, JA; Han, DH; Noh, JY; Kim, MH; Son, GH; Kim, K; Kim, CJ; Pak, YK; Cho, S				Yoon, Ji-Ae; Han, Dong-Hee; Noh, Jong-Yun; Kim, Mi-Hee; Son, Gi Hoon; Kim, Kyungjin; Kim, Chang-Ju; Pak, Youngmi Kim; Cho, Sehyung			Meal Time Shift Disturbs Circadian Rhythmicity along with Metabolic and Behavioral Alterations in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; CENTRAL PACEMAKER; FOOD-INTAKE; JET-LAG; CLOCK; WORK; OBESITY; GENE; EXPRESSION; GLUCOSE	In modern society, growing numbers of people are engaged in various forms of shift works or trans-meridian travels. Such circadian misalignment is known to disturb endogenous diurnal rhythms, which may lead to harmful physiological consequences including metabolic syndrome, obesity, cancer, cardiovascular disorders, and gastric disorders as well as other physical and mental disorders. However, the precise mechanism(s) underlying these changes are yet unclear. The present work, therefore examined the effects of 6 h advance or delay of usual meal time on diurnal rhythmicities in home cage activity (HCA), body temperature (BT), blood metabolic markers, glucose homeostasis, and expression of genes that are involved in cholesterol homeostasis by feeding young adult male mice in a time-restrictive manner. Delay of meal time caused locomotive hyperactivity in a significant portion (42%) of subjects, while 6 h advance caused a torpor-like symptom during the late scotophase. Accordingly, daily rhythms of blood glucose and triglyceride were differentially affected by time-restrictive feeding regimen with concurrent metabolic alterations. Along with these physiological changes, time-restrictive feeding also influenced the circadian expression patterns of low density lipoprotein receptor (LDLR) as well as most LDLR regulatory factors. Strikingly, chronic advance of meal time induced insulin resistance, while chronic delay significantly elevated blood glucose levels. Taken together, our findings indicate that persistent shifts in usual meal time impact the diurnal rhythms of carbohydrate and lipid metabolisms in addition to HCA and BT, thereby posing critical implications for the health and diseases of shift workers.	[Yoon, Ji-Ae; Han, Dong-Hee; Noh, Jong-Yun; Kim, Mi-Hee; Pak, Youngmi Kim; Cho, Sehyung] Kyung Hee Univ, Dept Neurosci, Seoul, South Korea; [Yoon, Ji-Ae; Han, Dong-Hee; Noh, Jong-Yun; Kim, Mi-Hee; Pak, Youngmi Kim; Cho, Sehyung] Kyung Hee Univ, Neurodegenerat Control Res Ctr, Seoul, South Korea; [Son, Gi Hoon] Korea Univ, Coll Med, Dept Legal Med, Seoul 136705, South Korea; [Kim, Kyungjin] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Kim, Chang-Ju; Pak, Youngmi Kim; Cho, Sehyung] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Kyung Hee University	Yoon, JA (corresponding author), Kyung Hee Univ, Dept Neurosci, Seoul, South Korea.	sehyung@khu.ac.kr	Pak, Youngmi Kim/AAI-1091-2020; Kim, Chang Ju/M-4216-2017	Pak, Youngmi Kim/0000-0001-7424-3484; Kim, Chang Ju/0000-0003-4749-5795; Son, Gi Hoon/0000-0001-9758-5903	Korea Research Foundation (KRF); Korea government (MEST) [331-2006-1-C00212, 313-2007-2-C00625, 2008-0062417, 2009-0088886]	Korea Research Foundation (KRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Research Foundation (KRF) grants funded by Korea government (MEST) (Nos. 331-2006-1-C00212, 313-2007-2-C00625, 2008-0062417, 2009-0088886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Arble DM, 2010, BEST PRACT RES CL EN, V24, P785, DOI 10.1016/j.beem.2010.08.003; BALASUBRAMANIAM S, 1994, BIOCHEM J, V298, P39, DOI 10.1042/bj2980039; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cho S, 1998, MOL BRAIN RES, V54, P74, DOI 10.1016/S0169-328X(97)00325-2; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; Culpepper L, 2010, J FAM PRACTICE, V59, pS3; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; DESIR D, 1981, J CLIN ENDOCR METAB, V52, P628, DOI 10.1210/jcem-52-4-628; Doi M, 2007, J BIOL RHYTHM, V22, P127, DOI 10.1177/0748730406298332; Dong XY, 2010, PEPTIDES, V31, P2145, DOI 10.1016/j.peptides.2010.07.020; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Fortes PC, 2009, PERITON DIALYSIS INT, V29, pS145; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gluck EF, 2006, AM J PHYSIOL-REG I, V291, pR1303, DOI 10.1152/ajpregu.00232.2006; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gutman R, 2012, INT J OBESITY, V36, P1131, DOI 10.1038/ijo.2011.215; Habbal OA, 2009, INT REV IMMUNOL, V28, P93, DOI 10.1080/08830180802645050; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kalra SP, 2003, REGUL PEPTIDES, V111, P1, DOI 10.1016/S0167-0115(02)00305-1; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Matsumoto E, 2010, J BIOL CHEM, V285, P33028, DOI 10.1074/jbc.M109.089391; Mieda M, 2011, J NEUROSCI, V31, P15391, DOI 10.1523/JNEUROSCI.2801-11.2011; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Nelson RJ, 2004, AM J PHYSIOL-REG I, V287, pR6, DOI 10.1152/ajpregu.00164.2004; Novakova M, 2011, CHRONOBIOL INT, V28, P630, DOI 10.3109/07420528.2011.596983; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Park N, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.005; Refinetti R., 2006, CIRCADIAN PHYSL, V2nd; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez-Alavez M, 2007, P NATL ACAD SCI USA, V104, P3009, DOI 10.1073/pnas.0611209104; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Sookoian S, 2007, WORLD J GASTROENTERO, V13, P4242, DOI 10.3748/wjg.v13.i31.4242; Swoap SJ, 2008, BIOCHEM PHARMACOL, V76, P817, DOI 10.1016/j.bcp.2008.06.017; Szosland D, 2010, INT J OCCUP MED ENV, V23, P287, DOI 10.2478/v10001-010-0032-5; Treuer T, 2010, EUR PSYCHIAT, V25, P328, DOI 10.1016/j.eurpsy.2009.11.012; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Van Cauter E, 2007, HORM RES, V67, P2, DOI 10.1159/000097543; Van Veen MM, 2010, BIOL PSYCHIAT, V67, P1091, DOI 10.1016/j.biopsych.2009.12.032; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Walters AS, 2008, J CLIN SLEEP MED, V4, P591; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	56	37	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44053	10.1371/journal.pone.0044053	http://dx.doi.org/10.1371/journal.pone.0044053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952870	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800091
J	Wang, Y; Wang, Z; Joshi, BH; Puri, RK; Stultz, B; Yuan, Q; Bai, Y; Zhou, P; Yuan, Z; Hursh, DA; Bi, X				Wang, Y.; Wang, Z.; Joshi, B. H.; Puri, R. K.; Stultz, B.; Yuan, Q.; Bai, Y.; Zhou, P.; Yuan, Z.; Hursh, D. A.; Bi, X.			The tumor suppressor Caliban regulates DNA damage-induced apoptosis through p53-dependent and -independent activity	ONCOGENE			English	Article						Apoptosis; Caliban; p53; tumor suppressor	CELL-DEATH; GENOMIC INSTABILITY; IONIZING-RADIATION; P53 FUNCTION; DROSOPHILA; ATM; SENESCENCE; PROTEIN; MAINTENANCE; RESTORATION	We previously identified Caliban (Clbn) as the Drosophila homolog of human Serologically defined colon cancer antigen 1 gene and demonstrated that it could function as a tumor suppressor in human non-small-cell lung cancer (NSCLC) cells, although its mode of action was unknown. Herein, we identify roles for Clbn in DNA damage response. We generate clbn knockout flies using homologous recombination and demonstrate that they have a heightened sensitivity to irradiation. We show that normal Clbn function facilitates both p53-dependent and -independent DNA damage-induced apoptosis. Clbn coordinates different apoptosis pathways, showing a two-stage upregulation following DNA damage. Clbn has proapoptotic functions, working with both caspase and the proapoptotic gene Hid. Finally, ecotopic expression of clbn(+) in NSCLC cells suppresses tumor formation in athymic nude mice. We conclude that Caliban is a regulator of DNA damage-induced apoptosis, functioning as a tumor suppressor in both p53-dependent and -independent pathways.	[Wang, Y.; Wang, Z.; Yuan, Q.; Bi, X.] Chinese Acad Sci, Inst High Energy Phys, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100049, Peoples R China; [Wang, Z.; Bi, X.] Dalian Med Univ, Inst Canc Stem Cell, Ctr Canc, Dalian, Peoples R China; [Joshi, B. H.; Puri, R. K.; Stultz, B.; Hursh, D. A.] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Bethesda, MD USA; [Bai, Y.; Yuan, Z.] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100049, Peoples R China; [Zhou, P.] Beijing Inst Radiat Med, Dept Radiat Toxicol & Oncol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Dalian Medical University; US Food & Drug Administration (FDA); Chinese Academy of Sciences; Institute of Biophysics, CAS; Academy of Military Medical Sciences - China	Bi, X (corresponding author), Chinese Acad Sci, Inst High Energy Phys, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100049, Peoples R China.	bixl@ihep.ac.cn	Bi, Xiaolin/E-7469-2010; Yuan, Qing/ABF-3033-2020; Bi, Xiaolin/C-7038-2014	Bi, Xiaolin/0000-0002-7172-7851; Bi, Xiaolin/0000-0003-2837-9457; Hursh, Deborah/0000-0002-5614-7111	National Basic Research Program of China (973 Program) [2010CB934004]; National Natural Science Foundation of China [30871388]; CAS; Food and Drug Administration, Center for Biologics Evaluation and Research	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Food and Drug Administration, Center for Biologics Evaluation and Research	We thank Drs Hermann Steller, Laura Johnston and Tin Tin Su; the Bloomington Stock Center for fly stocks; Dr Dong Han at National Center for Nanoscience and Technology for help with the scanning electron microscope; and the members of the Bi laboratory for advice and discussions. We also thank Dr Mark Mortin for generating the knockout clbn flies and for critically reading this manuscript. We are grateful for comments on this manuscript from Tehyen Chu and Brent McCright. This work was supported by grants from National Basic Research Program of China (973 Program grant no. 2010CB934004), National Natural Science Foundation of China (grant no. 30871388) and CAS Knowledge Innovation Program to XB and by the Food and Drug Administration, Center for Biologics Evaluation and Research.	Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; Attardi LD, 2005, MUTAT RES-FUND MOL M, V569, P145, DOI 10.1016/j.mrfmmm.2004.04.019; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Baum JS, 2007, CELL DEATH DIFFER, V14, P1508, DOI 10.1038/sj.cdd.4402155; Bennett K, 2010, J PROTEOME RES, V9, P4289, DOI 10.1021/pr1003467; Bi XL, 2005, ONCOGENE, V24, P8229, DOI 10.1038/sj.onc.1208962; Bi XL, 2004, CURR BIOL, V14, P1348, DOI 10.1016/j.cub.2004.06.063; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Carbonnelle D, 2001, INT J CANCER, V92, P388, DOI 10.1002/ijc.1197; Chalastanis A, 2010, J NATL CANCER I, V102, P1731, DOI 10.1093/jnci/djq389; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fan Y, 2010, CELL DEATH DIFFER, V17, P912, DOI 10.1038/cdd.2009.182; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Lannan E, 2007, J VIROL, V81, P9319, DOI 10.1128/JVI.00247-07; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Long SW, 2011, BIOSCIENCE REP, V31, P333, DOI 10.1042/BSR20100124; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; McNamee LM, 2009, GENETICS, V182, P423, DOI 10.1534/genetics.109.102327; Moon NS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000153; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Papait R, 2009, BIOCHEM BIOPH RES CO, V379, P434, DOI 10.1016/j.bbrc.2008.12.091; Rasti M, 2012, PATHOL ONCOL RES, V18, P169, DOI 10.1007/s12253-011-9423-6; Sabourin M, 2008, TRENDS CELL BIOL, V18, P337, DOI 10.1016/j.tcb.2008.04.004; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Silva E, 2004, CURR BIOL, V14, P1341, DOI 10.1016/j.cub.2004.06.056; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; Squillaro T, 2010, FASEB J, V24, P1593, DOI 10.1096/fj.09-143057; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Stultz BG, 2006, DEV BIOL, V296, P329, DOI 10.1016/j.ydbio.2006.05.034; Titen SWA, 2008, GENETICS, V180, P1821, DOI 10.1534/genetics.108.093625; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wichmann A, 2006, P NATL ACAD SCI USA, V103, P9952, DOI 10.1073/pnas.0510528103; Wichmann A, 2010, DEV BIOL, V346, P80, DOI 10.1016/j.ydbio.2010.07.023; Xie GF, 1998, ONCOGENE, V16, P721, DOI 10.1038/sj.onc.1201793; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	46	4	4	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3857	3866		10.1038/onc.2012.395	http://dx.doi.org/10.1038/onc.2012.395			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22964637				2022-12-25	WOS:000323210200008
J	Li, WQ; Shao, M; Zhong, WG; Yang, J; Okada, K; Yamane, H; Zhang, L; Wang, G; Wang, D; Xiao, SS; Chang, SS; Qian, GL; Liu, FQ				Li, Wenqi; Shao, Min; Zhong, Weigong; Yang, Jie; Okada, Kazunori; Yamane, Hisakazu; Zhang, Lei; Wang, Guang; Wang, Dong; Xiao, Shanshan; Chang, Shanshan; Qian, Guoliang; Liu, Fengquan			Ectopic Expression of Hrf1 Enhances Bacterial Resistance via Regulation of Diterpene Phytoalexins, Silicon and Reactive Oxygen Species Burst in Rice	PLOS ONE			English	Article							HARPIN-ENCODING GENE; DISEASE RESISTANCE; HYPERSENSITIVE RESPONSE; ARABIDOPSIS-THALIANA; MAGNAPORTHE-GRISEA; BLAST FUNGUS; DEFENSE RESPONSES; DROUGHT TOLERANCE; ERWINIA-AMYLOVORA; BOTRYTIS-CINEREA	Harpin proteins as elicitor derived from plant gram negative bacteria such as Xanthomonas oryzae pv. oryzae (Xoo), Erwinia amylovora induce disease resistance in plants by activating multiple defense responses. However, it is unclear whether phytoalexin production and ROS burst are involved in the disease resistance conferred by the expression of the harpin(Xoo) protein in rice. In this article, ectopic expression of hrf1 in rice enhanced resistance to bacterial blight. Accompanying with the activation of genes related to the phytoalexin biosynthesis pathway in hrf1-transformed rice, phytoalexins quickly and consistently accumulated concurrent with the limitation of bacterial growth rate. Moreover, the hrf1-transformed rice showed an increased ability for ROS scavenging and decreased hydrogen peroxide (H2O2) concentration. Furthermore, the localization and relative quantification of silicon deposition in rice leaves was detected by scanning electron microscopy (SEM) and energy-dispersive X-ray spectrometer (EDS). Finally, the transcript levels of defense response genes increased in transformed rice. These results show a correlation between Xoo resistance and phytoalexin production, H2O2, silicon deposition and defense gene expression in hrf1-transformed rice. These data are significant because they provide evidence for a better understanding the role of defense responses in the incompatible interaction between bacterial disease and hrf1-transformed plants. These data also supply an opportunity for generating nonspecific resistance to pathogens.	[Li, Wenqi; Shao, Min; Zhang, Lei; Wang, Guang; Wang, Dong; Xiao, Shanshan; Chang, Shanshan; Qian, Guoliang; Liu, Fengquan] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Li, Wenqi; Shao, Min; Zhang, Lei; Wang, Guang; Wang, Dong; Xiao, Shanshan; Chang, Shanshan; Qian, Guoliang; Liu, Fengquan] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Zhong, Weigong; Yang, Jie] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China; [Okada, Kazunori; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan	Nanjing Agricultural University; Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; University of Tokyo	Li, WQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	fqliu20011@sina.com			Major Program of National Transgenic Biology New Varieties Breeding from the Ministry of Agriculture of China [2009ZX08001-005B]; National High Technology Research and Development Program from the Ministry of Science and Technology of China [2008AA10Z108, 2007AA10Z188]	Major Program of National Transgenic Biology New Varieties Breeding from the Ministry of Agriculture of China; National High Technology Research and Development Program from the Ministry of Science and Technology of China(National High Technology Research and Development Program of China)	This work was supported by grants from the Major Program of National Transgenic Biology New Varieties Breeding from the Ministry of Agriculture of China (grant no. 2009ZX08001-005B), and the National High Technology Research and Development Program from the Ministry of Science and Technology of China (grant nos. 2008AA10Z108 and 2007AA10Z188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BAKER CJ, 1993, PLANT PHYSIOL, V102, P1341, DOI 10.1104/pp.102.4.1341; Cai KZ, 2008, PHYSIOL PLANTARUM, V134, P324, DOI 10.1111/j.1399-3054.2008.01140.x; Dayakar BV, 2003, PLANT MOL BIOL, V51, P913, DOI 10.1023/A:1023061303755; Dillon VM, 1997, PHYTOCHEMISTRY, V44, P599, DOI 10.1016/S0031-9422(96)00619-X; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HP, 2005, PLANTA, V221, P313, DOI 10.1007/s00425-004-1444-x; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Gupta A, 2008, FEMS MICROBIOL LETT, V278, P22, DOI 10.1111/j.1574-6968.2007.00937.x; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; Hasegawa M, 2010, MOL PLANT MICROBE IN, V23, P1000, DOI 10.1094/MPMI-23-8-1000; Hayasaka T, 2008, PHYTOPATHOLOGY, V98, P1038, DOI 10.1094/PHYTO-98-9-1038; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; Hou X, 2009, P NATL ACAD SCI USA, V106, P6410, DOI 10.1073/pnas.0901940106; Huo R, 2010, TRANSGENIC RES, V19, P841, DOI 10.1007/s11248-010-9365-x; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Kariola T, 2003, MOL PLANT MICROBE IN, V16, P179, DOI 10.1094/MPMI.2003.16.3.179; Kim JA, 2009, MOL CELLS, V28, P431, DOI 10.1007/s10059-009-0161-5; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; KOGA J, 1995, TETRAHEDRON, V51, P7907, DOI 10.1016/0040-4020(95)00423-6; KUC J, 1995, ANNU REV PHYTOPATHOL, V33, P275, DOI 10.1146/annurev.py.33.090195.001423; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Miao WG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-67; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Pavli OI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017306; Peng JL, 2004, PHYTOPATHOLOGY, V94, P1048, DOI 10.1094/PHYTO.2004.94.10.1048; Rodrigues FA, 2004, PHYTOPATHOLOGY, V94, P177, DOI 10.1094/PHYTO.2004.94.2.177; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P535, DOI 10.1094/PHYTO.2003.93.5.535; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Sohn S, 2007, MOL CELLS, V24, P232; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; Sun WC, 2010, EUR J PLANT PATHOL, V128, P39, DOI 10.1007/s10658-010-9625-x; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Umemura K, 2003, BIOSCI BIOTECH BIOCH, V67, P899, DOI 10.1271/bbb.67.899; VANETTEN HD, 1989, ANNU REV PHYTOPATHOL, V27, P143, DOI 10.1146/annurev.py.27.090189.001043; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wen W, 2001, ACTA PHYTOPATHOL SIN, V31, P296; [闻伟刚 Wen Weigang], 2003, [农业生物技术学报, Journol of Agricultural Biotechnology], V11, P192; Zhang L, 2011, J EXP BOT, V62, P4229, DOI 10.1093/jxb/err131; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	45	9	10	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43914	10.1371/journal.pone.0043914	http://dx.doi.org/10.1371/journal.pone.0043914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970151	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400025
J	Fang, EF; Zhang, CZY; Zhang, L; Wong, JH; Chan, YS; Pan, WL; Dan, XL; Yin, CM; Cho, CH; Ng, TB				Fang, Evandro Fei; Zhang, Chris Zhi Yi; Zhang, Lin; Wong, Jack Ho; Chan, Yau Sang; Pan, Wen Liang; Dan, Xiu Li; Yin, Cui Ming; Cho, Chi Hin; Ng, Tzi Bun			Trichosanthin Inhibits Breast Cancer Cell Proliferation in Both Cell Lines and Nude Mice by Promotion of Apoptosis	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEIN; RICIN-A-CHAIN; ANTITUMOR-ACTIVITY; MOMORDICA-CHARANTIA; HIV DISEASE; IN-VITRO; ANTI-HIV; ABORTIFACIENT; REPLICATION; MECHANISMS	Breast cancer ranks as a common and severe neoplasia in women with increasing incidence as well as high risk of metastasis and relapse. Translational and laboratory-based clinical investigations of new/novel drugs are in progress. Medicinal plants are rich sources of biologically active natural products for drug development. The 27-kDa trichosanthin (TCS) is a ribosome inactivating protein purified from tubers of the Chinese herbal plant Trichosanthes kirilowii Maximowicz (common name Tian Hua Fen). In this study, we extended the potential medicinal applications of TCS from HIV, ferticide, hydatidiform moles, invasive moles, to breast cancer. We found that TCS manifested anti-proliferative and apoptosis-inducing activities in both estrogen-dependent human MCF-7 cells and estrogen-independent MDA-MB-231 cells. Flow cytometric analysis disclosed that TCS induced cell cycle arrest. Further studies revealed that TCS-induced tumor cell apoptosis was attributed to activation of both caspase-8 and caspase-9 regulated pathways. The subsequent events including caspase-3 activation, and increased PARP cleavage. With regard to cell morphology, stereotypical apoptotic features were observed. Moreover, in comparison with control, TCS-treated nude mice bearing MDA-MB-231 xenograft tumors exhibited significantly reduced tumor volume and tumor weight, due to the potent effect of TCS on tumor cell apoptosis as determined by the increase of caspase-3 activation, PARP cleavage, and DNA fragmentation using immunohistochemistry. Considering the clinical efficacy and relative safety of TCS on other human diseases, this work opens up new therapeutic avenues for patients with estrogen-dependent and/or estrogen-independent breast cancers.	[Fang, Evandro Fei; Zhang, Lin; Wong, Jack Ho; Chan, Yau Sang; Pan, Wen Liang; Dan, Xiu Li; Yin, Cui Ming; Cho, Chi Hin; Ng, Tzi Bun] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Zhang, Chris Zhi Yi] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Chris Zhi Yi] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University	Fang, EF (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	fangfei1030@yahoo.com.cn; b021770@mailserv.cuhk.edu.hk	Zhang, Chris Zhiyi/F-9862-2013; Fang, Evandro Fei/AAV-4653-2020; Fang, Evandro Fei/AAC-5511-2019; ZHANG, Lin/O-9109-2015; Cho, Chi Hin/C-6543-2014	ZHANG, Lin/0000-0003-1634-3780; Cho, Chi Hin/0000-0002-7658-3260; WONG, Jack/0000-0002-9732-986X; Fang, Evandro Fei/0000-0003-0355-7202				Balunas MJ, 2006, CHEM BIODIVERS, V3, P897, DOI 10.1002/cbdv.200690092; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Baselga J, 2011, N ENGL J MED; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; BYERS VS, 1990, AIDS, V4, P1189, DOI 10.1097/00002030-199012000-00002; BYERS VS, 1994, AIDS RES HUM RETROV, V10, P413, DOI 10.1089/aid.1994.10.413; Cai YC, 2011, CELL MOL IMMUNOL, V8, P359, DOI 10.1038/cmi.2011.12; Chan WL, 2000, BIOCHEM BIOPH RES CO, V270, P453, DOI 10.1006/bbrc.2000.2441; Chan WL, 2002, TOXICOLOGY, V177, P245, DOI 10.1016/S0300-483X(02)00226-3; CHAN WY, 1993, INT J FERTIL, V38, P99; Dakeng S, 2012, J CELL BIOCHEM, V113, P49, DOI 10.1002/jcb.23326; Fang EF, 2011, CURR MED CHEM, V18, P4410; Fang EF, 2011, CURR MOL MED, V11, P417; Fang E. F, 2011, CANC PREV RES PHILA; Fang EF, CANC LETT IN PRESS; Fang EF, 2011, APOPTOSIS; Fang EF, 2012, CANCER PREV RES, V5, P109, DOI 10.1158/1940-6207.CAPR-11-0203; Fang EF, 2011, BBA-REV CANCER, V1815, P65, DOI 10.1016/j.bbcan.2010.09.001; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; He DX, 2010, BIOCHEM BIOPH RES CO, V402, P670, DOI 10.1016/j.bbrc.2010.10.080; He DX, 2011, MOL IMMUNOL, V48, P2000, DOI 10.1016/j.molimm.2011.06.217; Ho CY, 2005, CANCER BIOL THER, V4, P638, DOI 10.4161/cbt.4.6.1721; Hou X, 2011, CANC RES; Huang PL, 1999, BIOCHEM BIOPH RES CO, V262, P615, DOI 10.1006/bbrc.1999.1213; Jiang QS, 2011, MOL BIOL REP, V38, P2863, DOI 10.1007/s11033-010-0432-4; Jiao YZ, 2010, BIOCHEM BIOPH RES CO, V391, P1579, DOI 10.1016/j.bbrc.2009.12.006; Jin Y C, 1990, Shengzhi Yu Biyun, V10, P34; KAHN JO, 1994, ANTIMICROB AGENTS CH, V38, P260, DOI 10.1128/AAC.38.2.260; Komatsu N, 2000, J BIOCHEM-TOKYO, V128, P463, DOI 10.1093/oxfordjournals.jbchem.a022775; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Ledford H, 2010, NATURE, V468, P608, DOI 10.1038/468608a; Lee-Huang S, 2000, ANTICANCER RES, V20, P653; Li CT, 2010, PHARM BIOL, V48, P1302, DOI 10.3109/13880201003789432; Li J, 2007, BBA-GEN SUBJECTS, V1770, P1169, DOI 10.1016/j.bbagen.2007.04.007; Li J, 2007, BBA-GEN SUBJECTS, V1770, P63, DOI 10.1016/j.bbagen.2006.07.011; Li M, 2010, ANAT REC, V293, P986, DOI 10.1002/ar.21142; Li M, 2010, LIFE SCI, V86, P10, DOI 10.1016/j.lfs.2009.10.016; MARAGANORE JM, 1987, J BIOL CHEM, V262, P11628; MCGRATH MS, 1989, P NATL ACAD SCI USA, V86, P2844, DOI 10.1073/pnas.86.8.2844; Roy HK, 2004, MOL CANCER THER, V3, P1159; Seoane S, 2010, JNCI-J NATL CANCER I, V102, P1432, DOI 10.1093/jnci/djq315; Sha O, 2010, TOXICOL IN VITRO, V24, P1176, DOI 10.1016/j.tiv.2010.02.014; Shaw PC, 2005, TOXICON, V45, P683, DOI 10.1016/j.toxicon.2004.12.024; Wang P, 2007, LIFE SCI, V81, P1130, DOI 10.1016/j.lfs.2007.08.016; WANG QC, 1991, CANCER RES, V51, P3353; Xiang DJ, REPROD SCI IN PRESS; Zhang CZY, 2011, APOPTOSIS, V16, P683, DOI 10.1007/s10495-011-0597-x; Zhang CY, 2001, BIOCHEM J, V355, P653, DOI 10.1042/bj3550653; ZHANG XJ, 1986, NATURE, V321, P477	52	57	64	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41592	10.1371/journal.pone.0041592	http://dx.doi.org/10.1371/journal.pone.0041592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957017	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800009
J	Li, PP; Zhou, JJ; Meng, M; Madhavan, R; Peng, HB				Li, Pan P.; Zhou, Jie J.; Meng, Min; Madhavan, Raghavan; Peng, H. Benjamin			Reciprocal Regulation of Axonal Filopodia and Outgrowth during Neuromuscular Junction Development	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCANS; P75 NEUROTROPHIN RECEPTOR; CULTURED MUSCLE-CELLS; IN-VIVO; DENDRITIC FILOPODIA; ACETYLCHOLINE-RECEPTORS; NEURITE OUTGROWTH; SYNAPSE FORMATION; CORTICAL-NEURONS	Background: The assembly of the vertebrate neuromuscular junction (NMJ) is initiated when nerve and muscle first contact each other by filopodial processes which are thought to enable close interactions between the synaptic partners and facilitate synaptogenesis. We recently reported that embryonic Xenopus spinal neurons preferentially extended filopodia towards cocultured muscle cells and that basic fibroblast growth factor (bFGF) produced by muscle activated neuronal FGF receptor 1 (FGFR1) to induce filopodia and favor synaptogenesis. Intriguingly, in an earlier study we found that neurotrophins (NTs), a different set of target-derived factors that act through Trk receptor tyrosine kinases, promoted neuronal growth but hindered presynaptic differentiation and NMJ formation. Thus, here we investigated how bFGF-and NT-signals in neurons jointly elicit presynaptic changes during the earliest stages of NMJ development. Methodology/Principal Findings: Whereas forced expression of wild-type TrkB in neurons reduced filopodial extension and triggered axonal outgrowth, expression of a mutant TrkB lacking the intracellular kinase domain enhanced filopodial growth and slowed axonal advance. Neurons overexpressing wild-type FGFR1 also displayed more filopodia than control neurons, in accord with our previous findings, and, notably, this elevation in filopodial density was suppressed when neurons were chronically treated from the beginning of the culture period with BDNF, the NT that specifically activates TrkB. Conversely, inhibition by BDNF of NMJ formation in nerve-muscle cocultures was partly reversed by the overexpression of bFGF in muscle. Conclusions: Our results suggest that the balance between neuronal FGFR1- and TrkB-dependent filopodial assembly and axonal outgrowth regulates the establishment of incipient NMJs.	[Li, Pan P.; Zhou, Jie J.; Meng, Min; Madhavan, Raghavan; Peng, H. Benjamin] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Li, PP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.	penghb@ust.hk	Li, Pan/Y-6619-2019; meng, meng/GWZ-7461-2022	Li, Pan/0000-0001-6084-6348; 	Hong Kong GRF [662311]; HKUST [RPC11SC10]	Hong Kong GRF(Hong Kong Research Grants Council); HKUST	This work was supported by Hong Kong GRF grant 662311 and HKUST grant RPC11SC10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ANDERSON MJ, 1984, J CELL BIOL, V99, P1769, DOI 10.1083/jcb.99.5.1769; ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; Araki T, 2000, J NEUROCHEM, V74, P659, DOI 10.1046/j.1471-4159.2000.740659.x; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chen G, 2012, MOL BIOL CE IN PRESS, V23; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Coulson EJ, 2008, J NEUROSCI, V28, P315, DOI 10.1523/JNEUROSCI.2699-07.2008; DAI ZS, 1995, J NEUROSCI, V15, P5466; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Fagan AM, 1996, J NEUROSCI, V16, P6208; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Fiala JC, 1998, J NEUROSCI, V18, P8900; Frade JM, 1996, NATURE, V383, P166; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Hartmann M, 2004, J CELL SCI, V117, P5803, DOI 10.1242/jcs.01511; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Henriquez JP, 2011, INT J MOL SCI, V12, P8924, DOI 10.3390/ijms12128924; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Ketschek A, 2010, J NEUROSCI, V30, P12185, DOI 10.1523/JNEUROSCI.1740-10.2010; Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515; Li PP, 2011, MOL BIOL CELL, V22, P2480, DOI 10.1091/mbc.E11-03-0198; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Madhavan R, 2006, J NEUROBIOL, V66, P134, DOI 10.1002/neu.20206; Madhavan R, 2006, J NEUROBIOL, V66, P1511, DOI 10.1002/neu.20320; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Peng HB, 2003, J NEUROSCI, V23, P5050; PENG HB, 1995, J NEUROSCI, V15, P3027; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1991, METHOD CELL BIOL, V36, P511; Rimer M, 2007, J NEUROSCI RES, V85, P1827, DOI 10.1002/jnr.21237; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Seebach BS, 1999, J NEUROPHYSIOL, V81, P2398, DOI 10.1152/jn.1999.81.5.2398; Strochlic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029976; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; TAPLEY P, 1992, ONCOGENE, V7, P371; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; Vecino E, 2002, VISION RES, V42, P151, DOI 10.1016/S0042-6989(01)00251-6; Wang XXX, 2006, J CELL SCI, V119, P172, DOI 10.1242/jcs.02710; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; WONG V, 1993, EUR J NEUROSCI, V5, P466, DOI 10.1111/j.1460-9568.1993.tb00513.x; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; Yuen EC, 1999, EXP NEUROL, V159, P297, DOI 10.1006/exnr.1999.7148; Zhang B, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-7; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zhou H, 1997, MOL CELL NEUROSCI, V10, P56, DOI 10.1006/mcne.1997.0638; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	63	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44759	10.1371/journal.pone.0044759	http://dx.doi.org/10.1371/journal.pone.0044759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957106	gold, Green Submitted, Green Published			2022-12-25	WOS:000308463800099
J	Sun, YY; Zhu, ZH; Wang, RX; Sun, YN; Xu, TJ				Sun, Yueyan; Zhu, Zhihuang; Wang, Rixin; Sun, Yuena; Xu, Tianjun			Miiuy Croaker Transferrin Gene and Evidence for Positive Selection Events Reveal Different Evolutionary Patterns	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; VIBRIO-ANGUILLARUM; SERUM TRANSFERRIN; LIVER TRANSFERRIN; MESSENGER-RNA; CDNA	Transferrin (TF) is a protein that plays a central role in iron metabolism. This protein is associated with the innate immune system, which is responsible for disease defense responses after bacterial infection. The clear link between TF and the immune defense mechanism has led researchers to consider TF as a candidate gene for disease resistance. In this study, the Miichthys miiuy (miiuy croaker) TF gene (MIMI-TF) was cloned and characterized. The gene structure consisted of a coding region of 2070 nucleotides divided into 17 exons, as well as a non-coding region that included 16 introns and spans 6757 nucleotides. The deduced MIMI-TF protein consisted of 689 amino acids that comprised a signal peptide and two lobes (Nand C-lobes). MIMI-TF expression was significantly up-regulated after infection with Vibrio anguillarum. A series of model tests implemented in the CODEML program showed that TF underwent a complex evolutionary process. Branch-site models revealed that vertebrate TF was vastly different from that of invertebrates, and that the TF of the ancestors of aquatic and terrestrial organisms underwent different selection pressures. The site models detected 10 positively selected sites in extant TF genes. One site was located in the cleft between the N1 and N2 domains and was expected to affect the capability of TF to bind to or release iron indirectly. In addition, eight sites were found near the TF exterior. Two of these sites, which could have evolved from the competition for iron between pathogenic bacteria and TF, were located in potential pathogen-binding domains. Our results could be used to further investigate the function of TF and the selective mechanisms involved.	[Sun, Yueyan; Zhu, Zhihuang; Wang, Rixin; Sun, Yuena; Xu, Tianjun] Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China	Zhejiang Ocean University	Sun, YY (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China.	tianjunxu@163.com	Xu, Tianjun/G-2545-2013		Nation Nature Science Foundation of China [31001120]; Zhejiang Provincial Natural Science Foundation of China [Y3100013, Y12C030014]	Nation Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by Nation Nature Science Foundation of China (31001120) and Zhejiang Provincial Natural Science Foundation of China (Y3100013, Y12C030014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; BALDWIN GS, 1988, NUCLEIC ACIDS RES, V16, P8720, DOI 10.1093/nar/16.17.8720; BANFIELD DK, 1991, BIOCHIM BIOPHYS ACTA, V1089, P262, DOI 10.1016/0167-4781(91)90021-D; BARTFELD NS, 1990, J BIOL CHEM, V265, P21684; Bullen JJ, 2006, J MED MICROBIOL, V55, P251, DOI 10.1099/jmm.0.46386-0; CARPENTER MA, 1993, BIOCHIM BIOPHYS ACTA, V1173, P230, DOI 10.1016/0167-4781(93)90186-H; Ciuraszkiewicz J, 2007, ACTA BIOCHIM POL, V54, P175, DOI 10.18388/abp.2007_3284; Ciuraszklewicz J, 2007, GENE, V396, P28, DOI 10.1016/j.gene.2007.02.018; DenovanWright EM, 1996, COMP BIOCHEM PHYS B, V113, P269, DOI 10.1016/0305-0491(95)02023-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ford MJ, 1999, MOL ECOL, V8, P1055, DOI 10.1046/j.1365-294x.1999.00651.x; Ford MJ, 2001, MOL BIOL EVOL, V18, P639, DOI 10.1093/oxfordjournals.molbev.a003844; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; HIRONO I, 1995, J MAR BIOTECHNOL, V2, P193; HUEBERS HA, 1982, J COMP PHYSIOL, V148, P101, DOI 10.1007/BF00688893; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JAMIESON A, 1990, ANIM GENET, V21, P295, DOI 10.1111/j.1365-2052.1990.tb03239.x; JAMROZ RC, 1993, P NATL ACAD SCI USA, V90, P1320, DOI 10.1073/pnas.90.4.1320; JELTSCH JM, 1982, EUR J BIOCHEM, V122, P291, DOI 10.1111/j.1432-1033.1982.tb05879.x; Kvingedal Ane M., 1993, Molecular Marine Biology and Biotechnology, V2, P233; Lambert LA, 2005, COMP BIOCHEM PHYS B, V142, P129, DOI 10.1016/j.cbpb.2005.07.007; Lee J, 1995, FISH PATHOLOGY, V30; Lee JY, 1998, MOL MAR BIOL BIOTECH, V7, P287; Liu H, 2010, FISH SHELLFISH IMMUN, V28, P159, DOI 10.1016/j.fsi.2009.10.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEHR TM, 1989, IRON CARRIERS IRON P; Lou B., 2004, CHIN J MOD FISH, V6, P11; MARTINEZ JL, 1990, FEMS MICROBIOL LETT, V75, P45, DOI 10.1016/0378-1097(90)90522-R; Mikawa N, 1996, MOL MAR BIOL BIOTECH, V5, P225; MOSKAITIS JE, 1990, NUCLEIC ACIDS RES, V18, P6135, DOI 10.1093/nar/18.20.6135; Mount D. W., 2001, BIOINFORMATICS SEQUE; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PARK I, 1985, P NATL ACAD SCI USA, V82, P3149, DOI 10.1073/pnas.82.10.3149; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Retzer MD, 1999, MOL MICROBIOL, V32, P111, DOI 10.1046/j.1365-2958.1999.01331.x; ROED KH, 1995, FISH SHELLFISH IMMUN, V5, P71, DOI 10.1016/S1050-4648(05)80008-7; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Taboy CH, 2001, J BIOL CHEM, V276, P2719, DOI 10.1074/jbc.M004763200; Tange N, 1997, MOL MAR BIOL BIOTECH, V6, P351; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORANZO AE, 1990, DIS AQUAT ORGAN, V9, P73, DOI 10.3354/dao009073; Xu TJ, 2008, FISH SHELLFISH IMMUN, V25, P213, DOI 10.1016/j.fsi.2008.05.007; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; Xu TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023823; YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752; Yang L, 2004, MOL BIOL EVOL, V21, P1264, DOI 10.1093/molbev/msh121; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshiga T, 1997, P NATL ACAD SCI USA, V94, P12337, DOI 10.1073/pnas.94.23.12337; Zak O, 2002, BIOCHEMISTRY-US, V41, P1647, DOI 10.1021/bi015868w	54	32	34	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43936	10.1371/journal.pone.0043936	http://dx.doi.org/10.1371/journal.pone.0043936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957037	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800029
J	Wang, YJ; Wang, JF; Ping, J; Yu, Y; Wang, Y; Lian, P; Li, X; Li, YX; Hao, P				Wang, Ya-Jun; Wang, Jing-Fang; Ping, Jie; Yu, Yao; Wang, Ying; Lian, Peng; Li, Xuan; Li, Yi-Xue; Hao, Pei			Computational Studies on the Substrate Interactions of Influenza A Virus PB2 Subunit	PLOS ONE			English	Article							CAP-BINDING-PROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; M2 PROTON CHANNEL; MESSENGER-RNA; STRUCTURAL BASIS; DRUG-RESISTANCE; RECOGNITION; STACKING; OSELTAMIVIR; MECHANISM	Influenza virus, which spreads around the world in seasonal epidemics and leads to large numbers of deaths every year, has several ribonucleoproteins in the central core of the viral particle. These viral ribonucleoproteins can specifically bind the conserved 39 and 59 caps of the viral RNAs with responsibility for replication and transcription of the viral RNA in the nucleus of infected cells. A fundamental question of most importance is that how the cap-binding proteins in the influenza virus discriminates between capped RNAs and non-capped ones. To get an answer, we performed molecular dynamics simulations and free energy calculations on the influenza A virus PB2 subunit, an important component of the RNP complexes, with a cap analog m7GTP. Our calculations showed that some key residues in the active site, such as Arg355, His357, Glu361 as well as Gln406, could offer significant hydrogen bonding and hydrophobic interactions with the guanine ring of the cap analog m7GTP to form an aromatic sandwich mechanism for the cap recognition and positioning in the active site. Subsequently, we applied this idea to a virtual screening procedure and identified 5 potential candidates that might be inhibitors against the PB2 subunit. Interestingly, 2 candidates Cpd1 and Cpd2 have been already reported to have inhibitory activities to the influenza virus cap-binding proteins. Further calculation also showed that they had comparatively higher binding affinities to the PB2 subunit than that of m7GTP. We believed that our findings could give an atomic insight into the deeper understanding of the cap recognition and binding mechanism, providing useful information for searching or designing novel drugs against influenza viruses.	[Wang, Ya-Jun; Wang, Jing-Fang; Ping, Jie; Wang, Ying; Lian, Peng] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China; [Wang, Jing-Fang; Yu, Yao; Li, Xuan; Li, Yi-Xue; Hao, Pei] Shanghai Ctr Bioinformat & Technol, Shanghai, Peoples R China; [Li, Yi-Xue] Chinese Acad Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China; [Yu, Yao; Li, Xuan] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Hao, Pei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, YJ (corresponding author), Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China.	jfwang8113@sjtu.edu.cn; phao@sibs.ac.cn	Wang, Jingfang/Q-2597-2018; Lian, Peng/L-3862-2013	Wang, Jingfang/0000-0002-1355-5481; Hao, Pei/0000-0002-1498-7059	National Basic Research Program of China (973 Program) [2012CB517900]; National Key Basic Research Program [30800210]; National Natural Science Foundation of China [90913009]; Shanghai Pujiang Scholarship Program [10PJ1408000]; Doctoral Program Foundation of Institutions of Higher Education of China [20110073120078]; China Postdoctoral Science Foundation [20110490068]; SA-SIBS scholarship Program	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Scholarship Program(Shanghai Pujiang Program); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); SA-SIBS scholarship Program	This work was supported by the grants from the National Basic Research Program of China (973 Program, No. 2012CB517900), National Key Basic Research Program (No. 30800210), National Natural Science Foundation of China (Major Program, No. 90913009), Shanghai Pujiang Scholarship Program (No. 10PJ1408000), Doctoral Program Foundation of Institutions of Higher Education of China (No. 20110073120078), and China Postdoctoral Science Foundation (No. 20110490068). The authors gratefully acknowledge the support of SA-SIBS scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Borroso L, 2005, ANTIVIR THER, V10, P901; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Chen HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006516; Chen Y, 2010, CHEM BIOL DRUG DES, V75, P295, DOI 10.1111/j.1747-0285.2009.00935.x; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; DARZYNKIEWICZ E, 1989, BIOPHYS CHEM, V33, P289, DOI 10.1016/0301-4622(89)80030-4; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gu H, 2010, CHINESE SCI BULL, V55, P2677, DOI 10.1007/s11434-010-3257-6; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Hooker L, 2003, BIOCHEMISTRY-US, V42, P6234, DOI 10.1021/bi027081r; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; ISHIDA T, 1988, NUCLEIC ACIDS RES, V16, P6175, DOI 10.1093/nar/16.13.6175; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lamb RA, 1993, ANNU REV BIOCHEM, V52, P467; Lee RV, 2007, LANCET INFECT DIS, V7, P760, DOI 10.1016/S1473-3099(07)70270-0; Leung TWC, 2009, J CLIN VIROL, V46, P298, DOI 10.1016/j.jcv.2009.08.004; Li J, 2011, J CHEM INF MODEL, V51, P3217, DOI 10.1021/ci2004016; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Lian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018587; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pielak RM, 2010, PROTEIN CELL, V1, P246, DOI 10.1007/s13238-010-0025-y; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Qin F, 2011, PHYS CHEM CHEM PHYS, V13, P1407, DOI 10.1039/c0cp00701c; Qin F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3224126; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Stolarski R, 1996, BBA-PROTEIN STRUCT M, V1293, P97, DOI 10.1016/0167-4838(95)00232-4; Tang JW, 2007, LANCET INFECT DIS, V7, P758, DOI 10.1016/S1473-3099(07)70268-2; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1075, P181, DOI 10.1016/0304-4165(91)90249-G; Wang JF, 2012, J MOL MODEL, V18, P2717, DOI 10.1007/s00894-011-1295-x; Wang JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031048; Wang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018414; Wang JF, 2010, PROTEIN ENG DES SEL, V23, P663, DOI 10.1093/protein/gzq040; Wang JF, 2009, BIOCHEM BIOPH RES CO, V388, P413, DOI 10.1016/j.bbrc.2009.08.026; Wang J, 2008, BIOPHYS J, V95, P5037, DOI 10.1529/biophysj.108.131672; Wang NX, 2009, PROTEIN SCI, V18, P707, DOI 10.1002/pro.77; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Zeng QK, 2009, BIOTECHNOL LETT, V31, P1025, DOI 10.1007/s10529-009-9980-x	58	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44079	10.1371/journal.pone.0044079	http://dx.doi.org/10.1371/journal.pone.0044079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957044	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800036
J	Zavareh, RB; Sukhai, MA; Hurren, R; Gronda, M; Wang, XM; Simpson, CD; Maclean, N; Zih, F; Ketela, T; Swallow, CJ; Moffat, J; Rose, DR; Schachter, H; Schimmer, AD; Dennis, JW				Zavareh, Reza Beheshti; Sukhai, Mahadeo A.; Hurren, Rose; Gronda, Marcela; Wang, Xiaoming; Simpson, Craig D.; Maclean, Neil; Zih, Francis; Ketela, Troy; Swallow, Carol J.; Moffat, Jason; Rose, David R.; Schachter, Harry; Schimmer, Aaron D.; Dennis, James W.			Suppression of Cancer Progression by MGAT1 shRNA Knockdown	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE V; ASPARAGINE-LINKED OLIGOSACCHARIDES; TUMOR-CELLS; TRANSCRIPTIONAL REGULATION; ADVANCED MALIGNANCIES; ENZYMATIC BASIS; GROWTH; MICE; SWAINSONINE; INHIBITION	Oncogenic signaling promotes tumor invasion and metastasis, in part, by increasing the expression of tri- and tetra-branched N-glycans. The branched N-glycans bind to galectins forming a multivalent lattice that enhances cell surface residency of growth factor receptors, and focal adhesion turnover. N-acetylglucosaminyltransferase I (MGAT1), the first branching enzyme in the pathway, is required for the addition of all subsequent branches. Here we have introduced MGAT1 shRNA into human HeLa cervical and PC-3-Yellow prostate tumor cells lines, generating cell lines with reduced transcript, enzyme activity and branched N-glycans at the cell surface. MGAT1 knockdown inhibited HeLa cell migration and invasion, but did not alter cell proliferation rates. Swainsonine, an inhibitor of alpha-mannosidase II immediately downstream of MGAT1, also inhibited cell invasion and was not additive with MGAT1 shRNA, consistent with a common mechanism of action. Focal adhesion and microfilament organization in MGAT1 knockdown cells also indicate a less motile phenotype. In vivo, MGAT1 knockdown in the PC-3-Yellow orthotopic prostate cancer xenograft model significantly decreased primary tumor growth and the incidence of lung metastases. Our results demonstrate that blocking MGAT1 is a potential target for anti-cancer therapy.	[Zavareh, Reza Beheshti; Sukhai, Mahadeo A.; Hurren, Rose; Gronda, Marcela; Wang, Xiaoming; Maclean, Neil; Schimmer, Aaron D.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Zavareh, Reza Beheshti; Sukhai, Mahadeo A.; Hurren, Rose; Gronda, Marcela; Wang, Xiaoming; Maclean, Neil; Schimmer, Aaron D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Simpson, Craig D.; Zih, Francis; Swallow, Carol J.; Dennis, James W.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Ketela, Troy; Moffat, Jason] Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Schachter, Harry] Univ Toronto, Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Waterloo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Zavareh, RB (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada.	aaron.schimmer@utoronto.ca; dennis@lunenfeld.ca	Moffat, Jason/AAC-1110-2020; Zavareh, Reza Beheshti/D-8118-2016; Dennis, James/E-7268-2013	Moffat, Jason/0000-0002-5663-8586; Zavareh, Reza Beheshti/0000-0002-3345-408X; Schimmer, Aaron/0000-0003-4023-3899	Canadian Institutes of Health Research (CIHR) [MOP-62975]; Canada Research Chair (CRC) [950-202079]; Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (CRC)(Canada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Research was supported by grants from the Canadian Institutes of Health Research (CIHR) (MOP-62975) and Canada Research Chair (CRC) (950-202079) to JWD, and Canadian Institutes of Health Research (CIHR) to ADS, who is a CIHR Clinician Scientist and a Leukemia and Lymphoma Society Scholar in Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunelleschi S, 2002, CURR PHARM DESIGN, V8, P1959, DOI 10.2174/1381612023393530; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cheung P, 2007, GLYCOBIOLOGY, V17, P767, DOI 10.1093/glycob/cwm037; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; DENNIS JW, 1990, CANCER RES, V50, P1867; FERNANDES B, 1991, CANCER RES, V51, P718; Glinsky GV, 2006, CELL CYCLE, V5, P191, DOI 10.4161/cc.5.2.2320; GOSS PE, 1994, CANCER RES, V54, P1450; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Granovsky M, 2000, NAT MED, V6, P306; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; Korczak B, 2000, GLYCOBIOLOGY, V10, P595, DOI 10.1093/glycob/10.6.595; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Seelentag WKF, 1998, CANCER RES, V58, P5559; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Takamatsu S, 1999, CANCER RES, V59, P3949; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Xu GW, 2008, APOPTOSIS, V13, P413, DOI 10.1007/s10495-007-0175-4; YAGEL S, 1989, INT J CANCER, V44, P685, DOI 10.1002/ijc.2910440422; YAMASHITA K, 1985, J BIOL CHEM, V260, P3963; Zavareh RB, 2008, CANCER RES, V68, P6688, DOI 10.1158/0008-5472.CAN-07-6833	38	29	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43721	10.1371/journal.pone.0043721	http://dx.doi.org/10.1371/journal.pone.0043721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957033	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800025
J	Aguado-Fraile, E; Ramos, E; Saenz-Morales, D; Conde, E; Blanco-Sanchez, I; Stamatakis, K; del Peso, L; Cuppen, E; Brune, B; Garcia Bermejo, ML				Aguado-Fraile, Elia; Ramos, Edurne; Saenz-Morales, David; Conde, Elisa; Blanco-Sanchez, Ignacio; Stamatakis, Konstantinos; del Peso, Luis; Cuppen, Edwin; Bruene, Bernhard; Garcia Bermejo, Maria Laura			miR-127 Protects Proximal Tubule Cells against Ischemia/Reperfusion: Identification of Kinesin Family Member 3B as miR-127 Target	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; ACUTE-KIDNEY-INJURY; EPITHELIAL-CELLS; EXPRESSION; MICRORNAS; PATHOPHYSIOLOGY; RAT; TRANSCRIPTION; HYDROXYLASES	Ischemia/reperfusion (I/R) is at the basis of renal transplantation and acute kidney injury. Molecular mechanisms underlying proximal tubule response to I/R will allow the identification of new therapeutic targets for both clinical settings. microRNAs have emerged as crucial and tight regulators of the cellular response to insults including hypoxia. Here, we have identified several miRNAs involved in the response of the proximal tubule cell to I/R. Microarrays and RT-PCR analysis of proximal tubule cells submitted to I/R mimicking conditions in vitro demonstrated that miR-127 is induced during ischemia and also during reperfusion. miR-127 is also modulated in a rat model of renal I/R. Interference approaches demonstrated that ischemic induction of miR-127 is mediated by Hypoxia Inducible Factor-1alpha (HIF-1 alpha) stabilization. Moreover, miR-127 is involved in cell-matrix and cell-cell adhesion maintenance, since overexpression of miR-127 maintains focal adhesion complex assembly and the integrity of tight junctions. miR-127 also regulates intracellular trafficking since miR-127 interference promotes dextran-FITC uptake. In fact, we have identified the Kinesin Family Member 3B (KIF3B), involved in cell trafficking, as a target of miR-127 in rat proximal tubule cells. In summary, we have described a novel role of miR-127 in cell adhesion and its regulation by HIF-1 alpha. We also identified for the first time KIF3B as a miR-127 target. Both, miR-127 and KIF3B appear as key mediators of proximal epithelial tubule cell response to I/R with potential al application in renal ischemic damage management.	[Aguado-Fraile, Elia; Ramos, Edurne; Saenz-Morales, David; Conde, Elisa; Blanco-Sanchez, Ignacio; Garcia Bermejo, Maria Laura] Inst Ramon & Cajal Invest Sanitaria IRYCIS, Dept Pathol, Madrid, Spain; [Stamatakis, Konstantinos] Ctr Biol Mol Severo Ochoa CBM SO CSIC UAM, Dept Cell Biol & Immunol, Madrid, Spain; [del Peso, Luis] Hosp La Paz IdiPAZ, HIV Unit, Dept Biochem, Madrid, Spain; [del Peso, Luis] CSIC UAM, Inst Biomed Res Alberto Sols, Madrid, Spain; [Cuppen, Edwin] Hubrecht Inst, Genome Biol Grp, Utrecht, Netherlands; [Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Frankfurt, Germany; [Garcia Bermejo, Maria Laura] Alcala Univ, Dept Physiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Goethe University Frankfurt; Universidad de Alcala	Aguado-Fraile, E (corresponding author), Inst Ramon & Cajal Invest Sanitaria IRYCIS, Dept Pathol, Madrid, Spain.	mgarciab.hrc@salud.madrid.org	Cuppen, Edwin/H-2389-2016; MORENO, ELISA CONDE/H-7853-2017; García-Bermejo, María Laura/E-1542-2015; Conde-Moreno, Elisa/AAG-2295-2021; Stamatakis, Konstantinos/A-6596-2017; Cuppen, Edwin/F-5696-2011; del Peso, Luis/K-9391-2014	Cuppen, Edwin/0000-0002-0400-9542; MORENO, ELISA CONDE/0000-0002-3751-9602; García-Bermejo, María Laura/0000-0002-8167-2276; Conde-Moreno, Elisa/0000-0002-3751-9602; Stamatakis, Konstantinos/0000-0001-9934-3502; Cuppen, Edwin/0000-0002-0400-9542; del Peso, Luis/0000-0003-4014-5688; Ramos, Edurne/0000-0001-5388-0281	Instituto de Salud Carlos III; Ayuda Intramural Fundacion para la Investigacion en Biomedicina del Hospital Universitario Ramon y Cajal [122/2009];  [FIS PS09/02183]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ayuda Intramural Fundacion para la Investigacion en Biomedicina del Hospital Universitario Ramon y Cajal; 	This work was supported by grant FIS PS09/02183 funding by Instituto de Salud Carlos III and Ayuda Intramural Fundacion para la Investigacion en Biomedicina del Hospital Universitario Ramon y Cajal 122/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; Crosby ME, 2005, CURR PHARM DESIGN, V15, P3861; Duangtum N, 2011, BIOCHEM BIOPH RES CO, V413, P69, DOI 10.1016/j.bbrc.2011.08.050; Fasanaro P, 2010, PHARMACOL THERAPEUT, V125, P92, DOI 10.1016/j.pharmthera.2009.10.003; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim Gene H, 2011, Pulm Circ, V1, P347, DOI 10.4103/2045-8932.87300; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leucci E, 2010, INT J CANCER, V126, P1316, DOI 10.1002/ijc.24655; Lieberthal W, 2000, AM J PHYSIOL-RENAL, V278, pF1, DOI 10.1152/ajprenal.2000.278.1.F1; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Loscalzo J, 2010, J CLIN INVEST, V120, P3815, DOI 10.1172/JCI45105; Lujambio A, 2010, ONCOGENE, V29, P6390, DOI 10.1038/onc.2010.361; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Saenz-Morales D, 2006, EXP CELL RES, V312, P3711, DOI 10.1016/j.yexcr.2006.05.024; Saenz-Morales D, 2010, KIDNEY INT, V77, P781, DOI 10.1038/ki.2010.10; Saenz-Morales D, 2009, CELL PHYSIOL BIOCHEM, V23, P285, DOI 10.1159/000218175; Schodel J, 2009, AM J PATHOL, V174, P1663, DOI 10.2353/ajpath.2009.080687; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005	47	61	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44305	10.1371/journal.pone.0044305	http://dx.doi.org/10.1371/journal.pone.0044305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962609	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600037
J	Christensen, EA; Kulatunga, P; Lagerholm, BC				Christensen, Eva Arnspang; Kulatunga, Pasad; Lagerholm, B. Christoffer			A Single Molecule Investigation of the Photostability of Quantum Dots	PLOS ONE			English	Article							BLINKING; SUPERRESOLUTION; INTERMITTENCY; NANOCRYSTALS; DIFFUSION; TRACKING; PROTEIN	Quantum dots (QDs) are very attractive probes for multi-color fluorescence imaging in biological applications because of their immense brightness and reported extended photostability. We report here however that single QDs, suitable for biological applications, that are subject to continuous blue excitation from a conventional 100 W mercury arc lamp will undergo a continuous blue-switching of the emission wavelength eventually reaching a permanent dark, photobleached state. We further show that beta-mercaptoethanol has a dual stabilizing effect on the fluorescence emission of QDs: 1) by increasing the frequency of time that a QD is in its fluorescent state, and 2) by decreasing the photobleaching rate. The observed QD color spectral switching is especially detrimental for multi-color single molecule applications, as we regularly observe spectral blue-shifts of 50 nm, or more even after only ten seconds of illumination. However, of significant importance for biological applications, we find that even small, biologically compatible, concentrations (25 mu M) of beta-mercaptoethanol has a significant stabilizing effect on the emission color of QDs, but that greater amounts are required to completely abolish the spectral blue shifting or to minimize the emission intermittency of QDs.	[Christensen, Eva Arnspang; Lagerholm, B. Christoffer] Univ So Denmark, Dept Chem & Phys, Odense M, Denmark; [Christensen, Eva Arnspang; Lagerholm, B. Christoffer] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, Odense M, Denmark; [Kulatunga, Pasad] Hobart & William Smith Coll, Dept Phys, Geneva, NY 14456 USA	University of Southern Denmark; University of Southern Denmark	Christensen, EA (corresponding author), Univ So Denmark, Dept Chem & Phys, Odense M, Denmark.	lagerholm@memphys.sdu.dk	Arnspang, Eva C/Y-1132-2018	Arnspang, Eva C/0000-0002-3095-4070; Lagerholm, Christoffer/0000-0003-4678-5168	Villum Kann Rasmussen Foundation; Leo Pharma Forskningsfond; Novo Nordisk Fonden; Danish Natural Research Foundation; Danish Ministry of Science; Lundbeckfonden	Villum Kann Rasmussen Foundation(Villum Fonden); Leo Pharma Forskningsfond(LEO Pharma); Novo Nordisk Fonden(Novo Nordisk Foundation); Danish Natural Research Foundation(Danish Natural Science Research Council); Danish Ministry of Science; Lundbeckfonden(Lundbeckfonden)	This work was supported with grants from the Villum Kann Rasmussen Foundation to BioNET - Danish Center for Biophysics, and grants from Leo Pharma Forskningsfond, Lundbeckfonden and Novo Nordisk Fonden to BCL. This work was carried out in the laboratories of MEMPHYS - Center for Biomembrane Physics which is funded by the Danish Natural Research Foundation and using microscopy equipment at the Danish Molecular Biomedical Imaging Center (DaMBIC) which is funded by the Danish Ministry of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Biebricher A, 2006, J PHYS CHEM B, V110, P5174, DOI 10.1021/jp060660b; Chen HP, 2009, CHEM COMMUN, P1676, DOI 10.1039/b819356h; Chen Y, 2008, J AM CHEM SOC, V130, P5026, DOI 10.1021/ja711379k; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Durisic N, 2007, BIOPHYS J, V93, P1338, DOI 10.1529/biophysj.107.106864; Durisic N, 2009, ACS NANO, V3, P1167, DOI 10.1021/nn800684z; Fomenko V, 2008, NANO LETT, V8, P287, DOI 10.1021/nl0726609; Hohng S, 2004, J AM CHEM SOC, V126, P1324, DOI 10.1021/ja039686w; Hoyer P, 2011, NANO LETT, V11, P245, DOI 10.1021/nl103639f; Inui K, 1997, CELL BIOL INT, V21, P419, DOI 10.1006/cbir.1997.0165; Jones M, 2003, J PHYS CHEM B, V107, P11346, DOI 10.1021/jp035598m; KATARI JEB, 1994, J PHYS CHEM-US, V98, P4109, DOI 10.1021/j100066a034; Lagerholm BC, 2006, BIOPHYS J, V91, P3050, DOI 10.1529/biophysj.105.079178; Lee SF, 2007, J AM CHEM SOC, V129, P8936, DOI 10.1021/ja071876+; Lee SF, 2009, CHEMPHYSCHEM, V10, P2174, DOI 10.1002/cphc.200900200; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Mahler B, 2008, NAT MATER, V7, P659, DOI 10.1038/nmat2222; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Sark WGJHM, 2001, J PHYS CHEM B, V105, P8281, DOI 10.1021/jp012018h; Wang XY, 2009, NATURE, V459, P686, DOI 10.1038/nature08072; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; You CJ, 2010, ANGEW CHEM INT EDIT, V49, P4108, DOI 10.1002/anie.200907032	30	20	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44355	10.1371/journal.pone.0044355	http://dx.doi.org/10.1371/journal.pone.0044355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952963	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300085
J	Pircs, K; Nagy, P; Varga, A; Venkei, Z; Erdi, B; Hegedus, K; Juhasz, G				Pircs, Karolina; Nagy, Peter; Varga, Agnes; Venkei, Zsolt; Erdi, Balazs; Hegedus, Krisztina; Juhasz, Gabor			Advantages and Limitations of Different p62-Based Assays for Estimating Autophagic Activity in Drosophila	PLOS ONE			English	Article							P62; LONGEVITY; REF(2)P	Levels of the selective autophagy substrate p62 have been established in recent years as a specific readout for basal autophagic activity. Here we compared different experimental approaches for using this assay in Drosophila larvae. Similar to the more commonly used western blots, quantifying p62 dots in immunostained fat body cells of L3 stage larvae detected a strong accumulation of endogenous p62 aggregates in null mutants for Atg genes and S6K. Importantly, genes whose mutation or silencing results in early stage lethality can only be analyzed by microscopy using clonal analysis. The loss of numerous general housekeeping genes show a phenotype in large-scale screens including autophagy, and the p62 assay was potentially suitable for distinguishing bona fide autophagy regulators from silencing of a DNA polymerase subunit or a ribosomal gene that likely has a non-specific effect on autophagy. p62 accumulation upon RNAi silencing of known autophagy regulators was dependent on the duration of the knockdown effect, unlike in the case of starvation-induced autophagy. The endogenous p62 assay was more sensitive than a constitutively overexpressed p62-GFP reporter, which showed self-aggregation and large-scale accumulation even in control cells. We recommend western blots for following the conversion of overexpressed p62-GFP reporters to estimate autophagic activity if sample collection from mutant larvae or adults is possible. In addition, we also showed that overexpressed p62 or Atg8 reporters can strongly influence the phenotypes of each other, potentially giving rise to false or contradicting results. Overexpressed p62 aggregates also incorporated Atg8 reporter molecules that might lead to a wrong conclusion of strongly enhanced autophagy, whereas expression of an Atg8 reporter transgene rescued the inhibitory effect of a dominant-negative Atg4 mutant on basal and starvation-induced autophagy.	[Pircs, Karolina; Nagy, Peter; Varga, Agnes; Venkei, Zsolt; Erdi, Balazs; Hegedus, Krisztina; Juhasz, Gabor] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary	Eotvos Lorand University	Pircs, K (corresponding author), Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary.	szmrt@elte.hu	Juhasz, Gabor/G-5622-2013; Nagy, Peter/AFT-0238-2022; Pircs, Karolina/O-2016-2017	Juhasz, Gabor/0000-0001-8548-8874; Nagy, Peter/0000-0002-5053-0646; Pircs, Karolina/0000-0001-8281-4785; Varga, Agnes/0000-0002-2120-1499; Venkei, Zsolt G/0000-0003-1282-849X	Wellcome Trust [087518/Z/08/Z]; Hungarian Academy of Sciences [BO/00552/11]; European Union; European Social Fund [TAMOP 4.2.1./B-09/1/KMR-2010-0003]	Wellcome Trust(Wellcome TrustEuropean Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by the Wellcome Trust (087518/Z/08/Z), the Hungarian Academy of Sciences (BO/00552/11), and the European Union and the European Social Fund contributed to the purchase of the electron microscope (TAMOP 4.2.1./B-09/1/KMR-2010-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; DEZELEE S, 1989, EMBO J, V8, P3437, DOI 10.1002/j.1460-2075.1989.tb08508.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Erdi B, 2012, AUTOPHAGY, V8, P1124, DOI 10.4161/auto.20069; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Klionsky DJ, 2005, AUTOPHAGY, V1, P59, DOI 10.4161/auto.1.1.1536; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608	19	101	102	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44214	10.1371/journal.pone.0044214	http://dx.doi.org/10.1371/journal.pone.0044214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952930	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000308221300064
J	Javanbakht, M; Abolhasani, F; Mashayekhi, A; Baradaran, HR; Noudeh, YJ				Javanbakht, Mehdi; Abolhasani, Farid; Mashayekhi, Atefeh; Baradaran, Hamid R.; noudeh, Younes Jahangiri			Health Related Quality of Life in Patients with Type 2 Diabetes Mellitus in Iran: A National Survey	PLOS ONE			English	Article							PRIMARY-CARE; EQ-5D; COMPLICATIONS; PREVALENCE; ADULTS; QUESTIONNAIRE; POPULATION; SYMPTOMS; TURKEY; JAPAN	Introduction: The aim of this study was to measure health-related quality of life (HRQoL) in Iranian people with Type 2 Diabetes Mellitus using two different measures and examines which socio-demographic and diabetes-related characteristics are associated with better quality of life based on a nationally distributed sample. Methods: A multi-stage cluster sampling method was used to select 3472 subjects as a part of Iranian surveillance of risk factors of non-communicable disease (ISRFNCD). EuroQol-5 Dimensions questionnaire (EQ-5D) and Visual Analog Scale (VAS) were employed to measure HRQoL. Binary logistic and Tobit regression models were used to investigate factors associated with EQ-5D results. Results: The mean age of subjects was 59.4 years (SD = 11.7), 61.3% were female and had 8.08 years (SD = 6.7) known duration of diabetes. The patients reported "some or extreme problems" most frequently in Pain/Discomfort (69.3%) and Anxiety/Depression (56.6%) dimensions of EQ-5D. The mean EQ-5D and VAS score were 0.70 (95% CI 0.69-0.71) and 56.8 (95% CI 56.15-57.5) respectively. Female gender, lower education, unemployment, long duration of diabetes, diabetes-related hospitalization in past years and having nephropathy and lower extremity lesions were associated with higher probabilities of reporting "some or extreme problems" in most dimensions of EQ-5D in binary logistic regression models. The same factors in addition to retinopathy were significantly associated with lower levels of HRQoL in Tobit regression analysis too. Conclusions: The study findings indicate that patients with diabetes in Iran suffer from relatively poor HRQoL. Therefore much more attention should be paid to main determinants of HRQoL to identify and implement appropriate policies for achieving better management of diabetes and ultimately improving the quality of life of diabetic patients in this region.	[Javanbakht, Mehdi; Mashayekhi, Atefeh] Univ Tehran Med Sci, Sch Hlth Care Management, Hlth Care Management & Econ Res Ctr, Tehran, Iran; [Javanbakht, Mehdi] Shiraz Univ Med Sci, Sch Hlth Care Management & Informat Sci, Shiraz, Iran; [Abolhasani, Farid] Univ Tehran Med Sci, Endocrinol & Meolism Res Inst, Tehran, Iran; [Baradaran, Hamid R.] Univ Tehran Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr Firouzgar, Tehran, Iran; [noudeh, Younes Jahangiri] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Shiraz University of Medical Science; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Javanbakht, M (corresponding author), Univ Tehran Med Sci, Sch Hlth Care Management, Hlth Care Management & Econ Res Ctr, Tehran, Iran.	javanbakhtm@gmail.com	Baradaran, Hamid R/N-2577-2019; Baradaran, Hamid Reza/C-1556-2017	Baradaran, Hamid R/0000-0002-5070-5864; Baradaran, Hamid Reza/0000-0002-5070-5864; Jahangiri, Younes/0000-0002-3328-2919; Javanbakht, Mehdi/0000-0002-8661-8439	Endocrine Research Center affiliated with Tehran University of Medical Sciences [1213]	Endocrine Research Center affiliated with Tehran University of Medical Sciences	This study was supported by a grant (number 1213) from the Endocrine Research Center affiliated with Tehran University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci F, 2008, DIABETES RES CLIN PR, V79, P117, DOI 10.1016/j.diabres.2007.07.003; Al-Maskari MY, 2011, SAUDI MED J, V32, P1285; Ardito SQ, 2011, INT J CARDIOL, V152, P133, DOI 10.1016/j.ijcard.2011.07.060; Blumenschein K, 1996, HEALTH POLICY, V36, P155, DOI 10.1016/0168-8510(95)00809-8; Brown DW, 2004, DIABETES RES CLIN PR, V65, P105, DOI 10.1016/j.diabres.2003.11.014; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; Choi YJ, 2011, DIABETES METAB J, V35, P587, DOI 10.4093/dmj.2011.35.6.587; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Devlin NJ, 2007, EQ 5D VALUE SETS INV, DOI 10.1007/1-4020-5511-0; Esteghamati A, 2009, DIABETOLOGIA, V52, P1520, DOI 10.1007/s00125-009-1398-4; Hahl J, 2002, QUAL LIFE RES, V11, P427, DOI 10.1023/A:1015684100227; Hanninen J, 1998, DIABETES RES CLIN PR, V42, P17, DOI 10.1016/S0168-8227(98)00085-0; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Joshi VD, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-36; Kapur A, 2007, INDIAN J MED RES, V125, P473; KeinanenKiukaanniemi S, 1996, DIABETIC MED, V13, P382, DOI 10.1002/(SICI)1096-9136(199604)13:4<382::AID-DIA14>3.0.CO;2-Y; Lee WJ, 2012, J KOREAN MED SCI, V27, P255, DOI 10.3346/jkms.2012.27.3.255; Lloyd A, 2001, Value Health, V4, P392, DOI 10.1046/j.1524-4733.2001.45029.x; Murphy, 2000, VALUE HEALTH, V3, pS47, DOI [10.1046/j.1524-4733.2000.36028.x, DOI 10.1046/J.1524-4733.2000.36028.X]; O'Reilly DJ, 2011, QUAL LIFE RES, V20, P939, DOI 10.1007/s11136-010-9828-9; Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448; Quah JHM, 2011, ANN ACAD MED SINGAP, V40, P276; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Roglic G, 2011, MORTALITY ATTRIBUTAB; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Saito I, 2006, DIABETES RES CLIN PR, V73, P51, DOI 10.1016/j.diabres.2005.11.015; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Sanjari M, 2011, INT J LOW EXTR WOUND, V10, P200, DOI 10.1177/1534734611428728; Sobocki P, 2007, VALUE HEALTH, V10, P153, DOI 10.1111/j.1524-4733.2006.00162.x; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x; Taghdisi MH, 2012, HEALTH EDUC J, V71, P229, DOI 10.1177/0017896911398812; Ucan O, 2010, J CLIN NURS, V19, P2511, DOI 10.1111/j.1365-2702.2010.03295.x; Varghese RT, 2007, DIABETES METAB SYND, V1, P173, DOI 10.1016/j.dsx.2007.05.005; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	36	67	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44526	10.1371/journal.pone.0044526	http://dx.doi.org/10.1371/journal.pone.0044526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZH	22952989	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500075
J	Kostyuk, V; Potapovich, A; Stancato, A; De Luca, C; Lulli, D; Pastore, S; Korkina, L				Kostyuk, Vladimir; Potapovich, Alla; Stancato, Andrea; De Luca, Chiara; Lulli, Daniela; Pastore, Saveria; Korkina, Liudmila			Photo-Oxidation Products of Skin Surface Squalene Mediate Metabolic and Inflammatory Responses to Solar UV in Human Keratinocytes	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR RECEPTOR; OXIDATIVE STRESS; CHEMOKINE EXPRESSION; EGF RECEPTOR; ACTIVATION; TRANSCRIPTION; PATHWAY; KAPPA; AHR	The study aimed to identify endogenous lipid mediators of metabolic and inflammatory responses of human keratinocytes to solar UV irradiation. Physiologically relevant doses of solar simulated UVA+UVB were applied to human skin surface lipids (SSL) or to primary cultures of normal human epidermal keratinocytes (NHEK). The decay of photo-sensitive lipid-soluble components, alpha-tocopherol, squalene (Sq), and cholesterol in SSL was analysed and products of squalene photo-oxidation (SqPx) were quantitatively isolated from irradiated SSL. When administered directly to NHEK, low-dose solar UVA+UVB induced time-dependent inflammatory and metabolic responses. To mimic UVA+UVB action, NHEK were exposed to intact or photo-oxidised SSL, Sq or SqPx, 4-hydroxy-2-nonenal (4-HNE), and the product of tryptophan photo-oxidation 6-formylindolo[3,2-b]carbazole (FICZ). FICZ activated exclusively metabolic responses characteristic for UV, i.e. the aryl hydrocarbon receptor (AhR) machinery and downstream CYP1A1/CYP1B1 gene expression, while 4-HNE slightly stimulated inflammatory UV markers IL-6, COX-2, and iNOS genes. On contrast, SqPx induced the majority of metabolic and inflammatory responses characteristic for UVA+UVB, acting via AhR, EGFR, and G-protein-coupled arachidonic acid receptor (G2A). Conclusions/Significance: Our findings indicate that Sq could be a primary sensor of solar UV irradiation in human SSL, and products of its photo-oxidation mediate/induce metabolic and inflammatory responses of keratinocytes to UVA+UVB, which could be relevant for skin inflammation in the sun-exposed oily skin.	[Kostyuk, Vladimir; Potapovich, Alla; Stancato, Andrea; De Luca, Chiara; Lulli, Daniela; Pastore, Saveria; Korkina, Liudmila] Ist Dermopat Immacolata IDI IRCCS, Lab Tissue Engn & Skin Pathophysiol, Rome, Italy; [Kostyuk, Vladimir; Potapovich, Alla] Belarusian State Univ, Dept Biol, Minsk, BELARUS	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Belarusian State University	Kostyuk, V (corresponding author), Ist Dermopat Immacolata IDI IRCCS, Lab Tissue Engn & Skin Pathophysiol, Rome, Italy.	l.korkina@idi.it	Kostyuk, Vladimir A./AAB-6601-2021; Lulli, Daniela/AAA-2165-2019; Lulli, Daniela/K-6363-2016	Lulli, Daniela/0000-0002-6314-4699; Kostyuk, Vladimir/0000-0002-1246-4131	Italian Ministry for Health [IDI IRCCS-2010]	Italian Ministry for Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry for Health (Grant IDI IRCCS-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; De Luca C, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/321494; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Ekanayake-Mudiyanselage S, 2003, J INVEST DERMATOL, V120, P915, DOI 10.1046/j.1523-1747.2003.12233.x; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Katiyar SK, 2000, J INVEST DERMATOL, V114, P328, DOI 10.1046/j.1523-1747.2000.00876.x; KOHNO Y, 1995, BBA-LIPID LIPID MET, V1256, P52, DOI 10.1016/0005-2760(95)00005-W; Lamore SD, 2010, J PHOTOCH PHOTOBIO B, V101, P251, DOI 10.1016/j.jphotobiol.2010.07.010; Leonarduzzi G, 2004, FREE RADICAL BIO MED, V37, P1694, DOI 10.1016/j.freeradbiomed.2004.08.027; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu W, 1999, J CELL SCI, V112, P2409; Liu W, 2010, NITRIC OXIDE-BIOL CH, V23, P199, DOI 10.1016/j.niox.2010.06.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luecke S, 2010, CHEM-BIOL INTERACT, V184, P466, DOI 10.1016/j.cbi.2010.01.038; Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x; Martinez-Carpio PA, 2010, PHOTODERMATOL PHOTO, V26, P250, DOI 10.1111/j.1600-0781.2010.00534.x; McInturff JE, 2005, J INVEST DERMATOL, V125, P1, DOI 10.1111/j.0022-202X.2004.23459.x; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; NICOLAIDES N, 1968, J INVEST DERMATOL, V51, P83, DOI 10.1038/jid.1968.96; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; Ottaviani M, 2006, J INVEST DERMATOL, V126, P2430, DOI 10.1038/sj.jid.5700434; PASSI S, 1991, Journal of Dermatological Science, V2, P84, DOI 10.1016/0923-1811(91)90016-Q; Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pastore S, 2012, ANTIOXID REDOX SIGN, V16, P314, DOI 10.1089/ars.2011.4053; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; PICARDO M, 1991, PHOTODERMATOL PHOTO, V8, P105; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Rannug A, 2006, BIOL CHEM, V387, P1149, DOI 10.1515/BC.2006.143; Rannug A, 2010, P NATL ACAD SCI USA, V107, P18239, DOI 10.1073/pnas.1013653107; Ryu A, 2009, BIOL PHARM BULL, V32, P1504, DOI 10.1248/bpb.32.1504; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Sottero B, 2009, CURR MED CHEM, V16, P685, DOI 10.2174/092986709787458353; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Sutter CH, 2009, P NATL ACAD SCI USA, V106, P4266, DOI 10.1073/pnas.0900874106; Thiele J, 2005, SKIN AGING, P65; Thiele JJ, 1998, J INVEST DERMATOL, V110, P756, DOI 10.1046/j.1523-1747.1998.00169.x; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Vondracek J, 2011, CURR DRUG METAB, V12, P89, DOI 10.2174/138920011795016827; Xu YR, 2006, J BIOL CHEM, V281, P27389, DOI 10.1074/jbc.M602355200; Xu YR, 2009, J CELL BIOCHEM, V107, P873, DOI 10.1002/jcb.22195; Zouboulis CC, 2008, EXP DERMATOL, V17, P542, DOI 10.1111/j.1600-0625.2008.00725.x	47	57	58	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44472	10.1371/journal.pone.0044472	http://dx.doi.org/10.1371/journal.pone.0044472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952984	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500073
J	Abcejo, AJ; Sathish, V; Smelter, DF; Aravamudan, B; Thompson, MA; Hartman, WR; Pabelick, CM; Prakash, YS				Abcejo, Amard J.; Sathish, Venkatachalem; Smelter, Dan F.; Aravamudan, Bharathi; Thompson, Michael A.; Hartman, William R.; Pabelick, Christina M.; Prakash, Y. S.			Brain-Derived Neurotrophic Factor Enhances Calcium Regulatory Mechanisms in Human Airway Smooth Muscle	PLOS ONE			English	Article							OPERATED CA2+ INFLUX; TNF-ALPHA; INTRACELLULAR CA2+; PROTEIN EXPRESSION; TRKB RECEPTOR; BDNF; DYSFUNCTION; ACTIVATION; CHANNELS; AGONIST	Neurotrophins (NTs), which play an integral role in neuronal development and function, have been found in non-neuronal tissue (including lung), but their role is still under investigation. Recent reports show that NTs such as brain-derived neurotrophic factor (BDNF) as well as NT receptors are expressed in human airway smooth muscle (ASM). However, their function is still under investigation. We hypothesized that NTs regulate ASM intracellular Ca2+ ([Ca2+](i)) by altered expression of Ca2+ regulatory proteins. Human ASM cells isolated from lung samples incidental to patient surgery were incubated for 24 h (overnight) in medium (control) or 1 nM BDNF in the presence vs. absence of inhibitors of signaling cascades (MAP kinases; PI3/Akt; NF kappa B). Measurement of [Ca2+](i) responses to acetylcholine (ACh) and histamine using the Ca2+ indicator fluo-4 showed significantly greater responses following BDNF exposure: effects that were blunted by pathway inhibitors. Western analysis of whole cell lysates showed significantly higher expression of CD38, Orai1, STIM1, IP3 and RyR receptors, and SERCA following BDNF exposure, effects inhibited by inhibitors of the above cascades. The functional significance of BDNF effects were verified by siRNA or pharmacological inhibition of proteins that were altered by this NT. Overall, these data demonstrate that NTs activate signaling pathways in human ASM that lead to enhanced [Ca2+](i) responses via increased regulatory protein expression, thus enhancing airway contractility.	[Abcejo, Amard J.; Sathish, Venkatachalem; Smelter, Dan F.; Aravamudan, Bharathi; Thompson, Michael A.; Hartman, William R.; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Sathish, Venkatachalem; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Abcejo, AJ (corresponding author), Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA.	prakash.ys@mayo.edu		venkatachalem, sathish/0000-0001-9770-8299; Prakash, Y S/0000-0002-2968-224X	National Institutes of Health [HL088029, HL090595]; Flight Attendants Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088029, R01HL056470, R01HL090595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants HL088029 (Prakash) and HL090595 (Pabelick) from the National Institutes of Health, and the Flight Attendants Medical Research Institute (FAMRI; Prakash). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani Y, 2000, Respir Res, V1, P49, DOI 10.1186/rr12; Amrani Y, 2007, AM J RESP CELL MOL, V36, P387, DOI 10.1165/ajrcmb.36.3.387; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Braun A, 2004, BRIT J PHARMACOL, V141, P431, DOI 10.1038/sj.bjp.0705638; Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; COBURN RF, 1990, AM J PHYSIOL, V258, pL119, DOI 10.1152/ajplung.1990.258.4.L119; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hotta K, 1999, AM J PHYSIOL-LUNG C, V276, pL405, DOI 10.1152/ajplung.1999.276.3.L405; Hoyle GW, 2003, CYTOKINE GROWTH F R, V14, P551, DOI 10.1016/S1359-6101(03)00061-3; ITO Y, 1995, BRIT J PHARMACOL, V116, P2738, DOI 10.1111/j.1476-5381.1995.tb17235.x; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jude JA, 2011, ADV EXP MED BIOL, V691, P449, DOI 10.1007/978-1-4419-6612-4_46; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kannan MS, 1997, AM J PHYSIOL-LUNG C, V272, pL659, DOI 10.1152/ajplung.1997.272.4.L659; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kovalchuk Y, 2004, CURR OPIN NEUROBIOL, V14, P558, DOI 10.1016/j.conb.2004.08.014; Lahiri T, 2002, AM J PHYSIOL-LUNG C, V283, pL1239, DOI 10.1152/ajplung.00231.2001; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Lommatzsch M, 2005, INT J DEV NEUROSCI, V23, P495, DOI 10.1016/j.ijdevneu.2005.05.009; Lommatzsch M, 2003, ANN NY ACAD SCI, V992, P241, DOI 10.1111/j.1749-6632.2003.tb03154.x; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Luther JA, 2009, AUTON NEUROSCI-BASIC, V151, P46, DOI 10.1016/j.autneu.2009.08.009; Mantilla CB, 2012, MUSCLE NERVE, V45, P274, DOI 10.1002/mus.22295; Meuchel LW, 2011, AM J PHYSIOL-LUNG C, V301, pL91, DOI 10.1152/ajplung.00320.2010; MURRAY RK, 1991, J PHYSIOL-LONDON, V435, P123, DOI 10.1113/jphysiol.1991.sp018501; Pabelick CM, 2004, ANESTHESIOLOGY, V101, P373, DOI 10.1097/00000542-200408000-00018; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Prakash YS, 2006, AM J PHYSIOL-LUNG C, V291, pL447, DOI 10.1152/ajplung.00501.2005; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ricci A, 2004, AM J RESP CELL MOL, V30, P12, DOI 10.1165/rcmb.2002-0110OC; Ricci A, 2000, GROWTH FACTORS, V18, P193, DOI 10.3109/08977190009003244; Rochlitzer S, 2006, BIOCHEM SOC T, V34, P594, DOI 10.1042/BST0340594; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Scuri Mario, 2010, Inflammation & Allergy Drug Targets, V9, P173; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; UNDEM BJ, 1994, HOSP PRACT, V29, P59, DOI 10.1080/21548331.1994.11442974; Undem BJ, 1994, HOSP PRACT OFF ED, V29, P69; Wang XH, 1998, J NEUROSCI, V18, P4985; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; WORLEY JF, 1990, AM J PHYSIOL, V259, pL468, DOI 10.1152/ajplung.1990.259.6.L468; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	53	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44343	10.1371/journal.pone.0044343	http://dx.doi.org/10.1371/journal.pone.0044343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952960	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000098
J	Ubertini, M; Lefebvre, S; Gangnery, A; Grangere, K; Le Gendre, R; Orvain, F				Ubertini, Martin; Lefebvre, Sebastien; Gangnery, Aline; Grangere, Karine; Le Gendre, Romain; Orvain, Francis			Spatial Variability of Benthic-Pelagic Coupling in an Estuary Ecosystem: Consequences for Microphytobenthos Resuspension Phenomenon	PLOS ONE			English	Article							INTERTIDAL SEDIMENTS; CHLOROPHYLL-A; MICROALGAL BIOMASS; STABLE-ISOTOPES; HYDROBIA-ULVAE; CASSINO BEACH; TAGUS ESTUARY; DYNAMICS; COASTAL; ERODIBILITY	The high degree of physical factors in intertidal estuarine ecosystem increases material processing between benthic and pelagic compartments. In these ecosystems, microphytobenthos resuspension is a major phenomenon since its contribution to higher trophic levels can be highly significant. Understanding the sediment and associated microphytobenthos resuspension and its fate in the water column is indispensable for measuring the food available to benthic and pelagic food webs. To identify and hierarchize the physical/biological factors potentially involved in MPB resuspension, the entire intertidal area and surrounding water column of an estuarine ecosystem, the Bay des Veys, was sampled during ebb tide. A wide range of physical parameters (hydrodynamic regime, grain size of the sediment, and suspended matter) and biological parameters (flora and fauna assemblages, chlorophyll) were analyzed to characterize benthic-pelagic coupling at the bay scale. Samples were collected in two contrasted periods, spring and late summer, to assess the impact of forcing variables on benthic-pelagic coupling. A mapping approach using kriging interpolation enabled us to overlay benthic and pelagic maps of physical and biological variables, for both hydrological conditions and trophic indicators. Pelagic Chl a concentration was the best predictor explaining the suspension-feeders spatial distribution. Our results also suggest a perennial spatio-temporal structure of both benthic and pelagic compartments in the ecosystem, at least when the system is not imposed to intense wind, with MPB distribution controlled by both grain size and bathymetry. The benthic component appeared to control the pelagic one via resuspension phenomena at the scale of the bay. Co-inertia analysis showed closer benthic-pelagic coupling between the variables in spring. The higher MPB biomass observed in summer suggests a higher contribution to filter-feeders diets, indicating a higher resuspension effect in summer than in spring, in turn suggesting an important role of macrofauna bioturbation and filter feeding (Cerastoderma edule).	[Ubertini, Martin; Grangere, Karine; Orvain, Francis] Univ Caen Basse Normandie, FRE3484, BioMEA, Caen, France; [Ubertini, Martin; Grangere, Karine; Orvain, Francis] CNRS, INEE, FRE3484, BioMEA, Caen, France; [Gangnery, Aline; Le Gendre, Romain] IFREMER, LERN, Port En Bessin, France; [Lefebvre, Sebastien] Univ Lille 1, CNRS, UMR 8187, Stn Marine Wimereux,LOG, Wimereux, France; [Orvain, Francis] CNRS, UMR 7208, BOREA, Museum Hist Nat,CRESCO, Dinard, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Ubertini, M (corresponding author), Univ Caen Basse Normandie, FRE3484, BioMEA, Caen, France.	francis.orvain@unicaen.fr	Ubertini, Martin/AAH-3898-2020; Lefebvre, Sébastien/G-8562-2011	Lefebvre, Sébastien/0000-0002-7152-5897; Le Gendre, Romain/0000-0001-7015-8290	Regional council of Basse-Normandie	Regional council of Basse-Normandie(Region Normandie)	This work was funded by the Regional council of Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CL, 1997, ESTUAR COAST SHELF S, V45, P507, DOI 10.1006/ecss.1996.0193; Austen I, 1999, ESTUAR COAST SHELF S, V49, P99, DOI 10.1006/ecss.1998.0491; Blanchard GF, 2001, J EXP MAR BIOL ECOL, V264, P85, DOI 10.1016/S0022-0981(01)00312-4; BOUGRIER S, 1995, AQUACULTURE, V134, P143, DOI 10.1016/0044-8486(95)00036-2; BROTAS V, 1995, HYDROBIOLOGIA, V300, P93, DOI 10.1007/BF00024451; Callier MD, 2009, MAR POLLUT BULL, V58, P1544, DOI 10.1016/j.marpolbul.2009.05.010; CARPENTER SR, 1986, LIMNOL OCEANOGR, V31, P112, DOI 10.4319/lo.1986.31.1.0112; Cartaxana P, 2006, ESTUAR COAST SHELF S, V66, P225, DOI 10.1016/j.ecss.2005.08.011; Choy EJ, 2009, J EXP MAR BIOL ECOL, V382, P18, DOI 10.1016/j.jembe.2009.10.002; Cibic T, 2007, ESTUAR COAST SHELF S, V75, P50, DOI 10.1016/j.ecss.2007.01.020; Ciutat A, 2006, MAR ECOL-PROG SER, V346, P114; Cognie B, 1999, OCEANOL ACTA, V22, P441, DOI 10.1016/S0399-1784(00)88727-7; COLIJN F, 1984, MAR ECOL PROG SER, V14, P185, DOI 10.3354/meps014185; Consalvey M, 2004, PHOTOSYNTH RES, V81, P91, DOI 10.1023/B:PRES.0000028397.86495.b5; DEJONGE VN, 1995, LIMNOL OCEANOGR, V40, P766; Deroin JP, 2012, INT J APPL EARTH OBS, V18, P183, DOI 10.1016/j.jag.2012.01.019; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Dubois S, 2007, J EXP MAR BIOL ECOL, V351, P121, DOI 10.1016/j.jembe.2007.06.020; Dubois S, 2007, AQUACULTURE, V271, P336, DOI 10.1016/j.aquaculture.2007.03.023; Dubois S, 2007, MAR ECOL PROG SER, V336, P151, DOI 10.3354/meps336151; Eleftheriou A., 1984, METHODS STUDY MARINE, P140; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Grangere K, 2010, MAR ECOL PROG SER, V415, P141, DOI 10.3354/meps08659; Guarini JM, 2008, ECOL MODEL, V211, P267, DOI 10.1016/j.ecolmodel.2007.09.011; Guarini JM, 2004, J SEA RES, V52, P241, DOI 10.1016/j.seares.2004.04.003; Hammerstrom KK, 2010, INTEGR ENVIRON ASSES, P1; Hansen K, 1996, AQUAT MICROB ECOL, V10, P181, DOI 10.3354/ame010181; Hayward P.J., 1990, MARINE FAUNA BRIT IS, V1; Honkoop PJC, 2006, J SEA RES, V55, P278, DOI 10.1016/j.seares.2005.11.001; Huot Y, 2007, BIOGEOSCIENCES, V4, P853, DOI 10.5194/bg-4-853-2007; Kang CK, 2006, MAR ECOL PROG SER, V315, P113, DOI 10.3354/meps315113; Kasim M, 2006, J OCEANOGR, V62, P267, DOI 10.1007/s10872-006-0051-9; Koh CH, 2007, ESTUAR COAST SHELF S, V72, P42, DOI 10.1016/j.ecss.2006.10.005; Kon K, 2012, ESTUAR COAST SHELF S, V96, P236, DOI 10.1016/j.ecss.2011.11.015; Lazure P, 2008, ADV WATER RESOUR, V31, P233, DOI 10.1016/j.advwatres.2007.06.010; Lefebvre S, 2009, ESTUAR COAST SHELF S, V82, P415, DOI 10.1016/j.ecss.2009.02.002; Longphuirt SN, 2007, ESTUAR COAST SHELF S, V74, P367, DOI 10.1016/j.ecss.2007.04.025; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lucas CH, 2000, MAR ECOL PROG SER, V196, P59, DOI 10.3354/meps196059; Lucas CH, 2003, ESTUARIES, V26, P885, DOI 10.1007/BF02803347; Lund-Hansen LC, 1999, ESTUARIES, V22, P39, DOI 10.2307/1352925; Malet N, 2008, ESTUAR COAST SHELF S, V78, P576, DOI 10.1016/j.ecss.2007.11.001; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Odebrecht C, 2003, J COASTAL RES, P486; Orvain F, 2006, J SEA RES, V55, P54, DOI 10.1016/j.seares.2005.10.002; Orvain F, 2004, MAR ECOL PROG SER, V278, P205, DOI 10.3354/meps278205; Orvain F, 2012, MAR ECOL PROG SER, V458, P53, DOI 10.3354/meps09698; Pannard A, 2008, CAN J FISH AQUAT SCI, V65, P47, DOI 10.1139/F07-149; Perissinotto R, 2003, ACTA OECOL, V24, pS307, DOI 10.1016/S1146-609X(03)00028-6; Perkins RG, 2003, CONT SHELF RES, V23, P575, DOI 10.1016/S0278-4343(03)00006-2; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pillay D, 2007, MAR ECOL PROG SER, V347, P1, DOI 10.3354/meps07054; Porter ET, 2010, MAR ECOL PROG SER, V413, P33, DOI 10.3354/meps08709; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Rorig LR, 2003, J COASTAL RES, P167; Saburova MA, 1995, MAR ECOL PROG SER, V129, P229, DOI 10.3354/meps129229; Safi KA, 2003, MAR ECOL PROG SER, V259, P67, DOI 10.3354/meps259067; Schelske C.L., 1962, P GULF CARIBBEAN FIS, P75; Serodio J, 2006, ESTUAR COAST SHELF S, V68, P547, DOI 10.1016/j.ecss.2006.03.005; Snoeijs P, 2002, J PHYCOL, V38, P265, DOI 10.1046/j.1529-8817.2002.01105.x; Spears BM, 2008, MAR FRESHWATER RES, V59, P313, DOI 10.1071/MF07164; SPOONER N, 1994, ORG GEOCHEM, V22, P773, DOI 10.1016/0146-6380(94)90138-4; Tolhurst TJ, 2003, HYDROBIOLOGIA, V503, P183, DOI 10.1023/B:HYDR.0000008474.33782.8d; Tolhurst TJ, 2002, PROCEED MARINE SCI, V5, P409; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood G.J., 2006, FUNCTIONING MICROPHY, P121; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Utermohl V. H., 1931, VERH INT VEREIN THEO, V5, P567, DOI DOI 10.1080/03680770.1931.11898492; van der Wal D, 2008, MAR ECOL PROG SER, V367, P57, DOI 10.3354/meps07535; van der Wal D, 2010, ECOSYSTEMS, V13, P338, DOI 10.1007/s10021-010-9322-9; WAITE AM, 1992, LIMNOL OCEANOGR, V37, P468, DOI 10.4319/lo.1992.37.3.0468; Webster R, 2006, COMPUT GEOSCI-UK, V32, P1320, DOI 10.1016/j.cageo.2005.12.002; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985	73	73	74	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44155	10.1371/journal.pone.0044155	http://dx.doi.org/10.1371/journal.pone.0044155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952910	gold, Green Published			2022-12-25	WOS:000308206000091
J	Lacroix, R; McKemey, AR; Raduan, N; Wee, LK; Ming, WH; Ney, TG; Rahidah, AAS; Salman, S; Subramaniam, S; Nordin, O; Hanum, ATN; Angamuthu, C; Mansor, SM; Lees, RS; Naish, N; Scaife, S; Gray, P; Labbe, G; Beech, C; Nimmo, D; Alphey, L; Vasan, SS; Lim, LH; Wasi, AN; Murad, S				Lacroix, Renaud; McKemey, Andrew R.; Raduan, Norzahira; Wee, Lim Kwee; Ming, Wong Hong; Ney, Teoh Guat; Rahidah, Siti A. A.; Salman, Sawaluddin; Subramaniam, Selvi; Nordin, Oreenaiza; Hanum, Norhaida A. T.; Angamuthu, Chandru; Mansor, Suria Marlina; Lees, Rosemary S.; Naish, Neil; Scaife, Sarah; Gray, Pam; Labbe, Genevieve; Beech, Camilla; Nimmo, Derric; Alphey, Luke; Vasan, Seshadri S.; Lim, Lee Han; Wasi, Nazni A.; Murad, Shahnaz			Open Field Release of Genetically Engineered Sterile Male Aedes aegypti in Malaysia	PLOS ONE			English	Article							MOSQUITO-BORNE DISEASES; TRANSGENIC MOSQUITOS; DISPERSAL; FITNESS; POPULATION; RESISTANCE; DOMINANT; SURVIVAL; COMPETITION; RECAPTURE	Background: Dengue is the most important mosquito-borne viral disease. In the absence of specific drugs or vaccines, control focuses on suppressing the principal mosquito vector, Aedes aegypti, yet current methods have not proven adequate to control the disease. New methods are therefore urgently needed, for example genetics-based sterile-male-release methods. However, this requires that lab-reared, modified mosquitoes be able to survive and disperse adequately in the field. Methodology/Principal Findings: Adult male mosquitoes were released into an uninhabited forested area of Pahang, Malaysia. Their survival and dispersal was assessed by use of a network of traps. Two strains were used, an engineered 'genetically sterile' (OX513A) and a wild-type laboratory strain, to give both absolute and relative data about the performance of the modified mosquitoes. The two strains had similar maximum dispersal distances (220 m), but mean distance travelled of the OX513A strain was lower (52 vs. 100 m). Life expectancy was similar (2.0 vs. 2.2 days). Recapture rates were high for both strains, possibly because of the uninhabited nature of the site. Conclusions/Significance: After extensive contained studies and regulatory scrutiny, a field release of engineered mosquitoes was safely and successfully conducted in Malaysia. The engineered strain showed similar field longevity to an unmodified counterpart, though in this setting dispersal was reduced relative to the unmodified strain. These data are encouraging for the future testing and implementation of genetic control strategies and will help guide future field use of this and other engineered strains.	[Lacroix, Renaud; Raduan, Norzahira; Vasan, Seshadri S.] Oxitec Sendirian Berhad, Kuala Lumpur, Wilayah Perseku, Malaysia; [Lacroix, Renaud; McKemey, Andrew R.; Naish, Neil; Scaife, Sarah; Gray, Pam; Labbe, Genevieve; Beech, Camilla; Nimmo, Derric; Alphey, Luke] Oxitec Ltd, Oxford, England; [Raduan, Norzahira; Wee, Lim Kwee; Ming, Wong Hong; Ney, Teoh Guat; Rahidah, Siti A. A.; Salman, Sawaluddin; Subramaniam, Selvi; Nordin, Oreenaiza; Hanum, Norhaida A. T.; Angamuthu, Chandru; Mansor, Suria Marlina; Vasan, Seshadri S.; Lim, Lee Han; Wasi, Nazni A.] Inst Med Res, Med Entomol Unit, Kuala Lumpur 50588, Wilayah Perseku, Malaysia; [Lees, Rosemary S.; Vasan, Seshadri S.] Univ Malaya, Ctr Res Biotechnol Agr, Kuala Lumpur, Wilayah Perseku, Malaysia; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Kementerian Kesihatan Malaysia; Universiti Malaya; University of Oxford	Lacroix, R (corresponding author), Oxitec Sendirian Berhad, Kuala Lumpur, Wilayah Perseku, Malaysia.	Luke.Alphey@oxitec.com; leehl@imr.gov.my	Lees, Rosemary Susan/H-3425-2019	Lees, Rosemary Susan/0000-0002-4232-9125; Labbe, Genevieve/0000-0002-1015-8579; Alphey, Luke/0000-0002-2916-3802; Beech, Camilla/0000-0001-8348-9566	National Institutes of Health from the Ministry of Health, Malaysia [JPP-IMR 06-053]; Oxitec Ltd.	National Institutes of Health from the Ministry of Health, Malaysia; Oxitec Ltd.	This study was supported by a grant from the National Institutes of Health from the Ministry of Health, Malaysia (code: JPP-IMR 06-053). Oxitec Ltd. provided salary and other support for the research program of those authors employed by the company (as noted in the author list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2004, J ECON ENTOMOL, V97, P1181, DOI 10.1603/0022-0493(2004)097[1181:PFOTSO]2.0.CO;2; Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2007, J ECON ENTOMOL, V100, P1642, DOI 10.1603/0022-0493(2007)100[1642:MIRBMR]2.0.CO;2; Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384; Alphey N, 2011, J THEOR BIOL, V270, P42, DOI 10.1016/j.jtbi.2010.11.016; Alphey N, 2009, J ECON ENTOMOL, V102, P717, DOI 10.1603/029.102.0233; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Bargielowski I, 2012, VECTOR-BORNE ZOONOT, V12, P1053, DOI 10.1089/vbz.2012.0994; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026086; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Chee Y.C., 2005, REPORT EXPERT PANEL; Clements A.N., 1999, BIOL MOSQUITOES SENS; Coleman PG, 2004, TROP MED INT HEALTH, V9, P433, DOI 10.1111/j.1365-3156.2004.01225.x; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; Dyck V.A., 2006, STERILE INSECT TECHN; Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170; FAY R. W., 1959, MOSQUITO NEWS, V19, P144; FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Harbach R.E., 1980, TAXONOMISTS GLOSSARY; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; HARTBERG WK, 1971, B WORLD HEALTH ORGAN, V45, P847; HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kongmee M, 2010, J MED ENTOMOL, V47, P1092, DOI 10.1603/ME10046; Lambrechts L, 2008, TRENDS PARASITOL, V24, P4, DOI 10.1016/j.pt.2007.09.009; Lee H. L., 1992, Mosquito Borne Diseases Bulletin, V9, P9; Lee HL, 2013, TRANSGENIC RES, V22, P47, DOI 10.1007/s11248-012-9625-z; Lee HL, 2009, DENGUE B, V33; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; MORRIS CD, 1991, J AM MOSQUITO CONTR, V7, P608; Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277; Nazni W. A., 2009, Dengue Bulletin, V33, P124; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tee AS, 1997, GUIDELINES USE OVITR, P6; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; WHO/TDR, 2009, DENG GUID DIAGN TREA; WHO-TDR 2006, 2006, SCI WORK GROUP REP D; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	57	168	177	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42771	10.1371/journal.pone.0042771	http://dx.doi.org/10.1371/journal.pone.0042771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22970102	Green Submitted, gold, Green Published			2022-12-25	WOS:000308044800011
J	Sampson, ER; McMurray, HR; Hassane, DC; Newman, L; Salzman, P; Jordan, CT; Land, H				Sampson, E. R.; McMurray, H. R.; Hassane, D. C.; Newman, L.; Salzman, P.; Jordan, C. T.; Land, H.			Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery	ONCOGENE			English	Article						oncogene cooperation; gene expression; driver genes	HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; CELL-CYCLE ARREST; MYC-INDUCED PROLIFERATION; PHASE-I; VALPROIC ACID; SODIUM PHENYLBUTYRATE; EXPRESSION; APOPTOSIS; P53	Malignant cell transformation commonly results in the deregulation of thousands of cellular genes, an observation that suggests a complex biological process and an inherently challenging scenario for the development of effective cancer interventions. To better define the genes/pathways essential to regulating the malignant phenotype, we recently described a novel strategy based on the cooperative nature of carcinogenesis that focuses on genes synergistically deregulated in response to cooperating oncogenic mutations. These so-called 'cooperation response genes' (CRGs) are highly enriched for genes critical for the cancer phenotype, thereby suggesting their causal role in the malignant state. Here, we show that CRGs have an essential role in drug-mediated anticancer activity and that anticancer agents can be identified through their ability to antagonize the CRG expression profile. These findings provide proof-of-concept for the use of the CRG signature as a novel means of drug discovery with relevance to underlying anticancer drug mechanisms.	[Sampson, E. R.; McMurray, H. R.; Newman, L.; Land, H.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Hassane, D. C.; Jordan, C. T.] Univ Rochester, Med Ctr, Dept Hematol & Oncol, Rochester, NY 14642 USA; [Hassane, D. C.] Weill Cornell Med Coll, Dept Pathol & Lab Med, Inst Computat Biomed, New York, NY USA; [Salzman, P.] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Land, H.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Cornell University; University of Rochester; University of Rochester	Land, H (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	Land@urmc.rochester.edu	Hassane, Duane/AAA-3456-2021; jordan, craig/D-7666-2014	salzman, peter/0000-0001-8114-4863; McMurray, Helene/0000-0003-1738-8622; Hassane, Duane/0000-0002-0719-9572; jordan, craig/0000-0003-0869-3465	NIH [CA90663, CA120317, CA138249, GM075299, T32 CA09363, K99 LM009477]; James P Wilmot Cancer Center; NATIONAL CANCER INSTITUTE [R01CA120317, R01CA090663, R01CA138249, T32CA009363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075299] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM009477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James P Wilmot Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Drs D Bohmann and M Noble for discussion, Drs A Burgess and R Whitehead for materials. This work was supported in part by NIH grants CA90663, CA120317, CA138249, GM075299, and a James P Wilmot Cancer Center pilot grant. HRM was supported in part by NIH T32 CA09363, PS by NIH K99 LM009477.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Angelucci A, 2006, ANTI-CANCER DRUG, V17, P1141, DOI 10.1097/01.cad.0000236302.89843.fc; Atmaca A, 2007, BRIT J CANCER, V97, P177, DOI 10.1038/sj.bjc.6603851; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Braiteh F, 2008, CLIN CANCER RES, V14, P6296, DOI 10.1158/1078-0432.CCR-08-1247; Butler LM, 2000, CANCER RES, V60, P5165; Carducci MA, 2001, CLIN CANCER RES, V7, P3047; Corsello SM, 2009, BLOOD, V113, P6193, DOI 10.1182/blood-2008-07-166090; Fantin VR, 2007, CLIN CANCER RES, V13, P7237, DOI 10.1158/1078-0432.CCR-07-2114; Friedman DR, 2009, CLIN CANCER RES, V15, P6947, DOI 10.1158/1078-0432.CCR-09-1132; Fritsche P, 2009, GUT; Gilbert J, 2001, CLIN CANCER RES, V7, P2292; Gore SD, 2002, CLIN CANCER RES, V8, P963; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; HAGUE A, 1993, INT J CANCER, V55, P498, DOI 10.1002/ijc.2910550329; Hassane DC, 2008, BLOOD; HEERDT BG, 1994, CANCER RES, V54, P3288; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Mori S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006772; Munster P, 2007, J CLIN ONCOL, V25, P1979, DOI 10.1200/JCO.2006.08.6165; Patnaik A, 2002, CLIN CANCER RES, V8, P2142; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takai N, 2004, CANCER-AM CANCER SOC, V101, P2760, DOI 10.1002/cncr.20709; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Zhang HT, 2007, ACTA PHARMACOL SIN, V28, P1783, DOI 10.1111/j.1745-7254.2007.00660.x; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	59	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3809	3818		10.1038/onc.2012.389	http://dx.doi.org/10.1038/onc.2012.389			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22964631	Green Accepted			2022-12-25	WOS:000323210200003
J	Barnett, L; Platisa, J; Popovic, M; Pieribone, VA; Hughes, T				Barnett, Lauren; Platisa, Jelena; Popovic, Marko; Pieribone, Vincent A.; Hughes, Thomas			A Fluorescent, Genetically-Encoded Voltage Probe Capable of Resolving Action Potentials	PLOS ONE			English	Article							MEMBRANE VOLTAGE; NEURAL ACTIVITY; SENSING DOMAIN; PROTEIN; CA2+; INDICATORS; INSERTION; KINETICS; SENSORS; DESIGN	There is a pressing need in neuroscience for genetically-encoded, fluorescent voltage probes that can be targeted to specific neurons and circuits to allow study of neural activity using fluorescent imaging. We created 90 constructs in which the voltage sensing portion (S1-S4) of Ciona intestinalis voltage sensitive phosphatase (CiVSP) was fused to circularly permuted eGFP. This led to ElectricPk, a probe that is an order of magnitude faster (taus similar to 1-2 ms) than any currently published fluorescent protein-based voltage probe. ElectricPk can follow the rise and fall of neuronal action potentials with a modest decrease in fluorescence intensity (similar to 0.7% Delta F/F). The probe has a nearly linear fluorescence/membrane potential response to both hyperpolarizing and depolarizing steps. This is the first probe based on CiVSP that captures the rapid movements of the voltage sensor, suggesting that voltage probes designed with circularly permuted fluorescent proteins may have some advantages.	[Barnett, Lauren; Hughes, Thomas] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Platisa, Jelena; Pieribone, Vincent A.] John B Pierce Lab Inc, New Haven, CT USA; [Platisa, Jelena] Univ Belgrade, Fac Phys Chem, Belgrade, Serbia; [Popovic, Marko; Pieribone, Vincent A.] Yale Univ, Sch Med, New Haven, CT USA	Montana State University System; Montana State University Bozeman; Yale University; The John B Pierce Laboratory, Inc; University of Belgrade; Yale University	Barnett, L (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.	vpieribo@jbpierce.org	Platisa, Jelena/R-3785-2017; Platisa, Jelena/P-4987-2019	Platisa, Jelena/0000-0003-4813-609X; Platisa, Jelena/0000-0003-4813-609X; Hughes, Thomas/0000-0002-8430-070X; Pieribone, Vincent/0000-0002-5836-5454	NINDS [U24NS057631, ARRA U24NS057631-03S1]; NIH [ARRA-R01NS065110]; John B. Pierce Laboratory, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS065110, R01NS065110, U24NS057631] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John B. Pierce Laboratory, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported as an NINDS funded U24 consortium to produce voltage sensors for the neuroscience community (U24NS057631, ARRA U24NS057631-03S1). Consortium members include: Randall Stewart (National Institutes of Health [NIH] Program Officer) and the laboratories of Lawrence B. Cohen, Thomas Hughes, Ehud Isacoff, Thomas Knopfel, Vincent A. Pieribone, and Brian Salzberg. This project was also supported by NIH grant ARRA-R01NS065110 and by The John B. Pierce Laboratory, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Baker BJ, 2008, BRAIN CELL BIOL, V36, P53, DOI 10.1007/s11068-008-9026-7; Baker BJ, 2012, J NEUROSCI METH, V208, P190, DOI 10.1016/j.jneumeth.2012.05.016; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Gautam Sunita Ghimire, 2009, Front Neuroeng, V2, P14, DOI 10.3389/neuro.16.014.2009; Jin L, 2012, NEURON IN PRESS; Jin L, 2011, J NEUROSCI METH, V199, P1, DOI 10.1016/j.jneumeth.2011.03.028; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; Lundby A, 2010, EUR BIOPHYS J BIOPHY, V39, P1625, DOI 10.1007/s00249-010-0620-0; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Perron A, 2009, CHEM BIOL, V16, P1268, DOI 10.1016/j.chembiol.2009.11.014; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Villalba-Galea CA, BIOPHYSICAL J, V96, P19; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	24	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43454	10.1371/journal.pone.0043454	http://dx.doi.org/10.1371/journal.pone.0043454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970127	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400011
J	Carter, MQ; Xue, K; Brandl, MT; Liu, FF; Wu, LY; Louie, JW; Mandrell, RE; Zhou, JZ				Carter, Michelle Q.; Xue, Kai; Brandl, Maria T.; Liu, Feifei; Wu, Liyou; Louie, Jacqueline W.; Mandrell, Robert E.; Zhou, Jizhong			Functional Metagenomics of Escherichia coli O157:H7 Interactions with Spinach Indigenous Microorganisms during Biofilm Formation	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SEA OIL PLUME; MICROBIAL COMMUNITIES; EPIPHYTIC BACTERIA; LETTUCE; GEOCHIP; O157-H7; PHYLLOSPHERE; MICROARRAY; DIVERSITY	The increase in foodborne outbreaks worldwide attributed to fresh fruit and vegetables suggests that produce may serve as an ecological niche for enteric pathogens. Here we examined the interaction of E. coli O157:H7 (EcO157) with spinach leaf indigenous microorganisms during co-colonization and establishment of a mixed biofilm on a stainless steel surface. Stainless steel surface was selected to mimic the surface of produce-processing equipment, where retention of foodborne pathogens such as EcO157 could serve as a potential source for transmission. We observed a positive effect of spinach-associated microbes on the initial attachment of EcO157, but an antagonistic effect on the EcO157 population at the later stage of biofilm formation. Metagenomic analyses of the biofilm community with the GeoChip revealed an extremely diverse community (gene richness, 23409; Shannon-Weiner index H, 9.55). Presence of EcO157 in the mixed biofilm resulted in a significant decrease in the community alpha-diversity (t test, P<0.05), indicating a putative competition between the pathogen and indigenous spinach microbes. The decrease in the beta-diversity of the EcO157-inoculated biofilm at 48 h (ANOVA, P<0.05) suggested a convergent shift in functional composition in response to EcO157 invasion. The success of EcO157 in the mixed biofilm is likely associated with its metabolic potential in utilizing spinach nutrients: the generation time of EcO157 in spinach lysates at 28 degrees C is similar to 38 min, which is comparable to that in rich broth. The significant decrease in the abundance of many genes involved in carbon, nitrogen, and phosphorus cycling in the EcO157-inoculated biofilms (t test, P<0.05) further support our conclusion that competition for essential macronutrients is likely the primary interaction between the EcO157 and indigenous spinach-biofilm species.	[Carter, Michelle Q.; Brandl, Maria T.; Louie, Jacqueline W.; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA; [Xue, Kai; Liu, Feifei; Wu, Liyou; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA; [Zhou, Jizhong] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	United States Department of Agriculture (USDA); University of Oklahoma System; University of Oklahoma - Norman; Tsinghua University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Carter, MQ (corresponding author), ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA.	michelle.carter@ars.usda.gov	Liu, Feifei/AAP-9241-2021; 吴, 昊/AAB-1620-2020; Mandrell, Robert E/O-9814-2018	Liu, Feifei/0000-0003-1966-8759; Carter, Michelle Qiu/0000-0002-0710-7420; Xue, Kai/0000-0002-5990-4448	ENIGMA through the Office of Science, Office of Biological and Environmental Research, the U.S. Department of Energy [DE-AC02-05CH11231]; United States Department of Agriculture, (USDA-ARS CRIS) [5325-42000-046-00D]	ENIGMA through the Office of Science, Office of Biological and Environmental Research, the U.S. Department of Energy; United States Department of Agriculture, (USDA-ARS CRIS)	We thank J. D. Van Nostrand for technical support and Y. Deng for discussion on data analysis. The GeoChips and associated computational pipelines used in this study were supported by ENIGMA through the Office of Science, Office of Biological and Environmental Research, the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.; This work was supported by United States Department of Agriculture, (USDA-ARS CRIS project 5325-42000-046-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brand MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025553; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Castonguay MH, 2006, RES MICROBIOL, V157, P471, DOI 10.1016/j.resmic.2005.10.003; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Edwards JL, 2010, GENES, V1, P15; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Hill MO, 1980, VEGETATION, V42, P12; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Kinkel LL, 1997, ANNU REV PHYTOPATHOL, V35, P327, DOI 10.1146/annurev.phyto.35.1.327; Klayman BJ, 2009, ENVIRON SCI TECHNOL, V43, P2105, DOI 10.1021/es802218q; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Velasco G., 2011, Diversity, V3, P721, DOI 10.3390/d3040721; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V153, P351, DOI 10.1016/j.ijfoodmicro.2011.11.026; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Mandrell R. E., 2009, Microbial safety of fresh produce, P5; Mueller RS, 2011, ENVIRON MICROBIOL, V13, P2279, DOI 10.1111/j.1462-2920.2011.02486.x; Rivas L, 2007, J MICROBIOL METH, V69, P44, DOI 10.1016/j.mimet.2006.11.014; Teplitski M, 2009, CURR OPIN BIOTECH, V20, P166, DOI 10.1016/j.copbio.2009.03.002; Tyler HL, 2008, ANNU REV PHYTOPATHOL, V46, P53, DOI 10.1146/annurev.phyto.011708.103102; Villanueva-Suarez MJ, 2003, J AGR FOOD CHEM, V51, P5950, DOI 10.1021/jf021010h; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331	33	40	45	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44186	10.1371/journal.pone.0044186	http://dx.doi.org/10.1371/journal.pone.0044186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957052	gold, Green Submitted, Green Published			2022-12-25	WOS:000308463800044
J	Watanabe, TM; Tsukasaki, Y; Fujita, H; Ichimura, T; Saitoh, T; Akira, S; Yanagida, T				Watanabe, Tomonobu M.; Tsukasaki, Yoshikazu; Fujita, Hideaki; Ichimura, Taro; Saitoh, Tatsuya; Akira, Shizuo; Yanagida, Toshio			Distinct Modulated Pupil Function System for Real-Time Imaging of Living Cells	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; RESOLUTION LIMIT; PLASMA-MEMBRANE; E-CADHERIN; DYNAMICS; EB1; RECONSTRUCTION; MECHANISMS; RECEPTORS; AUTOPHAGY	Optical microscopy is one of the most contributive tools for cell biology in the past decades. Many microscopic techniques with various functions have been developed to date, i.e., phase contrast microscopy, differential interference contrast (DIC) microscopy, confocal microscopy, two photon microscopy, superresolution microscopy, etc. However, person who is in charge of an experiment has to select one of the several microscopic techniques to achieve an experimental goal, which makes the biological assay time-consuming and expensive. To solve this problem, we have developed a microscopic system with various functions in one instrument based on the optical Fourier transformation with a lens system for detection while focusing on applicability and user-friendliness for biology. The present instrument can arbitrarily modulate the pupil function with a micro mirror array on the Fourier plane of the optical pathway for detection. We named the present instrument DiMPS (Distinct optical Modulated Pupil function System). The DiMPS is compatible with conventional fluorescent probes and illumination equipment, and gives us a Fourier-filtered image, a pseudo-relief image, and a deep focus depth. Furthermore, DiMPS achieved a resolution enhancement (pseudo-superresolution) of 110 nm through the subtraction of two images whose pupil functions are independently modulated. In maximum, the spatial and temporal resolution was improved to 120 nm and 2 ms, respectively. Since the DiMPS is based on relay optics, it can be easily combined with another microscopic instrument such as confocal microscope, and provides a method for multi-color pseudo-superresolution. Thus, the DiMPS shows great promise as a flexible optical microscopy technique in biological research fields.	[Watanabe, Tomonobu M.; Tsukasaki, Yoshikazu; Fujita, Hideaki; Ichimura, Taro; Yanagida, Toshio] RIKEN Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Fujita, Hideaki; Saitoh, Tatsuya; Akira, Shizuo; Yanagida, Toshio] Osaka Univ, World Premier Int Res Ctr Initiat, Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 565, Japan; [Watanabe, Tomonobu M.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	RIKEN; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Watanabe, TM (corresponding author), RIKEN Quantitat Biol Ctr QBiC, 6-2-3 Furuedai, Suita, Osaka, Japan.	yanagida@fbs.osaka-u.ac.jp	Ichimura, Taro/E-2792-2010; Watanabe, Tomonobu/J-4812-2013; Akira, Shizuo/C-3134-2009; Fujita, Hideaki/B-7633-2008	Ichimura, Taro/0000-0002-3740-3634; Fujita, Hideaki/0000-0003-3430-5681; Watanabe, Tomonobu/0000-0002-2420-4230	Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23370072] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grant, PRESTO, from the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI 10.1007/ BF02956173; Abrahamsson S, 2006, PROC SPIE, V6090, DOI 10.1117/12.647022; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; CAMPOS J, 1989, J MOD OPTIC, V36, P733, DOI 10.1080/09500348914550821; Chtcheglova LA, 2007, BIOPHYS J, V93, pL11, DOI 10.1529/biophysj.107.109751; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; COX IJ, 1982, J OPT SOC AM, V72, P1287, DOI 10.1364/JOSA.72.001287; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Ellinger P, 1940, BIOL REV CAMB PHILOS, V15, P323, DOI 10.1111/j.1469-185X.1940.tb00761.x; FILLER AS, 1964, J OPT SOC AM, V54, P762, DOI 10.1364/JOSA.54.000762; Fujita K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228105; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; HARTMAN JS, 1981, APPL OPTICS, V20, P2665, DOI 10.1364/AO.20.002665; Heintzmann R, 2003, MICRON, V34, P293, DOI 10.1016/S0968-4328(03)00054-4; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HOFFMAN R, 1975, APPL OPTICS, V14, P1169, DOI 10.1364/AO.14.001169; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Matsumoto B, 2002, METHOD CELL BIOL, V70, P52; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Sako Y, 2003, NAT CELL BIOL, pSS1, DOI 10.1038/nrm1193; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Seebach J, 2007, CARDIOVASC RES, V75, P596, DOI 10.1016/j.cardiores.2007.04.017; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang Yu-li, 2003, Methods Cell Biol, V72, P337, DOI 10.1016/S0091-679X(03)72016-0; Watanabe TM, 2007, BIOCHEM BIOPH RES CO, V359, P1, DOI 10.1016/j.bbrc.2007.04.168; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345	49	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44028	10.1371/journal.pone.0044028	http://dx.doi.org/10.1371/journal.pone.0044028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962597	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600025
J	Frost, CJ; Nyamdari, B; Tsai, CJ; Harding, SA				Frost, Christopher J.; Nyamdari, Batbayar; Tsai, Chung-Jui; Harding, Scott A.			The Tonoplast-Localized Sucrose Transporter in Populus (PtaSUT4) Regulates Whole-Plant Water Relations, Responses to Water Stress, and Photosynthesis	PLOS ONE			English	Article							GALACTINOL-SYNTHASE GENE; INDUCED TREE MORTALITY; POPLAR POPULUS; DROUGHT; ARABIDOPSIS; TOLERANCE; BARLEY; MECHANISMS; RESISTANCE; EXPRESSION	The Populus sucrose (Suc) transporter 4 (PtaSUT4), like its orthologs in other plant taxa, is tonoplast localized and thought to mediate Suc export from the vacuole into the cytosol. In source leaves of Populus, SUT4 is the predominantly expressed gene family member, with transcript levels several times higher than those of plasma membrane SUTs. A hypothesis is advanced that SUT4-mediated tonoplast sucrose fluxes contribute to the regulation of osmotic gradients between cellular compartments, with the potential to mediate both sink provisioning and drought tolerance in Populus. Here, we describe the effects of PtaSUT4-RNA interference (RNAi) on sucrose levels and raffinose family oligosaccharides (RFO) induction, photosynthesis, and water uptake, retention and loss during acute and chronic drought stresses. Under normal water-replete growing conditions, SUT4-RNAi plants had generally higher shoot water contents than wild-type plants. In response to soil drying during a short-term, acute drought, RNAi plants exhibited reduced rates of water uptake and delayed wilting relative to wild-type plants. SUT4-RNAi plants had larger leaf areas and lower photosynthesis rates than wild-type plants under well-watered, but not under chronic water-limiting conditions. Moreover, the magnitude of shoot water content, height growth, and photosynthesis responses to contrasting soil moisture regimes was greater in RNAi than wild-type plants. The concentrations of stress-responsive RFOs increased in wild-type plants but were unaffected in SUT4-RNAi plants under chronically dry conditions. We discuss a model in which the subcellular compartmentalization of sucrose mediated by PtaSUT4 is regulated in response to both sink demand and plant water status in Populus.	[Frost, Christopher J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Frost, CJ (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	sharding@uga.edu	Tsai, CJ/C-2450-2009; Frost, Christopher/A-4506-2012	Tsai, CJ/0000-0002-9282-7704; Frost, Christopher/0000-0001-5986-8646	Office of Science (BER), U.S. Department of Energy [DE-SC0005140]	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by the Office of Science (BER), U.S. Department of Energy, award no. DE-SC0005140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Babushok VI, 2007, J CHROMATOGR A, V1157, P414, DOI 10.1016/j.chroma.2007.05.044; Baigorria GA, 2007, INT J CLIMATOL, V27, P749, DOI 10.1002/joc.1435; Bento dos Santos T, 2011, PLANT PHYSIOL BIOCH, V49, P441, DOI 10.1016/j.plaphy.2011.01.023; Berthier A, 2009, PLANT CELL PHYSIOL, V50, P1329, DOI 10.1093/pcp/pcp081; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Bradshaw HD, 2000, J PLANT GROWTH REGUL, V19, P306, DOI 10.1007/s003440000030; CEULEMANS R, 1988, CAN J BOT, V66, P1404, DOI 10.1139/b88-196; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Cho SM, 2010, BOTANY, V88, P452, DOI 10.1139/B10-009; Cong L, 2008, PLANT SCI, V174, P156, DOI 10.1016/j.plantsci.2007.11.002; Drozdova IS, 2004, RUSS J PLANT PHYSL+, V51, P668, DOI 10.1023/B:RUPP.0000040755.53233.a5; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Eom JS, 2011, PLANT PHYSIOL, V157, P109, DOI 10.1104/pp.111.176982; ERICKSON RO, 1957, AM J BOT, V44, P297, DOI 10.2307/2438380; Fu QS, 2011, PLANT PHYSIOL, V157, P1518, DOI 10.1104/pp.111.184820; GIAQUINTA RT, 1983, ANNU REV PLANT PHYS, V34, P347, DOI 10.1146/annurev.pp.34.060183.002023; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; HO LC, 1982, PHYSIOL PLANTARUM, V56, P225, DOI 10.1111/j.1399-3054.1982.tb00330.x; Hogg EH, 2002, CAN J FOREST RES, V32, P823, DOI [10.1139/x01-152, 10.1139/X01-152]; Jeong ML, 2004, PLANT PHYSIOL, V136, P3364, DOI 10.1104/pp.104.044776; KABAT EA, 1953, J AM CHEM SOC, V75, P4507, DOI 10.1021/ja01114a034; KAISER G, 1984, PLANTA, V161, P562, DOI 10.1007/BF00407090; Kim MS, 2008, MOL PLANT MICROBE IN, V21, P1643, DOI 10.1094/MPMI-21-12-1643; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Lalonde S, 2003, PLANT CELL ENVIRON, V26, P37, DOI 10.1046/j.1365-3040.2003.00847.x; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Li X, 2011, J PLANT PHYSIOL, V168, P1761, DOI 10.1016/j.jplph.2011.04.006; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Neuhaus HE, 2007, FEBS LETT, V581, P2223, DOI 10.1016/j.febslet.2007.02.003; Okubo-Kurihara E, 2011, J PLANT RES, V124, P395, DOI 10.1007/s10265-010-0377-7; Payyavula RS, 2011, PLANT J, V65, P757, DOI 10.1111/j.1365-313X.2010.04463.x; Penna S, 2003, TRENDS PLANT SCI, V8, P355, DOI 10.1016/S1360-1385(03)00159-6; Philippe RN, 2010, NEW PHYTOL, V188, P787, DOI 10.1111/j.1469-8137.2010.03392.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Possen BJHM, 2011, FOREST ECOL MANAG, V262, P1387, DOI 10.1016/j.foreco.2011.06.035; Reinders A, 2008, PLANT MOL BIOL, V68, P289, DOI 10.1007/s11103-008-9370-0; Reinders A, 2006, PLANT CELL ENVIRON, V29, P1871, DOI 10.1111/j.1365-3040.2006.01563.x; Rennie EA, 2009, P NATL ACAD SCI USA, V106, P14162, DOI 10.1073/pnas.0902279106; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Schneider S, 2012, PLANT BIOLOGY, V14, P325, DOI 10.1111/j.1438-8677.2011.00506.x; Schneider T, 2009, PLANT CELL PHYSIOL, V50, P2174, DOI 10.1093/pcp/pcp151; SCHULTE PJ, 1988, CAN J BOT, V66, P1073, DOI 10.1139/b88-153; Schulz A, 2011, PLANT J, V68, P129, DOI 10.1111/j.1365-313X.2011.04672.x; Silim S, 2009, TREES-STRUCT FUNCT, V23, P959, DOI 10.1007/s00468-009-0338-8; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TARDIEU F, 1993, PHILOS T R SOC B, V341, P57, DOI 10.1098/rstb.1993.0091; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; TSCHAPLINSKI TJ, 1994, CAN J FOREST RES, V24, P681, DOI 10.1139/x94-091; Tschaplinski TJ, 1998, TREE PHYSIOL, V18, P653; Turgeon R, 1998, P NATL ACAD SCI USA, V95, P12055, DOI 10.1073/pnas.95.20.12055; Turgeon R, 2004, PLANT PHYSIOL, V136, P3795, DOI 10.1104/pp.104.042036; Unda F, 2012, J EXP BOT, V63, P2059, DOI 10.1093/jxb/err411; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; van Heerden PDR, 2010, J EXP BOT, V61, P2877, DOI 10.1093/jxb/erq144; VOGELMANN TC, 1993, ANNU REV PLANT PHYS, V44, P231, DOI 10.1146/annurev.pp.44.060193.001311; Vogelmann TC, 2002, PLANT CELL ENVIRON, V25, P1313, DOI 10.1046/j.1365-3040.2002.00910.x; Wang Z, 2009, PLANTA, V230, P1155, DOI 10.1007/s00425-009-1014-3; Weise A, 2000, PLANT CELL, V12, P1345, DOI 10.1105/tpc.12.8.1345; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Weschke W, 2003, PLANT J, V33, P395, DOI 10.1046/j.1365-313X.2003.01633.x; Wingenter K, 2010, PLANT PHYSIOL, V154, P665, DOI 10.1104/pp.110.162040	70	53	59	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44467	10.1371/journal.pone.0044467	http://dx.doi.org/10.1371/journal.pone.0044467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952983	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300092
J	Chauvey, V; Hatwell, Y; Verine, B; Kaminski, G; Gentaz, E				Chauvey, Valerie; Hatwell, Yvette; Verine, Bertrand; Kaminski, Gwenael; Gentaz, Edouard			Lexical References to Sensory Modalities in Verbal Descriptions of People and Objects by Congenitally Blind, Late Blind and Sighted Adults	PLOS ONE			English	Article							COGNITION; CHILDREN	Background: Some previous studies have revealed that while congenitally blind people have a tendency to refer to visual attributes ('verbalism'), references to auditory and tactile attributes are scarcer. However, this statement may be challenged by current theories claiming that cognition is linked to the perceptions and actions from which it derives. Verbal productions by the blind could therefore differ from those of the sighted because of their specific perceptual experience. The relative weight of each sense in oral descriptions was compared in three groups with different visual experience Congenitally blind (CB), late blind (LB) and blindfolded sighted (BS) adults. Methodology/Principal Findings: Participants were asked to give an oral description of their mother and their father, and of four familiar manually-explored objects. The number of visual references obtained when describing people was relatively high, and was the same in the CB and BS groups ("verbalism" in the CB). While references to touch were scarce in all groups, the CB referred to audition more frequently than the LB and the BS groups. There were, by contrast, no differences between groups in descriptions of objects, and references to touch dominated the other modalities. Conclusion/Significance: The relative weight of each modality varies according to the cognitive processes involved in each task. Long term memory, internal representations and information acquired through social communication, are at work in the People task, seem to favour visual references in both the blind and the sighted, whereas the congenitally blind also refer often to audition. By contrast, the perceptual encoding and working memory at work in the Objects task enhance sensory references to touch in a similar way in all groups. These results attenuate the impact of verbalism in blindness, and support (albeit moderately) the idea that the perceptual experience of the congenitally blind is to some extent reflected in their cognition.	[Chauvey, Valerie; Hatwell, Yvette; Gentaz, Edouard] Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France; [Verine, Bertrand] Univ Montpellier 3, CNRS, UMR 5267, Lab Praxiling, F-34032 Montpellier, France; [Kaminski, Gwenael] Univ Toulouse Le Mirail, CNRS, UMR 5263, Lab CLLE LTC, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Montpellier; Universite Paul-Valery; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Universite Bordeaux-Montaigne	Chauvey, V (corresponding author), Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France.	Edouard.Gentaz@upmf-grenoble.fr	Kaminski, Gwenael/G-6394-2010; Kaminski, Gwenael/AAA-4214-2021	Kaminski, Gwenael/0000-0001-5300-5655; Kaminski, Gwenael/0000-0001-5300-5655	Federation des Aveugles de France (FAF) [075128]	Federation des Aveugles de France (FAF)	Funding came from Federation des Aveugles de France (FAF)http://www.faf.asso.fr/, Grant numbers No075128 (obtained by BV). The funders had no role in study design, data collection and analysis, decision to publish or preparation if the manuscript.	ANDERSON DW, 1981, J VISUAL IMPAIR BLIN, V75, P165; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Burlingham D, 1961, PSYCHOANALYTIC STUDY, V26, P121; Cutsforth T. D., 1932, TEACHERS FORUM, V25, P86; Cutsforth T.D., 1951, BLIND SCH SOC PSYCHO, P2013; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Eardley AF, 2006, MEMORY, V14, P925, DOI 10.1080/09658210600859582; Gentaz E, 2009, MAIN TOUCHER CERVEAU; Harley RK, 1963, AM FDN BLIND RES SER; Hatwell Y., 2003, PSYCHOL COGNITIVE CE; HATWELL Y, 2003, TOUCHING KNOWING; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Millar S, 1997, READING TOUCH; Miller S., 1983, LANG ACQUIS, P167; NOLAN CY, 1960, NEW OUTLOOK BLIND, V54, P100; Rosel J, 2005, J VISUAL IMPAIR BLIN, V99, P413, DOI 10.1177/0145482X0509900704; Sanchez MT, 2012, IMAGINATION COGNITIO, V31, P113; Vinter A, CHILD CARE IN PRESS; Von Tetzchner S., 1980, INT J PSYCHOLINGUIST, V7-3, P49; Warren D. H., 1994, BLINDNESS CHILDREN I; Warren D. H., 1984, BLINDNESS EARLY CHIL; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	23	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44020	10.1371/journal.pone.0044020	http://dx.doi.org/10.1371/journal.pone.0044020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956997	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500044
J	Madalena, CRG; Diez, JL; Gorab, E				Gutierrez Madalena, Christiane Rodriguez; Luis Diez, Jose; Gorab, Eduardo			Chromatin Structure of Ribosomal RNA Genes in Dipterans and Its Relationship to the Location of Nucleolar Organizers	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; POLYTENE CHROMOSOMES; SCIARA-COPROPHILA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION UNITS; CHIRONOMUS-TENTANS; DNA-SEQUENCES; CROSS-LINKING; POLYMERASE-I; RDNA	Nucleoli, nuclear organelles in which ribosomal RNA is synthesized and processed, emerge from nucleolar organizers (NORs) located in distinct chromosomal regions. In polytene nuclei of dipterans, nucleoli of some species can be observed under light microscopy exhibiting distinctive morphology: Drosophila and chironomid species display well-formed nucleoli in contrast to the fragmented and dispersed nucleoli seen in sciarid flies. The available data show no apparent relationship between nucleolar morphology and location of NORs in Diptera. The regulation of rRNA transcription involves controlling both the transcription rate per gene as well as the proportion of rRNA genes adopting a proper chromatin structure for transcription, since active and inactive rRNA gene copies coexist in NORs. Transcription units organized in nucleosomes and those lacking canonical nucleosomes can be analyzed by the method termed psoralen gel retarding assay (PGRA), allowing inferences on the ratio of active to inactive rRNA gene copies. In this work, possible connections between chromosomal location of NORs and proportion of active rRNA genes were studied in Drosophila melanogaster, and in chironomid and sciarid species. The data suggested a link between location of NORs and proportion of active rRNA genes since the copy number showing nucleosomal organization predominates when NORs are located in the pericentric heterochromatin. The results presented in this work are in agreement with previous data on the chromatin structure of rRNA genes from distantly related eukaryotes, as assessed by the PGRA.	[Gutierrez Madalena, Christiane Rodriguez; Gorab, Eduardo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Luis Diez, Jose] CSIC, Ctr Invest Biol, Dept Biol Celular & Desarrollo, Madrid, Spain	Universidade de Sao Paulo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Madalena, CRG (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil.	egorab@usp.br			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMELIN HA, 1969, GENETICS, V61, P351; BARR HJ, 1966, J CELL BIOL, V31, pC17, DOI 10.1083/jcb.31.3.C17; BEERMANN W, 1952, CHROMOSOMA, V5, P139; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; CHOOI WY, 1979, CHROMOSOMA, V74, P57, DOI 10.1007/BF00344483; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; CONCONI A, 1992, P NATL ACAD SCI USA, V89, P5256, DOI 10.1073/pnas.89.12.5256; DAMMANN R, 1995, MOL CELL BIOL, V15, P5294; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; DEGELMANN A, 1979, CHROMOSOMA, V71, P263, DOI 10.1007/BF00287136; EASTMAN EM, 1980, CHROMOSOMA, V79, P293, DOI 10.1007/BF00327321; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Fuchs J, 2004, CHROMOSOME RES, V12, P427, DOI 10.1023/B:CHRO.0000034726.05374.db; GABRUSEW.N, 1972, CHROMOSOMA, V38, P237, DOI 10.1007/BF00290924; GABRUSEW.N, 1966, J CELL BIOL, V29, P347, DOI 10.1083/jcb.29.2.347; GAMBARINI AG, 1974, J CELL BIOL, V62, P215, DOI 10.1083/jcb.62.1.215; Gorab E, 1995, J MOL EVOL, V41, P1016, DOI 10.1007/BF00173183; Greciano PG, 2009, CHROMOSOMA, V118, P361, DOI 10.1007/s00412-009-0203-y; Madalena CRG, 2007, CHROMOSOME RES, V15, P409, DOI 10.1007/s10577-007-1127-0; Madalena CRG, 2008, CHROMOSOME RES, V16, P1233, DOI 10.1007/s10577-008-1271-1; HAMMOND MP, 1985, CHROMOSOMA, V91, P279, DOI 10.1007/BF00328223; HENNIG W, 1971, NATURE-NEW BIOL, V233, P70, DOI 10.1038/newbio233070a0; HOLLENBERG CP, 1976, CHROMOSOMA, V57, P185, DOI 10.1007/BF00292917; Jones HS, 2007, NAT STRUCT MOL BIOL, V14, P123, DOI 10.1038/nsmb1199; KAHN J, 1962, Q J MICROSC SCI, V103, P407; KARPEN GH, 1988, GENE DEV, V2, P1745, DOI 10.1101/gad.2.12b.1745; KERREBROCK AW, 1989, J MOL BIOL, V210, P1, DOI 10.1016/0022-2836(89)90286-6; KEYL HG, 1957, CHROMOSOMA, V8, P739; LAIRD CD, 1976, CHROMOSOMA, V58, P193, DOI 10.1007/BF00701359; LUCCHINI R, 1992, MOL CELL BIOL, V12, P4288, DOI 10.1128/MCB.12.10.4288; MCKNIGHT SL, 1976, CELL, V8, P305, DOI 10.1016/0092-8674(76)90014-3; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nanda I, 2008, CYTOGENET GENOME RES, V122, P396, DOI 10.1159/000167828; PARDUE ML, 1970, CHROMOSOMA, V29, P268, DOI 10.1007/BF00325943; PARDUE ML, 1973, COLD SPRING HARB SYM, V38, P475, DOI 10.1101/SQB.1974.038.01.051; PAVAN C, 1965, BROOKHAVEN SYM BIOL, P222; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; RENKAWITZ R, 1979, MOL GEN GENET, V173, P1, DOI 10.1007/BF00267685; RITOSSA FM, 1966, GENETICS, V54, P819; ROIHA H, 1981, NATURE, V290, P749, DOI 10.1038/290749a0; Sanz C, 2007, CHROMOSOME RES, V15, P429, DOI 10.1007/s10577-007-1134-1; SPEAR BB, 1973, P NATL ACAD SCI USA, V70, P1359, DOI 10.1073/pnas.70.5.1359; Stancheva I, 1997, NUCLEIC ACIDS RES, V25, P1727, DOI 10.1093/nar/25.9.1727; Toussaint M, 2005, BIOCHEM CELL BIOL, V83, P449, DOI 10.1139/O05-141; Xu J, 1996, CHROMOSOMA, V104, P545, DOI 10.1007/BF00352294; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Ye JQ, 2006, MOL CELL BIOL, V26, P8781, DOI 10.1128/MCB.01409-06; Yosida TH, 1980, CYTOGENETICS BLACK R, P173; ZAHA A, 1982, CHROMOSOMA, V87, P103, DOI 10.1007/BF00333512	51	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44006	10.1371/journal.pone.0044006	http://dx.doi.org/10.1371/journal.pone.0044006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952852	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500039
J	Jost, T; Lacroix, C; Braegger, CP; Chassard, C				Jost, Ted; Lacroix, Christophe; Braegger, Christian P.; Chassard, Christophe			New Insights in Gut Microbiota Establishment in Healthy Breast Fed Neonates	PLOS ONE			English	Article							FORMULA-FED INFANTS; INTESTINAL MICROBIOTA; BACTERIAL COMMUNITIES; FECAL MICROFLORA; HUMAN-MILK; FLORA; BIFIDOBACTERIA; LACTOBACILLI; DELIVERY; LIFE	The establishment of a pioneer gut microbiota is increasingly recognized as a crucial stage in neonatal development influencing health throughout life. While current knowledge is mainly based on either culture or molecular analysis of feces, we opted for a comprehensive approach complementing culture with state-of-the-art molecular methods. The bacterial composition in feces from seven healthy vaginally-delivered, breast-fed neonates was analyzed at day 4-6, 9-14 and 25-30 postnatal, using culture, 16S rRNA gene sequencing of isolates, quantitative PCR and pyrosequencing. Anaerobes outnumbered facultative anaerobes in all seven neonates within the first days of life, owing to high levels of Bifidobacterium and unexpectedly also Bacteroides, which were inversely correlated. Four neonates harboured maternal Bacteroides levels, comprising typical adult species, throughout the neonatal period, while in three only subdominant levels were detected. In contrast, the major adult type butyrate producing anaerobic populations, Roseburia and Faecalibacterium, remained undetectable during the neonatal period. The presence of Bacteroidetes as pioneer bacteria in the majority of neonates studied demonstrates that adult-type strict anaerobes may reach adult-like population densities within the first week of life. Consequently the switch from facultative to strict anaerobes may occur earlier than previously assumed in breast fed neonates, and the establishment of the major butyrate-producing populations may be limited by other factors than the absence of anaerobic conditions. The impact of breast milk components on the timing of establishment of anaerobic pioneer bacteria, as well as opportunistic pathogens should be further studied in regard to priming of the gut-associated immune system and consequences on later health.	[Jost, Ted; Lacroix, Christophe; Chassard, Christophe] ETH, Lab Food Biotechnol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Braegger, Christian P.] Univ Childrens Hosp Zurich, Div Gastroenterol & Nutr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University Children's Hospital Zurich	Jost, T (corresponding author), ETH, Lab Food Biotechnol, Inst Food Nutr & Hlth, Schmelzbergstr, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Lacroix, Christophe/B-5139-2016; Braegger, Christian Peter/ABC-9884-2021	Lacroix, Christophe/0000-0003-4360-2020; Ravel, Jacques/0000-0002-0851-2233; Braegger, Christian/0000-0001-8069-9875	Nestle Nutrition (Vevey, Switzerland); Nestec (Lausanne, Switzerland); Swiss Foundation for Nutrition Research (SFEFS) (Zurich, Switzerland)	Nestle Nutrition (Vevey, Switzerland)(Nestle SA); Nestec (Lausanne, Switzerland); Swiss Foundation for Nutrition Research (SFEFS) (Zurich, Switzerland)	This research was supported by Nestle Nutrition (Vevey, Switzerland), Nestec (Lausanne, Switzerland) and the Swiss Foundation for Nutrition Research (SFEFS) (Zurich, Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Adlerberth I, 2008, NESTLE NUTR WORKS SE, V62, P13, DOI 10.1159/000146245; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BEERENS H, 1991, APPL ENVIRON MICROB, V57, P2418, DOI 10.1128/AEM.57.8.2418-2419.1991; BENNO Y, 1984, MICROBIOL IMMUNOL, V28, P975, DOI 10.1111/j.1348-0421.1984.tb00754.x; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Dai D, 1999, Adv Pediatr, V46, P353; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edwards CA, 2002, BRIT J NUTR, V88, pS11, DOI [10.1079/BJN2002625, 10.1079/BJNBJN2002580]; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Greer JB, 2011, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00168; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hartemink R, 1997, J MICROBIOL METH, V29, P77, DOI 10.1016/S0167-7012(97)00025-0; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; MACFARLANE GT, 1990, J APPL BACTERIOL, V68, P179, DOI 10.1111/j.1365-2672.1990.tb02564.x; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mitsou EK, 2008, ANAEROBE, V14, P94, DOI 10.1016/j.anaerobe.2007.11.002; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; Schack-Nielsen L, 2007, J NUTR, V137, p503S, DOI 10.1093/jn/137.2.503S; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Steer Toni E, 2004, Curr Issues Intest Microbiol, V5, P23; TANNOCK GW, 1990, J CLIN MICROBIOL, V28, P1225, DOI 10.1128/JCM.28.6.1225-1228.1990; Vael C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-68; Vaughan EE, 2002, ANTON LEEUW INT J G, V82, P341, DOI 10.1023/A:1020672724450; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; YOSHIOKA H, 1983, PEDIATRICS, V72, P317	50	203	211	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44595	10.1371/journal.pone.0044595	http://dx.doi.org/10.1371/journal.pone.0044595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957008	Green Published, gold			2022-12-25	WOS:000308206500079
J	Thessen, AE; Patterson, DJ; Murray, SA				Thessen, Anne E.; Patterson, David J.; Murray, Shauna A.			The Taxonomic Significance of Species That Have Only Been Observed Once: The Genus Gymnodinium (Dinoflagellata) as an Example	PLOS ONE			English	Article							SP-NOV DINOPHYCEAE; NEOBURSARIDIUM-GIGAS BALECH; COMB. NOV; PHYTOPLANKTON COMPOSITION; GEOGRAPHIC-DISTRIBUTION; PHYLOGENETIC ANALYSIS; WATER DINOFLAGELLATE; ELECTRON-MICROSCOPY; RDNA SEQUENCES; CHESAPEAKE BAY	Taxonomists have been tasked with cataloguing and quantifying the Earth's biodiversity. Their progress is measured in code-compliant species descriptions that include text, images, type material and molecular sequences. It is from this material that other researchers are to identify individuals of the same species in future observations. It has been estimated that 13% to 22% (depending on taxonomic group) of described species have only ever been observed once. Species that have only been observed at the time and place of their original description are referred to as oncers. Oncers are important to our current understanding of biodiversity. They may be validly described species that are members of a rare biosphere, or they may indicate endemism, or that these species are limited to very constrained niches. Alternatively, they may reflect that taxonomic practices are too poor to allow the organism to be re-identified or that the descriptions are unknown to other researchers. If the latter are true, our current tally of species will not be an accurate indication of what we know. In order to investigate this phenomenon and its potential causes, we examined the microbial eukaryote genus Gymnodinium. This genus contains 268 extant species, 103 (38%) of which have not been observed since their original description. We report traits of the original descriptions and interpret them in respect to the status of the species. We conclude that the majority of oncers were poorly described and their identity is ambiguous. As a result, we argue that the genus Gymnodinium contains only 234 identifiable species. Species that have been observed multiple times tend to have longer descriptions, written in English. The styles of individual authors have a major effect, with a few authors describing a disproportionate number of oncers. The information about the taxonomy of Gymnodinium that is available via the internet is incomplete, and reliance on it will not give access to all necessary knowledge. Six new names are presented - Gymnodinium campbelli for the homonymous name Gymnodinium translucens Campbell 1973, Gymnodinium antarcticum for the homonymous name Gymnodinium frigidum Balech 1965, Gymnodinium manchuriensis for the homonymous name Gymnodinium autumnale Skvortzov 1968, Gymnodinium christenum for the homonymous name Gymnodinium irregulare Christen 1959, Gymnodinium conkufferi for the homonymous name Gymnodinium irregulare Conrad & Kufferath 1954 and Gymnodinium chinensis for the homonymous name Gymnodinium frigidum Skvortzov 1968.	[Thessen, Anne E.; Patterson, David J.] Marine Biol Lab, Ctr Lib & Informat, Woods Hole, MA 02543 USA; [Murray, Shauna A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Murray, Shauna A.] Sydney Inst Marine Sci, Mosman, Australia	Marine Biological Laboratory - Woods Hole; University of New South Wales Sydney; Sydney Institute of Marine Science	Thessen, AE (corresponding author), Marine Biol Lab, Ctr Lib & Informat, Woods Hole, MA 02543 USA.	annethessen@gmail.com	Thessen, Anne/J-6449-2012; Murray, Shauna/K-5781-2015	Thessen, Anne/0000-0002-2908-3327; Murray, Shauna/0000-0001-7096-1307; Patterson, David J./0000-0003-2645-7335	John D and Catherine T MacArthur Foundation; Alfred P Sloan Foundation [0830976, DBI-1062387]	John D and Catherine T MacArthur Foundation; Alfred P Sloan Foundation(Alfred P. Sloan Foundation)	This work was funded by grants from the John D and Catherine T MacArthur Foundation and the Alfred P Sloan Foundation to the Encyclopedia of Life and the National Science Foundation Data Net Program 0830976 and Global Names Project DBI-1062387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti Donat, 2009, BMC Res Notes, V2, P53, DOI 10.1186/1756-0500-2-53; Akatsuka K, 1952, REP FAC FISH PREF U, V2, P19; AKSELMAN R, 1985, Physis Seccion A los Oceanos y sus Organismos, V43, P39; Al-Qassab S, 2002, ACTA PROTOZOOL, V41, P91; Allman GJ, 1854, P ROYAL IR AC, V6, P115; Alonso-Rodriguez R, 2003, AQUACULTURE, V219, P317, DOI 10.1016/S0044-8486(02)00509-4; Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; Alvarez C. M., 1984, ACTA BOT MALACITANA, V9, P27; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Amorim A, 2001, PHYCOLOGIA, V40, P572, DOI 10.2216/i0031-8884-40-6-572.1; Annenkova N V, 2009, Dokl Biol Sci, V426, P253; [Anonymous], 1929, BOT GAZ, V87, P556; Antipova N, 1955, REP ACAD SCI USSR, V103, P325; Arzul G, 2001, EFFECTS MARINE ANIMA, P115; Attaran-Fariman G, 2007, PHYCOLOGIA, V46, P644, DOI 10.2216/07-05.1; Bachmann H, 1924, VERH SCHWEIZ NATURF, V105, P15; Balech E., 1971, Revista Mus argent Cienc nat Bernardino Rivadavia Inst nac Invest Cienc nac (Hydrobiol), V3, P1; Balech E., 1965, Antarctic Research Series, V5, P107; Balech E., 1976, PUBL I ANTARTICO ARG, V11, P1; BALLANTINE D, 1961, J PROTOZOOL, V8, P217, DOI 10.1111/j.1550-7408.1961.tb01207.x; Baumeister W, 1943, ARCH PROTISTENKD, V96, P332; Berard-Therriault L., 1999, GUIDE IDENTIFICATION; Bergh RS, 1881, BIDRAG CILIOFLAGLATE, P60; Beszteri B, 2005, PROTIST, V156, P317, DOI 10.1016/j.protis.2005.07.002; Bickel DJ, 1999, TRZS NSW, P174; BICUDO C E M, 1970, Rickia, V5, P5; Biecheler B, 1939, B SOC ZOOL FRANCE, V64, P1; Bolch CJS, 1999, PHYCOLOGIA, V38, P301, DOI 10.2216/i0031-8884-38-4-301.1; Bondarenko Nina A., 2002, Limnology, V3, P127, DOI 10.1007/s102010200015; Bourquin Lindt E, 1918, CONTRIBUTION ETUDE P; Braarud T, 1953, RAPP PV REUN CONS PE, V133, P1; Bujak JP, 1983, MODERN FOSSIL PERINI; BURSA ADAM, 1963, ARCTIC JOUR ARCTIC INST N AMER, V16, P239; BURSA AS, 1961, J FISH RES BOARD CAN, V18, P563, DOI 10.1139/f61-046; BUSCH WERNER, 1927, ARCH PROTISTENK, V58, P456; Butschli O., 1885, BRONNS KLASSEN ORDNU, P906; Cachon J., 1967, PROTISTOLOGICA, V3, P427; Calado AJ, 2005, PHYCOLOGIA, V44, P112, DOI 10.2216/0031-8884(2005)44[112:OTFDPI]2.0.CO;2; Calkins GN., 1902, B US FISH COMM, V21, P413; Calliari D, 2006, STUD TRENTINI SCI S2, V81, P351; Campbell P. H., 1973, THESIS U N CAROLINA; Caraus I, 2002, THESIS U BACAU BACAU; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; CARTY S, 1993, OHIO J SCI, V93, P140; Carty S, FRESHWATER DINOFLAGE; Celekli Abuzer, 2007, Turkish Journal of Botany, V31, P49; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; Charubhun Bawpit, 2000, Kasetsart Journal Natural Sciences, V34, P486; Chatton uU., 1912, B SOC ZOOLOGIQUE FRA, V37, P85; Chen GF, 2008, CHINESE SCI BULL, V53, P561, DOI 10.1007/s11434-008-0108-9; Christen H. R., 1959, Mitteilungen der Naturwissenschaftlichen Gesellschaft in Winterthur, VNo. 27, P167; Churilova TY, 1992, THESIS UKRANIAN AKAD; Claparede E., 1858, ETUDES INFUSOIRES RH; Cleary DFR, 2007, ECOL APPL, V17, P1184, DOI 10.1890/05-0878; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; CONRAD W., 1926, ARCH PROTISTENK, V55, P63; Conrad W., 1954, MEM I R SCI NAT BELG, V127, P1; CORLISS JO, 1979, AM ZOOL, V19, P573; Cridland AA, 1958, NEW PHYTOL, V57, P285, DOI [10.1111/j.1469-8137.1958.tb05317.x, DOI 10.1111/J.1469-8137.1958.TB05317.X]; Crystal D., 2003, ENGLISH GLOBAL LANGU; CULLEN JJ, 1982, J EXP MAR BIOL ECOL, V63, P67, DOI 10.1016/0022-0981(82)90051-X; Danysz MJ, 1886, COMPTES RENDUS, V105, P238; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; Day SA, 1995, BIBLIO CHECK LIST NO; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Diesing KM, 1886, SB KGL AKAD WISS MN, V52, P287; Diesing KM, 1850, SYSTEMA HELMINTHUM; DODGE J.D., 1982, MARINE DINOFLAGELLAT; DODGE JD, 1975, BOT J LINN SOC, V71, P103, DOI 10.1111/j.1095-8339.1975.tb02449.x; DODGE JD, 1981, BRIT PHYCOL J, V16, P273, DOI 10.1080/00071618100650291; DODGE JOHN D., 1967, BRIT PHYCOL BULL, V3, P327; Dogiel V., 1906, Mitteilungen aus der Zoologischen Station zu Neapel Berlin, V18, P1; DRAGESCO J, 1965, CAH BIOL MAR, V6, P83; DREBES G., 1974, MARINES PHYTOPLANKTO; Drira Z, 2009, J MAR BIOL ASSOC UK, V89, P1559, DOI 10.1017/S002531540900023X; DRUART JC, 1983, SCHWEIZ Z HYDROL, V45, P430, DOI 10.1007/BF02538133; Ehrenberg CG., 1838, INFUSIONSTHIERCHEN A, DOI [10.5962/bhl.title.58475, DOI 10.5962/BHL.TITLE.58475]; ELBRACHTER M, 1994, HELGOLANDER MEERESUN, V48, P359, DOI 10.1007/BF02366252; Elbrachter M., 1979, METEOR FORSCHUNGS D, V30, P1; Ellegaard M, 1999, PHYCOLOGIA, V38, P289, DOI 10.2216/i0031-8884-38-4-289.1; Entz G xEza jun., 1910, Allattani Kozlemenyek Budapest, V9; Entz GJ, 1902, NOVEN KOZLEM, V1, P83; EPA, 2007, COMPR LIST CHES BAY; Evitt W., 1967, GEOLOGICAL SCI, V10, P1; Figueroa RI, 2006, J PHYCOL, V42, P350, DOI 10.1111/j.1529-8817.2006.00191.x; Finlay BJ, 2004, PROTIST, V155, P15, DOI 10.1078/1434461000160; Finlay BJ, 1996, Q REV BIOL, V71, P221, DOI 10.1086/419370; Foissner Wilhelm, 2002, Bulletin of Zoological Nomenclature, V59, P165; Fontaneto D, 2012, ROTIFEROLOGIST EFFEC; Foote M, 1982, PHYTOLOGIA, V52, P1; Forzza R.C, 2010, CATALOGO PLANTAS FUN, V1, P366; Fraga S, 1995, PHYCOLOGIA, V34, P514, DOI 10.2216/i0031-8884-34-6-514.1; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; FREUDENTHAL HD, 1963, J PROTOZOOL, V10, P182, DOI 10.1111/j.1550-7408.1963.tb01659.x; FRILIGOS N, 1989, TOXICOL ENVIRON CHEM, V24, P171, DOI 10.1080/02772248909357487; Ghinaglia LT, 2004, HYDROBIOLOGIA, V519, P85; Gil-Rodriguez M.C., 2003, LISTA ESPECIES MARIN, P5; Gomez F, 2006, J BIOGEOGR, V33, P261, DOI 10.1111/j.1365-2699.2005.01373.x; Gomez F, 2004, HYDROBIOLOGIA, V517, P43, DOI 10.1023/B:HYDR.0000027336.05452.07; Gomez F, 2003, BOT MAR, V46, P215, DOI 10.1515/BOT.2003.021; Gomez Fernando, 2005, Acta Botanica Croatica, V64, P129; Gomez Fernando, 2007, Algae, V22, P273; Gotelli NJ, 2004, PHILOS T R SOC B, V359, P585, DOI 10.1098/rstb.2003.1443; Gotsis-Skretas O, 2008, MICROPLANKTON ABUNDA, DOI [10.1594/PANGAEA.692046, DOI 10.1594/PANGAEA.692046]; Graham Herbert W, 1943, TRANS AMER MICROSC SOC, V62, P259, DOI 10.2307/3223028; Graham JM, 2004, MICROBIAL ECOL, V48, P528, DOI 10.1007/s00248-004-0223-3; Grasse PP, 1952, PHYLOGENIE PROTOZOAI; Guedon JC, 1994, DIRECTORY ELECT J NE, P17; Guo Feng, 2002, Journal of Oceanography in Taiwan Strait, V21, P469; HADA Y, 1974, Bulletin of Plankton Society of Japan, V20, P112; Hada Y., 1967, B SUZUGAMINE WOMENS, V13, P1; Hada Y, 1966, SCI REP JAPANESE ANT, V1, P209; Hada Y., 1968, B SUZUGAMINE WOMENS, V14, P1; Hada Y, 1970, BIOLOGY E, V31, P1; Hallegraeff G.M., 2003, Monographs on Oceanographic Methodology, V11, P25; Hallegraeff G. M., 2002, AQUACULTURISTS GUIDE; HALLEGRAEFF GM, 2010, ALGAE AUSTR PHYTOPLA; Hansen G, 2000, J PHYCOL, V36, P394, DOI 10.1046/j.1529-8817.2000.99172.x; HANSEN G, 1995, PHYCOLOGIA, V34, P166, DOI 10.2216/i0031-8884-34-2-166.1; Hansen G, 2000, PHYCOLOGIA, V39, P365, DOI 10.2216/i0031-8884-39-5-365.1; Hansen G, 2004, KARENIA SELLIFORMIS; Hansen G, 1992, PLANKTON INDRE DANSK, V11; Hansen G, 2007, J LIMNOL, V66, P107, DOI 10.4081/jlimnol.2007.107; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Harris T. M., 1940, Proceedings of the Linnean Society of London, V152, P4; Harvey M, 1997, CAN J FISH AQUAT SCI, V54, P1937, DOI 10.1139/f97-099; Hasle GR, 1960, OSLO I MN, V2, P1; Herdman E. C., 1922, Proceedings and Transactions of the Liverpool Biological Society, V36, P15; Herdman E. C., 1924, P T LIVERPOOL BIOL S, V38, P75; HOPE BRIGT, 1954, NYTT MAG BOT, V2, P149; HORIGUCHI T, 1994, EUR J PHYCOL, V29, P237, DOI 10.1080/09670269400650691; HORIGUCHI T, 1988, J PLANT RES, V101, P255; Hu H, 2006, FRESHWATER ALGAE CHI; Hu H., 1980, KEXUE TONGBAO, V25, P882; Hu H.J., 1983, Chinese Journal of Oceanology and Limnology, V1, P198; HUANG R, 1988, ESTUAR COAST SHELF S, V26, P643, DOI 10.1016/0272-7714(88)90040-6; Huber-Pestalozzi, 1950, PHYTOPLANKTON SUSSWA; HULBURT EM, 1957, BIOL BULL, V112, P196, DOI 10.2307/1539198; International Commision on Zoological Nomenclature, 1999, INT COD ZOOL NOM; Jakobsen HH, 2000, MAR ECOL PROG SER, V201, P121, DOI 10.3354/meps201121; Javornicky P, 1965, PHYCOLOGIA, V5, P53; Jorgensen E, 1912, UR SVENSKA HYDROGRAF, V4, P1; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Kang Wei, 2009, China Environmental Science, V29, P1285; Kim SY, 2009, ESTUAR COAST, V32, P1225, DOI 10.1007/s12237-009-9212-6; Kiselev IA, 1954, OPREDELITEL PRESNOVO, V6, P1; Klebs G, 1912, VERH NAT VER HEIDELB, V11, P367; Kobanova GI, 2009, CONTEMP PROBL ECOL, V2, P581, DOI 10.1134/S1995425509060150; Kofoid C. A., 1921, MEMOIRS U CALIFORNIA, DOI [10.5962/bhl.title.24995, DOI 10.5962/BHL.TITLE.24995]; KOFOID CHARLES A., 1931, SCI REPT TOHOKU IMP UNIV SER 4 BIOL, V6, P1; Konovalova G.V., 2001, Asian Marine Biology, V17, P1; Konovalova H, 1998, DINOFLAGELLATES DINO; Kopczynska EE, 1998, POLAR BIOL, V20, P342, DOI 10.1007/s003000050312; Labour MV, 1925, DINOFLAGELLATES NO S; LACKEY JAMES B., 1965, TRANS SAN DIEGO SOC NAT HIST, V14, P9; Lackey JB, 1936, BIOL BULL-US, V70, P264, DOI 10.2307/1537471; LACKEY JB, 1963, J MAR BIOL ASSOC UK, V43, P797, DOI 10.1017/S0025315400025698; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lantzsch K, 1914, Z WISS ZOOL, V108, P631; Largaiolli V, 1907, STEIN NUOVA NOTARISI, V18, P1; LARSEN J, 1990, J NAT HIST, V24, P801, DOI 10.1080/00222939000770571; Larsen J, 1994, PHYCOLOGIA; Larsen J, 1996, PHYCOLOGIA, V35, P342, DOI 10.2216/i0031-8884-35-4-342.1; Lebour M. V., 1917, J MAR BIOL ASS UK, V11, P183; Lee W.J., 1999, Protistology, V1, P10; Lee WJ, 1998, PROTIST, V149, P229, DOI 10.1016/S1434-4610(98)70031-8; Lee WJ, 1999, TRZS NSW, P232; Lemmermann E, 1903, FORSCHUNGSBER BIOL S, V10, P116; Lemmermann E., 1899, ABHANDLUNGEN HERAUSG, V16, P313, DOI DOI 10.1038/SJ.NPP.1300597; Lemmermann E., 1907, BOT JB, V38, P343; Lemmermann E., 1900, HEDWIGIA, V39, P115; Lemmermann EJ., 1905, FORSCHUNGSBERICHTE B, V12, P154; Lewis JM, 2002, PHYLUM PYRROPHYTA DI; Liebetanz B, 1925, B INT ACAD POLON S B, P116; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Lindberg K, 2005, PHYCOLOGIA, V44, P416, DOI 10.2216/0031-8884(2005)44[416:SOWDIW]2.0.CO;2; Lindemann E, 1928, NATURLICHEN PFLANZEN, P3; LOEBLICH ALFRED R. III, 1965, TAXON, V14, P15, DOI 10.2307/1216704; Lohmann H., 1908, Wissenschaftliche Meeresuntersuchungen Kiel N F, V10; Maggi L, 1880, B SCI PAVIA, V2, P7; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; MARGALEF R, 1969, Pubblicazioni della Stazione Zoologica di Napoli, V37, P40; Marshall HG, 2009, J COASTAL RES, P59; MARSHALL HG, 1980, ESTUARIES, V3, P207, DOI 10.2307/1352071; Marshall HG, 2005, J PLANKTON RES, V27, P1083, DOI 10.1093/plankt/fbi079; MARSHALL HG, 1976, MAR BIOL, V38, P81, DOI 10.1007/BF00391488; Maskell WM, 1887, T P NZ I, V20, P3; Massart J, 1920, B CL SCI AC ROY BELG, V35, P437; Massart J, 1901, RECHERCHES ORG INFER; MATZENAUER LOTHAR, 1933, BOT ARCH [LEIPZIG], V35, P437; May F.E., 1977, PALYNOLOGY, V1, P103; McLaughlin F., 2009, Canadian Data Report of Hydrography and Ocean Sciences, V180, P1; Mcmanus GB, 2009, J PLANKTON RES, V31, P1119, DOI 10.1093/plankt/fbp061; McMinn Andrew, 2005, P202; Michev T, 1998, BIODIVERSITY SREBARN; Mitchell EAD, 2005, PROTIST, V156, P263, DOI 10.1016/j.protis.2005.07.001; Moestrup O, 2008, PHYCOLOGIA, V47, P54, DOI 10.2216/07-32.1; Moestrup O, 2009, PHYCOL RES, V57, P203, DOI 10.1111/j.1440-1835.2009.00540.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Morris S., 1937, Archiv fuer Protistenkunde Jena, V89, P405; Murray S.A., 2003, THESIS U SYDNEY SYDN; Murray S, 2007, PHYCOL RES, V55, P176, DOI 10.1111/j.1440-1835.2007.00460.x; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Nentwich M, 2004, CYBERSCIENCE RES AGE; Nesterova D.A., 2006, NW PART BLACK SEA BI, P557; NGO HM, 1990, T AM MICROSC SOC, V109, P380, DOI 10.2307/3226692; NIKOLAIDES G, 1990, HELGOLANDER MEERESUN, V44, P487, DOI 10.1007/BF02365482; NILSSON JR, 1962, J PROTOZOOL, V9, P273, DOI 10.1111/j.1550-7408.1962.tb02619.x; Nordli O., 1954, Nyt Magazin for Naturvidenskaberne, V88, P49; NORRIS RICHARD E., 1961, NEW ZEALAND JOUR SCI, V4, P162; Novarino G, 1997, J PLANKTON RES, V19, P1081, DOI 10.1093/plankt/19.8.1081; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Nygaard G, 1945, DANSK PLANTE PLANKTO; OCHOA JL, 2002, HARMFUL ALGAL BLOOMS, P119; Ohno N, 1911, J COLL SCI IMP U TOK, V32, P78; Okolodkov YB, 1998, SARSIA, V83, P267, DOI 10.1080/00364827.1998.10413687; Okolodkov YB, 2000, SARSIA, V85, P345, DOI 10.1080/00364827.2000.10414585; Okolodkov YB, 1997, BOTANICHESKIY ZH ROS, V82, P97; Okolodkov Yuri B., 2006, Act. Bot. Mex, P1; Orlova T.Y., 2004, RUSS J MAR BIOL+, V30, P77, DOI [10.1023/B:RUMB.0000025983.20298.9a, DOI 10.1023/B:RUMB.0000025983.20298.9A]; Orlova TY, 2009, RUSS J MAR BIOL +, V35, P60, DOI 10.1134/S106307400901009X; Ostenfeld CH, 1913, VID SKRIF MATH NAT, V9, P113; PANT MC, 1985, INT REV GES HYDROBIO, V70, P269, DOI 10.1002/iroh.19850700215; PARKE M, 1976, J MAR BIOL ASSOC UK, V56, P527, DOI 10.1017/S002531540002066X; PARKE M, 1964, J MAR BIOL ASSOC UK, V44, P499, DOI 10.1017/S0025315400024954; PARSON M J, 1989, Castanea, V54, P79; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Patterson DJ, 2000, SYST ASSOC SPEC VOL, V59, P269; Paulmier G, 1992, CATALOGUE ILLUSTRE M; PAULSEN O, 1908, NORDISCHES PLANKTON, P1; Paulsen O., 1907, MEDDELELSER KOMMISSI, V1, P1; Pawlowski J., 2009, PROTIST DIVERSITY GE, P83, DOI DOI 10.1007/978-90-481-2801-3_7; Penard E., 1891, B TRAV SOC BOT GENEV, V6, P1; Perty M, 1852, KENNTNIS KLEINSTER L; Petersen J. B., 1956, Biologiske Meddelelser, V23, P1; Pfandl K, 2009, LIMNOL OCEANOGR, V54, P171, DOI 10.4319/lo.2009.54.1.0171; Phillips JA, 2002, ALGAE NAMES DISTRIBU; Piontkovsky S, 2011, PHYTOPLANKTON ABUNDA; Pitzik GK, 1967, NOVITATES SYSTEMATIC, P68; Playfair G. I., 1920, Proceedings of the Linnean Society of New South Wales, V44; Popovskaya GI, 2011, GEOGR NAT RESOUR, V32, P344, DOI 10.1134/S187537281104007X; Popovskaya G.I., 2000, Aquatic Ecosystem Health & Management, V3, P215, DOI 10.1016/S1463-4988(00)00021-X; POPOVSKY J, 1971, Archiv fuer Protistenkunde, V113, P277; POPOVSKY J, 1968, Preslia (Prague), V40, P251; POPOVSKY J, 1990, ARCH HYDROBIOL, P1; Popovsky J., 1990, SUSSWASSERFLORA MITT; Pouchet G., 1887, Journal de l'Anatomie et de la Physiologie, Vxxiii, P87; Pouchet M, 1894, NOUVELLES ARCH MISSI, V5, P155; Pylyshyn Z.W., 2003, SEEING VISUALIZING I; Raup D.M., 1992, EXTINCTION BAD GENES; Redeke H. C., 1919, Bijdragen tot de Dierkunde, V21; Rene A, 2011, HARMFUL ALGAE, V12, P11, DOI 10.1016/j.hal.2011.08.008; Revilla M, 2009, J SEA RES, V61, P60, DOI 10.1016/j.seares.2008.05.009; Riding James B., 2002, Palynology, V26, P5, DOI 10.2113/0260005; Ros M., 1985, Anales de Biologia (Murcia), V2, P169; Rouchijanen MI, 1968, NOVITATES SYSTEMATIC, P25; RUINEN JAKOBA, 1938, ARCH PRO TISTENK, V90, P210; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Saburova Maria, 2009, BioRisk, V3, P97; Saldarriaga JF, 2003, J PHYCOL, V39, P368, DOI 10.1046/j.1529-8817.2003.02113.x; SARMA Y S R K, 1974, British Phycological Journal, V9, P21; Saville-Kent W, 1880, MANUAL INFUSORIA; Scharff N, 2003, J ARACHNOL, V31, P246, DOI 10.1636/0161-8202(2003)031[0246:WTQESS]2.0.CO;2; Schiller J, 1954, PLANT SYST EVOL, V101, P236; Schiller J, 1957, WISSENSCHAFTLICHE AR, V9, P1; Schiller J, 1933, DINOFLAGELLATAE PERI, P617; SCHILLER JOS, 1928, ARCH PROTISTENK, V62, P119; Schilling AJ, 1891, FLORA ODER ALLGEMEIN, V3, P1; Schmarda L.K., 1846, KLEINE BEITRAGE NATU; Schmarda L.K., 1854, DENKSCH K AKAD WISS, VVII, P1; SCHNEPF E, 1989, PLANT SYST EVOL, V164, P75, DOI 10.1007/BF00940431; Schroder B, 1900, ABDRUCK MITTHEILUNGE, V14, P1; SCHUTT F, 1895, PERIDINEEN PLANKTONE; Seaborn David W., 1997, Virginia Journal of Science, V48, P265; Segers H, 2012, ZOOTAXA, P61; Senicheva MI, 2008, SPECIES DIVERSITY SE, P5; Senzaki Satoshi, 1994, Japanese Journal of Phycology, V42, P29; Shao P, 2004, MAR BIOL, V144, P215, DOI 10.1007/s00227-003-1157-x; Shen Y.F., 1990, MODERN BIOMONITORING; SHYAM R, 1975, PLANT SYST EVOL, V124, P205, DOI 10.1007/BF00992726; SHYAM R, 1980, NOVA HEDWIGIA, V32, P133; Siano R, 2010, PROTIST, V161, P385, DOI 10.1016/j.protis.2010.01.002; Simpson AGB, 1997, ARCH PROTISTENKD, V147, P213, DOI 10.1016/S0003-9365(97)80049-8; Skolka V.H., 1989, CERCETARI MARINE, V22, P147; SKUJA H., 1939, ACTA HORTI BOT UNIV LATVIENSIS, V11/12, P41; SKUJA H, 1956, NOVA ACTA R SOC SC 4, V16, P1; SKUJA H, 1948, SYMB BOT UPSAL, V9, P1, DOI DOI 10.1016/J.HAL.2015.12.001; Skuja H., 1964, NOVA ACTA R SOC SC 4, V18, P1; Skvortzov B. V., 1968, Q J TAIWAN MUSEUM, V21, P79; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Steidinger K.A., 1996, Nova Hedwigia Beiheft, V112, P415; Steidinger Karen A., 2009, P131; Stein F., 1878, ORG FLAGELLATEN; Stein F, 1883, ORG INFUSIONSTTHIERE; Stein R, 1997, BER POLARFORSCH, V255, P98; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Struder-Kypke MC, 2002, AQUAT MICROB ECOL, V27, P203, DOI 10.3354/ame027203; Subrahmanyan R., 1961, Indian Journal of Fisheries, V7, P307; Sukhanova IN, 2010, OCEANOLOGY+, V50, P743, DOI 10.1134/S0001437010050115; Sundstrom AM, 2009, J PHYCOL, V45, P938, DOI 10.1111/j.1529-8817.2009.00712.x; TAFT CLARENCE E., 1964, OHIO J SCI, V64, P43; Takano Y, 2004, PHYCOL RES, V52, P107, DOI 10.1111/j.1440-183.2004.00332.x; Tang YZ, 2008, J EUKARYOT MICROBIOL, V55, P91, DOI 10.1111/j.1550-7408.2008.00305.x; Taylor F.J.R., 1976, BIBLIOTHECA BOT, V132, P1; TAYLOR FJR, 1982, MAR BIOL, V67, P323, DOI 10.1007/BF00397673; Taylor WR, 1968, BIOL TRACE ELEMENTS; Thessen AE, 2011, ZOOKEYS, P15, DOI 10.3897/zookeys.150.1766; Thompson RH, 1947, CHESAPEAKE BIOL LAB, V67, P1; Throndsen J, 1983, WORKING PARTY TAXONO, P62; THURSTON JP, 1964, J PROTOZOOL, V11, P307, DOI 10.1111/j.1550-7408.1964.tb01759.x; Tiffany MA, 2007, LAKE RESERV MANAGE, V23, P582, DOI 10.1080/07438140709354039; Tilstone GH, 2000, MAR ECOL PROG SER, V205, P23, DOI 10.3354/meps205023; TILSTONE GH, 1994, MAR ECOL PROG SER, V112, P241, DOI 10.3354/meps112241; TSUJI T, 1979, Journal of the Oceanographical Society of Japan, V35, P173, DOI 10.1007/BF02114310; Utermohl H., 1925, Archiv Hydrobiol Stuttgart Suppl Bd, V5, P1; van Goor ACJ, 1925, REV TRAV BOT NEERL, V22, P275; van Meel L, 1969, B I R SCI NAT BELG, V45, P1; Ventsel MV, 1992, RESULTS 3 JOINT US U; Villeret S, 1953, B SOC BOT FRANCE, V100, P71; Wailes G. H., 1939, Canadian Pacific Fauna, V1, P1; Waters RE, 1992, PHYTOPLANKTON ESQUIM; Wawrik F., 1956, PLANT SYST EVOL, V103, P291, DOI DOI 10.1007/BF01279237; WEDEMAYER GJ, 1982, J PHYCOL, V18, P13, DOI 10.1111/j.1529-8817.1982.tb03152.x; West W., 1906, Dublin Transactions of the Royal Irish Academy, V33, P77; West W, 1909, P R SOC LOND B-CONTA, V81, P165, DOI 10.1098/rspb.1909.0016; Wiktor Jozef, 2005, Polish Polar Research, V26, P259; Williams G. L., 1978, INITIAL REPORTS DEEP, P783; Wolgar S., 2000, SCI PUBL POLICY, V27, P165, DOI [DOI 10.3152/147154300781782039, 10.3152/147154300781782039]; WOLOSZYNSKA JADWIGA, 1952, ACTA SOC BOT POLON, V21, P311; WOOD E. J. F., 1954, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V5, P171; Wulff A., 1919, Wissenschaftliche Meeresuntersuchungen Kiel Abt Helgoland N F, V13, P95; Yamaguchi H, 2011, PROTIST, V162, P650, DOI 10.1016/j.protis.2011.01.002; Zacharias O., 1899, BIOL CENTRALBLATT, V19, P141; Zenetos A, 2005, MEDITERR MAR SCI, V6, P63, DOI 10.12681/mms.186	337	35	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44015	10.1371/journal.pone.0044015	http://dx.doi.org/10.1371/journal.pone.0044015			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952856	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500041
J	Zeng, LL; Liu, L; Liu, YD; Shen, H; Li, YM; Hu, DW				Zeng, Ling-Li; Liu, Li; Liu, Yadong; Shen, Hui; Li, Yaming; Hu, Dewen			Antidepressant Treatment Normalizes White Matter Volume in Patients with Major Depression	PLOS ONE			English	Article							RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVATION; ILLNESS-DURATION; CINGULATE CORTEX; DISORDER; NETWORKS; ABNORMALITIES; 1ST-EPISODE; REDUCTION	Objective: To investigate white matter volume abnormalities in patients with major depression and the effects of antidepressant treatment on white matter volume. Method: Magnetic resonance imaging (MRI) was performed on 32 treatment-naive depressed patients, 17 recovered patients who had received antidepressant treatment and subsequently achieved clinical recovery and 34 matched controls. Results: Relative to the healthy controls, the treatment-naive depressed patients showed increased white matter volumes in the left dorsolateral prefrontal cortex (DLPFC) and left putamen and reduced white matter volumes in the left cerebellum posterior lobe and left inferior parietal lobule. For the treatment-naive patients, the length in months of the current depressive episode was positively correlated with the white matter volumes in both the left DLPFC and left putamen. In the recovered patients, the differences in white matter volume were no longer statistically significant relative to healthy controls. No significant difference was found in the total white matter volume among the three groups. Conclusions: This study demonstrates that there were alterations in the white matter volumes of depressed patients, which might disrupt the neural circuits that are involved in emotional and cognitive function and thus contribute to the pathophysiology of depression. The finding of the significant correlations between refractoriness and the white matter volumes in the left DLPFC and left putamen combined with the finding that antidepressant treatment normalized the white matter volume of recovered patients, suggests that a quantitative, structural MRI measurement could act as a potential biomarker in depression therapy for individual subjects.	[Zeng, Ling-Li; Liu, Yadong; Shen, Hui; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Liu, Li] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China; [Li, Yaming] China Med Univ, Affiliated Hosp 1, Dept Nucl Med, Shenyang, Liaoning, Peoples R China	National University of Defense Technology - China; China Medical University; China Medical University	Zeng, LL (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	lllyy2003@163.com; dwhu@nudt.edu.cn	Hu, Dewen/AAN-8511-2020; Hu, Dewen/D-1978-2015	Zeng, Ling-Li/0000-0002-0515-256X	National Basic Research Program of China [2011CB707802]; National Science Foundation of China [60835005, 61003202]; Hunan Provincial Innovation Foundation for Postgraduate [CX2011B015]; National University of Defense Technology [B110304]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation for Postgraduate; National University of Defense Technology	This work was supported by the National Basic Research Program of China (Grant No. 2011CB707802), National Science Foundation of China (Grant Nos. 60835005, 61003202), Hunan Provincial Innovation Foundation for Postgraduate (Grant No. CX2011B015), and Graduate Innovation Fund of National University of Defense Technology (Grant No. B110304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Alalade E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020035; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Du MY, 2012, PROG NEURO-PSYCHOPH, V36, P11, DOI 10.1016/j.pnpbp.2011.09.014; First M. B., 2002, STRUCTURED CLIN INTE; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Guy W, 1976, ECDEU ASSESSMENT MAN; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hu DW, 2008, CEREBELLUM, V7, P304, DOI 10.1007/s12311-008-0031-2; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Kim AJ, 2008, PSYCHIAT RES-NEUROIM, V164, P114, DOI 10.1016/j.pscychresns.2007.12.020; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039516; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Potter GG, 2007, NEUROPSYCHOPHARMACOL, V32, P2135, DOI 10.1038/sj.npp.1301339; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schlosser RGM, 2008, NEUROIMAGE, V43, P645, DOI 10.1016/j.neuroimage.2008.08.002; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Steingard RJ, 2002, BIOL PSYCHIAT, V52, P413, DOI 10.1016/S0006-3223(02)01393-8; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Vasic N, 2009, PSYCHOL MED, V39, P977, DOI 10.1017/S0033291708004443; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	44	44	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44248	10.1371/journal.pone.0044248	http://dx.doi.org/10.1371/journal.pone.0044248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957005	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500057
J	Li, CG; Yang, PH; Zhang, YL; Sun, Y; Wang, W; Zou, Z; Xing, L; Chen, ZW; Tang, C; Guo, F; Deng, JJ; Zhao, Y; Yan, YW; Tang, J; Wang, XL; Jiang, CY				Li, Chenggang; Yang, Penghui; Zhang, Yanli; Sun, Yang; Wang, Wei; Zou, Zhen; Xing, Li; Chen, Zhongwei; Tang, Chong; Guo, Feng; Deng, Jiejie; Zhao, Yan; Yan, Yiwu; Tang, Jun; Wang, Xiliang; Jiang, Chengyu			Corticosteroid Treatment Ameliorates Acute Lung Injury Induced by 2009 Swine Origin Influenza A (H1N1) Virus in Mice	PLOS ONE			English	Article							CYTOKINE RESPONSE; CLINICAL-ASPECTS; VIRAL LOAD; HOSPITALIZATION; INHIBITION; DISEASE; DEATH	Background: The 2009 influenza pandemic affected people in almost all countries in the world, especially in younger age groups. During this time, the debate over whether to use corticosteroid treatment in severe influenza H1N1 infections patients resurfaced and was disputed by clinicians. There is an urgent need for a susceptible animal model of 2009 H1N1 infection that can be used to evaluate the pathogenesis and the therapeutic effect of corticosteroid treatment during infection. Methodology/Principal Findings: We intranasally inoculated two groups of C57BL/6 and BALB/c mice (using 4- or 6-to 8-week-old mice) to compare the pathogenesis of several different H1N1 strains in mice of different ages. Based on the results, a very susceptible 4-week-old C57BL/6 mouse model of Beijing 501 strain of 2009 H1N1 virus infection was established, showing significantly elevated lung edema and cytokine levels compared to controls. Using our established animal model, the cytokine production profile and lung histology were assessed at different times post-infection, revealing increased lung lesions in a time-dependent manner. In additional, the mice were also treated with dexamethasone, which significantly improved survival rate and lung lesions in infected mice compared to those in control mice. Our data showed that corticosteroid treatment ameliorated acute lung injury induced by the 2009 A/H1N1 virus in mice and suggested that corticosteroids are valid drugs for treating 2009 A/H1N1 infection. Conclusions/Significance: Using the established, very susceptible 2009 Pandemic Influenza A (H1N1) mouse model, our studies indicate that corticosteroids are a potential therapeutic remedy that may address the increasing concerns over future 2009 A/H1N1pandemics.	[Li, Chenggang; Zhang, Yanli; Sun, Yang; Wang, Wei; Zou, Zhen; Guo, Feng; Deng, Jiejie; Zhao, Yan; Yan, Yiwu; Tang, Jun; Jiang, Chengyu] Tsinghua Univ, Peking Union Med Coll, Dept Biochem & Mol Biol,Inst Basic Med Sci, State Key Lab Med Mol Biol,Chinese Acad Med Sci, Beijing 100084, Peoples R China; [Yang, Penghui; Xing, Li; Chen, Zhongwei; Tang, Chong; Wang, Xiliang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University; Beijing Institute of Microbiology & Epidemiology	Li, CG (corresponding author), Tsinghua Univ, Peking Union Med Coll, Dept Biochem & Mol Biol,Inst Basic Med Sci, State Key Lab Med Mol Biol,Chinese Acad Med Sci, Beijing 100084, Peoples R China.	xiliangw@126.com; jiang@pumc.edu.cn	Yan, Yiwu/P-5499-2017; , 孙阳/B-2495-2016; Zou, Zhen/ABB-3301-2021; Wang, Wei/N-9423-2019	Yan, Yiwu/0000-0001-8289-7277; , 孙阳/0000-0002-1463-689X; Zou, Zhen/0000-0002-1651-591X; Wang, Wei/0000-0001-9243-8672; Tang, Jun/0000-0003-3177-8926; Guo, Feng/0000-0002-4506-7618	National Natural Scientific Foundation [30800977, 30972614]; Beijing Natural Science Foundation [7112105]; Ministry of Science and Technology of China [2009CB522102, 2009CB522105]; 111project [B08007]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 111project(Ministry of Education, China - 111 Project)	Funding provided by National Natural Scientific Foundation (30800977 and 30972614) (http://www.nsfc.gov.cn/Portal0/default106.htm), Beijing Natural Science Foundation (7112105) (http://www.bjnsf.org/) and Ministry of Science and Technology of China (2009CB522102 and 2009CB522105) (http://www.973.gov.cn/Default_3.aspx) 111project (B08007) (http://www.safea.gov.cn/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2006, CURR DRUG TARGETS, V7, P649, DOI 10.2174/138945006777435344; Annane D, 2011, AM J RESP CRIT CARE, V183, P1125, DOI 10.1164/rccm.201102-0345ED; [Anonymous], 2009, MMWR MORB MORTAL WKL, P913; ASHBAUGH DG, 1967, LANCET, V2, P319; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Confalonieri M, 2010, INTENS CARE MED, V36, P1780, DOI 10.1007/s00134-010-1964-8; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Kim Sangsoo, 2011, Genomics & Informatics, V9, P1; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Martin-Loeches I, 2011, INTENS CARE MED, V37, P272, DOI 10.1007/s00134-010-2078-z; Matthay MA, 2011, AM J RESP CRIT CARE, V183, P1127, DOI 10.1164/rccm.201103-0395ED; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Quispe-Laime AM, 2010, INTENS CARE MED, V36, P33, DOI 10.1007/s00134-009-1727-6; Nencioni L, 2009, J BIOL CHEM, V284, P16004, DOI 10.1074/jbc.M900146200; Salluh JIF, 2010, INTENS CARE MED, V36, P1098, DOI 10.1007/s00134-010-1815-7; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sauerzapf V, 2009, J EPIDEMIOL COMMUN H, V63, P324, DOI 10.1136/jech.2008.077024; Sun Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001931; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tyburski JG, 2001, SURGERY, V130, P748, DOI 10.1067/msy.2001.118094; World Health Organization, 2009, CLIN MAN HUM INF PAN; Yang N, 2011, J MOL CELL BIOL, V3, P221, DOI 10.1093/jmcb/mjr017; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029347	32	27	32	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44110	10.1371/journal.pone.0044110	http://dx.doi.org/10.1371/journal.pone.0044110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952892	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000084
J	Monteiro, NM; Lyons, DO				Monteiro, Nuno M.; Lyons, David O.			Stronger Sexual Selection in Warmer Waters: The Case of a Sex Role Reversed Pipefish	PLOS ONE			English	Article							NEROPHIS-LUMBRICIFORMIS PISCES; SIZE DIMORPHISM; ECOLOGY; TEMPERATURE; POPULATION; SYNGNATHIDAE; REPRODUCTION; RECRUITMENT; COMPETITION; DYNAMICS	In order to answer broader questions about sexual selection, one needs to measure selection on a wide array of phenotypic traits, simultaneously through space and time. Nevertheless, studies that simultaneously address temporal and spatial variation in reproduction are scarce. Here, we aimed to investigate the reproductive dynamics of a cold-water pipefish simultaneously through time (encompassing variation within each breeding cycle and as individuals grow) and space (by contrasting populations experiencing distinct water temperature regimes) in order to test hypothesized differences in sexual selection. Even though the sampled populations inhabited locations with very different water temperature regimes, they exhibited considerable similarities in reproductive parameters. The most striking was the existence of a well-defined substructure in reproductive activity, where larger individuals reproduce for longer periods, which seemed dependent on a high temperature threshold for breeding rather than on the low temperatures that vary heavily according to latitude. Furthermore, the perceived disparities among populations, such as size at first reproduction, female reproductive investment, or degree of sexual size dimorphism, seemed dependent on the interplay between seawater temperature and the operational sex ratio (OSR). Contrary to our expectations of an enhanced opportunity for sexual selection in the north, we found the opposite: higher female reproductive investment coupled with increased sexual size dimorphism in warmer waters, implying that a prolonged breeding season does not necessarily translate into reduced sexual selection pressure. In fact, if the limited sex has the ability to reproduce either continuously or recurrently during the entire breeding season, an increased opportunity for sexual selection might arise from the need to compete for available partners under strongly biased OSRs across protracted breeding seasons. A more general discussion on the effects of climate change in the pressure of sexual selection is also presented.	[Monteiro, Nuno M.] Ctr Invest Biodiversdade & Recursos Genet, Vairao, Portugal; [Monteiro, Nuno M.] Univ Fernando Pessoa, Fac Ciencias Saude, CEBIMED, Oporto, Portugal; [Lyons, David O.] Natl Pk & Wildlife Serv, Galway, Ireland	Universidade Fernando Pessoa	Monteiro, NM (corresponding author), Ctr Invest Biodiversdade & Recursos Genet, Vairao, Portugal.	nmonteir@fc.up.pt	Monteiro, Nuno/A-2900-2009	Monteiro, Nuno/0000-0001-6994-4673	Portuguese Foundation for Science and Technology (FCT) [PTDC/AAC-CLI/112936/2009]; FCT (Programa Ciencia)	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT (Programa Ciencia)	The Portuguese Foundation for Science and Technology (FCT) partially funded this study through the R&D project PTDC/AAC-CLI/112936/2009. NM was funded by FCT (Programa Ciencia 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNESJO I, 1995, BEHAV ECOL, V6, P229, DOI 10.1093/beheco/6.2.229; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Berglund A, 2003, ADV STUD BEHAV, V32, P131, DOI 10.1016/S0065-3454(03)01003-9; BERGLUND A, 1990, BEHAV ECOL SOCIOBIOL, V27, P129, DOI 10.1007/BF00168456; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Dawson C.E., 1986, P628; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Klug H, 2010, J EVOLUTION BIOL, V23, P447, DOI 10.1111/j.1420-9101.2009.01921.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Laptikhovsky V., 2006, RUSSIAN J MARINE BIO, V32, P201; Lester SE, 2007, ECOLOGY, V88, P2229, DOI 10.1890/06-1784.1; LEWIS JR, 1986, HYDROBIOLOGIA, V142, P1, DOI 10.1007/BF00026742; Lindman HR., 1974, ANAL VARIANCE COMPLE; Lyons David O., 2005, Biology and Environment, V105B, P9, DOI 10.3318/BIOE.2005.105.1.9; Lyons DO, 2004, J MAR BIOL ASSOC UK, V84, P461, DOI 10.1017/S0025315404009452h; McCoy EE, 2001, MOL ECOL, V10, P1793, DOI 10.1046/j.0962-1083.2001.01320.x; Mills SC, 2007, P ROY SOC B-BIOL SCI, V274, P143, DOI 10.1098/rspb.2006.3639; Monteiro N, 2001, J MAR BIOL ASSOC UK, V81, P1031, DOI 10.1017/S002531540100501X; Monteiro NM, 2006, J FISH BIOL, V69, P66, DOI 10.1111/j.0022-1112.2006.01064.x; Monteiro N.M., 2002, Acta Ethologica, V5, P39, DOI 10.1007/s10211-002-0060-7; Monteiro NM, 2005, ESTUAR COAST SHELF S, V63, P93, DOI 10.1016/j.ecss.2004.10.012; Monteiro NM, 2005, J FISH BIOL, V67, P1475, DOI 10.1111/j.0022-1112.2005.00818.x; Monteiro NM, 2003, J MAR BIOL ASSOC UK, V83, P1179, DOI 10.1017/S0025315403008452h; Monteiro Nuno, 2002, Acta Ethologica, V4, P109; Reaney LT, 2007, BEHAV ECOL SOCIOBIOL, V61, P1515, DOI 10.1007/s00265-007-0383-5; Rispoli VF, 2008, J EVOLUTION BIOL, V21, P30, DOI 10.1111/j.1420-9101.2007.01470.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Silva K, 2008, J ANIM ECOL, V77, P390, DOI 10.1111/j.1365-2656.2007.01346.x; Silva K, 2007, ANIM BEHAV, V74, P1525, DOI 10.1016/j.anbehav.2007.03.008; Silva K, 2010, ANIM BEHAV, V79, P885, DOI 10.1016/j.anbehav.2010.01.001; Silva K, 2009, BEHAV ECOL, V20, P768, DOI 10.1093/beheco/arp058; Sogabe A, 2011, J FISH BIOL, V78, P1833, DOI 10.1111/j.1095-8649.2011.02973.x; Spottiswoode CN, 2006, P ROY SOC B-BIOL SCI, V273, P3023, DOI 10.1098/rspb.2006.3688; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Twiss SD, 2007, BIOL LETTERS, V3, P12, DOI 10.1098/rsbl.2006.0559; Vincent A, 1994, BEHAV ECOL SOCIOBIOL, V34, P142; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; West PM, 2002, SCIENCE, V297, P1339, DOI 10.1126/science.1073257; Wilson AB, 2009, MOL ECOL, V18, P1263, DOI 10.1111/j.1365-294X.2009.04084.x; Zuo WY, 2012, P ROY SOC B-BIOL SCI, V279, P1840, DOI 10.1098/rspb.2011.2000	42	16	16	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44251	10.1371/journal.pone.0044251	http://dx.doi.org/10.1371/journal.pone.0044251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952940	gold, Green Published, Green Submitted			2022-12-25	WOS:000308044800101
J	Sandoval-Guzman, T; Gongrich, C; Moliner, A; Guo, TQ; Wu, HY; Broberger, C; Ibanez, CF				Sandoval-Guzman, Tatiana; Gongrich, Christina; Moliner, Annalena; Guo, Tingqing; Wu, Haiya; Broberger, Christian; Ibanez, Carlos F.			Neuroendocrine control of female reproductive function by the activin receptor ALK7	FASEB JOURNAL			English	Article						ovary; pituitary; hypothalamus; NPY; PCOS	HORMONE-RELEASING HORMONE; FOLLICLE-STIMULATING-HORMONE; NEUROPEPTIDE-Y; GENE-EXPRESSION; INHIBIN/ACTIVIN SUBUNITS; ARCUATE NUCLEUS; ADIPOSE-TISSUE; HYPOTHALAMUS; MODULATION; INHIBIN	Activins are critical components of the signaling network that controls female reproduction. However, their roles in hypothalamus, and the specific functions of their different receptors, have not been elucidated. Here, we investigated the expression and function of the activin receptor ALK7 in the female reproductive axis using Alk7-knockout mice. ALK7 was found in subsets of SF1-expressing granulosa cells in the ovary, FSH gonadotrophs in the pituitary, and NPY-expressing neurons in the arcuate nucleus of the hypothalamus. Alk7-knockout females showed delayed onset of puberty and abnormal estrous cyclicity, had abnormal diestrous levels of FSH and LH in serum, and their ovaries showed premature depletion of follicles, oocyte degeneration, and impaired responses to exogenous gonadotropins. In the arcuate nucleus, mutant mice showed reduced expression of Npy mRNA and lower numbers of Npy-expressing neurons than wildtype controls. Alk7 knockouts showed a selective loss of arcuate NPY/AgRP innervation in the medial preoptic area, a key central regulator of reproduction. These results indicate that ALK7 is an important regulator of female reproductive function and reveal a new role for activin signaling in the control of hypothalamic gene expression and wiring. Alk7 gene variants may contribute to female reproductive disorders in humans, such as polycystic ovary syndrome.-Sandoval-Guzman, T., Gongrich, C., Moliner, A., Guo, T., Wu, H., Broberger, C., Ibanez, C. F. Neuroendocrine control of female reproductive function by the activin receptor ALK7. FASEB J. 26, 4966-4976 (2012). www.fasebj.org	[Sandoval-Guzman, Tatiana; Gongrich, Christina; Moliner, Annalena; Guo, Tingqing; Wu, Haiya; Broberger, Christian; Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	Ibanez, CF (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	carlos.ibanez@ki.se	Sandoval-Guzman, Tatiana/P-3795-2018; Sandoval-Guzmán, Tatiana/B-8172-2017; Sandoval-Guzmán, Tatiana/P-2473-2019	Sandoval-Guzmán, Tatiana/0000-0003-1802-5145; Sandoval-Guzmán, Tatiana/0000-0003-1802-5145; Gongrich, Christina/0000-0003-4495-1476	Swedish Research Council; Swedish Cancer Society; European Research Council; Novo Nordisk Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the Swedish Research Council, the Swedish Cancer Society, and the European Research Council to C. F. I.; and the Swedish Research Council, Novo Nordisk Foundation, and European Research Council to C.B.	Andersson O, 2008, P NATL ACAD SCI USA, V105, P7252, DOI 10.1073/pnas.0800272105; Andersson O, 2007, DEV BIOL, V311, P500, DOI 10.1016/j.ydbio.2007.08.060; Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Andersson O, 2006, DEV BIOL, V293, P370, DOI 10.1016/j.ydbio.2006.02.002; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BAI FL, 1985, BRAIN RES, V331, P172, DOI 10.1016/0006-8993(85)90730-9; Bernard DJ, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-52; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; BILEZIKJIAN LM, 1993, ENDOCRINOLOGY, V133, P2554, DOI 10.1210/en.133.6.2554; Bondestam J, 2001, CYTOGENET CELL GENET, V95, P157, DOI 10.1159/000059339; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Broberger C, 1998, J COMP NEUROL, V402, P460; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Burger LL, 2007, AM J PHYSIOL-ENDOC M, V293, pE277, DOI 10.1152/ajpendo.00447.2006; Calogero AE, 1998, J ENDOCRINOL, V156, P269, DOI 10.1677/joe.0.1560269; Campbell RE, 2001, NEUROENDOCRINOLOGY, V74, P106, DOI 10.1159/000054676; Cho BN, 2001, ENDOCRINOLOGY, V142, P4994, DOI 10.1210/en.142.11.4994; CROWLEY WR, 1987, ENDOCRINOLOGY, V120, P941, DOI 10.1210/endo-120-3-941; CROWLEY WR, 1987, NEUROENDOCRINOLOGY, V46, P97, DOI 10.1159/000124804; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; Furuta C, 2008, ENDOCRINE, V33, P126, DOI 10.1007/s12020-008-9073-y; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GONZALEZMANCHON C, 1991, NEUROENDOCRINOLOGY, V54, P373, DOI 10.1159/000125916; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Gu ZY, 1998, GENE DEV, V12, P844, DOI 10.1101/gad.12.6.844; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hoggard N, 2009, J MOL ENDOCRINOL, V43, P171, DOI 10.1677/JME-09-0046; Jornvall H, 2004, MOL CELL BIOL, V24, P9383, DOI 10.1128/MCB.24.21.9383-9389.2004; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Kupershmidt L, 2007, J NEUROCHEM, V103, P962, DOI 10.1111/j.1471-4159.2007.04785.x; Li C, 1999, ENDOCRINOLOGY, V140, P5382, DOI 10.1210/en.140.11.5382; LI SY, 1994, MOL BRAIN RES, V26, P69, DOI 10.1016/0169-328X(94)90075-2; Lorentzon M, 1996, EXP NEUROL, V142, P351, DOI 10.1006/exnr.1996.0204; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; McGinnis MY, 1996, PHYSIOL BEHAV, V60, P783; Murata T, 1997, ENDOCR J, V44, P35, DOI 10.1507/endocrj.44.35; Nakane P. K., 1970, CLASSIFICATIONS ANTE, V18, P9; Pangas SA, 2007, MOL ENDOCRINOL, V21, P2458, DOI 10.1210/me.2007-0146; Paxinos G, 2004, MOUSE BRAIN STEREOTA; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; PLOTSKY PM, 1991, ENDOCRINOLOGY, V128, P2520, DOI 10.1210/endo-128-5-2520; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Ryden M, 1996, J BIOL CHEM, V271, P30603, DOI 10.1074/jbc.271.48.30603; SCHWARTZ MW, 1991, ENDOCRINOLOGY, V128, P2645, DOI 10.1210/endo-128-5-2645; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Thackray VG, 2008, ENDOCRINOLOGY, V149, P1091, DOI 10.1210/en.2007-1498; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V220, P59, DOI 10.1016/j.mce.2004.03.009; Turi GF, 2003, ENDOCRINOLOGY, V144, P4967, DOI 10.1210/en.2003-0470; Urban JH, 1996, NEUROENDOCRINOLOGY, V63, P112, DOI 10.1159/000126947; VALE W, 1988, RECENT PROG HORM RES, V44, P1; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; Wang H, 2006, MOL ENDOCRINOL, V20, P2469, DOI 10.1210/me.2005-0446; Weng Q, 2006, J REPROD DEVELOP, V52, P607, DOI 10.1262/jrd.18026; Wilson ME, 1998, BIOL REPROD, V59, P278, DOI 10.1095/biolreprod59.2.278; WOLLER MJ, 1991, ENDOCRINOLOGY, V128, P1144, DOI 10.1210/endo-128-2-1144; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Xu M, 2000, NEUROENDOCRINOLOGY, V72, P263, DOI 10.1159/000054595	62	20	22	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4966	4976		10.1096/fj.11-199059	http://dx.doi.org/10.1096/fj.11-199059			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22954591				2022-12-25	WOS:000311838300019
J	Taylor, PA; Cho, KH; Lin, CP; Biswal, BB				Taylor, Paul A.; Cho, Kuan-Hung; Lin, Ching-Po; Biswal, Bharat B.			Improving DTI Tractography by including Diagonal Tract Propagation	PLOS ONE			English	Article							WHITE-MATTER; AXONAL PROJECTIONS; FIBER TRACTOGRAPHY; DIFFUSION; BRAIN; MRI; CONNECTIVITY; RECONSTRUCTION; ANISOTROPY; REDUCTION	Tractography algorithms have been developed to reconstruct likely WM pathways in the brain from diffusion tensor imaging (DTI) data. In this study, an elegant and simple means for improving existing tractography algorithms is proposed by allowing tracts to propagate through diagonal trajectories between voxels, instead of only rectilinearly to their facewise neighbors. A series of tests (using both real and simulated data sets) are utilized to show several benefits of this new approach. First, the inclusion of diagonal tract propagation decreases the dependence of an algorithm on the arbitrary orientation of coordinate axes and therefore reduces numerical errors associated with that bias (which are also demonstrated here). Moreover, both quantitatively and qualitatively, including diagonals decreases overall noise sensitivity of results and leads to significantly greater efficiency in scanning protocols; that is, the obtained tracts converge much more quickly (i.e., in a smaller amount of scanning time) to those of data sets with high SNR and spatial resolution. Importantly, the inclusion of diagonal propagation adds essentially no appreciable time of calculation or computational costs to standard methods. This study focuses on the widely-used streamline tracking method, FACT (fiber assessment by continuous tracking), and the modified method is termed "FACTID" (FACT including diagonals).	[Taylor, Paul A.; Biswal, Bharat B.] UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA; [Cho, Kuan-Hung; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	Rutgers State University New Brunswick; Rutgers State University Medical Center; National Yang Ming Chiao Tung University	Taylor, PA (corresponding author), UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA.	neon.taylor@gmail.com		Taylor, Paul/0000-0003-0488-6796	National Institutes of Health (NIH) [R01 AG032088-02]; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grant R01 AG032088-02. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Chao YP, 2008, MED ENG PHYS, V30, P989, DOI 10.1016/j.medengphy.2008.01.010; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fillard P, 2003, LECT NOTES COMPUT SC, V2879, P16; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Kim M, 2006, NEUROIMAGE, V32, P1243, DOI 10.1016/j.neuroimage.2006.06.006; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Mangin JF, 2002, NMR BIOMED, V15, P481, DOI 10.1002/nbm.780; Minati L, 2007, J GERIATR PSYCH NEUR, V20, P3, DOI 10.1177/0891988706297089; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Poupon C, 2008, MAGN RESON MED, V60, P1276, DOI 10.1002/mrm.21789; Press W. H., 1992, ART SCI COMPUTING; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; REISERT M, 2009, MICCAI WORKSH DIFF M; Sherbondy A, 2005, IEEE T VIS COMPUT GR, V11, P419, DOI 10.1109/TVCG.2005.59; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Taylor PA, 2011, MAGN RESON IMAGING, V29, P777, DOI 10.1016/j.mri.2011.02.031; Tensaouti F., 2009, MICCAI WORKSH DIFF M; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Ulug AM, 1999, AM J NEURORADIOL, V20, P1044; Ulug AM, 1997, STROKE, V28, P483, DOI 10.1161/01.STR.28.3.483; Warach S, 1997, STROKE, V28, P481; Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P249, DOI 10.1109/VISUAL.1999.809894; Westin CF, 1999, LECT NOTES COMPUT SC, V1679, P441; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43415	10.1371/journal.pone.0043415	http://dx.doi.org/10.1371/journal.pone.0043415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970125	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400010
J	Anderson, SR; Porrill, J; Pearson, MJ; Pipe, AG; Prescott, TJ; Dean, P				Anderson, Sean R.; Porrill, John; Pearson, Martin J.; Pipe, Anthony G.; Prescott, Tony J.; Dean, Paul			An Internal Model Architecture for Novelty Detection: Implications for Cerebellar and Collicular Roles in Sensory Processing	PLOS ONE			English	Article							TRIGEMINAL GANGLION NEURONS; LOBULUS SIMPLEX PROJECTION; INFERIOR OLIVARY NEURONS; SACCADIC EYE-MOVEMENTS; ADAPTIVE-FILTER MODEL; CRUS-II PROJECTION; SUPERIOR COLLICULUS; ELECTROPHYSIOLOGICAL ANALYSIS; TACTILE AREAS; BRAIN-STEM	The cerebellum is thought to implement internal models for sensory prediction, but details of the underlying circuitry are currently obscure. We therefore investigated a specific example of internal-model based sensory prediction, namely detection of whisker contacts during whisking. Inputs from the vibrissae in rats can be affected by signals generated by whisker movement, a phenomenon also observable in whisking robots. Robot novelty-detection can be improved by adaptive noise-cancellation, in which an adaptive filter learns a forward model of the whisker plant that allows the sensory effects of whisking to be predicted and thus subtracted from the noisy sensory input. However, the forward model only uses information from an efference copy of the whisking commands. Here we show that the addition of sensory information from the whiskers allows the adaptive filter to learn a more complex internal model that performs more robustly than the forward model, particularly when the whisking-induced interference has a periodic structure. We then propose a neural equivalent of the circuitry required for adaptive novelty-detection in the robot, in which the role of the adaptive filter is carried out by the cerebellum, with the comparison of its output (an estimate of the self-induced interference) and the original vibrissal signal occurring in the superior colliculus, a structure noted for its central role in novelty detection. This proposal makes a specific prediction concerning the whisker-related functions of a region in cerebellar cortical zone A(2) that in rats receives climbing fibre input from the superior colliculus (via the inferior olive). This region has not been observed in non-whisking animals such as cats and primates, and its functional role in vibrissal processing has hitherto remained mysterious. Further investigation of this system may throw light on how cerebellar-based internal models could be used in broader sensory, motor and cognitive contexts.	[Anderson, Sean R.; Porrill, John; Prescott, Tony J.; Dean, Paul] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Pearson, Martin J.; Pipe, Anthony G.] Bristol Robot Lab, Bristol, Avon, England	University of Sheffield; University of Bristol; University of West England	Anderson, SR (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	p.dean@sheffield.ac.uk	Prescott, Tony J/A-7574-2008	Prescott, Tony J/0000-0003-4927-5390; Anderson, Sean/0000-0002-7452-5681; Pearson, Martin/0000-0002-8642-4845	European Union under Grant Biomimetic Technology for Vibrissal Active Touch (BIOTACT) [ICT-215910]; Engineering and Physical Sciences Research Council [EP/I032533/1] Funding Source: researchfish; EPSRC [EP/I032533/1] Funding Source: UKRI	European Union under Grant Biomimetic Technology for Vibrissal Active Touch (BIOTACT); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Union under Grant Biomimetic Technology for Vibrissal Active Touch (BIOTACT) ICT-215910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1986, BRAIN RES, V378, P186, DOI 10.1016/0006-8993(86)90304-5; AKAIKE T, 1986, BRAIN RES, V386, P400, DOI 10.1016/0006-8993(86)90180-0; AKAIKE T, 1987, BRAIN RES, V417, P371, DOI 10.1016/0006-8993(87)90467-7; AKAIKE T, 1989, BRAIN RES, V482, P402, DOI 10.1016/0006-8993(89)91209-2; AKAIKE T, 1992, J COMP NEUROL, V320, P398, DOI 10.1002/cne.903200311; AKAIKE T, 1988, BRAIN RES, V442, P373, DOI 10.1016/0006-8993(88)91529-6; AKAIKE T, 1985, BRAIN RES, V340, P369, DOI 10.1016/0006-8993(85)90934-5; Alloway KD, 2010, J COMP NEUROL, V518, P4546, DOI 10.1002/cne.22477; Anderson SR, 2010, IEEE T ROBOT, V26, P1065, DOI 10.1109/TRO.2010.2069990; APPS R, 1990, J COMP NEUROL, V302, P236, DOI 10.1002/cne.903020205; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; ARMSTRONG DM, 1980, J PHYSIOL-LONDON, V309, P357, DOI 10.1113/jphysiol.1980.sp013513; Atkins MJ, 1997, J COMP NEUROL, V389, P249; Bastian AJ, 2011, CURR OPIN NEUROBIOL, V21, P596, DOI 10.1016/j.conb.2011.06.007; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bell CC, 1999, J EXP BIOL, V202, P1339; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; BENTIVOGLIO M, 1982, EXP BRAIN RES, V46, P339; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1999, NEUROIMAGE, V10, P448, DOI 10.1006/nimg.1999.0478; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Bosman LWJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00053; Bower J, 2003, SCI AM, V289, P50, DOI 10.1038/scientificamerican0803-48; BOWER JM, 1981, BRAIN BEHAV EVOLUT, V18, P1, DOI 10.1159/000121772; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; BRUNI C, 1974, IEEE T AUTOMAT CONTR, VAC19, P334, DOI 10.1109/TAC.1974.1100617; BUISSERETDELMAS C, 1988, NEUROSCI RES, V5, P475, DOI 10.1016/0168-0102(88)90038-7; BUISSERETDELMAS C, 1993, PROG NEUROBIOL, V40, P63, DOI 10.1016/0301-0082(93)90048-W; Cerminara NL, 2011, CEREBELLUM, V10, P484, DOI 10.1007/s12311-010-0209-2; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; Curtis JC, 2006, NEURON, V50, P524, DOI 10.1016/j.neuron.2006.05.004; DEAN P, 1980, BRAIN RES, V197, P571, DOI 10.1016/0006-8993(80)91149-X; DEAN P, 1984, BRAIN RES REV, V8, P155, DOI 10.1016/0165-0173(84)90004-3; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; DEAN P, 1984, BRAIN RES REV, V8, P129, DOI 10.1016/0165-0173(84)90002-X; DEAN P, 1984, BRAIN RES REV, V8, P143, DOI 10.1016/0165-0173(84)90003-1; DEAN P, 1994, J COGNITIVE NEUROSCI, V6, P117, DOI 10.1162/jocn.1994.6.2.117; Dean P, 2002, P ROY SOC B-BIOL SCI, V269, P1895, DOI 10.1098/rspb.2002.2103; Dean P, 2011, J PHYSIOL-LONDON, V589, P3459, DOI 10.1113/jphysiol.2010.201574; Dean P, 2010, FUNCT NEUROL, V25, P173; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Fox C, 2009, AUTON ROBOT, V26, P223, DOI 10.1007/s10514-009-9109-z; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GELLMAN R, 1985, J NEUROPHYSIOL, V54, P40, DOI 10.1152/jn.1985.54.1.40; Gibson S, 2005, IEEE T AUTOMAT CONTR, V50, P1581, DOI 10.1109/TAC.2005.856664; GODSCHALK M, 1994, J PHYSIOL-LONDON, V480, P147, DOI 10.1113/jphysiol.1994.sp020348; Hartmann MJZ, 2011, ANN NY ACAD SCI, V1225, P110, DOI 10.1111/j.1749-6632.2011.06007.x; Hartmann MJZ, 2009, INTEGR COMP BIOL, V49, P681, DOI 10.1093/icb/icp107; Hemelt ME, 2008, J NEUROPHYSIOL, V100, P1245, DOI 10.1152/jn.90478.2008; Hemelt ME, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-12; HESS DT, 1982, BRAIN RES, V250, P143; Honda T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002087; HUERTA MF, 1983, J COMP NEUROL, V220, P147, DOI 10.1002/cne.902200204; HUSTON JP, 1980, BRAIN RES BULL, V5, P745, DOI 10.1016/0361-9230(80)90214-2; Imamizu H, 2010, JPN PSYCHOL RES, V52, P107, DOI 10.1111/j.1468-5884.2010.00428.x; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Iwamoto Y, 2010, EXP BRAIN RES, V204, P145, DOI 10.1007/s00221-010-2314-3; KASSEL J, 1980, BRAIN RES, V202, P291, DOI 10.1016/0006-8993(80)90142-0; Kawato M, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P409; Khatri V, 2009, J NEUROPHYSIOL, V101, P1836, DOI 10.1152/jn.90655.2008; KILPATRICK IC, 1982, NEUROSCIENCE, V7, P207, DOI 10.1016/0306-4522(82)90161-0; KIRVEL RD, 1975, J COMP PHYSIOL PSYCH, V89, P882, DOI 10.1037/h0077166; KIRVEL RD, 1974, J COMP PHYSIOL PSYCH, V87, P156, DOI 10.1037/h0036570; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Ko H, 2000, IEEE T AERO ELEC SYS, V36, P102, DOI 10.1109/7.826315; KOHONEN T, 1976, BIOL CYBERN, V21, P85, DOI 10.1007/BF01259390; KURIMOTO Y, 1995, NEUROSCI RES, V22, P57, DOI 10.1016/0168-0102(95)00874-S; Leergaard TB, 2006, EUR J NEUROSCI, V24, P2801, DOI 10.1111/j.1460-9568.2006.05150.x; Leiser SC, 2007, NEURON, V53, P117, DOI 10.1016/j.neuron.2006.10.036; Lepora NF, 2012, J R SOC INTERFACE, V9, P1517, DOI 10.1098/rsif.2011.0750; Lisberger SG, 2009, NEUROSCIENCE, V162, P763, DOI 10.1016/j.neuroscience.2009.03.059; Markou M, 2003, SIGNAL PROCESS, V83, P2499, DOI 10.1016/j.sigpro.2003.07.019; Markou M, 2003, SIGNAL PROCESS, V83, P2481, DOI 10.1016/j.sigpro.2003.07.018; MARSHALL JF, 1978, EXP NEUROL, V58, P203, DOI 10.1016/0014-4886(78)90134-6; Marsland S, 2005, ROBOT AUTON SYST, V51, P191, DOI 10.1016/j.robot.2004.10.006; Marsland S, 2002, NEURAL COMPUTING SUR, V3, P1; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Medina JF, 2011, CURR OPIN NEUROBIOL, V21, P616, DOI 10.1016/j.conb.2011.05.025; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Meredith MA, 2001, NEUROSCI RES, V40, P301, DOI 10.1016/S0168-0102(01)00240-1; MIHAILOFF GA, 1985, J COMP NEUROL, V237, P251, DOI 10.1002/cne.902370209; Mitchinson B., 2011, NEUROMORPHIC BRAIN B, ppp 23; Morissette J, 1996, EXP BRAIN RES, V109, P240; Niemi-Junkola UJ, 2000, NEUROSCIENCE, V97, P565, DOI 10.1016/S0306-4522(00)00044-0; NODA H, 1991, JPN J PHYSIOL, V41, P351, DOI 10.2170/jjphysiol.41.351; Odeh F, 2005, J NEUROSCI, V25, P5680, DOI 10.1523/JNEUROSCI.0558-05.2005; PAALLYSAHO J, 1991, NEUROSCI RES, V12, P217, DOI 10.1016/0168-0102(91)90112-C; Pearson MJ, 2007, ADAPT BEHAV, V15, P223, DOI 10.1177/1059712307082089; Pearson MJ, 2011, PHILOS T R SOC B, V366, P3085, DOI 10.1098/rstb.2011.0164; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006; Porrill J, 2004, P ROY SOC B-BIOL SCI, V271, P789, DOI 10.1098/rspb.2003.2658; Prescott TJ, 2009, IEEE ROBOT AUTOM MAG, V16, P42, DOI 10.1109/MRA.2009.933624; REDGRAVE P, 1981, PSYCHOPHARMACOLOGY, V75, P198, DOI 10.1007/BF00432187; Requarth T, 2011, CURR OPIN NEUROBIOL, V21, P602, DOI 10.1016/j.conb.2011.05.031; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; Roberts PD, 2000, J COMPUT NEUROSCI, V9, P67, DOI 10.1023/A:1008938428112; Roberts SJ, 1999, IEE P-VIS IMAGE SIGN, V146, P124, DOI 10.1049/ip-vis:19990428; Ruigrok TJH, 2000, J COMP NEUROL, V426, P209, DOI 10.1002/1096-9861(20001016)426:2<209::AID-CNE4>3.0.CO;2-0; Sawtell NB, 2008, J NEUROSCI, V28, P1598, DOI 10.1523/JNEUROSCI.4946-07.2008; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; SHAMBES GM, 1978, BRAIN RES, V157, P123, DOI 10.1016/0006-8993(78)91000-4; Shimansky Y, 1997, LEARN MEMORY, V4, P36, DOI 10.1101/lm.4.1.36; Soetedjo R, 2008, J NEUROPHYSIOL, V100, P1949, DOI 10.1152/jn.90526.2008; Speller JM, 1996, EXP BRAIN RES, V110, P425; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; SWENSON RS, 1983, NEUROSCIENCE, V8, P259, DOI 10.1016/0306-4522(83)90064-7; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Teune TM, 2000, PROG BRAIN RES, V124, P141; Towal RB, 2008, J NEUROPHYSIOL, V100, P740, DOI 10.1152/jn.01295.2007; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Voogd J, 2006, PROG BRAIN RES, V151, P231, DOI 10.1016/S0079-6123(05)51008-2; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Voogd J, 2003, J NEUROSCI, V23, P4645; WATSON CRR, 1978, NEUROSCI LETT, V10, P77, DOI 10.1016/0304-3940(78)90015-0; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Widrow B., 1985, ADAPTIVE SIGNAL PROC; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yatim N, 1996, NEUROSCI RES, V25, P267, DOI 10.1016/0168-0102(96)01061-9; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	132	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44560	10.1371/journal.pone.0044560	http://dx.doi.org/10.1371/journal.pone.0044560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957083	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800076
J	Mosberg, JA; Gregg, CJ; Lajoie, MJ; Wang, HH; Church, GM				Mosberg, Joshua A.; Gregg, Christopher J.; Lajoie, Marc J.; Wang, Harris H.; Church, George M.			Improving Lambda Red Genome Engineering in Escherichia coli via Rational Removal of Endogenous Nucleases	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; MEDIATED RECOMBINATION; EXONUCLEASE VII; REPAIR; PURIFICATION; EFFICIENT; GENE; IDENTIFICATION; REPLICATION; CHROMOSOMES	Lambda Red recombineering is a powerful technique for making targeted genetic changes in bacteria. However, many applications are limited by the frequency of recombination. Previous studies have suggested that endogenous nucleases may hinder recombination by degrading the exogenous DNA used for recombineering. In this work, we identify ExoVII as a nuclease which degrades the ends of single-stranded DNA (ssDNA) oligonucleotides and double-stranded DNA (dsDNA) cassettes. Removing this nuclease improves both recombination frequency and the inheritance of mutations at the 39 ends of ssDNA and dsDNA. Extending this approach, we show that removing a set of five exonucleases (RecJ, ExoI, ExoVII, ExoX, and Lambda Exo) substantially improves the performance of co-selection multiplex automatable genome engineering (CoS-MAGE). In a given round of CoS-MAGE with ten ssDNA oligonucleotides, the five nuclease knockout strain has on average 46% more alleles converted per clone, 200% more clones with five or more allele conversions, and 35% fewer clones without any allele conversions. Finally, we use these nuclease knockout strains to investigate and clarify the effects of oligonucleotide phosphorothioation on recombination frequency. The results described in this work provide further mechanistic insight into recombineering, and substantially improve recombineering performance.	[Gregg, Christopher J.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Mosberg, Joshua A.; Lajoie, Marc J.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Wang, Harris H.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Wang, Harris H.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University	Mosberg, JA (corresponding author), Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969	Department of Energy Genomes to Life Center [DE-FG02-03ER6344]; United States Department of Defense NDSEG; Wyss Institute for Biologically Inspired Engineering; National Institutes of Health [1DP5OD009172-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009172] Funding Source: NIH RePORTER	Department of Energy Genomes to Life Center(United States Department of Energy (DOE)); United States Department of Defense NDSEG(United States Department of Defense); Wyss Institute for Biologically Inspired Engineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Department of Energy Genomes to Life Center (Grant #DE-FG02-03ER6344). M.J.L. is supported by a United States Department of Defense NDSEG Fellowship. H. H. W. is supported by the Wyss Technology Development Fellowship from the Wyss Institute for Biologically Inspired Engineering and the Director's Early Independence Award from the National Institutes of Health (Grant #1DP5OD009172-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; CHASE JW, 1974, J BIOL CHEM, V249, P4553; CHASE JW, 1974, J BIOL CHEM, V249, P4545; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEUTSCHER MP, 1969, J BIOL CHEM, V244, P3029; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; JEKEL M, 1995, GENE, V154, P55, DOI 10.1016/0378-1119(94)00835-G; KULKARNI SK, 1989, GENETICS, V123, P249; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lemuth K, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-29; Li XT, 2003, NUCLEIC ACIDS RES, V31, P6674, DOI 10.1093/nar/gkg844; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Liu XP, 2010, PROTEIN SCI, V19, P967, DOI 10.1002/pro.374; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Muyrers JPP, 2000, GENE DEV, V14, P1971; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; PRASHER DC, 1983, J BIOL CHEM, V258, P6340; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; STEIN CA, 1988, NUCLEIC ACIDS RES, V16, P3209, DOI 10.1093/nar/16.8.3209; Thomason LC, 2007, PLASMID, V58, P148, DOI 10.1016/j.plasmid.2007.03.001; VALES LD, 1983, J BACTERIOL, V155, P1116, DOI 10.1128/JB.155.3.1116-1122.1983; Viswanathan M, 1999, J BIOL CHEM, V274, P30094, DOI 10.1074/jbc.274.42.30094; Wang HH, 2011, NUCLEIC ACIDS RES, V39, P7336, DOI 10.1093/nar/gkr183; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang HH, 2012, GENOME SCALE PROMOTE; Wang Y, 2008, METAB ENG, V10, P33, DOI 10.1016/j.ymben.2007.09.002; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	46	55	66	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44638	10.1371/journal.pone.0044638	http://dx.doi.org/10.1371/journal.pone.0044638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957093	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800086
J	Thurber, RV; Burkepile, DE; Correa, AMS; Thurber, AR; Shantz, AA; Welsh, R; Pritchard, C; Rosales, S				Thurber, Rebecca Vega; Burkepile, Deron E.; Correa, Adrienne M. S.; Thurber, Andrew R.; Shantz, Andrew A.; Welsh, Rory; Pritchard, Catharine; Rosales, Stephanie			Macroalgae Decrease Growth and Alter Microbial Community Structure of the Reef-Building Coral, Porites astreoides	PLOS ONE			English	Article							FIXATION ACETYLENE-REDUCTION; METAGENOMIC ANALYSIS; PRIMARY PRODUCERS; CARIBBEAN REEFS; ORGANIC-MATTER; CLIMATE-CHANGE; BACTERIA; CYANOBACTERIA; DIVERSITY; MORTALITY	With the continued and unprecedented decline of coral reefs worldwide, evaluating the factors that contribute to coral demise is of critical importance. As coral cover declines, macroalgae are becoming more common on tropical reefs. Interactions between these macroalgae and corals may alter the coral microbiome, which is thought to play an important role in colony health and survival. Together, such changes in benthic macroalgae and in the coral microbiome may result in a feedback mechanism that contributes to additional coral cover loss. To determine if macroalgae alter the coral microbiome, we conducted a field-based experiment in which the coral Porites astreoides was placed in competition with five species of macroalgae. Macroalgal contact increased variance in the coral-associated microbial community, and two algal species significantly altered microbial community composition. All macroalgae caused the disappearance of a gamma-proteobacterium previously hypothesized to be an important mutualist of P. astreoides. Macroalgal contact also triggered: 1) increases or 2) decreases in microbial taxa already present in corals, 3) establishment of new taxa to the coral microbiome, and 4) vectoring and growth of microbial taxa from the macroalgae to the coral. Furthermore, macroalgal competition decreased coral growth rates by an average of 36.8%. Overall, this study found that competition between corals and certain species of macroalgae leads to an altered coral microbiome, providing a potential mechanism by which macroalgae-coral interactions reduce coral health and lead to coral loss on impacted reefs.	[Thurber, Rebecca Vega; Burkepile, Deron E.; Correa, Adrienne M. S.; Shantz, Andrew A.; Welsh, Rory; Pritchard, Catharine; Rosales, Stephanie] Florida Int Univ, Deptartment Biol Sci, N Miami, FL USA; [Thurber, Rebecca Vega; Correa, Adrienne M. S.; Welsh, Rory; Rosales, Stephanie] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Pritchard, Catharine] Oregon Inst Marine Biol, Charleston, OR USA	State University System of Florida; Florida International University; Oregon State University; Oregon State University	Thurber, RV (corresponding author), Florida Int Univ, Deptartment Biol Sci, N Miami, FL USA.	Rebecca.Vega-Thurber@oregonstate.edu	Rosales, Stephanie/Z-4923-2019; Burkepile, Deron/F-2368-2013	Shantz, Andrew/0000-0001-5641-8914	Florida International University College of Arts and Sciences; OCE from National Science Foundation [1130786]; Division Of Ocean Sciences [1130786] Funding Source: National Science Foundation	Florida International University College of Arts and Sciences; OCE from National Science Foundation; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the Florida International University College of Arts and Sciences and grant OCE #1130786 from the National Science Foundation to DEB and RVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2011, ENVIRON MICROBIOL, P1; Barott KL, 2011, P ROYAL SOC B; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; BRYLINSKY M, 1977, MAR BIOL, V39, P213, DOI 10.1007/BF00390995; Burkepile DE, 2011, CORAL REEFS, V30, P351, DOI 10.1007/s00338-011-0726-6; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; DAVIES PS, 1989, MAR BIOL, V101, P389; Ferrer LM, 1988, P 6 INT COR REEF S, V2, P1; Fine M, 2002, P ROY SOC B-BIOL SCI, V269, P1205, DOI 10.1098/rspb.2002.1983; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; HOLM S, 1979, SCAND J STAT, V6, P65; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Klaus JS, 2005, CORAL REEFS, V24, P129, DOI 10.1007/s00338-004-0447-1; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Mumby PJ, 2009, CORAL REEFS, V28, P683, DOI 10.1007/s00338-009-0501-0; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; SHASHAR N, 1994, MAR ECOL PROG SER, V111, P259, DOI 10.3354/meps111259; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; WILLIAMS WM, 1987, MAR BIOL, V94, P531, DOI 10.1007/BF00431399; [No title captured]	57	84	85	3	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44246	10.1371/journal.pone.0044246	http://dx.doi.org/10.1371/journal.pone.0044246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957055	gold, Green Published			2022-12-25	WOS:000308463800047
J	Wang, JJ; Chen, SZ; Zhang, C; Stegeman, S; Pfaff-Amesse, T; Zhang, Y; Zhang, WF; Amesse, L; Chen, YF				Wang, Jinju; Chen, Shuzhen; Zhang, Cheng; Stegeman, Samantha; Pfaff-Amesse, Teresa; Zhang, Ying; Zhang, Wenfeng; Amesse, Lawrence; Chen, Yanfang			Human Endometrial Stromal Stem Cells Differentiate into Megakaryocytes with the Ability to Produce Functional Platelets	PLOS ONE			English	Article							BLOOD CD34(+) CELLS; IN-VITRO; GENERATION; TRANSFUSION; THROMBOCYTOPENIA; CONCENTRATE; PROGENITORS; MECHANISMS; EXPRESSION; SURVIVAL	Human endometrium is a high dynamic tissue that contains endometrial stromal stem cells (hESSCs). The hESSCs have been differentiated into a number of cell lineages. However, differentiation of hESSCs into megakaryocytes (MKs) has not yet been investigated. The aim of this study was to investigate the feasibility of MK generation from hESSCs and subsequent production of functional platelets (PLTs). In our study, hESSCs were cultured from endometrial stromal cells as confirmed by positive stromal cell specific markers (CD90 and CD29) and negative hematopoietic stem cell markers (CD45 and CD34) expression. Then, hESSCs were differentiated in a medium supplemented with thrombopoietin (TPO) for 18 days. The MK differentiation was analyzed by flow cytometry and confocal microscopy. The differentiation medium was collected for PLT production analysis by flow cytometry, transmission electron microscopy and functional measurements. Our results show: 1) MKs were successfully generated from hESSCs as identified by expression of specific markers (CD41a: 1 +/- 0.09% and 39 +/- 3.0%; CD42b: 1.2 +/- 0.06% and 28 +/- 2.0%, control vs. differentiation) accompanied with reduction of pluripotent transcription factors (Oct4 and Sox2) expression; 2) The level of PLTs in the differentiation medium was 16 +/- 1 number/mu l as determined by size (2-4 mu m) and CD41a expression (CD41a: 1 +/- 0.4% and 90 +/- 2.0%, control vs. differentiation); 3) Generated PLTs were functional as evidenced by the up-regulation of CD62p expression and fibrinogen binding following thrombin stimulation; 4) Released PLTs showed similar ultra-structure characteristics (alpha granules, vacuoles and dense tubular system) as PLTs from peripheral blood determined by electron microscopic analysis. Data demonstrate the feasibility of generating MKs from hESSCs, and that the generated MKs release functional PLTs. Therefore, hESSCs could be a potential new stem cell source for in vitro MK/PLT production.	[Wang, Jinju; Chen, Shuzhen; Zhang, Cheng; Stegeman, Samantha; Zhang, Wenfeng; Chen, Yanfang] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Pfaff-Amesse, Teresa; Amesse, Lawrence] Wright State Univ, Boonshoft Sch Med, Dept Obstet & Gynecol, Dayton, OH USA; [Zhang, Ying] Guangdong Med Coll, Affiliated Hosp, Dept Obstet & Gynecol, Zhanjiang, Guangdong, Peoples R China	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; Guangdong Medical University	Wang, JJ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.	yanfang.chen@wright.edu		chen, shuzhen/0000-0001-5709-9978; Wang, Jinju/0000-0003-1210-7676	National Institutes of Health (NIH) [HL098637]; Wright State University Boonshoft School of Medicine Emerging Science Seed Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098637] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wright State University Boonshoft School of Medicine Emerging Science Seed Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) HL098637 (YC) and Wright State University Boonshoft School of Medicine Emerging Science Seed Grant (LA and YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumberg N, 2008, LEUKEMIA, V22, P631, DOI 10.1038/sj.leu.2404920; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; CHOI ES, 1995, BLOOD, V85, P402; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fujimoto TT, 2003, BLOOD, V102, P4044, DOI 10.1182/blood-2003-06-1773; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Gaur M, 2006, J THROMB HAEMOST, V4, P436, DOI 10.1111/j.1538-7836.2006.01744.x; Kanbur Nuray O, 2003, Int J Adolesc Med Health, V15, P161; Kaushansky Kenneth, 2009, Hematology Am Soc Hematol Educ Program, P147, DOI 10.1182/asheducation-2009.1.147; Matsubara Y, 2009, BIOCHEM BIOPH RES CO, V378, P716, DOI 10.1016/j.bbrc.2008.11.117; Matsunaga T, 2006, STEM CELLS, V24, P2877, DOI 10.1634/stemcells.2006-0309; Matthai C, 2006, MOL HUM REPROD, V12, P7, DOI 10.1093/molehr/gah254; Mattia G, 2002, BLOOD, V99, P888, DOI 10.1182/blood.V99.3.888; Nevo S, 2007, TRANSFUSION, V47, P1700, DOI 10.1111/j.1537-2995.2007.01345.x; Nishikii H, 2008, J EXP MED, V205, P1917, DOI 10.1084/jem.20071482; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Proulx C, 2003, J HEMATOTH STEM CELL, V12, P179, DOI 10.1089/152581603321628322; Santamaria X, 2011, MOL THER, V19, P2065, DOI 10.1038/mt.2011.173; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Shim MH, 2004, EXP HEMATOL, V32, P638, DOI 10.1016/j.exphem.2004.04.002; Stephan F, 1999, CHEST, V115, P1363, DOI 10.1378/chest.115.5.1363; Stevens WT, 2006, TRANSFUSION, V46, P649, DOI 10.1111/j.1537-2995.2006.00760.x; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Ungerer M, 2004, CIRC RES, V95, pE36, DOI 10.1161/01.RES.0000141700.96085.2e; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Wolff EF, 2007, REPROD SCI, V14, P524, DOI 10.1177/1933719107306896; Wolff EF, 2011, J CELL MOL MED, V15, P747, DOI 10.1111/j.1582-4934.2010.01068.x	30	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44300	10.1371/journal.pone.0044300	http://dx.doi.org/10.1371/journal.pone.0044300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952951	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300077
J	Chen, YH; Wu, YW; Yang, WS; Wang, SS; Lee, CM; Chou, NK; Hsu, RB; Lin, YH; Lin, MS; Ho, YL; Chen, MF				Chen, Ying-Hsien; Wu, Yen-Wen; Yang, Wei-Shiung; Wang, Shoei-Shen; Lee, Chi-Ming; Chou, Nai-Kuan; Hsu, Ron-Bin; Lin, Yen-Hung; Lin, Mao-Shin; Ho, Yi-Lwun; Chen, Ming-Fong			Relationship between Bone Mineral Density and Serum Osteoprotegerin in Patients with Chronic Heart Failure	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MYOSTATIN; OSTEOPOROSIS; ACTIVATION; MARKERS; MASS; MEN	Purpose: Heart failure (HF) had been reported with increased risk of hip fractures. However, the relationship between circulating biomarkers and bone mineral density (BMD) in chronic HF remained unclear. Methods: This is a cross-sectional study which recruited stable chronic HF from registry of the Heart Failure Center of National Taiwan University Hospital. Patients underwent dual-energy x-ray absorptiometry (DEXA) measurements at hip and lumbar spines and biochemical assessments including B-type natriuretic peptide (BNP-32), myostatin, follistatin and osteoprotegerin (OPG). Results: A total of 115 stable chronic HF individuals with left ventricular ejection fraction (EF) <45% (74% of male, mean age at 59) were recruited with 24 patients in NYHA class I, 73 patients in NYHA class II and 18 patients in NYHA class III. Results of BMD showed that Z scores of hip in NYHA III group (-0.12 +/- 1.15) was significantly lower than who were NYHA II (0.58 +/- 1.04). Serum OPG was significantly higher in subjects of NYHA III (9.3 +/- 4.6 pmol/l) than NYHA II (7.4 +/- 2.8 pmol/l) or NYHA I (6.8 +/- 3.6 pmol/l) groups. There's a significant negative association between log transformed serum OPG and trochanteric BMD (R = -0.299, P = 0.001), which remained significant after multivariate analysis. Conclusions: Our study demonstrated an inverse association between serum OPG and trochanteric BMD in patients with HF. OPG may be a predictor of BMD and an alternative to DEXA for identifying at risk HF patients for osteoporosis.	[Chen, Ying-Hsien; Wu, Yen-Wen; Yang, Wei-Shiung; Wang, Shoei-Shen; Lee, Chi-Ming; Chou, Nai-Kuan; Hsu, Ron-Bin; Lin, Yen-Hung; Lin, Mao-Shin; Ho, Yi-Lwun; Chen, Ming-Fong] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wang, Shoei-Shen; Chou, Nai-Kuan; Hsu, Ron-Bin] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Lee, Chi-Ming] Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liu City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Chen, Ying-Hsien; Wu, Yen-Wen; Yang, Wei-Shiung; Lee, Chi-Ming; Lin, Yen-Hung; Lin, Mao-Shin; Ho, Yi-Lwun; Chen, Ming-Fong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Chen, YH (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	ylho@ntu.edu.tw	Chen, Ming/GVU-8412-2022; Lin, Yen-Hung/AAQ-1242-2020	Lin, Yen-Hung/0000-0001-8153-1441; Chou, Nai-Kuan/0000-0001-5494-7708; WU, YEN-WEN/0000-0003-1520-1166; Wang, Shoei-Shen/0000-0003-3201-4143; HO, YI-LWUN/0000-0002-8936-9570; YANG, WEI-SHIUNG/0000-0001-5087-373X	National Science Council of Taiwan [NSC 98-2314-B-002-145-MY2, NSC 99-2911-I-008-100]; Department of Health, Executive Yuan, R.O.C. [DOH 99-TD-B-111-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, R.O.C.	The work was supported by National Science Council of Taiwan [NSC 98-2314-B-002-145-MY2] to YW Wu and [NSC 99-2911-I-008-100] to YL Ho and Department of Health, Executive Yuan, R.O.C. [DOH 99-TD-B-111-001] to YL Ho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Raya S, 2009, ARCH GERONTOL GERIAT, V49, P250, DOI 10.1016/j.archger.2008.09.004; Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Baldini V, 2005, J Endocrinol Invest, V28, P69; Barasch E, 2009, CIRC-HEART FAIL, V2, P303, DOI 10.1161/CIRCHEARTFAILURE.108.828343; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bozic B, 2010, J CARD FAIL, V16, P301, DOI 10.1016/j.cardfail.2009.12.015; Carbone L, 2010, EUR HEART J, V31, P77, DOI 10.1093/eurheartj/ehp483; Chhokar VS, 2004, AM J PHYSIOL-HEART C, V287, pH2023, DOI 10.1152/ajpheart.00477.2004; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Gruson D, 2011, EUR J HEART FAIL, V13, P734, DOI 10.1093/eurjhf/hfr024; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Huang KC, 2004, CLIN ENDOCRINOL, V61, P204, DOI 10.1111/j.1365-2265.2004.02081.x; Hwang JJ, 2009, ATHEROSCLEROSIS, V204, P293, DOI 10.1016/j.atherosclerosis.2008.08.019; Jabbar S, 2011, J CLIN PATHOL; Jankowska EA, 2009, EUR J HEART FAIL, V11, P28, DOI 10.1093/eurjhf/hfn004; Jono S, 2010, J THROMB HAEMOST, V8, P1170, DOI 10.1111/j.1538-7836.2010.03833.x; Kochetkova EA, 2010, TERAPEVT ARKH, V82, P10; LEE AH, 1994, AM J MED, V96, P35, DOI 10.1016/0002-9343(94)90113-9; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lim LS, 2008, ARCH INTERN MED, V168, P735, DOI 10.1001/archinte.168.7.735; Loncar G, 2011, INT J CARDIOL; Loncar G, 2010, ENDOCRINE, V37, P148, DOI 10.1007/s12020-009-9282-z; Lyons K, 2011, CIRC HEART FAIL; Pobeha P, 2011, BONE, V48, P1008, DOI 10.1016/j.bone.2011.02.017; Roysland R, 2010, AM HEART J, V160, P286, DOI 10.1016/j.ahj.2010.05.015; Shaker OG, 2010, ANGIOLOGY, V61, P756, DOI 10.1177/0003319710370961; Shane E, 1997, AM J MED, V103, P197, DOI 10.1016/S0002-9343(97)00142-3; Ueland T, 2005, CIRCULATION, V111, P2461, DOI 10.1161/01.CIR.0000165119.62099.14; Ueland T, 2011, CIRC-HEART FAIL, V4, P145, DOI 10.1161/CIRCHEARTFAILURE.110.957332; van Diepen S, 2008, CIRCULATION, V118, P1946, DOI 10.1161/CIRCULATIONAHA.108.784009; Witasp A, 2011, EUR J CLIN INVEST, V41, P498, DOI 10.1111/j.1365-2362.2010.02432.x; Zamora E, 2010, REV ESP CARDIOL, V63, P992, DOI 10.1016/S0300-8932(10)70212-8; Zittermann A, 2006, CLIN CHIM ACTA, V366, P27, DOI 10.1016/j.cca.2005.10.006	33	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44242	10.1371/journal.pone.0044242	http://dx.doi.org/10.1371/journal.pone.0044242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957004	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500056
J	Xu, YQ; Zhang, D; Jin, T; Cai, DJ; Wu, Q; Lu, YF; Liu, J; Klaassen, CD				Xu, Yi-Qiao; Zhang, Dan; Jin, Tao; Cai, Ding-Jun; Wu, Qin; Lu, Yuanfu; Liu, Jie; Klaassen, Curtis D.			Diurnal Variation of Hepatic Antioxidant Gene Expression in Mice	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; MOLECULAR-MECHANISM; CLOCK; GLUTATHIONE; METALLOTHIONEIN; CADMIUM; TIME; TRANSCRIPTION; INFLAMMATION; STRESS	Background: This study was aimed to examine circadian variations of hepatic antioxidant components, including the Nrf2-pathway, the glutathione (GSH) system, antioxidant enzymes and metallothionein in mouse liver. Methods and Results: Adult mice were housed in light-and temperature-controlled facilities for 2 weeks, and livers were collected every 4 h during the 24 h period. Total RNA was isolated, purified, and subjected to real-time RT-PCR analysis. Hepatic mRNA levels of Nrf2, Keap1, Nqo1 and Gclc were higher in the light-phase than the dark-phase, and were female-predominant. Hepatic GSH presented marked circadian fluctuations, along with glutathione S-transferases (GST-alpha 1, GST-mu, GST-pi) and glutathione peroxidase (GPx1). The expressions of GPx1, GST-mu and GST-pi mRNA were also higher in females. Antioxidant enzymes Cu/Zn superoxide dismutase (Sod1), catalase (CAT), cyclooxygenase-2 (Cox-2) and heme oxygenase-1 (Ho-1) showed circadian rhythms, with higher expressions of Cox-2 and CAT in females. Metallothionein, a small nonenzymatic antioxidant protein, showed dramatic circadian variation in males, but higher expression in females. The circadian variations of the clock gene Brain and Muscle Arnt-like Protein-1(Bmal1), albumin site D-binding protein (Dbp), nuclear receptor Rev-Erb alpha (Nr1d1), period protein (Per1 and Per2) and cryptochrome 1(Cry1) were in agreement with the literature. Furthermore, acetaminophen hepatotoxicity is more severe when administered in the afternoon when hepatic GSH was lowest. Conclusions: Circadian variations and gender differences in transcript levels of antioxidant genes exist in mouse liver, which could affect body responses to oxidative stress at different times of the day.	[Xu, Yi-Qiao; Zhang, Dan; Jin, Tao; Wu, Qin; Lu, Yuanfu; Liu, Jie] Zunyi Med Coll, Zunyi, Peoples R China; [Cai, Ding-Jun] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China; [Liu, Jie; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	Zunyi Medical University; Chengdu University of Traditional Chinese Medicine; University of Kansas; University of Kansas Medical Center	Xu, YQ (corresponding author), Zunyi Med Coll, Zunyi, Peoples R China.	JLiu@kumc.edu			National Natural Science Foundation of China [81160415]; Science and Technology Foundation of Guizhou Province [TZJF2009-41, 2010-5, C-453]; Foundation of Zunyi Medical College	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Guizhou Province; Foundation of Zunyi Medical College	This study was supported by National Natural Science Foundation of China (No. 81160415), Science and Technology Foundation of Guizhou Province (No. TZJF2009-41, 2010-5 and C-453) and Foundation of Zunyi Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Bass J, 2011, NATURE, V469, P476, DOI 10.1038/469476a; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; Bozek K, 2010, BIOSYSTEMS, V102, P61, DOI 10.1016/j.biosystems.2010.07.010; Bruckner JV, 2002, J PHARMACOL EXP THER, V300, P273, DOI 10.1124/jpet.300.1.273; Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200; CAHILL AL, 1983, ENVIRON RES, V31, P54, DOI 10.1016/0013-9351(83)90061-0; Chen P, 2009, AM J PATHOL, V174, P63, DOI 10.2353/ajpath.2009.080430; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Gachon F, 2011, EXPERT OPIN DRUG MET, V7, P147, DOI 10.1517/17425255.2011.544251; Gadacha W, 2009, REDOX REP, V14, P154, DOI 10.1179/135100009X466131; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Immenschuh S, 2010, CURR DRUG TARGETS, V11, P1541, DOI 10.2174/1389450111009011541; Inoue N, 1999, XENOBIOTICA, V29, P43, DOI 10.1080/004982599238803; JAESCHKE H, 1985, BIOCHEM PHARMACOL, V34, P1029, DOI 10.1016/0006-2952(85)90606-9; Jang YS, 2011, BIOCHEM BIOPH RES CO, V409, P22, DOI 10.1016/j.bbrc.2011.04.099; Kakan X, 2011, EXP TOXICOL PATHOL, V63, P581, DOI 10.1016/j.etp.2010.04.011; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Lim FL, 2006, XENOBIOTICA, V36, P1140, DOI 10.1080/00498250600861819; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Luo C, 2011, MED HYPOTHESES, V77, P174, DOI 10.1016/j.mehy.2011.04.002; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Matsunaga N, 2011, TOXICOLOGY, V280, P144, DOI 10.1016/j.tox.2010.12.005; Matsunaga N, 2009, YAKUGAKU ZASSHI, V129, P1357, DOI 10.1248/yakushi.129.1357; Miura N, 2012, J TOXICOL SCI, V37, P191, DOI 10.2131/jts.37.191; Paschos GK, 2010, ANNU REV PHARMACOL, V50, P187, DOI 10.1146/annurev.pharmtox.010909.105621; Sani M, 2006, COMP BIOCHEM PHYS B, V145, P331, DOI 10.1016/j.cbpb.2006.08.005; SCHNELL RC, 1984, PHARMACOLOGY, V29, P149; Skrzypinska-Gawrysiak M, 2000, Int J Occup Med Environ Health, V13, P165; Skrzypinska-Gawrysiak M, 1995, Int J Occup Med Environ Health, V8, P115; Vina J, 2011, CURR PHARM DESIGN, V17, P3959, DOI 10.2174/138161211798764942; Yamamura Y, 2010, CHRONOBIOL INT, V27, P213, DOI 10.3109/07420521003769111; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174	41	73	78	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44237	10.1371/journal.pone.0044237	http://dx.doi.org/10.1371/journal.pone.0044237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952936	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000095
J	Sanchez-Martinez, A; Calleja, M; Peralta, S; Matsushima, Y; Hernandez-Sierra, R; Whitworth, AJ; Kaguni, LS; Garesse, R				Sanchez-Martinez, Alvaro; Calleja, Manuel; Peralta, Susana; Matsushima, Yuichi; Hernandez-Sierra, Rosana; Whitworth, Alexander J.; Kaguni, Laurie S.; Garesse, Rafael			Modeling Pathogenic Mutations of Human Twinkle in Drosophila Suggests an Apoptosis Role in Response to Mitochondrial Defects	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA-POLYMERASE-GAMMA; MULTIPLE DELETIONS; THYMIDINE PHOSPHORYLASE; LINKER REGION; HELICASE; MUTANT; REPLICATION; DISORDERS; PROTEINS	The human gene C10orf2 encodes the mitochondrial replicative DNA helicase Twinkle, mutations of which are responsible for a significant fraction of cases of autosomal dominant progressive external ophthalmoplegia (adPEO), a human mitochondrial disease caused by defects in intergenomic communication. We report the analysis of orthologous mutations in the Drosophila melanogaster mitochondrial DNA (mtDNA) helicase gene, d-mtDNA helicase. Increased expression of wild type d-mtDNA helicase using the UAS-GAL4 system leads to an increase in mtDNA copy number throughout adult life without any noteworthy phenotype, whereas overexpression of d-mtDNA helicase containing the K388A mutation in the helicase active site results in a severe depletion of mtDNA and a lethal phenotype. Overexpression of two d-mtDNA helicase variants equivalent to two human adPEO mutations shows differential effects. The A442P mutation exhibits a dominant negative effect similar to that of the active site mutant. In contrast, overexpression of d-mtDNA helicase containing the W441C mutation results in a slight decrease in mtDNA copy number during the third instar larval stage, and a moderate decrease in life span in the adult population. Overexpression of d-mtDNA helicase containing either the K388A or A442P mutations causes a mitochondrial oxidative phosphorylation (OXPHOS) defect that significantly reduces cell proliferation. The mitochondrial impairment caused by these mutations promotes apoptosis, arguing that mitochondria regulate programmed cell death in Drosophila. Our study of d-mtDNA helicase overexpression provides a tractable Drosophila model for understanding the cellular and molecular effects of human adPEO mutations.	[Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Univ Autonoma Madrid, Fac Med, Dept Bioquim,Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Univ Autonoma Madrid, Fac Med, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Hosp 12 Octubre I 12, Inst Invest Santitaria, Madrid, Spain; [Calleja, Manuel] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA; [Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, MRC Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Michigan State University; Michigan State University; University of Sheffield	Sanchez-Martinez, A (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim,Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain.	rafael.garesse@uam.es	Garesse, Rafael/F-3836-2012; Sanchez-Martinez, Alvaro/L-3851-2019; Sanchez-Martinez, Alvaro/L-1395-2013	Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Whitworth, Alexander/0000-0002-1154-6629; Garesse, Rafael/0000-0002-0338-2281	Centre for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III [PI 07/0167]; Comunidad de Madrid [GEN-0269/2006]; National Institutes of Health [GM45295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER; Medical Research Council [MC_G1000735] Funding Source: researchfish; MRC [MC_G1000735] Funding Source: UKRI	Centre for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III; Comunidad de Madrid(Comunidad de Madrid); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Centre for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III (grant number PI 07/0167), and the Comunidad de Madrid (grant number GEN-0269/2006) to RG, and the National Institutes of Health (grant number GM45295) to LSK. ASM was a Fellow from the Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Abdelwahid E, 2011, BBA-MOL CELL RES, V1813, P597, DOI 10.1016/j.bbamcr.2010.10.008; Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; El-Khoury R, 2009, GENETICS, V183, P861, DOI 10.1534/genetics.109.107813; Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002; Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Krieser RJ, 2009, APOPTOSIS; Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301; Lopez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401; Martinez-Azorin F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200; Mendes CS, 2006, EMBO REP, V7, P933, DOI 10.1038/sj.embor.7400773; Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Pickrell AM, 2009, J BIOENERG BIOMEMBR, V41, P453, DOI 10.1007/s10863-009-9245-3; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Umate Pavan, 2011, Commun Integr Biol, V4, P118, DOI 10.4161/cib.4.1.13844; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101; Wanrooij S, BIOCH BIOPHYS ACTA, V1797, P1378; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Ziviani E, AUTOPHAGY, V6; Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242	46	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43954	10.1371/journal.pone.0043954	http://dx.doi.org/10.1371/journal.pone.0043954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952820	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600064
J	Van Etten, J; Schagat, TL; Hrit, J; Weidmann, CA; Brumbaugh, J; Coon, JJ; Goldstrohm, AC				Van Etten, Jamie; Schagat, Trista L.; Hrit, Joel; Weidmann, Chase A.; Brumbaugh, Justin; Coon, Joshua J.; Goldstrohm, Aaron C.			Human Pumilio Proteins Recruit Multiple Deadenylases to Efficiently Repress Messenger RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMLINE STEM-CELLS; PUF FAMILY; CCR4-NOT COMPLEX; BINDING PROTEINS; PUM2 GENES; DROSOPHILA; TRANSLATION; NANOS; YEAST; EXPRESSION	PUF proteins are a conserved family of eukaryotic RNA-binding proteins that regulate specific mRNAs: they control many processes including stem cell proliferation, fertility, and memory formation. PUFs repress protein expression from their target mRNAs but the mechanism by which they do so remains unclear, especially for humans. Humans possess two PUF proteins, PUM1 and PUM2, which exhibit similar RNA binding specificities. Here we report new insights into their regulatory activities and mechanisms of action. We developed functional assays to measure sequence-specific repression by PUM1 and PUM2. Both robustly inhibit translation and promote mRNA degradation. Purified PUM complexes were found to contain subunits of the CCR4-NOT (CNOT) complex, which contains multiple enzymes that catalyze mRNA deadenylation. PUMs interact with the CNOT deadenylase subunits in vitro. We used three approaches to determine the importance of deadenylases for PUM repression. First, dominant-negative mutants of CNOT7 and CNOT8 reduced PUM repression. Second, RNA interference depletion of the deadenylases alleviated PUM repression. Third, the poly(A) tail was necessary for maximal PUM repression. These findings demonstrate a conserved mechanism of PUF-mediated repression via direct recruitment of the CCR4-POP2-NOT deadenylase leading to translational inhibition and mRNA degradation. A second, deadenylation independent mechanism was revealed by the finding that PUMs repress an mRNA that lacks a poly(A) tail. Thus, human PUMs are repressors capable of deadenylation-dependent and -independent modes of repression.	[Van Etten, Jamie; Schagat, Trista L.; Hrit, Joel; Weidmann, Chase A.; Goldstrohm, Aaron C.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Schagat, Trista L.] Promega Corp, Madison, WI 53711 USA; [Brumbaugh, Justin; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Brumbaugh, Justin; Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Promega Corporation; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goldstrohm, AC (corresponding author), 1150 W Med Ctr Dr,5301 MSRBIII,SPC 5606, Ann Arbor, MI 48109 USA.	acgold@umich.edu		Brumbaugh, Justin/0000-0002-9605-2010; Hrit, Joel/0000-0002-4497-956X; Weidmann, Chase/0000-0002-2941-0500	University of Michigan, Center for Genetics in Health and Medicine, Genomics and Genetics; Promega; Michigan Predoctoral Training Program in Genetics through National Institutes of Health National Research Service Award [5T32GM007544-33]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER	University of Michigan, Center for Genetics in Health and Medicine, Genomics and Genetics; Promega; Michigan Predoctoral Training Program in Genetics through National Institutes of Health National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the University of Michigan, Center for Genetics in Health and Medicine, Genomics and Genetics, and a grant from Promega. T. L. S, spouse of A. C. G., is an employee of Promega Corporation.; Supported by the Michigan Predoctoral Training Program in Genetics through National Institutes of Health National Research Service Award 5T32GM007544-33.	AHRINGER J, 1992, EMBO J, V11, P2303, DOI 10.1002/j.1460-2075.1992.tb05289.x; AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen D, 2012, CURR BIOL, V22, P420, DOI 10.1016/j.cub.2012.01.039; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Dong SY, 2011, J BIOL CHEM, V286, P26732, DOI 10.1074/jbc.M111.244889; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gamberi C, 2002, DEVELOPMENT, V129, P2699; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Goldstrohm A. C., 2012, MOL CELL BI IN PRESS; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Goldstrohm AC, 2008, METHOD ENZYMOL, V448, P77, DOI 10.1016/S0076-6879(08)02605-0; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Houshmandi SS, 2005, RNA, V11, P1655, DOI 10.1261/rna.2168505; Jackson JS, 2004, RNA, V10, P1625, DOI 10.1261/rna.7270204; Jenkins HT, 2009, J STRUCT BIOL, V167, P271, DOI 10.1016/j.jsb.2009.06.007; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; Lin HF, 1997, DEVELOPMENT, V124, P2463; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; McAlister GC, 2008, J PROTEOME RES, V7, P3127, DOI 10.1021/pr800264t; McAlister GC, 2010, ANAL CHEM, V82, P316, DOI 10.1021/ac902005s; Mee CJ, 2004, J NEUROSCI, V24, P8695, DOI 10.1523/JNEUROSCI.2282-04.2004; Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Parisi M, 1999, GENETICS, V153, P235; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweers BA, 2002, GENETICS, V161, P1177; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Spassov DS, 2003, BLOOD CELL MOL DIS, V30, P55, DOI 10.1016/S1079-9796(03)00003-2; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Weidmann CA, 2012, MOL CELL BIOL, V32, P527, DOI 10.1128/MCB.06052-11; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wreden C, 1997, DEVELOPMENT, V124, P3015; Xu EY, 2007, MOL REPROD DEV, V74, P912, DOI 10.1002/mrd.20687; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	88	119	120	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36370	36383		10.1074/jbc.M112.373522	http://dx.doi.org/10.1074/jbc.M112.373522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955276	Green Published, hybrid			2022-12-25	WOS:000310364000057
J	Rothbart, MM; Hennig, RM				Rothbart, Matti Michael; Hennig, Ralf Matthias			The Steppengrille (Gryllus spec./assimilis): Selective Filters and Signal Mismatch on Two Time Scales	PLOS ONE			English	Article							AUDITORY-BEHAVIOR; SONG RECOGNITION; FEMALE CRICKETS; CALLING SONGS; ORTHOPTERA; PHONOTAXIS; WALKING	In Europe, several species of crickets are available commercially as pet food. Here we investigated the calling song and phonotactic selectivity for sound patterns on the short and long time scales for one such a cricket, Gryllus spec., available as "Gryllus assimilis", the Steppengrille, originally from Ecuador. The calling song consisted of short chirps (2-3 pulses, carrier frequency: 5.0 kHz) emitted with a pulse period of 30.2 ms and chirp rate of 0.43 per second. Females exhibited high selectivity on both time scales. The preference for pulse period peaked at 33 ms which was higher then the pulse period produced by males. Two consecutive pulses per chirp at the correct pulse period were already sufficient for positive phonotaxis. The preference for the chirp pattern was limited by selectivity for small chirp duty cycles and for chirp periods between 200 ms and 500 ms. The long chirp period of the songs of males was unattractive to females. On both time scales a mismatch between the song signal of the males and the preference of females was observed. The variability of song parameters as quantified by the coefficient of variation was below 50% for all temporal measures. Hence, there was not a strong indication for directional selection on song parameters by females which could account for the observed mismatch. The divergence of the chirp period and female preference may originate from a founder effect, when the Steppengrille was cultured. Alternatively the mismatch was a result of selection pressures exerted by commercial breeders on low singing activity, to satisfy customers with softly singing crickets. In the latter case the prominent divergence between male song and female preference was the result of domestication and may serve as an example of rapid evolution of song traits in acoustic communication systems.	[Rothbart, Matti Michael; Hennig, Ralf Matthias] Univ Berlin, Dept Biol, Berlin, Germany		Rothbart, MM (corresponding author), Univ Berlin, Dept Biol, Berlin, Germany.	matthias.hennig@biologie.hu-berlin.de			Deutsche Forschungsgemeinschaft/Sonderforschungsbereich [DFG/SFB 618, SFB 618]	Deutsche Forschungsgemeinschaft/Sonderforschungsbereich(German Research Foundation (DFG))	This study was funded by DFG/SFB 618 from Deutsche Forschungsgemeinschaft/Sonderforschungsbereich (SFB 618 - Theoretische Biologie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDE.RD, 1968, Q REV BIOL, V43, P1, DOI 10.1086/405628; Anderson M, 1994, SEXUAL SELECTION; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Bradbury Jack W., 1998, pi; Deily JA, 2009, J COMP PHYSIOL A, V195, P31, DOI 10.1007/s00359-008-0379-2; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P173, DOI 10.1046/j.1463-6409.2003.00107.x; DOHERTY JA, 1985, J COMP PHYSIOL A, V156, P787, DOI 10.1007/BF00610831; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Grobe B, 2012, J EXP BIOL, V215, P1681, DOI 10.1242/jeb.065466; Hack MA, 1998, J INSECT BEHAV, V11, P853, DOI 10.1023/A:1020864111073; Hedwig B, 2004, NATURE, V430, P781, DOI 10.1038/nature02787; Hennig RM, 2009, J COMP PHYSIOL A, V195, P971, DOI 10.1007/s00359-009-0473-0; Hennig RM, 2003, J COMP PHYSIOL A, V189, P589, DOI 10.1007/s00359-003-0438-7; HENNIG RM, 1990, J COMP PHYSIOL A, V167, P617; Huber F., 1989, CRICKET BEHAV NEUROB; Kostarakos K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-22; Otte Daniel, 1992, Journal of Orthoptera Research, V1, P25; Poulet JFA, 2005, P NATL ACAD SCI USA, V102, P15665, DOI 10.1073/pnas.0505282102; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; Schmidt AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028593; Schneider E, 2012, J COMP PHYSIOL A, V198, P181, DOI 10.1007/s00359-011-0698-6; Schul J, 1998, J COMP PHYSIOL A, V183, P401, DOI 10.1007/s003590050266; Trobe D, 2011, J COMP PHYSIOL A, V197, P131, DOI 10.1007/s00359-010-0589-2; Verburgt L, 2008, J COMP PHYSIOL A, V194, P79, DOI 10.1007/s00359-007-0292-0; WALKER TJ, 1975, J COMP PHYSIOL, V101, P57, DOI 10.1007/BF00660119; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weissman DB, 2009, ANN ENTOMOL SOC AM, V102, P367, DOI 10.1603/008.102.0304; Wiley C, 2012, P ROY SOC B-BIOL SCI, V279, P1203, DOI 10.1098/rspb.2011.1740; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	31	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43975	10.1371/journal.pone.0043975	http://dx.doi.org/10.1371/journal.pone.0043975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970154	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000009
J	Grilo, C; Sousa, J; Ascensao, F; Matos, H; Leitao, I; Pinheiro, P; Costa, M; Bernardo, J; Reto, D; Lourenco, R; Santos-Reis, M; Revilla, E				Grilo, Clara; Sousa, Joana; Ascensao, Fernando; Matos, Hugo; Leitao, Ines; Pinheiro, Paula; Costa, Monica; Bernardo, Joao; Reto, Dyana; Lourenco, Rui; Santos-Reis, Margarida; Revilla, Eloy			Individual Spatial Responses towards Roads: Implications for Mortality Risk	PLOS ONE			English	Article							SMALL MAMMALS; TYTO-ALBA; GENE FLOW; HABITAT; HIGHWAY; MOVEMENT; FRAGMENTATION; MITIGATION; CULVERTS; BEHAVIOR	Background: Understanding the ecological consequences of roads and developing ways to mitigate their negative effects has become an important goal for many conservation biologists. Most mitigation measures are based on road mortality and barrier effects data. However, studying fine-scale individual spatial responses in roaded landscapes may help develop more cohesive road planning strategies for wildlife conservation. Methodology/Principal Findings: We investigated how individuals respond in their spatial behavior toward a highway and its traffic intensity by radio-tracking two common species particularly vulnerable to road mortality (barn owl Tyto alba and stone marten Martes foina). We addressed the following questions: 1) how highways affected home-range location and size in the immediate vicinity of these structures, 2) which road-related features influenced habitat selection, 3) what was the role of different road-related features on movement properties, and 4) which characteristics were associated with crossing events and road-kills. The main findings were: 1) if there was available habitat, barn owls and stone martens may not avoid highways and may even include highways within their home-ranges; 2) both species avoided using areas near the highway when traffic was high, but tended to move toward the highway when streams were in close proximity and where verges offered suitable habitat; and 3) barn owls tended to cross above-grade highway sections while stone martens tended to avoid crossing at leveled highway sections. Conclusions: Mortality may be the main road-mediated mechanism that affects barn owl and stone marten populations. Fine-scale movements strongly indicated that a decrease in road mortality risk can be realized by reducing sources of attraction, and by increasing road permeability through measures that promote safe crossings.	[Grilo, Clara; Sousa, Joana; Ascensao, Fernando; Matos, Hugo; Leitao, Ines; Pinheiro, Paula; Costa, Monica; Bernardo, Joao; Reto, Dyana; Santos-Reis, Margarida] Univ Lisbon, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Grilo, Clara; Revilla, Eloy] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Lourenco, Rui] Univ Evora, Inst Mediterranean Agrarian & Environm Sci, Evora, Portugal	Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Evora	Grilo, C (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	claragrilo@ua.pt	Ascensão, Fernando/G-1513-2014; Lourenço, Rui/AAB-6030-2020; Santos-Reis, Margarida/H-4064-2011; Revilla, Eloy/B-5100-2008; Grilo, Clara/H-2002-2012; Lourenço, Rui/B-7148-2012; Ascensão, Fernando/ABF-9787-2021	Ascensão, Fernando/0000-0003-1704-0212; Lourenço, Rui/0000-0001-7694-0478; Revilla, Eloy/0000-0001-5534-5581; Grilo, Clara/0000-0001-9870-3115; Lourenço, Rui/0000-0001-7694-0478; Ascensão, Fernando/0000-0003-1704-0212; Santos-Reis, Margarida/0000-0002-0337-963X; Sousa, Joana/0000-0001-5102-254X	Brisa (Auto-Estradas de Portugal S.A.); Fundacao para a Ciencia e a Tecnologia [CG SFRH/BPD/64205/2009, FA SFRH/BD/38053/2007]; Spanish Ministry of Science and Innovation [CGL2009-07301/BOS]; FEDER	Brisa (Auto-Estradas de Portugal S.A.); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission)	Funding was provided by Brisa (Auto-Estradas de Portugal S.A.) and Fundacao para a Ciencia e a Tecnologia with a Post-doctoral (CG SFRH/BPD/64205/2009) and PhD grant (FA SFRH/BD/38053/2007). ER was supported by the Spanish Ministry of Science and Innovation (CGL2009-07301/BOS co-funded with FEDER funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beaudry F, 2008, BIOL CONSERV, V141, P2550, DOI 10.1016/j.biocon.2008.07.016; Bellamy PE, 2000, MAMMAL REV, V30, P131, DOI 10.1046/j.1365-2907.2000.00061.x; Bjornstad O., 2009, NCF SPATIAL NONPARAM; Brostrom G., 2011, GLMMML GEN LINEAR MO; Cain AT, 2003, BIOL CONSERV, V114, P189, DOI 10.1016/S0006-3207(03)00023-5; Chandler D, 2011, BARL OWL; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; COLVIN BA, 1986, J FIELD ORNITHOL, V57, P200; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; Eigenbrod F, 2009, ECOL SOC, V14; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Fahrig L, 2009, ECOL SOC, V14; Fajardo I., 1990, Ardeola, V37, P101; Frey C, 2011, J ORNITHOL, V152, P279, DOI 10.1007/s10336-010-0579-8; Fuller RA, 2007, BIOLOGY LETT, V3, P368, DOI 10.1098/rsbl.2007.0134; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Gomes L, 2009, ECOL RES, V24, P355, DOI 10.1007/s11284-008-0515-z; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Grilo C, 2008, BIODIVERS CONSERV, V17, P1685, DOI 10.1007/s10531-008-9374-8; Grilo C, 2011, EUR J WILDLIFE RES, V57, P707, DOI 10.1007/s10344-010-0478-6; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Klar N, 2009, J WILDLIFE MANAGE, V73, P631, DOI 10.2193/2007-574; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; Langen TA, 2009, J WILDLIFE MANAGE, V73, P104, DOI 10.2193/2008-017; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Laurian C, 2008, J WILDLIFE MANAGE, V72, P1550, DOI 10.2193/2008-063; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Malo JE, 2004, J APPL ECOL, V41, P701, DOI 10.1111/j.0021-8901.2004.00929.x; Martinez JA, 2004, ARDEOLA, V51, P303; McDonald W, 2004, J APPL ECOL, V41, P82, DOI 10.1111/j.1365-2664.2004.00877.x; Mumme RL, 2000, CONSERV BIOL, V14, P501, DOI 10.1046/j.1523-1739.2000.98370.x; Neumann W, 2012, BIOL CONSERV, V145, P70, DOI 10.1016/j.biocon.2011.10.011; Parris KM, 2009, ECOL SOC, V14; PAYNE RS, 1971, J EXP BIOL, V54, P535; R Core Team, 2016, R FDN STAT COMP; Ramsden D.J., 2003, BARN OWLS MAJOR ROAD; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rivers James W., 1998, Kansas Ornithological Society Bulletin, V49, P43; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Roque Ines, 2004, Airo, V14, P11; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P459, DOI 10.1098/rspb.2000.1022; Rowland MM, 2000, J WILDLIFE MANAGE, V64, P672, DOI 10.2307/3802737; Sabino-Marques H, 2011, ECOL RES, V26, P277, DOI 10.1007/s11284-010-0781-4; Santens S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025429, 10.1371/journal.pone.0025383]; Santos-Reis M, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P147; Seiler A, 2005, J APPL ECOL, V42, P371, DOI 10.1111/j.1365-2664.2005.01013.x; Seiler A, 2003, THESIS SWEDISH U AGR; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Steen DA, 2004, CONSERV BIOL, V18, P1143, DOI 10.1111/j.1523-1739.2004.00240.x; Summers PD, 2011, J APPL ECOL, V48, P1527, DOI 10.1111/j.1365-2664.2011.02041.x; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Taylor I. R, 1994, BARN OWLS PREDATOR P; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Van Renterghem T, 2012, LANDSCAPE URBAN PLAN, V105, P199, DOI 10.1016/j.landurbplan.2011.12.017; Zuberogoitia Inigo, 1998, Ardeola, V45, P47; Zuur Alain F., 2009, P1	64	66	69	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43811	10.1371/journal.pone.0043811	http://dx.doi.org/10.1371/journal.pone.0043811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970143	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400020
J	Norton, KA; Namazi, S; Barnard, N; Fujibayashi, M; Bhanot, G; Ganesan, S; Iyatomi, H; Ogawa, K; Shinbrot, T				Norton, Kerri-Ann; Namazi, Sameera; Barnard, Nicola; Fujibayashi, Mariko; Bhanot, Gyan; Ganesan, Shridar; Iyatomi, Hitoshi; Ogawa, Koichi; Shinbrot, Troy			Automated Reconstruction Algorithm for Identification of 3D Architectures of Cribriform Ductal Carcinoma In Situ	PLOS ONE			English	Article							3-DIMENSIONAL RECONSTRUCTION; BORDER DETECTION; BREAST; SEGMENTATION; GROWTH; CLASSIFICATION; MORPHOGENESIS; MODEL; DCIS; VISUALIZATION	Ductal carcinoma in situ (DCIS) is a pre-invasive carcinoma of the breast that exhibits several distinct morphologies but the link between morphology and patient outcome is not clear. We hypothesize that different mechanisms of growth may still result in similar 2D morphologies, which may look different in 3D. To elucidate the connection between growth and 3D morphology, we reconstruct the 3D architecture of cribriform DCIS from resected patient material. We produce a fully automated algorithm that aligns, segments, and reconstructs 3D architectures from microscopy images of 2D serial sections from human specimens. The alignment algorithm is based on normalized cross correlation, the segmentation algorithm uses histogram equilization, Otsu's thresholding, and morphology techniques to segment the duct and cribra. The reconstruction method combines these images in 3D. We show that two distinct 3D architectures are indeed found in samples whose 2D histological sections are similarly identified as cribriform DCIS. These differences in architecture support the hypothesis that luminal spaces may form due to different mechanisms, either isolated cell death or merging fronds, leading to the different architectures. We find that out of 15 samples, 6 were found to have 'bubble-like' cribra, 6 were found to have 'tube-like' criba and 3 were 'unknown.' We propose that the 3D architectures found, 'bubbles' and 'tubes', account for some of the heterogeneity of the disease and may be prognostic indicators of different patient outcomes.	[Norton, Kerri-Ann; Namazi, Sameera; Bhanot, Gyan; Shinbrot, Troy] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08854 USA; [Norton, Kerri-Ann] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Barnard, Nicola] UMDNJ Robert Wood Johnson Med Sch, Dept Pathol, New Brunswick, NJ USA; [Fujibayashi, Mariko] Tokyo Womens Med Univ, Med Ctr E, Dept Surg Pathol, Tokyo, Japan; [Bhanot, Gyan] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Iyatomi, Hitoshi; Ogawa, Koichi] Hosei Univ, Dept Appl Informat, Tokyo, Japan; [Bhanot, Gyan; Ganesan, Shridar] UMDNJ Robert Wood Johnson, Sch Med, Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tokyo Women's Medical University; Institute for Advanced Study - USA; Hosei University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Norton, KA (corresponding author), Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08854 USA.	knorton4@jhmi.edu		Ogawa, Koichi/0000-0002-7137-9447	Hosei International Fund Foreign Scholars Fellowship; National Institutes of Health; New Jersey Commission on Cancer Research	Hosei International Fund Foreign Scholars Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research	This research was funded in part by the Hosei International Fund Foreign Scholars Fellowship. SG was supported by grants from the National Institutes of Health and the New Jersey Commission on Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NH, 1997, J PATHOL, V181, P374; Ando M, 2006, LECT NOTES COMPUT SC, V4046, P525, DOI 10.1007/11783237_71; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Bankhead A, 2007, J THEOR BIOL, V246, P491, DOI 10.1016/j.jtbi.2007.01.011; BARTELS PH, 1992, PATHOL RES PRACT, V188, P396, DOI 10.1016/S0344-0338(11)80026-9; Bartels PH, 1997, INT J IMAG SYST TECH, V8, P214, DOI 10.1002/(SICI)1098-1098(1997)8:2<214::AID-IMA8>3.0.CO;2-D; Celebi ME, 2007, COMPUT MED IMAG GRAP, V31, P362, DOI 10.1016/j.compmedimag.2007.01.003; Celebi ME, 2008, IEEE ENG MED BIO, P3056, DOI 10.1109/IEMBS.2008.4649848; Celebi ME, 2009, COMPUT MED IMAG GRAP, V33, P148, DOI 10.1016/j.compmedimag.2008.11.002; Chowdhury AR, 2002, IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I AND II, PROCEEDINGS, P449, DOI 10.1109/ICME.2002.1035815; Cornfield DB, 2004, CANCER, V100, P2317, DOI 10.1002/cncr.20260; Dadmanesh F, 2009, ARCH PATHOL LAB MED, V133, P26, DOI 10.1043/1543-2165-133.1.26; Davies JD, 1996, ANTICANCER RES, V16, P3971; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Diamond J, 2004, HUM PATHOL, V35, P1121, DOI 10.1016/j.humpath.2004.05.010; Eke I, 2011, RADIOTHER ONCOL, V99, P271, DOI 10.1016/j.radonc.2011.06.007; Fernandez-Aguilar S, 2005, VIRCHOWS ARCH, V447, P683, DOI 10.1007/s00428-005-0018-z; Fernandez-Gonzalez R, 2002, MICROSC RES TECHNIQ, V59, P522, DOI 10.1002/jemt.10233; Franks SJ, 2005, J THEOR BIOL, V232, P523, DOI 10.1016/j.jtbi.2004.08.032; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Going JJ, 2004, J PATHOL, V203, P538, DOI 10.1002/path.1556; Goulart R, 2002, COMPUTER AIDED MAPPI; Grin A, 2009, ARCH PATHOL LAB MED, V133, P31, DOI 10.1043/1543-2165-133.1.31; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haralick R.M., 1992, COMPUTER ROBOT VISIO, VVolume 1; Hong LC, 1997, IEEE T NUCL SCI, V44, P1297, DOI 10.1109/23.597004; Ichihara S, 2008, VIRCHOWS ARCH, V452, P41, DOI 10.1007/s00428-007-0528-y; Iyatomi H, 2010, IEEE ENG MED BIO, P5407, DOI 10.1109/IEMBS.2010.5626500; Jaffer S, 2002, MICROSC RES TECHNIQ, V59, P92, DOI 10.1002/jemt.10180; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kurien T, 2005, J CLIN PATHOL, V58, P968, DOI 10.1136/jcp.2004.024794; Lester SC, 2009, ARCH PATHOL LAB MED, V133, P13, DOI 10.1043/1543-2165-133.1.13; Lester SC, 2009, ARCH PATHOL LAB MED, V133, P15, DOI 10.1043/1543-2165-133.1.15; Macklin P, 2011, J THEOR BIOL; Mai KT, 2000, HUM PATHOL, V31, P464, DOI 10.1053/hp.2000.6536; Malandain G, 2003, LECT NOTES COMPUT SC, V2732, P487; Miller NA, 2010, CANCER INFORM, V9, P209; Munro E, 2006, CURR OPIN GENET DEV, V16, P399, DOI 10.1016/j.gde.2006.06.004; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelsona TR, 2008, MED PHYS, V35, P1078, DOI 10.1118/1.2839439; Norton KA, 2010, IEEE ENG MED BIO, P5403, DOI 10.1109/IEMBS.2010.5626499; Norton KA, 2010, J THEOR BIOL, V263, P393, DOI 10.1016/j.jtbi.2009.11.024; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohtake T, 2001, CANCER-AM CANCER SOC, V91, P2263, DOI 10.1002/1097-0142(20010615)91:12<2263::AID-CNCR1257>3.0.CO;2-5; OHUCHI N, 1985, BREAST CANCER RES TR, V5, P57, DOI 10.1007/BF01807651; Otsu N, 1975, AUTOMATICA, V11, P285; Paish EC, 2009, J CLIN PATHOL, V62, P617, DOI 10.1136/jcp.2009.065219; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Rejniak KA, 2007, J THEOR BIOL, V247, P186, DOI 10.1016/j.jtbi.2007.02.019; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Shumate SD, 2009, IEEE T BIO-MED ENG, V56, P1341, DOI 10.1109/TBME.2008.2005638; Silva AS, 2010, J THEOR BIOL, V262, P601, DOI 10.1016/j.jtbi.2009.10.031; Streicher J, 1997, ANAT REC, V248, P583; Tang J, 2011, INTEGR BIOL-UK, V3, P408, DOI 10.1039/c0ib00092b; THOMPSON D, 1995, ANAL QUANT CYTOL, V17, P314; THOMPSON D, 1993, ANAL QUANT CYTOL, V15, P236; VanderSal N., 2007, 3D RECONSTRUCTION IM; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WELLINGS SR, 1973, J NATL CANCER I, V50, P1111, DOI 10.1093/jnci/50.5.1111; Wiechmann L, 2008, CANCER-AM CANCER SOC, V112, P2130, DOI 10.1002/cncr.23430; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	63	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44011	10.1371/journal.pone.0044011	http://dx.doi.org/10.1371/journal.pone.0044011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970156	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400028
J	Bestaven, E; Guillaud, E; Cazalets, JR				Bestaven, Emma; Guillaud, Etienne; Cazalets, Jean-Rene			Is "Circling" Behavior in Humans Related to Postural Asymmetry?	PLOS ONE			English	Article							HUMAN WALKING; SPATIAL REPRESENTATION; NONVISUAL NAVIGATION; BLIND PEDESTRIANS; PATH-INTEGRATION; CURVED PATH; ORIENTATION; LOCOMOTION; STIMULATION; MOVEMENT	In attempting to walk rectilinearly in the absence of visual landmarks, persons will gradually turn in a circle to eventually become lost. The aim of the present study was to provide insights into the possible underlying mechanisms of this behavior. For each subject (N = 15) six trajectories were monitored during blindfolded walking in a large enclosed area to suppress external cues, and ground irregularities that may elicit unexpected changes in direction. There was a substantial variability from trial to trial for a given subject and between subjects who could either veer very early or relatively late. Of the total number of trials, 50% trajectories terminated on the left side, 39% on the right side and 11% were defined as "straight". For each subject, we established a "turning score" that reflected his/her preferential side of veering. The turning score was found to be unrelated to any evident biomechanical asymmetry or functional dominance (eye, hand.). Posturographic analysis, used to assess if there was a relationship between functional postural asymmetry and veering revealed that the mean position of the center of foot pressure during balance tests was correlated with the turning score. Finally, we established that the mean position of the center of pressure was correlated with perceived verticality assessed by a subjective verticality test. Together, our results suggest that veering is related to a "sense of straight ahead" that could be shaped by vestibular inputs.	[Bestaven, Emma; Guillaud, Etienne; Cazalets, Jean-Rene] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Unite Mixte Rech 5287, Bordeaux, France; [Bestaven, Emma; Guillaud, Etienne; Cazalets, Jean-Rene] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, Unite Mixte Rech 5287, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS)	Bestaven, E (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Unite Mixte Rech 5287, Bordeaux, France.	jean-rene.cazalets@u-bordeaux2.fr	Cazalets, Jean-René/D-7851-2014; GUILLAUD, Etienne/F-3824-2014	Cazalets, Jean-René/0000-0001-9047-3933; GUILLAUD, Etienne/0000-0002-4875-1458				Amorim MA, 1997, PERCEPT PSYCHOPHYS, V59, P404, DOI 10.3758/BF03211907; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Berthoz A, 1999, CURR OPIN NEUROBIOL, V9, P708, DOI 10.1016/S0959-4388(99)00041-0; Borel L, 2004, BEHAV BRAIN RES, V150, P191, DOI 10.1016/S0166-4328(03)00257-2; Borel L, 2008, NEUROPHYSIOL CLIN, V38, P375, DOI 10.1016/j.neucli.2008.09.002; Borel L, 2001, NEUROREPORT, V12, P3137, DOI 10.1097/00001756-200110080-00031; Boyadjian A, 1999, NEUROSCI LETT, V265, P21, DOI 10.1016/S0304-3940(99)00198-6; Carroll T, 1929, 314 NAT ADV COMM AER; Cicinelli J., 1989, VEER FUNCTION PREVIE; Cohen HS, 2000, J VESTIBUL RES-EQUIL, V10, P7; Courtine G, 2003, EUR J NEUROSCI, V18, P191, DOI 10.1046/j.1460-9568.2003.02737.x; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Cratty B. J., 1967, AM FDN BLIND RES B, V14, P13; Cratty B.J., 1966, PERCEPTUAL THRESHO 2; CRATTY BJ, 1965, PERCEPTUAL THRESHO 1; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Fitzpatrick RC, 1999, J PHYSIOL-LONDON, V517, P931, DOI 10.1111/j.1469-7793.1999.0931s.x; FRIEDMANN G, 1970, BRAIN, V93, P313, DOI 10.1093/brain/93.2.313; Glasauer S, 2002, EXP BRAIN RES, V145, P489, DOI 10.1007/s00221-002-1146-1; Grasso R, 1998, NEUROSCI LETT, V253, P115, DOI 10.1016/S0304-3940(98)00625-9; Guldberg FO, 1897, Z BIOL, V35, P419; Guldberg GA, 1896, BIOL CENTRALBL, V16, P806; GUTH D, 1994, J VISUAL IMPAIR BLIN, V88, P391; GUTH D, 1995, J VISUAL IMPAIR BLIN, V89, P28; Iles JF, 2007, EXP BRAIN RES, V178, P151, DOI 10.1007/s00221-006-0721-2; Ivanenko YP, 2011, HUM MOVEMENT SCI, V30, P341, DOI 10.1016/j.humov.2010.04.001; Kallie CS, 2007, J EXP PSYCHOL HUMAN, V33, P183, DOI 10.1037/0096-1523.33.1.183; KLATZKY RL, 1990, J MOTOR BEHAV, V22, P19; Lacour M, 2006, CURR MED RES OPIN, V22, P1651, DOI 10.1185/030079906X115694; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Lee SA, 2010, EXP BRAIN RES, V206, P179, DOI 10.1007/s00221-010-2349-5; Marques B, 2007, EXP BRAIN RES, V183, P457, DOI 10.1007/s00221-007-1063-4; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; Mittelstaedt ML, 2001, EXP BRAIN RES, V139, P318, DOI 10.1007/s002210100735; Mohr C, 2004, BEHAV BRAIN RES, V151, P321, DOI 10.1016/j.bbr.2003.09.006; Mohr C, 2007, LATERALITY, V12, P172, DOI 10.1080/13576500601051580; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Philbeck JW, 2001, J EXP PSYCHOL HUMAN, V27, P141, DOI 10.1037/0096-1523.27.1.141; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Schaeffer AA, 1928, ANAT REC, V34, P115; Schafffer AA, 1928, J MORPHOL PHYSIOL, V45, P293, DOI 10.1002/jmor.1050450110; ScientificAmerican, 1893, WHY LOST PEOPL WALK; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; Takei Y, 1997, EXP BRAIN RES, V115, P361, DOI 10.1007/PL00005705; TAKEMORI S, 1985, ORL-J OTO-RHIN-LARYN, V47, P76, DOI 10.1159/000275748; Vibert D, 2000, ACTA OTO-LARYNGOL, V120, P620, DOI 10.1080/000164800750000432; Vieilledent S, 2003, COGNITIVE BRAIN RES, V16, P238, DOI 10.1016/S0926-6410(02)00279-3	48	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43861	10.1371/journal.pone.0043861	http://dx.doi.org/10.1371/journal.pone.0043861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957035	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800027
J	Kamoi, M; Ogawa, Y; Nakamura, S; Dogru, M; Nagai, T; Obata, H; Ito, M; Kaido, M; Kawakita, T; Okada, Y; Kawakami, Y; Shimmura, S; Tsubota, K				Kamoi, Mizuka; Ogawa, Yoko; Nakamura, Shigeru; Dogru, Murat; Nagai, Toshihiro; Obata, Hiroto; Ito, Masataka; Kaido, Minako; Kawakita, Tetsuya; Okada, Yasunori; Kawakami, Yutaka; Shimmura, Shigeto; Tsubota, Kazuo			Accumulation of Secretory Vesicles in the Lacrimal Gland Epithelia Is Related to Non-Sjogren's Type Dry Eye in Visual Display Terminal Users	PLOS ONE			English	Article							REGULATED EXOCYTOSIS; OCULAR SURFACE; VAMP8/ENDOBREVIN; BLINKING; RAB3D; WORK	Previous observations in a rat model of a non-Sjogren's syndrome (non-SS) type of dry eye seen in users of visual display terminals (VDT) indicated that secretory vesicle (SV) accumulation in the lacrimal gland epithelia contributes to the condition. Here, to examine this possibility in humans, we compared the lacrimal gland histology and percent SV area in the cytoplasm of acinar epithelial cells using light microscopy and transmission electron microscopy, in patients with VDT work-related non-SS dry-eye (VDT group), SS-induced dry-eye, and autopsied normal controls. In addition, the VAMP8 (vesicle-associated membrane protein 8, an exocrine-pathway molecule) and Rab3D (mature vesicle marker) were histochemically examined in lacrimal gland tissue sections. The lacrimal gland acini were larger in the VDT group than in the SS group, and the percent SV area was significantly higher in the VDT group than in the normal controls (P = 0.021) or SS group (P = 0.004). Immunostaining revealed abnormal distributions of VAMP8 in the VDT and SS groups. Rab3D was more strongly expressed in the cytoplasm of acinar epithelial cells in the VDT group than in that of normal controls. The duration of VDT use was significantly longer in the VDT group than in the other groups. These findings suggest that excessive SV accumulation in the acinar epithelia may contribute to the reduced tear secretion in VDT users.	[Kamoi, Mizuka; Ogawa, Yoko; Nakamura, Shigeru; Dogru, Murat; Kaido, Minako; Kawakita, Tetsuya; Shimmura, Shigeto; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Nagai, Toshihiro; Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Obata, Hiroto] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan; [Ito, Masataka] Natl Def Med Coll, Dept Dev Anat & Regenerat Biol, Saitama, Japan; [Kawakami, Yutaka] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan	Keio University; Keio University; Jichi Medical University; National Defense Medical College - Japan; Keio University	Kamoi, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	yoko@z7.keio.jp	Okada, Yasunori/B-5550-2014; Kawakami, Yutaka/E-7429-2013; Ogawa, Yoko/AAV-1932-2021; Shimmura, Shigeto/J-4678-2013	Okada, Yasunori/0000-0001-9208-4755; Kawakami, Yutaka/0000-0003-4836-2855; Ogawa, Yoko/0000-0002-2906-9621; 	Japanese Ministry of Education, Science, Sports and Culture [24791877]; Japanese Medical Association; Grants-in-Aid for Scientific Research [24791877] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Medical Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japanese Ministry of Education, Science, Sports and Culture (no. 24791877 to Mizuka Kamoi), and the Japanese Medical Association 2010 (to Yoko Ogawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; Evans E, 2008, AM J PHYSIOL-CELL PH, V294, pC662, DOI 10.1152/ajpcell.00623.2006; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; FOX RI, 1986, ARTHRITIS RHEUM-US, V29, P577, DOI 10.1002/art.1780290501; Hollander M., 1999, NONPARAMETRIC STAT M, Vsecond, P106; Ishida R, 2005, AM J OPHTHALMOL, V139, P253, DOI 10.1016/j.ajo.2004.08.075; Kojima T, 2011, AM J OPHTHALMOL, V152, P933, DOI 10.1016/j.ajo.2011.05.025; Kokolakis G, 2008, J IMMUNOL METHODS, V331, P140, DOI 10.1016/j.jim.2007.12.013; Lemp Michael A., 1995, CLAO Journal, V21, P221; Lemp MA, 2007, OCUL SURF, V5, P75; Nakamura S, 2005, INVEST OPHTH VIS SCI, V46, P2379, DOI 10.1167/iovs.04-1344; Nakamura S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011119; Noma H, 2011, JPN J OPHTHALMOL, V55, P248, DOI 10.1007/s10384-011-0016-4; OBATA H, 1995, OPHTHALMOLOGY, V102, P678, DOI 10.1016/S0161-6420(95)30971-2; Obata H, 2006, CORNEA, V25, pS82, DOI 10.1097/01.ico.0000247220.18295.d3; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Rios JD, 2005, EXP EYE RES, V80, P477, DOI 10.1016/j.exer.2004.10.012; Rocha EM, 2008, OCUL SURF, V6, P162, DOI 10.1016/S1542-0124(12)70177-5; Sato N, 1992, J EYE, V9, P1739; Shimazaki J, 2007, ATARASHII GANKA, V24, P181; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; Tsubota K, 1996, LANCET, V347, P768, DOI 10.1016/S0140-6736(96)90122-1; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Wang YR, 2003, J CELL SCI, V116, P2051, DOI 10.1242/jcs.00398; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030; Wu KJ, 2006, EXP EYE RES, V83, P84, DOI 10.1016/j.exer.2005.11.009	32	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43688	10.1371/journal.pone.0043688	http://dx.doi.org/10.1371/journal.pone.0043688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962587	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600015
J	Kverka, M; Ulcova-Gallova, Z; Bartova, J; Cibulka, J; Bibkova, K; Micanova, Z; Tlaskalova-Hogenova, H				Kverka, Miloslav; Ulcova-Gallova, Zdenka; Bartova, Jirina; Cibulka, Jan; Bibkova, Katarina; Micanova, Zdenka; Tlaskalova-Hogenova, Helena			Sperm Cells Induce Distinct Cytokine Response in Peripheral Mononuclear Cells from Infertile Women with Serum Anti-Sperm Antibodies	PLOS ONE			English	Article							IMMUNE-RESPONSES; GROWTH-FACTOR; ENDOMETRIOSIS; ABORTION; SYSTEM; FLUID	Background and Aims: Anti-sperm antibodies in can markedly reduce the likelihood of natural conception. The etiology of this anti-sperm immunity in human females is unknown. We compared the cytokine response of peripheral blood mononuclear cells (PBMCs) from infertile patients with or without anti-sperm antibodies (ASA) and fertile women. Methodology/Principal Findings: We cultivated the PBMCs together with sperm antigens (whole cells or cell lysate), and screened the supernatants for 40 cytokines by antibody array. When stimulated with whole sperm cells, the PBMCs from patients with ASA produce less IL-3, IL-11, IL-13, ICAM-1, GCSF and more IL-2, IL-4 and IL-12p70 as compared to healthy women. PBMCs from patients with ASA produce typically less IL-13, IL-7, IL-17 and MIG, and more MIP-1 beta and IL-8, as compared to PBMCs from patients without ASA. In response to sperm cell lysate, PBMCs from infertile women without ASA respond initially by increase in production of growth factors (GCSF, GM-CSF and PDGF-BB) followed by increase in chemokines (e.g. IL-8, MCP-1 and MIP-1 beta). Conclusions: Cellular immune responses to sperm antigens, measured by production of cytokines, differ among infertile women with ASA, infertile women without ASA and healthy women. This difference could play an important role in the initial steps of the infertility pathogenesis.	[Kverka, Miloslav; Tlaskalova-Hogenova, Helena] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic; [Ulcova-Gallova, Zdenka; Cibulka, Jan; Bibkova, Katarina; Micanova, Zdenka] Charles Univ Prague, Dept Gynecol & Obstet, Plzen, Czech Republic; [Ulcova-Gallova, Zdenka; Cibulka, Jan; Bibkova, Katarina; Micanova, Zdenka] Fac Hosp, Plzen, Czech Republic; [Bartova, Jirina] Charles Univ Prague, Fac Med 1, Gen Univ Hosp, Inst Dent Res, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; General University Hospital Prague	Kverka, M (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic.	ulcova@fnplzen.cz	Tlaskalová-Hogenová, Helena/J-8008-2014; Kverka, Miloslav/H-2507-2014	Kverka, Miloslav/0000-0002-1335-5252	Ministry of Education, Youth and Sports of the Czech Republic [MSM 002 1620812]; Institutional Research Concept [RVO: 61388971]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept	This work was supported by a grant of the Ministry of Education, Youth and Sports of the Czech Republic (MSM 002 1620812) and by Institutional Research Concept (RVO: 61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaouat G, 2004, INT ARCH ALLERGY IMM, V134, P93, DOI 10.1159/000074300; CHAOUAT G, 1990, J REPROD FERTIL, V89, P447; Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9; CZERKINSKY C, 1987, P NATL ACAD SCI USA, V84, P2449, DOI 10.1073/pnas.84.8.2449; Friberg J, 1974, Acta Obstet Gynecol Scand Suppl, V36, P31; Fukushi J, 2000, J IMMUNOL, V165, P2818, DOI 10.4049/jimmunol.165.5.2818; Gallinelli A, 2004, GYNECOL ENDOCRINOL, V18, P144, DOI 10.1080/09513590310001653044; Hammadeh ME, 2003, AM J REPROD IMMUNOL, V50, P124, DOI 10.1034/j.1600-0897.2003.00056.x; HILL JA, 1987, J IMMUNOL, V139, P2250; HJORT T, 1988, HUM REPROD, V3, P59, DOI 10.1093/oxfordjournals.humrep.a136652; Kamada Masaharu, 1999, Journal of Medical Investigation, V46, P19; Koumantaki Y, 2001, EUR J OBSTET GYN R B, V98, P66, DOI 10.1016/S0301-2115(01)00289-5; Kverka M, 2007, CLIN CHEM, V53, P955, DOI 10.1373/clinchem.2006.077107; MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892; MCSHANE PM, 1985, JAMA-J AM MED ASSOC, V253, P3555, DOI 10.1001/jama.253.24.3555; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; NAZ RK, 1989, BIOL REPROD, V41, P533, DOI 10.1095/biolreprod41.3.533; Ostanin AA, 2007, B EXP BIOL MED+, V143, P75, DOI 10.1007/s10517-007-0021-2; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; Robertson SA, 2000, REV REPROD, V5, P164, DOI 10.1530/revreprod/5.3.164; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Somigliana E, 1996, HUM REPROD, V11, P1190; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulcova-Gallova Z, 2010, J REPROD IMMUNOL, V86, P115, DOI 10.1016/j.jri.2010.07.002; Ulcova-Gallova Z, 2000, Zentralbl Gynakol, V122, P495, DOI 10.1055/s-2000-10611; WELCH PA, 1989, J IMMUNOL, V143, P3562; WHO, 1999, WHO LAB MAN EX HUM S, P1; Wira CR, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1661, DOI 10.1016/B978-012491543-5/50101-7; Zdenka U-G., 2005, J REPROD CONTRACEPT, V16, P35; Zhao Ying, 2003, Methods Mol Biol, V224, P183	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44172	10.1371/journal.pone.0044172	http://dx.doi.org/10.1371/journal.pone.0044172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952917	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300058
J	Song, GL; Li, Q; Long, Y; Gu, QL; Hackett, PB; Cui, ZB				Song, Guili; Li, Qing; Long, Yong; Gu, Qilin; Hackett, Perry B.; Cui, Zongbin			Effective Gene Trapping Mediated by Sleeping Beauty Transposon	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MESSENGER-RNA DECAY; INSERTIONAL MUTAGENESIS; FUNCTIONAL-ANALYSIS; GENOME-WIDE; LARGE-SCALE; MOUSE; ZEBRAFISH; EXPRESSION; MICE	Gene trapping is a high-throughput approach to elucidate gene functions by disrupting and recapitulating expression of genes in a target genome. A number of transposon-based gene-trapping systems are developed for mutagenesis in cells and model organisms, but there is still much room for the improvement of their efficiency in gene disruption and mutation. Herein, a gene-trapping system mediated by Sleeping Beauty (SB) transposon was developed by inclusion of three functional cassettes. The mutation cassette can abrogate the splice of trapped genes and terminate their translation. Once an endogenous gene is captured, the finding cassette independently drives the translation of reporter gene in HeLa cells and zebrafish embryos. The efficiency cassette controls the remobilization of integrated traps through inducible expression of SB gene. Analysis of transposon-genome junctions indicate that most of trap cassettes are integrated into an intron without an obvious 39 bias. The transcription of trapped genes was abrogated by alternative splicing of the mutation cassette. In addition, integrated transposons can be induced to excise from their original insertion sites. Furthermore, the Cre/LoxP system was introduced to delete the efficiency cassette for stabilization of gene interruption and bio-safety. Thus, this gene-trap vector is an alternative and effective tool for the capture and disruption of endogenous genes in vitro and in vivo.	[Song, Guili; Li, Qing; Long, Yong; Gu, Qilin; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Song, Guili; Gu, Qilin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hackett, Perry B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Minnesota System; University of Minnesota Twin Cities	Song, GL (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zbcui@ihb.ac.cn	Gu, Qilin/H-3911-2017	Gu, Qilin/0000-0001-9193-077X	National Basic Research Program of China [2012CB944500]; National Natural Science Foundation of China [30871442]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (#2012CB944500) and the National Natural Science Foundation of China (#30871442 to Z. Cui). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; Amsterdam A, 2011, METHOD CELL BIOL, V104, P59, DOI 10.1016/B978-0-12-374814-0.00004-5; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Balciunas D, 2005, ZEBRAFISH, V1, P335, DOI 10.1089/zeb.2005.1.335; Bjarnadottir H, 2005, J BIOTECHNOL, V117, P173, DOI 10.1016/j.jbiotec.2005.01.016; Boeuf P, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-5; Bonaldo P, 1998, EXP CELL RES, V244, P125, DOI 10.1006/excr.1998.4208; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Carlson CM, 2005, NAT REV GENET, V6, P568, DOI 10.1038/nrg1638; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; De-Zolt Silke, 2009, V530, P29, DOI 10.1007/978-1-59745-471-1_3; Driever W, 1996, DEVELOPMENT, V123, P37; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Fahrenkrug SC, 1999, MAR BIOTECHNOL, V1, P552, DOI 10.1007/PL00011810; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; Galla M, NUCL ACIDS RES; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-30; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hackett PB, 2005, ADV GENET, V54, P189, DOI 10.1016/S0065-2660(05)54009-4; Haffter P, 1996, DEVELOPMENT, V123, P1; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Izsvak Z, 2005, NAT METHODS, V2, P735, DOI 10.1038/nmeth1005-735; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Largaespada David A., 2009, V530, P379, DOI 10.1007/978-1-59745-471-1_20; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YY, 2011, J BIOL CHEM, V286, P45116, DOI 10.1074/jbc.M111.267328; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Liu Z J, 1990, DNA Seq, V1, P125, DOI 10.3109/10425179009016040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClive P, 1998, DEV DYNAM, V212, P267, DOI 10.1002/(SICI)1097-0177(199806)212:2<267::AID-AJA11>3.0.CO;2-1; Medico E, 2001, NAT BIOTECHNOL, V19, P579, DOI 10.1038/89343; Mikkola HKA, 2004, METH MOLEC MED, V105, P3; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; Misra RP, 2002, ENDOCRINE, V19, P229, DOI 10.1385/ENDO:19:3:229; Molina A, 2001, BIOCHEM J, V356, P353, DOI 10.1042/0264-6021:3560353; Ni Jun, 2008, Briefings in Functional Genomics & Proteomics, V7, P444, DOI 10.1093/bfgp/eln049; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schnuetgen F, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn603; Shigeoka T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni022; Sinzelle L, 2008, P NATL ACAD SCI USA, V105, P4715, DOI 10.1073/pnas.0707746105; Sivasubbu S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S9; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Talbot WS, 2000, GENE DEV, V14, P755; Thorey IS, 1998, MOL CELL BIOL, V18, P3081, DOI 10.1128/MCB.18.5.3081; Tsakiridis A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp640; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang XQ, 2005, CLIN CANCER RES, V11, P483; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Xin HB, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni016; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yant SR, 2003, MOL CELL BIOL, V23, P8505, DOI 10.1128/MCB.23.23.8505-8518.2003; Yergeau DA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-11; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	81	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44123	10.1371/journal.pone.0044123	http://dx.doi.org/10.1371/journal.pone.0044123			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952894	gold, Green Submitted, Green Published			2022-12-25	WOS:000308221300053
J	Bakker, MG; Tu, ZJ; Bradeen, JM; Kinkel, LL				Bakker, Matthew G.; Tu, Zheng J.; Bradeen, James M.; Kinkel, Linda L.			Implications of Pyrosequencing Error Correction for Biological Data Interpretation	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; QUALITY; READS; SOIL	There has been a rapid proliferation of approaches for processing and manipulating second generation DNA sequence data. However, users are often left with uncertainties about how the choice of processing methods may impact biological interpretation of data. In this report, we probe differences in output between two different processing pipelines: a de-noising approach using the AmpliconNoise algorithm for error correction, and a standard approach using quality filtering and preclustering to reduce error. There was a large overlap in reads culled by each method, although AmpliconNoise removed a greater net number of reads. Most OTUs produced by one method had a clearly corresponding partner in the other. Although each method resulted in OTUs consisting entirely of reads that were culled by the other method, there were many more such OTUs formed in the standard pipeline. Total OTU richness was reduced by AmpliconNoise processing, but per-sample OTU richness, diversity and evenness were increased. Increases in per-sample richness and diversity may be a result of AmpliconNoise processing producing a more even OTU rank-abundance distribution. Because communities were randomly subsampled to equalize sample size across communities, and because rare sequence variants are less likely to be selected during subsampling, fewer OTUs were lost from individual communities when subsampling AmpliconNoise-processed data. In contrast to taxon-based diversity estimates, phylogenetic diversity was reduced even on a per-sample basis by de-noising, and samples switched widely in diversity rankings. This work illustrates the significant impacts of processing pipelines on the biological interpretations that can be made from pyrosequencing surveys. This study provides important cautions for analyses of contemporary data, for requisite data archiving (processed vs. non-processed data), and for drawing comparisons among studies performed using distinct data processing pipelines.	[Bakker, Matthew G.; Bradeen, James M.; Kinkel, Linda L.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Tu, Zheng J.] Univ Minnesota, Inst Supercomp, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bakker, MG (corresponding author), Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA.	matt.g.bakker@gmail.com	Bakker, Matthew/B-8610-2013	Bakker, Matthew/0000-0003-0345-0587; Bradeen, James/0000-0003-1930-4728	National Science Foundation; Mustard Seed Foundation; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, through the Microbial Observatories program [2006-04464]	National Science Foundation(National Science Foundation (NSF)); Mustard Seed Foundation; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, through the Microbial Observatories program	MGB gratefully acknowledges support from the National Science Foundation (Graduate Research Fellowship) and the Mustard Seed Foundation (Harvey Fellows program). Funding was provided by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, through the Microbial Observatories program (grant number 2006-04464 to LLK and JMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McVeigh HP, 1996, J IND MICROBIOL, V17, P197, DOI 10.1007/BF01574693; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rintala H, 2001, MOL CELL PROBE, V15, P337, DOI 10.1006/mcpr.2001.0379; Schlatter DC, 2010, APPL ENVIRON MICROB, V76, P2009, DOI 10.1128/AEM.02320-09; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	24	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44357	10.1371/journal.pone.0044357	http://dx.doi.org/10.1371/journal.pone.0044357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952965	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500064
J	Pan, LT; Wang, XX; Yang, SY; Wu, X; Lee, I; Zhang, XZ; Rupp, RA; Xu, JJ				Pan, Leiting; Wang, Xiaoxu; Yang, Shuying; Wu, Xian; Lee, Imshik; Zhang, Xinzheng; Rupp, Romano A.; Xu, Jingjun			Ultraviolet Irradiation-Dependent Fluorescence Enhancement of Hemoglobin Catalyzed by Reactive Oxygen Species	PLOS ONE			English	Article							VITAMIN-C; PHOTODYNAMIC THERAPY; HEME DEGRADATION; VISIBLE-LIGHT; RADIATION; ERYTHROCYTES; PEROXIDE; BLOOD; SKIN	Ultraviolet (UV) light has a potent effect on biological organisms. Hemoglobin, an oxygen-transport protein, plays an irreplaceable role in sustaining life of all vertebrates. In this study we scrutinize the effects of ultraviolet irradiation (UVI) as well as visible irradiation on the flourescence characteristics of bovine hemoglobin (BHb) in vitro. Data show that UVI results in flourescence enhancement of BHb in a dose-dependent manner. Furthermore, UVI-induced flourencence enhancement is significantly increased when BHb is pretreated with hydrogen peroxide (H2O2), a tye of reactive oxygen species (ROS). Meanwhile, The water-soluble antioxidant vitamin C suppresses this UVI-induced flourescence enhancement. In contrast, green light irradiation does not lead to flourescence enhancement of BHb no matter whether H2O2 is acting on the BHb solution or not. Taken together, these results indicate that catalysis of ROS and UVI-dependent irradiation play two key roles in the process of UVI-induced flourescence enhancement of BHb.	[Pan, Leiting; Wang, Xiaoxu; Yang, Shuying; Wu, Xian; Lee, Imshik; Zhang, Xinzheng; Rupp, Romano A.; Xu, Jingjun] Nankai Univ, TEDA Appl Phys Sch, Minist Educ, Key Lab Weak Light Nonlinear Photon, Tianjin 300071, Peoples R China; [Pan, Leiting; Wang, Xiaoxu; Yang, Shuying; Wu, Xian; Lee, Imshik; Zhang, Xinzheng; Rupp, Romano A.; Xu, Jingjun] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Rupp, Romano A.] Univ Vienna, Fac Phys, Vienna, Austria	Nankai University; Nankai University; University of Vienna	Pan, LT (corresponding author), Nankai Univ, TEDA Appl Phys Sch, Minist Educ, Key Lab Weak Light Nonlinear Photon, Tianjin 300071, Peoples R China.	plt@nankai.edu.cn; jjxu@nankai.edu.cn	Zhang, Xinzheng/C-5703-2009; xu, jing/GRR-8698-2022; Pan, Leiting/F-5001-2010; Lee, Imshik/G-6129-2010; Jingjun, Xu/A-1282-2010	Zhang, Xinzheng/0000-0001-8128-3273; Lee, Imshik/0000-0002-0098-392X; 	Specialized Research Fund for the Doctoral Program of Higher Education (New Teachers) [20110031120004]; Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [11074133]; National Basic Research Program of China [2007CB307002, 2010CB934101]; 111 project [B07013]; International S&T cooperation program of China [2011DFA52870]	Specialized Research Fund for the Doctoral Program of Higher Education (New Teachers)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); 111 project(Ministry of Education, China - 111 Project); International S&T cooperation program of China	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (New Teachers) (No. 20110031120004), the Fundamental Research Funds for the Central Universities, the National Natural Science Foundation of China (No. 11074133), the National Basic Research Program of China (Nos. 2007CB307002, 2010CB934101), 111 project (No. B07013) and International S&T cooperation program of China (2011DFA52870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CU A, 1975, J AM CHEM SOC, V97, P2579, DOI 10.1021/ja00842a066; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Farris PK, 2005, DERMATOL SURG, V31, P814; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; HEITZER T, 1996, NY TIMES        1026, V94, P6; Hussein MR, 2005, J CUTAN PATHOL, V32, P191, DOI 10.1111/j.0303-6987.2005.00281.x; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kaestner L, 2006, CELL CALCIUM, V39, P13, DOI 10.1016/j.ceca.2005.09.004; Kaestner L, 2004, PHOTOCH PHOTOBIO SCI, V3, P981, DOI 10.1039/b403127j; Krukoski DW, 2009, HEMATOLOGY, V14, P168, DOI 10.1179/102453309X402296; Lavi R, 2003, J BIOL CHEM, V278, P40917, DOI 10.1074/jbc.M303034200; Lavi R, 2010, LASER SURG MED, V42, P473, DOI 10.1002/lsm.20919; Lin JY, 2003, J AM ACAD DERMATOL, V48, P866, DOI 10.1067/mjd.2003.425; Longstreth J, 1998, J PHOTOCH PHOTOBIO B, V46, P20, DOI 10.1016/S1011-1344(98)00183-3; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Nagababu E, 1998, BIOCHEM BIOPH RES CO, V247, P592, DOI 10.1006/bbrc.1998.8846; Nghiem DX, 2001, J INVEST DERMATOL, V117, P1193, DOI 10.1046/j.0022-202x.2001.01503.x; Pamphilon DH, 1998, VOX SANG, V74, P15, DOI 10.1111/j.1423-0410.1998.tb05395.x; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Rowen RJ, 1996, INT J BIOSOCIAL MED, V14, P115; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Svobodova AR, 2011, BIOL PHARM BULL, V34, P471; Valencia A, 2006, FREE RADICAL BIO MED, V40, P641, DOI 10.1016/j.freeradbiomed.2005.09.036; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Yu L, 1997, CHINESE J MED PHYS, V14, P136; Zhao J, 2008, INT J MOL SCI, V9, P145, DOI 10.3390/ijms9020145	27	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44142	10.1371/journal.pone.0044142	http://dx.doi.org/10.1371/journal.pone.0044142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952902	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500049
J	Zhao, M; Sun, JC; Zhao, ZM				Zhao, Min; Sun, Jingchun; Zhao, Zhongming			Distinct and Competitive Regulatory Patterns of Tumor Suppressor Genes and Oncogenes in Ovarian Cancer	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; SIGNALING INDUCES APOPTOSIS; CELL-CYCLE; REPRODUCTIVE FACTORS; HMGA2 GENE; EXPRESSION; BIOLOGY; NETWORK; OVEREXPRESSION; SUSCEPTIBILITY	Background: So far, investigators have found numerous tumor suppressor genes (TSGs) and oncogenes (OCGs) that control cell proliferation and apoptosis during cancer development. Furthermore, TSGs and OCGs may act as modulators of transcription factors (TFs) to influence gene regulation. A comprehensive investigation of TSGs, OCGs, TFs, and their joint target genes at the network level may provide a deeper understanding of the post-translational modulation of TSGs and OCGs to TF gene regulation. Methodology/Principal Findings: In this study, we developed a novel computational framework for identifying target genes of TSGs and OCGs using TFs as bridges through the integration of protein-protein interactions and gene expression data. We applied this pipeline to ovarian cancer and constructed a three-layer regulatory network. In the network, the top layer was comprised of modulators (TSGs and OCGs), the middle layer included TFs, and the bottom layer contained target genes. Based on regulatory relationships in the network, we compiled TSG and OCG profiles and performed clustering analyses. Interestingly, we found TSGs and OCGs formed two distinct branches. The genes in the TSG branch were significantly enriched in DNA damage and repair, regulating macromolecule metabolism, cell cycle and apoptosis, while the genes in the OCG branch were significantly enriched in the ErbB signaling pathway. Remarkably, their specific targets showed a reversed functional enrichment in terms of apoptosis and the ErbB signaling pathway: the target genes regulated by OCGs only were enriched in anti-apoptosis and the target genes regulated by TSGs only were enriched in the ErbB signaling pathway. Conclusions/Significance: This study provides the first comprehensive investigation of the interplay of TSGs and OCGs in a regulatory network modulated by TFs. Our application in ovarian cancer revealed distinct regulatory patterns of TSGs and OCGs, suggesting a competitive regulatory mechanism acting upon apoptosis and the ErbB signaling pathway through their specific target genes.	[Zhao, Min; Sun, Jingchun; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Ctr Quantitat Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zhao, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Zhao, Min/J-6588-2019	Zhao, Min/0000-0001-5498-3434	National Institutes of Health [R01LM011177]; National Institutes of Health (VICC Cancer Center Core grant) [P30CA68485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (VICC Cancer Center Core grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was partially supported by grants from National Institutes of Health (R01LM011177 and the VICC Cancer Center Core grant P30CA68485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Aronson AR, 2004, STUD HEALTH TECHNOL, V107, P268; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Beleza-Meireles A, 2008, EUR J ENDOCRINOL, V158, P729, DOI 10.1530/EJE-07-0793; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Campan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028141; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Dwyer J, 2007, ANN NY ACAD SCI, V1114, P36, DOI 10.1196/annals.1396.022; Everett L, 2010, METHODS MOL BIOL, V674, P297, DOI 10.1007/978-1-60761-854-6_19; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Guler G, 2011, BREAST CANCER RES TR, V129, P421, DOI 10.1007/s10549-010-1248-6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HANKINSON SE, 1995, CANCER, V76, P284, DOI 10.1002/1097-0142(19950715)76:2<284::AID-CNCR2820760219>3.0.CO;2-5; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Holmes KA, 2008, CANCER RES, V68, P7380, DOI 10.1158/0008-5472.CAN-08-0133; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang Y, 2011, J LEUKOCYTE BIOL, V90, P87, DOI 10.1189/jlb.1210674; Hunter DS, 2002, CANCER RES, V62, P3766; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jia P, 2010, MOL PSYCHIATR, V15, P453, DOI 10.1038/mp.2009.93; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Khanna A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017979; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Klein G, 2002, TUMOR SUPPRESSOR GEN, P491; Konnikova L, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-23; KVALE G, 1988, INT J CANCER, V42, P246, DOI 10.1002/ijc.2910420217; Leung PCK, 2007, HUM REPROD UPDATE, V13, P143, DOI 10.1093/humupd/dml002; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Mahajan A, 2010, MODERN PATHOL, V23, P673, DOI 10.1038/modpathol.2010.49; Malek A, 2008, INT J CANCER, V123, P348, DOI 10.1002/ijc.23491; Martinez LA, 2010, MOL CELL BIOL, V30, P524, DOI 10.1128/MCB.00938-09; Osborne C, 2004, ONCOLOGIST, V9, P361, DOI 10.1634/theoncologist.9-4-361; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Park C, 2006, INT J MOL MED, V17, P715; R Development Core Team, 2008, R LANG ENV STAT COMP; Rebbeck TR, 2004, NAT REV GENET, V5, P589, DOI 10.1038/nrg1403; Riddick G, 2011, NAT REV NEUROL, V7, P439, DOI 10.1038/nrneurol.2011.100; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; SCHWAB M, 1989, BIOCHIM BIOPHYS ACTA, V989, P49, DOI 10.1016/0304-419X(89)90034-6; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shelton DN, 2011, P OBST GYN, V2, P16; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Takai N, 2002, INT J MOL MED, V9, P287; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; Teng CB, 2004, REPRODUCTION, V128, P197, DOI 10.1530/rep.1.00053; Trinh XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022469; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Xu DK, 2002, EMBO J, V21, P4081, DOI 10.1093/emboj/cdf413	76	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44175	10.1371/journal.pone.0044175	http://dx.doi.org/10.1371/journal.pone.0044175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952919	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500052
J	Blas, MM; Alva, IE; Garcia, PJ; Carcamo, C; Montano, SM; Munante, R; Zunt, JR				Blas, Magaly M.; Alva, Isaac E.; Garcia, Patricia J.; Carcamo, Cesar; Montano, Silvia M.; Munante, Ricardo; Zunt, Joseph R.			Association between Human Papillomavirus and Human T-Lymphotropic Virus in Indigenous Women from the Peruvian Amazon	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEMALE SEX WORKERS; RISK-FACTORS; CERVICAL NEOPLASIA; HUMAN RETROVIRUSES; I INFECTION; HTLV-I/II; PREVALENCE; GRADE; ABNORMALITIES	Background: No association between the Human T-cell lymphotropic virus (HTLV), an oncogenic virus that alters host immunity, and the Human Papillomavirus (HPV) has previously been reported. Examining the association between these two viruses may permit the identification of a population at increased risk for developing cervical cancer. Methods and Findings: Between July 2010 and February 2011, we conducted a cross-sectional study among indigenous Amazonian Peruvian women from the Shipibo-Konibo ethnic group, a group with endemic HTLV infection. We recruited women between 15 and 39 years of age who were living in the cities of Lima and Ucayali. Our objectives were to determine the association between HTLV and: (i) HPV infection of any type, and (ii) high-risk HPV type infection. Sexually active Shipibo-Konibo women were screened for HTLV-1 and HTLV-2 infections. All HTLV-1 or -2 positive women, along with two community-matched HTLV negative sexually active Shipibo-Konibo controls were later tested for the presence of HPV DNA, conventional cytology, and HIV. We screened 1,253 Shipibo-Konibo women, observing a prevalence of 5.9% (n = 74) for HTLV-1 and 3.8% (n = 47) for HTLV-2 infections. We enrolled 62 (60.8%) HTLV-1 positive women, 40 (39.2%) HTLV-2 positive women, and 205 community-matched HTLV negative controls. HTLV-1 infection was strongly associated with HPV infection of any type (43.6% vs. 29.3%; Prevalence Ratio (PR): 2.10, 95% CI: 1.53-2.87), and with high-risk HPV infection (32.3% vs. 22.4%; PR: 1.93, 95% CI: 1.04-3.59). HTLV-2 was not significantly associated with either of these HPV infections. Conclusions: HTLV-1 infection was associated with HPV infection of any type and with high-risk HPV infection. Future longitudinal studies are needed to evaluate the incidence of high-risk HPV infection as well as the incidence of cervical neoplasia among HTLV-1 positive women.	[Blas, Magaly M.; Alva, Isaac E.; Garcia, Patricia J.; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru; [Montano, Silvia M.] US Naval Med Res Unit 6 NAMRU 6, Lima, Peru; [Munante, Ricardo] Minist Hlth, Ucayali Reg Hlth Directorate, Ucayali, Peru; [Zunt, Joseph R.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Neurol Global Hlth & Med, Seattle, WA USA	Universidad Peruana Cayetano Heredia; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Blas, MM (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru.	magaly.blas.b@upch.pe	Zunt, Joseph/ABD-2886-2021		International Clinical Research Fellows Program at Vanderbilt University [R24 TW007988]; Fogarty International Center/National Institutes of Health (FIC/NIH) [R01 TW008398, RO1 NS055627]; Merck Co., Inc.; indigenous health program; regional organization (ORAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP); regional organization (FECONAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP); FOGARTY INTERNATIONAL CENTER [R01TW008398, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055627] Funding Source: NIH RePORTER	International Clinical Research Fellows Program at Vanderbilt University; Fogarty International Center/National Institutes of Health (FIC/NIH); Merck Co., Inc.(Merck & Company); indigenous health program; regional organization (ORAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP); regional organization (FECONAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988), by the Fogarty International Center/National Institutes of Health (FIC/NIH) grant R01 TW008398 to Magaly Blas, RO1 NS055627 to Joseph R. Zunt and supported in part by a research grant from the Merck Investigator-Initiated Studies Program of Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the indigenous health program and the regional organizations (ORAU and FECONAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP) for their support in the development of this study. We also want to thank the indigenous leaders who helped us conduct this study, and the personnel of this project, especially Yolanda Nunta, Jeiser Suarez, Greti Trigoso, Neylar Morales, Rosario Trujillo, Janet Soto, and Maybee Terrones. We also want to thank Monica Nieto and Ada Romero for conducting the HTLV testing, Donna Kenney for conducting the HPV testing, Martin Gutierrez for conducting the HIV testing and Dr. Jaime Caceres for evaluating the Pap smears.	Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165; Almonte M, 2011, INT J GYNECOL CANCER, V21, P1654, DOI 10.1097/IGC.0b013e3182288104; Alva IE, 2012, AM J TROP M IN PRESS; Beutner Karl R., 1997, American Journal of Medicine, V102, P9; Blattner WA, 1999, P ASSOC AM PHYSICIAN, V111, P563, DOI 10.1046/j.1525-1381.1999.99210.x; Brown B, 2012, INT J STD AIDS, V23, P242, DOI 10.1258/ijsa.2011.011193; Carneiro-Proietti ABF, 2002, J BIOMED SCI, V9, P587, DOI 10.1007/BF02254986; Castle PE, 2003, SEX TRANSM DIS, V30, P575, DOI 10.1097/00007435-200307000-00009; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Davey DD, 2003, CANCER J, V9, P327, DOI 10.1097/00130404-200309000-00002; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Duerr A, 2001, AM J OBSTET GYNECOL, V184, P584, DOI 10.1067/mob.2001.111791; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Fujiyoshi T, 1999, AIDS RES HUM RETROV, V15, P1235, DOI 10.1089/088922299310124; Gallo RC, 2002, IMMUNOL REV, V185, P236, DOI 10.1034/j.1600-065X.2002.18520.x; Gongora-Biachi R A, 1997, Ginecol Obstet Mex, V65, P141; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; MIYAZAKI K, 1991, OBSTET GYNECOL, V77, P107; Montano SM, 2011, SEX TRANSM INFECT, V87, P81, DOI 10.1136/sti.2010.043315; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Proietti FA, 2006, REV PANAM SALUD PUBL, V19, P7, DOI 10.1590/S1020-49892006000100002; Radja N, 2004, INT J STD AIDS, V15, P202, DOI 10.1258/095646204322916687; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; SPALTON DJ, 1991, BRIT J OPHTHALMOL, V75, P174, DOI 10.1136/bjo.75.3.174; STRICKLER HD, 1995, INT J CANCER, V61, P23, DOI 10.1002/ijc.2910610105; Vrielink H, 2004, TRANSFUS MED REV, V18, P46, DOI 10.1016/j.tmrv.2003.10.004; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization (WHO)/Institute Catala` d'Oncologia (ICO) Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, SUMM REP HPV CERV CA; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591; Zunt JR, 2002, J INFECT DIS, V186, P1669, DOI 10.1086/345364	31	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44240	10.1371/journal.pone.0044240	http://dx.doi.org/10.1371/journal.pone.0044240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952937	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000096
J	Mitchell, JD; McKellar, QA; McKeever, DJ				Mitchell, John D.; McKellar, Quintin A.; McKeever, Declan J.			Pharmacodynamics of Antimicrobials against Mycoplasma mycoides mycoides Small Colony, the Causative Agent of Contagious Bovine Pleuropneumonia	PLOS ONE			English	Article							IN-VITRO; INOCULUM SIZE; COMPARATIVE PHARMACOKINETICS; STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ACTIVITY; ANTIBACTERIAL AGENTS; ESCHERICHIA-COLI; PENICILLIN-G; DANOFLOXACIN; OXYTETRACYCLINE	Background: Mycoplasma mycoides subspecies mycoides Small Colony (MmmSC) is the causative agent of Contagious Bovine Pleuropneumonia (CBPP), a disease of substantial economic importance in sub-Saharan Africa. Failure of vaccination to curtail spread of this disease has led to calls for evaluation of the role of antimicrobials in CBPP control. Three major classes of antimicrobial are effective against mycoplasmas, namely tetracyclines, fluoroquinolones and macrolides. Therefore, the objectives of this study were to determine the effector kinetics of oxytetracycline, danofloxacin and tulathromycin against two MmmSC field strains in artificial medium and adult bovine serum. Methods: Minimum inhibitory concentrations (MIC) were determined for oxytetracycline, danofloxacin and tulathromycin against MmmSC strains B237 and Tan8 using a macrodilution technique, and time-kill curves were constructed for various multiples of the MIC over a 24 hour period in artificial medium and serum. Data were fitted to sigmoid E-max models to obtain 24 hour-area under curve/MIC ratios for mycoplasmastasis and, where appropriate, for mycoplasmacidal activity and virtual mycoplasmal elimination. Results: Minimum inhibitory concentrations against B237 were 20-fold higher, 2-fold higher and approximately 330-fold lower in serum than in artificial medium for oxytetracycline, danofloxacin and tulathromycin, respectively. Such differences were mirrored in experiments using Tan8. Oxytetracycline was mycoplasmastatic against both strains in both matrices. Danofloxacin elicited mycoplasmacidal activity against B237 and virtual elimination of Tan8; similar maximum antimycoplasmal effects were observed in artificial medium and serum. Tulathromycin effected virtual elimination of B237 but was mycoplasmastatic against Tan8 in artificial medium. However, this drug was mycoplasmastatic against both strains in the more physiologically relevant matrix of serum. Conclusions: Oxytetracycline, danofloxacin and tulathromycin are all suitable candidates for further investigation as potential treatments for CBPP. This study also highlights the importance of testing drug activity in biological matrices as well as artificial media.	[Mitchell, John D.; McKeever, Declan J.] Royal Vet Coll, Hatfield, Herts, England; [McKellar, Quintin A.] Univ Hertfordshire, Hatfield AL10 9AB, Herts, England	University of London; University of London Royal Veterinary College; University of Hertfordshire	Mitchell, JD (corresponding author), Royal Vet Coll, Hatfield, Herts, England.	jdmitchell@rvc.ac.uk			Biotechnology and Biological Sciences Research Council [BB/H009450/1]; BBSRC [BB/H009450/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Biotechnology and Biological Sciences Research Council (grant reference BB/H009450/1, http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi FS, 2003, RES VET SCI, V74, P247, DOI 10.1016/S0034-5288(03)00005-5; Ayling RD, 2005, ANTIMICROB AGENTS CH, V49, P5162, DOI 10.1128/AAC.49.12.5162-5165.2005; Ayling RD, 2000, VET REC, V146, P243, DOI 10.1136/vr.146.9.243; Bengtsson B, 1997, J VET PHARMACOL THER, V20, P258, DOI 10.1046/j.1365-2885.1997.00066.x; BROOK I, 1989, REV INFECT DIS, V11, P361; BURROWS GE, 1987, J VET PHARMACOL THER, V10, P54, DOI 10.1111/j.1365-2885.1987.tb00077.x; COOPER AC, 1993, RES VET SCI, V54, P329, DOI 10.1016/0034-5288(93)90130-8; Cottew, 1987, REV SCI TECH OIE, V6, P625; Craig WA, 2004, DIAGN MICR INFEC DIS, V50, P229, DOI 10.1016/j.diagmicrobio.2004.07.006; Craigmill AL, 2004, J VET PHARMACOL THER, V27, P343, DOI 10.1111/j.1365-2885.2004.00606.x; DAVEY LA, 1985, VET REC, V117, P426, DOI 10.1136/vr.117.17.426; DEVINE LF, 1970, APPL MICROBIOL, V19, P329, DOI 10.1128/AEM.19.2.329-334.1970; Evans NA, 2005, VET THER, V6, P83; Firsov AA, 1999, ANTIMICROB AGENTS CH, V43, P498, DOI 10.1128/AAC.43.3.498; FRIIS C, 1993, AM J VET RES, V54, P1122; Frimodt-Moller N, 2002, INT J ANTIMICROB AG, V19, P333, DOI 10.1016/S0924-8579(02)00029-8; GILES CJ, 1991, J VET PHARMACOL THER, V14, P400, DOI 10.1111/j.1365-2885.1991.tb00854.x; Gloede J, 2010, J ANTIMICROB CHEMOTH, V65, P186, DOI 10.1093/jac/dkp434; Godinho KS, 2008, VET MICROBIOL, V129, P426, DOI 10.1016/j.vetmic.2007.11.033; GUARD CL, 1986, CAN J VET RES, V50, P342; Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100; Huebschle OJB, 2006, RES VET SCI, V81, P304, DOI 10.1016/j.rvsc.2006.02.005; Jores J, 2008, VET IMMUNOL IMMUNOP, V124, P192, DOI 10.1016/j.vetimm.2008.02.019; Konig C, 1998, J ANTIMICROB CHEMOTH, V42, P227, DOI 10.1093/jac/42.2.227; Lees P, 2006, ANTIMICROBIAL RESIST, P49; Lees P, 2004, J REGULATORY AFFAIRS, V15, P175; Levison ME, 2004, INFECT DIS CLIN N AM, V18, P451, DOI 10.1016/j.idc.2004.04.012; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; March JB, 2000, J CLIN MICROBIOL, V38, P1419, DOI 10.1128/JCM.38.4.1419-1425.2000; MARCHANT CD, 1992, J PEDIATR-US, V120, P72, DOI 10.1016/S0022-3476(05)80601-8; Mariner JC, 2006, PREV VET MED, V73, P75, DOI 10.1016/j.prevetmed.2005.09.002; MARTIN SR, 1979, BIOPHYS CHEM, V10, P319, DOI 10.1016/0301-4622(79)85019-X; Martinez M., 2006, ANTIMICROBIAL THERAP, P81; Mckellar OA, 2004, J VET PHARMACOL THER, V27, P503, DOI 10.1111/j.1365-2885.2004.00603.x; Mizunaga S, 2005, J ANTIMICROB CHEMOTH, V56, P91, DOI 10.1093/jac/dki163; Morrissey I, 1999, J ANTIMICROB CHEMOTH, V43, P423; Niang M., 2010, Journal of Veterinary Medicine and Animal Health, V2, P35; Niang M, 2006, FAO OIE AU IBAR IAEA, P25; NOUWS JFM, 1985, VET QUART, V7, P306, DOI 10.1080/01652176.1985.9694004; Nowakowski MA, 2004, VET THER, V5, P60; Regalla J, 1996, REV SCI TECH OIE, V15, P1309, DOI 10.20506/rst.15.4.979; RWEYEMAMU MM, 1995, REV SCI TECH OIE, V14, P593, DOI 10.20506/rst.14.3.856; Sallovitz J, 2002, VET J, V164, P47, DOI 10.1053/tvjl.2002.0715; Sarasola P, 2002, ANTIMICROB AGENTS CH, V46, P3013, DOI 10.1128/AAC.46.9.3013-3019.2002; SORIANO F, 1990, J ANTIMICROB CHEMOTH, V25, P621, DOI 10.1093/jac/25.4.621; Thomson GR, 2005, T410 CYB; Toutain PL, 2002, RES VET SCI, V73, P105, DOI 10.1016/S0034-5288(02)00039-5; WITKAMP RF, 1992, AM J VET RES, V53, P1830; Yaya A, 2004, FAO OIE AU IBAR IAEA	49	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44158	10.1371/journal.pone.0044158	http://dx.doi.org/10.1371/journal.pone.0044158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952911	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800098
J	Richerioux, N; Blondeau, C; Wiedemann, A; Remy, S; Vautherot, JF; Denesvre, C				Richerioux, Nicolas; Blondeau, Caroline; Wiedemann, Agnes; Remy, Sylvie; Vautherot, Jean-Francois; Denesvre, Caroline			Rho-ROCK and Rac-PAK Signaling Pathways Have Opposing Effects on the Cell-to-Cell Spread of Marek's Disease Virus	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SMALL-MOLECULE INHIBITOR; SARCOMA-ASSOCIATED HERPESVIRUS; ACTIN CYTOSKELETON; PROTEIN-KINASE; GENE-PRODUCT; VIRAL SPREAD; MYOSIN-II; ADP-RIBOSYLTRANSFERASE; P21-ACTIVATED KINASE	Marek's Disease Virus (MDV) is an avian alpha-herpesvirus that only spreads from cell-to-cell in cell culture. While its cell-to-cell spread has been shown to be dependent on actin filament dynamics, the mechanisms regulating this spread remain largely unknown. Using a recombinant BAC20 virus expressing an EGFPVP22 tegument protein, we found that the actin cytoskeleton arrangements and cell-cell contacts differ in the center and periphery of MDV infection plaques, with cells in the latter areas showing stress fibers and rare cellular projections. Using specific inhibitors and activators, we determined that Rho-ROCK pathway, known to regulate stress fiber formation, and Rac-PAK, known to promote lamellipodia formation and destabilize stress fibers, had strong contrasting effects on MDV cell-to-cell spread in primary chicken embryo skin cells (CESCs). Inhibition of Rho and its ROCKs effectors led to reduced plaque sizes whereas inhibition of Rac or its group I-PAKs effectors had the adverse effect. Importantly, we observed that the shape of MDV plaques is related to the semi-ordered arrangement of the elongated cells, at the monolayer level in the vicinity of the plaques. Inhibition of Rho-ROCK signaling also resulted in a perturbation of the cell arrangement and a rounding of plaques. These opposing effects of Rho and Rac pathways in MDV cell-to-cell spread were validated for two parental MDV recombinant viruses with different ex vivo spread efficiencies. Finally, we demonstrated that Rho/Rac pathways have opposing effects on the accumulation of N-cadherin at cell-cell contact regions between CESCs, and defined these contacts as adherens junctions. Considering the importance of adherens junctions in HSV-1 cell-to-cell spread in some cell types, this result makes of adherens junctions maintenance one potential and attractive hypothesis to explain the Rho/Rac effects on MDV cell-to-cell spread. Our study provides the first evidence that MDV cell-to-cell spread is regulated by Rho/Rac signaling.	[Richerioux, Nicolas; Blondeau, Caroline; Remy, Sylvie; Vautherot, Jean-Francois; Denesvre, Caroline] INRA, Infect Dis & Publ Hlth UMR1282, ISP, BIOVA Team, F-37380 Nouzilly, France; [Wiedemann, Agnes] INRA, Infect Dis & Publ Hlth UMR1282, ISP, SPVB Team, F-37380 Nouzilly, France; [Richerioux, Nicolas; Blondeau, Caroline; Wiedemann, Agnes; Remy, Sylvie; Vautherot, Jean-Francois; Denesvre, Caroline] Univ Tours, Infect Dis & Publ Hlth UMR1282, ISP, Tours, France	INRAE; INRAE; Universite de Tours	Richerioux, N (corresponding author), INRA, Infect Dis & Publ Hlth UMR1282, ISP, BIOVA Team, F-37380 Nouzilly, France.	denesvre@tours.inra.fr	Blondeau, Caroline/D-4269-2017	Wiedemann, Agnes/0000-0001-8237-3545	INRA/(National Institute for Agricultural Research) Region Centre fellowship	INRA/(National Institute for Agricultural Research) Region Centre fellowship	Nicolas Richerioux is a PhD student supported by an INRA/(National Institute for Agricultural Research) Region Centre fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Albertinazzi C, 1999, J CELL SCI, V112, P3821; Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x; Aubert M, 2009, J VIROL, V83, P6171, DOI 10.1128/JVI.02163-08; BIGGS PM, 1967, J NATL CANCER I, V39, P267; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Blondeau C, 2008, J VIROL, V82, P9278, DOI 10.1128/JVI.00598-08; Blondeau C, 2007, VET RES, V38, P419, DOI 10.1051/vetres:2007009; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chan MWC, 2004, J BIOL CHEM, V279, P41047, DOI 10.1074/jbc.M406631200; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Comunale F, 2007, BIOL CELL, V99, P503, DOI 10.1042/BC20070011; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Denesvre C, 2007, J VIROL, V81, P12348, DOI 10.1128/JVI.01177-07; Dixit R, 2008, NEUROSCI LETT, V440, P113, DOI 10.1016/j.neulet.2008.05.031; Dorange F, 2000, J GEN VIROL, V81, P2219, DOI 10.1099/0022-1317-81-9-2219; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Favoreel HW, 2007, TRENDS MICROBIOL, V15, P426, DOI 10.1016/j.tim.2007.08.003; Favoreel HW, 2010, VET MICROBIOL, V143, P2, DOI 10.1016/j.vetmic.2010.02.007; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; Frampton AR, 2007, J VIROL, V81, P10879, DOI 10.1128/JVI.00504-07; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hase H, 1996, CELL STRUCT FUNCT, V21, P17, DOI 10.1247/csf.21.17; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Jarosinski KW, 2007, J VIROL, V81, P10575, DOI 10.1128/JVI.01065-07; Johnson DC, 2001, J VIROL, V75, P821, DOI 10.1128/JVI.75.2.821-833.2001; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Keyser J, 2007, FEBS LETT, V581, P5349, DOI 10.1016/j.febslet.2007.10.030; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Loubery S, 2008, CELL MOL LIFE SCI, V65, P2790, DOI 10.1007/s00018-008-8350-5; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; NAZERIAN K, 1968, CANCER RES, V28, P2454; Oh MJ, 2010, BIOCHEM BIOPH RES CO, V391, P176, DOI 10.1016/j.bbrc.2009.11.027; Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rosselin M, 2010, CELL RES, V20, P647, DOI 10.1038/cr.2010.45; Sahai E, 2006, METHOD ENZYMOL, V406, P128, DOI 10.1016/S0076-6879(06)06011-3; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schauer K, 2010, NAT METHODS, V7, P560, DOI [10.1038/NMETH.1462, 10.1038/nmeth.1462]; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schumacher D, 2005, J VIROL, V79, P3987, DOI 10.1128/JVI.79.7.3987-3997.2005; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Schumacher D, 2008, VIROLOGY, V375, P37, DOI 10.1016/j.virol.2008.01.026; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sward K, 2000, J PHYSIOL-LONDON, V522, P33, DOI 10.1111/j.1469-7793.2000.0033m.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Van den Broeke C, 2011, VIRUSES-BASEL, V3, P278, DOI 10.3390/v3040278; Van den Broeke C, 2009, P NATL ACAD SCI USA, V106, P8707, DOI 10.1073/pnas.0900436106; van Leeuwen H, 2002, J VIROL, V76, P3471, DOI 10.1128/JVI.76.7.3471-3481.2002; Veettil MV, 2006, J VIROL, V80, P11432, DOI 10.1128/JVI.01342-06; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; YONEMURA S, 1995, J CELL SCI, V108, P127; Yoon M, 2002, J VIROL, V76, P7203, DOI 10.1128/JVI.76.14.7203-7208.2002; Zelnik V, 2004, MAREKS DIS EVOLVING	88	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44072	10.1371/journal.pone.0044072	http://dx.doi.org/10.1371/journal.pone.0044072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952878	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800094
J	Suchanowska, A; Kaczmarek, R; Duk, M; Lukasiewicz, J; Smolarek, D; Majorczyk, E; Jaskiewicz, E; Laskowska, A; Wasniowska, K; Grodecka, M; Lisowska, E; Czerwinski, M				Suchanowska, Anna; Kaczmarek, Radoslaw; Duk, Maria; Lukasiewicz, Jolanta; Smolarek, Dorota; Majorczyk, Edyta; Jaskiewicz, Ewa; Laskowska, Anna; Wasniowska, Kazimiera; Grodecka, Magdalena; Lisowska, Elwira; Czerwinski, Marcin			A Single Point Mutation in the Gene Encoding Gb3/CD77 Synthase Causes a Rare Inherited Polyagglutination Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-GALACTOSYL ANTIBODIES; EMBRYONAL CARCINOMA-CELLS; P-PHENOTYPE; NOR PHENOTYPE; ANTI-NOR; EXPRESSION; GLYCOSYLTRANSFERASES; IDENTIFICATION; ERYTHROCYTES; INDIVIDUALS	Rare polyagglutinable NOR erythrocytes contain three unique globoside (Gb4Cer) derivatives, NOR1, NORint, and NOR2, in which Gal(alpha 1-4), GalNAc(beta 1-3)Gal(alpha 1-4), and Gal(alpha 1-4)GalNAc(beta 1-3)Gal(alpha 1-4), respectively, are linked to the terminal GalNAc residue of Gb4Cer. NOR1 and NOR2, which both terminate with a Gal(alpha 1-4)GalNAc- sequence, react with anti-NOR antibodies commonly present in human sera. While searching for an enzyme responsible for the biosynthesis of Gal(alpha 1-4)GalNAc, we identified a mutation in the A4GALT gene encoding Gb3/CD77 synthase (alpha 1,4-galactosyltransferase). Fourteen NOR-positive donors were heterozygous for the C>G mutation at position 631 of the open reading frame of the A4GALT gene, whereas 495 NOR-negative donors were homozygous for C at this position. The enzyme encoded by the mutated gene contains glutamic acid instead of glutamine at position 211 (substitution Q211E). To determine whether this mutation could change the enzyme specificity, we transfected a teratocarcinoma cell line (2102Ep) with vectors encoding the consensus Gb3/CD77 synthase and Gb3/CD77 synthase with Glu at position 211. The cellular glycolipids produced by these cells were analyzed by flow cytometry, high-performance thin-layer chromatography, enzymatic degradation, and MALDI-TOF mass spectrometry. Cells transfected with either vector expressed the P1 blood group antigen, which was absent from untransfected cells. Cells transfected with the vector encoding the Gb3/CD77 synthase with Glu at position 211 expressed both P1 and NOR antigens. Collectively, these results suggest that the C631G mutation alters the acceptor specificity of Gb3/CD77 synthase, rendering it able to catalyze synthesis of the Gal(alpha 1-4)Gal and Gal(alpha 1-4)GalNAc moieties.	[Czerwinski, Marcin] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Lab Glycoconjugate Immunochem, PL-53114 Wroclaw, Poland; [Lukasiewicz, Jolanta] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Microbial Immunochem & Vaccines, PL-53114 Wroclaw, Poland; [Majorczyk, Edyta] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Immunogenet & Tissue Immunol, PL-53114 Wroclaw, Poland; [Laskowska, Anna] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol & Cell Interact, PL-53114 Wroclaw, Poland; [Majorczyk, Edyta; Wasniowska, Kazimiera; Czerwinski, Marcin] Opole Univ Technol, Fac Phys Educ & Physiotherapy, Inst Physiotherapy, PL-45758 Opole, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Opole University of Technology	Czerwinski, M (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Lab Glycoconjugate Immunochem, PL-53114 Wroclaw, Poland.	czerwins@iitd.pan.wroc.pl	Majorczyk, Edyta/P-3066-2019	Majorczyk, Edyta/0000-0001-7248-9544; Wasniowska, Kazimiera/0000-0001-7629-2589; Kaczmarek, Radoslaw/0000-0001-8084-1958; Czerwinski, Marcin/0000-0003-2859-3699; Lukasiewicz, Jolanta/0000-0001-8081-7261	National Science Center of Poland [N N302 662940, N N401 631640]	National Science Center of Poland(National Science Centre, Poland)	This work was supported by National Science Center of Poland Grants N N302 662940 (to M. C.) and N N401 631640 (to A. S.).	Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; CHEN C, 1989, BIOCHEMISTRY-US, V28, P2229, DOI 10.1021/bi00431a039; Czerwinski M, 2007, BIOCHEM BIOPH RES CO, V356, P816, DOI 10.1016/j.bbrc.2007.03.054; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duk M, 2005, GLYCOBIOLOGY, V15, P109, DOI 10.1093/oxfordjournals.glycob.a034964; Duk M, 2003, GLYCOBIOLOGY, V13, P279, DOI 10.1093/glycob/cwg036; DUK M, 1994, ANAL BIOCHEM, V221, P266, DOI 10.1006/abio.1994.1410; Duk M, 2001, J BIOL CHEM, V276, P40574, DOI 10.1074/jbc.M102711200; Duk M, 2007, GLYCOBIOLOGY, V17, P304, DOI 10.1093/glycob/cwl071; Duk M, 2006, TRANSFUSION, V46, P1264, DOI 10.1111/j.1537-2995.2006.00882.x; Furukawa K, 2000, J BIOL CHEM, V275, P37752, DOI 10.1074/jbc.C000625200; HARRIS PA, 1982, VOX SANG, V42, P134, DOI 10.1111/j.1423-0410.1982.tb01083.x; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hellberg A, 2004, BRIT J HAEMATOL, V125, P528, DOI 10.1111/j.1365-2141.2004.04930.x; Hellberg A, 2008, TRANSFUSION, V48, P479, DOI 10.1111/j.1537-2995.2007.01552.x; Iwamura K, 2003, J BIOL CHEM, V278, P44429, DOI 10.1074/jbc.M301609200; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kusnierz-Alejska G, 1999, TRANSFUSION, V39, P32, DOI 10.1046/j.1537-2995.1999.39199116892.x; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4831, DOI 10.1021/bi00693a009; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Ramakrishnan B, 2007, J MOL BIOL, V365, P570, DOI 10.1016/j.jmb.2006.10.034; Sheeley DM, 1998, ANAL CHEM, V70, P3053, DOI 10.1021/ac9713058; SPITALNIK PF, 1995, TRANSFUS MED REV, V9, P110, DOI 10.1016/S0887-7963(05)80050-1; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Storry J R, 2009, Immunohematology, V25, P48; Takematsu H, 2011, J BIOL CHEM, V286, P27214, DOI 10.1074/jbc.M111.234526; Thuresson B, 2011, BLOOD, V117, P678, DOI 10.1182/blood-2010-08-301333; Varki A., 1999, ESSENTIALS GLYCOBIOL, P6; WENK J, 1994, INT J CANCER, V58, P108, DOI 10.1002/ijc.2910580118; Yazer MH, 2006, TRANSFUS MED REV, V20, P207, DOI 10.1016/j.tmrv.2006.03.002	33	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.408286	http://dx.doi.org/10.1074/jbc.M112.408286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22965229	Green Published, hybrid			2022-12-25	WOS:000310642200055
J	Cao, HB; Lei, SF; Deng, HW; Wang, YP				Cao, Hongbao; Lei, Shufeng; Deng, Hong-Wen; Wang, Yu-Ping			Identification of Genes for Complex Diseases Using Integrated Analysis of Multiple Types of Genomic Data	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; BONE-RESORPTION; OSTEOPOROSIS; EXPRESSION; WOMEN; DICER; HIP	Various types of genomic data (e. g., SNPs and mRNA transcripts) have been employed to identify risk genes for complex diseases. However, the analysis of these data has largely been performed in isolation. Combining these multiple data for integrative analysis can take advantage of complementary information and thus can have higher power to identify genes (and/or their functions) that would otherwise be impossible with individual data analysis. Due to the different nature, structure, and format of diverse sets of genomic data, multiple genomic data integration is challenging. Here we address the problem by developing a sparse representation based clustering (SRC) method for integrative data analysis. As an example, we applied the SRC method to the integrative analysis of 376821 SNPs in 200 subjects (100 cases and 100 controls) and expression data for 22283 genes in 80 subjects (40 cases and 40 controls) to identify significant genes for osteoporosis (OP). Comparing our results with previous studies, we identified some genes known related to OP risk (e. g., 'THSD4', 'CRHR1', 'HSD11B1', 'THSD7A', 'BMPR1B' 'ADCY10', 'PRL', 'CA8','ESRRA', 'CALM1', 'CALM1', 'SPARC', and 'LRP1'). Moreover, we uncovered novel osteoporosis susceptible genes ('DICER1', 'PTMA', etc.) that were not found previously but play functionally important roles in osteoporosis etiology from existing studies. In addition, the SRC method identified genes can lead to higher accuracy for the diagnosis/classification of osteoporosis subjects when compared with the traditional T-test and Fisher-exact test, which further validates the proposed SRC approach for integrative analysis.	[Cao, Hongbao; Wang, Yu-Ping] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Lei, Shufeng] Soochow Univ, Coll Med, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Peoples R China; [Deng, Hong-Wen; Wang, Yu-Ping] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA	Tulane University; Soochow University - China; Tulane University	Cao, HB (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	wyp@tulane.edu	Cao, Hongbao/G-8253-2014	Cao, Hongbao/0000-0001-9190-0511; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [1R21LM010042-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, R01AR050496] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM010042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health grant 1R21LM010042-01 (www.nlm.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger JA, 2006, IEEE ACM T COMPUT BI, V3, P2, DOI 10.1109/TCBB.2006.10; Cao HB, 2012, IEEE T NANOBIOSCI, V11, P111, DOI 10.1109/TNB.2012.2189414; COHENSOLAL ME, 1993, J CLIN ENDOCR METAB, V77, P1648, DOI 10.1210/jc.77.6.1648; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Deng FY, 2011, J BONE MINER RES, V26, P2695, DOI 10.1002/jbmr.471; Deng HW, 2002, GENET EPIDEMIOL, V22, P12, DOI 10.1002/gepi.1040; Dumble M, 2004, ANN NY ACAD SCI, V1019, P171, DOI 10.1196/annals.1297.027; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Fisher R.A., 1948, STAT TABLES BIOL AGR, V3rd edn, pp 26; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Hautaniemi S, 2004, J FRANKLIN I, V341, P77, DOI 10.1016/j.jfranklin.2003.12.005; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Jian WX, 2005, J BONE MINER METAB, V23, P181, DOI 10.1007/s00774-004-0558-3; Kobayashi T, 2006, CANCER RES, V66, P3137, DOI 10.1158/0008-5472.CAN-05-2112; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Liu PY, 2004, AM J HUM BIOL, V16, P68, DOI 10.1002/ajhb.10240; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Melton LJ, 2005, J BONE MINER RES, V20, P886, DOI 10.1359/jbmr.2005.20.5.886; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Soneson C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-191; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wang P, 2005, BIOSTATISTICS, V6, P45, DOI 10.1093/biostatistics/kxh017; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Xu XH, 2010, ENDOCR REV, V31, P447, DOI 10.1210/er.2009-0032; Yang HH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00192; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; ZALLONE AZ, 1984, J CELL SCI, V66, P335	35	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42755	10.1371/journal.pone.0042755	http://dx.doi.org/10.1371/journal.pone.0042755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957024	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800016
J	Latif, R; Teixeira, A; Michalek, K; Ali, MR; Schlesinger, M; Baliram, R; Morshed, SA; Davies, TF				Latif, Rauf; Teixeira, Avelino; Michalek, Krzysztof; Ali, M. Rejwan; Schlesinger, Max; Baliram, Ramkumarie; Morshed, Syed A.; Davies, Terry F.			Antibody Protection Reveals Extended Epitopes on the Human TSH Receptor	PLOS ONE			English	Article							THYROID-STIMULATING AUTOANTIBODY; HUMAN THYROTROPIN RECEPTOR; LEUCINE-RICH DOMAIN; HORMONE-RECEPTOR; CRYSTAL-STRUCTURE; HINGE REGION; MONOCLONAL-ANTIBODY; MASS-SPECTROMETRY; GRAVES-DISEASE; BINDING	Stimulating, and some blocking, antibodies to the TSH receptor (TSHR) have conformation-dependent epitopes reported to involve primarily the leucine rich repeat region of the ectodomain (LRD). However, successful crystallization of TSHR residues 22-260 has omitted important extracellular non-LRD residues including the hinge region which connects the TSHR ectodomain to the transmembrane domain and which is involved in ligand induced signal transduction. The aim of the present study, therefore, was to determine if TSHR antibodies (TSHR-Abs) have non-LRD binding sites outside the LRD. To obtain this information we employed the method of epitope protection in which we first protected TSHR residues 1-412 with intact TSHR antibodies and then enzymatically digested the unprotected residues. Those peptides remaining were subsequently delineated by mass spectrometry. Fourteen out of 23 of the reported stimulating monoclonal TSHR-Ab crystal contact residues were protected by this technique which may reflect the higher binding energies of certain residues detected in this approach. Comparing the protected epitopes of two stimulating TSHR-Abs we found both similarities and differences but both antibodies also contacted the hinge region and the amino terminus of the TSHR following the signal peptide and encompassing cysteine box 1 which has previously been shown to be important for TSH binding and activation. A monoclonal blocking TSHR antibody revealed a similar pattern of binding regions but the residues that it contacted on the LRD were again distinct. These data demonstrated that conformationally dependent TSHR-Abs had epitopes not confined to the LRDs but also incorporated epitopes not revealed in the available crystal structure. Furthermore, the data also indicated that in addition to overlapping contact regions within the LRD, there are unique epitope patterns for each of the antibodies which may contribute to their functional heterogeneity.	[Latif, Rauf; Teixeira, Avelino] Mt Sinai Sch Med, Dept Med, Prote Lab, New York, NY 10029 USA; [Latif, Rauf; Ali, M. Rejwan; Schlesinger, Max; Baliram, Ramkumarie; Morshed, Syed A.; Davies, Terry F.] James J Peters VA Med Ctr, Thyroid Res Unit, New York, NY USA; [Michalek, Krzysztof] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Dis, Poznan, Poland	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Poznan University of Medical Sciences	Latif, R (corresponding author), Mt Sinai Sch Med, Dept Med, Prote Lab, New York, NY 10029 USA.	rauf.latif@mssm.edu	latif, rauf/AAR-1634-2020; Latif, Rauf/ABH-4394-2020	Latif, Rauf/0000-0002-4226-3728	NIH [DK069713, DK052464]; Veterans Administration Merit Award program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052464, R01DK069713] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by NIH grants DK069713 and DK052464 and the Veterans Administration Merit Award program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2004, ENDOCRINOLOGY, V145, P5185, DOI 10.1210/en.2004-0789; Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Benjamin David C., 1996, Methods (Orlando), V9, P508, DOI 10.1006/meth.1996.0058; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Chen CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031973; Cornelis S, 2001, BIOCHEMISTRY-US, V40, P9860, DOI 10.1021/bi0107389; Costagliola S, 2004, MOL ENDOCRINOL, V18, P3020, DOI 10.1210/me.2004-0231; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Couet J, 1996, J BIOL CHEM, V271, P4545; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Hamidi S, 2011, THYROID, V21, P1013, DOI 10.1089/thy.2011.0147; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2011, J BIOL CHEM, V286, P22622, DOI 10.1074/jbc.M110.211193; Latif R, 2007, ENDOCRINOLOGY, V148, P3164, DOI 10.1210/en.2006-1580; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; Latif R, 2010, MOL ENDOCRINOL, V24, P2009, DOI 10.1210/me.2010-0001; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; Miguel RN, 2009, J MOL ENDOCRINOL, V42, P381, DOI 10.1677/JME-08-0152; Miguel RN, 2005, THYROID, V15, P746; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mizutori Y, 2009, J CLIN ENDOCR METAB, V94, P927, DOI 10.1210/jc.2008-2134; Morshed SA, 2010, ENDOCRINOLOGY, V151, P5537, DOI 10.1210/en.2010-0424; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; Oda Y, 1998, J MOL ENDOCRINOL, V20, P233, DOI 10.1677/jme.0.0200233; Parker CE, 1996, J IMMUNOL, V157, P198; Parker CE, 2002, MOL BIOTECHNOL, V20, P49, DOI 10.1385/MB:20:1:049; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Raska CS, 2003, J AM SOC MASS SPECTR, V14, P1076, DOI 10.1016/S1044-0305(03)00405-7; Raska CS, 2002, ANAL CHEM, V74, P3429, DOI 10.1021/ac0111199; RUSSO D, 1991, MOL ENDOCRINOL, V5, P1607, DOI 10.1210/mend-5-11-1607; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Sanders J, 1997, BAILLIERE CLIN ENDOC, V11, P451, DOI 10.1016/S0950-351X(97)80693-3; Sanders J, 2003, LANCET, V362, P126, DOI 10.1016/S0140-6736(03)13866-4; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44669	10.1371/journal.pone.0044669	http://dx.doi.org/10.1371/journal.pone.0044669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957097	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800090
J	Schneider, PN; Slusarski, DC; Houston, DW				Schneider, Patricia N.; Slusarski, Diane C.; Houston, Douglas W.			Differential Role of Axin RGS Domain Function in Wnt Signaling during Anteroposterior Patterning and Maternal Axis Formation	PLOS ONE			English	Article							BETA-CATENIN; NEGATIVE REGULATOR; PROTEIN; ZEBRAFISH; COMPLEX; PHOSPHORYLATION; EXPRESSION; INDUCTION; MECHANISM; MESODERM	Axin is a critical component of the beta-catenin destruction complex and is also necessary for Wnt signaling initiation at the level of co-receptor activation. Axin contains an RGS domain, which is similar to that of proteins that accelerate the GTPase activity of heterotrimeric G alpha/Gna proteins and thereby limit the duration of active G-protein signaling. Although G-proteins are increasingly recognized as essential components of Wnt signaling, it has been unclear whether this domain of Axin might function in G-protein regulation. This study was performed to test the hypothesis that Axin RGS-Gna interactions would be required to attenuate Wnt signaling. We tested these ideas using an axin1 genetic mutant (masterblind) and antisense oligo knockdowns in developing zebrafish and Xenopus embryos. We generated a point mutation that is predicted to reduce Axin-Gna interaction and tested for the ability of the mutant forms to rescue Axin loss-of-function function. This Axin point mutation was deficient in binding to Gna proteins in vitro, and was unable to relocalize to the plasma membrane upon Gna overexpression. We found that the Axin point mutant construct failed to rescue normal anteroposterior neural patterning in masterblind mutant zebrafish, suggesting a requirement for G-protein interactions in this context. We also found that the same mutant was able to rescue deficiencies in maternal axin1 loss-of-function in Xenopus. These data suggest that maternal and zygotic Wnt signaling may differ in the extent of Axin regulation of G-protein signaling. We further report that expression of a membrane-localized Axin construct is sufficient to inhibit Wnt/beta-catenin signaling and to promote Axin protein turnover.	[Schneider, Patricia N.; Slusarski, Diane C.; Houston, Douglas W.] Univ Iowa, Dept Biol, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA	University of Iowa	Schneider, PN (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	douglas-houston@uiowa.edu	Schneider, Patricia N/F-4372-2017; Schneider, Patricia/ABA-9787-2020	Schneider, Patricia N/0000-0002-9745-0694; Schneider, Patricia/0000-0002-9745-0694; Slusarski, Diane/0000-0003-3793-8636	National Institutes of Health [R01 GM083999, R01 CA112369]; NATIONAL CANCER INSTITUTE [R01CA112369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM083999 to DWH and R01 CA112369 to DCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cha S, 2008, DEVELOPMENT; Chia IV, 2009, GENETICS, V181, P1359, DOI 10.1534/genetics.109.101055; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Houston DW, 2012, WIRES DEV BIOL, V1, P371, DOI 10.1002/wdev.29; Houston DW, 2005, DEVELOPMENT, V132, P4845, DOI 10.1242/dev.02066; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jernigan KK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000647; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Katanaev VL, 2009, NATURE PRECEDINGS, P1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kofron M, 2001, DEV BIOL, V237, P183, DOI 10.1006/dbio.2001.0371; Koval A, 2010, BIOCH J; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Natochin M, 1998, J BIOL CHEM, V273, P6731, DOI 10.1074/jbc.273.12.6731; Niehrs C, 2001, INT J DEV BIOL, V45, P237; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; Schneider PN, 2010, J VIS EXP, pe1864; Sive H.L., 2000, EARLY DEV XENOPUS LA, P249; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; SMITH WC, 1995, CELL, V82, P37, DOI 10.1016/0092-8674(95)90050-0; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; Stemmle LN, 2006, MOL PHARMACOL, V70, P1461, DOI 10.1124/mol.106.023705; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Thisse C, 2005, ZFIN DIRECT DATA SUB; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van de Water S, 2001, DEVELOPMENT, V128, P3877; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Westerfield M, 1993, ZEBRAFISH BOOK; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247	49	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44096	10.1371/journal.pone.0044096	http://dx.doi.org/10.1371/journal.pone.0044096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957046	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800038
J	Si, JJ; Yang, JL; Xue, LF; Yang, CH; Luo, YX; Shi, HS; Lu, L				Si, Jijian; Yang, Jianli; Xue, Lifen; Yang, Chenhao; Luo, Yixiao; Shi, Haishui; Lu, Lin			Activation of NF-kappa B in Basolateral Amygdala Is Required for Memory Reconsolidation in Auditory Fear Conditioning	PLOS ONE			English	Article							LONG-TERM-MEMORY; POSTTRAUMATIC-STRESS-DISORDER; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; EXPRESSION; RETRIEVAL; ALPHA; MICE; CONSOLIDATION; ACETYLATION	Posttraumatic stress disorder (PTSD) is characterized by acute and chronic changes in the stress response, manifested as conditioned fear memory. Previously formed memories that are susceptible to disruption immediately after retrieval undergo a protein synthesis-dependent process to become persistent, termed reconsolidation, a process that is regulated by many distinct molecular mechanisms that control gene expression. Increasing evidence supports the participation of the transcription factor NF-kappa B in the different phases of memory. Here, we demonstrate that inhibition of NF-kappa B in the basolateral amygdala (BLA), but not central nucleus of the amygdala, after memory reactivation impairs the retention of amygdala-dependent auditory fear conditioning (AFC). We used two independent pharmacological strategies to disrupt the reconsolidation of AFC. Bilateral intra-BLA infusion of sulfasalazine, an inhibitor of I kappa B kinase that activates NF-kappa B, and bilateral intra-BLA infusion of SN50, a direct inhibitor of the NF-kappa B DNA-binding complex, immediately after retrieval disrupted the reconsolidation of AFC. We also found that systemic pretreatment with sodium butyrate, a histone deacetylase inhibitor that enhances histone acetylation, in the amygdala rescued the disruption of reconsolidation induced by NF-kappa B inhibition in the BLA. These findings indicate that NF-kappa B activity in the BLA is required for memory reconsolidation in AFC, suggesting that NF-kappa B might be a potential pharmacotherapy target for posttraumatic stress disorder.	[Si, Jijian; Yang, Chenhao] Tianjin Med Univ, Tianjin, Peoples R China; [Si, Jijian; Yang, Jianli; Yang, Chenhao] Tianjin Mental Hlth Ctr, Tianjin, Peoples R China; [Si, Jijian; Xue, Lifen; Yang, Chenhao; Luo, Yixiao; Shi, Haishui; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Tianjin Medical University; Peking University	Si, JJ (corresponding author), Tianjin Med Univ, Tianjin, Peoples R China.	yangjianli0722@sohu.com; xiaosmile0001@sina.com			National Science Foundation of China [30870895]; Natural Science Foundation of Beijing Municipality [7091003]; Science and Technology Foundation of Tianjin Health Bureau [06KR04, 09KY02]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Science and Technology Foundation of Tianjin Health Bureau	This work was supported by grants from the National Science Foundation of China (No. 30870895 to JLY), Natural Science Foundation of Beijing Municipality (No.7091003), and Science and Technology Foundation of Tianjin Health Bureau (No.06KR04 and 09KY02 to JLY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Baratti CM, 2009, BRAZ J MED BIOL RES, V42, P148, DOI 10.1590/S0100-879X2009000200001; Boccia M, 2007, J NEUROSCI, V27, P13436, DOI 10.1523/JNEUROSCI.4430-07.2007; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Izumi T, 2011, J NEUROSCI RES, V89, P773, DOI 10.1002/jnr.22592; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kasahara M, 2011, NEUROENDOCRINOL LETT, V32, P193; Li FQ, 2010, J NEUROSCI, V30, P10351, DOI 10.1523/JNEUROSCI.2112-10.2010; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Merlo E, 2005, LEARN MEMORY, V12, P23, DOI 10.1101/lm.82705; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sah P, 2008, NATURE, V454, P589, DOI 10.1038/454589a; Teng FYH, 2010, REV NEUROSCIENCE, V21, P299; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Viatour P, 2003, J BIOL CHEM, V278, P46541, DOI 10.1074/jbc.M306381200; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang JL, 2011, BEHAV BRAIN RES, V216, P592, DOI 10.1016/j.bbr.2010.08.047; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200; Yiu AP, 2011, NEUROPSYCHOPHARMACOL	41	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43973	10.1371/journal.pone.0043973	http://dx.doi.org/10.1371/journal.pone.0043973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957038	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800030
J	Xu, PX; Hooper, AM; Pickett, JA; Leal, WS				Xu, Pingxi; Hooper, Antony M.; Pickett, John A.; Leal, Walter S.			Specificity Determinants of the Silkworm Moth Sex Pheromone	PLOS ONE			English	Article							BINDING PROTEIN; SENSITIVE NEURONS; BOMBYX-MORI; RECEPTORS; ACTIVATION; RELEASE	The insect olfactory system, particularly the peripheral sensory system for sex pheromone reception in male moths, is highly selective, but specificity determinants at the receptor level are hitherto unknown. Using the Xenopus oocyte recording system, we conducted a thorough structure-activity relationship study with the sex pheromone receptor of the silkworm moth, Bombyx mori, BmorOR1. When co-expressed with the obligatory odorant receptor co-receptor (BmorOrco), BmorOR1 responded in a dose-dependent fashion to both bombykol and its related aldehyde, bombykal, but the threshold of the latter was about one order of magnitude higher. Solubilizing these ligands with a pheromone-binding protein (BmorPBP1) did not enhance selectivity. By contrast, both ligands were trapped by BmorPBP1 leading to dramatically reduced responses. The silkworm moth pheromone receptor was highly selective towards the stereochemistry of the conjugated diene, with robust response to the natural (10E, 12Z)-isomer and very little or no response to the other three isomers. Shifting the conjugated diene towards the functional group or elongating the carbon chain rendered these molecules completely inactive. In contrast, an analogue shortened by two omega carbons elicited the same or slightly higher responses than bombykol. Flexibility of the saturated C1-C9 moiety is important for function as addition of a double or triple bond in position 4 led to reduced responses. The ligand is hypothesized to be accommodated by a large hydrophobic cavity within the helical bundle of transmembrane domains.	[Xu, Pingxi; Leal, Walter S.] Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA; [Hooper, Antony M.; Pickett, John A.] Rothamsted Res, Harpenden, Herts, England	University of California System; University of California Davis; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Xu, PX (corresponding author), Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal, Walter/0000-0002-6800-1240; Hooper, Antony/0000-0002-0780-2167; Leal Filho, Walter/0000-0002-1241-5225	National Science Foundation [0918177]; Agriculture and Food Research Initiative from the United States Department of Agriculture-National Institute for Food and Agriculture [2010-65105-20582]; National Institutes of Health [1R01AI095514-01A1]; Biotechnology and Biological Sciences Research Council of the UK (BBSRC); BBSRC [BBS/E/C/00005194, BB/J020281/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194, BB/J020281/1] Funding Source: researchfish; Direct For Biological Sciences [0918177] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095514] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Agriculture and Food Research Initiative from the United States Department of Agriculture-National Institute for Food and Agriculture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council of the UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Science Foundation grant 0918177, Agriculture and Food Research Initiative competitive grant 2010-65105-20582 from the United States Department of Agriculture-National Institute for Food and Agriculture, and National Institutes of Health, 1R01AI095514-01A1. Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council of the UK (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Forstner Maike, 2009, Int J Biol Sci, V5, P745; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hooper AM, 2009, CHEM COMMUN, P5725, DOI 10.1039/b914294k; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; KAISSLING KE, 1987, WRIGHT LECT INSECT O; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; SYED Z, 2010, P NATL ACAD SCI US; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	20	26	27	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44190	10.1371/journal.pone.0044190	http://dx.doi.org/10.1371/journal.pone.0044190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957053	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800045
J	Zhang, T; Shi, N; Bai, DS; Chen, YL; Feng, G				Zhang, Tao; Shi, Ning; Bai, Dengsha; Chen, Yinglong; Feng, Gu			Arbuscular Mycorrhizal Fungi Promote the Growth of Ceratocarpus arenarius (Chenopodiaceae) with No Enhancement of Phosphorus Nutrition	PLOS ONE			English	Article							ATRIPLEX-NUMMULARIA; JUNGGAR BASIN; DIVERSITY; PLANTS; INOCULATION; PHOSPHATE; ROOTS; COLONIZATION; ASSOCIATIONS; EPHEMERALS	The mycorrhizal status of plants in the Chenopodiaceae is not well studied with a few controversial reports. This study examined arbuscular mycorrhizal (AM) colonization and growth response of Ceratocarpus arenarius in the field and a greenhouse inoculation trial. The colonization rate of AM fungi in C. arenarius in in-growth field cores was low (around 15%). Vesicles and intraradical hyphae were present during all growth stages, but no arbuscules were observed. Sequencing analysis of the large ribosomal rDNA subunit detected four culturable Glomus species, G. intraradices, G. mosseae, G. etunicatum and G. microaggregatum together with eight unculturable species belong to the Glomeromycota in the root system of C. arenarius collected from the field. These results establish the mycotrophic status of C. arenarius. Both in the field and in the greenhouse inoculation trial, the growth of C. arenarius was stimulated by the indigenous AM fungal community and the inoculated AM fungal isolates, respectively, but the P uptake and concentration of the mycorrhizal plants did not increase significantly over the controls in both experiments. Furthermore, the AM fungi significantly increased seed production. Our results suggest that an alternative reciprocal benefit to carbon-phosphorus trade-off between AM fungi and the chenopod plant might exist in the extremely arid environment.	[Zhang, Tao; Shi, Ning; Feng, Gu] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Zhang, Tao; Shi, Ning; Feng, Gu] China Agr Univ, Ctr Resource Environm & Food Secur, Beijing 100094, Peoples R China; [Bai, Dengsha] Xinjiang Acad Agr Sci, Inst Nucl Technol & Biotechnol, Urumqi, Xinjiang, Peoples R China; [Chen, Yinglong] Univ Western Australia, Sch Earth & Environm, Perth, WA 6009, Australia	China Agricultural University; China Agricultural University; University of Western Australia	Zhang, T (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	fenggu@cau.edu.cn	Chen, Yinglong/D-2104-2011; Feng, Gu/K-8367-2012	Chen, Yinglong/0000-0003-0798-8683; Feng, Gu/0000-0002-1052-5009	National Science Foundation of China [30770341, 31121062]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Science Foundation of China (No. 30770341 and the Innovative Group Grant No. 31121062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera LE, 1998, REV CHIL HIST NAT, V71, P291; Aleman R, 2010, T ROY SOC SOUTH AUST, V134, P1; ALLEN MF, 1983, MYCOLOGIA, V75, P773, DOI 10.2307/3792769; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARMSTRONG KA, 1983, Q REV BIOL, V58, P234, DOI 10.1086/413230; Asghari HR, 2005, PLANT SOIL, V273, P245, DOI 10.1007/s11104-004-7942-6; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Fitter AH, 2006, NEW PHYTOL, V172, P3, DOI 10.1111/j.1469-8137.2006.01861.x; Gao Rui, 2007, Acta Botanica Yunnanica, V29, P300; Gollotte A, 2004, MYCORRHIZA, V14, P111, DOI 10.1007/s00572-003-0244-7; Grime JP, 1979, 20 BRIT EC SOC S LON, P123; Gutterman Yitzchak, 2002, P1; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Huang PY, 2002, SHRUB VEGETATION RES; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Johnson D, 2001, NEW PHYTOL, V152, P555, DOI 10.1046/j.0028-646X.2001.00273.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Ma Z., 1994, ARID ZONE RES, V11, P1; Manjarrez M, 2010, FUNCT PLANT BIOL, V37, P1132, DOI 10.1071/FP09248; Marschner P, 2010, SOIL MICROBIOLOGY AND SUSTAINABLE CROP PRODUCTION, P297, DOI 10.1007/978-90-481-9479-7_8; Nie M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017961; O'Connor PJ, 2002, NEW PHYTOL, V154, P209, DOI 10.1046/j.1469-8137.2002.00364.x; O'Connor PJ, 2001, AUST J BOT, V49, P493, DOI 10.1071/BT00014; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Pennisi E, 2004, SCIENCE, V304, P1620, DOI 10.1126/science.304.5677.1620; Plenchette C, 2005, J ARID ENVIRON, V61, P535, DOI 10.1016/j.jaridenv.2004.10.003; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; SENGUPTA A, 1990, PLANT SOIL, V122, P111, DOI 10.1007/BF02851917; Shi ZY, 2006, MYCORRHIZA, V16, P269, DOI 10.1007/s00572-006-0041-1; Shi ZY, 2007, APPL SOIL ECOL, V35, P10, DOI 10.1016/j.apsoil.2006.06.002; Smith FA, 2009, NEW PHYTOL, V182, P347, DOI 10.1111/j.1469-8137.2008.02753.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; Wang XQ, 2004, CHINESE J APPL ECOLO, V15, P556; White JA, 2008, MYCOLOGIA, V100, P6, DOI 10.3852/mycologia.100.1.6; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; WILLIAMS SE, 1974, SOIL SCI SOC AM J, V38, P962, DOI 10.2136/sssaj1974.03615995003800060034x; Zhu YG, 2001, PLANT SOIL, V237, P249, DOI 10.1023/A:1013343811110	45	13	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41151	10.1371/journal.pone.0041151	http://dx.doi.org/10.1371/journal.pone.0041151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957011	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800003
J	Marchand, A; Proust, C; Morange, PE; Lompre, AM; Tregouet, DA				Marchand, Alexandre; Proust, Carole; Morange, Pierre-Emmanuel; Lompre, Anne-Marie; Tregouet, David-Alexandre			miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; RISK; ASSOCIATION; BINDING; BIOMARKERS; CARCINOMA; SEQUENCE; RECEPTOR	In this work, we assessed whether SERPINE1 expression could be under the influence of microRNAs (miRNAs) predicted to bind the SERPINE1 3'UTR region. We specifically focused on the 3'UTR region harboring a common polymorphism, rs1050955, that have been found associated to SERPINE1 monocyte expression, and investigated whether the presence of different alleles at rs1050955 could modify the miRNAs binding efficiency and affect PAI-1 protein levels. We demonstrated that, in human umbilical vein endothelial cells, both miR-421 and miR-30c directly interacted with PAI-1 mRNA to inhibit the expression of the associated protein. However, these inhibitory mechanisms were independent on the allele present at the rs1050955 locus. We further showed that miR-421 levels correlated with PAI-1 activity in the plasma sample of 40 patients with venous thrombosis. Our results strongly suggest that the regulation of PAI-1 molecule could be under the influence of several miRNAs whose measurement in the plasma of patients could be envisaged as a biomarker for inflammatory and thrombotic disorders.	[Marchand, Alexandre; Lompre, Anne-Marie] INSERM, UMR S 956, Paris, France; [Marchand, Alexandre; Proust, Carole; Lompre, Anne-Marie; Tregouet, David-Alexandre] Univ Paris 06, Fac Med, Paris, France; [Marchand, Alexandre; Proust, Carole; Lompre, Anne-Marie; Tregouet, David-Alexandre] ICAN Inst Cardiometab & Nutr, Paris, France; [Proust, Carole; Tregouet, David-Alexandre] INSERM, UMR S 937, Paris, France; [Morange, Pierre-Emmanuel] INSERM, UMR S 1062, Marseille, France; [Morange, Pierre-Emmanuel] Univ Mediterranee, Fac Med, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Marchand, A (corresponding author), INSERM, UMR S 956, Paris, France.	david.tregouet@upmc.fr	Trégouët, David-Alexandre/P-9210-2019; Morange, Pierre/T-9070-2019; LOMPRE, Anne-Marie/H-2872-2013; Tregouet, David-Alexandre/E-3961-2016	Trégouët, David-Alexandre/0000-0001-9084-7800; Morange, Pierre/0000-0002-9065-722X; Marchand, Alexandre/0000-0002-2670-6939	Association Francaise contre les Myopathies (AFM); Leducq Foundation (Caerus network); Program Hospitalier de Recherche Clinique [PHRC2099 RENOVA-TV]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Leducq Foundation (Caerus network)(Leducq Foundation); Program Hospitalier de Recherche Clinique	A. Marchand and A-M. Lompre were supported by Association Francaise contre les Myopathies (AFM), and by the Leducq Foundation (Caerus network). This works also benefitted from financial support from the Program Hospitalier de Recherche Clinique (PHRC2099 RENOVA-TV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2011, THROMB HAEMOSTASIS, V106, P416, DOI 10.1160/TH11-03-0179; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dupuis M, 2004, CIRCULATION, V110, P867, DOI 10.1161/01.CIR.0000138850.72900.FE; Haas U, 2012, RNA BIOL, V9, P924, DOI 10.4161/rna.20497; Hao J, 2011, BIOCHEM BIOPH RES CO, V406, P552, DOI 10.1016/j.bbrc.2011.02.086; Hitti E, 2012, FRONT BIOSCI-LANDMRK, V17, P1846, DOI 10.2741/4023; Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P2322, DOI 10.1046/j.1538-7836.2003.00458.x; JuhanVague I, 1996, CIRCULATION, V94, P2057, DOI 10.1161/01.CIR.94.9.2057; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Lanktree MB, 2010, BLOOD, V116, P2160, DOI 10.1182/blood-2010-02-269902; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Meltzer ME, 2009, SEMIN THROMB HEMOST, V35, P468, DOI 10.1055/s-0029-1234142; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morange PE, 2007, ARTERIOSCL THROM VAS, V27, P2250, DOI 10.1161/ATVBAHA.107.149468; Nossent AY, 2011, AM J HYPERTENS, V24, P999, DOI 10.1038/ajh.2011.92; Perez MP, 2012, MOL MED REP, V5, P1135, DOI 10.3892/mmr.2012.785; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Su SY, 2006, ARTERIOSCL THROM VAS, V26, P948, DOI 10.1161/01.ATV.0000204731.17646.f2; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhang Y, 2012, MOL CANCER RES, V10, P516, DOI 10.1158/1541-7786.MCR-11-0473	37	52	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44532	10.1371/journal.pone.0044532	http://dx.doi.org/10.1371/journal.pone.0044532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952991	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300097
J	Pedrazzi, M; Averna, M; Sparatore, B; Patrone, M; Salamino, F; Marcoli, M; Maura, G; Cervetto, C; Frattaroli, D; Pontremoli, S; Melloni, E				Pedrazzi, Marco; Averna, Monica; Sparatore, Bianca; Patrone, Mauro; Salamino, Franca; Marcoli, Manuela; Maura, Guido; Cervetto, Chiara; Frattaroli, Daniela; Pontremoli, Sandro; Melloni, Edon			Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INDUCED-DIFFERENTIATION; NEURITE OUTGROWTH; ACTIVATION; AMPHOTERIN; RELEASE; GLUTAMATE; CALPAIN; BINDING; HMGB1	Background: Extracellular high mobility group box 1 (HMGB1) protein can operate in a synergistic fashion with different signal molecules promoting an increase of cell Ca2+ influx. However, the mechanisms responsible for this effect of HMGB1 are still unknown. Principal Findings: Here we demonstrate that, at concentrations of agonist per se ineffective, HMGB1 potentiates the activation of the ionotropic glutamate N-methyl-D-aspartate receptor (NMDAR) in isolated hippocampal nerve terminals and in a neuroblastoma cell line. This effect was abolished by the NMDA channel blocker MK-801. The HMGB1-facilitated NMDAR opening was followed by activation of the Ca2+-dependent enzymes calpain and nitric oxide synthase in neuroblastoma cells, resulting in an increased production of NO, a consequent enhanced cell motility, and onset of morphological differentiation. We have also identified NMDAR as the mediator of HMGB1-stimulated murine erythroleukemia cell differentiation, induced by hexamethylenebisacetamide. The potentiation of NMDAR activation involved a peptide of HMGB1 located in the B box at the amino acids 130-139. This HMGB1 fragment did not overlap with binding sites for other cell surface receptors of HMGB1, such as the advanced glycation end products or the Toll-like receptor 4. Moreover, in a competition assay, the HMGB1(130-139) peptide displaced the NMDAR/HMGB1 interaction, suggesting that it comprised the molecular and functional site of HMGB1 regulating the NMDA receptor complex. Conclusion: We propose that the multifunctional cytokine-like molecule HMGB1 released by activated, stressed, and damaged or necrotic cells can facilitate NMDAR-mediated cell responses, both in the central nervous system and in peripheral tissues, independently of other known cell surface receptors for HMGB1.	[Pedrazzi, Marco; Averna, Monica; Sparatore, Bianca; Salamino, Franca; Marcoli, Manuela; Maura, Guido; Cervetto, Chiara; Frattaroli, Daniela; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, Dept Expt Med DIMES, Genoa, Italy; [Pedrazzi, Marco; Averna, Monica; Sparatore, Bianca; Salamino, Franca; Marcoli, Manuela; Maura, Guido; Melloni, Edon] Univ Genoa, CEBR, Genoa, Italy; [Patrone, Mauro] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Innovaz Tecnol, DiSIT, Alessandria, Italy	University of Genoa; University of Genoa; University of Eastern Piedmont Amedeo Avogadro	Pedrazzi, M (corresponding author), Univ Genoa, Dept Expt Med DIMES, Genoa, Italy.	monica.averna@unige.it	Averna, Maurizio/U-9527-2017; Cervetto, Chiara/G-6404-2010; AVERNA, MONICA/R-5719-2019	Cervetto, Chiara/0000-0001-8290-3008; AVERNA, MONICA/0000-0002-9463-7533; marcoli, manuela/0000-0003-3261-5264; PATRONE, Mauro/0000-0002-7740-2396	Italian Ministry of Education, University and Research (PRIN); University "A. Avogadro"; University of Genoa	Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University "A. Avogadro"; University of Genoa	This work was supported by the Italian Ministry of Education, University and Research (PRIN 2008), the University "A. Avogadro" and the University of Genoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2009, LAB INVEST, V89, P278, DOI 10.1038/labinvest.2008.165; Averna M, 2009, J NEUROCHEM, V110, P412, DOI 10.1111/j.1471-4159.2009.06149.x; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Cervetto C, 2010, J PHARMACOL EXP THER, V332, P210, DOI 10.1124/jpet.109.154955; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Corasaniti MT, 1996, BIOCHEM BIOPH RES CO, V229, P299, DOI 10.1006/bbrc.1996.1796; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Evangelopoulos ME, 2010, NEUROSCI LETT, V468, P28, DOI 10.1016/j.neulet.2009.10.054; Fages C, 2000, J CELL SCI, V113, P611; GILLO B, 1993, BLOOD, V81, P783; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2004, J INTERN MED, V255, P351, DOI 10.1111/j.1365-2796.2003.01301.x; Huttunen HJ, 2002, CANCER RES, V62, P4805; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Marcoli M, 2008, J NEUROCHEM, V105, P2330, DOI 10.1111/j.1471-4159.2008.05322.x; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; MELLONI E, 1988, P NATL ACAD SCI USA, V85, P3835, DOI 10.1073/pnas.85.11.3835; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Musante V, 2011, J NEUROCHEM, V117, P516, DOI 10.1111/j.1471-4159.2011.07223.x; NAKAMURA Y, 1993, GLIA, V9, P48, DOI 10.1002/glia.440090107; North WG, 1997, MOL CHEM NEUROPATHOL, V30, P77, DOI 10.1007/BF02815151; Passalacqua M, 2009, ARCH BIOCHEM BIOPHYS, V481, P202, DOI 10.1016/j.abb.2008.11.013; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; RAITERI M, 1974, EUR J PHARMACOL, V25, P411, DOI 10.1016/0014-2999(74)90272-6; Ranzato E, 2009, MOL CELL BIOCHEM, V332, P199, DOI 10.1007/s11010-009-0192-4; Schelman WR, 1997, MOL BRAIN RES, V48, P197, DOI 10.1016/S0169-328X(97)00093-4; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Sparatore B, 2005, BIOCHEM J, V389, P215, DOI 10.1042/BJ20050053; Sparatore B, 1996, BIOCHEM J, V320, P253, DOI 10.1042/bj3200253; Sparatore B, 2002, BIOCHEM J, V363, P529, DOI 10.1042/0264-6021:3630529; Sparatore B, 2001, BIOCHEM J, V357, P569, DOI 10.1042/0264-6021:3570569; Tagami K, 2006, BRIT J HAEMATOL, V135, P567, DOI 10.1111/j.1365-2141.2006.06335.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tzeng HP, 2008, AM J PHYSIOL-HEART C, V294, pH1490, DOI 10.1152/ajpheart.00910.2007; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107	47	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44518	10.1371/journal.pone.0044518	http://dx.doi.org/10.1371/journal.pone.0044518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952988	gold, Green Submitted, Green Published			2022-12-25	WOS:000308221300096
J	Deng, YM; Jiang, JF; Chen, SM; Teng, NJ; Song, AP; Guan, ZY; Fang, WM; Chen, FD				Deng, Yanming; Jiang, Jiafu; Chen, Sumei; Teng, Nianjun; Song, Aiping; Guan, Zhiyong; Fang, Weimin; Chen, Fadi			Combination of Multiple Resistance Traits from Wild Relative Species in Chrysanthemum via Trigeneric Hybridization	PLOS ONE			English	Article							ARTEMISIA-VULGARIS; SALT-TOLERANCE; MECHANISMS; HYBRID	Background: With the objective of combining multiple resistant traits from wild relative species in florist's chrysanthemums, trigeneric hybridization was conducted by crossing two intergeneric F-1 hybrids Chrysanthemum grandiflorum X Artemisia vulgaris and Chrysanthemum crassum X Crossostephium chinense. Methodology/Principal Findings: To assess post-pollination phenomena, we investigated pollen germination on the stigma and embryo development, using fluorescence and scanning electron microscopy and paraffin-embedded sections, respectively. We selected eight putative trigeneric hybrid lines that showed the greatest morphological differences from the parents from among the progeny derived via embryo rescue. The hybridity of one trigeneric hybrid was further confirmed by fluorescent genomic in situ hybridization; in addition, the aphid resistance and salt tolerance of this hybrid were higher than those of the chrysanthemum parent and the C. grandiflorum X A. vulgaris F-1 hybrid, respectively. Conclusions/Significance: The enhanced aphid resistance of the hybrid line reflects the inheritance of chromosomes from A. vulgaris, which carries genes that encode bioactive components. The enhanced salt tolerance of the trigeneric hybrid is attributable to inheritance of genetic materials from Chrysanthemum crassum and Crossostephium chinense, which act to maintain the compartmentation of Na+ and K+ ions and their selective transportation among different organs to avert deleterious effects and protect the photosynthetic apparatus. The results indicate that trigeneric hybridization between different bigeneric hybrids is a promising method for combination of multiple stress-resistance traits for improvement of chrysanthemum.	[Deng, Yanming; Jiang, Jiafu; Chen, Sumei; Teng, Nianjun; Song, Aiping; Guan, Zhiyong; Fang, Weimin; Chen, Fadi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Deng, Yanming] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Deng, YM (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenfd@njau.edu.cn		Deng, Yanming/0000-0001-7978-1417	Fundamental Research Funds for the Central Universities [KYJ 200907, KYZ201112]; Ministry of Science and Technology of the People's Republic of China [2011AA100208]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX(10)114]; Science and Technology Program of Jiangsu Province [BE2011325]; Program for New Century Excellent Talents in University of Chinese Ministry of Education [NCET-10-0492]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; Science and Technology Program of Jiangsu Province; Program for New Century Excellent Talents in University of Chinese Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Fundamental Research Funds for the Central Universities (KYJ 200907, KYZ201112), 863 project of Ministry of Science and Technology of the People's Republic of China (2011AA100208), Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province (CX(10)114), the Science and Technology Program of Jiangsu Province (BE2011325), the Program for New Century Excellent Talents in University of Chinese Ministry of Education (Grant No. NCET-10-0492), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkenar AA, 2007, SCI HORTIC-AMSTERDAM, V114, P74, DOI 10.1016/j.scienta.2007.06.022; Anderson NO, 2006, FLOWER BREEDING AND GENETICS: ISSUES, CHALLENGES AND OPPORTUNITIES FOR THE 21ST CENTURY, P389; Bremer K., 1993, B NAT HIST MUS LOND, V23, P71; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Cheng X, 2011, EUPHYTICA, V177, P45, DOI 10.1007/s10681-010-0248-2; Deng YM, 2012, PLANT PHYSIOL BIOCH, V55, P93, DOI 10.1016/j.plaphy.2012.03.006; Deng YM, 2012, SCI HORTIC-AMSTERDAM, V134, P185, DOI 10.1016/j.scienta.2011.11.012; Deng YM, 2011, PLANT CELL REP, V30, P2177, DOI 10.1007/s00299-011-1123-x; Deng YM, 2010, EUPHYTICA, V174, P41, DOI 10.1007/s10681-009-0113-3; Deng YM, 2010, SCI HORTIC-AMSTERDAM, V124, P500, DOI 10.1016/j.scienta.2010.02.009; Deng YM, 2010, PLANTA, V231, P693, DOI 10.1007/s00425-009-1081-5; DUMAS C, 1983, THEOR APPL GENET, V67, P1, DOI 10.1007/BF00303914; FEDAK G, 1980, THEOR APPL GENET, V56, P221, DOI 10.1007/BF00295452; Fukai S, 2003, ACTA HORTIC, P223, DOI 10.17660/ActaHortic.2003.620.26; Ge XH, 2007, CHROMOSOME RES, V15, P849, DOI 10.1007/s10577-007-1168-4; Guan Zhi-yong, 2010, Shengtaixue Zazhi, V29, P467; Jauhar PP, 2010, NUCLEUS CALCUTTA, V53, P3, DOI 10.1007/s13237-010-0010-0; Jenczewski E, 2004, CRIT REV PLANT SCI, V23, P21, DOI 10.1080/07352680490273239; Kang HY, 2012, GENET RESOUR CROP EV, V59, P445, DOI 10.1007/s10722-011-9694-5; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; Kondo Katsuhiko, 2002, Chromosome Science, V6, P87; Kosina R, 1996, ANN BOT-LONDON, V78, P583, DOI 10.1006/anbo.1996.0164; Lee YH, 1996, EUPHYTICA, V89, P235, DOI 10.1007/BF00034611; Li J, 2008, EUPHYTICA, V164, P293, DOI 10.1007/s10681-008-9734-1; Li XF, 2006, EUPHYTICA, V150, P117, DOI 10.1007/s10681-006-9099-2; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; SIDDIQUI KA, 1971, HEREDITAS-GENETISK A, V69, P263; Sun CQ, 2010, EUPHYTICA, V174, P51, DOI 10.1007/s10681-009-0117-z; Tang FP, 2009, EUPHYTICA, V169, P133, DOI 10.1007/s10681-009-9956-x; Wang B., 1995, PLANT PHYSL COMMUN, V31, P50; Wang J, 2006, J STORED PROD RES, V42, P339, DOI 10.1016/j.jspr.2005.06.001; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Zhao HE, 2009, GENET RESOUR CROP EV, V56, P937, DOI 10.1007/s10722-009-9412-8; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	38	10	11	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44337	10.1371/journal.pone.0044337	http://dx.doi.org/10.1371/journal.pone.0044337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952958	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500061
J	Geng, YP; Verhamme, IM; Messer, A; Sun, MF; Smith, SB; Bajaj, SP; Gailani, D				Geng, Yipeng; Verhamme, Ingrid M.; Messer, Amanda; Sun, Mao-fu; Smith, Stephen B.; Bajaj, S. Paul; Gailani, David			A Sequential Mechanism for Exosite-mediated Factor IX Activation by Factor XIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; SUBSTRATE-BINDING SITE; MACROMOLECULAR SUBSTRATE; EXTRINSIC PATHWAY; APPLE DOMAINS; TISSUE FACTOR; LIGHT-CHAINS; HEAVY-CHAIN; FACTOR-X; IDENTIFICATION	During blood coagulation, the protease factor XIa (fXIa) activates factor IX (fIX). We describe a new mechanism for this process. FIX is cleaved initially after Arg(145) to form fIX alpha, and then after Arg(180) to form the protease fIXa beta. FIX alpha is released from fXIa, and must rebind for cleavage after Arg(180) to occur. Catalytic efficiency of cleavage after Arg(180) is 7-fold greater than for cleavage after Arg(145), limiting fIX alpha accumulation. FXIa contains four apple domains (A1-A4) and a catalytic domain. Exosite(s) on fXIa are required for fIX binding, however, there is lack of consensus on their location(s), with sites on the A2, A3, and catalytic domains described. Replacing the A3 domain with the prekallikrein A3 domain increases K-m for fIX cleavage after Arg(145) and Arg(180) 25- and >= 90-fold, respectively, and markedly decreases k(cat) for cleavage after Arg(180). Similar results were obtained with the isolated fXIa catalytic domain, or fXIa in the absence of Ca2+. Forms of fXIa lacking the A3 domain exhibit 15-fold lower catalytic efficiency for cleavage after Arg(180) than for cleavage after Arg(145), resulting in fIX alpha accumulation. Replacing the A2 domain does not affect fIX activation. The results demonstrate that fXIa activates fIX by an exosite- and Ca2+-mediated release-rebind mechanism in which efficiency of the second cleavage is enhanced by conformational changes resulting from the first cleavage. Initial binding of fIX and fIX alpha requires an exosite on the fXIa A3 domain, but not the A2 or catalytic domain.	[Geng, Yipeng; Verhamme, Ingrid M.; Sun, Mao-fu; Smith, Stephen B.; Gailani, David] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Messer, Amanda; Bajaj, S. Paul] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA	Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gailani, D (corresponding author), 777 Preston Res Bldg,2220 Pierce Ave, Nashville, TN USA.	dave.gailani@vanderbilt.edu			National Institutes of Health from the NHLBI [HL58837, HL81326, HL080018, HL36365]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058837, R56HL036365, R55HL036365, R01HL081326, R01HL036365, R01HL080018] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58837 and HL81326 (to D. G.), HL080018 (to I. M. V.), and HL36365 (to S. P. B.) from the NHLBI.	Aktimur A, 2003, J BIOL CHEM, V278, P7981, DOI 10.1074/jbc.M212748200; BAGLIA FA, 1991, J BIOL CHEM, V266, P24190; BAGLIA FA, 1989, BLOOD, V74, P244; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; CARLISLE TL, 1990, J BIOL CHEM, V265, P22044; Cheng Q, 2003, J THROMB HAEMOST, V1, P2340, DOI 10.1046/j.1538-7836.2003.00418.x; Colman R. W., 2006, HEMOSTASIS THROMBOSI, P131; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; FURIE B, 2009, HEMATOLOGY BASIC PRI, P1819; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LAWSON JH, 1991, J BIOL CHEM, V266, P11317; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; Marcinkiewicz MM, 2012, J BIOL CHEM, V287, P6187, DOI 10.1074/jbc.M111.291989; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; NEMERSON Y, 1992, SEMIN HEMATOL, V29, P170; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x; Roth D. A., 2009, HEMATOLOGY BASIC PRI, P1899; Schmidt AE, 2008, BLOOD, V112, P708; SINHA D, 1987, BIOCHEMISTRY-US, V26, P3768, DOI 10.1021/bi00387a005; Sinha D, 2007, BIOCHEMISTRY-US, V46, P9830, DOI 10.1021/bi062296c; Smith SB, 2008, J BIOL CHEM, V283, P6696, DOI 10.1074/jbc.M707234200; Smith SB, 2008, EXPERT REV HEMATOL, V1, P87, DOI 10.1586/17474086.1.1.87; Su YC, 2011, J BIOL CHEM, V286, P31904, DOI 10.1074/jbc.M111.257527; Sun MF, 1999, J BIOL CHEM, V274, P36373, DOI 10.1074/jbc.274.51.36373; Sun YH, 1996, J BIOL CHEM, V271, P29023, DOI 10.1074/jbc.271.46.29023; Wolberg AS, 1997, BIOCHEMISTRY-US, V36, P4074, DOI 10.1021/bi962274y; Wu WM, 2008, J BIOL CHEM, V283, P18655, DOI 10.1074/jbc.M802275200; ZUR M, 1980, J BIOL CHEM, V255, P5703	38	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.376343	http://dx.doi.org/10.1074/jbc.M112.376343			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22961984	Green Published, hybrid			2022-12-25	WOS:000310642200053
J	Kitamoto, S; Yokoyama, S; Higashi, M; Yamada, N; Matsubara, S; Takao, S; Batra, SK; Yonezawa, S				Kitamoto, Sho; Yokoyama, Seiya; Higashi, Michiyo; Yamada, Norishige; Matsubara, Shyuichiro; Takao, Sonshin; Batra, Surinder K.; Yonezawa, Suguru			Expression of MUC17 Is Regulated by HIF1 alpha-Mediated Hypoxic Responses and Requires a Methylation-Free Hypoxia Responsible Element in Pancreatic Cancer	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; DNA METHYLATION; HELICOBACTER-PYLORI; MUCIN; GENE; CONTRIBUTES; METASTASIS; PROFILES; THERAPY	MUC17 is a type 1 membrane-bound glycoprotein that is mainly expressed in the digestive tract. Recent studies have demonstrated that the aberrant overexpression of MUC17 is correlated with the malignant potential of pancreatic ductal adenocarcinomas (PDACs); however, the exact regulatory mechanism of MUC17 expression has yet to be identified. Here, we provide the first report of the MUC17 regulatory mechanism under hypoxia, an essential feature of the tumor microenvironment and a driving force of cancer progression. Our data revealed that MUC17 was significantly induced by hypoxic stimulation through a hypoxia-inducible factor 1 alpha (HIF1 alpha)-dependent pathway in some pancreatic cancer cells ( e. g., AsPC1), whereas other pancreatic cancer cells (e.g., BxPC3) exhibited little response to hypoxia. Interestingly, these low-responsive cells have highly methylated CpG motifs within the hypoxia responsive element (HRE, 5'-RCGTG-3'), a binding site for HIF1a. Thus, we investigated the demethylation effects of CpG at HRE on the hypoxic induction of MUC17. Treatment of low-responsive cells with 5-aza-2'-deoxycytidine followed by additional hypoxic incubation resulted in the restoration of hypoxic MUC17 induction. Furthermore, DNA methylation of HRE in pancreatic tissues from patients with PDACs showed higher hypomethylation status as compared to those from non-cancerous tissues, and hypomethylation was also correlated with MUC17 mRNA expression. Taken together, these findings suggested that the HIF1 alpha-mediated hypoxic signal pathway contributes to MUC17 expression, and DNA methylation of HRE could be a determinant of the hypoxic inducibility of MUC17 in pancreatic cancer cells.	[Kitamoto, Sho; Yokoyama, Seiya; Higashi, Michiyo; Yamada, Norishige; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oncol, Dept Human Pathol, Kagoshima 890, Japan; [Matsubara, Shyuichiro; Takao, Sonshin] Kagoshima Univ, Frontier Sci Res Ctr, Kagoshima 890, Japan; [Batra, Surinder K.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	Kagoshima University; Kagoshima University; University of Nebraska System; University of Nebraska Medical Center	Kitamoto, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oncol, Dept Human Pathol, Kagoshima 890, Japan.	syoneza@m2.kufm.kagoshima-u.ac.jp	Kitamoto, Sho/AAE-4549-2021	Kitamoto, Sho/0000-0003-3597-6647	Princes Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan [23390085, 21590399, 24701008, 239349]; Pancreas Research Foundation of Japan; Kodama Memorial Foundation, Japan; National Institutes of Health [CA78590, CA163120, CA133944, CA111294]; NATIONAL CANCER INSTITUTE [U01CA111294, R03CA133944, U54CA163120, R01CA078590] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24701008] Funding Source: KAKEN	Princes Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan); Kodama Memorial Foundation, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Princes Takamatsu Cancer Research Fund to S. Yonezawa; Grants-in-Aid for Scientific Research on Scientific Research (B) 23390085 to S. Yonezawa; Scientific Research (C) 21590399 to M. Higashi; Young Scientists (B) 24701008 to S. Yokoyama; Scientific Research on Priority Areas 239349 to S. Kitamoto (JSPS Fellowship) from the Ministry of Education, Science, Sports, Culture and Technology, Japan; a Pancreas Research Foundation of Japan to S. Yokoyama; and the Kodama Memorial Foundation, Japan to M. Higashi. S. Batra is supported in part by the National Institutes of Health grants (CA78590, CA163120, CA133944 and CA111294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2009, CARCINOGENESIS, V30, P214, DOI 10.1093/carcin/bgn268; Ashida S, 2002, J CANCER RES CLIN, V128, P561, DOI 10.1007/s00432-002-0374-x; Aubert S, 2009, CANCER RES, V69, P5707, DOI 10.1158/0008-5472.CAN-08-4905; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; BHASKAR KR, 1992, NATURE, V360, P458, DOI 10.1038/360458a0; Fechner G, 2007, ANTICANCER RES, V27, P4225; Gum JR, 2002, BIOCHEM BIOPH RES CO, V291, P466, DOI 10.1006/bbrc.2002.6475; Hirono S, 2010, CANCER SCI, V101, P259, DOI 10.1111/j.1349-7006.2009.01359.x; Ho SB, 2006, GASTROENTEROLOGY, V131, P1501, DOI 10.1053/j.gastro.2006.09.006; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kitamoto S, 2011, GLYCOBIOLOGY, V21, P247, DOI 10.1093/glycob/cwq155; Kitamoto S, 2010, BIOCHEM BIOPH RES CO, V397, P333, DOI 10.1016/j.bbrc.2010.05.124; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Luu Y, 2010, INT J BIOCHEM CELL B, V42, P996, DOI 10.1016/j.biocel.2010.03.001; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Moehle C, 2006, J MOL MED, V84, P1055, DOI 10.1007/s00109-006-0100-2; Moniaux N, 2006, J BIOL CHEM, V281, P23676, DOI 10.1074/jbc.M600302200; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Rossler J, 2004, J CELL BIOCHEM, V93, P153, DOI 10.1002/jcb.20133; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Senapati S, 2010, J CLIN PATHOL, V63, P702, DOI 10.1136/jcp.2010.078717; Vincent A, 2008, FASEB J, V22, P3035, DOI 10.1096/fj.07-103390; Vorwerk P, 2002, J CLIN PATHOL-MOL PA, V55, P40, DOI 10.1136/mp.55.1.40; Yamada N, 2009, BRIT J CANCER, V100, P344, DOI 10.1038/sj.bjc.6604845; Yamada N, 2008, CANCER RES, V68, P2708, DOI 10.1158/0008-5472.CAN-07-6844; Yamada N, 2006, INT J CANCER, V119, P1850, DOI 10.1002/ijc.22047; Yamada N, 2010, J HEPATO-BIL-PAN SCI, V17, P844, DOI 10.1007/s00534-010-0278-0; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Yokoyama S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-67; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Zhu Y, 2010, MED ONCOLOGY	36	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44108	10.1371/journal.pone.0044108	http://dx.doi.org/10.1371/journal.pone.0044108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970168	gold, Green Published, Green Submitted			2022-12-25	WOS:000308748400010
J	Gropeanu, RA; Baumann, H; Ritz, S; Mailander, V; Surrey, T; del Campo, A				Gropeanu, Radu A.; Baumann, Hella; Ritz, Sandra; Mailaender, Volker; Surrey, Thomas; del Campo, Aranzazu			Phototriggerable 2 ',7-Caged Paclitaxel	PLOS ONE			English	Article							MICROTUBULE DYNAMICS; TUBULIN; BINDING; TAXOL; DERIVATIVES; PRODRUGS; POLARIZATION; INHIBITION; CHEMISTRY; ANALOGS	Three different variants of photoactivatable caged paclitaxel (PTX) have been synthesized and their bioactivity was characterized in in vitro assays and in living cells. The caged PTXs contain the photoremovable chromophore 4,5-dimethoxy-2-nitrobenzyloxycarbonyl (Nvoc) attached to position C7, C2' and to both of these positions via a carbonate bond. Single caged PTXs remained biologically active even at low dosages. Double caging was necessary in order to fully inhibit its activity and to obtain a phototriggerable PTX that can be applied successfully at commonly used concentrations. Irradiation of solutions containing the double caged PTX allowed dose-dependent delivery of functional PTX. Light-triggered stabilization of microtubule assemblies in vitro and in vivo by controlled light exposure of tubulin solutions or cell cultures containing caged PTX was demonstrated. Short light exposure under a fluorescence microscope allowed controlled delivery of free PTX during imaging.	[Gropeanu, Radu A.; Ritz, Sandra; Mailaender, Volker; del Campo, Aranzazu] Max Planck Inst Polymer Res, Mainz, Germany; [Baumann, Hella; Surrey, Thomas] Lincolns Inn Fields Labs, London Res Inst, Canc Res United Kingdom, London, England; [Mailaender, Volker] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany	Max Planck Society; Cancer Research UK; University of London; University College London; Johannes Gutenberg University of Mainz	Gropeanu, RA (corresponding author), Max Planck Inst Polymer Res, Mainz, Germany.	delcampo@mpip-mainz.mpg.de	Mailänder, Volker/H-3589-2012; Mailänder, Volker/AAD-1722-2019; Surrey, Thomas/AAC-4608-2021	Mailänder, Volker/0000-0001-6583-8136; Mailänder, Volker/0000-0001-6583-8136; del Campo, Aranzazu/0000-0001-5725-2135; Surrey, Thomas/0000-0001-9082-1870	Federal Ministry of Education and Research [0312005A]; Cancer Research United Kingdom; Boehringer Ingelheim Fonds; Cancer Research UK [14256] Funding Source: researchfish	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Cancer Research United Kingdom(Cancer Research UK); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Cancer Research UK(Cancer Research UK)	AdC acknowledges financial support from the Federal Ministry of Education and Research (grant no. 0312005A). TS acknowledges financial support from Cancer Research United Kingdom. HB thanks the Boehringer Ingelheim Fonds for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Baloglu E, 2001, BIOORG MED CHEM LETT, V11, P2249, DOI 10.1016/S0960-894X(01)00453-X; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Buck KB, 2002, J NEUROSCI, V22, P9358; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Ceruti M, 2000, J CONTROL RELEASE, V63, P141, DOI 10.1016/S0168-3659(99)00198-4; del Campo A, 2005, ANGEW CHEM INT EDIT, V44, P4707, DOI 10.1002/anie.200500092; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; Diaz JF, 2005, J BIOL CHEM, V280, P3928, DOI 10.1074/jbc.M407816200; Ellis-Davies GCR, 2008, CHEM REV, V108, P1603, DOI 10.1021/cr078210i; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Engelborghs Y, 2000, MOL BIOL CELL, V11, p189A; Fu Y, 2009, CURR MED CHEM, V16, P3966, DOI 10.2174/092986709789352277; Goeldner M, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P1, DOI 10.1002/3527605592; Gonzalez R. C., 2004, EDUCATION, V624, P609; Greenwald RB, 1996, J MED CHEM, V39, P424, DOI 10.1021/jm950475e; GREENWALD RB, 1995, J ORG CHEM, V60, P331, DOI 10.1021/jo00107a010; Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113; Han Y, 1996, BIOCHEMISTRY-US, V35, P14173, DOI 10.1021/bi960774l; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Korten T, 2010, CURR OPIN BIOTECH, V21, P477, DOI 10.1016/j.copbio.2010.05.001; Li YK, 2000, BIOCHEMISTRY-US, V39, P616, DOI 10.1021/bi992044u; Mayer G, 2006, ANGEW CHEM INT EDIT, V45, P4900, DOI 10.1002/anie.200600387; Morais S, 2003, ANAL BIOCHEM, V321, P44, DOI 10.1016/S0003-2697(03)00436-6; Noguchi M, 2008, BIOORGAN MED CHEM, V16, P5389, DOI 10.1016/j.bmc.2008.04.022; Petersen S, 2008, ANGEW CHEM INT EDIT, V47, P3192, DOI 10.1002/anie.200704857; Rao CS, 1998, BIOORGAN MED CHEM, V6, P2193, DOI 10.1016/S0968-0896(98)00158-8; San Miguel V, 2011, J AM CHEM SOC, V133, P5380, DOI 10.1021/ja110572j; Sengupta S, 1997, BIOCHEMISTRY-US, V36, P5179, DOI 10.1021/bi962891m; SENGUPTA S, 1995, BIOCHEMISTRY-US, V34, P11889, DOI 10.1021/bi00037a029; SENGUPTA S, 1995, MOL BIOL CELL, V6, P168; Shick AW, 2010, [No title captured], Patent No. [WO2010151073(A2), 2010151073]; Skwarczynski M, 2006, BIOORG MED CHEM LETT, V16, P4492, DOI 10.1016/j.bmcl.2006.06.030; Sun L, 2009, CHEMMEDCHEM, V4, P719, DOI 10.1002/cmdc.200900044; Wirkner M, 2011, ADV MATER, V23, P3907, DOI 10.1002/adma.201100925; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042	41	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43657	10.1371/journal.pone.0043657	http://dx.doi.org/10.1371/journal.pone.0043657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970137	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400016
J	ter Riet, G; Korevaar, DA; Leenaars, M; Sterk, PJ; Van Noorden, CJF; Bouter, LM; Lutter, R; Elferink, RPO; Hooft, L				ter Riet, Gerben; Korevaar, Daniel A.; Leenaars, Marlies; Sterk, Peter J.; Van Noorden, Cornelis J. F.; Bouter, Lex M.; Lutter, Rene; Elferink, Ronald P. Oude; Hooft, Lotty			Publication Bias in Laboratory Animal Research: A Survey on Magnitude, Drivers, Consequences and Potential Solutions	PLOS ONE			English	Article							ANTIDEPRESSANT TRIALS; MEDICAL STATISTICS; REVIEWS	Context: Publication bias jeopardizes evidence-based medicine, mainly through biased literature syntheses. Publication bias may also affect laboratory animal research, but evidence is scarce. Objectives: To assess the opinion of laboratory animal researchers on the magnitude, drivers, consequences and potential solutions for publication bias. And to explore the impact of size of the animals used, seniority of the respondent, working in a for-profit organization and type of research (fundamental, pre-clinical, or both) on those opinions. Design: Internet-based survey. Setting: All animal laboratories in The Netherlands. Participants: Laboratory animal researchers. Main Outcome Measure(s): Median (interquartile ranges) strengths of beliefs on 5 and 10-point scales (1: totally unimportant to 5 or 10: extremely important). Results: Overall, 454 researchers participated. They considered publication bias a problem in animal research (7 (5 to 8)) and thought that about 50% (32-70) of animal experiments are published. Employees (n = 21) of for-profit organizations estimated that 10% (5 to 50) are published. Lack of statistical significance (4 (4 to 5)), technical problems (4 (3 to 4)), supervisors (4 (3 to 5)) and peer reviewers (4 (3 to 5)) were considered important reasons for non-publication (all on 5-point scales). Respondents thought that mandatory publication of study protocols and results, or the reasons why no results were obtained, may increase scientific progress but expected increased bureaucracy. These opinions did not depend on size of the animal used, seniority of the respondent or type of research. Conclusions: Non-publication of "negative" results appears to be prevalent in laboratory animal research. If statistical significance is indeed a main driver of publication, the collective literature on animal experimentation will be biased. This will impede the performance of valid literature syntheses. Effective, yet efficient systems should be explored to counteract selective reporting of laboratory animal research.	[ter Riet, Gerben; Korevaar, Daniel A.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Leenaars, Marlies] Radboud Univ Nijmegen, Med Ctr, Cent Anim Lab, Res Ctr 3R, NL-6525 ED Nijmegen, Netherlands; [Sterk, Peter J.; Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands; [Van Noorden, Cornelis J. F.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Bouter, Lex M.] Vrije Univ Amsterdam, Execut Board, Amsterdam, Netherlands; [Elferink, Ronald P. Oude] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Hooft, Lotty] Univ Amsterdam, Acad Med Ctr, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	ter Riet, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.terriet@amc.nl	Leenaars, P.P.A.M./L-4478-2015; Korevaar, Daniël A./O-5809-2019; Bouter, Lex/X-1003-2019; Sterk, P.J./AAK-8175-2020; Riet, Gerben ter/A-6943-2011	Leenaars, P.P.A.M./0000-0002-9855-708X; Bouter, Lex/0000-0002-2659-5482; Riet, Gerben ter/0000-0002-2231-7637				Bennett DA, 2004, J CLIN EPIDEMIOL, V57, P349, DOI 10.1016/j.jclinepi.2003.09.015; Bernard C., 1865, INTRO ETUDE MED EXPT; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Bracken MB, 2009, J ROY SOC MED, V102, P120, DOI 10.1258/jrsm.2008.08k033; Bracken MB, 2009, ANN EPIDEMIOL, V19, P220, DOI 10.1016/j.annepidem.2008.11.006; De Angelis C, 2004, ANN INTERN MED, V141, P477, DOI 10.7326/0003-4819-141-6-200409210-00109; de Jong JP, 2010, J CLIN EPIDEMIOL, V63, P1342, DOI 10.1016/j.jclinepi.2010.01.018; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Greenland S, 2007, INT J EPIDEMIOL, V36, P944, DOI 10.1093/ije/dym174; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Knight J, 2003, NATURE, V422, P554, DOI 10.1038/422554a; Korevaar DA, 2011, LAB ANIM-UK, V45, P225, DOI 10.1258/la.2011.010121; Lemon R, 2005, BMJ-BRIT MED J, V330, P977, DOI 10.1136/bmj.330.7498.977; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Mignini Luciano E, 2006, BMC Med Res Methodol, V6, P10, DOI 10.1186/1471-2288-6-10; Ministerie van Economische Zaken Landbouw en Innovatie, 2010, RAPP NVWA ZO DOEND 2; Moreno SG, 2012, STAT MED, V31, P1407, DOI 10.1002/sim.4488; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126	29	64	66	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43404	10.1371/journal.pone.0043404	http://dx.doi.org/10.1371/journal.pone.0043404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957028	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800020
J	Okada, Y; Oh-Oka, K; Nakamura, Y; Ishimaru, K; Matsuoka, S; Okumura, K; Ogawa, H; Hisamoto, M; Okuda, T; Nakao, A				Okada, Yui; Oh-oka, Kyoko; Nakamura, Yuki; Ishimaru, Kayoko; Matsuoka, Shuji; Okumura, Ko; Ogawa, Hideoki; Hisamoto, Masashi; Okuda, Tohru; Nakao, Atsuhito			Dietary Resveratrol Prevents the Development of Food Allergy in Mice	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; CHOLERA-TOXIN; DENDRITIC CELLS; ORAL TOLERANCE; PATHWAY; ANTIGEN; HEALTH	Background: Resveratrol is a bioactive polyphenol enriched in red wine that exhibits many beneficial health effects via multiple mechanisms. However, it is unclear whether resveratrol is beneficial for the prevention of food allergy. This study investigated whether resveratrol inhibited the development of food allergy by using a mouse model of the disease. Methodology/Principal Findings: Mice fed standard diet or standard diet plus resveratrol were sensitized by intragastric administration of ovalbumin (OVA) and mucosal adjuvant cholera toxin (CT). Several manifestations of food allergy were then compared between the mice. The effects of resveratrol on T cells or dendritic cells were also examined by using splenocytes from OVA-specific T cell-receptor (TCR) transgenic DO11.10 mice or mouse bone marrow-derived dendritic cells (BMDCs) in vitro. We found that mice fed resveratrol showed reduced OVA-specific serum IgE production, anaphylactic reaction, and OVA-induced IL-13 and IFN-(a) over bar production from the mesenteric lymph nodes (MLNs) and spleens in comparison to the control mice, following oral sensitization with OVA plus CT. In addition, resveratrol inhibited OVA plus CT-induced IL-4, IL-13, and IFN-(a) over bar production in splenocytes from DO11.10 mice associated with inhibition of GATA-3 and T-bet expression. Furthermore, resveratrol suppressed the OVA plus CT-induced CD25 expression and IL-2 production in DO11.10 mice-splenocytes in association with decreases in CD80 and CD86 expression levels. Finally, resveratrol suppressed CT-induced cAMP elevation in association with decreases in CD80 and CD86 expression levels in BMDCs. Conclusions/Significance: Ingestion of resveratrol prevented the development of a food allergy model in mice. Given the in vitro findings, resveratrol might do so by inhibiting DC maturation and subsequent early T cell activation and differentiation via downregulation of CT-induced cAMP activation in mice. These results suggest that resveratrol may have potential for prophylaxis against food allergy.	[Okada, Yui; Oh-oka, Kyoko; Nakamura, Yuki; Ishimaru, Kayoko; Nakao, Atsuhito] Univ Yamanashi, Dept Immunol, Fac Med, Chuo Ku, Yamanashi, Japan; [Okada, Yui; Hisamoto, Masashi; Okuda, Tohru] Univ Yamanashi, Inst Enol & Viticulture, Koufu, Yamanashi, Japan; [Matsuoka, Shuji] Juntendo Univ, Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; [Okumura, Ko; Ogawa, Hideoki; Nakao, Atsuhito] Juntendo Univ, Sch Med, Dept Pathol, Atopy Res Ctr,Bunkyo Ku, Tokyo 113, Japan	University of Yamanashi; University of Yamanashi; Juntendo University; Juntendo University	Okada, Y (corresponding author), Univ Yamanashi, Dept Immunol, Fac Med, Chuo Ku, Yamanashi, Japan.	anakao@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [H23]; Grants-in-Aid for Scientific Research [23790904] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (H23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blazquez AB, 2008, J IMMUNOL, V180, P4441, DOI 10.4049/jimmunol.180.7.4441; Brandtzaeg P, 2010, NAT REV GASTRO HEPAT, V7, P380, DOI 10.1038/nrgastro.2010.80; Burks AW, 2008, J ALLERGY CLIN IMMUN, V121, P1344, DOI 10.1016/j.jaci.2008.02.037; Crespo JF, 2003, ALLERGY, V58, P98, DOI 10.1034/j.1398-9995.2003.02170.x; Ela Sala A, 2009, J EXP MED, V206, P1227; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; German JB, 2000, ANNU REV NUTR, V20, P561, DOI 10.1146/annurev.nutr.20.1.561; Hamelmann E, 2008, CLIN EXP ALLERGY, V38, P233, DOI 10.1111/j.1365-2222.2007.02901.x; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Lack G, 2008, NEW ENGL J MED, V359, P1252, DOI 10.1056/NEJMcp0800871; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Masilamani M, 2011, J ALLERGY CLIN IMMUN, V128, P1242, DOI 10.1016/j.jaci.2011.05.009; Morinaga N, 2010, TOXICON, V56, P29, DOI 10.1016/j.toxicon.2010.03.009; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakamura Y, 2011, J ALLERGY CLIN IMMUN, V127, P1038, DOI 10.1016/j.jaci.2011.02.006; Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022; Negri DRM, 2009, INFECT IMMUN, V77, P1924, DOI 10.1128/IAI.01559-08; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh A, 2011, CLIN EXP ALLERGY, V41, P1346, DOI 10.1111/j.1365-2222.2011.03773.x; Soleas GJ, 2001, ADV EXP MED BIOL, V492, P159; Wang J, 2011, J CLIN INVEST, V121, P827, DOI [10.1172/JCI45434, 10.1186/1710-1492-7-S1-S7]; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Zuercher AW, 2010, CLIN EXP ALLERGY, V40, P942, DOI 10.1111/j.1365-2222.2010.03460.x	28	35	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44338	10.1371/journal.pone.0044338	http://dx.doi.org/10.1371/journal.pone.0044338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962611	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600039
J	Ambrosio, MR; Piccaluga, PP; Ponzoni, M; Rocca, BJ; Malagnino, V; Onorati, M; De Falco, G; Calbi, V; Ogwang, M; Naresh, KN; Pileri, SA; Doglioni, C; Leoncini, L; Lazzi, S				Ambrosio, Maria R.; Piccaluga, Pier P.; Ponzoni, Maurilio; Rocca, Bruno J.; Malagnino, Valeria; Onorati, Monica; De Falco, Giulia; Calbi, Valeria; Ogwang, Martin; Naresh, Kikkeri N.; Pileri, Stefano A.; Doglioni, Claudio; Leoncini, Lorenzo; Lazzi, Stefano			The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CANCER; EXPRESSION; DROPLETS; PROLIFERATION; BIOLOGY; PROTEIN; TIP47	Background: Recent evidence suggests that lipid pathway is altered in many human tumours. In Burkitt lymphoma this is reflected by the presence of lipid droplets which are visible in the cytoplasm of neoplastic cells in cytological preparations. These vacuoles are not identifiable in biopsy section as lipids are "lost" during tissue processing. Methods and Results: In this study we investigated the expression of genes involved in lipid metabolism, at both RNA and protein level in Burkitt lymphoma and in other B-cell aggressive lymphoma cases. Gene expression profile indicated a significant over-expression of the adipophilin gene and marked up-regulation of other genes involved in lipid metabolism in Burkitt lymphoma. These findings were confirmed by immunohistochemistry on a series od additional histological samples: 45 out of 47 BL cases showed strong adipophilin expression, while only 3 cases of the 33 of the not-Burkitt lymphoma category showed weak adipophilin expression (p<0.05). Conclusions: Our preliminary results suggest that lipid metabolism is altered in BL, and this leads to the accumulation of lipid vacuoles. These vacuoles may be specifically recognized by a monoclonal antibody against adipophilin, which may therefore be a useful marker for Burkitt lymphoma because of its peculiar expression pattern. Moreover this peptide might represent an interesting candidate for interventional strategies.	[Ambrosio, Maria R.; Rocca, Bruno J.; Malagnino, Valeria; Onorati, Monica; De Falco, Giulia; Leoncini, Lorenzo; Lazzi, Stefano] Univ Siena, Anat Pathol Sect, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Piccaluga, Pier P.; Pileri, Stefano A.] Univ Bologna, S Orsola Malpighi Hosp, Dept Haematol & Oncol L & A Seragnoli, Mol Pathol Lab,Haematopathol Unit, Bologna, Italy; [Ponzoni, Maurilio; Doglioni, Claudio] Univ Sci Inst San Raffaele, Pathol Unit, Dept Oncol, Milan, Italy; [Naresh, Kikkeri N.] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England; [Calbi, Valeria; Ogwang, Martin] St Mary Hosp, Lacor Gulu, Uganda	University of Siena; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Imperial College London	Ambrosio, MR (corresponding author), Univ Siena, Anat Pathol Sect, Dept Human Pathol & Oncol, Via Laterina 8, I-53100 Siena, Italy.	leoncinil@unisi.it	LEONCINI, Lorenzo/U-4413-2019; Ambrosio, Maria Raffaella/K-8953-2016; leoncini, lorenzo/P-8361-2018; Piccaluga, Pier Paolo/H-7132-2019; Calbi, Valeria/K-4102-2018; Lazzi, Stefano/P-8265-2018	LEONCINI, Lorenzo/0000-0002-7457-300X; Ambrosio, Maria Raffaella/0000-0002-1172-6902; leoncini, lorenzo/0000-0002-7457-300X; Piccaluga, Pier Paolo/0000-0002-9432-0595; Calbi, Valeria/0000-0003-3514-666X; Lazzi, Stefano/0000-0002-2218-3771; Naresh, Kikkeri N/0000-0003-3807-3638; DOGLIONI, Claudio/0000-0002-4969-5216				Atshaves BP, 2001, J BIOL CHEM, V276, P25324, DOI 10.1074/jbc.M100560200; Bellan C, 2010, HEMATOL ONCOL, V28, P53, DOI 10.1002/hon.916; Bhatt AP, 2012, PNAS; Brasaemle DL, 1997, J LIPID RES, V38, P2249; de Jong D, 2009, HAEMATOL-HEMATOL J, V94, P894, DOI 10.3324/haematol.2009.008128; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Drut R, 2005, J PEDIAT HEMATOL ONC, V27, P370, DOI 10.1097/01.mph.0000173177.40894.8d; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Leoncini L, 2008, WHO CLASSIFICATION T, P262; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Muthusamy K, 2006, J CLIN PATHOL, V59, P1166, DOI 10.1136/jcp.2005.033381; Naresh KN, 2011, BJH             0701; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; Ostler DA, 2010, MODERN PATHOL, V23, P567, DOI 10.1038/modpathol.2010.1; Piccaluga PP, 2008, HAEMATOL-HEMATOL J, V93, P1033, DOI 10.3324/haematol.12754; Piccaluga PP, 2011, BLOOD, V117, P3596, DOI 10.1182/blood-2010-08-301556; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Schmidt SM, 2004, CANCER RES, V64, P1164, DOI 10.1158/0008-5472.CAN-03-2538; Straub BK, 2010, MODERN PATHOL, V23, P480, DOI 10.1038/modpathol.2009.191; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036	26	43	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44315	10.1371/journal.pone.0044315	http://dx.doi.org/10.1371/journal.pone.0044315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952953	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300079
J	Kumar, M; Roe, K; Nerurkar, PV; Namekar, M; Orillo, B; Verma, S; Nerurkar, VR				Kumar, Mukesh; Roe, Kelsey; Nerurkar, Pratibha V.; Namekar, Madhuri; Orillo, Beverly; Verma, Saguna; Nerurkar, Vivek R.			Impaired Virus Clearance, Compromised Immune Response and Increased Mortality in Type 2 Diabetic Mice Infected with West Nile Virus	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; BLOOD-BRAIN-BARRIER; INFLAMMATORY RESPONSE; ALPHA/BETA-INTERFERON; ADIPOSE-TISSUE; UNITED-STATES; MOUSE MODEL; IN-VITRO	Clinicoepidemiological data suggest that type 2 diabetes is associated with increased risk of West Nile virus encephalitis (WNVE). However, no experimental studies have elucidated the role of diabetes in WNV neuropathogenesis. Herein, we employed the db/db mouse model to understand WNV immunopathogenesis in diabetics. Nine-week old C57BL/6 WT and db/db mice were inoculated with WNV and mortality, virus burden in the periphery and brain, and antiviral defense responses were analyzed. db/db mice were highly susceptible to WNV disease, exhibited increased tissue tropism and mortality than the wild-type mice, and were unable to clear the infection. Increased and sustained WNV replication was observed in the serum, peripheral tissues and brain of db/db mice, and heightened virus replication in the periphery was correlated with enhanced neuroinvasion and replication of WNV in the brain. WNV infection in db/db mice was associated with enhanced inflammatory response and compromised antiviral immune response characterized by delayed induction of IFN-alpha, and significantly reduced concentrations of WNV-specific IgM and IgG antibodies. The compromised immune response in db/db mice correlated with increased viremia. These data suggest that delayed immune response coupled with failure to clear the virus leads to increased mortality in db/db mice. In conclusion, this study provides unique mechanistic insight into the immunopathogenesis of WNVE observed in diabetics and can be used to develop therapeutics for the management of WNVE among diabetic patients.	[Kumar, Mukesh; Roe, Kelsey; Namekar, Madhuri; Orillo, Beverly; Verma, Saguna; Nerurkar, Vivek R.] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA; [Kumar, Mukesh; Roe, Kelsey; Namekar, Madhuri; Orillo, Beverly; Verma, Saguna; Nerurkar, Vivek R.] Univ Hawaii Manoa, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA; [Nerurkar, Pratibha V.] Univ Hawaii Manoa, Lab Metab Disorders & Alternat Med, Dept Mol Biosci & Bioengn, Coll Trop Agr & Human Resources, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Kumar, M (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.	nerurkar@hawaii.edu	Kumar, Mukesh/N-8814-2015; Kumar, Mukesh/AAI-1046-2019; Namekar, Madhuri/AAU-9421-2021; Nerurkar, Pratibha/AAP-5734-2021; Nerurkar, Vivek R/F-5533-2011	Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875; 	Centers of Biomedical Research Excellence [P20GM103516]; National Institute of General Medicine; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Institutional funds and grant (P20GM103516) from the Centers of Biomedical Research Excellence, National Institute of General Medicine, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroug F, 2006, MAYO CLIN PROC, V81, P12, DOI 10.4065/81.1.12; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649; Bechah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008547; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Bouwman JJM, 2008, INT J OBESITY, V32, P892, DOI 10.1038/ijo.2008.36; Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033; Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x; Calvet HM, 2001, INFECT DIS CLIN N AM, V15, P407, DOI 10.1016/S0891-5520(05)70153-7; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Cook RL, 2010, AM J TROP MED HYG, V83, P1133, DOI 10.4269/ajtmh.2010.09-0717; Deonarain R, 2004, CIRCULATION, V110, P3540, DOI 10.1161/01.CIR.0000136824.73458.20; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Dhurandhar NV, 1997, OBES RES, V5, P464, DOI 10.1002/j.1550-8528.1997.tb00672.x; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Garcia-Tapia D, 2007, J NEUROVIROL, V13, P130, DOI 10.1080/13550280601187185; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Jean CM, 2007, EMERG INFECT DIS, V13, P1918, DOI 10.3201/eid1312.061265; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Khairallah M, 2007, OCUL IMMUNOL INFLAMM, V15, P435, DOI 10.1080/09273940701798488; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; LEITER EH, 1981, DIABETES, V30, P30, DOI 10.2337/diabetes.30.1.30; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Nagajyothi F, 2010, J INFECT DIS, V202, P1104, DOI 10.1086/656189; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Nerurkar PV, 2011, BR J NUTR, P1; O'Connor JC, 2005, J IMMUNOL, V174, P4991, DOI 10.4049/jimmunol.174.8.4991; Park S, 2009, INFECT IMMUN, V77, P1008, DOI 10.1128/IAI.00976-08; Patnaik JL, 2006, EMERG INFECT DIS, V12, P1129, DOI 10.3201/eid1207.051399; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Purtha WE, 2008, J VIROL, V82, P10964, DOI 10.1128/JVI.01646-08; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Sejvar JJ, 2011, VECTOR-BORNE ZOONOT, V11, P161, DOI 10.1089/vbz.2009.0086; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; TANOWITZ HB, 1988, T ROY SOC TROP MED H, V82, P90, DOI 10.1016/0035-9203(88)90272-6; Teitelbaum BA, 2007, CLIN EXP OPTOM, V90, P463, DOI 10.1111/j.1444-0938.2007.00140.x; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; WEBB SR, 1976, J EXP MED, V143, P1239, DOI 10.1084/jem.143.5.1239	52	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44682	10.1371/journal.pone.0044682	http://dx.doi.org/10.1371/journal.pone.0044682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22953001	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300105
J	Gylander, T; Hamann, A; Brouard, JS; Thomas, BR				Gylander, Tim; Hamann, Andreas; Brouard, Jean S.; Thomas, Barb R.			The Potential of Aspen Clonal Forestry in Alberta: Breeding Regions and Estimates of Genetic Gain from Selection	PLOS ONE			English	Article							SEED-TRANSFER GUIDELINES; POPULUS-TREMULOIDES; TREMBLING ASPEN; PHENOTYPIC VARIATION; NATURAL-POPULATIONS; ZONES; WOOD; REFORESTATION; DIVERSITY; GENOTYPE	Background: Aspen naturally grows in large, single-species, even-aged stands that regenerate clonally after fire disturbance. This offers an opportunity for an intensive clonal forestry system that closely emulates the natural life history of the species. In this paper, we assess the potential of genetic tree improvement and clonal deployment to enhance the productivity of aspen forests in Alberta. We further investigate geographic patterns of genetic variation in aspen and infer forest management strategies under uncertain future climates. Methodology/Principal Findings: Genetic variation among 242 clones from Alberta was evaluated in 13 common garden trials after 5-8 growing seasons in the field. Broad-sense heritabilities for height and diameter at breast height (DBH) ranged from 0.36 to 0.64, allowing 5-15% genetic gains in height and 9-34% genetic gains in DBH. Geographic partitioning of genetic variance revealed predominant latitudinal genetic differentiation. We further observed that northward movement of clones almost always resulted in increased growth relative to local planting material, while southward movement had a strong opposite effect. Conclusion/Significance: Aspen forests are an important natural resource in western Canada that is used for pulp and oriented strandboard production, accounting for similar to 40% of the total forest harvest. Moderate to high broad-sense heritabilities in growth traits suggest good potential for a genetic tree improvement program with aspen. Significant productivity gains appear possible through clonal selection from existing trials. We propose two breeding regions for Alberta, and suggest that well-tested southern clones may be used in the northern breeding region, accounting for a general warming trend observed over the last several decades in Alberta.	[Gylander, Tim; Hamann, Andreas; Thomas, Barb R.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Gylander, Tim] Weyerhaeuser Co Ltd, Edmonton, AB, Canada; [Brouard, Jean S.] Isabella Point Forestry Ltd, Salt Spring Isl, BC, Canada; [Thomas, Barb R.] Alberta Pacific Forest Ind Inc, Boyle, AB, Canada	University of Alberta	Gylander, T (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	andreas.hamann@ualberta.ca		Thomas, Barb R./0000-0002-9718-9297; Hamann, Andreas/0000-0003-2046-4550	NSERC/Industry Collaborative Development Grant [CRDPJ 349100-06]; Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Forest Research Institute; Alberta-Pacific Forest Industries Inc.; Ainsworth Engineered Canada LP; Daishowa-Marubeni International Ltd.; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	NSERC/Industry Collaborative Development Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Forest Research Institute; Alberta-Pacific Forest Industries Inc.; Ainsworth Engineered Canada LP; Daishowa-Marubeni International Ltd.; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	This study was supported by an NSERC/Industry Collaborative Development Grant CRDPJ 349100-06. Government funders included the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Alberta Forest Research Institute. Industry co-sponsors included Alberta-Pacific Forest Industries Inc., Ainsworth Engineered Canada LP, Daishowa-Marubeni International Ltd., Western Boreal Aspen Corporation, and Weyerhaeuser Company Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ASRD, 2009, ALB FOR GEN RES MAN; Balatinecz JJ, 2001, FOREST CHRON, V77, P265, DOI 10.5558/tfc77265-2; BARNES BV, 1975, FOREST SCI, V21, P319; CHELIAK WM, 1982, CAN J GENET CYTOL, V24, P611, DOI 10.1139/g82-065; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Dickmann DI, 1983, CULTURE POPLARS N AM; FARMER ROBERT E., 1962, FOREST SCI, V8, P403; Gray LK, 2011, ECOL APPL, V21, P1591, DOI 10.1890/10-1054.1; HAEUSSLER S, 1986, 33 MIN FOR INF SERV; Hamann A, 2000, FOREST ECOL MANAG, V136, P107, DOI 10.1016/S0378-1127(99)00284-4; Hamann A, 2011, TREE GENET GENOMES, V7, P399, DOI 10.1007/s11295-010-0341-7; HYUN JO, 1987, CAN J FOREST RES, V17, P1134, DOI 10.1139/x87-173; JELINSKI DE, 1992, AM J BOT, V79, P728, DOI 10.2307/2444937; Li BL, 1995, FOREST CHRON, V71, P720, DOI 10.5558/tfc71720-6; Lindroth RL, 2007, J CHEM ECOL, V33, P1049, DOI 10.1007/s10886-007-9281-6; Lowwood J., 1997, ENG WOOD PRODUCTS A, P12345; MANGOLD RD, 1978, SILVAE GENET, V27, P66; Marshall I.B., 1999, NATL ECOLOGICAL FRAM; Matyas C, 1990, JOINT M W FOR GEN AS; Mbogga MS, 2009, AGR FOREST METEOROL, V149, P881, DOI 10.1016/j.agrformet.2008.11.009; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; MORLEY PM, 1993, FOREST CHRON, V69, P46, DOI 10.5558/tfc69046-1; Namkoong G., 1988, TREE BREEDING PRINCI; O'Neill GA, 2004, CAN J FOREST RES, V34, P695, DOI 10.1139/X03-227; PARKER WH, 1992, CAN J FOREST RES, V22, P267, DOI 10.1139/x92-035; Peterson E.B., 1992, ECOLOGY MANAGEMENT U, P1; R Core Team, 2022, R LANG ENV STAT COMP; Rytter L, 2003, SILVA FENN, V37, P313, DOI 10.14214/sf.491; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; St Clair SB, 2010, FOREST SCI, V56, P222; Thomas BR, 1997, SILVAE GENET, V46, P317; Thomas BR, 1997, SILVAE GENET, V46, P309; YANCHUK AD, 1988, WOOD SCI TECHNOL, V22, P67, DOI 10.1007/BF00353229; YANCHUK AD, 1984, SILVAE GENET, V33, P11; Yates F., 1953, SAMPLING METHODS CEN; Yeh FC, 1995, J HERED, V86, P454, DOI 10.1093/oxfordjournals.jhered.a111620; Ying CC, 2006, FOREST ECOL MANAG, V227, P1, DOI 10.1016/j.foreco.2006.02.028; Zsuffa L, 1975, P 14 M CAN TREE IM 2, P107	40	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44303	10.1371/journal.pone.0044303	http://dx.doi.org/10.1371/journal.pone.0044303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957006	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500059
J	Gupta, R; Deedwania, PC; Sharma, K; Gupta, A; Guptha, S; Achari, V; Asirvatham, AJ; Bhansali, A; Gupta, B; Gupta, S; Jali, MV; Mahanta, TG; Maheshwari, A; Saboo, B; Singh, J; Gupta, R				Gupta, Rajeev; Deedwania, Prakash C.; Sharma, Krishnakumar; Gupta, Arvind; Guptha, Soneil; Achari, Vijay; Asirvatham, Arthur J.; Bhansali, Anil; Gupta, Balkishan; Gupta, Sunil; Jali, Mallikarjuna V.; Mahanta, Tulika G.; Maheshwari, Anuj; Saboo, Banshi; Singh, Jitendra; Gupta, Rajiv			Association of Educational, Occupational and Socioeconomic Status with Cardiovascular Risk Factors in Asian Indians: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; URBAN-POPULATION; MIDDLE-INCOME; HEALTH; INEQUALITIES; NONRESPONSE; COUNTRIES; SELECTION	Background: To determine correlation of multiple parameters of socioeconomic status with cardiovascular risk factors in India. Methods: The study was performed at eleven cities using cluster sampling. Subjects (n = 6198, men 3426, women 2772) were evaluated for socioeconomic, demographic, biophysical and biochemical factors. They were classified into low, medium and high socioeconomic groups based on educational level (<10, 1015 and >15 yr formal education), occupational class and socioeconomic scale. Risk factor differences were evaluated using multivariate logistic regression. Results: Age-adjusted prevalence (%) of risk factors in men and women was overweight or obesity in 41.1 and 45.2, obesity 8.3 and 15.8, high waist circumference 35.7 and 57.5, high waist-hip ratio 69.0 and 83.8, hypertension 32.5 and 30.4, hypercholesterolemia 24.8 and 25.3, low HDL cholesterol 34.1 and 35.1, high triglycerides 41.2 and 31.5, diabetes 16.7 and 14.4 and metabolic syndrome in 32.2 and 40.4 percent. Lifestyle factors were smoking 12.0 and 0.5, other tobacco use 12.7 and 6.3, high fat intake 51.2 and 48.2, low fruits/vegetables intake 25.3 and 28.9, and physical inactivity in 38.8 and 46.1%. Prevalence of > = 3 risk factors was significantly greater in low (28.0%) vs. middle (23.9%) or high (22.1%) educational groups (p<0.01). In low vs. high educational groups there was greater prevalence of high waist-hip ratio (odds ratio 2.18, confidence interval 1.652.71), low HDL cholesterol (1.51, 1.271.80), hypertriglyceridemia (1.16, 0.991.37), smoking/tobacco use (3.27, 2.664.01), and low physical activity (1.15, 0.971.37); and lower prevalence of high fat diet (0.47, 0.380.57),overweight/obesity (0.68, 0.580.80) and hypercholesterolemia (0.79, 0.660.94). Similar associations were observed with occupational and socioeconomic status. Conclusions: Low educational, occupational and socioeconomic status Asian Indians have greater prevalence of truncal obesity, low HDL cholesterol, hypertriglyceridemia, smoking or tobacco use and low physical activity and clustering of > = 3 major cardiovascular risk factors.	[Gupta, Rajeev; Sharma, Krishnakumar] Fortis Escorts Hosp, Dept Med, Jaipur, Rajasthan, India; [Gupta, Rajeev; Guptha, Soneil] Jaipur Heart Watch Fdn, Jaipur, Rajasthan, India; [Deedwania, Prakash C.] Univ Calif San Francisco, Dept Cardiol, Fresno, CA USA; [Deedwania, Prakash C.] Vet Adm Hosp, Fresno, CA USA; [Achari, Vijay] Patna Med Coll, Dept Med, Patna, Bihar, India; [Gupta, Arvind] Jaipur Diabet Res Ctr, Jaipur, Rajasthan, India; [Asirvatham, Arthur J.] Arthur Asirvatham Hosp, Dept Med, Madurai, Tamil Nadu, India; [Bhansali, Anil] Postgrad Inst Med Educ & Res, Dept Endocrinol, Chandigarh 160012, India; [Gupta, Balkishan] Sardar Patel Med Coll, Dept Med, Bikaner, Rajasthan, India; [Gupta, Sunil] Diabet Care & Res Ctr, Nagpur, Maharashtra, India; [Jali, Mallikarjuna V.] Jawaharlal Nehru Med Coll, Dept Med, Belgaum, Karnataka, India; [Mahanta, Tulika G.] Assam Med Coll, Dept Community Med, Dibrugarh, Assam, India; [Maheshwari, Anuj] Babu Banarasi Das Coll Dent Sci, Dept Med, Lucknow, Uttar Pradesh, India; [Saboo, Banshi] DiaCare & Res, Ahmadabad, Gujarat, India; [Singh, Jitendra] Govt Med Coll, Dept Med, Jammu, Jammu & Kashmir, India; [Gupta, Rajiv] Univ Rajasthan, Dept Sociol, Jaipur 302004, Rajasthan, India	Fortis Escorts Hospital; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Sardar Patel Medical College, Bikaner; K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; Babu Banarasi Das University; University of Rajasthan	Gupta, R (corresponding author), Fortis Escorts Hosp, Dept Med, Jaipur, Rajasthan, India.	rajeevg@satyam.net.in	Saboo, Banshi/AAE-8515-2020; Gupta, Arvind/AAB-4997-2021; Maheshwari, Anuj/AAA-8246-2021; Jali, Mallikarjun V/AAX-8795-2020	Saboo, Banshi/0000-0001-7293-8864; Gupta, Arvind/0000-0001-9828-8732; Maheshwari, Anuj/0000-0002-0924-7830; 	South Asian Society of Atherosclerosis and Thrombosis, Bangalore, India; Minneapolis, USA	South Asian Society of Atherosclerosis and Thrombosis, Bangalore, India; Minneapolis, USA	The study was funded by South Asian Society of Atherosclerosis and Thrombosis, Bangalore, India and Minneapolis, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ahuja R, 1997, SOCIAL PROBLEMS INDI, P282; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BLANE D, 1993, SOCIOL HEALTH ILL, V15, P2; Brunner E, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P181; CHADHA SL, 1990, INDIAN J MED RES-B, V92, P424; Elovainio M, 2011, AM J EPIDEMIOL, V174, P779, DOI 10.1093/aje/kwr149; Fuster, 2010, PROMOTING CARDIOVASC; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gupta R, 2006, INT J CARDIOL, V108, P291, DOI 10.1016/j.ijcard.2005.05.044; Gupta R, 1995, Indian Heart J, V47, P331; Gupta R, 1994, J Cardiovasc Risk, V1, P179; Gupta R, 2011, EUR J CARDIOVASC PRE, DOI 10.1177/1741826711424567; Gupta R, 1994, BMJ-BRIT MED J, V319, P1332; Gupta R, 2012, WORLD J CARDIOL, V4, P112, DOI 10.4330/wjc.v4.i4.112; Gupta R, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-8; Gupta R, 2010, PREV MED, V51, P408, DOI 10.1016/j.ypmed.2010.08.014; Gupta Rajeev, 2009, Indian Heart J, V61, P358; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Jeemon P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000068; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Johnson TP, 2004, 2003 P SECT SURV RES, P127; KAPLAN GA, 1993, NY TIMES        1026, V88, P1973; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Kinra S, 2010, BMJ-BRIT MED J, V341, pc4974; Krishna A., 2010, ONE ILLNESS AWAY WHY; Luepkar RV, 2002, CARDIOVASCULAR SURVE; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackintosh M., 2001, POVERTY INEQUALITY H; Manor O, 2003, SOC SCI MED, V57, P2217, DOI 10.1016/S0277-9536(03)00097-2; Marmot M, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P5; Marmot M., 2004, STATUS SYNDROME YOUR; Marmot M, 2006, SOCIAL DETERMINANTS; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; Office of Registrar General of India, 2009, REP CAUS DEATHS IND; Panagariya A, 2008, INDIA EMERGING GIANT, P8; Po JYT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016844; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; SARVOTHAM SG, 1968, CIRCULATION, V37, P939, DOI 10.1161/01.CIR.37.6.939; Stansfeld S, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P72; Varma Pavan, 2007, GREAT INDIAN MIDDLE; World Health Organization, 2002, DIET NUTR CHRON DIS; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; YUSUF S, 2001, NY TIMES        1026, V104, P2746; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	49	88	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44098	10.1371/journal.pone.0044098	http://dx.doi.org/10.1371/journal.pone.0044098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952886	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000082
J	Dong, MQ; Xu, XQ; Ball, AM; Makhoul, JA; Lam, PCH; Pinon, DI; Orry, A; Sexton, PM; Abagyan, R; Miller, LJ				Dong, Maoqing; Xu, Xiequn; Ball, Alicja M.; Makhoul, Joshua A.; Lam, Polo C. -H.; Pinon, Delia I.; Orry, Andrew; Sexton, Patrick M.; Abagyan, Ruben; Miller, Laurence J.			Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping	FASEB JOURNAL			English	Article						class B GPCRs; molecular modeling; ligand binding	PHOTOAFFINITY CROSS-LINKING; PROTEIN-COUPLED-RECEPTOR; 2ND TRANSMEMBRANE HELIX; PEPTIDE RECEPTOR; ANTAGONIST PEPTIDES; MUTATIONAL ANALYSIS; AGONIST BINDING; MOLECULAR-BASIS; LIGAND-BINDING; BASIC RESIDUES	While it is evident that the carboxylterminal region of natural peptide ligands bind to the amino-terminal domain of class B GPCRs, how their biologically critical amino-terminal regions dock to the receptor is unclear. We utilize cysteine trapping to systematically explore spatial approximations among residues in the first five positions of secretin and in every position within the receptor extracellular loops (ECLs). Only Cys(2) and Cys(5) secretin analogues exhibited full activity and retained moderate binding affinity (IC50: 92+/-4 and 83+/-1 nM, respectively). When these peptides probed 61 human secretin receptor cysteine-replacement mutants, a broad network of receptor residues could form disulfide bonds consistent with a dynamic ligand-receptor interface. Two distinct patterns of disulfide bond formation were observed: Cys2 predominantly labeled residues in the amino terminus of ECL2 and ECL3 (relative labeling intensity: Ser(340), 94+/-7%; Pro(341), 84+/-9%; Phe(258), 73+/-5%; Trp(274) 62+/-8%), and Cys(5) labeled those in the carboxyl terminus of ECL2 and ECL3 (Gln(348), 100%; Ile(347), 73+/-12%; Glu(342), 59+/-10%; Phe(351), 58+/-11%). These constraints were utilized in molecular modeling, providing improved understanding of the structure of the transmembrane bundle and interconnecting loops, the orientation between receptor domains, and the molecular basis of ligand docking. Key spatial approximations between peptide and receptor predicted by this model (H-1-W-274, D-3-N-268, G(4)-F-258) were supported by mutagenesis and residue-residue complementation studies.-Dong, M., Xu, X., Ball, A. M., Makhoul, J. A., Lam, P. C.-H., Pinon, D. I., Orry, A., Sexton, P. M., Abagyan, R., Miller, L. J. Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping. FASEB J. 26, 5092-5105 (2012). www.fasebj.org	[Dong, Maoqing; Xu, Xiequn; Ball, Alicja M.; Makhoul, Joshua A.; Pinon, Delia I.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. -H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA USA; [Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic, Australia; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Mayo Clinic; Mayo Clinic Phoenix; Monash University; Monash University; University of California System; University of California San Diego	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Xu, Xiequn/AAS-9773-2021; Sexton, Patrick M/B-1319-2008	Xu, Xiequn/0000-0003-0347-5258; Sexton, Patrick M/0000-0001-8902-2473	U.S. National Institutes of Health [DK46577]; National Health and Medical Research Council of Australia (NHMRC) [519461]; Peking Union Medical College Hospital (Beijing, China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Peking Union Medical College Hospital (Beijing, China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the U.S. National Institutes of Health (DK46577), and the National Health and Medical Research Council of Australia (NHMRC), program grant 519461. P.M.S. is a Principal Research Fellow of the NHMRC. X.X. was partially supported by Peking Union Medical College Hospital (Beijing, China). The authors thank Ms. Mary Lou Augustine for her excellent technical assistance, Dr. Ross Potter for his expert assistance in flow cytometry and analysis, and Dr. Kaleeckal G. Harikumar for his assistance and advice.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Buck E, 2005, P NATL ACAD SCI USA, V102, P2719, DOI 10.1073/pnas.0500016102; Buck E, 2005, J BIOL CHEM, V280, P4009, DOI 10.1074/jbc.C400500200; Ceraudo E, 2012, FASEB J, V26, P2060, DOI 10.1096/fj.11-196444; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Di Paolo E, 1999, RECEPTOR CHANNEL, V6, P309; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong M, 2011, J BIOL CHEM, V286, P23888, DOI 10.1074/jbc.M111.245969; Dong MQ, 2011, BIOCHEMISTRY-US, V50, P2983, DOI 10.1021/bi200133u; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Garcia GL, 2012, AM J PHYSIOL-CELL PH, V302, pC1202, DOI 10.1152/ajpcell.00273.2011; Gardella TJ, 1996, J BIOL CHEM, V271, P12820, DOI 10.1074/jbc.271.22.12820; GARDNER JD, 1977, GASTROENTEROLOGY, V73, P52; Gensure RC, 2001, J BIOL CHEM, V276, P42692, DOI 10.1074/jbc.M106215200; Hagemann IS, 2008, J BIOL CHEM, V283, P7763, DOI 10.1074/jbc.M709467200; Harikumar KG, 2007, J BIOL CHEM, V282, P32834, DOI 10.1074/jbc.M704563200; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JIANG SP, 1995, BIOCHEM BIOPH RES CO, V207, P883, DOI 10.1006/bbrc.1995.1268; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Monaghan P, 2008, BIOCHEMISTRY-US, V47, P5889, DOI 10.1021/bi800122f; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pellequer JL, 2006, PROTEINS, V65, P192, DOI 10.1002/prot.21059; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Vertongen P, 2001, BRIT J PHARMACOL, V133, P1249, DOI 10.1038/sj.bjp.0704195; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	41	29	29	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2012	26	12					5092	5105		10.1096/fj.12-212399	http://dx.doi.org/10.1096/fj.12-212399			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22964305	Green Published			2022-12-25	WOS:000311838300030
J	Jagtap, PKA; Soni, V; Vithani, N; Jhingan, GD; Bais, VS; Nandicoori, VK; Prakash, B				Jagtap, Pravin Kumar Ankush; Soni, Vijay; Vithani, Neha; Jhingan, Gagan Deep; Bais, Vaibhav Singh; Nandicoori, Vinay Kumar; Prakash, Balaji			Substrate-bound Crystal Structures Reveal Features Unique to Mycobacterium tuberculosis N-Acetyl-glucosamine 1-Phosphate Uridyltransferase and a Catalytic Mechanism for Acetyl Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE; GLUCOSAMINE-1-PHOSPHATE ACETYLTRANSFERASE; ACTIVE-SITE; UDP-GALNAC; GLMU; ACETYLGLUCOSAMINE; PYROPHOSPHORYLASE; VALIDATION; EXPRESSION	N-Acetyl-glucosamine-1-phosphateuridyltransferase(GlmU), a bifunctional enzyme involved in bacterial cell wall synthesis is exclusive to prokaryotes. GlmU, now recognized as a promising target to develop new antibacterial drugs, catalyzes two key reactions: acetyl transfer and uridyl transfer at two independent domains. Hitherto, we identified GlmU from Mycobacterium tuberculosis (GlmU(Mtb)) to be unique in possessing a 30-residue extension at the C terminus. Here, we present the crystal structures of GlmU(Mtb) in complex with substrates/products bound at the acetyltransferase active site. Analysis of these and mutational data, allow us to infer a catalytic mechanism operative in GlmU(Mtb). In this S(N)2 reaction, His-374 and Asn-397 act as catalytic residues by enhancing the nucleophilicity of the attacking amino group of glucosamine 1-phosphate. Ser-416 and Trp-460 provide important interactions for substrate binding. A short helix at the C-terminal extension uniquely found in mycobacterial GlmU provides the highly conserved Trp-460 for substrate binding. Importantly, the structures reveal an uncommon mode of acetyl-CoA binding in GlmU(Mtb); we term this the U conformation, which is distinct from the L conformation seen in the available non-mycobacterial GlmU structures. Residues, likely determining U/L conformation, were identified, and their importance was evaluated. In addition, we identified that the primary site for PknB-mediated phosphorylation is Thr-418, near the acetyltransferase active site. Down-regulation of acetyltransferase activity upon Thr-418 phosphorylation is rationalized by the structures presented here. Overall, this work provides an insight into substrate recognition, catalytic mechanism for acetyl transfer, and features unique to GlmU(Mtb), which may be exploited for the development of inhibitors specific to GlmU.	[Soni, Vijay; Jhingan, Gagan Deep; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Jagtap, Pravin Kumar Ankush; Vithani, Neha; Bais, Vaibhav Singh; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.ac.in; bprakash@iitk.ac.in	Jagtap, Pravin Kumar Ankush/AAB-8149-2020; Vithani, Neha/AEA-8375-2022	Jagtap, Pravin Kumar Ankush/0000-0002-9457-4130; SONI, VIJAY/0000-0002-3395-7429; Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology, India [PR13047/MED]; National Bioscience Award; Council of Scientific and Industrial Research; Department of Biotechnology; Indian Council of Medical Research; Department of Science and Technology (India)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Bioscience Award; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology (India)(Department of Science & Technology (India))	Supported by intramural and extramural funding provided by the Department of Biotechnology (PR13047/MED), India, and the National Bioscience Award.; Supported by the Council of Scientific and Industrial Research, the Department of Biotechnology, the Indian Council of Medical Research, the Department of Science and Technology (India), and the National Bioscience Award.	ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Buurman ET, 2011, J BIOL CHEM, V286, P40734, DOI 10.1074/jbc.M111.274068; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICKLAUS MC, 1995, BIOORGAN MED CHEM, V3, P411, DOI 10.1016/0968-0896(95)00031-B; Olsen LR, 2007, PROTEIN SCI, V16, P1230, DOI 10.1110/ps.072779707; Olsen LR, 2001, BIOCHEMISTRY-US, V40, P1913, DOI 10.1021/bi002503n; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; Verma SK, 2009, ACTA CRYSTALLOGR F, V65, P435, DOI 10.1107/S1744309109010252; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang-Gillam A, 1998, J BIOL CHEM, V273, P27055, DOI 10.1074/jbc.273.42.27055; Wang-Gillam A, 2000, J BIOL CHEM, V275, P1433, DOI 10.1074/jbc.275.2.1433; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; Zhang Z, 2009, ACTA CRYSTALLOGR D, V65, P275, DOI 10.1107/S0907444909001036; Zhou Y, 2012, GLYCOCONJUGATE J, V29, P297, DOI 10.1007/s10719-012-9402-5	24	19	19	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.390765	http://dx.doi.org/10.1074/jbc.M112.390765			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22969087	Green Published, hybrid			2022-12-25	WOS:000311233800024
J	Chan, CS; Ming-Lum, A; Golds, GB; Lee, SJ; Anderson, RJ; Mui, ALF				Chan, Catherine S.; Ming-Lum, Andrew; Golds, Gary B.; Lee, Shaina J.; Anderson, Raymond J.; Mui, Alice L. -F.			Interleukin-10 Inhibits Lipopolysaccharide-induced Tumor Necrosis Factor-alpha Translation through a SHIP1-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; MESSENGER-RNA TRANSLATION; CAP-BINDING PROTEIN; AU-RICH-ELEMENT; TNF-ALPHA; ANTIINFLAMMATORY RESPONSE; POSTTRANSCRIPTIONAL REGULATION; SIGNALING PATHWAY; CANCER-THERAPY; MACROPHAGES	Production of the proinflammatory cytokine TNF alpha by activated macrophages is an important component of host defense. However, TNF alpha production must be tightly controlled to avoid pathological consequences. The anti-inflammatory cytokine IL-10 inhibits TNF alpha mRNA expression through activation of the STAT3 transcription factor pathway and subsequent expression of STAT3-dependent gene products. We hypothesized that IL-10 must also have more rapid mechanisms of action and show that IL-10 rapidly shifts existing TNF alpha mRNA from polyribosome-associated polysomes to monosomes. This translation suppression requires the presence of SHIP1 (SH2 domain-containing inositol 5'-phosphatase 1) and involves inhibition of Mnk1 (MAPK signal-integrating kinase 1). Furthermore, activating SHIP1 using a small-molecule agonist mimics the inhibitory effect of IL-10 on Mnk1 phosphorylation and TNF alpha translation. Our data support the existence of an alternative STAT3-independent pathway through SHIP1 for IL-10 to regulate TNF alpha translation during the anti-inflammatory response.	[Chan, Catherine S.; Ming-Lum, Andrew; Golds, Gary B.; Lee, Shaina J.; Mui, Alice L. -F.] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC V6H 3Z6, Canada; [Chan, Catherine S.; Golds, Gary B.; Lee, Shaina J.; Mui, Alice L. -F.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada; [Chan, Catherine S.; Ming-Lum, Andrew; Golds, Gary B.; Lee, Shaina J.; Mui, Alice L. -F.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Anderson, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Anderson, Raymond J.] Univ British Columbia, Dept Oceanog, Vancouver, BC V6T 1Z1, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Mui, ALF (corresponding author), Jack Bell Res Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	alice.mui@ubc.ca			Canadian Institutes of Health Research [MOP-84539]; Canadian Cancer Society Research Institute Grant [017289]; CIHR Doctoral Research; Michael Smith Foundation for Health Research (MSFHR); CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute Grant; CIHR Doctoral Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Research Grant MOP-84539 from the Canadian Institutes of Health Research (to A. L.-F. M.), and Canadian Cancer Society Research Institute Grant 017289 (to R. J. A.). A. M.-L. held CIHR Doctoral Research, and Michael Smith Foundation for Health Research (MSFHR) awards. The CIHR Transplantation Training Program provided graduate scholarships (to A. M. L., G. B. G., and C. S. C.).	Anderson P, 2007, MOL CELL, V25, P796, DOI 10.1016/j.molcel.2007.03.005; Andersson K, 2006, CYTOKINE, V33, P52, DOI 10.1016/j.cyto.2005.11.017; Beisang D, 2012, WIRES RNA, V3, P719, DOI 10.1002/wrna.1125; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Denys A, 2002, J IMMUNOL, V168, P4837, DOI 10.4049/jimmunol.168.10.4837; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Glocker E. O., 2012, ANN NY ACAD SCI, V1246, P102; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hay N, 2010, P NATL ACAD SCI USA, V107, P13975, DOI 10.1073/pnas.1008908107; Hou JQ, 2012, ONCOTARGET, V3, P118; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1, DOI 10.1111/j.1749-6632.2010.05869.x; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; KRUYS V, 1992, P NATL ACAD SCI USA, V89, P673, DOI 10.1073/pnas.89.2.673; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Polunovsky Vitaly A, 2006, RNA Biol, V3, P10; Qi MY, 2012, MOL CELL BIOL, V32, P913, DOI 10.1128/MCB.05340-11; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V295, pG421, DOI 10.1152/ajpgi.00508.2007; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Stamou P, 2010, CURR DIR AUTOIMMUN, V11, P61, DOI 10.1159/000289197; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004	46	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.348599	http://dx.doi.org/10.1074/jbc.M112.348599			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22955274	Green Published, hybrid			2022-12-25	WOS:000310642200036
J	Grishin, AM; Ajamian, E; Zhang, LH; Rouiller, I; Bostina, M; Cygler, M				Grishin, Andrey M.; Ajamian, Eunice; Zhang, Linhua; Rouiller, Isabelle; Bostina, Mihnea; Cygler, Miroslaw			Protein-Protein Interactions in the beta-Oxidation Part of the Phenylacetate Utilization Pathway CRYSTAL STRUCTURE OF THE PaaF-PaaG HYDRATASE-ISOMERASE COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA(3)-DELTA(2)-ENOYL-COA ISOMERASE; ANGSTROM RESOLUTION; AEROBIC METABOLISM; COA HYDRATASE; ACID; BINDING; COENZYME; MECHANISM; THIOLASE; REVEALS	Microbial anaerobic and so-called hybrid pathways for degradation of aromatic compounds contain beta-oxidation-like steps. These reactions convert the product of the opening of the aromatic ring to common metabolites. The hybrid phenylacetate degradation pathway is encoded in Escherichia coli by the paa operon containing genes for 10 enzymes. Previously, we have analyzed protein-protein interactions among the enzymes catalyzing the initial oxidation steps in the paa pathway (Grishin, A. M., Ajamian, E., Tao, L., Zhang, L., Menard, R., and Cygler, M. (2011) J. Biol. Chem. 286, 10735-10743). Here we report characterization of interactions between the remaining enzymes of this pathway and show another stable complex, PaaFG, an enoyl-CoA hydratase and enoyl-Coa isomerase, both belonging to the crotonase superfamily. These steps are biochemically similar to the well studied fatty acid beta-oxidation, which can be catalyzed by individual monofunctional enzymes, multifunctional enzymes comprising several domains, or enzymatic complexes such as the bacterial fatty acid beta-oxidation complex. We have determined the structure of the PaaFG complex and determined that although individually PaaF and PaaG are similar to enzymes from the fatty acid beta-oxidation pathway, the structure of the complex is dissimilar from bacterial fatty acid beta-oxidation complexes. The PaaFG complex has a four-layered structure composed of homotrimeric discs of PaaF and PaaG. The active sites of PaaF and PaaG are adapted to accept the intermediary components of the Paa pathway, different from those of the fatty acid beta-oxidation. The association of PaaF and PaaG into a stable complex might serve to speed up the steps of the pathway following the conversion of phenylacetyl-CoA to a toxic and unstable epoxide-CoA by PaaABCE monooxygenase.	[Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Ajamian, Eunice; Zhang, Linhua; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Rouiller, Isabelle] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Bostina, Mihnea] McGill Univ, Facil Electron Microscopy Res, Montreal, PQ H3A 2B2, Canada	University of Saskatchewan; McGill University; McGill University; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca	Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012	rouiller, isabelle/0000-0002-1288-8575; Bostina, Mihnea/0000-0003-3621-3772	Canadian Institutes of Health Research [MOP-48370]; Canada Research Chair Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs)	This research was supported by Canadian Institutes of Health Research Grant MOP-48370 and the Canada Research Chair Program (to M. C.). X-ray diffraction data for this study were measured at the Canadian Macromolecular Crystallography Facility at the Canadian Light Source, which is supported by the Canadian Foundation for Innovation, the Natural Sciences and Engineering Research Council of Canada, and Canadian Institutes of Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; Cao B, 2009, APPL MICROBIOL BIOT, V85, P207, DOI 10.1007/s00253-009-2192-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fould B, 2010, BIOCHEMISTRY-US, V49, P8608, DOI 10.1021/bi100742w; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Grishin AM, 2011, J BIOL CHEM, V286, P10735, DOI 10.1074/jbc.M110.194423; Haapalainen AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/bi6026192; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hofstein HA, 1999, BIOCHEMISTRY-US, V38, P9508, DOI 10.1021/bi990506y; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Kasaragod P, 2010, J BIOL CHEM, V285, P24089, DOI 10.1074/jbc.M110.117606; Kichise T, 2009, PROTEINS, V76, P779, DOI 10.1002/prot.22455; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; Kim JJP, 2002, CURR OPIN STRUC BIOL, V12, P721, DOI 10.1016/S0959-440X(02)00390-1; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mathieu M, 1997, J MOL BIOL, V273, P714, DOI 10.1006/jmbi.1997.1331; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Mohamed ME, 2000, J BACTERIOL, V182, P286, DOI 10.1128/JB.182.2.286-294.2000; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Mursula AM, 2004, FEBS LETT, V557, P81, DOI 10.1016/S0014-5793(03)01450-9; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; Nogales J, 2007, MICROBIOL-SGM, V153, P357, DOI 10.1099/mic.0.2006/002444-0; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Teufel R, 2012, NATURE, V483, P359, DOI 10.1038/nature10862; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	39	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388231	http://dx.doi.org/10.1074/jbc.M112.388231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22961985	Green Published, hybrid			2022-12-25	WOS:000310642200033
J	Deng, YJ; Gam, J; French, JB; Zhao, H; An, S; Benkovic, SJ				Deng, Yijun; Gam, Jongsik; French, Jarrod B.; Zhao, Hong; An, Songon; Benkovic, Stephen J.			Mapping Protein-Protein Proximity in the Purinosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIENZYME COMPLEX; PURINE BIOSYNTHESIS; PURIFICATION; PATHWAY; CELLS	The enzymes in the human de novo purine synthesis pathway were found to form a cellular complex, the purinosome, upon culturing cells in purine-depleted medium (An, S., Kumar R., Sheets, E. D., and Benkovic, S. J. (2008) Science 320, 103-106). Purinosome formation and dissociation were found to be modulated by several factors, including the microtubule network and cell signaling involving protein phosphorylation. To determine whether the pathway enzymes are in physical contact, we probed for the protein-protein interactions (PPIs) within the purinosome with a novel application of the Tango PPI reporter system (Barnea, G., Strapps, W., Herrada, G., Berman, Y., Ong, J., Kloss, B., Axel, R., and Lee, K. J. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 64-69). We found PPIs among all six enzymes within the pathway and evidence for a core involving the first three enzymes. We also captured purinosomes under both purine-rich and purine-depleted conditions. The results provide additional insights into the transient nature and topography of the purinosome.	[Deng, Yijun; French, Jarrod B.; Zhao, Hong; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Gam, Jongsik] Korea Res Inst Biosci & Biotechnol, Taejon 306809, South Korea; [An, Songon] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University System of Maryland; University of Maryland Baltimore	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, 414 Wartik Lab, University Pk, PA 16802 USA.	sjb1@psu.edu	ZHAO, HONG/C-6464-2013; French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309; An, Songon/0000-0003-2189-7374	National Institutes of Health [3 R01 GM024129-31S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 3 R01 GM024129-31S1.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Baresova V, 2012, HUM MOL GENET, V21, P1534, DOI 10.1093/hmg/ddr591; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Brodsky G, 1997, HUM MOL GENET, V6, P2043, DOI 10.1093/hmg/6.12.2043; CAPERELLI CA, 1980, J BIOL CHEM, V255, P1885; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Lievens S, 2009, TRENDS BIOCHEM SCI, V34, P579, DOI 10.1016/j.tibs.2009.06.009; ROWE PB, 1978, J BIOL CHEM, V253, P7711; Verrier F, 2011, NAT CHEM BIOL, V7, P909, DOI [10.1038/NCHEMBIO.690, 10.1038/nchembio.690]; Wilkins MR, 2008, TRENDS BIOCHEM SCI, V33, P195, DOI 10.1016/j.tibs.2008.03.001; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	13	45	45	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36201	36207		10.1074/jbc.M112.407056	http://dx.doi.org/10.1074/jbc.M112.407056			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955281	Green Published, hybrid			2022-12-25	WOS:000310364000041
J	Chao, MW; Chen, CH; Chang, YL; Teng, CM; Pan, SL				Chao, Min-Wu; Chen, Chun-Han; Chang, Ya-Ling; Teng, Che-Ming; Pan, Shiow-Lin			alpha-Tomatine-Mediated Anti-Cancer Activity In Vitro and In Vivo through Cell Cycle- and Caspase-Independent Pathways	PLOS ONE			English	Article							CANCER-CELLS; BCL-2 FAMILY; APOPTOSIS PROTEIN; UP-REGULATION; SURVIVIN; DEATH; LEUKEMIA; GLYCOALKALOIDS; INHIBITION; ADJUVANT	alpha-Tomatine, a tomato glycoalkaloid, has been reported to possess antibiotic properties against human pathogens. However, the mechanism of its action against leukemia remains unclear. In this study, the therapeutic potential of alpha-tomatine against leukemic cells was evaluated in vitro and in vivo. Cell viability experiments showed that alpha-tomatine had significant cytotoxic effects on the human leukemia cancer cell lines HL60 and K562, and the cells were found to be in the Annexin V-positive/propidium iodide-negative phase of cell death. In addition, alpha-tomatine induced both HL60 and K562 cell apoptosis in a cell cycle-and caspase-independent manner. alpha-Tomatine exposure led to a loss of the mitochrondrial membrane potential, and this finding was consistent with that observed on activation of the Bak and Mcl-1 short form (Mcl-1s) proteins. Exposure to alpha-tomatine also triggered the release of the apoptosis-inducing factor (AIF) from the mitochondria into the nucleus and down-regulated survivin expression. Furthermore, alpha-tomatine significantly inhibited HL60 xenograft tumor growth without causing loss of body weight in severe combined immunodeficiency (SCID) mice. Immunohistochemical test showed that the reduced tumor growth in the alpha-tomatine-treated mice was a result of increased apoptosis, which was associated with increased translocation of AIF in the nucleus and decreased survivin expression ex vivo. These results suggest that alpha-tomatine may be a candidate for leukemia treatment.	[Chao, Min-Wu; Chen, Chun-Han; Chang, Ya-Ling; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Pan, Shiow-Lin] Natl Hlth Res Inst, Dept Biotechnol & Pharmaceut Res, Miaoli, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan	Chao, MW (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	cmteng@ntu.edu.tw; apan0826@nhri.org.tw	Pan, Shiow-Lin/C-1372-2010	TENG, CHE-MING/0000-0002-9719-7334	National Science Council of Taiwan [NSC 99-2320-B400-008-MY3, NSC 99-2628-B002-024-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Grants from the National Science Council of Taiwan (NSC 99-2320-B400-008-MY3) and (NSC 99-2628-B002-024-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri Dario C, 2003, Prog Cell Cycle Res, V5, P447; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Carter BZ, 2007, ONCOL REV, V1, P195, DOI 10.1007/s12156-008-0024-x; Carter BZ, 2003, BLOOD, V102, P4179, DOI 10.1182/blood-2003-03-0960; Chandele A, 2004, NEOPLASIA, V6, P29, DOI 10.1016/S1476-5586(04)80051-4; Croci DO, 2008, J CELL BIOCHEM, V105, P381, DOI 10.1002/jcb.21836; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Elangovan S, 2008, INT J ONCOL, V33, P833, DOI 10.3892/ijo_00000071; FONTAINE TD, 1948, ARCH BIOCHEM, V18, P467; Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Holstein SA, 2001, MOL CANCER THER, V1, P141; Huang DM, 2004, EUR J PHARMACOL, V503, P17, DOI 10.1016/j.ejphar.2004.09.040; Iwasaki R, 2009, CANCER SCI, V100, P349, DOI 10.1111/j.1349-7006.2008.01046.x; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Sandrock RW, 1998, PHYTOPATHOLOGY, V88, P137, DOI 10.1094/PHYTO.1998.88.2.137; Shih YW, 2009, FOOD CHEM TOXICOL; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wrzesien-Kus A, 2004, APOPTOSIS, V9, P705, DOI 10.1023/B:APPT.0000045788.61012.b2; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Yang YW, 2004, VACCINE, V22, P2316, DOI 10.1016/j.vaccine.2003.10.036; Yang YW, 2002, BIOMATERIALS, V23, P4677, DOI 10.1016/S0142-9612(02)00218-1	31	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44093	10.1371/journal.pone.0044093	http://dx.doi.org/10.1371/journal.pone.0044093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970166	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400035
J	Hermann, M; Maeder, ML; Rector, K; Ruiz, J; Becher, B; Burki, K; Khayter, C; Aguzzi, A; Joung, JK; Buch, T; Pelczar, P				Hermann, Mario; Maeder, Morgan L.; Rector, Kyle; Ruiz, Joseph; Becher, Burkhard; Buerki, Kurt; Khayter, Cyd; Aguzzi, Adriano; Joung, J. Keith; Buch, Thorsten; Pelczar, Pawel			Evaluation of OPEN Zinc Finger Nucleases for Direct Gene Targeting of the ROSA26 Locus in Mouse Embryos	PLOS ONE			English	Article							POOL ENGINEERING OPEN; KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; RAPID GENERATION; GENOME; MICE; ZEBRAFISH; MUTAGENESIS; CLEAVAGE; CELLS	Zinc finger nucleases (ZFNs) enable precise genome modification in a variety of organisms and cell types. Commercial ZFNs were reported to enhance gene targeting directly in mouse zygotes, whereas similar approaches using publicly available resources have not yet been described. Here we report precise targeted mutagenesis of the mouse genome using Oligomerized Pool Engineering (OPEN) ZFNs. OPEN ZFN can be constructed using publicly available resources and therefore provide an attractive alternative for academic researchers. Two ZFN pairs specific to the mouse genomic locus gt(ROSA26)Sor were generated by OPEN selections and used for gene disruption and homology-mediated gene replacement in single cell mouse embryos. One specific ZFN pair facilitated non-homologous end joining (NHEJ)-mediated gene disruption when expressed in mouse zygotes. We also observed a single homologous recombination (HR)-driven gene replacement event when this ZFN pair was co-injected with a targeting vector. Our experiments demonstrate the feasibility of achieving both gene ablation through NHEJ and gene replacement by HR by using the OPEN ZFN technology directly in mouse zygotes.	[Hermann, Mario; Buerki, Kurt; Pelczar, Pawel] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Maeder, Morgan L.; Khayter, Cyd; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Mol Pathol Unit, Charlestown, MA USA; [Rector, Kyle] Transposagen Biopharmaceut Inc, Lexington, KY USA; [Becher, Burkhard; Buch, Thorsten] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Hermann, Mario; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Maeder, Morgan L.; Khayter, Cyd; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA	University of Zurich; Harvard University; Massachusetts General Hospital; University of Zurich; University of Zurich; University Zurich Hospital; Harvard University; Harvard Medical School; Technical University of Munich; Harvard University; Massachusetts General Hospital	Hermann, M (corresponding author), Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland.	thorsten.buch@mikrobio.med.tum.de; pawel.pelczar@ltk.uzh.ch	Buch, Thorsten/P-1659-2019; Becher, Burkhard/ABE-4225-2020	Buch, Thorsten/0000-0002-2236-9074; Becher, Burkhard/0000-0002-1541-7867; Aguzzi, Adriano/0000-0002-0344-6708	National Institutes of Health [R01 GM088040]; Swiss National Science Foundation (SNSF), Sinergia grant [CRSI33_125073]; NCCR Neuro; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNSF), Sinergia grant; NCCR Neuro; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov) grant R01 GM088040 (MLM, CK, and JKJ), Swiss National Science Foundation (SNSF) (http://www.snf.ch), Sinergia grant CRSI33_125073 (AA, TB, and PP) and NCCR Neuro to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2002, GENETICS, V161, P1169; BRINSTER RL, 1989, P NATL ACAD SCI USA, V86, P7087, DOI 10.1073/pnas.86.18.7087; Cade L, 2012, NUCL ACIDS RES; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Haueter S, 2010, GENESIS, V48, P151, DOI 10.1002/dvg.20598; Johansson T, 2010, GENESIS, V48, P264, DOI 10.1002/dvg.20612; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437; Moreno C, 2011, HYPERTENSION, V57, P614, DOI 10.1161/HYPERTENSIONAHA.110.163840; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Perez-Pinera P, 2012, NUCLEIC ACIDS RES, V40, P3741, DOI 10.1093/nar/gkr1214; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	45	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e41796	10.1371/journal.pone.0041796	http://dx.doi.org/10.1371/journal.pone.0041796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970113	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000308458400002
J	Murrell, EG; Juliano, SA				Murrell, Ebony G.; Juliano, Steven A.			Competitive Abilities in Experimental Microcosms Are Accurately Predicted by a Demographic Index for R*	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; FEEDING-BEHAVIOR; LIFE-HISTORY; RESOURCE COMPETITION; SPECIES INTERACTIONS; DETRITUS TYPE; BODY-SIZE; FOOD; MOSQUITOS; AEGYPTI	Resource competition theory predicts that R*, the equilibrium resource amount yielding zero growth of a consumer population, should predict species' competitive abilities for that resource. This concept has been supported for unicellular organisms, but has not been well-tested for metazoans, probably due to the difficulty of raising experimental populations to equilibrium and measuring population growth rates for species with long or complex life cycles. We developed an index (R-index) of R* based on demography of one insect cohort, growing from egg to adult in a non-equilibrium setting, and tested whether R-index yielded accurate predictions of competitive abilities using mosquitoes as a model system. We estimated finite rate of increase (lambda') from demographic data for cohorts of three mosquito species raised with different detritus amounts, and estimated each species' R-index using nonlinear regressions of lambda' vs. initial detritus amount. All three species' R-index differed significantly, and accurately predicted competitive hierarchy of the species determined in simultaneous pairwise competition experiments. Our R-index could provide estimates and rigorous statistical comparisons of competitive ability for organisms for which typical chemostat methods and equilibrium population conditions are impractical.	[Murrell, Ebony G.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	University of Wisconsin System; University of Wisconsin Madison; Illinois State University	Murrell, EG (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	egmurre@ilstu.edu		Juliano, Steven/0000-0002-6178-4553	National Institute of Allergy and Infectious Diseases (NIAID) [R15 AI075306-01, R01-AI44793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044793, R15AI075306] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institute of Allergy and Infectious Diseases (NIAID) grants R15 AI075306-01 and R01-AI44793. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chmielewski MW, 2010, ANN ENTOMOL SOC AM, V103, P734, DOI 10.1603/AN09162; Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2; Damgaard C, 2010, J ECOL, V98, P1, DOI 10.1111/j.1365-2745.2009.01587.x; de Villemereuil PB, 2011, ECOL MODEL, V222, P419, DOI 10.1016/j.ecolmodel.2010.10.011; FISH D, 1982, ECOLOGY, V63, P283, DOI 10.2307/1938943; Frankino WA, 1999, OECOLOGIA, V120, P59, DOI 10.1007/s004420050833; Gibson DJ, 1999, J ECOL, V87, P1, DOI 10.1046/j.1365-2745.1999.00321.x; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; Grover J. P., 1997, RESOURCE COMPETITION; Halaj J, 2002, ECOLOGY, V83, P3141, DOI 10.2307/3071849; Huntsman BM, 2011, FRESHWATER BIOL, V56, P1746, DOI 10.1111/j.1365-2427.2011.02609.x; Inouye BD, 2001, ECOLOGY, V82, P2696, DOI 10.2307/2679954; Ives AR, 1996, ECOLOGY, V77, P681, DOI 10.2307/2265491; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Juliano S.A., 2001, DESIGN ANAL ECOLOGIC, P178; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kammenga JE, 2003, OIKOS, V100, P89, DOI 10.1034/j.1600-0706.2003.12160.x; Kaspari M, 2009, ECOLOGY, V90, P3342, DOI 10.1890/08-1795.1; Kaufman MG, 1999, APPL ENVIRON MICROB, V65, P2661; Kirk KL, 2002, FRESHWATER BIOL, V47, P1089, DOI 10.1046/j.1365-2427.2002.00841.x; Leisnham PT, 2009, ECOLOGY, V90, P2405, DOI 10.1890/08-1569.1; Leisnham PT, 2010, OECOLOGIA, V164, P221, DOI 10.1007/s00442-010-1624-2; LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535; LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; MacArthur R.H., 1972, pvii; McPeek MA, 1998, ECOLOGY, V79, P867, DOI 10.2307/176586; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2; ROTHHAUPT KO, 1988, NATURE, V333, P660, DOI 10.1038/333660a0; Sibly RM, 2000, OIKOS, V88, P335, DOI 10.1034/j.1600-0706.2000.880212.x; SOMMER U, 1986, MAR BIOL, V91, P345, DOI 10.1007/BF00428628; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; VANDONK E, 1990, J PHYCOL, V26, P40; Vinogradova E., 2006, INT J DIPTEROL RES, V17, P3; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x; Yee DA, 2004, J VECTOR ECOL, V29, P315; Yee DA, 2004, ANN ENTOMOL SOC AM, V97, P720, DOI 10.1603/0013-8746(2004)097[0720:IDIFBA]2.0.CO;2; Yee DA, 2011, OECOLOGIA IN PRESS; Yee DA, 2007, J ANIM ECOL, V76, P1105, DOI 10.1111/j.1365-2656.2007.01297.x; Yee DA, 2007, J MED ENTOMOL, V44, P580, DOI 10.1603/0022-2585(2007)44[580:DAIEOA]2.0.CO;2	49	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43458	10.1371/journal.pone.0043458	http://dx.doi.org/10.1371/journal.pone.0043458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970128	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400012
J	Baru, AM; Untucht, C; Ganesh, V; Hesse, C; Mayer, CT; Sparwasser, T				Baru, Abdul Mannan; Untucht, Christopher; Ganesh, Venkateswaran; Hesse, Christina; Mayer, Christian T.; Sparwasser, Tim			Optimal Isolation of Functional Foxp3(+) Induced Regulatory T Cells Using DEREG Mice	PLOS ONE			English	Article							SELECTIVE DEPLETION; TH2 RESPONSES; TARGET GENES; IN-VIVO; TREG	Foxp3 reporter mice including DEREG (DEpletion of REGulatory T cells) mice have greatly helped in exploring the biology of Foxp3(+) Tregs. DEREG mice express a DTR-eGFP fusion protein under the control of a bacterial artificial chromosome (BAC)-encoded Foxp3 promoter, allowing the viable isolation and inducible depletion of Foxp3(+) Tregs. Adaptive Tregs differentiated in vitro to express Foxp3 (iTregs) are gaining high interest as potential therapeutics for inflammatory conditions such as autoimmunity, allergy and transplant rejection. However, selective isolation of Foxp3(+) iTregs with a stable phenotype still remains to be a problem, especially in the human setting. While screening for culture conditions to generate stable CD4(+) Foxp3(+) iTregs from DEREG mice, with maximum suppressive activity, we observed an unexpected dichotomy of eGFP and Foxp3 expression which is not seen in ex vivo isolated cells from DEREG mice. Further characterization of eGFP(+) Foxp3(-) cells revealed relatively lower CD25 expression and a lack of suppressive activity in vitro. Similarly, eGFP(-) cells isolated from the same cultures were not suppressive despite of a broad CD25 expression reflecting mere T cell activation. In contrast, eGFP(+) Foxp3(+) iTregs exhibited potent suppressive activity comparable to that of natural eGFP(+) Foxp3(+) Tregs, emphasizing the importance of isolating Foxp3 expressing iTregs. Interestingly, the use of plate-bound anti-CD3 and anti-CD28 or Flt3L-driven BMDC resulted in considerable resolution of the observed dichotomy. In summary, we defined culture conditions for efficient generation of eGFP(+) Foxp3(+) iTregs by use of DEREG mice. Isolation of functional Foxp3(+) iTregs using DEREG mice can also be achieved under sub-optimal conditions based on the magnitude of surface CD25 expression, in synergy with transgene encoded eGFP. Besides, the reported phenomenon may be of general interest for exploring Foxp3 gene regulation, given that Foxp3 and eGFP expression are driven from distinct Foxp3 loci and because this dichotomy preferentially occurs only under defined in vitro conditions.	[Baru, Abdul Mannan; Untucht, Christopher; Ganesh, Venkateswaran; Hesse, Christina; Mayer, Christian T.; Sparwasser, Tim] Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, Hannover, Germany		Baru, AM (corresponding author), Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, Hannover, Germany.	Tim.Sparwasser@twincore.de	Sparwasser, Tim D/AAA-4306-2022; Sparwasser, Tim/AAF-7085-2019	Sparwasser, Tim/0000-0001-5645-902X	Deutsche Forschungsgemeinschaft [SFB587 (Sonderforschungsbereich 587)]; Research Training Group (German Research Foundation) [GRK 1441]; German National Academic Foundation; Research Training Group [GRK 1441]; Braukmann-Wittenberg-Herz-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Training Group (German Research Foundation)(German Research Foundation (DFG)); German National Academic Foundation; Research Training Group; Braukmann-Wittenberg-Herz-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft SFB587 (Sonderforschungsbereich 587). CH was supported by Research Training Group (German Research Foundation-GRK 1441) and CTM was supported by a stipend from the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christine Jaenke for technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft SFB587 (Sonderforschungsbereich 587). CH was supported by Research Training Group (GRK 1441) and CTM was supported by a stipend from the German National Academic Foundation. We would further like to thank the Cell Sorting Core Facility of the Hannover Medical School supported in part by the Braukmann-Wittenberg-Herz-Stiftung and Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baru AM, 2010, EUR J IMMUNOL, V40, P2259, DOI 10.1002/eji.200939972; Berod L, 2012, MICROB BIOTECHNOL, V5, P260, DOI 10.1111/j.1751-7915.2011.00299.x; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fyhrquist N, 2012, J INVEST DERMATOL, V132, P1672, DOI 10.1038/jid.2012.40; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; MANGER B, 1987, J IMMUNOL, V139, P2755; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mayer CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00183; Mayer CT, 2012, BLOOD, V119, P1314, DOI 10.1182/blood-2011-11-392266; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Rausch S, 2009, EUR J IMMUNOL, V39, P3066, DOI 10.1002/eji.200939644; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; VANLIER RAW, 1989, IMMUNOLOGY, V68, P45; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	26	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44760	10.1371/journal.pone.0044760	http://dx.doi.org/10.1371/journal.pone.0044760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957107	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800100
J	Elvira, G; Garcia, I; Benito, M; Gallo, J; Desco, M; Penades, S; Garcia-Sanz, JA; Silva, A				Elvira, Gema; Garcia, Isabel; Benito, Marina; Gallo, Juan; Desco, Manuel; Penades, Soledad; Garcia-Sanz, Jose A.; Silva, Augusto			Live Imaging of Mouse Endogenous Neural Progenitors Migrating in Response to an Induced Tumor	PLOS ONE			English	Article							ADULT MAMMALIAN BRAIN; STEM-CELLS; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; MONOCLONAL-ANTIBODIES; MULTIPLE-SCLEROSIS; PRECURSOR CELLS; TRACKING; MRI; MODEL	Adult neurogenesis is restricted to specific brain regions. Although involved in the continuous supply of interneurons for the olfactory function, the role of neural precursors in brain damage-repair remains an open question. Aiming to in vivo identify endogenous neural precursor cells migrating towards a brain damage site, the monoclonal antibody Nilo2 recognizing cell surface antigens on neuroblasts, was coupled to magnetic glyconanoparticles (mGNPs). The Nilo2-mGNP complexes allowed, by magnetic resonance imaging in living animals, the in vivo identification of endogenous neural precursors at their niche, as well as their migration to a lesion site (induced brain tumor), which was fast (within hours) and orderly. Interestingly, the rapid migration of neuroblasts towards a damage site is a characteristic that might be exploited to precisely localize early damage events in neurodegenerative diseases. In addition, it might facilitate the study of regenerative mechanisms through the activation of endogenous neural cell precursors. A similar approach, combining magnetic glyconanoparticles linked to appropriate antibodies could be applied to flag other small cell subpopulations within the organism, track their migration, localize stem cell niches, cancer stem cells or even track metastatic cells.	[Elvira, Gema; Garcia-Sanz, Jose A.; Silva, Augusto] Ctr Invest Biol CIB CSIC, Dept Cellular & Mol Med, Madrid, Spain; [Garcia, Isabel; Gallo, Juan; Penades, Soledad] CICbiomaGUNE, Lab Glyconanotechnol, San Sebastian, Spain; [Garcia, Isabel; Penades, Soledad] CIBER BBN, San Sebastian, Spain; [Benito, Marina; Desco, Manuel] Hosp Gen Gregorio Maranon, CIBERSAM, Madrid, Spain; [Desco, Manuel] Univ Carlos III Madrid, Dept Bioengn & Aerospatial Engn, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIC biomaGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; General University Gregorio Maranon Hospital; Universidad Carlos III de Madrid	Elvira, G (corresponding author), Ctr Invest Biol CIB CSIC, Dept Cellular & Mol Med, Madrid, Spain.	asilva@cib.csic.es	Gallo, Juan/K-8476-2019; Desco, Manuel/AAD-7137-2019; Garcia-Sanz, Jose A./AAA-2956-2019; Garcia, Isabel/B-2193-2009; Vicente, Marina Benito/N-5884-2014; Garcia-Sanz, Jose A/E-7684-2011; biomaGUNE, CIC/J-9136-2014	Gallo, Juan/0000-0002-2028-3234; Desco, Manuel/0000-0003-0989-3231; Garcia-Sanz, Jose A./0000-0002-1153-6025; Garcia, Isabel/0000-0002-4101-317X; Vicente, Marina Benito/0000-0002-0661-755X; Garcia-Sanz, Jose A/0000-0002-1153-6025; biomaGUNE, CIC/0000-0001-7690-0660	CSIC [PIF200620F0041]; MICINN (Instituto de Salud Carlos III) [SAF2009-07974, RD06/0010/1010]; MICINN [CTQ2008-04638]; Department of Industry, Innovation and Technology of the Basque Country	CSIC; MICINN (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Department of Industry, Innovation and Technology of the Basque Country	This work was supported by CSIC (PIF200620F0041), MICINN (SAF2009-07974; RD06/0010/1010 from the Instituto de Salud Carlos III, CTQ2008-04638) and the Department of Industry, Innovation and Technology of the Basque Country (grant ETORTEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ben-Hur T, 2007, MAGN RESON MED, V57, P164, DOI 10.1002/mrm.21116; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; Cantarella C, 2008, DEV NEUROBIOL, V68, P223, DOI 10.1002/dneu.20588; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; de Vries NA, 2009, CANCER TREAT REV, V35, P714, DOI 10.1016/j.ctrv.2009.08.011; Del Valle I, 2010, NEUROSCIENCE, V169, P1473, DOI 10.1016/j.neuroscience.2010.04.058; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Elvira G, 2012, J BIOMATER APPL, V26, P1069, DOI 10.1177/0885328210393294; Gallo J, 2011, BIOMATERIALS, V32, P9818, DOI 10.1016/j.biomaterials.2011.09.010; Gallo J, 2010, J MATER CHEM, V20, P10010, DOI 10.1039/c0jm01756f; Garcia I, 2011, BIOCONJUGATE CHEM, V22, P264, DOI 10.1021/bc1003923; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Martinez-Murillo R, 2007, HISTOL HISTOPATHOL, V22, P1309, DOI 10.14670/HH-22.1309; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Panizzo RA, 2009, NEUROIMAGE, V44, P1239, DOI 10.1016/j.neuroimage.2008.10.062; Politi LS, 2007, STEM CELLS, V25, P2583, DOI 10.1634/stemcells.2007-0037; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Shapiro EM, 2006, NEUROIMAGE, V32, P1150, DOI 10.1016/j.neuroimage.2006.04.219; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sumner JP, 2009, NEUROIMAGE, V44, P671, DOI 10.1016/j.neuroimage.2008.07.050; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Thu MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007218; Vreys R, 2010, NEUROIMAGE, V49, P2094, DOI 10.1016/j.neuroimage.2009.10.034; Zhang ZG, 2004, NEUROIMAGE, V23, P281, DOI 10.1016/j.neuroimage.2004.05.019; Zhao DH, 2008, MOL CANCER RES, V6, P1819, DOI 10.1158/1541-7786.MCR-08-0146	45	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44466	10.1371/journal.pone.0044466	http://dx.doi.org/10.1371/journal.pone.0044466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957072	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800065
J	Meslin, C; Mugnier, S; Callebaut, I; Laurin, M; Pascal, G; Poupon, A; Goudet, G; Monget, P				Meslin, Camille; Mugnier, Sylvie; Callebaut, Isabelle; Laurin, Michel; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe			Evolution of Genes Involved in Gamete Interaction: Evidence for Positive Selection, Duplications and Losses in Vertebrates	PLOS ONE			English	Article							ZONA-PELLUCIDA BINDING; SPERM-EGG BINDING; ANGIOTENSIN-CONVERTING ENZYME; FERTILIZATION IN-VITRO; CRYSTAL-STRUCTURE; ACROSOME REACTION; MOUSE FERTILIZATION; ADAPTIVE EVOLUTION; REPRODUCTIVE PROTEINS; PHYLOGENETIC ANALYSIS	Genes encoding proteins involved in sperm-egg interaction and fertilization exhibit a particularly fast evolution and may participate in prezygotic species isolation [1,2]. Some of them (ZP3, ADAM1, ADAM2, ACR and CD9) have individually been shown to evolve under positive selection [3,4], suggesting a role of positive Darwinian selection on sperm-egg interaction. However, the genes involved in this biological function have not been systematically and exhaustively studied with an evolutionary perspective, in particular across vertebrates with internal and external fertilization. Here we show that 33 genes among the 69 that have been experimentally shown to be involved in fertilization in at least one taxon in vertebrates are under positive selection. Moreover, we identified 17 pseudogenes and 39 genes that have at least one duplicate in one species. For 15 genes, we found neither positive selection, nor gene copies or pseudogenes. Genes of teleosts, especially genes involved in sperm-oolemma fusion, appear to be more frequently under positive selection than genes of birds and eutherians. In contrast, pseudogenization, gene loss and gene gain are more frequent in eutherians. Thus, each of the 19 studied vertebrate species exhibits a unique signature characterized by gene gain and loss, as well as position of amino acids under positive selection. Reflecting these clade-specific signatures, teleosts and eutherian mammals are recovered as clades in a parsimony analysis. Interestingly the same analysis places Xenopus apart from teleosts, with which it shares the primitive external fertilization, and locates it along with amniotes (which share internal fertilization), suggesting that external or internal environmental conditions of germ cell interaction may not be the unique factors that drive the evolution of fertilization genes. Our work should improve our understanding of the fertilization process and on the establishment of reproductive barriers, for example by offering new leads for experiments on genes identified as positively selected.	[Meslin, Camille; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Meslin, Camille; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe] CNRS, UMR6175, Nouzilly, France; [Meslin, Camille; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe] Univ Tours, Tours, France; [Meslin, Camille; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe] IFCE, Nouzilly, France; [Mugnier, Sylvie] AgroSup Dijon, Dept Agron Agroequipement Elevage Environm, Dijon, France; [Callebaut, Isabelle] Univ Paris 06, IMPMC UMR 7590, Paris, France; [Laurin, Michel] Museum Natl Hist Nat, CNRS MNHN UPMC, UMR 7207, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Meslin, C (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	philippe.monget@tours.inra.fr	Laurin, Michel/B-7884-2008; Pascal, Geraldine/P-8125-2019; PASCAL, Géraldine/A-7041-2008; PASCAL, Géraldine/L-4519-2013	Laurin, Michel/0000-0003-2974-9835; Pascal, Geraldine/0000-0002-5250-6594; PASCAL, Géraldine/0000-0002-5250-6594; Poupon, Anne/0000-0003-0617-0935; Goudet, Ghylene/0000-0001-7805-6985	MENRT PhD fellowship; INRA	MENRT PhD fellowship; INRA	CM is funded by a MENRT PhD fellowship. This work was supported by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard JE, 2010, MOL BIOL EVOL, V27, P193, DOI 10.1093/molbev/msp221; BABA T, 1994, J BIOL CHEM, V269, P31845; Barraud-Lange V, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-102; Berlin S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-65; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Boissonnas CC, 2010, DEV DYNAM, V239, P773, DOI 10.1002/dvdy.22206; BOUE F, 1994, BIOL REPROD, V51, P577, DOI 10.1095/biolreprod51.4.577; Brahmaraju M, 2004, BIOCHEM BIOPH RES CO, V318, P148, DOI 10.1016/j.bbrc.2004.04.006; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; Busset J, 2011, NUCLEIC ACIDS RES, V39, pW479, DOI 10.1093/nar/gkr243; Busso D, 2007, BIOL REPROD, V77, P848, DOI 10.1095/biolreprod.107.061788; Busso D, 2007, BIOL REPROD, V76, P701, DOI 10.1095/biolreprod.106.056770; Cheng GY, 2007, ASIAN J ANDROL, V9, P23, DOI 10.1111/j.1745-7262.2007.00247.x; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; Chiu PCN, 2008, BIOL REPROD, V79, P869, DOI 10.1095/biolreprod.108.069344; Chruszcz M, 2003, J INORG BIOCHEM, V96, P386, DOI 10.1016/S0162-0134(03)00176-4; Cohen DJ, 2008, INT J DEV BIOL, V52, P737, DOI 10.1387/ijdb.072538dc; Cohen DJ, 2001, BIOL REPROD, V65, P1000, DOI 10.1095/biolreprod65.4.1000; CORNWALL GA, 1991, BIOL REPROD, V44, P913, DOI 10.1095/biolreprod44.5.913; Da Ros VG, 2008, DEV BIOL, V320, P12, DOI 10.1016/j.ydbio.2008.03.015; Deguchi E, 2007, BIOL REPROD, V77, P794, DOI 10.1095/biolreprod.107.060004; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Esther CR, 1996, LAB INVEST, V74, P953; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fujihara Y, 2010, J CELL SCI, V2010, P7; Furlong LI, 2005, FERTIL STERIL, V83, P1780, DOI 10.1016/j.fertnstert.2004.12.042; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Ganguly A, 2010, HUM REPROD, V25, P1643, DOI 10.1093/humrep/deq105; Germain D, 2009, EVOL DEV, V11, P170, DOI 10.1111/j.1525-142X.2009.00318.x; Ghosh I, 2003, MOL REPROD DEV, V64, P235, DOI 10.1002/mrd.10207; Gibbs GM, 2010, ENDOCRINOLOGY, V151, P2331, DOI 10.1210/en.2009-1255; Glazar AI, 2009, REPROD FERT DEVELOP, V21, P293, DOI 10.1071/RD08158; Goncalves RF, 2008, ANIM REPROD SCI, V106, P188, DOI 10.1016/j.anireprosci.2007.12.019; Goncalves RF, 2007, THERIOGENOLOGY, V67, P468, DOI 10.1016/j.theriogenology.2006.08.013; Goudet G, 2008, BIOL REPROD, V78, P796, DOI 10.1095/biolreprod.107.064568; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jagadish N, 2005, J REPROD IMMUNOL, V67, P69, DOI 10.1016/j.jri.2005.06.004; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kohn MJ, 2010, FERTIL STERIL, V93, P1533, DOI 10.1016/j.fertnstert.2009.06.010; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Linfor J, 2000, J REPROD FERTIL, V120, P65, DOI 10.1530/reprod/120.1.65; Lu QX, 1997, DEVELOPMENT, V124, P4121; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP, 2017, MESQUITE MODULAR SYS; Marin-Briggiler CI, 2008, MOL HUM REPROD, V14, P561, DOI 10.1093/molehr/gan053; Marjanovic D, 2007, SYST BIOL, V56, P369, DOI 10.1080/10635150701397635; McCartney MA, 2004, MOL BIOL EVOL, V21, P732, DOI 10.1093/molbev/msh071; MIDFORD P, 2003, PDAP PACKAGE MESQUIT; Monne M, 2011, BIOL REPROD; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2007, J BIOL CHEM, V282, P17900, DOI 10.1074/jbc.M702268200; Okumura H, 2004, BIOCHEM J, V384, P191, DOI 10.1042/BJ20040299; Pasten-Hidalgo K, 2008, REPRODUCTION, V136, P41, DOI 10.1530/REP-07-0300; RANGANATHAN S, 1994, MOL REPROD DEV, V38, P69, DOI 10.1002/mrd.1080380112; Rattanachaiyanont M, 2001, MOL HUM REPROD, V7, P633, DOI 10.1093/molehr/7.7.633; Riginos C, 2003, MOL BIOL EVOL, V20, P200, DOI 10.1093/molbev/msg021; Sato Y, 2010, ENVIRON BIOL FISH, V88, P169, DOI 10.1007/s10641-010-9628-7; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; Sekiguchi S, 2006, AM J PATHOL, V169, P1722, DOI 10.2353/ajpath.2006.060301; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; Smith J, 2005, MOL REPROD DEV, V70, P133, DOI 10.1002/mrd.20197; Song XX, 2007, ASIAN AUSTRAL J ANIM, V20, P351, DOI 10.5713/ajas.2007.351; Sosnik J, 2010, J CELL PHYSIOL, V224, P575, DOI 10.1002/jcp.22211; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Studer RA, 2008, GENOME RES, V18, P1393, DOI 10.1101/gr.076992.108; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Takahashi Y, 2001, MOL BIOL CELL, V12, P809, DOI 10.1091/mbc.12.4.809; Tardif S, 2010, BIOL REPROD, V83, P464, DOI 10.1095/biolreprod.109.083238; TAYLOR CT, 1994, HUM REPROD, V9, P907, DOI 10.1093/oxfordjournals.humrep.a138615; Tengowski MW, 2001, MOL REPROD DEV, V58, P236, DOI 10.1002/1098-2795(200102)58:2&lt;236::AID-MRD13&gt;3.0.CO;2-0; Thys M, 2009, REPRODUCTION, V138, P471, DOI 10.1530/REP-09-0094; Tian X, 2009, BIOL REPROD, V80, P616, DOI 10.1095/biolreprod.108.073684; Vacquier VD, 1997, J MOL EVOL, V44, pS15, DOI 10.1007/PL00000049; van Tuinen M, 2009, TIMETREE LIFE; Veselsky L, 1999, AM J REPROD IMMUNOL, V42, P187; Vjugina U, 2009, BIOL REPROD, V80, P833, DOI 10.1095/biolreprod.108.075275; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Weinberger H, 2009, MOL BIOL EVOL, V17, P17; WILLIAMS TA, 1994, J BIOL CHEM, V269, P29430; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; YAMASAKI N, 1995, MOL REPROD DEV, V40, P48, DOI 10.1002/mrd.1080400107; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x; Yanagimachi R., 1994, P189; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275; Yin L, 2009, CELL MOL LIFE SCI, V66, P900, DOI 10.1007/s00018-009-8482-2; Ying XQ, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-10; Yu Y, 2006, DEV BIOL, V290, P32, DOI 10.1016/j.ydbio.2005.11.003; Zhao LM, 2008, REPRODUCTION, V136, P323, DOI 10.1530/REP-07-0569; Zitta K, 2006, MOL HUM REPROD, V12, P557, DOI 10.1093/molehr/gal059; Ziv S, 2002, MOL REPROD DEV, V62, P547, DOI 10.1002/mrd.10149; Ziyyat A, 2006, J CELL SCI, V119, P416, DOI 10.1242/jcs.02730; Ziyyat A, 2005, HUM REPROD, V20, P3452, DOI 10.1093/humrep/dei241	114	36	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44548	10.1371/journal.pone.0044548	http://dx.doi.org/10.1371/journal.pone.0044548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957080	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800073
J	Zhang, YP; Deng, FY; Yang, TL; Zhang, F; Chen, XD; Shen, H; Zhu, XZ; Tian, Q; Deng, HW				Zhang, Yin-Ping; Deng, Fei-Yan; Yang, Tie-Lin; Zhang, Feng; Chen, Xiang-Ding; Shen, Hui; Zhu, Xue-Zheng; Tian, Qing; Deng, Hong-Wen			Genome-Wide Association Study Identified CNP12587 Region Underlying Height Variation in Chinese Females	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENE-EXPRESSION; 18Q DELETIONS; HUMAN STATURE; ADULT HEIGHT; C2 DOMAIN; GROWTH; UBIQUITIN; LOCI; VARIANTS	Introduction: Human height is a highly heritable trait considered as an important factor for health. There has been limited success in identifying the genetic factors underlying height variation. We aim to identify sequence variants associated with adult height by a genome-wide association study of copy number variants (CNVs) in Chinese. Methods: Genome-wide CNV association analyses were conducted in 1,625 unrelated Chinese adults and sex specific subgroup for height variation, respectively. Height was measured with a stadiometer. Affymetrix SNP6.0 genotyping platform was used to identify copy number polymorphisms (CNPs). We constructed a genomic map containing 1,009 CNPs in Chinese individuals and performed a genome-wide association study of CNPs with height. Results: We detected 10 significant association signals for height (p < 0.05) in the whole population, 9 and 11 association signals for Chinese female and male population, respectively. A copy number polymorphism (CNP12587, chr18:54081842-54086942, p = 2.41 x 10(-4)) was found to be significantly associated with height variation in Chinese females even after strict Bonferroni correction (p = 0.048). Confirmatory real time PCR experiments lent further support for CNV validation. Compared to female subjects with two copies of the CNP, carriers of three copies had an average of 8.1% decrease in height. An important candidate gene, ubiquitin-protein ligase NEDD4-like (NEDD4L), was detected at this region, which plays important roles in bone metabolism by binding to bone formation regulators. Conclusions: Our findings suggest the important genetic variants underlying height variation in Chinese.	[Zhang, Yin-Ping; Zhang, Feng] Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China; [Deng, Fei-Yan; Shen, Hui; Tian, Qing; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Yang, Tie-Lin; Deng, Hong-Wen] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China; [Yang, Tie-Lin; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Peoples R China; [Chen, Xiang-Ding; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Zhu, Xue-Zheng; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Systemat Biomed Res, Shanghai 201800, Peoples R China	Xi'an Jiaotong University; Tulane University; Xi'an Jiaotong University; Xi'an Jiaotong University; Hunan Normal University; University of Shanghai for Science & Technology	Zhang, YP (corresponding author), Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China.	cathyzh@mail.xjtu.edu.cn; hdeng2@tulane.edu	Yang, Tie-Lin/G-8365-2014	Yang, Tie-Lin/0000-0001-7062-3025; Deng, Hong-Wen/0000-0002-0387-8818	National Science Foundation of China [81100628, 81000363, 31000554]; Shaanxi Province Science and Technology Foundation [2010K16-01]; Xi'an Jiaotong University, Guang hua foundation [GH0203416]; Huo Ying Dong Education Foundation, Hunan Province, Shanghai Leading Academic Discipline Project [S30501]; China Scholarship Council; Ministry of Education; NIH [R01 AR050496-01, R21 AG027110, R01 AG026564, R21 AA015973, P50 AR055081]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, R01AR057049, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Foundation; Xi'an Jiaotong University, Guang hua foundation; Huo Ying Dong Education Foundation, Hunan Province, Shanghai Leading Academic Discipline Project; China Scholarship Council(China Scholarship Council); Ministry of Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were funded in part by grants from National Science Foundation of China (81100628, 81000363, 31000554), Shaanxi Province Science and Technology Foundation (2010K16-01), Xi'an Jiaotong University, Guang hua foundation (GH0203416). Huo Ying Dong Education Foundation, Hunan Province, Shanghai Leading Academic Discipline Project (S30501). The study also benefited from NIH (R01 AR050496-01, R21 AG027110, R01 AG026564, R21 AA015973, and P50 AR055081). Yin-Ping Zhang was supported by China Scholarship Council, Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Beunen G, 2000, ANN HUM BIOL, V27, P173; Boniotto M, 2004, GENET TEST, V8, P325, DOI 10.1089/gte.2004.8.325; Cody JD, 1997, AM J MED GENET, V71, P420, DOI 10.1002/(SICI)1096-8628(19970905)71:4<420::AID-AJMG9>3.3.CO;2-A; Deng HW, 2000, GENET EPIDEMIOL, V19, P160, DOI 10.1002/1098-2272(200009)19:2<160::AID-GEPI4>3.0.CO;2-H; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feenstra I, 2007, AM J MED GENET A, V143A, P1858, DOI 10.1002/ajmg.a.31850; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Garrone NF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-26; Ghidoni PD, 1997, AM J MED GENET, V69, P7, DOI 10.1002/(SICI)1096-8628(19970303)69:1<7::AID-AJMG2>3.0.CO;2-P; GonzalezRodriguez E, 1997, AM J MED GENET, V72, P399, DOI 10.1002/(SICI)1096-8628(19971112)72:4<399::AID-AJMG5>3.0.CO;2-M; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hale DE, 2000, J CLIN ENDOCR METAB, V85, P4450, DOI 10.1210/jc.85.12.4450; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Hu J, 2006, J MOL DIAGN, V8, P521, DOI 10.2353/jmoldx.2006.060001; Kanaan RA, 2006, MED SCI MONITOR, V12, pRA164; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lei SF, 2009, HUM MOL GENET, V18, P1661, DOI 10.1093/hmg/ddn405; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li MX, 2004, J HUM GENET, V49, P148, DOI 10.1007/s10038-004-0125-8; Liu SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022035; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sammalisto S, 2005, J MED GENET, V42, P932, DOI 10.1136/jmg.2005.031278; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Shao W, 2007, GENES IMMUN, V8, P224, DOI 10.1038/sj.gene.6364378; Shmueli A, 2005, CELL, V121, P963, DOI 10.1016/j.cell.2005.06.018; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Stamoyannou L, 1997, AM J MED GENET, V72, P71, DOI 10.1002/(SICI)1096-8628(19971003)72:1<71::AID-AJMG15>3.0.CO;2-R; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; STRATHDEE G, 1995, AM J MED GENET, V59, P476, DOI 10.1002/ajmg.1320590414; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050	46	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44292	10.1371/journal.pone.0044292	http://dx.doi.org/10.1371/journal.pone.0044292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957059	gold, Green Submitted, Green Published			2022-12-25	WOS:000308463800052
J	Zheng, QX; Ren, YP; Tzekov, R; Zhang, YP; Chen, B; Hou, JP; Zhao, CH; Zhu, JL; Zhang, Y; Dai, XF; Ma, S; Li, J; Pang, JJ; Qu, J; Li, WS				Zheng, Qinxiang; Ren, Yueping; Tzekov, Radouil; Zhang, Yuanping; Chen, Bo; Hou, Jiangping; Zhao, Chunhui; Zhu, Jiali; Zhang, Ying; Dai, Xufeng; Ma, Shan; Li, Jia; Pang, Jijing; Qu, Jia; Li, Wensheng			Differential Proteomics and Functional Research following Gene Therapy in a Mouse Model of Leber Congenital Amaurosis	PLOS ONE			English	Article							CANINE MODEL; RETINAL DEGENERATION; CHILDHOOD BLINDNESS; RPE65 MUTATIONS; RESTORES VISION; PEROXIREDOXIN 6; LIGHT DAMAGE; MURINE MODEL; RAT RETINA; CELL-DEATH	Leber congenital amaurosis (LCA) is one of the most severe forms of inherited retinal degeneration and can be caused by mutations in at least 15 different genes. To clarify the proteomic differences in LCA eyes, a cohort of retinal degeneration 12 (rd12) mice, an LCA2 model caused by a mutation in the RPE65 gene, were injected subretinally with an AAV vector (scAAV5-smCBA-hRPE65) in one eye, while the contralateral eye served as a control. Proteomics were compared between untreated rd12 and normal control retinas on P14 and P21, and among treated and untreated rd12 retinas and control retinas on P42. Gene therapy in rd12 mice restored retinal function in treated eyes, which was demonstrated by electroretinography (ERG). Proteomic analysis successfully identified 39 proteins expressed differently among the 3 groups. The expression of 3 proteins involved in regulation of apoptosis and neuroptotection (alpha A crystallin, heat shock protein 70 and peroxiredoxin 6) were investigated further. Immunofluorescence, Western blot and real-time PCR confirmed the quantitative changes in their expression. Furthermore, cell culture studies suggested that peroxiredoxin 6 could act in an antioxidant role in rd12 mice. Our findings support the feasibility of gene therapy in LCA2 patients and support a role for alpha A crystallin, heat shock protein 70 and peroxiredoxin 6 in the pathogenetic mechanisms involved in LCA2 disease process.	[Zheng, Qinxiang; Ren, Yueping; Hou, Jiangping; Zhao, Chunhui; Zhu, Jiali; Zhang, Ying; Dai, Xufeng; Pang, Jijing; Qu, Jia; Li, Wensheng] Wenzhou Med Coll, Hosp Eye, Wenzhou, Peoples R China; [Tzekov, Radouil] Roskamp Inst, Sarasota, FL USA; [Zhang, Yuanping] Kunming Med Coll, Affiliated Hosp 2, Dept Ophthalmol, Kunming, Peoples R China; [Chen, Bo] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Ma, Shan; Li, Jia] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA USA; [Pang, Jijing] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Li, Wensheng] NEI, Neurobiol Neurodegenerat & Repair Lab, Retinal Cell Biol & Degenerat Sect, NIH, Bethesda, MD 20892 USA	Wenzhou Medical University; Kunming Medical University; Yale University; University of Massachusetts System; University of Massachusetts Worcester; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Zheng, QX (corresponding author), Wenzhou Med Coll, Hosp Eye, Wenzhou, Peoples R China.	jqu@wzmc.net; drlws@163.net		Tzekov, Radouil/0000-0002-3662-9818	Major Projects of the National Science and Technology of China [2009ZX09503]; Specilized Research Fund for the Doctoral Program of Higher Education [20103321110002]; Key Projects of National High-Tech R&D Program (863 Program) of China [2007AA021004]; Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical College, Wenzhou, China; NATIONAL EYE INSTITUTE [R01EY021502] Funding Source: NIH RePORTER	Major Projects of the National Science and Technology of China; Specilized Research Fund for the Doctoral Program of Higher Education; Key Projects of National High-Tech R&D Program (863 Program) of China; Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical College, Wenzhou, China; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants of Major Projects of the National Science and Technology of China (No: 2009ZX09503), Specilized Research Fund for the Doctoral Program of Higher Education (No: 20103321110002), Key Projects of National High-Tech R&D Program (863 Program) of China (No: 2007AA021004), retinal gene therapy study grants from Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical College, Wenzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BARBE MF, 1988, SCIENCE, V241, P1817, DOI 10.1126/science.3175623; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Bernstein SL, 2000, INVEST OPHTH VIS SCI, V41, P2857; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Cavusoglu N, 2003, MOL CELL PROTEOMICS, V2, P494, DOI 10.1074/mcp.M300029-MCP200; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; DeLaPaz MA, 1996, CURR EYE RES, V15, P273, DOI 10.3109/02713689609007621; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; DERETIC D, 1994, J BIOL CHEM, V269, P16853; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fatma N, 2008, BRAIN RES, V1233, P63, DOI 10.1016/j.brainres.2008.07.076; Finnegan S, 2010, MOL VIS, V16, P7; Fort PE, 2011, EXP EYE RES, V92, P98, DOI 10.1016/j.exer.2010.11.008; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hejtmancik JF, 1998, AM J HUM GENET, V62, P520, DOI 10.1086/301774; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Jacobson SG, 2006, HUM GENE THER, V17, P845, DOI 10.1089/hum.2006.17.845; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Kostic C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016588; Kubo E, 2009, LIFE SCI, V84, P857, DOI 10.1016/j.lfs.2009.03.019; Lai CM, 2004, GENET VACCINES THER, V2, P3; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; Li WS, 2009, MOL VIS, V15, P267; Li X, 2011, INVEST OPHTH VIS SCI, V52, P7, DOI 10.1167/iovs.10-6138; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Narfstrom K, 2003, ADV EXP MED BIOL, V533, P423; Narfstrom K, 2003, J HERED, V94, P31, DOI 10.1093/jhered/esg015; Organisciak DT, 1998, INVEST OPHTH VIS SCI, V39, P1107; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Pelletier V, 2007, HUM MUTAT, V28, P81, DOI 10.1002/humu.20417; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Siu AW, 2008, NEUROSCI LETT, V432, P193, DOI 10.1016/j.neulet.2007.12.046; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208; Tulsawani R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-125; Tzekov RT, 2001, INVEST OPHTH VIS SCI, V42, P1319; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Wang PF, 2007, GRAEF ARCH CLIN EXP, V245, P1401, DOI 10.1007/s00417-007-0554-0; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1085, DOI 10.1167/iovs.04-0042; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	57	13	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44855	10.1371/journal.pone.0044855	http://dx.doi.org/10.1371/journal.pone.0044855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22953002	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300106
J	Chang, CY; Koh, CL; Sam, CK; Chan, XY; Yin, WF; Chan, KG				Chang, Chien-Yi; Koh, Chong-Lek; Sam, Choon-Kook; Chan, Xin-Yue; Yin, Wai Fong; Chan, Kok Gan			Unusual Long-Chain N-Acyl Homoserine Lactone Production by and Presence of Quorum Quenching Activity in Bacterial Isolates from Diseased Tilapia Fish	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SENSING SIGNALS; VIRULENCE; COMMUNICATION; MOLECULES	Growth-dependent cell-cell communication termed quorum sensing is a key regulatory system in bacteria for controlling gene expression including virulence factors. In this study five potential bacterial pathogens including Bacillus sp. W2.2, Klebsiella sp. W4.2, Pseudomonas sp. W3 and W3.1 and Serratia sp. W2.3 were isolated from diseased Tilapia fish in Malaysia, supplied by the leading global fish supplier. Proteolytic activity assays confirmed that with the exception of Klebsiella sp. W4.2, all isolates showed distinct proteolytic activity. Furthermore Bacillus sp. W2.2 and Pseudomonas sp. strains W3 and W3.1 also displayed haemolytic activity. By using high resolution liquid chromatography mass spectrometry, we revealed the presence of unusually long-chain N-(3-oxohexadecanoyl)-homoserine lactone (3-oxo-C16-HSL) from Pseudomonas sp. W3.1 and N-dodecanoyl-homoserine lactone (C12-HSL) from Serratia sp. W2.3, respectively. Interestingly, Pseudomonas sp. W3.1 also produced a wide range of Pseudomonas quinolone signalling (PQS) molecules. Pseudomonas sp. W3 did not show any quorum sensing properties but possessed quorum quenching activity that inactivated AHLs. This study is the first documentation that shows unusual long-chain AHLs production in Serratia sp. and Pseudomonas sp. isolated from diseased fish and the latter also produce a wide range of PQS molecules.	[Chang, Chien-Yi] Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Koh, Chong-Lek; Sam, Choon-Kook] Nanyang Technol Univ, Nat Sci & Sci Educ AG, Natl Inst Educ, Singapore, Singapore; [Chan, Xin-Yue; Yin, Wai Fong; Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur 50603, Malaysia	University of Nottingham; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; Universiti Malaya	Chang, CY (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Nottingham NG7 2RD, England.	kokgan@um.edu.my	Koh, Chong Lek/H-3968-2016; Chan, Xin Yue/K-9094-2013; Chang, Chien-Yi/E-1338-2012; Yin, Wai-Fong/H-3376-2016; Chan, Kok Gan/B-8347-2010; Chang, Chien-Yi/ABH-6848-2020	Koh, Chong Lek/0000-0002-4468-0082; Chan, Xin Yue/0000-0002-3841-3017; Chang, Chien-Yi/0000-0003-3570-4019; Yin, Wai-Fong/0000-0003-2177-6169; Chan, Kok Gan/0000-0002-1883-1115; Chang, Chien-Yi/0000-0003-3570-4019	University of Malaya HIR Grant [A000001-50001]	University of Malaya HIR Grant	This work was supported by the University of Malaya HIR Grant (A000001-50001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; Chan KG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-51; Chan KG, 2010, ANTON LEEUW INT J G, V98, P299, DOI 10.1007/s10482-010-9438-0; Chan KG, 2009, INT J MOL SCI, V10, P345, DOI 10.3390/ijms10010345; Chong TM, 2012, SENSORS-BASEL, V12, P4846, DOI 10.3390/s120404846; Chowdhary PK, 2007, BIOCHEMISTRY-US, V46, P14429, DOI 10.1021/bi701945j; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Gao MS, 2005, J BACTERIOL, V187, P7931, DOI 10.1128/JB.187.23.7931-7944.2005; Hong KW, 2012, SENSORS-BASEL, V12, P4661, DOI 10.3390/s120404661; JONES S, 1993, EMBO J, V12, P2477, DOI 10.1002/j.1460-2075.1993.tb05902.x; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Pretto-Giordano LG, 2010, AQUAC RES, V41, P1539, DOI 10.1111/j.1365-2109.2009.02449.x; Savka MA, 2011, CURR MICROBIOL, V62, P101, DOI 10.1007/s00284-010-9679-1; Schaefer AL, 2002, J BACTERIOL, V184, P6515, DOI 10.1128/JB.184.23.6515-6521.2002; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; Tamura K, 2011, MOL BIOL EVOLUTION; Teplitski M, 2003, ARCH MICROBIOL, V180, P494, DOI 10.1007/s00203-003-0612-x; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Wang H, 2006, J MED MICROBIOL, V55, P1751, DOI 10.1099/jmm.0.46756-0; Wei JR, 2006, J BACTERIOL, V188, P1518, DOI 10.1128/JB.188.4.1518-1525.2006; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wong CS, 2012, WORLD J MICROB BIOT, V28, P453, DOI 10.1007/s11274-011-0836-x; Yin WF, 2012, SENSORS-BASEL, V12, P4065, DOI 10.3390/s120404065; Yin WF, 2012, SENSORS-BASEL, V12, P3472, DOI 10.3390/s120303472; Zhu H, 2004, INVEST OPHTH VIS SCI, V45, P1897, DOI 10.1167/iovs.03-0980; Zhu H, 2002, J MED MICROBIOL, V51, P1063, DOI 10.1099/0022-1317-51-12-1063	33	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44034	10.1371/journal.pone.0044034	http://dx.doi.org/10.1371/journal.pone.0044034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952864	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000071
J	de Magalhaes, JP				de Magalhaes, Joao Pedro			Programmatic features of aging originating in development: aging mechanisms beyond molecular damage?	FASEB JOURNAL			English	Article						epigenetics; functional genomics	TO-HEAD DEBATE; LIFE-SPAN; MESSENGER-RNA; GENES; MICRORNA; AGE; REPRODUCTION; LONGEVITY; EXTENSION; BIOLOGY	The idea that aging follows a predetermined sequence of events, a program, has been discredited by most contemporary authors. Instead, aging is largely thought to occur due to the accumulation of various forms of molecular damage. Recent work employing functional genomics now suggests that, indeed, certain facets of mammalian aging may follow predetermined patterns encoded in the genome as part of developmental processes. It appears that genetic programs coordinating some aspects of growth and development persist into adulthood and may become detrimental. This link between development and aging may occur due to regulated processes, including through the action of microRNAs and epigenetic mechanisms. Taken together with other results, in particular from worms, these findings provide evidence that some aging changes are not primarily a result of a build-up of stochastic damage but are rather a product of regulated processes. These processes are interpreted as forms of antagonistic pleiotropy, the product of a "shortsighted watchmaker," and thus do not assume aging evolved for a purpose. Overall, it appears that the genome does, indeed, contain specific instructions that drive aging in animals, a radical shift in our perception of the aging process.-de Magalhaes, J. P. Programmatic features of aging originating in development: aging mechanisms beyond molecular damage? FASEB J. 26, 4821-4826 (2012). www.fasebj.org	Univ Liverpool, Inst Integrat Biol, Integrat Genom Ageing Grp, Liverpool L69 7ZB, Merseyside, England	University of Liverpool	de Magalhaes, JP (corresponding author), Univ Liverpool, Inst Integrat Biol, Integrat Genom Ageing Grp, Biosci Bldg,Rm 245,Crown St, Liverpool L69 7ZB, Merseyside, England.	jp@senescence.info	de Magalhaes, Joao Pedro/B-4741-2010	de Magalhaes, Joao Pedro/0000-0002-6363-2465	UK Biotechnology and Biological Sciences Resource Council; Wellcome Trust; Ellison Medical Foundation; Marie Curie International Reintegration grant within EC-FP7	UK Biotechnology and Biological Sciences Resource Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Ellison Medical Foundation(Lawrence Ellison Foundation); Marie Curie International Reintegration grant within EC-FP7	The author thanks Pete Estep and George Martin for comments on previous drafts. The author is also grateful for support from the UK Biotechnology and Biological Sciences Resource Council, the Wellcome Trust, the Ellison Medical Foundation, and a Marie Curie International Reintegration grant within EC-FP7 for supporting the work in his laboratory.	Austad SN, 2004, AGING CELL, V3, P249, DOI 10.1111/j.1474-9728.2004.00112.x; Austad SN, 2009, J GERONTOL A-BIOL, V64, P199, DOI 10.1093/gerona/gln060; Ayyadevara S, 2008, AGING CELL, V7, P13, DOI 10.1111/j.1474-9726.2007.00348.x; Biddle FG, 1997, GENOME, V40, P229, DOI 10.1139/g97-032; Blagosklonny MV, 2006, CELL CYCLE, V5, P2087, DOI 10.4161/cc.5.18.3288; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Bredesen DE, 2004, AGING CELL, V3, P255, DOI 10.1111/j.1474-9728.2004.00121.x; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Comfort A, 1964, AGEING BIOL SENESCEN; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149; de Magalhaes JP, 2010, AGEING RES REV, V9, P315, DOI 10.1016/j.arr.2009.10.006; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; de Magalhaes JP, 2005, MECH AGEING DEV, V126, P1026, DOI 10.1016/j.mad.2005.04.004; de Magalhaes JP, 2005, PHYSIOLOGY, V20, P252, DOI 10.1152/physiol.00010.2005; de Magalhaes JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/j.febslet.2004.07.006; de Magalhaes JP, 2003, BIOGERONTOLOGY, V4, P119, DOI 10.1023/A:1023356005749; FINCH CE, 1976, Q REV BIOL, V51, P49, DOI 10.1086/409053; Finch CE, 1990, LONGEVITY SENESCENCE; Freitas AA, 2011, MUTAT RES-REV MUTAT, V728, P12, DOI 10.1016/j.mrrev.2011.05.001; Gombar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-353; Hayflick L., 1994, WHY WE AGE; Hayflick L, 2007, PLOS GENET, V3, P2351, DOI 10.1371/journal.pgen.0030220; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; HIGUCHI K, 1992, J LIPID RES, V33, P1753; Holliday R, 2006, ANN NY ACAD SCI, V1067, P1, DOI 10.1196/annals.1354.002; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kirkwood TBL, 2008, J INTERN MED, V263, P117, DOI 10.1111/j.1365-2796.2007.01901.x; Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Longo VD, 2005, NAT REV GENET, V6, DOI 10.1038/nrg1706; Lui JC, 2010, MECH AGEING DEV, V131, P641, DOI 10.1016/j.mad.2010.08.010; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; McCay C M, 1933, Science, V77, P410, DOI 10.1126/science.77.2000.410; Miller RA, 1999, J GERONTOL A-BIOL, V54, pB297, DOI 10.1093/gerona/54.7.B297; MILLER SE, 1990, SCIENCE, V248, P356, DOI 10.1126/science.248.4953.356; Nicholas A, 2010, MECH AGEING DEV, V131, P445, DOI 10.1016/j.mad.2010.06.001; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Raff M, 2006, BIOCHEM SOC T, V34, P663, DOI 10.1042/BST0340663; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P10314, DOI 10.1073/pnas.1005862107; Rollo CD, 2002, EVOL DEV, V4, P55, DOI 10.1046/j.1525-142x.2002.01053.x; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Takasugi M, 2011, MECH AGEING DEV, V132, P65, DOI 10.1016/j.mad.2010.12.003; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Walker RF, 2011, REJUV RES, V14, P429, DOI 10.1089/rej.2011.1162; Walker RF, 2009, MECH AGEING DEV, V130, P350, DOI 10.1016/j.mad.2009.02.003; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yuan R, 2012, P NATL ACAD SCI USA, V109, P8224, DOI 10.1073/pnas.1121113109	53	62	64	2	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4821	4826		10.1096/fj.12-210872	http://dx.doi.org/10.1096/fj.12-210872			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22964300	hybrid, Green Published			2022-12-25	WOS:000311838300005
J	Tataroglu, O; Lauinger, L; Sancar, G; Jakob, K; Brunner, M; Diernfellner, ACR				Tataroglu, Oezguer; Lauinger, Linda; Sancar, Gencer; Jakob, Katharina; Brunner, Michael; Diernfellner, Axel C. R.			Glycogen Synthase Kinase Is a Regulator of the Circadian Clock of Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-COLLAR COMPLEX; TRANSCRIPTION FACTOR; FREQUENCY DETERMINES; PROTEIN STABILITY; FEEDBACK LOOPS; PHOSPHORYLATION; REVEALS; PERIOD; LIGHT; DEGRADATION	Timekeeping by circadian clocks relies upon precise adjustment of expression levels of clock proteins. Here we identify glycogen synthase kinase (GSK) as a novel and critical component of the circadian clock of Neurospora crassa that regulates the abundance of its core transcription factor white collar complex (WCC) on a post-transcriptional level. We show that GSK specifically binds and phosphorylates both subunits of the WCC. Reduced expression of GSK promotes an increased accumulation of WC-1, the limiting factor of the WCC, causing an acceleration of the circadian clock and a shorter free-running period.	[Tataroglu, Oezguer; Lauinger, Linda; Sancar, Gencer; Jakob, Katharina; Brunner, Michael; Diernfellner, Axel C. R.] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Diernfellner, ACR (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	axel.diernfellner@bzh.uni-heidelberg.de	Tataroglu, Ozgur/AAR-9351-2020	Tataroglu, Ozgur/0000-0001-9118-2054; Brunner, Michael/0000-0001-9798-3047	PhD fellowship of CellNetworks; Deutsche Forschungsgemeinschaft	PhD fellowship of CellNetworks; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a PhD fellowship of CellNetworks (to O. T.) and by grants of the Deutsche Forschungsgemeinschaft.	Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Diernfellner ACR, 2011, FEBS LETT, V585, P1461, DOI 10.1016/j.febslet.2011.03.049; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; JOHNSSON A, 1979, PHARMAKOPSYCH NEURO, V12, P423, DOI 10.1055/s-0028-1094638; Jolma IW, 2006, J BIOL RHYTHM, V21, P327, DOI 10.1177/0748730406292453; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Merrow M, 2007, COLD SPRING HARB SYM, V72, P279, DOI 10.1101/sqb.2007.72.032; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Sancar G, 2009, FEBS LETT, V583, P1833, DOI 10.1016/j.febslet.2009.04.042; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2011, FEBS LETT, V585, P1467, DOI 10.1016/j.febslet.2011.03.050; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Tataroglu O, 2010, EMBO REP, V11, P927, DOI 10.1038/embor.2010.174	41	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36936	36943		10.1074/jbc.M112.396622	http://dx.doi.org/10.1074/jbc.M112.396622			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955278	hybrid, Green Published			2022-12-25	WOS:000310588500030
J	Hegde, M; Karki, SS; Thomas, E; Kumar, S; Panjamurthy, K; Ranganatha, SR; Rangappa, KS; Choudhary, B; Raghavan, SC				Hegde, Mahesh; Karki, Subhas S.; Thomas, Elizabeth; Kumar, Sujeet; Panjamurthy, Kuppusamy; Ranganatha, Somasagara R.; Rangappa, Kanchugarakoppal S.; Choudhary, Bibha; Raghavan, Sathees C.			Novel Levamisole Derivative Induces Extrinsic Pathway of Apoptosis in Cancer Cells and Inhibits Tumor Progression in Mice	PLOS ONE			English	Article							CYTOCHROME-C; CHROMOSOMAL TRANSLOCATIONS; PROSTATE-CANCER; NUCLEAR ANTIGEN; LEUKEMIC-CELLS; COLON-CANCER; P53; BCL-2; RELEASE; MITOCHONDRIA	Background: Levamisole, an imidazo(2,1-b) thiazole derivative, has been reported to be a potential antitumor agent. In the present study, we have investigated the mechanism of action of one of the recently identified analogues, 4a (2-benzyl-6-(4'-fluorophenyl)-5-thiocyanato-imidazo[2,1-b][1,3,4]thiadiazole). Materials and Methods: ROS production and expression of various apoptotic proteins were measured following 4a treatment in leukemia cell lines. Tumor animal models were used to evaluate the effect of 4a in comparison with Levamisole on progression of breast adenocarcinoma and survival. Immunohistochemistry and western blotting studies were performed to understand the mechanism of 4a action both ex vivo and in vivo. Results: We have determined the IC50 value of 4a in many leukemic and breast cancer cell lines and found CEM cells most sensitive (IC50 5 mu M). Results showed that 4a treatment leads to the accumulation of ROS. Western blot analysis showed upregulation of pro-apoptotic proteins t-BID and BAX, upon treatment with 4a. Besides, dose-dependent activation of p53 along with FAS, FAS-L, and cleavage of CASPASE-8 suggest that it induces death receptor mediated apoptotic pathway in CEM cells. More importantly, we observed a reduction in tumor growth and significant increase in survival upon oral administration of 4a (20 mg/kg, six doses) in mice. In comparison, 4a was found to be more potent than its parental analogue Levamisole based on both ex vivo and in vivo studies. Further, immunohistochemistry and western blotting studies indicate that 4a treatment led to abrogation of tumor cell proliferation and activation of apoptosis by the extrinsic pathway even in animal models. Conclusion: Thus, our results suggest that 4a could be used as a potent chemotherapeutic agent.	[Hegde, Mahesh; Thomas, Elizabeth; Panjamurthy, Kuppusamy; Ranganatha, Somasagara R.; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Karki, Subhas S.; Kumar, Sujeet] KLE Univ, Dept Pharmaceut Chem, Coll Pharm, Bangalore, Karnataka, India; [Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Choudhary, Bibha] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; K.L.E. Academy of Higher Education & Research; University of Mysore	Hegde, M (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	Kuppusamy, Panjamurthy/AAT-1518-2021; Hegde, MahesH/ABE-2057-2020; karki, subhas s/AAH-6451-2020; KUMAR, SUJEET/AAD-5081-2019; Thomas, Elizabeth/AAV-3393-2020	Kuppusamy, Panjamurthy/0000-0003-3293-7220; Hegde, MahesH/0000-0002-7853-6281; karki, subhas s/0000-0002-5599-3594; KUMAR, SUJEET/0000-0002-0833-158X; 	Lady Tata Memorial Trust, United Kingdom; Indian Institute of Science start up grant	Lady Tata Memorial Trust, United Kingdom; Indian Institute of Science start up grant	This work was supported by grant from Lady Tata Memorial Trust, United Kingdom, and Indian Institute of Science start up grant for SCR. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; ANDREANI A, 1982, ARCH PHARM, V315, P451, DOI 10.1002/ardp.19823150511; Aplan PD, 2005, BLOOD, V105, P1843, DOI 10.1182/blood-2004-12-4760; Artwohl M, 2000, BRIT J PHARMACOL, V131, P1577, DOI 10.1038/sj.bjp.0703660; ATTIA MAM, 1966, CANCER RES, V26, P1787; Bhattacharyya A, 2003, CARCINOGENESIS, V24, P75, DOI 10.1093/carcin/24.1.75; Buolamwini JK, 2000, CURR PHARM DESIGN, V6, P379, DOI 10.2174/1381612003400948; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; CHEUNG ANY, 1993, HISTOPATHOLOGY, V22, P565, DOI 10.1111/j.1365-2559.1993.tb00177.x; Chiruvella KK, 2011, INVEST NEW DRUG, V29, P583, DOI 10.1007/s10637-010-9393-7; Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001; Durland-Busbice S, 2002, LEUKEMIA, V16, P2165, DOI 10.1038/sj.leu.2402647; Friis Tina, 2005, Angiogenesis, V8, P25, DOI 10.1007/s10456-005-3588-0; Gadad AK, 1999, ARZNEIMITTEL-FORSCH, V49, P858; GEKELER V, 1993, MOL CELL BIOL, V13, P5020, DOI 10.1128/MCB.13.8.5020; GERDES J, 1984, J IMMUNOL, V133, P1710; Ghosh M, 1997, CANCER LETT, V119, P7, DOI 10.1016/S0304-3835(97)00244-9; GUMINSKA M, 1986, BIOCHEM PHARMACOL, V35, P4369, DOI 10.1016/0006-2952(86)90750-1; Hazra B, 2005, TOXICOL LETT, V157, P109, DOI 10.1016/j.toxlet.2005.01.016; Huang CX, 2008, CANCER LETT, V266, P135, DOI 10.1016/j.canlet.2008.02.059; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Karki SS, 2011, EUR J MED CHEM, V46, P2109, DOI 10.1016/j.ejmech.2011.02.064; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; KOVACH JS, 1992, J NATL CANCER I, V84, P515, DOI 10.1093/jnci/84.7.515; Kumagai H, 2004, CARCINOGENESIS, V25, P723, DOI 10.1093/carcin/bgh067; Kumar A, 2009, CANCER CHEMOTH PHARM, V64, P1221, DOI 10.1007/s00280-009-0992-y; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Luppi G, 1996, ANN ONCOL, V7, P412; MIYASHITA T, 1995, CELL, V80, P293; Moen MD, 2007, DRUGS, V67, P299, DOI 10.2165/00003495-200767020-00010; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nickoloff JA, 2008, CURR OPIN HEMATOL, V15, P338, DOI 10.1097/MOH.0b013e328302f711; Noaman E, 2008, CANCER LETT, V268, P348, DOI 10.1016/j.canlet.2008.04.012; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Ramanadham M, 2010, J IMMUNOTOXICOL, V7, P327, DOI 10.3109/1547691X.2010.514871; Robert J, 2003, J MED CHEM, V46, P4805, DOI 10.1021/jm030183a; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Salem FS, 2011, VET ITAL, V47, P89; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P523, DOI 10.1007/s10637-009-9379-5; Sharma S, 2012, MOL CARCINOG; STEVENSON HC, 1991, J CLIN ONCOL, V9, P2052, DOI 10.1200/JCO.1991.9.11.2052; Sugimoto Y, 2009, J MED CHEM, V52, P798, DOI 10.1021/jm801265e; SYMOENS J, 1978, CANCER TREAT REP, V62, P1721; Tang DG, 1997, PROSTATE, V32, P284; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vrekoussis T, 2009, ANTICANCER RES, V29, P4995; Wiebke EA, 2003, J SURG RES, V111, P63, DOI 10.1016/S0022-4804(03)00053-2; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	58	41	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43632	10.1371/journal.pone.0043632	http://dx.doi.org/10.1371/journal.pone.0043632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970136	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000308748400007
J	Gregory, SD; Brook, BW; Goossens, B; Ancrenaz, M; Alfred, R; Ambu, LN; Fordham, DA				Gregory, Stephen D.; Brook, Barry W.; Goossens, Benoit; Ancrenaz, Marc; Alfred, Raymond; Ambu, Laurentius N.; Fordham, Damien A.			Long-Term Field Data and Climate-Habitat Models Show That Orangutan Persistence Depends on Effective Forest Management and Greenhouse Gas Mitigation	PLOS ONE			English	Article							LAND-USE CHANGE; GENETIC DIVERSITY; SPECIES RICHNESS; PROTECTED AREAS; DANUM-VALLEY; BORNEO; SABAH; MALAYSIA; POPULATION; DEFORESTATION	Background: Southeast Asian deforestation rates are among the world's highest and threaten to drive many forest-dependent species to extinction. Climate change is expected to interact with deforestation to amplify this risk. Here we examine whether regional incentives for sustainable forest management will be effective in improving threatened mammal conservation, in isolation and when combined with global climate change mitigation. Methodology/Principal Findings: Using a long time-series of orangutan nest counts for Sabah (2000-10), Malaysian Borneo, we evaluated the effect of sustainable forest management and climate change scenarios, and their interaction, on orangutan spatial abundance patterns. By linking dynamic land-cover and downscaled global climate model projections, we determine the relative influence of these factors on orangutan spatial abundance and use the resulting statistical models to identify habitat crucial for their long-term conservation. We show that land-cover change the degradation of primary forest had the greatest influence on orangutan population size. Anticipated climate change was predicted to cause reductions in abundance in currently occupied populations due to decreased habitat suitability, but also to promote population growth in western Sabah by increasing the suitability of presently unoccupied regions. Conclusions/Significance: We find strong quantitative support for the Sabah government's proposal to implement sustainable forest management in all its forest reserves during the current decade; failure to do so could result in a 40 to 80 per cent regional decline in orangutan abundance by 2100. The Sabah orangutan is just one (albeit iconic) example of a forest-dependent species that stands to benefit from sustainable forest management, which promotes conservation of existing forests.	[Gregory, Stephen D.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Gregory, Stephen D.; Brook, Barry W.; Fordham, Damien A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Gregory, Stephen D.; Brook, Barry W.; Fordham, Damien A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Goossens, Benoit] Cardiff Univ, Organisms & Environm Div, Sch Biosci, Cardiff, S Glam, Wales; [Goossens, Benoit; Ancrenaz, Marc; Ambu, Laurentius N.] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc] Hutan Kinabatangan Orang Utan Conservat Programme, Sandakan, Sabah, Malaysia; [Ancrenaz, Marc] Chester Zoo, N England Zool Soc, Chester, Cheshire, England; [Alfred, Raymond] Borneo Conservat Trust, Kota Kinabalu, Sabah, Malaysia	University of Adelaide; University of Adelaide; University of Adelaide; Cardiff University	Gregory, SD (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA, Australia.	stephendavidgregory@gmail.com	Goossens, Benoit R/E-8812-2010; Gregory, Stephen D/A-1471-2010; Fordham, Damien A/E-9255-2013; Brook, Barry W./G-2686-2011	Gregory, Stephen D/0000-0002-8230-0191; Fordham, Damien A/0000-0003-2137-5592; Brook, Barry W./0000-0002-2491-1517	ARC [DP1096427]; Darwin Initiative for the Survival of Species, DEFRA, UK [09-016]; Cardiff University; Apenheul Primate Park; ZooParc de Beauval; Cleveland Metroparks Zoo; Chester Zoo; Columbus Zoo; Houston Zoo; Zoo de La Palmyre; Oregon Zoo; Philadelphia Zoo; Phoenix Zoo; Saint Louis Zoo; Utah's Hogle Zoo; Woodland Park Zoo; Abraham Foundation,; Arcus Foundation; Balikpapan Orangutan Survival Foundation (NL); Shared Earth Foundation; Elephant Family Foundation; Ensemble Foundation; Mohamed bin Zayed Foundation; Shining Hope Foundation; World Women Work Foundation; WoodTiger Fund; Wildlife Conservation Network; US Fish and Wildlife Services Great Ape Conservation Fund; North England Zoological Society; Orangutan Project	ARC(Australian Research Council); Darwin Initiative for the Survival of Species, DEFRA, UK(Department for Environment, Food & Rural Affairs (DEFRA)); Cardiff University; Apenheul Primate Park; ZooParc de Beauval; Cleveland Metroparks Zoo; Chester Zoo; Columbus Zoo; Houston Zoo; Zoo de La Palmyre; Oregon Zoo; Philadelphia Zoo; Phoenix Zoo; Saint Louis Zoo; Utah's Hogle Zoo; Woodland Park Zoo; Abraham Foundation,; Arcus Foundation; Balikpapan Orangutan Survival Foundation (NL); Shared Earth Foundation; Elephant Family Foundation; Ensemble Foundation; Mohamed bin Zayed Foundation; Shining Hope Foundation; World Women Work Foundation; WoodTiger Fund; Wildlife Conservation Network; US Fish and Wildlife Services Great Ape Conservation Fund(US Fish & Wildlife Service); North England Zoological Society; Orangutan Project	This research was funded by an ARC Discovery Grant awarded to DAF and BWB (DP1096427). BG was supported by a Darwin Initiative for the Survival of Species (Grant no. 09-016, DEFRA, UK) and Cardiff University. KOCP is supported by Apenheul Primate Park, ZooParc de Beauval, Cleveland Metroparks Zoo, Chester Zoo, Columbus Zoo, Houston Zoo, Zoo de La Palmyre, Oregon Zoo, Philadelphia Zoo, Phoenix Zoo, Saint Louis Zoo, Utah's Hogle Zoo, Woodland Park Zoo, Abraham Foundation, Arcus Foundation, Balikpapan Orangutan Survival Foundation (NL), Shared Earth Foundation, Elephant Family Foundation, Ensemble Foundation, Mohamed bin Zayed Foundation, Shining Hope Foundation, World Women Work Foundation, the WoodTiger Fund, Wildlife Conservation Network, US Fish and Wildlife Services Great Ape Conservation Fund, North England Zoological Society and the Orangutan Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Alfred R., 2010, ONLINE J BIOL SCI, V10, P73; Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; Bruford Michael W., 2010, Endangered Species Research, V12, P249, DOI 10.3354/esr00295; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Campbell-Smith G, 2012, J APPL ECOL, V49, P367, DOI 10.1111/j.1365-2664.2012.02109.x; Cannon CH, 2007, BIOTROPICA, V39, P747, DOI 10.1111/j.1744-7429.2007.00323.x; Corlett RT, 2012, BIOL CONSERV, V151, P22, DOI 10.1016/j.biocon.2011.11.027; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; EASTMAN JR, 1995, PHOTOGRAMM ENG REM S, V61, P539; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Fordham DA, 2012, ECOGRAPHY, V35, P4, DOI 10.1111/j.1600-0587.2011.07398.x; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Hector A, 2011, PHILOS T R SOC B, V366, P3165, DOI 10.1098/rstb.2011.0174; Hill JK, 2011, PHILOS T R SOC B, V366, P3265, DOI 10.1098/rstb.2011.0050; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; MacKinnon J., 1974, SEARCH RED APE; MARSH CW, 1992, PHILOS T ROY SOC B, V335, P331, DOI 10.1098/rstb.1992.0025; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P311; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; O'Brien TG, 2003, ANIM CONSERV, V6, P115, DOI 10.1017/S1367943003003159; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Pyle JA, 2011, PHILOS T R SOC B, V366, P3210, DOI 10.1098/rstb.2011.0060; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Sabah Forestry Department, 2010, ANN REP 2010 SAB FOR; Shearman P, 2012, BIOL CONSERV, V151, P17, DOI 10.1016/j.biocon.2011.10.036; Singleton Ian, 2009, P205; Sodhi N. S., 2006, SE ASIAN BIODIVERSIT; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Takada T, 2010, LANDSCAPE ECOL, V25, P561, DOI 10.1007/s10980-009-9433-x; Tingley R, 2009, J BIOGEOGR, V36, P1656, DOI 10.1111/j.1365-2699.2009.02117.x; Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X	48	20	20	3	170	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43846	10.1371/journal.pone.0043846	http://dx.doi.org/10.1371/journal.pone.0043846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970145	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000007
J	Han, NY; Liu, XW; Mu, YG				Han, Nanyu; Liu, Xuewei; Mu, Yuguang			Exploring the Mechanism of Zanamivir Resistance in a Neuraminidase Mutant: A Molecular Dynamics Study	PLOS ONE			English	Article							WELL-TEMPERED METADYNAMICS; INFLUENZA; SIMULATION; ENERGIES; VIRUSES; THREAT; PDBSUM; H5N1	It is critical to understand the molecular basis of the drug resistance of influenza viruses to efficiently treat this infectious disease. Recently, H1N1 strains of influenza A carrying a mutation of Q136K in neuraminidase were found. The new strain showed a strong Zanamivir neutralization effect. In this study, normal molecular dynamics simulations and metadynamics simulations were employed to explore the mechanism of Zanamivir resistance. The wild-type neuraminidase contained a 310 helix before the 150 loop, and there was interaction between the 150 and 430 loops. However, the helix and the interaction between the two loops were disturbed in the mutant protein due to interaction between K136 and nearby residues. Hydrogen-bond network analysis showed weakened interaction between the Zanamivir drug and E276/D151 on account of the electrostatic interaction between K136 and D151. Metadynamics simulations showed that the free energy landscape was different in the mutant than in the wild-type neuraminidase. Conformation with the global minimum of free energy for the mutant protein was different from the wild-type conformation. While the drug fit completely into the active site of the wild-type neuraminidase, it did not match the active site of the mutant variant. This study indicates that the altered hydrogen-bond network and the deformation of the 150 loop are the key factors in development of Zanamivir resistance. Furthermore, the Q136K mutation has a variable effect on conformation of different N1 variants, with conformation of the 1918 N1 variant being more profoundly affected than that of the other N1 variants studied in this paper. This observation warrants further experimental investigation.	[Han, Nanyu; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Liu, Xuewei] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Han, NY (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	ygmu@ntu.edu.sg			IDA;  [NMRC/H1N1R/001/2009]	IDA; 	The support of research grants, NMRC/H1N1R/001/2009 and the IDA Cloud Computing Call for Project Proposals 2012 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Barducci A, 2010, BIOPHYS J, V98, pL44, DOI 10.1016/j.bpj.2010.01.033; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chachra R, 2008, J CHEM THEORY COMPUT, V4, P1526, DOI 10.1021/ct800068v; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Cossio P, 2010, J PHYS CHEM B, V114, P3259, DOI 10.1021/jp907464b; Crespo Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055701; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Duan S, 2011, ANTIMICROB AGENTS CH, V55, P4718, DOI 10.1128/AAC.00316-11; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Frisch G. W. T. M. J., 2009, GAUSSIAN 09; Gervasio FL, 2005, J AM CHEM SOC, V127, P2600, DOI 10.1021/ja0445950; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Micheletti C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.170601; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nistal-Villan E, 2009, NAT MED, V15, P1253, DOI 10.1038/nm1109-1253; Oxford J, 2004, J ANTIMICROB CHEMOTH, V53, P133, DOI 10.1093/jac/dkh037; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith BJ, 2001, PROTEIN SCI, V10, P689, DOI 10.1110/ps.41801; Van Der Vries E, 2011, NEW ENGL J MED, V364, P1182; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	50	12	13	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44057	10.1371/journal.pone.0044057	http://dx.doi.org/10.1371/journal.pone.0044057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970161	Green Published, gold			2022-12-25	WOS:000308458400032
J	Imai, CM; Halldorsson, TI; Gunnarsdottir, I; Gudnason, V; Aspelund, T; Jonsson, G; Birgisdottir, BE; Thorsdottir, I				Imai, Cindy Mari; Halldorsson, Thorhallur Ingi; Gunnarsdottir, Ingibjorg; Gudnason, Vilmundur; Aspelund, Thor; Jonsson, Gudmundur; Birgisdottir, Bryndis Eva; Thorsdottir, Inga			Effect of Birth Year on Birth Weight and Obesity in Adulthood: Comparison between Subjects Born Prior to and during the Great Depression in Iceland	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CATCH-UP GROWTH; BODY-COMPOSITION; GLUCOSE-TOLERANCE; CHILDHOOD GROWTH; DUTCH FAMINE; SIZE; LIFE; POPULATION; CONSEQUENCES	Background: Many epidemiological studies have linked small size at birth to adverse adult health outcomes but the relative influence of environmental exposures is less well established. Methods: The authors investigated the impact of prenatal environmental exposure by comparing 2750 participants born before (1925-1929) and during (1930-1934) the Great Depression in Reykjavik, Iceland. Calendar year served as proxy for environmental effects. Anthropometric measurements at birth and school-age (8-13 years) were collected from national registries. Participants were medically examined as adults (33-65 years). Results: Mean birth weight, adjusted for maternal age and parity, decreased by 97 g (95% confidence interval (CI): 39, 156) for men and 70 g (95% CI: 11, 129) for women from 1925 to 1934; growth at school-age was significantly reduced for participants growing during the Depression. As adults, women prenatally exposed to the Depression had higher body mass index (Delta 0.6 kg/m(2), 95% CI: 0.2, 1.1), higher fasting blood glucose levels (Delta 0.16 mmol/L, 95% CI: 0.07, 0.23) and greater odds of being obese 1.43 (95% CI: 1.01, 2.02) compared to unexposed counterparts. Non-significant associations were observed in men. Conclusion: Reduction in birth weight due to rapid shifts in the economic environment appears to have a modest but significant association with later obesity for women while male offspring appear to be less affected by these conditions.	[Imai, Cindy Mari; Halldorsson, Thorhallur Ingi; Gunnarsdottir, Ingibjorg; Birgisdottir, Bryndis Eva; Thorsdottir, Inga] Landspitali Univ Hosp, Unit Nutr Res, Reykjavik, Iceland; [Imai, Cindy Mari; Halldorsson, Thorhallur Ingi; Gunnarsdottir, Ingibjorg; Birgisdottir, Bryndis Eva; Thorsdottir, Inga] Univ Iceland, Fac Food Sci & Nutr, Sch Hlth Sci, Reykjavik, Iceland; [Gudnason, Vilmundur; Aspelund, Thor] Iceland Heart Assocat, Kopavogur, Iceland; [Gudnason, Vilmundur; Aspelund, Thor] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland; [Jonsson, Gudmundur] Univ Iceland, Fac Humanities, Dept Hist & Philosophy, Reykjavik, Iceland	Landspitali National University Hospital; University of Iceland; Icelandic Heart Association; University of Iceland; University of Iceland	Imai, CM (corresponding author), Landspitali Univ Hosp, Unit Nutr Res, Reykjavik, Iceland.	cmi1@hi.is	Gunnarsdottir, Ingibjorg/L-9371-2015; Aspelund, Thor/K-7022-2019; Birgisdottir, Bryndis E/M-1504-2015; Halldorsson, Tohrhallur/M-1823-2015; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015; Thorsdottir, Inga/M-3260-2015	Aspelund, Thor/0000-0002-7998-5433; Halldorsson, Tohrhallur/0000-0001-5115-0162; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Thorsdottir, Inga/0000-0002-2946-287X; Halldorsson, Thorhallur/0000-0002-3488-0777; Gunnarsdottir, Ingibjorg/0000-0001-9447-8627; Jonsson, Gudmundur/0000-0001-8539-3189; Birgisdottir, Bryndis Eva/0000-0002-5788-4551	University of Iceland Research Fund; Landspitali National University Hospital Research Fund	University of Iceland Research Fund; Landspitali National University Hospital Research Fund	Support was received from the University of Iceland Research Fund and Landspitali National University Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2001, BMJ-BRIT MED J, V323, P1273, DOI 10.1136/bmj.323.7324.1273; BARTLEY M, 1994, BMJ-BRIT MED J, V309, P1475, DOI 10.1136/bmj.309.6967.1475; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Birgisdottir BE, 2002, AM J CLIN NUTR, V76, P399, DOI 10.1093/ajcn/76.2.399; Bjornsson B, 1941, ARBOK REYKJAVIKURBAE; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Gunnarsdottir I, 2004, EUR J CLIN NUTR, V58, P812, DOI 10.1038/sj.ejcn.1601881; Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290, DOI 10.1093/ajcn/76.6.1290; Gunnarsdottir I, 2002, J HYPERTENS, V20, P623, DOI 10.1097/00004872-200204000-00018; Halldorsson TI, 2011, HYPERTENSION, V58, P8, DOI 10.1161/HYPERTENSIONAHA.111.170985; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Jonsson G, 1997, SOGULEGUR HAGTOLUR I; Jonsson G, 2004, EXPLORING EC GROWTH, P131; JuEnsson, 1998, SCANDINAVIAN EC HIST, V46, P24, DOI DOI 10.1080/03585522.1998.10414677; LAW CM, 1992, J EPIDEMIOL COMMUN H, V46, P184, DOI 10.1136/jech.46.3.184; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Olafsdottir AS, 2005, BJOG-INT J OBSTET GY, V112, P424, DOI 10.1111/j.1471-0528.2005.00477.x; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Phillips DIW, 2005, DIABETES, V54, pS145, DOI 10.2337/diabetes.54.suppl_2.S145; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Portrait F, 2011, SOC SCI MED, V73, P711, DOI 10.1016/j.socscimed.2011.04.005; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Robinson R, 2001, BRIT MED J, V322, P375, DOI 10.1136/bmj.322.7283.375; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; SIGURDSSON E, 1993, EUR HEART J, V14, P584, DOI 10.1093/eurheartj/14.5.584; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; van Abeelen AFM, 2012, AM J CLIN NUTR, V95, P179, DOI 10.3945/ajcn.111.022038; Vilbergsson S, 1997, DIABETIC MED, V14, P491, DOI 10.1002/(SICI)1096-9136(199706)14:6<491::AID-DIA365>3.0.CO;2-1; Weyer C, 2000, OBES RES, V8, P559, DOI 10.1038/oby.2000.72; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44551	10.1371/journal.pone.0044551	http://dx.doi.org/10.1371/journal.pone.0044551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957081	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800074
J	Pirone, A; Cozzi, B; Edelstein, L; Peruffo, A; Lenzi, C; Quilici, F; Antonini, R; Castagna, M				Pirone, Andrea; Cozzi, Bruno; Edelstein, Larry; Peruffo, Antonella; Lenzi, Carla; Quilici, Francesca; Antonini, Rita; Castagna, Maura			Topography of Gng2-and NetrinG2-Expression Suggests an Insular Origin of the Human Claustrum	PLOS ONE			English	Article							EXPRESSION; MONKEY; CONNECTIONS; ANATOMY; COMPLEX; CORTEX; CAT	The claustrum has been described in the forebrain of all mammals studied so far. It has been suggested that the claustrum plays a role in the integration of multisensory information: however, its detailed structure and function remain enigmatic. The human claustrum is a thin, irregular, sheet of grey matter located between the inner surface of the insular cortex and the outer surface of the putamen. Recently, the G-protein gamma2 subunit (Gng2) was proposed as a specific claustrum marker in the rat, and used to better delineate its anatomical boundaries and connections. Additional claustral markers proposed in mammals include Netrin-G2 in the monkey and latexin in the cat. Here we report the expression and distribution of Gng2 and Netrin-G2 in human post-mortem samples of the claustrum and adjacent structures. Gng2 immunoreactivity was detected in the neuropil of the claustrum and of the insular cortex but not in the putamen. A faint labelling was present also in the external and extreme capsules. Double-labelling experiments indicate that Gng2 is also expressed in glial cells. Netrin-G2 labelling was seen in neuronal cell bodies throughout the claustrum and the insular cortex but not in the medially adjacent putamen. No latexin immunoreactive element was detected in the claustrum or adjacent structures. Our results confirm that both the Gng2 and the Netrin-G2 proteins show an affinity to the claustrum and related formations also in the human brain. The presence of Gng2 and Netrin-G2 immunoreactive elements in the insular cortex, but not in the putamen, suggests a possible common ontogeny of the claustrum and insula.	[Cozzi, Bruno; Peruffo, Antonella] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Pirone, Andrea; Lenzi, Carla] Univ Pisa, Dept Physiol Sci, Pisa, Italy; [Quilici, Francesca; Antonini, Rita; Castagna, Maura] Univ Pisa, Dept Surg, Pisa, Italy	University of Padua; University of Pisa; University of Pisa	Cozzi, B (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	bruno.cozzi@unipd.it	PIRONE, ANDREA/S-7228-2019; Edelstein, Lawrence/K-6774-2012; Cozzi, Bruno/H-9618-2019	Edelstein, Lawrence/0000-0003-1885-4285; Cozzi, Bruno/0000-0002-7531-7040; PIRONE, ANDREA/0000-0001-6363-392X; Peruffo, Antonella/0000-0003-0454-9087				AMARAL DG, 1980, J COMP NEUROL, V189, P573, DOI 10.1002/cne.901890402; AMARAL DG, 1992, EXP BRAIN RES, V88, P375, DOI 10.1007/BF02259113; ARIKUNI T, 1985, Neuroscience Research, V2, P239, DOI 10.1016/0168-0102(85)90003-3; Arimatsu Y, 2009, NEUROSCIENCE, V162, P1398, DOI 10.1016/j.neuroscience.2009.05.060; Ashwell KWS, 2004, BRAIN BEHAV EVOLUT, V64, P223, DOI 10.1159/000080243; BRAND S, 1981, ANAT EMBRYOL, V162, P475, DOI 10.1007/BF00301872; CAREY RG, 1985, BRAIN RES, V329, P185, DOI 10.1016/0006-8993(85)90524-4; CARMAN JB, 1964, J NEUROL NEUROSUR PS, V27, P46, DOI 10.1136/jnnp.27.1.46; Chang-Seon M, 2006, MOL PHARM, V69, P877; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; DINOPOULOS A, 1992, J COMP NEUROL, V316, P187, DOI 10.1002/cne.903160205; Edelstein LR, 2004, CELL MOL BIOL, V50, P675; Ferandez-Miranda JC, 2008, J NEUROSURG, V108, P764, DOI 10.3171/JNS/2008/108/4/0764; Filimonoff I N, 1966, J Hirnforsch, V8, P503; Kowianski P, 1999, BRAIN BEHAV EVOLUT, V53, P44, DOI 10.1159/000006581; LEVAY S, 1981, J NEUROSCI, V1, P956; Mathur BN, 2009, CEREB CORTEX, V19, P2372, DOI 10.1093/cercor/bhn253; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Miyashita T, 2005, NEUROSCIENCE, V136, P487, DOI 10.1016/j.neuroscience.2005.08.025; MORYS J, 1993, BRAIN RES, V616, P176, DOI 10.1016/0006-8993(93)90207-4; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; RAE A S, 1954, Confin Neurol, V14, P211; RAE ASL, 1954, J COMP NEUROL, V100, P15, DOI 10.1002/cne.901000103; Tanne-Gariepy J, 2002, J COMP NEUROL, V454, P140, DOI 10.1002/cne.10425; Wasilewska B, 2001, Folia Morphol (Warsz), V60, P41; Watakabe A, 2009, DEV GROWTH DIFFER, V51, P343, DOI 10.1111/j.1440-169X.2008.01085.x	27	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44745	10.1371/journal.pone.0044745	http://dx.doi.org/10.1371/journal.pone.0044745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957104	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800097
J	Su, HM; Lin, TH; Hsu, PC; Chu, CY; Lee, WH; Chen, SC; Lee, CS; Voon, WC; Lai, WT; Sheu, SH				Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Abnormally Low and High Ankle-Brachial Indices Are Independently Associated with Increased Left Ventricular Mass Index in Chronic Kidney Disease	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; VASCULAR-DISEASE; RISK-FACTORS; ALL-CAUSE; PREVALENCE; MORTALITY; HYPERTROPHY; ATHEROSCLEROSIS; RECOMMENDATIONS; CALCIFICATION	Abnormally low and high ankle-brachial indices (ABIs) are associated with high cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD), but the mechanisms responsible for the association are not fully known. This study is designed to assess whether there is a significant correlation between abnormal ABI and echocariographic parameters in patients with CKD stages 3-5. A total of 684 pre-dialysis CKD patients were included in the study. The ABI was measured using an ABI-form device. Patients were classified into ABI <0.9, >= 0.9 to <1.3, and >= 1.3. Clinical and echocariographic parameters were compared and analyzed. Compared with patients with ABI of >= 0.9 to <1.3, the values of left ventricular mass index (LVMI) were higher in patients with ABI <0.9 and ABI >= 1.3 (P <= 0.004). After the multivariate analysis, patients with ABI <0.9 (beta=0.099, P=0.004) and ABI >= 1.3 (beta=0.143, P<0.001) were independently associated with increased LVMI. Besides, increased LVMI (odds ratio, 1.017; 95% confidence interval, 1.002 to 1.033; P=0.031) was also significantly associated with ABI <0.9 or ABI >= 1.3. Our study in patients of CKD stages 3-5 demonstrated abnormally low and high ABIs were positively associated with LVMI. Future studies are required to determine whether increased LVMI is a causal intermediary between abnormal ABI and adverse cardiovascular outcomes in CKD.	[Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Div Cardiol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Div Nephrol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Su, Ho-Ming; Chen, Szu-Chia] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung Municipal Hsiao Kang Hosp, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Fac Mecicine, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Div Cardiol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	蘇, 河名/AAE-9843-2019	Lin, Tsung-Hsien/0000-0002-7226-8730; Su, Ho-Ming/0000-0003-0247-3250; Chu, Chun-Yuan/0000-0001-5550-102X				Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Chen JH, 2009, KAOHSIUNG J MED SCI, V25, P366, DOI 10.1016/S1607-551X(09)70529-7; Chen SC, 2012, HYPERTENS RES; Chen SC, 2012, NEPHROL DIAL TRANSPL, V27, P1064, DOI 10.1093/ndt/gfr407; Chen SC, 2012, AM J MED SCI, V343, P109, DOI 10.1097/MAJ.0b013e318223e814; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; de Albuquerque PF, 2012, ARQ BRAS CARDIOL, V98, P84, DOI 10.1590/S0066-782X2012000100013; de Vinuesa SG, 2005, KIDNEY INT, V67, pS44, DOI 10.1111/j.1523-1755.2005.09310.x; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Fu WC, 2006, NEPHROLOGY, V11, P9, DOI 10.1111/j.1440-1797.2006.00534.x; Guerrero A, 2006, NEPHROL DIAL TRANSPL, V21, P3525, DOI 10.1093/ndt/gfl470; Hasimu B, 2006, HYPERTENS RES, V29, P23, DOI 10.1291/hypres.29.23; Ix JH, 2010, J AM COLL CARDIOL, V55, P342, DOI 10.1016/j.jacc.2009.11.010; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; Nardi E, 2012, HYPERTENS RES; Niederhoffer N, 1997, HYPERTENSION, V29, P999, DOI 10.1161/01.HYP.29.4.999; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; O'Hare AM, 2006, CIRCULATION, V113, P388, DOI 10.1161/CIRCULATIONAHA.105.570903; O'Hare AM, 2004, CIRCULATION, V109, P320, DOI 10.1161/01.CIR.0000114519.75433.DD; O'Hare AM, 2002, J AM SOC NEPHROL, V13, P497, DOI 10.1681/ASN.V132497; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; ORCHARD TJ, 1993, DIABETES CARE, V16, P1199, DOI 10.2337/diacare.16.8.1199; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; ROMAN MJ, 1995, J AM COLL CARDIOL, V25, P83, DOI 10.1016/0735-1097(94)00316-I; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; WEBB AT, 1993, EUR J VASCULAR SURG, V7, P523, DOI 10.1016/S0950-821X(05)80364-0; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253	37	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44732	10.1371/journal.pone.0044732	http://dx.doi.org/10.1371/journal.pone.0044732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957102	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800095
J	Zhang, JL; Chen, GW; Liu, YC; Wang, PY; Wang, X; Wan, YL; Zhu, J; Gao, HQ; Yin, J; Wang, W; Tian, ML				Zhang, Jun-Ling; Chen, Guo-Wei; Liu, Yu-Cun; Wang, Peng-Yuan; Wang, Xin; Wan, Yuan-Lian; Zhu, Jing; Gao, Hong-Qiao; Yin, Jie; Wang, Wei; Tian, Mao-Lin			Secreted Protein Acidic and Rich in Cysteine (SPARC) Suppresses Angiogenesis by Down-Regulating the Expression of VEGF and MMP-7 in Gastric Cancer	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; GROWTH-FACTOR; PROGRESSION	Background: Secreted protein acidic and rich in cysteine (SPARC) is a glycoprotein that functions to inhibit angiogenesis, proliferation, and invasion in different types of cancer. The ability of SPARC to modulate neovascularisation is believed to be mediated in part by its ability to modulate the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). In this study, we aimed to determine the effect of SPARC expression in gastric cancer cells on proliferation and angiogenesis in vitro and in vivo. Method: We evaluated expression of SPARC in seven human gastric cancer cell lines. Then we established a stably transfected SPARC overexpressed cell line (BGC-SP) and a stably transfected SPARC knock-down cell line (HGC-sh). The effect of SPARC overexpression and SPARC silencing was studied by examining capillary formation of HUVECs in vitro and a dorsal skin-fold chamber model in vivo. Quantitative real-time PCR and western blotting were performed to detect if the expressions of VEGF and MMP-7 were modulated by SPARC expression. To further determine the effect of SPARC expression on angiogenesis in vivo, xenograft models were established and microvessel density (MVD) of different clones were detected by immunohistochemistry. Results: Endogenous SPARC overexpression inhibited the expression of VEGF and MMP-7, as well as the angiogenesis induced by BGC-SP cells. Correspondingly, SPARC silencing increased the expression of VEGF and MMP-7, as well as the angiogenesis induced by HGC-sh cells. Elevated angiogenesis induced by SPARC silencing in HGC-sh cells was decreased when VEGF was neutralised by antibodies, and MMP-7 was knocked down in vitro. Conclusion: SPARC suppresses angiogenesis of gastric cancer by down-regulating the expression of VEGF and MMP-7.	[Zhang, Jun-Ling; Chen, Guo-Wei; Liu, Yu-Cun; Wang, Peng-Yuan; Wang, Xin; Wan, Yuan-Lian; Zhu, Jing; Gao, Hong-Qiao; Yin, Jie; Wang, Wei; Tian, Mao-Lin] Peking Univ, Dept Gen Surg, Hosp 1, Beijing 100871, Peoples R China	Peking University	Zhang, JL (corresponding author), Peking Univ, Dept Gen Surg, Hosp 1, Beijing 100871, Peoples R China.	yucunliu@bjmu.edu.cn			National Natural Science Foundation of China [30901417/H1617]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 30901417/H1617). http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bhoopathi P, 2010, BRIT J CANCER, V102, P530, DOI 10.1038/sj.bjc.6605538; Chen G, 2010, BRIT J CANCER, V102, P188, DOI 10.1038/sj.bjc.6605440; Chlenski A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-138; Cody NAL, 2007, ONCOGENE, V26, P618, DOI 10.1038/sj.onc.1209821; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Franke K, 2009, TRANSL ONCOL, V2, P310, DOI 10.1593/tlo.09169; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Huo N, 2002, CANCER LETT, V177, P95, DOI 10.1016/S0304-3835(01)00772-8; Jia ZC, 2012, INT J COLORECTAL DIS, V27, P437, DOI 10.1007/s00384-011-1351-0; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Liang JF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-71; Nishizuka I, 2001, CANCER LETT, V173, P175, DOI 10.1016/S0304-3835(01)00634-6; Ordonez JL, 2005, MELANOMA RES, V15, P495, DOI 10.1097/00008390-200512000-00003; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Said N, 2007, MOL CANCER RES, V5, P1015, DOI 10.1158/1541-7786.MCR-07-0001; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Wang CS, 2004, BRIT J CANCER, V91, P1924, DOI 10.1038/sj.bjc.6602213; Wang LF, 2012, PATHOL ONCOL RES, V18, P697, DOI 10.1007/s12253-012-9497-9; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Yan M, 2004, PATHOBIOLOGY, V71, P253, DOI 10.1159/000080059; Yunker CK, 2008, INT J CANCER, V122, P2735, DOI 10.1002/ijc.23450	25	41	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44618	10.1371/journal.pone.0044618	http://dx.doi.org/10.1371/journal.pone.0044618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957090	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800083
J	Crolla, RMPH; van der Laan, L; Veen, EJ; Hendriks, Y; van Schendel, C; Kluytmans, J				Crolla, Rogier M. P. H.; van der Laan, Lijckle; Veen, Eelco J.; Hendriks, Yvonne; van Schendel, Caroline; Kluytmans, Jan			Reduction of Surgical Site Infections after Implementation of a Bundle of Care	PLOS ONE			English	Article							INTERVENTION	Background: Surgical Site Infections (SSI) are relatively frequent complications after colorectal surgery and are associated with substantial morbidity and mortality. Objective: Implementing a bundle of care and measuring the effects on the SSI rate. Design: Prospective quasi experimental cohort study. Methods: A prospective surveillance for SSI after colorectal surgery was performed in the Amphia Hospital, Breda, from January 1, 2008 until January 1, 2012. As part of a National patient safety initiative, a bundle of care consisting of 4 elements covering the surgical process was introduced in 2009. The elements of the bundle were perioperative antibiotic prophylaxis, hair removal before surgery, perioperative normothermia and discipline in the operating room. Bundle compliance was measured every 3 months in a random sample of surgical procedures. Results: Bundle compliance improved significantly from an average of 10% in 2009 to 60% in 2011. 1537 colorectal procedures were performed during the study period and 300 SSI (19.5%) occurred. SSI were associated with a prolonged length of stay (mean additional length of stay 18 days) and a significantly higher 6 months mortality (Adjusted OR: 2.71, 95% confidence interval 1.76-4.18). Logistic regression showed a significant decrease of the SSI rate that paralleled the introduction of the bundle. The adjusted Odds ratio of the SSI rate was 36% lower in 2011 compared to 2008. Conclusion: The implementation of the bundle was associated with improved compliance over time and a 36% reduction of the SSI rate after adjustment for confounders. This makes the bundle an important tool to improve patient safety.	[Crolla, Rogier M. P. H.; van der Laan, Lijckle; Veen, Eelco J.] Amphia Hosp, Dept Surg, Breda, Netherlands; [Hendriks, Yvonne; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, Amsterdam, Netherlands	Amphia Hospital; Amphia Hospital; Vrije Universiteit Amsterdam	Crolla, RMPH (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	jankluytmans@gmail.com	Crolla, Rogier/L-9847-2019	Crolla, Rogier/0000-0003-2617-1791; van der laan, lijckle/0000-0001-5631-594X				Anthony T, 2011, ARCH SURG-CHICAGO, V146, P263, DOI 10.1001/archsurg.2010.249; Berenholtz SM, 2011, INFECT CONT HOSP EP, V32, P305, DOI 10.1086/658938; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Bull A, 2011, J HOSP INFECT, V78, P297, DOI 10.1016/j.jhin.2011.03.029; de Bruijne M., 2007, ONBEDOELDE SCHADE NE; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Frederik J, 2011, NED TIJDSCHR GENEES, V155, pA3269; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Kurmann A, 2011, BRIT J SURG, V98, P1021, DOI 10.1002/bjs.7496; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115	11	80	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44599	10.1371/journal.pone.0044599	http://dx.doi.org/10.1371/journal.pone.0044599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962619	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600072
J	Briffaud, V; Fourcaud-Trocme, N; Messaoudi, B; Buonviso, N; Amat, C				Briffaud, Virginie; Fourcaud-Trocme, Nicolas; Messaoudi, Belkacem; Buonviso, Nathalie; Amat, Corine			The Relationship between Respiration-Related Membrane Potential Slow Oscillations and Discharge Patterns in Mitral/Tufted Cells: What Are the Rules?	PLOS ONE			English	Article							RAT OLFACTORY-BULB; LONG-LASTING DEPOLARIZATIONS; FREELY BREATHING RATS; MITRAL CELLS; UNIT-ACTIVITY; ODOR STIMULATION; CODING SCHEME; IN-VIVO; RESPONSES; CORTEX	Background: A slow respiration-related rhythm strongly shapes the activity of the olfactory bulb. This rhythm appears as a slow oscillation that is detectable in the membrane potential, the respiration-related spike discharge of the mitral/tufted cells and the bulbar local field potential. Here, we investigated the rules that govern the manifestation of membrane potential slow oscillations (MPSOs) and respiration-related discharge activities under various afferent input conditions and cellular excitability states. Methodology and Principal Findings: We recorded the intracellular membrane potential signals in the mitral/tufted cells of freely breathing anesthetized rats. We first demonstrated the existence of multiple types of MPSOs, which were influenced by odor stimulation and discharge activity patterns. Complementary studies using changes in the intracellular excitability state and a computational model of the mitral cell demonstrated that slow oscillations in the mitral/tufted cell membrane potential were also modulated by the intracellular excitability state, whereas the respiration-related spike activity primarily reflected the afferent input. Based on our data regarding MPSOs and spike patterns, we found that cells exhibiting an unsynchronized discharge pattern never exhibited an MPSO. In contrast, cells with a respiration-synchronized discharge pattern always exhibited an MPSO. In addition, we demonstrated that the association between spike patterns and MPSO types appeared complex. Conclusion: We propose that both the intracellular excitability state and input strength underlie specific MPSOs, which, in turn, constrain the types of spike patterns exhibited.	[Briffaud, Virginie; Fourcaud-Trocme, Nicolas; Messaoudi, Belkacem; Buonviso, Nathalie; Amat, Corine] Univ Lyon 1, Lyon Neurosci Res Ctr CRNL, Team Olfact Coding Memory, CNRS,INSERM,UMR 5292,U1028, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Briffaud, V (corresponding author), Univ Lyon 1, Lyon Neurosci Res Ctr CRNL, Team Olfact Coding Memory, CNRS,INSERM,UMR 5292,U1028, F-69365 Lyon, France.	vbriffaud@olfac.univ-lyon1.fr; corine.amat@olfac.univ-lyon1.fr	Fourcaud-Trocmé, Nicolas/N-9109-2017; Buonviso, Nathalie/G-8467-2017; amat, corine/O-1089-2017	Fourcaud-Trocmé, Nicolas/0000-0002-2211-7547; Buonviso, Nathalie/0000-0002-0018-1695; Briffaud, Virginie/0000-0002-9373-9159	"Agence Nationale de la Recherche" [ANR-07-NEURO-030]	"Agence Nationale de la Recherche"(French National Research Agency (ANR))	This work was supported by a grant from the "Agence Nationale de la Recherche" (#ANR-07-NEURO-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Aylwin MDL, 2005, BIOL RES, V38, P13, DOI 10.4067/S0716-97602005000100003; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Balu R, 2007, J NEUROPHYSIOL, V97, P1959, DOI 10.1152/jn.01115.2006; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Cang JH, 2003, J NEUROSCI, V23, P4108; Carey RM, 2011, J NEUROSCI, V31, P10615, DOI 10.1523/JNEUROSCI.1805-11.2011; Carlson GC, 2000, J NEUROSCI, V20, P2011; CHAPUT MA, 1992, EUR J NEUROSCI, V4, P813, DOI 10.1111/j.1460-9568.1992.tb00191.x; Chaput MA, 2000, CHEM SENSES, V25, P695, DOI 10.1093/chemse/25.6.695; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Courtiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016445; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Debarbieux F, 2003, J NEUROSCI, V23, P5553; Egger V, 2008, EUR J NEUROSCI, V27, P2066, DOI 10.1111/j.1460-9568.2008.06170.x; Ennis M., 2007, HDB NEUROCHEMISTRY M, P137, DOI [DOI 10.1007/978-0-387-30374-1_6, 10.1007/978-0-387-30374-1_6]; Fontanini A, 2003, J NEUROSCI, V23, P7993; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Garcia Samuel, 2009, Front Neuroinform, V3, P14, DOI 10.3389/neuro.11.014.2009; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Johnston J, 2010, J NEUROPHYSIOL, V103, P2557, DOI 10.1152/jn.00796.2009; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Lehmkuhle MJ, 2006, J NEUROPHYSIOL, V95, P1369, DOI 10.1152/jn.01334.2004; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Litalidon P, 2008, NEUROSCIENCE, V156, P781, DOI 10.1016/j.neuroscience.2008.07.077; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Migliore M, 2008, J COMPUT NEUROSCI, V24, P207, DOI 10.1007/s10827-007-0051-9; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Phillips ME, 2012, J NEUROSCI, V32, P85, DOI 10.1523/JNEUROSCI.4278-11.2012; RAVEL N, 1987, EXP BRAIN RES, V65, P623; RAVEL N, 1990, NEUROSCI LETT, V115, P213, DOI 10.1016/0304-3940(90)90457-K; Roux SG, 2006, J NEUROSCI METH, V152, P173, DOI 10.1016/j.jneumeth.2005.09.004; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Tristan C, 2009, EUR J NEUROSCI, V29, P921, DOI 10.1111/j.1460-9568.2009.06651.x; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yuan Q, 2006, J NEUROPHYSIOL, V95, P3097, DOI 10.1152/jn.00001.2006	48	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43964	10.1371/journal.pone.0043964	http://dx.doi.org/10.1371/journal.pone.0043964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952828	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300038
J	Zhou, XY; Liu, ZQ; Jang, F; Xiang, CN; Li, Y; He, YZ				Zhou, Xiangyu; Liu, Zhiqiang; Jang, Feng; Xiang, Chuannan; Li, Yuan; He, Yanzheng			Autocrine Sonic Hedgehog Attenuates Inflammation in Cerulein-Induced Acute Pancreatitis in Mice via Upregulation of IL-10	PLOS ONE			English	Article							DISEASED PANCREAS; DOWN-REGULATION; INTERLEUKIN-10; ACTIVATION; CANCER; CELLS; PATHWAY; INJURY; TISSUE	Hedgehog signaling plays critical roles in pancreatic oncogenesis and chronic pancreatitis, but its roles in acute pancreatitis (AP) are largely ambiguous. In this study, we provide evidence that Sonic hedgehog (Shh), but neither Desert hedgehog (Dhh) nor Indian hedgehog (Ihh), is the main protein whose expression is activated during the development of ceruleininduced acute pancreatitis in mice, and the Shh serves as an anti-inflammation factor in an autocrine manner. Blocking autocrine Shh signaling with anti-Shh neutralizing antibody aggravates the progression of acute pancreatitis. Mechanistic insight into Shh signaling activation in acute pancreatitis indicates that inflammatory stimulation activates Shh expression and secretion, and subsequently upregulates the expression and secretion of interleukin-10 (IL-10). Moreover, inhibition of Shh signaling with neutralizing antibody abolishes IL-10 production in vivo and in vitro. Molecular biological studies show that autocrine Shh signaling activates the key transcriptional factor Gli1 so that the target gene IL-10 is upregulated, leading to the protective and anti-inflammatory functions in the mouse model of acute pancreatitis. Thus, this study suggests autocrine Shh signaling functions as a protective signaling in the progression of acute pancreatitis.	[Zhou, Xiangyu; He, Yanzheng] Luzhou Med Coll, Affiliated Hosp, Dept Vasc Surg, Luzhou, Sichuan, Peoples R China; [Liu, Zhiqiang] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Div Canc Med, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Jang, Feng] Luzhou Med Coll, Affiliated Hosp, Dept Cardiol, Luzhou, Sichuan, Peoples R China; [Xiang, Chuannan] Luzhou Peoples Hosp, Dept Gen Surg, Luzhou, Sichuan, Peoples R China; [Li, Yuan] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Inst Digest Surg, Chengdu, Peoples R China	Southwest Medical University; University of Texas System; UTMD Anderson Cancer Center; Southwest Medical University; Sichuan University	He, YZ (corresponding author), Luzhou Med Coll, Affiliated Hosp, Dept Vasc Surg, Luzhou, Sichuan, Peoples R China.	heyanzheng2012@gmail.com	Liu, Zhiqiang/E-6950-2014	Liu, Zhiqiang/0000-0002-0677-8097	National Natural Science Foundation of China [81100272]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by grants from the National Natural Science Foundation of China (81100272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Blinman TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1993, DOI 10.1152/ajpcell.2000.279.6.C1993; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Franco-Pons N, 2010, J PATHOL, V221, P175, DOI 10.1002/path.2691; Guy CD, 2011, HEPTAOLOGY; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Heiser PW, 2004, CELL CYCLE, V3, P270; Heretsch P, 2010, BIOORGAN MED CHEM, V18, P6613, DOI 10.1016/j.bmc.2010.07.038; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kawahira H, 2005, DEV BIOL, V280, P111, DOI 10.1016/j.ydbio.2005.01.008; Kawahira H, 2003, DEVELOPMENT, V130, P4871, DOI 10.1242/dev.00653; Kayed H, 2005, MOL CARCINOGEN, V42, P183, DOI 10.1002/mc.20088; Kayed H, 2003, J ENDOCRINOL, V178, P467, DOI 10.1677/joe.0.1780467; Kayed H, 2006, PANCREAS, V32, P119, DOI 10.1097/01.mpa.0000202937.55460.0c; Keceli M, 2005, J INVEST SURG, V18, P7, DOI 10.1080/08941930590905080; Kylanpaa ML, 2010, WORLD J GASTROENTERO, V16, P2867, DOI 10.3748/wjg.v16.i23.2867; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Omenetti A, 2008, AM J PHYSIOL-GASTR L, V294, pG595, DOI 10.1152/ajpgi.00543.2007; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Shifrin AL, 2005, PANCREAS, V30, P122, DOI 10.1097/01.mpa.0000151578.99413.88; Stewart GA, 2002, J IMMUNOL, V169, P5451, DOI 10.4049/jimmunol.169.10.5451; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Van Dop WA, 2010, GASTROENTEROLOGY, V138, P426, DOI 10.1053/j.gastro.2009.12.013; Van Laethem JL, 1998, GUT, V43, P408, DOI 10.1136/gut.43.3.408; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wan MH, 2012, HPB, V14, P73, DOI 10.1111/j.1477-2574.2011.00408.x; Warzecha Z, 2003, J PHYSIOL PHARMACOL, V54, P575; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zhou XY, 2009, TOHOKU J EXP MED, V217, P279, DOI 10.1620/tjem.217.279	36	31	33	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44121	10.1371/journal.pone.0044121	http://dx.doi.org/10.1371/journal.pone.0044121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956998	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500047
J	Cornelissen, LAHM; de Leeuw, OS; Tacken, MG; Klos, HC; de Vries, RP; de Boer-Luijtze, EA; van Zoelen-Bos, DJ; Rigter, A; Rottier, PJM; Moormann, RJM; de Haan, CAM				Cornelissen, Lisette A. H. M.; de Leeuw, Olav S.; Tacken, Mirriam G.; Klos, Heleen C.; de Vries, Robert P.; de Boer-Luijtze, Els A.; van Zoelen-Bos, Diana J.; Rigter, Alan; Rottier, Peter J. M.; Moormann, Rob J. M.; de Haan, Cornelis A. M.			Protective Efficacy of Newcastle Disease Virus Expressing Soluble Trimeric Hemagglutinin against Highly Pathogenic H5N1 Influenza in Chickens and Mice	PLOS ONE			English	Article							AVIAN INFLUENZA; FUSION PROTEIN; NEUTRALIZING ANTIBODIES; RESPIRATORY-TRACT; LETHAL CHALLENGE; VACCINE VECTORS; FOWLPOX VIRUS; RECOMBINANT; IMMUNIZATION; VIRULENCE	Background: Highly pathogenic avian influenza virus (HPAIV) causes a highly contagious often fatal disease in poultry, resulting in significant economic losses in the poultry industry. HPAIV H5N1 also poses a major public health threat as it can be transmitted directly from infected poultry to humans. One effective way to combat avian influenza with pandemic potential is through the vaccination of poultry. Several live vaccines based on attenuated Newcastle disease virus (NDV) that express influenza hemagglutinin (HA) have been developed to protect chickens or mammalian species against HPAIV. However, the zoonotic potential of NDV raises safety concerns regarding the use of live NDV recombinants, as the incorporation of a heterologous attachment protein may result in the generation of NDV with altered tropism and/or pathogenicity. Methodology/Principal Findings: In the present study we generated recombinant NDVs expressing either full length, membrane-anchored HA of the H5 subtype (NDV-H5) or a soluble trimeric form thereof (NDV-sH5 3). A single intramuscular immunization with NDV-sH5 3 or NDV-H5 fully protected chickens against disease after a lethal challenge with H5N1 and reduced levels of virus shedding in tracheal and cloacal swabs. NDV-sH5 3 was less protective than NDV-H5 (50% vs 80% protection) when administered via the respiratory tract. The NDV-sH5 3 was ineffective in mice, regardless of whether administered oculonasally or intramuscularly. In this species, NDV-H5 induced protective immunity against HPAIV H5N1, but only after oculonasal administration, despite the poor H5-specific serum antibody response it elicited. Conclusions/Significance: Although NDV expressing membrane anchored H5 in general provided better protection than its counterpart expressing soluble H5, chickens could be fully protected against a lethal challenge with H5N1 by using the latter NDV vector. This study thus provides proof of concept for the use of recombinant vector vaccines expressing a soluble form of a heterologous viral membrane protein. Such vectors may be advantageous as they preclude the incorporation of heterologous membrane proteins into the viral vector particles.	[Cornelissen, Lisette A. H. M.; de Leeuw, Olav S.; Tacken, Mirriam G.; Klos, Heleen C.; de Boer-Luijtze, Els A.; van Zoelen-Bos, Diana J.; Moormann, Rob J. M.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [de Vries, Robert P.; Rigter, Alan; Rottier, Peter J. M.; Moormann, Rob J. M.; de Haan, Cornelis A. M.] Univ Utrecht, Fac Vet Med, Div Virol, Dept Infect Dis & Immunol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Cornelissen, LAHM (corresponding author), Wageningen UR, Cent Vet Inst, Lelystad, Netherlands.	lisette.cornelissen@wur.nl	de Vries, Robert/K-7212-2013	de Haan, Cornelis/0000-0002-4459-9874; de Vries, Robert/0000-0002-1586-4464	Economic Structure Enhancing Fund: "Impulse Veterinary Avian Influenza Research in the Netherlands"	Economic Structure Enhancing Fund: "Impulse Veterinary Avian Influenza Research in the Netherlands"	This work has been financially supported by the Economic Structure Enhancing Fund: "Impulse Veterinary Avian Influenza Research in the Netherlands". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2003, J DIS POULTRY, V11th, P63, DOI DOI 10.1007/S11262-007-0078-Z; ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Britton P, 1996, J GEN VIROL, V77, P963, DOI 10.1099/0022-1317-77-5-963; Bukreyev A, 2006, J VIROL, V80, P10293, DOI 10.1128/JVI.00919-06; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Capua I, 2004, EUR J CLIN MICROBIOL, V23, P1, DOI 10.1007/s10096-003-1059-3; CEC, 1992, OFFICIAL J EUROPEA L, VL260, P1; Collins PL, 2008, J VIROL, V82, P9805, DOI 10.1128/JVI.01336-08; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; DiNapoli JM, 2007, J VIROL, V81, P11560, DOI 10.1128/JVI.00713-07; DiNapoli JM, 2010, J VIROL, V84, P1489, DOI 10.1128/JVI.01946-09; Dortmans JCFM, 2009, J GEN VIROL, V90, P2746, DOI 10.1099/vir.0.014118-0; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hierholzer J. C., 1996, P25, DOI 10.1016/B978-012465330-6/50003-8; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; LEENAARS PPAM, 1994, VET IMMUNOL IMMUNOP, V40, P225, DOI 10.1016/0165-2427(94)90022-1; Loeffen WLA, 2011, VACCINE, V29, P1545, DOI 10.1016/j.vaccine.2010.12.096; Luschow D, 2001, VACCINE, V19, P4249, DOI 10.1016/S0264-410X(01)00167-0; Martinez-Sobrido L, 2006, J VIROL, V80, P1130, DOI 10.1128/JVI.80.3.1130-1139.2006; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; Nayak B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006509; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; Peeters BPH, 2000, ARCH VIROL, V145, P1829, DOI 10.1007/s007050070059; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Pillai SPS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-5; Swayne DE, 2003, AVIAN DIS, V47, P1047, DOI 10.1637/0005-2086-47.s3.1047; TAYLOR J, 1988, VACCINE, V6, P504, DOI 10.1016/0264-410X(88)90101-6; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; van Oirschot JT, 2001, VET QUART, V23, P100, DOI 10.1080/01652176.2001.9695094; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; WENSVOORT G, 1986, VET MICROBIOL, V12, P101, DOI 10.1016/0378-1135(86)90072-6; Wu QF, 2009, MOL IMMUNOL, V46, P2210, DOI 10.1016/j.molimm.2009.04.017; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang LJ, 2008, VIROLOGY, V377, P255, DOI 10.1016/j.virol.2008.04.029; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165	45	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44447	10.1371/journal.pone.0044447	http://dx.doi.org/10.1371/journal.pone.0044447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952980	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600104
J	Hulgan, T; Robbins, GK; Kalams, SA; Samuels, DC; Grady, B; Shafer, R; Murdock, DG; Selph, D; Haas, DW; Pollard, RB				Hulgan, Todd; Robbins, Gregory K.; Kalams, Spyros A.; Samuels, David C.; Grady, Benjamin; Shafer, Robert; Murdock, Deborah G.; Selph, Doug; Haas, David W.; Pollard, Richard B.		AIDS Clinical Trials Grp	T Cell Activation Markers and African Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials Group Study 384	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; SEQUENTIAL 3-DRUG REGIMENS; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; COUNT RECOVERY; PERIPHERAL NEUROPATHY; VIROLOGICAL RESPONSE; INITIAL THERAPY; APOPTOSIS	Introduction: Mitochondrial function influences T cell dynamics and is affected by mitochondrial DNA (mtDNA) variation. We previously reported an association between African mtDNA haplogroup L2 and less robust CD4 cell recovery on antiretroviral therapy (ART) in non-Hispanic black ACTG 384 subjects. We explored whether additional T cell parameters in this cohort differed by mtDNA haplogroup. Methods: ACTG 384 randomized ART-naive subjects to two different nucleoside regimens with efavirenz, nelfinavir, or both. CD4 and CD8 memory and activation markers were available at baseline and week 48 on most subjects. mtDNA sequencing was performed on whole blood DNA, and haplogroups were determined. We studied non-Hispanic black subjects with HIV RNA <400 copies/mL at week 48. Analyses included Wilcoxon ranksum test and linear regression. Results: Data from 104 subjects were included. Major African mtDNA haplogroups included L1 (N = 25), L2 (N = 31), and L3 (N = 32). Baseline age, HIV RNA, and CD4 cells did not differ between L2 and non-L2 haplogroups. Compared to non-L2 haplogroups, L2 subjects had lower baseline activated CD4 cells (median 12% vs. 17%; p = 0.03) and tended toward lower activated CD8 cells (41% vs. 47%; p = 0.06). At 48 weeks of ART, L2 subjects had smaller decreases in activated CD4 cells (-4% vs. -11%; p = 0.01), and smaller CD4 cell increases (+95 vs. +178; p = 0.002). In models adjusting for baseline age, CD4 cells, HIV RNA, and naive-to-memory CD4 cell ratio, haplogroup L2 was associated with lower baseline (p = 0.04) and 48-week change in (p = 0.01) activated CD4 cells. Conclusions: Among ART-naive non-Hispanic blacks, mtDNA haplogroup L2 was associated with baseline and 48-week change in T cell activation, and poorer CD4 cell recovery. These data suggest mtDNA variation may influence CD4 T cell dynamics by modulating T cell activation. Further study is needed to replicate these associations and identify mechanisms.	[Hulgan, Todd; Kalams, Spyros A.; Samuels, David C.; Grady, Benjamin; Murdock, Deborah G.; Selph, Doug; Haas, David W.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Robbins, Gregory K.] Harvard Univ, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shafer, Robert] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Pollard, Richard B.] Univ Calif Davis, Sacramento, CA 95817 USA	Vanderbilt University; Harvard University; Massachusetts General Hospital; Stanford University; University of California System; University of California Davis	Hulgan, T (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	todd.hulgan@vanderbilt.edu	Samuels, David/C-1365-2012; Hulgan, Todd/B-3947-2014; Murdock, Deborah/C-3483-2012; Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022; Hulgan, Todd/AAG-7491-2019	Hulgan, Todd/0000-0002-3339-067X; Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Robbins, Gregory/0000-0001-7545-5817	National Institutes of Health (NIH)/National Institute of Neurological Diseases and Stroke [NS059330]; National Institute of Allergy and Infectious Diseases [U01AI068636]; National Institute of Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); Agouron/Pfizer; Bristol Myers Squibb; GlaxoSmithKline; NIH [AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, AI32782, AI27661, AI25859, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR000445]; Merck; Gilead Sciences; Schering-Plough; Boehringer-Ingelheim; National Institutes of Health [AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI069502, AI069419, AI077505, AI54999, HL087726, AI69495, 5T32GM80178, AI062435];  [AI38858]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069472, UM1AI069452, U01AI069513, UM1AI069424, UM1AI069501, UM1AI069511, P30AI054999, U01AI038858, UM1AI069471, U01AI069502, UM1AI069434, UM1AI069472, U01AI046370, UM1AI069428, U01AI069452, U01AI069477, UM1AI069513, U01AI069484, U01AI069424, UM1AI069450, UM1AI069532, U01AI069474, UM1AI069467, U01AI027661, U01AI038844, U01AI068636, U01AI069471, UM1AI069415, UM1AI069556, U01AI069501, U01AI069423, U01AI069532, U01AI034853, U01AI025859, U01AI069511, UM1AI069484, U01AI069428, U01AI069432, UM1AI069502, U01AI069495, UM1AI069465, UM1AI069432, UM1AI069495, U01AI069434, UM1AI069419, U01AI069465, U01AI069450, U01AI069415, K01AI062435, U01AI034835, U01AI069467, U01AI069556, UM1AI069474, U01AI069419, UM1AI069423, R01AI077505, UM1AI069477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059330] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Neurological Diseases and Stroke; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Agouron/Pfizer(Pfizer); Bristol Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Merck(Merck & Company); Gilead Sciences(Gilead Sciences); Schering-Plough(Merck & CompanySchering Plough Corporation); Boehringer-Ingelheim(Boehringer Ingelheim); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for the genomic sequencing was provided by the National Institutes of Health (NIH)/National Institute of Neurological Diseases and Stroke grant NS059330. The project described was also supported by Award Number U01AI068636 from the National Institute of Allergy and Infectious Diseases and supported by National Institute of Mental Health (NIMH), and National Institute of Dental and Craniofacial Research (NIDCR). AIDS Clinical Trials Group (ACTG) Study 384 was also supported by grant AI38858, and by Agouron/Pfizer, Bristol Myers Squibb, and GlaxoSmithKline. The ACTG sites contributing DNA for these analyses were funded by NIH grants AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, AI32782, AI27661, AI25859, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI069502, and AI069419. The ACTG Human DNA Repository is also supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1 TR000445. Additional NIH grant support included: AI077505, AI54999, HL087726, AI69495, 5T32GM80178 and AI062435. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: TH has received research support from Merck. GKR has received research support from Gilead Sciences, Schering-Plough. DWH has received research grants from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, and Merck, and has served as a consultant for Boehringer-Ingelheim. AIDS Clinical Trials Group (ACTG) Study 384 was also supported in part by Agouron/Pfizer, Bristol Myers Squibb, and GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Badley AD, 2003, TRENDS PHARMACOL SCI, V24, P298, DOI 10.1016/S0165-6147(03)00125-1; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Casula M, 2007, J INFECT DIS, V196, P371, DOI 10.1086/519284; Chavan SJ, 1999, CLIN IMMUNOL, V93, P24, DOI 10.1006/clim.1999.4770; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Garg H, 2006, J LEUKOCYTE BIOL, V79, P351, DOI 10.1189/jlb.0805430; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Goicoechea M, 2006, J INFECT DIS, V194, P29, DOI 10.1086/504718; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Grady BJ, 2011, JAIDS-J ACQ IMM DEF, V58, P363, DOI 10.1097/QAI.0b013e31822c688b; Grimaldi Marina, 2005, Curr Opin Investig Drugs, V6, P1095; GROUX H, 1992, J EXP MED, V175, P331, DOI 10.1084/jem.175.2.331; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Haas DW, 2003, HIV CLIN TRIALS, V4, P287, DOI 10.1310/MUQC-QXBC-8118-BPM5; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Johnson N, 1998, CLIN EXP IMMUNOL, V113, P229; Kallianpur AR, 2006, AIDS, V20, P1503, DOI 10.1097/01.aids.0000237366.56864.3c; Karamchand L, 2008, JAIDS-J ACQ IMM DEF, V48, P381, DOI 10.1097/QAI.0b013e3181799662; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krishnan S, 2011, ONCOLOGY-BASEL, V80, P42, DOI 10.1159/000328032; Maagaard A, 2006, HIV MED, V7, P53, DOI 10.1111/j.1468-1293.2005.00336.x; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Mancuso Michelangelo, 2008, Human Genomics, V3, P71; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93; Motsinger AA, 2006, PHARMACOGENET GENOM, V16, P837, DOI 10.1097/01.fpc.0000230413.97596.fa; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Nasi M, 2005, IMMUNOGENETICS, V57, P628, DOI 10.1007/s00251-005-0031-z; Nasi M, 2008, CLIN INFECT DIS, V47, P962, DOI 10.1086/591706; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Nishigaki Y, 2010, GERIATR GERONTOL INT, V10, pS221, DOI 10.1111/j.1447-0594.2010.00599.x; Peraire J, 2007, CURR HIV RES, V5, P467, DOI 10.2174/157016207781662452; Petit F, 2003, BIOCHIMIE, V85, P795, DOI 10.1016/j.biochi.2003.09.007; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Rauch A, 2008, CLIN INFECT DIS, V46, P1921, DOI 10.1086/588479; Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013; Rigato PO, 2008, CURR HIV RES, V6, P466, DOI 10.2174/157016208785861131; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; Soria A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027349; Sternfeld T, 2009, HIV MED, V10, P512, DOI 10.1111/j.1468-1293.2009.00723.x; Sternfeld T, 2007, ANTIVIR THER, V12, P769; Varbanov M, 2006, AIDS REV, V8, P221; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798	61	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43803	10.1371/journal.pone.0043803	http://dx.doi.org/10.1371/journal.pone.0043803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22970105	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800061
J	Stoeckle, MY; Kerr, KCR				Stoeckle, Mark Y.; Kerr, Kevin C. R.			Frequency Matrix Approach Demonstrates High Sequence Quality in Avian BARCODEs and Highlights Cryptic Pseudogenes	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA; IDENTIFICATION; GENES; BIRDS; POLYMORPHISM; VARIABILITY; MUTATIONS; ORIGIN; TALE	The accuracy of DNA barcode databases is critical for research and practical applications. Here we apply a frequency matrix to assess sequencing errors in a very large set of avian BARCODEs. Using 11,000 sequences from 2,700 bird species, we show most avian cytochrome c oxidase I (COI) nucleotide and amino acid sequences vary within a narrow range. Except for third codon positions, nearly all (96%) sites were highly conserved or limited to two nucleotides or two amino acids. A large number of positions had very low frequency variants present in single individuals of a species; these were strongly concentrated at the ends of the barcode segment, consistent with sequencing error. In addition, a small fraction (0.1%) of BARCODEs had multiple very low frequency variants shared among individuals of a species; these were found to represent overlooked cryptic pseudogenes lacking stop codons. The calculated upper limit of sequencing error was 8x10(-5) errors/nucleotide, which was relatively high for direct Sanger sequencing of amplified DNA, but unlikely to compromise species identification. Our results confirm the high quality of the avian BARCODE database and demonstrate significant quality improvement in avian COI records deposited in GenBank over the past decade. This approach has potential application for genetic database quality control, discovery of cryptic pseudogenes, and studies of low-level genetic variation.	[Stoeckle, Mark Y.] Rockefeller Univ, Program Human Environm, New York, NY 10021 USA; [Kerr, Kevin C. R.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	Rockefeller University; Royal Ontario Museum	Stoeckle, MY (corresponding author), Rockefeller Univ, Program Human Environm, 1230 York Ave, New York, NY 10021 USA.	mark.stoeckle@rockefeller.edu	Kerr, Kevin/B-8510-2013; Stoeckle, Mark/D-3729-2011	Kerr, Kevin/0000-0002-6784-3884; Stoeckle, Mark/0000-0002-8280-4795	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	KCRK was supported by a post-doctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2001, BBA-PROTEIN STRUCT M, V1544, P1, DOI 10.1016/S0167-4838(00)00241-7; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; Baker AJ, 2009, MOL ECOL RESOUR, V9, P257, DOI 10.1111/j.1755-0998.2009.02650.x; Barraclough TG, 2010, PHILOS T R SOC B, V365, P1801, DOI 10.1098/rstb.2009.0276; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Campagna L, 2011, MOL PHYLOGENET EVOL, V61, P521, DOI 10.1016/j.ympev.2011.07.011; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; CHA RS, 1993, PCR METH APPL, V3, pS18; Coin L, 2004, BIOINFORMATICS, V20, P94, DOI 10.1093/bioinformatics/bth942; Consortium for the Barcode of Life Database Working Group, 2009, DAT STAND BARCODE RE; Cummings SM, 2010, CONSERV GENET, V11, P1095, DOI 10.1007/s10592-009-9864-6; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Dawson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015204; Dubey S, 2009, MOL PHYLOGENET EVOL, V50, P633, DOI 10.1016/j.ympev.2008.12.008; Dunshea G, 2008, B ENTOMOL RES, V98, P239, DOI 10.1017/S0007485308005993; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frey JE, 2004, HEREDITAS, V140, P92, DOI 10.1111/j.1601-5223.2004.01748.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Fry AJ, 1999, EVOLUTION, V53, P1617, DOI 10.1111/j.1558-5646.1999.tb05426.x; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; Hayden EC, 2012, NATURE NEWS; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2011, MOL ECOL RESOUR, V11, P1045, DOI 10.1111/j.1755-0998.2011.03049.x; Kerr KCR, 2010, GENOME, V53, P1103, DOI 10.1139/G10-085; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Kobayashi N, 1999, BIOCHEM GENET, V37, P317, DOI 10.1023/A:1018759210666; Kraytsberg Y, 2005, EXPER REV MOL DIAGNO, V5, P1; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwon YS, 2012, MITOCHONDRIAL D 0313; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Menashe I, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-393; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mirol PM, 2000, HEREDITY, V84, P538, DOI 10.1046/j.1365-2540.2000.00689.x; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Proutski V, 1998, BIOINFORMATICS, V14, P467, DOI 10.1093/bioinformatics/14.5.467; Ramos A, 2011, MITOCHONDRION, V11, P946, DOI 10.1016/j.mito.2011.08.009; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Schindel DE, 2011, ZOOKEYS, P87, DOI 10.3897/zookeys.152.2473; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Tavares ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028543; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vilaca Sibelle T., 2006, Revista Brasileira de Ornitologia, V14, P7; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Yoo HS, 2006, MOL CELLS, V22, P323; Yoshikawa S, 2003, FEBS LETT, V555, P8, DOI 10.1016/S0014-5793(03)01098-6	58	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43992	10.1371/journal.pone.0043992	http://dx.doi.org/10.1371/journal.pone.0043992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952842	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800085
J	Chadha, VK; Kumar, P; Anjinappa, S; Singh, S; Narasimhaiah, S; Joshi, MV; Gupta, J; Lakshminarayana; Ramchandra, J; Velu, M; Papkianathan, S; Babu, S; Krishna, H				Chadha, Vineet K.; Kumar, Prahlad; Anjinappa, SharadaM.; Singh, Sanjay; Narasimhaiah, Somashekar; Joshi, Malathi V.; Gupta, Joydev; Lakshminarayana; Ramchandra, Jitendra; Velu, Magesh; Papkianathan, Suganthi; Babu, Suseendra; Krishna, Hemalatha			Prevalence of Pulmonary Tuberculosis among Adults in a Rural Sub-District of South India	PLOS ONE			English	Article							DECLINE; DOTS	Background: We conducted a survey to estimate point prevalence of bacteriologically positive pulmonary TB (PTB) in a rural area in South India, implementing TB program DOTS strategy since 2002. Methods: Survey was conducted among persons >= 15 years of age in fifteen clusters selected by simple random sampling; each consisting of 5-12 villages. Persons having symptoms suggestive of PTB or history of anti-TB treatment (ATT) were eligible for sputum examination by smear microscopy for Acid Fast Bacilli and culture for Mycobacterium tuberculosis; two sputum samples were collected from each eligible person. Persons with one or both sputum specimen positive on microscopy and/or culture were labeled suffering from PTB. Prevalence was estimated after imputing missing values to correct for bias introduced by incompleteness of data. In six clusters, registered persons were also screened by X-ray chest. Persons with any abnormal shadow on X-ray were eligible for sputum examination in addition to those with symptoms and ATT. Multiplication factor calculated as ratio of prevalence while using both screening tools to prevalence using symptoms screening alone was applied to entire study population to estimate prevalence corrected for non-screening by X-ray. Results: Of 71,874 residents >= 15 years of age, 63,362 (88.2%) were screened for symptoms and ATT. Of them, 5120 (8.1%) 4681 (7.4%) with symptoms and an additional 439 (0.7%) with ATT were eligible for sputum examination. Spot specimen were collected from 4850 (94.7%) and early morning sputum specimens from 4719 (92.2%). Using symptom screening alone, prevalence of smear, culture and bacteriologically positive PTB in persons >= 15 years of age was 83 (CI: 57-109), 152 (CI: 108-197) and 196 (CI : 145-246) per 100,000 population respectively. Prevalence corrected for non-screening by X-ray was 108 (CI: 82-134), 198 (CI: 153-243) and 254 (CI: 204-301) respectively. Conclusion: Observed prevalence suggests further strengthening of TB control program.	[Chadha, Vineet K.; Anjinappa, SharadaM.; Singh, Sanjay; Gupta, Joydev; Lakshminarayana; Velu, Magesh; Papkianathan, Suganthi] Natl TB Inst, Epidemiol & Res Div, Bangalore, Karnataka, India; [Kumar, Prahlad] Natl TB Inst, Off Director, Bangalore, Karnataka, India		Chadha, VK (corresponding author), Natl TB Inst, Epidemiol & Res Div, Bangalore, Karnataka, India.	vineet2.chadha@gmail.com			World Health Organization (WHO)	World Health Organization (WHO)(World Health Organization)	Survey was undertaken with available human and capital resources already available in the institute, supplemented by funding of 11700000 Indian Rupees from World Health Organization (WHO) for supplies and additional manpower. Website of WHO India is whoindia.org/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Central TB Division Directorate General Health Services Ministry of Health and Family Welfare Government of India], 2012, REV NAT TUB CONTR PR; [Central TB Division Directorate General Health Services Ministry of Health and Family Welfare Government of India], 2012, TB IND 2012 REV NAT; Chadha VK, 2011, EPIDEMIOLOGY PULMONA, P489; Chen XY, 2004, LANCET, V364, P417; Gopi P. G., 1997, Indian Journal of Tuberculosis, V44, P171; Gopi P. G., 1999, Indian Journal of Tuberculosis, V46, P261; Gopi PG, 2006, INT J TUBERC LUNG D, V10, P343; Gothi G.D., 1974, INDIAN J TUBERC, V21, P90; GOTHI GD, 1976, INDIAN J MED RES, V64, P1150; Indian Council of Medical Research, 1959, ICMR SPECIAL REPORT, V34; Khatri GR, 2000, INT J TUBERC LUNG D, V4, P193; Manjula Datta, 2000, Indian Journal of Tuberculosis, V47, P147; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Styblo K., 1991, EPIDEMIOLOGY TUBERCU, V24; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Tupasi TE, 2009, INT J TUBERC LUNG D, V13, P1224; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; WHO, 2011, WHOHTMTB201017; *WHO, 1992, TUB PROGR REV IND; World Health Organization, 2012, SEATB338 WHO	20	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42625	10.1371/journal.pone.0042625	http://dx.doi.org/10.1371/journal.pone.0042625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22956993	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600020
J	Reiss, DJ; Howard, FM; Mobley, HLT				Reiss, Daniel J.; Howard, Frederick M.; Mobley, Harry L. T.			A Novel Approach for Transcription Factor Analysis Using SELEX with High-Throughput Sequencing (TFAST)	PLOS ONE			English	Article							DNA; ALIGNMENT; LIGANDS; TOOL	Background: In previous work, we designed a modified aptamer-free SELEX-seq protocol (afSELEX-seq) for the discovery of transcription factor binding sites. Here, we present original software, TFAST, designed to analyze afSELEX-seq data, validated against our previously generated afSELEX-seq dataset and a model dataset. TFAST is designed with a simple graphical interface (Java) so that it can be installed and executed without extensive expertise in bioinformatics. TFAST completes analysis within minutes on most personal computers. Methodology: Once afSELEX-seq data are aligned to a target genome, TFAST identifies peaks and, uniquely, compares peak characteristics between cycles. TFAST generates a hierarchical report of graded peaks, their associated genomic sequences, binding site length predictions, and dummy sequences. Principal Findings: Including additional cycles of afSELEX-seq improved TFAST's ability to selectively identify peaks, leading to 7,274, 4,255, and 2,628 peaks identified in two-, three-, and four-cycle afSELEX-seq. Inter-round analysis by TFAST identified 457 peaks as the strongest candidates for true binding sites. Separating peaks by TFAST into classes of worst, second-best and best candidate peaks revealed a trend of increasing significance (e-values 4.5x10(12), 2.9x10(-46), and 1.2x10(-73)) and informational content (11.0, 11.9, and 12.5 bits over 15 bp) of discovered motifs within each respective class. TFAST also predicted a binding site length (28 bp) consistent with non-computational experimentally derived results for the transcription factor PapX (22 to 29 bp). Conclusions/Significance: TFAST offers a novel and intuitive approach for determining DNA binding sites of proteins subjected to afSELEX-seq. Here, we demonstrate that TFAST, using afSELEX-seq data, rapidly and accurately predicted sequence length and motif for a putative transcription factor's binding site.	[Reiss, Daniel J.; Mobley, Harry L. T.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Reiss, Daniel J.; Howard, Frederick M.; Mobley, Harry L. T.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Reiss, DJ (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	hmobley@umich.edu		Mobley, Harry/0000-0001-9195-7665; Howard, Frederick/0000-0002-6039-1141	Public Health Service from the National Institute of Health [AI43363, AI59722, AI007528, T32 GM07863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059722, T32AI007528, R01AI043363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grants (grant numbers AI43363, AI59722, AI007528 and T32 GM07863) from the National Institute of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bulyk ML, 2005, NAT BIOTECHNOL, V23, P942, DOI 10.1038/nbt0805-942; Djordjevic M, 2006, PHYS BIOL, V3, P13, DOI 10.1088/1478-3975/3/1/002; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Feng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027862; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Gabanyi Margaret J., 2011, Journal of Structural and Functional Genomics, V12, P45, DOI 10.1007/s10969-011-9106-2; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Reiss DJ, 2011, J BIOL CHEM; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Schutze T, PLOS ONE, V6; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Stein LD, 2011, CURR PROTOC BIOINFOR; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang L, 2012, BIOTECHNOLOGY LETT; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Zhang KJ, 2012, CHEMMEDCHEM, V7, P79, DOI 10.1002/cmdc.201100457; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590; Zimmermann B, 2010, METHODS, V52, P125, DOI 10.1016/j.ymeth.2010.06.004	24	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42761	10.1371/journal.pone.0042761	http://dx.doi.org/10.1371/journal.pone.0042761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22956994	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100165
J	Kugler, J; Schmelz, S; Gentzsch, J; Haid, S; Pollmann, E; van den Heuvel, J; Franke, R; Pietschmann, T; Heinz, DW; Collins, J				Kuegler, Jonas; Schmelz, Stefan; Gentzsch, Juliane; Haid, Sibylle; Pollmann, Erik; van den Heuvel, Joop; Franke, Raimo; Pietschmann, Thomas; Heinz, Dirk W.; Collins, John			High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; NS4A COFACTOR PEPTIDE; DRUG-RESISTANCE; PLUS RIBAVIRIN; IN-VITRO; REPLICATION; INFECTION; TRANSDUCTION; DOMAIN; SOFTWARE	Hepatitis C virus (HCV) NS3-4A protease is essential for viral replication. All current small molecular weight drugs against NS3-4A are substrate peptidomimetics that have a similar binding and resistance profile. We developed inhibitory peptides (IPs) capping the active site and binding via a novel "tyrosine" finger at an alternative NS3-4A site that is of particular interest for further HCV drug development. The peptides are not cleaved due to a combination of geometrical constraints and impairment of the oxyanion hole function. Selection and optimization through combinatorial phagemid display, protein crystallography, and further modifications resulted in a 32-amino acid peptide with a K-i of 0.53 nM. Inhibition of viral replication in cell culture was demonstrated by fusion to a cell-penetrating peptide. Negligible susceptibility to known (A156V and R155K) resistance mutations of the NS3-4A protease was observed. This work shows for the first time that antiviral peptides can target an intracellular site and reveals a novel druggable site on the HCV protease.	[Kuegler, Jonas; Pollmann, Erik; Collins, John] Helmholtz Ctr Infect Res HZI, Res Grp Directed Evolut, D-38124 Braunschweig, Germany; [Schmelz, Stefan; van den Heuvel, Joop; Heinz, Dirk W.] Helmholtz Ctr Infect Res HZI, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Franke, Raimo] Helmholtz Ctr Infect Res HZI, Dept Biol Chem, D-38124 Braunschweig, Germany; [Gentzsch, Juliane; Haid, Sibylle; Pietschmann, Thomas] Ctr Expt & Clin Infect Res, TWINCORE, Dept Expt Virol, D-30625 Hannover, Germany; [Collins, John] Tech Univ Carolo Wilhelmina Braunschweig, Fac Life Sci, D-38100 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Collins, J (corresponding author), HZI, Helmholtz Ctr Infect Res, Res Grp Directed Evolut, Inhoffenstr 7, D-38124 Braunschweig, Germany.	jco@helmholtz-hzi.de	Pietschmann, Thomas/E-9241-2015	Pietschmann, Thomas/0000-0001-5138-6239; Collins, John/0000-0001-8009-4753; Franke, Raimo/0000-0002-5407-5521				Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Bartenschlager R, 2000, BEST PRACT RES CL GA, V14, P241, DOI 10.1053/bega.1999.0073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Collins J, 2001, J Biotechnol, V74, P317; de Bruijne J, 2009, VOX SANG, V97, P1, DOI 10.1111/j.1423-0410.2009.01187.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dimasi N, 1998, PROTEIN ENG, V11, P1257, DOI 10.1093/protein/11.12.1257; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gaudieri S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/hep.22773; Gentile I, 2010, EXPERT OPIN INV DRUG, V19, P151, DOI 10.1517/13543780903501505; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Ingallinella P, 1998, BIOCHEMISTRY-US, V37, P8906, DOI 10.1021/bi980314n; Jensen DM, 2011, NEW ENGL J MED, V364, P1272, DOI 10.1056/NEJMe1100829; Johnson RM, 2011, METHODS MOL BIOL, V683, P535, DOI 10.1007/978-1-60761-919-2_38; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landro JA, 1997, BIOCHEMISTRY-US, V36, P9340, DOI 10.1021/bi963054n; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misialek S, 2009, ANAL BIOCHEM, V394, P138, DOI 10.1016/j.ab.2009.07.007; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v; Taliani M, 1996, ANAL BIOCHEM, V240, P60, DOI 10.1006/abio.1996.0331; Tilstra J, 2007, BIOCHEM SOC T, V35, P811, DOI 10.1042/BST0350811; Tomei L, 1996, J GEN VIROL, V77, P1065, DOI 10.1099/0022-1317-77-5-1065; Urbani A, 1997, J BIOL CHEM, V272, P9204; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200	47	13	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39224	39232		10.1074/jbc.M112.393843	http://dx.doi.org/10.1074/jbc.M112.393843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22965230	Green Published, hybrid			2022-12-25	WOS:000310982800077
J	Katsurada, T; Kobayashi, W; Tomaru, U; Baba, T; Furukawa, S; Ishizu, A; Takeda, K; Sakamoto, N; Asaka, M; Takeda, H; Kasahara, M				Katsurada, Takehiko; Kobayashi, Waka; Tomaru, Utano; Baba, Tomohisa; Furukawa, Shigeru; Ishizu, Akihiro; Takeda, Kazuyoshi; Sakamoto, Naoya; Asaka, Masahiro; Takeda, Hiroshi; Kasahara, Masanori			Decrease of Peripheral and Intestinal NKG2A-Positive T Cells in Patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NATURAL-KILLER-CELL; INHIBITORY RECEPTORS; CD94/NKG2A EXPRESSION; REGULATORY CELLS; LYMPHOCYTES; NKG2A; PATHOGENESIS; RECOGNITION; RESPONSES	To investigate the role of inhibitory natural killer receptors (iNKRs) in inflammatory bowel disease (IBD), we analyzed the expression of NKG2A, one of the iNKRs, on T cells in a mouse colitis model and human IBD. During the active phase of dextran sulfate sodium (DSS)-induced mouse colitis, the frequency of NKG2A+ T cells was significantly decreased in the peripheral blood, and increased in the intestine, suggesting the mobilization of this T cell subset to the sites of inflammation. Administration of anti-NKG2A antibody increased the number of inflammatory foci in DSS-induced colitis, suggesting the involvement of NKG2A+ T cells in this colitis model. In ulcerative colitis (UC) patients, the frequency of peripheral blood NKG2A+ T cells was significantly decreased, compared with Crohn's disease (CD) patients and healthy controls, regardless of clinical conditions such as treatment modalities and disease activity. Notably, in sharp contrast to the DSS-induced mouse colitis model, the frequency of NKG2A+ cells among intestinal T cells was also decreased in UC patients. These results suggest that inadequate local infiltration of NKG2A+ T cells may be involved in the pathogenesis of UC.	[Katsurada, Takehiko; Kobayashi, Waka; Tomaru, Utano; Baba, Tomohisa; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Katsurada, Takehiko; Kobayashi, Waka; Furukawa, Shigeru; Sakamoto, Naoya; Asaka, Masahiro; Takeda, Hiroshi] Hokkaido Univ, Grad Sch, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Takeda, Kazuyoshi] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Takeda, Hiroshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Juntendo University; Hokkaido University	Katsurada, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	tomaruu@med.hokudai.ac.jp	Kasahara, Masanori/G-7651-2011; Takeda, Hiroshi/C-6551-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Bertone S, 1999, EUR J IMMUNOL, V29, P23, DOI 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; Braud VM, 2003, TRENDS IMMUNOL, V24, P162, DOI 10.1016/S1471-4906(03)00064-4; Byers AM, 2006, J IMMUNOL, V176, P6121, DOI 10.4049/jimmunol.176.10.6121; DEDOMBAL FT, 1987, GUT, V28, P474, DOI 10.1136/gut.28.4.474; Derre L, 2002, J IMMUNOL, V168, P4864, DOI 10.4049/jimmunol.168.10.4864; Eksteen B, 2008, INFLAMM BOWEL DIS, V14, P1298, DOI 10.1002/ibd.20453; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Freishtat RJ, 2005, HUM IMMUNOL, V66, P1223, DOI 10.1016/j.humimm.2006.02.005; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Hart AL, 2010, INFLAMM BOWEL DIS, V16, P1969, DOI 10.1002/ibd.21304; Jabri B, 2002, IMMUNITY, V17, P487, DOI 10.1016/S1074-7613(02)00427-2; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; Kawamura T, 2009, J IMMUNOL, V182, P250, DOI 10.4049/jimmunol.182.1.250; Kirman I, 1996, AM J GASTROENTEROL, V91, P1789; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Li WX, 2010, CLIN RHEUMATOL, V29, P315, DOI 10.1007/s10067-009-1322-9; Liao YH, 2006, BRIT J DERMATOL, V155, P318, DOI 10.1111/j.1365-2133.2006.07301.x; Liu ZJ, 2000, J IMMUNOL, V164, P3608, DOI 10.4049/jimmunol.164.7.3608; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; Marusina AI, 2005, J IMMUNOL, V174, P2152, DOI 10.4049/jimmunol.174.4.2152; Mingari MC, 2005, CURR OPIN IMMUNOL, V17, P312, DOI 10.1016/j.coi.2005.03.006; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Saito M, 2003, BLOOD, V102, P577, DOI 10.1182/blood-2002-09-2855; Sakai T, 1998, GASTROENTEROLOGY, V114, P1237, DOI 10.1016/S0016-5085(98)70430-5; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; Suvas S, 2006, J IMMUNOL, V176, P1703, DOI 10.4049/jimmunol.176.3.1703; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	40	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44113	10.1371/journal.pone.0044113	http://dx.doi.org/10.1371/journal.pone.0044113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970169	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400037
J	Chung, CJ; Huang, CY; Tsai, HB; Muo, CH; Chung, MC; Chang, CH; Huang, CC				Chung, Chi-Jung; Huang, Chao-Yuan; Tsai, Hung-Bin; Muo, Chih-Hsin; Chung, Mu-Chi; Chang, Chao-Hsiang; Huang, Chiu-Ching			Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in Taiwan	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CELL CARCINOMA; ARISTOLOCHIC ACID; CANCER; TRANSPLANTATION; DIALYSIS; RISK; MORTALITY; NEPHROPATHY; ASSOCIATION	Increasing evidence indicates that end-stage renal disease (ESRD) is associated with the morbidity of cancer. However, whether different dialysis modality and sex effect modify the cancer risks in ESRD patients remains unclear. A total of 3,570 newly diagnosed ESRD patients and 14,280 controls matched for age, sex, index month, and index year were recruited from the National Health Insurance Research Database in Taiwan. The ESRD status was ascertained from the registry of catastrophic illness patients. The incidence of cancer was identified through cross-referencing with the National Cancer Registry System. The Cox proportional hazards model and the Kaplan-Meier method were used for analyses. A similar twofold increase in cancer risk was observed among ESRD patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) after adjusting for other potential risk factors. Patients with the highest cancer risk, approximately fourfold increased risk, were those received renal transplants. Urothelial carcinoma (UC) had the highest incidence in HD and PD patients. However, renal cell carcinoma (RCC) had the highest incidence in the renal transplantation (RT) group. In addition, female patients undergoing RT or PD had a higher incidence of RCC and UC, respectively. Male patients under HD had both higher incidence of RCC and UC. In conclusion, different dialysis modality could modify the cancer risks in ESRD patients. We also found sex effect on genitourinary malignancy when they are under different dialysis modality.	[Chung, Chi-Jung] China Med Univ & Hosp, Dept Med Res, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ, Dept Hlth Risk Management, Coll Publ Hlth, Taichung, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Dept Urol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Tsai, Hung-Bin] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Muo, Chih-Hsin] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chung, Mu-Chi] Taichung Vet Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Chang, Chao-Hsiang] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan; [Chang, Chao-Hsiang; Huang, Chiu-Ching] China Med Univ & Hosp, Coll Med, Dept Med, Taichung, Taiwan; [Huang, Chiu-Ching] China Med Univ & Hosp, Div Nephrol, Taichung, Taiwan; [Huang, Chiu-Ching] China Med Univ & Hosp, Kidney Inst, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chung, CJ (corresponding author), China Med Univ & Hosp, Dept Med Res, Taichung, Taiwan.	cch@mail.cmuh.org.tw	Chung, Chi-Jung/G-4755-2013; Tsai, Hung-Bin/G-3761-2011	, Mu Chi/0000-0001-5283-2886; HUANG, CHAO-YUAN/0000-0002-9322-6062; Tsai, Hung-Bin/0000-0002-0689-8339	Department of Health, Taiwan [DOH 97-HP-1101]; Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; Cancer Research Center of Excellence [DOH99-TD-C-111-001, DOH100-TD-C-111-005]; National Science Council [NSC 99-2621-M-039-001]; China Medical University Hospital	Department of Health, Taiwan; Clinical Trial and Research Center of Excellence; Cancer Research Center of Excellence; National Science Council(Ministry of Science and Technology, Taiwan); China Medical University Hospital	The study was supported in part by grants from the Department of Health, Taiwan (DOH 97-HP-1101, 2008-2010), the Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), the Cancer Research Center of Excellence (DOH99-TD-C-111-001, 2010-2011, DOH100-TD-C-111-005), the National Science Council (NSC 99-2621-M-039-001), and the China Medical University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkeland SA, 2000, LANCET, V355, P1886, DOI 10.1016/S0140-6736(00)02298-4; BOON NA, 1984, BRIT J UROL, V56, P96, DOI 10.1111/j.1464-410X.1984.tb07172.x; Chang CH, 2009, CLIN NEPHROL, V72, P298; Chen CH, 2008, UROLOGY, V71, P1155, DOI 10.1016/j.urology.2007.11.140; CHEN KS, 1995, AM J KIDNEY DIS, V25, P694, DOI 10.1016/0272-6386(95)90544-8; Cosyns JP, 1999, AM J KIDNEY DIS, V33, P1011, DOI 10.1016/S0272-6386(99)70136-8; Cosyns JP, 2001, KIDNEY INT, V59, P2164, DOI 10.1046/j.1523-1755.2001.0590062164.x; Farivar-Mohseni H, 2006, J UROLOGY, V175, P2018, DOI 10.1016/S0022-5347(06)00340-5; Fischereder M, 2008, NEPHROL DIAL TRANSPL, V23, P2457, DOI 10.1093/ndt/gfn183; Hung PH, 2011, WORLD J UROL, V29, P511, DOI 10.1007/s00345-011-0682-3; Hurst FP, 2010, TRANSPLANTATION, V90, P898, DOI 10.1097/TP.0b013e3181f30479; Hurst FP, 2011, UROLOGY, V77, P1271, DOI 10.1016/j.urology.2011.01.007; Kummer S, 2012, PEDIATR NEPHROL, V27, P1213, DOI 10.1007/s00467-011-1963-1; Lai MN, 2009, NEPHROLOGY, V14, P227, DOI 10.1111/j.1440-1797.2008.01061.x; Lee JE, 2009, J KOREAN MED SCI, V24, pS95, DOI 10.3346/jkms.2009.24.S1.S95; Li WH, 2012, NEPHROL DIAL TRANSPL, V27, P833, DOI 10.1093/ndt/gfr277; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lindsay RM, 2011, HEMODIAL INT, V15, P15, DOI 10.1111/j.1542-4758.2010.00521.x; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Nouh MAAM, 2010, BJU INT, V105, P620, DOI 10.1111/j.1464-410X.2009.08817.x; Orskov B, 2012, NEPHROL DIAL TRANSPL, V27, P1607, DOI 10.1093/ndt/gfr467; Parfrey PS, 1999, TRANSPL P, V31, P291, DOI 10.1016/S0041-1345(98)01631-5; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Sassa N, 2011, NEPHROL DIAL TRANSPL, V26, P1677, DOI 10.1093/ndt/gfq529; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Stewart JH, 2009, NEPHROL DIAL TRANSPL, V24, P3225, DOI 10.1093/ndt/gfp331; SUTHANTHIRAN M, 1994, NEW ENGL J MED, V331, P365, DOI 10.1056/NEJM199408113310606; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Yang HY, 2009, J EPIDEMIOL, V19, P17, DOI 10.2188/jea.JE20080035	34	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44675	10.1371/journal.pone.0044675	http://dx.doi.org/10.1371/journal.pone.0044675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957098	gold, Green Published, Green Submitted			2022-12-25	WOS:000308463800091
J	Hu, XY; Zhang, ZD; Li, N; Liu, DX; Zhang, L; He, W; Zhang, W; Li, YX; Zhu, C; Zhu, GJ; Zhang, LP; Xu, F; Wang, SH; Cao, XY; Zhao, HY; Li, Q; Zhang, XJ; Lin, JD; Zhao, SP; Li, C; Du, B				Hu, Xiaoyun; Zhang, Zhidan; Li, Na; Liu, Dexin; Zhang, Li; He, Wei; Zhang, Wei; Li, Yuexia; Zhu, Cheng; Zhu, Guijun; Zhang, Lipeng; Xu, Fang; Wang, Shouhong; Cao, Xiangyuan; Zhao, Huiying; Li, Qian; Zhang, Xijing; Lin, Jiandong; Zhao, Shuangping; Li, Chen; Du, Bin		CCCCTG	Self-Reported Use of Personal Protective Equipment among Chinese Critical Care Clinicians during 2009 H1N1 Influenza Pandemic	PLOS ONE			English	Article							INTENSIVE-CARE; CONTACT ISOLATION; INFECTION-CONTROL; UNITED-STATES; HAND HYGIENE; SARS; RECOMMENDATIONS; TRANSMISSION; IMPROVEMENT; PREVENTION	Background: Critically ill patients with 2009 H1N1 influenza are often treated in intensive care units (ICUs), representing significant risk of nosocomial transmission to critical care clinicians and other patients. Despite a large body of literature and guidelines recommending infection control practices, numerous barriers have been identified in ICUs, leading to poor compliance to the use of personal protective equipment (PPE). The use of PPE among critical care clinicians has not been extensively evaluated, especially during the pandemic influenza. This study examined the knowledge, attitudes, and self-reported behaviors, and barriers to compliance with the use of PPE among ICU healthcare workers (HCWs) during the pandemic influenza. Methodology/Principal Findings: A survey instrument consisting of 36 questions was developed and mailed to all HCWs in 21 ICUs in 17 provinces in China. A total of 733 physicians, nurses, and other professionals were surveyed, and 650 (88.7%) were included in the analysis. Fifty-six percent of respondents reported having received training program of pandemic influenza before they cared for H1N1 patients, while 77% reported to have adequate knowledge of self and patient protection. Only 18% of respondents were able to correctly identify all components of PPE, and 55% reported high compliance (>80%) with PPE use during patient care. In multivariate analysis, vaccination for 2009 H1N1 influenza, positive attitudes towards PPE use, organizational factors such as availability of PPE in ICU, and patient information of influenza precautions, as well as reprimand for noncompliance by the supervisors were associated with high compliance, whereas negative attitudes towards PPE use and violation of PPE use were independent predictors of low compliance. Conclusion/Significance: Knowledge and self-reported compliance to recommended PPE use among Chinese critical care clinicians is suboptimal. The perceived barriers should be addressed in order to close the significant gap between perception and knowledge or behavior.	[Hu, Xiaoyun; Du, Bin] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Zhang, Zhidan] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China; [Li, Na] Hainan Prov Peoples Hosp, Haikou, Peoples R China; [Liu, Dexin] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China; [Zhang, Li] Capital Med Univ, Fuxing Hosp, Beijing, Peoples R China; [He, Wei] Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China; [Zhang, Wei] Kunming Med Coll, Affiliated Hosp 1, Kunming, Peoples R China; [Li, Yuexia] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Zhu, Cheng] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China; [Zhu, Guijun] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China; [Zhang, Lipeng] Inner Mongolia Med Coll, Affiliated Hosp, Hohhot, Peoples R China; [Xu, Fang] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Wang, Shouhong] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Cao, Xiangyuan] Ningxia Med Univ, Affiliated Hosp, Yinchuan, Peoples R China; [Zhao, Huiying] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Li, Qian] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xijing] Xijing Hosp, Xian, Peoples R China; [Lin, Jiandong] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China; [Zhao, Shuangping] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Li, Chen] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; China Medical University; Jilin University; Capital Medical University; Capital Medical University; Kunming Medical University; Zhengzhou University; Shanghai Jiao Tong University; Hebei Medical University; Inner Mongolia Medical University; Chongqing Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Ningxia Medical University; Peking University; Zhejiang Provincial People's Hospital; Air Force Military Medical University; Fujian Medical University; Central South University; Shandong University	Hu, XY (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	dubin98@gmail.com	zhao, shuangling/HCI-6255-2022; Zhu, Guangshan/E-2024-2013; Du, Bin/K-4283-2013	Du, Bin/0000-0001-6237-2895				Banach DB, 2011, INFECT CONT HOSP EP, V32, P293, DOI 10.1086/658911; Beam EL, 2011, AM J INFECT CONTROL, V39, P415, DOI 10.1016/j.ajic.2010.07.009; Bolyard EA, 1998, AM J INFECT CONTROL, V26, P289, DOI 10.1016/S0196-6553(98)80015-1; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Brunkhorst FM, 2008, CRIT CARE MED, V36, P2719, DOI 10.1097/CCM.0b013e318186b6f3; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; *CDCP, 2009 H1N1 FLU INT SI; Daugherty EL, 2009, CRIT CARE MED, V37, P1210, DOI [10.1097/CCM.0b013e3181b6fa29, 10.1097/CCM.0b013e31819d67b5]; de Vos MLG, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-52; Department of Health, 2008, PAND INFL GUID INF C; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Harriman K., 2009, Morbidity and Mortality Weekly Report, V58, P641; Huang DT, 2010, INT J QUAL HEALTH C, V22, P151, DOI 10.1093/intqhc/mzq017; Jaeger JL, 2011, INFECT CONT HOSP EP, V32, P1149, DOI 10.1086/662709; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kirkland KB, 1999, LANCET, V354, P1177, DOI 10.1016/S0140-6736(99)04196-3; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; Ma XC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-24; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; O'Boyle CA, 2001, AM J INFECT CONTROL, V29, P352, DOI 10.1067/mic.2001.18405; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Reid SM, 2011, CAN J EMERG MED, V13, P71, DOI 10.2310/8000.2011.110253; Saint S, 2003, AM J INFECT CONTROL, V31, P354, DOI 10.1016/S0196-6553(02)48250-8; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Swaminathan A, 2007, EMERG INFECT DIS, V13, P1541, DOI 10.3201/eid1310.070033; Tai DYH, 2006, ANN ACAD MED SINGAP, V35, P374; Timen A, 2010, AM J INFECT CONTROL, V38, P726, DOI 10.1016/j.ajic.2010.03.006; Vinck L, 2011, EURO SURVEILL, V16; World Health Organization, 2009, WORLD NOW START 2009; World Health Organization (WHO), 2009, COMMUNICATION   0425; Zilberberg MD, 2009, PLOS CURR INFLUENZA	33	29	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44723	10.1371/journal.pone.0044723	http://dx.doi.org/10.1371/journal.pone.0044723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957101	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800094
J	Moreno-Rueda, G; Redondo, T				Moreno-Rueda, Gregorio; Redondo, Tomas			Benefits of Extra Begging Fail to Compensate for Immunological Costs in Southern Shrike (Lanius meridionalis) Nestlings	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; IMMUNE-RESPONSE; NEED; GROWTH; BIRDS; PHYTOHEMAGGLUTININ; BEHAVIOR; SIGNALS	Theoretical models aimed at explaining the evolution of honest, informative begging signals employed by nestling birds to solicit food from their parents, require that dishonest signalers incur a net viability cost in order to prevent runaway escalation of signal intensity over evolutionary time. Previous attempts to determine such a cost empirically have identified two candidate physiological costs associated with exaggerated begging: a growth and an immunological cost. However, they failed to take into account the fact that those costs are potentially offset by the fact that nestlings that invest more in begging are also likely to obtain more food. In this study, we test experimentally whether a 25% increase in ingested food compensates for growth and immunological costs of extra begging in southern shrike (Lanius meridionalis) nestlings. Three nestmates matched by size were given three treatments: low begging, high begging-same food intake, and high begging-extra food intake. We found that, while a higher food intake did effectively compensate for the growth cost, it failed to compensate for the immunological cost, measured as T-cell mediated immune response against an innocuous mitogen. Thus, we show for the first time that escalated begging has an associated physiological net cost likely to affect nestling survival negatively.	[Redondo, Tomas] CSIC, Estac Biol Donana, Seville, Spain; [Moreno-Rueda, Gregorio] Univ Granada, Dept Zool, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Granada	Moreno-Rueda, G (corresponding author), Univ Granada, Dept Zool, Granada, Spain.	gmr@ugr.es	Redondo, Tomás/K-8896-2014; Moreno-Rueda, Gregorio/K-7068-2014	Redondo, Tomás/0000-0002-0927-9111; Moreno-Rueda, Gregorio/0000-0002-6726-7215	Spanish Government (Ministerio de Ciencia y Tecnologia); Consejo Superior de Investigaciones Cientificas (CSIC) [201030E079]; Spanish government (Ministerio de Ciencia e Innovacion) [CGL2011-29694]	Spanish Government (Ministerio de Ciencia y Tecnologia)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC); Spanish government (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	G.M.-R. was supported by the Spanish Government (Ministerio de Ciencia y Tecnologia, "Juan de la Cierva" program), and T. R. was supported by the Consejo Superior de Investigaciones Cientificas (CSIC; Proyectos Intramurales Especiales, ref. 201030E079). The study was economically supported by the Spanish government (Ministerio de Ciencia e Innovacion; project CGL2011-29694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; Bergstrom CT, 2002, PHILOS T R SOC B, V357, P1595, DOI 10.1098/rstb.2002.1068; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Brilot BO, 2003, P ROY SOC B-BIOL SCI, V270, P1055, DOI 10.1098/rspb.2003.2329; Budden AE, 2001, CURR ORNITHOL, V16, P83; Budden Amber E., 2001, Ring, V22, P165; Chappell MA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P143, DOI 10.1007/0-306-47660-6_8; Clark AB, 1998, ANIM BEHAV, V56, P563, DOI 10.1006/anbe.1998.0831; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GUNTURKUN O, 1989, PHARMACOL BIOCHEM BE, V32, P415, DOI 10.1016/0091-3057(89)90172-X; Haff TM, 2011, BIOL LETTERS, V7, P493, DOI 10.1098/rsbl.2010.1125; Hernandez A, 2004, LIBRO ROJO AVES ESPA, P351; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Injidi MH, 1989, BR POULT SCI, V282, P139; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Johnstone Rufus A., 1997, P155; Kedar H, 2000, P ROY SOC B-BIOL SCI, V267, P1723, DOI 10.1098/rspb.2000.1201; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Leonard ML, 2003, BEHAV ECOL SOCIOBIOL, V54, P573, DOI 10.1007/s00265-003-0668-2; LOCHMILLER RL, 1993, AUK, V110, P503, DOI 10.2307/4088414; Magrath RD, 2010, ADV STUD BEHAV, V41, P187, DOI 10.1016/S0065-3454(10)41006-2; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martin-Galvez D, 2011, J EXP BIOL, V214, P1463, DOI 10.1242/jeb.050153; Mock D. W., 1997, EVOLUTION SIBLING RI; Moreno-Rueda G, 2011, J EVOLUTION BIOL, V24, P1091, DOI 10.1111/j.1420-9101.2011.02242.x; Moreno-Rueda G, 2007, J ETHOL, V25, P215, DOI 10.1007/s10164-006-0020-1; Moreno-Rueda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040367; Moreno-Rueda G, 2010, P ROY SOC B-BIOL SCI, V277, P2083, DOI 10.1098/rspb.2010.0109; Moreno-Rueda G, 2009, ACTA ORNITHOL, V44, P167, DOI 10.3161/000164509X482740; Parker GA, 2002, ECOL LETT, V5, P206, DOI 10.1046/j.1461-0248.2002.00301.x; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; REDONDO T, 1992, ETHOLOGY, V92, P193; Rodriguez-Girones MA, 2001, BEHAV ECOL, V12, P269, DOI 10.1093/beheco/12.3.269; RodriguezGirones MA, 1996, P NATL ACAD SCI USA, V93, P14637, DOI 10.1073/pnas.93.25.14637; Roulin A, 2001, BEHAV ECOL, V12, P506, DOI 10.1093/beheco/12.4.506; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; SOSULSKI FW, 1990, J AGR FOOD CHEM, V38, P1351, DOI 10.1021/jf00096a011; Swain BK, 2000, BRIT POULTRY SCI, V41, P83, DOI 10.1080/00071660086457; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; TRIVERS RL, 1974, AM ZOOL, V14, P249; Verhulst S, 1997, AUK, V114, P134, DOI 10.2307/4089078; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Weathers Wesley W., 1996, P461; Wolf P, 2003, J ANIM PHYSIOL AN N, V87, P122, DOI 10.1046/j.1439-0396.2003.00424.x; Wright J, 2002, EVOLUTION BEGGING	55	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44647	10.1371/journal.pone.0044647	http://dx.doi.org/10.1371/journal.pone.0044647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957095	gold, Green Published			2022-12-25	WOS:000308463800088
J	Sachs, G; Traugott, J; Nesterova, AP; Dell'Omo, G; Kummeth, F; Heidrich, W; Vyssotski, AL; Bonadonna, F				Sachs, Gottfried; Traugott, Johannes; Nesterova, Anna P.; Dell'Omo, Giacomo; Kuemmeth, Franz; Heidrich, Wolfgang; Vyssotski, Alexei L.; Bonadonna, Francesco			Flying at No Mechanical Energy Cost: Disclosing the Secret of Wandering Albatrosses	PLOS ONE			English	Article							TRACKING; WIND	Albatrosses do something that no other birds are able to do: fly thousands of kilometres at no mechanical cost. This is possible because they use dynamic soaring, a flight mode that enables them to gain the energy required for flying from wind. Until now, the physical mechanisms of the energy gain in terms of the energy transfer from the wind to the bird were mostly unknown. Here we show that the energy gain is achieved by a dynamic flight manoeuvre consisting of a continually repeated up-down curve with optimal adjustment to the wind. We determined the energy obtained from the wind by analysing the measured trajectories of free flying birds using a new GPS-signal tracking method yielding a high precision. Our results reveal an evolutionary adaptation to an extreme environment, and may support recent biologically inspired research on robotic aircraft that might utilize albatrosses' flight technique for engineless propulsion.	[Sachs, Gottfried; Traugott, Johannes] Tech Univ Munich, Inst Flight Syst Dynam, D-8046 Garching, Germany; [Nesterova, Anna P.; Bonadonna, Francesco] 5175 CNRS, UMR, Ctr Ecol Fonct & Evolut, Behav Ecol Grp, Montpellier, France; [Dell'Omo, Giacomo] Ornis ital, Rome, Italy; [Kuemmeth, Franz; Heidrich, Wolfgang] E Obs GmbH, Grunwald, Germany; [Vyssotski, Alexei L.] Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland	Technical University of Munich; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Sachs, G (corresponding author), Tech Univ Munich, Inst Flight Syst Dynam, D-8046 Garching, Germany.	francesco.bonadonna@cefe.cnrs.fr	Bonadonna, Francesco/A-7456-2008	Bonadonna, Francesco/0000-0002-2702-5801; Chiaradia, Andre/0000-0002-6178-4211; Vyssotski, Alexei/0000-0002-9021-1471; Dell'Omo, Giacomo/0000-0002-9601-9675	Institut Polaire Francais Paul Emile Victor (IPEV) [354]; National Science Foundation [0700939]; Ornis italica	Institut Polaire Francais Paul Emile Victor (IPEV); National Science Foundation(National Science Foundation (NSF)); Ornis italica	This work was supported by Institut Polaire Francais Paul Emile Victor (IPEV, Program No. 354) A. P. Nesterova was supported by National Science Foundation International Research Fellowship (# 0700939). G. Dell'Omo was supported by Ornis italica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2012, 2009734 AIAA, V226, P1315; [Anonymous], NASA ALB DYN SOAR OP; Brooke M, 2004, ALBATROSSES PETRELS; Catry P, 2004, AUK, V121, P1208, DOI 10.1642/0004-8038(2004)121[1208:SFTBAG]2.0.CO;2; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Deittert M, 2009, J GUID CONTROL DYNAM, V32, P1446, DOI 10.2514/1.43270; Denny Mark, 2009, European Journal of Physics, V30, P75, DOI 10.1088/0143-0807/30/1/008; Hector J, 1895, T NZ I, V27, P651; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Langelaan JW, 2009, SCIENCE, V326, P1642, DOI 10.1126/science.1182497; Langelaan JW, 2008, 46 AER C AM I AER AS; Lighthill J., 1975, P423; Lindhe Norberg Ulla M., 2004, Acta Zoologica Sinica, V50, P921; Madsen J, 2006, J AVIAN BIOL, V37, P283, DOI 10.1111/j.2006.0908-8857.03555.x; Nicholas RJ, 2009, 20096112 AIAA; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; Pennycuik Colin J., 2002, Avian Science, V2, P1; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Sachs G, 2005, IBIS, V147, P1, DOI 10.1111/j.1474-919x.2004.00295.x; Stull R.B., 2003, INTRO BOUNDARY LAYER; Suryan RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004016; TICKELL, 2000, ALBATROSSES; Traugott J., 2008, GPS WORLD, V19, P48; Traugott J., 2008, P 21 INT TECHN M SAT, P1883; Warham J., 1996, BEHAV POPULATION BIO; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; Wilson RP, 1997, WILDLIFE SOC B, V25, P101	28	53	56	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41449	10.1371/journal.pone.0041449	http://dx.doi.org/10.1371/journal.pone.0041449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957014	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000308463800006
J	Landry, B; Aliabadi, HM; Samuel, A; Gul-Uludag, H; Jiang, XY; Kutsch, O; Uludag, H				Landry, Breanne; Aliabadi, Hamidreza Montazeri; Samuel, Anuja; Guel-Uludag, Hilal; Jiang, Xiaoyan; Kutsch, Olaf; Uludag, Hasan			Effective Non-Viral Delivery of siRNA to Acute Myeloid Leukemia Cells with Lipid-Substituted Polyethylenimines	PLOS ONE			English	Article							SMALL INTERFERING RNA; GENE-EXPRESSION; DOWN-REGULATION; P-GLYCOPROTEIN; CANCER-CELLS; APOPTOSIS; MEMBRANE; DNA; PROLIFERATION; ACTIVATION	Use of small interfering RNA (siRNA) is a promising approach for AML treatment as the siRNA molecule can be designed to specifically target proteins that contribute to aberrant cell proliferation in this disease. However, a clinical-relevant means of delivering siRNA molecules must be developed, as the cellular delivery of siRNA is problematic. Here, we report amphiphilic carriers combining a cationic polymer (2 kDa polyethyleneimine, PEI2) with lipophilic moieties to facilitate intracellular delivery of siRNA to AML cell lines. Complete binding of siRNA by the designed carriers was achieved at a polymer: siRNA ratio of similar to 0.5 and led to siRNA/polymer complexes of similar to 100 nm size. While the native PEI2 did not display cytotoxicity on AML cell lines THP-1, KG-1 and HL-60, lipid-modification on PEI2 slightly increased the cytotoxicity, which was consistent with increased interaction of polymers with cell membranes. Cellular delivery of siRNA was dependent on the nature of lipid substituent and the extent of lipid substitution, and varied among the three AML cell lines used. Linoleic acid-substituted polymers performed best among the prepared polymers and gave a siRNA delivery equivalent to better performing commercial reagents. Using THP-1 cells and a reporter (GFP) and an endogenous (CXCR4) target, effective silencing of the chosen targets was achieved with 25 to 50 nM of siRNA concentrations, and without adversely affecting subsequent cell growth. We conclude that lipid-substituted PEI2 can serve as an effective delivery of siRNA to leukemic cells and could be employed in molecular therapy of leukemia.	[Landry, Breanne; Aliabadi, Hamidreza Montazeri; Samuel, Anuja; Uludag, Hasan] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Guel-Uludag, Hilal; Uludag, Hasan] Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada; [Jiang, Xiaoyan] BC Canc Agcy, Terry Fox Labs, Vancouver, BC, Canada; [Kutsch, Olaf] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL USA; [Uludag, Hasan] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada	University of Alberta; University of Alberta; British Columbia Cancer Agency; University of Alabama System; University of Alabama Birmingham; University of Alberta	Landry, B (corresponding author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB, Canada.	hasan.uludag@ualberta.ca		Jiang, Xiaoyan/0000-0002-8974-7340	Alberta Innovates Health Sciences (AIHS); Canadian Institute of Health Research (CIHR); Natural Science and Engineering Research Council of Canada (NSERC); Women & Children's Research Institute (WCHRI); Alberta Cancer Foundation; AIHS Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	Alberta Innovates Health Sciences (AIHS); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Women & Children's Research Institute (WCHRI); Alberta Cancer Foundation; AIHS Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was financially supported by operating grants from Alberta Innovates Health Sciences (AIHS), Canadian Institute of Health Research (CIHR) and Natural Science and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. V. Somayaji for NMR analysis of polymers, Mr. C. Kucharski for technical help with cell culture and Ms. P. Mahdipoor for PCR analysis. We also thank Dr. Artphop Neamnark and Dr. Remant Bahadur K. C. for preparing the polymers for this study and Dr. Orawan Suwantong for help with electrophoresis studies. B. L. was supported by graduate studentships from Women & Children's Research Institute (WCHRI) and Alberta Cancer Foundation. H. M. is supported by an AIHS Fellowship.	Abbasi M, 2010, CANCER-AM CANCER SOC, V116, P5544, DOI 10.1002/cncr.25321; Abbasi S, 2011, CELL BIOCH BIOPHYS, P1; Agatha G, 2004, CANCER LETT, V209, P87, DOI 10.1016/j.canlet.2003.11.022; Agatha G, 2001, CANCER LETT, V173, P139, DOI 10.1016/S0304-3835(01)00674-7; Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Aliabadi HM, 2011, MOL PHARMACEUT, V8, P1821, DOI 10.1021/mp200176v; Aliabadi HM, 2011, MACROMOL BIOSCI, V11, P662, DOI 10.1002/mabi.201000402; Arthanari Y, 2010, J CONTROL RELEASE, V145, P272, DOI 10.1016/j.jconrel.2010.04.011; Breunig M, 2008, J CONTROL RELEASE, V130, P57, DOI 10.1016/j.jconrel.2008.05.016; Burnett A, 2000, NEW ENGL J MED, V341, P1051; Campbell NA, 2002, BIOL 6 EDITION MEMBR, P141; Cancer Facts & Figures, 2012, CANC FACTS FIGURES; Chen KC, 2010, J CELL PHYSIOL, V222, P625, DOI 10.1002/jcp.21979; Chen KC, 2010, J CELL BIOCHEM, V109, P245, DOI 10.1002/jcb.22404; Cioca DP, 2003, CANCER GENE THER, V10, P125, DOI 10.1038/sj.cgt.7700544; Coll JL, 1999, HUM GENE THER, V10, P1659, DOI 10.1089/10430349950017662; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Ferrari S, 1997, GENE THER, V4, P1100, DOI 10.1038/sj.gt.3300503; Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; Greiner J, 2008, CLIN CANCER RES, V14, P7161, DOI 10.1158/1078-0432.CCR-08-1102; Gul H, 2010, LEUKEMIA RES, V34, P235, DOI 10.1016/j.leukres.2009.05.014; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Hartig SM, 2007, BIOMATERIALS, V28, P3843, DOI 10.1016/j.biomaterials.2007.04.027; Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y; Incani V, 2007, J BIOMED MATER RES A, V81A, P493, DOI 10.1002/jbm.a.31249; Incani V, 2010, SOFT MATTER, V6, P2124, DOI 10.1039/b916362j; Jeong JH, 2001, J CONTROL RELEASE, V73, P391, DOI 10.1016/S0168-3659(01)00310-8; Kahn J, 2004, BLOOD, V103, P2942, DOI 10.1182/blood-2003-07-2607; Kaspers GJL, 2007, HAEMATOLOGICA, V92, P1519, DOI 10.3324/haematol.11203; Kloeckner J, 2006, BIOCONJUGATE CHEM, V17, P1339, DOI 10.1021/bc060133v; Koldehoff M, 2010, HAEMATOL-HEMATOL J, V95, P388, DOI 10.3324/haematol.2009.016063; Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; Lee JS, 2004, J BIOL CHEM, V279, P9379, DOI 10.1074/jbc.M310638200; Lima TM, 2002, TOXICOL IN VITRO, V16, P741, DOI 10.1016/S0887-2333(02)00095-4; Liu WH, 2009, TOXICOL LETT, V191, P140, DOI 10.1016/j.toxlet.2009.08.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClatchey KD, 2002, CLIN LAB MED; Mehrotra A, 2010, INT J CANCER, V127, P849, DOI 10.1002/ijc.25109; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Neamnark A, 2009, MOL PHARMACEUT, V6, P1798, DOI 10.1021/mp900074d; Ouyang SD, 2009, ZEBRAFISH, V6, P245, DOI 10.1089/zeb.2009.0589; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Puissant A, 2010, LEUKEMIA, V24, P115, DOI 10.1038/leu.2009.233; Sekeres MA, 2008, HAEMATOL-HEMATOL J, V93, P1769, DOI 10.3324/haematol.2008.000497; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Seo SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-199; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Shin JY, 2005, BBA-GEN SUBJECTS, V1725, P377, DOI 10.1016/j.bbagen.2005.05.018; Tallman MS, 2004, J CLIN ONCOL, V22, P1276, DOI 10.1200/JCO.2004.08.060; Taratula O, 2009, J CONTROL RELEASE, V140, P284, DOI 10.1016/j.jconrel.2009.06.019; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wang XH, 2008, CHEMMEDCHEM, V3, P940, DOI 10.1002/cmdc.200700329; Wightman L, 2001, J GENE MED, V3, P362, DOI 10.1002/jgm.187; Yang JS, 2010, J PHARMACOL EXP THER, V334, P477, DOI 10.1124/jpet.109.165415; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhu CH, 2010, BIOMATERIALS, V31, P2408, DOI 10.1016/j.biomaterials.2009.11.077; Zhu Q, 2010, MOL CELL BIOCHEM, V340, P275, DOI 10.1007/s11010-010-0428-3; Zintchenko A, 2008, BIOCONJUGATE CHEM, V19, P1448, DOI 10.1021/bc800065f	60	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44197	10.1371/journal.pone.0044197	http://dx.doi.org/10.1371/journal.pone.0044197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952927	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300062
J	Liu, T; Wang, Y; Peng, XR; Zhang, LQ; Cheng, JB; Jin, HJ; Wu, MC; Qian, QJ				Liu, Tao; Wang, Ying; Peng, Xinrong; Zhang, Liqing; Cheng, Jingbo; Jin, Huajun; Wu, Mengchao; Qian, Qijun			Establishment of Mouse Teratocarcinomas Stem Cells Line and Screening Genes Responsible for Malignancy	PLOS ONE			English	Article							SELF-RENEWAL; CANCER; EMBRYOS; DIFFERENTIATION; METASTASIS; EXPRESSION; OCT4; MICE	The sequential transplantation of embryonal carcinoma cells in vivo can accelerate the growth and malignancy of teratocarcinomas. However, the possible molecular mechanisms in this process that reflect cancer formation in the early stage are largely unknown and. To identify which genes are associated with the changes of malignancy of teratocarcinomas, we established a tumorigenesis model in which teratocarcinoma were induced via injecting embryonic stem cells into immuno-deficiency mice, isolating teratocarcinoma stem cell from a teratocarcinoma in serum-free culture medium and injecting teratocarcinoma stem cells into immune-deficient mice continuously. By using high-throughput deep sequence technology, we identified 26 differentially expressed genes related to the changes of characteristics of teratocarcinoma stem cell in which 18 out of 26 genes were down-regulated and 8 genes were up-regulated. Among these genes, several tumor-related genes such as Gata3, Arnt and Tdgf1, epigenetic associated genes such as PHC1 and Uty were identified. Pathway enrichment analysis result revealed that Wnt signaling pathway, primary immunodeficiency pathway, antigen processing and presentation pathway and allograft rejection pathway were involved in the teratocarcinoma tumorigenesis (corrected p value<0.05). In summary, our study established a tumorigenesis model and proposed some candidate genes and signaling pathways that may play a key role in the early stage of cancer occurrence.	[Liu, Tao; Wang, Ying; Peng, Xinrong; Cheng, Jingbo; Jin, Huajun; Wu, Mengchao; Qian, Qijun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Lab Viral & Gene Therapy, Shanghai, Peoples R China; [Zhang, Liqing; Qian, Qijun] Zhejiang Sci Tech Univ, Xinyuan Inst Med & Biotechnol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Naval Medical University; Zhejiang Sci-Tech University	Liu, T (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Lab Viral & Gene Therapy, Shanghai, Peoples R China.	qianqj@sino-gene.cn	Wang, Ying/AAY-4117-2021	Wang, Ying/0000-0002-1819-294X	National Science Funds for Distinguished Young Scholar [30925037]; Science Fund for Creative Research Group of NSFC [30921006]; National Significant Science and Technology Special Projects of New Drugs Creation [2011ZX09102-010-02]	National Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Science Fund for Creative Research Group of NSFC(Science Fund for Creative Research Groups); National Significant Science and Technology Special Projects of New Drugs Creation	This work was supported by the National Science Funds for Distinguished Young Scholar (No. 30925037), the Science Fund for Creative Research Group of NSFC (No. 30921006) and the National Significant Science and Technology Special Projects of New Drugs Creation (No. 2011ZX09102-010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Yosef T, 1998, MAMM GENOME, V9, P595, DOI 10.1007/s003359900825; Bonner AE, 2004, NEOPLASIA, V6, P490, DOI 10.1593/neo.04124; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Bulic-Jakus F, 2006, COLLEGIUM ANTROPOL, V30, P921; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; DAMJANOV I, 1993, INT J DEV BIOL, V37, P39; DAMJANOV I, 1973, VIRCHOWS ARCH B, V13, P179; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FAWCETT DW, 1950, CANCER RES, V10, P705; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lu D, 2011, ONCOTARGET, V2, P587; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Miyoshi N, 2010, INT J ONCOL, V36, P563, DOI 10.3892/ijo_00000530; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PAPAIOANNOU VE, 1975, NATURE, V258, P70, DOI 10.1038/258070a0; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tanaka SS, 2011, DEV GROWTH DIFFER, V53, P843, DOI 10.1111/j.1440-169X.2011.01292.x; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43955	10.1371/journal.pone.0043955	http://dx.doi.org/10.1371/journal.pone.0043955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952821	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300037
J	Masters, T; Engl, W; Weng, ZL; Arasi, B; Gauthier, N; Viasnoff, V				Masters, Thomas; Engl, Wilfried; Weng, Zhe L.; Arasi, Bakya; Gauthier, Nils; Viasnoff, Virgile			Easy Fabrication of Thin Membranes with Through Holes. Application to Protein Patterning	PLOS ONE			English	Article							DIP-PEN NANOLITHOGRAPHY; MAMMALIAN-CELLS; SURFACES; ADHESION; ORIENTATION; ENVIRONMENT; GEOMETRY; DIVISION	Since protein patterning on 2D surfaces has emerged as an important tool in cell biology, the development of easy patterning methods has gained importance in biology labs. In this paper we present a simple, rapid and reliable technique to fabricate thin layers of UV curable polymer with through holes. These membranes are as easy to fabricate as microcontact printing stamps and can be readily used for stencil patterning. We show how this microfabrication scheme allows highly reproducible and highly homogeneous protein patterning with micron sized resolution on surfaces as large as 10 cm(2). Using these stencils, fragile proteins were patterned without loss of function in a fully hydrated state. We further demonstrate how intricate patterns of multiple proteins can be achieved by stacking the stencil membranes. We termed this approach microserigraphy.	[Masters, Thomas; Engl, Wilfried; Weng, Zhe L.; Arasi, Bakya; Gauthier, Nils; Viasnoff, Virgile] MechanoBiol Inst Singapore, Singapore, Singapore; [Viasnoff, Virgile] CNRS, ESPCI Paristech, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Masters, T (corresponding author), MechanoBiol Inst Singapore, Singapore, Singapore.	virgile.viasnoff@espci.fr	viasnoff, virgile/H-8832-2012	viasnoff, virgile/0000-0003-3949-2244; WENG, ZHE/0000-0002-1490-9237	MechanoBiology Institute; International Associated Laboratory Cell Adhesion France Singapore	MechanoBiology Institute; International Associated Laboratory Cell Adhesion France Singapore	The work was supported by MechanoBiology Institute seed funding and International Associated Laboratory Cell Adhesion France Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsuta K, 2007, J MICROMECH MICROENG, V17, P496, DOI 10.1088/0960-1317/17/3/011; Azioune A, 2010, METHOD CELL BIOL, V97, P133, DOI 10.1016/S0091-679X(10)97008-8; Azioune A, 2009, LAB CHIP, V9, P1640, DOI 10.1039/b821581m; Bartolo D, 2008, LAB CHIP, V8, P274, DOI 10.1039/b712368j; Brown PS, 2011, ACS APPL MATER INTER, V3, P1204, DOI 10.1021/am2000278; Chen CS, 2005, MRS BULL, V30, P194, DOI 10.1557/mrs2005.52; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Doraiswamy A, 2009, J BIOMED MATER RES B, V89B, P28, DOI 10.1002/jbm.b.31183; Falconnet D, 2004, NANO LETT, V4, P1909, DOI 10.1021/nl0489438; Fink J, 2007, LAB CHIP, V7, P672, DOI 10.1039/b618545b; Frimat JP, 2009, ANAL BIOANAL CHEM, V395, P601, DOI 10.1007/s00216-009-2824-7; Iwanaga S, 2005, BIOMATERIALS, V26, P5395, DOI 10.1016/j.biomaterials.2005.01.021; Jinno S, 2008, J BIOMED MATER RES A, V86A, P278, DOI 10.1002/jbm.a.32030; Kaufmann S, 2011, LAB CHIP, V11, P2403, DOI 10.1039/c1lc20073a; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Lee SW, 2006, ADV MATER, V18, P1133, DOI 10.1002/adma.200600070; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Morel M, 2009, LAB CHIP, V9, P1011, DOI 10.1039/b819090a; Ng E, 2011, APPL NANOSCI, V1, P79, DOI 10.1007/s13204-011-0009-0; Orth RN, 2003, BIOPHYS J, V85, P3066, DOI 10.1016/S0006-3495(03)74725-0; Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m; Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Quist AP, 2010, EXPERT OPIN DRUG DIS, V5, P569, DOI 10.1517/17460441.2010.489606; Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Wright D, 2008, J BIOMED MATER RES A, V85A, P530, DOI 10.1002/jbm.a.31281; Zheng Y., 2010, BIOMICROFLUIDICS, V4	34	33	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44261	10.1371/journal.pone.0044261	http://dx.doi.org/10.1371/journal.pone.0044261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952944	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300071
J	Zhang, J; Silao, FGS; Bigol, UG; Bungay, AAC; Nicolas, MG; Heitman, J; Chen, YL				Zhang, Jing; Silao, Fitz Gerald S.; Bigol, Ursela G.; Bungay, Alice Alma C.; Nicolas, Marilou G.; Heitman, Joseph; Chen, Ying-Lien			Calcineurin Is Required for Pseudohyphal Growth, Virulence, and Drug Resistance in Candida lusitaniae	PLOS ONE			English	Article							AMPHOTERICIN-B; STRESS-ADAPTATION; OPPORTUNISTIC PATHOGEN; CALCOFLUOR WHITE; ALBICANS; FILAMENTATION; SENSITIVITY; INVOLVEMENT; TOLERANCE; FUNGEMIA	Candida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the role of the calcium-activated protein phosphatase calcineurin in several virulence attributes of C. lusitaniae including pseudohyphal growth, serum survival, and growth at 37 degrees C. We found that calcineurin and Crz1, a C. albicans Crz1 homolog acting as a downstream target of calcineurin, are required for C. lusitaniae pseudohyphal growth, a process for which the underlying mechanism remains largely unknown in C. lusitaniae but hyphal growth is fundamental to C. albicans virulence. We demonstrate that calcineurin is required for cell wall integrity, ER stress response, optimal growth in serum, virulence in a murine systemic infection model, and antifungal drug tolerance in C. lusitaniae. To further examine the potential of targeting the calcineurin signaling cascade for antifungal drug development, we examined the activity of a calcineurin inhibitor FK506 in combination with caspofungin against echinocandin resistant C. lusitaniae clinical isolates. Broth microdilution and drug disk diffusion assays demonstrate that FK506 has synergistic fungicidal activity with caspofungin against echinocandin resistant isolates. Our findings reveal that pseudohyphal growth is controlled by the calcineurin signaling cascade, and highlight the potential use of calcineurin inhibitors and caspofungin for emerging drug-resistant C. lusitaniae infections.	[Zhang, Jing; Heitman, Joseph; Chen, Ying-Lien] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Zhang, Jing] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Silao, Fitz Gerald S.; Bungay, Alice Alma C.] Dr Jose G Tamayo Med Univ, Univ Perpetual Help, Dept Microbiol & Parasitol, Binan, Laguna, Philippines; [Bigol, Ursela G.] Dept Sci & Technol, Environm & Biotechnol Div, Bicutan, Philippines; [Bungay, Alice Alma C.; Nicolas, Marilou G.] Univ Philippines, Natl Inst Hlth Philippines, Manila, Philippines	Duke University; Duke University; Department of Science & Technology (DOST), Philippines; University of the Philippines System; University of the Philippines Manila	Zhang, J (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	heitm001@duke.edu; joseph.chen@duke.edu	Heitman, Joseph/ABC-6006-2021	Chen, Ying-Lien/0000-0002-1966-470X	Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH) [2P30 AI064518-06]; NIH/National Institute of Allergy and Infectious Diseases [AI50438]; Astellas Pharma Inc.; Merck Co. Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050438, P30AI064518] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Astellas Pharma Inc.(Astellas Pharmaceuticals); Merck Co. Inc.(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH)-funded program (2P30 AI064518-06 to Y.-L.C.) and NIH/National Institute of Allergy and Infectious Diseases R01 grant AI50438 (J.H.). This work was also supported by Pilot funds from Astellas Pharma Inc. and Merck & Co. Inc. (J.H. and Y.- L.C.). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Atkinson BJ, 2008, MED MYCOL, V46, P541, DOI 10.1080/13693780801968571; BAKER JG, 1984, DIAGN MICR INFEC DIS, V2, P145, DOI 10.1016/0732-8893(84)90010-5; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; BLINKHORN RJ, 1989, J CLIN MICROBIOL, V27, P236, DOI 10.1128/JCM.27.2.236-240.1989; Boisnard S, 2008, YEAST, V25, P849, DOI 10.1002/yea.1636; Boisnard S, 2008, EUKARYOT CELL, V7, P2179, DOI 10.1128/EC.00262-08; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Canton E, 2009, EXPERT REV ANTI-INFE, V7, P107, DOI 10.1586/14787210.7.1.107; Chapeland-Leclerc F, 2007, EUKARYOT CELL, V6, P1782, DOI 10.1128/EC.00155-07; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Chen YL, 2010, CURR FUNGAL INFECT R, V4, P244, DOI 10.1007/s12281-010-0027-5; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Cruz MC, 2001, EMBO J, V20, P1020, DOI 10.1093/emboj/20.5.1020; Desnos-Ollivier M, 2011, J CLIN MICROBIOL, V49, P2304, DOI 10.1128/JCM.00325-11; Dutta A, 2011, PEDIATR INFECT DIS J, V30, P664, DOI 10.1097/INF.0b013e318213da0f; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Favel A, 2003, DIAGN MICR INFEC DIS, V47, P331, DOI 10.1016/S0732-8893(03)00094-4; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GUINET R, 1983, J CLIN MICROBIOL, V18, P443, DOI 10.1128/JCM.18.2.443-444.1983; Hawkins JL, 2003, CLIN INFECT DIS, V36, pE14, DOI 10.1086/344651; Huynh N, 2012, OCUL IMMUNOL INFLAMM, V20, P100, DOI 10.3109/09273948.2011.646383; Jackson BE, 2007, MICROB PATHOGENESIS, V42, P88, DOI 10.1016/j.micpath.2006.11.005; Jinhee C, 2009, J MICROBIOL BIOTECHN, V19, P11, DOI 10.4014/jmb.0804.268; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; MERZ WG, 1984, J CLIN MICROBIOL, V20, P1194, DOI 10.1128/JCM.20.6.1194-1195.1984; Miller NS, 2006, J CLIN MICROBIOL, V44, P1536, DOI 10.1128/JCM.44.4.1536-1539.2006; Minari A, 2001, CLIN INFECT DIS, V32, P186, DOI 10.1086/318473; Morris MI, 2006, AM J HEALTH-SYST PH, V63, P1693, DOI 10.2146/ajhp050464.p1; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Onyewu C, 2004, INFECT IMMUN, V72, P7330, DOI 10.1128/IAI.72.12.7330-7333.2004; PAPPAGIANIS D, 1979, ANTIMICROB AGENTS CH, V16, P123, DOI 10.1128/AAC.16.2.123; Parentin F, 2006, OCUL IMMUNOL INFLAMM, V14, P129, DOI 10.1080/09273940500328487; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Ruprich-Robert G, 2008, EUKARYOT CELL, V7, P1071, DOI 10.1128/EC.00066-08; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Santos M, 2005, CURR GENET, V48, P88, DOI 10.1007/s00294-005-0003-8; SEWELL DL, 1994, J CLIN MICROBIOL, V32, P2099, DOI 10.1128/JCM.32.9.2099-2102.1994; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Stokes C, 2007, FUNGAL GENET BIOL, V44, P920, DOI 10.1016/j.fgb.2006.11.014; TUKMACHEV VA, 1979, BIOFIZIKA+, V24, P55; Young LY, 2003, ANTIMICROB AGENTS CH, V47, P2717, DOI 10.1128/AAC.47.9.2717-2724.2003; Young LY, 2000, GENETICS, V155, P17; Zhang Jing, 2012, Commun Integr Biol, V5, P122, DOI 10.4161/cib.18833	50	37	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44192	10.1371/journal.pone.0044192	http://dx.doi.org/10.1371/journal.pone.0044192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952924	gold, Green Submitted, Green Published			2022-12-25	WOS:000308221300061
J	Chang, CM; Su, YC; Lai, NS; Huang, KY; Chien, SH; Chang, YH; Lian, WC; Hsu, TW; Lee, CC				Chang, Chun-Ming; Su, Yu-Chieh; Lai, Ning-Sheng; Huang, Kuang-Yung; Chien, Sou-Hsin; Chang, Yu-Han; Lian, Wei-Cheng; Hsu, Ta-Wen; Lee, Ching-Chih			The Combined Effect of Individual and Neighborhood Socioeconomic Status on Cancer Survival Rates	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ADVANCED PANCREATIC-CANCER; BREAST-CANCER; RADICAL PROSTATECTOMY; MULTILEVEL EVIDENCE; SOCIAL-ENVIRONMENT; ALAMEDA COUNTY; MORTALITY; RISK; DEATH	Background: This population-based study investigated the relationship between individual and neighborhood socioeconomic status (SES) and mortality rates for major cancers in Taiwan. Methods: A population-based follow-up study was conducted with 20,488 cancer patients diagnosed in 2002. Each patient was traced to death or for 5 years. The individual income-related insurance payment amount was used as a proxy measure of individual SES for patients. Neighborhood SES was defined by income, and neighborhoods were grouped as living in advantaged or disadvantaged areas. The Cox proportional hazards model was used to compare the death-free survival rates between the different SES groups after adjusting for possible confounding and risk factors. Results: After adjusting for patient characteristics (age, gender, Charlson Comorbidity Index Score, urbanization, and area of residence), tumor extent, treatment modalities (operation and adjuvant therapy), and hospital characteristics (ownership and teaching level), colorectal cancer, and head and neck cancer patients under 65 years old with low individual SES in disadvantaged neighborhoods conferred a 1.5 to 2-fold higher risk of mortality, compared with patients with high individual SES in advantaged neighborhoods. A cross-level interaction effect was found in lung cancer and breast cancer. Lung cancer and breast cancer patients less than 65 years old with low SES in advantaged neighborhoods carried the highest risk of mortality. Prostate cancer patients aged 65 and above with low SES in disadvantaged neighborhoods incurred the highest risk of mortality. There was no association between SES and mortality for cervical cancer and pancreatic cancer. Conclusions: Our findings indicate that cancer patients with low individual SES have the highest risk of mortality even under a universal health-care system. Public health strategies and welfare policies must continue to focus on this vulnerable group.	[Chang, Chun-Ming; Chien, Sou-Hsin; Hsu, Ta-Wen] Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan; [Chang, Chun-Ming; Su, Yu-Chieh; Lai, Ning-Sheng; Huang, Kuang-Yung; Chien, Sou-Hsin; Hsu, Ta-Wen; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Lai, Ning-Sheng; Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Rheumatol, Chiayi, Taiwan; [Chang, Yu-Han] Buddhist Dalin Tzu Chi Gen Hosp, Dept Med Res, Chiayi, Taiwan; [Lian, Wei-Cheng] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chang, CM (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan.	hematcd@hotmail.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017				Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Bao YH, 2007, HEALTH SERV RES, V42, P950, DOI 10.1111/j.1475-6773.2006.00638.x; Benard VB, 2008, CANCER-AM CANCER SOC, V113, P2910, DOI 10.1002/cncr.23742; Booth CM, 2010, CANCER-AM CANCER SOC, V116, P4160, DOI 10.1002/cncr.25427; Borrell LN, 2004, INT J EPIDEMIOL, V33, P398, DOI 10.1093/ije/dyh063; Boyd C, 1999, J CLIN ONCOL, V17, P2244, DOI 10.1200/JCO.1999.17.7.2244; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Brewster DH, 2001, BRIT MED J, V322, P830, DOI 10.1136/bmj.322.7290.830; Bureau of Health Promotion, 2011, CANC STAT; Castellanos EH, 2011, ONCOLOGY-NY, V25, P182; Chen VW, 1997, CANCER EPIDEM BIOMAR, V6, P1087; Chiao C, 2012, J PUBLIC HEALTH-UK, V34, P217, DOI 10.1093/pubmed/fdr069; Chou FHC, 2011, SCHIZOPHR RES, V129, P97, DOI 10.1016/j.schres.2011.02.018; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Engelhardt Joseph B, 2008, Home Healthc Nurse, V26, P166, DOI 10.1097/01.NHH.0000313348.85980.1e; Gapstur SM, 1996, CANCER, V77, P1465, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B; Griggs JJ, 2007, J CLIN ONCOL, V25, P277, DOI 10.1200/JCO.2006.08.3063; Hellenthal NJ, 2010, UROLOGY, V76, P1409, DOI 10.1016/j.urology.2010.03.024; Hook EB, 2000, AM J EPIDEMIOL, V151, P1132; Ignatius SH, 2009, J THORAC ONCOL, V4, P37, DOI 10.1097/JTO.0b013e31819140fb; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson S, 2010, ORAL ONCOL, V46, P366, DOI 10.1016/j.oraloncology.2010.02.010; Koil CE, 2003, GENET MED, V5, P364, DOI 10.1097/01.GIM.0000086477.00766.C9; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Liu CY HY, 2006, J HLTH MANAGE, P1; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; MARMOT MG, 1983, J PSYCHOSOM RES, V27, P377, DOI 10.1016/0022-3999(83)90069-7; Mell LK, 2010, J CLIN ONCOL, V28, P15, DOI 10.1200/JCO.2008.20.9288; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Paquette L, 2007, J AM COLL SURGEONS, V205, P636, DOI 10.1016/j.jamcollsurg.2007.04.043; Pu C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-166; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Roos LL, 2004, SOC SCI MED, V59, P1435, DOI 10.1016/j.socscimed.2004.01.024; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Snow AN, 2010, ADV ANAT PATHOL, V17, P394, DOI 10.1097/PAP.0b013e3181f895c1; Srougi V, 2011, INT BRAZ J UROL, V37, P507, DOI 10.1590/S1677-55382011000400010; Stojadinovic A, 2003, J AM COLL SURGEONS, V196, P954, DOI 10.1016/S1072-7515(03)00010-3; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9; Winkleby M, 2006, AM J PUBLIC HEALTH, V96, P2145, DOI 10.2105/AJPH.2004.060970; Yen IH, 1999, AM J EPIDEMIOL, V149, P898; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/00000658-200209000-00012; Zell JA, 2008, J CLIN ONCOL, V26, P66, DOI 10.1200/JCO.2007.12.3604	46	65	65	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44325	10.1371/journal.pone.0044325	http://dx.doi.org/10.1371/journal.pone.0044325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZH	22957007	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500060
J	Chintinne, M; Stange, G; Denys, B; Ling, ZD; 't Veld, PI; Pipeleers, D				Chintinne, Marie; Stange, Geert; Denys, Bart; Ling, Zhidong; 't Veld, Peter In; Pipeleers, Daniel			Beta Cell Count Instead of Beta Cell Mass to Assess and Localize Growth in Beta Cell Population following Pancreatic Duct Ligation in Mice	PLOS ONE			English	Article							EXOCRINE PANCREAS; ADULT PANCREAS; ISLET GROWTH; PROGENITORS; NEOGENESIS; ENDOCRINE; BIRTH; DIFFERENTIATION; RATS	Background: Pancreatic-tail duct ligation (PDL) in adult rodents has been reported to induce beta cell generation and increase beta cell mass but increases in beta cell number have not been demonstrated. This study examines whether PDL increases beta cell number and whether this is caused by neogenesis of small clusters and/or their growth to larger aggregates. Methodology: Total beta cell number and its distribution over small (<50 mu m), medium, large (>100 mu m) clusters was determined in pancreatic tails of 10-week-old mice, 2 weeks after PDL or sham. Principal findings: PDL increased total beta cell mass but not total beta cell number. It induced neogenesis of small beta cell clusters (2.2-fold higher number) which contained a higher percent proliferating beta cells (1.9% Ki67+cells) than sham tails (<0.2%); their higher beta cell number represented <5% of total beta cell number and was associated with a similar increase in alpha cell number. It is unknown whether the regenerative process is causally related to the inflammatory infiltration in PDL-tails. Human pancreases with inflammatory infiltration also exhibited activation of proliferation in small beta cell clusters. Conclusions/significance: The PDL model illustrates the advantage of direct beta cell counts over beta cell mass measurements when assessing and localizing beta cell regeneration in the pancreas. It demonstrates the ability of the adult mouse pancreas for neogenesis of small beta cell clusters with activated beta cell proliferation. Further studies should investigate conditions under which neoformed small beta cell clusters grow to larger aggregates and hence to higher total beta cell numbers.	[Chintinne, Marie; Stange, Geert; Denys, Bart; Ling, Zhidong; 't Veld, Peter In; Pipeleers, Daniel] Free Univ Brussels VIB, Diabet Res Ctr, B-1050 Brussels, Belgium; [Chintinne, Marie] UZ Brussel, Dept Pathol, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University Hospital Brussels	Chintinne, M (corresponding author), Free Univ Brussels VIB, Diabet Res Ctr, B-1050 Brussels, Belgium.	Daniel.Pipeleers@vub.ac.be	Veld, Peter A In't/E-3624-2013; stange, geert m/C-1092-2009	Veld, Peter A In't/0000-0001-5596-7129; stange, geert m/0000-0003-3148-1372; Pipeleers, Daniel/0000-0002-6440-2485	Research Foundation Flanders [FWO-G.0400.07]; Belgian Inter-University Poles of Attraction Program [IUAP P6/40]; 7th EU-framework [GA241883]	Research Foundation Flanders(FWO); Belgian Inter-University Poles of Attraction Program; 7th EU-framework	This work was supported by grants from Research Foundation Flanders (FWO-G.0400.07), the Belgian Inter-University Poles of Attraction Program (IUAP P6/40), the 7th EU-framework (BetaCellTherapy number GA241883). M. Chintinne and B. Denys were Ph.D. fellows of FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertelli E, 1997, AM J PHYSIOL-CELL PH, V273, pC1641, DOI 10.1152/ajpcell.1997.273.5.C1641; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Chintinne M, 2010, DIABETOLOGIA, V53, P2380, DOI 10.1007/s00125-010-1851-4; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Criscimanna A, 2011, GASTROENTEROLOGY; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hakonen E, 2011, DIABETOLOGIA; In't Veld P, 2010, DIABETES, V59, P1702, DOI 10.2337/db09-1698; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Nakamura K, 2011, BIOMED RES-TOKYO, V32, P167, DOI 10.2220/biomedres.32.167; Rooman I, 2002, DIABETES, V51, P686, DOI 10.2337/diabetes.51.3.686; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Svenstrup K, 2002, APMIS, V110, P372, DOI 10.1034/j.1600-0463.2002.100502.x; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	18	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43959	10.1371/journal.pone.0043959	http://dx.doi.org/10.1371/journal.pone.0043959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952825	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500031
J	Helle, M; Cassette, E; Bezdetnaya, L; Pons, T; Leroux, A; Plenat, F; Guillemin, F; Dubertret, B; Marchal, F				Helle, Marion; Cassette, Elsa; Bezdetnaya, Lina; Pons, Thomas; Leroux, Agnes; Plenat, Francois; Guillemin, Francois; Dubertret, Benoit; Marchal, Frederic			Visualisation of Sentinel Lymph Node with Indium-Based near Infrared Emitting Quantum Dots in a Murine Metastatic Breast Cancer Model	PLOS ONE			English	Article							BIOPSY; NANOPARTICLES; CYTOTOXICITY; TOXICITY; BONE; PHARMACOKINETICS; EXPRESSION; CLEARANCE; CELLS; LIGHT	Due to its non-invasiveness, high temporal resolution and lower cost, fluorescence imaging is an interesting alternative to the current method (blue dye and radiocolloid) of sentinel lymph node (SLN) mapping in breast cancer. Near-infrared (NIR) emitting cadmium-based Quantum Dots (QDs) could be used for this purpose; however, their wide application is limited because of the toxicity of heavy metals composing the core. Our recent work demonstrated that indium-based QDs exhibit a weak acute local toxicity in vivo compared to their cadmium-based counterparts. In the present study we confirmed the weak toxicity of CuInS2/ZnS QDs in different in vitro models. Further in vivo studies in healthy mice showed that In-based QDs could be visualised in SLN in a few minutes after administration with a progressive increase in fluorescence until 8 h. The quantity of indium was assessed in selected organs and tissues by inductively coupled plasma - mass spectroscopy (ICP-MS) as a function of post-injection time. QD levels decrease rapidly at the injection point in the first hours after administration with a parallel increase in the lymph nodes and to a lesser extent in the liver and spleen. In addition, we observed that 3.5% of the injected indium dose was excreted in faeces in the first 4 days, with only trace quantities in the urine. Metastatic spread to the lymph nodes may hamper its visualisation. Therefore, we further performed non-invasive fluorescence measurement of QDs in SLN in tumour-bearing mice. Metastatic status was assessed by immunohistology and molecular techniques and revealed the utmost metastatic invasion of 36% of SLN. Fluorescence signal was the same irrespective of SLN status. Thus, near-infrared emitting cadmium-free QDs could be an excellent SLN tracer.	[Helle, Marion; Bezdetnaya, Lina; Guillemin, Francois; Marchal, Frederic] Univ Lorraine, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Helle, Marion; Bezdetnaya, Lina; Guillemin, Francois; Marchal, Frederic] CNRS, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Helle, Marion; Bezdetnaya, Lina; Guillemin, Francois; Marchal, Frederic] Ctr Alexis Vautrin, Res Unit, Vandoeuvre Les Nancy, France; [Leroux, Agnes; Plenat, Francois] Univ Lorraine, Signalisat EA4421, Genom & Rech Translationnelle Oncol SiGReTO, Vandoeuvre Les Nancy, France; [Cassette, Elsa; Pons, Thomas; Dubertret, Benoit] Univ Paris 06, CNRS, Lab Phys & Etud Mat, Ecole Super Phys & Chim Ind,UMR 8213, Paris, France	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite	Helle, M (corresponding author), Univ Lorraine, CRAN, UMR 7039, Vandoeuvre Les Nancy, France.	l.bolotine@nancy.unicancer.fr	Pons, Thomas/A-8667-2008; Pons, Thomas/J-2751-2019	Pons, Thomas/0000-0001-8800-4302; Pons, Thomas/0000-0001-8800-4302; Cassette, Elsa/0000-0002-1471-6558	Institut National du Cancer (INCa); Ligue Nationale contre le cancer; Lorraine Region; Centre Alexis Vautrin	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Lorraine Region(Region Grand-Est); Centre Alexis Vautrin	This work was supported by the Institut National du Cancer (INCa), the Ligue Nationale contre le cancer, the Lorraine Region and the Centre Alexis Vautrin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus J, 2005, J MOL DIAGN, V7, P327, DOI 10.1016/S1525-1578(10)60561-2; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Barthelmes L, 2010, EJSO-EUR J SURG ONC, V36, P399, DOI 10.1016/j.ejso.2009.10.007; Bonnema J, 2002, ANN ONCOL, V13, P1531, DOI 10.1093/annonc/mdf319; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; CASTRONOVO FP, 1971, BRIT J EXP PATHOL, V52, P543; Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3; Chen HW, 2007, B ENVIRON CONTAM TOX, V78, P5, DOI 10.1007/s00128-007-9037-6; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; CHOULY C, 1994, CLIN MATER, V15, P293, DOI 10.1016/0267-6605(94)90061-2; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dreau D, 2006, CLIN EXP METASTAS, V23, P41, DOI 10.1007/s10585-006-9016-z; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Estourgie SH, 2003, EUR J SURG ONCOL, V29, P336, DOI 10.1053/ejso.2002.1379; Fischer HC, 2006, ADV FUNCT MATER, V16, P1299, DOI 10.1002/adfm.200500529; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; Goyal A, 2005, BREAST J, V11, P188, DOI 10.1111/j.1075-122X.2005.21591.x; Gravier J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3625405; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Hirche C, 2010, ANN SURG ONCOL, V17, P2357, DOI 10.1245/s10434-010-1010-7; Hirche C, 2012, INT J COLORECTAL DIS, V27, P319, DOI 10.1007/s00384-011-1306-5; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Hoet P, 2011, TOXICOL LETT; Hunter F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-5; Jamieson T, 2007, BIOMATERIALS, V28, P4717, DOI 10.1016/j.biomaterials.2007.07.014; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu YF, 2010, J COLLOID INTERF SCI, V351, P1, DOI 10.1016/j.jcis.2010.07.047; Male KB, 2008, ANAL CHEM, V80, P5487, DOI 10.1021/ac8004555; McMasters KM, 2000, J CLIN ONCOL, V18, P2560, DOI 10.1200/JCO.2000.18.13.2560; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; NTP, 2001, TOX CARC STUD IND PH; PIC E, 2009, MOL IMAGING BIOL; Pons T, 2010, ACS NANO, V4, P2531, DOI 10.1021/nn901421v; Riviere JE, 2009, WIRES NANOMED NANOBI, V1, P26, DOI 10.1002/wnan.24; Slowing II, 2009, SMALL, V5, P57, DOI 10.1002/smll.200800926; Tanaka E, 2006, ANN SURG ONCOL, V13, P1671, DOI 10.1245/s10434-006-9194-6; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Tsay JM, 2005, CHEM BIOL, V12, P1159, DOI 10.1016/j.chembiol.2005.11.002; Vincent-Salomon A, 2009, EUR J CANCER, V45, P1979, DOI 10.1016/j.ejca.2009.03.015; Wong Sandra L, 2002, Breast J, V8, P192, DOI 10.1046/j.1524-4741.2002.08402.x; Yong KT, 2010, INTEGR BIOL-UK, V2, P121, DOI 10.1039/b916663g; ZHENG W, 1994, J TOXICOL ENV HEALTH, V43, P483, DOI 10.1080/15287399409531936; Zurrida S, 1999, INT J ONCOL, V15, P475	47	40	41	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44433	10.1371/journal.pone.0044433	http://dx.doi.org/10.1371/journal.pone.0044433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952979	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500071
J	Ibarz-Pavon, AB; Lemos, AP; Gorla, MC; Regueira, M; Gabastou, JM				Ibarz-Pavon, Ana Belen; Lemos, Ana Paula; Gorla, Maria Cecilia; Regueira, Mabel; Gabastou, Jean-Marc		SIREVA II Working Grp	Laboratory-Based Surveillance of Neisseria meningitidis Isolates from Disease Cases in Latin American and Caribbean Countries, SIREVA II 2006-2010	PLOS ONE			English	Article							INVASIVE MENINGOCOCCAL DISEASE; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; CARRIED MENINGOCOCCI; C DISEASE; SEROGROUP; VACCINATION; SUSCEPTIBILITY; EPIDEMIOLOGY; PENICILLIN	Background: Published data on the epidemiology of meningococcal disease in Latin America and the Caribbean region is scarce and, when available, it is often published in Spanish and/or in non-peer-reviewed journals, making it difficult for the international scientific community to have access. Methods: Laboratory data on 4,735 Neisseria meningitidis strains was collected and reported by the National Reference Laboratories in 19 Latin American countries and the Caribbean Epidemiology Centre (CAREC) between 2006 and 2010 as part of the work carried out by the SIREVA II network. Serogroup and MIC to penicillin, rifampin and chloramphenicol were determined. Results: Isolates were mainly obtained from patients < 5 years, but each year around 25% of isolates came from adult patients. Serogroup distribution was highly variable among countries. Serogroup C was the main cause of disease in Brazil; the majority of disease seen in the Southern cone was caused by serogroup B, but serogroup W135 strains have increased in recent years. In the Andean and Mexico, Central America and Caribbean regions, serogroups B and C were equally present, and serogroup Y was frequently isolated. Isolates were generally susceptible to chloramphenicol, penicillin and rifampin, but almost 60% of isolates characterized in Southern cone countries presented intermediate resistance to penicillin. Five rifampin-resistant isolates have been isolated in Uruguay and Brazil. Conclusions: Serogroup distribution is highly variable among countries, but some geographic structuring can be inferred from these data. Epidemiological and laboratory data are scarce among Andean and Mexico, Central America and Caribbean countries. Evaluation and implementation of corrective measures on disease surveillance and reporting systems and the implementation of molecular diagnostic techniques and molecular characterization on meningococcal isolates are advised.	[Ibarz-Pavon, Ana Belen; Gabastou, Jean-Marc] Pan Amer Hlth Org, Washington, DC USA; [Lemos, Ana Paula; Gorla, Maria Cecilia] Adolfo Lutz Inst, Dept Bacteriol, Div Med Biol, Sao Paulo, Brazil; [Regueira, Mabel] ANLIS INEI Dr Carlos G Malbran, Dept Bacteriol, Buenos Aires, DF, Argentina	Pan American Health Organization; Instituto Adolfo Lutz	Ibarz-Pavon, AB (corresponding author), Pan Amer Hlth Org, Washington, DC USA.	ibarzpav@paho.org	Lemos, Ana Paula/ABE-6240-2021	Echaniz-Aviles, Gabriela/0000-0002-3167-0168; Castaneda, Elizabeth/0000-0001-5970-1598	Canadian International Development Agency (CIDA); Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Canadian International Development Agency (CIDA); Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Funding to the SIREVA II network was provided by the Canadian International Development Agency (CIDA). Since 2010, funding for meningococcal disease surveillance in 2010 is provided by Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2009, J INFECTION, V59, P104, DOI 10.1016/j.jinf.2009.06.001; Agudelo C I, 2000, Rev Panam Salud Publica, V8, P181, DOI 10.1590/S1020-49892000000800005; Agudelo CI, 2008, EMERG INFECT DIS, V14, P990, DOI 10.3201/eid1406.071357; Aguilar-Garcia J, 2009, REV CLIN ESP, V209, P221, DOI 10.1016/S0014-2565(09)71238-X; [Anonymous], 1996, EPI Newsl, V18, P6; Baquero F, 1998, Enferm Infecc Microbiol Clin, V16, P85; Barroso DE, 2007, MEM I OSWALDO CRUZ, V102, P773, DOI [10.1590/S0074-02762007005000104, 10.1590/S0074-02762007000600019]; BROOME CV, 1986, J ANTIMICROB CHEMOTH, V18, P25, DOI 10.1093/jac/18.Supplement_A.25; Brown EM, 2010, ANTIMICROB AGENTS CH, V54, P1016, DOI 10.1128/AAC.01077-09; Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en; Cartwright K., 1995, MENINGOCOCCAL DIS, P115; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Deghmane AE, 2010, J INFECT DIS, V202, P247, DOI 10.1086/653583; Di Fabio JL, 2001, PEDIATR INFECT DIS J, V20, P959, DOI 10.1097/00006454-200110000-00009; Diaz JM, 2001, REV MED CHILE, V129, P719; DiFabio JL, 1997, MICROB DRUG RESIST, V3, P131, DOI 10.1089/mdr.1997.3.131; Doyle TJ, 2010, EMERG INFECT DIS, V16, P113, DOI 10.3201/eid1601.091026; du Plessis M, 2008, J CLIN MICROBIOL, V46, P3208, DOI 10.1128/JCM.00221-08; Gabastou JM, 2008, REV PANAM SALUD PUBL, V24, P1, DOI 10.1590/S1020-49892008000700001; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison LH, 2010, CLIN INFECT DIS, V50, pS37, DOI 10.1086/648963; Hortal M, 2000, Rev Panam Salud Publica, V8, P185, DOI 10.1590/S1020-49892000000800006; Ibarz-Pavon AB, 2011, J INFECT DIS, V204, P1046, DOI 10.1093/infdis/jir466; Jardine A, 2009, COMMUN DIS INTELL, V33, P221; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Kafetzis DA, 2007, CLIN MICROBIOL INFEC, V13, P550, DOI 10.1111/j.1469-0691.2007.01704.x; KUZEMENSKA P, 1984, ZBL BAKT-INT J MED M, V257, P195, DOI 10.1016/S0174-3031(84)80053-0; Lagos R, 1996, PEDIATR INFECT DIS J, V15, P216, DOI 10.1097/00006454-199603000-00008; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Lopez L, 2011, EPIDEMIOLOGY MENINGO; Lovgren M, 2007, J CLIN MICROBIOL, V45, P3184, DOI 10.1128/JCM.00789-07; McEllistrem MC, 2004, EMERG INFECT DIS, V10, P451; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Núñez Niury, 2007, Vaccimonitor, V16, P1; OPS, 2010, INF REG SIREVA 2 201; OPS, 2007, INF REG SIREVA 2 DAT; OPS, 2010, INF REG SIREVA 2 200; OPS, 2008, INF REG SIREVA 2 200; OPS, 2009, INF REG SIREVA 2 200; Safadi MAP, 2010, NEUROL RES, V32, P263, DOI 10.1179/016164110X12644252260754; Parodi V, 1998, REV MED URUG, V14, P221; PELTOLA H, 1982, LANCET, V2, P595; Pereira CS, 2008, J MED MICROBIOL, V57, P338, DOI 10.1099/jmm.0.47631-0; Giffoni GP, 2011, REV PANAM SALUD PUBL, V30, P540, DOI 10.1590/S1020-49892011001200007; Perez Rodriguez A, 1999, Rev Cubana Med Trop, V51, P189; Popovic T, 1998, LAB METHODS DIAGNOSI; Rodriguez AP, 1999, MEM I OSWALDO CRUZ, V94, P433, DOI 10.1590/S0074-02761999000400002; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Salisbury D, 2001, J Paediatr Child Health, V37, pS34, DOI 10.1046/j.1440-1754.2001.00738.x; Skoczynska A, 2010, EUROSURVEILLANCE, V15; Sotolongo F, 2008, MEDICC REV, V9, P16; Stefanelli P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-135; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Taylor-Robinson D, 2010, J PUBLIC HEALTH-UK, V32, P32, DOI 10.1093/pubmed/fdp080; Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Weiss D, 2009, CLIN INFECT DIS, V48, P894, DOI 10.1086/597257; Wikler M., 2006, METHODS DILUTION ANT	64	31	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44102	10.1371/journal.pone.0044102	http://dx.doi.org/10.1371/journal.pone.0044102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952888	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500046
J	Watkins, SC; Maniar, S; Mosher, M; Roman, BL; Tsang, M; St Croix, CM				Watkins, Simon C.; Maniar, Salony; Mosher, Mackenzie; Roman, Beth L.; Tsang, Michael; St Croix, Claudette M.			High Resolution Imaging of Vascular Function in Zebrafish	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; ENDOTHELIAL FUNCTION; EUROPEAN-SOCIETY; GENE-EXPRESSION; WORKING GROUP; NITRIC-OXIDE; DANIO-RERIO; BLOOD-FLOW; DYSFUNCTION; CELL	Rationale: The role of the endothelium in the pathogenesis of cardiovascular disease is an emerging field of study, necessitating the development of appropriate model systems and methodologies to investigate the multifaceted nature of endothelial dysfunction including disturbed barrier function and impaired vascular reactivity. Objective: We aimed to develop and test an optimized high-speed imaging platform to obtain quantitative real-time measures of blood flow, vessel diameter and endothelial barrier function in order to assess vascular function in live vertebrate models. Methods and Results: We used a combination of cutting-edge optical imaging techniques, including high-speed, camera-based imaging (up to 1000 frames/second), and 3D confocal methods to collect real time metrics of vascular performance and assess the dynamic response to the thromboxane A(2) (TXA(2)) analogue, U-46619 (1 mu M), in transgenic zebrafish larvae. Data obtained in 3 and 5 day post-fertilization larvae show that these methods are capable of imaging blood flow in a large (1 mm) segment of the vessel of interest over many cardiac cycles, with sufficient speed and sensitivity such that the trajectories of individual erythrocytes can be resolved in real time. Further, we are able to map changes in the three dimensional sizes of vessels and assess barrier function by visualizing the continuity of the endothelial layer combined with measurements of extravasation of fluorescent microspheres. Conclusions: We propose that this system-based microscopic approach can be used to combine measures of physiologic function with molecular behavior in zebrafish models of human vascular disease.	[Watkins, Simon C.; St Croix, Claudette M.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Maniar, Salony; Mosher, Mackenzie; St Croix, Claudette M.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Roman, Beth L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Tsang, Michael] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Watkins, SC (corresponding author), Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15260 USA.	cls13@pitt.edu	St Croix, Claudette/AAA-3338-2022; Watkins, Simon/ABG-2590-2021; TSANG, Michael/E-2758-2013; Tsang, Michael/AAG-9338-2020; Tsang, Michael/ABV-0504-2022; Tsang, Michael W/I-9305-2014	Watkins, Simon/0000-0003-4092-1552; TSANG, Michael/0000-0001-6384-2422; Tsang, Michael/0000-0001-7123-0063; Tsang, Michael W/0000-0001-7123-0063; Roman, Beth/0000-0002-1250-1705	National Institutes of Health [NIH HL081421, NIH HL079108, NIH HL088016, NIH 1 U54 RR022241-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079108, R01HL081421, R01HL088016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from National Institutes of Health NIH HL081421 (CMS); NIH HL079108 (BLR); NIH HL088016 (MT) and NIH 1 U54 RR022241-01 (SCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird William C, 2006, Curr Atheroscler Rep, V8, P69, DOI 10.1007/s11883-006-0067-z; Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Bagatto B, 2006, PHYSIOL BIOCHEM ZOOL, V79, P194, DOI 10.1086/498185; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Bernal PJ, 2008, CIRC RES, V102, P1575, DOI 10.1161/CIRCRESAHA.108.171264; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Denvir MA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-21; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Feletou M, PFLUGERS ARCH, V459, P941; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; Glyn MCP, 2000, CARDIOVASC RES, V48, P346, DOI 10.1016/S0008-6363(00)00173-5; Glyn MCP, 2002, J VASC RES, V39, P72, DOI 10.1159/000048995; Hove Jay R, 2004, Birth Defects Res C Embryo Today, V72, P277, DOI 10.1002/bdrc.20019; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kopp R, 2010, PHYSIOL GENOMICS, V42A, P8, DOI 10.1152/physiolgenomics.00052.2010; Lai YC, 2011, CIRC RES, V109, P1375, DOI 10.1161/CIRCRESAHA.111.256479; Lang MR, 2010, J THROMB HAEMOST, V8, P1159, DOI 10.1111/j.1538-7836.2010.03815.x; Lucitt MB, 2008, MOL CELL PROTEOMICS, V7, P981, DOI 10.1074/mcp.M700382-MCP200; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Pelster B, 2005, COMP BIOCHEM PHYS A, V142, P215, DOI 10.1016/j.cbpb.2005.05.036; Roman BL, 2000, BIOESSAYS, V22, P882; Roman BL, 2002, DEVELOPMENT, V129, P3009; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Schwerte T, 2003, COMP BIOCHEM PHYS A, V135, P131, DOI 10.1016/S1095-6433(03)00044-8; Schwerte T, 2000, J EXP BIOL, V203, P1659; SEPICH DS, 1994, DEV BIOL, V161, P84, DOI 10.1006/dbio.1994.1010; Shin JT, 2010, PHYSIOL GENOMICS, V42, P300, DOI 10.1152/physiolgenomics.00206.2009; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Teraoka H, 2009, TOXICOL APPL PHARM, V234, P33, DOI 10.1016/j.taap.2008.09.021; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; WESTERFIELD M, 1995, ZEBRAFISH BOOK; WILLERT CE, 1991, EXP FLUIDS, V10, P181; Xu H, 2011, DEV DYNAM, V240, P278, DOI 10.1002/dvdy.22517; Yeh HC, 2006, PROSTAG LEUKOTR ESS, V75, P397, DOI 10.1016/j.plefa.2006.08.001	44	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44018	10.1371/journal.pone.0044018	http://dx.doi.org/10.1371/journal.pone.0044018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952858	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000308206500043
J	Kizilel, R; Demir, E; Azizoglu, S; Asimgi, H; Kavakli, IH; Kizilel, S				Kizilel, Riza; Demir, Enis; Azizoglu, Selimcan; Asimgi, Hande; Kavakli, Ibrahim Halil; Kizilel, Seda			Investigation of Real-Time Photorepair Activity on DNA via Surface Plasmon Resonance	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTORS; CYCLOBUTANE PYRIMIDINE DIMERS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PHOTOLYASE/CRYPTOCHROME FAMILY; ARABIDOPSIS-THALIANA; PHOTOLYASE ACTIVITY; REACTION-MECHANISM; CRYPTOCHROME; REPAIR	The cyclobutane pyrimidine dimer (CPD) and 6-4 lesion formations along with the specific breaks on strands are the most common type of DNA damage caused by Ultraviolet light (UV) irradiation. CPD photolyase I and II construct two subfamilies of flavoproteins, which have recognition and repair capabilities of CPD sites on both single stranded (ssDNA) and double stranded DNA (dsDNA) with the aid of blue light energy. The other types of flavoprotein family consist of cryptochromes (CRY) that act as photoreceptors in plants, or circadian rhythm regulators in animals. Recent findings showed that a specific type of Cryptochrome-Drosophila, Arabidopsis, Synechocystis, Human (CRY-DASH) has photorepair activity on ssDNA. In this work, real-time interactions between CRY-DASH and ss/dsDNA as well as the interactions between Vibrio cholerae photolyase (VcPHR) and ss/dsDNA were investigated using Surface Plasmon Resonance (SPR). The interactions were then characterized and compared in order to investigate the effect of different types of flavoprotein on UV damaged ss/dsDNA. SPR results confirm the specific binding of VcPHR and CRY-DASH with UV treated DNA. This study is the first instance to quantify the interactions of UV treated and untreated DNA with flavoproteins.	[Kizilel, Riza; Demir, Enis; Azizoglu, Selimcan; Asimgi, Hande; Kavakli, Ibrahim Halil; Kizilel, Seda] Koc Univ, Istanbul, Turkey	Koc University	Kizilel, R (corresponding author), Koc Univ, Istanbul, Turkey.	rkizilel@ku.edu.tr; hkavakli@ku.edu.tr; skizilel@ku.edu.tr	Kizilel, Seda/P-3959-2014; Schmidt, Hande/ABF-2338-2020; Kavakli, Ibrahim/AAF-5468-2020	Kizilel, Seda/0000-0001-9092-2698; Kavakli, Ibrahim/0000-0001-6624-3505	College of Engineering at Koc University in Turkey; TUBITAK [110T423, 105T417]; Marie Curie FP7-IRG-DMIOL [239471]; TUBA-GEBIP	College of Engineering at Koc University in Turkey(Koc University); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Marie Curie FP7-IRG-DMIOL; TUBA-GEBIP(Turkish Academy of Sciences)	This study was supported by grants from the College of Engineering at Koc University in Turkey, TUBITAK-110T423, Marie Curie FP7-IRG-DMIOL-239471, TUBITAK-105T417 and TUBA-GEBIP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimgil H, 2012, PLANT SCI, V185, P190, DOI 10.1016/j.plantsci.2011.10.005; Boon EM, 2002, NAT BIOTECHNOL, V20, P282, DOI 10.1038/nbt0302-282; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; Day YSN, 2003, J PHARM SCI-US, V92, P333, DOI 10.1002/jps.10293; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; FOX ME, 1994, MOL CELL BIOL, V14, P8071, DOI 10.1128/MCB.14.12.8071; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; HEELIS PF, 1993, J PHOTOCH PHOTOBIO B, V17, P219, DOI 10.1016/1011-1344(93)80019-6; Henn C, 2012, ANAL BIOCH; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; HUSAIN I, 1987, J BIOL CHEM, V262, P13188; HUSAIN I, 1987, NUCLEIC ACIDS RES, V15, P1109; Kavakli Ibrahim Halil, 2002, Mol Interv, V2, P484, DOI 10.1124/mi.2.8.484; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; Komori H, 2001, P NATL ACAD SCI USA, V98, P13560, DOI 10.1073/pnas.241371398; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; OKAMURA T, 1991, J AM CHEM SOC, V113, P3143, DOI 10.1021/ja00008a050; Otoshi E, 2000, CANCER RES, V60, P1729; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; Roos H, 1998, J MOL RECOGNIT, V11, P204, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<204::AID-JMR424>3.0.CO;2-T; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sancar A, 2000, COLD SPRING HARB SYM, V65, P157, DOI 10.1101/sqb.2000.65.157; SANCAR GB, 1985, BIOCHEMISTRY-US, V24, P1849, DOI 10.1021/bi00329a007; Saxena C, 2005, J AM CHEM SOC, V127, P7984, DOI 10.1021/ja0421607; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; SMITH CA, 1993, J BIOL CHEM, V268, P11143; Svoboda LD, 1993, J BIOL CHEM, V268, P10694; Swinney DC, 2004, NAT REV DRUG DISCOV, V3, P801, DOI 10.1038/nrd1500; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200; Yang KS, 2007, J PHYS CHEM B, V111, P10615, DOI 10.1021/jp071035p; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; Zhao XD, 1997, J BIOL CHEM, V272, P32580, DOI 10.1074/jbc.272.51.32580	43	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44392	10.1371/journal.pone.0044392	http://dx.doi.org/10.1371/journal.pone.0044392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952969	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000099
J	Poza, M; Gayoso, C; Gomez, MJ; Rumbo-Feal, S; Tomas, M; Aranda, J; Fernandez, A; Bou, G				Poza, Margarita; Gayoso, Carmen; Gomez, Manuel J.; Rumbo-Feal, Soraya; Tomas, Maria; Aranda, Jesus; Fernandez, Ana; Bou, German			Exploring Bacterial Diversity in Hospital Environments by GS-FLX Titanium Pyrosequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA; METAGENOMIC ANALYSIS; MICROBIAL DIVERSITY; INFECTIONS; PATHOGENS; SEQUENCE; DATABASE; DOMAIN	Understanding microbial populations in hospital environments is crucial for improving human health. Hospital-acquired infections are an increasing problem in intensive care units (ICU). In this work we present an exploration of bacterial diversity at inanimate surfaces of the ICU wards of the University Hospital A Coruna (Spain), as an example of confined hospital environment subjected to selective pressure, taking the entrance hall of the hospital, an open and crowded environment, as reference. Surface swab samples were collected from both locations and recovered DNA used as template to amplify a hypervariable region of the bacterial 16S rRNA gene. Sequencing of the amplicons was performed at the Roche 454 Sequencing Center using GS-FLX Titanium procedures. Reads were pre-processed and clustered into OTUs (operational taxonomic units), which were further classified. A total of 16 canonical bacterial phyla were detected in both locations. Members of the phyla Firmicutes (mainly Staphylococcus and Streptococcus) and Actinobacteria (mainly Micrococcaceae, Corynebacteriaceae and Brevibacteriaceae) were over-represented in the ICU with respect to the Hall. The phyllum Proteobacteria was also well represented in the ICU, mainly by members of the families Enterobacteriaceae, Methylobacteriaceae and Sphingomonadaceae. In the Hall sample, the phyla Proteobacteria, Bacteroidetes, Deinococcus-Thermus and Cyanobacteria were over-represented with respect to the ICU. Over-representation of Proteobacteria was mainly due to the high abundance of Enterobacteriaceae members. The presented results demonstrate that bacterial diversity differs at the ICU and entrance hall locations. Reduced diversity detected at ICU, relative to the entrance hall, can be explained by its confined character and by the existence of antimicrobial selective pressure. This is the first study using deep sequencing techniques made in hospital wards showing substantial hospital microbial diversity.	[Poza, Margarita; Gayoso, Carmen; Rumbo-Feal, Soraya; Tomas, Maria; Aranda, Jesus; Fernandez, Ana; Bou, German] Univ Hosp, Microbioloy Dept, Biomed Res Inst, La Coruna, Spain; [Gomez, Manuel J.] CSIC, Astrobiol Ctr INTA, Sequencing & Bioinformat Dept, Madrid, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Poza, M (corresponding author), Univ Hosp, Microbioloy Dept, Biomed Res Inst, La Coruna, Spain.	German.Bou.Arevalo@sergas.es	Gómez, Manuel J/F-8854-2016; ARANDA, JESUS/G-9393-2015; Tomas, Maria/AAQ-5899-2020; M, Poza/AAA-2962-2021; Bou, German/H-6683-2015	Gómez, Manuel J/0000-0002-4111-4835; ARANDA, JESUS/0000-0002-1135-095X; Tomas, Maria/0000-0003-4501-0387; Bou, German/0000-0001-8837-0062; Rumbo-Feal, Soraya/0000-0002-1796-1815; Poza, Margarita/0000-0001-9423-7268	Spanish Network for Research in Infectious Diseases (REIPI) [RD06/0008/0025, RD025/0008]; Fondo de Investigaciones Sanitarias [PI081368, PS09/00687]; SERGAS [PS07/90]; Xunta de Galicia [07CSA050916PR]; SERGAS (Galicia, Spain) [PS08/24]; Isidro Parga Pondal Program (Xunta de Galicia, Spain); INTA-CSIC (Madrid, Spain); Instituto de Salud Carlos III (Spain);  [CSD2007-0005]	Spanish Network for Research in Infectious Diseases (REIPI); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); SERGAS; Xunta de Galicia(Xunta de GaliciaEuropean Commission); SERGAS (Galicia, Spain); Isidro Parga Pondal Program (Xunta de Galicia, Spain)(Xunta de Galicia); INTA-CSIC (Madrid, Spain); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); 	This work was supported by the Spanish Network for Research in Infectious Diseases (REIPI, RD06/0008/0025), grants from Fondo de Investigaciones Sanitarias (PI081368 and PS09/00687), SERGAS (PS07/90) and Xunta de Galicia (07CSA050916PR) to GB and a grant from SERGAS (PS08/24, Galicia, Spain) to MP. MP was supported by the Isidro Parga Pondal Program (Xunta de Galicia, Spain), CG by the Spanish Network for Research in Infectious Diseases (REIPI, RD025/0008), MJG by the project Consolider INGENIO CSD2007-0005 and INTA-CSIC (Madrid, Spain) and SRF, MT, JA and AF by Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Armougom F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-576; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bulut C, 2008, MIKROBIYOL BUL, V42, P685; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Ciric L, 2011, J ANTIMICROB CHEMOTH, V66, P2235, DOI 10.1093/jac/dkr311; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins MD, 2001, INT J SYST EVOL MICR, V51, P1349, DOI 10.1099/00207713-51-4-1349; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ehrlich SD, 2010, GASTROEN CLIN BIOL, V34, pS23, DOI 10.1016/S0399-8320(10)70017-8; Fordyce SL, 2011, BIOTECHNIQUES, V51, P127, DOI 10.2144/000113721; Furrie E, 2006, GUT, V55, P141, DOI 10.1136/gut.2005.081695; Gai ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010018; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hanberger H, 2011, INT J ANTIMICROB AG, V38, P331, DOI 10.1016/j.ijantimicag.2011.05.013; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Lai CC, 2011, J CLIN MICROBIOL, V49, P3329, DOI 10.1128/JCM.01241-11; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Mobberley JM, 2012, ENVIRON MICROBIOL, V14, P82, DOI 10.1111/j.1462-2920.2011.02509.x; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Scheckenbach F, 2010, P NATL ACAD SCI USA, V107, P115, DOI 10.1073/pnas.0908816106; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang JL, 2009, J CLIN MICROBIOL, V47, P3226, DOI 10.1128/JCM.00034-09; Weber DJ, 1999, CHEST, V115, p34S, DOI 10.1378/chest.115.suppl_1.34S; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yao KH, 2011, DIAGN MICR INFEC DIS, V70, P291, DOI 10.1016/j.diagmicrobio.2011.03.015; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	45	44	44	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44105	10.1371/journal.pone.0044105	http://dx.doi.org/10.1371/journal.pone.0044105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952889	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000083
J	Gao, YJ; Bertuccio, CA; Balut, CM; Watkins, SC; Devor, DC				Gao, Yajuan; Bertuccio, Claudia A.; Balut, Corina M.; Watkins, Simon C.; Devor, Daniel C.			Dynamin- and Rab5-Dependent Endocytosis of a Ca2+-Activated K+ Channel, KCa2.3	PLOS ONE			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; INTERMEDIATE CONDUCTANCE; DEPENDENT REGULATION; POTASSIUM CHANNEL; TERMINAL DOMAIN; EARLY ENDOSOMES; SKCA CHANNELS; TRAFFICKING; HIK1; KCA3.1	Regulation of the number of ion channels at the plasma membrane is a critical component of the physiological response. We recently demonstrated that the Ca2+-activated K+ channel, KCa2.3 is rapidly endocytosed and enters a Rab35- and EPI64C-dependent recycling compartment. Herein, we addressed the early endocytic steps of KCa2.3 using a combination of fluorescence and biotinylation techniques. We demonstrate that KCa2.3 is localized to caveolin-rich domains of the plasma membrane using fluorescence co-localization, transmission electron microscopy and co-immunoprecipitation (co-IP). Further, in cells lacking caveolin-1, we observed an accumulation of KCa2.3 at the plasma membrane as well as a decreased rate of endocytosis, as assessed by biotinylation. We also demonstrate that KCa2.3 and dynamin II are co-localized following endocytosis as well as demonstrating they are associated by co-IP. Further, expression of K44A dynamin II resulted in a 2-fold increase in plasma membrane KCa2.3 as well as a 3-fold inhibition of endocytosis. Finally, we evaluated the role of Rab5 in the endocytosis of KCa2.3. We demonstrate that expression of a dominant active Rab5 (Q79L) results in the accumulation of newly endocytosed KCa2.3 on to the membrane of the Rab5-induced vacuoles. We confirmed this co-localization by coIP; demonstrating that KCa2.3 and Rab5 are associated. As expected, if Rab5 is required for the endocytosis of KCa2.3, expression of a dominant negative Rab5 (S34N) resulted in an approximate 2-fold accumulation of KCa2.3 at the plasma membrane. This was confirmed by siRNA-mediated knockdown of Rab5. Expression of the dominant negative Rab5 also resulted in a decreased rate of KCa2.3 endocytosis. These results demonstrate that KCa2.3 is localized to a caveolin-rich domain within the plasma membrane and is endocytosed in a dynamin-and Rab5-dependent manner prior to entering the Rab35/EPI64C recycling compartment and returning to the plasma membrane.	[Gao, Yajuan; Bertuccio, Claudia A.; Balut, Corina M.; Watkins, Simon C.; Devor, Daniel C.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gao, YJ (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA.	dd2@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [HL092157]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health grant (HL092157) to DCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; Barbieri MA, 1996, ARCH BIOCHEM BIOPHYS, V326, P64, DOI 10.1006/abbi.1996.0047; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bomberger JM, 2010, CHANNELS, V4, P150, DOI 10.4161/chan.4.3.11223; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Frei E, 2006, CELL PHYSIOL BIOCHEM, V18, P165, DOI 10.1159/000097665; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Girault A, 2012, CURR MED CHEM, V19, P697, DOI 10.2174/092986712798992039; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hamilton KL, 2003, J BIOL CHEM, V278, P16690, DOI 10.1074/jbc.M212959200; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones HM, 2007, CHANNELS, V1, P80, DOI 10.4161/chan.3999; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Ng EL, 2012, CELL BIOCHEM FUNCT, V30, P515, DOI 10.1002/cbf.2827; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Roncarati R, 2005, MOL CELL NEUROSCI, V28, P314, DOI 10.1016/j.mcn.2004.09.015; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233	45	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44150	10.1371/journal.pone.0044150	http://dx.doi.org/10.1371/journal.pone.0044150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952906	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000308213600084
J	Ravasi, DF; O'Riain, MJ; Davids, F; Illing, N				Ravasi, Damiana F.; O'Riain, Mannus J.; Davids, Faezah; Illing, Nicola			Phylogenetic Evidence That Two Distinct Trichuris Genotypes Infect both Humans and Non-Human Primates	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BABOONS PAPIO-URSINUS; GASTROINTESTINAL PARASITES; HELMINTH INFECTIONS; PUBLIC-HEALTH; RISK; IDENTIFICATION; DISEASES; ECOLOGY; MUSCLE	Although there has been extensive debate about whether Trichuris suis and Trichuris trichiura are separate species, only one species of the whipworm T. trichiura has been considered to infect humans and non-human primates. In order to investigate potential cross infection of Trichuris sp. between baboons and humans in the Cape Peninsula, South Africa, we sequenced the ITS1-5.8S-ITS2 region of adult Trichuris sp. worms isolated from five baboons from three different troops, namely the Cape Peninsula troop, Groot Olifantsbos troop and Da Gama Park troop. This region was also sequenced from T. trichiura isolated from a human patient from central Africa (Cameroon) for comparison. By combining this dataset with Genbank records for Trichuris isolated from other humans, non-human primates and pigs from several different countries in Europe, Asia, and Africa, we confirmed the identification of two distinct Trichuris genotypes that infect primates. Trichuris sp. isolated from the Peninsula baboons fell into two distinct clades that were found to also infect human patients from Cameroon, Uganda and Jamaica (named the CP-GOB clade) and China, Thailand, the Czech Republic, and Uganda (named the DG clade), respectively. The divergence of these Trichuris clades is ancient and precedes the diversification of T. suis which clustered closely to the CP-GOB clade. The identification of two distinct Trichuris genotypes infecting both humans and non-human primates is important for the ongoing treatment of Trichuris which is estimated to infect 600 million people worldwide. Currently baboons in the Cape Peninsula, which visit urban areas, provide a constant risk of infection to local communities. A reduction in spatial overlap between humans and baboons is thus an important measure to reduce both cross-transmission and zoonoses of helminthes in Southern Africa.	[Ravasi, Damiana F.; O'Riain, Mannus J.] Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; [Davids, Faezah; Illing, Nicola] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa	University of Cape Town; University of Cape Town	Ravasi, DF (corresponding author), Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa.	Nicola.Illing@uct.ac.za		O'Riain, M. Justin/0000-0001-5233-8327	National Research Foundation (South Africa); University of Cape Town	National Research Foundation (South Africa)(National Research Foundation - South Africa); University of Cape Town	Partial funding was provided by grants from the National Research Foundation (South Africa) and University of Cape Town to M. J. O'Riain and N. Illing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Vera J, 2005, Afr Health Sci, V5, P276; ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cogswell F., 2007, Flynn's parasites of laboratory animals, P693, DOI 10.1002/9780470344552.ch21; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Cutillas C, 2002, PARASITOL RES, V88, P574, DOI 10.1007/s00436-002-0596-5; Cutillas C, 2009, ACTA TROP, V111, P299, DOI 10.1016/j.actatropica.2009.05.011; Cutillas C, 2007, PARASITOL RES, V100, P383, DOI 10.1007/s00436-006-0275-z; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gasser R, 1996, MOL CELL PROBE, V10, P99, DOI 10.1006/mcpr.1996.0014; Hahn NE, 2003, INT J PRIMATOL, V24, P271, DOI 10.1023/A:1023092915171; HAUSFATER G, 1984, NAT HIST, V93, P54; Hoffman TS, 2011, INT J PRIMATOL, V32, P308, DOI 10.1007/s10764-010-9467-6; Hoffman TS, 2012, FRONT ZOOL IN PRESS, V9; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jones-Engel L, 2006, AM J PRIMATOL, V68, P851, DOI 10.1002/ajp.20292; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Liu GH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001539; McManus DP, 1996, INT J PARASITOL, V26, P687, DOI 10.1016/0020-7519(96)82612-9; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; Nissen S, 2012, VET PARASIT IN PRESS; OOI HK, 1993, J VET MED SCI, V55, P363, DOI 10.1292/jvms.55.363; Ravasi DF, 2012, S AFR J WIL IN PRESS; ROLLAND RM, 1985, APPL ENVIRON MICROB, V49, P791, DOI 10.1128/AEM.49.4.791-794.1985; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 2001, MOL CLONING LAB MANU; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Trueba G, 2012, PLOS NEGLET IN PRESS, V6; Turner J, 2002, PARASITE IMMUNOL, V24, P83, DOI 10.1046/j.0141-9838.2001.00442.x; van Doorn AC, 2010, AM J PRIMATOL, V72, P104, DOI 10.1002/ajp.20759; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202	38	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44187	10.1371/journal.pone.0044187	http://dx.doi.org/10.1371/journal.pone.0044187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952922	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600089
J	Karunasekara, Y; Rebbeck, RT; Weaver, LM; Board, PG; Dulhunty, AF; Casarotto, MG				Karunasekara, Yamuna; Rebbeck, Robyn T.; Weaver, Llara M.; Board, Philip G.; Dulhunty, Angela F.; Casarotto, Marco G.			An alpha-helical C-terminal tail segment of the skeletal L-type Ca2+ channel beta(1a) subunit activates ryanodine receptor type 1 via a hydrophobic surface	FASEB JOURNAL			English	Article						excitation-contraction coupling; protein-protein interaction	BETA-1A SUBUNIT; EXCITATION; MUSCLE; SPECTROSCOPY; INVOLVEMENT	Excitation-contraction (EC) coupling in skeletal muscle depends on protein interactions between the transverse tubule dihydropyridine receptor (DHPR) voltage sensor and intracellular ryanodine receptor (RyR1) calcium release channel. We present novel data showing that the C-terminal 35 residues of the beta(1a) subunit adopt a nascent alpha-helix in which 3 hydrophobic residues align to form a hydrophobic surface that binds to RyR1 isolated from rabbit skeletal muscle. Mutation of the hydrophobic residues (L496, L500, W503) in peptide beta(1a)V490-M524, corresponding to the C-terminal 35 residues of beta(1a), reduced peptide binding to RyR1 to 15.2 +/- 7.1% and prevented the 2.9 +/- 0.2-fold activation of RyR1 by 10 nM wild-type peptide. An upstream hydrophobic heptad repeat implicated in beta(1a) binding to RyR1 does not contribute to RyR1 activation. Wild-type beta(1a)A474-A508 peptide (10 nM), containing heptad repeat and hydrophobic surface residues, increased RyR1 activity by 2.3 +/- 0.2- and 2.2 +/- 0.3-fold after mutation of the heptad repeat residues. We conclude that specific hydrophobic surface residues in the 35 residue beta(1a) C-terminus bind to RyR1 and increase channel activity in lipid bilayers and thus may support skeletal EC coupling.-Karunasekara, Y., Rebbeck, R. T., Weaver, L. M., Board, P. G., Dulhunty, A. F., Casarotto, M. G. An alpha-helical C-terminal tail segment of the skeletal L-type Ca2+ channel beta(1a) subunit activates ryanodine receptor type 1 via a hydrophobic surface. FASEB J. 26, 5049-5059 (2012). www.fasebj.org	[Karunasekara, Yamuna; Rebbeck, Robyn T.; Weaver, Llara M.; Board, Philip G.; Dulhunty, Angela F.; Casarotto, Marco G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Translat Biosci, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Casarotto, MG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Translat Biosci, POB 334, Canberra, ACT 2601, Australia.	marco.casarotto@anu.edu.au	Dulhunty, Angela/AAO-5421-2020	Dulhunty, Angela/0000-0001-9493-4944; Casarotto, Marco/0000-0002-0571-7671				Bannister RA, 2007, J MUSCLE RES CELL M, V28, P275, DOI 10.1007/s10974-007-9118-5; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Beam KG, 2010, J GEN PHYSIOL, V136, P7, DOI 10.1085/jgp.201010461; Beurg M, 1999, BIOPHYS J, V77, P2953, DOI 10.1016/S0006-3495(99)77128-6; BODENHAUSEN G, 1984, J MAGN RESON, V58, P370, DOI 10.1016/0022-2364(84)90142-2; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Dayal A, 2010, CELL CALCIUM, V47, P500, DOI 10.1016/j.ceca.2010.04.003; Goddard T. D., THESIS U CALIFORNIA; Karunasekara Y, 2009, EUR BIOPHYS J BIOPHY, V39, P75, DOI 10.1007/s00249-009-0467-4; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kourie JI, 1996, AM J PHYSIOL-CELL PH, V270, pC1675, DOI 10.1152/ajpcell.1996.270.6.C1675; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rebbeck RT, 2011, BIOPHYS J, V100, P922, DOI 10.1016/j.bpj.2011.01.022; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Sheridan DC, 2004, BIOPHYS J, V87, P929, DOI 10.1529/biophysj.104.043810; Wei L, 2009, INT J BIOCHEM CELL B, V41, P2214, DOI 10.1016/j.biocel.2009.04.017; Wurthrich K., 1986, NMR PROTEINS NUCL AC	18	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2012	26	12					5049	5059		10.1096/fj.12-211334	http://dx.doi.org/10.1096/fj.12-211334			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22962299				2022-12-25	WOS:000311838300026
J	Chen, TD; Xue, LX; Niu, J; Ma, LW; Li, N; Cao, XX; Li, Q; Wang, M; Zhao, WT; Li, GD; Wang, JM; Tong, TJ				Chen, Tianda; Xue, Lixiang; Niu, Jing; Ma, Liwei; Li, Na; Cao, Xiaoxiao; Li, Qian; Wang, Meng; Zhao, Wenting; Li, Guodong; Wang, Jiamu; Tong, Tanjun			The Retinoblastoma Protein Selectively Represses E2F1 Targets via a TAAC DNA Element during Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLASTS; TUMOR-SUPPRESSOR; HETEROCHROMATIN FORMATION; REPLICATIVE SENESCENCE; GENES; CYCLE; PROLIFERATION; ACTIVATION; P27(KIP1); MYB	The retinoblastoma (Rb) protein mediates heterochromatin formation at the promoters of E2 transcription factor 1 (E2F1) target genes, such as proliferating cell nuclear antigen and cyclin A2 (CCNA2), and represses these genes during cellular senescence. However, the selectivity of Rb recruitment is still not well understood. Here, we demonstrate that a senescence-associated gene is a direct target of E2F1 and is also repressed by heterochromatin in senescent cells. In contrast, ARF and p27(KIP1), which are also E2F1 targets, are not repressed by Rb and heterochromatin formation. By comparing the promoter sequences of these genes, we found a novel TAAC element that is present in the cellular senescence-inhibited gene, proliferating cell nuclear antigen, and CCNA2 promoters but absent from the ARF and p27KIP1 promoters. This TAAC element associates with Rb and is required for Rb recruitment. We further determined that TAAC element-mediated Rb association requires the E2F1 binding site, but not E2F1 protein. These results provide a novel molecular mechanism for the different expression patterns of E2F1 targets and afford new mechanistic insight regarding the selectivity of Rb-mediated heterochromatin formation and gene repression during cellular senescence.	[Chen, Tianda; Xue, Lixiang; Niu, Jing; Ma, Liwei; Li, Na; Cao, Xiaoxiao; Li, Qian; Wang, Meng; Zhao, Wenting; Li, Guodong; Wang, Jiamu; Tong, Tanjun] Peking Univ, Hlth Sci Ctr, Res Ctr Aging, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China	Peking University	Tong, TJ (corresponding author), Peking Univ, Hlth Sci Ctr, Res Ctr Aging, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.	ttj@bjmu.edu.cn	Li, Na/AAV-8761-2020		National Basic Research Programs of China [2012CB911200, 2013CB530801]; National Natural Science Foundation of China [30973146, 31000609, 31071206]; Ministry of Education of the People's Republic of China [20090001120044]	National Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China(Ministry of Education, China)	This work was supported by National Basic Research Programs of China Grants 2012CB911200 and 2013CB530801; National Natural Science Foundation of China Grants 30973146, 31000609, and 31071206; and Ministry of Education of the People's Republic of China Grant 20090001120044.	Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; Elliott MJ, 2001, CLIN CANCER RES, V7, P3590; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Guo SZ, 2004, EXP CELL RES, V298, P465, DOI 10.1016/j.yexcr.2004.04.044; Haddad MM, 1999, EXP CELL RES, V253, P561, DOI 10.1006/excr.1999.4688; Humbert PO, 2000, GENE DEV, V14, P690; Iaquinta PJ, 2005, COLD SH Q B, V70, P309, DOI 10.1101/sqb.2005.70.050; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Joaquin M, 2002, ONCOGENE, V21, P7923, DOI 10.1038/sj.onc.1206001; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Li QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013732; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Ma LW, 2008, MOL CELL BIOL, V28, P6290, DOI 10.1128/MCB.00142-08; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Mittnacht S, 1997, CURR BIOL, V7, P219, DOI 10.1016/S0960-9822(97)70094-0; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; SAIKUMAR P, 1990, P NATL ACAD SCI USA, V87, P8452, DOI 10.1073/pnas.87.21.8452; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zhu L, 2010, CELL RES, V20, P605, DOI 10.1038/cr.2010.71	37	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37540	37551		10.1074/jbc.M111.260679	http://dx.doi.org/10.1074/jbc.M111.260679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955272	hybrid, Green Published			2022-12-25	WOS:000310588500082
J	Reinke, LM; Xu, YL; Cheng, CH				Reinke, Lauren M.; Xu, Yilin; Cheng, Chonghui			Snail Represses the Splicing Regulator Epithelial Splicing Regulatory Protein 1 to Promote Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; GENE; CELLS; SF2/ASF	Epithelial-mesenchymal transition (EMT), a tightly regulated process that is critical for development, is frequently re-activated during cancer metastasis and recurrence. We reported previously that CD44 isoform switching is critical for EMT and showed that the splicing factor ESRP1 inhibits CD44 isoform switching during EMT. However, the mechanism by which ESRP1 is regulated during EMT has not been fully understood. Here we show that the transcription repressor Snail binds to E-boxes in the ESRP1 promoter, causing repression of the ESRP1 gene. Biochemically, we define the mechanism by which ESRP1 regulates CD44 alternative splicing: ESRP1 binds to the intronic region flanking a CD44 variable exon and causes increased variable exon inclusion. We further show that ectopically expressing ESRP1 inhibits Snail-induced EMT, suggesting that down-regulation of ESRP1 is required for function by Snail in EMT. Together, these data reveal how the transcription factor Snail mediates EMT through regulation of a splicing factor.	[Reinke, Lauren M.; Xu, Yilin; Cheng, Chonghui] Northwestern Univ, Dept Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol,Feinberg Sch Med, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Cheng, CH (corresponding author), Northwestern Univ, Dept Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol,Feinberg Sch Med, 303 E Super St, Chicago, IL 60611 USA.	chengc@northwestern.edu			American Cancer Society; American Association for Cancer Research; Department of Defense Breast Cancer Research Program; Schweppe Foundation; Lynn Sage Foundation; National Institutes of Health Carcinogenesis Training Grant [T32-CA009560-21]; Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009560] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); American Association for Cancer Research; Department of Defense Breast Cancer Research Program(United States Department of Defense); Schweppe Foundation; Lynn Sage Foundation; National Institutes of Health Carcinogenesis Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the American Cancer Society, American Association for Cancer Research, the Department of Defense Breast Cancer Research Program, the Schweppe Foundation, and the Lynn Sage Foundation (to C. C.).; Supported by a predoctoral fellowship from the National Institutes of Health Carcinogenesis Training Grant T32-CA009560-21 and a Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BRICKELL PM, 1983, NATURE, V306, P756, DOI 10.1038/306756a0; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Dittmar KA, 2012, MOL CELL BIOL, V32, P1468, DOI 10.1128/MCB.06536-11; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Galiana-Arnoux D, 2005, BIOCHEM BIOPH RES CO, V336, P667, DOI 10.1016/j.bbrc.2005.08.153; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Jia R, 2009, J VIROL, V83, P167, DOI 10.1128/JVI.01719-08; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MAUHIN V, 1993, NUCLEIC ACIDS RES, V21, P3951, DOI 10.1093/nar/21.17.3951; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nakayama H, 1998, DEV BIOL, V199, P150, DOI 10.1006/dbio.1998.8914; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Sharma S, 2009, BLOOD, V114, P4179, DOI 10.1182/blood-2009-03-206482; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	25	72	74	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36435	36442		10.1074/jbc.M112.397125	http://dx.doi.org/10.1074/jbc.M112.397125			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22961986	Green Published, hybrid			2022-12-25	WOS:000310364000063
J	Chen, KY; Chang, SS; Chen, CYC				Chen, Kuan-Yu; Chang, Su-Sen; Chen, Calvin Yu-Chian			In Silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors from Traditional Chinese Medicine	PLOS ONE			English	Article							DRUG DISCOVERY; OBESITY; ORLISTAT; ABSORPTION; PROGRAM; PROTEIN; WEIGHT; DESIGN	Pancreatic triacylglycerol lipase (PNLIP) are primary lipases that are critical for triacylglyceride digestion in human. Since reduced metabolism of triacylglyceride might be a plausible concept for weight loss, we screened for potential PNLIP inhibitors from traditional Chinese medicine (TCM) with the aim to identify weight loss candidate compounds. TCM candidates Aurantiamide, Cnidiadin, and 2-hexadecenoic acid exhibited higher Dock Scores than the commercial drug Orlistat, and were also predicted to have inhibitory characteristics against PNLIP using constructed MLR (R-2 = 0.8664) and SVM (R-2 = 0.9030) models. Molecular dynamics indicated that the TCM-PNLIP complexes formed were stable. We identified that the PNLIP binding site has several residues that can serve as anchors, and a hydrophobic corridor that provides additional stability to the complex. Aurantiamide, Cnidiadin, and 2-hexadecenoic acid all have features that correspond to these binding site features, indicating their potential as candidates for PNLIP inhibitors. The information presented in this study may provide helpful insights to designing novel weight-control drugs.	[Chen, Kuan-Yu] China Med Univ, Dept Chinese Med, Taichung, Taiwan; [Chen, Kuan-Yu; Chang, Su-Sen; Chen, Calvin Yu-Chian] China Med Univ, Lab Computat & Syst Biol, Taichung, Taiwan; [Chang, Su-Sen; Chen, Calvin Yu-Chian] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chen, Calvin Yu-Chian] China Med Univ, Beigang Hosp, Yunlin, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Asia University Taiwan; China Medical University Taiwan	Chen, KY (corresponding author), China Med Univ, Dept Chinese Med, Taichung, Taiwan.	ycc929@MIT.EDU	Chen, Calvin Yu-Chian/E-9402-2010	Chen, Calvin Yu-Chian/0000-0003-3306-250X; Chen, Calvin Yu-Chian/0000-0001-9213-9832	National Science Council of Taiwan [NSC 100-2325-B-039-001]; Committee on Chinese Medicine and Pharmacy [CCMP100-RD-030]; China Medical University and Asia University [DMR-101-094]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH101-TD-C111-005]; China Medical University Beigang Hospital [CMUBH R101-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy; China Medical University and Asia University; Taiwan Department of Health Clinical Trial and Research Center of Excellence; Taiwan Department of Health Cancer Research Center of Excellence; China Medical University Beigang Hospital(China Medical University)	The research was supported by grants from the National Science Council of Taiwan (NSC 100-2325-B-039-001), Committee on Chinese Medicine and Pharmacy (CCMP100-RD-030), China Medical University and Asia University (DMR-101-094). This study is also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004) and Taiwan Department of Health Cancer Research Center of Excellence (DOH101-TD-C111-005). Partial funding is also provided by China Medical University Beigang Hospital (CMUBH R101-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borhani DW, 2012, J COMPUT AID MOL DES, V26, P15, DOI 10.1007/s10822-011-9517-y; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110; Chang KW, 2011, J BIOMOL STRUCT DYN, V29, P243, DOI 10.1080/073911011010524988; Chang PC, 2011, J BIOMOL STRUCT DYN, V29, P471, DOI 10.1080/07391102.2011.10507399; Chang SS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002315; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen CYC, 2009, J MOL GRAPH MODEL, V28, P261, DOI 10.1016/j.jmgm.2009.08.004; Chen JH, 2012, CLIN RHEUMATOL, V31, P239, DOI 10.1007/s10067-011-1802-6; Chen KC, 2011, CHEM BIOL DRUG DES, V78, P679, DOI 10.1111/j.1747-0285.2011.01202.x; Chen KC, 2011, MOL BIOSYST, V7, P2711, DOI 10.1039/c1mb05164d; Ge H, 2010, NAT PROD REP, V27, P1758, DOI 10.1039/c0np00005a; Guerciolini R, 1997, INT J OBESITY, V21, pS12; Hodgson J, 2001, NAT BIOTECHNOL, V19, P722, DOI 10.1038/90761; IVANCIUC O, 2007, REV COMPUTATIONAL CH, V23, P291, DOI DOI 10.1002/9780470116449.CH6; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Karamadoukis L, 2009, CLIN NEPHROL, V71, P430; Lin HY, 2008, J CHIN MED ASSOC, V71, P305, DOI 10.1016/S1726-4901(08)70127-8; Lin WY, 2011, CAN MED ASSOC J, V183, pE329, DOI 10.1503/cmaj.101303; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mukherjee M, 2003, J MOL CATAL B-ENZYM, V22, P369, DOI 10.1016/S1381-1177(03)00052-3; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; ROGERS D, 1994, J CHEM INF COMP SCI, V34, P854, DOI 10.1021/ci00020a020; Sampson HA, 2009, J ALLERGY CLIN IMMUN, V123, P317, DOI 10.1016/j.jaci.2008.12.1112; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Slinker BK, 2008, CIRCULATION, V117, P1732, DOI 10.1161/CIRCULATIONAHA.106.654376; Thomson ABR, 1997, METHOD ENZYMOL, V286, P3; Tsai TY, 2011, J COMPUT AID MOL DES, V25, P525, DOI 10.1007/s10822-011-9438-9; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vapnik V., 1963, AUTOM REMOTE, V24, P774; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WHO, 2010, 10 FACTS OB; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yang SC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002189; ZHI JG, 1995, J CLIN PHARMACOL, V35, P1103, DOI 10.1002/j.1552-4604.1995.tb04034.x	36	20	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43932	10.1371/journal.pone.0043932	http://dx.doi.org/10.1371/journal.pone.0043932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970152	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400026
J	Kawanabe, Y; Takahashi, M; Jin, XJ; Abdul-Majeed, S; Nauli, AM; Sari, Y; Nauli, SM				Kawanabe, Yoshifumi; Takahashi, Maki; Jin, Xingjian; Abdul-Majeed, Shakila; Nauli, Andromeda M.; Sari, Youssef; Nauli, Surya M.			Cilostazol Prevents Endothelin-Induced Smooth Muscle Constriction and Proliferation	PLOS ONE			English	Article							PHOSPHODIESTERASE INHIBITOR; BASILAR ARTERY; CA2+ CHANNELS; CONTRACTION; CELLS; POLYCYSTIN-2; INVOLVEMENT; PLASMA; INFLUX; CILIA	Cilostazol is a phosphodiesterase inhibitor that has been shown to inhibit platelet activation. Endothelin is known to be the most potent endogenous growth promoting and vasoactive peptide. In patients and animal models with stroke, the level of circulating endothelin increases and complicates the recovery progress contributed by vascular constriction (an immediate pathology) and vascular proliferation (a long-term pathology). However, the effects of cilostazol on endothelin have not been explored. To demonstrate the dual-antagonizing effects of cilostazol on vasoconstriction and cell proliferation induced by endothelin, we used primary culture of mouse vascular smooth muscle cells in vitro, mouse femoral artery ex vivo, and intracranial basilar artery ex vivo. We show that the dual-inhibition effects of cilostazol are mediated by blocking endothelin-induced extracellular calcium influx. Although cilostazol does not inhibit endothelin-induced intraorganellar calcium release, blockade of extracellular calcium influx is sufficient to blunt endothelin-induced vasoconstriction. We also show that cilostazol inhibits endothelin-induced cellular proliferation by blocking extracellular calcium influx. Inhibition of cAMP-dependent protein kinase (PKA) can block anti-proliferation activity of cilostazol, confirming the downstream role of PKA in cellular proliferation. To further demonstrate the selectivity of the dual-antagonizing effects of cilostazol, we used a different phosphodiesterase inhibitor. Interestingly, sildenafil inhibits endothelin-induced vasoconstriction but not cellular proliferation in smooth muscle cells. For the first time, we show selective dual-antagonizing effects of cilostazol on endothelin. We propose that cilostazol is an excellent candidate to treat endothelin-associated diseases, such as stroke.	[Kawanabe, Yoshifumi; Takahashi, Maki; Jin, Xingjian; Abdul-Majeed, Shakila; Sari, Youssef; Nauli, Surya M.] Univ Toledo, Dept Pharmacol, Toledo, OH 43606 USA; [Nauli, Andromeda M.] E Tennessee State Univ, Dept Hlth Sci, Johnson City, TN 37614 USA	University System of Ohio; University of Toledo; East Tennessee State University	Kawanabe, Y (corresponding author), Otsu Municipal Hosp, Dept Neurosurg, Otsu, Shiga, Japan.	Surya.Nauli@UToledo.Edu	Sari, Youssef/X-5449-2018					Abdul-Majeed S, 2011, CELL MOL LIFE SCI; Abdul-Majeed S, 2012, CELL MOL LIFE SCI, V69, P165, DOI 10.1007/s00018-011-0744-0; Abdul-Majeed S, 2011, HYPERTENSION, V58, P325, DOI 10.1161/HYPERTENSIONAHA.111.172080; AbouAlaiwi WA, 2011, HUM MOL GENET, V20, P354, DOI 10.1093/hmg/ddq470; AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Al-Qudah ZA, 2011, EXPERT OPIN PHARMACO, V12, P1305, DOI 10.1517/14656566.2011.576248; ALABADI JA, 1993, NEUROSURGERY, V33, P707, DOI 10.1227/00006123-199310000-00022; Chen WJ, 2011, ARTERIOSCL THROM VAS, V31, P2106, DOI 10.1161/ATVBAHA.111.230987; FUJIMORI A, 1990, LANCET, V336, P633, DOI 10.1016/0140-6736(90)93432-O; Hefke T, 2012, THORAC CARDIOV SURG, V60, P26, DOI 10.1055/s-0030-1250726; Kawanabe Y, 2005, CELL SIGNAL, V17, P911, DOI 10.1016/j.cellsig.2005.01.001; Kawanabe Y, 2002, AM J PHYSIOL-CELL PH, V282, pC330, DOI 10.1152/ajpcell.00227.2001; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; Kawanabe Y, 2006, J NEUROSURG, V105, P288, DOI 10.3171/jns.2006.105.2.288; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Lucchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020785; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Nakamura K, 2006, J VASC RES, V43, P86, DOI 10.1159/000089723; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2003, BIOL NEONATE, V83, P123, DOI 10.1159/000067595; Nauli SM, 2000, GEN PHARMACOL-VASC S, V35, P107, DOI 10.1016/S0306-3623(01)00100-8; Nauli SM, 2001, AM J PHYSIOL-HEART C, V280, pH1019, DOI 10.1152/ajpheart.2001.280.3.H1019; Nauli SM, 2001, AM J PHYSIOL-CELL PH, V281, pC1785, DOI 10.1152/ajpcell.2001.281.6.C1785; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Sallustio F, 2010, CURR VASC PHARMACOL, V8, P363, DOI 10.2174/157016110791112331; Sanganalmath SK, 2008, CAN J PHYSIOL PHARM, V86, P180, DOI 10.1139/Y08-005; Shiraishi Y, 1998, BRIT J PHARMACOL, V123, P869, DOI 10.1038/sj.bjp.0701699; SUZUKI R, 1992, J NEUROSURG, V77, P96, DOI 10.3171/jns.1992.77.1.0096; TAKAHASHI S, 1992, J CARDIOVASC PHARM, V20, P900, DOI 10.1097/00005344-199212000-00009; TANAKA T, 1988, PHARMACOLOGY, V36, P313, DOI 10.1159/000138400; Witteveen PO, 2010, NEOPLASIA, V12, P941, DOI 10.1593/neo.10582; YAMAURA I, 1992, J NEUROSURG, V76, P99, DOI 10.3171/jns.1992.76.1.0099; ZIV I, 1992, STROKE, V23, P1014, DOI 10.1161/01.STR.23.7.1014	34	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44476	10.1371/journal.pone.0044476	http://dx.doi.org/10.1371/journal.pone.0044476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957074	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800067
J	Meyer, GF; Wong, LT; Timson, E; Perfect, P; White, MD				Meyer, Georg F.; Wong, Li Ting; Timson, Emma; Perfect, Philip; White, Mark D.			Objective Fidelity Evaluation in Multisensory Virtual Environments: Auditory Cue Fidelity in Flight Simulation	PLOS ONE			English	Article							SUPERIOR COLLICULUS NEURONS; VISUAL-MOTION SIGNALS; PSYCHOMETRIC FUNCTION; VESTIBULAR CUES; SELF-MOTION; INTEGRATION; PERFORMANCE; REALITY; DETERMINANTS; FACILITATION	We argue that objective fidelity evaluation of virtual environments, such as flight simulation, should be human-performance-centred and task-specific rather than measure the match between simulation and physical reality. We show how principled experimental paradigms and behavioural models to quantify human performance in simulated environments that have emerged from research in multisensory perception provide a framework for the objective evaluation of the contribution of individual cues to human performance measures of fidelity. We present three examples in a flight simulation environment as a case study: Experiment 1: Detection and categorisation of auditory and kinematic motion cues; Experiment 2: Performance evaluation in a target-tracking task; Experiment 3: Transferrable learning of auditory motion cues. We show how the contribution of individual cues to human performance can be robustly evaluated for each task and that the contribution is highly task dependent. The same auditory cues that can be discriminated and are optimally integrated in experiment 1, do not contribute to target-tracking performance in an in-flight refuelling simulation without training, experiment 2. In experiment 3, however, we demonstrate that the auditory cue leads to significant, transferrable, performance improvements with training. We conclude that objective fidelity evaluation requires a task-specific analysis of the contribution of individual cues.	[Meyer, Georg F.; Wong, Li Ting] Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England; [Timson, Emma; Perfect, Philip; White, Mark D.] Univ Liverpool, Sch Engn, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Meyer, GF (corresponding author), Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England.	georg@liv.ac.uk	White, Mark/AAG-8761-2020	White, Mark/0000-0002-8611-9525; Meyer, Georg/0000-0002-3739-1653	Engineering and Physical Sciences Research Council [EP/K503538/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aggarwal R, 2007, ANN SURG, V246, P771, DOI 10.1097/SLA.0b013e3180f61b09; Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; [Anonymous], 2008, JAR FSTD H HELICOPTE; Barnett-Cowan M, 2011, EXP BRAIN RES, V214, P27, DOI 10.1007/s00221-011-2802-0; Barnett-Cowan M, 2009, EXP BRAIN RES, V198, P221, DOI 10.1007/s00221-009-1779-4; Bell HH, 1998, INT J AVIAT PSYCHOL, V8, P223, DOI 10.1207/s15327108ijap0803_4; Berger DR, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1658349.1658354; Berger DR, 2009, EXP BRAIN RES, V198, P287, DOI 10.1007/s00221-009-1767-8; Badia SBI, 2009, PRESENCE-TELEOP VIRT, V18, P277, DOI 10.1162/pres.18.4.277; Bowman DA, 2007, COMPUTER, V40, P36, DOI 10.1109/MC.2007.257; Burki-Cohen J, 2007, AIAA MOD SIM TECHN C, P6564; Calvert G., 2004, HDB MULTISENSORY PRO; Dahlstrom N, 2009, THEOR ISS ERGON SCI, V10, P305, DOI 10.1080/14639220802368864; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ferwerda JA, 2003, PROC SPIE, V5007, P290, DOI 10.1117/12.473899; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Grant P, 2007, J AIRCRAFT, V44, P927, DOI 10.2514/1.25807; Green AM, 2010, CURR OPIN NEUROBIOL, V20, P353, DOI 10.1016/j.conb.2010.04.009; Hale KS, 2009, ERGONOMICS, V52, P187, DOI 10.1080/00140130802376000; Harrison NR, 2010, J VISION, V10, DOI 10.1167/10.14.16; Ho C., 2008, MULTISENSORY DRIVER; Hodge SJ, 2011, P 67 ANN FOR AM HEL; Jones E. R., 1985, HUMAN FACTORS ASPECT; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Lathan CE, 2002, PRESENCE-TELEOP VIRT, V11, P368, DOI 10.1162/105474602760204282; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; Longridge T, 2001, P 11 INT S AV PSYCH; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; Maran NJ, 2003, MED EDUC, V37, P22, DOI 10.1046/j.1365-2923.37.s1.9.x; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Meyer G, 2003, SPEECH COMMUN, V41, P429, DOI 10.1016/S0167-6393(03)00013-X; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Meyer GF, 2005, EXP BRAIN RES, V166, P538, DOI 10.1007/s00221-005-2394-7; Padfield G, 2005, AEROSP SCI TECHNOL, V9, P400, DOI 10.1016/j.ast.2005.03.004; Padfield GD, 2003, AERONAUT J, V107, P529; Perfect P, 2011, P 37 EUR ROT FOR GAL; Perfect P, 2010, P 36 EUR ROT FOR PAR; Quick R., 1974, BIOL CYBERN, V16, P65, DOI DOI 10.1007/BF00271628; Schricker BC, 2001, PROC ANNU SIMUL SYMP, P109, DOI 10.1109/SIMSYM.2001.922122; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Shapiro MJ, 2004, QUAL SAF HEALTH CARE, V13, P417, DOI 10.1136/qshc.2003.005447; Valjamae A, 2008, PRESENCE-TELEOP VIRT, V17, P43, DOI 10.1162/pres.17.1.43; Wallet G, 2010, STUD HEALTH TECHNOL, V154, P145, DOI 10.3233/978-1-60750-561-7-145; White MD, 2009, P 35 EUR ROT FOR; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wuerger SM, 2003, PERCEPT PSYCHOPHYS, V65, P1188, DOI 10.3758/BF03194844; [No title captured]	49	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44381	10.1371/journal.pone.0044381	http://dx.doi.org/10.1371/journal.pone.0044381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957068	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800061
J	Pennell, MW; Sarver, BAJ; Harmon, LJ				Pennell, Matthew W.; Sarver, Brice A. J.; Harmon, Luke J.			Trees of Unusual Size: Biased Inference of Early Bursts from Large Molecular Phylogenies	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; DIVERSIFICATION RATES; EVOLUTIONARY RADIATIONS; SPECIES DELIMITATION; FOSSIL RECORD; EXTINCTION; DIVERSITY; SPECIATION; DYNAMICS; PATTERNS	An early burst of speciation followed by a subsequent slowdown in the rate of diversification is commonly inferred from molecular phylogenies. This pattern is consistent with some verbal theory of ecological opportunity and adaptive radiations. One often-overlooked source of bias in these studies is that of sampling at the level of whole clades, as researchers tend to choose large, speciose clades to study. In this paper, we investigate the performance of common methods across the distribution of clade sizes that can be generated by a constant-rate birth-death process. Clades which are larger than expected for a given constant-rate branching process tend to show a pattern of an early burst even when both speciation and extinction rates are constant through time. All methods evaluated were susceptible to detecting this false signature when extinction was low. Under moderate extinction, both the c-statistic and diversity-dependent models did not detect such a slowdown but only because the signature of a slowdown was masked by subsequent extinction. Some models which estimate time-varying speciation rates are able to detect early bursts under higher extinction rates, but are extremely prone to sampling bias. We suggest that examining clades in isolation may result in spurious inferences that rates of diversification have changed through time.	[Pennell, Matthew W.; Sarver, Brice A. J.; Harmon, Luke J.] Univ Idaho, Inst Bioinformat & Evolutionary Studies IBEST, Moscow, ID 83843 USA; [Pennell, Matthew W.; Sarver, Brice A. J.; Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Pennell, Matthew W.; Sarver, Brice A. J.; Harmon, Luke J.] BEACON Ctr Study Evolut Act, E Lansing, MI USA	Idaho; University of Idaho; Idaho; University of Idaho	Pennell, MW (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies IBEST, Moscow, ID 83843 USA.	mwpennell@gmail.com		Harmon, Luke/0000-0002-4985-5750	National Science Foundation [DEB-0919499, DBI-0939454]; NSERC-PGS-M award	National Science Foundation(National Science Foundation (NSF)); NSERC-PGS-M award	LJH and MWP were funded by National Science Foundation grant DEB-0919499. MWP also received funding from a NSERC-PGS-M award. This material is based in part upon work supported by the National Science Foundation under Cooperative Agreement No. DBI-0939454. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Benton MJ, 2007, PALAEONTOLOGY, V50, P23, DOI 10.1111/j.1475-4983.2006.00612.x; Bokma F, 2009, P ROY SOC B-BIOL SCI, V276, P993, DOI 10.1098/rspb.2008.1249; Brock CD, 2011, SYST BIOL, V60, P410, DOI 10.1093/sysbio/syr007; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cusimano N, 2012, SYSTEMATIC BIOL; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Davies TJ, 2004, P ROY SOC B-BIOL SCI, V271, P2195, DOI 10.1098/rspb.2004.2849; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Etienne RS, 2012, SYST BIOL, V61, P204, DOI 10.1093/sysbio/syr091; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Fordyce JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011781; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Price T, 2007, SPECIATION BIRDS; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Quental TB, 2009, EVOLUTION, V63, P3158, DOI 10.1111/j.1558-5646.2009.00794.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; Revell LJ, 2005, SYST BIOL, V54, P973, DOI 10.1080/10635150500354647; Rosenblum EB, 2012, EVOL BIOL, V39, P255, DOI 10.1007/s11692-012-9171-x; Ruber L, 2005, EVOLUTION, V59, P1119; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; SLOWINSKI JB, 1993, AM NAT, V142, P1019, DOI 10.1086/285586; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Stadler T, 2011, SYST BIOL, V60, P676, DOI 10.1093/sysbio/syr029; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Stadler T, 2008, MATH BIOSCI, V216, P163, DOI 10.1016/j.mbs.2008.09.006; Weir JT, 2006, EVOLUTION, V60, P842; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x	53	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43348	10.1371/journal.pone.0043348	http://dx.doi.org/10.1371/journal.pone.0043348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957027	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800019
J	Wang, L; Xiang, SY; Williams, KA; Dong, HQ; Bai, WL; Nicosia, SV; Khochbin, S; Bepler, G; Zhang, XH				Wang, Lei; Xiang, Shengyan; Williams, Kendra A.; Dong, Huiqin; Bai, Wenlong; Nicosia, Santo V.; Khochbin, Saadi; Bepler, Gerold; Zhang, Xiaohong			Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; VINORELBINE PLUS CISPLATIN; ADJUVANT CHEMOTHERAPY; ANTICANCER AGENTS; CLINICAL-TRIALS; GASTRIC-CANCER; EXPRESSION; P53; PHOSPHORYLATION; ACETYLATION	Histone deacetylase inhibitors (HDACi) are promising therapeutic agents which are currently used in combination with chemotherapeutic agents in clinical trials for cancer treatment including non-small cell lung cancer (NSCLC). However, the mechanisms underlying their anti-tumor activities remain elusive. Previous studies showed that inhibition of HDAC6 induces DNA damage and sensitizes transformed cells to anti-tumor agents such as etoposide and doxorubicin. Here, we showed that depletion of HDAC6 in two NSCLC cell lines, H292 and A549, sensitized cells to cisplatin, one of the first-line chemotherapeutic agents used to treat NSCLC. We suggested that depletion of HDAC6 increased cisplatin-induced cytotoxicity was due to the enhancement of apoptosis via activating ATR/Chk1 pathway. Furthermore, we showed that HDAC6 protein levels were positively correlated with cisplatin IC50 in 15 NSCLC cell lines. Lastly, depletion of HDAC6 in H292 xenografts rendered decreased tumor weight and volume and exhibited increased basal apoptosis compared with the controls in a xenograft mouse model. In summary, our findings suggest that HDAC6 is positively associated with cisplatin resistance in NSCLC and reveal HDAC6 as a potential novel therapeutic target for platinum refractory NSCLC.	[Wang, Lei; Xiang, Shengyan; Williams, Kendra A.; Dong, Huiqin; Bai, Wenlong; Nicosia, Santo V.; Zhang, Xiaohong] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33620 USA; [Bai, Wenlong; Zhang, Xiaohong] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; [Khochbin, Saadi] Albert Bonniot Inst, French Natl Inst Hlth & Med Res, Grenoble, France; [Bepler, Gerold] Karmanos Canc Inst, Dept Oncol, Detroit, MI USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Barbara Ann Karmanos Cancer Institute	Wang, L (corresponding author), Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33620 USA.	beplerg@karmanos.org; xzhang1@health.usf.edu	Khochbin, Saadi/M-8090-2013; Bai, Wenlong/A-8977-2013; Wang, Lei/E-3063-2012; XIANG, SHENGYAN/C-3176-2013	Khochbin, Saadi/0000-0002-0455-0857; Bai, Wenlong/0000-0002-9536-0556; XIANG, SHENGYAN/0000-0002-6940-3559	National Cancer Institute of the National Institutes of Health [R01CA164147]; Florida James and Esther King Biomedical Program [09KN-17]; Marsha Rivkin Foundation; Ovarian Cancer Research Fund (OCRF); H. Lee Moffitt Cancer Center Lung Cancer SPORE; USF Graduate Student Success Diversity Fellowship; NATIONAL CANCER INSTITUTE [P30CA076292, P50CA119997, R01CA164147] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida James and Esther King Biomedical Program; Marsha Rivkin Foundation; Ovarian Cancer Research Fund (OCRF); H. Lee Moffitt Cancer Center Lung Cancer SPORE; USF Graduate Student Success Diversity Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Cancer Institute of the National Institutes of Health under Award Number R01CA164147, New Investigator grant (09KN-17) from Florida James and Esther King Biomedical Program, the Marsha Rivkin Foundation pilot grant, Ovarian Cancer Research Fund (OCRF), the career development grant from H. Lee Moffitt Cancer Center Lung Cancer SPORE to XZ and USF Graduate Student Success Diversity Fellowship to KAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PA, 1992, CANCER RES, V52, P1895; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hartley JM, 1999, CLIN CANCER RES, V5, P507; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamemura K, 2008, BIOCHEM BIOPH RES CO, V374, P84, DOI 10.1016/j.bbrc.2008.06.092; Kanamori Y, 1998, EUR J CANCER, V34, P1802, DOI 10.1016/S0959-8049(98)00199-3; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kigawa J, 2002, GYNECOL ONCOL, V84, P210, DOI 10.1006/gyno.2001.6488; Kim IA, 2009, RADIOTHER ONCOL, V92, P125, DOI 10.1016/j.radonc.2009.03.008; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; LONG BH, 1994, CANCER RES, V54, P4355; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Olive PL, 2009, CYTOM PART B-CLIN CY, V76B, P79, DOI 10.1002/cyto.b.20450; Owonikoko TK, 2010, INT J CANCER, V126, P743, DOI 10.1002/ijc.24759; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; POZAROWSKI P, 2004, CURR PROTOC CELL BIO, pCH18, DOI DOI 10.1002/0471143030.CB1808S21; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Vekris A, 2004, CANCER RES, V64, P356, DOI 10.1158/0008-5472.CAN-03-2258; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zhou J, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/597098; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	55	22	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44265	10.1371/journal.pone.0044265	http://dx.doi.org/10.1371/journal.pone.0044265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957056	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800048
J	Jung, WY; Kwon, SG; Son, M; Cho, ES; Lee, Y; Kim, JH; Kim, BW; Park, DH; Hwang, JH; Kim, TW; Park, HC; Park, BY; Choi, JS; Cho, KK; Chung, KH; Song, YM; Kim, IS; Jin, SK; Kim, DH; Lee, SW; Lee, KW; Bang, WY; Kim, CW				Jung, Won Yong; Kwon, Seul Gi; Son, Minky; Cho, Eun Seok; Lee, Yuno; Kim, Jae Hwan; Kim, Byeong-Woo; Park, Da Hye; Hwang, Jung Hye; Kim, Tae Wan; Park, Hwa Choon; Park, Beom Young; Choi, Jong-Soon; Cho, Kwang Keun; Chung, Ki Hwa; Song, Young Min; Kim, Il Suk; Jin, Sang Keun; Kim, Doo Hwan; Lee, Seung-Won; Lee, Keun Woo; Bang, Woo Young; Kim, Chul Wook			RNA-Seq Approach for Genetic Improvement of Meat Quality in Pig and Evolutionary Insight into the Substrate Specificity of Animal Carbonyl Reductases	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; 20-BETA-HYDROXYSTEROID DEHYDROGENASE; GENOME; TRAITS; MUSCLE; SNPS; PHOSPHORYLATION; IDENTIFICATION; POLYMORPHISMS; VARIANTS	Changes in meat quality traits are strongly associated with alterations in postmortem metabolism which depend on genetic variations, especially nonsynonymous single nucleotide variations (nsSNVs) having critical effects on protein structure and function. To selectively identify metabolism-related nsSNVs, next-generation transcriptome sequencing (RNA-Seq) was carried out using RNAs from porcine liver, which contains a diverse range of metabolic enzymes. The multiplex SNV genotyping analysis showed that various metabolism-related genes had different nsSNV alleles. Moreover, many nsSNVs were significantly associated with multiple meat quality traits. Particularly, ch7:g.22112616A.G SNV was identified to create a single amino acid change (Thr/Ala) at the 145th residue of H1.3-like protein, very close to the putative 147th threonine phosphorylation site, suggesting that the nsSNV may affect multiple meat quality traits by affecting the epigenetic regulation of postmortem metabolism-related gene expression. Besides, one nonsynonymous variation, probably generated by gene duplication, led to a stop signal in porcine testicular carbonyl reductase (PTCR), resulting in a C-terminal (E281-A288) deletion. Molecular docking and energy minimization calculations indicated that the binding affinity of wild-type PTCR to 5 alpha-DHT, a C-21-steroid, was superior to that of C-terminal-deleted PTCR or human carbonyl reductase, which was very consistent with experimental data, reported previously. Furthermore, P284 was identified as an important residue mediating the specific interaction between PTCR and 5 alpha-DHT, and phylogenetic analysis showed that P284 is an evolutionarily conserved residue among animal carbonyl reductases, which suggests that the C-terminal tails of these reductases may have evolved under evolutionary pressure to increase the substrate specificity for C-21-steroids and facilitate metabolic adaptation. Altogether, our RNA-Seq revealed that selective nsSNVs were associated with meat quality traits that could be useful for successful marker-assisted selection in pigs and also represents a useful resource to enhance understanding of protein folding, substrate specificity, and the evolution of enzymes such as carbonyl reductase.	[Jung, Won Yong; Kwon, Seul Gi; Cho, Kwang Keun; Chung, Ki Hwa; Song, Young Min; Kim, Il Suk; Jin, Sang Keun; Kim, Doo Hwan; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Dept Anim Resources Technol, Jinju, South Korea; [Kwon, Seul Gi; Cho, Eun Seok; Kim, Jae Hwan; Park, Da Hye; Hwang, Jung Hye; Kim, Tae Wan; Cho, Kwang Keun; Chung, Ki Hwa; Song, Young Min; Kim, Il Suk; Jin, Sang Keun; Kim, Doo Hwan; Bang, Woo Young; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea; [Jung, Won Yong; Lee, Seung-Won] SeqGenesis, Taejon, South Korea; [Son, Minky; Lee, Yuno; Kim, Byeong-Woo; Lee, Keun Woo] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju, South Korea; [Son, Minky; Lee, Yuno; Lee, Keun Woo] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Jinju, South Korea; [Park, Hwa Choon] Da San Jong Don Co Ltd, Namwon, South Korea; [Cho, Eun Seok; Park, Beom Young] Natl Inst Anim Sci, RDA, Suwon, South Korea; [Choi, Jong-Soon] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Choi, Jong-Soon] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Gyeongnam National University of Science and Technology; Gyeongnam National University of Science and Technology; Gyeongsang National University; Gyeongsang National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Korea Basic Science Institute (KBSI); Chungnam National University	Jung, WY (corresponding author), Gyeongnam Natl Univ Sci & Technol, Dept Anim Resources Technol, Jinju, South Korea.	wybang@gntech.ac.kr; cwkim@gntech.ac.kr		Jung, WonYong/0000-0002-1751-8418	National Research Foundation of Korea (NRF) [2011-0022965, 2012-0008319]; Ministry of Education, Science and Technology; Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [107091-5]; Rural Development Administration, Republic of Korea [PJ0077672011]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by grants from the Priority Research Centers Program (2011-0022965) and Basic Science Research Program (2012-0008319) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, and the Technology Development Program for Agriculture and Forestry (107091-5), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. It was also carried out with the support of "Cooperative Research Program for Agriculture Science and Technology Development (PJ0077672011)" Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chai LYA, 2011, J INFECT DIS, V203, P736, DOI 10.1093/infdis/jiq102; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cherel P, 2012, J ANIM SCI, V90, P699, DOI 10.2527/jas.2011-4198; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Fan B, 2010, MEAT SCI, V84, P645, DOI 10.1016/j.meatsci.2009.10.025; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Geissler R, 2007, PLANT PHYSIOL, V143, P1493, DOI 10.1104/pp.106.095166; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; Ho MR, 2011, NUCLEIC ACIDS RES, V39, pD920, DOI 10.1093/nar/gkq1197; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kobayashi K, 1996, J STEROID BIOCHEM, V59, P485, DOI 10.1016/S0960-0760(96)00137-9; Lalonde E, 2010, GENOME RES, DOI [10.1101/gr.111211.111110, DOI 10.1101/GR.111211.111110]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li X, 2009, MEAT SCI, V81, P218, DOI 10.1016/j.meatsci.2008.07.022; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; McCabe M, 2010, ADV ANIM BIOSCI, V1, P62; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakajin S, 2001, BBA-PROTEIN STRUCT M, V1550, P175, DOI 10.1016/S0167-4838(01)00285-0; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Peng YB, 2009, ANIM GENET, V40, P242, DOI 10.1111/j.1365-2052.2008.01818.x; Philibert P, 2010, FERTIL STERIL, V94, P472, DOI 10.1016/j.fertnstert.2009.03.057; Ponsuksili S, 2011, J LIPID RES, V52, P668, DOI 10.1194/jlr.M013342; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sampath V, 2012, PEDIATR PULM, V47, P460, DOI 10.1002/ppul.21568; Savas Sevtap, 2006, Human Genomics, V2, P274; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TANAKA M, 1992, J BIOL CHEM, V267, P13451; Uzun A, 2007, NUCLEIC ACIDS RES, V35, pW384, DOI 10.1093/nar/gkm232; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Warner RD, 2010, MEAT SCI, V86, P171, DOI 10.1016/j.meatsci.2010.04.042; WERMUTH B, 1981, J BIOL CHEM, V256, P1206; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wojcik SE, 2010, CARCINOGENESIS, V31, P208, DOI 10.1093/carcin/bgp209; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wu XF, 2009, J ANDROL, V30, P46, DOI 10.2164/jandrol.108.005736; Xu DQ, 2007, LIVEST SCI, V106, P96, DOI 10.1016/j.livsci.2006.07.005; Yang JO, 2011, NUCLEIC ACIDS RES, V39, pD939, DOI 10.1093/nar/gkq957; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	49	35	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e42198	10.1371/journal.pone.0042198	http://dx.doi.org/10.1371/journal.pone.0042198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962580	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600007
J	Rebollo, R; Horard, B; Begeot, F; Delattre, M; Gilson, E; Vieira, C				Rebollo, Rita; Horard, Beatrice; Begeot, Flora; Delattre, Marion; Gilson, Eric; Vieira, Cristina			A Snapshot of Histone Modifications within Transposable Elements in Drosophila Wild Type Strains	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; GENOME; MELANOGASTER; GENES; EVOLUTION; RETROTRANSPOSON; DYNAMICS; OPINION; DNA; EPIGENETICS	Transposable elements (TEs) are a major source of genetic variability in genomes, creating genetic novelty and driving genome evolution. Analysis of sequenced genomes has revealed considerable diversity in TE families, copy number, and localization between different, closely related species. For instance, although the twin species Drosophila melanogaster and D. simulans share the same TE families, they display different amounts of TEs. Furthermore, previous analyses of wild type derived strains of D. simulans have revealed high polymorphism regarding TE copy number within this species. Several factors may influence the diversity and abundance of TEs in a genome, including molecular mechanisms such as epigenetic factors, which could be a source of variation in TE success. In this paper, we present the first analysis of the epigenetic status of four TE families (roo, tirant, 412 and F) in seven wild type strains of D. melanogaster and D. simulans. Our data shows intra- and inter-specific variations in the histone marks that adorn TE copies. Our results demonstrate that the chromatin state of common TEs varies among TE families, between closely related species and also between wild type strains.	[Rebollo, Rita; Vieira, Cristina] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolutive, F-69622 Villeurbanne, France; [Horard, Beatrice; Gilson, Eric] UNS, Fac Med, Inst Res Canc & Aging, CNRS UMR7284,INSERM U1081, Nice, France; [Begeot, Flora; Delattre, Marion] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Geneva	Rebollo, R (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	cristina.vieira@univ-lyon1.fr	Vieira, Cristina/Q-3137-2017	Vieira, Cristina/0000-0003-3414-3993; Rebollo, Rita/0000-0002-8138-5082; Gilson, Marion/0000-0001-7521-0799	Centre National de Recherche Scientifique (CNRS); Agence National de la Recherche [(ANR)-09-Programe Blanc-0103-01]; Swiss National Science Foundation; State of Geneva fund	Centre National de Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Geneva fund	This work was funded by Centre National de Recherche Scientifique (CNRS), the Agence National de la Recherche (ANR)-09-Programe Blanc-0103-01, and Cible 2008 (Region Rhone Alpes) for C. Vieira's laboratory. Prof. E. Gilson is an associate member of European Union 6th framework program The Epigenome Network of Excellence (NoE), and his laboratory was funded by a European Union 6th framework program grant RISCRAD and ARECA framework program from Canceropole Lyon Auvergne Rhone Alpes. The Swiss National Science Foundation and the State of Geneva fund the work of F. Begeot and M. Delattre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestar E, 2009, CLIN REV ALLERGY IMM; Bartolome C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r22; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boulesteix M, 2006, MOL BIOL EVOL, V23, P162, DOI 10.1093/molbev/msj012; Brookfield JFY, 2006, GENETICS, V173, P1115, DOI 10.1534/genetics.104.027219; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Fablet M, 2009, FASEB J, V23, P1482, DOI 10.1096/fj.08-123513; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Granzotto A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-174; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; KAMINKER JS, 2002, GENOME BIOL, V0003; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Lerat E, 2003, GENOME RES, V13, P1889, DOI 10.1101/gr.827603; Lerat E, 2009, GENOME BIOL EVOLUTIO; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Polavarapu N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-226; Rebollo R, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-9; Rebollo R, 2010, GENE, V454, P1, DOI 10.1016/j.gene.2010.01.003; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Rigal M, 2011, BIOCH BIOPHYS ACTA; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Schulze SR, 2007, ANNU REV ENTOMOL, V52, P171, DOI 10.1146/annurev.ento.51.110104.151007; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira C, 1996, J MOL EVOL, V42, P443; Vieira C, 1999, MOL BIOL EVOL, V16, P1251, DOI 10.1093/oxfordjournals.molbev.a026215; Vieira C, 2009, GENOME DYNAM STABIL, V4, P21, DOI 10.1007/7050_2009_044; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Yin H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002380; 2004, NATURE, V431, P931	43	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44253	10.1371/journal.pone.0044253	http://dx.doi.org/10.1371/journal.pone.0044253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962605	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600033
J	Simwaka, BN; Theobald, S; Willets, A; Salaniponi, FML; Nkhonjera, P; Bello, G; Squire, SB				Simwaka, Bertha Nhlema; Theobald, Sally; Willets, Annie; Salaniponi, Felix M. L.; Nkhonjera, Patnice; Bello, George; Squire, Stephen Bertel			Acceptability and Effectiveness of the Storekeeper-Based TB Referral System for TB Suspects in Sub-Districts of Lilongwe in Malawi	PLOS ONE			English	Article							TUBERCULOSIS SERVICES; HEALTH; COMMUNITY; DOCTORS; ACCESS; POOR	Background: Early access to tuberculosis diagnosis and treatment remains a challenge in developing countries. General use of informal providers such as storekeepers is common. The aim of this study was to determine the effectiveness and acceptability of a storekeeper-based referral system for TB suspects in urban settings of Lilongwe, Malawi. Methods: The referral system intervention was implemented in two sub-districts. This was evaluated using a pre and post comparison as well as comparison with a third sub-district designated as the control. The intervention included training of storekeepers to detect and refer clients with chronic cough using predesigned referral letters along with monitoring and supervision. Data from a community based chronic cough survey and an audit of health centre records were used to measure its effectiveness. Focus group discussions and in-depth interviews were carried out to document acceptability of the intervention with the different stakeholders. Results: Following the intervention, the mean patient delay appeared lower in the intervention than comparison areas (2.14 weeks (SD 5.8) vs 8.8 weeks (SD 15.1)). However, after adjusting for confounding variables this difference was not significant (p = 0.07). After the intervention the proportion of the population diagnosed with smear positive TB in the intervention sites (1.2 per 1000) was significantly higher than in the comparison area (0.6 per 1000, p < 0.01) even after adjusting for sex and age. Qualitative findings suggested that (a) the referral letters triggered health workers to ask patients to submit sputum for TB diagnosis (b) the approach may be sustainable as the referral role was linked to the livelihood of the storekeepers. Conclusion: The study suggests that the referral system with storekeepers is sustainable and effective in increasing smear positive TB case notification. Studies that assess this approach for control of other diseases along with collection of specimens by storekeepers or similar providers are needed.	[Simwaka, Bertha Nhlema; Nkhonjera, Patnice; Bello, George] Res Equ & Community Hlth Trust, Lilongwe, Malawi; [Theobald, Sally; Squire, Stephen Bertel] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Willets, Annie] Wellsense Int Publ Hlth Consultants, Kilifi, Kenya; [Salaniponi, Felix M. L.] Malawi Natl TB Control Programme, Lilongwe, Malawi	Liverpool School of Tropical Medicine; University of Liverpool	Simwaka, BN (corresponding author), Res Equ & Community Hlth Trust, Lilongwe, Malawi.	bertha@africa-online.net		Theobald, Sally/0000-0002-9053-211X; Squire, Stephen/0000-0001-7173-9038	Norwegian Lung and Heart Patients Organisation (LHL); Department for International Development (DFID)	Norwegian Lung and Heart Patients Organisation (LHL); Department for International Development (DFID)	This research was funded by Norwegian Lung and Heart Patients Organisation (LHL) and Department for International Development (DFID) funded EQUI-TB Knowledge Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2000, INT J TUBERC LUNG D, V4, P1047; Kamat VR, 2010, SOC SCI MED, V71, P626, DOI 10.1016/j.socscimed.2010.04.016; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Lal SS, 2011, TROP MED INT HEALTH, V16, P685, DOI 10.1111/j.1365-3156.2011.02749.x; Malmborg R, 2006, B WORLD HEALTH ORGAN, V84, P752; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Paul V, 2004, BMJ-BRIT MED J, V329, P1117, DOI 10.1136/bmj.329.7475.1117; Perry H, 1999, SOC SCI MED, V48, P1053, DOI 10.1016/S0277-9536(98)00406-7; Ritchie J, 2004, QUALITATIVE RES PRAC, P24; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Simwaka BN, 2007, INT J TUBERC LUNG D, V11, P65; Simwaka Bertha Nhlema, 2007, Int J Equity Health, V6, P24, DOI 10.1186/1475-9276-6-24; Spencer L, 2003, QUALITATIVE RES PRAC, P199; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Thorson A, 2004, HEALTH POLICY, V68, P37, DOI 10.1016/j.healthpol.2003.07.010; Weiss M. G., 2008, International Journal of Tuberculosis and Lung Disease, V12, P825; WHO, 2010, GLOB TUB CONTR SURV; Yan F, 2007, HEALTH POLICY, V82, P186, DOI 10.1016/j.healthpol.2006.08.001; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	22	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e39746	10.1371/journal.pone.0039746	http://dx.doi.org/10.1371/journal.pone.0039746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962575	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600002
J	Wang, ZK; Zheng, J; Zhang, XJ; Peng, JJ; Liu, JY; Huang, Y				Wang, Zhikang; Zheng, Jia; Zhang, Xiaojie; Peng, Jingjing; Liu, Jinyu; Huang, Ying			Identification and Sequence Analysis of Metazoan tRNA 3 '-End Processing Enzymes tRNase Zs	PLOS ONE			English	Article							CANCER SUSCEPTIBILITY GENE; FLEXIBLE ARM; CRYSTAL-STRUCTURE; CLEAVAGE SITE; FAMILY; DROSOPHILA; RESIDUES; END; MITOCHONDRIAL; EVOLUTION	tRNase Z is the endonuclease responsible for removing the 3'-trailer sequences from precursor tRNAs, a prerequisite for the addition of the CCA sequence. It occurs in the short (tRNase Z(S)) and long (tRNase Z(L)) forms. Here we report the identification and sequence analysis of candidate tRNase Zs from 81 metazoan species. We found that the vast majority of deuterostomes, lophotrochozoans and lower metazoans have one tRNase Z(S) and one tRNase Z L genes, whereas ecdysozoans possess only a single tRNase Z(L) gene. Sequence analysis revealed that in metazoans, a single nuclear tRNase Z(L) gene is likely to encode both the nuclear and mitochondrial forms of tRNA 39-end processing enzyme through mechanisms that include alternative translation initiation from two in-frame start codons and alternative splicing. Sequence conservation analysis revealed a variant PxKxRN motif, PxPxRG, which is located in the N-terminal region of tRNase Z(S)s. We also identified a previously unappreciated motif, AxDx, present in the C-terminal region of both tRNase Z(S)s and tRNase Z(L)s. The AxDx motif consisting mainly of a very short loop is potentially close enough to form hydrogen bonds with the loop containing the PxKxRN or PxPxRG motif. Through complementation analysis, we demonstrated the likely functional importance of the AxDx motif. In conclusion, our analysis supports the notion that in metazoans a single tRNase Z(L) has evolved to participate in both nuclear and mitochondrial tRNA 39-end processing, whereas tRNase Z(S) may have evolved new functions. Our analysis also unveils new evolutionarily conserved motifs in tRNase Zs, including the C-terminal AxDx motif, which may have functional significance.	[Wang, Zhikang; Zheng, Jia; Zhang, Xiaojie; Peng, Jingjing; Liu, Jinyu; Huang, Ying] Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Huang, Y (corresponding author), Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing, Jiangsu, Peoples R China.	yhuang@njnu.edu.cn			National Science Foundation of China [31070703]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Nanjing Normal University [2007104XGQ0148]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Nanjing Normal University	This work was supported in part by grants from the National Science Foundation of China (31070703) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/) and Nanjing Normal University (2007104XGQ0148). The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aravind L, 1999, In Silico Biol, V1, P69; Bogerd HP, 2010, MOL CELL, V37, P135, DOI 10.1016/j.molcel.2009.12.016; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Canino G, 2009, PLANT PHYSL; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Ceballos M, 2007, PROTEIN PEPTIDE LETT, V14, P137, DOI 10.2174/092986607779816050; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Diebel KW, 2010, RNA, V16, P170, DOI 10.1261/rna.1873910; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Dumont M, 2004, BBA-GENE STRUCT EXPR, V1679, P230, DOI 10.1016/j.bbaexp.2004.07.001; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fan LJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-219; Gan X, 2011, BIOCH J; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hopkinson A, 2008, RNA BIOL, V5, P104, DOI 10.4161/rna.5.2.6086; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Ishii R, 2007, ACTA CRYSTALLOGR F, V63, P637, DOI 10.1107/S1744309107033623; Karkashon S, 2007, BIOCHEMISTRY-US, V46, P9380, DOI 10.1021/bi700578v; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1995, P NATL ACAD SCI USA, V92, P2662, DOI 10.1073/pnas.92.7.2662; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Levinger L, 2009, J BIOL CHEM, V284, P15685, DOI 10.1074/jbc.M900745200; Lopez Sanchez MI, 2011, CELL CYCLE, V10; Minagawa A, 2008, J MOL BIOL, V381, P289, DOI 10.1016/j.jmb.2008.05.016; Minagawa A, 2006, NUCLEIC ACIDS RES, V34, P3811, DOI 10.1093/nar/gkl517; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossmanith W, 2011, BIOCH BIOPHYS ACTA; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; Smith MM, 2004, DEV BIOL, V266, P151, DOI 10.1016/j.ydbio.2003.10.016; Spath B, 2007, CELL MOL LIFE SCI, V64, P2404, DOI 10.1007/s00018-007-7160-5; Takahashi M, 2008, FEBS LETT, V582, P2532, DOI 10.1016/j.febslet.2008.06.020; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Xie X, 2010, INSECT BIOCH MOL BIO; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Yanaihara N, 2001, GENOMICS, V72, P169, DOI 10.1006/geno.2000.6454; Zareen N, 2006, RNA, V12, P1104, DOI 10.1261/rna.4206; Zhao W, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-272; Zhao Z, 2009, BIOCHEM J, V422, P483, DOI 10.1042/BJ20090743	59	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44264	10.1371/journal.pone.0044264	http://dx.doi.org/10.1371/journal.pone.0044264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962606	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600034
J	Advani, MJ; Siddiqui, I; Sharma, P; Reddy, H				Advani, Meeta J.; Siddiqui, Imran; Sharma, Pawan; Reddy, Hemalatha			Activity of Trifluoperazine against Replicating, Non-Replicating and Drug Resistant M-tuberculosis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; PHENOTHIAZINES; GROWTH; PROTEIN; THIORIDAZINE; SURVIVAL; STRAINS; AGENTS; CELLS; MODEL	Trifluoperazine, a knowm calmodulin antagonist, belongs to a class of phenothiazine compounds that have multiple sites of action in mycobacteria including lipid synthesis, DNA processes, protein synthesis and respiration. The objective of this study is to evaluate the potential of TFP to be used as a lead molecule for development of novel TB drugs by showing its efficacy on multiple drug resistant (MDR) Mycobacterium tuberculosis (M.tb) and non-replicating dormant M.tb. Wild type and MDR M.tb were treated with TFP under different growth conditions of stress like low pH, starvation, presence of nitric oxide and in THP-1 infection model. Perturbation in growth kinetics of bacilli at different concentrations of TFP was checked to determine the MIC of TFP for active as well as dormant bacilli. Results show that TFP is able to significantly reduce the actively replicating as well as non-replicating bacillary load. It has also shown inhibitory effect on the growth of MDR M.tb. TFP has shown enhanced activity against intracellular bacilli, presumably because phenothiazines are known to get accumulated in macrophages. This concentration was, otherwise, found to be non-toxic to macrophage in vitro. Our results show that TFP has the potential to be an effective killer of both actively growing and non-replicating bacilli including MDR TB. Further evaluation and in vivo studies with Trifluoperazine can finally help us know the feasibility of this compound to be used as either a lead compound for development of new TB drugs or as an adjunct in the current TB chemotherapy.	[Advani, Meeta J.; Reddy, Hemalatha] Univ Delhi, Dept Biochem, Sri Venkateswara Coll, New Delhi, India; [Siddiqui, Imran; Sharma, Pawan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India	University of Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Advani, MJ (corresponding author), Univ Delhi, Dept Biochem, Sri Venkateswara Coll, South Campus, New Delhi, India.	phreddy.svc@gmail.com	Sharma, Pawan/F-7806-2010; Siddiqui, Imran/K-5000-2012	Sharma, Pawan/0000-0002-2525-5451; Siddiqui, Imran/0000-0002-6792-8730	Defence Research and Development Organization, India [LSRB-90/BTB/2006]; University of Delhi	Defence Research and Development Organization, India(Defence Research & Development Organisation (DRDO)); University of Delhi(University of Delhi)	This work is supported by a grant received from Defence Research and Development Organization, India (No. LSRB-90/BTB/2006) and a student fellowship received from the University of Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L., 2007, Infectious Disorders - Drug Targets, V7, P257, DOI 10.2174/187152607782110022; Amaral L, 2001, J ANTIMICROB CHEMOTH, V47, P505, DOI 10.1093/jac/47.5.505; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Chan YY, 2007, ANTIMICROB AGENTS CH, V51, P623, DOI 10.1128/AAC.01033-06; Cohen T, 2004, MICROB DRUG RESIST, V10, P280, DOI 10.1089/mdr.2004.10.280; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Gadre DV, 1999, J CHEMOTHERAPY, V11, P203, DOI 10.1179/joc.1999.11.3.203; Gadre DV, 1998, INT CLIN PSYCHOPHARM, V13, P129, DOI 10.1097/00004850-199805000-00006; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Garbe TR, 1999, INFECT IMMUN, V67, P460, DOI 10.1128/IAI.67.1.460-465.1999; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; Haydel SE, 2010, PHARMACEUTICALS-BASE, V3, P2268, DOI 10.3390/ph3072268; Hussain S, 2009, ANTIMICROB AGENTS CH, V53, P157, DOI 10.1128/AAC.00442-08; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Kim SY, 2008, J MED MICROBIOL, V57, P1473, DOI 10.1099/jmm.0.2008/001545-0; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Koul S, 2009, INDIAN J EXP BIOL, V47, P480; Kristiansen MM, 2006, IN VIVO, V20, P361; Kristiansen MM, 2003, INT J ANTIMICROB AG, V22, P250, DOI 10.1016/S0924-8579(03)00200-0; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Loebel RO, 1933, J BACTERIOL, V26, P167, DOI 10.1128/JB.26.2.167-200.1933; LUNAHERRERA J, 1995, ANTIMICROB AGENTS CH, V39, P440, DOI 10.1128/AAC.39.2.440; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Rao SP, 1995, INDIAN J CLIN BIOCH, V10, P77; RATNAKAR P, 1992, FEMS MICROBIOL LETT, V97, P73; RATNAKAR P, 1993, FEMS MICROBIOL LETT, V110, P291, DOI 10.1111/j.1574-6968.1993.tb06337.x; Reddy MV, 1996, J ANTIMICROB CHEMOTH, V37, P196, DOI 10.1093/jac/37.1.196; Riska Paul F, 2002, Semin Pediatr Infect Dis, V13, P263, DOI 10.1053/spid.2002.127198; SIBLEY LD, 1985, NATURE, V315, P416, DOI 10.1038/315416a0; Sinha I, 2004, J ANTIMICROB CHEMOTH, V53, P1072, DOI 10.1093/jac/dkh241; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Viveiros M, 2003, INT J ANTIMICROB AG, V22, P274, DOI 10.1016/S0924-8579(03)00208-5; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200	39	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44245	10.1371/journal.pone.0044245	http://dx.doi.org/10.1371/journal.pone.0044245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952939	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300069
J	Gomez, AM; Midde, NM; Mactutus, CF; Booze, RM; Zhu, J				Gomez, Adrian M.; Midde, Narasimha M.; Mactutus, Charles F.; Booze, Rosemarie M.; Zhu, Jun			Environmental Enrichment Alters Nicotine-Mediated Locomotor Sensitization and Phosphorylation of DARPP-32 and CREB in Rat Prefrontal Cortex	PLOS ONE			English	Article							CAMP-REGULATED PHOSPHOPROTEIN; BEHAVIORAL SENSITIZATION; ORBITOFRONTAL CORTEX; DOPAMINE TRANSPORTER; 32 KDA; ADDICTION; PROTEIN; RECEPTORS; AMPHETAMINE; ACTIVATION	Exposure within an environmental enrichment paradigm results in neurobiological adaptations and decreases the baseline of locomotor activity. The current study determined activation of DARPP-32 (dopamine-and cAMP-regulated phosphoprotein-32) and CREB (cAMP response element binding protein), and locomotor activity in rats raised in enriched (EC), impoverished (IC), and standard (SC) conditions following repeated administration of nicotine or saline. In the saline-control group, the basal phosphorylation state of DARPP-32 at Threonine-34 site (pDARPP-32 Thr34) in the prefrontal cortex (PFC) was lower in EC compared to IC and SC rats, which was positively correlated with their respective baseline activities. While nicotine (0.35 mg/kg, freebase) produced locomotor sensitization across all housing conditions when the nicotine-mediated locomotor activity was expressed as a percent change from their respective saline control, EC rats displayed greater sensitization to nicotine than IC and SC rats. Consistent with the behavioral findings, repeated nicotine injection increased pDARPP-32 Thr34 in PFC of EC and IC rats and in nucleus accumbens of EC rats; however, the magnitude of change from saline control in nicotine-induced enhancement of pDARPP-32 Thr34 in PFC was strikingly increased in EC rats relative to IC rats. Moreover, EC rats had lower basal phosphorylation levels of CREB at serine 133 in PFC and nucleus accumbens compared to IC and SC rats, whereas the nicotine-induced increase in phosphorylated CREB-Ser133 was more pronounced in PFC of EC rats relative to IC and SC rats. Collectively, these findings suggest innovative insights into advancing our understanding of the molecular mechanisms of enrichment-induced changes in the motivational effects of nicotine, and aiding in the identification of new therapeutic strategies for tobacco smokers.	[Gomez, Adrian M.; Midde, Narasimha M.; Zhu, Jun] Univ S Carolina, Dept Pharmaceut & Biomed Sci, S Carolina Coll Pharm, Columbia, SC 29208 USA; [Mactutus, Charles F.; Booze, Rosemarie M.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Gomez, AM (corresponding author), Univ S Carolina, Dept Pharmaceut & Biomed Sci, S Carolina Coll Pharm, Columbia, SC 29208 USA.	zhuj@sccp.sc.edu	Booze, Rosemarie/F-7543-2014; Gomez, Adrian/Y-5962-2019	Booze, Rosemarie/0000-0003-3908-8313; Gomez, Adrian/0000-0002-4278-8209	National Institute on Drug Abuse [DA024275, DA026721]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM076277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026721, R03DA024275] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse to Jun Zhu (DA024275 and DA026721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolahi A, 2010, EUR J NEUROSCI, V31, P733, DOI 10.1111/j.1460-9568.2010.07114.x; Addy NA, 2007, J NEUROSCI, V27, P8571, DOI 10.1523/JNEUROSCI.2601-07.2007; Balfour DJK, 2002, RESPIRATION, V69, P7, DOI 10.1159/000049362; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; BLANC G, 1980, NATURE, V284, P265, DOI 10.1038/284265a0; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; CLARKE PBS, 1983, BRIT J PHARMACOL, V80, P587, DOI 10.1111/j.1476-5381.1983.tb10733.x; CLARKE PBS, 1983, BRIT J PHARMACOL, V78, P329, DOI 10.1111/j.1476-5381.1983.tb09398.x; Coolon RA, 2009, PHARMACOL BIOCHEM BE, V93, P59, DOI 10.1016/j.pbb.2009.04.007; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Del Arco A, 2007, J NEURAL TRANSM, V114, P43, DOI 10.1007/s00702-006-0565-8; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gipson CD, 2011, PSYCHOPHARMACOLOGY, V214, P557, DOI 10.1007/s00213-010-2060-z; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Green TA, 2003, PSYCHOPHARMACOLOGY, V170, P235, DOI 10.1007/s00213-003-1538-3; Green TA, 2002, PSYCHOPHARMACOLOGY, V162, P373, DOI 10.1007/s00213-002-1134-y; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Harrod SB, 2008, PHARMACOL BIOCHEM BE, V90, P723, DOI 10.1016/j.pbb.2008.05.020; Harrod SB, 2009, PHARMACOL BIOCHEM BE, V94, P296, DOI 10.1016/j.pbb.2009.09.009; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hiroi N, 1999, EUR J NEUROSCI, V11, P1114, DOI 10.1046/j.1460-9568.1999.00570.x; Hotte M, 2006, BEHAV BRAIN RES, V171, P127, DOI 10.1016/j.bbr.2006.03.026; KALIVAS PW, 1995, DRUG ALCOHOL DEPEN, V37, P95, DOI 10.1016/0376-8716(94)01063-Q; KANAREK RB, 1995, PHARMACOL BIOCHEM BE, V51, P725, DOI 10.1016/0091-3057(95)00022-O; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Leshner AI, 2000, AM J MED GENET, V96, P590, DOI 10.1002/1096-8628(20001009)96:5<590::AID-AJMG2>3.0.CO;2-2; Lindskog M, 1999, NEUROSCIENCE, V88, P1005, DOI 10.1016/S0306-4522(98)00411-4; Lynch WJ, 2010, BIOL PSYCHIAT, V68, P774, DOI 10.1016/j.biopsych.2010.06.022; Mathieu-Kia AM, 2002, PSYCHOPHARMACOLOGY, V162, P102, DOI 10.1007/s00213-002-1096-0; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; Midde NM, 2011, PHARMACOL BIOCHEM BE, V98, P587, DOI 10.1016/j.pbb.2011.03.013; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moghaddam B, 2002, BIOL PSYCHIAT, V51, P775, DOI 10.1016/S0006-3223(01)01362-2; Nairn AC, 2004, NEUROPHARMACOLOGY, V47, P14, DOI 10.1016/j.neuropharm.2004.05.010; Nichols JA, 2007, NEUROSCIENCE, V145, P832, DOI 10.1016/j.neuroscience.2006.12.061; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1997, J NEUROSCI, V17, P8147; POST RM, 1980, LIFE SCI, V26, P1275, DOI 10.1016/0024-3205(80)90085-5; Rhee SH, 2003, ARCH GEN PSYCHIAT, V60, P1256, DOI 10.1001/archpsyc.60.12.1256; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROSENBERG DR, 1995, J COMP NEUROL, V358, P383, DOI 10.1002/cne.903580306; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Solinas M, 2008, P NATL ACAD SCI USA, V105, P17145, DOI 10.1073/pnas.0806889105; Stairs DJ, 2009, PHARMACOL BIOCHEM BE, V92, P377, DOI 10.1016/j.pbb.2009.01.016; Steketee JD, 2003, BRAIN RES REV, V41, P203, DOI 10.1016/S0165-0173(02)00233-3; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Svenningsson P, 2000, J NEUROCHEM, V75, P248, DOI 10.1046/j.1471-4159.2000.0750248.x; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Tzschentke TM, 2001, PROG NEUROBIOL, V63, P241, DOI 10.1016/S0301-0082(00)00033-2; Valjent E, 2010, NEUROPSYCHOPHARMACOL, V35, P401, DOI 10.1038/npp.2009.143; Vezina P, 2007, PROG NEURO-PSYCHOPH, V31, P1553, DOI 10.1016/j.pnpbp.2007.08.030; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Wong V, 2008, J PHYS CHEM B, V112, P6013, DOI 10.1021/jp0761564; Wooters TE, 2011, BEHAV BRAIN RES, V219, P98, DOI 10.1016/j.bbr.2011.01.001; Zachariou V, 2006, NEUROPSYCHOPHARMACOL, V31, P555, DOI 10.1038/sj.npp.1300832; Zhang Y, 2006, J NEUROSCI, V26, P2645, DOI 10.1523/JNEUROSCI.3923-05.2006; Zhu HW, 2005, BIOL PSYCHIAT, V58, P981, DOI 10.1016/j.biopsych.2005.05.026; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x; Zhu J, 2004, BEHAV BRAIN RES, V148, P107, DOI 10.1016/S0166-4328(03)00190-6; Zhu J, 2007, J NEUROCHEM, V103, P2575, DOI 10.1111/j.1471-4159.2007.04951.x; Zlebnik NE, 2012, PSYCHOPHARMACOLOGY B	79	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44149	10.1371/journal.pone.0044149	http://dx.doi.org/10.1371/journal.pone.0044149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952905	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300056
J	Hu, BL; Liu, SA; Shen, LD; Zheng, P; Xu, XY; Lou, LP				Hu Baolan; Liu Shuai; Shen Lidong; Zheng Ping; Xu Xiangyang; Lou Liping			Effect of Different Ammonia Concentrations on Community Succession of Ammonia-oxidizing Microorganisms in a Simulated Paddy Soil Column	PLOS ONE			English	Article							MESOPHILIC CRENARCHAEOTA; NITROSPIRA SPP.; IN-SITU; ARCHAEA; BACTERIA; NITRIFICATION; DIVERSITY; OXIDATION; ABUNDANCE; MONOOXYGENASE	Ammonia oxidation is performed by both ammonia-oxidizing bacteria (AOB) and ammonia-oxidizing archaea (AOA). To explore the effect of ammonia concentration on the population dynamic changes of ammonia-oxidizing microorganisms, we examined changes in the abundance and community composition of AOA and AOB in different layers. Most of the archaeal amoA sequences were Nitrosotalea-related and the proportion that Nitrosotalea cluster occupied decreased in the surface layer and increased in the deep layer during the cultivation process. Nitrosopumilus-related sequences were only detected in the deep layer in the first stage and disappeared later. Both phylogenetic and quantitative analysis showed that there were increased Nitrosomonas-related sequences appeared in the surface layer where the ammonia concentration was the highest. Both AOA and AOB OTU numbers in different layers decreased under selective pressure and then recovered. The potential nitrification rates were 25.06 mu g.N.L-1.g(-1) dry soil.h(-1) in the mid layer which was higher than the other two layers. In general, obvious population dynamic changes were found for both AOA and AOB under the selective pressure of exogenous ammonia and the changes were different in three layers of the soil column.	[Hu Baolan; Liu Shuai; Shen Lidong; Zheng Ping; Xu Xiangyang; Lou Liping] Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, BL (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	baolanhz@hotmail.com	Hu, baolan/K-8163-2012; 郑, 平/B-1890-2014; LOU, Liping/A-4525-2015		National Natural Science Foundation of China [40801198]; National Key Technologies Research and Development program of China [2012BAJ25B00]; Natural Science Foundation of Zhejiang province [Y507227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development program of China(National Key Technology R&D Program); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province)	The authors wish to thank the National Natural Science Foundation of China (40801198), National Key Technologies Research and Development program of China (2012BAJ25B00) and the Natural Science Foundation of Zhejiang province (Y507227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SE, 1989, CHEM ANAL ECOLOGICAL; *APHA AWWA, 1998, STAND METH EX WAT WA; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Bohrerova Z, 2004, SOIL TILL RES, V77, P25, DOI 10.1016/j.still.2003.10.006; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; Chen XP, 2008, ENVIRON MICROBIOL, V10, P1978, DOI 10.1111/j.1462-2920.2008.01613.x; Dang HY, 2010, APPL ENVIRON MICROB, V76, P4691, DOI 10.1128/AEM.02563-09; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hofferle S, 2010, FEMS MICROBIOL ECOL, V74, P302, DOI 10.1111/j.1574-6941.2010.00961.x; Hommes NG, 2003, J BACTERIOL, V185, P6809, DOI 10.1128/JB.185.23.6809-6814.2003; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu QH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002731; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; MCTAVISH H, 1993, J BACTERIOL, V175, P2436, DOI 10.1128/JB.175.8.2436-2444.1993; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nicolaisen MH, 2004, FEMS MICROBIOL ECOL, V49, P359, DOI 10.1016/j.femsec.2004.04.015; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmidt I, 2004, MICROBIOL-SGM, V150, P1405, DOI 10.1099/mic.0.26719-0; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Schramm A, 1998, APPL ENVIRON MICROB, V64, P3480; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107	48	12	14	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44122	10.1371/journal.pone.0044122	http://dx.doi.org/10.1371/journal.pone.0044122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952893	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300052
J	Larras, F; Bouchez, A; Rimet, F; Montuelle, B				Larras, Floriane; Bouchez, Agnes; Rimet, Frederic; Montuelle, Bernard			Using Bioassays and Species Sensitivity Distributions to Assess Herbicide Toxicity towards Benthic Diatoms	PLOS ONE			English	Article							ECOLOGICAL GUILDS; LIFE-FORMS; ATRAZINE; COMMUNITIES; PERIPHYTON; GROWTH; DIURON; PHOTOSYNTHESIS; ISOPROTURON; ASSEMBLAGES	Although benthic diatoms are widely used in ecological studies of aquatic systems, there is still a dearth of data concerning species sensitivities towards several contaminants. Within the same community, different species may respond differently depending on their physiological and ecological characteristics. This lack of knowledge makes specific appropriate risk assessment impossible. To find out whether species sensitivity distribution (SSD) could be used to estimate the risk of herbicide toxicity for diatoms, we need to know whether their sensitivity depends on their physiological and ecological characteristics. We carried out single-species bioassays on 11 diatom species exposed to 8 herbicides. Dose-responses relationships were used to extrapolate the Effective Concentration 5 (EC5) and the Effective Concentration 50 (EC50) for each exposure. These data were used to fit a SSD curve for each herbicide, and to determine the Hazardous concentration 5 (HC5) and 50 (HC50). Our results revealed a high level of variability of the sensitivity in the set of species tested. For photosystem-II inhibitor (PSII) herbicides, diatoms species displayed a typical grouping of sensitivity levels consistent with their trophic mode and their ecological guild. N-heterotroph and "motile" guild species were more tolerant of PSII inhibitors, while N-autotroph and "low profile" guild species were more sensitive. Comprehensive SSD curves were obtained for 5 herbicides, but not for sulfonylurea herbicides or for dimetachlor, which had toxicity levels that were below the range of concentration tested. The SSD curves provided the following ranking of toxicity: diuron > terbutryn > isoproturon > atrazine > metolachlor. The HC that affected 5% of the species revealed that, even at the usual environmental concentrations of herbicides, diatom assemblages could be affected, especially by isoproturon, terbutryn, and diuron.	[Larras, Floriane; Bouchez, Agnes; Rimet, Frederic; Montuelle, Bernard] INRA, UMR 0042, Carrtel, Thonon, France	INRAE	Larras, F (corresponding author), INRA, UMR 0042, Carrtel, Thonon, France.	floriane.larras@thonon.inra.fr	RIMET, Frédéric/S-2702-2018	RIMET, Frédéric/0000-0002-5514-869X; Bouchez, Agnes/0000-0001-8802-6966	Programme Assessing and reducing environmental risks from plant protection products (PESTICIDES); French Ministry in charge of Ecology and Sustainable Development (project IMPALAC) [CV2100204294]	Programme Assessing and reducing environmental risks from plant protection products (PESTICIDES); French Ministry in charge of Ecology and Sustainable Development (project IMPALAC)	This work was financially supported by the Programme Assessing and reducing environmental risks from plant protection products (PESTICIDES) and funded by the French Ministry in charge of Ecology and Sustainable Development (project IMPALAC), grant CV2100204294. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence de l'eau Adour-Garonne, 2009, QUAL EAUX PROD PHYT; Aldenberg T, 2000, ECOTOX ENVIRON SAFE, V46, P1, DOI 10.1006/eesa.1999.1869; ASTM International, 2007, STAND GUID COND STAT, pE1218; Berard A., 1999, Revue des Sciences de l'Eau, V12, P333; Berthon V, 2011, HYDROBIOLOGIA, V673, P259, DOI 10.1007/s10750-011-0786-1; Boger P, 2003, J PESTIC SCI, V28, P324, DOI 10.1584/jpestics.28.324; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; Chevre N, 2006, ENVIRON SCI TECHNOL, V40, P426, DOI 10.1021/es050239l; de Zwart D, 2002, ENVIRON ECOL RISK AS, P133; Debenest T, 2009, AQUAT TOXICOL, V93, P11, DOI 10.1016/j.aquatox.2009.02.014; Dorigo U, 2010, ARCH ENVIRON CON TOX, V59, P555, DOI 10.1007/s00244-010-9511-8; Dubois A, 2011, BIL PRES MICR MIL AQ, P59; Forbes VE, 2002, HUM ECOL RISK ASSESS, V8, P473, DOI 10.1080/10807030290879781; Guasch H, 1998, J APPL PHYCOL, V10, P203, DOI 10.1023/A:1008035212208; GUERRERO M, 1991, Hydrobiological Bulletin, V25, P117, DOI 10.1007/BF02291241; HOAGLAND KD, 1982, AM J BOT, V69, P188, DOI 10.2307/2443006; Knauert S, 2008, ENVIRON SCI TECHNOL, V42, P6424, DOI 10.1021/es072037q; Kotrikla A., 1999, GLOBAL NEST J, V1, P39; LECOINTE C, 1993, HYDROBIOLOGIA, V269, P509, DOI 10.1007/BF00028048; Lenoir A., 1996, USE ALGAE MONITORING, P29; Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020; Magnusson M, 2008, MAR POLLUT BULL, V56, P1545, DOI 10.1016/j.marpolbul.2008.05.023; Maltby L, 2005, ENVIRON TOXICOL CHEM, V24, P379, DOI 10.1897/04-025R.1; Montuelle B, 2010, HYDROBIOLOGIA, V657, P123, DOI 10.1007/s10750-010-0105-2; Nelson KJ, 1999, ENVIRON TOXICOL CHEM, V18, P1038, DOI [10.1002/etc.5620180531, 10.1897/1551-5028(1999)018&lt;1038:CEOAOT&gt;2.3.CO;2]; Nystrom B, 1998, AQUAT TOXICOL, V43, P25, DOI 10.1016/S0166-445X(97)00093-3; Nystrom B, 1999, AQUAT TOXICOL, V47, P9, DOI 10.1016/S0166-445X(99)00007-7; Ortelli D, 2009, METALS ORGANIC MICRO; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Peres F, 1996, ENVIRON POLLUT, V94, P141, DOI 10.1016/S0269-7491(96)00080-2; Pesce S, 2011, REV ENVIRON CONTAM T, V214, P87, DOI 10.1007/978-1-4614-0668-6_5; Posthuma L, 2002, ENVIRON ECOL RISK AS, P3; Ricart M, 2009, CHEMOSPHERE, V76, P1392, DOI 10.1016/j.chemosphere.2009.06.017; Rimet F, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012018; Rimet F, 2011, ECOL INDIC, V11, P489, DOI 10.1016/j.ecolind.2010.07.004; Ritz C, 2005, J STAT SOFTW, V12, P1; Rivard L., 2003, ENV FATE METOLACHLOR; Roubeix V, 2011, ANN LIMNOL-INT J LIM, V47, P239, DOI 10.1051/limn/2011009; Roubeix V, 2011, J ENVIRON MONITOR, V13, P1768, DOI 10.1039/c0em00783h; Rumeau A., 1988, B FRANCAIS P CHE PIS, V309, P1, DOI DOI 10.1051/KMAE:1988009; Schaumburg J, 2004, LIMNOLOGICA, V34, P302, DOI 10.1016/S0075-9511(04)80003-3; Schmitt-Jansen M, 2005, ENVIRON TOXICOL CHEM, V24, P304, DOI 10.1897/03-647.1; Seguin F, 2001, ANN LIMNOL-INT J LIM, V37, P3, DOI 10.1051/limn/2001004; Tang JX, 1997, B ENVIRON CONTAM TOX, V59, P631, DOI 10.1007/s001289900526; Vallotton N, 2008, CHEMOSPHERE, V73, P395, DOI 10.1016/j.chemosphere.2008.05.039; Van Dam Herman, 1994, Netherlands Journal of Aquatic Ecology, V28, P117; van Straalen NM, 2002, ENVIRON TOXICOL PHAR, V11, P167, DOI 10.1016/S1382-6689(01)00114-4; Wheeler JR, 2002, MAR POLLUT BULL, V45, P192, DOI 10.1016/S0025-326X(01)00327-7	49	53	55	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44458	10.1371/journal.pone.0044458	http://dx.doi.org/10.1371/journal.pone.0044458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952981	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500072
J	Shen, P; Gong, YH; Wang, T; Chen, YY; Jia, J; Ni, SS; Zhou, B; Song, YP; Zhang, L; Zhou, R				Shen, Pei; Gong, Yunhui; Wang, Tao; Chen, Yueyue; Jia, Jin; Ni, Shanshan; Zhou, Bin; Song, Yapin; Zhang, Lin; Zhou, Rong			Expression of Osteoprotegerin in Placenta and Its Association with Preeclampsia	PLOS ONE			English	Article							SERUM OSTEOPROTEGERIN; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; INHIBITORY FACTOR; PREGNANCY; ARTERY; RECEPTORS; LACTATION; CALCIUM; DISEASE	Background: Osteoprotegerin (OPG), a key regulatory factor in bone metabolism, was documented also a potential pro-angiogenic factor, which acts an important role in protecting vascular endothelial cells. Since preeclampsia has gradually been employed to be vascular diseases, we speculated that OPG might be associated with preeclampsia. The study was to evaluate the level of OPG protein and mRNA in placenta, and investigate the relationship between OPG and the pathogenesis of preeclampsia. Methodology/Principal Findings: Placental specimens from 30 term normal pregnancy, 30 severe preeclampsia and 30 mild cases were studied. The expression and levels of OPGs' protein and mRNA were detected by immunohistochemisty, western blot analysis and real-time quantitative PCR analysis respectively. The expression of OPG protein was found in cytoplasm of placenta cytotrophoblasts and syncytiotrophoblasts in three groups. There were no significant differences of OPG protein between the maternal and fetal side in each group. The OPG protein and mRNA levels in severe preeclampsia were significantly higher than those in mild cases and normal pregnancy. However, there were no markedly differences of the OPG protein and mRNA levels between term delivery and preterm delivery in severe cases. In preeclampsia, the OPG protein and mRNA level was positively correlated with systolic blood pressure and 24 h urinary protein respectively. Conclusions/Significance: OPG protein and mRNA level in placentas of preeclampsia were found abnormal compared with normal pregnancy. In preeclampsia, the OPG protein and mRNA levels were closely related with its important clinical parameters. Taken together, OPG might be closely correlated with the pathogenesis of preeclampsia.	[Shen, Pei; Gong, Yunhui; Chen, Yueyue; Jia, Jin; Ni, Shanshan; Zhou, Rong] Sichuan Univ, W China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [Wang, Tao; Zhou, Bin; Song, Yapin; Zhang, Lin] Sichuan Univ, W China Univ Hosp 2, Lab Mol & Translat Med, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Shen, P (corresponding author), Sichuan Univ, W China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China.	zhourong_hx@scu.edu.cn	ZHANG, LIN/GYD-9123-2022		National Natural Science Foundation of China [81170593]; Ministry of Education of China [20110181110010]; Office of Science & Technology of Sichuan province [2009SZ0149]; Office of Science & Technology of Chengdu City [10GGYB899SF-023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Office of Science & Technology of Sichuan province; Office of Science & Technology of Chengdu City	National Natural Science Foundation of China (No. 81170593), Ministry of Education of China (20110181110010),the Office of Science & Technology of Sichuan province (No. 2009SZ0149), as well as the Office of Science & Technology of Chengdu City (No. 10GGYB899SF-023)The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2007, AM J CARDIOL, V99, P513, DOI 10.1016/j.amjcard.2006.08.064; ACOG practice bulletin, 2002, OBSTET GYNECOL, V299, P159; Brandstrom H, 2004, BLOOD PRESSURE, V13, P152, DOI 10.1080/08037050410035563; Brodszki J, 2008, ACTA OBSTET GYN SCAN, V87, P154, DOI 10.1080/00016340701733646; Diaz E, 2005, CLIN BIOCHEM, V38, P243, DOI 10.1016/j.clinbiochem.2004.10.013; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Hong JS, 2005, AM J OBSTET GYNECOL, V193, P1011, DOI 10.1016/j.ajog.2005.06.051; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kim SM, 2005, CLIN ENDOCRINOL, V63, P594, DOI 10.1111/j.1365-2265.2005.02390.x; Kobayashi-Sakamoto M, 2006, FEMS MICROBIOL LETT, V264, P238, DOI 10.1111/j.1574-6968.2006.00458.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2008, AM J PATHOL, V172, P1571, DOI 10.2353/ajpath.2008.070629; Ming Fang, 2008, Zhonghua Fu Chan Ke Za Zhi, V43, P90; Naylor KE, 2003, J CLIN ENDOCR METAB, V88, P5361, DOI 10.1210/jc.2003-030486; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Powers RW, 2008, REPROD SCI, V15, P374, DOI 10.1177/1933719107311780; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; Shin JY, 2006, DIABETES CARE, V29, P1664, DOI 10.2337/dc06-0631; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tie WW, 2009, REPROD SCI, V16, P676, DOI 10.1177/1933719109334258; Uemura H, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740353; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yaturu S, 2008, CYTOKINE, V44, P168, DOI 10.1016/j.cyto.2008.07.471; Yucesoy Gulseren, 2005, Archives of Gynecology and Obstetrics, V273, P43, DOI 10.1007/s00404-005-0741-3; Ziegler S, 2005, ATHEROSCLEROSIS, V182, P175, DOI 10.1016/j.atherosclerosis.2005.01.042	28	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44340	10.1371/journal.pone.0044340	http://dx.doi.org/10.1371/journal.pone.0044340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952959	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500062
J	Shibata, K; Chang, LH; Kim, D; Nanez, JE; Kamitani, Y; Watanabe, T; Sasaki, Y				Shibata, Kazuhisa; Chang, Li-Hung; Kim, Dongho; Nanez, Jose E., Sr.; Kamitani, Yukiyasu; Watanabe, Takeo; Sasaki, Yuka			Decoding Reveals Plasticity in V3A as a Result of Motion Perceptual Learning	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; SURFACE-BASED ANALYSIS; CORTICAL AREA; HUMAN BRAIN; RETINOTOPIC ORGANIZATION; FUNCTIONAL MRI; V1 NEURONS; DORSAL V4; ORIENTATION; DISCRIMINATION	Visual perceptual learning (VPL) is defined as visual performance improvement after visual experiences. VPL is often highly specific for a visual feature presented during training. Such specificity is observed in behavioral tuning function changes with the highest improvement centered on the trained feature and was originally thought to be evidence for changes in the early visual system associated with VPL. However, results of neurophysiological studies have been highly controversial concerning whether the plasticity underlying VPL occurs within the visual cortex. The controversy may be partially due to the lack of observation of neural tuning function changes in multiple visual areas in association with VPL. Here using human subjects we systematically compared behavioral tuning function changes after global motion detection training with decoded tuning function changes for 8 visual areas using pattern classification analysis on functional magnetic resonance imaging (fMRI) signals. We found that the behavioral tuning function changes were extremely highly correlated to decoded tuning function changes only in V3A, which is known to be highly responsive to global motion with human subjects. We conclude that VPL of a global motion detection task involves plasticity in a specific visual cortical area.	[Shibata, Kazuhisa; Chang, Li-Hung; Kim, Dongho; Watanabe, Takeo; Sasaki, Yuka] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Nanez, Jose E., Sr.] Arizona State Univ, Div Social & Behav Sci, Phoenix, AZ USA; [Kamitani, Yukiyasu] Adv Telecommun Res Inst Int, Brain Informat Commun Res Lab Grp, Kyoto, Japan	Brown University; Arizona State University; Arizona State University-Downtown Phoenix; Advanced Telecommunications Research Institute International	Shibata, K (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	takeo_watanabe@brown.edu		Chang, Li-Hung/0000-0002-4245-0152; Sasaki, Yuka/0000-0002-0061-0250; Kim, Dongho/0000-0002-2619-1234	NSF [BCS-0549036]; NIH [R01 EY015980, R01 EY019466, R21 EY018925, R01 AG031941]; NCRR [P41RR14075]; MIND Institute; Athinoula A. Martinos Center for Biomedical Imaging; Uehara Memorial Foundation; Nissan Science Foundation; SRPBS (MEXT, Japan); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015980, R01EY019466, R21EY018925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031941] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MIND Institute; Athinoula A. Martinos Center for Biomedical Imaging; Uehara Memorial Foundation(Uehara Memorial Foundation); Nissan Science Foundation; SRPBS (MEXT, Japan); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NSF (BCS-0549036), NIH (R01 EY015980, R01 EY019466, R21 EY018925, R01 AG031941), NCRR (P41RR14075), MIND Institute, Athinoula A. Martinos Center for Biomedical Imaging, Uehara Memorial Foundation, Nissan Science Foundation, and SRPBS (MEXT, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Adab HZ, 2011, CURR BIOL, V21, P1661, DOI 10.1016/j.cub.2011.08.037; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fahle M, 2002, PERCEPTUAL LEARNING; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fize D, 2003, J NEUROSCI, V23, P7395; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gold JI, 2010, CURR BIOL, V20, pR46, DOI 10.1016/j.cub.2009.10.066; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Kahnt T, 2011, NEURON, V70, P549, DOI 10.1016/j.neuron.2011.02.054; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Koyama S, 2005, CURR BIOL, V15, P2027, DOI 10.1016/j.cub.2005.10.069; Koyama S, 2004, PERCEPTION, V33, P1139, DOI 10.1068/p5195; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Vapnik V., 1998, STAT LEARNING THEORY; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	37	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44003	10.1371/journal.pone.0044003	http://dx.doi.org/10.1371/journal.pone.0044003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952849	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600068
J	Packel, L; Keller, A; Dow, WH; de Walque, D; Nathan, R; Mtenga, S				Packel, Laura; Keller, Ann; Dow, William H.; de Walque, Damien; Nathan, Rose; Mtenga, Sally			Evolving Strategies, Opportunistic Implementation: HIV Risk Reduction in Tanzania in the Context of an Incentive-Based HIV Prevention Intervention	PLOS ONE			English	Article							SERO-DISCORDANT COUPLES; DAR-ES-SALAAM; PREGNANT-WOMEN; CONDOM USE; MARRIAGE; TRANSMISSION; HIV/AIDS; BEHAVIOR; DISCLOSURE; CHALLENGES	Background: Behavior change communication (BCC) interventions, while still a necessary component of HIV prevention, have not on their own been shown to be sufficient to stem the tide of the epidemic. The shortcomings of BCC interventions are partly due to barriers arising from structural or economic constraints. Arguments are being made for combination prevention packages that include behavior change, biomedical, and structural interventions to address the complex set of risk factors that may lead to HIV infection. Methods: In 2009/2010 we conducted 216 in-depth interviews with a subset of study participants enrolled in the RESPECT study - an HIV prevention trial in Tanzania that used cash awards to incentivize safer sexual behaviors. We analyzed community diaries to understand how the study was perceived in the community. We drew on these data to enhance our understanding of how the intervention influenced strategies for risk reduction. Results: We found that certain situations provide increased leverage for sexual negotiation, and these situations facilitated opportunistic implementation of risk reduction strategies. Opportunities enabled by the RESPECT intervention included leveraging conditional cash awards, but participants also emphasized the importance of exploiting new health status knowledge from regular STI testing. Risk reduction strategies included condom use within partnerships and/or with other partners, and an unexpected emphasis on temporary abstinence. Conclusions: Our results highlight the importance of increasing opportunities for implementing risk reduction strategies. We found that an incentive-based intervention could be effective in part by creating such opportunities, particularly among groups such as women with limited sexual agency. The results provide new evidence that expanding regular testing of STIs is another important mechanism for providing opportunities for negotiating behavior change, beyond the direct benefits of testing. Exploiting the latent demand for STI testing should receive renewed attention as part of innovative new combination interventions for HIV prevention.	[Packel, Laura] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Keller, Ann; Dow, William H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [de Walque, Damien] World Bank, World Bank Dev Res Grp, Washington, DC 20433 USA; [Nathan, Rose; Mtenga, Sally] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	University of California System; University of California San Francisco; University of California System; University of California Berkeley; The World Bank; Ifakara Health Institute	Packel, L (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	ljpackel@gmail.com	de Walque, Damien/K-7049-2012; KELLER, ANN/Y-2086-2019	de Walque, Damien/0000-0003-1592-7602; KELLER, ANN/0000-0001-5467-2898; Dow, William/0000-0002-4080-1668	World Bank Research Committee; Spanish Impact Evaluation Fund; Knowledge for Change Program; Berkeley Population Center [R21 HD056581]; CDC dissertation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056581] Funding Source: NIH RePORTER	World Bank Research Committee; Spanish Impact Evaluation Fund; Knowledge for Change Program; Berkeley Population Center; CDC dissertation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded by the World Bank Research Committee, the Spanish Impact Evaluation Fund and the Knowledge for Change Program managed by the World Bank, the William and Flora Hewlett Foundation through the Population Reference Bureau, the Berkeley Population Center (R21 HD056581), and a CDC dissertation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; BANDURA A, 1990, EVAL PROGRAM PLANN, V13, P9, DOI 10.1016/0149-7189(90)90004-G; Bankole A, 2011, AIDS EDUC PREV, V23, P313, DOI 10.1521/aeap.2011.23.4.313; Beyeza-Kashesya J, 2009, AFR HEALTH SCI, V9, P2; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chimbiri AM, 2007, SOC SCI MED, V64, P1102, DOI 10.1016/j.socscimed.2006.10.012; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; De Walque D, 2012, STIMULATING DEMAND A; De Walque D, 2007, POPUL DEV REV, V33, P501, DOI 10.1111/j.1728-4457.2007.00182.x; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; de Walque D, 2011, STUD FAMILY PLANN, V42, P1, DOI 10.1111/j.1728-4465.2011.00259.x; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Gupta GR, 2011, GLOB PUBLIC HEALTH, V6, pS370, DOI 10.1080/17441692.2011.617381; Gupta P, 2008, LANCET, V6736, P60887; Harrison A, 2010, AIDS BEHAV, V14, P991, DOI 10.1007/s10461-010-9687-y; Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47; Hirsch J. S., 2009, SECRET LOVE MARRIAGE; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kaler A, 2004, SOC SCI MED, V59, P285, DOI 10.1016/j.socscimed.2003.10.023; Kilewo C, 2001, J ACQ IMMUN DEF SYND, V28, P458, DOI 10.1097/00042560-200112150-00009; Kohler HP, 2011, WORLD BANK ECON REV, DOI [10.1093/wber/lhr1041, DOI 10.1093/WBER/LHR1041]; Krishnan S, 2011, POP ASS AM C WASH DC; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; London AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001193; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; Moustakas Clark, 1994, PHENOMENOLOGICAL RES; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Poulin M, 2007, SOC SCI MED, V65, P2383, DOI 10.1016/j.socscimed.2007.05.030; Reniers G, 2008, DEMOGRAPHY, V45, P417, DOI 10.1353/dem.0.0002; Schatz E, 2005, CULT HEALTH SEX, V7, P479, DOI 10.1080/13691050500151255; Schellenberg JA, 2002, POPULATION HLTH DEV, V1, P159; Smith KP, 2005, SOC SCI MED, V60, P649, DOI 10.1016/j.socscimed.2004.06.009; Tavory I, 2009, AM SOCIOL REV, V74, P171, DOI 10.1177/000312240907400201; TEMMERMAN M, 1995, LANCET, V345, P969, DOI 10.1016/S0140-6736(95)90707-6; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; Watkins SC, 2004, POPUL DEV REV, V30, P673, DOI 10.1111/j.1728-4457.2004.00037.x; Watkins SC, 2009, POETICS, V37, P162, DOI 10.1016/j.poetic.2009.03.002; World Health Organization Joint United Nations Programme on HIV/AIDS, 2010, ADDR VIOL WOM HIV AI	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44058	10.1371/journal.pone.0044058	http://dx.doi.org/10.1371/journal.pone.0044058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952872	gold, Green Published			2022-12-25	WOS:000308044800092
J	Leisner, TM; Moran, C; Holly, SP; Parise, LV				Leisner, T. M.; Moran, C.; Holly, S. P.; Parise, L. V.			CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling	ONCOGENE			English	Article						cell death; CIB1; GAPDH; AKT; ERK	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BAD PHOSPHORYLATION; BINDING PROTEIN; DNA-REPAIR; PATHWAYS; TRANSLOCATION; ACTIVATION; IDENTIFICATION; TRANSFORMATION; LOCALIZATION	CIB1 is a 22-kDa regulatory protein previously implicated in cell survival and proliferation. However, the mechanism by which CIB1 regulates these processes is poorly defined. Here, we report that CIB1 depletion in SK-N-SH neuroblastoma and MDA-MB-468 breast cancer cells promotes non-apoptotic, caspase-independent cell death that is not initiated by increased outer mitochondrial membrane permeability or translocation of apoptosis-inducing factor to the nucleus. Instead, cell death requires nuclear GAPDH accumulation. Furthermore, CIB1 depletion disrupts two commonly dysregulated, oncogenic pathways-PI3K/AKT and Ras/MEK/ERK, resulting in a synergistic mechanism of cell death, which was mimicked by simultaneous pharmacological inhibition of both pathways, but not either pathway alone. In defining each pathway's contributions, we found that AKT inhibition alone maximally induced GAPDH nuclear accumulation, whereas MEK/ERK inhibition alone had no effect on GAPDH localization. Concurrent GAPDH nuclear accumulation and ERK inhibition were required, however, to induce a significant DNA damage response, which was critical to subsequent cell death. Collectively, our results indicate that CIB1 is uniquely positioned to regulate PI3K/AKT and MEK/ERK signaling and that simultaneous disruption of these pathways synergistically induces a nuclear GAPDH-dependent cell death. The mechanistic insights into cell death induced by CIB1 interference suggest novel molecular targets for cancer therapy.	[Leisner, T. M.; Moran, C.; Holly, S. P.; Parise, L. V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Moran, C.] PRA Int, Raleigh, NC USA; [Parise, L. V.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Leisner, TM (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd Suite 3010, Chapel Hill, NC 27599 USA.	tml13@med.unc.edu			NIH [HL07149T32, 5R01HL092544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092544, T32HL007149] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Parise, Cook and A Sancar laboratories, Drs Yue Xiong, Matthew Torres, and Howard Fried for critical review and suggestions. We also thank Dr Akira Sawa for generously providing GAPDH plasmids. Special thanks to Dr H Fried and Andrew McFadden for lentiviral plasmid construction. This work was funded by the postdoctoral fellowship grant HL07149T32 (CM) and 5R01HL092544 (LVP) from the NIH.	Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Broniowska KA, 2010, AM J PHYSIOL-HEART C, V299, pH1212, DOI 10.1152/ajpheart.00472.2010; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Dai Y, 2008, BLOOD, V112, P2439, DOI 10.1182/blood-2008-05-159392; Dastoor Z, 2001, J CELL SCI, V114, P1643; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dent P, 2009, DRUG RESIST UPDATE, V12, P65, DOI 10.1016/j.drup.2009.03.001; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; Kodama R, 2005, GENES CELLS, V10, P1211, DOI 10.1111/j.1365-2443.2005.00911.x; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Kwon HJ, 2010, EXP MOL MED, V42, P254, DOI 10.3858/emm.2010.42.4.025; Lartigue L, 2009, MOL BIOL CELL, V20, P4871, DOI 10.1091/mbc.E09-07-0649; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mikami I, 2010, ONCOL REP, V24, P1677, DOI 10.3892/or_00001033; Mills JR, 2012, CELL CYCLE, V11, P88, DOI 10.4161/cc.11.1.18408; Milosevic J, 2009, PROTEOMICS, V9, P1230, DOI 10.1002/pmic.200700604; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Phadke MS, 2009, J PHARMACOL EXP THER, V331, P77, DOI 10.1124/jpet.109.155671; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sastry KSR, 2006, J BIOL CHEM, V281, P27367, DOI 10.1074/jbc.M511485200; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schmitz HD, 2001, EUR J CELL BIOL, V80, P419, DOI 10.1078/0171-9335-00174; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Xing CG, 2004, P NATL ACAD SCI USA, V101, P5862, DOI 10.1073/pnas.0307476101; Xu Y, 2008, ONCOGENE, V27, P3501, DOI 10.1038/sj.onc.1211023; Yoon KB, 2009, TOP CATAL, V52, P1, DOI 10.1007/s11244-008-9132-x; Yuan J, 2006, ONCOGENE, V25, P1753, DOI 10.1038/sj.onc.1209202; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zayed MA, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-17	53	29	33	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					4017	4027		10.1038/onc.2012.408	http://dx.doi.org/10.1038/onc.2012.408			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22964641	Green Accepted			2022-12-25	WOS:000323748100010
J	Sieh, S; Taubenberger, AV; Rizzi, SC; Sadowski, M; Lehman, ML; Rockstroh, A; An, JY; Clements, JA; Nelson, CC; Hutmacher, DW				Sieh, Shirly; Taubenberger, Anna V.; Rizzi, Simone C.; Sadowski, Martin; Lehman, Melanie L.; Rockstroh, Anja; An, Jiyuan; Clements, Judith A.; Nelson, Colleen C.; Hutmacher, Dietmar W.			Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment	PLOS ONE			English	Article							ANDROGEN RECEPTOR-ACTIVITY; DE-NOVO STEROIDOGENESIS; 3-DIMENSIONAL CULTURE; EXTRACELLULAR-MATRIX; SPHEROID FORMATION; COLLAGEN GELS; TUMOR-CELLS; GROWTH; HYPOXIA; BREAST	Biophysical and biochemical properties of the microenvironment regulate cellular responses such as growth, differentiation, morphogenesis and migration in normal and cancer cells. Since two-dimensional (2D) cultures lack the essential characteristics of the native cellular microenvironment, three-dimensional (3D) cultures have been developed to better mimic the natural extracellular matrix. To date, 3D culture systems have relied mostly on collagen and Matrigel (TM) hydrogels, allowing only limited control over matrix stiffness, proteolytic degradability, and ligand density. In contrast, bioengineered hydrogels allow us to independently tune and systematically investigate the influence of these parameters on cell growth and differentiation. In this study, polyethylene glycol (PEG) hydrogels, functionalized with the Arginine-glycine-aspartic acid (RGD) motifs, common cell-binding motifs in extracellular matrix proteins, and matrix metalloproteinase (MMP) cleavage sites, were characterized regarding their stiffness, diffusive properties, and ability to support growth of androgen-dependent LNCaP prostate cancer cells. We found that the mechanical properties modulated the growth kinetics of LNCaP cells in the PEG hydrogel. At culture periods of 28 days, LNCaP cells underwent morphogenic changes, forming tumor-like structures in 3D culture, with hypoxic and apoptotic cores. We further compared protein and gene expression levels between 3D and 2D cultures upon stimulation with the synthetic androgen R1881. Interestingly, the kinetics of R1881 stimulated androgen receptor (AR) nuclear translocation differed between 2D and 3D cultures when observed by immunofluorescent staining. Furthermore, microarray studies revealed that changes in expression levels of androgen responsive genes upon R1881 treatment differed greatly between 2D and 3D cultures. Taken together, culturing LNCaP cells in the tunable PEG hydrogels reveals differences in the cellular responses to androgen stimulation between the 2D and 3D environments. Therefore, we suggest that the presented 3D culture system represents a powerful tool for high throughput prostate cancer drug testing that recapitulates tumor microenvironment.	[Sieh, Shirly; Taubenberger, Anna V.; Rizzi, Simone C.; Sadowski, Martin; Clements, Judith A.; Nelson, Colleen C.; Hutmacher, Dietmar W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Regenerat Med & Canc Program, Brisbane, Qld 4001, Australia; [Taubenberger, Anna V.; Sadowski, Martin; Lehman, Melanie L.; Rockstroh, Anja; An, Jiyuan; Clements, Judith A.; Nelson, Colleen C.; Hutmacher, Dietmar W.] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Woolloongabba, Qld, Australia; [Taubenberger, Anna V.; Sadowski, Martin; Lehman, Melanie L.; Rockstroh, Anja; An, Jiyuan; Clements, Judith A.; Nelson, Colleen C.; Hutmacher, Dietmar W.] Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [Lehman, Melanie L.; Nelson, Colleen C.] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of British Columbia	Sieh, S (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Regenerat Med & Canc Program, Brisbane, Qld 4001, Australia.	dietmar.hutmacher@qut.edu.au	An, Jiyuan/ABD-2471-2020	Hutmacher, Dietmar Werner/0000-0001-5678-2134; An, Jiyuan/0000-0002-8183-8248; Taubenberger, Anna/0000-0002-7916-0394; Clements, Judith/0000-0001-6026-1964	Queensland University of Technology; Prostate Cancer Foundation of Australia; Australian Canadian Prostate Cancer Research Alliance; Australian Prostate Cancer Research Centre-Queensland; NHMRC	Queensland University of Technology; Prostate Cancer Foundation of Australia; Australian Canadian Prostate Cancer Research Alliance; Australian Prostate Cancer Research Centre-Queensland; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Queensland University of Technology start up grant for chair Prof. D. W. Hutmacher, Prostate Cancer Foundation of Australia, Australian Canadian Prostate Cancer Research Alliance, Australian Prostate Cancer Research Centre-Queensland and NHMRC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Ballangrud AM, 1999, CLIN CANCER RES, V5, p3171S; Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046; Butterworth KT, 2008, INT J CANCER, V123, P760, DOI 10.1002/ijc.23418; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chou SC, 2004, BRIT J CANCER, V90, P728, DOI 10.1038/sj.bjc.6601585; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f; Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027; Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hensley HH, 2011, INT J CANCER, V128, P962, DOI 10.1002/ijc.25634; Herrala A, 1998, EUR J BIOCHEM, V255, P329, DOI 10.1046/j.1432-1327.1998.2550329.x; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Hoyt K, 2008, CANCER BIOMARK, V4, P213, DOI 10.3233/CBM-2008-44-505; Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001; Indra I, 2011, J CELL BIOCHEM, V112, P3151, DOI 10.1002/jcb.23241; Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kesler CT, 2007, MOL ENDOCRINOL, V21, P2071, DOI 10.1210/me.2007-0240; Khandrika L, 2009, ONCOGENE, V28, P1248, DOI 10.1038/onc.2008.476; Koike C, 2002, BRIT J CANCER, V86, P947, DOI 10.1038/sj.bjc.6600158; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lamb LE, 2011, CANCER RES, V71, P2739, DOI 10.1158/0008-5472.CAN-10-2745; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li Song, 2003, FASEB Journal, V17, P97; Li XF, 2008, CANCER LETT, V264, P172, DOI 10.1016/j.canlet.2008.02.037; Li YR, 2011, CLIN CANCER RES, V17, P4414, DOI 10.1158/1078-0432.CCR-11-0431; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liu YC, 2007, TISSUE ENG, V13, P1091, DOI 10.1089/ten.2006.0297; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Movsas B, 2001, AM J CLIN ONCOL-CANC, V24, P458, DOI 10.1097/00000421-200110000-00009; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Parker C, 2004, INT J RADIAT ONCOL, V58, P750, DOI 10.1016/S0360-3016(03)01621-3; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; PCFA, 2012, PROST CANC STAT; Quaranta V, 2008, SEMIN CANCER BIOL, V18, P338, DOI 10.1016/j.semcancer.2008.03.018; Quent VMC, 2010, J CELL MOL MED, V14, P1003, DOI 10.1111/j.1582-4934.2010.01013.x; RALEIGH JA, 1987, BRIT J CANCER, V56, P395, DOI 10.1038/bjc.1987.213; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Sayeed A, 2012, J CELL PHYSIOL, V227, P751, DOI 10.1002/jcp.22784; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a; Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9; Sieh S, 2010, ORGANOGENESIS, V6, P181, DOI 10.4161/org.6.3.12041; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SYMS AJ, 1985, J BIOL CHEM, V260, P455; Takagi A, 2007, ANTICANCER RES, V27, P45; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tupper J, 2004, CANCER GENE THER, V11, P508, DOI 10.1038/sj.cgt.7700713; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yeap BB, 1999, ENDOCRINOLOGY, V140, P3282, DOI 10.1210/en.140.7.3282; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Zhang J, 2007, INT J MOL SCI, V8, P156, DOI 10.3390/i8020156; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544; Zhao DW, 2001, RADIAT RES, V156, P510, DOI 10.1667/0033-7587(2001)156[0510:TODWRT]2.0.CO;2	92	67	68	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e40217	10.1371/journal.pone.0040217	http://dx.doi.org/10.1371/journal.pone.0040217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957009	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800001
J	Terai, G; Okida, H; Asai, K; Mituyama, T				Terai, Goro; Okida, Hiroaki; Asai, Kiyoshi; Mituyama, Toutai			Prediction of Conserved Precursors of miRNAs and Their Mature Forms by Integrating Position-Specific Structural Features	PLOS ONE			English	Article							MICRORNA GENES; IDENTIFICATION; MODEL; BIOGENESIS; SEQUENCE; VERTEBRATE; SYSTEM	MicroRNA (miRNA) precursor hairpins have a unique secondary structure, nucleotide length, and nucleotide content that are in most cases evolutionarily conserved. The aim of this study was to utilize position-specific features of miRNA hairpins to improve their identification. To this end, we defined the evolutionary and structurally conserved features in each position of miRNA hairpins with heuristically derived values, which were successfully integrated using a probabilistic framework. Our method, miRRim2, can not only accurately detect miRNA hairpins, but infer the location of a mature miRNA sequence. To evaluate the accuracy of miRRim2, we designed a cross validation test in which the whole human genome was used for evaluation. miRRim2 could more accurately detect miRNA hairpins than the other computational predictions that had been performed on the human genome, and detect the position of the 5'-end of mature miRNAs with sensitivity and positive predictive value (PPV) above 0.4. To further evaluate miRRim2 on independent data, we applied it to the Ciona intestinalis genome. Our method detected 47 known miRNA hairpins among top 115 candidates, and pinpointed the 5'-end of mature miRNAs with sensitivity and PPV about 0.4. When our results were compared with deep-sequencing reads of small RNA libraries from Ciona intestinalis cells, we found several candidates in which the predicted mature miRNAs were in good accordance with deep-sequencing results.	[Terai, Goro; Okida, Hiroaki] INTEC Inc, Tokyo, Japan; [Terai, Goro; Asai, Kiyoshi; Mituyama, Toutai] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan; [Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Terai, G (corresponding author), INTEC Inc, Tokyo, Japan.	terai_goro@intec.co.jp	Asai, Kiyoshi/AAT-8344-2020; Mituyama, Toutai/A-5610-2017	Asai, Kiyoshi/0000-0003-0909-4982; Mituyama, Toutai/0000-0002-1110-6375	Functional RNA Project of the New Energy and Industrial Technology Development Organization	Functional RNA Project of the New Energy and Industrial Technology Development Organization	This work was supported partly by a Grant-in-Aid for Scientific Research (A) and the Functional RNA Project of the New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; BAUM LE, 1967, B AM MATH SOC, V73, P360, DOI 10.1090/S0002-9904-1967-11751-8; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Brameier M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-478; DeCaprio D, 2007, GENOME RES, V17, P1389, DOI 10.1101/gr.6558107; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Do CB, 2006, LECT NOTES COMPUT SC, V3909, P160, DOI 10.1007/11732990_15; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hendrix D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r39; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kiryu H, 2008, BIOINFORMATICS, V24, P367, DOI 10.1093/bioinformatics/btm591; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032797; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Norden-Krichmar TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-445; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Saetrom P, 2006, OLIGONUCLEOTIDES, V16, P115, DOI 10.1089/oli.2006.16.115; Sato K, 2005, BIOINFORMATICS, V21, P237, DOI 10.1093/bioinformatics/bti1139; Sheng Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000946; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Terai G, 2007, RNA, V13, P2081, DOI 10.1261/rna.655107; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094	47	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44314	10.1371/journal.pone.0044314	http://dx.doi.org/10.1371/journal.pone.0044314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957063	Green Submitted, Green Published, gold			2022-12-25	WOS:000308463800056
J	Chen, M; Wang, K; Lin, B				Chen, Miao; Wang, Ke; Lin, Bin			Development and Degeneration of Cone Bipolar Cells Are Independent of Cone Photoreceptors in a Mouse Model of Retinitis Pigmentosa	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; HORIZONTAL CELLS; GLUTAMATE RECEPTORS; SPATIAL ORDER; GENE-THERAPY; RD/RD MOUSE; RAT RETINA; RD MICE; ORGANIZATION; MELANOPSIN	Retinal photoreceptors die during retinal synaptogenesis in a portion of retinal degeneration. Whether cone bipolar cells establish regular retinal mosaics and mature morphologies, and resist degeneration are not completely understood. To explore these issues, we backcrossed a transgenic mouse expressing enhanced green fluorescent protein (EGFP) in one subset of cone bipolar cells (type 7) into rd1 mice, a classic mouse model of retinal degeneration, to examine the development and survival of cone bipolar cells in a background of retinal degeneration. Our data revealed that both the development and degeneration of cone bipolar cells are independent of the normal activity of cone photoreceptors. We found that type 7 cone bipolar cells achieved a uniform tiling of the retinal surface and developed normal dendritic and axonal arbors without the influence of cone photoreceptor innervation. On the other hand, degeneration of type 7 cone bipolar cells, contrary to our belief of central-to-peripheral progression, was spatially uniform across the retina independent of the spatiotemporal pattern of cone degeneration. The results have important implications for the design of more effective therapies to restore vision in retinal degeneration.	[Chen, Miao; Wang, Ke; Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Pokfulam, Hong Kong, Peoples R China; [Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chen, M (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	blin@hku.hk	Lin, Bin/E-9871-2010	Lin, Bin/0000-0003-1309-3480	University of Hong Kong; Hong Kong Research Grants Council	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by University of Hong Kong Seed Funding Program for Basic Research and General Research Fund from the Hong Kong Research Grants Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Berntson A, 2000, J PHYSIOL-LONDON, V524, P879, DOI 10.1111/j.1469-7793.2000.00879.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Euler T, 1996, J NEUROSCI, V16, P2934; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Fei YJ, 2002, MOL VIS, V8, P306; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; GARCIAFERNANDEZ JM, 1995, NEUROSCI LETT, V187, P33; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Grunert U, 2003, J COMP NEUROL, V466, P136, DOI 10.1002/cne.10862; Hartveit E, 1997, J NEUROPHYSIOL, V77, P1716, DOI 10.1152/jn.1997.77.4.1716; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; HINDS JW, 1979, J COMP NEUROL, V187, P495, DOI 10.1002/cne.901870303; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Keeley PW, 2010, J NEUROSCI, V30, P1677, DOI 10.1523/JNEUROSCI.5153-09.2010; Keeley PW, 2012, DISR CIRC OUT RET FO; KOLB H, 1974, INVEST OPHTH VISUAL, V13, P487; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LaVail MM, 1997, EXP EYE RES, V65, P45, DOI 10.1006/exer.1997.0308; Lee SCS, 2011, J NEUROSCI, V31, P14126, DOI 10.1523/JNEUROSCI.2844-11.2011; Lin B, 2005, EUR J NEUROSCI, V21, P1257, DOI 10.1111/j.1460-9568.2005.03967.x; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; Petit-Jacquea J, 2005, J NEUROPHYSIOL, V94, P1770, DOI 10.1152/jn.00279.2005; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Puthussery T, 2010, ADV EXP MED BIOL, V664, P525, DOI 10.1007/978-1-4419-1399-9_60; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raven MA, 2003, INVEST OPHTH VIS SCI, V44, P965, DOI 10.1167/iovs.02-0831; Rich KA, 1997, J COMP NEUROL, V388, P47; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Rossi C, 2003, J NEUROSCI, V23, P9924; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Shi ZW, 2011, J NEUROSCI, V31, P13118, DOI 10.1523/JNEUROSCI.2331-11.2011; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Strettoi E, 2002, J COMP NEUROL, V446, P1, DOI 10.1002/cne.10177; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2002, J NEUROSCI, V22, P5492; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; YANAI D, 2003, T AM OPHTHAL SOC, V101, P228; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	68	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44036	10.1371/journal.pone.0044036	http://dx.doi.org/10.1371/journal.pone.0044036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952865	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300045
J	Zhu, XY; Li, XP; Chen, WX; Chen, JY; Lu, WJ; Chen, L; Fu, DW				Zhu, Xiaoyang; Li, Xueping; Chen, Weixin; Chen, Jianye; Lu, Wangjin; Chen, Lei; Fu, Danwen			Evaluation of New Reference Genes in Papaya for Accurate Transcript Normalization under Different Experimental Conditions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; QUANTITATIVE RT-PCR; RELIABLE REFERENCE GENES; REAL-TIME PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; EXPRESSION NORMALIZATION; GOSSYPIUM-HIRSUTUM; VALIDATION; SELECTION	Real-time reverse transcription PCR (RT-qPCR) is a preferred method for rapid and accurate quantification of gene expression studies. Appropriate application of RT-qPCR requires accurate normalization though the use of reference genes. As no single reference gene is universally suitable for all experiments, thus reference gene(s) validation under different experimental conditions is crucial for RT-qPCR analysis. To date, only a few studies on reference genes have been done in other plants but none in papaya. In the present work, we selected 21 candidate reference genes, and evaluated their expression stability in 246 papaya fruit samples using three algorithms, geNorm, NormFinder and RefFinder. The samples consisted of 13 sets collected under different experimental conditions, including various tissues, different storage temperatures, different cultivars, developmental stages, postharvest ripening, modified atmosphere packaging, 1-methylcyclopropene (1-MCP) treatment, hot water treatment, biotic stress and hormone treatment. Our results demonstrated that expression stability varied greatly between reference genes and that different suitable reference gene(s) or combination of reference genes for normalization should be validated according to the experimental conditions. In general, the internal reference genes EIF (Eukaryotic initiation factor 4A), TBP1 (TATA binding protein 1) and TBP2 (TATA binding protein 2) genes had a good performance under most experimental conditions, whereas the most widely present used reference genes, ACTIN (Actin 2), 18S rRNA (18S ribosomal RNA) and GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) were not suitable in many experimental conditions. In addition, two commonly used programs, geNorm and Normfinder, were proved sufficient for the validation. This work provides the first systematic analysis for the selection of superior reference genes for accurate transcript normalization in papaya under different experimental conditions.	[Zhu, Xiaoyang; Li, Xueping; Chen, Weixin; Chen, Jianye; Lu, Wangjin; Chen, Lei; Fu, Danwen] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangdong Key Lab Postharvest Sci & Technol, Coll Hort, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhu, XY (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangdong Key Lab Postharvest Sci & Technol, Coll Hort, Guangzhou, Guangdong, Peoples R China.	lxp280477@yahoo.cn	Chen, Jian-ye/V-8278-2019	Chen, Jian-ye/0000-0002-8975-6941	National Natural Science Foundation of China [U0631004]; Guangdong Science Foundation [04020590, 06200670]; National Key Technology R&D Program of China [2011BAD24B02-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science Foundation; National Key Technology R&D Program of China(National Key Technology R&D Program)	The research work was funded by the Project of Guangdong Science Foundation (04020590), National Natural Science Foundation of China (U0631004), Guangdong Science Foundation (06200670), and the National Key Technology R&D Program of China (2011BAD24B02-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bezier A, 2002, EUR J PLANT PATHOL, V108, P111, DOI 10.1023/A:1015061108045; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Burleigh SH, 2001, PLANT SCI, V160, P899, DOI 10.1016/S0168-9452(00)00460-X; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chen NJ, 2003, FUNCT PLANT BIOL, V30, P433, DOI 10.1071/FP02208; Chen YT, 2003, PLANT SCI, V164, P531, DOI 10.1016/S0168-9452(03)00002-5; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; de Capdeville G, 2007, SCI HORTIC-AMSTERDAM, V111, P179, DOI 10.1016/j.scienta.2006.10.003; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Devitt LC, 2006, PLANT SCI, V170, P356, DOI 10.1016/j.plantsci.2005.09.003; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hernandez M, 2007, VACCINE, V25, P4252, DOI 10.1016/j.vaccine.2007.02.080; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Le Bail A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-75; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Manenoi A, 2007, PHYSIOL PLANTARUM, V131, P470, DOI 10.1111/j.1399-3054.2007.00967.x; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reece R.J., 2004, ANAL GENES GENOMES; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Shiga TM, 2009, J AGR FOOD CHEM, V57, P7064, DOI 10.1021/jf900073b; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Xie Fuliang, 2012, Plant Mol Biol; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yu QY, 2008, PLANT J, V53, P124, DOI 10.1111/j.1365-313X.2007.03329.x; Yu QY, 2005, CELL RES, V15, P576, DOI 10.1038/sj.cr.7290327; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	71	221	235	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44405	10.1371/journal.pone.0044405	http://dx.doi.org/10.1371/journal.pone.0044405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952972	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300088
J	Li, X; Li, JJ; Yang, JY; Wang, DS; Zhao, W; Song, WJ; Li, WM; Wang, JF; Han, W; Zhang, ZC; Yu, Y; Cao, DY; Dou, KF				Li, Xiao; Li, Jun-Jie; Yang, Jing-Yue; Wang, De-Sheng; Zhao, Wei; Song, Wen-Jie; Li, Wei-Min; Wang, Jian-Feng; Han, Wei; Zhang, Zhuo-Chao; Yu, Yong; Cao, Da-Yong; Dou, Ke-Feng			Tolerance Induction by Exosomes from Immature Dendritic Cells and Rapamycin in a Mouse Cardiac Allograft Model	PLOS ONE			English	Article							TRANSPLANTATION; DISEASE; ALLOANTIGEN; GENERATION; EXPOSURE	Background: Dendritic cells (DCs) release bioactive exosomes that play an important role in immune regulation. Because they express low levels of class I major histocompatibility complex (MHC) and co-stimulatory molecules, exosomes derived from donor immature DCs (imDex) prolong allograft survival by inhibiting T-cell activation. However, this effect is limited and does not induce immunological tolerance when imDex are administered alone. Thus, we tested the effect of combined treatment with donor imDex and low-dose rapamycin on inducing tolerance in a mouse cardiac transplantation model. Methods: ImDex were obtained from the culture supernatant of immature DCs derived from donor mouse (C57BL/6) bone marrow and were injected with suboptimal doses of rapamycin into recipient mouse (BALB/c) before and after transplantation. The capacity of this treatment to induce immune tolerance was analyzed in vitro and in vivo using the mouse cardiac transplantation model. Results: Donor imDex expressed moderate levels of MHC class II and low levels of MHC class I and co-stimulatory molecules, but neither imDex nor subtherapeutic rapamycin dose alone induced cardiac allograft tolerance. Combined treatment with imDex and rapamycin, however, led to donor specific cardiac allograft tolerance. This effect was accompanied by decreased anti-donor antigen cellular response and an increased percentage of spleen CD4(+)CD25(+) T cells in recipients. Furthermore, this donor specific tolerance could be further transferred to naive allograft recipients through injection of splenocytes, but not serum, from tolerant recipients. Conclusion: Combined with immunosuppressive treatment, donor imDex can prolong cardiac allograft survival and induce donor specific allograft tolerance.	[Li, Xiao; Li, Jun-Jie; Wang, De-Sheng; Zhao, Wei; Song, Wen-Jie; Li, Wei-Min; Wang, Jian-Feng; Han, Wei; Zhang, Zhuo-Chao; Yu, Yong; Cao, Da-Yong; Dou, Ke-Feng] Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xijing Hosp, Xian 710032, Shaanxi Provinc, Peoples R China; [Yang, Jing-Yue] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Oncol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, X (corresponding author), Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xijing Hosp, Xian 710032, Shaanxi Provinc, Peoples R China.	caody777@sina.com; gdwkgwx@fmmu.edu.cn			National High Technology Research and Development Program of China [2012AA021000]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The study was supported by grants from National High Technology Research and Development Program of China (2012AA021000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bianco NR, 2009, ARTHRITIS RHEUM-US, V60, P380, DOI 10.1002/art.24229; Cai ZJ, 2012, CELL RES, V22, P607, DOI 10.1038/cr.2011.196; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; CHEN ZH, 1991, TRANSPLANTATION, V52, P1099, DOI 10.1097/00007890-199112000-00035; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mendieta-Zeron H, 2011, IMMUNOTHERAPY-UK, V3, P1499, DOI [10.2217/IMT.11.142, 10.2217/imt.11.142]; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Morelli AE, 2006, AM J TRANSPLANT, V6, P254, DOI 10.1111/j.1600-6143.2005.01197.x; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Muthana M, 2004, J IMMUNOL METHODS, V294, P165, DOI 10.1016/j.jim.2004.09.006; Niimi M, 2001, J HEART LUNG TRANSPL, V20, P1123, DOI 10.1016/S1053-2498(01)00309-6; Peche H, 2005, AM J TRANSPLANT, V5, P255, DOI 10.1111/j.1600-6143.2004.00683.x; Peche H, 2003, TRANSPLANTATION, V76, P1503, DOI 10.1097/01.TP.0000092494.75313.38; Pliszczynski J, 2011, TRANSPL P, V43, P3657, DOI 10.1016/j.transproceed.2011.10.052; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schonder KS, 2011, CRIT CARE NURS CLIN, V23, P405, DOI 10.1016/j.ccell.2011.06.001; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Taner T, 2005, AM J TRANSPLANT, V5, P228, DOI 10.1046/j.1600-6143.2004.00673.x; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; van Kooten C, 2011, TRANSPLANTATION, V91, P2, DOI 10.1097/TP.0b013e31820263b3; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Yang XJ, 2011, J SURG RES, V171, P826, DOI 10.1016/j.jss.2010.05.021; Yang XJ, 2010, SCAND J GASTROENTERO, V45, P1168, DOI 10.3109/00365521.2010.490596	34	77	80	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44045	10.1371/journal.pone.0044045	http://dx.doi.org/10.1371/journal.pone.0044045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952868	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000073
J	Kumari, S; Mukhopadhyay, G; Tyagi, RK				Kumari, Sangeeta; Mukhopadhyay, Gauranga; Tyagi, Rakesh K.			Transcriptional Regulation of Mouse PXR Gene: An Interplay of Transregulatory Factors	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; ENHANCER COMPLEX; C-MYB; ACTIVATION; EXPRESSION; CYP3A4; INDUCTION; PROMOTER; INHIBITION	Pregnane X Receptor (PXR) is an important ligand-activated nuclear receptor functioning as a 'master regulator' of expression of phase I, phase II drug metabolizing enzymes, and members of the drug transporters. PXR is primarily expressed in hepatic tissues and to lesser extent in other non-hepatic tissues both in human and in mice. Although its expression profile is well studied but little is known about the regulatory mechanisms that govern PXR gene expression in these cells. In the present study, we have cloned and characterized over 5 kb (-4963 to +54) region lying upstream of mouse PXR transcription start site. Promoter-reporter assays revealed that the proximal promoter region of up to 1 kb is sufficient to support the expression of PXR in the mouse liver cell lines. It was evident that the 500 bp proximal promoter region contains active binding sites for Ets, Tcf, Ikarose and nuclear factor families of transcription factors. Electrophoretic mobility shift assays demonstrated that the minimal region of 134 bp PXR promoter was able to bind Ets-1 and beta-catenin proteins. This result was further confirmed by chromatin immunoprecipitation analysis. In summary, the present study identified a promoter region of mouse PXR gene and the transregulatory factors responsible for PXR promoter activity. The results presented herein are expected to provide important cues to gain further insight into the regulatory mechanisms of PXR function.	[Kumari, Sangeeta; Mukhopadhyay, Gauranga; Tyagi, Rakesh K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Kumari, S (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	garunga@hotmail.com; rktyagi@yahoo.com	Kumari, Sangeeta/AAB-7154-2022	Kumari, Sangeeta/0000-0002-0692-0452	Department of Science and Technology (DST), India [SR/SO/bb-17/2006]; Council of Scientific and Industrial Research (CSIR), India	Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The research work presented in this paper was financially supported by a research grant to RKT from the Department of Science and Technology (DST), India [Grant no. SR/SO/bb-17/2006]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sangeeta Kumari, acknowledges Council of Scientific and Industrial Research (CSIR), India, for the award of Research Fellowship. Infrastructural facilities supported by UGC-SAP (DRS-1) to our centre is thankfully acknowledged.	Aouabdi S, 2006, DRUG METAB DISPOS, V34, P138, DOI 10.1124/dmd.105.006064; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Goodwin B, 2001, MOL PHARMACOL, V60, P427; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Iwazaki N, 2008, DRUG METAB PHARMACOK, V23, P59, DOI 10.2133/dmpk.23.59; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Jung D, 2006, J BIOL CHEM, V281, P19081, DOI 10.1074/jbc.M600116200; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kliewer SA, 2002, J LIPID RES, V43, P359; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lau AJ, 2012, DRUG METAB DISPOS, V40, P178, DOI 10.1124/dmd.111.042879; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lemaire G, 2004, BIOCHEM PHARMACOL, V68, P2347, DOI 10.1016/j.bcp.2004.07.041; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Li YY, 2009, CANCER SCI, V100, P396, DOI 10.1111/j.1349-7006.2008.01059.x; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361; Pascussi JM, 1999, BIOCHEM BIOPH RES CO, V260, P377, DOI 10.1006/bbrc.1999.0745; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; RASCHELLA G, 1992, CANCER RES, V52, P4221; Raynal C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-46; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Saradhi M., 2006, Journal of Endocrinology and Reproduction, V10, P1; Sharma M, 2007, BIOCHEM BIOPH RES CO, V358, P379, DOI 10.1016/j.bbrc.2007.04.149; Shi DS, 2010, BIOCHEM PHARMACOL, V80, P1274, DOI 10.1016/j.bcp.2010.06.043; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Wisniewska MB, 2010, J NEUROSCI, V30, P4957, DOI 10.1523/JNEUROSCI.1425-09.2010	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44126	10.1371/journal.pone.0044126	http://dx.doi.org/10.1371/journal.pone.0044126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952895	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600080
J	Gu, ZP; Li, YR; Lee, P; Liu, T; Wan, CD; Wang, ZX				Gu, Zhongping; Li, Yirong; Lee, Peng; Liu, Tao; Wan, Chidan; Wang, Zhengxin			Protein Arginine Methyltransferase 5 Functions in Opposite Ways in the Cytoplasm and Nucleus of Prostate Cancer Cells	PLOS ONE			English	Article							RECEPTOR COFACTOR P44; CAJAL BODIES; SM PROTEINS; GERM-CELLS; METHYLATION; PRMT5; HISTONE; COMPLEX; EXPRESSION; GENE	Protein arginine methyltransferase 5 (PRMT5) plays multiple roles in a large number of cellular processes, and its subcellular localization is dynamically regulated during mouse development and cellular differentiation. However, little is known of the functional differences between PRMT5 in the cytoplasm and PRMT5 in the nucleus. Here, we demonstrated that PRMT5 predominantly localized in the cytoplasm of prostate cancer cells. Subcellular localization assays designed to span the entire open-reading frame of the PRMT5 protein revealed the presence of three nuclear exclusion signals (NESs) in the PRMT5 protein. PRMT5 and p44/MED50/WD45/WDR77 co-localize in the cytoplasm, and both are required for the growth of prostate cancer cells in an PRMT5 methyltransferase activity-dependent manner. In contrast, PRMT5 in the nucleus inhibited cell growth in a methyltransferase activity-independent manner. Consistent with these observations, PRMT5 localized in the nucleus in benign prostate epithelium, whereas it localized in the cytoplasm in prostate premalignant and cancer tissues. We further found that PRMT5 alone methylated both histone H4 and SmD3 proteins but PRMT5 complexed with p44 and pICln methylated SmD3 but not histone H4. These results imply a novel mechanism by which PRMT5 controls cell growth and contributes to prostate tumorigenesis.	[Gu, Zhongping; Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Gu, Zhongping] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China; [Li, Yirong; Lee, Peng] NYU, Langone Med Ctr, Dept Pathol & Urol, New York, NY USA; [Liu, Tao; Wan, Chidan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University; New York University; NYU Langone Medical Center; Huazhong University of Science & Technology	Gu, ZP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	zhenwang@mdanderson.org			National Institute of Diabetes and Digestive and Kidney Diseases, United States National Institutes of Health (NIH) [1R01 DK065156 01]; Cancer Center Support (Core) grant from the National Cancer Institute, NIH [CA16672]; NYUSOM Urology Center of Excellence; National Natural Science Foundation of China [81171922]; Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China [2008K27G01]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065156] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, United States National Institutes of Health (NIH); Cancer Center Support (Core) grant from the National Cancer Institute, NIH; NYUSOM Urology Center of Excellence; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grant 1R01 DK065156 01 from the National Institute of Diabetes and Digestive and Kidney Diseases, United States National Institutes of Health (NIH) (to ZW), by the Cancer Center Support (Core) grant CA16672 from the National Cancer Institute, NIH to The University of Texas MD Anderson Cancer Center, by NYUSOM Urology Center of Excellence funding to PL, and by National Natural Science Foundation of China (81171922) and Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China. (2008K27G01) to ZP. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amente S, 2005, FEBS LETT, V579, P683, DOI 10.1016/j.febslet.2004.12.045; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Eckert D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-106; Eguizabal C, 2009, DIFFERENTIATION, V78, P116, DOI 10.1016/j.diff.2009.07.001; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gao S, 2010, ENDOCRINOLOGY, V151, P3941, DOI 10.1210/en.2009-1080; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Gu ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022395; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Hayward SW, 1996, ACTA ANAT, V155, P81; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; KELLOKUMPULEHTINEN P, 1985, BIOL NEONATE, V48, P157; Kroiss M, 2009, FLY, V3, P221; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Liang JJ, 2007, J UROLOGY, V177, P1918, DOI 10.1016/j.juro.2007.01.017; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Morgan GT, 2000, J STRUCT BIOL, V129, P258, DOI 10.1006/jsbi.2000.4231; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Peng Y, 2008, AM J PATHOL, V172, P225, DOI 10.2353/ajpath.2008.070065; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Shen JC, 1998, MOL CARCINOGEN, V23, P13, DOI 10.1002/(SICI)1098-2744(199809)23:1<13::AID-MC2>3.0.CO;2-I; Spector DL, 2001, J CELL SCI, V114, P2891; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; TIMMS BG, 1994, J UROLOGY, V151, P1427, DOI 10.1016/S0022-5347(17)35273-4; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Yang M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000514; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062; Zhou ZW, 2010, CELL RES, V20, P1023, DOI 10.1038/cr.2010.56	52	68	86	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44033	10.1371/journal.pone.0044033	http://dx.doi.org/10.1371/journal.pone.0044033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952863	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800090
J	Santag, S; Jager, W; Karsten, CB; Kati, S; Pietrek, M; Steinemann, D; Sarek, G; Ojala, PM; Schulz, TF				Santag, S.; Jaeger, W.; Karsten, C. B.; Kati, S.; Pietrek, M.; Steinemann, D.; Sarek, G.; Ojala, P. M.; Schulz, T. F.			Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells	ONCOGENE			English	Article						KSHV; primary effusion lymphoma; LANA; p73; Nutlin-3; RETRA	DNA-SEQUENCES; TRANSCRIPTIONAL ACTIVATION; ENDOTHELIAL-CELLS; ONCOPROTEIN MDM2; GENE-EXPRESSION; P53 PATHWAY; APOPTOSIS; BINDING; VIRUS; INSTABILITY	Kaposi's Sarcoma Herpesvirus (KSHV) is the causative agent of Kaposi's Sarcoma (KS) and two rare lymphoproliferative disorders, primary effusion lymphoma (PEL) and the plasmablastic variant of multicentric Castleman's disease (MCD). The KSHV latency-associated nuclear antigen-1 (LANA), required for the replication and maintenance of latent viral episomal DNA, is involved in the transcriptional regulation of viral and cellular genes and interacts with different cellular proteins, including the tumour suppressor p53. Here, we report that LANA also recruits the p53-related nuclear transcription factor p73, which influences cellular processes like DNA damage response, cell cycle progression and apoptosis. Both the full-length isoform TAp73 alpha, as well as its dominant negative regulator Delta Np73 alpha, interact with LANA. LANA affects TAp73 alpha stability and sub-nuclear localisation, as well as TAp73 alpha-mediated transcriptional activation of target genes. We observed that the small-molecule inhibitor Nutlin-3, which disrupts the interaction of p53 and p73 with MDM2, induces apoptotic cell death in p53 wild-type, as well as p53-mutant PEL cell lines, suggesting a possible involvement of p73. The small-molecule RETRA, which activates p73 in the context of mutant p53, leads to the induction of apoptosis in p53-mutant PEL cell lines. RNAi-mediated knockdown of p73 confirmed that these effects depend on the presence of the p73 protein. Furthermore, both Nutlin-3 and RETRA disrupt the LANA-p73 interaction in different PEL cell lines. These results suggest that LANA modulates p73 function and that the LANA-p73 interaction may represent a therapeutic target to interfere with the survival of latently KSHV-infected cells.	[Santag, S.; Jaeger, W.; Karsten, C. B.; Kati, S.; Pietrek, M.; Schulz, T. F.] Hannover Med Sch, Inst Virol, D-30625 Hannover, Germany; [Steinemann, D.] Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany; [Sarek, G.; Ojala, P. M.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Sarek, G.; Ojala, P. M.] Univ Helsinki, Res Programs Unit, Genome Scale Biol Biomedicum Helsinki, Helsinki, Finland	Hannover Medical School; Hannover Medical School; University of Helsinki; University of Helsinki	Schulz, TF (corresponding author), Hannover Med Sch, Inst Virol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	schulz.thomas@mh-hannover.de	Karsten, Christina B./J-8689-2019; Schulz, Thomas/AAA-1634-2019; Karsten, Christina B./GNH-2673-2022; Ojala, Paivi M/J-3266-2014	Karsten, Christina B./0000-0003-1934-6442; Ojala, Paivi/0000-0001-9065-1832; Schulz, Thomas/0000-0001-8792-5345	DFG IRTG [1273]; EU Integrated Project INCA [LSHC-CT-18730]; collaborative research centre (CRC) 900 of the Deutsche Forschungsgemeinschaft	DFG IRTG(German Research Foundation (DFG)); EU Integrated Project INCA; collaborative research centre (CRC) 900 of the Deutsche Forschungsgemeinschaft	We thank Magdalena Weidner-Glunde for cloning of the GST fusion construct LANA N, as well as Eva Gellermann for cloning the GST fusion constructs C8a and C8b. This work was supported by the DFG IRTG 1273, the EU Integrated Project INCA (LSHC-CT-18730) and the collaborative research centre (CRC) 900 of the Deutsche Forschungsgemeinschaft.	Accardi R, 2006, EMBO REP, V7, P334, DOI 10.1038/sj.embor.7400615; Amin ARMR, 2007, CANCER RES, V67, P5617, DOI 10.1158/0008-5472.CAN-07-0655; An FQ, 2005, J BIOL CHEM, V280, P3862, DOI 10.1074/jbc.M407435200; Ben-Yehoyada M, 2003, J BIOL CHEM, V278, P34475, DOI 10.1074/jbc.M301051200; Busuttil V, 2010, P NATL ACAD SCI USA, V107, P18061, DOI 10.1073/pnas.1006163107; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Carbone A, 2000, LEUKEMIA, V14, P1301, DOI 10.1038/sj.leu.2401802; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; D'Amours D, 2001, J CELL SCI, V114, P3771; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Gwack Y, 2001, J VIROL, V75, P6245, DOI 10.1128/JVI.75.13.6245-6248.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kaida A, 2000, ONCOGENE, V19, P827, DOI 10.1038/sj.onc.1203387; Katano H, 2001, CANCER, V92, P3076, DOI 10.1002/1097-0142(20011215)92:12<3076::AID-CNCR10117>3.0.CO;2-D; Kliche S, 1998, J VIROL, V72, P8143, DOI 10.1128/JVI.72.10.8143-8149.1998; Kravchenko JE, 2008, P NATL ACAD SCI USA, V105, P6302, DOI 10.1073/pnas.0802091105; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Moll UM, 2004, MOL CANCER RES, V2, P371; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Ohsaki E, 2009, VIRUS RES, V139, P74, DOI 10.1016/j.virusres.2008.10.011; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pan HY, 2004, CANCER RES, V64, P4064, DOI 10.1158/0008-5472.CAN-04-0657; Park J, 2000, J VIROL, V74, P11977, DOI 10.1128/JVI.74.24.11977-11982.2000; Park JS, 2001, INT J CANCER, V91, P822, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0; Petre CE, 2007, J VIROL, V81, P1912, DOI 10.1128/JVI.01757-06; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Renne R, 2001, J VIROL, V75, P458, DOI 10.1128/JVI.75.1.458-468.2001; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Rosenbluth JM, 2008, GENE DEV, V22, P2591, DOI 10.1101/gad.1727408; Roth J, 1998, J VIROL, V72, P8510, DOI 10.1128/JVI.72.11.8510-8516.1998; Santarelli R, 2008, J VIROL, V82, P4562, DOI 10.1128/JVI.02400-07; Sarek G, 2013, ONCOGENE, V32, P1091, DOI 10.1038/onc.2012.118; Sarek G, 2007, J CLIN INVEST, V117, P1019, DOI 10.1172/JCI30945; Seo T, 2001, J VIROL, V75, P6193, DOI 10.1128/JVI.75.13.6193-6198.2001; Si HX, 2006, J VIROL, V80, P697, DOI 10.1128/JVI.80.2.697-709.2006; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Steegenga WT, 1999, MOL CELL BIOL, V19, P3885; Toh WH, 2010, CELL DEATH DIFFER, V17, P787, DOI 10.1038/cdd.2009.181; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Viejo-Borbolla A, 2005, J VIROL, V79, P13618, DOI 10.1128/JVI.79.21.13618-13629.2005; Viejo-Borbolla A, 2003, J VIROL, V77, P7093, DOI 10.1128/JVI.77.12.7093-7100.2003; Wang L, 2008, CANCER RES, V68, P4640, DOI 10.1158/0008-5472.CAN-07-5988; Wies E, 2008, BLOOD, V111, P320, DOI 10.1182/blood-2007-05-092288; Wong LY, 2004, J VIROL, V78, P10074, DOI 10.1128/JVI.78.18.10074-10085.2004; Zeng XY, 1999, MOL CELL BIOL, V19, P3257	55	28	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 8	2013	32	32					3676	3685		10.1038/onc.2012.385	http://dx.doi.org/10.1038/onc.2012.385			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22964633				2022-12-25	WOS:000322904400003
J	Pelosi, A; Careccia, S; Lulli, V; Romania, P; Marziali, G; Testa, U; Lavorgna, S; Lo-Coco, F; Petti, MC; Calabretta, B; Levrero, M; Piaggio, G; Rizzo, MG				Pelosi, A.; Careccia, S.; Lulli, V.; Romania, P.; Marziali, G.; Testa, U.; Lavorgna, S.; Lo-Coco, F.; Petti, M. C.; Calabretta, B.; Levrero, M.; Piaggio, G.; Rizzo, M. G.			miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia	ONCOGENE			English	Article						acute myeloid leukemia; microRNA; PBX2	ACUTE PROMYELOCYTIC LEUKEMIA; MICRORNA; EXPRESSION; CELLS; ALPHA; RAS; TRANSFORMATION; HEMATOPOIESIS; DELTA-N-P73; PREDICTION	MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression post-transcriptionally, are involved in many complex cellular processes. Several miRNAs are differentially expressed in hematopoietic tissues and play important roles in normal differentiation, but, when aberrantly regulated, contribute to the abnormal proliferation and differentiation of leukemic cells. Recently, we reported that a small subset of miRNAs is differentially expressed in acute promyelocytic leukemia (APL) blasts and is modulated by treatment with all-trans-retinoic acid (ATRA). In particular, PML/RARa-positive blasts from APL patients display lower levels of miRNA let-7c, a member of the let-7 family, than normal promyelocytes and its expression increases after ATRA treatment. In this study, we investigated the effects of let-7c in acute myeloid leukemia (AML) cells. We found that ectopic expression of let-7c promotes granulocytic differentiation of AML cell lines and primary blasts. Moreover, we identified PBX2, a well-known homeodomain protein whose aberrant expression enhances HoxA9-dependent leukemogenesis, as a novel let-7c target that may contribute to the AML phenotype. Together, these studies raise the possibility that perturbation of the let-7c-PBX2 pathway may have a therapeutic value in AML.	[Pelosi, A.; Careccia, S.; Piaggio, G.; Rizzo, M. G.] Regina Elena Inst Canc Res, Dept Expt Oncol, Lab Mol Oncogenesis, I-00158 Rome, Italy; [Lulli, V.; Romania, P.; Marziali, G.; Testa, U.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Lavorgna, S.; Lo-Coco, F.] Univ Roma Tor Vergata, Dept Biopathol, Rome, Italy; [Lavorgna, S.; Lo-Coco, F.] Santa Lucia Fdn, Lab Neurooncohematol, Rome, Italy; [Petti, M. C.] Regina Elena Inst Canc Res, Dept Med Oncol, Div Hematol, Rome, Italy; [Calabretta, B.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Levrero, M.] Univ Roma La Sapienza, Dept Internal Med, I-00185 Rome, Italy; [Levrero, M.] Fdn Andrea Cesalpino, Gene Express Lab, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; IRCCS Santa Lucia; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Jefferson University; Sapienza University Rome	Rizzo, MG (corresponding author), Regina Elena Inst Canc Res, Dept Expt Oncol, Via delle Messi dOro 156, I-00158 Rome, Italy.	rizzo@ifo.it	Lulli, Valentina/J-9189-2016; Rizzo, Maria Giulia/B-2107-2018; lavorgna, serena/O-8490-2016; Pelosi, Andrea/J-9690-2018; Piaggio, Giulia/J-7214-2018; Romania, Paolo/K-3839-2018; Careccia, Silvia/K-6475-2016; Piaggio, Giulia/AAD-7336-2022; Marziali, Giovanna/J-9808-2016; Testa, Ugo/J-6472-2016; Levrero, Massimo/G-5680-2016	Lulli, Valentina/0000-0002-2143-4436; Rizzo, Maria Giulia/0000-0002-5009-2412; lavorgna, serena/0000-0001-8812-2325; Pelosi, Andrea/0000-0003-2308-9215; Piaggio, Giulia/0000-0003-2114-1892; Romania, Paolo/0000-0001-6855-1464; Careccia, Silvia/0000-0001-7221-8170; Marziali, Giovanna/0000-0001-7450-1017; Testa, Ugo/0000-0001-7900-8942; Levrero, Massimo/0000-0002-4978-0875	NCI [CA95111]; AIL 'Alberto Landi'; Associazione Italiana Ricerca sul Cancro (AIRC); NATIONAL CANCER INSTITUTE [R01CA095111] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIL 'Alberto Landi'; Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Alessandro Fatica from 'Sapienza' University in Rome for a kind gift of lentiviral vector pRRLSIN-cPPT-PGK-GFP-WPRE and Dr Gianluca Bossi for kindly providing information on lentiviral utilization; Alessandra Boe for technical assistance for cell sorting and FACS analysis. We also acknowledge Dr Silvia Bacchetti for helpful comments on the manuscript. Associazione Italiana Leucemie (AIL) and Ministry of Health, Ricerca oncologica-Project of integrated program to MGR. G Piaggio was supported, in part, by Associazione Italiana Ricerca sul Cancro (AIRC). B Calabretta was supported, in part, by NCI grant CA95111. A Pelosi and S Careccia are PhD students University of Rome 'Sapienza'. A Pelosi is a recipient of a fellowship from AIRC. S Careccia is a recipient of the fellowship AIL 'Alberto Landi'.	Bhatia M, 1996, CELL GROWTH DIFFER, V7, P91; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brown G, 2002, EXP CELL RES, V281, P28, DOI 10.1006/excr.2002.5654; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Careccia S, 2009, ONCOGENE, V28, P4034, DOI 10.1038/onc.2009.255; Chan IT, 2006, BLOOD, V108, P1708, DOI 10.1182/blood-2006-04-015040; Chaudhuri AA, 2012, P NATL ACAD SCI USA, V109, P4233, DOI 10.1073/pnas.1200677109; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Isken F, 2008, BRIT J HAEMATOL, V140, P153, DOI 10.1111/j.1365-2141.2007.06915.x; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Laurent A, 2008, INT J DEV BIOL, V52, P9, DOI 10.1387/ijdb.072304al; Leucci E, 2008, J PATHOL, V216, P440, DOI 10.1002/path.2410; Li X, 2012, NAT PROD COMMUN, V7, P181; Mainardi S, 2007, CELL DEATH DIFFER, V14, P1968, DOI 10.1038/sj.cdd.4402210; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Rizzo MG, 2004, LEUKEMIA, V18, P1804, DOI 10.1038/sj.leu.2403483; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; Shen WF, 1999, MOL CELL BIOL, V19, P3051; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107	34	49	51	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 1	2013	32	31					3648	3654		10.1038/onc.2012.398	http://dx.doi.org/10.1038/onc.2012.398			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	194MW	22964640	Green Accepted			2022-12-25	WOS:000322638400009
J	Lok, BH; Carley, AC; Tchang, B; Powell, SN				Lok, B. H.; Carley, A. C.; Tchang, B.; Powell, S. N.			RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination	ONCOGENE			English	Article						BRCA1; PALB2; BRCA2; RAD52; synthetic lethality; RAD51	CANCER SUSCEPTIBILITY GENE; REPLICATION PROTEIN-A; STRAND BREAK REPAIR; DNA-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; CELLS; PHOSPHORYLATION; COMPLEX; TUMORS; DAMAGE	Synthetic lethality is an approach to study selective cell killing based on genotype. Previous work in our laboratory has shown that loss of RAD52 is synthetically lethal with BRCA2 deficiency, while exhibiting no impact on cell growth and viability in BRCA2-proficient cells. We now show that this same synthetically lethal relationship is evident in cells with deficiencies in BRCA1 or PALB2, which implicates BRCA1, PALB2 and BRCA2 in an epistatic relationship with one another. When RAD52 was depleted in BRCA1- or PALB2-deficient cells, a severe reduction in plating efficiency was observed, with many abortive attempts at cell division apparent in the double-depleted background. In contrast, when RAD52 was depleted in a BRCA1- or PALB2-wildtype background, a negligible decrease in colony survival was observed. The frequency of ionizing radiation-induced RAD51 foci formation and double-strand break-induced homologous recombination (HR) was decreased by 3- and 10-fold, respectively, when RAD52 was knocked down in BRCA1- or PALB2-depleted cells, with minimal effect in BRCA1- or PALB2-proficient cells. RAD52 function was independent of BRCA1 status, as evidenced by the lack of any defect in RAD52 foci formation in BRCA1-depleted cells. Collectively, these findings suggest that RAD52 is an alternative repair pathway of RAD51-mediated HR, and a target for therapy in cells deficient in the BRCA1-PALB2-BRCA2 repair pathway.	[Lok, B. H.; Carley, A. C.; Tchang, B.; Powell, S. N.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Lok, B. H.] NYU, Langone Med Ctr, Sch Med, Dept Med, New York, NY USA; [Lok, B. H.] NYU, Langone Med Ctr, Sch Med, Dept Radiat Oncol, New York, NY USA; [Tchang, B.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY USA; [Powell, S. N.] Suny Downstate Med Ctr, Coll Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Powell, SN (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1250 1st Ave,Box 33, New York, NY 10065 USA.	Powells@mskcc.org		Lok, Benjamin/0000-0002-3675-8847	Howard Hughes Medical Institute Medical Research Training Fellowship; Radiological Society of North America Research Medical Student Grant; National Cancer Institute; Susan G. Komen for the Cure; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA107640] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Medical Research Training Fellowship(Howard Hughes Medical Institute); Radiological Society of North America Research Medical Student Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Howard Hughes Medical Institute Medical Research Training Fellowship, the Radiological Society of North America Research Medical Student Grant (BHL) and by grants from the National Cancer Institute and the Susan G. Komen for the Cure (SNP).	Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Iglehart JD, 2009, NEW ENGL J MED, V361, P189, DOI 10.1056/NEJMe0903044; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kojic M, 2011, MOL MICROBIOL, V79, P180, DOI 10.1111/j.1365-2958.2010.07440.x; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shi W, 2008, J BIOL CHEM, V283, P31608, DOI 10.1074/jbc.M801082200; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Wang WY, 2010, CLIN CANCER RES, V16, P1016, DOI 10.1158/1078-0432.CCR-09-2796; Willers H, 2009, MOL CANCER RES, V7, P1304, DOI 10.1158/1541-7786.MCR-09-0149; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	35	133	136	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 25	2013	32	30					3552	3558		10.1038/onc.2012.391	http://dx.doi.org/10.1038/onc.2012.391			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	188UQ	22964643	Green Accepted			2022-12-25	WOS:000322220800008
J	Krypotou, E; Kosti, V; Amillis, S; Myrianthopoulos, V; Mikros, E; Diallinas, G				Krypotou, Emilia; Kosti, Vasiliki; Amillis, Sotiris; Myrianthopoulos, Vassilios; Mikros, Emmanuel; Diallinas, George			Modeling, Substrate Docking, and Mutational Analysis Identify Residues Essential for the Function and Specificity of a Eukaryotic Purine-Cytosine NCS1 Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATING ACCESS MECHANISM; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHARACTERIZATION; MEMBRANE-TRANSPORT; CRYSTAL-STRUCTURE; NAT FAMILY; PERMEASE; PROTEIN; GENE	The recent elucidation of crystal structures of a bacterial member of the NCS1 family, the Mhp1 benzyl-hydantoin permease from Microbacterium liquefaciens, allowed us to construct and validate a three-dimensional model of the Aspergillus nidulans purine-cytosine/H+ FcyB symporter. The model consists of 12 transmembrane alpha-helical, segments (TMSs) and cytoplasmic N- and C-tails. Adistinct core of 10 TMSs is made of two intertwined inverted repeats (TMS1-5 and TMS6-10) that are followed by two additional TMSs. TMS1, TMS3, TMS6, and TMS8 form an open cavity that is predicted to host the substrate binding site. Based on primary sequence alignment, three-dimensional topology, and substrate docking, we identified five residues as potentially essential for substrate binding in FcyB; Ser-85 (TMS1), Trp-159, Asn-163 (TMS3), Trp-259 (TMS6), and Asn-354 (TMS8). To validate the role of these and other putatively critical residues, we performed a systematic functional analysis of relevant mutants. We show that the proposed substrate binding residues, plus Asn-350, Asn-351, and Pro-353 are irreplaceable for FcyB function. Among these residues, Ser-85, Asn-163, Asn-350, Asn-351, and Asn-354 are critical for determining the substrate binding affinity and/or the specificity of FcyB. Our results suggest that Ser-85, Asn-163, and Asn-354 directly interact with substrates, Trp-159 and Trp-259 stabilize binding through pi-pi stacking interactions, and Pro-353 affects the local architecture of substrate binding site, whereas Asn-350 and Asn-351 probably affect substrate binding indirectly. Our work is the first systematic approach to address structure-function-specificity relationships in a eukaryotic member of NCS1 family by combining genetic and computational approaches.	[Krypotou, Emilia; Kosti, Vasiliki; Amillis, Sotiris; Diallinas, George] Univ Athens, Fac Biol, Athens 15784, Greece; [Myrianthopoulos, Vassilios; Mikros, Emmanuel] Univ Athens, Sch Pharm, GR-15771 Athens, Greece	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Diallinas, G (corresponding author), Univ Athens, Fac Biol, Athens 15784, Greece.	diallina@biol.uoa.gr	Mikros, Emmanuel/E-4223-2017; Diallinas, George/AAE-8457-2019; Myrianthopoulos, Vassilios/AGN-8510-2022	Mikros, Emmanuel/0000-0002-5984-5169; Diallinas, George/0000-0002-3426-726X; Myrianthopoulos, Vassilios/0000-0001-8359-9634; Krypotou, Aimilia/0000-0003-3258-9983	John S. Latsis Public Benefit Foundation; European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALIS and Heracleitus II, Investing in knowledge society through the European Social Fund	John S. Latsis Public Benefit Foundation; European Union (European Social Fund)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALIS and Heracleitus II, Investing in knowledge society through the European Social Fund	This work was supported in part by the John S. Latsis Public Benefit Foundation.; Co-financed by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALIS and Heracleitus II, Investing in knowledge society through the European Social Fund.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adelman JL, 2011, BIOPHYS J, V101, P2399, DOI 10.1016/j.bpj.2011.09.061; Amillis S, 2004, MOL MICROBIOL, V52, P205, DOI 10.1046/j.1365-2958.2003.03956.x; Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; Barrett MP, 2006, ADV PARASIT, V63, P125, DOI 10.1016/S0065-308X(06)63002-9; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Cecchetto G, 2004, J BIOL CHEM, V279, P3132, DOI 10.1074/jbc.M308826200; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; DIALLINAS G, 1995, J BIOL CHEM, V270, P8610; Diallinas G, 2008, CHANNELS, V2, P363, DOI 10.4161/chan.2.5.6902; Edgerton-Morgan H, 2012, J CELL BIOL, V198, P785, DOI 10.1083/jcb.201203115; Erpapazoglou Z, 2006, FUNGAL GENET BIOL, V43, P222, DOI 10.1016/j.fgb.2005.11.006; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Ferreira T, 1999, EUR J BIOCHEM, V263, P57, DOI 10.1046/j.1432-1327.1999.00454.x; Ferreira T, 1997, J BIOL CHEM, V272, P9697; Ferreira T, 1999, EUR J BIOCHEM, V260, P22, DOI 10.1046/j.1432-1327.1999.00140.x; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; GORFINKIEL L, 1993, J BIOL CHEM, V268, P23376; Goudela S, 2006, MOL MEMBR BIOL, V23, P291, DOI 10.1080/09687860600685109; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Gournas C, 2010, MOL MICROBIOL, V75, P246, DOI 10.1111/j.1365-2958.2009.06997.x; Hamari Z, 2009, MOL MICROBIOL, V73, P43, DOI 10.1111/j.1365-2958.2009.06738.x; Harada N, 2000, ACTA HAEMATOL-BASEL, V103, P144, DOI 10.1159/000041037; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kose M, 2009, FUTURE MED CHEM, V1, P303, DOI [10.4155/fmc.09.29, 10.4155/FMC.09.29]; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2003, J MICROBIOL METH, V55, P687, DOI 10.1016/S0167-7012(03)00208-2; KRAUPP M, 1995, GEN PHARMACOL-VASC S, V26, P1185, DOI 10.1016/0306-3623(95)00005-L; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mourad GS, 2006, J EXP BOT, V57, P3563, DOI 10.1093/jxb/erl107; Mourad GS, 2012, FEBS LETT, V586, P1370, DOI 10.1016/j.febslet.2012.03.058; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schultes NP, 1996, PLANT CELL, V8, P463, DOI 10.1105/tpc.8.3.463; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070; Vlanti A, 2008, MOL MICROBIOL, V68, P959, DOI 10.1111/j.1365-2958.2008.06198.x; WEBER E, 1990, MOL MICROBIOL, V4, P585, DOI 10.1111/j.1365-2958.1990.tb00627.x; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Weyand S, 2011, J SYNCHROTRON RADIAT, V18, P20, DOI 10.1107/S0909049510032449; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	57	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36792	36803		10.1074/jbc.M112.400382	http://dx.doi.org/10.1074/jbc.M112.400382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22969088	Green Published, hybrid			2022-12-25	WOS:000310588500016
J	Forman, RA; deSchoolmeester, ML; Hurst, RJM; Wright, SH; Pemberton, AD; Else, KJ				Forman, Ruth A.; deSchoolmeester, Matthew L.; Hurst, Rebecca J. M.; Wright, Steven H.; Pemberton, Alan D.; Else, Kathryn J.			The Goblet Cell Is the Cellular Source of the Anti-Microbial Angiogenin 4 in the Large Intestine Post Trichuris muris Infection	PLOS ONE			English	Article							NEMATODE INFECTION; PANETH CELLS; MEDIATED REGULATION; INNATE IMMUNITY; EXPULSION; MICE; PARASITE; MOUSE; IDENTIFICATION; EXPRESSION	Background: Mouse angiogenin 4 (Ang4) has previously been described as a Paneth cell-derived antimicrobial peptide important in epithelial host defence in the small intestine. However, a source for Ang4 in the large intestine, which is devoid of Paneth cells, has not been defined. Methodology/Principal Findings: Analysis was performed on Ang4 expression in colonic tissue by qPCR and immunohistochemistry following infection with the large intestine dwelling helminth parasite Trichuris muris. This demonstrated an increase in expression of the peptide following infection of resistant BALB/c mice. Further, histological analysis of colonic tissue revealed the cellular source of this Ang4 to be goblet cells. To elucidate the mechanism of Ang4 expression immunohistochemistry and qPCR for Ang4 was performed on colonic tissue from T. muris infected mouse mutants. Experiments comparing C3H/HeN and C3H/HeJ mice, which have a natural inactivating mutation of TLR4, revealed that Ang4 expression is TLR4 independent. Subsequent experiments with IL-13 and IL-4 receptor alpha deficient mice demonstrated that goblet cell expression of Ang4 is controlled either directly or indirectly by IL-13. Conclusions: The cellular source of mouse Ang4 in the colon following T. muris infection is the goblet cell and expression is under the control of IL-13.	[Forman, Ruth A.; deSchoolmeester, Matthew L.; Hurst, Rebecca J. M.; Else, Kathryn J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Wright, Steven H.; Pemberton, Alan D.] Univ Edinburgh, Roslin Inst, Div Vet Clin Sci, Roslin, Midlothian, Scotland	University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Forman, RA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	ruth.forman@manchester.ac.uk	Hurst, Rebecca/G-6253-2014	Else, Kathryn/0000-0001-6660-055X; Forman, Ruth/0000-0003-0374-6679	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E012647/1]; Wellcome Trust; BBSRC [BB/E012647/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012647/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) grant number BB/E012647/1. RAF is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 2006, INT J PARASITOL, V36, P723, DOI 10.1016/j.ijpara.2006.02.011; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Codoner FM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-310; D'Elia R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-492; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; ELSE K, 1988, PARASITOLOGY, V96, P543, DOI 10.1017/S0031182000080173; ELSE KJ, 1993, PARASITE IMMUNOL, V15, P595; ELSE KJ, 1992, IMMUNOLOGY, V75, P232; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Grencis RK, 2004, CLIN REV ALLERG IMMU, V26, P51, DOI 10.1385/CRIAI:26:1:51; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hayes KS, 2004, IMMUNOL REV, V201, P75, DOI 10.1111/j.0105-2896.2004.00193.x; Helmby H, 2003, EUR J IMMUNOL, V33, P2974, DOI 10.1002/eji.200324264; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; McDermott JR, 2005, J IMMUNOL, V175, P3207, DOI 10.4049/jimmunol.175.5.3207; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Pemberton AD, 2004, PROTEOMICS, V4, P1101, DOI 10.1002/pmic.200300658; Rumio C, 2011, J CELL PHYSL; RYBAK SM, 1987, BIOCHEM BIOPH RES CO, V146, P1240, DOI 10.1016/0006-291X(87)90781-9; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Strydom DJ, 1998, CELL MOL LIFE SCI, V54, P811, DOI 10.1007/s000180050210; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Wehkamp J, 2006, CURR OPIN GASTROEN, V22, P644, DOI 10.1097/01.mog.0000245541.95408.86	28	42	42	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e42248	10.1371/journal.pone.0042248	http://dx.doi.org/10.1371/journal.pone.0042248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970115	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400003
J	Yamanari, M; Ishii, K; Fukuda, S; Lim, Y; Duan, L; Makita, S; Miura, M; Oshika, T; Yasuno, Y				Yamanari, Masahiro; Ishii, Kotaro; Fukuda, Shinichi; Lim, Yiheng; Duan, Lian; Makita, Shuichi; Miura, Masahiro; Oshika, Tetsuro; Yasuno, Yoshiaki			Optical Rheology of Porcine Sclera by Birefringence Imaging	PLOS ONE			English	Article							NERVE HEAD; COHERENCE TOMOGRAPHY; PERIPAPILLARY SCLERA; COLLAGEN; ORGANIZATION; DEFORMATION; CORNEA; TISSUE; MYOPIA	Purpose: To investigate a relationship between birefringence and elasticity of porcine sclera ex vivo using polarizationsensitive optical coherence tomography (PS-OCT). Methods: Elastic parameters and birefringence of 19 porcine eyes were measured. Four pieces of scleral strips which were parallel to the limbus, with a width of 4 mm, were dissected from the optic nerve head to the temporal side of each porcine eye. Birefringence of the sclera was measured with a prototype PS-OCT. The strain and force were measured with a uniaxial material tester as the sample was stretched with a speed of 1.8 mm/min after preconditioning. A derivative of the exponentially-fitted stress-strain curve at 0% strain was extracted as the tangent modulus. Power of exponential stress-strain function was also extracted from the fitting. To consider a net stiffness of sclera, structural stiffness was calculated as a product of tangent modulus and thickness. Correlations between birefringence and these elastic parameters were examined. Results: Statistically significant correlations between birefringence and all of the elastic parameters were found at 2 central positions. Structural stiffness and power of exponential stress-strain function were correlated with birefringence at the position near the optic nerve head. No correlation was found at the position near the equator. Conclusions: The evidence of correlations between birefringence and elasticity of sclera tested uniaxially was shown for the first time. This work may become a basis for in vivo measurement of scleral biomechanics using PS-OCT.	[Yamanari, Masahiro; Lim, Yiheng; Duan, Lian; Makita, Shuichi; Yasuno, Yoshiaki] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan; [Ishii, Kotaro; Fukuda, Shinichi; Oshika, Tetsuro] Univ Tsukuba, Inst Clin Med, Dept Ophthalmol, Tsukuba, Ibaraki 305, Japan; [Miura, Masahiro] Tokyo Med Univ, Ibaraki Med Ctr, Dept Ophthalmol, Ami, Ibaraki, Japan; [Yamanari, Masahiro; Ishii, Kotaro; Fukuda, Shinichi; Lim, Yiheng; Duan, Lian; Makita, Shuichi; Miura, Masahiro; Oshika, Tetsuro; Yasuno, Yoshiaki] Computat Opt & Ophthalmol Grp, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Tokyo Medical University	Yamanari, M (corresponding author), Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan.	yasuno@optlab2.bk.tsukuba.ac.jp	Makita, Shuichi/G-3806-2011; Yamanari, Masahiro/B-3147-2010; Yasuno, Yoshiaki/F-2586-2011	Makita, Shuichi/0000-0002-6614-3640; Yamanari, Masahiro/0000-0001-9873-2151; Yasuno, Yoshiaki/0000-0003-1645-7948	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported in part by the Japan Science and Technology Agency under a program of development of systems and technology for advanced measurement and analysis (http://www.jst.go.jp/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Bouma BE, 2009, CURR OPIN BIOTECH, V20, P111, DOI 10.1016/j.copbio.2009.02.007; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chandran PL, 2004, J BIOMECH ENG-T ASME, V126, P152, DOI 10.1115/1.1688774; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Downs JC, 2003, J BIOMECH ENG-T ASME, V125, P124, DOI 10.1115/1.1536930; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; Drexler W, 2001, J RHEUMATOL, V28, P1311; Duan L, OPT EXPRESS UNPUB; Eilaghi A, 2010, J BIOMECH, V43, P1696, DOI 10.1016/j.jbiomech.2010.02.031; Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010; FRIBERG TR, 1988, EXP EYE RES, V47, P429, DOI 10.1016/0014-4835(88)90053-X; Fung Y.C., 1993, BIOMECHANICS MECH PR; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P9684, DOI 10.1167/iovs.11-7894; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113683; Gotzinger E, 2008, OPT EXPRESS, V16, P16410, DOI 10.1364/OE.16.016410; Hogan MJ, 1971, HISTOLOGY HUMAN EYE; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; INOUE S, 1953, CHROMOSOMA, V5, P487, DOI 10.1007/BF01271498; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Lim Y, 2011, BIOMED OPT EXPRESS, V2, P2392, DOI 10.1364/BOE.2.002892; Litwiller DV, 2010, J MAGN RESON IMAGING, V32, P44, DOI 10.1002/jmri.22217; LU SY, 1994, J OPT SOC AM A, V11, P766, DOI 10.1364/JOSAA.11.000766; Makita S, 2010, OPT EXPRESS, V18, P854, DOI 10.1364/OE.18.000854; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Nadkarni SK, 2007, J AM COLL CARDIOL, V49, P1474, DOI 10.1016/j.jacc.2006.11.040; Oldenbourg R, 1998, BIOPHYS J, V74, P645, DOI 10.1016/S0006-3495(98)77824-5; Oldenbourg R, 1996, NATURE, V381, P811, DOI 10.1038/381811a0; Olsen TW, 2002, INVEST OPHTH VIS SCI, V43, P2529; Ophir Jonathan, 2002, J Med Ultrason (2001), V29, P155, DOI 10.1007/BF02480847; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Schultz DS, 2008, INVEST OPHTH VIS SCI, V49, P4232, DOI 10.1167/iovs.08-1970; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Tower TT, 2002, ANN BIOMED ENG, V30, P1221, DOI 10.1114/1.1527047; van Turnhout MC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3241986; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Wolf E, 2000, PRINCIPLES OPTICS EL; Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032; Yamanari M, 2010, OPT EXPRESS, V18, P13964, DOI 10.1364/OE.18.013964; Yan DM, 2011, INVEST OPHTH VIS SCI, V52, P821, DOI 10.1167/iovs.09-4651; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122; ZEIMER RC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1232, DOI 10.1001/archopht.1989.01070020298042	48	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44026	10.1371/journal.pone.0044026	http://dx.doi.org/10.1371/journal.pone.0044026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970158	gold, Green Submitted, Green Published			2022-12-25	WOS:000308458400029
J	Jeng, SR; Yueh, WS; Pen, YT; Gueguen, MM; Pasquier, J; Dufour, S; Chang, CF; Kah, O				Jeng, Shan-Ru; Yueh, Wen-Shiun; Pen, Yi-Ting; Gueguen, Marie-Madeleine; Pasquier, Jeremy; Dufour, Sylvie; Chang, Ching-Fong; Kah, Olivier			Expression of Aromatase in Radial Glial Cells in the Brain of the Japanese Eel Provides Insight into the Evolution of the cyp191a Gene in Actinopterygians	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; CYTOCHROME-P450 AROMATASE; ANGUILLA-JAPONICA; ZEBRAFISH BRAIN; ADULT ZEBRAFISH; PARS-DISTALIS; FOLLICULOSTELLATE CELLS; DIFFERENTIAL EXPRESSION; SUBVENTRICULAR ZONE; GENOME DUPLICATION	The cyp19a1 gene that encodes aromatase, the only enzyme permitting conversion of C19 aromatizable androgens into estrogens, is present as a single copy in the genome of most vertebrate species, except in teleosts in which it has been duplicated. This study aimed at investigating the brain expression of a cyp19a1 gene expressed in both gonad and brain of Japanese eel, a basal teleost. By means of immunohistochemistry and in situ hybridization, we show that cyp19a1 is expressed only in radial glial cells of the brain and in pituitary cells. Treatments with salmon pituitary homogenates (female) or human chorionic gonadotrophin (male), known to turn on steroid production in immature eels, strongly stimulated cyp19a1 messenger and protein expression in radial glial cells and pituitary cells. Using double staining studies, we also showed that aromatase-expressing radial glial cells exhibit proliferative activity in both the brain and the pituitary. Altogether, these data indicate that brain and pituitary expression of Japanese eel cyp19a1 exhibits characteristics similar to those reported for the brain specific cyp19a1b gene in teleosts having duplicated cyp19a1 genes. This supports the hypothesis that, despite the fact that eels also underwent the teleost specific genome duplication, they have a single cyp19a1 expressed in both brain and gonad. Such data also suggest that the intriguing features of brain aromatase expression in teleost fishes were not gained after the whole genome duplication and may reflect properties of the cyp19a1 gene of ancestral Actinopterygians.	[Jeng, Shan-Ru; Yueh, Wen-Shiun; Pen, Yi-Ting] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Jeng, Shan-Ru; Gueguen, Marie-Madeleine; Kah, Olivier] Univ Rennes 1, Team NEED, Inst Rech Sante Environm & Travail, INSERM U1085,IFR140, Rennes, France; [Pasquier, Jeremy; Dufour, Sylvie; Chang, Ching-Fong] Museum Natl Hist Nat, Res Unit BOREA, CNRS IRD UPMC 207 7208, F-75231 Paris, France; [Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Dept Aquaculture, Keelung, Taiwan	National Kaohsiung University of Science & Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); National Taiwan Ocean University	Jeng, SR (corresponding author), Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan.	B0044@mail.ntou.edu.tw; Olivier.kah@univ-rennes1.fr	kah, olivier/K-7624-2012; GUEGUEN, marie madeleine/K-1731-2015		Universite of Rennes 1; CNRS (Centre National de la Recherche Scientifique); bilateral France Agence Nationale Recherche/Taiwan National Science Council project [PUBERTEEL: NSC98-2923-B-019-001-MY3]	Universite of Rennes 1; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); bilateral France Agence Nationale Recherche/Taiwan National Science Council project	This study was supported by the Universite of Rennes 1, the CNRS (Centre National de la Recherche Scientifique) and the bilateral France Agence Nationale Recherche/Taiwan National Science Council project PUBERTEEL: NSC98-2923-B-019-001-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta M, 2010, EUR J HISTOCHEM, V54, P1, DOI 10.4081/ejh.2010.e1; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2004, GENOME RES, V14, P1, DOI 10.1101/gr.1717804; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Anthony TE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-30; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Balthazart J, 1996, J NEUROBIOL, V31, P129, DOI 10.1002/(SICI)1097-4695(199610)31:2<129::AID-NEU1>3.3.CO;2-2; Barha CK, 2010, BBA-GEN SUBJECTS, V1800, P1056, DOI 10.1016/j.bbagen.2010.01.006; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Brock O, 2010, NEUROSCIENCE, V166, P368, DOI 10.1016/j.neuroscience.2009.12.050; BUREK MJ, 1995, DEV BRAIN RES, V85, P220, DOI 10.1016/0165-3806(94)00215-L; CALLARD GV, 1988, GEN COMP ENDOCR, V71, P70, DOI 10.1016/0016-6480(88)90296-1; Cresko WA, 2003, DEV DYNAM, V228, P480, DOI 10.1002/dvdy.10424; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Diotel N, 2012, HORMONE BEH IN PRESS; Diotel N, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00137; Diotel N, 2011, EUR J NEUROSCI, V34, P45, DOI 10.1111/j.1460-9568.2011.07731.x; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; DUFOUR S, 1989, FISH PHYSIOL BIOCHEM, V7, P157, DOI 10.1007/BF00004702; Dufour S, 2003, EEL BIOLOGY, P373; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Force A, 1999, GENETICS, V151, P1531; Forlano PM, 2006, FRONT NEUROENDOCRIN, V27, P247, DOI 10.1016/j.yfrne.2006.05.002; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Gonzalez A, 2002, J EXP ZOOL, V293, P500, DOI 10.1002/jez.90005; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guo BC, 2010, J EXP ZOOL PART B, V314B, P135, DOI 10.1002/jez.b.21318; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Harada N, 2005, J STEROID BIOCHEM, V95, P49, DOI 10.1016/j.jsbmb.2005.04.003; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Ijiri S, 2003, GEN COMP ENDOCR, V130, P193, DOI 10.1016/S0016-6480(02)00589-0; Jeng SR, 2007, GEN COMP ENDOCR, V154, P161, DOI 10.1016/j.ygcen.2007.05.026; Jeng SR, 2012, GEN COMP ENDOCR, V175, P163, DOI 10.1016/j.ygcen.2011.11.005; Jeng SR, 2005, J EXP ZOOL PART A, V303A, P802, DOI 10.1002/jez.a.194; Kallivretaki E, 2007, DEV DYNAM, V236, P3155, DOI 10.1002/dvdy.21344; Kazeto Y, 2005, J MOL ENDOCRINOL, V35, P571, DOI 10.1677/jme.1.01805; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Lange IG, 2002, J STEROID BIOCHEM, V83, P219, DOI 10.1016/S0960-0760(02)00225-X; Le Page Y, 2006, ENVIRON HEALTH PERSP, V114, P752, DOI 10.1289/ehp.8141; Le Page Y, 2010, EUR J NEUROSCI, V32, P2105, DOI 10.1111/j.1460-9568.2010.07519.x; Lephart ED, 1996, BRAIN RES REV, V22, P1; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Marsh KE, 2006, BRAIN RES, V1126, P91, DOI 10.1016/j.brainres.2006.09.017; Martinez-Cerdeno V, 2006, EUR J NEUROSCI, V24, P3475, DOI 10.1111/j.1460-9568.2006.05239.x; Mazzucco CA, 2006, NEUROSCIENCE, V141, P1793, DOI 10.1016/j.neuroscience.2006.05.032; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Menuet A, 2003, J COMP NEUROL, V462, P180, DOI 10.1002/cne.10726; Mouriec K, 2008, BRAIN RES BULL, V75, P274, DOI 10.1016/j.brainresbull.2007.10.030; Mouriec K, 2009, DEV DYNAM, V238, P2641, DOI 10.1002/dvdy.22069; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; Mukuda T., 2003, MEM FAC INTEGR ARTS, V29, P1; Ohno S., 1970, EVOLUTION GENE DUPLI; Okubo K, 2011, J NEUROENDOCRINOL, V23, P412, DOI 10.1111/j.1365-2826.2011.02120.x; OLIVEREAU M, 1986, CELL TISSUE RES, V246, P425, DOI 10.1007/BF00215905; PASMANIK M, 1988, ENDOCRINOLOGY, V122, P1349, DOI 10.1210/endo-122-4-1349; PASMANIK M, 1985, GEN COMP ENDOCR, V60, P244, DOI 10.1016/0016-6480(85)90320-X; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Peterson RS, 2004, J COMP NEUROL, V475, P261, DOI 10.1002/cne.20157; Piferrer F, 2005, FISH PHYSIOL BIOCHEM, V31, P215, DOI 10.1007/s10695-006-0027-0; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; RAKIC P, 1978, POSTGRAD MED J, V54, P25; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; ROTHENAIGNER I, 2011, DEVELOPMENT; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Saldanha CJ, 2010, GEN COMP ENDOCR, V166, P606, DOI 10.1016/j.ygcen.2010.01.007; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Simpson ER, 2004, SEMIN REPROD MED, V22, P11; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; Steinke D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-16; Strobl-Mazzulla PH, 2010, BRAIN BEHAV EVOLUT, V76, P20, DOI 10.1159/000316022; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; Tchoudakova A, 1998, ENDOCRINOLOGY, V139, P2179, DOI 10.1210/en.139.4.2179; TIMMERS RJM, 1987, J COMP NEUROL, V258, P368, DOI 10.1002/cne.902580305; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tzchori I, 2004, GEN COMP ENDOCR, V138, P271, DOI 10.1016/j.ygcen.2004.06.007; Veyrac A, 2011, FASEB J, V25, P1048, DOI 10.1096/fj.10-172635; Vosges M, 2010, AQUAT TOXICOL, V99, P479, DOI 10.1016/j.aquatox.2010.06.009; YAMAMOTO K, 1974, NATURE, V251, P220, DOI 10.1038/251220a0; Yamashita M, 2005, PATHOL INT, V55, P244, DOI 10.1111/j.1440-1827.2005.01820.x; Zupanc GKH, 1999, J EXP BIOL, V202, P1435	89	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44750	10.1371/journal.pone.0044750	http://dx.doi.org/10.1371/journal.pone.0044750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957105	Green Published, gold			2022-12-25	WOS:000308463800098
J	Kujala, K; Paavola, J; Lahti, A; Larsson, K; Pekkanen-Mattila, M; Viitasalo, M; Lahtinen, AM; Toivonen, L; Kontula, K; Swan, H; Laine, M; Silvennoinen, O; Aalto-Setala, K				Kujala, Kirsi; Paavola, Jere; Lahti, Anna; Larsson, Kim; Pekkanen-Mattila, Mari; Viitasalo, Matti; Lahtinen, Annukka M.; Toivonen, Lauri; Kontula, Kimmo; Swan, Heikki; Laine, Mika; Silvennoinen, Olli; Aalto-Setala, Katriina			Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations	PLOS ONE			English	Article							TORSADES-DE-POINTES; T-WAVE PEAK; RYANODINE RECEPTORS; CA2+ RELEASE; STEM-CELLS; SUPPRESSION; DYSFUNCTION; MECHANISM	Background: Induced pluripotent stem cells (iPSC) provide means to study the pathophysiology of genetic disorders. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a malignant inherited ion channel disorder predominantly caused by mutations in the cardiac ryanodine receptor (RyR2). In this study the cellular characteristics of CPVT are investigated and whether the electrophysiological features of this mutation can be mimicked using iPSC -derived cardiomyocytes (CM). Methodology/Principal Findings: Spontaneously beating CMs were differentiated from iPSCs derived from a CPVT patient carrying a P2328S mutation in RyR2 and from two healthy controls. Calcium (Ca2+) cycling and electrophysiological properties were studied by Ca2+ imaging and patch-clamp techniques. Monophasic action potential (MAP) recordings and 24h-ECGs of CPVT-P2328S patients were analyzed for the presence of afterdepolarizations. We found defects in Ca2+ cycling and electrophysiology in CPVT CMs, reflecting the cardiac phenotype observed in the patients. Catecholaminergic stress led to abnormal Ca2+ signaling and induced arrhythmias in CPVT CMs. CPVT CMs also displayed reduced sarcoplasmic reticulum (SR) Ca2+ content, indicating leakage of Ca2+ from the SR. Patch-clamp recordings of CPVT CMs revealed both delayed afterdepolarizations (DADs) during spontaneous beating and in response to adrenaline and also early afterdepolarizations (EADs) during spontaneous beating, recapitulating the changes seen in MAP and 24h-ECG recordings of patients carrying the same mutation. Conclusions/Significance: This cell model shows aberrant Ca2+ cycling characteristic of CPVT and in addition to DADs it displays EADs. This cell model for CPVT provides a platform to study basic pathology, to screen drugs, and to optimize drug therapy.	[Kujala, Kirsi; Paavola, Jere; Lahti, Anna; Larsson, Kim; Pekkanen-Mattila, Mari; Silvennoinen, Olli; Aalto-Setala, Katriina] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Kujala, Kirsi; Paavola, Jere; Lahti, Anna; Larsson, Kim; Pekkanen-Mattila, Mari; Silvennoinen, Olli; Aalto-Setala, Katriina] BioMediTech, Tampere, Finland; [Paavola, Jere; Laine, Mika] Minerva Fdn, Helsinki, Finland; [Viitasalo, Matti; Toivonen, Lauri; Laine, Mika] Helsinki Univ Hosp, Dept Cardiol, Helsinki, Finland; [Lahtinen, Annukka M.] Univ Helsinki, Res Programs Unit Mol Med, Helsinki, Finland; [Kontula, Kimmo; Swan, Heikki] Univ Helsinki, Dept Med, Helsinki, Finland; [Silvennoinen, Olli] Tampere Univ Hosp, Tampere, Finland; [Aalto-Setala, Katriina] Ctr Heart, Tampere, Finland	Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Tampere University; Tampere University Hospital	Kujala, K (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	katriina.aalto-setala@uta.fi	Paavola, Jere/GRF-6451-2022; Tuiskula, Annukka/ABF-6377-2020	Tuiskula, Annukka/0000-0002-6538-635X; Pekkanen-Mattila, Mari/0000-0002-8621-4303	Academy of Finland; Finnish Foundation for Cardiovascular Research; Pirkanmaa Hospital District; Ida Montin Foundation; Finnish Medical Foundation/The Finnish Medical Society Duodecim; Aarne Koskelo Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation; Oskar Oflund Foundation; TEKES	Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Pirkanmaa Hospital District; Ida Montin Foundation; Finnish Medical Foundation/The Finnish Medical Society Duodecim; Aarne Koskelo Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Oskar Oflund Foundation; TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by Academy of Finland (http://www.aka.fi/en-GB/A/), TEKES (http://www.tekes.fi/en/), Finnish Foundation for Cardiovascular Research (http://www.sydantutkimussaatio.fi), Pirkanmaa Hospital District (www.pshp.fi), Ida Montin Foundation (http://www.idamontininsaatio.fi), Finnish Medical Foundation/The Finnish Medical Society Duodecim (www.duodecim.fi/), Aarne Koskelo Foundation (www.aarnekoskelonsaatio.fi/), Orion-Farmos Research Foundation (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio/), Finnish Cultural Foundation (www.skr.fi/), and Oskar Oflund Foundation (www.oskaroflund.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2006, INT HEART J, V47, P381, DOI 10.1536/ihj.47.381; Antzelevitch C, 2011, HEART RHYTHM, V8, P1281, DOI 10.1016/j.hrthm.2011.03.045; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Choi BR, 2002, J PHYSIOL-LONDON, V543, P615, DOI 10.1113/jphysiol.2002.024570; Fatima A, 2011, CELL PHYSIOL BIOCHEM, V28, P579, DOI 10.1159/000335753; Gbadebo TD, 2002, CIRCULATION, V105, P770, DOI 10.1161/hc0602.103724; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JANUARY CT, 1992, ANN NY ACAD SCI, V644, P23, DOI 10.1111/j.1749-6632.1992.tb30999.x; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P791, DOI 10.1111/j.1540-8167.2007.00766.x; Morita N, 2011, J AM COLL CARDIOL, V57, P366, DOI 10.1016/j.jacc.2010.07.045; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Paavola J, 2007, EUR HEART J, V28, P1135, DOI 10.1093/eurheartj/ehl543; Parikh A, 2012, HEART RHYTHM, V9, P953, DOI 10.1016/j.hrthm.2012.01.010; PATTERSON E, 1990, J CARDIOVASC PHARM, V15, P323, DOI 10.1097/00005344-199002000-00021; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; Spencer CI, 2003, AM J PHYSIOL-HEART C, V285, pH2552, DOI 10.1152/ajpheart.00274.2003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Viitasalo M, 2006, J AM COLL CARDIOL, V47, P112, DOI 10.1016/j.jacc.2005.07.068; Viitasalo M, 2008, HEART RHYTHM, V5, P1382, DOI 10.1016/j.hrthm.2008.06.011; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Volders PGA, 1997, CARDIOVASC RES, V34, P348, DOI 10.1016/S0008-6363(96)00270-2; Vos MA, 2000, MONOPHASIC ACTION POTENTIALS: BRIDGING CELL AND BEDSIDE, P571; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; Xu J, 1996, HEART VESSELS, V11, P289, DOI 10.1007/BF01747188	28	93	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44660	10.1371/journal.pone.0044660	http://dx.doi.org/10.1371/journal.pone.0044660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962621	gold, Green Published, Green Submitted			2022-12-25	WOS:000308577600075
J	Santos, MJ; Carmona-Fernandes, D; Canhao, H; da Silva, JC; Fonseca, JE; Gil, V				Santos, Maria Jose; Carmona-Fernandes, Diana; Canhao, Helena; da Silva, Jose Canas; Fonseca, Joao Eurico; Gil, Victor			Early Vascular Alterations in SLE and RA Patients-A Step towards Understanding the Associated Cardiovascular Risk	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS PATIENTS; CORONARY-HEART-DISEASE; ADHESION MOLECULES ICAM-1; FLOW-MEDIATED DILATION; ENDOTHELIAL FUNCTION; E-SELECTIN; CAROTID ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; ARTERIAL STIFFNESS	Accelerated atherosclerosis represents a major problem in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients, and endothelial damage is a key feature of atherogenesis. We aimed to assess early endothelial changes in SLE and RA female patients (127 SLE and 107 RA) without previous CV events. Biomarkers of endothelial cell activation (intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), thrombomodulin (TM), and tissue factor (TF)) were measured and endothelial function was assessed using peripheral artery tonometry. Reactive hyperemia index (RHI), an indicator of microvascular reactivity, and augmentation index (AIx), a measure of arterial stiffness, were obtained. In addition, traditional CV risk factors, disease activity and medication were determined. Women with SLE displayed higher sICAM-1 and TM and lower TF levels than women with RA (p = 0.001, p < 0.001 and p < 0.001, respectively). These differences remained significant after controlling for CV risk factors and medication. Serum levels of vascular biomarkers were increased in active disease and a moderate correlation was observed between sVCAM-1 levels and lupus disease activity (rho = 0.246) and between TF levels and RA disease activity (rho = 0.301). Although RHI was similar across the groups, AIx was higher in lupus as compared to RA (p = 0.04). Also in active SLE, a trend towards poorer vasodilation was observed (p = 0.06). In conclusion, women with SLE and RA present with distinct patterns of endothelial cell activation biomarkers not explained by differences in traditional CV risk factors. Early vascular alterations are more pronounced in SLE which is in line with the higher CV risk of these patients.	[Santos, Maria Jose; Carmona-Fernandes, Diana; Canhao, Helena; Fonseca, Joao Eurico] Fac Med Lisbon, Rheumatol Res Unit, Inst Med Mol, Lisbon, Portugal; [Santos, Maria Jose; da Silva, Jose Canas] Hosp Garcia de Orta, Dept Rheumatol, Almada, Portugal; [Canhao, Helena; Fonseca, Joao Eurico] Hosp Santa Maria, Rheumatol & Metab Bone Dis Dept, Lisbon, Portugal; [Gil, Victor] Hosp Fernando Fonseca, Dept Cardiol, Amadora, Portugal	Universidade de Lisboa; Hospital Garcia de Orta; Universidade de Lisboa; Hospital Santa Maria; Hospital Professor Doutor Fernando Fonseca, EPE	Santos, MJ (corresponding author), Fac Med Lisbon, Rheumatol Res Unit, Inst Med Mol, Lisbon, Portugal.	mjps@netvisao.pt	Canhao, Helena/C-9611-2018; Santos, Maria Jose/N-6913-2014; Carmona-Fernandes, Diana/D-5916-2011	Canhao, Helena/0000-0003-1894-4870; Santos, Maria Jose/0000-0002-7946-1365; Canhao, Helena/0000-0002-3239-2809; Gil, Victor/0000-0003-4014-5450; Fonseca, Joao/0000-0003-1432-3671; Carmona-Fernandes, Diana/0000-0002-1015-3946	Fundacao para a Ciencia e a Tecnologia, Portugal [PIC/IC/82920/2007]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This study was supported by a grant from Fundacao para a Ciencia e a Tecnologia, Portugal (PIC/IC/82920/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer J, 2009, LUPUS, V18, P235, DOI 10.1177/0961203308096663; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1761, DOI 10.1016/S0735-1097(03)00329-2; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; Demerath E, 2001, ANN HUM BIOL, V28, P664, DOI 10.1080/03014460110048530; DRAKE TA, 1993, AM J PATHOL, V142, P1458; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Foster W, 2010, J RHEUMATOL, V37, P711, DOI 10.3899/jrheum.090699; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P373; Gonzalez-Gay MA, 2012, ACTA REUMATOL PORT, V37, P155; Gonzalez-Juanatey C, 2004, ARTHRIT RHEUM-ARTHR, V51, P447, DOI 10.1002/art.20407; Gonzalez-Juanatey C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3382; Gustafsson J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2878; Gustafsson JT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3759; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Hansel S, 2003, ATHEROSCLEROSIS, V170, P177, DOI 10.1016/S0021-9150(03)00281-8; Hwang SJ, 1997, CIRCULATION, V96, P4219; KIRCHHOFER D, 1994, J CLIN INVEST, V93, P2073, DOI 10.1172/JCI117202; Kozera L, 2011, RHEUMATOLOGY, V50, P1944, DOI 10.1093/rheumatology/ker232; Lane HA, 2006, VASC HEALTH RISK MAN, V2, P19, DOI 10.2147/vhrm.2006.2.1.19; LANGUINO LR, 1995, P NATL ACAD SCI USA, V92, P1505, DOI 10.1073/pnas.92.5.1505; Lopez-Mejias R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3755; Luc G, 2003, ATHEROSCLEROSIS, V170, P169, DOI 10.1016/S0021-9150(03)00280-6; Mak A, 2011, J RHEUMATOL, V38, P1296, DOI 10.3899/jrheum.101182; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Provan SA, 2011, J RHEUMATOL, V38, P606, DOI 10.3899/jrheum.100689; Rho YH, 2008, J RHEUMATOL, V35, P1789; Rho YH, 2009, ARTHRIT RHEUM-ARTHR, V61, P1580, DOI 10.1002/art.25009; Rodriguez-Rodriguez L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3444; Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010; Sandoo A, 2011, RHEUMATOLOGY, V50, P2125, DOI 10.1093/rheumatology/ker275; Selzer F, 2001, HYPERTENSION, V37, P1075, DOI 10.1161/01.HYP.37.4.1075; Shang Q, 2008, LUPUS, V17, P1096, DOI 10.1177/0961203308092160; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Thompson T, 2008, ARTHRITIS RHEUM-US, V58, P835, DOI 10.1002/art.23196; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; WOOD KM, 1993, HISTOPATHOLOGY, V22, P437, DOI 10.1111/j.1365-2559.1993.tb00157.x; Yao GH, 2008, LUPUS, V17, P720, DOI 10.1177/0961203308089441; Yee CS, 2011, RHEUMATOLOGY, V50, P982, DOI 10.1093/rheumatology/keq376; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; Zoller B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033442	51	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44668	10.1371/journal.pone.0044668	http://dx.doi.org/10.1371/journal.pone.0044668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962622	Green Submitted, gold, Green Published			2022-12-25	WOS:000308577600077
J	Tian, XL; Xu, F; Lung, WY; Meyerson, C; Ghaffari, AA; Cheng, GH; Deng, JC				Tian, Xiaoli; Xu, Feng; Lung, Wing Yi; Meyerson, Cherise; Ghaffari, Amir Ali; Cheng, Genhong; Deng, Jane C.			Poly I:C Enhances Susceptibility to Secondary Pulmonary Infections by Gram-Positive Bacteria	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-TRACT INFECTION; TOLL-LIKE RECEPTOR-3; CHRONIC HEPATITIS-C; DOUBLE-STRANDED-RNA; NF-KAPPA-B; INFLUENZA INFECTION; MICROBIAL ETIOLOGY; RIG-I; PANDEMIC INFLUENZA	Secondary bacterial pneumonias are a frequent complication of influenza and other respiratory viral infections, but the mechanisms underlying viral-induced susceptibility to bacterial infections are poorly understood. In particular, it is unclear whether the host's response against the viral infection, independent of the injury caused by the virus, results in impairment of antibacterial host defense. Here, we sought to determine whether the induction of an "antiviral" immune state using various viral recognition receptor ligands was sufficient to result in decreased ability to combat common bacterial pathogens of the lung. Using a mouse model, animals were administered polyinosine-polycytidylic acid (poly I:C) or Toll-like 7 ligand (imiquimod or gardiquimod) intranasally, followed by intratracheal challenge with Streptococcus pneumoniae. We found that animals pre-exposed to poly I:C displayed impaired bacterial clearance and increased mortality. Poly I:C-exposed animals also had decreased ability to clear methicillin-resistant Staphylococcus aureus. Furthermore, we showed that activation of Toll-like receptor (TLR)3 and Retinoic acid inducible gene (RIG-I)/Cardif pathways, which recognize viral nucleic acids in the form of dsRNA, both contribute to poly I:C mediated impairment of bacterial clearance. Finally, we determined that poly I:C administration resulted in significant induction of type I interferons (IFNs), whereas the elimination of type I IFN signaling improved clearance and survival following secondary bacterial pneumonia. Collectively, these results indicate that in the lung, poly I:C administration is sufficient to impair pulmonary host defense against clinically important gram-positive bacterial pathogens, which appears to be mediated by type I IFNs.	[Tian, Xiaoli; Lung, Wing Yi; Deng, Jane C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Xu, Feng] Zhejiang Univ, Sch Med, Dept Resp Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Meyerson, Cherise; Ghaffari, Amir Ali; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Zhejiang University; University of California System; University of California Los Angeles	Tian, XL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA.	JDeng@mednet.ucla.edu			United States National Institutes of Health [5K08HL081229]; Pfizer ASPIRE award; National Natural Science Foundation of China [30871130]; NIH [AI069120, AI056154]; Outstanding Young Investigator of Zhejiang Province [R12H010004]; Qianjiang Talent Project of Science and Technology Department of Zhejiang Province [2010R10080]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154, R01AI069120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer ASPIRE award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Outstanding Young Investigator of Zhejiang Province; Qianjiang Talent Project of Science and Technology Department of Zhejiang Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health grant 5K08HL081229 and Pfizer ASPIRE award to J.C.D.; National Natural Science Foundation of China (30871130), NIH AI069120 and AI056154 to G.C., and Outstanding Young Investigator of Zhejiang Province (R12H010004), Qianjiang Talent Project of Science and Technology Department of Zhejiang Province (2010R10080) to F.X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Marcos MA, 2006, ANTIVIR THER, V11, P351; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Hammerbeck DM, 2007, ANTIVIR RES, V73, P1, DOI 10.1016/j.antiviral.2006.07.011; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Korppi M, 2002, APMIS, V110, P515, DOI 10.1034/j.1600-0463.2002.11007801.x; KORPPI M, 1993, ACTA PAEDIATR, V82, P360, DOI 10.1111/j.1651-2227.1993.tb12697.x; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Li Y, 2011, J GENE MED, V13, P60, DOI 10.1002/jgm.1536; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; NOHYNEK H, 1991, AM J DIS CHILD, V145, P618, DOI 10.1001/archpedi.1991.02160060036016; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Oliveira EC, 2001, CHEST, V119, P1717, DOI 10.1378/chest.119.6.1717; Pyles RB, 2010, INFECT IMMUN, V78, P1700, DOI 10.1128/IAI.00736-09; Roomer R, 2010, HEPATOLOGY, V52, P1225, DOI 10.1002/hep.23842; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Socan M, 1999, EUR J CLIN MICROBIOL, V18, P777, DOI 10.1007/s100960050400; Soza A, 2002, HEPATOLOGY, V36, P1273, DOI 10.1053/jhep.2002.36502; Stockman LJ, 2010, PEDIATR INFECT DIS J, V29, P1048, DOI 10.1097/INF.0b013e3181eb7315; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Viasus D, 2011, MEDICINE, V90, P328, DOI 10.1097/MD.0b013e31822e67a7; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	38	54	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e41879	10.1371/journal.pone.0041879	http://dx.doi.org/10.1371/journal.pone.0041879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962579	gold, Green Submitted, Green Published			2022-12-25	WOS:000308577600006
J	Winder, VL				Winder, Virginia L.			Characterization of Mercury and Its Risk in Nelson's, Saltmarsh, and Seaside Sparrows	PLOS ONE			English	Article							SHARP-TAILED SPARROWS; COMMON LOONS; ENVIRONMENTAL MERCURY; REPRODUCTIVE SUCCESS; MODEL SELECTION; MARKED ANIMALS; EXPOSURE; SURVIVAL; ACCUMULATION; CAUDACUTUS	Background: Nelson's, Saltmarsh, and Seaside Sparrows (Ammodramus nelsoni, A. caudacutus, and A. maritimus, respectively) depend on marsh and wetland habitats - ecosystems in which mercury (Hg) bioavailability is notoriously high. The purpose of the present study was to address the potential impact of Hg on these species using first primary and breast feathers as non-destructive biomonitoring tools. Methods and Principal Findings: Feathers were sampled from wintering sparrows in North Carolina salt marshes (2006-2010). Feather Hg data were used in three risk analysis components (1) Threshold Component - examined feather Hg with regard to published negative effects thresholds; (2) Hg Dynamics Component - examined Hg in sparrows captured multiple times; and (3) Capture Frequency and Survival Component - tested for links between Hg and return frequency and survival. Threshold Component analyses indicated that Hg concentrations in 42-77% of sampled individuals (breast feather n = 879; first primary feather n = 663) were within the range associated with decreased reproduction in other avian species. Hg Dynamics Component analyses demonstrated that Hg increased between first and second captures for Nelson's (n = 9) and Seaside Sparrows (n = 23). Capture Frequency and Survival Component analyses detected a negative relationship between Hg and capture frequency in Nelson's Sparrows (n = 315). However, MARK models detected no effect of Hg on apparent survival in any species. Conclusion and Significance: This study indicates that current Hg exposure places a considerable proportion of each population at risk. In particular, 52% of all sampled Saltmarsh Sparrows exhibited first primary feather Hg concentrations exceeding those associated with a.60% reduction in reproductive success in other species. This study reports evidence for net annual bioaccumulation, indicating an increased risk in older individuals. These data can be used to inform future population assessments and management for these species.	Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington	Winder, VL (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	vlwinder@k-state.edu			National Oceanic and Atmospheric Administration (NOAA) through a National Estuary Research Reserve System Graduate Research Fellowship; Ralph Brauer Fellowship; Sigma Xi Grants in Aid of Research; Eastern Bird Banding Association; North Carolina Sea Grant; James and Francis Parnell Fellowship; Department of Biology and Marine Biology at the University of North Carolina Wilmington	National Oceanic and Atmospheric Administration (NOAA) through a National Estuary Research Reserve System Graduate Research Fellowship; Ralph Brauer Fellowship; Sigma Xi Grants in Aid of Research; Eastern Bird Banding Association; North Carolina Sea Grant; James and Francis Parnell Fellowship; Department of Biology and Marine Biology at the University of North Carolina Wilmington	Funding and support for this project were provided by the National Oceanic and Atmospheric Administration (NOAA) through a National Estuary Research Reserve System Graduate Research Fellowship, Ralph Brauer Fellowship, Sigma Xi Grants in Aid of Research, Eastern Bird Banding Association, North Carolina Sea Grant, the James and Francis Parnell Fellowship, and the Department of Biology and Marine Biology at the University of North Carolina Wilmington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bayard TS, 2011, AUK, V128, P393, DOI 10.1525/auk.2011.10178; Bearhop S, 2000, ENVIRON TOXICOL CHEM, V19, P1638, DOI [10.1002/etc.5620190622, 10.1897/1551-5028(2000)019&lt;1638:DOMIBA&gt;2.3.CO;2]; Brasso RL, 2008, ECOTOXICOLOGY, V17, P133, DOI 10.1007/s10646-007-0163-z; Braune BM, 2005, SCI TOTAL ENVIRON, V351, P4, DOI 10.1016/j.scitotenv.2004.10.034; Burgess NM, 2008, ECOTOXICOLOGY, V17, P83, DOI 10.1007/s10646-007-0167-8; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cristol DA, 2008, SCIENCE, V320, P335, DOI 10.1126/science.1154082; Cristol DA, 2011, ECOTOXICOLOGY, V20, P1773, DOI 10.1007/s10646-011-0710-5; Dettmers R., 2000, PARTNERS FLIGHT LAND; DiQuinzio DA, 2001, AUK, V118, P888, DOI 10.1642/0004-8038(2001)118[0888:SFPASO]2.0.CO;2; Edmonds ST, 2010, CONDOR, V112, P789, DOI 10.1525/cond.2010.100145; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; Evers DC, 2005, ECOTOXICOLOGY, V14, P193, DOI 10.1007/s10646-004-6269-7; Greenlaw JS, 2007, WILSON J ORNITHOL, V119, P361, DOI 10.1676/05-152.1; Greenlaw JS, 1994, BIRDS N AM ONLINE; Hallinger KK, 2011, ECOTOXICOLOGY, V20, P39, DOI 10.1007/s10646-010-0554-4; Howell S. N, 1997, IDENTIFICATION GUIDE; IUCN, 2019, INT UNION CONSERVATI; Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106; Lane OP, 2011, ECOTOXICOLOGY, V20, P1984, DOI 10.1007/s10646-011-0740-z; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Marvin-DiPasquale MC, 2003, ENVIRON GEOL, V43, P260, DOI 10.1007/s00254-002-0623-y; Meyer MW, 2011, ECOTOXICOLOGY, V20, P1659, DOI 10.1007/s10646-011-0759-1; Michaelis A, 2009, WINTER ECOLOGY SHARP; Mitro MG, 2008, J WILDLIFE MANAGE, V72, P665, DOI 10.2193/2006-551; Pittman HT, 2011, ECOTOXICOLOGY, V20, P1626, DOI 10.1007/s10646-011-0736-8; Post W. W., 2009, BIRDS N AM ONLINE; RICH TD, 2004, PARTNERS FLIGHT N AM; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Seewagen CL, 2010, BIRD CONSERV INT, V20, P112, DOI 10.1017/S095927090999030X; Shriver GW, 2011, BIRDS N AM ONLINE; Shriver W. Gregory, 2006, Environmental Bioindicators, V1, P129, DOI 10.1080/15555270600695734; THOMPSON DR, 1991, J APPL ECOL, V28, P672, DOI 10.2307/2404575; UNEP Chemicals Branch, 2008, GLOB ATM MERC ASS SO; *US FISH WILDL SER, 2002, BIRDS CONS 2002; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS TP, 1994, MAR POLLUT BULL, V28, P277, DOI 10.1016/0025-326X(94)90152-X; Winder V, WINTER SURV IN PRESS; Winder VL, 2011, ECOTOXICOLOGY, V20, P218, DOI 10.1007/s10646-010-0573-1; Winder VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032257; Winder VL, 2012, ECOTOXICOLOGY, V21, P325, DOI 10.1007/s10646-011-0794-y	44	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44446	10.1371/journal.pone.0044446	http://dx.doi.org/10.1371/journal.pone.0044446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962614	gold, Green Published, Green Submitted			2022-12-25	WOS:000308577600055
J	Kot, BCW; Zhang, ZJ; Lee, AWC; Leung, VYF; Fu, SN				Kot, Brian Chin Wing; Zhang, Zhi Jie; Lee, Arthur Wai Chun; Leung, Vivian Yee Fong; Fu, Siu Ngor			Elastic Modulus of Muscle and Tendon with Shear Wave Ultrasound Elastography: Variations with Different Technical Settings	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; SKELETAL-MUSCLE; HEALTHY	Standardization on Shear wave ultrasound elastography (SWUE) technical settings will not only ensure that the results are accurate, but also detect any differences over time that may be attributed to true physiological changes. The present study evaluated the variations of elastic modulus of muscle and tendon using SWUE when different technical aspects were altered. The results of this study indicated that variations of elastic modulus of muscle and tendon were found when different transducer's pressure and region of interest (ROI)'s size were applied. No significant differences in elastic modulus of the rectus femoris muscle and patellar tendon were found with different acquisition times of the SWUE sonogram. The SWUE on the muscle and tendon should be performed with the lightest transducer's pressure, a shorter acquisition time for the SWUE sonogram, while measuring the mean elastic modulus regardless the ROI's size.	[Kot, Brian Chin Wing; Zhang, Zhi Jie; Lee, Arthur Wai Chun; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Leung, Vivian Yee Fong] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Chinese University of Hong Kong; Prince of Wales Hospital	Kot, BCW (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	briankot@yahoo.co.uk; rsamyfu@polyu.edu.hk	Zhang, Zhi Jie/AAR-1686-2020	FU, Amy/0000-0003-4405-015X; Kot, Brian Chin Wing/0000-0002-8932-1884	Dr and Mrs Lui Che Woo Special Centre for the Knee, Department of Rehabilitation Sciences, The Hong Kong Polytechnic University	Dr and Mrs Lui Che Woo Special Centre for the Knee, Department of Rehabilitation Sciences, The Hong Kong Polytechnic University	Funding of the project was supported by Dr and Mrs Lui Che Woo Special Centre for the Knee, Department of Rehabilitation Sciences, The Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P1523, DOI 10.1109/TUFFC.2004.1367494; Cowan S. M., 2000, PHYS THER SPORT, V1, P129, DOI DOI 10.1054/PTSP.2000.0036; Garra Brian Stephen, 2007, Ultrasound Q, V23, P255, DOI 10.1097/ruq.0b013e31815b7ed6; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Klauser AS, 2010, SEMIN MUSCULOSKEL R, V14, P323, DOI 10.1055/s-0030-1254521; Lee AC, 2007, SCI FDN PRINCIPLES P, P1; Leonard CT, 2003, ARCH PHYS MED REHAB, V84, P928, DOI 10.1016/S0003-9993(03)00006-6; Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Papazoglou S, 2006, MAGN RESON MED, V56, P489, DOI 10.1002/mrm.20993; Ringleb SI, 2007, J MAGN RESON IMAGING, V25, P301, DOI 10.1002/jmri.20817; Sebag F, 2010, J CLIN ENDOCR METAB, V95, P5281, DOI 10.1210/jc.2010-0766; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Weismann C, 2011, BREAST CARE, V6, P98, DOI 10.1159/000327504; Zhang ZJ, 2011, J ULTRAS MED, V37, pS141	19	187	202	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44348	10.1371/journal.pone.0044348	http://dx.doi.org/10.1371/journal.pone.0044348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952961	Green Published, gold			2022-12-25	WOS:000308221300084
J	Yao, JX; Buschman, LL; Oppert, B; Khajuria, C; Zhu, KY				Yao, Jianxiu; Buschman, Lawrent L.; Oppert, Brenda; Khajuria, Chitvan; Zhu, Kun Yan			Characterization of cDNAs Encoding Serine Proteases and Their Transcriptional Responses to Cry1Ab Protoxin in the Gut of Ostrinia nubilalis Larvae	PLOS ONE			English	Article							MAMESTRA-CONFIGURATA LEPIDOPTERA; EARLY TRYPSIN ACTIVITY; INSECT RESISTANCE; HELICOVERPA-ZEA; PROTEINASE ACTIVITIES; HELIOTHIS-VIRESCENS; AGROTIS-IPSILON; COTTON BOLLWORM; CORN-BORER; MIDGUT	Serine proteases, such as trypsin and chymotrypsin, are the primary digestive enzymes in lepidopteran larvae, and are also involved in Bacillus thuringiensis (Bt) protoxin activation and protoxin/toxin degradation. We isolated and sequenced 34 cDNAs putatively encoding trypsins, chymotrypsins and their homologs from the European corn borer (Ostrinia nubilalis) larval gut. Our analyses of the cDNA-deduced amino acid sequences indicated that 12 were putative trypsins, 12 were putative chymotrypsins, and the remaining 10 were trypsin and chymotrypsin homologs that lack one or more conserved residues of typical trypsins and chymotrypsins. Reverse transcription PCR analysis indicated that all genes were highly expressed in gut tissues, but one group of phylogenetically-related trypsin genes, OnTry-G2, was highly expressed in larval foregut and midgut, whereas another group, OnTry-G3, was highly expressed in the midgut and hindgut. Real-time quantitative PCR analysis indicated that several trypsin genes (OnTry5 and OnTry6) were significantly up-regulated in the gut of third-instar larvae after feeding on Cry1Ab protoxin from 2 to 24 h, whereas one trypsin (OnTry2) was down-regulated at all time points. Four chymotrypsin and chymotrypsin homolog genes (OnCTP2, OnCTP5, OnCTP12 and OnCTP13) were up-regulated at least 2-fold in the gut of the larvae after feeding on Cry1Ab protoxin for 24 h. Our data represent the first in-depth study of gut transcripts encoding expanded families of protease genes in O. nubilalis larvae and demonstrate differential expression of protease genes that may be related to Cry1Ab intoxication and/or resistance.	[Yao, Jianxiu; Buschman, Lawrent L.; Khajuria, Chitvan; Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Oppert, Brenda] ARS, USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA	Kansas State University; United States Department of Agriculture (USDA)	Yao, JX (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	kzhu@ksu.edu	Khajuria, Chitvan/E-7690-2012	Zhu, Kun Yan/0000-0001-9372-8030	Kansas Agricultural Experiment Station; K-State Arthropod Genomics Center; K-State Targeted Excellence program at Kansas State University	Kansas Agricultural Experiment Station; K-State Arthropod Genomics Center; K-State Targeted Excellence program at Kansas State University	This research was supported in part by the Kansas Agricultural Experiment Station and the K-State Arthropod Genomics Center funded by the K-State Targeted Excellence program at Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunkumar KP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-338; Baptista AM, 1998, J MOL EVOL, V47, P353, DOI 10.1007/PL00006393; BARILLASMURY CV, 1995, INSECT BIOCHEM MOLEC, V25, P241, DOI 10.1016/0965-1748(94)00061-L; Barlow V, 2004, SAMPLING EUROPEAN CO; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Brioschi D, 2007, INSECT BIOCHEM MOLEC, V37, P1283, DOI 10.1016/j.ibmb.2007.07.016; Campbell PM, 2008, INSECT BIOCHEM MOLEC, V38, P950, DOI 10.1016/j.ibmb.2008.07.009; CHOMA CT, 1990, EUR J BIOCHEM, V189, P523, DOI 10.1111/j.1432-1033.1990.tb15518.x; Coates BS, 2008, INSECT MOL BIOL, V17, P607, DOI 10.1111/j.1365-2583.2008.00833.x; COHEN AC, 1993, J INSECT PHYSIOL, V39, P823, DOI 10.1016/0022-1910(93)90114-7; DEHAEN C, 1974, BIOCHEMISTRY-US, V13, P2673, DOI 10.1021/bi00710a002; Diaz-Mendoza M, 2005, INSECT BIOCHEM MOLEC, V35, P1005, DOI 10.1016/j.ibmb.2005.04.003; EBORA RV, 1994, J ECON ENTOMOL, V87, P1122, DOI 10.1093/jee/87.4.1122; Erlandson MA, 2010, ARCH INSECT BIOCHEM, V75, P70, DOI 10.1002/arch.20381; Forcada C, 1996, ARCH INSECT BIOCHEM, V31, P257, DOI 10.1002/(SICI)1520-6327(1996)31:3&lt;257::AID-ARCH2&gt;3.0.CO;2-V; Forcada C, 1999, ARCH INSECT BIOCHEM, V42, P51, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;51::AID-ARCH6&gt;3.0.CO;2-6; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Giri AP, 1998, PLANT PHYSIOL, V116, P393, DOI 10.1104/pp.116.1.393; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hegedus D, 2003, ARCH INSECT BIOCHEM, V53, P30, DOI 10.1002/arch.10084; Herrero S, 2005, INSECT BIOCHEM MOLEC, V35, P1073, DOI 10.1016/j.ibmb.2005.05.006; HILDER VA, 1987, NATURE, V330, P160, DOI 10.1038/330160a0; Hosseininaveh V, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.7001; Hughes J, 2006, INSECT BIOCHEM MOLEC, V36, P584, DOI 10.1016/j.ibmb.2006.04.007; JOHNSON R, 1989, P NATL ACAD SCI USA, V86, P9871, DOI 10.1073/pnas.86.24.9871; JOHNSTON KA, 1991, INSECT BIOCHEM, V21, P389, DOI 10.1016/0020-1790(91)90005-Y; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; LAROCQUE AM, 1990, J INSECT PHYSIOL, V36, P691, DOI 10.1016/0022-1910(90)90075-Q; LEE MK, 1992, J BIOL CHEM, V267, P3115; Li HR, 2005, INSECT BIOCHEM MOLEC, V35, P847, DOI 10.1016/j.ibmb.2005.03.004; Li HR, 2004, INSECT BIOCHEM MOLEC, V34, P753, DOI 10.1016/j.ibmb.2004.03.010; LIPKE H, 1954, J AGR FOOD CHEM, V2, P410, DOI 10.1021/jf60028a003; Liu Y, 2009, ARCH INSECT BIOCHEM, V72, P74, DOI 10.1002/arch.20324; Lopes AR, 2009, ARCH INSECT BIOCHEM, V70, P188, DOI 10.1002/arch.20289; Lopes AR, 2004, ARCH INSECT BIOCHEM, V55, P140, DOI 10.1002/arch.10134; Lu SJ, 2006, INSECT BIOCHEM MOLEC, V36, P336, DOI 10.1016/j.ibmb.2006.01.011; Ma WZ, 2005, BIOPHYS J, V89, P1183, DOI 10.1529/biophysj.104.057158; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P645, DOI 10.1016/S0965-1748(00)00169-7; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P633, DOI 10.1016/S0965-1748(00)00168-5; Mazumdar-Leighton S, 2000, INSECT BIOCHEM MOLEC, V30, P57, DOI 10.1016/S0965-1748(99)00097-1; Nation JL, 2001, INSECT PHYSL BIOCH, P43; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Oppert B, 1996, INSECT BIOCHEM MOLEC, V26, P571, DOI 10.1016/S0965-1748(96)00013-6; Oppert B, 1999, ARCH INSECT BIOCHEM, V42, P1, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;1::AID-ARCH2&gt;3.0.CO;2-#; Oppert B, 2012, COMP BIOCHEM PHYS D, V7, P233, DOI 10.1016/j.cbd.2012.03.005; Oppert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034624; Oppert B, 2010, COMP BIOCHEM PHYS D, V5, P280, DOI 10.1016/j.cbd.2010.08.001; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; Patankar AG, 2001, INSECT BIOCHEM MOLEC, V31, P453, DOI 10.1016/S0965-1748(00)00150-8; PETERSON AM, 1995, INSECT BIOCHEM MOLEC, V25, P765, DOI 10.1016/0965-1748(94)00092-V; PETERSON AM, 1994, INSECT BIOCHEM MOLEC, V24, P463, DOI 10.1016/0965-1748(94)90041-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puntheeranurak T, 2004, MOL MEMBR BIOL, V21, P67, DOI 10.1080/09687680310001625792; PURCELL JP, 1992, INSECT BIOCHEM MOLEC, V22, P41, DOI 10.1016/0965-1748(92)90098-Y; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Reddy ST, 1998, BIOTECHNOL LETT, V20, P279, DOI 10.1023/A:1005338205018; Rodriguez-Cabrera L, 2010, ENVIRON MICROBIOL, V12, P2894, DOI 10.1111/j.1462-2920.2010.02259.x; SAS Institute, 1996, SAS 9 1 3; Shao ZZ, 1998, J INVERTEBR PATHOL, V72, P73, DOI 10.1006/jipa.1998.4757; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Showers WB, 1989, N CENTRAL REGIONAL E; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Sui YP, 2009, INSECT MOL BIOL, V18, P443, DOI 10.1111/j.1365-2583.2009.00884.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x; Volpicella M, 2003, EUR J BIOCHEM, V270, P10, DOI 10.1046/j.1432-1033.2003.03368.x; Wang S, 1999, INSECT BIOCHEM MOLEC, V25, P899; Witkowski JF, 1997, N CENTRAL REGIONAL E; Yan YL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-405, 10.1186/1471-2164-11-11]; Zhan QL, 2011, ARCH INSECT BIOCHEM, V76, P130, DOI 10.1002/arch.20353; Zhu YC, 2000, INSECT BIOCHEM MOLEC, V30, P1027, DOI 10.1016/S0965-1748(00)00073-4; Zhu YC, 2011, J INVERTEBR PATHOL, V106, P296, DOI 10.1016/j.jip.2010.10.007	77	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44090	10.1371/journal.pone.0044090	http://dx.doi.org/10.1371/journal.pone.0044090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952884	gold, Green Published			2022-12-25	WOS:000308221300050
J	Azzag, N; Haddad, N; Durand, B; Petit, E; Ammouche, A; Chomel, B; Boulouis, HJ				Azzag, Naouelle; Haddad, Nadia; Durand, Benoit; Petit, Elisabeth; Ammouche, Ali; Chomel, Bruno; Boulouis, Henri-Jean			Population Structure of Bartonella henselae in Algerian Urban Stray Cats	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; DOMESTIC CATS; MOLECULAR EPIDEMIOLOGY; SCRATCH DISEASE; PREVALENCE; INFECTION; IDENTIFICATION; VARIANTS; TRANSMISSION; CLARRIDGEIAE	Whole blood samples from 211 stray cats from Algiers, Algeria, were cultured to detect the presence of Bartonella species and to evaluate the genetic diversity of B. henselae strains by multiple locus VNTR analysis (MLVA). Bartonella henselae was the only species isolated from 36 (17%) of 211 cats. B. henselae genotype I was the predominant genotype (64%). MLVA typing of 259 strains from 30 bacteremic cats revealed 52 different profiles as compared to only 3 profiles using MLST. Of these 52 profiles, 48 (92.3%) were identified for the first time. One-third of the cats harbored one MLVA profile only. As there was a correlation between the age of cats and the number of MLVA profiles, we hypothesized that the single profile in these cats was the profile of the initial infecting strain. Two-third of the cats harbored 2 to 6 MLVA profiles simultaneously. The similarity of MLVA profiles obtained from the same cat, neighbor-joining clustering and structure-neighbor clustering indicate that such a diversity likely results from two different mechanisms occurring either independently or simultaneously: independent infections and genetic drift from a primary strain.	[Azzag, Naouelle] Ecole Natl Super Vet Alger, El Harrach, Alger, Algeria; [Haddad, Nadia; Petit, Elisabeth; Boulouis, Henri-Jean] Univ Paris Est, Ecole Natl Vet Alfort, UMR BIPAR ENVA Anses UPEC USC INRA, Maisons Alfort, France; [Durand, Benoit] Anses, Lab St Anim, Unite Epidemiol, Maisons Alfort, France; [Ammouche, Ali] Ecole Natl Super Agron, Dept Technol Alimentaire, El Harrach, Alger, Algeria; [Chomel, Bruno] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Ecole Nationale Superieure Veterinaire; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Polytechnique - Algeria; University of California System; University of California Davis	Azzag, N (corresponding author), Ecole Natl Super Vet Alger, El Harrach, Alger, Algeria.	hjboulouis@vet-alfort.fr	Durand, Benoit/GSE-2511-2022; ENSA - NHSA, Algiers/AAF-1768-2019	Durand, Benoit/0000-0003-0669-1394	Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Algerie; Ministere de l'agriculture, de l'alimentation, de la peche, de la ruralite et de l'amenagement du territories, DGER, France	Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Algerie; Ministere de l'agriculture, de l'alimentation, de la peche, de la ruralite et de l'amenagement du territories, DGER, France	Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Algerie and Ministere de l'agriculture, de l'alimentation, de la peche, de la ruralite et de l'amenagement du territories, DGER, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Angelakis E, 2010, EMERG INFECT DIS, V16, P385, DOI [10.3201/eid1603.091685, 10.3201/eid1603.081685]; Arvand M, 2006, MICROBES INFECT, V8, P1315, DOI 10.1016/j.micinf.2005.12.015; Arvand M, 2001, J CLIN MICROBIOL, V39, P743, DOI 10.1128/JCM.39.2.743-746.2001; Arvand M, 2008, EMERG INFECT DIS, V14, P152, DOI 10.3201/eid1401.070768; Berghoff J, 2007, MICROBIOL-SGM, V153, P2045, DOI 10.1099/mic.0.2007/006379-0; Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996; Bouchouicha R, 2009, CLIN MICROBIOL INFEC, V15, P104, DOI 10.1111/j.1469-0691.2008.02183.x; Bouchouicha R, 2009, EMERG INFECT DIS, V15, P813, DOI 10.3201/eid1505.080995; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Buchmann AU, 2010, J CLIN MICROBIOL, V48, P3295, DOI 10.1128/JCM.00750-10; Celebi B, 2009, ZOONOSES PUBLIC HLTH, V56, P169, DOI 10.1111/j.1863-2378.2008.01170.x; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; Chung CY, 2004, EMERG INFECT DIS, V10, P1311; Drancourt M, 1996, LANCET, V347, P441, DOI 10.1016/S0140-6736(96)90012-4; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Fabbi M, 2004, J CLIN MICROBIOL, V42, P264, DOI 10.1128/JCM.42.1.264-268.2004; Frutos R, 2006, J BACTERIOL, V188, P2533, DOI 10.1128/JB.188.7.2533-2542.2006; Gurfield AN, 1997, J CLIN MICROBIOL, V35, P2120, DOI 10.1128/JCM.35.8.2120-2123.1997; Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2; Hall BG, 2010, J CLIN MICROBIOL, V48, P1997, DOI 10.1128/JCM.00149-10; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Inoue K, 2009, EPIDEMIOL INFECT, V137, P1568, DOI 10.1017/S095026880900257X; Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003; Jensen WA, 2000, J CLIN MICROBIOL, V38, P1717, DOI 10.1128/JCM.38.5.1717-1722.2000; Kabeya H, 2002, VET MICROBIOL, V89, P211, DOI 10.1016/S0378-1135(02)00175-X; KOEHLER JE, 1994, JAMA-J AM MED ASSOC, V271, P531, DOI 10.1001/jama.271.7.531; Li WJ, 2006, J CLIN MICROBIOL, V44, P2499, DOI 10.1128/JCM.00498-06; Maillard R, 2004, VET MICROBIOL, V98, P63, DOI 10.1016/j.vetmic.2003.09.022; Maruyama S, 2000, J VET MED SCI, V62, P273, DOI 10.1292/jvms.62.273; Monteil M, 2007, MICROBIOL-SGM, V153, P1141, DOI 10.1099/mic.0.2006/001164-0; Pritchard JK, 2000, GENETICS, V155, P945; Sander A, 1997, J CLIN MICROBIOL, V35, P584, DOI 10.1128/JCM.35.3.584-587.1997; Team R. D. C, 2011, R LANG ENV STAT COMP; Tsai YL, 2011, VECTOR-BORNE ZOONOT, V11, P1023, DOI 10.1089/vbz.2010.0085; Tsai YL, 2011, COMP IMMUNOL MICROB, V34, P299, DOI 10.1016/j.cimid.2011.04.005; Viezens J, 2008, MICROBIOL-SGM, V154, P2881, DOI 10.1099/mic.0.2008/018630-0; Xu CB, 2009, J MICROBIOL METH, V76, P6, DOI 10.1016/j.mimet.2008.09.001; Yuan CL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001301; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101	44	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43621	10.1371/journal.pone.0043621	http://dx.doi.org/10.1371/journal.pone.0043621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956995	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206500017
J	Sasidharan, K; Soga, T; Tomita, M; Murray, DB				Sasidharan, Kalesh; Soga, Tomoyoshi; Tomita, Masaru; Murray, Douglas B.			A Yeast Metabolite Extraction Protocol Optimised for Time-Series Analyses	PLOS ONE			English	Article							RESPIRATORY OSCILLATION; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE; ACID; QUANTIFICATION	There is an increasing call for the absolute quantification of time-resolved metabolite data. However, a number of technical issues exist, such as metabolites being modified/degraded either chemically or enzymatically during the extraction process. Additionally, capillary electrophoresis mass spectrometry (CE-MS) is incompatible with high salt concentrations often used in extraction protocols. In microbial systems, metabolite yield is influenced by the extraction protocol used and the cell disruption rate. Here we present a method that rapidly quenches metabolism using dry-ice ethanol bath and methanol N-ethylmaleimide solution (thus stabilising thiols), disrupts cells efficiently using bead-beating and avoids artefacts created by live-cell pelleting. Rapid sample processing minimised metabolite leaching. Cell weight, number and size distribution was used to calculate metabolites to an attomol/cell level. We apply this method to samples obtained from the respiratory oscillation that occurs when yeast are grown continuously.	[Sasidharan, Kalesh; Soga, Tomoyoshi; Tomita, Masaru; Murray, Douglas B.] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Keio University	Sasidharan, K (corresponding author), Keio Univ, Inst Adv Biosci, Nipponkoku 403-1, Tsuruoka, Yamagata, Japan.	dougie@ttck.keio.ac.jp	Soga, Tomoyoshi/B-8105-2014	Soga, Tomoyoshi/0000-0001-9502-2509	Tsuruoka city; Yamagata prefecture; JST-BBSRC	Tsuruoka city(Tsuruoka City Government); Yamagata prefecture; JST-BBSRC	The authors are grateful to Tsuruoka city and Yamagata prefecture for supporting this work. In part this work was funded by a joint JST-BBSRC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban E, 2012, ELECTROPHORESIS, V33, P2, DOI 10.1002/elps.201100344; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Barri T, 2012, ANAL CHIM ACTA, V718, P47, DOI 10.1016/j.aca.2011.12.065; Bolten CJ, 2008, BIOTECHNOL LETT, V30, P1993, DOI 10.1007/s10529-008-9789-z; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Buchholz A, 2001, ANAL BIOCHEM, V295, P129, DOI 10.1006/abio.2001.5183; Canelas AB, 2008, METABOLOMICS, V4, P226, DOI 10.1007/s11306-008-0116-4; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; D'Agostino LA, 2011, J PROTEOME RES, V10, P592, DOI 10.1021/pr100771g; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; ELLIOTT B, 1993, YEAST, V9, P33, DOI 10.1002/yea.320090105; Faijes M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-27; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Machne R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037906; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Murray DB, 1999, MICROBIOL-SGM, V145, P2739, DOI 10.1099/00221287-145-10-2739; Murray DB, 2007, BIOSYSTEMS, V90, P287, DOI 10.1016/j.biosystems.2006.09.032; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Murray DB, 2011, BBA-GEN SUBJECTS, V1810, P945, DOI 10.1016/j.bbagen.2011.04.005; Ohta D, 2010, CURR OPIN BIOTECH, V21, P35, DOI 10.1016/j.copbio.2010.01.012; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Sasidharan K, 2012, YEAST; SATROUTDINOV AD, 1992, FEMS MICROBIOL LETT, V98, P261, DOI 10.1016/0378-1097(92)90167-M; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Sohn HY, 2005, BIOSCI BIOTECH BIOCH, V69, P2450, DOI 10.1271/bbb.69.2450; Sohn HY, 2005, J MICROBIOL, V43, P375; Sohn HY, 2001, ARCH MICROBIOL, V176, P69, DOI 10.1007/s002030100295; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Theobald U, 1997, BIOTECHNOL BIOENG, V55, P305, DOI 10.1002/(SICI)1097-0290(19970720)55:2<305::AID-BIT8>3.0.CO;2-M; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308	34	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44283	10.1371/journal.pone.0044283	http://dx.doi.org/10.1371/journal.pone.0044283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952947	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000097
J	Streitburger, DP; Moller, HE; Tittgemeyer, M; Hund-Georgiadis, M; Schroeter, ML; Mueller, K				Streitbuerger, Daniel-Paolo; Moeller, Harald E.; Tittgemeyer, Marc; Hund-Georgiadis, Margret; Schroeter, Matthias L.; Mueller, Karsten			Investigating Structural Brain Changes of Dehydration Using Voxel-Based Morphometry	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CLUSTER-SIZE INFERENCE; VENTRICULAR ENLARGEMENT; ALZHEIMERS-DISEASE; GRAY-MATTER; PERMUTATION METHODS; MULTIPLE-SCLEROSIS; RANDOM-FIELD; VOLUME; PROGRESSION	Dehydration can affect the volume of brain structures, which might imply a confound in volumetric and morphometric studies of normal or diseased brain. Six young, healthy volunteers were repeatedly investigated using three-dimensional T-1-weighted magnetic resonance imaging during states of normal hydration, hyperhydration, and dehydration to assess volume changes in gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). The datasets were analyzed using voxel-based morphometry (VBM), a widely used voxel-wise statistical analysis tool, FreeSurfer, a fully automated volumetric segmentation measure, and SIENAr a longitudinal brain-change detection algorithm. A significant decrease of GM and WM volume associated with dehydration was found in various brain regions, most prominently, in temporal and sub-gyral parietal areas, in the left inferior orbito-frontal region, and in the extra-nuclear region. Moreover, we found consistent increases in CSF, that is, an expansion of the ventricular system affecting both lateral ventricles, the third, and the fourth ventricle. Similar degrees of shrinkage in WM volume and increase of the ventricular system have been reported in studies of mild cognitive impairment or Alzheimer's disease during disease progression. Based on these findings, a potential confound in GM and WM or ventricular volume studies due to the subjects' hydration state cannot be excluded and should be appropriately addressed in morphometric studies of the brain.	[Streitbuerger, Daniel-Paolo; Moeller, Harald E.; Hund-Georgiadis, Margret; Schroeter, Matthias L.; Mueller, Karsten] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Tittgemeyer, Marc] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany	Max Planck Society; Max Planck Society; Leipzig University	Streitburger, DP (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	paolo@cbs.mpg.de	Moller, Harald E/A-1565-2008; Möller, Harald/AAB-4679-2019	Moller, Harald E/0000-0002-5659-1925; Möller, Harald/0000-0002-5659-1925				Apostolova LG, 2010, MOVEMENT DISORD, V25, P687, DOI 10.1002/mds.22799; Armstrong LE, 2010, INT J SPORT NUTR EXE, V20, P145, DOI 10.1123/ijsnem.20.2.145; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barta PE, 1997, J NEUROSCI METH, V75, P111, DOI 10.1016/S0165-0270(97)00049-6; Bendel P, 2010, AM J NEURORADIOL, V31, P370, DOI 10.3174/ajnr.A1804; Bendfeldt K, 2009, NEUROIMAGE, V45, P60, DOI 10.1016/j.neuroimage.2008.10.006; Berk L, 2006, J SUPPORT ONCOL, V4, P455; Berk Lawrence, 2006, J Support Oncol, V4, P447; Brex PA, 2000, NEUROLOGY, V54, P1689, DOI 10.1212/WNL.54.8.1689; Dickson JM, 2005, INT J SPORTS MED, V26, P481, DOI 10.1055/s-2004-821318; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.me.44.020193.001445; Guo XJ, 2010, NEUROSCI LETT, V468, P146, DOI 10.1016/j.neulet.2009.10.086; Hagemann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014655; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kempton MJ, 2011, HUM BRAIN MAPP, V32, P71, DOI 10.1002/hbm.20999; Kempton MJ, 2009, HUM BRAIN MAPP, V30, P291, DOI 10.1002/hbm.20500; Kinkingnehum S, 2008, NEUROLOGY, V70, P2201, DOI 10.1212/01.wnl.0000303960.01039.43; Koo MS, 2006, ARCH GEN PSYCHIAT, V63, P1090, DOI 10.1001/archpsyc.63.10.1090; Righini NC, 2005, SWISS MED WKLY, V135, P440; Schols JMGA, 2009, J NUTR HEALTH AGING, V13, P150, DOI 10.1007/s12603-009-0023-z; Schott JM, 2005, NEUROLOGY, V65, P119, DOI 10.1212/01.wnl.0000167542.89697.0f; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tardif CL, 2010, HUM BRAIN MAPP, V31, P943, DOI 10.1002/hbm.20908; Turner B, 2001, NEURORADIOLOGY, V43, P608, DOI 10.1007/s002340000457; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; Worsley KJ, 2009, OHBM; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16	35	103	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44195	10.1371/journal.pone.0044195	http://dx.doi.org/10.1371/journal.pone.0044195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952926	gold, Green Published			2022-12-25	WOS:000308206000092
J	Kulak, MV; Cyr, AR; Woodfield, GW; Bogachek, M; Spanheimer, PM; Li, T; Price, DH; Domann, FE; Weigel, RJ				Kulak, M. V.; Cyr, A. R.; Woodfield, G. W.; Bogachek, M.; Spanheimer, P. M.; Li, T.; Price, D. H.; Domann, F. E.; Weigel, R. J.			Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer	ONCOGENE			English	Article						TFAP2C; GPX1; breast cancer; oxidative stress	OXIDATIVE STRESS; PRO198LEU POLYMORPHISM; ACTIVATOR PROTEIN-2; CELL-LINES; EXPRESSION; AP-2; RECEPTOR; OVEREXPRESSION; CLONING; FAMILY	The complexity of gene regulation has created obstacles to defining mechanisms that establish the patterns of gene expression characteristic of the different clinical phenotypes of breast cancer. TFAP2C is a transcription factor that has a critical role in the regulation of both estrogen receptor-alpha (ER alpha) and c-ErbB2/HER2 (Her2). Herein, we performed chromatin immunoprecipitation and direct sequencing (ChIP-seq) for TFAP2C in four breast cancer cell lines. Comparing the genomic binding sites for TFAP2C, we identified that glutathione peroxidase (GPX1) is regulated by TFAP2C through an AP-2 regulatory region in the promoter of the GPX1 gene. Knockdown of TFAP2C, but not the related factor TFAP2A, resulted in an abrogation of GPX1 expression. Selenium-dependent GPX activity correlated with endogenous GPX1 expression and overexpression of exogenous GPX1 induced GPX activity and significantly increased resistance to tert-butyl hydroperoxide. Methylation of the CpG island encompassing the AP-2 regulatory region was identified in cell lines where TFAP2C failed to bind the GPX1 promoter and GPX1 expression was unresponsive to TFAP2C. Furthermore, in cell lines where GPX1 promoter methylation was associated with gene silencing, treatment with 5'-aza-2-deoxycytidine (5'-aza-dC) (an inhibitor of DNA methylation) allowed TFAP2C to bind to the GPX1 promoter resulting in the activation of GPX1 RNA and protein expression. Methylation of the GPX1 promoter was identified in similar to 20% of primary breast cancers and a highly significant correlation between the TFAP2C and GPX1 expression was confirmed when considering only those tumors with an unmethylated promoter, whereas the related factor, TFAP2A, failed to demonstrate a correlation. The results demonstrate that TFAP2C regulates the expression of GPX1, which influences the redox state and sensitivity to oxidative stress induced by peroxides. Given the established role of GPX1 in breast cancer, the results provide an important mechanism for TFAP2C to further influence oncogenesis and progression of breast carcinoma cells.	[Kulak, M. V.; Woodfield, G. W.; Bogachek, M.; Spanheimer, P. M.; Weigel, R. J.] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA; [Cyr, A. R.; Domann, F. E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Li, T.; Price, D. H.; Weigel, R. J.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Weigel, RJ (corresponding author), Univ Iowa, Dept Surg, 200 Hawkins Dr,1516 JCP, Iowa City, IA 52242 USA.	Ronald-Weigel@uiowa.edu	Li, Tiandao/F-4039-2012	Li, Tiandao/0000-0003-1650-0555; Kulak, Mikhail/0000-0002-4307-5868; Price, David/0000-0002-5597-385X; Domann, Frederick/0000-0002-0489-2179; Weigel, Ronald/0000-0002-9249-0793	National Institutes of Health [R01CA109294, R01CA115438, F30 AA019856, T32CA148062]; NATIONAL CANCER INSTITUTE [R01CA109294, T32CA078586, T32CA148062, R01CA115438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA019856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We appreciate tumor samples provided by Dr Ryan Askeland and Christine Hochstedler (Department of Pathology, University of Iowa) and statistical support from Dr Junlin Liao (Department of Surgery, University of Iowa). This work was supported in part by the National Institutes of Health grants R01CA109294 (PI: RJ Weigel) and R01CA115438 (PI: FE Domann). Anthony Cyr received salary support from NIH F30 AA019856 and Dr Philip Spanheimer was supported by the NIH grant T32CA148062 (PI: RJ Weigel). The work was also supported by a generous gift from the Kristen Olewine Milke Breast Cancer Research Fund.	Allouche A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1851; Begon DY, 2005, J BIOL CHEM, V280, P24428, DOI 10.1074/jbc.M503790200; Bosher JM, 1996, ONCOGENE, V13, P1701; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Buzdar AU, 2009, ANN ONCOL, V20, P993, DOI 10.1093/annonc/mdn739; Cox DG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-217; Delacroix L, 2005, DNA CELL BIOL, V24, P582, DOI 10.1089/dna.2005.24.582; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1; Feng WG, 2003, MOL CELL NEUROSCI, V24, P460, DOI 10.1016/S1044-7431(03)00209-4; Gao JP, 2008, BBA-MOL CELL RES, V1783, P2020, DOI 10.1016/j.bbamcr.2008.05.027; Gouaze V, 2001, MOL PHARMACOL, V60, P488; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; He AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-279; Hu J, 2010, BREAST CANCER RES TR, V124, P425, DOI 10.1007/s10549-010-0841-z; Hu YJ, 2005, J NUTR, V135, p3021S, DOI 10.1093/jn/135.12.3021S; Hu YJ, 2003, CANCER RES, V63, P3347; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jenssen TK, 2002, HUM GENET, V111, P411, DOI 10.1007/s00439-002-0804-5; Johansson K, 2010, FREE RADICAL BIO MED, V49, P1638, DOI 10.1016/j.freeradbiomed.2010.08.013; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Maiti AK, 2012, INT J CANCER, V130, P1, DOI 10.1002/ijc.26306; McPherson LA, 1999, NUCLEIC ACIDS RES, V27, P4040, DOI 10.1093/nar/27.20.4040; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; McPherson LA, 2002, J BIOL CHEM, V277, P45028, DOI 10.1074/jbc.M208924200; MOSER M, 1995, DEVELOPMENT, V121, P2779; Pellikainen J, 2004, EUR J CANCER, V40, P1485, DOI 10.1016/j.ejca.2004.02.020; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Scibetta AG, 2010, CELL CYCLE, V9, P4525, DOI 10.4161/cc.9.22.13746; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tan SK, 2011, EMBO J, V30, P2569, DOI 10.1038/emboj.2011.151; Thewes V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-192; TOWNSEND AJ, 1991, CANCER COMMUN, V3, P265, DOI 10.3727/095535491820873119; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Turner BC, 1998, CANCER RES, V58, P5466; Vibet S, 2008, FREE RADICAL BIO MED, V44, P1483, DOI 10.1016/j.freeradbiomed.2008.01.009; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Woodfield GW, 2009, CLIN CANCER RES, V15, P3672, DOI 10.1158/1078-0432.CCR-08-2343; Yang JW, 2006, FEBS LETT, V580, P6501, DOI 10.1016/j.febslet.2006.10.059; Yu L, 2009, J ONCOL, V2009, DOI 10.1155/2009/780874; Zhao F, 2001, J BIOL CHEM, V276, P40755, DOI 10.1074/jbc.M106284200; Zhu CH, 2001, J BIOL CHEM, V276, P14407, DOI 10.1074/jbc.M009708200; Zhuo P, 2009, CANCER RES, V69, P8183, DOI 10.1158/0008-5472.CAN-09-1791	53	35	41	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					4043	4051		10.1038/onc.2012.400	http://dx.doi.org/10.1038/onc.2012.400			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22964634	Green Accepted			2022-12-25	WOS:000323748100013
J	Kurnellas, MP; Brownell, SE; Su, L; Malkovskiy, AV; Rajadas, J; Dolganov, G; Chopra, S; Schoolnik, GK; Sobel, RA; Webster, J; Ousman, SS; Becker, RA; Steinman, L; Rothbard, JB				Kurnellas, Michael P.; Brownell, Sara E.; Su, Leon; Malkovskiy, Andrey V.; Rajadas, Jayakumar; Dolganov, Gregory; Chopra, Sidharth; Schoolnik, Gary K.; Sobel, Raymond A.; Webster, Jonathan; Ousman, Shalina S.; Becker, Rachel A.; Steinman, Lawrence; Rothbard, Jonathan B.			Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; FUNCTIONAL ELEMENT; AGGREGATION; TRANSLOCATION; ACTIVATION; PREDICTION; APOPTOSIS; SEQUESTER; PEPTIDES; REVEALS	To determine whether the therapeutic activity of alpha B crystallin, small heat shock protein B5 (HspB5), was shared with other human sHsps, a set of seven human family members, a mutant of HspB5 G120 known to exhibit reduced chaperone activity, and a mycobacterial sHsp were expressed and purified from bacteria. Each of the recombinant proteins was shown to be a functional chaperone, capable of inhibiting aggregation of denatured insulin with varying efficiency. When injected into mice at the peak of disease, they were all effective in reducing the paralysis in experimental autoimmune encephalomyelitis. Additional structure activity correlations between chaperone activity and therapeutic function were established when linear regions within HspB5 were examined. A single region, corresponding to residues 73-92 of HspB5, forms amyloid fibrils, exhibited chaperone activity, and was an effective therapeutic for encephalomyelitis. The linkage of the three activities was further established by demonstrating individual substitutions of critical hydrophobic amino acids in the peptide resulted in the loss of all of the functions.	[Kurnellas, Michael P.; Brownell, Sara E.; Webster, Jonathan; Ousman, Shalina S.; Becker, Rachel A.; Steinman, Lawrence; Rothbard, Jonathan B.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Su, Leon; Rothbard, Jonathan B.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA; [Sobel, Raymond A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Malkovskiy, Andrey V.; Rajadas, Jayakumar] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA; [Dolganov, Gregory; Chopra, Sidharth; Schoolnik, Gary K.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Dept Med, Stanford, CA 94305 USA; [Schoolnik, Gary K.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Steinman, L (corresponding author), Beckman B002,279 Campus Dr, Stanford, CA 94305 USA.	Steinman@stanford.edu	Rajadas, Jayakumar/AHC-0630-2022	Steinman, Lawrence/0000-0002-2437-2250; Sobel, Raymond/0000-0002-0477-9002; Chopra, Sidharth/0000-0001-8823-6074; Rajadas, Jayakumar/0000-0001-6520-3923	National Institutes of Health [R01NS55997, UO1 DK078123, 1R43 AI0949]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000949, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS55997 (to L. S.), UO1 DK078123 (to J. B. R.), 1R43 AI0949 (to J. B. R. and L. S.), grants form the National MS Society (to J. B. R., M. K., and L. S.), and the Endriz Fund (to L. S.).	Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; Cazalla D, 2005, PROTEIN EXPRES PURIF, V42, P54, DOI 10.1016/j.pep.2005.03.035; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kappe Guido, 2002, Prog Mol Subcell Biol, V28, P1; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim R, 1998, P NATL ACAD SCI USA, V95, P9129, DOI 10.1073/pnas.95.16.9129; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; Pasta SY, 2004, MOL VIS, V10, P655; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Rothbard JB, 2012, J BIOL CHEM, V287, P9708, DOI 10.1074/jbc.M111.337691; Rothbard JB, 2011, J IMMUNOL, V186, P4263, DOI 10.4049/jimmunol.1003934; Santhoshkumar P, 2006, PROTEIN SCI, V15, P2488, DOI 10.1110/ps.062338206; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	49	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36423	36434		10.1074/jbc.M112.371229	http://dx.doi.org/10.1074/jbc.M112.371229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955287	Green Published, hybrid			2022-12-25	WOS:000310364000062
J	Nyfeler, B; Hoepfner, D; Palestrant, D; Kirby, CA; Whitehead, L; Yu, R; Deng, G; Caughlan, RE; Woods, AL; Jones, AK; Barnes, SW; Walker, JR; Gaulis, S; Hauy, E; Brachmann, SM; Krastel, P; Studer, C; Riedl, R; Estoppey, D; Aust, T; Movva, NR; Wang, Z; Salcius, M; Michaud, GA; McAllister, G; Murphy, LO; Tallarico, JA; Wilson, CJ; Dean, CR				Nyfeler, Beat; Hoepfner, Dominic; Palestrant, Deborah; Kirby, Christina A.; Whitehead, Lewis; Yu, Robert; Deng, Gejing; Caughlan, Ruth E.; Woods, Angela L.; Jones, Adriana K.; Barnes, S. Whitney; Walker, John R.; Gaulis, Swann; Hauy, Ervan; Brachmann, Saskia M.; Krastel, Philipp; Studer, Christian; Riedl, Ralph; Estoppey, David; Aust, Thomas; Movva, N. Rao; Wang, Zuncai; Salcius, Michael; Michaud, Gregory A.; McAllister, Gregory; Murphy, Leon O.; Tallarico, John A.; Wilson, Christopher J.; Dean, Charles R.			Identification of Elongation Factor G as the Conserved Cellular Target of Argyrin B	PLOS ONE			English	Article							IMMUNOSUPPRESSIVE CYCLIC-PEPTIDES; BACTERIAL PROTEIN-SYNTHESIS; FUSIDIC ACID; EF-G; RIBOSOME; PROTEASOME; MYXOBACTERIA; ELUCIDATION; RESISTANCE; INHIBITORS	Argyrins, produced by myxobacteria and actinomycetes, are cyclic octapeptides with antibacterial and antitumor activity. Here, we identify elongation factor G (EF-G) as the cellular target of argyrin B in bacteria, via resistant mutant selection and whole genome sequencing, biophysical binding studies and crystallography. Argyrin B binds a novel allosteric pocket in EF-G, distinct from the known EF-G inhibitor antibiotic fusidic acid, revealing a new mode of protein synthesis inhibition. In eukaryotic cells, argyrin B was found to target mitochondrial elongation factor G1 (EF-G1), the closest homologue of bacterial EF-G. By blocking mitochondrial translation, argyrin B depletes electron transport components and inhibits the growth of yeast and tumor cells. Further supporting direct inhibition of EF-G1, expression of an argyrin B-binding deficient EF-G1 L693Q variant partially rescued argyrin B-sensitivity in tumor cells. In summary, we show that argyrin B is an antibacterial and cytotoxic agent that inhibits the evolutionarily conserved target EF-G, blocking protein synthesis in bacteria and mitochondrial translation in yeast and mammalian cells.	[Palestrant, Deborah; Kirby, Christina A.] Novartis Inst BioMed Res, Ctr Prote Chem, Cambridge, MA USA; [Gaulis, Swann; Hauy, Ervan; Brachmann, Saskia M.] Novartis Inst BioMed Res, Dis Area Oncol, Basel, Switzerland; [Yu, Robert; Deng, Gejing; Caughlan, Ruth E.; Woods, Angela L.; Jones, Adriana K.; Dean, Charles R.] Novartis Inst BioMed Res, Emeryville, CA USA; [Barnes, S. Whitney; Walker, John R.] Novartis Inst Biomed Res, Novartis Inst Funct Gen, San Diego, CA USA; [Krastel, Philipp] Novartis Inst BioMed Res, Ctr Prote Chem, Nat Prod Unit, Basel, Switzerland	Novartis; Novartis; Novartis; Novartis; Novartis	Nyfeler, B (corresponding author), Novartis Inst BioMed Res, Ctr Prote Chem, Cambridge, MA USA.	charlesr.dean@novartis.com		Wilson, Christopher/0000-0002-9146-522X; Whitehead, Lewis/0000-0002-6125-0893	NIBR; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	NIBR; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Funding of this research was provided solely within the Novartis organization as per standard research activities. The funders (NIBR) had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was assessed by the Novartis legal department as well as senior mangement in chemistry and biolgy (Infectious diseases and Global) to ascertain that release of this manuscript did not contravene Novartis policy regarding release of proprietary information, but this was limited only to approval for release of the material and was not related to the results or interpretations/conclusions contained in the manuscript.; We thank Frank Petersen, Jennifer Leeds and Vic E. Myer for their generous support of this project; Travis Stams, Rajiv Chopra and Jason Baird for their assistance with the structural biology effort; JoAnnDzink-Fox and Stacey Tiamfook for assistance with MICs; Silvio Roggo, Carl Balibar, David Six, David Parker, Andreas Katopodis, Sovanda Som and Greg Bebernitz for comments and helpful discussion; Keith Poole and Ian Chopra for bacterial strains. Use of the IMCA-CAT beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; ANGUS BL, 1987, J GEN MICROBIOL, V133, P2905; ANGUS BL, 1982, ANTIMICROB AGENTS CH, V21, P299, DOI 10.1128/AAC.21.2.299; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BODLEY JW, 1969, BIOCHEM BIOPH RES CO, V37, P437, DOI 10.1016/0006-291X(69)90934-6; Brachmann CB, 1998, YEAST, V14, P115; Bulow L, 2010, CHEMMEDCHEM, V5, P832, DOI 10.1002/cmdc.201000080; Caughlan RE, 2012, ANTIMICROB AGENTS CH, V56, P17, DOI 10.1128/AAC.05417-11; Chen Y, 2010, FEBS J, V277, P3789, DOI 10.1111/j.1742-4658.2010.07780.x; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrari P, 1996, J ANTIBIOT, V49, P150, DOI 10.7164/antibiotics.49.150; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Ley SV, 2002, ORG LETT, V4, P711, DOI 10.1021/ol017184m; Li W, 2011, PROTEINS, V79, P1478, DOI 10.1002/prot.22976; MASUDA N, 1992, ANTIMICROB AGENTS CH, V36, P1847, DOI 10.1128/AAC.36.9.1847; McConkey DJ, 2008, CANCER CELL, V14, P1, DOI 10.1016/j.ccr.2008.06.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Sasse F, 2002, J ANTIBIOT, V55, P543, DOI 10.7164/antibiotics.55.543; Selva E, 1996, J ANTIBIOT, V49, P145, DOI 10.7164/antibiotics.49.145; Seo HS, 2006, BIOCHEMISTRY-US, V45, P2504, DOI 10.1021/bi0516677; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Stauch B, 2010, ANGEW CHEM INT EDIT, V49, P3934, DOI 10.1002/anie.201000140; TANAKA N, 1968, BIOCHEM BIOPH RES CO, V30, P278, DOI 10.1016/0006-291X(68)90447-6; Vollbrecht L, 2002, J ANTIBIOT, V55, P715, DOI 10.7164/antibiotics.55.715; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773	34	33	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e42657	10.1371/journal.pone.0042657	http://dx.doi.org/10.1371/journal.pone.0042657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970117	Green Submitted, Green Published, gold			2022-12-25	WOS:000308748400003
J	Ditlev, SB; Nielsen, MA; Resende, M; Agerbaek, MO; Pinto, VV; Andersen, PH; Magistrado, P; Lusingu, J; Dahlback, M; Theander, TG; Salanti, A				Ditlev, Sisse B.; Nielsen, Morten A.; Resende, Mafalda; Agerbaek, Mette O.; Pinto, Vera V.; Andersen, Pernille H.; Magistrado, Pamela; Lusingu, John; Dahlback, Madeleine; Theander, Thor G.; Salanti, Ali			Identification and Characterization of B-Cell Epitopes in the DBL4 epsilon Domain of VAR2CSA	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PREGNANCY-ASSOCIATED MALARIA; CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM; ANTIBODIES; PROTEIN; ADHESION; VACCINE; SURFACE	Malaria during pregnancy in Plasmodium falciparum endemic regions is a major cause of mortality and severe morbidity. VAR2CSA is the parasite ligand responsible for sequestration of Plasmodium falciparum infected erythrocytes to the receptor chondroitin sulfate A (CSA) in the placenta and is the leading candidate for a placental malaria vaccine. Antibodies induced in rats against the recombinant DBL4 epsilon domain of VAR2CSA inhibit the binding of a number of laboratory and field parasite isolates to CSA. In this study, we used a DBL4 epsilon peptide-array to identify epitopes targeted by DBL4 epsilon-specific antibodies that inhibit CSA-binding of infected erythrocytes. We identified three regions of overlapping peptides which were highly antigenic. One peptide region distinguished itself particularly by showing a clear difference in the binding profile of highly parasite blocking IgG compared to the IgG with low capacity to inhibit parasite adhesion to CSA. This region was further characterized and together these results suggest that even though antibodies against the synthetic peptides which cover this region did not recognize native protein, the results using the mutant domain suggest that this linear epitope might be involved in the induction of inhibitory antibodies induced by the recombinant DBL4 epsilon domain.	[Ditlev, Sisse B.; Nielsen, Morten A.; Resende, Mafalda; Agerbaek, Mette O.; Pinto, Vera V.; Andersen, Pernille H.; Magistrado, Pamela; Dahlback, Madeleine; Theander, Thor G.; Salanti, Ali] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Ditlev, Sisse B.; Nielsen, Morten A.; Resende, Mafalda; Agerbaek, Mette O.; Pinto, Vera V.; Andersen, Pernille H.; Magistrado, Pamela; Dahlback, Madeleine; Theander, Thor G.; Salanti, Ali] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Magistrado, Pamela; Lusingu, John] Tanga Med Res Ctr, Natl Inst Med Res, Tanga, Tanzania	University of Copenhagen; Rigshospitalet; University of Copenhagen; National Institute of Medical Research	Ditlev, SB (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	salanti@sund.ku.dk	Theander, Thor/F-6714-2015; Lusingu, John P. A./GSJ-3228-2022	Theander, Thor/0000-0002-3509-7514; Salanti, Ali/0000-0003-2207-5575; Lusingu, John P. A./0000-0002-9407-0602; Nielsen, Morten Agertoug/0000-0003-2668-4992; Ditlev, Sisse Bolm/0000-0003-4417-9711; Agerbaek, Mette Orskov/0000-0001-5865-2034	Danish Research Council for Development Research (RUF); Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU	Danish Research Council for Development Research (RUF); Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU	SBD is supported by a PhD studentship from the Danish Research Council for Development Research (RUF). This study received funding from Danish National Advanced Technology Foundation and Proof of Concept Foundation DTU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Clausen TM, 2012, J BIOL CHEM, P18; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Pinto VV, 2012, VACCINE, V30, P572, DOI 10.1016/j.vaccine.2011.11.068; Pinto VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017942; Ricke CH, 2000, PLASMA ANTIBODIES MA; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012	23	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43663	10.1371/journal.pone.0043663	http://dx.doi.org/10.1371/journal.pone.0043663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970138	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400017
J	Kidd, TJ; Ritchie, SR; Ramsay, KA; Grimwood, K; Bell, SC; Rainey, PB				Kidd, Timothy J.; Ritchie, Stephen R.; Ramsay, Kay A.; Grimwood, Keith; Bell, Scott C.; Rainey, Paul B.			Pseudomonas aeruginosa Exhibits Frequent Recombination, but Only a Limited Association between Genotype and Ecological Setting	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; SEQUENCE; STRAINS; CLONE; VIRULENCE; ENVIRONMENT; INFECTIONS; EVOLUTION; EBURST	Pseudomonas aeruginosa is an opportunistic pathogen and an important cause of infection, particularly amongst cystic fibrosis (CF) patients. While specific strains capable of patient-to-patient transmission are known, many infections appear to be caused by unique and unrelated strains. There is a need to understand the relationship between strains capable of colonising the CF lung and the broader set of P. aeruginosa isolates found in natural environments. Here we report the results of a multilocus sequence typing (MLST)-based study designed to understand the genetic diversity and population structure of an extensive regional sample of P. aeruginosa isolates from South East Queensland, Australia. The analysis is based on 501 P. aeruginosa isolates obtained from environmental, animal and human (CF and non-CF) sources with particular emphasis on isolates from the Lower Brisbane River and isolates from CF patients obtained from the same geographical region. Overall, MLST identified 274 different sequence types, of which 53 were shared between one or more ecological settings. Our analysis revealed a limited association between genotype and environment and evidence of frequent recombination. We also found that genetic diversity of P. aeruginosa in Queensland, Australia was indistinguishable from that of the global P. aeruginosa population. Several CF strains were encountered frequently in multiple ecological settings; however, the most frequently encountered CF strains were confined to CF patients. Overall, our data confirm a non-clonal epidemic structure and indicate that most CF strains are a random sample of the broader P. aeruginosa population. The increased abundance of some CF strains in different geographical regions is a likely product of chance colonisation events followed by adaptation to the CF lung and horizontal transmission among patients.	[Kidd, Timothy J.; Ramsay, Kay A.; Grimwood, Keith; Bell, Scott C.] Univ Queensland, Royal Childrens Hosp, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Ritchie, Stephen R.; Rainey, Paul B.] Massey Univ Albany, New Zealand Inst Adv Study, Auckland, New Zealand; [Ritchie, Stephen R.; Rainey, Paul B.] Massey Univ Albany, Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand; [Bell, Scott C.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany	Royal Children's Hospital Brisbane; University of Queensland; Massey University; Massey University; Prince Charles Hospital; Max Planck Society	Kidd, TJ (corresponding author), Univ Queensland, Royal Childrens Hosp, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia.	Tim_Kidd@health.qld.gov.au	Rainey, Paul/A-3207-2008; Kidd, Timothy/F-2149-2010; Grimwood, Keith/F-9334-2011; Bell, Scott/AAJ-4298-2020; Bell, Scott C/A-7241-2011	Rainey, Paul/0000-0003-0879-5795; Kidd, Timothy/0000-0002-6135-6364; Bell, Scott/0000-0001-8651-7139; Bell, Scott C/0000-0001-8651-7139; Grimwood, Keith/0000-0003-3174-9834; Ritchie, Stephen/0000-0001-5001-8899	Australian Cystic Fibrosis Research Trust; National Health and Medical Research Council [455919]; Children's Health Foundation Queensland; Queensland Health Office of Health and Medical Research; Gerry Lawlor Memorial Scholarship; Prince Charles Hospital Foundation; Rotary Australia; Wellcome Trust	Australian Cystic Fibrosis Research Trust; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Children's Health Foundation Queensland; Queensland Health Office of Health and Medical Research; Gerry Lawlor Memorial Scholarship; Prince Charles Hospital Foundation; Rotary Australia; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Australian Cystic Fibrosis Research Trust, the National Health and Medical Research Council Project Grant 455919, The Children's Health Foundation Queensland, The Queensland Health Office of Health and Medical Research, the Gerry Lawlor Memorial Scholarship, The Prince Charles Hospital Foundation and Rotary Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the participants, research and clinical staff, and clinical microbiology laboratories at The Prince Charles Hospital, Royal Children's Hospital, Mater Adult Hospital, Mater Children's Hospital, and Gold Coast Hospital for the provision of clinical samples and CF isolates. We also thank staff from the Pathology Queensland Central Laboratory, Queensland Health Public Health Microbiology Laboratory, IDEXX Laboratories Pty. Ltd, The University of Queensland Diagnostic Laboratory, Professor Claire Wainwright and Ms Snehal Anuj for the environmental, animal and non-CF human isolates they contributed to the study. PBR is a James Cook Research Fellow and SCB is a Health Research Fellow (Office of Health and Medical Research, Queensland Health). This publication made use of the Pseudomonas aeruginosa PubMLST website (http://pubmlst.org/paeruginosa/) developed by Keith Jolley and sited at the University of Oxford [35]. The development of this site has been funded by the Wellcome Trust.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2012, PSEUDOMONAS AERUGINO; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Blondel-Hill E, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P734; CARSON LA, 1975, APPL MICROBIOL, V30, P935; CHAO A, 1984, SCAND J STAT, V11, P265; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Cramer N, 2010, INT J MED MICROBIOL, V300, P526, DOI 10.1016/j.ijmm.2010.08.004; Curran B, 2005, J CLIN MICROBIOL, V43, P5830, DOI 10.1128/JCM.43.11.5830-5831.2005; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Fothergill JL, 2012, EUR RESP J; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Garcia-Castillo M, 2011, J CLIN MICROBIOL, V49, P2905, DOI 10.1128/JCM.00753-11; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; Guttman D.S., 2010, BACTERIAL POPULATION, P121; Hardalo C, 1997, CRIT REV MICROBIOL, V23, P47, DOI 10.3109/10408419709115130; Johnson JK, 2007, J CLIN MICROBIOL, V45, P3707, DOI 10.1128/JCM.00560-07; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jones AM, 2005, AM J RESP CRIT CARE, V171, P257, DOI 10.1164/rccm.200404-513OC; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Khan NH, 2007, MICROB ECOL, V53, P173, DOI 10.1007/s00248-006-9059-3; Kidd TJ, 2011, VET MICROBIOL, V149, P508, DOI 10.1016/j.vetmic.2010.11.030; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Kidd TJ, 2009, J CLIN MICROBIOL, V47, P1503, DOI 10.1128/JCM.00014-09; Kidd TJ, 2010, RESPIROLOGY, V15, pA19; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; Lederberg Joshua, 2000, PSEUD ENCY MICR, V3, P876; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; McVean G, 2002, GENETICS, V160, P1231; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Naughton S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024526; Nemec A, 2010, RES MICROBIOL, V161, P234, DOI 10.1016/j.resmic.2010.02.002; Palleroni Norberto J., 2008, P1; Pier GB, 2005, MANDELL DOUGLAS BENN, V6th, P2587; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Regnath T, 2004, INT J HYG ENVIR HEAL, V207, P585, DOI 10.1078/1438-4639-00331; Remold SK, 2011, MICROB ECOL, V62, P505, DOI 10.1007/s00248-011-9844-5; Romling U, 2005, ENVIRON MICROBIOL, V7, P1029, DOI 10.1111/j.1462-2920.2005.00780.x; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Schelstraete P, 2008, EUR RESPIR J, V31, P822, DOI 10.1183/09031936.00088907; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Standards Australia, 2008, 4276132008 AS NZS; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tan MW, 2002, ANNU REV MICROBIOL, V56, P539, DOI 10.1146/annurev.micro.56.012302.161110; Tramper-Stranders GA, 2008, CLIN MICROBIOL INFEC, V14, P935, DOI 10.1111/j.1469-0691.2008.02054.x; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Waine DJ, 2009, J CLIN MICROBIOL, V47, P3444, DOI 10.1128/JCM.00459-09; Westman EL, 2010, PSEUDOMONAS, P443; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108	75	88	89	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44199	10.1371/journal.pone.0044199	http://dx.doi.org/10.1371/journal.pone.0044199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970178	gold, Green Published			2022-12-25	WOS:000308458400044
J	Ramli, NSK; Guan, CE; Nathan, S; Vadivelu, J				Ramli, Nur Siti K.; Guan, Chua Eng; Nathan, Sheila; Vadivelu, Jamuna			The Effect of Environmental Conditions on Biofilm Formation of Burkholderia pseudomallei Clinical Isolates	PLOS ONE			English	Article							LACTONE SIGNAL MOLECULES; SMALL-COLONY VARIANTS; IDENTIFICATION; SURVIVAL; ASSAY	Burkholderia pseudomallei, a Gram-negative saprophytic bacterium, is the causative agent of the potentially fatal melioidosis disease in humans. In this study, environmental parameters including temperature, nutrient content, pH and the presence of glucose were shown to play a role in in vitro biofilm formation by 28 B. pseudomallei clinical isolates, including four isolates with large colony variants (LCVs) and small colony variants (SCVs) morphotypes. Enhanced biofilm formation was observed when the isolates were tested in LB medium, at 30 degrees C, at pH 7.2, and in the presence of as little as 2 mM glucose respectively. It was also shown that all SVCs displayed significantly greater capacity to form biofilms than the corresponding LCVs when cultured in LB at 37 degrees C. In addition, octanoyl-homoserine lactone (C-8-HSL), a quorum sensing molecule, was identified by mass spectrometry analysis in bacterial isolates referred to as LCV CTH, LCV VIT, SCV TOM, SCV CTH, 1 and 3, and the presence of other AHL's with higher masses; decanoyl-homoserine lactone (C-10-HSL) and dodecanoyl-homoserine lactone (C-12-HSL) were also found in all tested strain in this study. Last but not least, we had successfully acquired two Bacillus sp. soil isolates, termed KW and SA respectively, which possessed strong AHLs degradation activity. Biofilm formation of B. pseudomallei isolates was significantly decreased after treated with culture supernatants of KW and SA strains, demonstrating that AHLs may play a role in B. pseudomallei biofilm formation.	[Ramli, Nur Siti K.; Guan, Chua Eng; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Nathan, Sheila] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor, Malaysia	Universiti Malaya; Universiti Kebangsaan Malaysia	Ramli, NSK (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Nathan, Sheila/C-1182-2011; VADIVELU, JAMUNARANI S/B-8696-2010; Chua, Eng Guan/W-3023-2019	Nathan, Sheila/0000-0002-2132-2346; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Chua, Eng Guan/0000-0002-1508-5284	Ministry of Science, Technology and Innovation, Malaysia (IRPA) [06-02-03-1002]; University of Malaya (PPP) [PS202/2010A]; Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project [E000013-20001]	Ministry of Science, Technology and Innovation, Malaysia (IRPA)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); University of Malaya (PPP)(Universiti Malaya); Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project	This work was supported by the Ministry of Science, Technology and Innovation, Malaysia (IRPA grant 06-02-03-1002), University of Malaya (PPP grant (PS202/2010A)) and Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project (E000013-20001). The authors would like to acknowledge Prof. Shamala Devi Sekaran (University of Malaya) for providing us C. violaceum CV026 strain in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SW, 2007, J CLIN MICROBIOL, V45, P529, DOI 10.1128/JCM.01444-06; Boddey JA, 2006, INFECT IMMUN, V74, P5374, DOI 10.1128/IAI.00569-06; BRENNER S, 1974, GENETICS, V77, P71; Cano DA, 2003, INFECT IMMUN, V71, P3690, DOI 10.1128/IAI.71.7.3690-3698.2003; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Coil DA, 2009, FEMS MICROBIOL LETT, V293, P271, DOI 10.1111/j.1574-6968.2009.01532.x; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Dance D. A. B., 1990, Reviews in Medical Microbiology, V1, P143; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Di Bonaventura G, 2007, FOLIA MICROBIOL, V52, P86, DOI 10.1007/BF02932144; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gan Chan K, 2007, ASIA PAC J MOL BIOL, V15, P153; Harrison JJ, 2005, AM SCI, V93, P508, DOI 10.1511/2005.6.508; Haubler S, 2003, EUR J CLIN MICROBIOL, V22, P249; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; HIRSCH HM, 1961, J BACTERIOL, V81, P448, DOI 10.1128/JB.81.3.448-458.1961; Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Lee SH, 2007, DIAGN MICR INFEC DIS, V58, P263, DOI 10.1016/j.diagmicrobio.2007.01.002; Lopresti AEE, 2005, INFECT IMMUN, V73, P1260; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Puthucheary S D, 2009, Med J Malaysia, V64, P266; Samuelsen O, 2005, J ANTIMICROB CHEMOTH, V56, P1126, DOI 10.1093/jac/dki385; Savoia D, 2007, CURR MICROBIOL, V54, P440, DOI 10.1007/s00284-006-0601-9; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Suppiah J, 2010, FEMS MICROBIOL LETT, V306, P9, DOI 10.1111/j.1574-6968.2010.01923.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Vivas J, 2008, VET MICROBIOL, V129, P150, DOI 10.1016/j.vetmic.2007.11.007	38	48	48	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44104	10.1371/journal.pone.0044104	http://dx.doi.org/10.1371/journal.pone.0044104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970167	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400036
J	Arsenovic, PT; Maldonado, AT; Colleluori, VD; Bloss, TA				Arsenovic, Paul T.; Maldonado, Anthony T.; Colleluori, Vaughn D.; Bloss, Tim A.			Depletion of the C. elegans NAC Engages the Unfolded Protein Response, Resulting in Increased Chaperone Expression and Apoptosis	PLOS ONE			English	Article							POLYPEPTIDE-ASSOCIATED COMPLEX; NEMATODE CAENORHABDITIS-ELEGANS; RIBOSOME-ASSOCIATED CHAPERONES; ENDOPLASMIC-RETICULUM STRESS; HEAT-SHOCK FACTOR; ER STRESS; BETA-NAC; YEAST; PROTEOSTASIS; LIPOFUSCIN	The nascent polypeptide-associated complex (NAC) is a highly conserved heterodimer important for metazoan development, but its molecular function is not well understood. Recent evidence suggests the NAC is a component of the cytosolic chaperone network that interacts with ribosomal complexes and their emerging nascent peptides, such that the loss of the NAC in chaperone-depleted cells results in an increase in misfolded protein stress. We tested whether the NAC functions similarly in Caeonorhabditis (C.) elegans and found that its homologous NAC subunits, i.e. ICD-1 and -2, have chaperone-like characteristics. Loss of the NAC appears to induce misfolded protein stress in the ER triggering the unfolded protein response (UPR). Depletion of the NAC altered the response to heat stress, and led to an up-regulation of hsp-4, a homologue of the human chaperone and ER stress sensor GRP78/BiP. Worms lacking both ICD-1 and the UPR transcription factor XBP-1 generated a higher proportion of defective embryos, showed increased embryonic apoptosis and had a diminished survival rate relative to ICD-1-depleted animals with an intact UPR. Up-regulation of hsp-4 in NAC-depleted animals was specific to certain regions of the embryo; in embryos lacking ICD-1, the posterior region of the embryo showed strong up-regulation of hsp-4, while the anterior region did not. Furthermore, loss of ICD-1 produced prominent lysosomes in the gut region of adults and embryos putatively containing lipofuscins, lipid/protein aggregates associated with cellular aging. These results are the first set of evidence consistent with a role for C. elegans NAC in protein folding and localization during translation. Further, these findings confirm C. elegans as a valuable model for studying organismal and cell-type specific responses to misfolded protein stress.	[Arsenovic, Paul T.; Maldonado, Anthony T.; Colleluori, Vaughn D.; Bloss, Tim A.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	James Madison University	Arsenovic, PT (corresponding author), James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA.	blossta@jmu.edu			NIH Office of the Director; Jeffress Memorial Trust [J-925]; James Madison University	NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jeffress Memorial Trust; James Madison University	We would like to thank Alex Bannigan at James Madison University and Ammasi Periasamy at the W.M. Keck Center for Cellular Imaging at the University of Virginia for their help with microscopy; Ann Rougvie and Aric Daul for the C. elegans strains provided by the Caenorhabditis Genetics Center, funded by the NIH Office of the Director; Kim Slekar and Caylin Murray for comments on the manuscript; members of the Bloss and Slekar labs for discussions, and Robert Rotzin for technical support.; The research presented in this manuscript was funded by a grant from the Jeffress Memorial Trust (grant number J-925), and start-up funding from James Madison University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Chin-Sang ID, 2000, TRENDS GENET, V16, P544, DOI 10.1016/S0168-9525(00)02143-0; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Franke J, 2001, J CELL SCI, V114, P2641; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kapulkin V, 2005, FEBS LETT, V579, P3063, DOI 10.1016/j.febslet.2005.04.062; Kern A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008568; Kim SH, 2002, J INVEST MED, V50, P293, DOI 10.2310/6650.2002.33287; Kimura K, 2007, J BIOL CHEM, V282, P5910, DOI 10.1074/jbc.M609025200; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Ledwich D, 2000, METHOD ENZYMOL, V322, P76; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Markesich DC, 2000, DEVELOPMENT, V127, P559; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Waldmeier PC, 2003, PROG NEURO-PSYCHOPH, V27, P303, DOI 10.1016/S0278-5846(03)00025-3; Walker GA, 2003, FASEB J, V17, P1960, DOI 10.1096/fj.03-0164fje; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	45	26	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44038	10.1371/journal.pone.0044038	http://dx.doi.org/10.1371/journal.pone.0044038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957041	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800033
J	Gettler, LT; McKenna, JJ; McDade, TW; Agustin, SS; Kuzawa, CW				Gettler, Lee T.; McKenna, James J.; McDade, Thomas W.; Agustin, Sonny S.; Kuzawa, Christopher W.			Does Cosleeping Contribute to Lower Testosterone Levels in Fathers? Evidence from the Philippines	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; SALIVARY TESTOSTERONE; SENSATION-SEEKING; SLEEPING ARRANGEMENTS; LIFE-HISTORY; RISK-TAKING; MATO-GROSSO; MEN; BEHAVIOR; HORMONES	Because cross-species evidence suggests that high testosterone (T) may interfere with paternal investment, the relationships between men's transition to parenting and changes in their T are of growing interest. Studies of human males suggest that fathers who provide childcare often have lower T than uninvolved fathers, but no studies to date have evaluated how nighttime sleep proximity between fathers and their offspring may affect T. Using data collected in 2005 and 2009 from a sample of men (n = 362; age 26.0 +/- 6 0.3 years in 2009) residing in metropolitan Cebu, Philippines, we evaluated fathers' T based on whether they slept on the same surface as their children (same surface cosleepers), slept on a different surface but in the same room (roomsharers), or slept separately from their children (solitary sleepers). A large majority (92%) of fathers in this sample reported practicing same surface cosleeping. Compared to fathers who slept solitarily, same surface cosleeping fathers had significantly lower evening (PM) T and also showed a greater diurnal decline in T from waking to evening (both p<0.05). Among men who were not fathers at baseline (2005), fathers who were cosleepers at follow-up (2009) experienced a significantly greater longitudinal decline in PM T over the 4.5-year study period (p<0.01) compared to solitary sleeping fathers. Among these same men, baseline T did not predict fathers' sleeping arrangements at follow-up (p>0.2). These results are consistent with previous findings indicating that daytime father-child interaction contributes to lower T among fathers. Our findings specifically suggest that close sleep proximity between fathers and their offspring results in greater longitudinal decreases in T as men transition to fatherhood and lower PM T overall compared to solitary sleeping fathers.	[Gettler, Lee T.; McKenna, James J.] Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA; [Gettler, Lee T.; McDade, Thomas W.; Kuzawa, Christopher W.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Gettler, Lee T.; McDade, Thomas W.; Kuzawa, Christopher W.] Northwestern Univ, Inst Policy Res, Cells Soc Ctr Social Dispar & Hlth C2S, Evanston, IL USA; [Agustin, Sonny S.] Univ San Carlos, Off Populat Studies Fdn, Cebu, Philippines	University of Notre Dame; Northwestern University; Northwestern University; University of San Carlos	Gettler, LT (corresponding author), Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA.	lgettler@nd.edu		Gettler, Lee/0000-0001-7325-8852	Wenner Gren Foundation [7356, 8186]; National Science Foundation [BCS-0542182, BCS-0962212]; Interdisciplinary Obesity Center [RR20649]; Center for Environmental Health and Susceptibility [ES10126, 7-2004-E]; National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Wenner Gren Foundation; National Science Foundation(National Science Foundation (NSF)); Interdisciplinary Obesity Center; Center for Environmental Health and Susceptibility; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Wenner Gren Foundation (Gr. 7356; Gr. 8186), National Science Foundation (BCS-0542182; BCS-0962212), The Interdisciplinary Obesity Center (RR20649), and The Center for Environmental Health and Susceptibility (ES10126; project 7-2004-E). LTG was supported by a National Science Foundation Graduate Research Fellowship during write-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Alvergne A, 2010, PERS INDIV DIFFER, V49, P840, DOI 10.1016/j.paid.2010.07.006; Alvergne A, 2009, HORM BEHAV, V56, P491, DOI 10.1016/j.yhbeh.2009.07.013; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Baddock SA, 2007, PEDIATRICS, V119, pE200, DOI 10.1542/peds.2006-0744; Ball H, 2006, HUM NATURE-INT BIOS, V17, P301, DOI 10.1007/s12110-006-1011-1; Ball HL, 2003, BIRTH-ISS PERINAT C, V30, P181, DOI 10.1046/j.1523-536X.2003.00243.x; Ball HL, 1999, AM ANTHROPOL, V101, P143, DOI 10.1525/aa.1999.101.1.143; Ball HL, 2000, INFANT CHILD DEV, V9, P67, DOI 10.1002/1522-7219(200006)9:2<67::AID-ICD209>3.3.CO;2-Z; BARRY H, 1971, ETHNOLOGY, V10, P466; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; BOOTH A, 1993, SOC FORCES, V72, P463, DOI 10.2307/2579857; Bribiescas RG, 2001, YEARB PHYS ANTHROPOL, V44, P148, DOI 10.1002/ajpa.10025; Burnham TC, 2003, HORM BEHAV, V44, P119, DOI 10.1016/S0018-506X(03)00125-9; CARPENTER RG, 2006, PAEDIAT CHILD HLT SA, V11, pA24; Carroll-Pankhurst C, 2001, PEDIATRICS, V107, P530, DOI 10.1542/peds.107.3.530; Chiocchio SR, 1999, ENDOCRINOLOGY, V140, P1036, DOI 10.1210/en.140.3.1036; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DABBS JM, 1990, PHYSIOL BEHAV, V48, P83, DOI 10.1016/0031-9384(90)90265-6; DABBS JM, 1990, PSYCHOL SCI, V1, P209, DOI 10.1111/j.1467-9280.1990.tb00200.x; DAITZMAN R, 1980, PERS INDIV DIFFER, V1, P103, DOI 10.1016/0191-8869(80)90027-6; Drago DA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e59; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Edelstein RS, 2010, HORM BEHAV, V57, P230, DOI 10.1016/j.yhbeh.2009.11.007; Ellison P.T., 2001, FERTILE GROUND NATUR; Escasa MJ, 2011, ARCH SEX BEHAV, V40, P921, DOI 10.1007/s10508-010-9711-3; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; Flinn M, HUMAN NATURE, V23, P68; Flouri E, 2005, FATHERING AND CHILD OUTCOMES, P1, DOI 10.1002/9780470713228; Germo GR, 2007, INFANT CHILD DEV, V16, P433, DOI 10.1002/icd.521; Gerra G, 1999, NEUROPSYCHOBIOLOGY, V39, P207, DOI 10.1159/000026586; Gettler LT, 2011, HORM BEHAV, V60, P599, DOI 10.1016/j.yhbeh.2011.08.009; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; Gettler LT, 2011, AM J HUM BIOL, V23, P609, DOI 10.1002/ajhb.21187; Gettler LT, 2010, CURR PEDIATR REV, V6, P71, DOI 10.2174/157339610791317250; Gettler LT, 2010, AM J PHYS ANTHROPOL, V142, P590, DOI 10.1002/ajpa.21282; Gettler LT, 2010, AM ANTHROPOL, V112, P7, DOI 10.1111/j.1548-1433.2009.01193.x; Gnessi L, 1997, ENDOCR REV, V18, P541, DOI 10.1210/er.18.4.541; Goudriaan AE, 2010, PSYCHONEUROENDOCRINO, V35, P1416, DOI 10.1016/j.psyneuen.2010.04.005; Gray PB, 2007, HORM BEHAV, V52, P499, DOI 10.1016/j.yhbeh.2007.07.005; Gray PB, 2006, P ROY SOC B-BIOL SCI, V273, P333, DOI 10.1098/rspb.2005.3311; Gray PB, 2004, PSYCHONEUROENDOCRINO, V29, P1153, DOI 10.1016/j.psyneuen.2004.01.008; Gray PB, 2003, AM J PHYS ANTHROPOL, V122, P279, DOI 10.1002/ajpa.10293; Gray Peter B., 2010, FATHERHOOD EVOLUTION; Griffin P. B., 1992, FATHER CHILD RELATIO, P297; Guthrie G., 1966, CHILD REARING PERSON; HART BL, 1974, PSYCHOL BULL, V81, P383, DOI 10.1037/h0036568; Hauck FR, 2008, PEDIATRICS, V122, pS113, DOI 10.1542/peds.2008-1315o; HELLHAMMER DH, 1985, PSYCHONEUROENDOCRINO, V10, P77, DOI 10.1016/0306-4530(85)90041-1; Jenni OG, 2005, PEDIATRICS, V115, P204, DOI 10.1542/peds.2004-0815B; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KLACKENBERG G, 1982, ACTA PAEDIATR SCAND, V71, P501, DOI 10.1111/j.1651-2227.1982.tb09459.x; Kleiman D.G., 1981, P347; Kuzawa CW, 2009, HORM BEHAV, V56, P429, DOI 10.1016/j.yhbeh.2009.07.010; Lamb M. E., 2004, ROLE FATHER CHILD DE, V4th; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Leproult R, 2011, JAMA-J AM MED ASSOC, V305, P2173, DOI 10.1001/jama.2011.710; Liening SH, 2010, PHYSIOL BEHAV, V99, P8, DOI 10.1016/j.physbeh.2009.10.001; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Luboshitzky R, 2001, J CLIN ENDOCR METAB, V86, P1134, DOI 10.1210/jc.86.3.1134; McGarvey C, 2006, ARCH DIS CHILD, V91, P318, DOI 10.1136/adc.2005.074674; McKenna JJ, 2007, YEARB PHYS ANTHROPOL, V50, P133, DOI 10.1002/ajpa.20736; MCKENNA JJ, 1993, SLEEP, V16, P263, DOI 10.1093/sleep/16.3.263; Messmer RL, 2009, RELATIONSHIP PARENT; Mindell JA, 2010, SLEEP MED, V11, P274, DOI 10.1016/j.sleep.2009.04.012; Mitchell EA, 2009, ACTA PAEDIATR, V98, P1712, DOI 10.1111/j.1651-2227.2009.01503.x; MORELLI GA, 1992, DEV PSYCHOL, V28, P604, DOI 10.1037/0012-1649.28.4.604; Muller MN, 2009, P ROY SOC B-BIOL SCI, V276, P347, DOI 10.1098/rspb.2008.1028; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Perini T, 2012, HORM BEHAV, V61, P191, DOI 10.1016/j.yhbeh.2011.12.004; Pollet TV, 2011, HORM BEHAV, V60, P72, DOI 10.1016/j.yhbeh.2011.03.005; Raouf SA, 1997, P ROY SOC B-BIOL SCI, V264, P1599, DOI 10.1098/rspb.1997.0223; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Reimao R, 1999, ARQ NEURO-PSIQUIAT, V57, P556, DOI 10.1590/S0004-282X1999000400003; Reimao R, 1998, ARQ NEURO-PSIQUIAT, V56, P703, DOI 10.1590/S0004-282X1998000500001; Rigda RS, 2000, J PAEDIATR CHILD H, V36, P117, DOI 10.1046/j.1440-1754.2000.00468.x; Ronay R, 2010, SOC PSYCHOL PERS SCI, V1, P57, DOI 10.1177/1948550609352807; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Sellers JG, 2007, J RES PERS, V41, P126, DOI 10.1016/j.jrp.2006.02.004; Smart J, 2007, J PAEDIATR CHILD H, V43, P293, DOI 10.1111/j.1440-1754.2007.01060.x; SPRATT DI, 1988, AM J PHYSIOL, V254, pE658, DOI 10.1152/ajpendo.1988.254.5.E658; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Storey AE, 2011, HORM BEHAV, V60, P353, DOI 10.1016/j.yhbeh.2011.07.001; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; Suay F, 1999, PSYCHONEUROENDOCRINO, V24, P551, DOI 10.1016/S0306-4530(99)00011-6; TOUITOU Y, 1990, EUR J APPL PHYSIOL O, V60, P288, DOI 10.1007/BF00379398; Trivers RL., 1972, SEXUAL SELECTION DES; Trumble BC, 2011, AM J HUM BIOL, V23, P281; Trumble BC, P R SOC B IN PRESS; van Anders SM, HORM BEHAV IN PRESS, V61, P31; Veldhuis JD, 2004, J CLIN ENDOCR METAB, V89, P4474, DOI 10.1210/jc.2004-0203; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P762, DOI 10.1002/ajhb.20927; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; ZOHOORI N, 1993, J BIOSOC SCI, V25, P127, DOI 10.1017/S002193200002037X	95	54	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41559	10.1371/journal.pone.0041559	http://dx.doi.org/10.1371/journal.pone.0041559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001MC	22957016	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800008
J	Mena, S; Rodriguez, ML; Ponsoda, X; Estrela, JM; Jaattela, M; Ortega, AL				Mena, Salvador; Rodriguez, Maria L.; Ponsoda, Xavier; Estrela, Jose M.; Jaattela, Marja; Ortega, Angel L.			Pterostilbene-Induced Tumor Cytotoxicity: A Lysosomal Membrane Permeabilization-Dependent Mechanism	PLOS ONE			English	Article							INDUCED CELL-DEATH; CANCER-CELLS; B16 MELANOMA; DOWN-REGULATION; CATHEPSIN-D; RESVERATROL; AUTOPHAGY; APOPTOSIS; THERAPY; ARREST	The phenolic phytoalexin resveratrol is well known for its health-promoting and anticancer properties. Its potential benefits are, however, limited due to its low bioavailability. Pterostilbene, a natural dimethoxylated analog of resveratrol, presents higher anticancer activity than resveratrol. The mechanisms by which this polyphenol acts against cancer cells are, however, unclear. Here, we show that pterostilbene effectively inhibits cancer cell growth and stimulates apoptosis and autophagosome accumulation in cancer cells of various origins. However, these mechanisms are not determinant in cell demise. Pterostilbene promotes cancer cell death via a mechanism involving lysosomal membrane permeabilization. Different grades of susceptibility were observed among the different cancer cells depending on their lysosomal heat shock protein 70 (HSP70) content, a known stabilizer of lysosomal membranes. A375 melanoma and A549 lung cancer cells with low levels of HSP70 showed high susceptibility to pterostilbene, whereas HT29 colon and MCF7 breast cancer cells with higher levels of HSP70 were more resistant. Inhibition of HSP70 expression increased susceptibility of HT29 colon and MCF7 breast cancer cells to pterostilbene. Our data indicate that lysosomal membrane permeabilization is the main cell death pathway triggered by pterostilbene.	[Mena, Salvador; Estrela, Jose M.; Ortega, Angel L.] Green Mol, Valencia, Spain; [Rodriguez, Maria L.; Estrela, Jose M.; Ortega, Angel L.] Univ Valencia, Dept Physiol, E-46100 Burjassot, Spain; [Ponsoda, Xavier] Univ Valencia, Dept Cell Biol, E-46100 Burjassot, Spain; [Jaattela, Marja] Danish Canc Soc, Inst Canc Biol, Apoptosis Dept, Copenhagen, Denmark; [Jaattela, Marja] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Response, Copenhagen, Denmark	University of Valencia; University of Valencia; Danish Cancer Society; Danish Cancer Society	Mena, S (corresponding author), Green Mol, Valencia, Spain.	angel.ortega@uv.es	Ponsoda, Xavier/L-8272-2014; Mena, Salvador/F-6696-2016; Rodriguez, Maria/A-8510-2016; Jäättelä, Marja/AAT-7932-2021; Estrela, Jose/H-4449-2015; Mena, Salvador/L-8780-2014; Ortega, Angel L./A-4113-2014	Ponsoda, Xavier/0000-0002-4051-4458; Jäättelä, Marja/0000-0001-5950-7111; Estrela, Jose/0000-0002-2540-9190; Mena, Salvador/0000-0002-6423-4741; Ortega, Angel L./0000-0002-9901-3383	MICINN [JC2008-00282, SAF2009-07729, IPT-010000-2010-21]; GV-Conselleria d'Educacio [GVPRE/2008/272]; Danish Cancer Society; Danish Medical Council; Danish National Research Foundation	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); GV-Conselleria d'Educacio; Danish Cancer Society(Danish Cancer Society); Danish Medical Council(Danish Medical Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond)	This research was supported by grants from the MICINN (JC2008-00282 ALO SAF2009-07729 and IPT- 010000-2010-21 to JME), the GV-Conselleria d'Educacio (GVPRE/2008/272 to ALO), the Danish Cancer Society (to MJ), the Danish Medical Council (to MJ) and the Danish National Research Foundation (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Ahmad N, 2001, CLIN CANCER RES, V7, P1466; [Anonymous], 2010, ALTERN MED REV, V15, P159; Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Asensi M, 2011, CRIT REV CL LAB SCI, V48, P197, DOI 10.3109/10408363.2011.631268; Bernhard D, 2000, CELL DEATH DIFFER, V7, P834, DOI 10.1038/sj.cdd.4400719; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chen RJ, 2010, MOL NUTR FOOD RES, V54, P1819, DOI 10.1002/mnfr.201000067; Cui J, 2010, PHYTOTHER RES, V24, P1637, DOI 10.1002/ptr.3157; Davalli P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/984219; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Ferrer P, 2005, NEOPLASIA, V7, P37, DOI 10.1593/neo.04337; Ferrer P, 2007, J BIOL CHEM, V282, P2880, DOI 10.1074/jbc.M605934200; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; Gassmann P, 2008, CLIN EXP METASTAS, V25, P171, DOI 10.1007/s10585-007-9130-6; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kagedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje; Kairisalo M, 2011, NEUROSCI LETT, V488, P263, DOI 10.1016/j.neulet.2010.11.042; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mannal PW, 2010, J GASTROINTEST SURG, V14, P873, DOI 10.1007/s11605-010-1164-4; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Ortega A, 2003, J BIOL CHEM, V278, P39591, DOI 10.1074/jbc.M303753200; Ostenfeld MS, 2008, AUTOPHAGY, V4, P487, DOI 10.4161/auto.5774; Pan MH, 2007, J AGR FOOD CHEM, V55, P7777, DOI 10.1021/jf071520h; Priego S, 2008, MOL CANCER THER, V7, P3330, DOI 10.1158/1535-7163.MCT-08-0363; PUNNONEN EL, 1990, EXP MOL PATHOL, V52, P87, DOI 10.1016/0014-4800(90)90061-H; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Ruiz MJ, 2009, J AGR FOOD CHEM, V57, P3180, DOI 10.1021/jf803579e; Schneider JG, 2010, J SURG RES, V161, P18, DOI 10.1016/j.jss.2009.06.027; Schneider Y, 2003, INT J CANCER, V107, P189, DOI 10.1002/ijc.11344; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Trincheri NF, 2007, CARCINOGENESIS, V28, P922, DOI 10.1093/carcin/bgl223; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Wang YS, 2012, AM J TRANSL RES, V4, P44; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663	55	76	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44524	10.1371/journal.pone.0044524	http://dx.doi.org/10.1371/journal.pone.0044524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957077	Green Published, Green Submitted, gold			2022-12-25	WOS:000308463800070
J	Kwong, JC; Ratnasingham, S; Campitelli, MA; Daneman, N; Deeks, SL; Manuel, DG; Allen, VG; Bayoumi, AM; Fazil, A; Fisman, DN; Gershon, AS; Gournis, E; Heathcote, EJ; Jamieson, FB; Jha, P; Khan, KM; Majowicz, SE; Mazzulli, T; McGeer, AJ; Muller, MP; Raut, A; Rea, E; Remis, RS; Shahin, R; Wright, AJ; Zagorski, B; Crowcroft, NS				Kwong, Jeffrey C.; Ratnasingham, Sujitha; Campitelli, Michael A.; Daneman, Nick; Deeks, Shelley L.; Manuel, Douglas G.; Allen, Vanessa G.; Bayoumi, Ahmed M.; Fazil, Aamir; Fisman, David N.; Gershon, Andrea S.; Gournis, Effie; Heathcote, E. Jenny; Jamieson, Frances B.; Jha, Prabhat; Khan, Kamran M.; Majowicz, Shannon E.; Mazzulli, Tony; McGeer, Allison J.; Muller, Matthew P.; Raut, Abhishek; Rea, Elizabeth; Remis, Robert S.; Shahin, Rita; Wright, Alissa J.; Zagorski, Brandon; Crowcroft, Natasha S.			The Impact of Infection on Population Health: Results of the Ontario Burden of Infectious Diseases Study	PLOS ONE			English	Article							VIRUS; CANADA; CANCER; DALYS; HIV	Background: Evidence-based priority setting is increasingly important for rationally distributing scarce health resources and for guiding future health research. We sought to quantify the contribution of a wide range of infectious diseases to the overall infectious disease burden in a high-income setting. Methodology/Principal Findings: We used health-adjusted life years (HALYs), a composite measure comprising premature mortality and reduced functioning due to disease, to estimate the burden of 51 infectious diseases and associated syndromes in Ontario using 2005-2007 data. Deaths were estimated from vital statistics data and disease incidence was estimated from reportable disease, healthcare utilization, and cancer registry data, supplemented by local modeling studies and national and international epidemiologic studies. The 51 infectious agents and associated syndromes accounted for 729 lost HALYs, 44.2 deaths, and 58,987 incident cases per 100,000 population annually. The most burdensome infectious agents were: hepatitis C virus, Streptococcus pneumoniae, Escherichia coli, human papillomavirus, hepatitis B virus, human immunodeficiency virus, Staphylococcus aureus, influenza virus, Clostridium difficile, and rhinovirus. The top five, ten, and 20 pathogens accounted for 46%, 67%, and 75% of the total infectious disease burden, respectively. Marked sex-specific differences in disease burden were observed for some pathogens. The main limitations of this study were the exclusion of certain infectious diseases due to data availability issues, not considering the impact of co-infections and co-morbidity, and the inability to assess the burden of milder infections that do not result in healthcare utilization. Conclusions/Significance: Infectious diseases continue to cause a substantial health burden in high-income settings such as Ontario. Most of this burden is attributable to a relatively small number of infectious agents, for which many effective interventions have been previously identified. Therefore, these findings should be used to guide public health policy, planning, and research.	[Kwong, Jeffrey C.; Ratnasingham, Sujitha; Campitelli, Michael A.; Daneman, Nick; Manuel, Douglas G.; Bayoumi, Ahmed M.; Gershon, Andrea S.; Zagorski, Brandon] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.; Deeks, Shelley L.; Allen, Vanessa G.; Jamieson, Frances B.; Mazzulli, Tony; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada; [Kwong, Jeffrey C.; Deeks, Shelley L.; Fisman, David N.; Gournis, Effie; Jha, Prabhat; McGeer, Allison J.; Raut, Abhishek; Rea, Elizabeth; Remis, Robert S.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Bayoumi, Ahmed M.; Khan, Kamran M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Allen, Vanessa G.; Jamieson, Frances B.; Mazzulli, Tony; McGeer, Allison J.; Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Bayoumi, Ahmed M.; Heathcote, E. Jenny; Khan, Kamran M.; Mazzulli, Tony; Muller, Matthew P.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Jha, Prabhat] St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.; Khan, Kamran M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Gournis, Effie; Rea, Elizabeth; Shahin, Rita] Toronto Publ Hlth, Toronto, ON, Canada; [Manuel, Douglas G.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Majowicz, Shannon E.] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada; [Majowicz, Shannon E.] Univ Waterloo, Dept Hlth Studies & Gerontol, Waterloo, ON N2L 3G1, Canada; [Fazil, Aamir] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Wright, Alissa J.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Guelph; University of Waterloo; Public Health Agency of Canada; University of British Columbia	Kwong, JC (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	jeff.kwong@utoronto.ca	McGeer, Allison/AAB-6885-2020; Allen, Vanessa/AAE-2756-2022; Jamieson, Frances/B-2040-2013; mcgeer, allison/H-7747-2014; Manuel, Doug/D-7100-2014	McGeer, Allison/0000-0001-5647-6137; Allen, Vanessa/0000-0001-9802-9730; mcgeer, allison/0000-0001-5647-6137; Jha, Prabhat/0000-0001-7067-8341; Manuel, Doug/0000-0003-0912-0845; Majowicz, Shannon/0000-0002-0006-8369	Public Health Ontario (PHO); Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); MOHLTC; University of Toronto Department of Family and Community Medicine Clinician Scientist Award; Canadian Institutes of Health Research (CIHR); CIHR/Ontario MOHLTC Applied Chair in Health Services and Policy Research; Public Health Agency of Canada; Novartis; Sanofi-Pasteur; GlaxoSmithKline	Public Health Ontario (PHO); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); MOHLTC(Ministry of Health and Long-Term Care, Ontario); University of Toronto Department of Family and Community Medicine Clinician Scientist Award; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Ontario MOHLTC Applied Chair in Health Services and Policy Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Novartis(Novartis); Sanofi-Pasteur; GlaxoSmithKline(GlaxoSmithKline)	This study was funded by Public Health Ontario (PHO) and was supported by the Institute for Clinical Evaluative Sciences (ICES), both of which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). JCK was supported by a MOHLTC Career Scientist Award and a University of Toronto Department of Family and Community Medicine Clinician Scientist Award. ND was supported by a Canadian Institutes of Health Research (CIHR) Clinician Scientist Award. AMB was supported by a CIHR/Ontario MOHLTC Applied Chair in Health Services and Policy Research. KMK was supported by a CIHR New Investigator Award. DGM was supported by a Chair in Applied Public Health from the CIHR and the Public Health Agency of Canada. The study sponsors were involved in the conception and design of the study, data interpretation, revision of the paper for important intellectual content, and the decision to publish.r The authors have read the journal's policy and the following authors wish to report these potential conflicts. DNF has previously received research funding and/or served as a consultant to Novartis, Sanofi-Pasteur, and GlaxoSmithKline on issues related to vaccination. AJM has received research honoraria from Gilead Biosciences, Hoffman-Laroche, GlaxoSmithKline, Pfizer, Merck, Sanofi-Pasteur, and Wyeth. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The remaining authors declare that they have no conflict of interest.	Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; [Anonymous], 1996, PATTERNS HLTH CARE O; Barendregt JJ, 1996, B WORLD HEALTH ORGAN, V74, P439; Bonneux L, 2001, J EPIDEMIOL COMMUN H, V55, P123, DOI 10.1136/jech.55.2.123; CBC News, 2009, CBC NEWS; CBC News, 2006, CBC NEWS; Chan B., 1999, SUPPLY PHYS SERVICES; Chan B., 2005, SUPPLY UTILIZATION G; COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567; Evans WK, 2005, HLTH STATE DESCRIPTI; Flanagan W, 2005, POPUL HEALTH METR, V3, P5; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Goodin R. E., 1982, J PUBLIC POLICY, V2, P53; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Improving health care data in Ontario, 2005, IMPR HLTH CAR DAT ON; Juurlink D, 2006, CANADIAN I HLTH INFO; Kliewer EV, 2009, SEX TRANSM DIS, V36, P380, DOI 10.1097/OLQ.0b013e318198de8c; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mathers C., 1999, BURDEN DIS INJURY AU; McIntosh Cameron N, 2007, Chronic Dis Can, V28, P29; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Naylor CD, 1999, CARDIOVASCULAR HLTH; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Public Health Agency of Canada, 2006, I TRACK ENH SURV RIS; Public Health Agency of Canada, 2006, POP HLTH IMP DIS CAN; Public Health Group Rural and Regional Health and Aged Care Services Division, 2005, VICT BURD DIS STUD M; Remis R, 2008, MODELLING INCIDENCE; Remis RS, 2010, REPORT HIV AIDS ONTA; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Statistics Canada, 2007, ONT 2006 COMM PROF 2; Statistics Canada, 2009, PLAC BIRTH IMM POP P; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Thomas M Kate, 2006, Can J Infect Dis Med Microbiol, V17, P229; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; van Lier E A, 2007, Euro Surveill, V12, pE3; World Health Organization, 2010, SUMM PROB SARS CAS O; World Health Organization, 2011, MEASL OUTBR EUR; Yang HI, 2010, J CLIN ONCOL, V28, P2437, DOI 10.1200/JCO.2009.27.4456; Yang QY, 2010, CAN J PUBLIC HEALTH, V101, P486, DOI 10.1007/BF03403969	41	80	80	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44103	10.1371/journal.pone.0044103	http://dx.doi.org/10.1371/journal.pone.0044103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22962601	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600029
J	Catalogna, M; Cohen, E; Fishman, S; Halpern, Z; Nevo, U; Ben-Jacob, E				Catalogna, Merav; Cohen, Eyal; Fishman, Sigal; Halpern, Zamir; Nevo, Uri; Ben-Jacob, Eshel			Artificial Neural Networks Based Controller for Glucose Monitoring during Clamp Test	PLOS ONE			English	Article							FEEDFORWARD NETWORKS; DECISION-SUPPORT; ALGORITHM; METABOLISM; MODEL; PREDICTION; RESISTANCE; ENSEMBLE	Insulin resistance (IR) is one of the most widespread health problems in modern times. The gold standard for quantification of IR is the hyperinsulinemic-euglycemic glucose clamp technique. During the test, a regulated glucose infusion is delivered intravenously to maintain a constant blood glucose concentration. Current control algorithms for regulating this glucose infusion are based on feedback control. These models require frequent sampling of blood, and can only partly capture the complexity associated with regulation of glucose. Here we present an improved clamp control algorithm which is motivated by the stochastic nature of glucose kinetics, while using the minimal need in blood samples required for evaluation of IR. A glucose pump control algorithm, based on artificial neural networks model was developed. The system was trained with a data base collected from 62 rat model experiments, using a back-propagation Levenberg-Marquardt optimization. Genetic algorithm was used to optimize network topology and learning features. The predictive value of the proposed algorithm during the temporal period of interest was significantly improved relative to a feedback control applied at an equivalent low sampling interval. Robustness to noise analysis demonstrates the applicability of the algorithm in realistic situations.	[Catalogna, Merav; Nevo, Uri] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel; [Cohen, Eyal] HEMDA, Ctr Sci Educ, Tel Aviv, Israel; [Fishman, Sigal; Halpern, Zamir] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Hepatol, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Catalogna, M (corresponding author), Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.	eshel@tamar.tau.ac.il			Maugy-Glass Chair in Physics of Complex Systems; Tauber Family Foundation at Tel-Aviv University; Colton Family Foundation; FP7 (IRG) program	Maugy-Glass Chair in Physics of Complex Systems; Tauber Family Foundation at Tel-Aviv University; Colton Family Foundation; FP7 (IRG) program	This research has been supported in part by the Maugy-Glass Chair in Physics of Complex Systems and the Tauber Family Foundation at Tel-Aviv University. UN is supported by the Colton Family Foundation and the FP7 (IRG) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fahoum AS, 1999, MED BIOL ENG COMPUT, V37, P566, DOI 10.1007/BF02513350; Ambrosiadou BV, 1996, MED INFORM, V21, P23, DOI 10.3109/14639239609009008; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Andrianasy F, 1997, APPL NEURAL NETWORKS, P182; Ao SI, 2011, APPL SOFT COMPUT, V11, P1718, DOI 10.1016/j.asoc.2010.05.014; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Ben-Shlomo S, 2012, OBESITY, V20, P151, DOI 10.1038/oby.2011.261; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Bequette B Wayne, 2009, J Diabetes Sci Technol, V3, P1005; CLEMENS AH, 1982, CLIN CHEM, V28, P1899; Damour C, 2010, J FOOD ENG, V99, P225, DOI 10.1016/j.jfoodeng.2010.02.027; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; FURLER SM, 1986, MED BIOL ENG COMPUT, V24, P365, DOI 10.1007/BF02442689; HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Leung FHF, 2003, IEEE T NEURAL NETWOR, V14, P79, DOI 10.1109/TNN.2002.804317; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Montana D. J., 1989, P 11 INT JOINT C ART, V1; Mougiakakou SG, 2005, P ANN INT IEEE EMBS, P298, DOI 10.1109/IEMBS.2005.1616403; Naftaly U, 1997, NETWORK-COMP NEURAL, V8, P283, DOI 10.1088/0954-898X/8/3/004; Nguyen HT, 2008, DIABETES, V57, pA122; PACINI G, 1982, DIABETES, V31, P432, DOI 10.2337/diabetes.31.5.432; Papaloukas C, 2002, ARTIF INTELL MED, V24, P167, DOI 10.1016/S0933-3657(01)00100-2; Pappada Scott M, 2008, J Diabetes Sci Technol, V2, P792; Perez-Gandia C, 2010, DIABETES TECHNOL THE, V12, P81, DOI 10.1089/dia.2009.0076; Reed R. D., 1999, NEURAL SMITHING SUPE; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Satyanarayana Dondeti, 2005, GENETIC ALGORITHM OP; Shanker MS, 1996, J CHEM INF COMP SCI, V36, P35, DOI 10.1021/ci950063e; Silipo R, 1998, IEEE T SIGNAL PROCES, V46, P1417, DOI 10.1109/78.668803; Sivanandam S., 2008, INTRO GENETIC ALGORI, P15; SMITH D, 1987, METABOLISM, V36, P1167, DOI 10.1016/0026-0495(87)90244-7; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; WHITLEY D, 1990, PARALLEL COMPUT, V14, P347, DOI 10.1016/0167-8191(90)90086-O; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organisation, 2011, DIABETES	38	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44587	10.1371/journal.pone.0044587	http://dx.doi.org/10.1371/journal.pone.0044587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952998	Green Submitted, gold, Green Published			2022-12-25	WOS:000308221300102
J	Elphick, MR				Elphick, Maurice R.			The Protein Precursors of Peptides That Affect the Mechanics of Connective Tissue and/or Muscle in the Echinoderm Apostichopus japonicus	PLOS ONE			English	Article							STARFISH ASTERIAS-RUBENS; CUCUMBER HOLOTHURIA-GLABERRIMA; SALMFAMIDE NEUROPEPTIDES S1; SEA-CUCUMBER; HEPTAPEPTIDE GFSKLYFAMIDE; POLYCLONAL ANTIBODIES; VASOPRESSIN; RELAXATION; PROHORMONE; DOMAINS	Peptides that cause muscle relaxation or contraction or that modulate electrically-induced muscle contraction have been discovered in the sea cucumber Apostichopus japonicus (Phylum Echinodermata; Class Holothuroidea). By analysing transcriptome sequence data, here the protein precursors of six of these myoactive peptides (the SALMFamides Sticho-MFamide-1 and -2, NGIWYamide, stichopin, GN-19 and GLRFA) have been identified, providing novel insights on neuropeptide and endocrine-type signalling systems in echinoderms. The A. japonicus SALMFamide precursor comprises eight putative neuropeptides including both L-type and F-type SALMFamides, which contrasts with previous findings from the sea urchin Strongylocentrotus purpuratus where L-type and F-type SALMFamides are encoded by different genes. The NGIWYamide precursor contains five copies of NGIWYamide but, unlike other NG peptide-type neuropeptide precursors in deuterostomian invertebrates, the NGIWYamide precursor does not have a C-terminal neurophysin domain, indicating loss of this character in holothurians. NGIWYamide was originally discovered as a muscle contractant, but it also causes stiffening of mutable connective tissue in the body wall of A. japonicus, whilst holokinins (PLGYMFR and derivative peptides) cause softening of the body wall. However, the mechanisms by which these peptides affect the stiffness of body wall connective tissue are unknown. Interestingly, analysis of the A. japonicus transcriptome reveals that the only protein containing the holokinin sequence PLGYMFR is an alpha-5 type collagen. This suggests that proteolysis of collagen may generate peptides (holokinins) that affect body wall stiffness in sea cucumbers, providing a novel perspective on mechanisms of mutable connective tissue in echinoderms.	Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Elphick, MR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	M.R.Elphick@qmul.ac.uk		Elphick, Maurice/0000-0002-9169-0048				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birenheide R, 1998, BIOL BULL-US, V194, P253, DOI 10.2307/1543095; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Campbell DJ, 2003, INT J BIOCHEM CELL B, V35, P784, DOI 10.1016/S1357-2725(02)00262-5; Cluzel C, 2004, J BIOL CHEM, V279, P9811, DOI 10.1074/jbc.M311803200; de Bree FM, 1998, CELL MOL NEUROBIOL, V18, P173, DOI 10.1023/A:1022564803093; de Bree FM, 2000, J NEUROENDOCRINOL, V12, P589, DOI 10.1046/j.1365-2826.2000.00521.x; DIAZMIRANDA L, 1995, J COMP NEUROL, V352, P626, DOI 10.1002/cne.903520410; DIAZMIRANDA L, 1995, COMP BIOCHEM PHYS C, V110, P171, DOI 10.1016/0742-8413(94)00094-Q; DIAZMIRANDA L, 1992, BIOL BULL, V182, P241, DOI 10.2307/1542117; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Elphick MR, 2010, GENE, V458, P20, DOI 10.1016/j.gene.2010.03.004; Elphick MR, 2009, J EXP BIOL, V212, P1067, DOI 10.1242/jeb.027599; Elphick MR, 2005, J EXP BIOL, V208, P4273, DOI 10.1242/jeb.01910; Elphick MR, 2001, J EXP BIOL, V204, P875; ELPHICK MR, 1995, J EXP BIOL, V198, P2519; ELPHICK MR, 1991, P ROY SOC B-BIOL SCI, V243, P121, DOI 10.1098/rspb.1991.0020; GREENBERG MJ, 1983, ANNU REV PHYSIOL, V45, P271, DOI 10.1146/annurev.ph.45.030183.001415; Inoue M, 1999, P BIOL SCI, V266; IWAKOSHI E, 1995, PEPTIDE CH, P261; Kato S, 2009, DEV BIOL, V326, P169, DOI 10.1016/j.ydbio.2008.11.003; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Melarange R, 2003, J EXP BIOL, V206, P893, DOI 10.1242/jeb.00197; Melarange R, 1999, P ROY SOC B-BIOL SCI, V266, P1785, DOI 10.1098/rspb.1999.0847; MOORE SJ, 1993, CELL TISSUE RES, V274, P605, DOI 10.1007/BF00314559; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P187, DOI 10.1098/rspb.1995.0135; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P139, DOI 10.1098/rspb.1995.0128; Ohtani M, 1999, PEPTIDE SCIENCE - PRESENT AND FUTURE, P419; OSHEA M, 1985, ANNU REV NEUROSCI, V8, P171; Priyam A., SEQUENCESERVER UNPUB; Rowe ML, 2010, MAR GENOM, V3, P91, DOI 10.1016/j.margen.2010.08.003; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Strand FL, 1999, NEUROPEPTIDES REGULA; Tamori M, 2007, P ROY SOC B-BIOL SCI, V274, P2279, DOI 10.1098/rspb.2007.0583; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; Wilkie IC, 2005, PROG MOLEC, V39, P221; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	39	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44492	10.1371/journal.pone.0044492	http://dx.doi.org/10.1371/journal.pone.0044492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952987	Green Submitted, gold, Green Published			2022-12-25	WOS:000308221300095
J	Pacheco, SE; Anderson, LM; Sandrof, MA; Vantangoli, MM; Hall, SJ; Boekelheide, K				Pacheco, Sara E.; Anderson, Linnea M.; Sandrof, Moses A.; Vantangoli, Marguerite M.; Hall, Susan J.; Boekelheide, Kim			Sperm mRNA Transcripts Are Indicators of Sub-Chronic Low Dose Testicular Injury in the Fischer 344 Rat	PLOS ONE			English	Article							MARINESCO-SJOGREN-SYNDROME; GERM-CELL APOPTOSIS; GENE-EXPRESSION; 2,5-HEXANEDIONE INTOXICATION; SPERMATOZOAL RNA; CARBENDAZIM; TESTIS; EPIDIDYMIS; TOXICITY; PROTEINS	Current human reproductive risk assessment methods rely on semen and serum hormone analyses, which are not easily comparable to the histopathological endpoints and mating studies used in animal testing. Because of these limitations, there is a need to develop universal evaluations that reliably reflect male reproductive function. We hypothesized that toxicant-induced testicular injury can be detected in sperm using mRNA transcripts as indicators of insult. To test this, we exposed adult male Fischer 344 rats to low doses of model testicular toxicants and classically characterized the testicular injury while simultaneously evaluating sperm mRNA transcripts from the same animals. Overall, this study aimed to: 1) identify sperm transcripts altered after exposure to the model testicular toxicant, 2,5-hexanedione (HD) using microarrays; 2) expand on the HD-induced transcript changes in a comprehensive time course experiment using qRT-PCR arrays; and 3) test these injury indicators after exposure to another model testicular toxicant, carbendazim (CBZ). Microarray analysis of HD-treated adult Fischer 344 rats identified 128 altered sperm mRNA transcripts when compared to control using linear models of microarray analysis (q < 0.05). All transcript alterations disappeared after 3 months of post-exposure recovery. In the time course experiment, time-dependent alterations were observed for 12 candidate transcripts selected from the microarray data based upon fold change and biological relevance, and 8 of these transcripts remained significantly altered after the 3-month recovery period (p < 0.05). In the last experiment, 8 candidate transcripts changed after exposure to CBZ (p < 0.05). The two testicular toxicants produced distinct molecular signatures with only 4 overlapping transcripts between them, each occurring in opposite directions. Overall, these results suggest that sperm mRNA transcripts are indicators of low dose toxicant-induced testicular injury in the rat.	[Pacheco, Sara E.; Anderson, Linnea M.; Sandrof, Moses A.; Vantangoli, Marguerite M.; Hall, Susan J.; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Brown University	Pacheco, SE (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kim_Boekelheide@Brown.edu		Vantangoli, Marguerite/0000-0001-8757-440X	Superfund Research Program (National Institute of Health/National Institute of Environmental Health Science) [P42ES013660]; National Institute of Environmental Health Science "Training in Environmental Pathology'' training grant [T32ES007272-17]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013660, T32ES007272] Funding Source: NIH RePORTER	Superfund Research Program (National Institute of Health/National Institute of Environmental Health Science); National Institute of Environmental Health Science "Training in Environmental Pathology'' training grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Superfund Research Program (National Institute of Health/National Institute of Environmental Health Science) grant [P42ES013660] and by the National Institute of Environmental Health Science "Training in Environmental Pathology'' training grant [T32ES007272-17] (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Allanach K, 2008, AM J TRANSPLANT, V8, P1006, DOI 10.1111/j.1600-6143.2008.02199.x; Anton E, 2012, SYST BIOL REPROD MED, V58, P41, DOI 10.3109/19396368.2011.637152; Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Aveic S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026097; Belleannee C, 2011, J PROTEOMICS, V74, P59, DOI 10.1016/j.jprot.2010.07.013; BOEKELHEIDE K, 1988, TOXICOL APPL PHARM, V92, P18, DOI 10.1016/0041-008X(88)90223-2; BOEKELHEIDE K, 1988, TOXICOL APPL PHARM, V94, P76, DOI 10.1016/0041-008X(88)90338-9; Boekelheide K, 2003, ANNU REV PHARMACOL, V43, P125, DOI 10.1146/annurev.pharmtox.43.100901.135930; Boekelheide K, 2005, SERTOLI CELL BIOL, P345; Boerke A, 2007, THERIOGENOLOGY, V68, pS147, DOI 10.1016/j.theriogenology.2007.05.058; Bryant BH, 2008, TOXICOL PATHOL, V36, P552, DOI 10.1177/0192623308317426; Buck Wayne R., 2008, V460, P23, DOI 10.1007/978-1-60327-048-9_2; Campion SN, 2010, TOXICOL SCI, V117, P457, DOI 10.1093/toxsci/kfq204; CARTER SD, 1987, BIOL REPROD, V37, P709, DOI 10.1095/biolreprod37.3.709; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Correa LM, 2001, BIOL REPROD, V64, P1644, DOI 10.1095/biolreprod64.6.1644; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Goncalves RF, 2008, ANIM REPROD SCI, V106, P188, DOI 10.1016/j.anireprosci.2007.12.019; GRAY LE, 1990, FUND APPL TOXICOL, V15, P281, DOI 10.1016/0272-0590(90)90055-O; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Hess RA, 1998, J REPROD FERTIL, P247; HOWARD RJ, 1980, J CELL BIOL, V87, P55, DOI 10.1083/jcb.87.1.55; Kempisty B, 2008, REPROD FERT DEVELOP, V20, P513, DOI 10.1071/RD07211; Laatikainen LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024456; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Lim JH, 1997, TOXICOL APPL PHARM, V142, P401, DOI 10.1006/taap.1996.8042; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; Moffit JS, 2007, TOXICOL PATHOL, V35, P719, DOI 10.1080/01926230701481931; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neuer A, 1999, Infect Dis Obstet Gynecol, V7, P10, DOI 10.1155/S1064744999000034; Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Pacheco SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020280; Pacheco SE, 2012, J ANDROL; Peng JS, 2002, MOL BIOL REP, V29, P353, DOI 10.1023/A:1021232518628; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; QUINLAN RA, 1980, J CELL SCI, V46, P341; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Sorrentino C, 1998, BIOL REPROD, V59, P843, DOI 10.1095/biolreprod59.4.843; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Winder BS, 2001, TOXICOL SCI, V59, P138, DOI 10.1093/toxsci/59.1.138; Yamasaki H, 2010, TOXICOL SCI, V117, P449, DOI 10.1093/toxsci/kfq203; Yon JM, 2007, J REPROD DEVELOP, V53, P1007, DOI 10.1262/jrd.19032; Yu G, 2009, TOXICOL IND HEALTH, V25, P41, DOI 10.1177/0748233709103033; Zhang KX, 2005, ARCH ANDROLOGY, V51, P7, DOI 10.1080/014850190512914; Zhao LH, 2010, HUM MOL GENET, V19, P25, DOI 10.1093/hmg/ddp464	52	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44280	10.1371/journal.pone.0044280	http://dx.doi.org/10.1371/journal.pone.0044280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952946	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300073
J	Pick, E; Golan, A; Zimbler, JZ; Guo, L; Sharaby, Y; Tsuge, T; Hofmann, K; Wei, N				Pick, Elah; Golan, Amnon; Zimbler, Jacob Z.; Guo, Liquan; Sharaby, Yehonatan; Tsuge, Tomohiko; Hofmann, Kay; Wei, Ning			The Minimal Deneddylase Core of the COP9 Signalosome Excludes the Csn6 MPN- Domain	PLOS ONE			English	Article							UBIQUITIN LIGASE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; REGULATORY PARTICLE; 26S PROTEASOME; PCI COMPLEXES; DNA-DAMAGE; YEAST; SUBUNITS; PROTEIN	The COP9 signalosome (CSN) is a eukaryotic protein complex, which regulates a wide range of biological processes mainly through modulating the cullin ubiquitin E3 ligases in the ubiquitin-proteasome pathway. The CSN possesses a highly conserved deneddylase activity that centers at the JAMM motif of the Csn5 subunit but requires other subunits in a complex assembly. The classic CSN is composed of 8 subunits (Csn1-8), yet in several Ascomycota, the complex is smaller and lacks orthologs for a few CSN subunits, but nevertheless contains a conserved Csn5. This feature makes yeast a powerful model to determine the minimal assemblage required for deneddylation activity. Here we report, that Csi1, a diverged S. cerevisiae CSN subunit, displays significant homology with the carboxyl terminal domain of the canonical Csn6, but lacks the amino terminal MPN- domain. Through the comparative and experimental analyses of the budding yeast and the mammalian CSNs, we demonstrate that the MPN- domain of the canonical mouse Csn6 is not part of the CSN deneddylase core. We also show that the carboxyl domain of Csn6 has an indispensable role in maintaining the integrity of the CSN complex. The CSN complex assembled with the carboxyl fragment of Csn6, despite its lack of an MPN- domain, is fully active in deneddylation of cullins. We propose that the budding yeast Csi1 is a functional equivalent of the canonical Csn6, and thus the composition of the CSN across phyla is more conserved than hitherto appreciated.	[Pick, Elah; Golan, Amnon; Zimbler, Jacob Z.; Sharaby, Yehonatan] Univ Haifa, Dept Biol, Tivon, Israel; [Pick, Elah; Zimbler, Jacob Z.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50931 Cologne, Germany; [Guo, Liquan; Tsuge, Tomohiko; Wei, Ning] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	University of Haifa; University of Haifa; University of Cologne; Yale University	Pick, E (corresponding author), Univ Haifa, Dept Biol, Tivon, Israel.	elahpic@research.haifa.ac.il	Tsuge, Tomohiko/GVY-1467-2022; Pick, Elah/G-6137-2018	Tsuge, Tomohiko/0000-0003-2736-0295; Pick, Elah/0000-0002-6591-2217; Wei, Ning/0000-0001-8827-1320; Sharaby, Yehonatan/0000-0002-1936-431X	Israel Science Foundation grant [EP355/10]; Ministry of Science and Technology, Israel Italy [3-9022]; China Program for New Century Excellent Talent in University [NCET-10-0153]; China Postdoctoral Science Foundation [201104519, 20100481042]; Grants-in-Aid for Scientific Research [22570041] Funding Source: KAKEN	Israel Science Foundation grant(Israel Science Foundation); Ministry of Science and Technology, Israel Italy; China Program for New Century Excellent Talent in University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Israel Science Foundation grant [EP355/10] and by the Ministry of Science and Technology, Israel Italy [3-9022] to EP. LG is supported by China Program for New Century Excellent Talent in University [NCET-10-0153] and China Postdoctoral Science Foundation [201104519; 20100481042]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bellare P, 2006, RNA, V12, P292, DOI 10.1261/rna.2152306; Braus GH, 2010, CURR OPIN MICROBIOL, V13, P672, DOI 10.1016/j.mib.2010.09.011; Chang Eric C, 2004, EMBO Rep, V5, P1041, DOI 10.1038/sj.embor.7400275; Choi ES, 2011, J BIOL CHEM, V286, P23600, DOI 10.1074/jbc.M111.228510; Choi HH, 2011, ONCOGENE, V30, P4791, DOI 10.1038/onc.2011.192; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Correia JD, 2007, J BIOL CHEM, V282, P12557, DOI 10.1074/jbc.M609587200; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Golan A, 2010, CELL CYCLE, V9, P2647, DOI 10.4161/cc.9.13.12121; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Hetfeld BKJ, 2008, APOPTOSIS, V13, P187, DOI 10.1007/s10495-007-0164-7; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Jiang HY, 2011, NUCLEIC ACIDS RES, V39, P5119, DOI 10.1093/nar/gkr103; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Maytal-Kivity V, 2002, EMBO REP, V3, P1215, DOI 10.1093/embo-reports/kvf235; Maytal-Kivity V, 2003, INT J BIOCHEM CELL B, V35, P706, DOI 10.1016/S1357-2725(02)00378-3; Menon S, 2005, METHOD ENZYMOL, V398, P468, DOI 10.1016/S0076-6879(05)98038-5; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Peth Andreas, 2007, BMC Biochemistry, V8, P27, DOI 10.1186/1471-2091-8-27; Pick E, 2009, EMBO REP IN PRESS; Pick E, 2007, MOL CELL BIOL, V27, P4708, DOI 10.1128/MCB.02432-06; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Rossignol T, 2008, NUCLEIC ACIDS RES, V36, pD557, DOI 10.1093/nar/gkm1010; Sanches M, 2007, J MOL BIOL, V370, P846, DOI 10.1016/j.jmb.2007.04.084; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schwechheimer C, 2010, EUR J CELL BIOL, V89, P157, DOI 10.1016/j.ejcb.2009.11.021; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Su H, 2008, INT J BIOCH CELL BIO; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; von Arnim AG, 2006, MOL CELL, V23, P621, DOI 10.1016/j.molcel.2006.08.012; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yu ZL, 2011, MOL BIOL CELL, V22, P911, DOI 10.1091/mbc.E10-08-0655; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111	56	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43980	10.1371/journal.pone.0043980	http://dx.doi.org/10.1371/journal.pone.0043980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956996	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500033
J	Aleman-Muench, GR; Mendoza, V; Stenvers, K; Garcia-Zepeda, EA; Lopez-Casillas, F; Raman, C; Soldevila, G				Aleman-Muench, German R.; Mendoza, Valentin; Stenvers, Kaye; Garcia-Zepeda, Eduardo A.; Lopez-Casillas, Fernando; Raman, Chander; Soldevila, Gloria			Betaglycan (T beta RIII) Is Expressed in the Thymus and Regulates T Cell Development by Protecting Thymocytes from Apoptosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEINS; III RECEPTOR; INHIBIN BINDING; PROLIFERATION; SUPERFAMILY; CORECEPTOR; ACTIVATION; MIGRATION; TGFBR3	TGF-beta type III receptor (T beta RIII) is a coreceptor for TGF beta family members required for high-affinity binding of these ligands to their receptors, potentiating their cellular functions. TGF-beta [1-3], bone morphogenetic proteins (BMP2/4) and inhibins regulate different checkpoints during T cell differentiation. Although T beta RIII is expressed on hematopoietic cells, the role of this receptor in the immune system remains elusive. Here, we provide the first evidence that T beta RIII is developmentally expressed during T cell ontogeny, and plays a crucial role in thymocyte differentiation. Blocking of endogenous T beta RIII in fetal thymic organ cultures led to a delay in DN-DP transition. In addition, in vitro development of T beta RIII-/- thymic lobes also showed a significant reduction in absolute thymocyte numbers, which correlated with increased thymocyte apoptosis, resembling the phenotype reported in Inhibin alpha(-/-) thymic lobes. These data suggest that Inhibins and T beta RIII may function as a molecular pair regulating T cell development.	[Aleman-Muench, German R.; Garcia-Zepeda, Eduardo A.; Soldevila, Gloria] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Mendoza, Valentin; Lopez-Casillas, Fernando] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular, Mexico City 04510, DF, Mexico; [Stenvers, Kaye] Prince Henrys Inst Med Res, Reprod Dev & Canc Lab, Clayton, Vic, Australia; [Raman, Chander] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Dept Med, Birmingham, AL USA; [Raman, Chander] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Dept Microbiol, Birmingham, AL USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Prince Henry's Institute of Medical Research; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Aleman-Muench, GR (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	soldevi@servidor.unam.mx		Soldevila, Gloria/0000-0003-1539-2548	DGAPA, UNAM (PAPIIT) [IN228205]; CONACyT [208213]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076562] Funding Source: NIH RePORTER	DGAPA, UNAM (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in GS's lab was supported by a grant from DGAPA, UNAM (PAPIIT #IN228205). GRAM was a recipient of a doctoral fellowship #208213 from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair CR, 2011, BBA-MOL CELL RES, V1813, P332, DOI 10.1016/j.bbamcr.2010.12.005; Brooks SP, 1998, AIDS, V12, P481, DOI 10.1097/00002030-199805000-00009; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Chapman SC, 2002, MOL CELL ENDOCRINOL, V196, P79, DOI 10.1016/S0303-7207(02)00227-7; Chen YG, 2006, EXP BIOL MED, V231, P534; Chu WF, 2011, J CELL PHYSIOL, V226, P2586, DOI 10.1002/jcp.22604; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Ethier JF, 2002, MOL ENDOCRINOL, V16, P2754, DOI 10.1210/me.2002-0014; Farnworth PG, 2007, ENDOCRINOLOGY, V148, P5355, DOI 10.1210/en.2007-0155; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Graf D, 2002, J EXP MED, V196, P163, DOI 10.1084/jem.20020276; KADIN ME, 1994, P NATL ACAD SCI USA, V91, P6002, DOI 10.1073/pnas.91.13.6002; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Licona P, 2006, DEV DYNAM, V235, P1124, DOI 10.1002/dvdy.20707; Licona-Limon P, 2007, IMMUNOL LETT, V109, P1, DOI 10.1016/j.imlet.2006.12.010; Licona-Limon P, 2009, BIOCHEM BIOPH RES CO, V381, P229, DOI 10.1016/j.bbrc.2009.02.029; Looyenga BD, 2010, MOL ENDOCRINOL, V24, P608, DOI 10.1210/me.2008-0374; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Margulis V, 2008, CLIN CANCER RES, V14, P5722, DOI 10.1158/1078-0432.CCR-08-0546; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mythreye K, 2009, CELL CYCLE, V8, P3069, DOI 10.4161/cc.8.19.9419; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Rosendahl A, 2003, INT IMMUNOL, V15, P1401, DOI 10.1093/intimm/dxg139; SANKAR S, 1995, J BIOL CHEM, V270, P13567, DOI 10.1074/jbc.270.22.13567; Sarraj MA, 2007, GROWTH FACTORS, V25, P334, DOI 10.1080/08977190701833619; Sarraj MA, 2010, BIOL REPROD, V82, P153, DOI 10.1095/biolreprod.109.078766; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; Slimani H, 2003, BBA-BIOMEMBRANES, V1617, P80, DOI 10.1016/j.bbamem.2003.09.006; Sporer KRB, 2007, VET IMMUNOL IMMUNOP, V118, P19, DOI 10.1016/j.vetimm.2007.04.002; Stenvers KL, 2010, TRENDS ENDOCRIN MET, V21, P174, DOI 10.1016/j.tem.2009.11.009; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Varas A, 2003, TRENDS IMMUNOL, V24, P197, DOI 10.1016/S1471-4906(03)00033-4; Walker KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018723; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44217	10.1371/journal.pone.0044217	http://dx.doi.org/10.1371/journal.pone.0044217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952931	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000094
J	Zhang, YL; Gan, ZJ; Huang, P; Zhou, LT; Mao, T; Shao, ML; Jiang, XM; Chen, Y; Ying, H; Cao, MN; Li, JY; Li, J; Zhang, WPJ; Yang, L; Liu, Y				Zhang, Yongliang; Gan, Zhenji; Huang, Ping; Zhou, Luting; Mao, Ting; Shao, Mengle; Jiang, Xiaomeng; Chen, Yan; Ying, Hao; Cao, Meina; Li, Jingya; Li, Jia; Zhang, Weiping J.; Yang, Liu; Liu, Yong			A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; ORPHAN NUCLEAR RECEPTORS; FATTY-ACID SYNTHESIS; LXR-ALPHA; TRANSCRIPTIONAL REGULATION; MEDIATES TRANSREPRESSION; HEPATIC LIPOGENESIS; RESPONSE PATHWAY; GENE-ACTIVATION; PPAR-GAMMA	Liver X receptors (LXRs) are nuclear receptors that function to modulate lipid metabolism as well as immune and inflammatory responses. Upon activation by their ligands, LXRs up-regulate a spectrum of gene transcription programs involved in cholesterol and fatty acid homeostasis. However, the mechanisms by which LXR-mediated transcriptional activation is regulated remain incompletely understood. Here, we show that PIAS1, a member of the protein inhibitor of the activated STAT family of proteins with small ubiquitin-like modifier (SUMO) E3 ligase activity, acts to suppress LXR ligand-dependent transcriptional activation of the lipogenic program in hepatocytes. We found that liver mRNA expression levels of Pias1 and Pias3 were inversely associated with those of genes involved in lipogenesis in mouse models with diet-induced or genetic obesity. Overexpression of PIAS1 in primary hepatocytes resulted in a reduction of LXR ligand-induced fatty acid synthesis and suppression of the expression of lipogenic genes, including Srebp1c and Fas. Moreover, PIAS1 was able to interact with LXR beta and repress its transcriptional activity upon ligand stimulation, which did not require PIAS1-promoted SUMO modification of LXR beta. In addition, PIAS1 could also interact with PGC-1 beta and attenuate its association with LXR beta, blunting the ability of PGC-1 beta to co-activate LXR beta. Importantly, PIAS1 impaired LXR beta binding to its target DNA sequence. Taken together, our results suggest that PIAS1 may serve as a lipogenic regulator by negatively modulating LXRs in a SUMOylation-independent manner.	[Zhang, Yongliang; Gan, Zhenji; Huang, Ping; Mao, Ting; Shao, Mengle; Jiang, Xiaomeng; Chen, Yan; Ying, Hao; Yang, Liu; Liu, Yong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai 200031, Peoples R China; [Zhou, Luting; Zhang, Weiping J.] Second Mil Med Univ, Ctr Obes & Diabet Res & Innovat, Dept Pathophysiol, Shanghai 200433, Peoples R China; [Cao, Meina; Li, Jingya; Li, Jia] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Naval Medical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Liu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	liuy@sibs.ac.cn	Shao, Mengle/AAH-8392-2019; li, jia/GVT-7587-2022; Shao, Mengle/D-9951-2014; Li, Jia/F-9116-2011	Shao, Mengle/0000-0002-5488-9904; Shao, Mengle/0000-0002-5488-9904; LIU, YONG/0000-0001-7771-4181; Gan, Zhenji/0000-0001-5940-207X	Ministry of Science and Technology from the 973 Program [2012CB524900, 2011CB910900]; National Natural Science Foundation [81021002, 30988002, 30830033]; Chinese Academy of Sciences Knowledge Innovation Programs [KSCX2-EW-R-09, KSCX2-EW-Q-1-09]; Science and Technology Commission of Shanghai Municipality [10XD1406400]	Ministry of Science and Technology from the 973 Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Knowledge Innovation Programs; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology Grants 2012CB524900 and 2011CB910900 from the 973 Program, National Natural Science Foundation Grants 81021002, 30988002, and 30830033, Chinese Academy of Sciences Knowledge Innovation Programs KSCX2-EW-R-09 and KSCX2-EW-Q-1-09, and Science and Technology Commission of Shanghai Municipality Grant 10XD1406400 (to Y. L.).	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Glass CK, 2000, GENE DEV, V14, P121; Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-59; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; MCGARRY JD, 1978, J BIOL CHEM, V253, P8294; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Song YY, 2012, J HEPATOL, V56, P248, DOI 10.1016/j.jhep.2011.07.014; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	48	14	14	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.403139	http://dx.doi.org/10.1074/jbc.M112.403139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22969086	Green Published, hybrid			2022-12-25	WOS:000310642200032
J	Lin, S; Cronan, JE				Lin, Steven; Cronan, John E.			The BioC O-Methyltransferase Catalyzes Methyl Esterification of Malonyl-Acyl Carrier Protein, an Essential Step in Biotin Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; FATTY-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; ACTIVE-SITE; PHOSPHOPANTETHEINYL TRANSFERASE; DEPENDENT ENZYMES; PATHWAY; TRANSACYLASE; INHIBITION; EXPRESSION	Recent work implicated the Escherichia coli BioC protein as the initiator of the synthetic pathway that forms the pimeloyl moiety of biotin (Lin, S., Hanson, R. E., and Cronan, J. E. (2010) Nat. Chem. Biol. 6, 682-688). BioC was believed to be an O-methyltransferase that methylated the free carboxyl of either malonyl-CoA or malonyl-acyl carrier protein based on the ability of O-methylated (but not unmethylated) precursors to bypass the BioC requirement for biotin synthesis both in vivo and in vitro. However, only indirect proof of the hypothesized enzymatic activity was obtained because the activities of the available BioC preparations were too low for direct enzymatic assay. Because E. coli BioC protein was extremely recalcitrant to purification in an active form, BioC homologues of other bacteria were tested. We report that the native form of Bacillus cereus ATCC10987 BioC functionally replaced E. coli BioC in vivo, and the protein could be expressed in soluble form and purified to homogeneity. In disagreement with prior scenarios that favored malonyl-CoA as the methyl acceptor, malonyl-acyl carrier protein was a far better acceptor of methyl groups from S-adenosyl-L-methionine than was malonyl-CoA. BioC was specific for the malonyl moiety and was inhibited by S-adenosyl-L-homocysteine and sinefungin. High level expression of B. cereus BioC in E. coli blocked cell growth and fatty acid synthesis.	[Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019; Lin, Steven/ABD-7821-2021; Lin, Steven/G-6142-2019	Lin, Steven/0000-0002-7542-4663; Lin, Steven/0000-0002-7542-4663	National Institutes of Health [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650.	Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BORCHARDT RT, 1979, BIOCHEM BIOPH RES CO, V89, P919, DOI 10.1016/0006-291X(79)91866-7; Borgaro JG, 2011, BIOCHEMISTRY-US, V50, P10678, DOI 10.1021/bi201199x; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; De Lay NR, 2008, GENETICS, V178, P1327, DOI 10.1534/genetics.107.081836; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halliday NM, 2010, ANAL BIOCHEM, V403, P20, DOI 10.1016/j.ab.2010.04.021; HARDER ME, 1974, J BIOL CHEM, V249, P7468; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; IFUKU O, 1994, EUR J BIOCHEM, V220, P585, DOI 10.1111/j.1432-1033.1994.tb18659.x; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Lemoine Y, 1996, MOL MICROBIOL, V19, P645, DOI 10.1046/j.1365-2958.1996.t01-4-442924.x; LEVYSCHIL S, 1993, APPL MICROBIOL BIOT, V38, P755, DOI 10.1007/BF00167141; Lin S, 2011, MOL BIOSYST, V7, P1811, DOI 10.1039/c1mb05022b; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Park J, 1996, BIOORGAN MED CHEM, V4, P2179, DOI 10.1016/S0968-0896(96)00228-3; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; REICH NO, 1990, J BIOL CHEM, V265, P8966; RUCH FE, 1973, J BIOL CHEM, V248, P8086; Sanishvili R, 2003, J BIOL CHEM, V278, P26039, DOI 10.1074/jbc.M303867200; SANYAL I, 1994, J AM CHEM SOC, V116, P2637, DOI 10.1021/ja00085a061; Tomczyk NH, 2002, FEBS LETT, V513, P299, DOI 10.1016/S0014-5793(02)02342-6; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Yang G, 1997, BIOCHEMISTRY-US, V36, P4751, DOI 10.1021/bi9631677	34	41	58	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37010	37020		10.1074/jbc.M112.410290	http://dx.doi.org/10.1074/jbc.M112.410290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22965231	Green Published, hybrid			2022-12-25	WOS:000310588500036
J	Neal, MD; Sodhi, CP; Jia, H; Dyer, M; Egan, CE; Yazji, I; Good, M; Afrazi, A; Marino, R; Slagle, D; Ma, CR; Branca, MF; Prindle, T; Grant, Z; Ozolek, J; Hackam, DJ				Neal, Matthew D.; Sodhi, Chhinder P.; Jia, Hongpeng; Dyer, Mitchell; Egan, Charlotte E.; Yazji, Ibrahim; Good, Misty; Afrazi, Amin; Marino, Ryan; Slagle, Dennis; Ma, Congrong; Branca, Maria F.; Prindle, Thomas, Jr.; Grant, Zachary; Ozolek, John; Hackam, David J.			Toll-like Receptor 4 Is Expressed on Intestinal Stem Cells and Regulates Their Proliferation and Apoptosis via the p53 Up-regulated Modulator of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROTIZING ENTEROCOLITIS; IN-VIVO; STEM/PROGENITOR CELLS; WNT RECEPTORS; BETA-CATENIN; PUMA; TLR4; PATHOGENESIS; INJURY; COLON	Factors regulating the proliferation and apoptosis of intestinal stem cells (ISCs) remain incompletely understood. Because ISCs exist among microbial ligands, immune receptors such as toll-like receptor 4 (TLR4) could play a role. We now hypothesize that ISCs express TLR4 and that the activation of TLR4 directly on the intestinal stem cells regulates their ability to proliferate or to undergo apoptosis. Using flow cytometry and fluorescent in situ hybridization for the intestinal stem cell marker Lgr5, we demonstrate that TLR4 is expressed on the Lgr5-positive intestinal stem cells. TLR4 activation reduced proliferation and increased apoptosis in ISCs both in vivo and in ISC organoids, a finding not observed in mice lacking TLR4 in the Lgr5-positive ISCs, confirming the in vivo significance of this effect. To define molecular mechanisms involved, TLR4 inhibited ISC proliferation and increased apoptosis via the p53-up-regulated modulator of apoptosis (PUMA), as TLR4 did not affect crypt proliferation or apoptosis in organoids or mice lacking PUMA. In vivo effects of TLR4 on ISCs required TIR-domain-containing adapter-inducing interferon-beta (TRIF) but were independent of myeloid-differentiation primary response-gene 88 (MYD88) and TNF alpha. Physiological relevance was suggested, as TLR4 activation in necrotizing enterocolitis led to reduced proliferation and increased apoptosis of the intestinal crypts in a manner that could be reversed by inhibition of PUMA, both globally or restricted to the intestinal epithelium. These findings illustrate that TLR4 is expressed on ISCs where it regulates their proliferation and apoptosis through activation of PUMA and that TLR4 regulation of ISCs contributes to the pathogenesis of necrotizing enterocolitis.	[Neal, Matthew D.; Sodhi, Chhinder P.; Jia, Hongpeng; Dyer, Mitchell; Egan, Charlotte E.; Yazji, Ibrahim; Afrazi, Amin; Marino, Ryan; Ma, Congrong; Branca, Maria F.; Prindle, Thomas, Jr.; Grant, Zachary; Hackam, David J.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Div Pediat Surg, Pittsburgh, PA 15224 USA; [Neal, Matthew D.; Sodhi, Chhinder P.; Jia, Hongpeng; Dyer, Mitchell; Egan, Charlotte E.; Yazji, Ibrahim; Afrazi, Amin; Marino, Ryan; Ma, Congrong; Branca, Maria F.; Prindle, Thomas, Jr.; Grant, Zachary; Hackam, David J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15224 USA; [Good, Misty; Slagle, Dennis] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Div Newborn Med, Pittsburgh, PA 15224 USA; [Good, Misty; Slagle, Dennis] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Ozolek, John] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Div Pathol, Pittsburgh, PA 15224 USA; [Ozolek, John] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hackam, DJ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	david.hackam@chp.edu	Neal, Matthew/GMW-5601-2022; Good, Misty/AAI-6192-2020; Marino, Ryan/AAM-8665-2020	Neal, Matthew/0000-0001-8931-6236; Good, Misty/0000-0002-0264-5721; Hackam, David/0000-0001-5195-8807	National Institutes of Health [R01GM078238, RO1DK08752, 5K12HD052892]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health Grant [F30DK085930]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752, F30DK085930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238, P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM078238 and RO1DK08752 (to D. J. H.) and 5K12HD052892 (to M. G.) and by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health Grant F30DK085930 (to A. A.).	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Afrazi A, 2012, J IMMUNOL, V188, P4543, DOI 10.4049/jimmunol.1103114; Afrazi A, 2011, PEDIATR RES, V69, P183, DOI 10.1203/PDR.0b013e3182093280; Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Chen CL, 2012, LAB INVEST, V92, P331, DOI 10.1038/labinvest.2011.167; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dehmer JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027070; Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008; Dirisina R, 2011, GASTROENTEROLOGY, V141, P1036, DOI 10.1053/j.gastro.2011.05.032; Garrison AP, 2009, J PEDIATR GASTR NUTR, V49, P2, DOI 10.1097/MPG.0b013e3181ad3021; Good M, 2012, P NATL ACAD SCI USA, V109, P11330, DOI 10.1073/pnas.1200856109; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Khailova L, 2010, AM J PHYSIOL-GASTR L, V299, pG1118, DOI 10.1152/ajpgi.00131.2010; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Neal MD, 2011, J SURG RES, V167, P1, DOI 10.1016/j.jss.2010.04.037; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Qiu W, 2009, CANCER RES, V69, P4999, DOI 10.1158/0008-5472.CAN-09-0262; Qureshi FG, 2005, GASTROENTEROLOGY, V128, P1012, DOI 10.1053/j.gastro.2005.01.052; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; Ruemmele FM, 2002, GUT, V51, P842, DOI 10.1136/gut.51.6.842; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Suzuki A, 2010, LAB INVEST, V90, P1425, DOI 10.1038/labinvest.2010.150; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yu TX, 2012, J BIOL CHEM, V287, P3760, DOI 10.1074/jbc.M111.316349; Zamora R, 2005, AM J PHYSIOL-GASTR L, V289, pG822, DOI 10.1152/ajpgi.00181.2005	47	138	147	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37296	37308		10.1074/jbc.M112.375881	http://dx.doi.org/10.1074/jbc.M112.375881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955282	hybrid, Green Published			2022-12-25	WOS:000310588500061
J	Van Engen, KJ; Chandrasekaran, B; Smiljanic, R				Van Engen, Kristin J.; Chandrasekaran, Bharath; Smiljanic, Rajka			Effects of Speech Clarity on Recognition Memory for Spoken Sentences	PLOS ONE			English	Article							CLEAR SPEECH; VOWEL INTELLIGIBILITY; CONVERSATIONAL SPEECH; HEARING-LOSS; ACOUSTIC CHARACTERISTICS; TALKER DIFFERENCES; VOICE RECOGNITION; OLDER-ADULTS; SPEAKING; WORD	Extensive research shows that inter-talker variability (i.e., changing the talker) affects recognition memory for speech signals. However, relatively little is known about the consequences of intra-talker variability (i.e. changes in speaking style within a talker) on the encoding of speech signals in memory. It is well established that speakers can modulate the characteristics of their own speech and produce a listener-oriented, intelligibility-enhancing speaking style in response to communication demands (e. g., when speaking to listeners with hearing impairment or non-native speakers of the language). Here we conducted two experiments to examine the role of speaking style variation in spoken language processing. First, we examined the extent to which clear speech provided benefits in challenging listening environments (i.e. speech-in-noise). Second, we compared recognition memory for sentences produced in conversational and clear speaking styles. In both experiments, semantically normal and anomalous sentences were included to investigate the role of higher-level linguistic information in the processing of speaking style variability. The results show that acoustic-phonetic modifications implemented in listener-oriented speech lead to improved speech recognition in challenging listening conditions and, crucially, to a substantial enhancement in recognition memory for sentences.	[Van Engen, Kristin J.; Smiljanic, Rajka] Univ Texas Austin, Dept Linguist, Austin, TX 78712 USA; [Van Engen, Kristin J.; Chandrasekaran, Bharath] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Dept Psychol, Inst Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Van Engen, KJ (corresponding author), Univ Texas Austin, Dept Linguist, Austin, TX 78712 USA.	kvanengen@wustl.edu		Van Engen, Kristin/0000-0001-9069-5464; Chandrasekaran, Bharath/0000-0002-3673-9435				Abercrombie D., 1967, ELEMENTS GEN PHONETI; [Anonymous], 1979, SOCIAL MARKERS SPEEC; Boersma P., 2021, PRAAT DOING PHONETIC; BOOTHROYD A, 1988, J ACOUST SOC AM, V84, P101, DOI 10.1121/1.396976; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P206, DOI 10.3758/BF03206883; Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); Bradlow AR, 2002, J ACOUST SOC AM, V112, P272, DOI 10.1121/1.1487837; Calandruccio L, 2012, J SPEECH LANG HEAR R; Chandrasekaran B, 2011, J COGNITIVE NEUROSCI, V23, P2690, DOI 10.1162/jocn.2011.21631; Clopper CG, 2005, BLACKW HBK LINGUIST, P313; DAVIES GM, 1979, AM J PSYCHOL, V92, P507, DOI 10.2307/1421569; Ferguson SH, 2012, J SPEECH LANG HEAR R, V55, P779, DOI 10.1044/1092-4388(2011/10-0342); Ferguson SH, 2004, J ACOUST SOC AM, V116, P2365, DOI 10.1121/1.1788730; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; GLANZER M, 1974, J VERB LEARN VERB BE, V13, P114, DOI 10.1016/S0022-5371(74)80036-8; GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229; GOLDINGER SD, 1991, J EXP PSYCHOL LEARN, V17, P152, DOI 10.1037/0278-7393.17.1.152; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Hazan V, 2004, J ACOUST SOC AM, V116, P3108, DOI 10.1121/1.1806826; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kang KH, 2008, J ACOUST SOC AM, V124, P3909, DOI 10.1121/1.2988292; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; Krause JC, 2002, J ACOUST SOC AM, V112, P2165, DOI 10.1121/1.1509432; KREIMAN J, 1988, BRAIN LANG, V34, P246, DOI 10.1016/0093-934X(88)90136-8; Kreiman J., 1997, TALKER VARIABILITY S, P85; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; Lamont AC, 2005, MEM COGNITION, V33, P1017, DOI 10.3758/BF03193209; LANDIS T, 1982, NEUROPSYCHOLOGIA, V20, P501, DOI 10.1016/0028-3932(82)90049-5; Laver J, 1989, LOGIC LINGUISTICS, P37; LAVER JDM, 1968, BRIT J DISORD COMMUN, V3, P43; Liu S, 2004, J ACOUST SOC AM, V116, P2374, DOI 10.1121/1.1787528; Liu S, 2006, J ACOUST SOC AM, V120, P424, DOI 10.1121/1.2208427; Maniwa K, 2009, J ACOUST SOC AM, V125, P3962, DOI 10.1121/1.2990715; Matthies M, 2001, J SPEECH LANG HEAR R, V44, P340, DOI 10.1044/1092-4388(2001/028); McCoy SL, 2005, Q J EXP PSYCHOL-A, V58, P22, DOI 10.1080/02724980443000151; MILLER GA, 1963, J VERB LEARN VERB BE, V2, P217, DOI 10.1016/S0022-5371(63)80087-0; MULLENNIX JW, 1990, PERCEPT PSYCHOPHYS, V47, P379, DOI 10.3758/BF03210878; Murphy DR, 2000, PSYCHOL AGING, V15, P49; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Nye PW, 1974, SR3738 HASK LAB; NYGAARD LC, 1994, PSYCHOL SCI, V5, P42, DOI 10.1111/j.1467-9280.1994.tb00612.x; PALMERI TJ, 1993, J EXP PSYCHOL LEARN, V19, P309, DOI 10.1037/0278-7393.19.2.309; PAYTON KL, 1994, J ACOUST SOC AM, V95, P1581, DOI 10.1121/1.408545; Perkell JS, 2002, J ACOUST SOC AM, V112, P1627, DOI 10.1121/1.1506369; PICHENY MA, 1989, J SPEECH HEAR RES, V32, P600, DOI 10.1044/jshr.3203.600; PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; PODD J, 1990, APPL COGNITIVE PSYCH, V4, P47, DOI 10.1002/acp.2350040105; R Development Core Team, 2005, R LANG ENV STAT COMP; RABBITT P, 1991, ACTA OTO-LARYNGOL, P167; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P241, DOI 10.1080/14640746808400158; Remez RE, 1997, J EXP PSYCHOL HUMAN, V23, P651, DOI 10.1037/0096-1523.23.3.651; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; Schneider W., 2002, E PRIME USERS GUIDE; Schum D J, 1996, J Am Acad Audiol, V7, P212; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Smiljanic R, 2005, J ACOUST SOC AM, V118, P1677, DOI 10.1121/1.2000788; Smiljanic R, 2008, J ACOUST SOC AM, V124, P3171, DOI 10.1121/1.2990712; Smiljanic R, 2009, LANG LINGUIST COMPAS, V3, P236, DOI 10.1111/j.1749-818x.2008.00112.x; Smlljanlc R, 2008, J PHONETICS, V36, P91, DOI 10.1016/j.wocn.2007.02.002; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stevens AA, 2004, COGNITIVE BRAIN RES, V18, P162, DOI 10.1016/j.cogbrainres.2003.10.008; Surprenant AM, 2007, AGING NEUROPSYCHOL C, V14, P126, DOI 10.1080/13825580701217710; Surprenant AM, 1999, INT J PSYCHOL, V34, P328, DOI 10.1080/002075999399648; TULVING E, 1962, CAN J PSYCHOLOGY, V16, P83, DOI 10.1037/h0083231; Tun PA, 2009, PSYCHOL AGING, V24, P761, DOI 10.1037/a0014802; Uchanski RM, 2005, BLACKW HBK LINGUIST, P207, DOI 10.1002/9780470757024.ch9; van Boxtel MPJ, 2000, J CLIN EXP NEUROPSYC, V22, P147, DOI 10.1076/1380-3395(200002)22:1;1-8;FT147; VANLANCKER D, 1985, J PHONETICS, V13, P19, DOI 10.1016/S0095-4470(19)30723-5; Wingfield A, 2005, CURR DIR PSYCHOL SCI, V14, P144, DOI 10.1111/j.0963-7214.2005.00356.x	72	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43753	10.1371/journal.pone.0043753	http://dx.doi.org/10.1371/journal.pone.0043753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970141	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000006
J	Sohn, JJ; Schetter, AJ; Yfantis, HG; Ridnour, LA; Horikawa, I; Khan, MA; Robles, AI; Hussain, SP; Goto, A; Bowman, ED; Hofseth, LJ; Bartkova, J; Bartek, J; Wogan, GN; Wink, DA; Harris, CC				Sohn, Jane J.; Schetter, Aaron J.; Yfantis, Harris G.; Ridnour, Lisa A.; Horikawa, Izumi; Khan, Mohammed A.; Robles, Ana I.; Hussain, S. Perwez; Goto, Akiteru; Bowman, Elise D.; Hofseth, Lorne J.; Bartkova, Jirina; Bartek, Jiri; Wogan, Gerald N.; Wink, David A.; Harris, Curtis C.			Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; ULCERATIVE-COLITIS; CELLULAR SENESCENCE; COLORECTAL-CANCER; CROHNS-DISEASE; SYNTHASE EXPRESSION; SUSCEPTIBILITY LOCI; BREAST-CANCER; TUMOR-GROWTH; IN-VIVO	Background: Cellular senescence can be a functional barrier to carcinogenesis. We hypothesized that inflammation modulates carcinogenesis through senescence and DNA damage response (DDR). We examined the association between senescence and DDR with macrophage levels in inflammatory bowel disease (IBD). In vitro experiments tested the ability of macrophages to induce senescence in primary cells. Inflammation modulating microRNAs were identified in senescence colon tissue for further investigation. Methodology/Principal Findings: Quantitative immunohistochemistry identified protein expression by colon cell type. Increased cellular senescence (HP1 gamma; P = 0.01) or DDR (gamma H2A.X; P = 0.031, phospho-Chk2, P = 0.014) was associated with high macrophage infiltration in UC. Co-culture with macrophages (ANA-1) induced senescence in .80% of primary cells (fibroblasts MRC5, WI38), illustrating that macrophages induce senescence. Interestingly, macrophage-induced senescence was partly dependent on nitric oxide synthase, and clinically relevant NO center dot levels alone induced senescence. NO center dot induced DDR in vitro, as detected by immunofluorescence. In contrast to UC, we noted in Crohn's disease (CD) that senescence (HP1 gamma; P < 0.001) and DDR (gamma H2A.X; P < 0.05, phospho-Chk2; P < 0.001) were higher, and macrophages were not associated with senescence. We hypothesize that nitric oxide may modulate senescence in CD; epithelial cells of CD had higher levels of NOS2 expression than in UC (P = 0.001). Microarrays and quantitative-PCR identified miR-21 expression associated with macrophage infiltration and NOS2 expression. Conclusions: Senescence was observed in IBD with senescence-associated beta-galactosidase and HP1 gamma. Macrophages were associated with senescence and DDR in UC, and in vitro experiments with primary human cells showed that macrophages induce senescence, partly through NO center dot, and that NO center dot can induce DDR associated with senescence. Future experiments will investigate the role of NO center dot and miR-21 in senescence. This is the first study to implicate macrophages and nitrosative stress in a direct effect on senescence and DDR, which is relevant to many diseases of inflammation, cancer, and aging.	[Sohn, Jane J.; Schetter, Aaron J.; Horikawa, Izumi; Khan, Mohammed A.; Robles, Ana I.; Hussain, S. Perwez; Goto, Akiteru; Bowman, Elise D.; Harris, Curtis C.] Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Bethesda, MD USA; [Yfantis, Harris G.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Yfantis, Harris G.] Univ Maryland, Sch Med, Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Ridnour, Lisa A.; Wink, David A.] Natl Canc Inst, Radiat Biol Branch, Bethesda, MD USA; [Hofseth, Lorne J.] Univ S Carolina, S Carolina Coll Pharm, Dept Pharmaceut & Biomed Sci, Columbia, SC USA; [Bartkova, Jirina; Bartek, Jiri] Canc Soc Res Ctr, Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic; [Wogan, Gerald N.] MIT, Ctr Environm Hlth Sci, Dept Biol Engn, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Danish Cancer Society; Palacky University Olomouc; Massachusetts Institute of Technology (MIT)	Sohn, JJ (corresponding author), Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Bethesda, MD USA.	Curtis_Harris@nih.gov	Bartek, Jiri/G-5870-2014; Goto, Akiteru/P-5775-2014	Goto, Akiteru/0000-0001-8776-9004; Hussain, S. Perwez/0000-0002-2294-522X; Wink, David/0000-0002-5652-7480; Ridnour, Lisa A./0000-0001-9446-8349; Robles, Ana/0000-0001-5019-4374; Azad, Mahan/0000-0002-8633-3513	National Cancer Institute; Danish Cancer Society; Danish National Research Foundation; European Commission	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by the Intramural Research Program of the National Cancer Institute. Dr. Sohn was supported by the Cancer Research Training Award Fellowship from the National Cancer Institute. Dr. Bartkova and Dr. Bartek were supported by the Danish Cancer Society, the Danish National Research Foundation, and the European Commission (projects: Infla-Care, Biomedreg and DDResponse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Ambs S, 1998, NAT MED, V4, P1371, DOI 10.1038/3957; Ambs S, 1999, J NATL CANCER I, V91, P86, DOI 10.1093/jnci/91.1.86; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x; Clemons NJ, 2007, GASTROENTEROLOGY, V133, P1198, DOI 10.1053/j.gastro.2007.06.061; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Espey MG, 2000, J BIOL CHEM, V275, P11341, DOI 10.1074/jbc.275.15.11341; Favetta LA, 2004, EXP CELL RES, V299, P36, DOI 10.1016/j.yexcr.2004.05.009; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Hussain SP, 2000, CANCER RES, V60, P3333; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Nair J, 2006, ANTIOXID REDOX SIGN, V8, P1003, DOI 10.1089/ars.2006.8.1003; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Oliveira CJR, 2003, FREE RADICAL BIO MED, V35, P381, DOI 10.1016/S0891-5849(03)00311-3; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Risques RA, 2011, CANCER RES, V71, P1669, DOI 10.1158/0008-5472.CAN-10-1966; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Salk JJ, 2009, P NATL ACAD SCI US; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Stewart B, 2003, WORLD CANC REPORT, P56; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	68	48	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44156	10.1371/journal.pone.0044156	http://dx.doi.org/10.1371/journal.pone.0044156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970173	gold, Green Submitted, Green Published			2022-12-25	WOS:000308458400040
J	Feng, J; Pan, XL; Yu, JB; Chen, Z; Xu, H; El-Rifai, W; Zhang, GX; Xu, ZK				Feng, Jin; Pan, Xiaolin; Yu, Junbo; Chen, Zheng; Xu, Hao; El-Rifai, Wael; Zhang, Guoxin; Xu, Zekuan			Functional PstI/RsaI Polymorphism in CYP2E1 Is Associated with the Development, Progression and Poor Outcome of Gastric Cancer	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; CYTOCHROME-P450 2E1; N-NITROSODIALKYLAMINES; METABOLIZING-ENZYMES; LUNG-CANCER; P450 2E1; RISK; SUSCEPTIBILITY; TOBACCO; EXPRESSION	Background: Cytochrome P450 2E1 (CYP2E1), an ethanol-inducible enzyme, has been shown to metabolically activate various carcinogens, which is critical for the development and progression of cancers. It has demonstrated that CYP2E1 polymorphisms alter the transcriptional activity of the gene. However, studies on the association between CYP2E1 polymorphisms (PstI/RsaI or DraI) and gastric cancer have reported conflicting results. Thus, the aim of the present study was to investigate whether CYP2E1 polymorphisms is associated with the development and progression of gastric cancer and its prognosis in Chinese patients. Methods: A case-control study was conducted in which CYP2E1 PstI/RsaI and DraI polymorphisms were analyzed in 510 Chinese patients with gastric cancer and 510 age- and sex-matched healthy controls by PCR-RFLP. Odds ratios were estimated by multivariate logistic regression, and the lifetime was calculated by Kaplan-Meier survival curves. In addition, a meta-analysis was also conducted to verify the findings. Results: For CYP2E1 PstI/RsaI polymorphism, C2C2 homozygotes (OR = 2.15; CI: 1.18-3.94) and C2 carriers (OR = 1.48; CI: 1.13-1.96) were associated with an increased risk of gastric cancer when compared with C1C1 homozygotes. Both C1C2 and C2C2 genotypes were associated with advanced stage, but not the grade of gastric cancer. Moreover, C2C2 genotype was identified as an independent marker of poor overall survival for gastric cancer. However, there was not any significant association between CYP2E1 DraI polymorphism and the risk of gastric cancer. In the meta-analysis, pooled data from 13 studies confirmed that the CYP2E1 PstI/RsaI polymorphism was associated with a significantly increased risk of gastric cancer. Conclusion: CYP2E1 PstI/RsaI polymorphism is associated with increased risk of development, progression and poor prognosis of gastric cancer in Chinese patients. Pooled data from 13 studies, mainly in Asian countries, are in agreement with our findings.	[Feng, Jin; Yu, Junbo; Chen, Zheng; Xu, Hao; Xu, Zekuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Peoples R China; [Pan, Xiaolin; Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Peoples R China; [El-Rifai, Wael] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [El-Rifai, Wael] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Nanjing Medical University; Nanjing Medical University; Vanderbilt University; Vanderbilt University	Feng, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Peoples R China.	guoxinz@njmu.edu.cn; xuzekuan@njmu.edu.cn			National Natural Science Foundation of China [81072031(BA10)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [NO. 81072031(BA10)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621; Augenlicht LH, 2002, EUR J CANCER PREV, V11, pS12; Balaji L, 2011, ASIAN PAC J CANCER P, V12, P1523; Bellec G, 1996, CARCINOGENESIS, V17, P2029, DOI 10.1093/carcin/17.9.2029; Boccia S, 2007, CARCINOGENESIS, V28, P101, DOI 10.1093/carcin/bgl124; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Cai L, 2001, WORLD J GASTROENTERO, V7, P792, DOI 10.3748/wjg.v7.i6.792; Cai L, 2001, WORLD J GASTROENTERO, V7, P506; Cai L, 2005, WORLD J GASTROENTERO, V11, P1867, DOI 10.3748/wjg.v11.i12.1867; CAMUS AM, 1993, MOL CARCINOGEN, V7, P268, DOI 10.1002/mc.2940070410; Colombo J, 2004, WORLD J GASTROENTERO, V10, P1240; Gao CM, 2002, CANCER EPIDEM BIOMAR, V11, P29; Glatt HR, 2000, BIOCHEM SOC T, V28, P1; Haque AK, 2004, APPL IMMUNOHISTO M M, V12, P315, DOI 10.1097/00129039-200412000-00005; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; HOFFMANN D, 1985, CANCER RES, V45, P935; Hu Y, 1999, BIOCHEM BIOPH RES CO, V263, P286, DOI 10.1006/bbrc.1999.1362; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Indulski JA, 2000, INT ARCH OCC ENV HEA, V73, P71, DOI 10.1007/PL00007942; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kato S, 2011, J NIPPON MED SCH, V78, P224, DOI 10.1272/jnms.78.224; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Kiyohara C, 2000, J Epidemiol, V10, P349; Kuno S, 1996, CANCER CAUSE CONTROL, V7, P41; Lee Han Chu, 1997, Korean Journal of Internal Medicine (English Edition), V12, P128; Malats N, 2001, PANCREATOLOGY, V1, P472, DOI 10.1159/000055850; Malik Manzoor A, 2009, J Gastrointest Cancer, V40, P26, DOI 10.1007/s12029-009-9072-0; Munaka M, 2003, J CANCER RES CLIN, V129, P355, DOI 10.1007/s00432-003-0439-5; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3175, DOI 10.3748/wjg.v11.i21.3175; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3834; Neuhaus T, 2004, TOXICOL LETT, V151, P273, DOI 10.1016/j.toxlet.2003.09.017; Nishimoto IN, 2000, CANCER EPIDEM BIOMAR, V9, P675; Oyama T, 2007, FRONT BIOSCI, V12, P4497, DOI 10.2741/2404; Park GT, 2003, J GASTROEN HEPATOL, V18, P1257, DOI 10.1046/j.1440-1746.2003.03167.x; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Olivieri EHR, 2009, ORAL ONCOL, V45, pE73, DOI 10.1016/j.oraloncology.2009.03.004; Shparyk Ia V, 1998, Klin Khir, P36; SOBIN LH, 1981, B WORLD HEALTH ORGAN, V59, P813; Suzuki S, 2004, J GASTROENTEROL, V39, P220, DOI 10.1007/s00535-003-1281-x; Tang KF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-575; Tsukino H, 2002, INT J CANCER, V100, P425, DOI 10.1002/ijc.10492; Tsunedomi R, 2005, INT J ONCOL, V27, P661; UMENO M, 1988, BIOCHEMISTRY-US, V27, P9006, DOI 10.1021/bi00425a019; Vaclavikova R, 2007, ANTICANCER RES, V27, P4443; WATANABE J, 1994, J BIOCHEM-TOKYO, V116, P321, DOI 10.1093/oxfordjournals.jbchem.a124526; Wu MS, 2002, INT J COLORECTAL DIS, V17, P338, DOI 10.1007/s00384-001-0383-2; Xue HP, 2010, J GASTROEN HEPATOL, V25, P1604, DOI 10.1111/j.1440-1746.2010.06428.x; YAMAZAKI H, 1992, CARCINOGENESIS, V13, P1789, DOI 10.1093/carcin/13.10.1789; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zagorac D, 2008, J CEREBR BLOOD F MET, V28, P1431, DOI 10.1038/jcbfm.2008.31; Zhan P, 2010, LUNG CANCER, V69, P19, DOI 10.1016/j.lungcan.2009.09.001	52	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44478	10.1371/journal.pone.0044478	http://dx.doi.org/10.1371/journal.pone.0044478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957075	Green Submitted, gold, Green Published			2022-12-25	WOS:000308463800068
J	Foulquier, S; Dupuis, F; Perrin-Sarrado, C; Gate, KM; Leroy, P; Liminana, P; Atkinson, J; Capdeville-Atkinson, C; Lartaud, I				Foulquier, Sebastien; Dupuis, Francois; Perrin-Sarrado, Caroline; Gate, Katy Maguin; Leroy, Pierre; Liminana, Patrick; Atkinson, Jeffrey; Capdeville-Atkinson, Christine; Lartaud, Isabelle			Differential Effects of Short-Term Treatment with Two AT(1) Receptor Blockers on Diameter of Pial Arterioles in SHR	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; CONVERTING ENZYME-INHIBITOR; NITRIC-OXIDE SYNTHASE; HIGH-SALT INTAKE; ANGIOTENSIN-II; PPAR-GAMMA; CEREBRAL ARTERIOLES; BLOOD-PRESSURE; INCREASED EXPRESSION; BRAIN MICROVESSELS	Chronic treatment with angiotensin receptor blockers is largely accepted for protecting cerebral circulation during hypertension, but beneficial effects of short-term treatments are questionable, as highlighted by the recent SCAST trial. We compared the impact of 10 days treatment with candesartan (as SCAST) versus telmisartan (previously described to reverse arteriolar remodeling, chronic treatment) on pial arterioles of spontaneously hypertensive rats (SHR). We explored whether PPAR-gamma agonist activity or AT(1) receptor blockade are involved in their differential effects. In the first study, 4-monthold male SHR were treated with telmisartan (TELMI, 2 mg/kg per day) or candesartan cilexetil (CANDE, 10 mg/kg per day) and compared to vehicle treated SHR and normotensive WKY. In a second study, SHR were treated with CANDE, pioglitazone (a PPAR-gamma agonist, PIO 2.5 mg/kg per day) or CANDE+PIO, compared to TELMI. Internal diameter of pial arterioles (ID, cranial window) was measured at baseline, during hemorrhage-induced hypotension, or following suffusion of Ang II (10(-6) mol/L) or EDTA inactivation of smooth muscle cells (passive ID). PPAR-gamma and eNOS (target gene of PPARgamma) mRNA were evaluated in brain microvessels. For similar antihypertensive effects, TELMI (+44% versus SHR), but not CANDE, increased baseline ID. During hemorrhage, ID in TELMI group was similar to WKY, while ID in SHR and CANDE remained lower. In the second study, TELMI (+36%, versus SHR) and CANDE+PIO (+43%) increased baseline ID, but not CANDE or PIO alone. TELMI (-66%) and CANDE+PIO (-69%), but neither CANDE nor PIO alone, decreased Ang II-induced vasoconstriction. CANDE+PIO, but not CANDE, increased passive ID. In both studies, PPAR-gamma and eNOS expressions were higher in TELMI than CANDE. Short-term treatment with TELMI, but not with CANDE, reverses narrowing of pial arteriolar ID in SHR. This may involve PPAR-gamma related mechanisms, since CANDE+PIO treatment induced similar effects, and a better blockade of AT(1) receptors.	[Foulquier, Sebastien; Dupuis, Francois; Perrin-Sarrado, Caroline; Gate, Katy Maguin; Leroy, Pierre; Liminana, Patrick; Atkinson, Jeffrey; Capdeville-Atkinson, Christine; Lartaud, Isabelle] Univ Lorraine, Fac Pharm, CITHEFOR Drug Targets Formulat & Preclin Assessme, Nancy, France	Universite de Lorraine	Foulquier, S (corresponding author), Univ Lorraine, Fac Pharm, CITHEFOR Drug Targets Formulat & Preclin Assessme, Nancy, France.	isabelle.lartaud@univ-lorraine.fr	Foulquier, Sébastien/AAE-6998-2019	Foulquier, Sébastien/0000-0002-2523-0748; DUPUIS, Francois/0000-0003-1947-3839; perrin-sarrado, caroline/0000-0002-3483-1211; Lartaud, Isabelle/0000-0001-9257-6311	French Ministry of Education, Research and Technology (Paris, France) [EA3452]; Lorraine Regional Development Committee (Metz, France); Regional Coordination and Research Council (Nancy, Metz, France); "Universite de Lorraine" (Nancy, France); Pharmacolor Association (Nancy, France)	French Ministry of Education, Research and Technology (Paris, France); Lorraine Regional Development Committee (Metz, France); Regional Coordination and Research Council (Nancy, Metz, France); "Universite de Lorraine" (Nancy, France); Pharmacolor Association (Nancy, France)	The work was funded by the French Ministry of Education, Research and Technology (Paris, France, EA3452), the Lorraine Regional Development Committee (Metz, France), the Regional Coordination and Research Council (Nancy, Metz, France), the "Universite de Lorraine" (Nancy, France) and the Pharmacolor Association (Nancy, France). Sebastien Foulquier had a PhD grant from the Lorraine Regional Development Committee (Metz, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1999, NEUROCHEM RES, V24, P1507, DOI 10.1023/A:1021191729865; Ando H, 2004, STROKE, V35, P1726, DOI 10.1161/01.STR.0000129788.26346.18; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Beyer AM, 2008, HYPERTENSION, V51, P867, DOI 10.1161/HYPERTENSIONAHA.107.103648; Bian C, 2009, BIOL PHARM BULL, V32, P416, DOI 10.1248/bpb.32.416; Chan SL, 2008, J CARDIOVASC PHARM, V51, P304, DOI 10.1097/FJC.0b013e318163a946; Chillon JM, 1999, HYPERTENSION, V33, P856, DOI 10.1161/01.HYP.33.3.856; Diener HC, 2009, J HYPERTENS, V27, pS31, DOI 10.1097/01.hjh.0000357906.60778.7f; Diep QN, 2002, CIRCULATION, V105, P2296, DOI 10.1161/01.CIR.0000016049.86468.23; Diep QN, 2001, HYPERTENSION, V38, P249, DOI 10.1161/01.HYP.38.2.249; Dupuis F, 2005, J HYPERTENS, V23, P1061, DOI 10.1097/01.hjh.0000166848.95592.a5; Dupuis F, 2010, J HYPERTENS, V28, P1566, DOI 10.1097/HJH.0b013e328339f1f3; Fog M, 1937, ARCH NEURO PSYCHIATR, V37, P351, DOI 10.1001/archneurpsyc.1937.02260140137007; Foulquier S, 2011, J HYPERTENS, V29, P1392, DOI 10.1097/HJH.0b013e328347050e; Gaillard V, 2005, HYPERTENSION, V46, P372, DOI 10.1161/01.HYP.0000171472.24422.33; Gate KM, 2011, BRAIN RES, V1369, P95, DOI 10.1016/j.brainres.2010.10.100; Gohlke P, 2002, J HYPERTENS, V20, P909, DOI 10.1097/00004872-200205000-00026; Iwanami J, 2010, J HYPERTENS, V28, P1730, DOI 10.1097/HJH.0b013e32833a551a; Kagota S, 2001, BRIT J PHARMACOL, V134, P737, DOI 10.1038/sj.bjp.0704300; Kobayashi N, 2008, AM J HYPERTENS, V21, P576, DOI 10.1038/ajh.2008.27; Kuipers I, 2008, HYPERTENSION, V51, P1442, DOI 10.1161/HYPERTENSIONAHA.107.108530; Kumai Y, 2008, EXP NEUROL, V210, P441, DOI 10.1016/j.expneurol.2007.11.028; Li YQ, 2007, EUR J PHARMACOL, V577, P100, DOI 10.1016/j.ejphar.2007.08.008; Nakamura T, 2007, STROKE, V38, P3016, DOI 10.1161/STROKEAHA.107.486522; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; Pelisch N, 2010, HYPERTENS RES, V33, P161, DOI 10.1038/hr.2009.200; Roberts TJM, 2009, AM J PHYSIOL-HEART C, V297, pH1347, DOI 10.1152/ajpheart.00630.2009; Ryan MJ, 2004, HYPERTENSION, V43, P661, DOI 10.1161/01.HYP.0000116303.71408.c2; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Seltzer A, 2004, BRAIN RES, V1028, P9, DOI 10.1016/j.brainres.2004.06.079; Sigmund CD, 2010, HYPERTENSION, V55, P437, DOI 10.1161/HYPERTENSIONAHA.109.144170; SUGIYAMA Y, 1990, ARZNEIMITTEL-FORSCH, V40-1, P263; Touyz RM, 2006, VASC PHARMACOL, V45, P19, DOI 10.1016/j.vph.2005.11.014; Trenkwalder P, 2006, J HYPERTENS, V24, pS107, DOI 10.1097/01.hjh.0000220415.99610.22; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincent JM, 2005, STROKE, V36, P2691, DOI 10.1161/01.STR.0000190002.79052.bf; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Xiao J, 2009, CLIN IMMUNOL, V132, P266, DOI 10.1016/j.clim.2009.04.004; Yamakawa H, 2003, J CEREBR BLOOD F MET, V23, P371, DOI 10.1097/01.WCB.0000047369.05600.03; Yuen CY, 2011, CARDIOVASC RES, V90, P122, DOI 10.1093/cvr/cvq392; Zhou J, 2005, J CEREBR BLOOD F MET, V25, P878, DOI 10.1038/sj.jcbfm.9600082; Zorad S, 2006, EUR J PHARMACOL, V552, P112, DOI 10.1016/j.ejphar.2006.08.062	43	6	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42469	10.1371/journal.pone.0042469	http://dx.doi.org/10.1371/journal.pone.0042469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957022	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800014
J	Hu, CP; Zou, YQ; Feng, JT; Li, XZ				Hu, Cheng-Ping; Zou, Ye-Qiang; Feng, Jun-Tao; Li, Xiao-Zhao			The Effect of Unilateral Adrenalectomy on Transformation of Adrenal Medullary Chromaffin Cells In Vivo: A Potential Mechanism of Asthma Pathogenesis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; CIRCULATING CATECHOLAMINES; NGF; TRANSCRIPTION; DYSFUNCTION; EXPRESSION	Background: Decreased epinephrine (EPI) is an important underlying factor of bronchoconstriction in asthma. Exogenous beta(2)-adrenergic receptor agonist is one of the preferred options to treat asthma. We previously showed that this phenomenon involved adrenal medullary chromaffin cell (AMCC) transformation to a neuron phenotype. However, the underlying molecular mechanism is not fully understood. To further explore this, an asthmatic model with unilateral adrenalectomy was established in this study. Methodology/Principal Findings: Thirty-two rats were randomly into four groups (n = 8 each) control rats (controls), unilateral adrenalectomy rats (surgery-control, s-control), asthmatic rats (asthma), unilateral adrenalectomy asthmatic rats (surgery-induced asthma, s-asthma). Asthmatic rats and s-asthmatic rats were sensitized and challenged with ovalbumin (OVA). The pathological changes in adrenal medulla tissues were observed under microscopy. EPI and its rate-limiting enzyme, phenylethanolamine N-methyl transferase (PNMT), were measured. Peripherin, a type III intermediate filament protein, was also detected in each group. The asthmatic rats presented with decreased chromaffin granules and swollen mitochondria in AMCCs, and the s-asthmatic rats presented more serious pathological changes than those in asthmatic rats and s-control rats. The expressions of EPI and PNMT in asthmatic rats were significantly decreased, as compared with levels in controls (P<0.05), and a further decline was observed in s-asthmatic rats (P<0.05). The expression of peripherin was higher in the asthmatic rats than in the controls, and the highest level was found in the s-asthmatic rats (P<0.05). Conclusion/Significance: Compared with asthmatic rats and s-control rats, the transformation tendency of AMCCs to neurons is more obvious in the s-asthmatic rats. Moreover, this phenotype alteration in the asthmatic rats is accompanied by reduced EPI and PNMT, and increased peripherin expression. This result provides further evidence to support the notion that phenotype alteration of AMCCs contributes to asthma pathogenesis.	[Hu, Cheng-Ping; Zou, Ye-Qiang; Feng, Jun-Tao; Li, Xiao-Zhao] Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Peoples R China; [Zou, Ye-Qiang] First Peoples Hosp Changde, Dept Resp Med, Changde, Peoples R China	Central South University	Hu, CP (corresponding author), Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Peoples R China.	jtfeng1976@hotmail.com; xiaozhaosun@hotmail.com			National Natural Science Foundation of China [30801505, 30800502, 81070026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30801505, No. 30800502 and No. 81070026) [http://www.nsfc.gov.cn/Portal0/default124.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; BARNES PJ, 1981, THORAX, V36, P435, DOI 10.1136/thx.36.6.435; BLASCHKO H, 1967, BIOCHEM J, V104, P545, DOI 10.1042/bj1040545; Bonini S, 1996, P NATL ACAD SCI USA, V93, P10955, DOI 10.1073/pnas.93.20.10955; DERER M, 1989, NEUROSCIENCE, V31, P471, DOI 10.1016/0306-4522(89)90389-8; Dupin E, 2007, CR BIOL, V330, P521, DOI 10.1016/j.crvi.2007.04.004; EVINGER MJ, 1992, CELL MOL NEUROBIOL, V12, P193, DOI 10.1007/BF00712926; Feng JT, 2005, MED HYPOTHESES, V65, P1043, DOI 10.1016/j.mehy.2005.06.029; Feng JT, 2010, CHINESE MED J-PEKING, V123, P1333, DOI 10.3760/cma.j.issn.0366-6999.2010.10.020; Fukuda T, 2007, J ANESTH, V21, P348, DOI 10.1007/s00540-007-0521-2; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Hodel A, 2001, J NEUROENDOCRINOL, V13, P217; Huber K, 2002, DEVELOPMENT, V129, P4729; Huber K, 2009, AUTON NEUROSCI-BASIC, V151, P10, DOI 10.1016/j.autneu.2009.07.020; IND PW, 1985, BRIT MED J, V290, P267, DOI 10.1136/bmj.290.6464.267; JENKINS CJ, 1987, THORAX, V42, P664, DOI 10.1136/thx.42.9.664; Kvetnansky R, 2006, CELL MOL NEUROBIOL, V26, P735, DOI 10.1007/s10571-006-9063-7; LILLIEN LE, 1985, NATURE, V317, P632, DOI 10.1038/317632a0; LILLIEN LE, 1985, EXP CELL RES, V161, P255, DOI 10.1016/0014-4827(85)90083-7; Liu Yi, 2000, Shengli Xuebao, V52, P5; MORIMOTO M, 1994, NEUROREPORT, V5, P954, DOI 10.1097/00001756-199404000-00025; Nie HP, 2010, THESIS CENTRAL S U C; Qin LY, 2009, J SNAKE, V21, P257; Unsicker K, 2005, NEUROCHEM RES, V30, P921, DOI 10.1007/s11064-005-6966-5; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; Wang Jun, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P812; Wu XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020337; Yamaguchi-Shima N, 2007, EUR J PHARMACOL, V564, P94, DOI 10.1016/j.ejphar.2007.02.021	29	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44586	10.1371/journal.pone.0044586	http://dx.doi.org/10.1371/journal.pone.0044586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957086	Green Published, gold, Green Submitted			2022-12-25	WOS:000308463800079
J	Toure, O; Konate, S; Sissoko, S; Niangaly, A; Barry, A; Sall, AH; Diarra, E; Poudiougou, B; Sepulveda, N; Campino, S; Rockett, KA; Clark, TG; Thera, MA; Doumbo, O				Toure, Ousmane; Konate, Salimata; Sissoko, Sibiri; Niangaly, Amadou; Barry, Abdoulaye; Sall, Abdourahmane H.; Diarra, Elisabeth; Poudiougou, Belco; Sepulveda, Nuno; Campino, Susana; Rockett, Kirk A.; Clark, Taane G.; Thera, Mahamadou A.; Doumbo, Ogobara		MalariaGEN Consortium	Candidate Polymorphisms and Severe Malaria in a Malian Population	PLOS ONE			English	Article							SUSCEPTIBILITY; ASSOCIATION; PROTECTION	Malaria is a major health burden in sub-Saharan African countries, including Mali. The disease is complex, with multiple genetic determinants influencing the observed variation in response to infection, progression, and severity. We assess the influence of sixty-four candidate loci, including the sickle cell polymorphism (HbS), on severe malaria in a case-control study consisting of over 900 individuals from Bamako, Mali. We confirm the known protective effects of the blood group O and the HbS AS genotype on life-threatening malaria. In addition, our analysis revealed a marginal susceptibility effect for the CD40 ligand (CD40L)+220C allele. The lack of statistical evidence for other candidates may demonstrate the need for large-scale genome-wide association studies in malaria to discover new polymorphisms. It also demonstrates the need for establishing the region-specific repertoire of functional variation in important genes, including the glucose-6-phosphatase deficiency gene, before embarking on focused genotyping.	[Toure, Ousmane; Konate, Salimata; Sissoko, Sibiri; Niangaly, Amadou; Barry, Abdoulaye; Sall, Abdourahmane H.; Diarra, Elisabeth; Poudiougou, Belco; Thera, Mahamadou A.; Doumbo, Ogobara] Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Dent, Bamako, Mali; [Barry, Abdoulaye; Sall, Abdourahmane H.; Diarra, Elisabeth] Gabriel Toure Hosp, Ctr Hosp Univ, Bamako, Mali; [Sepulveda, Nuno; Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Campino, Susana] Wellcome Trust Sanger Inst, Cambridge, England; [Rockett, Kirk A.; MalariaGEN Consortium] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	University of Bamako; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine	Toure, O (corresponding author), Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Dent, Bamako, Mali.	taane.clark@lshtm.ac.uk; mthera@icermali.org; okd@icermali.org	Sepulveda, Nuno/AAA-5544-2021; Sepulveda, Nuno/S-9936-2019; Clark, Taane G./AAM-2570-2020; Campino, Susana/AAM-2577-2020	Clark, Taane G./0000-0001-8985-9265; Campino, Susana/0000-0003-1403-6138; Sepulveda, Nuno/0000-0002-8542-1706; Thera, Mahamadou A/0000-0002-2679-035X	Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 075491/Z/04, 090532/Z/09/Z]; Foundation for the National Institutes of Health as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative [566]; Medical Research Council [G0600718, G0600230]; Wellcome Trust Sanger Institute [G0600230, 077012/Z/05/Z, 087285, 096527]; MRC [G0600230, G0600718] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Foundation for the National Institutes of Health as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Sanger Institute(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and by the Foundation for the National Institutes of Health (566) as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). This research was supported by the Medical Research Council (G0600718; G0600230). The Wellcome Trust also provided core awards to the Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger Institute (077012/Z/05/Z). G0600230), the Wellcome Trust Biomedical ethics Enhancement Award (087285) and Strategic Award (096527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; [Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Clark IA, 1996, ADV PARASIT, V37, P1, DOI 10.1016/S0065-308X(08)60218-3; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Modiano D., 1995, Parassitologia (Rome), V37, P255; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.6363877; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	23	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43987	10.1371/journal.pone.0043987	http://dx.doi.org/10.1371/journal.pone.0043987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957039	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000308463800031
J	Li, XX; Xu, X; Wang, JN; Yu, H; Wang, X; Yang, HJ; Xu, HY; Tang, SH; Li, Y; Yang, L; Huang, LQ; Wang, YH; Yang, SL				Li, Xiuxiu; Xu, Xue; Wang, Jinan; Yu, Hua; Wang, Xia; Yang, Hongjun; Xu, Haiyu; Tang, Shihuan; Li, Yan; Yang, Ling; Huang, Luqi; Wang, Yonghua; Yang, Shengli			A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment	PLOS ONE			English	Article							SALVIANOLIC-ACID-B; SMOOTH-MUSCLE-CELLS; P-GLYCOPROTEIN; DRUG DISCOVERY; MOLECULAR-MECHANICS; PANAX-NOTOGINSENG; GINSENOSIDE RB-1; IN-VITRO; MILTIORRHIZA; INHIBITORS	Compound Danshen Formula (CDF) is a widely used Traditional Chinese Medicine (TCM) which has been extensively applied in clinical treatment of cardiovascular diseases (CVDs). However, the underlying mechanism of clinical administrating CDF on CVDs is not clear. In this study, the pharmacological effect of CDF on CVDs was analyzed at a systemic point of view. A systems-pharmacological model based on chemical, chemogenomics and pharmacological data is developed via network reconstruction approach. By using this model, we performed a high-throughput in silico screen and obtained a group of compounds from CDF which possess desirable pharmacodynamical and pharmacological characteristics. These compounds and the corresponding protein targets are further used to search against biological databases, such as the compound-target associations, compound-pathway connections and disease-target interactions for reconstructing the biologically meaningful networks for a TCM formula. This study not only made a contribution to a better understanding of the mechanisms of CDF, but also proposed a strategy to develop novel TCM candidates at a network pharmacology level.	[Li, Xiuxiu; Xu, Xue; Wang, Jinan; Yu, Hua; Wang, Xia; Wang, Yonghua] NW A&F Univ, Bioinformat Ctr, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yang, Hongjun; Xu, Haiyu; Tang, Shihuan; Huang, Luqi] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Li, Yan] Dalian Univ Technol, Sch Chem Engn, Dalian, Liaoning, Peoples R China; [Yang, Ling; Yang, Shengli] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian, Liaoning, Peoples R China	Northwest A&F University - China; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Dalian University of Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Li, XX (corresponding author), NW A&F Univ, Bioinformat Ctr, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	huangluqi@263.net; yh_wang@nwsuaf.edu.cn	li, yong/HDN-3885-2022; , Paulin/U-9063-2019; Li, Yang/GWM-7879-2022; WANG, XIA/S-3431-2018; Li, Yuan/GXV-1310-2022	, Paulin/0000-0001-6045-3712; WANG, XIA/0000-0003-1960-4157; Tang, Shihuan/0000-0003-0589-4499; ling, yang/0000-0001-7093-5926	National Natural Science Fund of China [31170796]; Special Research Foundation for Traditional Chinese Medicine [200907001-5]; Innovation Fund of Northwest AF University	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Special Research Foundation for Traditional Chinese Medicine; Innovation Fund of Northwest AF University	This work was supported by the National Natural Science Fund of China (Grant No. 31170796), the Special Research Foundation for Traditional Chinese Medicine (Grant No. 200907001-5), as well as the Innovation Fund of Northwest A&F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 1998, J PHARM PHARMACOL, V50, P1155, DOI 10.1111/j.2042-7158.1998.tb03327.x; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Azuaje FJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00052; Bae EA, 2004, ARCH PHARM RES, V27, P61, DOI 10.1007/BF02980048; Bao Hua-ying, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P28; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case D., 2008, AMBER 10, P32; Cases M, 2009, DRUG DISCOV TODAY, V14, P479, DOI 10.1016/j.drudis.2009.02.010; Chang Y, 2009, SEEK MED ASK MED, V1, P32; Chen F, 2006, FASEB J, V20, P1269, DOI 10.1096/fj.05-5530fje; Chen XH, 2010, J PHARM PHARMACOL, V62, P915, DOI 10.1211/jpp.62.07.0013; Chen Yan-ming, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P632; Chen YL, 2006, J CELL BIOCHEM, V98, P618, DOI 10.1002/jcb.20793; Citterio L, 2011, PHARMACOGENOMICS, V12, P1587, DOI [10.2217/PGS.11.110, 10.2217/pgs.11.110]; Du D, 2008, CHIN J INF TCM, V9, P44; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DZAU V, 1991, AM HEART J, V121, P1244, DOI 10.1016/0002-8703(91)90694-D; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gu Y, 2009, FOOD CHEM TOXICOL, V47, P2257, DOI 10.1016/j.fct.2009.06.013; Han M, 2006, ACTA PHARMACOL SIN, V27, P499, DOI 10.1111/j.1745-7254.2006.00303.x; Hasegawa H, 1997, PLANTA MED, V63, P436, DOI 10.1055/s-2006-957729; He F, 2007, J CARDIOVASC PHARM, V50, P314, DOI 10.1097/FJC.0b013e3180cab12e; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Hwang YP, 2010, TOXICOL APPL PHARM, V242, P18, DOI 10.1016/j.taap.2009.09.009; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Janga SC, 2009, MOL BIOSYST, V5, P1536, DOI [10.1039/b908147j, 10.1039/B908147j]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; KARIKURA M, 1990, CHEM PHARM BULL, V38, P2859, DOI 10.1248/cpb.38.2859; Karmin O, 2001, LIFE SCI, V68, P903, DOI 10.1016/S0024-3205(00)00989-9; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kong DX, 2009, DRUG DISCOV TODAY, V14, P115, DOI 10.1016/j.drudis.2008.07.002; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee S, 2009, EXPERT OPIN DRUG DIS, V4, P1177, DOI 10.1517/17460440903322234; Leung K.W., 2010, CHINESE MED, V5, P20; Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200; Li J, 2011, ILLUSTRATION TRADITI; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Li XM, 2009, J ALLERGY CLIN IMMUN, V123, P297, DOI 10.1016/j.jaci.2008.12.026; Li Y, 2005, J MOL STRUCT, V733, P111, DOI 10.1016/j.molstruc.2004.08.012; Liu H, 2008, MODERN J INTEGRATED, V17, P5397; Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; McQuarrie DA, 2000, STAT MECH; Medina-Franco JL, 2011, MOL DIVERS, V15, P293, DOI 10.1007/s11030-010-9262-5; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; ODANI T, 1983, CHEM PHARM BULL, V31, P292; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Pei WJ, 2004, J CHROMATOGR B, V809, P237, DOI 10.1016/j.jchromb.2004.06.028; Peitz GJ, 2009, SOUTH MED J, V102, P411, DOI 10.1097/SMJ.0b013e31818fc03a; Popovich DG, 2002, ARCH BIOCHEM BIOPHYS, V406, P1, DOI 10.1016/S0003-9861(02)00398-3; Qiao XB, 2002, J CHEM INF COMP SCI, V42, P481, DOI 10.1021/ci010113h; Reddy AS, 2007, CURR PROTEIN PEPT SC, V8, P329; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Sangkuhl K, 2011, PHARMACOGENET GENOM, V21, P516, DOI 10.1097/FPC.0b013e3283406323; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Shen YJ, 2009, PHARM TRADITIONAL CH; Shi CS, 2007, THROMB RES, V119, P769, DOI 10.1016/j.thromres.2006.06.008; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Sucher NJ, 2006, EPILEPSY BEHAV, V8, P350, DOI 10.1016/j.yebeh.2005.11.015; Takahashi K, 2002, BIOCHEM PHARMACOL, V64, P745, DOI 10.1016/S0006-2952(02)01250-9; The State Pharmacopoeia Commission of the PRC, 2005, PHARM PEOPL REP CHIN; Thorn CF, 2005, METH MOL B, V311, P179; Tian P, 2011, NATURE, V480, pS84, DOI 10.1038/480S84a; Tian Xiao-hui, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P404; van der Greef J, 2011, NATURE, V480, pS87, DOI 10.1038/480S87a; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang BQ, 2010, J MED PLANTS RES, V4, P2813; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang Y S, 1998, PHARM APPL CHINESE M; Wang YH, 2005, J COMPUT AID MOL DES, V19, P137, DOI 10.1007/s10822-005-3321-5; Wang YH, 2005, J CHEM INF MODEL, V45, P750, DOI 10.1021/ci050041k; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; [吴寿荣 Wu Shourong], 2003, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V20, P245; Wu YJ, 1998, ARTERIOSCL THROM VAS, V18, P481, DOI 10.1161/01.ATV.18.3.481; Wu YT, 2006, INT J PHARM, V326, P25, DOI 10.1016/j.ijpharm.2006.07.003; WYATT AW, 2004, BIOCH SOC S, V71, P143; Xie GX, 2007, J PHARMACEUT BIOMED, V43, P920, DOI 10.1016/j.jpba.2006.09.009; Xie HT, 2005, BIOL PHARM BULL, V28, P383, DOI 10.1248/bpb.28.383; Xu De-Ran, 2005, Chinese Journal of Natural Medicines, V3, P148; Xu J., 2009, J GERIATR CARDIOL, V6, P56; Xu QF, 2003, J ETHNOPHARMACOL, V84, P187, DOI 10.1016/S0378-8741(02)00317-3; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Xu X, 2012, SOFT MATTER, V8, P2915, DOI 10.1039/c2sm06811g; Yang L. L., 2007, WORLD SCI TECH MODER, V9, P98; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu XY, 2007, NEUROSCI LETT, V417, P261, DOI 10.1016/j.neulet.2007.02.079; Zhang HX, 2011, CURR MED CHEM, V18, P4019, DOI 10.2174/092986711796957220; Zhang HS, 2006, J MOL CELL CARDIOL, V41, P138, DOI 10.1016/j.yjmcc.2006.03.007; Zhang JL, 2005, BIOMED CHROMATOGR, V19, P51, DOI 10.1002/bmc.415; Zhang Mei, 2003, Zhong Yao Cai, V26, P738; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zheng X, 2007, J XIAN JIAOTONG U ME, V28, P171; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhou M, 2009, CHIN J THROMB HEM, V15, P8; Zhou YQ, 2010, ENVIRON TOXICOL PHAR, V29, P229, DOI 10.1016/j.etap.2010.01.004; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020; 鲍建才, 2006, [中成药, Chinese Traditional Patent Medicine], V28, P246; 赵保胜, 2002, [中国药理学通报, Chinese Pharmacological Bulletin], V18, P590; 丁宁, 2002, [中草药, Chinese Traditional and Herbal Drugs], V33, P1147; 陈建南, 2005, [中药材, Journal of Chinese Medicinal Materials], V28, P781	120	134	148	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43918	10.1371/journal.pone.0043918	http://dx.doi.org/10.1371/journal.pone.0043918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962593	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600021
J	Liu, WL; Yang, HC; Su, WC; Wang, CC; Chen, HL; Wang, HY; Huang, WH; Chen, DS; Lai, MY				Liu, Wei-Liang; Yang, Hung-Chih; Su, Wen-Cheng; Wang, Chih-Chiang; Chen, Hui-Ling; Wang, Hurng-Yi; Huang, Wen-Hung; Chen, Ding-Shinn; Lai, Ming-Yang			Ribavirin Enhances the Action of Interferon-alpha against Hepatitis C Virus by Promoting the p53 Activity through the ERK1/2 Pathway	PLOS ONE			English	Article							SUBGENOMIC REPLICON; PHOSPHORYLATION; DIFFERENTIATION; REPLICATION; SUPPRESSION; EXPRESSION; INHIBITORS; RESPONSES; NS5B	Background/Aims: Ribavirin significantly enhances the antiviral response of interferon-alpha (IFN-alpha) against Hepatitis C virus (HCV), but the underlying mechanisms remain poorly understood. Recently, p53 has been identified as an important factor involving the suppression of HCV replication in hepatocytes. We, therefore, decided to investigate whether and how ribavirin inhibits the replication of HCV by promoting the activity of p53. Methods: HepG2 and HCV replicons (JFH1/HepG2) were utilized to study the relationship between ribavirin and p53. The effect of ribavirin on cell cycles was analyzed by flow cytometry. The activation of p53 and the signaling pathways were determined using immunoblotting. By knocking down ERK1/ERK2 and p53 utilizing RNA interference strategy, we further assessed the role of ERK1/2 and p53 in the suppression of HCV replication by ribavirin in a HCV replicon system. Results: Using HepG2 and HCV replicons, we demonstrated that ribavirin caused the cell cycle arrest at G1 phase and stabilized and activated p53, which was associated with the antiviral activity of ribavirin. Compared to either ribavirin or IFN-alpha alone, ribavirin plus IFN-alpha resulted in greater p53 activation and HCV suppression. We further identified ERK1/2 that linked ribavirin signals to p53 activation. More importantly, knockdown of ERK1/2 and p53 partially mitigated the inhibitory effects of ribavirin on the HCV replication, indicating that ERK1/2-p53 pathway was involved in the anti-HCV effects of ribavirin. Conclusion: Ribavirin stimulates ERK1/2 and subsequently promotes p53 activity which at least partly contributes to the enhanced antiviral response of IFN-alpha plus ribavirin against HCV.	[Liu, Wei-Liang; Su, Wen-Cheng; Wang, Chih-Chiang; Wang, Hurng-Yi; Huang, Wen-Hung; Chen, Ding-Shinn; Lai, Ming-Yang] Natl Taiwan Univ, Coll Med & Hosp, Grad Inst Clin Med, Taipei 10764, Taiwan; [Liu, Wei-Liang; Su, Wen-Cheng; Wang, Chih-Chiang; Wang, Hurng-Yi; Huang, Wen-Hung; Chen, Ding-Shinn; Lai, Ming-Yang] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Taipei 10764, Taiwan; [Yang, Hung-Chih] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Chen, Hui-Ling; Chen, Ding-Shinn; Lai, Ming-Yang] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Liu, WL (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Grad Inst Clin Med, Taipei 10764, Taiwan.	hcyang88@ntu.edu.tw; mylai@ntu.edu.tw	CHEN, DING-SHINN/T-4395-2019	Chen, Hui-Ling/0000-0002-2572-0595; LIU, WEI-LIANG/0000-0002-1159-1286; CHEN, DING-SHINN/0000-0001-7791-6154; WANG, HURNG-YI/0000-0003-1708-8734; YANG, HUNG-CHIH/0000-0003-3864-9895	National Science Council [NSC-97-2314-B-002-147-MY3]; Department of Health of the Executive Yuan in Taiwan [DOH95-DC-1002]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health of the Executive Yuan in Taiwan	This research was supported by grants from the National Science Council (NSC-97-2314-B-002-147-MY3) and Department of Health of the Executive Yuan in Taiwan (DOH95-DC-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bodenheimer HC, 1997, HEPATOLOGY, V26, P473, DOI 10.1002/hep.510260231; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Corouge M, 2011, MED MALADIES INFECT, V41, P579, DOI 10.1016/j.medmal.2011.04.003; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Date T, 2004, J BIOL CHEM, V279, P22371, DOI 10.1074/jbc.M311120200; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Graci JD, 2002, VIROLOGY, V298, P175, DOI 10.1006/viro.2002.1487; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lanford RE, 2001, J VIROL, V75, P8074, DOI 10.1128/JVI.75.17.8074-8081.2001; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Liu WL, 2007, J INFECT DIS, V196, P425, DOI 10.1086/518894; Lutchman G, 2007, GASTROENTEROLOGY, V132, P1757, DOI 10.1053/j.gastro.2007.03.035; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; MALINOSKI F, 1981, VIROLOGY, V110, P281, DOI 10.1016/0042-6822(81)90060-X; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Ning Q, 1998, J IMMUNOL, V160, P3487; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Pawlotsky JM, 2004, GASTROENTEROLOGY, V126, P703, DOI 10.1053/j.gastro.2003.12.002; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Reyes G R, 2001, Curr Opin Drug Discov Devel, V4, P651; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Soriano V, 2011, J ANTIMICROB CHEMOTH, V66, P1673, DOI 10.1093/jac/dkr215; Stevenson NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027866; Su WC, 2009, FEBS LETT, V583, P2793, DOI 10.1016/j.febslet.2009.07.027; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tam RC, 1999, J HEPATOL, V30, P376, DOI 10.1016/S0168-8278(99)80093-2; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Vo NV, 2003, BIOCHEMISTRY-US, V42, P10462, DOI 10.1021/bi0344681; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Yalowitz JA, 2000, ANTICANCER RES, V20, P2329; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	44	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43824	10.1371/journal.pone.0043824	http://dx.doi.org/10.1371/journal.pone.0043824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962590	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600018
J	Petre, B; Morin, E; Tisserant, E; Hacquard, S; Da Silva, C; Poulain, J; Delaruelle, C; Martin, F; Rouhier, N; Kohler, A; Duplessis, S				Petre, Benjamin; Morin, Emmanuelle; Tisserant, Emilie; Hacquard, Stephane; Da Silva, Corinne; Poulain, Julie; Delaruelle, Christine; Martin, Francis; Rouhier, Nicolas; Kohler, Annegret; Duplessis, Sebastien			RNA-Seq of Early-Infected Poplar Leaves by the Rust Pathogen Melampsora larici-populina Uncovers PtSultr3;5, a Fungal-Induced Host Sulfate Transporter	PLOS ONE			English	Article							GENOME-WIDE ANALYSES; LEAF RUST; OBLIGATE BIOTROPHY; SECRETED PROTEINS; LACCARIA-BICOLOR; EFFECTOR PROTEIN; FLAX RUST; PLANT; EXPRESSION; GENES	Biotroph pathogens establish intimate interactions with their hosts that are conditioned by the successful secretion of effectors in infected tissues and subsequent manipulation of host physiology. The identification of early-expressed pathogen effectors and early-modulated host functions is currently a major goal to understand the molecular basis of biotrophy. Here, we report the 454-pyrosequencing transcriptome analysis of early stages of poplar leaf colonization by the rust fungus Melampsora larici-populina. Among the 841,301 reads considered for analysis, 616,879 and 649 were successfully mapped to Populus trichocarpa and M. larici-populina genome sequences, respectively. From a methodological aspect, these results indicate that this single approach is not appropriate to saturate poplar transcriptome and to follow transcript accumulation of the pathogen. We identified 19 pathogen transcripts encoding early-expressed small-secreted proteins representing candidate effectors of interest for forthcoming studies. Poplar RNA-Seq data were validated by oligoarrays and quantitatively analysed, which revealed a highly stable transcriptome with a single transcript encoding a sulfate transporter (herein named PtSultr3; 5, POPTR_0006s16150) showing a dramatic increase upon colonization by either virulent or avirulent M. larici-populina strains. Perspectives connecting host sulfate transport and biotrophic lifestyle are discussed.	[Petre, Benjamin; Morin, Emmanuelle; Tisserant, Emilie; Hacquard, Stephane; Delaruelle, Christine; Martin, Francis; Rouhier, Nicolas; Kohler, Annegret; Duplessis, Sebastien] Univ Lorraine, Ctr INRA Nancy, UMR Interact Arbres Microorgan 1136, INRA, Champenoux, France; [Da Silva, Corinne; Poulain, Julie] CEA Genoscope, Ctr Natl Sequencage, Evry, France	INRAE; Universite de Lorraine; CEA; UDICE-French Research Universities; Universite Paris Saclay	Petre, B (corresponding author), Univ Lorraine, Ctr INRA Nancy, UMR Interact Arbres Microorgan 1136, INRA, Champenoux, France.	duplessi@nancy.inra.fr	Petre, Benjamin/AAF-1156-2019; , DUPLESSIS/G-4150-2011; morin, emmanuelle/AAA-1246-2019; Kohler, Annegret/AAD-1876-2019	Petre, Benjamin/0000-0002-3204-4249; , DUPLESSIS/0000-0002-2072-2989; morin, emmanuelle/0000-0002-7268-972X; DA SILVA, Corinne/0000-0002-7618-7831; Rouhier, Nicolas/0000-0002-2036-7884; Poulain, Julie/0000-0002-8744-3116	CG Lorraine (France); INRA innovating grant	CG Lorraine (France); INRA innovating grant	This work was founded by grants of the CG Lorraine (France) to S. Duplessis and F. Martin and an INRA innovating grant to S. Duplessis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sequencing was supported by the CEA-Genoscope in the frame of a collaborative project. The CEA-Genoscope had no role in the study design, analysis of the data or preparation of the manuscript. The CEA-Genoscope was in charge of 454-data production and collection, and provided agreement on the final version of the manuscript prior publication.	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Azaiez A, 2009, MOL PLANT MICROBE IN, V22, P190, DOI 10.1094/MPMI-22-2-0190; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boyle B, 2005, APPL ENVIRON MICROB, V71, P1546, DOI 10.1128/AEM.71.3.1546-1552.2005; Boyle B, 2010, PLANT BIOLOGY, V12, P364, DOI 10.1111/j.1438-8677.2009.00310.x; Caillaud MC, 2012, PLANT J, V69, P252, DOI 10.1111/j.1365-313X.2011.04787.x; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; de Jonge R, 2011, CURR OPIN PLANT BIOL, V14, P400, DOI 10.1016/j.pbi.2011.03.005; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dowkiw A, 2003, PHYTOPATHOLOGY, V93, P421, DOI 10.1094/PHYTO.2003.93.4.421; Durr J, 2010, PLANT MOL BIOL, V72, P499, DOI 10.1007/s11103-009-9587-6; Duplessis S., 2012, EFFECTORS PLANT MICR; Duplessis S, 2011, MOL PLANT MICROBE IN, V24, P808, DOI 10.1094/MPMI-01-11-0006; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Duplessis S, 2009, CRIT REV PLANT SCI, V28, P309, DOI 10.1080/07352680903241063; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; Fernandez D, 2012, MOL PLANT PATHOL, V5, P515; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hacquard S, 2011, J PATHOG, V2011, DOI 10.4061/2011/716041; Hacquard S, 2012, MOL PLANT MICROBE IN, V25, P279, DOI 10.1094/MPMI-09-11-0238; Hacquard S, 2011, PHYSIOL MOL PLANT P, V75, P106, DOI 10.1016/j.pmpp.2010.10.003; Hacquard S, 2010, MOL PLANT MICROBE IN, V23, P1275, DOI 10.1094/MPMI-05-10-0111; Hahn M, 1997, MOL PLANT MICROBE IN, V10, P427, DOI 10.1094/MPMI.1997.10.4.427; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Hok S, 2010, MOL PLANT MICROBE IN, V23, P1253, DOI 10.1094/MPMI-04-10-0103; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kataoka T, 2004, PLANT PHYSIOL, V136, P4198, DOI 10.1104/pp.104.045625; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; Krusell L, 2005, PLANT CELL, V17, P1625, DOI 10.1105/tpc.104.030106; Kumar S, 2011, FUNCT INTEGR GENOMIC, V11, P259, DOI 10.1007/s10142-010-0207-y; Laurans E, 1999, PHYTOPATHOLOGY, V89, P233, DOI 10.1094/PHYTO.1999.89.3.233; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Nirmala J, 2010, MOL PLANT MICROBE IN, V23, P1635, DOI 10.1094/MPMI-06-10-0136; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Schmidt SM, 2011, CURR OPIN PLANT BIOL, V14, P392, DOI 10.1016/j.pbi.2011.03.006; Schneider D, 2010, IEEE SPECTRUM, V47, P48, DOI 10.1109/MSPEC.2010.5372501; Schneider KT, 2011, PLANT PHYSIOL, V157, P355, DOI 10.1104/pp.111.181149; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Talbot NJ, 2010, NATURE, V510, P468; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wessling R, 2012, FUNGAL GENET BIOL, V49, P470, DOI 10.1016/j.fgb.2012.04.001; Wienkoop S, 2003, PLANT PHYSIOL, V131, P1080, DOI 10.1104/pp.102.015362; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	72	50	51	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44408	10.1371/journal.pone.0044408	http://dx.doi.org/10.1371/journal.pone.0044408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952974	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500069
J	Zhan, HM; Xu, SZ				Zhan, Haimao; Xu, Shizhong			Adaptive Ridge Regression for Rare Variant Detection	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; LIPID-METABOLISM; COMMON DISEASES; SUSCEPTIBILITY; SELECTION; ANGPTL3; LOCI; TRIGLYCERIDES; TESTS; RISK	It is widely believed that both common and rare variants contribute to the risks of common diseases or complex traits and the cumulative effects of multiple rare variants can explain a significant proportion of trait variances. Advances in high-throughput DNA sequencing technologies allow us to genotype rare causal variants and investigate the effects of such rare variants on complex traits. We developed an adaptive ridge regression method to analyze the collective effects of multiple variants in the same gene or the same functional unit. Our model focuses on continuous trait and incorporates covariate factors to remove potential confounding effects. The proposed method estimates and tests multiple rare variants collectively but does not depend on the assumption of same direction of each rare variant effect. Compared with the Bayesian hierarchical generalized linear model approach, the state-of-the-art method of rare variant detection, the proposed new method is easy to implement, yet it has higher statistical power. Application of the new method is demonstrated using the well-known data from the Dallas Heart Study.	[Zhan, Haimao; Xu, Shizhong] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Zhan, HM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	shizhong.xu@ucr.edu			USDA National Institute of Food and Agriculture [2007-02784]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	The project was supported by the USDA National Institute of Food and Agriculture Grant 2007-02784 to SX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antoniadis A, 2001, J AM STAT ASSOC, V96, P939, DOI 10.1198/016214501753208942; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; CHURCHILL GA, 1994, GENETICS, V138, P963; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; GRANDVALET Y, 1998, INT C ART NEUR NETW; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.1093/biomet/54.1-2.93; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Pan W, 2011, GENET EPIDEMIOL, V35, P381, DOI 10.1002/gepi.20586; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xu SZ, 1998, HEREDITY, V80, P364, DOI 10.1046/j.1365-2540.1998.00307.x; Yi NJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002382; Yi NJ, 2011, GENET EPIDEMIOL, V35, P57, DOI 10.1002/gepi.20554; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	43	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44173	10.1371/journal.pone.0044173	http://dx.doi.org/10.1371/journal.pone.0044173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952918	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600088
J	Xiong, CJ; Huang, B; Zhou, Y; Cun, YP; Liu, LT; Wang, J; Li, CQ; Pan, Y; Wang, H				Xiong, Cheng-jie; Huang, Bo; Zhou, Yue; Cun, Yan-ping; Liu, Lan-tao; Wang, Jian; Li, Chang-qing; Pan, Yong; Wang, Hai			Macrophage Migration Inhibitory Factor Inhibits the Migration of Cartilage End Plate-Derived Stem Cells by Reacting with CD74	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; MESENCHYMAL STROMAL CELLS; NUCLEUS PULPOSUS; PROGENITOR CELLS; EXPRESSION; IDENTIFICATION; CHONDROCYTES; TARGET; MIF	Background: Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that regulates inflammatory reactions and the pathophysiology of many inflammatory diseases. Intervertebral disc (IVD) degeneration is characterized by an inflammatory reaction, but the potential role of MIF in IVD degeneration has not been determined. Recent studies have shown that MIF and its receptor, CD74, are involved in regulating the migration of human mesenchymal stem cells (MSCs); Thus, MIF might impair the ability of mesenchymal stem cells (MSCs) to home to injured tissues. Our previous studies indicated that cartilage endplate (CEP)-derived stem cells (CESCs) as a type of MSCs exist in human degenerate IVDs. Here, we investigate the role of MIF in regulating the migration of CESCs. Methods and Findings: CESCs were isolated and identified. We have shown that MIF was distributed in human degenerate IVD tissues and was subject to regulation by the pro-inflammatory cytokine TNF-alpha. Furthermore, in vitro cell migration assays revealed that nucleus pulposus (NP) cells inhibited the migration of CESCs in a number-dependent manner, and ELISA assays revealed that the amount of MIF in conditioned medium (CM) was significantly increased as a function of increasing cell number. Additionally, recombinant human MIF (r-MIF) inhibited the migration of CESCs in a dose-dependent manner. CESCs migration was restored when an antagonist of MIF, (S, R)-3(4-hydroxyphenyl)-4, 5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1), was added. Finally, a CD74 activating antibody (CD74Ab) was used to examine the effect of CD74 on CESCs motility and inhibited the migration of CESCs in a dose-dependent manner. Conclusions: We have identified and characterized a novel regulatory mechanism governing cell migration during IVD degeneration. The results will benefit understanding of another possible mechanism for IVD degeneration, and might provide a new method to repair degenerate IVD by enhancing CESCs migration to degenerated NP tissues to exert their regenerative effects.	[Xiong, Cheng-jie; Huang, Bo; Zhou, Yue; Liu, Lan-tao; Wang, Jian; Li, Chang-qing; Pan, Yong; Wang, Hai] Third Millitary Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Cun, Yan-ping] Third Mil Med Univ, Ctr Canc, Daping Hosp, Chongqing, Peoples R China; [Cun, Yan-ping] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Xiong, CJ (corresponding author), Third Millitary Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	happyzhou@vip.163.com			National Natural Science Foundation of China [81101364]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81101364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol S, 2010, TURK NEUROSURG, V20, P492, DOI 10.5137/1019-5149.JTN.3394-10.1; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Barrilleaux BL, 2010, IN VITRO CELL DEV-AN, V46, P566, DOI 10.1007/s11626-010-9279-1; Barrilleaux BL, 2009, TISSUE ENG PT A, V15, P2335, DOI 10.1089/ten.tea.2008.0434; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; Beswick EJ, 2009, WORLD J GASTROENTERO, V15, P2855, DOI 10.3748/wjg.15.2855; Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; BUCKWALTER JA, 1994, MICROSC RES TECHNIQ, V28, P398, DOI 10.1002/jemt.1070280506; Burke JG, 2003, SPINE, V28, P2685, DOI 10.1097/01.BRS.0000103341.45133.F3; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cao WG, 2006, HUM REPROD, V21, P421, DOI 10.1093/humrep/dei315; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672; Fischer-Valuck BW, 2010, BIOTECHNOL LETT, V32, P19, DOI 10.1007/s10529-009-0110-6; Gabr MA, J ORTHOPAEDIC RES; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2; Huang B, 2011, EUROPEAN SPINE J, P1; Kim H, 2009, SPINE, V34, P1834, DOI 10.1097/BRS.0b013e3181ae18ba; Kim KW, 2009, SPINE J, V9, P323, DOI 10.1016/j.spinee.2008.05.003; Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Leng L, 2005, CRIT CARE MED, V33, pS475, DOI 10.1097/01.CCM.0000191278.04636.D8; Leung VYL, 2006, EUR SPINE J, V15, pS406, DOI 10.1007/s00586-006-0183-z; Liu LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026285; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Morales TI, 2007, OSTEOARTHR CARTILAGE, V15, P861, DOI 10.1016/j.joca.2007.02.022; Niu CC, 2010, J ORTHOPAEDIC RES; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Sinclair SM, 2011, SPINE, V36, P1190, DOI 10.1097/BRS.0b013e3181ebdb43; Studer RK, 2007, SPINE, V32, P2827, DOI 10.1097/BRS.0b013e31815b757a; Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011; Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0; Yang H, 2010, SPINE J	41	22	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43984	10.1371/journal.pone.0043984	http://dx.doi.org/10.1371/journal.pone.0043984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952837	gold, Green Published, Green Submitted			2022-12-25	WOS:000308044800084
J	Wu, B; Miao, YF; Bai, YR; Ye, M; Xu, YJ; Chen, HF; Shen, JF; Qiu, YM				Wu, Bin; Miao, Yifeng; Bai, Yongrui; Ye, Min; Xu, Yuejuan; Chen, Huafeng; Shen, Jinfang; Qiu, Yongming			Subgroup Economic Analysis for Glioblastoma in a Health Resource-Limited Setting	PLOS ONE			English	Article							HIGH-GRADE GLIOMA; RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; COST-EFFECTIVENESS; MALIGNANT GLIOMAS; RADIOTHERAPY; THERAPY; CHEMOTHERAPY; MULTIFORME; BEVACIZUMAB	Background: The aim of this research was to evaluate the economic outcomes of radiotherapy (RT), temozolomide (TMZ) and nitrosourea (NT) strategies for glioblastoma patients with different prognostic factors. Methodology/Principal Findings: A Markov model was developed to track monthly patient transitions. Transition probabilities and utilities were derived primarily from published reports. Costs were estimated from the perspective of the Chinese healthcare system. The survival data with different prognostic factors were simulated using Weibull survival models. Costs over a 5-year period and quality-adjusted life years (QALYs) were estimated. Probabilistic sensitivity and one-way analyses were performed. The baseline analysis in the overall cohort showed that the TMZ strategy increased the cost and QALY relative to the RT strategy by $ 25,328.4 and 0.29, respectively; and the TMZ strategy increased the cost and QALY relative to the NT strategy by $ 23,906.5 and 0.25, respectively. Therefore, the incremental cost effectiveness ratio (ICER) per additional QALY of the TMZ strategy, relative to the RT strategy and the NT strategy, amounts to $ 87,940.6 and $ 94,968.3, respectively. Subgroups with more favorable prognostic factors achieved more health benefits with improved ICERs. Probabilistic sensitivity analyses confirmed that the TMZ strategy was not cost-effective. In general, the results were most sensitive to the cost of TMZ, which indicates that better outcomes could be achieved by decreasing the cost of TMZ. Conclusions/Significance: In health resource-limited settings, TMZ is not a cost-effective option for glioblastoma patients. Selecting patients with more favorable prognostic factors increases the likelihood of cost-effectiveness.	[Wu, Bin; Chen, Huafeng; Shen, Jinfang] Shanghai Jiao Tong Univ, Sch Med, Dept Pharm, Clin Outcomes & Econ Grp,Renji Hosp, Shanghai 200030, Peoples R China; [Miao, Yifeng] Nanjing Med Univ, Wuxi Peoples Hosp 2, Ctr Neurosci, Shanghai, Peoples R China; [Bai, Yongrui] Shanghai Jiao Tong Univ, Sch Med, Dept Radiotherapy, Renji Hosp, Shanghai 200030, Peoples R China; [Ye, Min] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, Renji Hosp, Shanghai 200030, Peoples R China; [Xu, Yuejuan] South East Univ, Sch Med, Dept Oncol, Hosp Nanjing 2, Nanjing, Jiangsu, Peoples R China; [Qiu, Yongming] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Southeast University - China; Shanghai Jiao Tong University	Wu, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharm, Clin Outcomes & Econ Grp,Renji Hosp, Shanghai 200030, Peoples R China.	qiuzhoub@sina.com	Ma, Yimian/AAD-8777-2019	Ma, Yimian/0000-0003-2466-7697; Yuan, lichai/0000-0002-6413-8848	project of building hospital clinical key disciplines [RJ.4101307]; Shanghai government [0952nm03900]	project of building hospital clinical key disciplines; Shanghai government	This work was supported by a project of building hospital clinical key disciplines (NO. RJ.4101307) and a grant from Shanghai government (NO. 0952nm03900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra D, 2002, LANCET, V359, P1011; Aoki T, 2006, J NEUROSURG, V105, P385, DOI 10.3171/jns.2006.105.3.385; Chamberlain M, 2011, EXPERT REV NEUROTHER, V11, P519, DOI [10.1586/ERN.11.30, 10.1586/ern.11.30]; Chamberlain MC, 2010, J NEURO-ONCOL, V96, P259, DOI 10.1007/s11060-009-9957-6; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Garside R, 2007, Health Technol Assess, V11, piii; Garside R, 2007, HEALTH TECHNOL ASSES, V11, P221; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hu Y M, 1999, Sheng Li Xue Bao, V51, P45; Lamers LM, 2008, CANCER-AM CANCER SOC, V112, P1337, DOI 10.1002/cncr.23297; Mangiola A, 2010, EXPERT REV NEUROTHER, V10, P507, DOI [10.1586/ern.09.158, 10.1586/ERN.09.158]; Mason WP, 2005, NAT CLIN PRACT NEURO, V1, P88, DOI 10.1038/ncpneuro0045; Moen MD, 2010, DRUGS, V70, P181, DOI 10.2165/11203890-000000000-00000; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Nishikawa R, 2010, NEUROL MED-CHIR, V50, P713, DOI 10.2176/nmc.50.713; Remak E, 2008, J CLIN ONCOL, V26, P3995, DOI 10.1200/JCO.2007.13.2662; Schmidt F, 2006, NEUROLOGY, V66, P587, DOI 10.1212/01.wnl.0000197792.73656.c2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Uyl-de Groot Carin A, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P235, DOI 10.1586/erp.09.15; Vordermark D, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-247; Wasserfallen JB, 2005, NEURO-ONCOLOGY, V7, P189, DOI 10.1215/S1152851704000687; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wolff JEA, 2008, J NEURO-ONCOL, V88, P57, DOI 10.1007/s11060-008-9533-5	24	59	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34588	10.1371/journal.pone.0034588	http://dx.doi.org/10.1371/journal.pone.0034588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511951	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338600037
J	Wu, JY; Wang, YH; Wang, GJ; Ho, ML; Wang, CZ; Yeh, ML; Chen, CH				Wu, Jyun-Yi; Wang, Yan-Hsiung; Wang, Gwo-Jaw; Ho, Mei-Ling; Wang, Chau-Zen; Yeh, Ming-Long; Chen, Chia-Hsin			Low-Power GaAlAs Laser Irradiation Promotes the Proliferation and Osteogenic Differentiation of Stem Cells via IGF1 and BMP2	PLOS ONE			English	Article							RAT CALVARIAL CELLS; BONE-MARROW; IN-VITRO; GENE-EXPRESSION; THERAPY; OSTEOBLASTS; OSTEOPOROSIS; TGF-BETA-1; CULTURE; ARREST	Low-power laser irradiation (LPLI) has been found to induce various biological effects and cellular processes. Also, LPLI has been shown to promote fracture repair. Until now, it has been unclear how LPLI promotes bone formation and fracture healing. The aim of this study was to investigate the potential mechanism of LPLI-mediated enhancement of bone formation using mouse bone marrow mesenchymal stem cells (D1 cells). D1 cells were irradiated daily with a gallium-aluminum-arsenide (GaAlAs) laser at dose of 0, 1, 2, or 4 J/cm(2). The lactate dehydrogenase (LDH) assay showed no cytotoxic effects of LPLI on D1 cells, and instead, LPLI at 4 J/cm(2) significantly promoted D1 cell proliferation. LPLI also enhanced osteogenic differentiation in a dose-dependent manner and moderately increased expression of osteogenic markers. The neutralization experiments indicated that LPLI regulated insulin-like growth factor 1 (IGF1) and bone morphogenetic protein 2 (BMP2) signaling to promote cell proliferation and/or osteogenic differentiation. In conclusion, our study suggests that LPLI may induce IGF1 expression to promote both the proliferation and osteogenic differentiation of D1 cells, whereas it may induce BMP2 expression primarily to enhance osteogenic differentiation.	[Wu, Jyun-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Wang, Gwo-Jaw; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Kaohsiung Med Univ, Dept Orthopaed, Coll Med, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA USA; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Dept Phys Med & Rehabil, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Virginia; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Wu, JY (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	mlyeh@mail.ncku.edu.tw; chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020; Wang, Yan-Hsiung/C-8792-2009; Zhu, Zhi/D-3721-2011	Wang, Yan-Hsiung/0000-0001-8161-7472; Zhu, Zhi/0000-0002-3287-4920; Ho, Mei-Ling/0000-0001-8064-8488; Chen, Chia-Hsin/0000-0002-6557-9848	National Science Council [NSC 96-2221-E-006-259, NSC 96-2314-B-037-059]; National Health Research Institutes, Taiwan [NHRI-EX97-9615EP]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by two grants from the National Science Council (NSC 96-2221-E-006-259, NSC 96-2314-B-037-059) and a grant from the National Health Research Institutes (NHRI-EX97-9615EP) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany PR, 2007, WOUND REPAIR REGEN, V15, P866, DOI 10.1111/j.1524-475X.2007.00306.x; Arisu HD, 2006, LASER MED SCI, V21, P175, DOI 10.1007/s10103-006-0398-6; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BARUSHKA O, 1995, BONE, V16, P47, DOI 10.1016/S8756-3282(94)00006-9; Bouvet-Gerbettaz S, 2009, LASER SURG MED, V41, P291, DOI 10.1002/lsm.20759; Cen Shiqiang, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P84; Chen CH, 2005, OSTEOPOROSIS INT, V16, P2039, DOI 10.1007/s00198-005-1995-0; Coombe A R, 2001, Clin Orthod Res, V4, P3, DOI 10.1034/j.1600-0544.2001.040102.x; Dahir GA, 2000, CLIN ORTHOP RELAT R, pS134; DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012; Eduardo FD, 2008, LASER SURG MED, V40, P433, DOI 10.1002/lsm.20646; Fukuhara E, 2006, CALCIFIED TISSUE INT, V79, P443, DOI 10.1007/s00223-006-0072-9; Gal P, 2009, LASER MED SCI, V24, P539, DOI 10.1007/s10103-008-0604-9; Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9; Horvat-Karajz K, 2009, LASER SURG MED, V41, P463, DOI 10.1002/lsm.20791; Hou JF, 2008, LASER SURG MED, V40, P726, DOI 10.1002/lsm.20709; Huang XM, 2003, FRONT BIOSCI-LANDMRK, V8, pS740, DOI 10.2741/1093; IIJIMA K, 1989, CLIN J PAIN, V5, P271; Jin Dong-mei, 2006, Zhejiang Da Xue Xue Bao Yi Xue Ban, V35, P55; Khadra M, 2005, BIOMATERIALS, V26, P3503, DOI 10.1016/j.biomaterials.2004.09.033; Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x; Mehler PS, 2009, INT J EAT DISORDER, V42, P195, DOI 10.1002/eat.20593; Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019; Mvula B, 2008, LASER MED SCI, V23, P277, DOI 10.1007/s10103-007-0479-1; Ninomiya T, 2003, J BONE MINER METAB, V21, P67, DOI 10.1007/s007740300011; Oliveira DAAP, 2008, PHOTOMED LASER SURG, V26, P401, DOI 10.1089/pho.2007.2101; Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9; Pietschmann P, 2009, GERONTOLOGY, V55, P3, DOI 10.1159/000166209; Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; Schindl A, 2003, BRIT J DERMATOL, V148, P334, DOI 10.1046/j.1365-2133.2003.05070.x; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Stein E, 2008, WIEN KLIN WOCHENSCHR, V120, P112, DOI 10.1007/s00508-008-0932-6; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Taniguchi D, 2009, LASER SURG MED, V41, P232, DOI 10.1002/lsm.20750; Totosy de Zepetnek JO, 2009, J REHABIL RES DEV, V46, P529, DOI 10.1682/JRRD.2008.09.0136; Tuby H, 2007, LASER SURG MED, V39, P373, DOI 10.1002/lsm.20492; Wang YH, 2009, MOL THER, V17, P302, DOI 10.1038/mt.2008.267; Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512; Xu M, 2009, PHOTOMED LASER SURG, V27, P309, DOI 10.1089/pho.2008.2283	41	76	80	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44027	10.1371/journal.pone.0044027	http://dx.doi.org/10.1371/journal.pone.0044027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	23029506	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600024
